Citrus Sinensis ID: 006968

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620---
Protein Sequence
MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHEKRYSDFIEESSLVIEAMELSGPR
Secondary Structure (PSIPRED)
cccccHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHccccccccccccccccccccccEEEEcccccEEEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccEEcccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEccccccccccccccccccccccccccHHHHHHHHcccccccEEEEccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEEcccccEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccEEEcccccEEEcccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccccEEEcccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHcccccccccccccccccccccccEEccccccEEEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEcccccHHccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHccccccccccccccccccEEcHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEcccccEEcccccccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccHHHHcccHccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHccccccccHHHcccccccccccccccccccccccccccEEEccccc
Coil and Loop (DISEMBL)
memksykfWRVGFLVLALIDICYatlspagiNYEVVALVAVKnnlhdpynvlenwditsvdpcswrmitcspdgyvsalglpsqslsgtlspwigNLTKLQSVLLQnnailgpipaslgkleklqtldlsnnkftgeipdslgdlgnlnylrlnnnsltgscpeslskiesLTLVDLsynnlsgslpkisartfkvtgnplicgpkatnnctavfpeplslppnglkdqsdsgtkSHRVAVALGASFGAAFFVIIVVGLLVWLRYRHNqqiffdvndqydpevslghlkryTFKELRAAtsnfsaknilgrggfGIVYKGCFSDGALVAVKRLKdyniaggevqfQTEVETISLAVHRNLLRLCgfcstenerllvypympngsvasrlrdhihgrpalDWARRKRIALGTARGLLylheqcdpkiiHRDVKAANILldedfeavvgdfglaklldhrdshvttavrgtvghiapeylstgqssektdvFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDlkgnfdriELEEMVQVALLCtqfnplhrpkmSEVLKMLEGDGLAEKWEASQkietpryrthekrysdfIEESSLVIEAMELSGPR
Flexible Loop (DISEMBL)
MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRaatsnfsakniLGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPeylstgqsseKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLhqegklsqmvdkDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKweasqkietpryrthekrysdfieesslVIEAMELSGPR
Low Complexity Region (SEG)
MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDlgnlnylrlnnnslTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHEKRYSDFIEESSLVIEAMELSGPR
Disordered region (IsUnstruct)
*****YKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFP*********************RVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE**********************************************
Disordered Region (DISOPRED)
******KFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKAT********************************VALGASFGAAFFVIIVVGLLVWLR*********************GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLK************TEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG**************************************MELS***
Disordered Region (DISEMBL)
MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPN**********KSHRVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHEKRYSDFIEESSLVIEAMELSGPR
Disordered Region (DISPRO)
**MKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPL***************KSHRVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEK**************************SLVIE**EL****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHEKRYSDFIEESSLVIEAMELSGPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	623	2.2.26 [Sep-21-2011]
Q93ZS4	632	Protein NSP-INTERACTING K	yes	no	0.988	0.974	0.766	0.0
Q8RY65	635	Protein NSP-INTERACTING K	no	no	0.955	0.937	0.663	0.0
Q9LFS4	638	Protein NSP-INTERACTING K	no	no	0.979	0.956	0.632	0.0
Q0WVM4	634	Probable LRR receptor-lik	no	no	0.980	0.963	0.590	0.0
Q8VYT3	648	Probable LRR receptor-lik	no	no	0.911	0.876	0.616	0.0
C0LGU5	614	Probable LRR receptor-lik	no	no	0.977	0.991	0.555	0.0
Q94AG2	625	Somatic embryogenesis rec	no	no	0.983	0.980	0.558	1e-177
Q9XIC7	628	Somatic embryogenesis rec	no	no	0.996	0.988	0.549	1e-176
Q94F62	615	BRASSINOSTEROID INSENSITI	no	no	0.961	0.973	0.548	1e-172
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.932	0.937	0.544	1e-168

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  945 bits (2442), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 490/639 (76%), Positives = 551/639 (86%), Gaps = 23/639 (3%)

Query: 1   MEMKSYKFWRVGFLVLA-LIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITS 59
           ME   +  WR+GFLV     DI  ATLSP G+NYEV ALVAVKN L+DPY VLENWD+ S
Sbjct: 1   MEGVRFVVWRLGFLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNS 60

Query: 60  VDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG 119
           VDPCSWRM++C+ DGYVS+L LPSQSLSGTLSP IGNLT LQSV+LQNNAI GPIP ++G
Sbjct: 61  VDPCSWRMVSCT-DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIG 119

Query: 120 KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSY 179
           +LEKLQ+LDLSNN FTGEIP SLG+L NLNYLRLNNNSL G+CPESLSKIE LTLVD+SY
Sbjct: 120 RLEKLQSLDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISY 179

Query: 180 NNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRV 239
           NNLSGSLPK+SARTFKV GN LICGPKA +NC+AV PEPL+LP +G  D+S + T  H V
Sbjct: 180 NNLSGSLPKVSARTFKVIGNALICGPKAVSNCSAV-PEPLTLPQDG-PDESGTRTNGHHV 237

Query: 240 AVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAA 299
           A+A  ASF AAFFV    G+ +W RYR N+QIFFDVN+QYDPEVSLGHLKRYTFKELR+A
Sbjct: 238 ALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSA 297

Query: 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           T++F++KNILGRGG+GIVYKG  +DG LVAVKRLKD NIAGGEVQFQTEVETISLA+HRN
Sbjct: 298 TNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRN 357

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           LLRL GFCS+  ER+LVYPYMPNGSVASRL+D+I G PALDW+RRK+IA+GTARGL+YLH
Sbjct: 358 LLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLH 417

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS
Sbjct: 418 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 477

Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
           TGQSSEKTDVFGFGILLLELITGQ+ALDFGR+A+Q+GVMLDWVKKLHQEGKL Q++DKDL
Sbjct: 478 TGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDL 537

Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQK--------- 590
              FDR+ELEE+VQVALLCTQFNP HRPKMSEV+KMLEGDGLAE+WEA+Q          
Sbjct: 538 NDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPP 597

Query: 591 ------IETPRYRTHEKRYSDFIEESSLVIEAMELSGPR 623
                   +PR R     YSD+I+ESSLV+EA+ELSGPR
Sbjct: 598 LPPGMVSSSPRVRY----YSDYIQESSLVVEAIELSGPR 632

Involved in defense response to geminivirus infection.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1

 Score =  818 bits (2113), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/609 (66%), Positives = 483/609 (79%), Gaps = 14/609 (2%)

Query: 24  ATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPS 83
           A L+  G+N+EVVAL+ +K++L DP+ VL NWD T+VDPCSW MITCS DG+V  L  PS
Sbjct: 32  AELTDKGVNFEVVALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITCS-DGFVIRLEAPS 90

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
           Q+LSGTLS  IGNLT LQ+VLLQNN I G IP  +GKL KL+TLDLS N FTG+IP +L 
Sbjct: 91  QNLSGTLSSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLS 150

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLIC 203
              NL YLR+NNNSLTG+ P SL+ +  LT +DLSYNNLSG +P+  A+TF V GN  IC
Sbjct: 151 YSKNLQYLRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNSQIC 210

Query: 204 GPKATNNCTAVFPEPLSLPPNGLKDQS-DSGTKSHRVAVALGASFGAAFFVIIVVGLLVW 262
                 +C    P+P+S+  N  +++S D GTK+ ++AV  G S      +II  G L+W
Sbjct: 211 PTGTEKDCNGTQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLW 270

Query: 263 LRYRHNQQI-FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGC 321
            R RHN+Q+ FFD+N+Q   E+ LG+L+R+ FKEL++ATSNFS+KN++G+GGFG VYKGC
Sbjct: 271 WRRRHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGC 330

Query: 322 FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381
             DG+++AVKRLKD N  GGEVQFQTE+E ISLAVHRNLLRL GFC+T +ERLLVYPYM 
Sbjct: 331 LHDGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMS 390

Query: 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED 441
           NGSVASRL+     +P LDW  RKRIALG  RGLLYLHEQCDPKIIHRDVKAANILLD+ 
Sbjct: 391 NGSVASRLK----AKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDY 446

Query: 442 FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           FEAVVGDFGLAKLLDH +SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT
Sbjct: 447 FEAVVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 506

Query: 502 GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQF 561
           G RAL+FG+AANQRG +LDWVKKL QE KL Q+VDKDLK N+DRIE+EEMVQVALLCTQ+
Sbjct: 507 GLRALEFGKAANQRGAILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQY 566

Query: 562 NPLHRPKMSEVLKMLEGDGLAEKWEA-SQKIET------PRYRTHEKRYSDFIEESSLVI 614
            P+HRPKMSEV++MLEGDGL EKWEA SQ+ ET      P   +  +RYSD  ++SS+++
Sbjct: 567 LPIHRPKMSEVVRMLEGDGLVEKWEASSQRAETNRSYSKPNEFSSSERYSDLTDDSSVLV 626

Query: 615 EAMELSGPR 623
           +AMELSGPR
Sbjct: 627 QAMELSGPR 635

Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1

 Score =  792 bits (2045), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 398/629 (63%), Positives = 489/629 (77%), Gaps = 19/629 (3%)

Query: 8   FWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRM 67
           F  +GFL L L    +  LSP G+N+EV AL+ +K +LHDP+ VL+NWD  +VDPCSW M
Sbjct: 16  FCFLGFLCL-LCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTM 74

Query: 68  ITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTL 127
           +TCS + +V  LG PSQ+LSGTLSP I NLT L+ VLLQNN I G IPA +G+L +L+TL
Sbjct: 75  VTCSSENFVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETL 134

Query: 128 DLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           DLS+N F GEIP S+G L +L YLRLNNNSL+G  P SLS +  L  +DLSYNNLSG +P
Sbjct: 135 DLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVP 194

Query: 188 KISARTFKVTGNPLIC--GPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGA 245
           + +A+TF + GNPLIC  G +   N T + P  ++L   G+   +  G+++H++A+A+G+
Sbjct: 195 RFAAKTFSIVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYA-GGSRNHKMAIAVGS 253

Query: 246 SFGAAFFVIIVVGLLVWLRYRHNQQIFFDVND-QYDPEVSLGHLKRYTFKELRAATSNFS 304
           S G    + I VGL +W R RHNQ  FFDV D  +  EVSLG+L+R+ F+EL+ AT+NFS
Sbjct: 254 SVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFS 313

Query: 305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +KN+LG+GG+G VYKG   D  +VAVKRLKD    GGE+QFQTEVE ISLAVHRNLLRL 
Sbjct: 314 SKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLY 373

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           GFC T+ E+LLVYPYM NGSVASR++     +P LDW+ RKRIA+G ARGL+YLHEQCDP
Sbjct: 374 GFCITQTEKLLVYPYMSNGSVASRMK----AKPVLDWSIRKRIAIGAARGLVYLHEQCDP 429

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           KIIHRDVKAANILLD+  EAVVGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEYLSTGQSS
Sbjct: 430 KIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 489

Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL--KGN 542
           EKTDVFGFGILLLEL+TGQRA +FG+AANQ+GVMLDWVKK+HQE KL  +VDK+L  K +
Sbjct: 490 EKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDKELLKKKS 549

Query: 543 FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQK---IETPRYRTH 599
           +D IEL+EMV+VALLCTQ+ P HRPKMSEV++MLEGDGLAEKWEASQ+   +     R +
Sbjct: 550 YDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRIN 609

Query: 600 E-----KRYSDFIEESSLVIEAMELSGPR 623
           E      RYSD  ++SSL+++AMELSGPR
Sbjct: 610 ELMSSSDRYSDLTDDSSLLVQAMELSGPR 638

Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1

 Score =  716 bits (1847), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 380/643 (59%), Positives = 458/643 (71%), Gaps = 32/643 (4%)

Query: 1   MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
           M++ + K + V  L+L     C  +LS    N EV AL+ +KN LHDP+ V +NWD  SV
Sbjct: 4   MKLITMKIFSV-LLLLCFFVTC--SLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSV 60

Query: 61  DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
           DPCSW MI+CS D  V  LG PSQSLSGTLS  IGNLT L+ V LQNN I G IP  +  
Sbjct: 61  DPCSWTMISCSSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICS 120

Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180
           L KLQTLDLSNN+F+GEIP S+  L NL YLRLNNNSL+G  P SLS+I  L+ +DLSYN
Sbjct: 121 LPKLQTLDLSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYN 180

Query: 181 NLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVA 240
           NL G +PK  ARTF V GNPLIC       C+      +S  P  +  +S SG +++ +A
Sbjct: 181 NLRGPVPKFPARTFNVAGNPLICKNSLPEICSG----SISASPLSVSLRSSSGRRTNILA 236

Query: 241 VALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVND-QYDPEVSLGHLKRYTFKELRAA 299
           VALG S G A  VI+ +G  +W R +  +     ++D Q +  + LG+L+ +TF+EL  A
Sbjct: 237 VALGVSLGFAVSVILSLGF-IWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVA 295

Query: 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           T  FS+K+ILG GGFG VY+G F DG +VAVKRLKD N   G  QF+TE+E ISLAVHRN
Sbjct: 296 TDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRN 355

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           LLRL G+C++ +ERLLVYPYM NGSVASRL+     +PALDW  RK+IA+G ARGL YLH
Sbjct: 356 LLRLIGYCASSSERLLVYPYMSNGSVASRLK----AKPALDWNTRKKIAIGAARGLFYLH 411

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           EQCDPKIIHRDVKAANILLDE FEAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLS
Sbjct: 412 EQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLS 471

Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
           TGQSSEKTDVFGFGILLLELITG RAL+FG++ +Q+G ML+WV+KLH+E K+ ++VD++L
Sbjct: 472 TGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDREL 531

Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIE-----TP 594
              +DRIE+ EM+QVALLCTQF P HRPKMSEV++MLEGDGLAE+W AS           
Sbjct: 532 GTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLAERWAASHDHSHFYHANM 591

Query: 595 RYRT-----------HEKRYSDFIEE---SSLVIEAMELSGPR 623
            YRT           H    S F +E    +L   AMELSGPR
Sbjct: 592 SYRTITSTDGNNQTKHLFGSSGFEDEDDNQALDSFAMELSGPR 634

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1

 Score =  700 bits (1807), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/579 (61%), Positives = 438/579 (75%), Gaps = 11/579 (1%)

Query: 14  LVLALIDICYATL--SPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCS 71
           L+ + + +C++TL  S    N EV AL++++NNLHDP+  L NWD  SVDPCSW MITCS
Sbjct: 15  LLYSFLFLCFSTLTLSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCS 74

Query: 72  PDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN 131
           PD  V  LG PSQSLSG LS  IGNLT L+ V LQNN I G IP  LG L KLQTLDLSN
Sbjct: 75  PDNLVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSN 134

Query: 132 NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA 191
           N+F+G+IP S+  L +L YLRLNNNSL+G  P SLS+I  L+ +DLSYNNLSG +PK  A
Sbjct: 135 NRFSGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPA 194

Query: 192 RTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAF 251
           RTF V GNPLIC       C+      ++  P  +   S SG +S+R+A+AL  S G+  
Sbjct: 195 RTFNVAGNPLICRSNPPEICSG----SINASPLSVSLSSSSGRRSNRLAIALSVSLGSVV 250

Query: 252 FVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVS-LGHLKRYTFKELRAATSNFSAKNILG 310
            +++ +G   W R +  + +  ++ND+ +  +  LG+L+ +TF+EL   T  FS+KNILG
Sbjct: 251 ILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILG 310

Query: 311 RGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE 370
            GGFG VY+G   DG +VAVKRLKD N   G+ QF+ E+E ISLAVH+NLLRL G+C+T 
Sbjct: 311 AGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATS 370

Query: 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRD 430
            ERLLVYPYMPNGSVAS+L+     +PALDW  RKRIA+G ARGLLYLHEQCDPKIIHRD
Sbjct: 371 GERLLVYPYMPNGSVASKLKS----KPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRD 426

Query: 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
           VKAANILLDE FEAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF
Sbjct: 427 VKAANILLDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 486

Query: 491 GFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEE 550
           GFGILLLELITG RAL+FG+  +Q+G ML+WV+KLH+E K+ +++D++L  N+D+IE+ E
Sbjct: 487 GFGILLLELITGLRALEFGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVGE 546

Query: 551 MVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQ 589
           M+QVALLCTQ+ P HRPKMSEV+ MLEGDGLAE+W AS 
Sbjct: 547 MLQVALLCTQYLPAHRPKMSEVVLMLEGDGLAERWAASH 585

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/628 (55%), Positives = 447/628 (71%), Gaps = 19/628 (3%)

Query: 1   MEMKSYKF-----WRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENW 55
           ME+   KF     W   + VL  +    + LSP G+NYEV AL++VKN + D   VL  W
Sbjct: 1   MEISLMKFLFLGIWVYYYSVLDSVSAMDSLLSPKGVNYEVAALMSVKNKMKDEKEVLSGW 60

Query: 56  DITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIP 115
           DI SVDPC+W M+ CS +G+V +L + S+ LSG LS  IG LT L ++LLQNN + GPIP
Sbjct: 61  DINSVDPCTWNMVGCSSEGFVVSLEMASKGLSGILSTSIGELTHLHTLLLQNNQLTGPIP 120

Query: 116 ASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLV 175
           + LG+L +L+TLDLS N+F+GEIP SLG L +LNYLRL+ N L+G  P  ++ +  L+ +
Sbjct: 121 SELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQVPHLVAGLSGLSFL 180

Query: 176 DLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTK 235
           DLS+NNLSG  P ISA+ +++ GN  +CGP +   C+   P        GL ++ +S   
Sbjct: 181 DLSFNNLSGPTPNISAKDYRIVGNAFLCGPASQELCSDATP---VRNATGLSEKDNSKHH 237

Query: 236 SHRVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKE 295
           S  ++ A G       F+I ++ L  W+ +  ++     V  Q D E  +GHLKR++F+E
Sbjct: 238 SLVLSFAFGI---VVAFIISLMFLFFWVLWHRSRLSRSHV--QQDYEFEIGHLKRFSFRE 292

Query: 296 LRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           ++ ATSNFS KNILG+GGFG+VYKG   +G +VAVKRLKD  I  GEVQFQTEVE I LA
Sbjct: 293 IQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKD-PIYTGEVQFQTEVEMIGLA 351

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
           VHRNLLRL GFC T  ER+LVYPYMPNGSVA RLRD+   +P+LDW RR  IALG ARGL
Sbjct: 352 VHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGAARGL 411

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
           +YLHEQC+PKIIHRDVKAANILLDE FEA+VGDFGLAKLLD RDSHVTTAVRGT+GHIAP
Sbjct: 412 VYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAP 471

Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV 535
           EYLSTGQSSEKTDVFGFG+L+LELITG + +D G    ++G++L WV+ L  E + ++MV
Sbjct: 472 EYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTLKAEKRFAEMV 531

Query: 536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPR 595
           D+DLKG FD + LEE+V++ALLCTQ +P  RP+MS+VLK+LE  GL E+ E   +   P 
Sbjct: 532 DRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVLE--GLVEQCEGGYEARAP- 588

Query: 596 YRTHEKRYSDFIEESSLVIEAMELSGPR 623
             +  + YS+  EE S +IEA+ELSGPR
Sbjct: 589 --SVSRNYSNGHEEQSFIIEAIELSGPR 614

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2

 Score =  623 bits (1606), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 346/620 (55%), Positives = 425/620 (68%), Gaps = 7/620 (1%)

Query: 11  VGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITC 70
           V F++L+LI +   +L  A  N E  AL  ++  L DP NVL++WD T V+PC+W  +TC
Sbjct: 6   VVFILLSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTC 65

Query: 71  SPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLS 130
           + +  V  + L +  LSG L P +G L  LQ + L +N I GPIP++LG L  L +LDL 
Sbjct: 66  NNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLY 125

Query: 131 NNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
            N F+G IP+SLG L  L +LRLNNNSLTGS P SL+ I +L ++DLS N LSGS+P   
Sbjct: 126 LNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNG 185

Query: 191 ARTF----KVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGAS 246
           + +         N  +CGP  ++ C    P     P       S         A+A G +
Sbjct: 186 SFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVA 245

Query: 247 FGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAK 306
            GAA           W R R    IFFDV  + DPEV LG LKR++ +EL+ A+  FS K
Sbjct: 246 AGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNK 305

Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           NILGRGGFG VYKG  +DG LVAVKRLK+    GGE+QFQTEVE IS+AVHRNLLRL GF
Sbjct: 306 NILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 365

Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           C T  ERLLVYPYM NGSVAS LR+    +P LDW  RKRIALG+ARGL YLH+ CDPKI
Sbjct: 366 CMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKI 425

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           IHRDVKAANILLDE+FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEK
Sbjct: 426 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 485

Query: 487 TDVFGFGILLLELITGQRALDFGRAANQRGVM-LDWVKKLHQEGKLSQMVDKDLKGNFDR 545
           TDVFG+GI+LLELITGQRA D  R AN   VM LDWVK L +E KL  +VD DL+ N++ 
Sbjct: 486 TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEE 545

Query: 546 IELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRT--HEKRY 603
            ELE+++QVALLCTQ +P+ RPKMSEV++MLEGDGLAEKW+  QK+E  R          
Sbjct: 546 RELEQVIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPN 605

Query: 604 SDFIEESSLVIEAMELSGPR 623
           SD+I +S+  + A+ELSGPR
Sbjct: 606 SDWILDSTYNLHAVELSGPR 625

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1

 Score =  619 bits (1596), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 345/628 (54%), Positives = 427/628 (67%), Gaps = 7/628 (1%)

Query: 3   MKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDP 62
           M   KF   GF+ L  + + + +L  A  N E  AL +++ NL DP NVL++WD T V+P
Sbjct: 1   MGRKKFEAFGFVCLISLLLLFNSLWLASSNMEGDALHSLRANLVDPNNVLQSWDPTLVNP 60

Query: 63  CSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLE 122
           C+W  +TC+ +  V  + L +  LSG L P +G L  LQ + L +N I GP+P+ LG L 
Sbjct: 61  CTWFHVTCNNENSVIRVDLGNADLSGQLVPQLGQLKNLQYLELYSNNITGPVPSDLGNLT 120

Query: 123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
            L +LDL  N FTG IPDSLG L  L +LRLNNNSLTG  P SL+ I +L ++DLS N L
Sbjct: 121 NLVSLDLYLNSFTGPIPDSLGKLFKLRFLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRL 180

Query: 183 SGSLPKISARTF----KVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHR 238
           SGS+P   + +         N  +CGP  +  C    P     P          G  S  
Sbjct: 181 SGSVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGSPPFSPPPPFIPPPIVPTPGGYSAT 240

Query: 239 VAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRA 298
            A+A G + GAA           W R R  Q+ FFDV  + DPEV LG LKR++ +EL+ 
Sbjct: 241 GAIAGGVAAGAALLFAAPALAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQV 300

Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
           AT +FS KNILGRGGFG VYKG  +DG LVAVKRLK+    GGE+QFQTEVE IS+AVHR
Sbjct: 301 ATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 360

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           NLLRL GFC T  ERLLVYPYM NGSVAS LR+    +  L W+ R++IALG+ARGL YL
Sbjct: 361 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYL 420

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           H+ CDPKIIHRDVKAANILLDE+FEAVVGDFGLA+L+D++D+HVTTAVRGT+GHIAPEYL
Sbjct: 421 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYL 480

Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM-LDWVKKLHQEGKLSQMVDK 537
           STG+SSEKTDVFG+GI+LLELITGQRA D  R AN   VM LDWVK L +E KL  +VD 
Sbjct: 481 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 540

Query: 538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYR 597
           DL+ N+   E+E+++QVALLCTQ +P+ RPKMSEV++MLEGDGLAEKW+  QK+E  R  
Sbjct: 541 DLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQE 600

Query: 598 THEKRY--SDFIEESSLVIEAMELSGPR 623
                +  SD+I +S+  + AMELSGPR
Sbjct: 601 VELSSHPTSDWILDSTDNLHAMELSGPR 628

Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  605 bits (1559), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 341/622 (54%), Positives = 422/622 (67%), Gaps = 23/622 (3%)

Query: 8   FWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRM 67
           FW +  LVL L+      L  +G N E  AL A+KN+L DP  VL++WD T V PC+W  
Sbjct: 11  FWLI--LVLDLV------LRVSG-NAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFH 61

Query: 68  ITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTL 127
           +TC+ D  V+ + L + +LSG L   +G L  LQ + L +N I G IP  LG L +L +L
Sbjct: 62  VTCNSDNSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSL 121

Query: 128 DLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           DL  N  +G IP +LG L  L +LRLNNNSL+G  P SL+ + +L ++DLS N L+G +P
Sbjct: 122 DLYLNNLSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIP 181

Query: 188 KISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASF 247
                   V G+  +  P +  N           PP      S +G+     A+A G + 
Sbjct: 182 --------VNGSFSLFTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAA 233

Query: 248 GAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKN 307
           GAA    +    L W R +  Q  FFDV  + DPEV LG LKR++ +EL+ A+ NFS KN
Sbjct: 234 GAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKN 293

Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           ILGRGGFG VYKG  +DG LVAVKRLK+    GGE+QFQTEVE IS+AVHRNLLRL GFC
Sbjct: 294 ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 353

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
            T  ERLLVYPYM NGSVAS LR+    +P LDW +R+RIALG+ARGL YLH+ CDPKII
Sbjct: 354 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 413

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRDVKAANILLDE+FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKT
Sbjct: 414 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 473

Query: 488 DVFGFGILLLELITGQRALDFGRAANQRGVM-LDWVKKLHQEGKLSQMVDKDLKGNFDRI 546
           DVFG+G++LLELITGQRA D  R AN   VM LDWVK L +E KL  +VD DL+GN+   
Sbjct: 474 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 533

Query: 547 ELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPR----YRTHEKR 602
           E+E+++QVALLCTQ +P+ RPKMSEV++MLEGDGLAE+WE  QK E  R    Y TH   
Sbjct: 534 EVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPTHHPA 593

Query: 603 YSDF-IEESSLVIEAMELSGPR 623
            S + I +S+  IE    SGPR
Sbjct: 594 VSGWIIGDSTSQIENEYPSGPR 615

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  593 bits (1528), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 328/602 (54%), Positives = 410/602 (68%), Gaps = 21/602 (3%)

Query: 32  NYEVVALVAVKNNLH--DPYN-VLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSG 88
           N E  AL  +KN+L   DP N VL++WD T V PC+W  +TC+P+  V+ + L +  LSG
Sbjct: 30  NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKLSG 89

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
            L P +G L  LQ + L +N I G IP  LG L +L +LDL  N  +G IP SLG LG L
Sbjct: 90  KLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKL 149

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKA- 207
            +LRLNNNSL+G  P +L+ ++ L ++D+S N LSG +P        V G+  +  P + 
Sbjct: 150 RFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIP--------VNGSFSLFTPISF 200

Query: 208 TNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWLRYRH 267
            NN     PEP     +        G  +  +A  + A   A  F +  +    WLR R 
Sbjct: 201 ANNSLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGA-ALLFAVPAIAFAWWLR-RK 258

Query: 268 NQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL 327
            Q  FFDV  + DPEV LG LKR+T +EL  AT NFS KN+LGRGGFG VYKG  +DG L
Sbjct: 259 PQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNL 318

Query: 328 VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVAS 387
           VAVKRLK+    GGE+QFQTEVE IS+AVHRNLLRL GFC T  ERLLVYPYM NGSVAS
Sbjct: 319 VAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 378

Query: 388 RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 447
            LR+   G PALDW +RK IALG+ARGL YLH+ CD KIIHRDVKAANILLDE+FEAVVG
Sbjct: 379 CLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVG 438

Query: 448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
           DFGLAKL+++ DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ+A D
Sbjct: 439 DFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFD 498

Query: 508 FGRAANQRGVM-LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHR 566
             R AN   +M LDWVK++ +E KL  +VD +L+G +   E+E+++Q+ALLCTQ + + R
Sbjct: 499 LARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMER 558

Query: 567 PKMSEVLKMLEGDGLAEKWEASQKIETP----RYRTHEKRYSDF-IEESSLVIEAMELSG 621
           PKMSEV++MLEGDGLAE+WE  QK E P     Y+ +    +D+ I  S+ +IE    SG
Sbjct: 559 PKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSG 618

Query: 622 PR 623
           PR
Sbjct: 619 PR 620

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	623
297739079	626	unnamed protein product [Vitis vinifera]	1.0	0.995	0.833	0.0
147833308	608	hypothetical protein VITISV_035381 [Viti	0.963	0.986	0.849	0.0
225425599	623	PREDICTED: protein NSP-INTERACTING KINAS	0.995	0.995	0.832	0.0
255568858	618	BRASSINOSTEROID INSENSITIVE 1-associated	0.985	0.993	0.850	0.0
224102457	625	predicted protein [Populus trichocarpa]	0.991	0.988	0.849	0.0
224110926	605	predicted protein [Populus trichocarpa]	0.963	0.991	0.869	0.0
449450444	621	PREDICTED: protein NSP-INTERACTING KINAS	0.956	0.959	0.839	0.0
356501661	624	PREDICTED: protein NSP-INTERACTING KINAS	0.991	0.990	0.837	0.0
357485807	625	Leucine-rich repeat receptor-like kinase	0.969	0.966	0.830	0.0
356497611	623	PREDICTED: protein NSP-INTERACTING KINAS	0.969	0.969	0.843	0.0

>gi|297739079|emb|CBI28568.3| unnamed protein product [Vitis vinifera]

 Score = 1078 bits (2787), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 522/626 (83%), Positives = 570/626 (91%), Gaps = 3/626 (0%)

Query: 1   MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
           ME + Y  W VG L+L L++   ATLSP+GINYEVVAL+ +KNNL+DPYNVLENWDI SV
Sbjct: 1   MESRGYVLWGVGLLLLTLMEGSSATLSPSGINYEVVALMTIKNNLNDPYNVLENWDINSV 60

Query: 61  DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
           DPCSWRM+TCS DGYVSALGLPSQSLSGTLSPWIGNLT LQSVLLQNNAI GPIP S+GK
Sbjct: 61  DPCSWRMVTCSSDGYVSALGLPSQSLSGTLSPWIGNLTNLQSVLLQNNAISGPIPDSIGK 120

Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180
           LEKL+TLDLS+NKF G IP SLG L  LNYLRLNNNSLTG CPESLS++E L+LVDLS+N
Sbjct: 121 LEKLETLDLSHNKFDGGIPSSLGGLKKLNYLRLNNNSLTGPCPESLSQVEGLSLVDLSFN 180

Query: 181 NLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVA 240
           NLSGS+PKISARTFK+ GNP +CG  ATNNC+A+ PEPLS PP+ L+  SDSG+KSHRVA
Sbjct: 181 NLSGSMPKISARTFKIIGNPSLCGANATNNCSAISPEPLSFPPDALRAHSDSGSKSHRVA 240

Query: 241 VALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAAT 300
           +A GASFGAA  +II+VGL VW RYR NQQIFFDVNDQYDPEV LGHL+RYTFKELRAAT
Sbjct: 241 IAFGASFGAALLIIIIVGLSVWWRYRRNQQIFFDVNDQYDPEVRLGHLRRYTFKELRAAT 300

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
            +F+ KNILGRGGFGIVYKGC +D  LVAVKRLKDYN  GGE+QFQTEVE ISLAVHRNL
Sbjct: 301 DHFNPKNILGRGGFGIVYKGCLNDRTLVAVKRLKDYNAVGGEIQFQTEVEMISLAVHRNL 360

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           LRLCGFC+TE+ERLLVYPYMPNGSVASRLRD IHGRPALDW+RRKRIALGTARGLLYLHE
Sbjct: 361 LRLCGFCTTESERLLVYPYMPNGSVASRLRDQIHGRPALDWSRRKRIALGTARGLLYLHE 420

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
           QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR+SHVTTAVRGTVGHIAPEYLST
Sbjct: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRESHVTTAVRGTVGHIAPEYLST 480

Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK 540
           GQSSEKTDVFGFGILLLELITGQ+ALDFGRAANQ+GVMLDWVKKLHQEGKL+ MVDKDLK
Sbjct: 481 GQSSEKTDVFGFGILLLELITGQKALDFGRAANQKGVMLDWVKKLHQEGKLNLMVDKDLK 540

Query: 541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHE 600
            NFDR+ELEEMV+VALLCTQFNP HRPKMSE+L+MLEGDGLAEKWEASQK+ETPR+R+ E
Sbjct: 541 NNFDRVELEEMVKVALLCTQFNPSHRPKMSEILRMLEGDGLAEKWEASQKVETPRFRSCE 600

Query: 601 ---KRYSDFIEESSLVIEAMELSGPR 623
              +RYSD+IEESSLVIEAMELSGPR
Sbjct: 601 NPPQRYSDYIEESSLVIEAMELSGPR 626

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147833308|emb|CAN75190.1| hypothetical protein VITISV_035381 [Vitis vinifera]

 Score = 1075 bits (2781), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 512/603 (84%), Positives = 556/603 (92%), Gaps = 3/603 (0%)

Query: 24  ATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPS 83
           ATLSP+GINYEVVAL+ +KNNL+DPYNVLENWDI SVDPCSWRM+TCS DGYVSALGLPS
Sbjct: 6   ATLSPSGINYEVVALMTIKNNLNDPYNVLENWDINSVDPCSWRMVTCSSDGYVSALGLPS 65

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
           QSLSGTLSPWIGNLT LQSVLLQNNAI GPIP S+GKLEKL+TLDLS+NKF G IP SLG
Sbjct: 66  QSLSGTLSPWIGNLTNLQSVLLQNNAISGPIPDSIGKLEKLETLDLSHNKFDGGIPSSLG 125

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLIC 203
            L  LNYLRLNNNSLTG CPESLS++E L+LVDLS+NNLSGS+PKISARTFK+ GNP +C
Sbjct: 126 GLKKLNYLRLNNNSLTGPCPESLSQVEGLSLVDLSFNNLSGSMPKISARTFKIIGNPSLC 185

Query: 204 GPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWL 263
           G  ATNNC+A+ PEPLS PP+ L+  SDSG+KSHRVA+A GASFGAA  +I +VGL VW 
Sbjct: 186 GANATNNCSAISPEPLSFPPDALRAHSDSGSKSHRVAIAFGASFGAALLIIXIVGLSVWW 245

Query: 264 RYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS 323
           RYR NQQIFFDVNDQYDPEV LGHL+RYTFKELRAAT +F+ KNILGRGGFGIVYKGC +
Sbjct: 246 RYRRNQQIFFDVNDQYDPEVRLGHLRRYTFKELRAATDHFNPKNILGRGGFGIVYKGCLN 305

Query: 324 DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383
           D  LVAVKRLKDYN  GGE+QFQTEVE ISLAVHRNLLRLCGFC+TE+ERLLVYPYMPNG
Sbjct: 306 DRTLVAVKRLKDYNAVGGEIQFQTEVEMISLAVHRNLLRLCGFCTTESERLLVYPYMPNG 365

Query: 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443
           SVASRLRD IHGRPALDW+RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE
Sbjct: 366 SVASRLRDQIHGRPALDWSRRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 425

Query: 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           AVVGDFGLAKLLDHR+SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ
Sbjct: 426 AVVGDFGLAKLLDHRESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 485

Query: 504 RALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNP 563
           +ALDFGRAANQ+GVMLDWVKKLHQEGKL+ MVDKDLK NFDR+ELEEMV+VALLCTQFNP
Sbjct: 486 KALDFGRAANQKGVMLDWVKKLHQEGKLNLMVDKDLKNNFDRVELEEMVKVALLCTQFNP 545

Query: 564 LHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHE---KRYSDFIEESSLVIEAMELS 620
            HRPKMSE+L+MLEGDGLAEKWEASQK+ETPR+R+ E   +RYSD+IEESSLVIEAMELS
Sbjct: 546 SHRPKMSEILRMLEGDGLAEKWEASQKVETPRFRSCENPPQRYSDYIEESSLVIEAMELS 605

Query: 621 GPR 623
           GPR
Sbjct: 606 GPR 608

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225425599|ref|XP_002263138.1| PREDICTED: protein NSP-INTERACTING KINASE 3-like [Vitis vinifera]

 Score = 1071 bits (2769), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 521/626 (83%), Positives = 569/626 (90%), Gaps = 6/626 (0%)

Query: 1   MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
           ME + Y  W VG L+L L++   ATLSP+GINYEVVAL+ +KNNL+DPYNVLENWDI SV
Sbjct: 1   MESRGYVLWGVGLLLLTLMEGSSATLSPSGINYEVVALMTIKNNLNDPYNVLENWDINSV 60

Query: 61  DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
           DPCSWRM+TCS DGYVSALGLPSQSLSGTLSPWIGNLT LQSVLLQNNAI GPIP S+GK
Sbjct: 61  DPCSWRMVTCSSDGYVSALGLPSQSLSGTLSPWIGNLTNLQSVLLQNNAISGPIPDSIGK 120

Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180
           LEKL+TLDLS+NKF G IP SLG L  LNYLRLNNNSLTG CPESLS++E L+LVDLS+N
Sbjct: 121 LEKLETLDLSHNKFDGGIPSSLGGLKKLNYLRLNNNSLTGPCPESLSQVEGLSLVDLSFN 180

Query: 181 NLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVA 240
           NLSGS+PKISARTFK+ GNP +CG  ATNNC+A+ PEPLS PP+ L+D   SG+KSHRVA
Sbjct: 181 NLSGSMPKISARTFKIIGNPSLCGANATNNCSAISPEPLSFPPDALRD---SGSKSHRVA 237

Query: 241 VALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAAT 300
           +A GASFGAA  +II+VGL VW RYR NQQIFFDVNDQYDPEV LGHL+RYTFKELRAAT
Sbjct: 238 IAFGASFGAALLIIIIVGLSVWWRYRRNQQIFFDVNDQYDPEVRLGHLRRYTFKELRAAT 297

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
            +F+ KNILGRGGFGIVYKGC +D  LVAVKRLKDYN  GGE+QFQTEVE ISLAVHRNL
Sbjct: 298 DHFNPKNILGRGGFGIVYKGCLNDRTLVAVKRLKDYNAVGGEIQFQTEVEMISLAVHRNL 357

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           LRLCGFC+TE+ERLLVYPYMPNGSVASRLRD IHGRPALDW+RRKRIALGTARGLLYLHE
Sbjct: 358 LRLCGFCTTESERLLVYPYMPNGSVASRLRDQIHGRPALDWSRRKRIALGTARGLLYLHE 417

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
           QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR+SHVTTAVRGTVGHIAPEYLST
Sbjct: 418 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRESHVTTAVRGTVGHIAPEYLST 477

Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK 540
           GQSSEKTDVFGFGILLLELITGQ+ALDFGRAANQ+GVMLDWVKKLHQEGKL+ MVDKDLK
Sbjct: 478 GQSSEKTDVFGFGILLLELITGQKALDFGRAANQKGVMLDWVKKLHQEGKLNLMVDKDLK 537

Query: 541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHE 600
            NFDR+ELEEMV+VALLCTQFNP HRPKMSE+L+MLEGDGLAEKWEASQK+ETPR+R+ E
Sbjct: 538 NNFDRVELEEMVKVALLCTQFNPSHRPKMSEILRMLEGDGLAEKWEASQKVETPRFRSCE 597

Query: 601 ---KRYSDFIEESSLVIEAMELSGPR 623
              +RYSD+IEESSLVIEAMELSGPR
Sbjct: 598 NPPQRYSDYIEESSLVIEAMELSGPR 623

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255568858|ref|XP_002525400.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223535363|gb|EEF37038.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score = 1068 bits (2761), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 529/622 (85%), Positives = 571/622 (91%), Gaps = 8/622 (1%)

Query: 5   SYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCS 64
           S+  WRVG LVL L++I  ATLSP      VVAL  +K+ LHDPYNVLE+WD  SVDPCS
Sbjct: 2   SFWLWRVGLLVLTLVEISSATLSPT-----VVALANIKSALHDPYNVLESWDANSVDPCS 56

Query: 65  WRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL 124
           WRM+TCSPDGYV+ALGLPSQSLSGTLS  IGNLT LQSVLLQNNAI GPIP ++G+LEKL
Sbjct: 57  WRMVTCSPDGYVTALGLPSQSLSGTLSSGIGNLTNLQSVLLQNNAISGPIPFAIGRLEKL 116

Query: 125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
           QTLDLSNN F+G+IP SLGDL NLNYLRLNNNSLTGSCPESLS IE LTLVDLS+NNLSG
Sbjct: 117 QTLDLSNNSFSGDIPASLGDLKNLNYLRLNNNSLTGSCPESLSNIEGLTLVDLSFNNLSG 176

Query: 185 SLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALG 244
           SLPKISARTFKV GNPLICGPKA NNC+AV PEPLSLPP+GLK QSDSG   HR+A+A G
Sbjct: 177 SLPKISARTFKVVGNPLICGPKANNNCSAVLPEPLSLPPDGLKGQSDSGHSGHRIAIAFG 236

Query: 245 ASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFS 304
           ASFGAAF VII++GLLVW RYR NQQIFFDVN+QYD +V LGHL+RYTFKELRAAT +F+
Sbjct: 237 ASFGAAFSVIIMIGLLVWWRYRRNQQIFFDVNEQYDRDVCLGHLRRYTFKELRAATDHFN 296

Query: 305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +KNILGRGGFGIVY+GC +DG +VAVKRLKDYN AGGE+QFQTEVETISLAVH+NLLRL 
Sbjct: 297 SKNILGRGGFGIVYRGCLTDGTVVAVKRLKDYNAAGGEIQFQTEVETISLAVHKNLLRLS 356

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           GFC+TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK+IALGTARGLLYLHEQCDP
Sbjct: 357 GFCTTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKKIALGTARGLLYLHEQCDP 416

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS
Sbjct: 417 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 476

Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD 544
           EKTDVFGFGILLLELITGQ+ALDFGRAANQ+GVMLDWVKKLHQEGKL+ +VDKDLKGNFD
Sbjct: 477 EKTDVFGFGILLLELITGQKALDFGRAANQKGVMLDWVKKLHQEGKLNLLVDKDLKGNFD 536

Query: 545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYR---THEK 601
           R+ELEEMVQVALLCTQFNP HRPKMSEVLKMLEGDGLAEKWEASQKIETPR+R   +H +
Sbjct: 537 RVELEEMVQVALLCTQFNPSHRPKMSEVLKMLEGDGLAEKWEASQKIETPRFRSCESHPQ 596

Query: 602 RYSDFIEESSLVIEAMELSGPR 623
           RYSDFIEESSLV+EAMELSGPR
Sbjct: 597 RYSDFIEESSLVVEAMELSGPR 618

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224102457|ref|XP_002312685.1| predicted protein [Populus trichocarpa] gi|222852505|gb|EEE90052.1| predicted protein [Populus trichocarpa]

 Score = 1066 bits (2756), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 529/623 (84%), Positives = 574/623 (92%), Gaps = 5/623 (0%)

Query: 4   KSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPC 63
           +S+ F  V FLVLAL++I  ATLSP GIN+E  ALVA+K  L DPYNVLENWDI SVDPC
Sbjct: 5   RSFGFCTVVFLVLALMEISSATLSPTGINFE--ALVAIKTALLDPYNVLENWDINSVDPC 62

Query: 64  SWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEK 123
           SWRM+TCSPDGYVSALGLPSQSLSGTLSP IGNLT LQSVLLQNNAI GPIP ++GKLEK
Sbjct: 63  SWRMVTCSPDGYVSALGLPSQSLSGTLSPSIGNLTNLQSVLLQNNAISGPIPVAIGKLEK 122

Query: 124 LQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           LQTLDLSNN F+G++P SLGDL NLNYLRLNNNSLTG CPESLS ++ LTLVDLS+NNLS
Sbjct: 123 LQTLDLSNNTFSGDMPTSLGDLKNLNYLRLNNNSLTGPCPESLSNLKGLTLVDLSFNNLS 182

Query: 184 GSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVAL 243
           GSLPKISARTFKVTGNPLICGPKA+N+C+AVFPEPLSLPP+GL  QS SGT  HRVA+A 
Sbjct: 183 GSLPKISARTFKVTGNPLICGPKASNSCSAVFPEPLSLPPDGLNGQSSSGTNGHRVAIAF 242

Query: 244 GASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNF 303
           GASFGAAF  IIV+GLLVW RYRHNQQIFFDVN+QYDPEV LGH++RYTFKELR AT +F
Sbjct: 243 GASFGAAFSTIIVIGLLVWWRYRHNQQIFFDVNEQYDPEVCLGHVRRYTFKELRTATDHF 302

Query: 304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           S+KNILG GGFGIVYKG  +DG +VAVKRLKD+N+AGGE+QFQTEVETISLAVHRNLLRL
Sbjct: 303 SSKNILGTGGFGIVYKGWLNDGTVVAVKRLKDFNVAGGEIQFQTEVETISLAVHRNLLRL 362

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
            GFC+TENERLLVYPYMPNGSVAS+LRDHIH RPALDWARRKRIALGTARGLLYLHEQCD
Sbjct: 363 SGFCTTENERLLVYPYMPNGSVASQLRDHIHDRPALDWARRKRIALGTARGLLYLHEQCD 422

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
           PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI+PEYLSTGQS
Sbjct: 423 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHISPEYLSTGQS 482

Query: 484 SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNF 543
           SEKTDVFGFGILLLELITGQ+ALDFGRAANQ+GVMLDWVKKLHQ+ KL+ MVDKDL+G F
Sbjct: 483 SEKTDVFGFGILLLELITGQKALDFGRAANQKGVMLDWVKKLHQDRKLNLMVDKDLRGKF 542

Query: 544 DRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHE--- 600
           DRIELEEMVQVALLCTQFNP HRPKMSEVLKMLEGDGLAEKWEASQK+ETPR+R+ E   
Sbjct: 543 DRIELEEMVQVALLCTQFNPSHRPKMSEVLKMLEGDGLAEKWEASQKVETPRFRSCENPP 602

Query: 601 KRYSDFIEESSLVIEAMELSGPR 623
           ++YSDFIEESSLV+EAMELSGPR
Sbjct: 603 QKYSDFIEESSLVVEAMELSGPR 625

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224110926|ref|XP_002315684.1| predicted protein [Populus trichocarpa] gi|222864724|gb|EEF01855.1| predicted protein [Populus trichocarpa]

 Score = 1058 bits (2735), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 525/604 (86%), Positives = 566/604 (93%), Gaps = 4/604 (0%)

Query: 24  ATLSPAGINYE-VVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLP 82
           ATLSPAGINYE VVALVA+K  L DPYNVL+NWDI SVDPCSWRM+TC+PDGYV ALGLP
Sbjct: 2   ATLSPAGINYEAVVALVAIKTALRDPYNVLDNWDINSVDPCSWRMVTCTPDGYVLALGLP 61

Query: 83  SQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
           SQSLSGTLSP IGNLT LQSVLLQNNAI GPIPA++GKLEKL TLDLSNN F+GE+P SL
Sbjct: 62  SQSLSGTLSPSIGNLTNLQSVLLQNNAISGPIPAAIGKLEKLLTLDLSNNTFSGEMPTSL 121

Query: 143 GDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLI 202
           G+L NLNYLRLNNNSLTG CPESLSK+  LTLVDLS+NNLSGSLPKISARTFKVTGNPLI
Sbjct: 122 GNLKNLNYLRLNNNSLTGPCPESLSKLNGLTLVDLSFNNLSGSLPKISARTFKVTGNPLI 181

Query: 203 CGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVW 262
           CGPKA++NC+AVFPEPLSLPPNGL  QSDS T SHRVA+A GASFGAAF +II++GLLVW
Sbjct: 182 CGPKASDNCSAVFPEPLSLPPNGLNCQSDSRTNSHRVAIAFGASFGAAFSIIIIIGLLVW 241

Query: 263 LRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF 322
            R RHNQQIFFDVN+QYDPEV LGHL+RYTFKELR+AT +FS+KNILGRGGFGIVYKGC 
Sbjct: 242 WRCRHNQQIFFDVNEQYDPEVCLGHLRRYTFKELRSATDHFSSKNILGRGGFGIVYKGCL 301

Query: 323 SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382
           +DG LVAVKRLKDY+IAGGE+QFQTEVETISLA+HRNLLRL GFC+TENERLLVYPYMPN
Sbjct: 302 NDGTLVAVKRLKDYDIAGGEIQFQTEVETISLAIHRNLLRLSGFCTTENERLLVYPYMPN 361

Query: 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442
           GSVAS+LRDHIHGR ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF
Sbjct: 362 GSVASQLRDHIHGRAALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 421

Query: 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL+TG
Sbjct: 422 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTG 481

Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
           Q+ALDFGRAANQ+GVMLDWVKKLH E KL+ MVDKDL+GNFDRIELEEMVQVALLCTQFN
Sbjct: 482 QKALDFGRAANQKGVMLDWVKKLHHERKLNLMVDKDLRGNFDRIELEEMVQVALLCTQFN 541

Query: 563 PLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHE---KRYSDFIEESSLVIEAMEL 619
           P HRPKMSEVLKMLEGDGLAEKWEASQ++ETPR+R+ E   +RYSD+IEESSLV+EAMEL
Sbjct: 542 PSHRPKMSEVLKMLEGDGLAEKWEASQRVETPRFRSCENPPQRYSDYIEESSLVVEAMEL 601

Query: 620 SGPR 623
           SGPR
Sbjct: 602 SGPR 605

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449450444|ref|XP_004142972.1| PREDICTED: protein NSP-INTERACTING KINASE 3-like [Cucumis sativus]

 Score = 1047 bits (2707), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 506/603 (83%), Positives = 550/603 (91%), Gaps = 7/603 (1%)

Query: 24  ATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPS 83
           ATLSP+G+N+EVVAL+A+K +L DP+NVLENWD  SVDPCSWRM+TCSPDGYVS LGLPS
Sbjct: 23  ATLSPSGVNFEVVALMAIKYDLLDPHNVLENWDSNSVDPCSWRMVTCSPDGYVSVLGLPS 82

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
           QSLSG LSP IGNLTKL+SVLLQNN I GPIPA++GKLE LQTLDLSNN F+G+IP SLG
Sbjct: 83  QSLSGVLSPGIGNLTKLESVLLQNNDISGPIPATIGKLENLQTLDLSNNLFSGQIPSSLG 142

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLIC 203
           DL  LNYLRLNNNSLTG CPESLSK+E LTLVDLSYNNLSGSLPKISARTFK+ GNPLIC
Sbjct: 143 DLKKLNYLRLNNNSLTGPCPESLSKVEGLTLVDLSYNNLSGSLPKISARTFKIVGNPLIC 202

Query: 204 GPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWL 263
           GP   NNC+A+FPEPLS  P+ L++    G KSHR A+A GASF AAF V++++GLLVW 
Sbjct: 203 GP---NNCSAIFPEPLSFAPDALEENLGFG-KSHRKAIAFGASFSAAFIVLVLIGLLVWW 258

Query: 264 RYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS 323
           RYRHNQQIFFDVNDQYDPEV LGHL+RYTFKELRAAT +F+ KNILGRGGFGIVYKGC +
Sbjct: 259 RYRHNQQIFFDVNDQYDPEVRLGHLRRYTFKELRAATDHFNPKNILGRGGFGIVYKGCLN 318

Query: 324 DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383
           DG+LVAVKRLKDYN AGGE+QFQTEVE ISLAVHRNLL+L GFCSTE+ERLLVYP+MPNG
Sbjct: 319 DGSLVAVKRLKDYNTAGGEIQFQTEVEMISLAVHRNLLKLFGFCSTESERLLVYPFMPNG 378

Query: 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443
           SV SRLRD IHG+PALDWA RKRIALGTARGL+YLHEQCDPKIIHRDVKAANILLDEDFE
Sbjct: 379 SVGSRLRDRIHGQPALDWAMRKRIALGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFE 438

Query: 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ
Sbjct: 439 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498

Query: 504 RALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNP 563
           +ALDFGR ANQ+GVMLDWVKKLHQEGKL+ MVDKDLKGNFDR+ELEEMVQVALLCTQFNP
Sbjct: 499 KALDFGRGANQKGVMLDWVKKLHQEGKLNMMVDKDLKGNFDRVELEEMVQVALLCTQFNP 558

Query: 564 LHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHE---KRYSDFIEESSLVIEAMELS 620
            HRPKMSEVLKMLEGDGLAEKWEASQ IETPR R  E   +RYSD+IEESSL++EAMELS
Sbjct: 559 SHRPKMSEVLKMLEGDGLAEKWEASQHIETPRCRPCENPPQRYSDYIEESSLIVEAMELS 618

Query: 621 GPR 623
           GPR
Sbjct: 619 GPR 621

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356501661|ref|XP_003519642.1| PREDICTED: protein NSP-INTERACTING KINASE 3-like isoform 1 [Glycine max]

 Score = 1041 bits (2691), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 519/620 (83%), Positives = 567/620 (91%), Gaps = 2/620 (0%)

Query: 5   SYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCS 64
           S  FW +G L+L L++I  A LSP+GINYEVVAL+A+KN+L DP+NVLENWDI SVDPCS
Sbjct: 6   SLVFWLLGLLLLLLMEISSAALSPSGINYEVVALMAIKNDLIDPHNVLENWDINSVDPCS 65

Query: 65  WRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL 124
           WRMITCSPDG VSALGLPSQ+LSGTLSP IGNLT LQSVLLQNNAI G IPA++G LEKL
Sbjct: 66  WRMITCSPDGSVSALGLPSQNLSGTLSPGIGNLTNLQSVLLQNNAISGRIPAAIGSLEKL 125

Query: 125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
           QTLDLSNN F+GEIP SLG L NLNYLRLNNNSLTGSCP+SLS IE LTLVDLSYNNLSG
Sbjct: 126 QTLDLSNNTFSGEIPSSLGGLKNLNYLRLNNNSLTGSCPQSLSNIEGLTLVDLSYNNLSG 185

Query: 185 SLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALG 244
           SLP+ISART K+ GN LICGPKA NNC+ + PEPLS PP+ L+ QSDSG KSH VA+A G
Sbjct: 186 SLPRISARTLKIVGNSLICGPKA-NNCSTILPEPLSFPPDALRGQSDSGKKSHHVALAFG 244

Query: 245 ASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFS 304
           ASFGAAF ++I+VG LVW RYR NQQIFFDVN+ YDPEV LGHLKR++FKELRAAT +F+
Sbjct: 245 ASFGAAFVLVIIVGFLVWWRYRRNQQIFFDVNEHYDPEVRLGHLKRFSFKELRAATDHFN 304

Query: 305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +KNILGRGGFGIVYK C +DG++VAVKRLKDYN AGGE+QFQTEVETISLAVHRNLLRL 
Sbjct: 305 SKNILGRGGFGIVYKACLNDGSVVAVKRLKDYNAAGGEIQFQTEVETISLAVHRNLLRLS 364

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           GFCST++ERLLVYPYM NGSVASRL+DHIHGRPALDW RRKRIALGTARGL+YLHEQCDP
Sbjct: 365 GFCSTQHERLLVYPYMSNGSVASRLKDHIHGRPALDWTRRKRIALGTARGLVYLHEQCDP 424

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS
Sbjct: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484

Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD 544
           EKTDVFGFGILLLELITG +ALDFGRAANQ+GVMLDWVKKLHQ+G+LSQMVDKDLKGNFD
Sbjct: 485 EKTDVFGFGILLLELITGHKALDFGRAANQKGVMLDWVKKLHQDGRLSQMVDKDLKGNFD 544

Query: 545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHE-KRY 603
            IELEEMVQVALLCTQFNP HRPKMSEVLKMLEGDGLAE+WEASQ+IETPR+R+ E +RY
Sbjct: 545 LIELEEMVQVALLCTQFNPSHRPKMSEVLKMLEGDGLAERWEASQRIETPRFRSCEPQRY 604

Query: 604 SDFIEESSLVIEAMELSGPR 623
           SD IEESSLV+EAMELSGPR
Sbjct: 605 SDLIEESSLVVEAMELSGPR 624

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357485807|ref|XP_003613191.1| Leucine-rich repeat receptor-like kinase [Medicago truncatula] gi|308154498|gb|ADO15296.1| somatic embryogenesis receptor kinase-like protein 2 [Medicago truncatula] gi|355514526|gb|AES96149.1| Leucine-rich repeat receptor-like kinase [Medicago truncatula]

 Score = 1037 bits (2681), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 505/608 (83%), Positives = 555/608 (91%), Gaps = 4/608 (0%)

Query: 19  IDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSA 78
           + +  A LSP+GINYEVVAL+A+KN+L+DP+NVLENWDI  VDPCSWRMITC+PDG VSA
Sbjct: 19  MKVSSAALSPSGINYEVVALMAIKNDLNDPHNVLENWDINYVDPCSWRMITCTPDGSVSA 78

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           LG PSQ+LSGTLSP IGNLT LQSVLLQNNAI G IPA++G LEKLQTLDLSNN+F+GEI
Sbjct: 79  LGFPSQNLSGTLSPRIGNLTNLQSVLLQNNAISGHIPAAIGSLEKLQTLDLSNNEFSGEI 138

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTG 198
           P SLG L NLNYLR+NNNSLTG+CP+SLS IESLTLVDLSYNNLSGSLP+I ART K+ G
Sbjct: 139 PSSLGGLKNLNYLRINNNSLTGACPQSLSNIESLTLVDLSYNNLSGSLPRIQARTLKIVG 198

Query: 199 NPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVG 258
           NPLICGPK  NNC+ V PEPLS PP+ LK + DSG K H VA+A GASFGAAF V+I+VG
Sbjct: 199 NPLICGPK-ENNCSTVLPEPLSFPPDALKAKPDSGKKGHHVALAFGASFGAAFVVVIIVG 257

Query: 259 LLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVY 318
           LLVW RYRHNQQIFFD+++ YDPEV LGHLKRY+FKELRAAT +F++KNILGRGGFGIVY
Sbjct: 258 LLVWWRYRHNQQIFFDISEHYDPEVRLGHLKRYSFKELRAATDHFNSKNILGRGGFGIVY 317

Query: 319 KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378
           K C +DG++VAVKRLKDYN AGGE+QFQTEVETISLAVHRNLLRL GFCST+NERLLVYP
Sbjct: 318 KACLNDGSVVAVKRLKDYNAAGGEIQFQTEVETISLAVHRNLLRLRGFCSTQNERLLVYP 377

Query: 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438
           YM NGSVASRL+DHIHGRPALDW RRKRIALGTARGL+YLHEQCDPKIIHRDVKAANILL
Sbjct: 378 YMSNGSVASRLKDHIHGRPALDWTRRKRIALGTARGLVYLHEQCDPKIIHRDVKAANILL 437

Query: 439 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 498
           DEDFEAVVGDFGLAKLLDHRD+HVTTAVRGT+GHIAPEYLSTGQSSEKTDVFG+GILLLE
Sbjct: 438 DEDFEAVVGDFGLAKLLDHRDTHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGYGILLLE 497

Query: 499 LITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLC 558
           LITG +ALDFGRAANQ+GVMLDWVKKLH EGKLSQMVDKDLKGNFD +EL EMVQVALLC
Sbjct: 498 LITGHKALDFGRAANQKGVMLDWVKKLHLEGKLSQMVDKDLKGNFDIVELGEMVQVALLC 557

Query: 559 TQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHE---KRYSDFIEESSLVIE 615
           TQFNP HRPKMSEVLKMLEGDGLAEKWEASQ+IETPR+R  E   +RYSDFIEESSL++E
Sbjct: 558 TQFNPSHRPKMSEVLKMLEGDGLAEKWEASQRIETPRFRFCENPPQRYSDFIEESSLIVE 617

Query: 616 AMELSGPR 623
           AMELSGPR
Sbjct: 618 AMELSGPR 625

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356497611|ref|XP_003517653.1| PREDICTED: protein NSP-INTERACTING KINASE 3-like [Glycine max]

 Score = 1036 bits (2679), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 511/606 (84%), Positives = 557/606 (91%), Gaps = 2/606 (0%)

Query: 19  IDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSA 78
           ++I  A LSP+GINYEVVAL+A+KN L DP+NVLENWDI SVDPCSWRMITCSPDG VS 
Sbjct: 19  MEISSAALSPSGINYEVVALMAIKNGLIDPHNVLENWDINSVDPCSWRMITCSPDGSVSV 78

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           LGLPSQ+LSGTLSP IGNLT LQSVLLQNNAI G IPA++G LEKLQTLD+SNN F+GEI
Sbjct: 79  LGLPSQNLSGTLSPGIGNLTNLQSVLLQNNAISGRIPAAIGSLEKLQTLDISNNAFSGEI 138

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTG 198
           P SLG L NLNYLRLNNNSLTGSCP+SLS IE LTLVDLSYNNLSGSLP+ISART K+ G
Sbjct: 139 PSSLGGLKNLNYLRLNNNSLTGSCPQSLSNIEGLTLVDLSYNNLSGSLPRISARTLKIVG 198

Query: 199 NPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVG 258
           NPLICGPKA NNC+ V PEPLS PP+ L+ QSDSG KSH VA+A GASFGAAF ++I+VG
Sbjct: 199 NPLICGPKA-NNCSTVLPEPLSFPPDALRGQSDSGKKSHHVALAFGASFGAAFVLVIIVG 257

Query: 259 LLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVY 318
            LVW RYR NQQIFFDVN+ YDPEV LGHLKR++FKELRAAT +F++KNILGRGGFGIVY
Sbjct: 258 FLVWWRYRRNQQIFFDVNEHYDPEVRLGHLKRFSFKELRAATDHFNSKNILGRGGFGIVY 317

Query: 319 KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378
           K C +DG++VAVKRLKDYN AGGE+QFQTEVETISLAVHRNLLRL GFCST++ERLLVYP
Sbjct: 318 KACLNDGSVVAVKRLKDYNAAGGEIQFQTEVETISLAVHRNLLRLSGFCSTQHERLLVYP 377

Query: 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438
           YM NGSVASRL+DHIHGRPALDW RRKRIALGTARGL+YLHEQCDPKIIHRDVKAANILL
Sbjct: 378 YMSNGSVASRLKDHIHGRPALDWTRRKRIALGTARGLVYLHEQCDPKIIHRDVKAANILL 437

Query: 439 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 498
           DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE
Sbjct: 438 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 497

Query: 499 LITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLC 558
           LITG +ALDFGRAANQ+GVMLDWVKKLHQ+G+LSQMVDKDLKGNFD IELEEMVQVALLC
Sbjct: 498 LITGHKALDFGRAANQKGVMLDWVKKLHQDGRLSQMVDKDLKGNFDLIELEEMVQVALLC 557

Query: 559 TQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHE-KRYSDFIEESSLVIEAM 617
           TQFNP HRPKMSEVLKMLEGDGLAE+WEASQ+IETPR+R+ E +RYSD IEESSL++EAM
Sbjct: 558 TQFNPSHRPKMSEVLKMLEGDGLAERWEASQRIETPRFRSCEPQRYSDLIEESSLIVEAM 617

Query: 618 ELSGPR 623
           ELSGPR
Sbjct: 618 ELSGPR 623

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	623
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.995	0.981	0.749	2.6e-253
TAIR|locus:2146102	638	NIK1 "NSP-interacting kinase 1	0.988	0.965	0.611	6.6e-200
TAIR|locus:2118811	648	SARK "SENESCENCE-ASSOCIATED RE	0.908	0.873	0.601	7.8e-183
TAIR|locus:2061466	634	AT2G23950 [Arabidopsis thalian	0.924	0.908	0.595	9.1e-180
TAIR|locus:2171973	614	AT5G45780 [Arabidopsis thalian	0.975	0.990	0.543	1e-171
TAIR|locus:2013021	625	SERK1 "somatic embryogenesis r	0.980	0.977	0.548	7.3e-162
TAIR|locus:2026097	628	SERK2 "somatic embryogenesis r	0.987	0.979	0.541	9.3e-162
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.953	0.958	0.530	2.5e-152
TAIR|locus:2145407	613	AT5G10290 [Arabidopsis thalian	0.967	0.983	0.469	4e-138
TAIR|locus:2040471	601	SERK5 "somatic embryogenesis r	0.812	0.841	0.526	2.8e-130

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 2439 (863.6 bits), Expect = 2.6e-253, P = 2.6e-253
 Identities = 476/635 (74%), Positives = 537/635 (84%)

Query:     1 MEMKSYKFWRVGFLVLA-LIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITS 59
             ME   +  WR+GFLV     DI  ATLSP G+NYEV ALVAVKN L+DPY VLENWD+ S
Sbjct:     1 MEGVRFVVWRLGFLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNS 60

Query:    60 VDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG 119
             VDPCSWRM++C+ DGYVS+L LPSQSLSGTLSP IGNLT LQSV+LQNNAI GPIP ++G
Sbjct:    61 VDPCSWRMVSCT-DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIG 119

Query:   120 KLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSY 179
             +LEKLQ+LDLSNN FTGEIP SLG+               G+CPESLSKIE LTLVD+SY
Sbjct:   120 RLEKLQSLDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISY 179

Query:   180 NNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRV 239
             NNLSGSLPK+SARTFKV GN LICGPKA +NC+AV PEPL+LP +G  D+S + T  H V
Sbjct:   180 NNLSGSLPKVSARTFKVIGNALICGPKAVSNCSAV-PEPLTLPQDG-PDESGTRTNGHHV 237

Query:   240 AVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAA 299
             A+A  ASF AAFFV    G+ +W RYR N+QIFFDVN+QYDPEVSLGHLKRYTFKELR+A
Sbjct:   238 ALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSA 297

Query:   300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
             T++F++KNILGRGG+GIVYKG  +DG LVAVKRLKD NIAGGEVQFQTEVETISLA+HRN
Sbjct:   298 TNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRN 357

Query:   360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
             LLRL GFCS+  ER+LVYPYMPNGSVASRL+D+I G PALDW+RRK+IA+GTARGL+YLH
Sbjct:   358 LLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLH 417

Query:   420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
             EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS
Sbjct:   418 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 477

Query:   480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             TGQSSEKTDVFGFGILLLELITGQ+ALDFGR+A+Q+GVMLDWVKKLHQEGKL Q++DKDL
Sbjct:   478 TGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDL 537

Query:   540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIE------- 592
                FDR+ELEE+VQVALLCTQFNP HRPKMSEV+KMLEGDGLAE+WEA+Q          
Sbjct:   538 NDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPP 597

Query:   593 -TPRYRTHEKR---YSDFIEESSLVIEAMELSGPR 623
               P   +   R   YSD+I+ESSLV+EA+ELSGPR
Sbjct:   598 LPPGMVSSSPRVRYYSDYIQESSLVVEAIELSGPR 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1935 (686.2 bits), Expect = 6.6e-200, P = 6.6e-200
 Identities = 389/636 (61%), Positives = 482/636 (75%)

Query:     1 MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
             M  +S+ F  +GFL L L    +  LSP G+N+EV AL+ +K +LHDP+ VL+NWD  +V
Sbjct:    10 MITRSF-FCFLGFLCL-LCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAV 67

Query:    61 DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
             DPCSW M+TCS + +V  LG PSQ+LSGTLSP I NLT L+ VLLQNN I G IPA +G+
Sbjct:    68 DPCSWTMVTCSSENFVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGR 127

Query:   121 LEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYN 180
             L +L+TLDLS+N F GEIP S+G               +G  P SLS +  L  +DLSYN
Sbjct:   128 LTRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYN 187

Query:   181 NLSGSLPKISARTFKVTGNPLIC--GPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHR 238
             NLSG +P+ +A+TF + GNPLIC  G +   N T + P  ++L   G+   +  G+++H+
Sbjct:   188 NLSGPVPRFAAKTFSIVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYA-GGSRNHK 246

Query:   239 VAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVND-QYDPEVSLGHLKRYTFKELR 297
             +A+A+G+S G    + I VGL +W R RHNQ  FFDV D  +  EVSLG+L+R+ F+EL+
Sbjct:   247 MAIAVGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQ 306

Query:   298 AATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH 357
              AT+NFS+KN+LG+GG+G VYKG   D  +VAVKRLKD    GGE+QFQTEVE ISLAVH
Sbjct:   307 IATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVH 366

Query:   358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
             RNLLRL GFC T+ E+LLVYPYM NGSVASR++     +P LDW+ RKRIA+G ARGL+Y
Sbjct:   367 RNLLRLYGFCITQTEKLLVYPYMSNGSVASRMK----AKPVLDWSIRKRIAIGAARGLVY 422

Query:   418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
             LHEQCDPKIIHRDVKAANILLD+  EAVVGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEY
Sbjct:   423 LHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY 482

Query:   478 LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK 537
             LSTGQSSEKTDVFGFGILLLEL+TGQRA +FG+AANQ+GVMLDWVKK+HQE KL  +VDK
Sbjct:   483 LSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDK 542

Query:   538 DL--KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPR 595
             +L  K ++D IEL+EMV+VALLCTQ+ P HRPKMSEV++MLEGDGLAEKWEASQ+ ++  
Sbjct:   543 ELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVS 602

Query:   596 Y---RTHE-----KRYSDFIEESSLVIEAMELSGPR 623
                 R +E      RYSD  ++SSL+++AMELSGPR
Sbjct:   603 KCSNRINELMSSSDRYSDLTDDSSLLVQAMELSGPR 638

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0051607 "defense response to virus" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009736 "cytokinin mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)]

 Score = 1754 (622.5 bits), Expect = 7.8e-183, Sum P(2) = 7.8e-183
 Identities = 348/579 (60%), Positives = 429/579 (74%)

Query:    14 LVLALIDICYATL--SPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCS 71
             L+ + + +C++TL  S    N EV AL++++NNLHDP+  L NWD  SVDPCSW MITCS
Sbjct:    15 LLYSFLFLCFSTLTLSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCS 74

Query:    72 PDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN 131
             PD  V  LG PSQSLSG LS  IGNLT L+ V LQNN I G IP  LG L KLQTLDLSN
Sbjct:    75 PDNLVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSN 134

Query:   132 NKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA 191
             N+F+G+IP S+                +G  P SLS+I  L+ +DLSYNNLSG +PK  A
Sbjct:   135 NRFSGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPA 194

Query:   192 RTFKVTGNPLICGPKATNNCT-AVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAA 250
             RTF V GNPLIC       C+ ++   PLS+  +     S SG +S+R+A+AL  S G+ 
Sbjct:   195 RTFNVAGNPLICRSNPPEICSGSINASPLSVSLS-----SSSGRRSNRLAIALSVSLGSV 249

Query:   251 FFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVS-LGHLKRYTFKELRAATSNFSAKNIL 309
               +++ +G   W R +  + +  ++ND+ +  +  LG+L+ +TF+EL   T  FS+KNIL
Sbjct:   250 VILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNIL 309

Query:   310 GRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST 369
             G GGFG VY+G   DG +VAVKRLKD N   G+ QF+ E+E ISLAVH+NLLRL G+C+T
Sbjct:   310 GAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCAT 369

Query:   370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHR 429
               ERLLVYPYMPNGSVAS+L+     +PALDW  RKRIA+G ARGLLYLHEQCDPKIIHR
Sbjct:   370 SGERLLVYPYMPNGSVASKLKS----KPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHR 425

Query:   430 DVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 489
             DVKAANILLDE FEAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV
Sbjct:   426 DVKAANILLDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 485

Query:   490 FGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELE 549
             FGFGILLLELITG RAL+FG+  +Q+G ML+WV+KLH+E K+ +++D++L  N+D+IE+ 
Sbjct:   486 FGFGILLLELITGLRALEFGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVG 545

Query:   550 EMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEAS 588
             EM+QVALLCTQ+ P HRPKMSEV+ MLEGDGLAE+W AS
Sbjct:   546 EMLQVALLCTQYLPAHRPKMSEVVLMLEGDGLAERWAAS 584

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010150 "leaf senescence" evidence=IMP

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

GO:0048438 "floral whorl development" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)]

 Score = 1725 (612.3 bits), Expect = 9.1e-180, Sum P(2) = 9.1e-180
 Identities = 351/589 (59%), Positives = 427/589 (72%)

Query:     1 MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
             M++ + K + V  L+L     C  +  P   N EV AL+ +KN LHDP+ V +NWD  SV
Sbjct:     4 MKLITMKIFSV-LLLLCFFVTCSLSSEPR--NPEVEALINIKNELHDPHGVFKNWDEFSV 60

Query:    61 DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
             DPCSW MI+CS D  V  LG PSQSLSGTLS  IGNLT L+ V LQNN I G IP  +  
Sbjct:    61 DPCSWTMISCSSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICS 120

Query:   121 LEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYN 180
             L KLQTLDLSNN+F+GEIP S+                +G  P SLS+I  L+ +DLSYN
Sbjct:   121 LPKLQTLDLSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYN 180

Query:   181 NLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVA 240
             NL G +PK  ARTF V GNPLIC       C+      +S  P  +  +S SG +++ +A
Sbjct:   181 NLRGPVPKFPARTFNVAGNPLICKNSLPEICSG----SISASPLSVSLRSSSGRRTNILA 236

Query:   241 VALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVND-QYDPEVSLGHLKRYTFKELRAA 299
             VALG S G A  VI+ +G  +W R +  +     ++D Q +  + LG+L+ +TF+EL  A
Sbjct:   237 VALGVSLGFAVSVILSLGF-IWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVA 295

Query:   300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
             T  FS+K+ILG GGFG VY+G F DG +VAVKRLKD N   G  QF+TE+E ISLAVHRN
Sbjct:   296 TDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRN 355

Query:   360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
             LLRL G+C++ +ERLLVYPYM NGSVASRL+     +PALDW  RK+IA+G ARGL YLH
Sbjct:   356 LLRLIGYCASSSERLLVYPYMSNGSVASRLK----AKPALDWNTRKKIAIGAARGLFYLH 411

Query:   420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
             EQCDPKIIHRDVKAANILLDE FEAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLS
Sbjct:   412 EQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLS 471

Query:   480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             TGQSSEKTDVFGFGILLLELITG RAL+FG++ +Q+G ML+WV+KLH+E K+ ++VD++L
Sbjct:   472 TGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDREL 531

Query:   540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEAS 588
                +DRIE+ EM+QVALLCTQF P HRPKMSEV++MLEGDGLAE+W AS
Sbjct:   532 GTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLAERWAAS 580

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)]

 Score = 1669 (592.6 bits), Expect = 1.0e-171, P = 1.0e-171
 Identities = 342/629 (54%), Positives = 440/629 (69%)

Query:     1 MEMKSYKF-----WRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENW 55
             ME+   KF     W   + VL  +    + LSP G+NYEV AL++VKN + D   VL  W
Sbjct:     1 MEISLMKFLFLGIWVYYYSVLDSVSAMDSLLSPKGVNYEVAALMSVKNKMKDEKEVLSGW 60

Query:    56 DITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIP 115
             DI SVDPC+W M+ CS +G+V +L + S+ LSG LS  IG LT L ++LLQNN + GPIP
Sbjct:    61 DINSVDPCTWNMVGCSSEGFVVSLEMASKGLSGILSTSIGELTHLHTLLLQNNQLTGPIP 120

Query:   116 ASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLV 175
             + LG+L +L+TLDLS N+F+GEIP SLG               +G  P  ++ +  L+ +
Sbjct:   121 SELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQVPHLVAGLSGLSFL 180

Query:   176 DLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTK 235
             DLS+NNLSG  P ISA+ +++ GN  +CGP +   C+   P   +    GL ++ +S  K
Sbjct:   181 DLSFNNLSGPTPNISAKDYRIVGNAFLCGPASQELCSDATPVRNA---TGLSEKDNS--K 235

Query:   236 SHRVAVALGASFGAAF-FVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFK 294
              H  ++ L  +FG    F+I ++ L  W+ + H  ++    + Q D E  +GHLKR++F+
Sbjct:   236 HH--SLVLSFAFGIVVAFIISLMFLFFWVLW-HRSRLSRS-HVQQDYEFEIGHLKRFSFR 291

Query:   295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
             E++ ATSNFS KNILG+GGFG+VYKG   +G +VAVKRLKD  I  GEVQFQTEVE I L
Sbjct:   292 EIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKD-PIYTGEVQFQTEVEMIGL 350

Query:   355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
             AVHRNLLRL GFC T  ER+LVYPYMPNGSVA RLRD+   +P+LDW RR  IALG ARG
Sbjct:   351 AVHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGAARG 410

Query:   415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             L+YLHEQC+PKIIHRDVKAANILLDE FEA+VGDFGLAKLLD RDSHVTTAVRGT+GHIA
Sbjct:   411 LVYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIA 470

Query:   475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM 534
             PEYLSTGQSSEKTDVFGFG+L+LELITG + +D G    ++G++L WV+ L  E + ++M
Sbjct:   471 PEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTLKAEKRFAEM 530

Query:   535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETP 594
             VD+DLKG FD + LEE+V++ALLCTQ +P  RP+MS+VLK+LEG  L E+ E   +   P
Sbjct:   531 VDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVLEG--LVEQCEGGYEARAP 588

Query:   595 RYRTHEKRYSDFIEESSLVIEAMELSGPR 623
                   + YS+  EE S +IEA+ELSGPR
Sbjct:   589 SV---SRNYSNGHEEQSFIIEAIELSGPR 614

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009560 "embryo sac egg cell differentiation" evidence=RCA

TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1576 (559.8 bits), Expect = 7.3e-162, P = 7.3e-162
 Identities = 341/622 (54%), Positives = 421/622 (67%)

Query:    11 VGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITC 70
             V F++L+LI +   +L  A  N E  AL  ++  L DP NVL++WD T V+PC+W  +TC
Sbjct:     6 VVFILLSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTC 65

Query:    71 SPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLS 130
             + +  V  + L +  LSG L P +G L  LQ + L +N I GPIP++LG L  L +LDL 
Sbjct:    66 NNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLY 125

Query:   131 NNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLP--- 187
              N F+G IP+SLG               TGS P SL+ I +L ++DLS N LSGS+P   
Sbjct:   126 LNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNG 185

Query:   188 KISART-FKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRV--AVALG 244
               S  T      N  +CGP  ++ C    P P S PP  ++    S    + +  A+A G
Sbjct:   186 SFSLFTPISFANNLDLCGPVTSHPCPGS-P-PFSPPPPFIQPPPVSTPSGYGITGAIAGG 243

Query:   245 ASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFS 304
              + GAA           W R R    IFFDV  + DPEV LG LKR++ +EL+ A+  FS
Sbjct:   244 VAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFS 303

Query:   305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
              KNILGRGGFG VYKG  +DG LVAVKRLK+    GGE+QFQTEVE IS+AVHRNLLRL 
Sbjct:   304 NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 363

Query:   365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
             GFC T  ERLLVYPYM NGSVAS LR+    +P LDW  RKRIALG+ARGL YLH+ CDP
Sbjct:   364 GFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDP 423

Query:   425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
             KIIHRDVKAANILLDE+FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SS
Sbjct:   424 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 483

Query:   485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVML-DWVKKLHQEGKLSQMVDKDLKGNF 543
             EKTDVFG+GI+LLELITGQRA D  R AN   VML DWVK L +E KL  +VD DL+ N+
Sbjct:   484 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNY 543

Query:   544 DRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTH--EK 601
             +  ELE+++QVALLCTQ +P+ RPKMSEV++MLEGDGLAEKW+  QK+E  R        
Sbjct:   544 EERELEQVIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPN 603

Query:   602 RYSDFIEESSLVIEAMELSGPR 623
               SD+I +S+  + A+ELSGPR
Sbjct:   604 PNSDWILDSTYNLHAVELSGPR 625

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0043234 "protein complex" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI;IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0007030 "Golgi organization" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IGI

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0009880 "embryonic pattern specification" evidence=RCA

GO:0010072 "primary shoot apical meristem specification" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0010431 "seed maturation" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045595 "regulation of cell differentiation" evidence=RCA

GO:0051301 "cell division" evidence=RCA

TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1575 (559.5 bits), Expect = 9.3e-162, P = 9.3e-162
 Identities = 339/626 (54%), Positives = 419/626 (66%)

Query:     7 KFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWR 66
             KF   GF+ L  + + + +L  A  N E  AL +++ NL DP NVL++WD T V+PC+W 
Sbjct:     5 KFEAFGFVCLISLLLLFNSLWLASSNMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTWF 64

Query:    67 MITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQT 126
              +TC+ +  V  + L +  LSG L P +G L  LQ + L +N I GP+P+ LG L  L +
Sbjct:    65 HVTCNNENSVIRVDLGNADLSGQLVPQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVS 124

Query:   127 LDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSL 186
             LDL  N FTG IPDSLG               TG  P SL+ I +L ++DLS N LSGS+
Sbjct:   125 LDLYLNSFTGPIPDSLGKLFKLRFLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSV 184

Query:   187 P---KISART-FKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQ--SDSGTKSHRVA 240
             P     S  T      N  +CGP  +  C    P P S PP  +        G  S   A
Sbjct:   185 PDNGSFSLFTPISFANNLDLCGPVTSRPCPGS-P-PFSPPPPFIPPPIVPTPGGYSATGA 242

Query:   241 VALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAAT 300
             +A G + GAA           W R R  Q+ FFDV  + DPEV LG LKR++ +EL+ AT
Sbjct:   243 IAGGVAAGAALLFAAPALAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVAT 302

Query:   301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
              +FS KNILGRGGFG VYKG  +DG LVAVKRLK+    GGE+QFQTEVE IS+AVHRNL
Sbjct:   303 DSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 362

Query:   361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             LRL GFC T  ERLLVYPYM NGSVAS LR+    +  L W+ R++IALG+ARGL YLH+
Sbjct:   363 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHD 422

Query:   421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
              CDPKIIHRDVKAANILLDE+FEAVVGDFGLA+L+D++D+HVTTAVRGT+GHIAPEYLST
Sbjct:   423 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLST 482

Query:   481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML-DWVKKLHQEGKLSQMVDKDL 539
             G+SSEKTDVFG+GI+LLELITGQRA D  R AN   VML DWVK L +E KL  +VD DL
Sbjct:   483 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDL 542

Query:   540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTH 599
             + N+   E+E+++QVALLCTQ +P+ RPKMSEV++MLEGDGLAEKW+  QK+E  R    
Sbjct:   543 QSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEVLRQEVE 602

Query:   600 EKRY--SDFIEESSLVIEAMELSGPR 623
                +  SD+I +S+  + AMELSGPR
Sbjct:   603 LSSHPTSDWILDSTDNLHAMELSGPR 628

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1486 (528.2 bits), Expect = 2.5e-152, P = 2.5e-152
 Identities = 331/624 (53%), Positives = 412/624 (66%)

Query:    13 FLVLALIDICYATLSPAGINYEVVALVAVKNNLH--DPYN-VLENWDITSVDPCSWRMIT 69
             FL L L+     TL  AG N E  AL  +KN+L   DP N VL++WD T V PC+W  +T
Sbjct:    14 FLYLLLL--FNFTLRVAG-NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVT 70

Query:    70 CSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129
             C+P+  V+ + L +  LSG L P +G L  LQ + L +N I G IP  LG L +L +LDL
Sbjct:    71 CNPENKVTRVDLGNAKLSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDL 130

Query:   130 SNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
               N  +G IP SLG               +G  P +L+ ++ L ++D+S N LSG +P  
Sbjct:   131 YANSISGPIPSSLGKLGKLRFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIP-- 187

Query:   190 SARTFKVTGNPLICGPKA-TNNCTAVFPEPLSLPPNGLKDQSD--SGTKSHRVAVALGAS 246
                   V G+  +  P +  NN     PEP   PP          SG +    A+A G +
Sbjct:   188 ------VNGSFSLFTPISFANNSLTDLPEP---PPTSTSPTPPPPSGGQM-TAAIAGGVA 237

Query:   247 FGAAF-FVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSA 305
              GAA  F +  +    WLR R  Q  FFDV  + DPEV LG LKR+T +EL  AT NFS 
Sbjct:   238 AGAALLFAVPAIAFAWWLR-RKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSN 296

Query:   306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
             KN+LGRGGFG VYKG  +DG LVAVKRLK+    GGE+QFQTEVE IS+AVHRNLLRL G
Sbjct:   297 KNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRG 356

Query:   366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
             FC T  ERLLVYPYM NGSVAS LR+   G PALDW +RK IALG+ARGL YLH+ CD K
Sbjct:   357 FCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQK 416

Query:   426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
             IIHRDVKAANILLDE+FEAVVGDFGLAKL+++ DSHVTTAVRGT+GHIAPEYLSTG+SSE
Sbjct:   417 IIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSE 476

Query:   486 KTDVFGFGILLLELITGQRALDFGRAANQRGVML-DWVKKLHQEGKLSQMVDKDLKGNFD 544
             KTDVFG+G++LLELITGQ+A D  R AN   +ML DWVK++ +E KL  +VD +L+G + 
Sbjct:   477 KTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYV 536

Query:   545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETP----RYRTHE 600
               E+E+++Q+ALLCTQ + + RPKMSEV++MLEGDGLAE+WE  QK E P     Y+ + 
Sbjct:   537 ETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMPIHDFNYQAYP 596

Query:   601 KRYSDF-IEESSLVIEAMELSGPR 623
                +D+ I  S+ +IE    SGPR
Sbjct:   597 HAGTDWLIPYSNSLIENDYPSGPR 620

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)]

 Score = 1352 (481.0 bits), Expect = 4.0e-138, P = 4.0e-138
 Identities = 297/633 (46%), Positives = 403/633 (63%)

Query:     1 MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
             M M S +   + F +L    +C + +SP   + +  AL A++ +L    N L +W+   V
Sbjct:     1 MRMFSLQKMAMAFTLLFFACLC-SFVSP---DAQGDALFALRISLRALPNQLSDWNQNQV 56

Query:    61 DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
             +PC+W  + C    +V++L L   + SGTLS  +G L  L+++ L+ N I G IP   G 
Sbjct:    57 NPCTWSQVICDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGN 116

Query:   121 LEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYN 180
             L  L +LDL +N+ TG IP ++G+               G+ PESL+ + +L  + L  N
Sbjct:   117 LTSLTSLDLEDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSN 176

Query:   181 NLSGSLPK--ISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHR 238
             +LSG +P+       +  T N L CG +  + C +      ++  +G  D S   T    
Sbjct:   177 SLSGQIPQSLFEIPKYNFTSNNLNCGGRQPHPCVS------AVAHSG--DSSKPKT---- 224

Query:   239 VAVALGASFGAAFFVIIVVGLLVWL--RYRHN---QQIFFDVNDQYDPEVSLGHLKRYTF 293
               +  G   G     +++ G+L++L  + RH    + +F DV  + D  ++ G LKR+ +
Sbjct:   225 -GIIAGVVAGVT---VVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAW 280

Query:   294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS 353
             +EL+ AT NFS KN+LG+GGFG VYKG   D   VAVKRL D+   GG+  FQ EVE IS
Sbjct:   281 RELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMIS 340

Query:   354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
             +AVHRNLLRL GFC+T+ ERLLVYP+M N S+A RLR+   G P LDW  RKRIALG AR
Sbjct:   341 VAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAAR 400

Query:   414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
             G  YLHE C+PKIIHRDVKAAN+LLDEDFEAVVGDFGLAKL+D R ++VTT VRGT+GHI
Sbjct:   401 GFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHI 460

Query:   474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML-DWVKKLHQEGKLS 532
             APEYLSTG+SSE+TDVFG+GI+LLEL+TGQRA+DF R   +  V+L D VKKL +E +L 
Sbjct:   461 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLG 520

Query:   533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIE 592
              +VDK+L G + + E+E M+QVALLCTQ +P  RP MSEV++MLEG+GLAE+WE  Q +E
Sbjct:   521 AIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVE 580

Query:   593 TPRYRTHEK--RYSDFIEESSLVIEAMELSGPR 623
               R    E+  R  D+ E+S    +A+ELSG R
Sbjct:   581 VTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1278 (454.9 bits), Expect = 2.8e-130, P = 2.8e-130
 Identities = 276/524 (52%), Positives = 349/524 (66%)

Query:   112 GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIES 171
             G +   L +L  LQ L+L NN  TGEIP+ LGD              +G  P SL K+  
Sbjct:    84 GELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPIPSSLGKLGK 143

Query:   172 LTLVDLSYNNLSGSLPK-ISARTFKVT--GNPLICGPKATNNCTAVFPEPLSLPPNGLKD 228
             L  + L  N+LSG +P+ ++A    V    N  + G    N   + F   +S   N L+ 
Sbjct:   144 LRFLRLYNNSLSGEIPRSLTALPLDVLDISNNRLSGDIPVNGSFSQFTS-MSFANNKLRP 202

Query:   229 QSDSGTKSHR---VAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSL 285
             +  S + S      A+ +G + GAA    ++  L  WLR R  Q  F DV  + DPEV L
Sbjct:   203 RPASPSPSPSGTSAAIVVGVAAGAA----LLFALAWWLR-RKLQGHFLDVPAEEDPEVYL 257

Query:   286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF 345
             G  KR++ +EL  AT  FS +N+LG+G FGI+YKG  +D  LVAVKRL +    GGE+QF
Sbjct:   258 GQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQF 317

Query:   346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             QTEVE IS+AVHRNLLRL GFC T  ERLLVYPYM NGSVAS LR+   G PALDW +RK
Sbjct:   318 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRK 377

Query:   406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
              IALG+ARGL YLH+ CD KIIH DVKAANILLDE+FEAVVGDFGLAKL+++ DSHVTTA
Sbjct:   378 HIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTA 437

Query:   466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML-DWVKK 524
             VRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ+A D  R AN   +ML DWVK+
Sbjct:   438 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKE 497

Query:   525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEK 584
             + +E KL  +VD +L+G +   E+E+++Q+ALLCTQ + + RPKMSEV++MLEGDGLAE+
Sbjct:   498 VLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAER 557

Query:   585 WEASQKIETP----RYRTHEKRYSDF-IEESSLVIEAMELSGPR 623
             WE  QK E P     Y+ +    +D+ I  S+ +IE    SGPR
Sbjct:   558 WEEWQKEEMPIHDFNYQAYPHAGTDWLIPYSNSLIENDYPSGPR 601

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q93ZS4	NIK3_ARATH	2, ., 7, ., 1, 1, ., 1	0.7668	0.9887	0.9746	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	623
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-53
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-48
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-44
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-42
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-24
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-12
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-09
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	2e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-09
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	9e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-04
COG5238	388	COG5238, RNA1, Ran GTPase-activating protein (RanG	6e-04
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	7e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-04
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	9e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.001
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.001
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.001
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.002
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.003
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.004
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.004
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  196 bits (499), Expect = 3e-53
 Identities = 147/513 (28%), Positives = 257/513 (50%), Gaps = 57/513 (11%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L L     SG +   +G+L++L  + L  N + G IP  L   +KL +LDLS+N+ +G+I
Sbjct: 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTF 194
           P S  ++  L+ L L+ N L+G  P++L  +ESL  V++S+N+L GSLP   A       
Sbjct: 540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS 599

Query: 195 KVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVI 254
            V GN  +CG   T+           LPP   K    + +    +   LG     AF V+
Sbjct: 600 AVAGNIDLCGGDTTS----------GLPP--CKRVRKTPSWWFYITCTLG-----AFLVL 642

Query: 255 IVVGL-LVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAAT-----SNFSAKNI 308
            +V    V++R R+N ++      + + E     L+ +  K  ++ T     S+   +N+
Sbjct: 643 ALVAFGFVFIRGRNNLEL-----KRVENEDGTWELQFFDSKVSKSITINDILSSLKEENV 697

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           + RG  G  YKG    +G    VK + D N I   E+    +++      H N+++L G 
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ------HPNIVKLIGL 751

Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           C +E    L++ Y+   +++  LR+       L W RR++IA+G A+ L +LH +C P +
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAV 804

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +  ++    I++D   E  +    L  LL        ++      ++APE   T   +EK
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRETKDITEK 858

Query: 487 TDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN--FD 544
           +D++GFG++L+EL+TG+   D     +  G +++W +  + +  L   +D  ++G+   +
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVH--GSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916

Query: 545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           + E+ E++ +AL CT  +P  RP  ++VLK LE
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  168 bits (427), Expect = 7e-48
 Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 29/277 (10%)

Query: 306 KNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
              LG G FG VYKG            VAVK LK+        +F  E   +    H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           ++L G C+ E    +V  YM  G + S LR +   RP L  +     AL  ARG+ YL  
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLES 120

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
           +     IHRD+ A N L+ E+    + DFGL++ L   D +     +  +  +APE L  
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 481 GQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
           G+ + K+DV+ FG+LL E+ T G++   +   +N+   +L+++K      +L Q  +   
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQ--PYPGMSNEE--VLEYLKN---GYRLPQPPNCP- 229

Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
                     E+  + L C   +P  RP  SE++++L
Sbjct: 230 ---------PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  165 bits (420), Expect = 6e-47
 Identities = 78/277 (28%), Positives = 124/277 (44%), Gaps = 32/277 (11%)

Query: 308 ILGRGGFGIVYKGCFSDG-----ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
            LG G FG VYKG            VAVK LK+        +F  E   +    H N+++
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L G C+ E   ++V  YMP G +   LR   +    L  +     AL  ARG+ YL  + 
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRK--NRPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
               IHRD+ A N L+ E+    + DFGL++ L   D +     +  +  +APE L  G+
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 483 SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN 542
            + K+DV+ FG+LL E+ T       G             ++ +     +++++   KG 
Sbjct: 181 FTSKSDVWSFGVLLWEIFT------LG-------------EEPYPGMSNAEVLEYLKKGY 221

Query: 543 FDRIEL---EEMVQVALLCTQFNPLHRPKMSEVLKML 576
                     E+ ++ L C   +P  RP  SE++++L
Sbjct: 222 RLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  163 bits (415), Expect = 4e-46
 Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 53/293 (18%)

Query: 307 NILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
             LG G FG VYKG           VAVK LK+         F  E   +    H N++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDH-----IHGRPALDWARRKRIALGTARGLLY 417
           L G C+ E    LV  YM  G +   LR          +  L        A+  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI---A 474
           L  +   K +HRD+ A N L+ ED    + DFGL++ +   D +      G    I   A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR-----AANQRGVMLDWVKKLHQEG 529
           PE L  G  + K+DV+ FG+LL E+ T       G       +N+   +L++++      
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT------LGATPYPGLSNEE--VLEYLR------ 221

Query: 530 KLSQMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                     KG   R+       +E+ ++ L C Q +P  RP  SE+++ LE
Sbjct: 222 ----------KGY--RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  161 bits (409), Expect = 6e-46
 Identities = 79/271 (29%), Positives = 111/271 (40%), Gaps = 59/271 (21%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG GGFG VY       G  VA+K +K  + +    +   E+E +    H N+++L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
             EN   LV  Y   GS+   L+++      L      RI L    GL YLH      II
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GII 114

Query: 428 HRDVKAANILLDED-FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SE 485
           HRD+K  NILLD D  +  + DFGL+KLL    S + T + GT  ++APE L      SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSE 173

Query: 486 KTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDR 545
           K+D++  G++L                                                 
Sbjct: 174 KSDIWSLGVILY------------------------------------------------ 185

Query: 546 IELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            EL E+  +     Q +P  RP   E+L+ L
Sbjct: 186 -ELPELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  157 bits (399), Expect = 6e-44
 Identities = 74/275 (26%), Positives = 113/275 (41%), Gaps = 26/275 (9%)

Query: 303 FSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           +     LG G FG VY       G LVA+K +K   I     +   E++ +    H N++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           RL      E++  LV  Y   G     L D +  R  L     +         L YLH +
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGD----LFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
               I+HRD+K  NILLDED    + DFGLA+ LD     +TT V GT  ++APE L   
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFV-GTPEYMAPEVLLGK 171

Query: 482 QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH-QEGKLSQMVDKDLK 540
              +  D++  G++L EL+TG+         +Q   +   + K           +  + K
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFP---GDDQLLELFKKIGKPKPPFPPPEWDISPEAK 228

Query: 541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM 575
                    ++++        +P  R    E L+ 
Sbjct: 229 ---------DLIR---KLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  153 bits (388), Expect = 3e-42
 Identities = 76/199 (38%), Positives = 100/199 (50%), Gaps = 11/199 (5%)

Query: 308 ILGRGGFGIVYKGCF-SDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
            LG G FG VYK      G +VAVK L K    +  +   + E+  +    H N++RL  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
               ++   LV  Y   G     L D++     L     K+IAL   RGL YLH      
Sbjct: 66  AFEDKDHLYLVMEYCEGGD----LFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ-SS 484
           IIHRD+K  NILLDE+    + DFGLAK L    S +TT V GT  ++APE L  G    
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177

Query: 485 EKTDVFGFGILLLELITGQ 503
            K DV+  G++L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  152 bits (387), Expect = 3e-42
 Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 38/279 (13%)

Query: 309 LGRGGFGIVYKG-----CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           LG G FG VYKG            VAVK LK+        +F  E   +    H N++RL
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
            G C+      +V  YMP G +   LR H      L      ++AL  A+G+ YL  +  
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK-- 121

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIAPEYL 478
              +HRD+ A N L+ E+    + DFGL++ +   D +         ++      APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESL 176

Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK-LSQMVDK 537
             G+ + K+DV+ FG+LL E+ T       G      G+  + V +L ++G  L +  + 
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFT------LGEQPYP-GMSNEEVLELLEDGYRLPRPENC 229

Query: 538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
                      +E+ ++ L C  ++P  RP  SE+++ L
Sbjct: 230 P----------DELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  124 bits (314), Expect = 4e-32
 Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 14/204 (6%)

Query: 307 NILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEV-QFQTEVETISLAVHRNLLRL 363
            +LGRG FG VY        G L+AVK ++    +  E+   + E+  +S   H N++R 
Sbjct: 6   ELLGRGSFGSVYLA-LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 364 CGFCSTE--NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
            G    E  N   +   Y+  GS    L   +     L     ++       GL YLH  
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGS----LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTTAVRGTVGHIAPEYLST 480
               I+HRD+K ANIL+D D    + DFG AK L D      T +VRGT   +APE +  
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 481 GQSSEKTDVFGFGILLLELITGQR 504
            +     D++  G  ++E+ TG+ 
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 2e-30
 Identities = 86/278 (30%), Positives = 122/278 (43%), Gaps = 40/278 (14%)

Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
              +G+G FG V  G +  G  VAVK LKD   +     F  E   ++   H NL++L G
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
                N   +V  YM  GS+   LR    GR  +  A++   AL    G+ YL E+    
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---N 122

Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-RGTVGHIAPEYLSTGQSS 484
            +HRD+ A N+L+ ED  A V DFGLAK     ++       +  V   APE L   + S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFS 177

Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD 544
            K+DV+ FGILL E+ +      FGR    R               L  +V    KG   
Sbjct: 178 TKSDVWSFGILLWEIYS------FGRVPYPR-------------IPLKDVVPHVEKGY-- 216

Query: 545 RIELEE-----MVQVALLCTQFNPLHRPKMSEVLKMLE 577
           R+E  E     + +V   C + +P  RP   ++ + L 
Sbjct: 217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  116 bits (294), Expect = 2e-29
 Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 10/204 (4%)

Query: 302 NFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           N+   +++GRG FG+VYKG     G  VA+K++    I    ++    E++ +    H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++  G   T +   ++  Y  NGS+   ++      P    A      L   +GL YLH
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVL---QGLAYLH 116

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           EQ    +IHRD+KAANIL  +D    + DFG+A  L+   S    +V GT   +APE + 
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIE 172

Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
              +S  +D++  G  ++EL+TG 
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  116 bits (292), Expect = 3e-29
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G+GGFG VYK      G  VA+K +K       + +   E++ +    H N+++  G  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIK-LESKEKKEKIINEIQILKKCKHPNIVKYYG-S 65

Query: 368 STENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
             + + L +V  +   GS+   L+           A    +     +GL YLH      I
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY---VCKELLKGLEYLHSN---GI 119

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           IHRD+KAANILL  D E  + DFGL+  L    +  T    GT   +APE ++      K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYK 177

Query: 487 TDVFGFGILLLELITGQ 503
            D++  GI  +EL  G+
Sbjct: 178 ADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (295), Expect = 7e-29
 Identities = 82/285 (28%), Positives = 121/285 (42%), Gaps = 23/285 (8%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRL-KDYNIAGGEV-QFQTEVETI-SLAVHR 358
           ++     LG G FG VY     D  LVA+K L K       EV +F  E++ + SL    
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N+++L  F   E    LV  Y+  GS+   L+      P L  +    I       L YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP-LSESEALFILAQILSALEYL 117

Query: 419 HEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLLDHRDSHV-----TTAVRGTVGH 472
           H +    IIHRD+K  NILLD D     + DFGLAKLL    S        +   GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 473 IAPEYL---STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG 529
           +APE L   S   +S  +D++  GI L EL+TG    +  + ++     L  + +L    
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL---- 230

Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
             +  +   L  +   +  +    +       +P +R   S  L 
Sbjct: 231 -PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  113 bits (285), Expect = 3e-28
 Identities = 71/201 (35%), Positives = 105/201 (52%), Gaps = 7/201 (3%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
             F+ +  LG G FG V++G + +   VA+K LK  ++   +  FQ EV+ +    H++L
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHL 64

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           + L   CS      ++   M  GS+ + LR    G+  L  A    +A   A G+ YL E
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQ-VLPVASLIDMACQVAEGMAYLEE 122

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
           Q     IHRD+ A NIL+ ED    V DFGLA+L+   D ++++  +      APE  S 
Sbjct: 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASH 178

Query: 481 GQSSEKTDVFGFGILLLELIT 501
           G  S K+DV+ FGILL E+ T
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  110 bits (278), Expect = 3e-27
 Identities = 78/290 (26%), Positives = 129/290 (44%), Gaps = 51/290 (17%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRN 359
            +     +G+G FG VY     SDG L  +K +   N++  E +    EV+ +    H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 360 LLRLCGFCSTENERLL-VYPYMPNGSVASRLRDHIH-GRP-----ALDWARRKRIALGTA 412
           +++       E  +L  V  Y   G ++ +++     G+P      LDW  +  + L   
Sbjct: 61  IIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA-- 115

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
             L YLH +   KI+HRD+K  NI L  +    +GDFG++K+L        T V GT  +
Sbjct: 116 --LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYY 169

Query: 473 IAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           ++PE L   +  + K+D++  G +L EL T +   +     N   + L            
Sbjct: 170 LSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLELAL------------ 213

Query: 532 SQMVDKDLKGNFDRI------ELEEMVQVALLCTQFNPLHRPKMSEVLKM 575
                K LKG +  I      EL  +V  +LL  Q +P  RP ++++L+ 
Sbjct: 214 -----KILKGQYPPIPSQYSSELRNLVS-SLL--QKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  110 bits (276), Expect = 9e-27
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)

Query: 307 NILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQ---FQTEVETISLAVHR 358
             LG G FG V    +     + G  VAVK L   N +G E     F+ E+E +    H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL---NHSGEEQHRSDFEREIEILRTLDHE 66

Query: 359 NLLRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           N+++  G C     R   L+  Y+P+GS+   L+ H   R  ++  R    +    +G+ 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMD 123

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIA 474
           YL  Q   + IHRD+ A NIL++ +    + DFGLAK+L     +      G   +   A
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT 501
           PE L T + S  +DV+ FG+ L EL T
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (258), Expect = 1e-24
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           S+     +LG+G  G+VYK      G + A+K++          Q   E++T+       
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 360 LLRLCG-FCSTENERL-LVYPYMPNGSVASRLRDHIH-GRPALDWARRKRIALGTARGLL 416
           +++  G F       + +V  YM  GS+A  L+       P L       IA    +GL 
Sbjct: 61  VVKCYGAFYK--EGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLD 113

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           YLH      IIHRD+K +N+L++   E  + DFG++K+L++      T V GTV +++PE
Sbjct: 114 YLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE 170

Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
            +     S   D++  G+ LLE   G+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 74/281 (26%), Positives = 129/281 (45%), Gaps = 37/281 (13%)

Query: 307 NILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
            ++G G FG V +G           VA+K LK  +     + F TE   +    H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L G  +     +++  YM NGS+   LR++          +   +  G A G+ YL E  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIAPEY 477
               +HRD+ A NIL++ +    V DFGL++ L+  ++  TT      +R T    APE 
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179

Query: 478 LSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD 536
           ++  + +  +DV+ FGI++ E+++ G+R   +   +NQ     D +K +    +L   +D
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERP--YWDMSNQ-----DVIKAVEDGYRLPPPMD 232

Query: 537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                         + Q+ L C Q +   RP  S+++  L+
Sbjct: 233 CP----------SALYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 2e-24
 Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 29/273 (10%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G+G FG VYKG       VAVK  +       + +F  E E +    H N+++L G C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    +V   +P GS+ + LR     +  L   +  +++L  A G+ YL  +     IH
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116

Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT----VGHIAPEYLSTGQSS 484
           RD+ A N L+ E+    + DFG+++     +  + T   G     +   APE L+ G+ +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD 544
            ++DV+ +GILL E  +      +   +NQ+                 + ++   +    
Sbjct: 174 SESDVWSYGILLWETFSLG-DTPYPGMSNQQT---------------RERIESGYRMPAP 217

Query: 545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           ++  EE+ ++ L C  ++P +RP  SE+   L+
Sbjct: 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score =  107 bits (268), Expect = 3e-24
 Identities = 76/245 (31%), Positives = 100/245 (40%), Gaps = 54/245 (22%)

Query: 34  EVVALVAVKNNLHDPYNVLENWDITSVDPCS-----WRMITCSPDG-----YVSALGLPS 83
           EV AL  +K++L  P      W+    DPC      W    C  D      ++  LGL +
Sbjct: 373 EVSALQTLKSSLGLPLRF--GWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDN 427

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
           Q L G +   I  L  LQS+ L  N+I G IP SLG +  L+ LDLS N F G IP+SLG
Sbjct: 428 QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLIC 203
            L +L  L LN NSL+G  P +L                 G      A  F  T N  +C
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHRAS-FNFTDNAGLC 529

Query: 204 GPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWL 263
           G      C                     G K   + +A G S     F+ +V+  + W 
Sbjct: 530 GIPGLRACGPHLS---------------VGAK---IGIAFGVSVA---FLFLVICAMCWW 568

Query: 264 RYRHN 268
           + R N
Sbjct: 569 KRRQN 573

Length = 623

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  104 bits (262), Expect = 2e-23
 Identities = 59/155 (38%), Positives = 90/155 (58%), Gaps = 4/155 (2%)

Query: 34  EVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPW 93
           E+  L++ K++++DP   L NW+ +S D C W+ ITC+    V ++ L  +++SG +S  
Sbjct: 30  ELELLLSFKSSINDPLKYLSNWN-SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSA 88

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKL-EKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
           I  L  +Q++ L NN + GPIP  +      L+ L+LSNN FTG IP   G + NL  L 
Sbjct: 89  IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146

Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           L+NN L+G  P  +    SL ++DL  N L G +P
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181

Length = 968

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  100 bits (250), Expect = 2e-23
 Identities = 69/203 (33%), Positives = 98/203 (48%), Gaps = 14/203 (6%)

Query: 307 NILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
            ++G+G FG VY G   D        AVK L          QF  E   +    H N+L 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           L G C  +E   L+V PYM +G + + +R   H     D        L  A+G+ YL  +
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQVAKGMEYLASK 117

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYL 478
              K +HRD+ A N +LDE F   V DFGLA+ +   ++   H  T  +  V  +A E L
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 479 STGQSSEKTDVFGFGILLLELIT 501
            T + + K+DV+ FG+LL EL+T
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 15/197 (7%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK   ++     F  E + +    H  L++L   CS
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 369 TENERLLVYPYMPNGSVASRLRD----HIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
            E    +V  YM  GS+   L+      +     +D      +A   A G+ YL  +   
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQIAEGMAYLESR--- 122

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
             IHRD+ A NIL+ E+    + DFGLA+L++  +       +  +   APE  + G+ +
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182

Query: 485 EKTDVFGFGILLLELIT 501
            K+DV+ FGILL E++T
Sbjct: 183 IKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 20/207 (9%)

Query: 308 ILGRGGFGIVYKGCF---SDGAL--VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           +LG G FG VYKG +    +     VA+K L++        +   E   ++   H +++R
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTARGLLYLH 419
           L G C +  +  L+   MP G +   +R+H   I  +  L+W  +       A+G+ YL 
Sbjct: 74  LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYL 478
           E+   +++HRD+ A N+L+       + DFGLAKLLD  +        +  +  +A E +
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 479 STGQSSEKTDVFGFGILLLELIT-GQR 504
                + K+DV+ +G+ + EL+T G +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 4e-23
 Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 36/284 (12%)

Query: 309 LGRGGFGIVYKGC---FSDGAL---VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG+VY+G       G     VA+K + +       ++F  E   +      +++R
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPALDWARRKRIALGTARGLL 416
           L G  ST    L+V   M  G + S LR      ++  G       +  ++A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAP 475
           YL  +   K +HRD+ A N ++ ED    +GDFG+ + +   D +         V  +AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ--RGVMLDWVKKLHQEGKLSQ 533
           E L  G  + K+DV+ FG++L E+ T          A Q  +G+  + V K   +G    
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQPYQGLSNEEVLKFVIDGGH-- 239

Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               DL  N     LE M     +C Q+NP  RP   E++  L+
Sbjct: 240 ---LDLPENCPDKLLELM----RMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 80/280 (28%), Positives = 125/280 (44%), Gaps = 36/280 (12%)

Query: 309 LGRGGFGIVYKGCF--SDGAL--VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +    G    VAVK LK  +IA G+ +F  E   ++   H  ++RL 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G C  E   +LV    P G     L  ++  R  +  +  K +A   A G+ YL  +   
Sbjct: 63  GVCKGE-PLMLVMELAPLGP----LLKYLKKRREIPVSDLKELAHQVAMGMAYLESK--- 114

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH--VTTAVRGTVGHIAPEYLSTGQ 482
             +HRD+ A N+LL    +A + DFG+++ L     +   TTA R  +   APE ++ G+
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 483 SSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG 541
            S K+DV+ +G+ L E  + G +          +G   + +  L    +L          
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPY-----GEMKGA--EVIAMLESGERL---------- 217

Query: 542 NFDRIEL--EEMVQVALLCTQFNPLHRPKMSEVLKMLEGD 579
              R E   +E+  + L C ++ P  RP  SE+      D
Sbjct: 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 77/281 (27%), Positives = 131/281 (46%), Gaps = 30/281 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +      VAVK LK+  +   E  F  E   +    H N
Sbjct: 6   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 63

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 121

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 122 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 178

Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+             LSQ+ +   
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GI------------DLSQVYELLE 219

Query: 540 KG-NFDRIE--LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           KG   +R E    ++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 220 KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 1e-22
 Identities = 69/201 (34%), Positives = 89/201 (44%), Gaps = 17/201 (8%)

Query: 309 LGRGGFGIVYKGCF--SDGALVAVKRL-KDYNIAGGEV-QFQTEVETISLAVHRNLLRL- 363
           LG+G FG V         G L A+K L K   I   EV    TE   +S   H  +++L 
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 364 CGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
             F     E+L LV  Y P G     L  H+         R +  A      L YLH   
Sbjct: 60  YAF--QTEEKLYLVLEYAPGGE----LFSHLSKEGRFSEERARFYAAEIVLALEYLHSL- 112

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
              II+RD+K  NILLD D    + DFGLAK L    S   T   GT  ++APE L    
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKG 169

Query: 483 SSEKTDVFGFGILLLELITGQ 503
             +  D +  G+LL E++TG+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 67/205 (32%), Positives = 98/205 (47%), Gaps = 17/205 (8%)

Query: 307 NILGRGGFGIVYKG-CFSDGALVAVKR--LKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
            ++G G   +VY   C  +   VA+KR  L+    +  E++   EV+ +S   H N+++ 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR--KEVQAMSQCNHPNVVKY 64

Query: 364 CGFCS-TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
             + S    + L LV PY+  GS+   ++   + R  LD A    +     +GL YLH  
Sbjct: 65  --YTSFVVGDELWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGL-AKLLDHRD--SHVTTAVRGTVGHIAPEYL 478
                IHRD+KA NILL ED    + DFG+ A L D  D    V     GT   +APE +
Sbjct: 122 ---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 479 STGQS-SEKTDVFGFGILLLELITG 502
                   K D++ FGI  +EL TG
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 95.8 bits (238), Expect = 3e-22
 Identities = 73/269 (27%), Positives = 126/269 (46%), Gaps = 22/269 (8%)

Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +LG+G FG V+KG   D   VAVK  K+      +++F +E   +    H N+++L G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
           +      +V   +P G   S LR     +  L   +  + AL  A G+ YL  +     I
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCI 115

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+ A N L+ E+    + DFG+++  D      +   +  +   APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 488 DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE 547
           DV+ +GILL E          G        +  +    +Q+ +  + V+K  + +  +  
Sbjct: 176 DVWSYGILLWE------TFSLG--------VCPYPGMTNQQAR--EQVEKGYRMSCPQKC 219

Query: 548 LEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            +++ +V   C  + P +RPK SE+ K L
Sbjct: 220 PDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 84/280 (30%), Positives = 120/280 (42%), Gaps = 39/280 (13%)

Query: 309 LGRGGFGIVYKGCFSDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG+V +G +S        VAVK LK   ++     F  E   +    H NL+RL 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   T    ++V    P GS+  RLR           +     A+  A G+ YL  +   
Sbjct: 63  GVVLTH-PLMMVTELAPLGSLLDRLRKD--ALGHFLISTLCDYAVQIANGMRYLESK--- 116

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV--GHIAPEYLSTGQ 482
           + IHRD+ A NILL  D +  +GDFGL + L   + H        V     APE L T  
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 483 SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK-DLKG 541
            S  +DV+ FG+ L E+ T      +G           W       G  SQ++ K D +G
Sbjct: 177 FSHASDVWMFGVTLWEMFT------YGEEP--------WA---GLSG--SQILKKIDKEG 217

Query: 542 NFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKML 576
             +R+E      +++  V L C   NP  RP  + + + L
Sbjct: 218 --ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 95.6 bits (238), Expect = 6e-22
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)

Query: 308 ILGRGGFGIVYKGCFSD-GALVAVKRLK-DYNIAGGEVQFQ--------TEVETISLAVH 357
           ++G+G +G VY       G ++AVK+++    IAG     Q        +E+ET+    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N+++  GF +TE    +   Y+P GS+ S LR +      L     +        GL Y
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFFTEQVLEGLAY 123

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPE 476
           LH +    I+HRD+KA N+L+D D    + DFG++K  D   D+    +++G+V  +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 477 YLSTGQS--SEKTDVFGFGILLLELITGQR 504
            + +     S K D++  G ++LE+  G+R
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 95.6 bits (238), Expect = 7e-22
 Identities = 78/297 (26%), Positives = 131/297 (44%), Gaps = 52/297 (17%)

Query: 306 KNILGRGGFGIVYKG-CFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           K  LG G FG V+ G C+      D  LVAVK LK+         F+ E E ++   H N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRK----------RI 407
           +++  G C+  +  ++V+ YM +G +   LR   HG  A  L                +I
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRS--HGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
           A+  A G++YL  Q     +HRD+   N L+  D    +GDFG++     RD + T   R
Sbjct: 128 AVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMS-----RDVYTTDYYR 179

Query: 468 GTVGH-------IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD 520
              GH       + PE +   + + ++DV+ FG++L E+ T  +   +G +  +      
Sbjct: 180 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------ 232

Query: 521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            V +   +G+L Q           R    E+  + L C + +P  R  + ++ + L+
Sbjct: 233 -VIECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 75/281 (26%), Positives = 125/281 (44%), Gaps = 37/281 (13%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEV--ETISLAV--H 357
           +F   N +G+G FG+V+K        V    +K  +++    + + E   E   LA    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYA--MKQIDLSKMNRREREEAIDEARVLAKLDS 58

Query: 358 RNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALD---WARRKRIALGTAR 413
             ++R       +  +L +V  Y  NG +   L+    GRP  +   W    R  +    
Sbjct: 59  SYIIRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQ-RGRPLPEDQVW----RFFIQILL 112

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           GL +LH +   KI+HRD+K+ N+ LD      +GD G+AKLL    +   T V GT  ++
Sbjct: 113 GLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYL 168

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
           +PE       +EK+DV+  G++L E  TG+   D   A NQ  ++L  ++ +     +SQ
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALILKIIRGVFP--PVSQ 223

Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
           M  + L             Q+   C   +   RP   ++L+
Sbjct: 224 MYSQQL------------AQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 13/202 (6%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V++G +++   VAVK LK   +   +  F  E + +    H  L++L   C+
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V   M  GS+   L+    GR AL   +   +A   A G+ YL  Q     IH
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQ-GGAGR-ALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126

Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N+L+ E+    V DFGLA+++           +  +   APE     + S K+D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 489 VFGFGILLLELITGQRALDFGR 510
           V+ FGILL E++T      +GR
Sbjct: 187 VWSFGILLTEIVT------YGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 76/275 (27%), Positives = 125/275 (45%), Gaps = 38/275 (13%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG+V+ G +     VA+K +++  ++  E  F  E + +    H NL++L G C+
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    +V  YM NG + + LR+   G+   +W     +       + YL        IH
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLD--MCSDVCEAMEYLESNG---FIH 123

Query: 429 RDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTAVRGT---VGHIAPEYLSTGQSS 484
           RD+ A N L+ ED    V DFGLA+ +LD  D +  T+ +GT   V    PE     + S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLD--DQY--TSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG-NF 543
            K+DV+ FG+L+ E+ +  + + + R +N                  S++V+    G   
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK-MPYERFSN------------------SEVVESVSAGYRL 220

Query: 544 DRIEL--EEMVQVALLCTQFNPLHRPKMSEVLKML 576
            R +L   E+  +   C    P  RP   ++L  L
Sbjct: 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 309 LGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           LG+G FG V    +     + G +VAVK+L+ ++ A     F+ E+E +    H N+++ 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 364 CGFCSTENER--LLVYPYMPNGSVASRLRDH-IHGRPALDWARRKRIALGTARGLLYLHE 420
            G C +   R   LV  Y+P GS    LRD+    R  LD  +    A    +G+ YL  
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGS----LRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + +HRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 127 K---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 92.7 bits (230), Expect = 5e-21
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 17/207 (8%)

Query: 307 NILGRGGFGIVYKGCFSDGALVAVKR--LKDYNIAGGEVQF---QTEVETISLAVHRNLL 361
            +LG+G +G VY G  + G L+AVK+  L   N+   E ++   Q EV+ +    H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           +  G C  +N   +   ++P GS++S L       P   + +  +  L    G+ YLH  
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQIL---DGVAYLHNN 121

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-----TAVRGTVGHIAPE 476
           C   ++HRD+K  N++L  +    + DFG A+ L     H T      ++ GT   +APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++      K+D++  G  + E+ TG+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 68/198 (34%), Positives = 101/198 (51%), Gaps = 14/198 (7%)

Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           I+G G FG V +G ++ G  VAVK +K    A     F  E   ++   H+NL+RL G  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              N   +V   M  G++ + LR    GR  +   +  + +L  A G+ YL  +   K++
Sbjct: 69  -LHNGLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+ A NIL+ ED  A V DFGLA++     S      +  V   APE L   + S K+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKS 178

Query: 488 DVFGFGILLLELITGQRA 505
           DV+ +G+LL E+ +  RA
Sbjct: 179 DVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 80/282 (28%), Positives = 121/282 (42%), Gaps = 38/282 (13%)

Query: 307 NILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGE-VQFQTEVETISLAVHRNLLRLC 364
             +G+G FG V K    SDG ++  K +   N+   E  Q  +EV  +    H N++R  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 365 G-FCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALD----WARRKRIALGTARGLLYL 418
                  N+ L +V  Y   G +A  ++     R  ++    W    RI       L   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALYEC 121

Query: 419 H--EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           H        ++HRD+K ANI LD +    +GDFGLAK+L H  S   T V GT  +++PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPE 180

Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD 536
            L+     EK+D++  G L+ EL        F  A NQ               +L+  + 
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS--PPF-TARNQL--------------QLASKI- 222

Query: 537 KDLKGNFDRIEL---EEMVQVALLCTQFNPLHRPKMSEVLKM 575
           K+  G F RI      E+ +V       +P  RP   E+L++
Sbjct: 223 KE--GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 80/293 (27%), Positives = 130/293 (44%), Gaps = 50/293 (17%)

Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG+VY+G   D         VAVK + +       ++F  E   +      +++R
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPALDWARRKRIALGTARGLL 416
           L G  S     L+V   M +G + S LR      ++  GRP        ++A   A G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TV 470
           YL+ +   K +HRD+ A N ++  DF   +GDFG+      RD + T   R        V
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLPV 185

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ--RGVMLDWVKKLHQE 528
             +APE L  G  +  +D++ FG++L E+ +          A Q  +G+  + V K   +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQPYQGLSNEQVLKFVMD 236

Query: 529 GKLSQMVDKDLKGNFDRIE--LEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD 579
           G           G  D+ +   E +  +  +C QFNP  RP   E++ +L+ D
Sbjct: 237 G-----------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 90.4 bits (224), Expect = 4e-20
 Identities = 74/284 (26%), Positives = 134/284 (47%), Gaps = 30/284 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
           S+ + + ++G G FG V++G           VA+K LK          F +E   +    
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N++RL G  +     +++  YM NG++   LRDH     +       R   G A G+ 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMK 121

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIA 474
           YL    D   +HRD+ A NIL++ + E  V DFGL+++L  D   ++ T+  +  +   A
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
           PE ++  + +  +DV+ FGI++ E+++ G+R   +   +N   VM    K ++   +L  
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP--YWDMSNHE-VM----KAINDGFRLPA 231

Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            +D              + Q+ L C Q +   RP+  +++ +L+
Sbjct: 232 PMDCP----------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.8 bits (233), Expect = 8e-20
 Identities = 54/141 (38%), Positives = 77/141 (54%), Gaps = 5/141 (3%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L L   +L+G +   +GNL  LQ + L  N + GPIP S+  L+KL +LDLS+N  +GEI
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTG 198
           P+ +  L NL  L L +N+ TG  P +L+ +  L ++ L  N  SG +PK   +      
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH----- 355

Query: 199 NPLICGPKATNNCTAVFPEPL 219
           N L     +TNN T   PE L
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGL 376

Length = 968

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 89.3 bits (221), Expect = 8e-20
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 9/194 (4%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           LG G FG V+ G +++   VAVK LK   ++   VQ F  E   +    H  L+RL    
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
           + E    ++  YM  GS+   L+    G+  L   +    +   A G+ Y+  +     I
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYI 125

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD++AAN+L+ E     + DFGLA++++  +       +  +   APE ++ G  + K+
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 488 DVFGFGILLLELIT 501
           DV+ FGILL E++T
Sbjct: 186 DVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 39/276 (14%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVKR--LKDYNIAGGEV--QFQTEVETISLAVHRNLLRL 363
           LG G FG VY+G   D G   AVK   L D    G E   Q + E+  +S   H N+++ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 364 CGFCSTENERLLVY-PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR---GLLYLH 419
            G    E + L ++   +P GS+A  L+ +              I L T +   GL YLH
Sbjct: 68  LG-TEREEDNLYIFLELVPGGSLAKLLKKY-------GSFPEPVIRLYTRQILLGLEYLH 119

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL- 478
           ++     +HRD+K ANIL+D +    + DFG+AK +         + +G+   +APE + 
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIA 174

Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
             G      D++  G  +LE+ TG+        +   GV   +  K+ +  +L  + D  
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW-----SQLEGVAAVF--KIGRSKELPPIPD-H 226

Query: 539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
           L       E ++ +   L C Q +P  RP  +E+L+
Sbjct: 227 LSD-----EAKDFI---LKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 68/202 (33%), Positives = 96/202 (47%), Gaps = 17/202 (8%)

Query: 309 LGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           LG G FG V   C+       G +VAVK LK          ++ E+  +    H N+++ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 364 CGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
            G CS +  +   L+  Y+P GS    LRD++  +  L+ A+    A     G+ YLH Q
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGS----LRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQ 126

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLS 479
                IHRD+ A N+LLD D    +GDFGLAK +   H    V       V   A E L 
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 480 TGQSSEKTDVFGFGILLLELIT 501
             + S  +DV+ FG+ L EL+T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 16/201 (7%)

Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG+GGFG V   C   + G + A K+L  K      GE     E + +     R ++ L 
Sbjct: 1   LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARGLLYLHEQC 422
               T+++  LV   M  G     L+ HI   G P    AR    A     GL +LH++ 
Sbjct: 60  YAFETKDDLCLVMTLMNGGD----LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR- 114

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
             +I++RD+K  N+LLD+     + D GLA  ++ +         GT G++APE L    
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEV 170

Query: 483 SSEKTDVFGFGILLLELITGQ 503
                D F  G  L E+I G+
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 18/211 (8%)

Query: 308 ILGRGGFGIVYKGCFS--DGAL--VAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLR 362
           ILG G FG V +G  S  DG+   VAVK +K       E++ F +E   +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 363 LCGFCSTENER------LLVYPYMPNGSVASRL-RDHIHGRPA-LDWARRKRIALGTARG 414
           L G C   +        +++ P+M +G + S L    + G P  L      +  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-AVRGTVGHI 473
           + YL  +     IHRD+ A N +L ED    V DFGL+K +   D +      +  V  I
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELIT-GQ 503
           A E L+    + K+DV+ FG+ + E+ T GQ
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 8/193 (4%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G G FG+V+ G + +   VA+K +++   A  E  F  E + +    H  L++L G C+
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREG--AMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
             +   LV+ +M +G ++  LR     R          + L    G+ YL       +IH
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+ E+    V DFG+ + +       +T  +  V   +PE  S  + S K+D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 489 VFGFGILLLELIT 501
           V+ FG+L+ E+ +
Sbjct: 184 VWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 23/214 (10%)

Query: 308 ILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNL 360
            LG G FG V K         ++ + VAVK LKD           +E+E +  +  H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDH---------IHGRPALDWARRKRI---A 408
           + L G C+ E    +V  Y  +G++   LR              RP  +   +K +   A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVR 467
              ARG+ +L  +   K IHRD+ A N+L+ ED    + DFGLA+ + H D +  TT  R
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
             V  +APE L     + ++DV+ FG+LL E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 19/205 (9%)

Query: 303 FSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           F     LG G +G VYK      G +VA+K +    +     +   E+  +       ++
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           +  G      +  +V  Y   GSV+  ++  I  +  L       I   T +GL YLH  
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKT-LTEEEIAAILYQTLKGLEYLHSN 118

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV-G---HIAPEY 477
              K IHRD+KA NILL+E+ +A + DFG++  L       T A R TV G    +APE 
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMAPEV 170

Query: 478 LSTGQSSEKTDVFGFGILLLELITG 502
           +     + K D++  GI  +E+  G
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 78/298 (26%), Positives = 134/298 (44%), Gaps = 43/298 (14%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAV 356
           ++   ++++G G FG V K       L    A+KR+K+Y        F  E+E +  L  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH--IHGRPALDWARRKRIALGT--- 411
           H N++ L G C       L   Y P+G++   LR    +   PA   A      L +   
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 412 -------ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-T 463
                  ARG+ YL ++   + IHRD+ A NIL+ E++ A + DFGL++    ++ +V  
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180

Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           T  R  V  +A E L+    +  +DV+ +G+LL E+++       G          +  +
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYE 234

Query: 524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL----KMLE 577
           KL Q  +L + ++ D          +E+  +   C +  P  RP  +++L    +MLE
Sbjct: 235 KLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 86.6 bits (214), Expect = 6e-19
 Identities = 81/271 (29%), Positives = 116/271 (42%), Gaps = 30/271 (11%)

Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
            +G+G FG V  G +  G  VAVK +K+   A     F  E   ++   H NL++L G  
Sbjct: 13  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68

Query: 368 STENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
             E   L +V  YM  GS+   LR    GR  L      + +L     + YL        
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD+ A N+L+ ED  A V DFGL K            V+ T    APE L   + S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179

Query: 487 TDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRI 546
           +DV+ FGILL E+ +      FGR    R  + D V ++ +  K+      D       +
Sbjct: 180 SDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKM------DAPDGCPPV 227

Query: 547 ELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
             + M Q    C   +   RP   ++ + LE
Sbjct: 228 VYDVMKQ----CWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 30/211 (14%)

Query: 303 FSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           F+    +G+G FG VYK        +VA+K +   ++   E     E+E I   +    L
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI---DLEEAE----DEIEDIQQEI--QFL 53

Query: 362 RLC---------GFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
             C         G    +  +L ++  Y   GS    L+        LD      I    
Sbjct: 54  SQCRSPYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGK-----LDETYIAFILREV 107

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
             GL YLHE+     IHRD+KAANILL E+ +  + DFG++  L    S   T V GT  
Sbjct: 108 LLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPF 163

Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            +APE +      EK D++  GI  +EL  G
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.5 bits (215), Expect = 9e-19
 Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 36/229 (15%)

Query: 301 SNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRL-KDYNIAGGEVQF-QTEVETIS-LA 355
            +F    I+G G F  V             A+K L K   I   +V++ + E E ++ L 
Sbjct: 1   DDFKFGKIIGEGSFSTVVL-AKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN 59

Query: 356 VHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
            H  +++L  + + ++E  L  V  Y PNG     L  +I    +LD    +  A     
Sbjct: 60  GHPGIIKL--YYTFQDEENLYFVLEYAPNGE----LLQYIRKYGSLDEKCTRFYAAEILL 113

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR------ 467
            L YLH +    IIHRD+K  NILLD+D    + DFG AK+LD   S  +          
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 468 -------------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
                        GT  +++PE L+   + + +D++  G ++ +++TG+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 86.1 bits (213), Expect = 9e-19
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 12/198 (6%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VA+K LK  +++     F  E   +    H  L+RL     
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVV- 70

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI--ALGTARGLLYLHEQCDPKI 426
           T+    ++  YM NGS    L D +     +     K I  A   A G+ ++  +     
Sbjct: 71  TQEPIYIITEYMENGS----LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NY 123

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           IHRD++AANIL+ E     + DFGLA+L++  +       +  +   APE ++ G  + K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 487 TDVFGFGILLLELITGQR 504
           +DV+ FGILL E++T  R
Sbjct: 184 SDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 82/289 (28%), Positives = 125/289 (43%), Gaps = 55/289 (19%)

Query: 307 NILGRGGFGIVYKGC-FSDGALVAVK--RLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           N +G G FG VY       G L+AVK  R++D +    + +   E++ + L  H NL++ 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-EIADEMKVLELLKHPNLVKY 64

Query: 364 CGFCSTENERLLVYPYMP---NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
            G    E  R  VY +M     G++   L    HGR  LD    +   L    GL YLH 
Sbjct: 65  YG---VEVHREKVYIFMEYCSGGTLEELLE---HGR-ILDEHVIRVYTLQLLEGLAYLHS 117

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG---HIAPEY 477
                I+HRD+K ANI LD +    +GDFG A  L +  + +   V+   G   ++APE 
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 478 LSTGQSSEK---TDVFGFGILLLELITGQR---------ALDFGRAANQRGVMLDWVKKL 525
           ++ G+        D++  G ++LE+ TG+R          + F   A  +         +
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP-------I 227

Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
               +LS    KD     DR            C + +P  RP  SE+L+
Sbjct: 228 PDSLQLSPEG-KDF---LDR------------CLESDPKKRPTASELLQ 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 81/302 (26%), Positives = 137/302 (45%), Gaps = 51/302 (16%)

Query: 306 KNILGRGGFGIVYKG-CFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           K  LG G FG V+   C++     D  LVAVK LKD  +A  +  FQ E E ++   H +
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEH 68

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDH-------IHGRP-----ALDWARRKRI 407
           +++  G C   +  ++V+ YM +G +   LR H       + G+P      L  ++   I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
           A   A G++YL  Q     +HRD+   N L+  +    +GDFG++     RD + T   R
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS-----RDVYSTDYYR 180

Query: 468 GTVGH-------IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD 520
              GH       + PE +   + + ++DV+ FG++L E+ T  +   F  +  +      
Sbjct: 181 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------ 233

Query: 521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG 580
            V +   +G++ +           R+  +E+  + L C Q  P  R  + E+ K+L   G
Sbjct: 234 -VIECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283

Query: 581 LA 582
            A
Sbjct: 284 KA 285

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 16/203 (7%)

Query: 307 NILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLC 364
             +G G +G VYK      G LVA+K+++  N   G  +    E++ +    H N++RL 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 365 GFCSTENER---LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
               T   +    +V+ YM +    + L D    +     ++ K        GL YLH  
Sbjct: 65  EIV-TSKGKGSIYMVFEYMDHD--LTGLLDSPEVK--FTESQIKCYMKQLLEGLQYLHSN 119

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL--S 479
               I+HRD+K +NIL++ D    + DFGLA+    R+S   T    T+ +  PE L  +
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176

Query: 480 TGQSSEKTDVFGFGILLLELITG 502
           T +   + D++  G +L EL  G
Sbjct: 177 T-RYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 89.1 bits (221), Expect = 2e-18
 Identities = 43/119 (36%), Positives = 68/119 (57%), Gaps = 3/119 (2%)

Query: 72  PDGYVS---ALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLD 128
           P G +     L L +  LSG +   IG+ + L+ + L  N ++G IP SL  L  L+ L 
Sbjct: 135 PRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLT 194

Query: 129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           L++N+  G+IP  LG + +L ++ L  N+L+G  P  +  + SL  +DL YNNL+G +P
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253

Length = 968

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 12/195 (6%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG+V  G +     VA+K +K+ +++  E +F  E + +    H  L++L G C+
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    +V  YM NG + + LR+H         ++   +      G+ YL  +   + IH
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKR---FQPSQLLEMCKDVCEGMAYLESK---QFIH 123

Query: 429 RDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTT-AVRGTVGHIAPEYLSTGQSSEK 486
           RD+ A N L+D+     V DFGL++ +LD  D + ++   +  V    PE L   + S K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 487 TDVFGFGILLLELIT 501
           +DV+ FG+L+ E+ +
Sbjct: 182 SDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 60/207 (28%), Positives = 88/207 (42%), Gaps = 14/207 (6%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALV-AVKRL-KDYNIAGGEVQ-FQTEVETISLAVHR 358
           +F    ++G+G FG V      D   + A+K + K   +  G V+    E   +    H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 359 NLLRLC-GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            L+ L   F   EN   LV   +  G     LR H+  +      + K         L Y
Sbjct: 61  FLVNLWYSFQDEEN-MYLVVDLLLGGD----LRYHLSQKVKFSEEQVKFWICEIVLALEY 115

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
           LH +    IIHRD+K  NILLDE     + DF +A  +      +TT+  GT G++APE 
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPEV 170

Query: 478 LSTGQSSEKTDVFGFGILLLELITGQR 504
           L     S   D +  G+   E + G+R
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 89.1 bits (221), Expect = 3e-18
 Identities = 48/110 (43%), Positives = 61/110 (55%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L L S + +G +   + +L +LQ + L +N   G IP +LGK   L  LDLS N  TGEI
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           P+ L   GNL  L L +NSL G  P+SL    SL  V L  N+ SG LP 
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422

Length = 968

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 78/280 (27%), Positives = 129/280 (46%), Gaps = 37/280 (13%)

Query: 302 NFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHR 358
            +    ++GRG FGIV+  C   +D  LV +K++    +   E    Q E + + L  H 
Sbjct: 1   KYEKIRVVGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N++        +   ++V  Y P G++A  ++        LD      I     + LL L
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLD---EDTILHFFVQILLAL 114

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
           H      I+HRD+K  NILLD+    V +GDFG++K+L  +    T  V GT  +I+PE 
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPEL 172

Query: 478 LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK 537
                 ++K+D++  G +L EL + +RA +   AAN                 L  +V K
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFE---AAN-----------------LPALVLK 212

Query: 538 DLKGNF----DRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
            + G F    DR    ++ Q+ L     +P  RP++S+++
Sbjct: 213 IMSGTFAPISDRYS-PDLRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 37/277 (13%)

Query: 308 ILGRGGFG--IVYKGCFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRNLLRLC 364
           +LG+G FG   +Y+    D +LV  K +    ++  E +    E+  +SL  H N++   
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL--GTARGLLYLHEQC 422
                +N  L+   Y   G++     D I  +    +     +         + Y+H+  
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLY----DKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA- 120

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
              I+HRD+K  NI L +     +GDFG++K+L    S   T V GT  +++PE     +
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVK 177

Query: 483 SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN 542
            + K+D++  G +L EL+T +R  D   A N                    +V K ++GN
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFD---ATN-----------------PLNLVVKIVQGN 217

Query: 543 FDRIE---LEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           +  +      E++ +     Q +P  RP   EVL   
Sbjct: 218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 65/196 (33%), Positives = 97/196 (49%), Gaps = 8/196 (4%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK   ++     F  E + +    H  L++L    S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  GS+   L+D   GR AL       +A   A G+ Y+        IH
Sbjct: 72  -EEPIYIVTEYMSKGSLLDFLKDG-EGR-ALKLPNLVDMAAQVAAGMAYIERM---NYIH 125

Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+++ANIL+ +     + DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL+T  R
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 18/209 (8%)

Query: 302 NFSAKNILGRGGFGIVYKGCFS--DGALVAVKRL---KDYNIAGGEV-QFQTEVETISLA 355
           N+    +LG+G FG VY  C+    G  +AVK++    D      EV   + E++ +   
Sbjct: 3   NWRRGKLLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 356 VHRNLLRLCGFCSTENERLLVY-PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
            H  +++  G C  ++E L ++  YMP GSV    +D +    AL     ++       G
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQILEG 116

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAVRGTVGH 472
           + YLH      I+HRD+K ANIL D      +GDFG +K L    S  T   +V GT   
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           ++PE +S      K DV+  G  ++E++T
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 70/214 (32%), Positives = 101/214 (47%), Gaps = 25/214 (11%)

Query: 307 NILGRGGFGIVYKGCFSD-------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           N LG G FG VY+G  +D          VAVK L+       + +F  E   +S   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPALDWARRKRIALGTARGLL 416
           +++L G C     + ++   M  G + S LRD      G P L       I L  A+G +
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 417 YLHEQCDPKIIHRDVKAANILLDE---DFEAVV--GDFGLAKLLDHRDSHVTTAVRG--- 468
           YL        IHRD+ A N L+ E   D + VV  GDFGLA+ +   D +      G   
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174

Query: 469 -TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
             V  +APE L  G+ + ++DV+ FG+L+ E++T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 29/213 (13%)

Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQ-----------FQTEVETISLA 355
           ++G G FG VY G   S G L+AVK+++   +                    E+  +   
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVE---LPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 356 VHRNLLRLCGFCSTENERLLVY-PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
            H N+++  G  S + + L ++  Y+P GSVA+ L ++     A +    +       +G
Sbjct: 64  QHENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKG 118

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-----AVRGT 469
           L YLH +    IIHRD+K ANIL+D      + DFG++K L+       T     +++G+
Sbjct: 119 LNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           V  +APE +     + K D++  G L++E++TG
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 21/204 (10%)

Query: 308 ILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV----HR 358
           +LG G FG V+KG +     S    VA+K ++D +   G   FQ E+    LA+    H 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQ-EITDHMLAMGSLDHA 69

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
            ++RL G C   + +L V    P GS+   +R H   R +LD  R     +  A+G+ YL
Sbjct: 70  YIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYL 125

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEY 477
            E     ++HR++ A NILL  D    + DFG+A LL   D  +  +  +  +  +A E 
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           +  G+ + ++DV+ +G+ + E+++
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 85.7 bits (212), Expect = 3e-17
 Identities = 46/114 (40%), Positives = 64/114 (56%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L L S  L G +   +G +  L+ + L  N + G IP  +G L  L  LDL  N  TG I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISAR 192
           P SLG+L NL YL L  N L+G  P S+  ++ L  +DLS N+LSG +P++  +
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306

Length = 968

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 71/275 (25%), Positives = 115/275 (41%), Gaps = 34/275 (12%)

Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEV---QFQTEVETISLAVHRNLLRLC 364
           LG G  G+V K      G ++AVK ++   +   E    Q   E++ +       ++   
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIR---LEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G      +  +   YM  GS+   L++     P        +IA+   +GL YLHE+   
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERIL---GKIAVAVLKGLTYLHEKH-- 120

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           KIIHRDVK +NIL++   +  + DFG++  L   +S   T V GT  ++APE +     S
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYS 177

Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL----K 540
            K+D++  G+ L+EL TG+                           L  +V++       
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPEND--------PPDGIFEL---LQYIVNEPPPRLPS 226

Query: 541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM 575
           G F      +      LC   +P  RP   E+L+ 
Sbjct: 227 GKFS----PDFQDFVNLCLIKDPRERPSYKELLEH 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 81.3 bits (200), Expect = 4e-17
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 12/198 (6%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARGLLYLHEQCDPKI 426
            E    +V  YM  GS    L D + G     L   +   +A   A G+ Y+        
Sbjct: 72  -EEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 123

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 487 TDVFGFGILLLELITGQR 504
           +DV+ FGILL EL T  R
Sbjct: 184 SDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.5 bits (209), Expect = 7e-17
 Identities = 42/110 (38%), Positives = 64/110 (58%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L L    L G +   + NLT L+ + L +N ++G IP  LG+++ L+ + L  N  +GEI
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           P  +G L +LN+L L  N+LTG  P SL  +++L  + L  N LSG +P 
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278

Length = 968

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 29/288 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
           SN      LGRG FG V+              LV VK L+       + +F+ E++    
Sbjct: 5   SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64

Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGS-----VASRLRDHIHGRPALDWARRKRIAL 409
             H+N++RL G C       ++  Y   G       A++ +D     P L   ++  +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
             A G+ +L      + +HRD+ A N L+    E  V    L+K + + + +        
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181

Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG 529
           +  +APE +     S K+DV+ FG+L+ E+ T Q  L F   +++     + + +L Q G
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDE-----EVLNRL-QAG 234

Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           KL   V +       ++           C   NP  RP  SE++  L 
Sbjct: 235 KLELPVPEGCPSRLYKLMTR--------CWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 66/237 (27%), Positives = 107/237 (45%), Gaps = 42/237 (17%)

Query: 287 HLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFS-----DGALVAVKRLKDYNIAG 340
           H+KR+          N   K  LG G FG V+   C++     D  LVAVK LKD +   
Sbjct: 1   HIKRH----------NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DN 49

Query: 341 GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH-------I 393
               F  E E ++   H ++++  G C   +  ++V+ YM +G +   LR H        
Sbjct: 50  ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA 109

Query: 394 HGRPALDWARRK--RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451
            G    +  + +   IA   A G++YL  Q     +HRD+   N L+ E+    +GDFG+
Sbjct: 110 EGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGM 166

Query: 452 AKLLDHRDSHVTTAVRGTVGH-------IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           +     RD + T   R   GH       + PE +   + + ++DV+  G++L E+ T
Sbjct: 167 S-----RDVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 37/285 (12%)

Query: 309 LGRGGFGIVYKGCFSDG---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           +G G FG V  G    G   A V VK L+       ++ F  EV+      H N+L+  G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 366 FCSTENERLLVYPYMPNGSVASRLR-DHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
            C      LLV  + P G + + LR +             +R+A   A GLL+LH+    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--HIAPEYLSTGQ 482
             IH D+   N  L  D    +GD+GLA L  + + +  T     V    +APE +    
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 483 S-------SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV 535
                   ++K++++  G+ + EL T         AA+Q          L  E  L Q+V
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT---------AADQP------YPDLSDEQVLKQVV 223

Query: 536 -DKDLKGNFDRIEL---EEMVQVALLCTQFNPLHRPKMSEVLKML 576
            ++D+K    +++L   +   +V   C   +P  RP   EV ++L
Sbjct: 224 REQDIKLPKPQLDLKYSDRWYEVMQFC-WLDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 66/210 (31%), Positives = 91/210 (43%), Gaps = 24/210 (11%)

Query: 307 NILGRGGFGIVYKGCFS--DGAL----VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
             LG G FG VY+G +   DG      VAVK L +      E  F  E   +S   H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR------IALGTARG 414
           +RL G       R ++   M  G + S LR     RP  +             A   A+G
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLR---ENRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 415 LLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTTAVRGT-- 469
             YL E      IHRD+ A N LL        A + DFG+A+ + +R S+     R    
Sbjct: 129 CKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYYRKGGRAMLP 184

Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLEL 499
           +  + PE    G  + KTDV+ FG+LL E+
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 70/206 (33%), Positives = 93/206 (45%), Gaps = 23/206 (11%)

Query: 308 ILGRGGFGIV----YKGCFSDGALVAVKRLK-DYNIAGGEVQ-FQTE---VETISLAVHR 358
           +LGRG FG V    YK     G L A+K LK    IA  EV+    E    ET +   H 
Sbjct: 6   VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
            L+ L     TE+    V  Y   G     L  HIH        R    A     GL YL
Sbjct: 63  FLVNLFACFQTEDHVCFVMEYAAGGD----LMMHIH-TDVFSEPRAVFYAACVVLGLQYL 117

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL-LDHRDSHVTTAVRGTVGHIAPEY 477
           HE    KI++RD+K  N+LLD +    + DFGL K  +   D   T+   GT   +APE 
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEV 172

Query: 478 LSTGQSSEKTDVFGFGILLLELITGQ 503
           L+    +   D +G G+L+ E++ G+
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGE 198

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 48/290 (16%)

Query: 309 LGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           LG+G FG+VY+G  + G +       VA+K + +       ++F  E   +      +++
Sbjct: 14  LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPALDWARRKRI---ALGTARGL 415
           RL G  S     L++   M  G + S LR     +   P       K++   A   A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------T 469
            YL+     K +HRD+ A N ++ EDF   +GDFG+      RD + T   R        
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLP 184

Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ--RGVMLDWVKKLHQ 527
           V  ++PE L  G  +  +DV+ FG++L E+ T          A Q  +G+  + V +   
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQPYQGMSNEQVLRFVM 235

Query: 528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           EG L    D     N   +  E M     +C Q+NP  RP   E++  ++
Sbjct: 236 EGGLLDKPD-----NCPDMLFELM----RMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 68/273 (24%), Positives = 120/273 (43%), Gaps = 30/273 (10%)

Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +GRG FG V+ G   +D   VAVK  ++      + +F  E   +    H N++RL G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
           + +    +V   +  G   + LR      P L      ++    A G+ YL  +     I
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT----VGHIAPEYLSTGQS 483
           HRD+ A N L+ E     + DFG+++     +  V  +  G     V   APE L+ G+ 
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173

Query: 484 SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNF 543
           S ++DV+ FGILL E  +   A+ +   +NQ               +  + +++ ++   
Sbjct: 174 SSESDVWSFGILLWEAFS-LGAVPYANLSNQ---------------QTREAIEQGVRLPC 217

Query: 544 DRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
             +  + + ++   C +++P  RP  S V + L
Sbjct: 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 79.0 bits (194), Expect = 4e-16
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 19/203 (9%)

Query: 308 ILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           +LG G FG VYKG +  +G  V    A+K L +       V+F  E   ++   H +L+R
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTARGLLYLH 419
           L G C +   +L V   MP+G +   + +H   I  +  L+W       +  A+G++YL 
Sbjct: 74  LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWC------VQIAKGMMYLE 126

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-AVRGTVGHIAPEYL 478
           E+   +++HRD+ A N+L+       + DFGLA+LL+  +        +  +  +A E +
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 479 STGQSSEKTDVFGFGILLLELIT 501
              + + ++DV+ +G+ + EL+T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 71/278 (25%), Positives = 117/278 (42%), Gaps = 33/278 (11%)

Query: 302 NFSAKNILGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGGEVQFQ-TEVETISLAVHRN 359
           +F     LG+G +G VYK    SD    A+K +   +++  E +    E+  ++   H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           ++         N+  +V  Y P G ++  +      R  +      RI +   RGL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           EQ   KI+HRD+K+ANILL  +    +GD G++K+L      +     GT  ++APE   
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWK 174

Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK-LSQMVDKD 538
               S K+D++  G LL E+ T   A  F                   E + +  +  K 
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATF--APPF-------------------EARSMQDLRYKV 213

Query: 539 LKGNFDRIEL---EEMVQVALLCTQFNPLHRPKMSEVL 573
            +G +  I     +++        Q  P  RP   ++L
Sbjct: 214 QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 78.0 bits (193), Expect = 7e-16
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 22/211 (10%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRL------KDYNIAGGEVQFQTEVETI 352
              +     +G G  G VYK      G  VA+K++      K+  I         E+  +
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII--------NEILIM 69

Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
               H N++         +E  +V  YM  GS+   +  +      ++  +   +     
Sbjct: 70  KDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVL 126

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           +GL YLH Q    +IHRD+K+ NILL +D    + DFG A  L    S   + V GT   
Sbjct: 127 QGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYW 182

Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           +APE +       K D++  GI+ +E+  G+
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 36/218 (16%)

Query: 309 LGRGGFGIVYKG-CF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG V+   C       D  LVAVK LK+ +       FQ E E +++  H++++R
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVR 71

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK-----------RIALGT 411
             G C+     L+V+ YM +G +   LR H      L                  IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
           A G++YL        +HRD+   N L+ +     +GDFG++     RD + T   R  VG
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS-----RDIYSTDYYR--VG 181

Query: 472 H--------IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
                    + PE +   + + ++D++ FG++L E+ T
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 16/200 (8%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   +      F  E + +    H  L+ L    S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM--PEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 369 TENERLLVYPYMPNGSVASRLRD----HIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
            E    +V  +M  GS+   L++    ++     +D A +       A G+ Y+      
Sbjct: 72  -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ------IADGMAYIERM--- 121

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
             IHRD++AANIL+ ++    + DFGLA+L++  +       +  +   APE    G+ +
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 485 EKTDVFGFGILLLELITGQR 504
            K+DV+ FGILL EL+T  R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 30/284 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
           S    + ++G G FG V  G           VA+K LK          F +E   +    
Sbjct: 4   SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N++ L G  +     ++V  YM NGS+ + LR H      +      R   G A G+ 
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMK 120

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIA 474
           YL    D   +HRD+ A NIL++ +    V DFGL+++L  D   ++ T   +  +   A
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
           PE ++  + +  +DV+ +GI++ E+++ G+R   +   +NQ     D +K + +  +L  
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP--YWEMSNQ-----DVIKAIEEGYRLPA 230

Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            +D              + Q+ L C Q +   RPK  +++ +L+
Sbjct: 231 PMDCPAA----------LHQLMLDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)

Query: 307 NILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLR 362
           +++G G FG V K       L    A+KR+K+Y        F  E+E +  L  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRD-----------HIHGRPALDWARRK-RIALG 410
           L G C       L   Y P+G++   LR              +   +   +++    A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGT 469
            ARG+ YL ++   + IHRD+ A NIL+ E++ A + DFGL++    ++ +V  T  R  
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           V  +A E L+    +  +DV+ +G+LL E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 63/207 (30%), Positives = 91/207 (43%), Gaps = 28/207 (13%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLK-----DYNIAGGEVQFQTEVETISLAVHRNLLR 362
           +G G +G VYK    + G LVA+K +K     D+ I       Q E+  +    H N++ 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI------IQQEISMLKECRHPNIVA 64

Query: 363 LCGFCSTENERLLVYPYMPNGSVA---SRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
             G     ++  +V  Y   GS+       R  +     L  A   R  L   +GL YLH
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL---SELQIAYVCRETL---KGLAYLH 118

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL- 478
           E      IHRD+K ANILL ED +  + DFG++  L    +   + + GT   +APE   
Sbjct: 119 ET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAA 174

Query: 479 --STGQSSEKTDVFGFGILLLELITGQ 503
               G    K D++  GI  +EL   Q
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.1 bits (195), Expect = 3e-15
 Identities = 46/111 (41%), Positives = 63/111 (56%)

Query: 78  ALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE 137
           +L L   SLSG +   +  L  L+ + L +N   G IP +L  L +LQ L L +NKF+GE
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE 347

Query: 138 IPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           IP +LG   NL  L L+ N+LTG  PE L    +L  + L  N+L G +PK
Sbjct: 348 IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398

Length = 968

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 31/227 (13%)

Query: 296 LRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETI-S 353
           L   T  F    ++G G +G VYK      G LVA+K +    I   E + + E   +  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEEEIKEEYNILRK 58

Query: 354 LAVHRNLLRLCGF------CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR- 406
            + H N+    G          +++  LV      GSV + L   +  +      +R + 
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-TDLVKGLRKKG-----KRLKE 112

Query: 407 -----IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
                I   T RGL YLHE    K+IHRD+K  NILL ++ E  + DFG++  LD     
Sbjct: 113 EWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169

Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELITGQ 503
             T + GT   +APE ++  +  + +     DV+  GI  +EL  G+
Sbjct: 170 RNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 66/198 (33%), Positives = 90/198 (45%), Gaps = 20/198 (10%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQ---TEVETISLAVHRNLLRLC 364
           +G G FG VY         +VA+K++  Y+      ++Q    EV  +    H N +   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G    E+   LV  Y   GS AS + + +H +P L       I  G  +GL YLH     
Sbjct: 82  GCYLREHTAWLVMEYCL-GS-ASDILE-VHKKP-LQEVEIAAICHGALQGLAYLHSHE-- 135

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY---LSTG 481
             IHRD+KA NILL E     + DFG A L+   +S V     GT   +APE    +  G
Sbjct: 136 -RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189

Query: 482 QSSEKTDVFGFGILLLEL 499
           Q   K DV+  GI  +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 30/227 (13%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSDGA------LVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           N      LG G FG V K              VAVK LK+   +       +E   +   
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR------------DHIHGRPALDWAR 403
            H ++++L G CS +   LL+  Y   GS+ S LR            D       LD   
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 404 RKRIALG--------TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455
            + + +G         +RG+ YL E    K++HRD+ A N+L+ E  +  + DFGL++ +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 456 DHRDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
              DS+V  +  R  V  +A E L     + ++DV+ FG+LL E++T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 75/290 (25%), Positives = 118/290 (40%), Gaps = 57/290 (19%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVH-RNLLRL--- 363
           +GRG FG V K      G ++AVKR++       + +   +++ +  +     +++    
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 364 ------CGFC------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
                 C  C      S +     VY       + S + + I G+          IA+ T
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGK----------IAVAT 116

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
            + L YL E  + KIIHRDVK +NILLD +    + DFG++  L   DS   T   G   
Sbjct: 117 VKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRP 172

Query: 472 HIAPEYLSTGQSSE---KTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE 528
           ++APE +          ++DV+  GI L E+ TG+                 W     Q 
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP------------KWNSVFDQ- 219

Query: 529 GKLSQMVDKD---LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM 575
             L+Q+V  D   L  + +R      V    LC   +   RPK  E+L+ 
Sbjct: 220 --LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 23/209 (11%)

Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQ--FQTEVETISLAV---HRNLL 361
            LG G F   Y+      G L+AVK++        E +   +   + I L     H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           R+ G    ++   L   +M  GSV+  L  +     A   A          RGL YLHE 
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 422 CDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTA------VRGTVGHIA 474
              +IIHRDVK AN+L+D   + + + DFG A  L    +  T A      + GT+  +A
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLLGTIAFMA 176

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           PE L   Q     DV+  G +++E+ T +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 32/279 (11%)

Query: 308 ILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++G G FG V +G           VA+K LK          F +E   +    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
            G  +     +++  +M NG++ S LR +      +      R   G A G+ YL E   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM-- 125

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGT--VGHIAPEYLS 479
              +HRD+ A NIL++ +    V DFGL++ L  D  D   T+++ G   +   APE ++
Sbjct: 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 480 TGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
             + +  +DV+ +GI++ E+++ G+R   +   +NQ     D +  + Q+ +L   +D  
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQ-----DVINAIEQDYRLPPPMDCP 237

Query: 539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                       + Q+ L C Q +   RPK  +++  L+
Sbjct: 238 ----------TALHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 23/213 (10%)

Query: 306 KNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLL 361
           ++++G G FG V +       L    A+K LK++        F  E+E +  L  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRD-----------HIHGRPALDWARRK-RIAL 409
            L G C       +   Y P G++   LR              HG  +   +++  + A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRG 468
             A G+ YL E+   + IHRD+ A N+L+ E+  + + DFGL++     + +V  T  R 
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180

Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
            V  +A E L+    + K+DV+ FG+LL E+++
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 309 LGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG VYKG             VA+K LK+      + +F+ E E +S   H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRL------------RDHIHGRPALDWARRKRIALG 410
           L G C+ E    +++ Y+ +G +   L                  + +LD +    IA+ 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-----SHVTTA 465
            A G+ YL        +HRD+ A N L+ E     + DFGL++ +   D     S     
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 499
           VR     + PE +  G+ + ++D++ FG++L E+
Sbjct: 190 VR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 74.7 bits (183), Expect = 7e-15
 Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 8/196 (4%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+   ++    VAVK +K  +++     F  E   +    H  L++L    +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    ++  +M  GS+   L+     +  L   +    +   A G+ ++ ++     IH
Sbjct: 72  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 125

Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+       + DFGLA++++  +       +  +   APE ++ G  + K+D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185

Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL+E++T  R
Sbjct: 186 VWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.4 bits (185), Expect = 8e-15
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 21/211 (9%)

Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G      VA+K L++        +   E   ++  
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L +   MP G +   +R+H   I  +  L+W       +  A
Sbjct: 67  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 119

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL E+   +++HRD+ A N+L+       + DFGLAKLL  D ++ H     +  +
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPI 175

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
             +A E +     + ++DV+ +G+ + EL+T
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.5 bits (183), Expect = 9e-15
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 28/209 (13%)

Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCG 365
           +LG+G +GIVY     S    +A+K + + +     VQ    E+   S   HRN+++  G
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR----IALGTAR---GLLYL 418
             S      +    +P GS+++ LR          W   K     I   T +   GL YL
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRS--------KWGPLKDNEQTIIFYTKQILEGLKYL 124

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVV--GDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           H+    +I+HRD+K  N+L++  +  VV   DFG +K L    +  T    GT+ ++APE
Sbjct: 125 HDN---QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPE 179

Query: 477 YLSTGQS--SEKTDVFGFGILLLELITGQ 503
            +  G        D++  G  ++E+ TG+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 79/283 (27%), Positives = 125/283 (44%), Gaps = 34/283 (12%)

Query: 309 LGRGGFGIVYKGCFS--DGAL-VAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLC 364
           LG G FG V +G  +  D  L VAVK +K       E++ F +E   +    H N++RL 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 365 GFC--STENER----LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT--ARGLL 416
           G C  + E+E     +++ P+M +G + S L     G        +  +   T  A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-RGTVGHIAP 475
           YL  +     IHRD+ A N +L+E+    V DFGL+K + + D +    + +  V  IA 
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM 534
           E L+    + K+DV+ FG+ + E+ T GQ          +   + D+   L Q  +L Q 
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPY----PGVENSEIYDY---LRQGNRLKQP 236

Query: 535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            D           L+ +  +   C   NP  RP    +   LE
Sbjct: 237 PDC----------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 10/199 (5%)

Query: 308 ILGRGGFG-IVYKGCFSDGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLAVHRNLLRLC 364
           +LG+G FG ++       G L AVK LK D  +   +V+   TE   +SLA +   L   
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
             C    +RL       NG     L  HI      D AR +  A      L++LH++   
Sbjct: 62  YCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDK--- 115

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
            II+RD+K  N+LLD +    + DFG+ K     +   T+   GT  +IAPE L      
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 485 EKTDVFGFGILLLELITGQ 503
              D +  G+LL E++ G 
Sbjct: 175 PSVDWWAMGVLLYEMLCGH 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 24/205 (11%)

Query: 308 ILGRGGFGIVYKG-CFSDGALVAVKRLK----DYNIAG--GEVQFQTEVETISLAVHRNL 360
           ++GRG +G VY+G     G +VA+K +     D +++    EV   ++   +  +   N+
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQ---LRQSQPPNI 64

Query: 361 LRLCGFCSTENERL-LVYPYMPNGSVASRLR-DHIHGRPALDWARRKRIALGTARGLLYL 418
            +  G    +  RL ++  Y   GSV + ++   I  +      R   +AL       Y+
Sbjct: 65  TKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK------YI 117

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           H+     +IHRD+KAANIL+       + DFG+A LL+   S  +T V GT   +APE +
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVI 173

Query: 479 STGQSSE-KTDVFGFGILLLELITG 502
           + G+  + K D++  GI + E+ TG
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 12/199 (6%)

Query: 309 LGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGF 366
           +G G  GIV+K      G  VA+K++    + GG   Q   E++ +    H  +++L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 367 CSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
                    LV  YMP   ++  LRD       L  A+ K       +G+ Y+H      
Sbjct: 68  -FPHGSGFVLVMEYMP-SDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHAN---G 119

Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-S 484
           I+HRD+K AN+L+  D    + DFGLA+L    +  + +    T  + APE L   +   
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179

Query: 485 EKTDVFGFGILLLELITGQ 503
              D++  G +  EL+ G 
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           LG G FG VYK    +  L A  ++     +  E++ F  E++ +S   H N++ L    
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
             EN+  ++  +   G++ S + +   G   L   + + +       L +LH     K+I
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERG---LTEPQIRYVCRQMLEALNFLHSH---KVI 125

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 485
           HRD+KA NILL  D +  + DFG++           T + GT   +APE ++     +  
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNP 184

Query: 486 ---KTDVFGFGILLLEL 499
              K D++  GI L+EL
Sbjct: 185 YDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 68/204 (33%), Positives = 94/204 (46%), Gaps = 20/204 (9%)

Query: 308 ILGRGGFGIV----YKGCFSDGALVAVKRL-KDYNIAGGEVQF-QTEVETISLA-VHRNL 360
           +LG+G FG V     KG      L AVK L KD  +   +V+   TE   ++LA  H  L
Sbjct: 2   VLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 361 LRL-CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
            +L   F  T++    V  Y+  G     L  HI      D  R +  A     GL +LH
Sbjct: 59  TQLHSCF-QTKDRLFFVMEYVNGGD----LMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           E+    II+RD+K  N+LLD +    + DFG+ K         T+   GT  +IAPE LS
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILS 169

Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
                   D +  G+LL E++ GQ
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 16/207 (7%)

Query: 303 FSAKNILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHR 358
           F    +LG+GGFG V   C   + G + A KRL+   I    GE     E + +     +
Sbjct: 2   FRQYRVLGKGGFGEVC-ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLL 416
            ++ L     T++   LV   M  G     L+ HI+  G P  +  R    A     GL 
Sbjct: 61  FVVNLAYAYETKDALCLVLTIMNGGD----LKFHIYNMGNPGFEEERALFYAAEILCGLE 116

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
            LH +     ++RD+K  NILLD+     + D GLA  +   +S       GTVG++APE
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPE 171

Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
            L+  + +   D +G G L+ E+I GQ
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 60/192 (31%), Positives = 94/192 (48%), Gaps = 25/192 (13%)

Query: 328 VAVKRLKDYNIAGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYMPNGSVA 386
           VAVK LKD           +E+E + +   H+N++ L G C+ +    ++  Y   G+  
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN-- 104

Query: 387 SRLRDHIHGR--PALDWARRK--------------RIALGTARGLLYLHEQCDPKIIHRD 430
             LR+++  R  P +D++                   A   ARG+ YL  Q   K IHRD
Sbjct: 105 --LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRD 159

Query: 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDV 489
           + A N+L+ ED    + DFGLA+ + + D +  TT  R  V  +APE L     + ++DV
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219

Query: 490 FGFGILLLELIT 501
           + FG+LL E+ T
Sbjct: 220 WSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 25/192 (13%)

Query: 328 VAVKRLKDYNIAGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYMPNGSVA 386
           VAVK LK            +E+E + +   H+N++ L G C+ +    ++  Y   G+  
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN-- 110

Query: 387 SRLRDHIHGR--PALDWARRK--------------RIALGTARGLLYLHEQCDPKIIHRD 430
             LR+++  R  P +++                    A   ARG+ YL  +   K IHRD
Sbjct: 111 --LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRD 165

Query: 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDV 489
           + A N+L+ ED    + DFGLA+ + H D +  TT  R  V  +APE L     + ++DV
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225

Query: 490 FGFGILLLELIT 501
           + FG+LL E+ T
Sbjct: 226 WSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 15/211 (7%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
            +   + ILG G FG + +GC          VA+  L+          F  E  T+    
Sbjct: 5   KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD 64

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N++RL G  +  N  ++V  YM NG++ S LR H      L   +   +  G A G+ 
Sbjct: 65  HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMK 121

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG--TVGHIA 474
           YL E      +H+ + A  +L++ D    +  F   +L + +   + T + G   V   A
Sbjct: 122 YLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAA 176

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
           PE +     S  +DV+ FGI++ E+++ G+R
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 74.9 bits (184), Expect = 3e-14
 Identities = 80/286 (27%), Positives = 116/286 (40%), Gaps = 41/286 (14%)

Query: 306 KNILGRGGFGIV-YKGCFSDGALVAVKRL-------KDYNIAGGEVQFQTEVETIS-LAV 356
             +LG G  G V      SDG   AVK +        D N A  EV      +  S +  
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96

Query: 357 HRNLLRLCGFCSTEN--ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA-LGTAR 413
           H +  +           E +L+   + + + A  LR  I  R   +   R+  A L   +
Sbjct: 97  HEDFAK-----KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGH 472
            LL +H      +IHRD+K+ANILL  +    +GDFG +K+     S  V     GT  +
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS 532
           +APE       S+K D+F  G+LL EL+T +R  D     N   VM              
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEVM-------------- 254

Query: 533 QMVDKDLKGNFDRIELE---EMVQVALLCTQFNPLHRPKMSEVLKM 575
               K L G +D +      EM ++       +P  RP  S++L M
Sbjct: 255 ---HKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 38/223 (17%)

Query: 309 LGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           +G+G FG V++        +    +VAVK LK+   A  +  FQ E   ++   H N+++
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 363 LCGFCSTENERLLVYPYMPNG------------------SVASRLRDHIHGRPALDWARR 404
           L G C+      L++ YM  G                     S  R        L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
             IA   A G+ YL E+   K +HRD+   N L+ E+    + DFGL+     R+ +   
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS-----RNIYSAD 184

Query: 465 AVRGT------VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
             + +      +  + PE +   + + ++DV+ +G++L E+ +
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 309 LGRGGFGIVYKG-----CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           LG   FG +YKG           LVA+K LKD N      +FQ E   ++   H N++ L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 364 CGFCSTENERLLVYPYM-------------PNGSVASRLRDHIHGRPALDWARRKRIALG 410
            G  + E    +++ Y+             P+  V     +    + +LD      IA+ 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGT 469
            A G+ YL        +H+D+ A NIL+ E     + D GL++ +   D + V       
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           +  + PE +  G+ S  +D++ FG++L E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG V + C  D      G  VAVK LK  +        + E+E +    H N+++
Sbjct: 12  LGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRL---RDHIHGRPALDWARRKRIALGTARGLLY 417
             G C+ +      L+  ++P+GS+   L   ++ I+ +  L +A +        +G+ Y
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ------ICKGMDY 124

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA--VRGTVGHIAP 475
           L  +   + +HRD+ A N+L++ + +  +GDFGL K ++    + T    +   V   AP
Sbjct: 125 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT 501
           E L   +    +DV+ FG+ L EL+T
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT---EVETISLAVHRNLLRLC 364
           +G G +G+V K      G +VA+K+ K+      E   +T   EV+ +    H N++ L 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIALGTARGLLYLHEQCD 423
                +    LV+ Y+        L + +   P  L     +       + + Y H    
Sbjct: 67  EAFRRKGRLYLVFEYVER-----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH-- 119

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL-STGQ 482
             IIHRD+K  NIL+ E     + DFG A+ L  R +   T    T  + APE L     
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 483 SSEKTDVFGFGILLLELITGQ 503
             +  DV+  G ++ EL+ G+
Sbjct: 179 YGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 33/219 (15%)

Query: 309 LGRGGFGIVYK----GCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V +    G           VAVK LKD           +E+E + L   H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWA--------------R 403
           ++ L G C+ E    ++  Y   G+    LR+ +  R  P  D+                
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGN----LREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
               A   ARG+ YL  +   + IHRD+ A N+L+ ED    + DFGLA+ +   D +  
Sbjct: 136 LVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           T+  R  V  +APE L     + ++DV+ FGIL+ E+ T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 17/215 (7%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA---VH 357
           NF     LG G +  VYKG   + G +VA   LK+ ++   E    T +  ISL     H
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVA---LKEIHLDAEEGTPSTAIREISLMKELKH 57

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLL 416
            N++RL     TEN+ +LV+ YM       +  D  HG   ALD    K       +G+ 
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYMDKD--LKKYMD-THGVRGALDPNTVKSFTYQLLKGIA 114

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + HE    +++HRD+K  N+L+++  E  + DFGLA+      +  +  V  T+ + AP+
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPD 170

Query: 477 YLSTGQS-SEKTDVFGFGILLLELITGQRALDFGR 510
            L   ++ S   D++  G ++ E+ITG R L  G 
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGT 204

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 35/219 (15%)

Query: 302 NFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-L 354
           N S    LG G FG V +        SD  + VAVK LK    +       +E++ +S L
Sbjct: 36  NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95

Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
             H N++ L G C+     L++  Y   G +             L++ RRKR +  T   
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDL-------------LNFLRRKRESFLTLED 142

Query: 415 LLYLHEQ--------CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
           LL    Q             IHRD+ A N+LL       + DFGLA+ + +  ++V   V
Sbjct: 143 LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---V 199

Query: 467 RGT----VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           +G     V  +APE +     + ++DV+ +GILL E+ +
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 77/278 (27%), Positives = 122/278 (43%), Gaps = 37/278 (13%)

Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLL 361
           F+    +G+G FG V+KG  +    V   ++ D   A  E++  Q E+  +S      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           +  G    + +  ++  Y+  GS      D +   P LD  +   I     +GL YLH +
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGP-LDETQIATILREILKGLDYLHSE 120

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-TAVRGTVGHIAPEYLST 480
              K IHRD+KAAN+LL E  E  + DFG+A  L   D+ +      GT   +APE +  
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD-- 538
                K D++  GI  +EL  G+                    +LH   K+  ++ K+  
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPH----------------SELHPM-KVLFLIPKNNP 218

Query: 539 --LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
             L+GN+ +  L+E V+    C    P  RP   E+LK
Sbjct: 219 PTLEGNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 71.6 bits (175), Expect = 8e-14
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 18/211 (8%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLK---DYNIAGGEVQ-FQTEVETISL 354
           +N+    +LG+G FG VY  C+    G  +AVK+++   +      EV   + E++ +  
Sbjct: 2   TNWRLGKLLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60

Query: 355 AVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
            +H  +++  G      ER L     +MP GS+    +D +    AL     ++      
Sbjct: 61  LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSI----KDQLKSYGALTENVTRKYTRQIL 116

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAVRGTV 470
            G+ YLH      I+HRD+K ANIL D      +GDFG +K L       T   +V GT 
Sbjct: 117 EGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
             ++PE +S      K D++  G  ++E++T
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 71.8 bits (176), Expect = 9e-14
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 16/207 (7%)

Query: 303 FSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHR 358
           F    +LG+GGFG V   C     G + A K+L+   I    GE     E + +     R
Sbjct: 2   FRHYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLL 416
            ++ L     T++   LV   M  G     L+ HI+  G P  D  R    A     GL 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGD----LKFHIYNMGNPGFDEERAVFYAAEITCGLE 116

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
            LH +   +I++RD+K  NILLD+     + D GLA  ++  +        GTVG++APE
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPE 171

Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
            +   + +   D +G G L+ E+I G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 38/275 (13%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG+V+ G +     VA+K + +   A  E  F  E + +    H  L++L G C+
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR----GLLYLHEQCDP 424
            +    +V  +M NG + + LR    G+        K + L   +    G+ YL      
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQR-QGK------LSKDMLLSMCQDVCEGMEYLERN--- 119

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTA-VRGTVGHIAPEYLSTGQ 482
             IHRD+ A N L+       V DFG+ + +LD  D + +++  +  V    PE  +  +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 483 SSEKTDVFGFGILLLELITGQRALDFGRAANQRGV-MLDWVKKLHQEGKLSQMVDKDLKG 541
            S K+DV+ FG+L+ E+ T  + + F + +N   V M+    +L++  KL+ M       
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGK-MPFEKKSNYEVVEMISRGFRLYRP-KLASMT------ 229

Query: 542 NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
                    + +V   C    P  RP  +E+L+ +
Sbjct: 230 ---------VYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 31/218 (14%)

Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-----ALDWARRKRIALG---- 410
           ++ L G C+ +    ++  Y   G++   LR     RP     + D AR     +     
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGMEYSYDIARVPDEQMTFKDL 139

Query: 411 ------TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VT 463
                  ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  T
Sbjct: 140 VSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           T  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 71.4 bits (176), Expect = 1e-13
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 29/213 (13%)

Query: 303 FSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQFQT--EVETISLAVHR 358
           +     LG G +G+VYK      G +VA+K+++ D    G  +      E+  +    H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG--IPSTALREISLLKELKHP 58

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLY 417
           N+++L     TE +  LV+ Y         L+ ++  RP  L     K I     RGL Y
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYC-----DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-----RGTVGH 472
            H     +I+HRD+K  NIL++ D    + DFGLA+         T  V     R     
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR----- 165

Query: 473 IAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
            APE L  S   S+   D++  G +  E+ITG+
Sbjct: 166 -APEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 10/202 (4%)

Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLL 361
           F+    +G+G FG VYKG  +    V   ++ D   A  E++  Q E+  +S      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           R  G      +  ++  Y+  GS    L+        L+      I     +GL YLH +
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE 120

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              + IHRD+KAAN+LL E  +  + DFG+A  L        T V GT   +APE +   
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176

Query: 482 QSSEKTDVFGFGILLLELITGQ 503
               K D++  GI  +EL  G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 21/204 (10%)

Query: 308 ILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           +LG G FG VYKG +  DG      VA+K L++        +   E   ++      + R
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTARGLLYLH 419
           L G C T   +L V   MP G +   +R++   I  +  L+W       +  A+G+ YL 
Sbjct: 74  LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWC------VQIAKGMSYLE 126

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEY 477
           E    +++HRD+ A N+L+       + DFGLA+LL  D  + H     +  +  +A E 
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG-KVPIKWMALES 182

Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           +   + + ++DV+ +G+ + EL+T
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 69/233 (29%), Positives = 105/233 (45%), Gaps = 18/233 (7%)

Query: 303 FSAKNILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHR 358
           F    +LG+GGFG V   C   + G + A K+L+   I    GE     E + +     R
Sbjct: 2   FRQYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLL 416
            ++ L     T++   LV   M  G     L+ HI+  G    +  R    A     GL 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGD----LKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAP 475
            LH++   +I++RD+K  NILLD+     + D GLA    H     T   R GTVG++AP
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAP 170

Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE 528
           E +   + +   D +  G LL E+I GQ      +   +R  +   VK++ +E
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 66/204 (32%), Positives = 91/204 (44%), Gaps = 20/204 (9%)

Query: 308 ILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLAVHRNLLR-- 362
           +LG+G FG V+           A+K LK D  +   +V+    E   +SLA     L   
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            C F + EN    V  Y+  G     L  HI      D  R    A     GL +LH + 
Sbjct: 62  YCTFQTKEN-LFFVMEYLNGGD----LMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK- 115

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAK---LLDHRDSHVTTAVRGTVGHIAPEYLS 479
              I++RD+K  NILLD D    + DFG+ K   L D +    T    GT  +IAPE L 
Sbjct: 116 --GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----TCTFCGTPDYIAPEILL 169

Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
             + +   D + FG+LL E++ GQ
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 32/215 (14%)

Query: 309 LGRGGFGIVYKGCFSDGA--LVAVKRLKDYNIAGGEVQFQ---------TEVETISLAV- 356
           LG G FG VYK    +    L+A+K +  +N A G+ + +         +EV  I   + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI------HGRPALD--WARRKRIA 408
           H N++R       EN+RL +   +  G+    L +H         R   +  W    ++ 
Sbjct: 68  HPNIVRYYK-TFLENDRLYIVMDLIEGA---PLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG 468
           L     L YLH++   +I+HRD+   NI+L ED +  + DFGLAK     +S +T+ V G
Sbjct: 124 LA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-G 175

Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           T+ +  PE +      EK DV+ FG +L ++ T Q
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 18/210 (8%)

Query: 302 NFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLK---DYNIAGGEVQ-FQTEVETISLA 355
           N+    +LGRG FG VY  C+    G  +AVK++    D      EV   + E++ +   
Sbjct: 3   NWRLGKLLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 356 VHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
            H  +++  G      E+ L     YMP GS+    +D +    AL     +R      +
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI----KDQLKAYGALTENVTRRYTRQILQ 117

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD--HRDSHVTTAVRGTVG 471
           G+ YLH      I+HRD+K ANIL D      +GDFG +K +           +V GT  
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
            ++PE +S      K DV+     ++E++T
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 22/201 (10%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG G FG VYK    + GAL A K ++  +    E  +  E+E ++   H  +++L G  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYMVEIEILATCNHPYIVKLLGAF 78

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
             + +  ++  + P G+V + + +   G   L   + + I       L YLH     KII
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSM---KII 132

Query: 428 HRDVKAANILLDEDFEAVVGDFGLA----KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
           HRD+KA N+LL  D +  + DFG++    K L  RDS +     GT   +APE +     
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETM 187

Query: 484 SE-----KTDVFGFGILLLEL 499
            +     K D++  GI L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 66/201 (32%), Positives = 96/201 (47%), Gaps = 14/201 (6%)

Query: 308 ILGRGGFGIVYKGCFSD-GALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           +LG+G FG V            A+K LK D  +   +V+  T VE   LA+      L  
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVE-CTMVERRVLALAWEHPFLTH 60

Query: 366 -FCS--TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            FC+  T+     V  Y+  G     L  HI      D AR +  A     GL +LH++ 
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGD----LMFHIQSSGRFDEARARFYAAEIICGLQFLHKK- 115

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
              II+RD+K  N+LLD+D    + DFG+ K   + +   +T   GT  +IAPE L   +
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQK 172

Query: 483 SSEKTDVFGFGILLLELITGQ 503
            +E  D + FG+LL E++ GQ
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 71.4 bits (175), Expect = 4e-13
 Identities = 44/112 (39%), Positives = 56/112 (50%), Gaps = 9/112 (8%)

Query: 413 RGLL----YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVR 467
           R LL    YLH +    IIHRDVK  NI LDE   AV+GDFG A KL  H D+       
Sbjct: 192 RRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML 519
           GT+   +PE L+      KTD++  G++L E+      L FG+        L
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL-FGKQVKSSSSQL 299

Length = 392

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 20/200 (10%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG VYK    +  ++A  ++ D         +  E++ ++   H N+++L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            EN   ++  +   G+V + +   +     L   + + +   T   L YLHE    KIIH
Sbjct: 73  YENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 429 RDVKAANILLDEDFEAVVGDFGLA----KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           RD+KA NIL   D +  + DFG++    + +  RDS +     GT   +APE +    S 
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181

Query: 485 E-----KTDVFGFGILLLEL 499
           +     K DV+  GI L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 33/212 (15%)

Query: 309 LGRGGFGIVY---KGCFSDGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLRL 363
           + +G +G V+   K   S G + A+K +K  ++       Q  TE + +S A    +++L
Sbjct: 1   ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 364 CGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARR--KRIALGTARGLLYLH 419
             + S + ++   LV  Y+P G +AS L     G    D AR     I L     L YLH
Sbjct: 59  --YYSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLA----LEYLH 110

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL--------LDHRDSHVTTAVRGTVG 471
                 IIHRD+K  NIL+D +    + DFGL+K+        L+  +      V GT  
Sbjct: 111 SN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPD 166

Query: 472 HIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
           +IAPE +  GQ   KT D +  G +L E + G
Sbjct: 167 YIAPEVI-LGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.8 bits (168), Expect = 9e-13
 Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 25/204 (12%)

Query: 306 KNILGRGGFGIVYKGC-FSDGALVAVKRLK-DYNIAGGEVQFQ--TEVETISLAVHRNLL 361
           + ILG G  G VYK        ++AVK +  D  +   E+Q Q  +E+E +       ++
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV---ELQKQIMSELEILYKCDSPYII 62

Query: 362 RLCGFCSTENERLLVYPYMPNGS--VASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
              G    EN   +   +M  GS  V  ++ +H+ GR          IA+   +GL YL 
Sbjct: 63  GFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGR----------IAVAVVKGLTYLW 112

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
                KI+HRDVK +N+L++   +  + DFG++  L   +S   T V GT  ++APE +S
Sbjct: 113 SL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERIS 166

Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
             Q    +DV+  GI  +EL  G+
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 71.0 bits (174), Expect = 1e-12
 Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 2/119 (1%)

Query: 70  CSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129
           CS  G +  L L S SL G +   +G    L+ V LQ+N+  G +P+   KL  +  LD+
Sbjct: 377 CS-SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435

Query: 130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           SNN   G I     D+ +L  L L  N   G  P+S    + L  +DLS N  SG++P+
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS-FGSKRLENLDLSRNQFSGAVPR 493

Length = 968

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 10/202 (4%)

Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLL 361
           F+    +G+G FG V+KG  +    V   ++ D   A  E++  Q E+  +S      + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           +  G      +  ++  Y+  GS    LR         D  +   +     +GL YLH +
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              K IHRD+KAAN+LL E  +  + DFG+A  L        T V GT   +APE +   
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176

Query: 482 QSSEKTDVFGFGILLLELITGQ 503
               K D++  GI  +EL  G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 18/210 (8%)

Query: 302 NFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLK---DYNIAGGEVQ-FQTEVETISLA 355
           N+    +LG+G FG VY  C+    G  +A K+++   +      EV   + E++ +   
Sbjct: 3   NWRRGKLLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 356 VHRNLLRLCGFCSTENERLLV--YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
            H  +++  G      E+ L     YMP GSV    +D +    AL  +  ++       
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSV----KDQLKAYGALTESVTRKYTRQILE 117

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAVRGTVG 471
           G+ YLH      I+HRD+K ANIL D      +GDFG +K L       T   +V GT  
Sbjct: 118 GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174

Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
            ++PE +S      K DV+  G  ++E++T
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 25/205 (12%)

Query: 309 LGRGGFGIVYKGCFS--DGALVAVKRLK-------DYNIAGGEVQFQTEVETISLAVHRN 359
           +G G +G+VYK       G +VA+K++K           A  E++   E+       H N
Sbjct: 7   IGEGTYGVVYK-ARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN------HPN 59

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L      + +  LV+ +M +  +   ++D   G   L  +  K       +GL + H
Sbjct: 60  IIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLAFCH 115

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
                 I+HRD+K  N+L++ +    + DFGLA+         T  V  T  + APE L 
Sbjct: 116 SH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLL 171

Query: 480 T-GQSSEKTDVFGFGILLLELITGQ 503
                S   D++  G +  EL++ +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 67/205 (32%), Positives = 92/205 (44%), Gaps = 20/205 (9%)

Query: 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQ---TEVETISLAVHRNLLRLC 364
           +G G FG VY    S    +VAVK++  Y+      ++Q    EV+ +    H N +   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G    E+   LV  Y   GS +  L   +H +P L       I  G  +GL YLH     
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLE--VHKKP-LQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY---LSTG 481
            +IHRD+KA NILL E  +  + DFG A      +S V     GT   +APE    +  G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195

Query: 482 QSSEKTDVFGFGILLLELITGQRAL 506
           Q   K DV+  GI  +EL   +  L
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 14/201 (6%)

Query: 308 ILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLAVHRNLLR-- 362
           +LG+G FG V        G   AVK LK D  +   +V+    E   ++LA     L   
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            C F  T+     V  ++  G     L  HI  +   D  R    A     GL +LH + 
Sbjct: 62  YCTF-QTKEHLFFVMEFLNGGD----LMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK- 115

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
              II+RD+K  N++LD D    + DFG+ K     D+  +T   GT  +IAPE L   +
Sbjct: 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLK 172

Query: 483 SSEKTDVFGFGILLLELITGQ 503
            +   D + FG+LL E++ GQ
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 20/219 (9%)

Query: 307 NILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           N +G G  G VYK      G L A+K +   +      Q   E+E +    H N+++   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL-DWARRKRIALGTARGLLYLHEQCDP 424
                 E  ++  +M  GS+      HI     L D AR+         G+ YLH +   
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGT---HIADEQFLADVARQ------ILSGIAYLHRR--- 187

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
            I+HRD+K +N+L++      + DFG++++L        ++V GT+ +++PE ++T  + 
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNH 246

Query: 485 EK-----TDVFGFGILLLELITGQRALDFGRAANQRGVM 518
                   D++  G+ +LE   G+     GR  +   +M
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM 285

Length = 353

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 16/207 (7%)

Query: 303 FSAKNILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHR 358
           F    +LG+GGFG V   C   + G + A K+L+   I    GE     E   +     R
Sbjct: 2   FRHYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLL 416
            ++ L     T++   LV   M  G     L+ HI+  G P  D  R    A     GL 
Sbjct: 61  FVVSLAYAYETKDALCLVLTIMNGGD----LKFHIYNMGNPGFDEQRAIFYAAELCCGLE 116

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
            L  +   +I++RD+K  NILLD+     + D GLA  +   +        GTVG++APE
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGRVGTVGYMAPE 171

Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++  + +   D +G G L+ E+I GQ
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 25/215 (11%)

Query: 302 NFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVE-TISLAV 356
           NF    +LG G +G V+     G    G L A+K LK   I    VQ     E T +   
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEHTRTERQ 56

Query: 357 HRNLLRLCGFC-------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
               +R C F         T+ +  L+  Y+  G     L  H++ R     +  +    
Sbjct: 57  VLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGG----ELFTHLYQREHFTESEVRVYIA 112

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
                L +LH+     II+RD+K  NILLD +   V+ DFGL+K     +     +  GT
Sbjct: 113 EIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169

Query: 470 VGHIAPEYLSTGQS--SEKTDVFGFGILLLELITG 502
           + ++APE +  G     +  D +  G+L  EL+TG
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 64/198 (32%), Positives = 91/198 (45%), Gaps = 20/198 (10%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQ---TEVETISLAVHRNLLRLC 364
           +G G FG VY      +  +VA+K++  Y+      ++Q    EV  +    H N ++  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G    E+   LV  Y   GS +  L   +H +P L       +  G  +GL YLH     
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDLLE--VHKKP-LQEVEIAAVTHGALQGLAYLHSH--- 134

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY---LSTG 481
            +IHRDVKA NILL E     +GDFG A ++   +  V     GT   +APE    +  G
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEG 189

Query: 482 QSSEKTDVFGFGILLLEL 499
           Q   K DV+  GI  +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 23/225 (10%)

Query: 296 LRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETIS 353
           LR     F    ++G G +G VYKG     G L A+K +   ++ G E +  + E+  + 
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLK 57

Query: 354 -LAVHRNLLRLCGFCSTEN------ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
             + HRN+    G    +N      +  LV  +   GSV   +++        +W     
Sbjct: 58  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AY 115

Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
           I     RGL +LH+    K+IHRD+K  N+LL E+ E  + DFG++  LD       T +
Sbjct: 116 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 172

Query: 467 RGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELITGQRAL 506
            GT   +APE ++  ++ +     K+D++  GI  +E+  G   L
Sbjct: 173 -GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 27/163 (16%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRL-----KDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG VYK      G +VA+K++     KD    G  +    E++ +    H N++ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKD----GFPITALREIKILKKLKHPNVVP 71

Query: 363 LCGFC-----STENERLLVY---PYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTAR 413
           L          ++ +R  VY   PYM        L   +      L  ++ K   L    
Sbjct: 72  LIDMAVERPDKSKRKRGSVYMVTPYM-----DHDLSGLLENPSVKLTESQIKCYMLQLLE 126

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
           G+ YLHE     I+HRD+KAANIL+D      + DFGLA+  D
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 17/201 (8%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           +G G +G+V+K    + G +VA+K+      D  I   ++  + E+  +    H NL+ L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK--KIALR-EIRMLKQLKHPNLVNL 65

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
                 + +  LV+ Y  + +V + L  +  G   +     K+I   T + + + H+   
Sbjct: 66  IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKH-- 119

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL-STGQ 482
              IHRDVK  NIL+ +  +  + DFG A++L       T  V  T  + APE L    Q
Sbjct: 120 -NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQ 177

Query: 483 SSEKTDVFGFGILLLELITGQ 503
                DV+  G +  EL+TGQ
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 66/201 (32%), Positives = 90/201 (44%), Gaps = 19/201 (9%)

Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VH-RNLLRLC 364
           LG+GGFG V   C   + G L A K+L    +   +      VE   LA VH R ++ L 
Sbjct: 1   LGKGGFGEVS-ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHG----RPALDWARRKRIALGTARGLLYLHE 420
               T+ +  LV   M  G     LR HI+      P     R          GL +LH+
Sbjct: 60  YAFQTKTDLCLVMTIMNGGD----LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           +   +II+RD+K  N+LLD D    + D GLA +L D +    T    GT G +APE L 
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQ 170

Query: 480 TGQSSEKTDVFGFGILLLELI 500
             +     D F  G+ L E+I
Sbjct: 171 GEEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 43/223 (19%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAV-H 357
           + F   N +G G +GIVY+    + G +VA+K+++  N   G  +    E+ T+ L + H
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI-TLLLNLRH 65

Query: 358 RNLLRL---------------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWA 402
            N++ L                 +C  +   LL    MP                    +
Sbjct: 66  PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT---------------PFSES 108

Query: 403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462
           + K + L   RGL YLHE     IIHRD+K +N+LL +     + DFGLA+        +
Sbjct: 109 QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165

Query: 463 TTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
           T  V  T+ + APE L   T   +   D++  G +L EL+  +
Sbjct: 166 TPKVV-TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 38/229 (16%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSDG------------------ALVAVKRLKDYNIAGGEV 343
           NF  K  LG G FG V+  C +DG                   LVAVK L+         
Sbjct: 8   NFVEK--LGEGQFGEVHL-CEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64

Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI-------HGR 396
            F  EV+ +S     N+ RL G C+ +    ++  YM NG +   L+ H+          
Sbjct: 65  DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124

Query: 397 PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
            +L ++    +A   A G+ YL        +HRD+   N L+ +++   + DFG+++ L 
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 457 HRDSHVTTAVRG-TVGHI---APEYLSTGQSSEKTDVFGFGILLLELIT 501
             D +    V+G     I   A E +  G+ + K+DV+ FG+ L E++T
Sbjct: 182 SSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 61/281 (21%), Positives = 121/281 (43%), Gaps = 27/281 (9%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQ--TEVETISLAVH 357
           +NF  +  +GRG F  VY+  C  DG  VA+K+++ +++   + +     E++ +    H
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N+++       +NE  +V      G ++  ++     +  +      +  +     L +
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG---HIA 474
           +H +   +++HRD+K AN+ +       +GD GL +    +    TTA    VG   +++
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK----TTAAHSLVGTPYYMS 174

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM 534
           PE +     + K+D++  G LL E+   Q    +G   N    +    KK+ Q       
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMN----LYSLCKKIEQCDYPPLP 229

Query: 535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM 575
            D            EE+ Q+  +C   +P  RP ++ V  +
Sbjct: 230 SDH---------YSEELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 66.0 bits (162), Expect = 7e-12
 Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 30/213 (14%)

Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIA--GGEVQFQTEVETISL 354
            +F     LG G FG V    +KG    G   A+K L    I           E   +  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57

Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR--RKRIALGTA 412
             H  L+ L G    ++   LV  Y+P G + S LR    GR     AR    ++ L   
Sbjct: 58  IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLA-- 113

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
             L YLH      I++RD+K  N+LLD D    + DFG AK +  R    T  + GT  +
Sbjct: 114 --LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEY 164

Query: 473 IAPEYLST---GQSSEKTDVFGFGILLLELITG 502
           +APE + +   G++    D +  GIL+ E++ G
Sbjct: 165 LAPEIILSKGYGKAV---DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.1 bits (161), Expect = 7e-12
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 20/203 (9%)

Query: 309 LGRGGFGIVYKGCF----SDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+GGFG V   C     + G + A K+L  K      GE     E E +       ++ 
Sbjct: 1   LGKGGFGEV---CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLLYLHE 420
           L     ++    LV   M  G     L+ HI+  G   L+  R    +     G+L+LH 
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGD----LKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
                I++RD+K  N+LLD+     + D GLA  ++ +D    T   GT G++APE L  
Sbjct: 114 M---DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKE 168

Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
              S   D F  G  + E++ G+
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 66.4 bits (163), Expect = 8e-12
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 50/226 (22%)

Query: 303 FSAKNILGRGGFGIVYKGCFSD---GALVAVKRLKDYNIAGGEVQFQT---------EVE 350
           +     +G G +G+V      D   G  VA+K++ +         F           E++
Sbjct: 2   YELLKPIGSGAYGVVCSA--VDKRTGRKVAIKKISNV--------FDDLIDAKRILREIK 51

Query: 351 TISLAVHRNLLRLCGF-----CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
            +    H N++ L            N+  +V   M      + L   I     L     +
Sbjct: 52  LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-----TDLHKVIKSPQPLTDDHIQ 106

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH---- 461
                  RGL YLH      +IHRD+K +NIL++ + +  + DFGLA+ +D  +      
Sbjct: 107 YFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 462 ----VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITG 502
               VT   R      APE  LS+ + ++  D++  G +  EL+T 
Sbjct: 164 TEYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 65.7 bits (160), Expect = 9e-12
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 24/219 (10%)

Query: 303 FSAKNILGRGGFGIVYKGCF--SDGAL--VAVKRLKDYNIAGGEV-QFQTEVETISLAVH 357
           F+   +LG+G FG V +      DG+   VAVK LK    +  ++ +F  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 358 RNLLRLCGFC--STENERL----LVYPYMPNGSV-----ASRLRDHIHGRPALDWARRKR 406
            N+++L G    S    RL    ++ P+M +G +      SR+ +     P     R   
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR--- 117

Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-TA 465
             +  A G+ YL  +     IHRD+ A N +L+E+    V DFGL+K +   D +    A
Sbjct: 118 FMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQ 503
            +  V  +A E L+    +  +DV+ FG+ + E++T GQ
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 37/281 (13%)

Query: 306 KNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
              +G G FG VY+G +    ++   VAVK  K+        +F  E   +    H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           +L G   TEN   +V    P G + S L+ +   + +LD A     +   +  L YL  +
Sbjct: 71  KLIGVI-TENPVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK 126

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              + +HRD+ A N+L+       +GDFGL++ L+    +  +  +  +  +APE ++  
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183

Query: 482 QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG 541
           + +  +DV+ FG+ + E+      L  G    Q       VK     G++          
Sbjct: 184 RFTSASDVWMFGVCMWEI------LMLGVKPFQ------GVKNNDVIGRIE--------- 222

Query: 542 NFDRIELEEMVQVAL-----LCTQFNPLHRPKMSEVLKMLE 577
           N +R+ +       L      C  ++P  RP+ +E+   L 
Sbjct: 223 NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 31/282 (10%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQ--TEVETISLAV 356
             NF  +  +G+G F +VYK  C  DG +VA+K+++ + +   + +     E++ +    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARG 414
           H N+++        NE  +V      G + SR+  H     R   +    K   +     
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYF-VQLCSA 118

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--- 471
           L ++H +   +I+HRD+K AN+ +       +GD GL +      S  TTA    VG   
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPY 171

Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           +++PE +     + K+D++  G LL E+   Q    +G   N    +    K      K+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMN----LYSLCK------KI 220

Query: 532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
            +     L  +    EL ++V     C   +P  RP +S VL
Sbjct: 221 EKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 19/205 (9%)

Query: 309 LGRGGFGIVYKGCF---SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           LG G FG V KG +        VA+K LK+ N      +   E E +    +  ++R+ G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 366 FCSTENERLLVYPYMPNGSVASRL---RDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            C  E   +LV      G +   L   +D I     ++   +       + G+ YL  + 
Sbjct: 63  VCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQ------VSMGMKYLEGK- 114

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAVRGTVGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L   DS+    +A +  +   APE ++ 
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172

Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
            + S ++DV+ +GI + E  + GQ+
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 8/95 (8%)

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTT 464
           +IA    +GL YLH +   KIIHRD+K +NILL    +  + DFG++ +L++      T 
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164

Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 499
              GT  ++APE +     S  +DV+  G+ LLE+
Sbjct: 165 ---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 65.9 bits (160), Expect = 1e-11
 Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 26/207 (12%)

Query: 303 FSAKNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQ---TEVETISLA 355
           F+    +G G FG VY   F+       +VA+K++  Y+      ++Q    EV+ +   
Sbjct: 27  FTDLREIGHGSFGAVY---FARDVRTNEVVAIKKMS-YSGKQSNEKWQDIIKEVKFLQRI 82

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N +   G    E+   LV  Y   GS +  L   +H +P L       I  G  +GL
Sbjct: 83  KHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--VHKKP-LQEVEIAAITHGALQGL 138

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            YLH      +IHRD+KA NILL E  +  + DFG A +    +S V     GT   +AP
Sbjct: 139 AYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAP 190

Query: 476 EY---LSTGQSSEKTDVFGFGILLLEL 499
           E    +  GQ   K DV+  GI  +EL
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 31/178 (17%)

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
           +IA+   + L YLH +    +IHRDVK +N+L++ + +  + DFG++  L   DS   T 
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTI 162

Query: 466 VRGTVGHIAPEYLSTGQSSE----KTDVFGFGILLLELITGQRALDFGRAANQRGVMLDW 521
             G   ++APE ++   + +    K+DV+  GI ++EL TG+   D             W
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD------------SW 210

Query: 522 VKKLHQEGKLSQMVD----KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM 575
                Q   L Q+V+    +     F   E ++ V     C + N   RP   E+L+ 
Sbjct: 211 KTPFQQ---LKQVVEEPSPQLPAEKFS-PEFQDFVNK---CLKKNYKERPNYPELLQH 261

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 66.4 bits (162), Expect = 3e-11
 Identities = 37/118 (31%), Positives = 62/118 (52%), Gaps = 6/118 (5%)

Query: 76  VSALGLPSQSLSGTLSPWI---GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNN 132
           ++ L L + +L+G +   +   GNL KL   +L +N++ G IP SLG    L+ + L +N
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKL---ILFSNSLEGEIPKSLGACRSLRRVRLQDN 414

Query: 133 KFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
            F+GE+P     L  + +L ++NN+L G        + SL ++ L+ N   G LP   
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF 472

Length = 968

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 33/88 (37%), Positives = 50/88 (56%), Gaps = 5/88 (5%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
            GL YLH Q   +IIHRDVK  NI +++  +  +GD G A+      + +  A  GTV  
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--GTVET 222

Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELI 500
            APE L+  + + K D++  GI+L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 64.5 bits (158), Expect = 3e-11
 Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 28/158 (17%)

Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGG----------EVQFQTEVETISLAVH 357
           LG G + +VYK      G +VA+K++K                 E++   E++      H
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61

Query: 358 RNLLRLCG-FCSTENERLLVYPYMPNGSVASRLRDHIHGR-PALDWARRKRIALGTARGL 415
            N++ L   F    N  L V+ +M      + L   I  +   L  A  K   L T RGL
Sbjct: 62  PNIIGLLDVFGHKSNINL-VFEFME-----TDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
            YLH      I+HRD+K  N+L+  D    + DFGLA+
Sbjct: 116 EYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 42/130 (32%), Positives = 70/130 (53%), Gaps = 21/130 (16%)

Query: 379 YMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVK 432
           +M  GS+      A R+ ++I G+          I++   RGL YL E+   KI+HRDVK
Sbjct: 80  HMDGGSLDQVLKKAGRIPENILGK----------ISIAVLRGLTYLREK--HKIMHRDVK 127

Query: 433 AANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 492
            +NIL++   E  + DFG++  L   DS   + V GT  +++PE L     + ++D++  
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYTVQSDIWSL 184

Query: 493 GILLLELITG 502
           G+ L+E+  G
Sbjct: 185 GLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 44/285 (15%)

Query: 302 NFSAKNILGRGGFGIVY--KGCFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHR 358
            +     +G G FG +Y  K   SD     +K +    +   E +  + EV  ++   H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHG-----RPALDWARRKRIALGTAR 413
           N++             +V  Y   G +  R+     G        L W    +I+LG   
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWF--VQISLG--- 113

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
            L ++H   D KI+HRD+K+ NI L ++   A +GDFG+A+ L+       T V GT  +
Sbjct: 114 -LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYY 168

Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS 532
           ++PE       + KTD++  G +L EL T                    +K   +   L 
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCT--------------------LKHPFEGNNLH 208

Query: 533 QMVDKDLKGNFDRIELEEMVQVALLCTQF---NPLHRPKMSEVLK 574
           Q+V K  +G F  I       +  L +Q    +P  RP ++ +LK
Sbjct: 209 QLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 49/176 (27%), Positives = 86/176 (48%), Gaps = 22/176 (12%)

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
           +IA+    GL YL+     +I+HRD+K +NIL++   +  + DFG++  L   +S   T 
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL--INSIADTF 162

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGV----MLDW 521
           V GT  +++PE +  G+ + K+DV+  GI ++EL  G+    F    +        +LD 
Sbjct: 163 V-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL 221

Query: 522 VKKLHQEG--KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM 575
           ++++ QE   +L          +F    L + V   LL    +P  RP   ++  M
Sbjct: 222 LQQIVQEPPPRLP-------SSDFPED-LRDFVDACLLK---DPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 27/208 (12%)

Query: 308 ILGRGGFGIVYKGC--FSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           I+GRGGFG VY GC     G + A+K L  K   +  GE     E   +SL    +    
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---- 55

Query: 364 CGF--C-----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           C F  C      T ++   +   M  G +   L  H         A  +  A     GL 
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLE 111

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           ++H +    +++RD+K ANILLDE     + D GLA     +  H +    GT G++APE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165

Query: 477 YLSTGQSSEKT-DVFGFGILLLELITGQ 503
            L  G + + + D F  G +L +L+ G 
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 18/203 (8%)

Query: 308 ILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISLAV-HRNL 360
           +LG+G FG V     KG  +D  + A+K L KD  +   +V    TE   ++LA  H  L
Sbjct: 2   VLGKGSFGKVMLAELKG--TD-EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             L     T++    V  Y+  G     L   I      D  R +  A      L++LH 
Sbjct: 59  TALHCCFQTKDRLFFVMEYVNGGD----LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
                +I+RD+K  NILLD +    + DFG+ K     +   TT   GT  +IAPE L  
Sbjct: 115 H---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQE 170

Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
            +     D +  G+L+ E++ GQ
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 63.0 bits (154), Expect = 6e-11
 Identities = 56/198 (28%), Positives = 84/198 (42%), Gaps = 14/198 (7%)

Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCG 365
           LG GGFG V      S     A+K +K  +I   G +    +E E +    H  +++L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 366 FCSTENERLLVYPYMPNGSVAS-RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           + + ++++   Y YM         L   +  R   D    +           YLH +   
Sbjct: 59  YRTFKDKK---YIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR--- 112

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
            II+RD+K  N+LLD +    + DFG AK L       T    GT  ++APE +      
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKGYD 170

Query: 485 EKTDVFGFGILLLELITG 502
              D +  GILL EL+TG
Sbjct: 171 FSVDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)

Query: 309 LGRGGFGIVYKGCFSDG---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           +G G FG V  G  + G   A V VK L+       +++F  E +      H NLL+  G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 366 FCSTENERLLVYPYMPNGSVASRLRD-HIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
            C+     LLV  + P G +   LR          D    +R+A   A GLL+LH+    
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--HIAPEYLSTGQ 482
             IH D+   N LL  D    +GD+GL+    +++ +  T  +  V    IAPE +    
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 483 S-------SEKTDVFGFGILLLEL 499
                   +++++V+  G+ + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 27/163 (16%)

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           G+ ++HE+   +++HRD+K+ NI L ++ +  +GDFG A+LL    ++  T V GT  ++
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
            PE       + K+D++  G +L EL T                    +K   Q      
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCT--------------------LKHPFQANSWKN 207

Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQF---NPLHRPKMSEVL 573
           ++ K  +G++  +      ++  L  Q    NP  RP  + +L
Sbjct: 208 LILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 62.5 bits (152), Expect = 9e-11
 Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 27/164 (16%)

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
            L ++H   D KI+HRD+K+ NI L +D    +GDFG+A++L+       T + GT  ++
Sbjct: 113 ALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYL 168

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
           +PE       + K+D++  G +L E+ T + A + G   N                    
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-------------------- 208

Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQF---NPLHRPKMSEVLK 574
           +V K ++G++  +       +  L +Q    NP  RP ++ +L+
Sbjct: 209 LVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 33/211 (15%)

Query: 308 ILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL-- 363
           I+GRGGFG VY GC     G + A+K L    I         + ET++L   R +L L  
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIK------MKQGETLALN-ERIMLSLVS 52

Query: 364 ---CGFC-------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
              C F         T ++   +   M  G +   L  H            +  A     
Sbjct: 53  TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIIL 108

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           GL ++H +    +++RD+K ANILLDE     + D GLA     +  H +    GT G++
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162

Query: 474 APEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
           APE L  G + + + D F  G +L +L+ G 
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 21/220 (9%)

Query: 296 LRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS- 353
           LR     F    ++G G +G VYKG     G L A+K +        E + + E+  +  
Sbjct: 11  LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKK 68

Query: 354 LAVHRNLLRLCGF------CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
            + HRN+    G          +++  LV  +   GSV   +++        DW     I
Sbjct: 69  YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYI 126

Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
                RGL +LH     K+IHRD+K  N+LL E+ E  + DFG++  LD       T + 
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI- 182

Query: 468 GTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELITG 502
           GT   +APE ++  ++ + T     D++  GI  +E+  G
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 68/270 (25%), Positives = 114/270 (42%), Gaps = 30/270 (11%)

Query: 309 LGRGGFGIVYKGCFS---DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +        VAVK LK D N    + +   E   +    +  ++R+ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G C  E+  +LV      G +   L+ + H    +       +    + G+ YL E    
Sbjct: 63  GICEAES-WMLVMELAELGPLNKFLQKNKH----VTEKNITELVHQVSMGMKYLEET--- 114

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLSTGQ 482
             +HRD+ A N+LL     A + DFGL+K L   +++      G   V   APE ++  +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 483 SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN 542
            S K+DV+ FG+L+ E      A  +G+   +            +  +++QM++   +  
Sbjct: 175 FSSKSDVWSFGVLMWE------AFSYGQKPYKG----------MKGNEVTQMIESGERME 218

Query: 543 FDRIELEEMVQVALLCTQFNPLHRPKMSEV 572
             +    EM  +  LC  +    RP  + V
Sbjct: 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 21/163 (12%)

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
           A  L YLHE+    I+HRD+K  N+ L       VGD G+A++L+++    +T + GT  
Sbjct: 112 AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPY 167

Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           +++PE  S    + K+DV+  G  + E+ T + A +   A +   ++   +     EGKL
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN---AKDMNSLVYRII-----EGKL 219

Query: 532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
             M            EL E++   +L  +  P  RP +  +L+
Sbjct: 220 PPMPKDYSP------ELGELIA-TMLSKR--PEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 35/224 (15%)

Query: 306 KNILGRGGFGIVYKGCFSDG----------------ALVAVKRLKDYNIAGGEVQFQTEV 349
           K  LG G FG V+  C ++G                 LVAVK L+          F  E+
Sbjct: 10  KEKLGEGQFGEVHL-CEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD--------HIHGRPALDW 401
           + +S   + N++RL G C +++   ++  YM NG +   L          H +  P++  
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
           A    +A+  A G+ YL        +HRD+   N L+   +   + DFG+++ L   D +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 462 VTTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
               ++G     +  +A E +  G+ +  +DV+ FG+ L E+ T
Sbjct: 186 ---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 20/213 (9%)

Query: 303 FSAKNILGRGGFGIVYKGCFSDGAL-----VAVKRLKDYNIAGGEVQ---FQTEVETISL 354
            +  ++L  G FG ++ G   D        V VK +KD+     E+Q      E   +  
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYG 64

Query: 355 AVHRNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKR----IAL 409
             H+N+L +   C  + E   V YPYM  G++   L+    G      A   +    +A+
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRG 468
             A G+ YLH++    +IH+D+ A N ++DE+ +  + D  L++ L   D H +      
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181

Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
            V  +A E L   + S  +DV+ FG+LL EL+T
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 16/218 (7%)

Query: 300 TSNFSAKNILGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
           T  +     +G+G +G VYK     DG+L AVK L   +    E++ +  +   SL  H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ-SLPNHP 79

Query: 359 NLLRLCGFCSTENERL-----LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
           N+++  G     ++ +     LV      GSV   ++  +     LD A    I  G   
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           GL +LH     +IIHRDVK  NILL  +    + DFG++  L        T+V GT   +
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 195

Query: 474 APEYLSTGQSSE-----KTDVFGFGILLLELITGQRAL 506
           APE ++  Q  +     + DV+  GI  +EL  G   L
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 8/102 (7%)

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
           ++ +   + L YL E+    +IHRDVK +NILLD      + DFG++  L   DS   T 
Sbjct: 118 KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTR 173

Query: 466 VRGTVGHIAPEYLSTGQSSEK----TDVFGFGILLLELITGQ 503
             G   ++APE +     + K     DV+  GI L+EL TGQ
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 32/210 (15%)

Query: 307 NILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGG-------EVQFQTEVETISLAVHR 358
             +G G +G VYK    + G  VA+K+++      G       E+    ++E+     H 
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---HP 61

Query: 359 NLLRL---CGFCSTENERL--LVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGT 411
           N++RL   C    T+ E    LV+ +     V   L  ++    +P L     K +    
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
            RG+ +LH      I+HRD+K  NIL+  D +  + DFGLA++    +  +T+ V  T+ 
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS-FEMALTSVVV-TLW 171

Query: 472 HIAPEYLSTGQSSEKT--DVFGFGILLLEL 499
           + APE L   QSS  T  D++  G +  EL
Sbjct: 172 YRAPEVLL--QSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 308 ILGRGGFGIVY---KGCFSD-GALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLR 362
           +LG+G FG V+   K    D G L A+K LK   +     V+ + E + ++   H  +++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L     TE +  L+  ++  G + +RL   +           K      A  L +LH   
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL- 117

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              II+RD+K  NILLDE+    + DFGL+K  +DH       +  GTV ++APE ++  
Sbjct: 118 --GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRR 173

Query: 482 QSSEKTDVFGFGILLLELITG 502
             ++  D + FG+L+ E++TG
Sbjct: 174 GHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 16/212 (7%)

Query: 302 NFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           +F+   +LG+G FG ++         L A+K LK D  I   +V+  T VE   LA+   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC-TMVEKRVLALQDK 59

Query: 360 ---LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              L +L     T +    V  Y+  G     L  HI         +    A   + GL 
Sbjct: 60  PPFLTQLHSCFQTVDRLYFVMEYVNGGD----LMYHIQQVGKFKEPQAVFYAAEISVGLF 115

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAP 475
           +LH +    II+RD+K  N++LD +    + DFG+ K  +H    VTT    GT  +IAP
Sbjct: 116 FLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAP 170

Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
           E ++     +  D + +G+LL E++ GQ   D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 22/213 (10%)

Query: 302 NFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLKDYNIAGGE-VQFQTEVETISLAV 356
           NF    +LG G +G V+          G L A+K L+   +         T  E   L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 357 HRN---LLRLCGFCSTENERLLVYPYMPNGSVASRL--RDHIHGRPALDWARRKRIALG- 410
            R    L+ L     TE +  L+  Y+  G + + L  RD+             R   G 
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV-------RFYSGE 113

Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
               L +LH+     I++RD+K  NILLD +   V+ DFGL+K     +   T +  GT+
Sbjct: 114 IILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170

Query: 471 GHIAPEYL-STGQSSEKTDVFGFGILLLELITG 502
            ++APE +   G   +  D +  GIL+ EL+TG
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 60.6 bits (148), Expect = 4e-10
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLK-------DYNIAGGEVQFQTEVETISLAVHRNL 360
           LG G FG VY       G LVA+K++K       +  +   EV+         L  H N+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEEC-MNLREVKS-----LRKLNEHPNI 60

Query: 361 LRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           ++L      EN+ L  V+ YM  G++   ++D   G+P    +  + I     +GL ++H
Sbjct: 61  VKLKEVFR-ENDELYFVFEYM-EGNLYQLMKDR-KGKP-FSESVIRSIIYQILQGLAHIH 116

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL- 478
           +       HRD+K  N+L+       + DFGLA+ +  R  + T  V  T  + APE L 
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILL 171

Query: 479 -STGQSSEKTDVFGFGILLLELITGQ 503
            ST  SS   D++  G ++ EL T +
Sbjct: 172 RSTSYSS-PVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 61.2 bits (149), Expect = 5e-10
 Identities = 37/104 (35%), Positives = 60/104 (57%), Gaps = 12/104 (11%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-----DHRDSHVTTAVR 467
           RGL Y+H      +IHRD+K +N+L++ED E  +GDFG+A+ L     +H+   +T  V 
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-YFMTEYV- 172

Query: 468 GTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510
            T  + APE  LS  + +   D++  G +  E++ G+R L  G+
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGK 215

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           S+F     LG G FG V    +KG    G   A+K LK   I    +VQ   + ++I + 
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74

Query: 356 VHRNLL--RLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
           +    +   +C F   +  R+  +  ++  G + + LR    GR   D A+     L  A
Sbjct: 75  LSHPFIVNMMCSF--QDENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLA 130

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
               YLH   D  II+RD+K  N+LLD      V DFG AK +  R    T  + GT  +
Sbjct: 131 --FEYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEY 181

Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           +APE + +    +  D +  G+LL E I G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 23/211 (10%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCFSDGAL----VAVKRL-KDYNIAGGEVQFQTEVETISL 354
           T+ +     +G G FG+V   C +   L    VA+K++ K ++      +   E++ +  
Sbjct: 9   TNRYVDLQPVGMGAFGLV---CSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65

Query: 355 AVHRNLLRLCG-FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
             H N++ L   F S   +   V   +  G+   RL   +  RP L+    +       R
Sbjct: 66  LRHENIISLSDIFISPLEDIYFVTELL--GTDLHRL---LTSRP-LEKQFIQYFLYQILR 119

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           GL Y+H      ++HRD+K +NIL++E+ +  + DFGLA++ D +     T    T  + 
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYR 172

Query: 474 APEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
           APE + T Q    + D++  G +  E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 59.9 bits (145), Expect = 8e-10
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 327 LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVA 386
           LVAVK L+          F  EV+ +S     N++RL G C  E+   ++  YM NG + 
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 387 SRLRDHI---------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV 431
             L  H                H  PA+ ++    +AL  A G+ YL        +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDL 164

Query: 432 KAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG----TVGHIAPEYLSTGQSSEKT 487
              N L+ E+    + DFG+++ L   D +    ++G     +  +A E +  G+ +  +
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTAS 221

Query: 488 DVFGFGILLLELITGQRALDFGRAANQR 515
           DV+ FG+ L E++   +   +G   +++
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGELTDEQ 249

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 20/214 (9%)

Query: 302 NFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLA 355
           +F+   +LG+G FG V     KG  +D  L A+K LK D  I   +V+    E   ++L 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKG--TD-ELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57

Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
                L     C    +RL  V  Y+  G     L  HI              A   A G
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGD----LMYHIQQVGKFKEPHAVFYAAEIAIG 113

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHI 473
           L +LH +    II+RD+K  N++LD +    + DFG+ K  ++     TT    GT  +I
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYI 168

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
           APE ++     +  D + FG+LL E++ GQ   D
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 60.1 bits (145), Expect = 9e-10
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 22/202 (10%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFC 367
           LG G  G+V K       L+  ++L    I      Q   E++ +       ++   G  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 368 STENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
            ++ E  +   +M  GS+      A R+ + I G+          +++   RGL YL E+
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK----------VSIAVLRGLAYLREK 122

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              +I+HRDVK +NIL++   E  + DFG++  L   DS   + V GT  +++PE L   
Sbjct: 123 --HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGT 177

Query: 482 QSSEKTDVFGFGILLLELITGQ 503
             S ++D++  G+ L+EL  G+
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.4 bits (149), Expect = 1e-09
 Identities = 55/194 (28%), Positives = 83/194 (42%), Gaps = 19/194 (9%)

Query: 325 GALVAVKRLKDYNIAGGE--VQFQTEVETISLAVHRNLLRLCGFCSTENERLL-VYPYMP 381
           G  VA+K L+           +F+ E    +   H N++ L          L  V+ Y+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--- 438
             ++   L        AL      R+ L     L   H Q    I+HRD+K  NI++   
Sbjct: 63  GRTLREVLA----ADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115

Query: 439 DEDFEAVVGDFGLAKLL-DHRDSHVTTAVR-----GTVGHIAPEYLSTGQSSEKTDVFGF 492
                A V DFG+  LL   RD+ V T  R     GT  + APE L     +  +D++ +
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 493 GILLLELITGQRAL 506
           G++ LE +TGQR +
Sbjct: 176 GLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 27/222 (12%)

Query: 294 KELRAATSNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIA--GGEVQFQT 347
           ++L+    ++    ++GRG FG V    +K   S   + A+K L  + +        F  
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 348 EVETISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRK 405
           E + ++ A    +++L  FC+ ++++ L  V  YMP G + + + ++    P   WA+  
Sbjct: 93  ERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPE-KWAK-- 145

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTT 464
                TA  +L L       +IHRDVK  N+LLD+     + DFG    +D        T
Sbjct: 146 ---FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202

Query: 465 AVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITG 502
           AV GT  +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 19/199 (9%)

Query: 312 GGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRL----CG 365
           G +G+VY+      G +VA+K+LK +    G  +    E+  +    H N++ +     G
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75

Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHI-HGRPALDWARRKRIALGTARGLLYLHEQCDP 424
             S  ++  +V  Y+ +      L+  +   +     +  K + L    G+ +LH+    
Sbjct: 76  --SNLDKIYMVMEYVEH-----DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN--- 125

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YLSTGQS 483
            I+HRD+K +N+LL+      + DFGLA+         T  V  T+ + APE  L   + 
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGAKEY 184

Query: 484 SEKTDVFGFGILLLELITG 502
           S   D++  G +  EL+T 
Sbjct: 185 STAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 3/94 (3%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           R + YLHE    +IIHRD+KA NI ++   +  +GDFG A      +++      GT+  
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249

Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL 506
            APE L+        D++  GI+L E+ T   +L
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 18/213 (8%)

Query: 302 NFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLA 355
           +F+   +LG+G FG V     KG      L A+K LK D  I   +V+    E   ++L+
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
                L     C    +RL  V  Y+  G     L   I              A   A G
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGD----LMYQIQQVGRFKEPHAVFYAAEIAIG 113

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L +LH +    II+RD+K  N++LD +    + DFG+ K  +  D   T    GT  +IA
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIA 169

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
           PE ++     +  D + FG+LL E++ GQ   +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 22/203 (10%)

Query: 309 LGRGGFGIVYKG--CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +  VYKG    +D  LVA+K ++  +  G       EV  +    H N++ L   
Sbjct: 14  LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 367 CSTENERLLVYPYMPNGSVASRLRD-----HIHGRPALDWARRKRIALGTARGLLYLHEQ 421
             TE    LV+ Y+ +  +   L D     ++H          K       RGL Y H +
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNV--------KLFLFQLLRGLNYCHRR 123

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YLST 480
              K++HRD+K  N+L++E  E  + DFGLA+         +  V  T+ +  P+  L +
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGS 179

Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
              S + D++G G +  E+ TG+
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 67/236 (28%), Positives = 102/236 (43%), Gaps = 38/236 (16%)

Query: 288 LKRY-----TFKELRAATSNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRL-KDYN 337
           L RY        +LR    +F    ++GRG FG V    +K   S   + A+K L K   
Sbjct: 25  LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEM 81

Query: 338 IAGGEVQFQTEVETISLAVHRN---LLRLCGFCSTENERLL--VYPYMPNGSVASRLRDH 392
           I   +  F  E   I    H N   +++L    + ++++ L  V  YMP G + + + ++
Sbjct: 82  IKRSDSAFFWEERDI--MAHANSEWIVQLH--YAFQDDKYLYMVMEYMPGGDLVNLMSNY 137

Query: 393 IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452
                   WAR       TA  +L L        IHRDVK  N+LLD+     + DFG  
Sbjct: 138 ---DIPEKWAR-----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189

Query: 453 KLLDHRDS--HVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITG 502
             +D  +      TAV GT  +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 190 MKMD-ANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNL 360
           +F   + LG G  G+V+K       L+  ++L    I      Q   E++ +       +
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 361 LRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARG 414
           +   G   ++ E  +   +M  GS+      A R+ + I G+          +++   +G
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKG 115

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L YL E+   KI+HRDVK +NIL++   E  + DFG++  L   DS   + V GT  +++
Sbjct: 116 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMS 170

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           PE L     S ++D++  G+ L+E+  G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 52.7 bits (127), Expect = 2e-09
 Identities = 16/42 (38%), Positives = 27/42 (64%), Gaps = 1/42 (2%)

Query: 31 INYEVVALVAVKNNLHDPYN-VLENWDITSVDPCSWRMITCS 71
          +N +  AL+A K++L+   +  L +W+ +S DPCSW  +TC 
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 60/281 (21%), Positives = 118/281 (41%), Gaps = 27/281 (9%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQ--TEVETISLAVH 357
           +NF  +  +GRG F  VY+  C  D   VA+K+++ + +   + +     E++ +    H
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N+++       +NE  +V      G ++  ++     +  +      +  +     + +
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG---HIA 474
           +H +   +++HRD+K AN+ +       +GD GL +      S  TTA    VG   +++
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMS 174

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM 534
           PE +     + K+D++  G LL E+           AA Q     D +       K+ Q 
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM-----------AALQSPFYGDKMNLFSLCQKIEQC 223

Query: 535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM 575
               L       +L E+V    +C   +P  RP +  V ++
Sbjct: 224 DYPPLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 63/238 (26%), Positives = 96/238 (40%), Gaps = 46/238 (19%)

Query: 301 SNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISLAV 356
            +F    ++GRG FG V+        G + A+K L K   I   ++   + E + ++ A 
Sbjct: 1   DDFEVIKVIGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59

Query: 357 HRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
              +++L  + S ++E  L  V  YMP G + + L          + AR        A  
Sbjct: 60  SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETAR-----FYIAEL 110

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK--------------------- 453
           +L L        IHRD+K  NIL+D D    + DFGL K                     
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 454 --LLDHRDSHVTTAVR-----GTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
             +L  R  H    VR     GT  +IAPE L  G     + D +  G++L E++ G 
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYGF 227

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 31/167 (18%)

Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWAR 403
             E   +    H  ++RL  F +  ++R L  +  Y+P G + S LR+            
Sbjct: 49  HNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRN------------ 94

Query: 404 RKRIALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455
             R +  T           L YLH +   +I++RD+K  NILLD++    + DFG AK L
Sbjct: 95  SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151

Query: 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
             R    T  + GT  ++APE + +   ++  D +  GIL+ E++ G
Sbjct: 152 RDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 20/202 (9%)

Query: 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG G +  V+KG       LVA+K ++  +  G       EV  +    H N++ L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL-GTARGLLYLHEQCDPKI 426
            TE    LV+ Y+      S L+ ++     L      +I +    RGL Y H++   KI
Sbjct: 73  HTERCLTLVFEYLD-----SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG----TVGHIAPE-YLSTG 481
           +HRD+K  N+L++E  E  + DFGLA     R   V T        T+ +  P+  L + 
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLA-----RAKSVPTKTYSNEVVTLWYRPPDVLLGST 179

Query: 482 QSSEKTDVFGFGILLLELITGQ 503
           + S   D++G G +L E+ TG+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 17/211 (8%)

Query: 302 NFSAKNILGRGGFGIVY---KGCFSD-GALVAVKRLKDYNIA-GGEVQFQTEVETISLAV 356
           NF    +LG G +G V+   K    D G L A+K LK   I    +    T  E   L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 357 HRN---LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
            R    L+ L     T+ +  L+  Y+  G     L  H+  R      + + + + +  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGG----ELFTHLSQRERF---KEQEVQIYSGE 113

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
            +L L       II+RD+K  NILLD +   V+ DFGL+K     +     +  GT+ ++
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 474 APEYLSTGQS--SEKTDVFGFGILLLELITG 502
           AP+ +  G     +  D +  G+L+ EL+TG
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.8 bits (143), Expect = 3e-09
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 8/92 (8%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +NI ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 181

Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 27/212 (12%)

Query: 301 SNFSAKNILGRGGFGIVYKGC----FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
           S       +G G  GIV   C     S G  VAVK++        E+ F  EV  +    
Sbjct: 19  SYLDNFVKIGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQ 74

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI-HGRPALDWARRKRIALGTARGL 415
           H N++ +       +E  +V  ++  G+    L D + H R  ++  +   + L   + L
Sbjct: 75  HPNIVEMYSSYLVGDELWVVMEFLEGGA----LTDIVTHTR--MNEEQIATVCLAVLKAL 128

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG----LAKLLDHRDSHVTTAVRGTVG 471
            +LH Q    +IHRD+K+ +ILL  D    + DFG    ++K +  R S V     GT  
Sbjct: 129 SFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPY 180

Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            +APE +S      + D++  GI+++E++ G+
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.2 bits (140), Expect = 3e-09
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 12/201 (5%)

Query: 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG G +  VYKG    +G LVA+K ++     G       E   +    H N++ L    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIALGTARGLLYLHEQCDPKI 426
            T+    LV+ Y     V + L  ++   P  L     K       RGL Y+H++    I
Sbjct: 73  HTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YI 124

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YLSTGQSSE 485
           +HRD+K  N+L+ +  E  + DFGLA+      SH  +    T+ +  P+  L + + S 
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 486 KTDVFGFGILLLELITGQRAL 506
             D++G G + +E+I G  A 
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 38/221 (17%)

Query: 303 FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNL 360
           F     +G G +G VYK    D G LVA+K+++ D    G  +    E++ +    HRN+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 361 LRLCGFCSTENERL----------LVYPYMPN---GSVASRL----RDHIHG--RPALDW 401
           + L    + + + L          LV+ YM +   G + S L     DHI    +  L+ 
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE- 127

Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
                       GL Y H++     +HRD+K +NILL+   +  + DFGLA+L +  +S 
Sbjct: 128 ------------GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 462 VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELIT 501
             T    T+ +  PE  L   +     DV+  G +L EL T
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 23/205 (11%)

Query: 308 ILGRGGFGIVYKGCFSD-GALVAVKRLKDY-------NIAGGEVQFQTEVETISLAVHRN 359
           ++G G +G+V K    + G +VA+K+  +         IA  E++   ++       H N
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR------HEN 61

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L+ L      +    LV+ ++ + +V   L  + +G   LD +R ++      RG+ + H
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
                 IIHRD+K  NIL+ +     + DFG A+ L       T  V  T  + APE L 
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLV 173

Query: 480 TGQSSEK-TDVFGFGILLLELITGQ 503
                 +  D++  G L+ E++TG+
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 36/130 (27%), Positives = 60/130 (46%), Gaps = 12/130 (9%)

Query: 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAA 434
           LV  Y+  G  AS ++    G    DWA++         G+  LH++    IIHRD+K  
Sbjct: 74  LVMEYLNGGDCASLIK--TLGGLPEDWAKQ--YIAEVVLGVEDLHQR---GIIHRDIKPE 126

Query: 435 NILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 494
           N+L+D+     + DFGL+     R+        GT  ++APE +      + +D +  G 
Sbjct: 127 NLLIDQTGHLKLTDFGLS-----RNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181

Query: 495 LLLELITGQR 504
           ++ E + G  
Sbjct: 182 VIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 52.2 bits (126), Expect = 5e-09
 Identities = 27/60 (45%), Positives = 36/60 (60%)

Query: 123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
            L++LDLSNN+ T     +   L NL  L L+ N+LT   PE+ S + SL  +DLS NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 19/200 (9%)

Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G G  GIV      S G LVAVK++        E+ F  EV  +    H N++ +    
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  ++  G++   +    H R  ++  +   + L   + L  LH Q    +I
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV---THTR--MNEEQIAAVCLAVLKALSVLHAQ---GVI 138

Query: 428 HRDVKAANILLDEDFEAVVGDFG----LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
           HRD+K+ +ILL  D    + DFG    ++K +  R S V     GT   +APE +S    
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPELISRLPY 193

Query: 484 SEKTDVFGFGILLLELITGQ 503
             + D++  GI+++E++ G+
Sbjct: 194 GPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.2 bits (140), Expect = 8e-09
 Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 23/182 (12%)

Query: 331 KRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLCGFCSTENERLLVYP---YMPNGSV 385
           + +     AG     Q E E ++L    H N+L++        E +L      YM     
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKY 245

Query: 386 ASRLRDHIHGRPALDWARR------KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD 439
              L   ++   A DW  R      + I       + Y+H   D K+IHRD+K  NI L+
Sbjct: 246 DFDLYSFMYDE-AFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301

Query: 440 EDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 499
            D + V+GDFG A   +           GTV   +PE L+     E TD++  G++LL++
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361

Query: 500 IT 501
           ++
Sbjct: 362 LS 363

Length = 501

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 44/215 (20%)

Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQT---------EVETISLA 355
           +G G +G V   C +     GA VA+K+L           FQ+         E+  +   
Sbjct: 23  VGSGAYGTV---CSALDRRTGAKVAIKKLYR--------PFQSELFAKRAYRELRLLKHM 71

Query: 356 VHRNLLRLCGFCSTE------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
            H N++ L    + +      ++  LV P+M  G+   +L  H      L   R + +  
Sbjct: 72  KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKH----EKLSEDRIQFLVY 125

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
              +GL Y+H      IIHRD+K  N+ ++ED E  + DFGLA+     DS +T  V  T
Sbjct: 126 QMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-T 178

Query: 470 VGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
             + APE  L+    ++  D++  G ++ E++TG+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 56.8 bits (137), Expect = 9e-09
 Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 11/196 (5%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G+G  G VY     + G  VA+K++        E+    E+  +    H N++      
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  Y+  GS+   + +       +D  +   +     + L +LH     ++I
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVI 137

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ NILL  D    + DFG    +    S  +T V GT   +APE ++      K 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 488 DVFGFGILLLELITGQ 503
           D++  GI+ +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 21/213 (9%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLA---V 356
           NF     +G G +G+VYK      G +VA+K+++ D    G      T +  ISL     
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELN 57

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARG 414
           H N+++L     TEN+  LV+ ++        L+  +   P   +     K       +G
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFL-----HQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L + H     +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + A
Sbjct: 113 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 168

Query: 475 PE-YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
           PE  L     S   D++  G +  E++T +RAL
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 31/204 (15%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLK-----DYNIAGGEVQFQTEVETISLAVHRNLLR 362
           +G G +G VYK      G L AVK +K     D+++       Q E+  +    H N++ 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL------IQQEIFMVKECKHCNIVA 70

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
             G   +  +  +   Y   GS    L+D  H    L   +   +   T +GL YLH + 
Sbjct: 71  YFGSYLSREKLWICMEYCGGGS----LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR----GTVGHIAPEYL 478
               +HRD+K ANILL ++ +  + DFG+A  +       T A R    GT   +APE  
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVA 178

Query: 479 S---TGQSSEKTDVFGFGILLLEL 499
           +    G  ++  D++  GI  +EL
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 31/273 (11%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYN-IAGGE------VQFQTEVETISLAVHRNLL 361
           LG+G FG VY     D   VA +RLK    I  GE      VQ   E + +S   H  ++
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           +        +   ++  Y     +  +L +  H    L   +     +    G+ Y+H++
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              +I+HRD+KA NI L  +    +GDFG+++LL      + T   GT  +++PE L   
Sbjct: 126 ---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQ 180

Query: 482 QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG 541
               K+D++  G +L E+     A +     N   V+L  V     EG    + +   + 
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHAFE---GQNFLSVVLRIV-----EGPTPSLPETYSR- 231

Query: 542 NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
                +L  ++Q  L     +P  RP  +E+L+
Sbjct: 232 -----QLNSIMQSML---NKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 23/206 (11%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQT---EVETISLAVHRNLLRLCG 365
           LG+G +G VYK       +     +K+  +   E +F     E++ +  AV   ++   G
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMA--MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
               E    +   YM  GS+  +L         +     +RI     +GL +L E+ +  
Sbjct: 67  AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123

Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG---HIAPEYLSTGQ 482
           IIHRDVK  N+L++ + +  + DFG++  L      V +  +  +G   ++APE + +G 
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177

Query: 483 SSE------KTDVFGFGILLLELITG 502
            ++      ++DV+  G+ +LE+  G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 21/204 (10%)

Query: 308 ILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQ-TEVETISLAVHRNLL 361
           +LG+G FG V     K   + G   A+K L K+  IA  EV    TE   +    H  L 
Sbjct: 2   LLGKGTFGKVILVREK---ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 362 RLCGFCSTENERL-LVYPYMPNGSVASRL-RDHIHGRPALDWARRKRIALGTARGLLYLH 419
            L  +    ++RL  V  Y   G +   L R+ +         R +         L YLH
Sbjct: 59  AL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSALGYLH 112

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
                 +++RD+K  N++LD+D    + DFGL K     D        GT  ++APE L 
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLE 168

Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
                   D +G G+++ E++ G+
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 3/94 (3%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
           +L   + NL  L+++ L  N +   +P  L  L  L  LDLS NK + ++P  +  L  L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
             L L+NNS+      SLS +++L+ ++LS N L
Sbjct: 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL 244

Length = 394

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 21/204 (10%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           +G+G FG VY+    D   + A+K L K   +A  EV        I   + R LL    F
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNI---LVRTLLDESPF 57

Query: 367 C-------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
                    T+++  LV  YM  G +   L+    GR + D A+     L  A  L +LH
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLA--LEHLH 113

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           +     I++RD+K  NILLD      + DFGL+K  +  D+  T    GT  ++APE L 
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLL 169

Query: 480 TGQSSEK-TDVFGFGILLLELITG 502
             +   K  D +  G+L+ E+  G
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 35/221 (15%)

Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
              GL Y+H      IIHRD+K  N+ ++ED E  + DFGLA+   H D+ +T  V  T 
Sbjct: 126 MLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TR 178

Query: 471 GHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG 529
            + APE  L+    ++  D++  G ++ E++TG + L  G+         D++ +L Q  
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGK---------DYLDQLTQIL 228

Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALL------CTQFNPLHRPKMSEVL-KMLEGDGLA 582
           K++ +   +     +    +  ++ +L        +   P   P+  ++L KMLE D   
Sbjct: 229 KVTGVPGPEFVQKLEDKAAKSYIK-SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDV-D 286

Query: 583 EKWEASQKIETPRY--------RTHEKRYSDFIEESSLVIE 615
           ++  A++ +E P +         T ++ Y D +E   L ++
Sbjct: 287 KRLTATEALEHPYFDSFRDADEETEQQPYDDSLENEKLSVD 327

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 36/235 (15%)

Query: 288 LKRYT-----FKELRAATSNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNI 338
           L RY       ++LR    ++    ++GRG FG V    +K   S   + A+K L  + +
Sbjct: 25  LNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEM 81

Query: 339 A--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDH-I 393
                   F  E + ++ A    +++L  F + +++R L  V  YMP G + + + ++ +
Sbjct: 82  IKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV 139

Query: 394 HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
             +    WAR       TA  +L L        IHRDVK  N+LLD+     + DFG   
Sbjct: 140 PEK----WAR-----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190

Query: 454 LLDHRDSHV--TTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITG 502
            ++ ++  V   TAV GT  +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 191 KMN-KEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 28/227 (12%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGG-------EVQFQTEVETISLAVHRNL 360
           +G G +G VYK      G  VA+K ++      G       EV     +E      H N+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD---HPNI 64

Query: 361 LRLCGFCST-----ENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTAR 413
           +RL   C+T     E +  LV+ +     V   LR ++   P   L     K +     R
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           GL +LH  C   I+HRD+K  NIL+    +  + DFGLA++   +     T V  T+ + 
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYR 174

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD 520
           APE L     +   D++  G +  E+   +        A+Q G + D
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 27/162 (16%)

Query: 307 NILGRGGFGIVYKG-CFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
             +G+G FG V+K        +VA+K+ L +    G  +    E++ + L  H N++ L 
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 365 GFCSTENERLLVYPYMPNGSVAS-------------RLRDHIHGRPALDWARRKRIALGT 411
             C T+           N    S              L  + + +  L  +  K++    
Sbjct: 78  EICRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL--SEIKKVMKML 128

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
             GL Y+H     KI+HRD+KAANIL+ +D    + DFGLA+
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 25/203 (12%)

Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G  GIV   C +     G  VAVK++        E+ F  EV  +    H N++ + 
Sbjct: 30  IGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMY 85

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
                 +E  +V  ++  G++   +    H R  ++  +   + L   R L YLH Q   
Sbjct: 86  NSYLVGDELWVVMEFLEGGALTDIV---THTR--MNEEQIATVCLSVLRALSYLHNQ--- 137

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFG----LAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
            +IHRD+K+ +ILL  D    + DFG    ++K +  R S V     GT   +APE +S 
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEVISR 192

Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
                + D++  GI+++E+I G+
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 36/122 (29%), Positives = 63/122 (51%), Gaps = 7/122 (5%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
           RGL Y+H      ++HRD+K AN+ ++ ED    +GDFGLA+++D   SH      G V 
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 472 --HIAPE-YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE 528
             + +P   LS    ++  D++  G +  E++TG+          Q  ++L+ V  + +E
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241

Query: 529 GK 530
            +
Sbjct: 242 DR 243

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 9/196 (4%)

Query: 309 LGRGGFGIVYKGCFSDGALV-AVKRL-KDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           +G+G FG V +    D   + A+K + K + ++  EV       T+   V+   +    F
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
                E+L +     NG     L  H+      D +R +     TA  L  L       +
Sbjct: 61  SFQSPEKLYLVLAFINGG---ELFHHLQREGRFDLSRAR---FYTAELLCALENLHKFNV 114

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           I+RD+K  NILLD      + DFGL K L+ +D   T    GT  ++APE L     ++ 
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 487 TDVFGFGILLLELITG 502
            D +  G+LL E++TG
Sbjct: 174 VDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.1 bits (132), Expect = 4e-08
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 11/199 (5%)

Query: 308 ILGRGGFG-IVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQ-TEVETISLAVHRNLLRLC 364
           +LG+G FG ++     + G   A+K LK +  IA  EV    TE   +    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
               T++    V  Y+  G     L  H+         R +         L YLH     
Sbjct: 62  YSFQTKDRLCFVMEYVNGG----ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           KI++RD+K  N++LD+D    + DFGL K     D+       GT  ++APE L      
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 485 EKTDVFGFGILLLELITGQ 503
              D +G G+++ E++ G+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 48/180 (26%), Positives = 91/180 (50%), Gaps = 19/180 (10%)

Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG----SVASRLRDHIHGRPALDW 401
           ++E+  ++   H  +++      ++++ LL+  Y   G     +  RL++H+   P  ++
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL---PFQEY 169

Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS- 460
                + L   + +L L E    K++HRD+K+ANI L       +GDFG +K   + DS 
Sbjct: 170 ----EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSV 223

Query: 461 --HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM 518
              V ++  GT  ++APE     + S+K D++  G++L EL+T  R     +  +QR +M
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIM 280

Length = 478

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 59/200 (29%), Positives = 84/200 (42%), Gaps = 14/200 (7%)

Query: 308 ILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL---AVHRNLLRL 363
           ++G+G FG ++     SDG+  AVK L+   I   + Q     E   L     H  L+ L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 364 CGFCSTENERLLVYPYMPNGSVASRL-RDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
                T  +   V  Y+  G +   L R+     P     R +  A   A  + YLH   
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSL- 115

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
              II+RD+K  NILLD     V+ DFGL K         T+   GT  ++APE L    
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEP 172

Query: 483 SSEKTDVFGFGILLLELITG 502
                D +  G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 55/175 (31%), Positives = 89/175 (50%), Gaps = 24/175 (13%)

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRGTV 470
           ARG+ +L  +   K IHRD+ A NILL E+    + DFGLA+ +     +V     R  +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKLHQE 528
             +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L +E
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS------LG-ASPYPGVQIDEEFCRRL-KE 291

Query: 529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAE 583
           G  ++M   +           E+  + L C   NP  RP  SE++++L GD L E
Sbjct: 292 G--TRMRAPEYA-------TPEIYSIMLDCWHNNPEDRPTFSELVEIL-GDLLQE 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 29/230 (12%)

Query: 309 LGRGGFGIVYKG--CFSDGALVAVKRLKDYNIAGG-------EVQFQTEVETISLAVHRN 359
           +G G +G V+K     + G  VA+KR++      G       EV     +ET     H N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE---HPN 65

Query: 360 LLRLCGFCST-----ENERLLVYPYMPNGSVASRLRDHIHG--RPALDWARRKRIALGTA 412
           ++RL   C+      E +  LV+ +     V   L  ++     P +     K +     
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL +LH     +++HRD+K  NIL+    +  + DFGLA++   +     T+V  T+ +
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWY 175

Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
            APE L     +   D++  G +  E+   +         +Q G +LD +
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 297 RAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-----DYNIAGGEVQFQTEVE 350
           R    +F     +G G +G VYK    + G L A+K +K     D+ +       Q E+ 
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVV------QQEII 58

Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
            +    H N++   G     ++  +   +   GS    L+D  H    L  ++   ++  
Sbjct: 59  MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRE 114

Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG----LAKLLDHRDSHVTTAV 466
           T +GL YLH +     +HRD+K ANILL ++    + DFG    +   +  R S +    
Sbjct: 115 TLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI---- 167

Query: 467 RGTVGHIAPEYLST---GQSSEKTDVFGFGILLLEL 499
            GT   +APE  +    G  ++  D++  GI  +EL
Sbjct: 168 -GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 51/209 (24%), Positives = 79/209 (37%), Gaps = 23/209 (11%)

Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRNLLRLCGF 366
                    + K       LVAVK++   + +  +++  Q E+ T     H N+L     
Sbjct: 9   CFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-T 66

Query: 367 CSTENERL-LVYPYMPNGSVASRLRDHI-HGRPALDWARRKRIALGTARGLLYLHEQCDP 424
               +  L +V P M  GS    L+ H   G P L  A    I       L Y+H +   
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---ILKDVLNALDYIHSK--- 120

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI------APEYL 478
             IHR VKA++ILL  D + V+     +  +                 +      +PE L
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180

Query: 479 STGQS----SEKTDVFGFGILLLELITGQ 503
              Q+    +EK+D++  GI   EL  G 
Sbjct: 181 Q--QNLQGYNEKSDIYSVGITACELANGH 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 17/199 (8%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLRLCG- 365
           +G G F  V K      G   A+K +K +  +  +V    E++ +  L+ H N+LRL   
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 366 -FCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLYLHEQCD 423
            F        LV+  M        L + I GR   L   R K       + L ++H    
Sbjct: 67  LFDRKTGRLALVFELMD-----MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN-- 119

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YLSTGQ 482
             I HRD+K  NIL+ +D    + DFG  + +  +  +  T    T  + APE  L+ G 
Sbjct: 120 -GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGY 175

Query: 483 SSEKTDVFGFGILLLELIT 501
              K D++  G +  E+++
Sbjct: 176 YGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 58/240 (24%), Positives = 100/240 (41%), Gaps = 44/240 (18%)

Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDG------------------ALVAV 330
           KR TFKE             LG G FG V+  C ++G                   LVAV
Sbjct: 5   KRLTFKEK------------LGEGQFGEVHL-CEAEGMEKFMDKDFSLDVSGNQPVLVAV 51

Query: 331 KRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
           K L++         F  E++ +S     N++RL   C T +   ++  YM NG +   L 
Sbjct: 52  KMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLS 111

Query: 391 DH-------IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443
            H             + ++    +A   A G+ YL        +HRD+   N L+ +++ 
Sbjct: 112 RHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYT 168

Query: 444 AVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
             + DFG+++ L +   +     R    +  ++ E +  G+ +  +DV+ FG+ L E++T
Sbjct: 169 IKIADFGMSRNL-YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183

Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 11/196 (5%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G+G  G VY     + G  VA+K++        E+    E+  +    + N++      
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  Y+  GS+   + +       +D  +   +     + L +LH     ++I
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVI 137

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ NILL  D    + DFG    +    S  +T V GT   +APE ++      K 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 488 DVFGFGILLLELITGQ 503
           D++  GI+ +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 23/215 (10%)

Query: 302 NFSAKNILGRGGFG----IVYKGCFSDGALVAVKRLKDYNIAGGE--VQFQTEVETISLA 355
           +F  K+++GRG FG    +  K   + G + A+K +K   +   E    F+ E + +S++
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
               + +L      ++   LV  Y P G + S L  +   +   D A+        A  +
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQ-----FYLAELV 112

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIA 474
           L +H       +HRD+K  N+L+D      + DFG A  L   +  V +    GT  +IA
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIA 171

Query: 475 PEYLSTGQSSEKT------DVFGFGILLLELITGQ 503
           PE L+T     K       D +  G++  E+I G+
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 22/203 (10%)

Query: 309 LGRGGFGIVYKG--CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +  V+KG    ++  LVA+K ++  +  G       EV  +    H N++ L   
Sbjct: 14  LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL-GTARGLLYLHEQCDPK 425
             T+    LV+ Y+        L+ ++     +      +I L    RGL Y H +   K
Sbjct: 73  VHTDKSLTLVFEYLDKD-----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124

Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG----TVGHIAPE-YLST 480
           ++HRD+K  N+L++E  E  + DFGLA     R   V T        T+ +  P+  L +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA-----RAKSVPTKTYSNEVVTLWYRPPDVLLGS 179

Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
            + S + D++G G +  E+ +G+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.8 bits (129), Expect = 8e-08
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 13/209 (6%)

Query: 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
           AATS  + +  LG G +  VYKG    +G LVA+K +      G       E   +    
Sbjct: 3   AATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N++ L     T+     V+ YM +  +A  +  H  G   L     +       RGL 
Sbjct: 62  HANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGG---LHPYNVRLFMFQLLRGLA 117

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           Y+H Q    I+HRD+K  N+L+    E  + DFGLA+      S   ++   T+ +  P+
Sbjct: 118 YIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPD 173

Query: 477 YL--STGQSSEKTDVFGFGILLLELITGQ 503
            L  +T  SS   D++G G + +E++ GQ
Sbjct: 174 VLLGATDYSSA-LDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.9 bits (132), Expect = 8e-08
 Identities = 50/154 (32%), Positives = 76/154 (49%), Gaps = 14/154 (9%)

Query: 311 RGGFGIVY---KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           RG FG VY   K    +  L AVK +K  ++    +  Q + E  +LA+ ++   +  + 
Sbjct: 14  RGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 368 S--TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
           S  + N   LV  Y+  G V S L  HI+G    + A  K I+   A  L YLH      
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAV-KYIS-EVALALDYLHRH---G 124

Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
           IIHRD+K  N+L+  +    + DFGL+K+  +R+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.9 bits (129), Expect = 9e-08
 Identities = 40/139 (28%), Positives = 62/139 (44%), Gaps = 8/139 (5%)

Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T +   LV  Y+  G     L  H+  +  L     +  A      L +LHE+    II+
Sbjct: 67  TTSRLFLVIEYVNGGD----LMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIY 119

Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+K  N+LLD D    + D+G+ K         T+   GT  +IAPE L   +     D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 178

Query: 489 VFGFGILLLELITGQRALD 507
            +  G+L+ E++ G+   D
Sbjct: 179 WWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 83/343 (24%), Positives = 140/343 (40%), Gaps = 84/343 (24%)

Query: 308 ILGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNL 360
           +LG G FG +V    F     S    VAVK LK+   A       +E++  I +  H N+
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73

Query: 361 LRLCGFCSTENERLLV-YPYMPNGSVASRLR---------------DHIHGRPALDWAR- 403
           + L G C+  N  L+V   +   G++++ LR                    R  ++ +R 
Sbjct: 74  VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133

Query: 404 RKRIALGTARGLLYLHEQCDP--------------------------------------- 424
            +RI  G A  L    +                                           
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-AVRGTVGHIAPEYLSTGQS 483
           K IHRD+ A NILL E+    + DFGLA+ +     +V   + R  +  +APE +     
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253

Query: 484 SEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--DWVKKLHQEGKLSQMVDKDLKG 541
           + ++DV+ FG+LL E+ +       G A+   GV +  ++ ++L ++G  ++M   +   
Sbjct: 254 TTQSDVWSFGVLLWEIFS------LG-ASPYPGVQINEEFCQRL-KDG--TRMRAPENAT 303

Query: 542 NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEK 584
                   E+ ++ L C Q +P  RP  S ++++L GD L E 
Sbjct: 304 -------PEIYRIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 36/101 (35%), Positives = 50/101 (49%), Gaps = 6/101 (5%)

Query: 403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL-LDHRDSH 461
           R +  A   A  L YLH      II+RD+K  NILLD     V+ DFGL K  ++H  + 
Sbjct: 97  RARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT- 152

Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            T+   GT  ++APE L         D +  G +L E++ G
Sbjct: 153 -TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 25/218 (11%)

Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL--VAVKRLKDYNIAGGEV--QFQTEV 349
           ++ +    +F+    LG G FG V    + +     VA+KR +   I   +      +E 
Sbjct: 23  RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82

Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI-- 407
           + ++   H   + L G    E+   LV  ++  G   + LR            R KR   
Sbjct: 83  KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR------------RNKRFPN 130

Query: 408 ---ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
                  A+ +L         I++RD+K  N+LLD+D    + DFG AK++D R    T 
Sbjct: 131 DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TY 186

Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            + GT  +IAPE L      +  D +  GI + E++ G
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 31/213 (14%)

Query: 306 KNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
             +LG+GG+G V++     GA    + A+K LK   I       + + +T      RN+L
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV------RNQKDTAHTKAERNIL 54

Query: 362 R---------LCGFCSTENERLLVYPYMPNGSVASRL-RDHIHGR-PALDWARRKRIALG 410
                     L     T  +  L+  Y+  G +   L R+ I     A  +     +AL 
Sbjct: 55  EAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE 114

Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
                 +LH+Q    II+RD+K  NILLD      + DFGL K   H  + VT    GT+
Sbjct: 115 ------HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTI 164

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++APE L      +  D +  G L+ +++TG 
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.5 bits (114), Expect = 2e-07
 Identities = 20/60 (33%), Positives = 30/60 (50%)

Query: 99  KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL 158
            L+S+ L NN +      +   L  L+ LDLS N  T   P++   L +L  L L+ N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 19/140 (13%)

Query: 90  LSPWIGNLT-KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
           + P IG L   L+ + L +N I   +P+ L  L  L+ LDLS N  + ++P  L +L NL
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG 204
           N L L+ N ++   P  +  + +L  +DLS N++   L  +S        +++ N L   
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED- 246

Query: 205 PKATNNCTAVFPEPLSLPPN 224
                      PE +    N
Sbjct: 247 ----------LPESIGNLSN 256

Length = 394

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 47/163 (28%), Positives = 71/163 (43%), Gaps = 9/163 (5%)

Query: 346 QTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
           QTE      A  H  L+ L     TE+    V  Y+  G     L  H+  +  L     
Sbjct: 43  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD----LMFHMQRQRKLPEEHA 98

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
           +  +   +  L YLHE+    II+RD+K  N+LLD +    + D+G+ K    R    T+
Sbjct: 99  RFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS 154

Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
              GT  +IAPE L         D +  G+L+ E++ G+   D
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 9/133 (6%)

Query: 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRD 430
           +E  +V  Y+  GS+   + +       +D A+   +     + L +LH     ++IHRD
Sbjct: 89  DELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140

Query: 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
           +K+ N+LL  D    + DFG    +    S  +T V GT   +APE ++      K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199

Query: 491 GFGILLLELITGQ 503
             GI+ +E++ G+
Sbjct: 200 SLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 4/92 (4%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL YLH      I+HRD+K  N+L++ +    + DFGLA++ +  +S   T    T  +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 473 IAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
            APE L   +  +   D++  G +  EL+  +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 43/173 (24%), Positives = 84/173 (48%), Gaps = 19/173 (10%)

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
           R +   A+G+ +L  +     IHRDV A N+LL +   A + DFGLA+ + +  ++V   
Sbjct: 216 RFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 466 -VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
             R  V  +APE +     + ++DV+ +GILL E+ +       G++    G++++    
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGKSPYP-GILVN---- 321

Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                K  +MV +  + +       E+  +  +C    P  RP  S++ ++++
Sbjct: 322 ----SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 23/168 (13%)

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRGTV 470
           A+G+ +L  +   K IHRD+ A NILL E+    + DFGLA+ +     +V     R  +
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKLHQE 528
             +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L +E
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL-KE 297

Query: 529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           G  ++M   D           EM Q  L C    P  RP  SE+++ L
Sbjct: 298 G--TRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 4/93 (4%)

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L +LHE+    II+RD+K  N+LLD +    + D+G+ K    R    T+   GT  +IA
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIA 164

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
           PE L         D +  G+L+ E++ G+   D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 38/215 (17%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAV----------H 357
           +G G +G+VYK         A  R+ +  IA  +++ + E E + S A+          H
Sbjct: 10  IGEGTYGVVYK---------ARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA----LGTAR 413
            N++RL     +E    LV+ Y+        L+ H+   P  D+A+  R+         R
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLD-----LDLKKHMDSSP--DFAKNPRLIKTYLYQILR 113

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           G+ Y H     +++HRD+K  N+L+D    A+ + DFGLA+         T  V  T+ +
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWY 169

Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
            APE  L +   S   D++  G +  E++  Q+ L
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 35/218 (16%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT--EVETISLAVH 357
           + F    ++G G +G+V K    +   +VA+K+ KD      EV+  T  E++ +     
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE-ENEEVKETTLRELKMLRTLKQ 59

Query: 358 RNLLRLCGFCSTENERLLVYPY-----------MPNGSVASRLRDHIHGR-PALDWARRK 405
            N++ L        +  LV+ Y           MPNG    ++R +I+    A+ W  + 
Sbjct: 60  ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
                               I+HRD+K  N+L+  +    + DFG A+ L    +   T 
Sbjct: 120 -------------------DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
              T  + +PE L      +  D++  G +L EL  GQ
Sbjct: 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 11/196 (5%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G+G  G VY     + G  VA++++        E+    E+  +    + N++      
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  Y+  GS+   + +       +D  +   +     + L +LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVI 138

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ NILL  D    + DFG    +    S  +T V GT   +APE ++      K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197

Query: 488 DVFGFGILLLELITGQ 503
           D++  GI+ +E+I G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.9 bits (127), Expect = 4e-07
 Identities = 55/233 (23%), Positives = 102/233 (43%), Gaps = 54/233 (23%)

Query: 308 ILGRGGFGIVY----KGCFSDGALVAVKRLKDYNIAGGEV---QFQTEVETISLAVHRNL 360
           ++G+GG G VY      C      VA+K++++ +++   +   +F  E +  +  +H  +
Sbjct: 9   LIGKGGMGEVYLAYDPVC---SRRVALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGI 64

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR---RKRIALGTARGLL- 416
           + +   CS  +      PY+   ++ S L+          W +    K +A  T+ G   
Sbjct: 65  VPVYSICSDGDPVYYTMPYIEGYTLKSLLKS--------VWQKESLSKELAEKTSVGAFL 116

Query: 417 -----------YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK--------LLD- 456
                      Y+H +    ++HRD+K  NILL    E V+ D+G A         LLD 
Sbjct: 117 SIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173

Query: 457 --------HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
                   +    +   + GT  ++APE L    +SE TD++  G++L +++T
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.4 bits (124), Expect = 5e-07
 Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 13/148 (8%)

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           + N ++L    +T    +L+  Y+ +G     L D +     L  A  K+I       L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            LH+     IIH D+K  N+L D   + + + D+GL K++     +      GT+ + +P
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175

Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +         D +  G+L  EL+TG+
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 12/200 (6%)

Query: 308 ILGRGGFG-IVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQ-TEVETISLAVHRNLLRLC 364
           +LG+G FG ++     + G   A+K LK +  +A  EV    TE   +  + H  L  L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 365 GFCSTENERLLVYPYMPNGSVASRL-RDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
               T +    V  Y   G +   L R+ +      D AR     + +A  L YLH +  
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE---DRARFYGAEIVSA--LDYLHSE-- 114

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
             +++RD+K  N++LD+D    + DFGL K    +D        GT  ++APE L     
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDY 173

Query: 484 SEKTDVFGFGILLLELITGQ 503
               D +G G+++ E++ G+
Sbjct: 174 GRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 59/249 (23%), Positives = 94/249 (37%), Gaps = 59/249 (23%)

Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG------ 341
           +RY  K              LG G +G V K   +  G +VA+K++K   I+        
Sbjct: 8   ERYIQKG-----------AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQ 56

Query: 342 -------------EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASR 388
                        E++   E++      H N++ L       +   LV   M     AS 
Sbjct: 57  LVGMCGIHFTTLRELKIMNEIK------HENIMGLVDVYVEGDFINLVMDIM-----ASD 105

Query: 389 LRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448
           L+  +  +  L  ++ K I L    GL  LH+      +HRD+  ANI ++      + D
Sbjct: 106 LKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIAD 162

Query: 449 FGLAK------LLDHRDSHVTTAVRG-------TVGHIAPEYL-STGQSSEKTDVFGFGI 494
           FGLA+        D      T   R        T+ + APE L    +     D++  G 
Sbjct: 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGC 222

Query: 495 LLLELITGQ 503
           +  EL+TG+
Sbjct: 223 IFAELLTGK 231

Length = 335

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 51.4 bits (124), Expect = 6e-07
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 45/218 (20%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGG----------EVQFQTEVETISLAVH 357
           LG+G +GIV+K        +VA+K++ D   A            E+ F  E     L  H
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFD---AFRNATDAQRTFREIMFLQE-----LGDH 66

Query: 358 RNLLRLCGFCSTENER--LLVYPYMPNG--SV--ASRLRDHIHGRPALDWARRKRIALGT 411
            N+++L      EN++   LV+ YM     +V  A+ L D +H         ++ I    
Sbjct: 67  PNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED-VH---------KRYIMYQL 116

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR---- 467
            + L Y+H      +IHRD+K +NILL+ D    + DFGLA+ L   + +    V     
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 468 GTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
            T  + APE L  ST + ++  D++  G +L E++ G+
Sbjct: 174 ATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 4/91 (4%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           + L YLH Q    +IHRD+K+ +ILL  D    + DFG    +  +D     ++ GT   
Sbjct: 128 QALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYW 183

Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           +APE +S      + D++  GI+++E++ G+
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 51.6 bits (123), Expect = 7e-07
 Identities = 78/307 (25%), Positives = 134/307 (43%), Gaps = 49/307 (15%)

Query: 297 RAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R+   ++   NI+G G FG+VY+  C      VA+K+ L+D      E+     +     
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN---- 117

Query: 355 AVHRNLLRLCGFCSTE----NERLL----VYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
             H N++ L  +  TE    NE+ +    V  ++P  +V   ++ +     AL     K 
Sbjct: 118 --HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKL 174

Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTA 465
            +    R L Y+H +    I HRD+K  N+L+D +   + + DFG AK L         A
Sbjct: 175 YSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--------LA 223

Query: 466 VRGTVGHI------APEYLSTGQSSEKT--DVFGFGILLLELI------TGQRALD-FGR 510
            + +V +I      APE L  G ++  T  D++  G ++ E+I      +GQ ++D   R
Sbjct: 224 GQRSVSYICSRFYRAPE-LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR 282

Query: 511 AANQRGV-MLDWVKKL---HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHR 566
                G    D +K++   + + K   +  KDLK  F +   ++ +       ++ PL R
Sbjct: 283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342

Query: 567 PKMSEVL 573
               E L
Sbjct: 343 LNPIEAL 349

Length = 440

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 24/204 (11%)

Query: 309 LGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +  VYKG  S   G LVA+K ++  +  G       E   +    H N++ L   
Sbjct: 13  LGEGSYATVYKG-RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
             T+    LV+ Y+ +  +   + D   G   L     +       RGL Y H++   ++
Sbjct: 72  IHTKKTLTLVFEYL-DTDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLAYCHQR---RV 124

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAK---LLDHRDSH--VTTAVRGTVGHIAPEYL--S 479
           +HRD+K  N+L+ E  E  + DFGLA+   +     S+  VT   R       P+ L  S
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR------PPDVLLGS 178

Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
           T  S+   D++G G +  E+ TG+
Sbjct: 179 TEYSTS-LDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---HRNLLRLC 364
           +G G +G+VYKG     G +VA+K+++  +   G     T +  ISL     H N++ L 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPS--TAIREISLLKELQHPNIVCLQ 65

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA---LDWARRKRIALGTARGLLYLHEQ 421
                E+   L++ ++     +  L+ ++   P    +D    K       +G+L+ H +
Sbjct: 66  DVLMQESRLYLIFEFL-----SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              +++HRD+K  N+L+D      + DFGLA+        V T    T+ + APE L   
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTHEVVTLWYRAPEVLLGS 176

Query: 482 QS-SEKTDVFGFGILLLELIT 501
              S   D++  G +  E+ T
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 29/157 (18%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETI-SLAV---------- 356
           +G G +G V+K    +   +VA+KR          V+   + E + S A+          
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKR----------VRLDDDDEGVPSSALREICLLKELK 57

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H+N++RL     ++ +  LV+ Y        +  D  +G    D    K       +GL 
Sbjct: 58  HKNIVRLYDVLHSDKKLTLVFEYCDQD--LKKYFDSCNGDI--DPEIVKSFMFQLLKGLA 113

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
           + H      ++HRD+K  N+L++++ E  + DFGLA+
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 9e-07
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 20/153 (13%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVK--RLKDYNIAGGEVQFQTEVETISL---AVHRNLLR 362
           +G G +G+VYK      G +VA+K  RL+  +    E    T +  ISL     H N++R
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETED----EGVPSTAIREISLLKELNHPNIVR 62

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP--ALDWARRKRIALGTARGLLYLHE 420
           L     +EN+  LV+ +     +   L+ ++   P   LD    K       +G+ Y H 
Sbjct: 63  LLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
               +++HRD+K  N+L+D +    + DFGLA+
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.0 bits (122), Expect = 9e-07
 Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 19/167 (11%)

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRGTV 470
           A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     R  V
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK 530
             +APE +     + ++DV+ +GILL E+ +       G ++   G+ +D         K
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS------LG-SSPYPGMPVD--------SK 325

Query: 531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
             +M+ +  +         EM  +   C   +PL RP   ++++++E
Sbjct: 326 FYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 42/216 (19%)

Query: 309 LGRGGFGIV-----YKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           +G G FG V     Y    +  A V VK LK    +  + +F  + +   +  H N+L+ 
Sbjct: 3   IGNGWFGKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR-------KRIALGTARGLL 416
            G C      LLV+ Y   G + S L           W RR       +R+A   A G+ 
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQE-------QWHRRNSQLLLLQRMACEIAAGVT 113

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT------AVRGTV 470
           ++H+      +H D+   N  L  D    VGD+G+     +++ ++ T       +R   
Sbjct: 114 HMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWL- 168

Query: 471 GHIAPEYLSTGQ----SSEKT---DVFGFGILLLEL 499
              APE +        ++E+T   +V+  G+ L EL
Sbjct: 169 ---APELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 69/298 (23%), Positives = 113/298 (37%), Gaps = 73/298 (24%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEV-----------------ET 351
           LG+G F  ++KG   +        + DY    GE+  +TEV                 E 
Sbjct: 3   LGQGTFTKIFKGIRRE--------VGDY----GELH-KTEVLLKVLDKSHRNYSESFFEA 49

Query: 352 ISLAV---HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
            S+     H++L+   G C   +E ++V  Y+  GS+ + L+ + +      W       
Sbjct: 50  ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W------K 102

Query: 409 LGTARGLLY-LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
           L  A+ L + LH   D  + H +V A N+LL  + +   G+    KL D   S       
Sbjct: 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE 162

Query: 468 GTVGHI---APEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
             +  I    PE +   Q+ S   D + FG  L E+ +G          ++    LD  K
Sbjct: 163 ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG---------GDKPLSALDSQK 213

Query: 524 KLHQEGKLSQMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKML 576
           KL       Q  +       DR +L      E+  +   C  + P  RP    +++ L
Sbjct: 214 KL-------QFYE-------DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 11/199 (5%)

Query: 308 ILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQ-TEVETISLAVHRNLLRLC 364
           +LG+G FG ++     + G   A+K L K+  IA  EV    TE   +    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
               T +    V  Y   G     L  H+         R +         L YLH +   
Sbjct: 62  YAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 114

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
            +++RD+K  N++LD+D    + DFGL K     D        GT  ++APE L      
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 485 EKTDVFGFGILLLELITGQ 503
              D +G G+++ E++ G+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+  D       T    T  +
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181

Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 16/209 (7%)

Query: 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF- 366
           +G+G +G V+K     +G+  AVK L   +    E++ +  +   +L+ H N+++  G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK-ALSDHPNVVKFYGMY 84

Query: 367 ----CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
                   ++  LV      GSV   ++  +     ++      I      GL +LH   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
             K IHRDVK  NILL  +    + DFG++  L        T+V GT   +APE ++  Q
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200

Query: 483 S-----SEKTDVFGFGILLLELITGQRAL 506
                   + DV+  GI  +EL  G   L
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 57/199 (28%), Positives = 81/199 (40%), Gaps = 12/199 (6%)

Query: 308 ILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISL---AVHRNLLRL 363
           ++G+G FG V       DG   AVK L+   +   + Q     E   L     H  L+ L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
                T  +   V  ++  G     L  H+    +    R +  A   A  L YLH    
Sbjct: 62  HYSFQTTEKLYFVLDFVNGG----ELFFHLQRERSFPEPRARFYAAEIASALGYLHSI-- 115

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
             I++RD+K  NILLD     V+ DFGL K      S  TT   GT  ++APE +     
Sbjct: 116 -NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 484 SEKTDVFGFGILLLELITG 502
               D +  G +L E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 9/94 (9%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      ++HRD+K +N+LL+ + +  + DFGLA+    +   +T  V  T  +
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174

Query: 473 IAPEYLSTGQSSEKT---DVFGFGILLLELITGQ 503
            APE L     SE T   DV+  G +  EL+  +
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 42/172 (24%)

Query: 310 GRGGFGIVYKG---CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA---VHRNLLRL 363
           GRG +G VYK       DG   A+K+ K        +  Q+    I+L     H N++ L
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS-QSACREIALLRELKHENVVSL 67

Query: 364 CGFCSTENERL--LVYPYMPNGSVASR-----LRDHIHGRPALDWARRKRIALGTAR--- 413
                   ++   L++ Y      A       ++ H         A+R  I     +   
Sbjct: 68  VEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQ-------AKRVSIPPSMVKSLL 114

Query: 414 -----GLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVV--GDFGLAKLLD 456
                G+ YLH      ++HRD+K ANIL+  +     VV  GD GLA+L +
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 52/229 (22%), Positives = 95/229 (41%), Gaps = 30/229 (13%)

Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGA------LVAVKRLKDYNIAGGEVQFQTE 348
           E+  +T  F  +  LG   FG VYKG     A       VA+K LKD        +F+ E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 349 VETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL------------RDHIHGR 396
               S   H N++ L G  + E    +++ Y  +  +   L             D    +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 397 PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
             L+ A    I    A G+ +L       ++H+D+   N+L+ +     + D GL + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 457 HRDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
             D +    + G     +  ++PE +  G+ S  +D++ +G++L E+ +
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 6e-06
 Identities = 29/93 (31%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD--HRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+ + +  + DFGLA++ D  H  +   T    T 
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 471 GHIAPE-YLSTGQSSEKTDVFGFGILLLELITG 502
            + APE  L++   ++  D++  G +L E+++ 
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 16/201 (7%)

Query: 308 ILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLC 364
           ++G+G FG V      ++    AVK L+   I     E    +E   +   V    L   
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 365 GFCSTENERL-LVYPYMPNGSVASRL-RDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            F     ++L  V  Y+  G +   L R+     P     R +  A   A  L YLH   
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSL- 115

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKL-LDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              I++RD+K  NILLD     V+ DFGL K  ++H  +  T+   GT  ++APE L   
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQ 171

Query: 482 QSSEKTDVFGFGILLLELITG 502
                 D +  G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 55/197 (27%), Positives = 82/197 (41%), Gaps = 32/197 (16%)

Query: 325 GALVAVKRLKDYNIAGGE--VQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382
           G LV V R+ D      E     Q EV       H N++      +T +   ++ P+M  
Sbjct: 25  GTLVTV-RITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83

Query: 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442
           GS  S L+ +      +  A    I  G  RGL YLH+      IHR++KA++IL+  D 
Sbjct: 84  GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGD- 137

Query: 443 EAVVGDFGLAKL--LDHRDSHVTTAVRGTVGHIAPEYLSTGQ---SSE-----------K 486
                  GL  L  L H  S V    +  V +  P++ ++     S E           K
Sbjct: 138 -------GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVK 190

Query: 487 TDVFGFGILLLELITGQ 503
           +D++  GI   EL TG+
Sbjct: 191 SDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 27/211 (12%)

Query: 309 LGRGGFGIVYKGCF---SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV----HRNLL 361
           LG+G +GIV        S+   VA+K++   N+   ++  +  +  + L      H+N+ 
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKIT--NVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 362 RLCG----FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            L      F    NE   +Y Y     + + L   I     L  A  +        GL Y
Sbjct: 66  CLYDMDIVFPGNFNE---LYLYEE--LMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKY 120

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD----HRDSHVTTAVRGTVGHI 473
           +H      ++HRD+K  N+L++ D E  + DFGLA+            +T  V  T  + 
Sbjct: 121 IHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWYR 176

Query: 474 APEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
           APE + + QS  K  DV+  G +L EL+  +
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 10/94 (10%)

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT-- 469
           ARG+ +L  +     +HRD+ A N+LL +     + DFGLA+ + H  ++V+   +G+  
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300

Query: 470 --VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
             V  +APE +     +  +DV+ +GILL E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 8/92 (8%)

Query: 412 ARGLL----YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-HRDSHVTTAV 466
           AR LL    Y+H +    IIHRD+K  N+L++   +  +GDFG A        +     +
Sbjct: 266 ARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322

Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 498
            GTV   APE L+    +   D++  G+++ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 6e-05
 Identities = 68/238 (28%), Positives = 95/238 (39%), Gaps = 62/238 (26%)

Query: 309 LGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEV-QFQTEVETISLAVHRNLLR 362
           LG+G  G V+    KG    G L A+K L K   I   +V +  TE E ++   H  L  
Sbjct: 9   LGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65

Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR------- 413
           L  + S + E    LV  Y P G +   L+     +P       K ++   AR       
Sbjct: 66  L--YASFQTETYLCLVMDYCPGGELFRLLQR----QP------GKCLSEEVARFYAAEVL 113

Query: 414 -GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR----- 467
             L YLH      I++RD+K  NILL E    ++ DF L+K  D     V+ A+R     
Sbjct: 114 LALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 468 -----------------------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
                                  GT  +IAPE +S        D +  GILL E++ G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 35/127 (27%), Positives = 64/127 (50%), Gaps = 10/127 (7%)

Query: 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438
           Y+P+    +R    I+  PAL +      +   A G+ +L  +     +HRD+ A N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272

Query: 439 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGI 494
            E     + DFGLA+ +    ++++   +G+    +  +APE +     +  +DV+ FGI
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI 329

Query: 495 LLLELIT 501
           LL E+ T
Sbjct: 330 LLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.4 bits (105), Expect = 1e-04
 Identities = 62/227 (27%), Positives = 92/227 (40%), Gaps = 40/227 (17%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALV---------AVKRLKDYNIAGGEVQFQTEVET 351
            +F    ++  G +G VY        LV         A+K++   N+       Q  VE 
Sbjct: 1   EDFETIKLISNGAYGAVY--------LVRHKETRQRFAMKKINKQNLILRNQIQQVFVER 52

Query: 352 ISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             L    N   +  FCS E +R L  V  Y+  G  A+ L+ +I   P  D AR      
Sbjct: 53  DILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPV-DMARMYFAE- 109

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL------------LDH 457
            T   L YLH      I+HRD+K  N+L+       + DFGL+K+               
Sbjct: 110 -TVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165

Query: 458 RDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           +D+   +   V GT  +IAPE +      +  D +  GI+L E + G
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 48/238 (20%)

Query: 309 LGRGGFGIVYKGCF---SDGAL--------VAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           LG+G F  +YKG     SD  +        V +K L  D+  +   + F      +S   
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS---LAFFETASLMSQLS 59

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL-GTARGL 415
           H++L++L G C   +E ++V  Y+  G     L   +H          K       A  L
Sbjct: 60  HKHLVKLYGVC-VRDENIMVEEYVKFGP----LDVFLHREKNNVSLHWKLDVAKQLASAL 114

Query: 416 LYLHEQCDPKIIHRDVKAANILL--DEDFE-----AVVGDFGLAKLLDHRDSHVTTAVRG 468
            YL ++   K++H +V   NIL+      E       + D G+   +  R+  V      
Sbjct: 115 HYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--- 168

Query: 469 TVGHIAPEYLSTGQSS--EKTDVFGFGILLLEL----------ITGQRALDFGRAANQ 514
               IAPE +  GQ+S     D + FG  LLE+          ++      F +  ++
Sbjct: 169 --PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 40/223 (17%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYN-IAGGEVQFQTEV----ETISLAV 356
           +F    ++GRG FG            VAV ++K    I   ++  + E+    ET     
Sbjct: 2   DFEIIKVIGRGAFG-----------EVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE 50

Query: 357 HRNLLRLCGFCS----------TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
            RN+L + G C            EN   LV  Y   G + + L      R   D AR   
Sbjct: 51  ERNVL-VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDRLPEDMAR--- 105

Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
                A  +L +H       +HRD+K  N+LLD +    + DFG + L  ++D  V ++V
Sbjct: 106 --FYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSV 162

Query: 467 R-GTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQ 503
             GT  +I+PE L       G+   + D +  G+ + E++ G+
Sbjct: 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 22/214 (10%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLAVHR 358
           +F    ++GRG FG V      +   V A+K L  + +        F+ E + +    ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 359 NLLRLCGFCSTENERLLVYPYMPNG---SVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            +  L      EN   LV  Y   G   ++ S+  D +    A  +     IA+ +   L
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG-LAKLLDHRDSHVTTAVRGTVGHIA 474
            Y         +HRD+K  NIL+D +    + DFG   KL++      + AV GT  +I+
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 171

Query: 475 PEYLST-----GQSSEKTDVFGFGILLLELITGQ 503
           PE L       G+   + D +  G+ + E++ G+
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 22/201 (10%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNI-AGGEV-QFQTEVETISLAVHRNLLRLC- 364
           +G+GG+G V+     D G +VA+KR+K   +    EV    TE + ++      L++L  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
            F   E    L   Y+P G   + L +   G  + D AR     +  A  +  LHE    
Sbjct: 69  AFQDDEY-LYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEA--VDALHEL--- 120

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG---HIAPEYLSTG 481
             IHRD+K  N L+D      + DFGL+K        + T     VG   ++APE L   
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYANSVVGSPDYMAPEVLRGK 173

Query: 482 QSSEKTDVFGFGILLLELITG 502
                 D +  G +L E + G
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

 Score = 42.2 bits (99), Expect = 6e-04
 Identities = 33/93 (35%), Positives = 44/93 (47%), Gaps = 10/93 (10%)

Query: 118 LGKLEKLQTLDLSNNKFTGEIPDSLGDL----GNLNYLRLNNNSLTGSCPESLSKIESLT 173
           L K  +LQ +DLS+N F  E P+ LGDL     +L +L+LNNN L       + K     
Sbjct: 88  LLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGK----A 143

Query: 174 LVDLSYNNLSGSLPKISARTFKVTGNPLICGPK 206
           L  L+YN  +   PK+         N L  G K
Sbjct: 144 LFHLAYNKKAADKPKL--EVVICGRNRLENGSK 174

Length = 388

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 37.1 bits (87), Expect = 7e-04
 Identities = 18/37 (48%), Positives = 25/37 (67%), Gaps = 2/37 (5%)

Query: 123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
            L+TLDLSNN+ T ++P  L +L NL  L L+ N +T
Sbjct: 2   NLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 41.7 bits (98), Expect = 8e-04
 Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 7/95 (7%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK--LLDHRDSHVTTAVRGTV 470
           R L Y+H      + HRD+K  NIL + D +  + DFGLA+    D   +   T    T 
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 471 GHIAPEYLST--GQSSEKTDVFGFGILLLELITGQ 503
            + APE   +   + +   D++  G +  E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 42.0 bits (98), Expect = 9e-04
 Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 18/111 (16%)

Query: 124 LQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESL-SKIESLTLVDLSYNNL 182
           LQ+LDL +NK +  +P++L +   L YL + +NS+  + P  L S I  L +   S   L
Sbjct: 264 LQSLDLFHNKISC-LPENLPE--ELRYLSVYDNSIR-TLPAHLPSGITHLNVQSNSLTAL 319

Query: 183 SGSLPKISARTFKVTGNPLICGPKA----------TNNCTAVFPEPLSLPP 223
             +LP    +T +   N L   P +          + N   V PE  +LPP
Sbjct: 320 PETLP-PGLKTLEAGENALTSLPASLPPELQVLDVSKNQITVLPE--TLPP 367

Length = 754

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 30/214 (14%)

Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKR----LKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
            +G G +G VYK    + G LVA+K+    + +  I    ++  + ++ +S +++  ++R
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY--IVR 65

Query: 363 LCGFCSTENER-----LLVYPYMPNGSVASRLRDHI------HGRPALDWARRKRIALGT 411
           L      E +       LV+ Y+      S L+  +       GRP L     K      
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYL-----DSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQL 119

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTV 470
            +G+ + H+     ++HRD+K  N+L+D+    + + D GL +         T  +  T+
Sbjct: 120 LKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TL 175

Query: 471 GHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            + APE  L +   S   D++  G +  E+   Q
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 39/199 (19%), Positives = 83/199 (41%), Gaps = 27/199 (13%)

Query: 316 IVYKGCFSDGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLRLCGFCSTENER 373
            +YKG F +   V ++  K ++     +    + E++ +      N+L++ GF     + 
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 374 LLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
           L      P  S+         LR+ +     L +  +  +A+   +GL  L++       
Sbjct: 94  L------PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKP 145

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAV---RGTVGHIAPEYLSTGQS 483
           ++++ + + L+ E+++  +   GL K+L      +V   V      +  I  EY      
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYT----- 200

Query: 484 SEKTDVFGFGILLLELITG 502
             K D++  G++L E+ TG
Sbjct: 201 -IKDDIYSLGVVLWEIFTG 218

Length = 283

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)

Query: 288 LKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRL-KDYNIAGGEVQF 345
           LKRY  ++L+           +G G  GIV     +  G  VAVK+L + +       + 
Sbjct: 20  LKRY--QQLKP----------IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRA 67

Query: 346 QTEVETISLAVHRNLLRLCG-FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
             E+  +    H+N++ L   F   ++       Y+    + + L   IH    LD  R 
Sbjct: 68  YRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME--LDHERM 125

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
             +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+      + + T
Sbjct: 126 SYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC--TNFMMT 180

Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
               T  + APE +      E  D++  G ++ EL+ G
Sbjct: 181 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 51/195 (26%), Positives = 75/195 (38%), Gaps = 28/195 (14%)

Query: 325 GALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383
           G  V V+R+         V F Q E+    L  H N++        +NE  +V  +M  G
Sbjct: 25  GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84

Query: 384 SVASRLRDH-IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442
           S    +  H + G   L  A    I  G  + L Y+H       +HR VKA++IL+  D 
Sbjct: 85  SAKDLICTHFMDGMSELAIA---YILQGVLKALDYIHHM---GYVHRSVKASHILISVDG 138

Query: 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGH------------IAPEYLSTGQS--SEKTD 488
           +  +   GL   L    S +    R  V H            ++PE L         K+D
Sbjct: 139 KVYLS--GLRSNL----SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 192

Query: 489 VFGFGILLLELITGQ 503
           ++  GI   EL  G 
Sbjct: 193 IYSVGITACELANGH 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.002
 Identities = 18/49 (36%), Positives = 25/49 (51%), Gaps = 4/49 (8%)

Query: 147 NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           NL  L L+NN LT     +   + +L ++DLS NNL+     IS   F 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS----ISPEAFS 45

Length = 60

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           G+ +LH      IIHRD+K +NI++  D    + DFGLA+      S + T    T  + 
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYR 184

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           APE +      E  D++  G ++ E+I G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 9/84 (10%)

Query: 427 IHRDVKAANILLDEDFEAVVGDFG-LAKLLDHRDSHVTTAVR-GTVGHIAPEYL-----S 479
           +HRD+K  N+LLD++    + DFG   +LL   D  V + V  GT  +I+PE L      
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLA--DGTVQSNVAVGTPDYISPEILQAMEDG 181

Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
            G+   + D +  G+ + E++ G+
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 5/105 (4%)

Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
           LD  R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 177

Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            S + T    T  + APE +      E  D++  G ++ E+I G 
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.2 bits (82), Expect = 0.004
 Identities = 18/38 (47%), Positives = 23/38 (60%), Gaps = 2/38 (5%)

Query: 98  TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT 135
           T L+++ L NN I   +P  L  L  L+TLDLS NK T
Sbjct: 1   TNLETLDLSNNQITD-LPP-LSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 40/176 (22%), Positives = 61/176 (34%), Gaps = 55/176 (31%)

Query: 302 NFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           +F     LG G FG+VYK          +G  V +K+  +Y    G V+           
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKATEY----GAVEIWM-------- 179

Query: 356 VHRNLLRLCG-----FCST---------ENERLLVYPYMPNGSVASRLRDH--------- 392
            +  + R C      F            E+E  LV+ Y    ++A  ++           
Sbjct: 180 -NERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPY 238

Query: 393 ----IHGRPALDWARRKRIALGTARGLLY----LHEQCDPKIIHRDVKAANILLDE 440
               +   P     R  +I     R +L+    LH      I+HRDVK  NI+  E
Sbjct: 239 LLGKVQDLPK-GLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIFSE 290

Length = 566

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 39.3 bits (92), Expect = 0.004
 Identities = 31/114 (27%), Positives = 50/114 (43%), Gaps = 17/114 (14%)

Query: 82  PSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK----LEKLQTLDLSNNKFTGE 137
             ++L+  L         L+ + L NN I      +L +       L+ LDL+NN  T E
Sbjct: 153 SCEALAKALR----ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208

Query: 138 ----IPDSLGDLGNLNYLRLNNNSLTGS-----CPESLSKIESLTLVDLSYNNL 182
               + ++L  L +L  L L +N+LT +         LS   SL  + LS N++
Sbjct: 209 GASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	623
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.87
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PLN03150	623	hypothetical protein; Provisional	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
PRK10345	210	hypothetical protein; Provisional	99.75
smart00090	237	RIO RIO-like kinase.	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.55
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.47
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.42
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.35
PLN03150	623	hypothetical protein; Provisional	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.33
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
KOG1243	690	consensus Protein kinase [General function predict	99.26
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.26
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.19
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.16
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.14
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.1
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.1
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.09
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.09
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.08
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.06
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.04
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.98
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.96
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.91
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.9
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.9
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.89
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.89
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.88
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.87
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.86
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.84
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.83
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.8
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.78
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.74
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.69
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.68
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.67
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.62
COG4248	637	Uncharacterized protein with protein kinase and he	98.62
PRK09902	216	hypothetical protein; Provisional	98.61
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.56
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.56
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.53
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.51
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.49
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.48
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.44
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.43
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.41
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.4
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.34
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.34
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.27
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.21
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.18
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.17
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.15
PLN02876	822	acyl-CoA dehydrogenase	98.11

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.8e-60  Score=556.20  Aligned_cols=466  Identities=31%  Similarity=0.532  Sum_probs=343.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|++++.+|..+.++++|+.|+|++|++++.+|..+.++++|++|+|++|+++|.+|..+..+++|+.|+|+
T Consensus       476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  555 (968)
T PLN00113        476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS  555 (968)
T ss_pred             cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence            67888888888888888888888889999999999988888888888999999999999998888888889999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCCCCCCCCCccCCCCCCCCCCCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQS  230 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~~~~~~~~~~p~~~slp~~~~~~~~  230 (623)
                      +|+++|.+|..+..+++|+.|++++|+++|.+|....    ....+.||+..|+......          .++..     
T Consensus       556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~----------~~~c~-----  620 (968)
T PLN00113        556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG----------LPPCK-----  620 (968)
T ss_pred             CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC----------CCCCc-----
Confidence            9999888888888888899999999999988886533    2345778888887542110          01110     


Q ss_pred             CCCCCCcceeeeecchhhhHHHHHHHhhhhhheeeccccccccccCCCCCCccc---cCcccccCHHHHHHHhcCCCcCC
Q 006968          231 DSGTKSHRVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVS---LGHLKRYTFKELRAATSNFSAKN  307 (623)
Q Consensus       231 ~~~~~~~~~~i~~~~~~g~~~~~~~~~~~l~~~~~r~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~~~~~  307 (623)
                       .........+++++++++++++++++++++++++|++.+...........+..   ......++++++   ...|...+
T Consensus       621 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  696 (968)
T PLN00113        621 -RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEEN  696 (968)
T ss_pred             -cccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCccc
Confidence             00111122233333344433333333333333333221111000000001110   011122344444   34577788


Q ss_pred             ceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCChh
Q 006968          308 ILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVA  386 (623)
Q Consensus       308 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~  386 (623)
                      .||+|+||.||+|.. .+|..||||+++....     ....|++.+++++||||++++|+|..++..++||||+++|+|.
T Consensus       697 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~  771 (968)
T PLN00113        697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS  771 (968)
T ss_pred             EEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence            999999999999997 4789999999864321     1235688899999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeecc
Q 006968          387 SRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV  466 (623)
Q Consensus       387 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  466 (623)
                      ++++.       ++|..+.+++.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||........     ...
T Consensus       772 ~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~  838 (968)
T PLN00113        772 EVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKC  838 (968)
T ss_pred             HHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCc
Confidence            99853       7899999999999999999997777799999999999999999888875 6655432211     122


Q ss_pred             ccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC--CC
Q 006968          467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN--FD  544 (623)
Q Consensus       467 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  544 (623)
                      .||..|+|||++.+..++.++|||||||++|||+||+.|++....  ......+|.+...........+|+.+...  .+
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (968)
T PLN00113        839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN  916 (968)
T ss_pred             cccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence            578999999999999999999999999999999999999853222  23345577766555555555666665432  34


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       545 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ..+..++.+++.+||+.+|++||||.||++.|+..
T Consensus       917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            56677899999999999999999999999999873

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-56  Score=458.76  Aligned_cols=287  Identities=52%  Similarity=0.872  Sum_probs=254.1

Q ss_pred             cccccCHHHHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeee
Q 006968          287 HLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF  366 (623)
Q Consensus       287 ~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~  366 (623)
                      ....|++.+++.||++|+..+.||+|+||.||+|...+|..||||++....... ..+|..|++++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            456799999999999999999999999999999999999999999887654333 5679999999999999999999999


Q ss_pred             eecCC-ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEE
Q 006968          367 CSTEN-ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       367 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                      |.+.+ +.+||||||++|+|.++|+.....  +++|.+|.+|+.++|+||+|||+.+.|+||||||||+|||+|+++++|
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            99988 599999999999999999875332  899999999999999999999999999999999999999999999999


Q ss_pred             EeecccccccCC-CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH
Q 006968          446 VGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       446 l~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      |+|||+|+.... .....+.. .||.+|+|||++..+..+.|+|||||||+++||+||+.+.+.... .....+.+|...
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l~~w~~~  295 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSLVEWAKP  295 (361)
T ss_pred             ccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-cccccHHHHHHH
Confidence            999999965543 22211111 799999999999999999999999999999999999998876542 233347899999


Q ss_pred             HhhcCccccccccccC-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          525 LHQEGKLSQMVDKDLK-GNFDR-IELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....+.+.+++|+.+. ..+.. .+...+..++.+|++.+|++||+|.||+++|+.
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            9999999999999987 66664 678889999999999999999999999999965

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=393.60  Aligned_cols=252  Identities=33%  Similarity=0.507  Sum_probs=208.1

Q ss_pred             cCCceeccCCeEEEEEEeCCCcEEEEEEecccccccc-hHHHHHHHHHHhhcCCCceeeeeeeeecCC-ceEEEEecccC
Q 006968          305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTEN-ERLLVYPYMPN  382 (623)
Q Consensus       305 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~~  382 (623)
                      ..+.||+|+||+||+|.+.....||||++........ ..+|.+|+.+|.+++|||||+++|+|.++. ..++||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            3456999999999999995545599999976543222 558999999999999999999999999887 79999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCCeEECCCC-cEEEeecccccccCCCCC
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK-IIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~  460 (623)
                      |+|..+++..  ....+++..+.+++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            9999999874  356799999999999999999999999   7 99999999999999997 99999999998765432 


Q ss_pred             ceeeccccccccccccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ...+...||+.|||||++.  ...|+.|+|||||||++|||+||+.||.....       ...+..+..         ..
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~---------~~  262 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVV---------GG  262 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHh---------cC
Confidence            2233367999999999999  56999999999999999999999999974322       111111111         11


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .+...+..++..+..++.+||..||+.||++.+++..|+.
T Consensus       263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~  302 (362)
T KOG0192|consen  263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES  302 (362)
T ss_pred             CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence            2222333356789999999999999999999999999986

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-47  Score=370.06  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=209.7

Q ss_pred             cCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC-ceEEEEecccC
Q 006968          305 AKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-ERLLVYPYMPN  382 (623)
Q Consensus       305 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~~  382 (623)
                      ..+.||+|..|+|||+.++ +++.+|+|.+.........+++.+|+++++..+||+||+++|.|..++ ...++||||++
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg  162 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG  162 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence            3678999999999999986 689999999966555556778999999999999999999999999988 49999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|++.+...    +.+++....+|+.+|++||.|||+..  +||||||||+|||++..|++||||||.+..+...   .
T Consensus       163 GSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~  233 (364)
T KOG0581|consen  163 GSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I  233 (364)
T ss_pred             CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence            9999998764    56999999999999999999999632  9999999999999999999999999999876543   4


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      ...++||..|||||.+.+..|+.++||||||++++|+.+|+.|+.....  ......+.+..+..+.          ...
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~--~~~~~~~Ll~~Iv~~p----------pP~  301 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP--PYLDIFELLCAIVDEP----------PPR  301 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC--CCCCHHHHHHHHhcCC----------CCC
Confidence            5667799999999999999999999999999999999999999864311  1111122222222111          112


Q ss_pred             CCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          543 FDR-IELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       543 ~~~-~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ++. ..+.++.+++..||++||.+|||++|+++|=
T Consensus       302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            222 2568899999999999999999999999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-47  Score=388.41  Aligned_cols=251  Identities=30%  Similarity=0.451  Sum_probs=214.5

Q ss_pred             cCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCC
Q 006968          305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS  384 (623)
Q Consensus       305 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  384 (623)
                      ..+.||+|.||+||.|.++....||||.++...  ....+|.+|+++|.+++|+|||+++|+|..++..+||||||+.|+
T Consensus       210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            457899999999999999878899999998653  345689999999999999999999999999889999999999999


Q ss_pred             hhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceee
Q 006968          385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT  464 (623)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  464 (623)
                      |.+||+.  ..+..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+...+..+....
T Consensus       288 Ll~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~  362 (468)
T KOG0197|consen  288 LLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE  362 (468)
T ss_pred             HHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence            9999997  3456799999999999999999999999   9999999999999999999999999999976655555555


Q ss_pred             ccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCC
Q 006968          465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNF  543 (623)
Q Consensus       465 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  543 (623)
                      ...-...|.|||.+..+.++.|||||||||+||||+| |+.|+....       ..+.+..+          +...+-..
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------n~ev~~~l----------e~GyRlp~  425 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------NEEVLELL----------ERGYRLPR  425 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------HHHHHHHH----------hccCcCCC
Confidence            5455689999999999999999999999999999999 666654221       12223332          33333334


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          544 DRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       544 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      +..++.++.+++..||..+|++|||+..+...|++.
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            666889999999999999999999999999998873

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-46  Score=382.03  Aligned_cols=249  Identities=26%  Similarity=0.410  Sum_probs=212.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|...+.||+|+|+.||.++. ..|+.||+|++.+....  .......+||++.+.++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999997 78999999999765433  23456899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      |+|++++|..++++    +.++++..++.++.||+.||.|||+.   +|+|||||-.|++++++.++||+|||+|..+..
T Consensus        98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999998874    46899999999999999999999999   999999999999999999999999999998874


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      . .+...+.+||+.|+|||++.....+..+||||+|||+|-|+.|++||+...       ..+-...+..    .+.   
T Consensus       171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~----~~Y---  235 (592)
T KOG0575|consen  171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKL----NEY---  235 (592)
T ss_pred             c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHh----cCc---
Confidence            4 234566789999999999999899999999999999999999999997321       1111111111    000   


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          .++.....+..+||.++|+.+|.+|||+.+|+.+
T Consensus       236 ----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  236 ----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                1123344778999999999999999999999873

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=360.12  Aligned_cols=199  Identities=28%  Similarity=0.454  Sum_probs=179.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .+|...+.||+|+||+||+|+++ ++..||||.+..... ....+.+..|+++|+.++|||||++++++..++..++|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            56778888999999999999975 589999999976653 3334457899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC------CcEEEeecccc
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED------FEAVVGDFGLA  452 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~Dfgla  452 (623)
                      ||.+|+|.+|++.+    +.+++.+.+.++.|+|.||++||++   +||||||||+|||++..      -.+||+|||+|
T Consensus        90 yC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999874    4799999999999999999999999   99999999999999864      45899999999


Q ss_pred             cccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCc
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF  508 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~  508 (623)
                      +.+..+  ......+|++-|||||++...+|+.|+|+||.|+|+|++++|+.||+.
T Consensus       163 R~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  163 RFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            988743  344567899999999999999999999999999999999999999974

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-46  Score=363.14  Aligned_cols=258  Identities=25%  Similarity=0.344  Sum_probs=208.9

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccc------hHHHHHHHHHHhhcCCCceeeeeeeeecCCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG------EVQFQTEVETISLAVHRNLLRLCGFCSTENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  372 (623)
                      .+.|.+.+.||+|+||.|-+|..+ +|+.||||++++......      .....+|+++|+++.|||||++++++..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            355778899999999999999864 799999999987654432      2235799999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC---CcEEEeec
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED---FEAVVGDF  449 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Df  449 (623)
                      .||||||++||.|.+++-.+    +.+.+..-+.++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             eEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999998763    4577777789999999999999999   99999999999999866   77999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccccCCC---CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHh
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH  526 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  526 (623)
                      |+|+..+  ......+.+||+.|.|||++.++.+   ..++|+||+||++|-+++|.+||........       +.+..
T Consensus       324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------l~eQI  394 (475)
T KOG0615|consen  324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------LKEQI  394 (475)
T ss_pred             chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------HHHHH
Confidence            9999875  3445677899999999999977543   4488999999999999999999974222110       11111


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ..+++..      .........++..++|.+||..||++|||+.|++++-+-.
T Consensus       395 ~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  395 LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence            1222211      0112244568899999999999999999999999986653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-46  Score=348.62  Aligned_cols=260  Identities=22%  Similarity=0.365  Sum_probs=212.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeee-eeecCCc-eEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCG-FCSTENE-RLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~-~~~~~~~-~~lv  376 (623)
                      .+|++.++||+|.||+|||+.. .+|..||.|.++-..... ..++...|+.+|++++|||||+.++ .+.++.+ .++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3577789999999999999974 589999999997443332 3446899999999999999999998 4555555 8999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP-KIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      |||+..|+|...++....+...+++..+++++.|++.||+++|+..+. -|+||||||.||+++.+|.+|++|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999998888888999999999999999999999994321 2889999999999999999999999999988


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ..... .....+|||.||+||.+....|+.||||||+||++|||+.-++||...       .+.+.-+++.+ +++..  
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~~KI~q-gd~~~--  247 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLCKKIEQ-GDYPP--  247 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHHHHHHc-CCCCC--
Confidence            75443 344567999999999999999999999999999999999999999742       22332232221 22221  


Q ss_pred             ccccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          536 DKDLKGNFD-RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       536 ~~~~~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                             .+ ..++..+..|+..|+.+||+.||+.-.++..+..
T Consensus       248 -------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  248 -------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                   22 5667899999999999999999996555554443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.2e-44  Score=383.51  Aligned_cols=259  Identities=28%  Similarity=0.427  Sum_probs=216.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      ..+....+.||+|+||+||+|...      +...||||.+++....+...+|++|+++++.++|||||+|+|.|..++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            345566789999999999999853      35679999999888776788999999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccC------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc
Q 006968          374 LLVYPYMPNGSVASRLRDHIH------G----RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE  443 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  443 (623)
                      +||+|||..|+|.+||+.+..      .    ..+++..+.+.|+.|||.||.||-++   .+|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence            999999999999999975422      1    23489999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccccccCCCCCceee-ccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHH
Q 006968          444 AVVGDFGLAKLLDHRDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDW  521 (623)
Q Consensus       444 ~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  521 (623)
                      |||+|||+++..-..+++... ...-..+||+||.+..+++|.+||||||||+|||+++ |+.|+.....       .+ 
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------~E-  713 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------QE-  713 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------HH-
Confidence            999999999976555544332 2234689999999999999999999999999999998 7778753211       01 


Q ss_pred             HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          522 VKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      +-...+.+.+         -..++.++.+++.|+..||+.+|++||+++||-..|+.
T Consensus       714 VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~  761 (774)
T KOG1026|consen  714 VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA  761 (774)
T ss_pred             HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence            1111122221         23467788999999999999999999999999999876

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-45  Score=381.86  Aligned_cols=269  Identities=26%  Similarity=0.401  Sum_probs=225.4

Q ss_pred             cccCHHHHHHHhcCC---------CcCCceeccCCeEEEEEEeC----CCcEEEEEEecccccccchHHHHHHHHHHhhc
Q 006968          289 KRYTFKELRAATSNF---------SAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLA  355 (623)
Q Consensus       289 ~~~~~~~l~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l  355 (623)
                      ..++|+|--++...|         .+.++||.|.||.||+|.++    ....||||.+|....++.+.+|+.|..+|.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            345666554444433         56789999999999999975    24579999999888788888999999999999


Q ss_pred             CCCceeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 006968          356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN  435 (623)
Q Consensus       356 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N  435 (623)
                      .||||++|.|+.......++|+|||+||+|+.||+.+.   ..+++.+...++.+||.||+||.+.   ++|||||.++|
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARN  761 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARN  761 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhh
Confidence            99999999999999999999999999999999999863   4599999999999999999999999   99999999999


Q ss_pred             eEECCCCcEEEeecccccccCCCCCceeecccc--ccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCccccc
Q 006968          436 ILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAA  512 (623)
Q Consensus       436 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~  512 (623)
                      ||++.+..+|++|||+++.+++......+...|  ..+|.|||.+..+++|.++||||||++|||.++ |.+|+-...  
T Consensus       762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--  839 (996)
T KOG0196|consen  762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--  839 (996)
T ss_pred             eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--
Confidence            999999999999999999886654333333323  478999999999999999999999999999887 888864211  


Q ss_pred             ccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 006968          513 NQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG  580 (623)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  580 (623)
                           ..+.++.          ++..++-.-+.+++..|.+|++.||++|-.+||++.||+.+|+...
T Consensus       840 -----NQdVIka----------Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  840 -----NQDVIKA----------IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             -----hHHHHHH----------HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence                 1122333          3333444457788999999999999999999999999999998743

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-44  Score=347.66  Aligned_cols=243  Identities=27%  Similarity=0.311  Sum_probs=205.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccc--hHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG--EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .++|++.++||+|+||.||.+..+ +++.+|+|++++......  .+....|..+|.+++||+||+++..|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999865 589999999988765543  44688999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      +||+.||.|..+|.+    ...+++..++.++..|+.||.|||+.   +||||||||+|||+|.+|+++|+|||+++..-
T Consensus       104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999998876    35799999999999999999999999   99999999999999999999999999998543


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      . ....+..++||+.|||||++....|+..+|.||+|+++|||++|.+||.....       ..+...+....       
T Consensus       177 ~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-------~~~~~~I~~~k-------  241 (357)
T KOG0598|consen  177 K-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-------KKMYDKILKGK-------  241 (357)
T ss_pred             c-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-------HHHHHHHhcCc-------
Confidence            2 23345668999999999999999999999999999999999999999974322       22333332222       


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRP  567 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP  567 (623)
                         ....+..-..+..+++.+.+..||++|-
T Consensus       242 ---~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 ---LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ---CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence               0011222346788999999999999996

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=354.20  Aligned_cols=266  Identities=23%  Similarity=0.312  Sum_probs=211.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCC-ceEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTEN-ERLLV  376 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~-~~~lv  376 (623)
                      .++|...+.||.|+||+||+|+.. +|+.||||+|+.....-++.--++|++.|+++. ||||+++..++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            467888899999999999999864 689999999987554433444589999999998 999999999998887 99999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||| ..+|++.+++.   +..+++..++.|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+||.+.
T Consensus        89 fE~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             HHhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence            9999 56999999875   56899999999999999999999999   99999999999999988899999999999876


Q ss_pred             CCCCceeeccccccccccccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc-----
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK-----  530 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  530 (623)
                      +..  ..+.++.|..|.|||++. .+.|+.+.||||+|||++|+.+-++-|-+....++...+.+.+.....+.+     
T Consensus       162 Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  162 SKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            543  356677899999999885 567899999999999999999999888755443332222222211111110     


Q ss_pred             cccccc--------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVD--------KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~--------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      +...+.        ..+..-++. ...+..+++.+|+.+||++|||+.|.+++
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            111111        111111122 56889999999999999999999999885

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8e-43  Score=329.37  Aligned_cols=266  Identities=20%  Similarity=0.274  Sum_probs=205.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      +.|+...++|+|+||+|||++.+ +|+.||||++...... .-.+-.++|+++|++++|||+|.++.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35777788999999999999986 5999999999765432 223457899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |++. ++.+-|..+   ...++.....+++.|+++|+.|+|++   ++|||||||+|||++.++.+||||||+|+.+.. 
T Consensus        82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-  153 (396)
T KOG0593|consen   82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-  153 (396)
T ss_pred             ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence            9976 444445544   23588899999999999999999999   999999999999999999999999999998874 


Q ss_pred             CCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH--------HHhhcC
Q 006968          459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK--------KLHQEG  529 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~  529 (623)
                      .....+.++.|..|.|||.+.+ ..|+..+||||.||++.||++|.+-|....+.++...+...+.        .+...+
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            3445666778999999999988 6899999999999999999999988865443332211111111        111111


Q ss_pred             ccccccccc------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          530 KLSQMVDKD------LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       530 ~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .+.-+.-+.      +...++ ....-+++++..|+..||.+|++-+|++.+
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            111111111      111121 123468999999999999999999999874

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=344.83  Aligned_cols=256  Identities=29%  Similarity=0.415  Sum_probs=205.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC-CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC--ceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--ERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~  377 (623)
                      .++...+.||+|+||+||++...+ |...|||.+....... ...+.+|+.+|.+++|||||+.+|.....+  .++++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            456678899999999999999764 9999999986653222 456899999999999999999999865555  589999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCcEEEeecccccccC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLAKLLD  456 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~  456 (623)
                      ||+++|+|.+++.+..  . .+++..++.++.|+++||+|||++   +||||||||+|||++. ++.+||+|||+++...
T Consensus        96 Ey~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            9999999999998752  2 699999999999999999999999   9999999999999999 7999999999998766


Q ss_pred             C--CCCceeeccccccccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          457 H--RDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       457 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      .  ..........||+.|||||++..+. ...++||||+||++.||+||++||...      ....+++-........  
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~--  241 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSL--  241 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCC--
Confidence            3  2222344577999999999998643 345999999999999999999998632      0111122221111111  


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                             ..++...+.+..+++.+|+..+|++||||.+++++.--
T Consensus       242 -------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  242 -------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             -------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence                   13334445788999999999999999999999997654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=350.93  Aligned_cols=250  Identities=26%  Similarity=0.434  Sum_probs=210.8

Q ss_pred             ccccCHHHHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeee
Q 006968          288 LKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC  367 (623)
Q Consensus       288 ~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~  367 (623)
                      +..++|+++..       .+-||+|+.|.||+|.+ .++.||||+++.-+        ..+|+-|++++||||+.+.|+|
T Consensus       118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             hccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeee
Confidence            34566666543       57799999999999999 57889999986432        4678899999999999999999


Q ss_pred             ecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 006968          368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG  447 (623)
Q Consensus       368 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  447 (623)
                      .....+++|||||..|-|++.|+.    ..++.......+..+||.||.|||.+   .|||||||+-||||..+..+||+
T Consensus       182 tqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIs  254 (904)
T KOG4721|consen  182 TQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKIS  254 (904)
T ss_pred             cCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEec
Confidence            999999999999999999999986    45688888999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh
Q 006968          448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       448 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      |||.++.....  .....++||..|||||++.+.+.++|+||||||||||||+||..|+..-+..   ..          
T Consensus       255 DFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AI----------  319 (904)
T KOG4721|consen  255 DFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AI----------  319 (904)
T ss_pred             cccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---ee----------
Confidence            99999876543  2344578999999999999999999999999999999999999998632210   00          


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         +--+-...+.-.++..+++.+.-|++.||+-.|..||++.+++.+|+-
T Consensus       320 ---IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  320 ---IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ---EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence               001112234445677788899999999999999999999999999975

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.6e-42  Score=355.83  Aligned_cols=260  Identities=26%  Similarity=0.397  Sum_probs=204.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe------CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecC-C
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE-N  371 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~  371 (623)
                      .++|.+.+.||+|+||.||+|..      .++..||||+++..........+.+|+.++..+ +||||++++++|... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46788899999999999999974      235789999997544334455789999999999 899999999988764 4


Q ss_pred             ceEEEEecccCCChhhhhhhccCC--------------------------------------------------------
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHG--------------------------------------------------------  395 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------  395 (623)
                      ..++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            578999999999999998753210                                                        


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc-eeecccccccc
Q 006968          396 --RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGH  472 (623)
Q Consensus       396 --~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y  472 (623)
                        ..++++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++........ ......++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              13588899999999999999999999   9999999999999999999999999999865432221 12233466889


Q ss_pred             ccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHH
Q 006968          473 IAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEM  551 (623)
Q Consensus       473 ~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  551 (623)
                      +|||++.+..++.++|||||||++|||++ |+.||......      ....... ..+...         ..+...+.++
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~-~~~~~~---------~~~~~~~~~l  306 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRL-KDGTRM---------RAPENATPEI  306 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHH-hcCCCC---------CCCCCCCHHH
Confidence            99999999999999999999999999997 99998643211      0111111 111110         1122234678


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          552 VQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       552 ~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .+++.+||+.||++|||+.|+++.|++
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.9e-42  Score=318.42  Aligned_cols=266  Identities=24%  Similarity=0.336  Sum_probs=209.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccc-hHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .+|...++||+|.||.||+|.. .+|+.||||+++.....++ .....+|++.|+.++|+||+.+++.|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            3577788999999999999996 4799999999986654433 3467999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      ||+. +|+..+++.   ...++...+..++.++.+|++|||++   .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus        82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9964 888888764   45799999999999999999999999   9999999999999999999999999999998766


Q ss_pred             CCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc--ccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK--LSQMV  535 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  535 (623)
                      ....+.. +-|..|.|||.+.+ +.|+..+||||.|||+.||+.|.+-|....+.++...+..-+.....+.+  +..+.
T Consensus       155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            5544433 57999999999877 46899999999999999999998777654433332222111111111110  11111


Q ss_pred             c---------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          536 D---------KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       536 ~---------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      |         +.... +-..+.....+++..|+..||.+|+|+.|++++
T Consensus       234 dY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1         11111 122344667999999999999999999999886

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-42  Score=346.86  Aligned_cols=267  Identities=22%  Similarity=0.292  Sum_probs=207.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchH-HHHHHHHHHhhcCCCceeeeeeeeecC--CceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEV-QFQTEVETISLAVHRNLLRLCGFCSTE--NERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv  376 (623)
                      +.|+..++||+|+||.||||.. .+|+.||+|+++-.....+.. -..+||.+|+++.||||++|.+...+.  ...|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            3466678899999999999985 579999999998766444433 357999999999999999999998776  689999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      +|||+. +|.-++..   ..-.++..++..++.|++.||+|+|++   +|+|||||.+|||||.+|.+||+|||+|+.+.
T Consensus       197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999976 66666653   234699999999999999999999999   99999999999999999999999999999888


Q ss_pred             CCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc-ccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL-SQM  534 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  534 (623)
                      .......+..+-|..|.|||++.+. .|+.++|+||.|||+.||++|++.+......++...+.........+.+. .++
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            7766666677789999999999875 79999999999999999999999887654433332222211111111111 000


Q ss_pred             cc---cccCCCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          535 VD---KDLKGNFDR-------IELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       535 ~~---~~~~~~~~~-------~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                      ..   -.....+.+       ..+...++|+..+|..||.+|.|+.++++
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            00   000011111       12356889999999999999999999987

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=336.74  Aligned_cols=265  Identities=28%  Similarity=0.423  Sum_probs=203.9

Q ss_pred             CCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhh--cCCCceeeeeeeeecCC----ceEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL--AVHRNLLRLCGFCSTEN----ERLL  375 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~~~----~~~l  375 (623)
                      ..+..++||+|+||.||||.+ +++.||||++...    ..+.|+.|-++++.  ++|+||++++++-....    +++|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             chhhHHHhhcCccceeehhhc-cCceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            344567899999999999999 5699999999743    46689999988875  58999999999876655    8899


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ------CDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                      |+||.++|+|.+||..+     .++|....+|+..+++||+|||+.      ++|+|+|||||++||||.+|++..|+||
T Consensus       286 Vt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            99999999999999875     699999999999999999999974      5889999999999999999999999999


Q ss_pred             ccccccCCCCCc-eeeccccccccccccccccCCC------CCccchhhHHHHHHHHHhCCCCCCcccccccc-------
Q 006968          450 GLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQS------SEKTDVFGFGILLLELITGQRALDFGRAANQR-------  515 (623)
Q Consensus       450 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~-------  515 (623)
                      |+|..+...... .+...+||.+|||||++.+.-.      -.+.||||+|.|+|||+++...++.+...+..       
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            999988755432 2334679999999999976422      24689999999999999987655321111111       


Q ss_pred             --cchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          516 --GVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       516 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                        .--.+-++..+-.++.+..+......   ...+..+.+.+..||+.|++.|.|+.=+-+.+.+.
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence              11112233322222222222211111   13457789999999999999999999888877664

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-41  Score=333.45  Aligned_cols=262  Identities=26%  Similarity=0.371  Sum_probs=210.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .+.|++.+.||.|..++||+|.. ..++.||||++.-......-..+.+|+..++.+.||||++.+..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            35788899999999999999986 46899999999877766666789999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      ||.+|++.+.++.....  .+++..+..|.+++++||.|||.+   |.||||||+.||||+.+|.|||+|||.+..+.+.
T Consensus       105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            99999999999887543  499999999999999999999999   9999999999999999999999999987655433


Q ss_pred             CCce-e--ecccccccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          459 DSHV-T--TAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       459 ~~~~-~--~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      .... .  ...+||+.|||||++..  ..|+.|+||||||++..||.+|..||....+..      -.+.++.  +....
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLq--n~pp~  251 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQ--NDPPT  251 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhc--CCCCC
Confidence            2221 1  45679999999999643  468999999999999999999999997433211      1111111  11111


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                      ..-..+...-.......+.+++..||..||++|||+.++++
T Consensus       252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00001111111222357899999999999999999999976

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=343.23  Aligned_cols=252  Identities=24%  Similarity=0.338  Sum_probs=210.3

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccc--hHHHHHHHHHHhhc-CCCceeeeeeeeecCCceE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG--EVQFQTEVETISLA-VHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  374 (623)
                      ...+|..++.||+|+|++|++|... .++.+|||++.+..+...  .+....|-++|.++ .||.|++|+..|+++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3467888999999999999999865 689999999976654433  23578899999999 8999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +|+||+++|+|.++|...    +.+++...+.++.+|+.||+|||++   |||||||||+|||+|+||++||+|||.|+.
T Consensus       151 FvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999875    4699999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCc----------ee--eccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHH
Q 006968          455 LDHRDSH----------VT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV  522 (623)
Q Consensus       455 ~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  522 (623)
                      +.+....          ..  ..++||..|.+||++.....+..+|+|+||||+|+|+.|++||.....      .+.+-
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------yliFq  297 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------YLIFQ  297 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------HHHHH
Confidence            8643211          11  347899999999999999999999999999999999999999974321      22221


Q ss_pred             HHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          523 KKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      +.+.        ++-.+    ++..++...+|+.+.|..||.+|+|..||.+|
T Consensus       298 kI~~--------l~y~f----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  298 KIQA--------LDYEF----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHH--------hcccC----CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            1111        11122    22333678899999999999999999999775

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=352.57  Aligned_cols=264  Identities=28%  Similarity=0.422  Sum_probs=208.1

Q ss_pred             HHHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccc-hHHHHHHHHHHhhcCCCceeeeeeeeecCCc
Q 006968          294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTENE  372 (623)
Q Consensus       294 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  372 (623)
                      .++....+.+.+.+.||+|.||+||+|.|.  ..||||+++-...... .+.|..|+..+++-+|.||+-+.|||..++.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            334444455667889999999999999984  4699999986654433 3579999999999999999999999988877


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                       .+|+.+|+|.+|+.+++..   +..++..+.+.|+.|||+||.|||.+   +|||||||+.||++.+++.|||+|||++
T Consensus       463 -AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             -eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence             9999999999999999875   35799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCC-CCceeecccccccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc
Q 006968          453 KLLDHR-DSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       453 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      ..-..- ........-|...|||||++..   .+|++.+||||||+|+|||+||..|+. ....++.  +       ...
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqI--i-------fmV  605 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQI--I-------FMV  605 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhhe--E-------EEe
Confidence            653321 1111222337789999999964   368999999999999999999999997 2221111  0       001


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ++-.  ..+++. .....++.++.+|+..||.+++++||.+.+|+..|++.
T Consensus       606 GrG~--l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l  653 (678)
T KOG0193|consen  606 GRGY--LMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL  653 (678)
T ss_pred             cccc--cCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence            1110  001111 12344667899999999999999999999999988873

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=373.68  Aligned_cols=260  Identities=30%  Similarity=0.463  Sum_probs=214.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCC--Cc----EEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSD--GA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      ..+....+.||+|+||.||.|.+.+  |.    .||||.++.........+|.+|..+|+.+.|||||+++|+|-+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3445667899999999999999753  43    49999998877777788999999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          374 LLVYPYMPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      ++++|||++|+|..||++...   +...++..+...++.|||+|+.||+++   ++|||||..+|+|++....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999997532   244689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecc-ccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhc
Q 006968          451 LAKLLDHRDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       451 la~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      +|+.+...++...... .-..+|||||.+..+.+|.|+|||||||++||++| |..|+...+       ..+.+..+...
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~-------n~~v~~~~~~g  920 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-------NFEVLLDVLEG  920 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-------hHHHHHHHHhC
Confidence            9996544443332222 34579999999999999999999999999999999 556664211       11222222223


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      +++          ..+..+++.+.++|..||+.+|++||++..|++.++.+
T Consensus       921 gRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  921 GRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             Ccc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            321          23556778999999999999999999999999987764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=344.94  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=208.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ..|...+.||+|+.|.||.|.. .+++.||||++...... .+.-+..|+.+|+..+|+|||.++..|...++.++||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            4566678899999999999985 46889999999765533 344578999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      |++|+|.+.+...     .+++.++..|...+++||+|||.+   +|+|||||++|||++.+|.+||+|||++..+....
T Consensus       352 m~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             cCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            9999999888654     589999999999999999999999   99999999999999999999999999999876554


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      . .....+||+.|||||++....|++|+||||||++++||+.|++||-...+...       +.-+...+.      +.+
T Consensus       424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA-------lyLIa~ng~------P~l  489 (550)
T KOG0578|consen  424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATNGT------PKL  489 (550)
T ss_pred             C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH-------HHHHhhcCC------CCc
Confidence            4 34456699999999999999999999999999999999999999864322111       111111111      111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ..+......+.+++.+||..|+++||+++|+|+|
T Consensus       490 --k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 --KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             --CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence              1234445789999999999999999999999984

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=344.47  Aligned_cols=254  Identities=22%  Similarity=0.328  Sum_probs=208.2

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc----cchHHHHHHHHHHhhcC-CCceeeeeeeeecCCc
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA----GGEVQFQTEVETISLAV-HRNLLRLCGFCSTENE  372 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~  372 (623)
                      ...+|.+.+.||+|.||+|+.|... +|..||+|++......    .....+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3467899999999999999999764 6899999977654221    23445678999999999 9999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CcEEEeeccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGL  451 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgl  451 (623)
                      .++||||+.+|+|.+++.+    ..++.+..+.+++.|++.|++|+|++   +|+||||||+|||+|.+ +++||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999986    34688899999999999999999999   99999999999999999 9999999999


Q ss_pred             ccccCCCCCceeeccccccccccccccccCC-C-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ-S-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      +.... .........+||+.|+|||++.+.. | +.++||||+||++|-|++|+.||+....       ....+.+ ..+
T Consensus       168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------~~l~~ki-~~~  238 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------PNLYRKI-RKG  238 (370)
T ss_pred             ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------HHHHHHH-hcC
Confidence            99874 2334456678999999999999877 7 4889999999999999999999984221       1111111 011


Q ss_pred             ccccccccccCCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          530 KLSQMVDKDLKGNFDRIE-LEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .        +  .++... ..++..++.+|+..+|.+|+|+.+++++=+-
T Consensus       239 ~--------~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~  278 (370)
T KOG0583|consen  239 E--------F--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWF  278 (370)
T ss_pred             C--------c--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhh
Confidence            0        0  112222 5788999999999999999999999965443

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.7e-40  Score=350.23  Aligned_cols=260  Identities=27%  Similarity=0.386  Sum_probs=205.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe------CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~  372 (623)
                      .++|.+.+.||+|+||.||+|..      .++..||||+++..........+.+|+.++..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34688899999999999999963      246689999997654444456789999999999 89999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccC----------------------------------------------------------
Q 006968          373 RLLVYPYMPNGSVASRLRDHIH----------------------------------------------------------  394 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  394 (623)
                      .++||||+++|+|.++++....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999865321                                                          


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          395 -------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       395 -------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                                   ....+++..+.+++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         112578999999999999999999999   9999999999999999999999999999866433221


Q ss_pred             e-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          462 V-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       462 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      . .....++..|+|||.+.+..++.++||||||+++|||++ |..||......   .....++.    .+.         
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~~----~~~---------  334 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMIK----EGY---------  334 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHHH----hCc---------
Confidence            1 122335678999999999999999999999999999998 88887532211   11111111    111         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            000111224678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.1e-41  Score=339.61  Aligned_cols=248  Identities=24%  Similarity=0.350  Sum_probs=211.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+..... +-+.+.+|+++++.++||||+.++++|++..+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46788899999999999999865 68999999987654433 33468999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+.| +|..+|..    +..++++.++.++.+++.||.|||+.   +|+|||+||+|||++..+.+|+||||+|+.+...
T Consensus        82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9976 88888865    56799999999999999999999999   9999999999999999999999999999987653


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                       ....+.+.||+-|||||++.+..|+..+|.||+|||+||+++|++||...       .+...++.+..+..        
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~d~v--------  217 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILKDPV--------  217 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhcCCC--------
Confidence             34556678999999999999999999999999999999999999999621       13333444332221        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         ..+......+..++...+..||..|.|..+++.|
T Consensus       218 ---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 ---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence               1233556788999999999999999999999764

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-40  Score=324.73  Aligned_cols=272  Identities=26%  Similarity=0.346  Sum_probs=212.6

Q ss_pred             CHHHHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhh--cCCCceeeeeeeeec
Q 006968          292 TFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL--AVHRNLLRLCGFCST  369 (623)
Q Consensus       292 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~  369 (623)
                      ++--.+....+..+.+.||+|.||.||+|.| .|+.||||+|..    .++..|.+|.++++.  ++|+||+.+++.-..
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            3333455667788899999999999999999 689999999964    346789999999874  599999999987654


Q ss_pred             C----CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCeEECC
Q 006968          370 E----NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-----QCDPKIIHRDVKAANILLDE  440 (623)
Q Consensus       370 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~Dlk~~NIll~~  440 (623)
                      +    .+++||++|.+.|||++||.+.     .++....++++..+|.||+|||.     +.+|.|.|||||+.|||+.+
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk  351 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  351 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence            4    3579999999999999999864     79999999999999999999995     45889999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCce---eeccccccccccccccccCCC------CCccchhhHHHHHHHHHhC---------
Q 006968          441 DFEAVVGDFGLAKLLDHRDSHV---TTAVRGTVGHIAPEYLSTGQS------SEKTDVFGFGILLLELITG---------  502 (623)
Q Consensus       441 ~~~~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~SlGvil~elltg---------  502 (623)
                      ++...|+|+|+|..........   ....+||.+|||||++...-.      -..+||||||.|+||+.-+         
T Consensus       352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee  431 (513)
T KOG2052|consen  352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE  431 (513)
T ss_pred             CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence            9999999999998766543322   234579999999999965321      3468999999999999864         


Q ss_pred             -CCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          503 -QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       503 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                       +.||..--+   .+...+-+++++...+++..++.+..   .......+.+++..||..+|.-|-|+-.+-+.|.+.
T Consensus       432 y~~Pyyd~Vp---~DPs~eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  432 YQLPYYDVVP---SDPSFEEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             hcCCcccCCC---CCCCHHHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence             344432111   11122334444444444444443332   456778999999999999999999999998888764

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-40  Score=333.61  Aligned_cols=256  Identities=26%  Similarity=0.368  Sum_probs=206.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC----CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ..+|++.+.||+|+||.||+|.+.    .+..||+|.++..........|.+|+.++.+++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888899999999999999863    3678999999865444445578999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999999764   24689999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ............++..|+|||.+.+..++.++||||||+++||+++ |+.||......       +...... .+.    
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~-~~~----  225 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------DVIKAVE-DGF----  225 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHH-CCC----
Confidence            3222111222335678999999999999999999999999999775 99998633211       1111111 110    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                           ....+...+..+.+++.+||+.+|.+||++.+|.+.|+.
T Consensus       226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence                 011123345678999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=336.08  Aligned_cols=250  Identities=28%  Similarity=0.359  Sum_probs=213.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ..|...+.||+|.||.||||... .++.||+|++.-........+.++|+.++..++++||.+.+|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            34666789999999999999874 68999999998877776677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +.+|++.+.|..    ...+++..+.-++.++..|+.|||.+   +.+|||||+.|||+..+|.+|++|||++..+....
T Consensus        93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            999999998875    23457888888999999999999999   99999999999999999999999999998876544


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      ... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+..-.+                 .++.-++.+..
T Consensus       166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----------------mrvlflIpk~~  227 (467)
T KOG0201|consen  166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----------------MRVLFLIPKSA  227 (467)
T ss_pred             hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----------------ceEEEeccCCC
Confidence            433 667899999999999988999999999999999999999999863222                 12233333333


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...+.......+.+++..||+.+|+.||++.+++++
T Consensus       228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            333444455779999999999999999999999874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=349.97  Aligned_cols=256  Identities=30%  Similarity=0.409  Sum_probs=206.9

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCC--C--cE-EEEEEeccc--ccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSD--G--AL-VAVKRLKDY--NIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~--~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  372 (623)
                      .++....++||+|+||.||+|.+..  +  .. ||||..+..  .......+|+.|.++++.++|||||+++|++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3455556899999999999999753  2  23 899999852  333445689999999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++|||+++||+|.++|+...   ..++..++..++.+.|.||+|||++   ++|||||.++|+|++.++.+||+|||++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccc
Confidence            999999999999999999752   2699999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCceee-ccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          453 KLLDHRDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       453 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      +.-..  ..... ...-..+|+|||.+..+.++.++|||||||++||+++ |..|+......       +....+..   
T Consensus       310 ~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~kI~~---  377 (474)
T KOG0194|consen  310 RAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKAKIVK---  377 (474)
T ss_pred             cCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHHHHHh---
Confidence            75431  11111 1125689999999999999999999999999999999 78887633221       11111111   


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                            ...+...+...+.++..++.+||..+|++||+|.++.+.++..
T Consensus       378 ------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~  420 (474)
T KOG0194|consen  378 ------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL  420 (474)
T ss_pred             ------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence                  1122233445568899999999999999999999999998874

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.8e-40  Score=335.89  Aligned_cols=265  Identities=24%  Similarity=0.342  Sum_probs=204.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC-----------------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeee
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD-----------------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL  363 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l  363 (623)
                      .+|.+.+.||+|+||.||++.+.+                 +..||+|.++.........+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467888999999999999997532                 347999999765444445679999999999999999999


Q ss_pred             eeeeecCCceEEEEecccCCChhhhhhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 006968          364 CGFCSTENERLLVYPYMPNGSVASRLRDHIH---------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIH  428 (623)
Q Consensus       364 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  428 (623)
                      ++++...+..++||||+++|+|.+++.....               ....++|..+.+++.|++.||+|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            9999999999999999999999999865321               123578999999999999999999999   9999


Q ss_pred             cCCCCCCeEECCCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhC--CCC
Q 006968          429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG--QRA  505 (623)
Q Consensus       429 ~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg--~~p  505 (623)
                      |||||+|||++.++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999865433221 12233457899999999888999999999999999999974  455


Q ss_pred             CCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          506 LDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      +.....    ......+......... ...     ...+..++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       242 ~~~~~~----~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTD----EQVIENAGEFFRDQGR-QVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCH----HHHHHHHHHHhhhccc-ccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            543221    1111222221111100 000     00112234678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.5e-40  Score=333.20  Aligned_cols=260  Identities=17%  Similarity=0.268  Sum_probs=205.4

Q ss_pred             cccccCHHHHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccc--hHHHHHHHHHHhhcCCCceeeee
Q 006968          287 HLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG--EVQFQTEVETISLAVHRNLLRLC  364 (623)
Q Consensus       287 ~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~H~niv~l~  364 (623)
                      ..+.++.+++.     ......||+|++|.||+|.+ +|+.||||+++.......  ...|.+|+.++.+++||||++++
T Consensus        11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~   84 (283)
T PHA02988         11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY   84 (283)
T ss_pred             cceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence            44555666652     22236799999999999998 789999999976543221  24678999999999999999999


Q ss_pred             eeeec----CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 006968          365 GFCST----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE  440 (623)
Q Consensus       365 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~  440 (623)
                      |++.+    ....++||||+++|+|.+++...    ..+++....+++.|++.||.|||+..  +++||||||+||++++
T Consensus        85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~  158 (283)
T PHA02988         85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTE  158 (283)
T ss_pred             eeEEecccCCCceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECC
Confidence            99876    34678999999999999999753    46899999999999999999999732  7889999999999999


Q ss_pred             CCcEEEeecccccccCCCCCceeecccccccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch
Q 006968          441 DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM  518 (623)
Q Consensus       441 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~  518 (623)
                      ++.+||+|||+++......    ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||.....       
T Consensus       159 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-------  227 (283)
T PHA02988        159 NYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-------  227 (283)
T ss_pred             CCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-------
Confidence            9999999999998654321    12347899999999976  6789999999999999999999999974321       


Q ss_pred             HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          519 LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .+........+.         ....+...+.++.+++.+||+.||++|||+.++++.|+.
T Consensus       228 ~~~~~~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        228 KEIYDLIINKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             HHHHHHHHhcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            112222211111         111222345789999999999999999999999999876

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-41  Score=315.38  Aligned_cols=237  Identities=24%  Similarity=0.333  Sum_probs=202.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccc--hHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG--EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|++++.....-  .+....|..+|+.+.||+++++++.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46778899999999999999875 689999999987654332  234788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||++||.|.++|+..    ..+++..++.++.+|+.||+|||+.   +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus       124 eyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            999999999999874    4699999999999999999999999   999999999999999999999999999997653


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                          .+.+.+||+.|+|||.+..+.+..++|.|||||++|||+.|.+||....+      +..+          ..++..
T Consensus       197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY----------~KI~~~  256 (355)
T KOG0616|consen  197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIY----------EKILEG  256 (355)
T ss_pred             ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHH----------HHHHhC
Confidence                36778999999999999999999999999999999999999999974332      1111          111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHR  566 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~R  566 (623)
                      .+  .+++....++.+|+...+++|-.+|
T Consensus       257 ~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 KV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            11  2344455778999999999999999

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-41  Score=346.23  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=211.6

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      -|.+++.||+|+-|.|-.|++. +|+.+|||++.+...  ......+.+|+.+|+.+.|||++++++++.+..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            3667889999999999999864 799999999976521  2223458899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|-|.++|..    ++++.+..+.+++.||+.|+.|+|..   +|+|||+||+|+|+|..+++||+|||+|..-.. 
T Consensus        93 yv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-  164 (786)
T KOG0588|consen   93 YVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP-  164 (786)
T ss_pred             ecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence            9999999999986    45799999999999999999999999   999999999999999999999999999986433 


Q ss_pred             CCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                       .....+.||++.|.|||++.+.+| +.++||||.|||+|.|+||+.||+.+                    .+..++.+
T Consensus       165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------------------Nir~LLlK  223 (786)
T KOG0588|consen  165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------------------NIRVLLLK  223 (786)
T ss_pred             -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------------------cHHHHHHH
Confidence             334456689999999999999988 68999999999999999999999821                    12222222


Q ss_pred             ccCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCC
Q 006968          538 DLKGNF--DRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLA  582 (623)
Q Consensus       538 ~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  582 (623)
                      -..+.|  +...+.+..+|+.+|+.+||.+|.|+.||++|-.-....
T Consensus       224 V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  224 VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence            222322  334457889999999999999999999999987554333

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=339.12  Aligned_cols=266  Identities=22%  Similarity=0.318  Sum_probs=217.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .+...+.++||+|-||.|.......+..||||.++.......+.+|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            34566789999999999999999778999999999888777788999999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      |++|+|.+|+..+...  .++-..-.+|+.|||.||+||.+.   ++|||||.++|+|+|.++++||+|||+++-+-.++
T Consensus       617 mEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence            9999999999886432  256666778999999999999999   99999999999999999999999999999665555


Q ss_pred             Cce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh--CCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          460 SHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       460 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ++. ....+-..+|||+|.+..+++|.++|||+||+++||+++  ...|+.....    ....+-...+...+.....  
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~~~~~--  765 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQGRQVV--  765 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCCccee--
Confidence            443 334456789999999999999999999999999999876  5667653221    1111222222211111111  


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG  580 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  580 (623)
                          ...+..++.++++++.+||+.+.++||+++++...|.++.
T Consensus       766 ----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  766 ----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             ----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence                1124556789999999999999999999999999998743

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.6e-40  Score=347.55  Aligned_cols=260  Identities=26%  Similarity=0.391  Sum_probs=204.9

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~  372 (623)
                      .++|++.+.||+|+||.||+|...      ++..||||+++..........+.+|+++++.+ +|+||++++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457888999999999999998742      34579999997654444455688999999999 89999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccC----------------------------------------------------------
Q 006968          373 RLLVYPYMPNGSVASRLRDHIH----------------------------------------------------------  394 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  394 (623)
                      .++||||+++|+|.++++....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            9999999999999999864211                                                          


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc-eeec
Q 006968          395 --------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTA  465 (623)
Q Consensus       395 --------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~  465 (623)
                              ...++++..+.+++.|+++||+|||++   +|+||||||+||++++++.+||+|||+++........ ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    113478899999999999999999999   9999999999999999999999999999765433221 1122


Q ss_pred             cccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCC
Q 006968          466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD  544 (623)
Q Consensus       466 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  544 (623)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||.......      .... ....+         .....+
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~-~~~~~---------~~~~~~  337 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYK-MVKRG---------YQMSRP  337 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHH-HHHcc---------cCccCC
Confidence            335678999999998899999999999999999997 999986322110      0111 11111         000011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       545 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ...+.++.+++.+||+.+|++|||+.+|++.|++
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1124678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-40  Score=332.53  Aligned_cols=250  Identities=30%  Similarity=0.508  Sum_probs=196.1

Q ss_pred             cCCceeccCCeEEEEEEeC-----CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          305 AKNILGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       305 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ..+.||.|.||.||+|.+.     .+..|+||.++..........|.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999986     36789999997654444467899999999999999999999999988889999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.++|...  ....+++..+..|+.|+++||+|||++   +++||||+++||++++++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999875  235699999999999999999999999   99999999999999999999999999998763322


Q ss_pred             Cc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          460 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       460 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .. ......+...|+|||.+....++.++||||||+++|||++ |+.|+....       ..++..... .+...     
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------~~~~~~~~~-~~~~~-----  224 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------NEEIIEKLK-QGQRL-----  224 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------HHHHHHHHH-TTEET-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccc-ccccc-----
Confidence            22 2233446789999999999999999999999999999999 678875321       112222221 11111     


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                          ..+...+..+.+++..||+.+|++|||+.++++.|
T Consensus       225 ----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 ----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                11122346789999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.4e-39  Score=329.32  Aligned_cols=268  Identities=18%  Similarity=0.243  Sum_probs=204.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|.+.+.||+|+||.||+|... +++.||+|+++..... .....+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999986 5889999999754322 234468899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |++++.+..+...    ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9998876654332    34689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch--------HHHHHHHhhcCc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM--------LDWVKKLHQEGK  530 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~  530 (623)
                      .........|++.|+|||++.+..++.++|||||||++|||++|+.||......+.....        ..+.+.......
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            333333456899999999999888999999999999999999999999643221110000        011111111111


Q ss_pred             cccccccccC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKDLK------GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ......+...      ..+....+.++.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            1111111100      00111234679999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.8e-40  Score=332.44  Aligned_cols=267  Identities=21%  Similarity=0.296  Sum_probs=201.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|.+.+.||+|+||.||+|... ++..||+|+++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999875 68999999997654344445678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      ++ |+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            97 5898888653   33578999999999999999999999   99999999999999999999999999997654322


Q ss_pred             Cceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHH--------HHHhhcCc
Q 006968          460 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV--------KKLHQEGK  530 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~  530 (623)
                      . ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.........        ........
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence            1 1233457899999998865 568999999999999999999999996433211110000000        00000000


Q ss_pred             cccccccccCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKDLKGN----FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ......+.....    .......+..+++.+|+..||.+|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            011111110000    001123567899999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-39  Score=330.56  Aligned_cols=254  Identities=26%  Similarity=0.346  Sum_probs=202.9

Q ss_pred             CCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .|...+.||+|+||.||+|.. .+|+.||+|.+......  .....+.+|+.++.+++|+||+++.+++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999986 47899999998654322  233457899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|..++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++......
T Consensus        81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            999999988886532  33689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      .  ......||..|+|||++.+..++.++|||||||++|||++|+.||........    .+-+.......         
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~---------  220 (285)
T cd05631         156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKED---------  220 (285)
T ss_pred             C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhcc---------
Confidence            2  22344689999999999999999999999999999999999999974332111    01011100000         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHh
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPK-----MSEVLKML  576 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~L  576 (623)
                       ...++...+.++.+++.+||+.||++||+     +.+++++-
T Consensus       221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~  262 (285)
T cd05631         221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP  262 (285)
T ss_pred             -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence             01122223467899999999999999997     88888753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.7e-39  Score=329.63  Aligned_cols=258  Identities=25%  Similarity=0.406  Sum_probs=207.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|++.+.||+|+||.||+|....      ...||+|.++..........|.+|+.++..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467788999999999999998642      25799999876544444567899999999999999999999999888999


Q ss_pred             EEEecccCCChhhhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 006968          375 LVYPYMPNGSVASRLRDHIHG------------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF  442 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  442 (623)
                      ++|||+++|+|.+++......            ...+++..+..++.|++.||+|||+.   +++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999999764211            14588999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHH
Q 006968          443 EAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLD  520 (623)
Q Consensus       443 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  520 (623)
                      .++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......       +
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------~  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------E  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence            999999999986543322 12233346789999999988899999999999999999998 99998632211       1


Q ss_pred             HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....+. .+.         ....+...+.++.+++.+||+.+|.+||++.||+++|+.
T Consensus       235 ~~~~i~-~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIR-SRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHH-cCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            111111 111         111233445789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-39  Score=311.99  Aligned_cols=268  Identities=23%  Similarity=0.282  Sum_probs=205.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccch-HHHHHHHHHHhhcCCCceeeeeeeeec--CCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGE-VQFQTEVETISLAVHRNLLRLCGFCST--ENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv  376 (623)
                      +.|+..+.|++|+||.||+|+.+ +++.||+|+++-.....+- ..-++|+.+|.+++|||||.+..+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45777899999999999999975 6899999999765433222 246899999999999999999888764  4679999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||++. +|.+.|...   .+++...+..-++.|+++|++|||.+   .|+|||||++|+|+...|.+||+|||+|+.++
T Consensus       156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999976 788888764   35799999999999999999999999   99999999999999999999999999999987


Q ss_pred             CCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC------
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG------  529 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  529 (623)
                      ..... .+..+-|..|.|||.+.+. .|+...|+||+|||+.||+++++-|......++...+...+.......      
T Consensus       229 sp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  229 SPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             CCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            65433 4445579999999999774 689999999999999999999998875544333222221111100000      


Q ss_pred             -------ccccccccccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          530 -------KLSQMVDKDLKGNFDRI-ELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       530 -------~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                             ...+.....+...|... -.+.-++++..++..||++|-|+.|.+++=
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~  362 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE  362 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence                   00000011111222211 236788999999999999999999998863

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.5e-39  Score=323.53  Aligned_cols=251  Identities=24%  Similarity=0.406  Sum_probs=204.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|.+.+.||+|+||.||+|.++++..+|+|.++...  ....+|..|++++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            4577889999999999999999888899999986433  23567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.++++..   ...+++..+..++.|++.||+|||+.   +|+||||+|+||+++.++.+||+|||.++.......
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            999999998753   23589999999999999999999999   999999999999999999999999999986543322


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+.+........   ..    
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~---~~----  221 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGFR---LY----  221 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCC---CC----
Confidence            22223335678999999988889999999999999999999 8888863221       111222211111   00    


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                         .+...+.++.+++.+||..+|++||++.++++.|
T Consensus       222 ---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         222 ---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               1112236789999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=325.44  Aligned_cols=259  Identities=23%  Similarity=0.305  Sum_probs=202.7

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-------------chHHHHHHHHHHhhcCCCceeeee
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-------------GEVQFQTEVETISLAVHRNLLRLC  364 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~H~niv~l~  364 (623)
                      ..++|.+.+.||+|.||.|-+|+.. +++.||||++.+.....             ..+...+|+.+|+++.|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3467889999999999999999864 69999999996543211             123678999999999999999999


Q ss_pred             eeeecC--CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 006968          365 GFCSTE--NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF  442 (623)
Q Consensus       365 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  442 (623)
                      .+..++  +..|||+|||..|.+..    .......++..++++++.++..||+|||.+   +||||||||+|+|++++|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w----~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKW----CPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCcccc----CCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence            998764  57899999999987432    222223399999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccccccCCCCC----ceeeccccccccccccccccCC----CCCccchhhHHHHHHHHHhCCCCCCccccccc
Q 006968          443 EAVVGDFGLAKLLDHRDS----HVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGQRALDFGRAANQ  514 (623)
Q Consensus       443 ~~kl~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~  514 (623)
                      ++||+|||.+.....+..    ......+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||.....   
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---  324 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---  324 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence            999999999986632211    1122356999999999987743    36788999999999999999999963221   


Q ss_pred             ccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 006968          515 RGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG  580 (623)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  580 (623)
                          ++..         .+++...+.-.-.++..+.+.+|+.++|.+||++|.+..+|..|.+-..
T Consensus       325 ----~~l~---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  325 ----LELF---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             ----HHHH---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence                1111         1222223322222345678999999999999999999999999887643

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-40  Score=322.72  Aligned_cols=263  Identities=24%  Similarity=0.328  Sum_probs=203.1

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC-----ceEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-----ERLL  375 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~l  375 (623)
                      .|...+++|+|+||.||+|... +++.||||+...+..     .-.+|+++|+.+.|||||++.-+|....     ...+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            4566789999999999999975 479999999865432     1257999999999999999998886432     2358


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CcEEEeecccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKL  454 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgla~~  454 (623)
                      |||||+. +|+..++.....+..++...++-++.|+.+||+|||+.   +|+||||||+|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999975 89999987666667788888999999999999999998   99999999999999965 8999999999999


Q ss_pred             cCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh------
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ------  527 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  527 (623)
                      +..++...+  ..-|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+..++...+...++....      
T Consensus       176 L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  176 LVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            877665533  335889999999976 57899999999999999999999998765554443333322211000      


Q ss_pred             --c---CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          528 --E---GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       528 --~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        .   -...++.......-+......+..+++.+++..+|.+|.++.|++.+
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence              0   00111111111111234455789999999999999999999999874

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.8e-39  Score=324.06  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=207.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|++.+.||+|+||.||+|...++..||+|.++...  .....+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            5688899999999999999998888899999986533  23457899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.++++...  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          84 AKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999997542  34688999999999999999999998   999999999999999999999999999987654332


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .......++..|+|||++....++.++||||||+++|+|+| |+.||......       +....... ..     ... 
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~-~~-----~~~-  224 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------DVMSALQR-GY-----RMP-  224 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------HHHHHHHc-CC-----CCC-
Confidence            22223346678999999988889999999999999999998 89888532211       11111111 10     000 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         .....+.++.+++.+|+..+|++||+++++.+.|++
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 ---RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               111234678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.2e-39  Score=332.23  Aligned_cols=264  Identities=22%  Similarity=0.293  Sum_probs=205.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|++.+.||+|+||.||++... +|..||+|.++..........+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            67889999999999999999975 58899999987543333345799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++...    ..+++..+..++.|++.||.|||+.+  +|+||||||+||+++.++.+||+|||++...... 
T Consensus        85 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          85 MDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            9999999998753    35889999999999999999999852  6999999999999999999999999998765332 


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc---Cccc----
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE---GKLS----  532 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~----  532 (623)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||........    ...+......   +...    
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL----EAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHhcccccccccCCccccCc
Confidence              22334689999999999998999999999999999999999999964322110    0000000000   0000    


Q ss_pred             -----------------------c----ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          533 -----------------------Q----MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       533 -----------------------~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                                             +    +...............++.+++.+||..||++|||+.+++++-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~  303 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF  303 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence                                   0    00000000001123467899999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-39  Score=322.34  Aligned_cols=255  Identities=28%  Similarity=0.381  Sum_probs=207.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .++|.+.+.||+|+||.||+|...+++.||+|.++...  ....++.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            35688889999999999999998778899999987543  2356789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++....  ...+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            99999999987642  34689999999999999999999999   99999999999999999999999999998765332


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      .........+..|+|||++.+..++.++||||||+++|||++ |+.||......       ...........        
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~--------  222 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQGYR--------  222 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC--------
Confidence            221222223468999999998899999999999999999999 88888532210       11111111000        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                        ...+...+..+.+++.+|++.+|++||++.++++.|++
T Consensus       223 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 --MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             --CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence              01122234778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-40  Score=322.13  Aligned_cols=250  Identities=20%  Similarity=0.361  Sum_probs=212.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccch--HHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGE--VQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|++.+.||+|.||.|-+|.. ..|+.||||.+++..+.+..  ..+.+|+++|+.++||||+.++.+|...+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4677889999999999999986 57999999999988765443  35789999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||..+|.|++|+.+.    ..+++..++.++.||..|+.|+|.+   +++|||||-+|||+|.++++||+|||++.++..
T Consensus       133 EYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  133 EYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999874    4699999999999999999999999   999999999999999999999999999988764


Q ss_pred             CCCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..  ....++|++-|.+||++.+.+| ++.+|.||+||++|-|+.|..||+.-+-       -..++++.. +.+.    
T Consensus       206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~-GaYr----  271 (668)
T KOG0611|consen  206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISR-GAYR----  271 (668)
T ss_pred             cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhc-cccc----
Confidence            33  3456789999999999999888 6889999999999999999999984321       122222211 1111    


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                             ++..+....-||.+||.++|++|.|+.+|..+-+-
T Consensus       272 -------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  272 -------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             -------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence                   22234556789999999999999999999988764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=330.91  Aligned_cols=249  Identities=24%  Similarity=0.268  Sum_probs=204.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++.....  .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888899999999999999975 6899999998653321  23446889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            999999999998753    4689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....       ......... +..      
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~~-~~~------  215 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKILA-GKL------  215 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh-CCc------
Confidence            2    2234589999999999988899999999999999999999999964321       111111111 110      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhc
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPK-----MSEVLKMLEG  578 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~L~~  578 (623)
                          .++......+.+++.+||+.||.+||+     +.+++++-.-
T Consensus       216 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  257 (291)
T cd05612         216 ----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF  257 (291)
T ss_pred             ----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence                112222467889999999999999995     8898877544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=323.02  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=206.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|.+.+.||+|+||.||+|.+..    ...||||.++..........|.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999998742    4579999987655444556799999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++++|.+++...   ...+++..+.+++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999999764   23689999999999999999999998   99999999999999999999999999998775


Q ss_pred             CCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          457 HRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       457 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....       .+...........   
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~---  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------QDVIKAVEDGYRL---  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-------HHHHHHHHcCCCC---
Confidence            22221 2222335678999999998899999999999999999998 9888853211       1111111111000   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                             ..+...+..+.+++.+|++.+|++||++.+|+++|+.
T Consensus       228 -------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         228 -------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                   1112234678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.2e-39  Score=332.29  Aligned_cols=256  Identities=25%  Similarity=0.428  Sum_probs=203.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCc----EEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.++.........++..|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888999999999999999864 333    48999987544444456789999999999999999999999764 5789


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ++||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999999764   33588999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCcee-eccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ........ ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......       ++.... ..+.   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~~~~-~~~~---  228 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSIL-EKGE---  228 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHH-hCCC---
Confidence            54332221 22234678999999999999999999999999999998 99998632211       111111 1110   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG  580 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  580 (623)
                            ....+..+..++.+++.+||..+|.+||++.+++..+....
T Consensus       229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                  00111223467899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.9e-39  Score=327.95  Aligned_cols=257  Identities=21%  Similarity=0.293  Sum_probs=206.4

Q ss_pred             HHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       297 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      +...++|+....||+|+||.||+|.-+ +|..+|+|++++.....  .......|..+|....+|+||+|+..|++.+.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            345678999999999999999999865 69999999998765432  234578899999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ||||||++||++..+|..    ...|++..++.++.+++.|+..+|..   |+|||||||+|+|||..|++||+|||++.
T Consensus       217 YLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             EEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence            999999999999998876    35799999999999999999999999   99999999999999999999999999984


Q ss_pred             ccCC----------------------CCCc-----e-------------------eeccccccccccccccccCCCCCcc
Q 006968          454 LLDH----------------------RDSH-----V-------------------TTAVRGTVGHIAPEYLSTGQSSEKT  487 (623)
Q Consensus       454 ~~~~----------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~  487 (623)
                      -+..                      .+..     .                   ....+|||.|||||++.+..|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            3211                      0000     0                   0124599999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 006968          488 DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRP  567 (623)
Q Consensus       488 Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP  567 (623)
                      |.||+|||+|||+.|-+||....+......+..|-..+....              ......+..++|.+|+. ||++|-
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhc
Confidence            999999999999999999986554333222333322211100              11123678899999999 999996


Q ss_pred             C---HHHHHHH
Q 006968          568 K---MSEVLKM  575 (623)
Q Consensus       568 s---~~evl~~  575 (623)
                      .   +.||-+|
T Consensus       435 G~~G~~EIK~H  445 (550)
T KOG0605|consen  435 GSKGAEEIKKH  445 (550)
T ss_pred             CcccHHHHhcC
Confidence            5   6666543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=335.82  Aligned_cols=255  Identities=20%  Similarity=0.240  Sum_probs=205.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      +|.+.+.||+|+||.||+|... +++.||||+++.....  .....+..|++++..++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            6888999999999999999976 5899999999754322  234468899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..... 
T Consensus        82 ~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          82 YVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999998653    4688999999999999999999999   999999999999999999999999999986543 


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||........       ........   ......
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~---~~~~~~  220 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLKYWK---ETLQRP  220 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHHhcc---ccccCC
Confidence               22345689999999999999999999999999999999999999974332111       11111000   000000


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .........+.++.+++.+|+..+|.+||++.+++++-.
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~  259 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF  259 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence            000000123467899999999999999999999998743

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.3e-39  Score=326.13  Aligned_cols=257  Identities=26%  Similarity=0.447  Sum_probs=207.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      .+|.+.+.||+|+||.||+|...+      +..||||.++..........|.+|+++++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457788999999999999998633      47899999976554445668999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhcc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcE
Q 006968          375 LVYPYMPNGSVASRLRDHI----------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA  444 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  444 (623)
                      +||||+++++|.++++...          .....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999999997642          1234588999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHH
Q 006968          445 VVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWV  522 (623)
Q Consensus       445 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  522 (623)
                      ||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......       +..
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------~~~  234 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------EVI  234 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHH
Confidence            99999999764332211 1122335788999999999999999999999999999999 99998532211       111


Q ss_pred             HHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          523 KKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .... .+...         ..+...+..+.+++.+||..+|++||++.||++.|+
T Consensus       235 ~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECIT-QGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHH-cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1111 11111         112223477899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.2e-39  Score=333.23  Aligned_cols=243  Identities=23%  Similarity=0.270  Sum_probs=197.6

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG  383 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  383 (623)
                      +.||+|+||.||++... +|+.||+|+++....  ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 689999999975432  122346788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCcee
Q 006968          384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT  463 (623)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  463 (623)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~  152 (323)
T cd05571          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  152 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence            99988875    34689999999999999999999999   99999999999999999999999999987532221 223


Q ss_pred             eccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCC
Q 006968          464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNF  543 (623)
Q Consensus       464 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  543 (623)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||......       ....... .+.      .    .+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~~~-~~~------~----~~  214 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELIL-MEE------I----RF  214 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHHHHH-cCC------C----CC
Confidence            3456999999999999999999999999999999999999999632211       1111111 111      0    12


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006968          544 DRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKM  575 (623)
Q Consensus       544 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  575 (623)
                      +.....++.+++.+||..||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            222346789999999999999999     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-40  Score=302.18  Aligned_cols=252  Identities=26%  Similarity=0.358  Sum_probs=211.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .++|++.+.||+|.||.||.|..+ ++-.||+|++.+.....  -+.++.+|+++.+.++||||++++++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            357889999999999999999975 57899999997665432  345799999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      +||.++|+++..|+...  ...+++.....++.|+|.|+.|+|..   +++||||||+|+|++.++..||+|||-+..-.
T Consensus       101 lEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            99999999999998532  34688889999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                         .......+||..|.+||...+...+..+|+|++|++.||++.|.+||.....       .+-.+.+.         .
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-------~etYkrI~---------k  236 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-------SETYKRIR---------K  236 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-------HHHHHHHH---------H
Confidence               3345567899999999999999999999999999999999999999973221       01111111         0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      -  .-.++...+....++|.+|+..+|.+|.+..|++++-+
T Consensus       237 ~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  237 V--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             c--cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence            0  11123444577899999999999999999999998754

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.3e-39  Score=340.14  Aligned_cols=260  Identities=24%  Similarity=0.353  Sum_probs=205.9

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~  372 (623)
                      .++|.+.+.||+|+||.||+|...      .+..||||+++..........|.+|+++++++. ||||+++++++...+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            467888999999999999999852      234799999976554444567999999999996 9999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccC----------------------------------------------------------
Q 006968          373 RLLVYPYMPNGSVASRLRDHIH----------------------------------------------------------  394 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  394 (623)
                      .++||||+++|+|.+++.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999999865311                                                          


Q ss_pred             ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 006968          395 ----------------------------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE  440 (623)
Q Consensus       395 ----------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~  440 (623)
                                                        ....+++..+..++.|+++||+|||+.   +|+||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                              012478899999999999999999999   9999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccch
Q 006968          441 DFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVM  518 (623)
Q Consensus       441 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~  518 (623)
                      ++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......   .  
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---~--  347 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---S--  347 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---H--
Confidence            999999999999865432221 1222346788999999998899999999999999999997 88888632110   0  


Q ss_pred             HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          519 LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       ...... ..+.         ....+...+.++.+++.+||..+|++|||+.+|.++|+.
T Consensus       348 -~~~~~~-~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         348 -TFYNKI-KSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             -HHHHHH-hcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence             001111 1110         011122345678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=335.12  Aligned_cols=259  Identities=26%  Similarity=0.412  Sum_probs=217.6

Q ss_pred             HHHHhcCCCcCCceeccCCeEEEEEEeCC-CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          296 LRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       296 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++-...+....++||-|.||.||.|+|+. .-.||||.++.+..  ...+|+.|..+|+.++|||+|+|+|+|..+...|
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            33334566778999999999999999975 56899999987653  3568999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +|+|||.+|+|.+||++..  +..++.-..+.++.||+.||+||..+   ++|||||..+|+|+.++..+||+|||++++
T Consensus       340 IiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence            9999999999999999863  34577778899999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      +....+.......-.+.|.|||-+....++.|+|||+|||++||+.| |-.|+..-+        +.         .+..
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lS---------qVY~  477 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LS---------QVYG  477 (1157)
T ss_pred             hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HH---------HHHH
Confidence            87665544444445678999999999999999999999999999998 556654221        11         1223


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ++++.++..-+..++..+++|+..||+++|.+||++.|+-+.+|.
T Consensus       478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence            344444445567788999999999999999999999999888776

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-40  Score=333.77  Aligned_cols=267  Identities=22%  Similarity=0.383  Sum_probs=224.7

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeCC---C--cEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFSD---G--ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      ..+.....+.||.|-||.||+|.+.+   |  -.||||.-|.....+..+.|++|..+|+.+.||||++++|+|.+ ...
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            33445567899999999999999743   3  35999999887777778889999999999999999999999965 578


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++|||.++-|.|.+||...   ...++..+...++.|++.||+|||+.   ++|||||..+|||+....-+|++|||+++
T Consensus       466 WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence            9999999999999999875   45689999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      .+............-...|||||-+.-.++|.++|||.|||.+||++. |..||.+-..                 .++-
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------sDVI  602 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------SDVI  602 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------cceE
Confidence            998877666555556789999999999999999999999999999886 8899863221                 1222


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCCccchhhh
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQ  589 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~  589 (623)
                      --++..-+...++.++..+..++.+||..+|.+||++.++...|.++...++...++
T Consensus       603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~E  659 (974)
T KOG4257|consen  603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSE  659 (974)
T ss_pred             EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHH
Confidence            222222233456778889999999999999999999999999998877666554443

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7e-39  Score=321.65  Aligned_cols=254  Identities=28%  Similarity=0.413  Sum_probs=206.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .+|.+.+.||+|+||.||+|... ++..||+|.++...  ....++.+|+++++.++||||+++++++..++..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            45777889999999999999875 58899999987532  2345789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++....  ...+++..++.++.|+++||+|||+.   +++||||||+||++++++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          84 MTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             CCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            99999999987532  34689999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |..|+.....       .+....... .         
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~-~---------  221 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEK-G---------  221 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHC-C---------
Confidence            222222234678999999988899999999999999999998 8888853221       111111111 0         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .....+...+.++.+++.+||+.+|++|||+.+++++|+.
T Consensus       222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            1111222334779999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.7e-39  Score=324.86  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=205.6

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCc
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE  372 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  372 (623)
                      ..++|++.+.||+|+||.||+|...      ++..||||.++.........+|.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567899999999999999998753      3567999998654433345578999999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHG------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV  446 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  446 (623)
                      .++||||+++|+|.+++......      ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999998753221      23468899999999999999999998   9999999999999999999999


Q ss_pred             eecccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHH
Q 006968          447 GDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       447 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      +|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....       .+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~~~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLRF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHH
Confidence            9999987654332211 112235778999999998899999999999999999999 6788753221       111111


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .. .....         ..+...+..+.+++.+|++.+|++|||+.|++++|++
T Consensus       234 ~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VM-EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HH-cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            11 11111         1112234678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-39  Score=319.96  Aligned_cols=250  Identities=26%  Similarity=0.413  Sum_probs=202.3

Q ss_pred             CCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEeccc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP  381 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  381 (623)
                      +|.+.+.||+|+||.||+|.+.++..+|+|.++...  .....|.+|+++++.++||||+++++++...+..++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            477789999999999999998777889999986433  234568899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      +++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++........
T Consensus        83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999998754   23689999999999999999999999   9999999999999999999999999999865432222


Q ss_pred             eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       462 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......       +....... +     .    .
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~-~-----~----~  219 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------EVVESVSA-G-----Y----R  219 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------HHHHHHHc-C-----C----c
Confidence            2222224568999999998899999999999999999999 78888643221       11111111 1     0    0


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ...+...+.++.+++.+||..+|++|||+.++++.|
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            111122457899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-39  Score=335.66  Aligned_cols=247  Identities=24%  Similarity=0.301  Sum_probs=202.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|... +|+.||+|.++.....  .....+.+|+.++++++||||+++++++..++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888899999999999999975 5899999999754321  23346889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999998753    4688999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ..    ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ........ .+..      
T Consensus       171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~-~~~~------  232 (329)
T PTZ00263        171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKIL-AGRL------  232 (329)
T ss_pred             Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHh-cCCc------
Confidence            22    234689999999999999999999999999999999999999963221       11111111 1110      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHh
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPK-----MSEVLKML  576 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~L  576 (623)
                          .++.....++.+++.+||+.||++||+     +.+++++-
T Consensus       233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp  272 (329)
T PTZ00263        233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP  272 (329)
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence                111112356889999999999999997     68887763

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.7e-39  Score=320.07  Aligned_cols=252  Identities=26%  Similarity=0.418  Sum_probs=203.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|.+.+.||+|+||.||+|...++..+|+|.++...  .....|.+|+.++.+++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            4577788999999999999998777789999987543  23457899999999999999999999999888899999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.++.......
T Consensus        82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            999999998753   23689999999999999999999999   999999999999999999999999999986544332


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......       +...........        
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~--------  220 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------ETVEKVSQGLRL--------  220 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHhcCCCC--------
Confidence            22222335678999999988889999999999999999999 99898632211       111111111110        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                        ..+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              011112478899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.4e-38  Score=328.88  Aligned_cols=262  Identities=22%  Similarity=0.312  Sum_probs=203.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|++.+.||+|+||.||++... ++..+|+|.++..........+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367899999999999999999976 5889999998764333344578999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.+++...    ..+++.....++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            99999999998753    35889999999999999999999742  7999999999999999999999999998765332


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc------
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS------  532 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  532 (623)
                         ......|+..|+|||.+.+..++.++|||||||++|||++|+.||........    ...+.. ...+...      
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~  229 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL----ELMFGC-PVEGDPAESETSP  229 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH----HHHhcC-cccCCccccccCc
Confidence               12234589999999999988899999999999999999999999864322110    000000 0000000      


Q ss_pred             -----------------------ccccc---ccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          533 -----------------------QMVDK---DLKGNFD-RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       533 -----------------------~~~~~---~~~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                                             ...+.   ......+ .....++.+++.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                                   00000   0000000 1123568999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=336.12  Aligned_cols=242  Identities=26%  Similarity=0.377  Sum_probs=203.5

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhc-CCCceeeeeeeeecCCceE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLA-VHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  374 (623)
                      ..++|...++||+|.||+|+++..+ +++.+|||.+++..+-.  +....+.|..++... +||.++++++.+++.++.+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4467899999999999999999986 58899999999876532  334678888888776 5999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      .||||+.||++..+.+     ...+++.++..++..|+.||.|||++   +||+||||-+|||+|.+|.+||+|||+++.
T Consensus       446 fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999433332     34799999999999999999999999   999999999999999999999999999985


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      -- .....+.+++||+.|||||++.+..|+..+|.|||||+||||+.|+.||...+.++                    +
T Consensus       518 ~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--------------------~  576 (694)
T KOG0694|consen  518 GM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--------------------V  576 (694)
T ss_pred             cC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--------------------H
Confidence            32 23346778899999999999999999999999999999999999999997543311                    1


Q ss_pred             ccccc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006968          535 VDKDL--KGNFDRIELEEMVQVALLCTQFNPLHRPKM  569 (623)
Q Consensus       535 ~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~  569 (623)
                      .|..+  ...|+...+.+...++.+++..+|++|-.+
T Consensus       577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            11111  113455566889999999999999999866

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5e-39  Score=336.92  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=194.5

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      +|+..+.||+|+||.||+|... +|+.||||++...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3455688999999999999875 689999999975543344567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.+..        ..++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            999975432        356778889999999999999999   999999999999999999999999999987643221


Q ss_pred             ceeecccccccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                       ......||..|+|||.+..     ...+.++|||||||++|||++|+.||.....    ..............      
T Consensus       224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~~~------  292 (353)
T PLN00034        224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GDWASLMCAICMSQ------  292 (353)
T ss_pred             -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----ccHHHHHHHHhccC------
Confidence             2233468999999998743     2345689999999999999999999973221    11111111110000      


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          ..........++.+++.+||..||++|||+.|++++
T Consensus       293 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                011122334678999999999999999999999986

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.4e-39  Score=330.54  Aligned_cols=244  Identities=23%  Similarity=0.275  Sum_probs=197.0

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG  383 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  383 (623)
                      +.||+|+||.||++... +|..||+|.++.....  .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999864 6899999999754321  22345788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCcee
Q 006968          384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT  463 (623)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  463 (623)
                      +|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~  152 (323)
T cd05595          81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  152 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence            998888653    3689999999999999999999999   99999999999999999999999999987532221 122


Q ss_pred             eccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCC
Q 006968          464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNF  543 (623)
Q Consensus       464 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  543 (623)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......       ........ +.      .    .+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~-~~------~----~~  214 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILM-EE------I----RF  214 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhc-CC------C----CC
Confidence            3356899999999999999999999999999999999999998633211       11111111 10      0    11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 006968          544 DRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKML  576 (623)
Q Consensus       544 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L  576 (623)
                      +.....++.+++.+||..||++||     ++.+++++-
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~  252 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  252 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence            222346788999999999999998     899988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8e-39  Score=332.72  Aligned_cols=259  Identities=28%  Similarity=0.413  Sum_probs=202.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecC-Cc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE-NE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~  372 (623)
                      ++|.+.+.||+|+||.||+|...      +++.||+|+++..........+..|+.++.++ .|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            46888999999999999999642      35789999997544333445688899999999 799999999988654 56


Q ss_pred             eEEEEecccCCChhhhhhhccCC---------------------------------------------------------
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHG---------------------------------------------------------  395 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------------  395 (623)
                      .++++||+++|+|.+++......                                                         
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            78999999999999998643210                                                         


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce-eecccccccccc
Q 006968          396 RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIA  474 (623)
Q Consensus       396 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~a  474 (623)
                      ...++|..+.+++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++.+....... .....++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            13689999999999999999999999   99999999999999999999999999998764332221 222346678999


Q ss_pred             ccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHH
Q 006968          475 PEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQ  553 (623)
Q Consensus       475 PE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  553 (623)
                      ||++.+..++.++|||||||++|||++ |+.||.......      ...... ..+..         ...+.....++.+
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~-~~~~~---------~~~~~~~~~~~~~  307 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRL-KEGTR---------MRAPEYATPEIYS  307 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHH-hccCC---------CCCCccCCHHHHH
Confidence            999999999999999999999999998 999985321100      111111 11110         0111223467899


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          554 VALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       554 l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ++.+||+.+|++||++.|++++|++
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.6e-39  Score=325.77  Aligned_cols=266  Identities=24%  Similarity=0.342  Sum_probs=196.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC--CCcEEEEEEeccccccc-chHHHHHHHHHHhhc---CCCceeeeeeeee-----c
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAG-GEVQFQTEVETISLA---VHRNLLRLCGFCS-----T  369 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~H~niv~l~~~~~-----~  369 (623)
                      ++|.+.+.||+|+||.||+|...  +|..||+|+++...... ....+.+|+.+++.+   .||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  46889999987543322 234567787777665   6999999999885     2


Q ss_pred             CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                      ....++||||++ ++|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999996 68998887532  34589999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      |+++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|++||.............+...... ..
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~-~~  231 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG-EE  231 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC-hh
Confidence            999865433  223345589999999999888999999999999999999999999975432211111111100000 00


Q ss_pred             ccc-------cccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          530 KLS-------QMVDKDLKG---NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       530 ~~~-------~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...       .........   .........+.+++.+|++.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            000       000000000   0011234667899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.2e-38  Score=324.90  Aligned_cols=265  Identities=23%  Similarity=0.302  Sum_probs=199.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|... +++.||||+++..........+.+|+.+++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367889999999999999999976 6899999999755433344567899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |++ ++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            995 6788877653   34588999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC---cc---
Q 006968          459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG---KL---  531 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~---  531 (623)
                      . .......|++.|+|||++.+ ..++.++||||+||++|||++|+.||........   ....+.......   ..   
T Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD---QLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhCCCChhhccch
Confidence            2 12233458899999998865 4578899999999999999999999974321100   011110000000   00   


Q ss_pred             ---ccccccccCCCCC---H------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          532 ---SQMVDKDLKGNFD---R------IELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       532 ---~~~~~~~~~~~~~---~------~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         ............+   .      .....+.+++.+|++.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence               0000000000000   0      012467899999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-38  Score=316.59  Aligned_cols=261  Identities=19%  Similarity=0.321  Sum_probs=210.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|... +++.||||.++....  ......+..|+++++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888999999999999999865 689999998865332  223346889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++.........+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999999876544455689999999999999999999999   999999999999999999999999999887643


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.....     ...++.......+        
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~~~~~~--------  224 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKIEQCD--------  224 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHHHhcCC--------
Confidence            322 12234588899999999888899999999999999999999999853211     1112222211111        


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                       .........+..+.+++.+||..+|++||++.+|++.+++.
T Consensus       225 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 -YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence             01111223457799999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-38  Score=316.87  Aligned_cols=248  Identities=26%  Similarity=0.404  Sum_probs=198.3

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCCh
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV  385 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  385 (623)
                      +.||+|+||.||+|... +++.||+|.+...........+.+|+++++.+.||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999875 68999999986544344456799999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCcee-e
Q 006968          386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-T  464 (623)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~  464 (623)
                      .+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++........... .
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            9998753   34689999999999999999999999   999999999999999999999999999876443211111 1


Q ss_pred             ccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCC
Q 006968          465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNF  543 (623)
Q Consensus       465 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  543 (623)
                      ...++..|+|||.+.++.++.++||||||+++|||++ |..|+......       ....... .         ......
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~-~---------~~~~~~  217 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIE-Q---------GVRLPC  217 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHH-c---------CCCCCC
Confidence            1123467999999998899999999999999999998 88887532110       0011111 0         111112


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          544 DRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       544 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      +...+..+.+++.+|+..+|++|||+.+++++|+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2233567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-38  Score=315.37  Aligned_cols=248  Identities=29%  Similarity=0.448  Sum_probs=200.4

Q ss_pred             CceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCChh
Q 006968          307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVA  386 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~  386 (623)
                      ++||+|+||.||+|...++..||+|.++..........+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46899999999999988899999999876543334457899999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeecc
Q 006968          387 SRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV  466 (623)
Q Consensus       387 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  466 (623)
                      +++...   ...+++..+..++.|++.||.|+|+.   +++||||+|+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            988653   23589999999999999999999999   999999999999999999999999999976443322222222


Q ss_pred             ccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCH
Q 006968          467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDR  545 (623)
Q Consensus       467 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (623)
                      .++..|+|||++.+..++.++||||||+++||+++ |..||......       ...... ..+.         ....+.
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~-~~~~---------~~~~~~  217 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQV-EKGY---------RMSCPQ  217 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHH-HcCC---------CCCCCC
Confidence            34678999999998899999999999999999998 88898632211       111111 1110         001112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          546 IELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       546 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ..+..+.+++.+|+..+|++||++.++++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            23467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-38  Score=335.02  Aligned_cols=261  Identities=21%  Similarity=0.266  Sum_probs=198.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .+|.+.+.||+|+||.||++... +++.||+|...       ...+.+|++++++++||||+++++++......++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            57999999999999999999874 68899999753       23468899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +. ++|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus       165 ~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        165 YK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             CC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            95 6888887653    3588999999999999999999999   99999999999999999999999999997543332


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHh-hcCc--------
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH-QEGK--------  530 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~--------  530 (623)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+..............-+..+. ..+.        
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            2333445699999999999998999999999999999999999988753221111000000000000 0000        


Q ss_pred             ----ccccc---------ccccCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          531 ----LSQMV---------DKDLKGNF--DRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       531 ----~~~~~---------~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                          .....         .+......  ....+.++.+++.+||+.||++|||+.|++++=
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp  377 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA  377 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence                00000         00000000  012346789999999999999999999998753

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2e-38  Score=328.77  Aligned_cols=244  Identities=24%  Similarity=0.279  Sum_probs=198.0

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG  383 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  383 (623)
                      +.||+|+||.||++... +|+.||+|+++....  ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 689999999975432  223346888999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCcee
Q 006968          384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT  463 (623)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  463 (623)
                      +|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~  152 (328)
T cd05593          81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM  152 (328)
T ss_pred             CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence            998888653    4689999999999999999999999   99999999999999999999999999987533221 122


Q ss_pred             eccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCC
Q 006968          464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNF  543 (623)
Q Consensus       464 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  543 (623)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......       ........ +      +.    .+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~~~~~~~~-~------~~----~~  214 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILM-E------DI----KF  214 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-------HHHHHhcc-C------Cc----cC
Confidence            3456999999999999889999999999999999999999999632211       11111110 0      01    11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 006968          544 DRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKML  576 (623)
Q Consensus       544 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L  576 (623)
                      +.....++.+++.+||..||++||     ++.|++++-
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  252 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS  252 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence            222346788999999999999997     899998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-38  Score=331.36  Aligned_cols=254  Identities=24%  Similarity=0.312  Sum_probs=201.3

Q ss_pred             CCCcCCceeccCCeEEEEEEe----CCCcEEEEEEecccccc---cchHHHHHHHHHHhhc-CCCceeeeeeeeecCCce
Q 006968          302 NFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIA---GGEVQFQTEVETISLA-VHRNLLRLCGFCSTENER  373 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  373 (623)
                      +|++.+.||+|+||.||++..    .++..||+|++++....   .....+..|+.++..+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999875    35889999999754321   2234578899999999 499999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999998753    4589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||........   ..........     
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~-----  225 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILK-----  225 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhc-----
Confidence            6544433334456799999999998765 478899999999999999999999964322111   1111111111     


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKML  576 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L  576 (623)
                        .++.    ++......+.+++.+||..||++||     ++.+++++-
T Consensus       226 --~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  268 (332)
T cd05614         226 --CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP  268 (332)
T ss_pred             --CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence              0111    1222346788999999999999999     778888764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.2e-39  Score=320.60  Aligned_cols=255  Identities=31%  Similarity=0.431  Sum_probs=208.9

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ..+|...+.||+|+||.||+|...++..+|+|.++.... ....++..|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            456888899999999999999998899999999875432 2345689999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++....  ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.+||+|||.+.......
T Consensus        84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999997642  34689999999999999999999999   99999999999999999999999999998764432


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      .. .....++..|+|||.+....++.++||||||+++|+|++ |+.||.....       .+.........         
T Consensus       159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~---------  221 (261)
T cd05148         159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-------HEVYDQITAGY---------  221 (261)
T ss_pred             cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHHhCC---------
Confidence            22 223346778999999988889999999999999999998 8888863221       11111111110         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       ....+...+..+.+++.+||..+|++|||+.++++.|+.
T Consensus       222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 -RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence             111122334778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9e-39  Score=326.13  Aligned_cols=261  Identities=30%  Similarity=0.410  Sum_probs=207.5

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCC
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN  371 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  371 (623)
                      ..++|+..+.||+|+||.||+|...      +...+|+|.++.........++.+|++++.++ +|+||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3456888899999999999999864      23689999987654444445688999999999 7999999999999999


Q ss_pred             ceEEEEecccCCChhhhhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC
Q 006968          372 ERLLVYPYMPNGSVASRLRDHI------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD  439 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~  439 (623)
                      ..+++|||+++|+|.++++...            .....+++..+++++.|++.||+|||+.   +|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence            9999999999999999997532            2245689999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccc
Q 006968          440 EDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGV  517 (623)
Q Consensus       440 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~  517 (623)
                      +++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..|+......     
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  241 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-----  241 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----
Confidence            9999999999999876543221 1122235678999999988899999999999999999998 88887532211     


Q ss_pred             hHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                        +..... ..+.         ....+......+.+++.+|+..+|++|||+.++++.|++.
T Consensus       242 --~~~~~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         242 --ELFKLL-KEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             --HHHHHH-HcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence              111111 1111         0011222346789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=327.92  Aligned_cols=241  Identities=23%  Similarity=0.264  Sum_probs=194.9

Q ss_pred             eeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCCh
Q 006968          309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV  385 (623)
Q Consensus       309 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  385 (623)
                      ||+|+||.||+|... +++.||+|+++....  ......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999875 588999999875432  22334678999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeec
Q 006968          386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA  465 (623)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  465 (623)
                      .+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus        81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~  152 (312)
T cd05585          81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT  152 (312)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence            9998753    4689999999999999999999999   99999999999999999999999999997543222 22334


Q ss_pred             cccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCH
Q 006968          466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDR  545 (623)
Q Consensus       466 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (623)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.....       ......... +.          ..++.
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~~-~~----------~~~~~  214 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKILQ-EP----------LRFPD  214 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHHc-CC----------CCCCC
Confidence            5699999999999999999999999999999999999999963221       111121111 10          01222


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 006968          546 IELEEMVQVALLCTQFNPLHRPK---MSEVLKM  575 (623)
Q Consensus       546 ~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~  575 (623)
                      ....++.+++.+||..||++||+   +.+++.+
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            23467889999999999999975   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.8e-38  Score=322.31  Aligned_cols=258  Identities=25%  Similarity=0.385  Sum_probs=204.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-----CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ++|++.+.||+|+||.||+|..     .++..||+|.++..........+.+|+++++.++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999984     24678999999764433444578999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 006968          376 VYPYMPNGSVASRLRDHIH-------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF  442 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  442 (623)
                      ||||+++++|.+++.....             ....+++.....++.|++.||+|||++   +++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999999864211             123588999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHH
Q 006968          443 EAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLD  520 (623)
Q Consensus       443 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  520 (623)
                      .+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.....       .+
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~  234 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QE  234 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence            999999999986543321 12223345678999999988889999999999999999998 8888853211       11


Q ss_pred             HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ...... .....         ..+...+.++.+++.+|++.+|++||++.+|.++|+.
T Consensus       235 ~~~~~~-~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVR-KRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHH-cCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111111 11110         1112234678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.2e-38  Score=315.15  Aligned_cols=259  Identities=21%  Similarity=0.362  Sum_probs=211.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||+|.++.....  .....+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999986 7899999998743322  23457899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++.........+++.++..++.+++.||+|||+.   +|+||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999976545556789999999999999999999999   999999999999999999999999999886543


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.....     ...+....... +..      
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~-~~~------  225 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEK-CDY------  225 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHhhhhc-CCC------
Confidence            3222 2234588899999999888899999999999999999999999853221     11111111111 111      


Q ss_pred             ccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          538 DLKGNFD-RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       538 ~~~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         ...+ ......+.+++.+||..+|++|||+.+|+++|++
T Consensus       226 ---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         226 ---PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             ---CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence               1111 2345678999999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-38  Score=321.03  Aligned_cols=266  Identities=27%  Similarity=0.400  Sum_probs=202.6

Q ss_pred             CCcCCceeccCCeEEEEEEe-----CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC--CceEE
Q 006968          303 FSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLL  375 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l  375 (623)
                      |...+.||+|+||+||++.+     .++..||+|.++..........|.+|+++++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37789999999999988653     357889999997654333456789999999999999999999988653  35789


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|.+++...     .+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||+++..
T Consensus        86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence            99999999999998653     589999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCCc--eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ......  ......++..|+|||.+....++.++||||||+++|||+||+.|+........  ....+...........+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE--EMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh--hhhcccccccchhhhhh
Confidence            433221  11222356679999999888899999999999999999999999754321100  00000000000001111


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ..+.......+...+.++.+++.+||+.+|++|||++++++.|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            111111112233345789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.2e-38  Score=329.01  Aligned_cols=254  Identities=21%  Similarity=0.274  Sum_probs=204.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||++... +|+.||+|+++....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999875 689999999976432  223446889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..+..
T Consensus        81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            999999999999764   24689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeccccccccccccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      ..........||+.|+|||++.      ...++.++|||||||++|||++|+.||......       .....+......
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~  227 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNFQRF  227 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcCCCc
Confidence            4433334456899999999986      456789999999999999999999999643221       111221111111


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ....+       ....+.++.+++..|+. +|++|||+.+++++
T Consensus       228 ~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         228 LKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             cCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            11000       11124668899999998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.2e-38  Score=316.72  Aligned_cols=253  Identities=28%  Similarity=0.421  Sum_probs=204.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      .+|.+.+.||+|+||.||+|...+...||+|.++....  ....|.+|+++++.++||||+++++++. .+..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            46888999999999999999987777899999975332  3457899999999999999999999874 45689999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.+++....  ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.++|+|||.++.+.....
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999997532  34579999999999999999999999   999999999999999999999999999987654333


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .......++..|+|||...+..++.++||||||+++|||+| |+.||......       ........ +         .
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~-~---------~  220 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVER-G---------Y  220 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhc-C---------C
Confidence            22223346778999999988899999999999999999999 77787532211       11111110 0         0


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ........+..+.+++.+|++.+|++||++.++++.|++
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            011123345778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-38  Score=322.89  Aligned_cols=257  Identities=30%  Similarity=0.403  Sum_probs=203.8

Q ss_pred             CCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      +|.+.+.||+|+||.||+|...      ....+|+|.++.........++.+|+.+++.+.||||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677899999999999999853      2357999988765433344578999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 006968          376 VYPYMPNGSVASRLRDHIH--------------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN  435 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N  435 (623)
                      ++||+++|+|.+++.....                    ....+++.+++.++.|++.||+|||+.   +|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999999864311                    123588999999999999999999998   99999999999


Q ss_pred             eEECCCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccc
Q 006968          436 ILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAAN  513 (623)
Q Consensus       436 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~  513 (623)
                      |++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            99999999999999999865433221 1222345678999999988889999999999999999998 98888532211 


Q ss_pred             cccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          514 QRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                            ... ......         .....+...+.++.+++.+|++.+|++||++.++++.|++
T Consensus       237 ------~~~-~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         237 ------RLF-NLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             ------HHH-HHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence                  111 111111         0111122234678999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.5e-38  Score=316.01  Aligned_cols=253  Identities=28%  Similarity=0.417  Sum_probs=204.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|++.+.||+|+||.||+|...++..||+|.++....  ....|.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            46788899999999999999988888999999976432  3457999999999999999999999875 45689999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|.+++....  ...+++.+++.++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++..+.....
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          83 SKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            9999999987532  34589999999999999999999999   999999999999999999999999999987654332


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+.........          
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~----------  220 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------REVLEQVERGY----------  220 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC----------
Confidence            22222335678999999988889999999999999999999 8888853211       11111111110          


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....+...+..+.+++.+|+..+|++|||+.++.+.|++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            111222334679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.8e-39  Score=311.92  Aligned_cols=270  Identities=22%  Similarity=0.281  Sum_probs=205.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCc-eeeeeeeeecCC------
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRN-LLRLCGFCSTEN------  371 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~------  371 (623)
                      ..|...++||+|+||+||+|... +|+.||+|+++-.... .......+|+.+++.++|+| |+++++++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            44666778999999999999964 6899999999765442 22334689999999999999 999999998877      


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL  451 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  451 (623)
                      ..++|+||++ -+|..++.........++...++.++.|++.||+|||++   +|+||||||.|||++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            7889999995 589999987543224577789999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      |+...-.... .+..++|..|.|||++.+. .|+...||||+|||+.||+++++-|......++...+.+.+.....+.+
T Consensus       167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            9976543332 3445689999999999886 7899999999999999999999888754442222111121111111111


Q ss_pred             cccccccccCCCC---------CHHHH---HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKDLKGNF---------DRIEL---EEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~~~~---------~~~~~---~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .....-++....+         ....+   ....+++.+|++.+|.+|.|++.+++|
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1111111111111         11111   368899999999999999999999987

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-38  Score=329.89  Aligned_cols=248  Identities=24%  Similarity=0.276  Sum_probs=202.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC--CcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD--GALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|.+.+.||+|+||.||+|...+  +..||+|++.....  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            568889999999999999998643  36899999865432  22334688999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       110 ~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999998753    4689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......       ....... .+..     
T Consensus       183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~-~~~~-----  245 (340)
T PTZ00426        183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKIL-EGII-----  245 (340)
T ss_pred             CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHh-cCCC-----
Confidence            32    23456999999999999888999999999999999999999999643221       1111111 1110     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKMLE  577 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L~  577 (623)
                           .++......+.+++.+|++.+|++|+     ++++++++-.
T Consensus       246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~  286 (340)
T PTZ00426        246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW  286 (340)
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence                 11122235678999999999999995     8999988743

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.4e-38  Score=318.25  Aligned_cols=249  Identities=24%  Similarity=0.301  Sum_probs=199.0

Q ss_pred             eeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCCh
Q 006968          309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV  385 (623)
Q Consensus       309 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  385 (623)
                      ||+|+||+||++... +|+.||+|.+.......  ....+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 68899999986543222  234578899999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeec
Q 006968          386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA  465 (623)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  465 (623)
                      ..++.........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++..+..... ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            988865444456799999999999999999999999   999999999999999999999999999986654332 2234


Q ss_pred             cccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCH
Q 006968          466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDR  545 (623)
Q Consensus       466 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (623)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||........   ........         ....  ..++.
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~---------~~~~--~~~~~  222 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRI---------LNDS--VTYPD  222 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHhh---------cccC--CCCcc
Confidence            5689999999999999999999999999999999999999964321110   00000100         0000  11223


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006968          546 IELEEMVQVALLCTQFNPLHRP-----KMSEVLKM  575 (623)
Q Consensus       546 ~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  575 (623)
                      ..+..+.+++.+||+.||++||     ++.+++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            3456789999999999999999     67777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-38  Score=320.68  Aligned_cols=258  Identities=26%  Similarity=0.362  Sum_probs=204.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCC------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      .++|.+.+.||+|+||.||+|.+.+      +..||+|.++..........|..|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4668889999999999999998753      5689999887554444455799999999999999999999999998999


Q ss_pred             EEEEecccCCChhhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---cEEEe
Q 006968          374 LLVYPYMPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---EAVVG  447 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~  447 (623)
                      ++||||+++++|.+++.....   ....+++..+.+++.|++.||+|||+.   +++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            999999999999999976432   123589999999999999999999999   999999999999998654   59999


Q ss_pred             ecccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHH
Q 006968          448 DFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       448 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      |||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......       +.....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEFV  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHH
Confidence            999998763322111 112223568999999998999999999999999999997 88888643221       111111


Q ss_pred             hhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .....          ...+...+..+.+++.+|++.+|++||++.+|+++|+
T Consensus       235 ~~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11111          1112223467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.8e-38  Score=315.72  Aligned_cols=254  Identities=28%  Similarity=0.427  Sum_probs=205.9

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .++|++.++||+|+||.||+|...+++.||+|.+.....  ...+|.+|+.++++++|+||+++++++ ..+..+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence            356888999999999999999988899999999875432  345789999999999999999999987 45678999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          82 MENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            99999999987532  34689999999999999999999998   99999999999999999999999999998765333


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ........++..|+|||.+....++.++||||||+++||+++ |+.||......       +.........         
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~---------  220 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNLERGY---------  220 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHHHHcCC---------
Confidence            222223346778999999988889999999999999999999 99998633211       1111111100         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       ....+...+.++.+++.+|+..+|++||++.++++.|++
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 -RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence             001112234679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2e-38  Score=321.43  Aligned_cols=259  Identities=27%  Similarity=0.382  Sum_probs=208.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCC-----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec-CCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST-ENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~  373 (623)
                      .++|.+.+.||+|+||.||+|...+     +..||+|+++..........+.+|+.+++.+.||||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999999765     788999998755444445678999999999999999999998766 5678


Q ss_pred             EEEEecccCCChhhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          374 LLVYPYMPNGSVASRLRDHIHG----RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                      ++++||+++|+|.+++......    ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999999764322    15689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhh
Q 006968          450 GLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       450 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      |+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||.....       .++......
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-------FEMAAYLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHc
Confidence            9998664433221 122346778999999988889999999999999999999 9999864221       111111111


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .....          .....+.++.+++.+||..+|++|||+.++++.|++
T Consensus       235 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  275 (280)
T cd05043         235 GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD  275 (280)
T ss_pred             CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            11100          111234678999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.7e-39  Score=337.55  Aligned_cols=256  Identities=20%  Similarity=0.271  Sum_probs=203.0

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ..++|.+.+.||+|+||.||++... ++..||+|+++.....  .....+..|+.+++.++||||+++++++..++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3467889999999999999999875 5889999999653221  223457889999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       121 v~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999988653     478888999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCceeeccccccccccccccccC----CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      ............||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....       .............
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~  265 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMDHKNS  265 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCCc
Confidence            54332223345699999999998653    478899999999999999999999964321       1111111111000


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLH--RPKMSEVLKML  576 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~L  576 (623)
                        .   ....  ....+.++.+++.+|+..+|++  |||+.+++++-
T Consensus       266 --~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         266 --L---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             --C---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence              0   0000  1123467889999999999988  99999998874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-38  Score=320.48  Aligned_cols=258  Identities=26%  Similarity=0.418  Sum_probs=206.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|.+.+.||+|+||.||+|...+      +..||+|.+...........+.+|+.++..+.||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            568888999999999999998642      46899999875543344557899999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 006968          375 LVYPYMPNGSVASRLRDHIHG------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD  448 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  448 (623)
                      +||||+++|+|.+++......      ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence            999999999999999764321      23478999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHh
Q 006968          449 FGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH  526 (623)
Q Consensus       449 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  526 (623)
                      ||+++....... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||......       +......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~  235 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-------EVLKFVI  235 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-------HHHHHHh
Confidence            999976543322 12223346789999999988889999999999999999998 88888532211       1111111


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       .+...         ..+...+.++.+++.+||..+|++|||+.++++.|++
T Consensus       236 -~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 -DGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence             11111         1112235789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-39  Score=336.46  Aligned_cols=254  Identities=23%  Similarity=0.295  Sum_probs=205.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||||+++.....  .....+..|++++..++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999975 6899999999754322  23456889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999998764    4689999999999999999999998   999999999999999999999999999986654


Q ss_pred             CC----------------------------CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 006968          458 RD----------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG  509 (623)
Q Consensus       458 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~  509 (623)
                      ..                            ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            33                            11223345899999999999999999999999999999999999999743


Q ss_pred             cccccccchHHHHHHHhh-cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHhh
Q 006968          510 RAANQRGVMLDWVKKLHQ-EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK-MSEVLKMLE  577 (623)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~L~  577 (623)
                      ...       ........ .....      +.  .....+.++.+++.+|+. +|.+||+ +.+++++-.
T Consensus       234 ~~~-------~~~~~i~~~~~~~~------~p--~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         234 TLQ-------ETYNKIINWKESLR------FP--PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             CHH-------HHHHHHhccCCccc------CC--CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            321       11111111 00000      00  001134678899999997 9999999 999998743

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-38  Score=346.02  Aligned_cols=257  Identities=24%  Similarity=0.311  Sum_probs=206.8

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCC-----
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-----  371 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----  371 (623)
                      ...+|.+.+.||+|+||+||+|... +|+.||||+++..... .....+.+|+.++..++|+|++++...+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            4568999999999999999999864 6899999998654332 23446889999999999999999987765432     


Q ss_pred             ---ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 006968          372 ---ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD  448 (623)
Q Consensus       372 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  448 (623)
                         ..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               36799999999999999987555556799999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCC-CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh
Q 006968          449 FGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       449 fgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      ||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .+.+.....
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~~  259 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTLA  259 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhc
Confidence            99998654322 1223345699999999999999999999999999999999999999963221       122222111


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       +...         ..+...+.++.+++.+||+.+|++||++.+++++
T Consensus       260 -~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 -GRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -CCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence             1111         1122234678999999999999999999999875

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.3e-38  Score=326.76  Aligned_cols=247  Identities=27%  Similarity=0.368  Sum_probs=195.8

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHH---hhcCCCceeeeeeeeecCCceEEE
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETI---SLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l---~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      |.+.+.||+|+||.||+|... +|+.||||+++....  ......+.+|+.++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999875 689999999975432  12233566666554   567899999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|..+++.     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999887753     3689999999999999999999999   99999999999999999999999999987533


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......       +.........       
T Consensus       153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~-------  217 (324)
T cd05589         153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------EVFDSIVNDE-------  217 (324)
T ss_pred             CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC-------
Confidence            222 2233456999999999999999999999999999999999999999643221       1111111111       


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKML  576 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L  576 (623)
                      .    .++...+..+.+++.+||..||.+||     ++.+++++-
T Consensus       218 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         218 V----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence            0    11222346788999999999999999     577777653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=294.10  Aligned_cols=263  Identities=27%  Similarity=0.342  Sum_probs=209.5

Q ss_pred             HhcCCCcCCceeccCCeEEEEEE-eCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC-----Cc
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NE  372 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  372 (623)
                      ..++|.+.+.||+|||+-||.++ ..++..+|+|++.-.. .++....++|++..++++|||++++++++..+     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            34678899999999999999998 4578999999996544 44566789999999999999999999988543     34


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .|++++|+..|+|.+.+......+..+++.+.++|+.++++||++||+. .|+++||||||.|||+.+++.+++.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            8999999999999999988766677899999999999999999999998 346999999999999999999999999998


Q ss_pred             cccCCCCCce--------eecccccccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHH
Q 006968          453 KLLDHRDSHV--------TTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDW  521 (623)
Q Consensus       453 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  521 (623)
                      ....-.....        .....-|..|.|||.+.-   ...++++|||||||++|+|+.|..||+....          
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------  246 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------  246 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence            7543111100        112236889999998853   3568999999999999999999999973211          


Q ss_pred             HHHHhhcCcccccc-ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          522 VKKLHQEGKLSQMV-DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       522 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                           +.+.+.-.+ ...+.-.-....++.+.+++.+|+++||.+||++.+++..+++
T Consensus       247 -----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  247 -----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             -----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                 122222111 1111111122356889999999999999999999999999876

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.8e-38  Score=332.47  Aligned_cols=258  Identities=19%  Similarity=0.264  Sum_probs=202.0

Q ss_pred             HHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       298 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ...++|.+.+.||+|+||.||++... +++.||+|.+++....  .....+.+|+.+++.++||||+++++++..++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34567999999999999999999975 5889999998653221  22345789999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +||||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       120 lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence            999999999999998643     478899999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCceeeccccccccccccccccC----CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      .............||+.|+|||++.+.    .++.++||||+||++|||++|+.||.....       ............
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-------~~~~~~i~~~~~  264 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-------VGTYSKIMDHKN  264 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCc
Confidence            654333233455699999999998654    378899999999999999999999964321       111111111110


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhh
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLH--RPKMSEVLKMLE  577 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~L~  577 (623)
                      ...     ...  .......+.+++..|+..++.+  ||++.|++++-.
T Consensus       265 ~~~-----~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~  306 (370)
T cd05621         265 SLN-----FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF  306 (370)
T ss_pred             ccC-----CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence            000     000  1112456788899999866544  899999999743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3e-38  Score=334.25  Aligned_cols=260  Identities=23%  Similarity=0.331  Sum_probs=205.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~  372 (623)
                      .++|.+.+.||+|+||.||+|.+.      .+..||||+++..........+.+|++++.++. ||||+++++++...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            346778899999999999999853      346899999976543433457899999999997 9999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccC----------------------------------------------------------
Q 006968          373 RLLVYPYMPNGSVASRLRDHIH----------------------------------------------------------  394 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  394 (623)
                      .++|+||+++|+|.++++....                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999975321                                                          


Q ss_pred             ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 006968          395 ------------------------------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL  438 (623)
Q Consensus       395 ------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll  438 (623)
                                                          ....+++....+++.|++.||+|||+.   +|+||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence                                                113478889999999999999999998   99999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCccccccccc
Q 006968          439 DEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRG  516 (623)
Q Consensus       439 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~  516 (623)
                      ++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......    
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~----  348 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN----  348 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch----
Confidence            9999999999999986533221 11122346788999999988889999999999999999998 88887532211    


Q ss_pred             chHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          517 VMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         +........+.         ....+.....++.+++.+||..+|.+||++.+|++.|++
T Consensus       349 ---~~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         349 ---EQFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             ---HHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               00111111110         011122234789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.5e-37  Score=320.53  Aligned_cols=242  Identities=26%  Similarity=0.355  Sum_probs=191.9

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhh-cCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|... +++.||+|.++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 588999999975432  1223345667777664 4899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            9999888653    3689999999999999999999999   99999999999999999999999999997643322 22


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....       ......... .          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~-~----------~~~  214 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILN-D----------RPH  214 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHc-C----------CCC
Confidence            3345699999999999998999999999999999999999999964321       111111111 0          011


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKMS-EVLK  574 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  574 (623)
                      ++.....++.+++.+||+.+|++||++. ++++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            2222346788999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.4e-38  Score=318.75  Aligned_cols=254  Identities=26%  Similarity=0.426  Sum_probs=199.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCc----EEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      .+|...+.||+|+||.||+|.+. ++.    .|++|.+..........++..|+..++++.||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            45777899999999999999874 344    478888754332223356788888999999999999999885 456789


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ++||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            99999999999999754   34689999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......    .    .......+....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~----~~~~~~~~~~~~  231 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----E----VPDLLEKGERLA  231 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----H----HHHHHHCCCcCC
Confidence            433222 2233457789999999998899999999999999999998 99898633211    0    111111111110


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                        .       +..+...+.+++.+||..+|.+|||+.|+++.|+.
T Consensus       232 --~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         232 --Q-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             --C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence              0       11123567889999999999999999999998876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.1e-38  Score=321.70  Aligned_cols=257  Identities=21%  Similarity=0.300  Sum_probs=203.4

Q ss_pred             CCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      +|.+.+.||+|+||.||+|...      ++..||+|+++..........+..|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4566788999999999999863      2578999999755433334568899999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc
Q 006968          376 VYPYMPNGSVASRLRDHI------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE  443 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  443 (623)
                      ++||+++++|.+++....            .....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999985321            1123588999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHH
Q 006968          444 AVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDW  521 (623)
Q Consensus       444 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  521 (623)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+.....       .++
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~  235 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDV  235 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence            99999999886543322 11223346789999999988889999999999999999998 7777753211       122


Q ss_pred             HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          522 VKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ........ .         ..++...+..+.+++.+||+.+|++||++.+|+..|+.
T Consensus       236 ~~~i~~~~-~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRNRQ-V---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHcCC-c---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            22221111 1         11223345778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.4e-38  Score=313.59  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=197.5

Q ss_pred             ceeccCCeEEEEEEeC---CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCC
Q 006968          308 ILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS  384 (623)
Q Consensus       308 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  384 (623)
                      .||+|+||.||+|.+.   ++..||+|+++..........|.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999764   356799999876543334457999999999999999999999885 457899999999999


Q ss_pred             hhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCcee-
Q 006968          385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-  463 (623)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-  463 (623)
                      |.+++...   ...+++..+++++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........... 
T Consensus        81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99998753   34689999999999999999999999   999999999999999999999999999986543322211 


Q ss_pred             -eccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccccCC
Q 006968          464 -TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG  541 (623)
Q Consensus       464 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  541 (623)
                       ....++..|+|||.+.+..++.++||||||+++||+++ |+.||.....       .++...... +.         ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~-~~---------~~  217 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-------PEVMSFIEQ-GK---------RL  217 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHC-CC---------CC
Confidence             11223578999999988889999999999999999996 9999863221       112222111 11         11


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          542 NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       542 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ..+...+.++.+++.+||..+|++||++.+|.+.|+..
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            12223457889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.6e-38  Score=318.98  Aligned_cols=266  Identities=23%  Similarity=0.359  Sum_probs=207.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCC-----------------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceee
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSD-----------------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR  362 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~  362 (623)
                      ..+|.+.+.||+|+||.||+|...+                 +..||+|.++..........+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999987642                 24689999876554445567899999999999999999


Q ss_pred             eeeeeecCCceEEEEecccCCChhhhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 006968          363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIH-------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN  435 (623)
Q Consensus       363 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N  435 (623)
                      +++++..++..++++||+++++|.+++.....       ....+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999999999999999999999999976531       123689999999999999999999999   99999999999


Q ss_pred             eEECCCCcEEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh--CCCCCCccccc
Q 006968          436 ILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALDFGRAA  512 (623)
Q Consensus       436 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~  512 (623)
                      |+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++  |..|+..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999976543322 12223446788999999988889999999999999999998  5666643211 


Q ss_pred             ccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          513 NQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         ....................      ..+...+.++.+++.+|++.+|++|||+.+|++.|++
T Consensus       240 ---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 ---QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ---HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence               11111111111111111000      1122234689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-38  Score=343.41  Aligned_cols=253  Identities=21%  Similarity=0.280  Sum_probs=204.9

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-C-CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-D-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .|.+.+.||+|+||.||+|... + +..||+|.+.... ......+..|+.+++.++||||+++++++..++..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            4888899999999999999854 3 6788888764332 22334578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.++++.......++++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+....
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999999876555556789999999999999999999999   99999999999999999999999999998765432


Q ss_pred             C-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 S-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .+.+..... +...      
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~-~~~~------  289 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLY-GKYD------  289 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh-CCCC------
Confidence            2 223445699999999999999999999999999999999999999863221       111121111 1111      


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         .++...+.++.+++.+||..+|++||++.+++.+
T Consensus       290 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        290 ---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence               1112234678999999999999999999998753

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.3e-39  Score=326.73  Aligned_cols=252  Identities=26%  Similarity=0.393  Sum_probs=213.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCc-eEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENE-RLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-~~lv~  377 (623)
                      ++|...+++|+|+||.++....+ ++..+++|.+.-..... .+....+|+.++++++|||||.+.+.+..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888899999999999998865 57899999997655433 33467899999999999999999999999988 99999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      +|++||++.+.+.+..  +.-+++.++.+++.|++.|+.|||++   .|+|||||+.||+++.+..+||+|||+|+.++.
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999998753  45689999999999999999999998   999999999999999999999999999999886


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ... ....+.||+.||.||.+.+.+|..|+||||+||++|||++-+++|...+.       ...+-+...         .
T Consensus       159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ki~~---------~  221 (426)
T KOG0589|consen  159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELILKINR---------G  221 (426)
T ss_pred             chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-------HHHHHHHhh---------c
Confidence            552 34556799999999999999999999999999999999999999974332       111111111         0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       .....+..+..++..++..|+..+|+.||++.+++.+
T Consensus       222 -~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 -LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             1123345566889999999999999999999999886

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.9e-38  Score=326.97  Aligned_cols=244  Identities=26%  Similarity=0.335  Sum_probs=196.7

Q ss_pred             CceeccCCeEEEEEEe----CCCcEEEEEEeccccc---ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          307 NILGRGGFGIVYKGCF----SDGALVAVKRLKDYNI---AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +.||+|+||.||++..    .+++.||||+++....   ......+..|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    3578999999975432   12234578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++...    ..+.+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999988653    4578889999999999999999999   99999999999999999999999999987543222


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......       ........ +..        
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~~~~-~~~--------  217 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDKILK-GKL--------  217 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHHHHc-CCC--------
Confidence             1223456999999999999888999999999999999999999999643211       11111111 110        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKML  576 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L  576 (623)
                        .++.....++.+++.+||..+|++||     ++.+++++-
T Consensus       218 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~  257 (323)
T cd05584         218 --NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP  257 (323)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence              11222336788999999999999999     888887753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.2e-38  Score=314.86  Aligned_cols=260  Identities=21%  Similarity=0.360  Sum_probs=209.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|.. .++..+|||.++.....  ....++.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677889999999999999996 47899999988653322  23357889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++.........+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999876444456789999999999999999999999   999999999999999999999999999886643


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......     ...+.+...      ....+
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~------~~~~~  226 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIE------QCDYP  226 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-----HHHHhhhhh------cCCCC
Confidence            322 122345889999999998888999999999999999999999998532110     111111111      11111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ..   .......++.+++.+||..+|++|||+.+|++.+++
T Consensus       227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            11   112345689999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.7e-38  Score=330.45  Aligned_cols=254  Identities=23%  Similarity=0.309  Sum_probs=197.2

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .|...+.||+|+||+||+|... +++.||||+++.....  .....+.+|++++..++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999864 6889999999764322  223468899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            99999999998753    3588999999999999999999999   9999999999999999999999999997643210


Q ss_pred             CC----------------------------------------------ceeeccccccccccccccccCCCCCccchhhH
Q 006968          459 DS----------------------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF  492 (623)
Q Consensus       459 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~Sl  492 (623)
                      ..                                              .......||+.|+|||.+.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                              00123469999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHH--ccCCCCCCCCCHH
Q 006968          493 GILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALL--CTQFNPLHRPKMS  570 (623)
Q Consensus       493 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~P~~RPs~~  570 (623)
                      ||++|||++|+.||.........      .+........      ....  ......++.+++.+  |+..+|..||++.
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~~------~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQ------LKVINWENTL------HIPP--QVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHH------HHHHcccccc------CCCC--CCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            99999999999999743321110      0100000000      0000  00123567778777  5566667799999


Q ss_pred             HHHHHh
Q 006968          571 EVLKML  576 (623)
Q Consensus       571 evl~~L  576 (623)
                      +++++-
T Consensus       301 ~~l~hp  306 (381)
T cd05626         301 DIKAHP  306 (381)
T ss_pred             HHhcCc
Confidence            999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-38  Score=319.09  Aligned_cols=254  Identities=26%  Similarity=0.346  Sum_probs=203.2

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      +|+..+.||+|+||.||++... +++.||+|.+......  .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4777899999999999999864 6899999998654322  223457889999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999888653  234689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ..  .....|+..|+|||++.+..++.++||||+|+++|||++|+.||.......    ....+.......         
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~---------  220 (285)
T cd05605         156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVKED---------  220 (285)
T ss_pred             Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhhhc---------
Confidence            21  223458999999999998889999999999999999999999997432111    001111110000         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKML  576 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L  576 (623)
                       ...++...+..+.+++.+||..||++||     ++.+++++-
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~  262 (285)
T cd05605         221 -QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP  262 (285)
T ss_pred             -ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence             1112233456789999999999999999     888987763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-37  Score=312.42  Aligned_cols=253  Identities=27%  Similarity=0.393  Sum_probs=203.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|.+.+.||+|+||.||+|...++..+|+|.+....  .....+.+|+.+++.++|||++++++++. .+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4577889999999999999998777789999986543  23457899999999999999999999875 45688999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.++++...  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            9999999997632  34589999999999999999999999   999999999999999999999999999987644332


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .......++..|+|||...+..++.++||||||+++|||++ |+.||......       +..........         
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~---------  221 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------EVLEQVERGYR---------  221 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCC---------
Confidence            22223346778999999988899999999999999999999 88888632211       11111111100         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       ...+...+..+.+++.+||..+|++||++.+|++.|++
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 -MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             11122345779999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6e-38  Score=319.32  Aligned_cols=258  Identities=27%  Similarity=0.439  Sum_probs=204.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEe------CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      .+|.+.+.||+|+||.||++..      .++..+|+|.++... ......+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            4678889999999999999974      235679999986543 233457899999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEE
Q 006968          375 LVYPYMPNGSVASRLRDHIH---------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                      +||||+++++|.+++.....         ....+++..+++++.|++.||+|||+.   +++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            99999999999999975421         123589999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHH
Q 006968          446 VGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       446 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      |+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......       +...
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~~~~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIE  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH
Confidence            9999999865432211 1122335778999999988889999999999999999999 88888532211       1111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ... .+....     .    +...+.++.+++.+||+.+|.+|||+.++.+.|++.
T Consensus       234 ~i~-~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         234 CIT-QGRVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             HHH-cCCcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            111 111110     1    112235789999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.2e-38  Score=324.69  Aligned_cols=251  Identities=23%  Similarity=0.297  Sum_probs=196.4

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|... +++.||+|+++.....  .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 5889999999764322  2234577888888766 799999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~  152 (329)
T cd05618          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence            9998887653    4689999999999999999999999   99999999999999999999999999987532221 12


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccccc-ccchHHHHHHHhhcCccccccccccCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ-RGVMLDWVKKLHQEGKLSQMVDKDLKG  541 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  541 (623)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......++.........          
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence            2345689999999999999999999999999999999999999963221111 11112222222211111          


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 006968          542 NFDRIELEEMVQVALLCTQFNPLHRPK------MSEVLKM  575 (623)
Q Consensus       542 ~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evl~~  575 (623)
                      .++.....++.+++.+||..||++||+      +.+++++
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            122233467889999999999999998      4677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.4e-38  Score=320.33  Aligned_cols=260  Identities=27%  Similarity=0.424  Sum_probs=205.5

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCc
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE  372 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  372 (623)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.++..........+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3567899999999999999999753      2458999998755433344568899999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 006968          373 RLLVYPYMPNGSVASRLRDHIH------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV  446 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  446 (623)
                      .++||||+++|+|.+++.....      .....++..+.+++.|++.||.|||++   +|+||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999975321      124567888999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHH
Q 006968          447 GDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       447 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      +|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.....       .++...
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~~~~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLKF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH
Confidence            9999998654322211 112235678999999998899999999999999999999 6778753221       111222


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ... +...         ..+...+..+.+++.+|++.+|++|||+.++++.|++
T Consensus       234 ~~~-~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  277 (288)
T cd05061         234 VMD-GGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD  277 (288)
T ss_pred             HHc-CCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            111 1111         1112234689999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.6e-38  Score=323.54  Aligned_cols=243  Identities=27%  Similarity=0.343  Sum_probs=196.0

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|... ++..||||+++....  ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 578999999976432  22334577888888877 699999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  152 (318)
T cd05570          81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT  152 (318)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence            9999888653    3689999999999999999999999   99999999999999999999999999987532221 22


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||.....       ......... ..          ..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~-~~----------~~  214 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILE-DE----------VR  214 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHc-CC----------CC
Confidence            2344689999999999999999999999999999999999999964321       111111111 10          01


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKM-----SEVLKM  575 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  575 (623)
                      ++...+.++.+++.+||..||++||++     .+++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            122234678999999999999999999     888775

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.7e-38  Score=321.10  Aligned_cols=257  Identities=26%  Similarity=0.374  Sum_probs=204.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  373 (623)
                      ++|.+.+.||+|+||.||+|...      .+..||||.++..........+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            56888999999999999999741      35579999987654344445789999999999 799999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++|+|.++++...  ...+++.++..++.|++.||+|||++   +|+|+||||+||+++.++.++++|||+++
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999997532  23489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          454 LLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       454 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      ........ ......++..|+|||.+....++.++||||||+++|||++ |+.||......      ... ......+. 
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~-~~~~~~~~-  261 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKF-YKLIKEGY-  261 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHH-HHHHHcCC-
Confidence            65433221 1222345778999999998899999999999999999998 89988532211      011 11111110 


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                              ....+...+.++.+++.+|++.+|++|||+.|+++.|++
T Consensus       262 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         262 --------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                    001111224678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.7e-38  Score=320.96  Aligned_cols=256  Identities=27%  Similarity=0.414  Sum_probs=201.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC-C--cEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD-G--ALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999998753 3  357999887544334455789999999999 799999999999999999999


Q ss_pred             EecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcE
Q 006968          377 YPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA  444 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  444 (623)
                      +||+++|+|.+++.....            ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999975321            113588999999999999999999998   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHH
Q 006968          445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      ||+|||++.......  .......+..|+|||.+.+..++.++|||||||++|||++ |+.||.....       .+...
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~~~~  229 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AELYE  229 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence            999999986432111  1111223567999999988889999999999999999997 9999863221       11111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .... +         .....+...+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus       230 ~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  274 (297)
T cd05089         230 KLPQ-G---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR  274 (297)
T ss_pred             HHhc-C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1111 1         1111122234678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=312.22  Aligned_cols=267  Identities=22%  Similarity=0.333  Sum_probs=202.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecc-cccccchHHHHHHHHHHhhcCCCceeeeeeeeec-----CCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKD-YNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST-----ENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~  372 (623)
                      ...|...+.||+|+||.|++|... +|+.||||++.. .......++-.+|+++|+.++|+||+.+.+.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345666789999999999999875 689999999863 2223334567899999999999999999998854     356


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .|+|+|+| +.+|...++.    +..++......++.|+++||+|+|+.   +|+||||||+|++++.+...||+|||+|
T Consensus       101 vYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence            89999999 5577776654    45599999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC-Cceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH-----
Q 006968          453 KLLDHRD-SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL-----  525 (623)
Q Consensus       453 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----  525 (623)
                      +...... ....+..+.|..|.|||++.. ..||...||||.|||+.||++|++-|.+.+..++...+.+.+...     
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            9875431 122355668999999998854 689999999999999999999999987665444433322211110     


Q ss_pred             --hhcCccccccc-------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          526 --HQEGKLSQMVD-------KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       526 --~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        .........+.       ..+...++ .......+++.+||..||.+|+|++|.+++
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence              00000000100       00011111 223567899999999999999999999885

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.8e-37  Score=320.36  Aligned_cols=251  Identities=22%  Similarity=0.284  Sum_probs=198.2

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      ++||+|+||.||+|... +++.||+|+++.....  .....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875 6889999999764322  2234578899999888 799999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~  152 (329)
T cd05588          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence            9998888653    4689999999999999999999999   9999999999999999999999999998743211 122


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccc-cccchHHHHHHHhhcCccccccccccCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN-QRGVMLDWVKKLHQEGKLSQMVDKDLKG  541 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  541 (623)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||+...... ......++..........          
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------
Confidence            334569999999999999999999999999999999999999996422211 111122233322222211          


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 006968          542 NFDRIELEEMVQVALLCTQFNPLHRPK------MSEVLKM  575 (623)
Q Consensus       542 ~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evl~~  575 (623)
                      .++.....++.+++.+||+.||.+||+      +.+++++
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            112223467899999999999999997      6777765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.1e-38  Score=325.49  Aligned_cols=265  Identities=20%  Similarity=0.328  Sum_probs=196.1

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecC-----CceE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NERL  374 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~  374 (623)
                      +|.+.+.||+|+||.||+|... +|..||||+++.... ......+.+|+++++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999865 689999999874322 22344688999999999999999999988543     2479


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +||||+. ++|.+++...    ..+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 6888887642    4689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCC--ceeecccccccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH--------HHH
Q 006968          455 LDHRDS--HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--------DWV  522 (623)
Q Consensus       455 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~  522 (623)
                      ......  .......||..|+|||++.+  ..++.++|||||||++|||++|+.||.............        .+.
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            432211  11234568999999999865  678999999999999999999999996432211100000        000


Q ss_pred             HHHhhcCccccc---cccccCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          523 KKLHQEGKLSQM---VDKDLKGNFD---RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       523 ~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..... ......   +.......+.   ......+.+++.+||+.+|++|||+.|++++
T Consensus       233 ~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         233 SRVRN-EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHhhh-hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00000 000000   0000000000   0123567899999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=334.97  Aligned_cols=254  Identities=20%  Similarity=0.274  Sum_probs=200.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|++.+.||+|+||.||+|... +|+.||||+++.....  .....+.+|+.++..++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36888999999999999999975 6899999999754321  22345788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            999999999998753    3689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCc-------------------------------------eeeccccccccccccccccCCCCCccchhhHHHHHHHHH
Q 006968          458 RDSH-------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI  500 (623)
Q Consensus       458 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ell  500 (623)
                      ....                                     ......||+.|+|||++....++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     011235899999999999889999999999999999999


Q ss_pred             hCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHh
Q 006968          501 TGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK---MSEVLKML  576 (623)
Q Consensus       501 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~L  576 (623)
                      +|+.||.......       .............     ...  ......++.+++.+|+. +|.+|++   +.|++++-
T Consensus       234 ~G~~Pf~~~~~~~-------~~~~i~~~~~~~~-----~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~  297 (364)
T cd05599         234 VGYPPFCSDNPQE-------TYRKIINWKETLQ-----FPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP  297 (364)
T ss_pred             cCCCCCCCCCHHH-------HHHHHHcCCCccC-----CCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence            9999996432211       1111111000000     000  00123567889999996 9999998   99988764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=312.75  Aligned_cols=253  Identities=26%  Similarity=0.339  Sum_probs=203.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc----chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG----GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ++|...+.||+|++|.||+|... ++..||+|.++......    ....+.+|++++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888999999999999999864 68999999986543211    22468889999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      |+||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            99999999999988753    3588999999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCCcee--eccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ........  ....|+..|+|||.+.+..++.++||||+|+++|||++|+.||......      .. .......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~-~~~~~~~-----  222 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AA-IFKIATQ-----  222 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HH-HHHHhcc-----
Confidence            43222111  2345788999999999988999999999999999999999998632111      00 1111100     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                          .....++......+.+++.+||..+|++|||+.+++++.
T Consensus       223 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         223 ----PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             ----CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                011122233446789999999999999999999998863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.2e-38  Score=319.22  Aligned_cols=258  Identities=27%  Similarity=0.456  Sum_probs=205.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.++... ......+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            45778899999999999999742      35679999986533 233456899999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 006968          375 LVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF  442 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  442 (623)
                      +||||+++++|.+++.....            ....+++..+++++.|++.|++|||++   +|+||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            99999999999999975421            123589999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHH
Q 006968          443 EAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLD  520 (623)
Q Consensus       443 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  520 (623)
                      .++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||......       +
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~  233 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------E  233 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H
Confidence            9999999999765432211 1223346788999999998899999999999999999999 99998543221       1


Q ss_pred             HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ..... ..+....         .+...+..+.+++.+||..+|++|||+.+|+++|++.
T Consensus       234 ~~~~~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         234 VIECI-TQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             HHHHH-hCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            11111 1111111         1122346789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.9e-38  Score=312.18  Aligned_cols=246  Identities=26%  Similarity=0.375  Sum_probs=196.4

Q ss_pred             ceeccCCeEEEEEEeC---CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCC
Q 006968          308 ILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG  383 (623)
Q Consensus       308 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  383 (623)
                      .||+|+||.||+|.++   ++..+|+|+++..... ....++..|+.+++.+.||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   5789999998654322 23457899999999999999999999885 45678999999999


Q ss_pred             ChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCcee
Q 006968          384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT  463 (623)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  463 (623)
                      +|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999998653    3589999999999999999999999   999999999999999999999999999987654433221


Q ss_pred             --eccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          464 --TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       464 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                        ....++..|+|||.+....++.++||||||+++|||++ |+.||.....       .++..... .+..         
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~i~-~~~~---------  216 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------NEVTQMIE-SGER---------  216 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH-CCCC---------
Confidence              12234578999999988889999999999999999998 9999863221       11122211 1111         


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ...+...+.++.+++.+||+.||++||++.+|.+.|++
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            11122234678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.7e-38  Score=321.86  Aligned_cols=258  Identities=28%  Similarity=0.426  Sum_probs=202.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCc--EEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGA--LVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  375 (623)
                      .++|++.+.||+|+||.||+|... ++.  .+|+|.++..........+.+|++++.++ +||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            356888899999999999999874 444  46888876544344456789999999999 89999999999999999999


Q ss_pred             EEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc
Q 006968          376 VYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE  443 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  443 (623)
                      |+||+++|+|.++++....            ....+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            9999999999999975421            123689999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHH
Q 006968          444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWV  522 (623)
Q Consensus       444 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  522 (623)
                      +||+|||++.......  ......++..|+|||.+.+..++.++||||||+++|||+| |..||......       +..
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~  233 (303)
T cd05088         163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELY  233 (303)
T ss_pred             EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-------HHH
Confidence            9999999986422111  1111224678999999988889999999999999999998 99998532211       111


Q ss_pred             HHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          523 KKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ..... +         .....+...+..+.+++.+||+.+|++||++.+++++|++.
T Consensus       234 ~~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         234 EKLPQ-G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHHhc-C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111 0         00011112235689999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-38  Score=319.28  Aligned_cols=264  Identities=22%  Similarity=0.358  Sum_probs=202.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC---------------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeee
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD---------------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG  365 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~  365 (623)
                      .+|.+.+.||+|+||.||++...+               ...||+|.++..........|.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578889999999999999987532               23589999876543334457999999999999999999999


Q ss_pred             eeecCCceEEEEecccCCChhhhhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 006968          366 FCSTENERLLVYPYMPNGSVASRLRDHIH--------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANIL  437 (623)
Q Consensus       366 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIl  437 (623)
                      ++...+..++||||+++++|.+++.....        ....+++..++.++.|++.||+|||+.   +++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            99999999999999999999999865321        112478999999999999999999999   9999999999999


Q ss_pred             ECCCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh--CCCCCCccccccc
Q 006968          438 LDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALDFGRAANQ  514 (623)
Q Consensus       438 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~~~  514 (623)
                      +++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++  |..||......  
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence            999999999999999765432221 1122335678999999988889999999999999999998  55566432111  


Q ss_pred             ccchHHHHHHHhh-cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          515 RGVMLDWVKKLHQ-EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       515 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                        ........... .+.....       ..+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus       240 --~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 --QVIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             --HHHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence              01111111111 0110000       0111234689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.9e-37  Score=326.50  Aligned_cols=264  Identities=20%  Similarity=0.278  Sum_probs=205.9

Q ss_pred             HHHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeec
Q 006968          293 FKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCST  369 (623)
Q Consensus       293 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~  369 (623)
                      +.++....++|.+.+.||+|+||.||++... +++.||+|+++....  ......+.+|+.+++.++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445556688999999999999999999976 588999999865322  1223457889999999999999999999999


Q ss_pred             CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                      ++..++||||+++|+|.+++...     .++...+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999998653     478888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccccC----CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      |++...............||+.|+|||++...    .++.++|||||||++|||++|+.||.....       ......+
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i  259 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKI  259 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence            99987654333333455699999999998654    378899999999999999999999974322       1111111


Q ss_pred             hhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhhc
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLH--RPKMSEVLKMLEG  578 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~L~~  578 (623)
                      ..........+       ....+.++.+++..|+..++.+  ||++.+++++..-
T Consensus       260 ~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         260 MNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             HcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            11111000000       1123467889999999844443  7899999987654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.9e-38  Score=322.43  Aligned_cols=258  Identities=29%  Similarity=0.389  Sum_probs=204.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC--------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCC
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN  371 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  371 (623)
                      ++|.+.+.||+|+||.||+|...        ++..+|+|.++..........+..|++++..+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            56889999999999999999752        23579999997654334455688999999999 7999999999999999


Q ss_pred             ceEEEEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD  439 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~  439 (623)
                      ..++||||+++|+|.+++.....            ....+++.++++++.|++.||+|||+.   +++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            99999999999999999976422            123589999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccc
Q 006968          440 EDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGV  517 (623)
Q Consensus       440 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~  517 (623)
                      .++.+||+|||.++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....      
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------  248 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------  248 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence            9999999999998765432211 1122224578999999988889999999999999999998 8888753221      


Q ss_pred             hHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       .+...... .+.         ....+...+.++.+++.+|+..+|++|||+.++++.|+.
T Consensus       249 -~~~~~~~~-~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~  298 (307)
T cd05098         249 -EELFKLLK-EGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  298 (307)
T ss_pred             -HHHHHHHH-cCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence             11111111 111         011122334688999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8e-38  Score=316.84  Aligned_cols=255  Identities=25%  Similarity=0.419  Sum_probs=202.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCc----EEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      .+|...+.||+|+||.||+|.+. +|.    .||+|.++..........+.+|+.++..+.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            56788899999999999999853 444    4899998765544456678999999999999999999999875 45789


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ++||+++|+|.++++..   ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++..
T Consensus        86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999998753   34689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||+.....    ....++.    .+... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~----~~~~~-  230 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----EIPDLLE----KGERL-  230 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH----CCCcC-
Confidence            5332221 112235678999999988899999999999999999998 88888632210    0111111    11100 


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                              ..+...+.++.+++.+||..||++||++.++++.|+..
T Consensus       231 --------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         231 --------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             --------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                    11122346789999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=337.64  Aligned_cols=255  Identities=22%  Similarity=0.242  Sum_probs=205.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCC-cEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeee-ec------CC
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDG-ALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFC-ST------EN  371 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~-~~------~~  371 (623)
                      .++.+.++|.+|||+.||.|....+ ..||+|++-.. ....-....+|+++|++++ |+|||.+++.. ..      .-
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            4566788999999999999998765 99999998654 3344556899999999997 99999999932 11      13


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL  451 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  451 (623)
                      +.+|.||||++|.|-++|..+...  .|++.++++|+.|+++|+++||.. +|+|||||||.+||||+.+++.||||||.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            578999999999999999877654  399999999999999999999996 77899999999999999999999999999


Q ss_pred             ccccCCCC-Ccee-------ecccccccccccccc---ccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH
Q 006968          452 AKLLDHRD-SHVT-------TAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD  520 (623)
Q Consensus       452 a~~~~~~~-~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  520 (623)
                      |.-.-... ....       ....-|+.|.|||.+   .+...++|+|||||||+||-|+....||+...          
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----------  262 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----------  262 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence            86432221 1110       112368999999988   45678999999999999999999999997321          


Q ss_pred             HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                                ...+++..+.-.-.+.+...+.+||..||++||.+||++-||++.+-..
T Consensus       263 ----------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  263 ----------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             ----------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                      1223333333222356778999999999999999999999999987764

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.7e-38  Score=320.68  Aligned_cols=259  Identities=27%  Similarity=0.392  Sum_probs=205.7

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC--------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecC
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE  370 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~  370 (623)
                      ..+|.+.+.||+|+||.||+|...        ++..||+|.++..........+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            356788899999999999999741        34579999987544344456789999999999 899999999999999


Q ss_pred             CceEEEEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL  438 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll  438 (623)
                      +..++||||+++|+|.+++.....            ....+++.++..++.|+++||+|||++   +++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            999999999999999999976421            123588999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCccccccccc
Q 006968          439 DEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRG  516 (623)
Q Consensus       439 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~  516 (623)
                      +.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..|+....      
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------  244 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------  244 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence            999999999999998764432221 222345678999999988889999999999999999998 777775321      


Q ss_pred             chHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          517 VMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       ..++..........          ..+...+.++.+++.+||..+|++|||+.++++.|+.
T Consensus       245 -~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         245 -VEELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             -HHHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence             11222222111110          1112234778999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-37  Score=317.50  Aligned_cols=265  Identities=22%  Similarity=0.331  Sum_probs=203.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-----------------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeee
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-----------------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL  363 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l  363 (623)
                      ++|++.+.||+|+||.||++...                 ++..||+|.++.........+|.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56888999999999999998532                 2446999999765434445679999999999999999999


Q ss_pred             eeeeecCCceEEEEecccCCChhhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 006968          364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHG-------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANI  436 (623)
Q Consensus       364 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI  436 (623)
                      ++++...+..++||||+++|+|.+++......       ...+++.++..++.|++.||+|||+.   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999999764321       23478899999999999999999999   999999999999


Q ss_pred             EECCCCcEEEeecccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh--CCCCCCcccccc
Q 006968          437 LLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALDFGRAAN  513 (623)
Q Consensus       437 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~~  513 (623)
                      +++.++.++|+|||+++.+....... .....++..|+|||...++.++.++|||||||++|||++  |..|+.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999998654332211 122234678999999888889999999999999999998  667775322111


Q ss_pred             cccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          514 QRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                          ..................      ..+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus       242 ----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 ----VIENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ----HHHHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                111111111101000000      0112234678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-37  Score=313.49  Aligned_cols=255  Identities=27%  Similarity=0.456  Sum_probs=205.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CC---cEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DG---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .+|...+.||+|+||.||+|... ++   ..+|+|.++..........+..|+++++.++|||++++.+++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46777899999999999999875 23   379999987554344456789999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++++|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++....
T Consensus        85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          85 TEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999998753   34689999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCCceee--ccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          457 HRDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       457 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ........  ....+..|+|||++.+..++.++||||||+++|||++ |+.||.....       .++.+........  
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~~~i~~~~~~--  229 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDGFRL--  229 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhcCCCC--
Confidence            33222111  1223457999999988889999999999999999998 9999853221       1222222211110  


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                              ......+.++.+++.+|+..+|++||++.+|++.|++
T Consensus       230 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         230 --------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                    1112234678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.1e-37  Score=313.59  Aligned_cols=255  Identities=26%  Similarity=0.400  Sum_probs=204.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC----CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .+|.+.+.||+|+||.||+|...    .+..+|+|.++..........|..|+.++.+++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999863    23479999987644334456789999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++++|.+++...   ...+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++|||++....
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999999754   24589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceee--ccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          457 HRDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       457 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ........  ...++..|+|||.+.+..++.++||||||+++||+++ |+.||......       +..........   
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~~~---  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------DVIKAIEEGYR---  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------HHHHHHhCCCc---
Confidence            43322221  1223568999999998889999999999999999887 99998632211       11111111100   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         .    ..+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus       228 ---~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 ---L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             ---C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence               0    1112234678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.7e-38  Score=325.75  Aligned_cols=244  Identities=23%  Similarity=0.273  Sum_probs=196.5

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG  383 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  383 (623)
                      +.||+|+||.||++... +|..||+|.++.....  .....+..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 6899999999754322  22346788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      +|..++...    ..+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~  152 (325)
T cd05594          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT  152 (325)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence            998888653    468999999999999999999997 6   99999999999999999999999999987533221 12


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......       ........ ..      .    .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~-~~------~----~  214 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILM-EE------I----R  214 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhc-CC------C----C
Confidence            23456999999999999999999999999999999999999999632211       11111110 10      0    1


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKML  576 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L  576 (623)
                      ++.....++.+++.+||+.||++|+     ++.+++++-
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  253 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK  253 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence            1122346788999999999999996     899998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=311.88  Aligned_cols=255  Identities=28%  Similarity=0.428  Sum_probs=207.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .++|.+.+.||+|+||.||+|..+++..||||.++...  ....++.+|+.++++++|+||+++++++......++||||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            46788899999999999999998888899999987543  2346789999999999999999999999988999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++....  ...+++..+..++.|++.|++|||++   +++|+||||+||++++++.+|++|||.+..+....
T Consensus        83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999999997642  34689999999999999999999999   99999999999999999999999999998765422


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ........++..|+|||.+.+..++.++||||||+++||+++ |+.||.....       ..........  .       
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~~~~~~~~--~-------  221 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------REVLEQVERG--Y-------  221 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcC--C-------
Confidence            222222235678999999998889999999999999999999 9989853221       1111111110  0       


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       ....+...+.++.+++.+|+..+|++||+++++.+.|++
T Consensus       222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 -RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             001111224678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5e-38  Score=324.66  Aligned_cols=243  Identities=27%  Similarity=0.366  Sum_probs=194.6

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|... +++.||||+++....  ......+..|..++... .||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 588999999975432  22334577888888766 699999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~  152 (320)
T cd05590          81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT  152 (320)
T ss_pred             chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence            9999888753    3589999999999999999999999   99999999999999999999999999987543221 22


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....       ......... +..          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~-~~~----------~  214 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILN-DEV----------V  214 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhc-CCC----------C
Confidence            3345699999999999988999999999999999999999999964321       111111111 110          1


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKM------SEVLKM  575 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~~  575 (623)
                      ++.....++.+++.+|++.||++||++      ++++++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            112234678999999999999999998      666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4e-38  Score=338.44  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=196.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC--------
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--------  370 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------  370 (623)
                      ..+|.+.+.||+|+||.||+|... +++.||||++....     ....+|+.+++.++||||+++++++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            457999999999999999999875 68899999885422     2345799999999999999999876432        


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-cEEEeec
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDF  449 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Df  449 (623)
                      ...++||||++ ++|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            13568999997 478887765544556799999999999999999999999   999999999999999664 6999999


Q ss_pred             ccccccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHH-------
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDW-------  521 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-------  521 (623)
                      |+++.+.....  .....||+.|+|||++.+ ..++.++|||||||++|||++|++||...............       
T Consensus       216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            99987643322  223458999999998865 46899999999999999999999999643321111000000       


Q ss_pred             -HHHHhh---cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          522 -VKKLHQ---EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       522 -~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                       ......   .-.+.......+...++...+.++.+++.+||..||.+|||+.|++++-
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp  352 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP  352 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence             000000   0000001111111112223346789999999999999999999998753

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-37  Score=312.22  Aligned_cols=256  Identities=28%  Similarity=0.386  Sum_probs=201.2

Q ss_pred             CCcCCceeccCCeEEEEEEeCC----CcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCc-----
Q 006968          303 FSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENE-----  372 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----  372 (623)
                      |.+.+.||+|+||.||+|....    +..||+|+++..... .....+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4677899999999999998642    367999998754322 223578999999999999999999998866544     


Q ss_pred             -eEEEEecccCCChhhhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          373 -RLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       373 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                       .++++||+++|+|..++.....  ....+++.....++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             7999999999999999865422  234689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhh
Q 006968          450 GLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       450 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      |+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....       .+.......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-------~~~~~~~~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------HEIYDYLRH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHc
Confidence            9998664432221 122235678999999988889999999999999999999 8888753221       111111111


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       +..         ...+...+.++.+++.+||+.||++|||+.++++.|++
T Consensus       231 -~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         231 -GNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             -CCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence             110         01122345689999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.2e-37  Score=325.65  Aligned_cols=201  Identities=22%  Similarity=0.326  Sum_probs=174.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|+..+.||+|+||+||+|... +++.||||+++.....  .....+..|+.++.+++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999865 5899999999754321  22346788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            999999999998753    4689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCC----------------------------------ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCC
Q 006968          458 RDS----------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ  503 (623)
Q Consensus       458 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~  503 (623)
                      ...                                  .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0012346999999999999999999999999999999999999


Q ss_pred             CCCCc
Q 006968          504 RALDF  508 (623)
Q Consensus       504 ~p~~~  508 (623)
                      .||..
T Consensus       234 ~Pf~~  238 (363)
T cd05628         234 PPFCS  238 (363)
T ss_pred             CCCCC
Confidence            99964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-37  Score=313.22  Aligned_cols=256  Identities=27%  Similarity=0.366  Sum_probs=197.9

Q ss_pred             CCcCCceeccCCeEEEEEEeCC-Cc--EEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecC------Cc
Q 006968          303 FSAKNILGRGGFGIVYKGCFSD-GA--LVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTE------NE  372 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~  372 (623)
                      |.+.+.||+|+||.||+|...+ +.  .||+|.++..... .....+..|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999998754 32  6999998754322 2345688999999999999999999987432      24


Q ss_pred             eEEEEecccCCChhhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          373 RLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      .++++||+++|+|.+++....  .....+++.....++.|++.||+|||++   +|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999875322  1234589999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCCcee-eccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhc
Q 006968          451 LAKLLDHRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       451 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      +++.......... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....       ........ .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~-~  229 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLR-Q  229 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHH-c
Confidence            9987644322111 22235678999999998899999999999999999999 7888853211       11111111 1


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      +...         ..+...+..+.+++.+||..+|++|||+.++++.|++
T Consensus       230 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         230 GNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            1110         0111234678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-37  Score=323.81  Aligned_cols=257  Identities=19%  Similarity=0.242  Sum_probs=200.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||++... +++.||+|.+++...  ......+.+|..++..+.|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999875 578999999865321  122345788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999763   23688999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeecccccccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ..........||+.|+|||++.+     ..++.++|||||||++|||++|+.||.....       .+............
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~  227 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHEERF  227 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------HHHHHHHHcCCCcc
Confidence            43333334569999999999875     4678899999999999999999999963321       11111111111000


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLH--RPKMSEVLKML  576 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~L  576 (623)
                           .+... ....+.++.+++.+|+..++++  |+++.+++++-
T Consensus       228 -----~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~  267 (331)
T cd05624         228 -----QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA  267 (331)
T ss_pred             -----cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence                 00100 0122467888999998866554  56888888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7e-38  Score=324.16  Aligned_cols=238  Identities=25%  Similarity=0.285  Sum_probs=189.1

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHH-HHhhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVE-TISLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||+||+|... +|+.||+|++......  .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 6899999999754321  12234555554 45789999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (323)
T cd05575          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT  152 (323)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence            999988865    34688999999999999999999999   99999999999999999999999999987532221 22


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .+....... +..      .+   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~-~~~------~~---  215 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILN-KPL------RL---  215 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHc-CCC------CC---
Confidence            3345689999999999999999999999999999999999999964221       111111111 100      11   


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKMS  570 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~  570 (623)
                       ....+.++.+++.+|++.||++||++.
T Consensus       216 -~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 -KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             112246789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.8e-38  Score=324.47  Aligned_cols=244  Identities=25%  Similarity=0.336  Sum_probs=196.0

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|... +++.||+|+++....  ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999875 578999999976432  22334577888888765 799999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~  152 (321)
T cd05591          81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT  152 (321)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence            9999888653    3689999999999999999999999   99999999999999999999999999987543222 22


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......       +......... .          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~~~~~i~~~~-~----------~  214 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-------DLFESILHDD-V----------L  214 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC-C----------C
Confidence            33456899999999999889999999999999999999999999743221       1111111111 0          0


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHHh
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRP-------KMSEVLKML  576 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RP-------s~~evl~~L  576 (623)
                      ++.....++.+++.+||..||++||       ++.+++++-
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp  255 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP  255 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence            1112236788999999999999999       888888763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-37  Score=329.29  Aligned_cols=265  Identities=22%  Similarity=0.280  Sum_probs=199.4

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCC-----ceE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-----ERL  374 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~  374 (623)
                      +|+..+.||+|+||.||+|... +|+.||||++..... ......+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999864 789999999865321 223456889999999999999999999998776     789


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +|+||+. ++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999996 577776653    34689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH---------H---
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD---------W---  521 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~---------~---  521 (623)
                      .............++..|+|||.+.+. .++.++||||+||++|||++|+.||...........+.+         +   
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            544333333344578999999998764 478999999999999999999999975432211110000         0   


Q ss_pred             ---HHHHh-hcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          522 ---VKKLH-QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       522 ---~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                         ..... ........... . .........++.+++.+|+..||++|||+.|++++-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPV-L-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHH-h-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence               00000 00000000000 0 001112246789999999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.1e-37  Score=309.35  Aligned_cols=251  Identities=24%  Similarity=0.376  Sum_probs=205.4

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|...+.||+|+||.||+|... +++.|++|.+..... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999875 689999999865432 23455789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.++++...  ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            99999999997642  34689999999999999999999998   99999999999999999999999999998765432


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .. .....|++.|+|||+..+..++.++||||||+++|||++|+.||......       ....... .+..        
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~-~~~~--------  218 (256)
T cd08529         156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKII-RGVF--------  218 (256)
T ss_pred             ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH-cCCC--------
Confidence            22 23345889999999999988999999999999999999999998643211       1111111 1111        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ...+......+.+++.+||+.+|++||++.+++++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 -PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             11122344679999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.8e-37  Score=321.25  Aligned_cols=248  Identities=24%  Similarity=0.314  Sum_probs=197.2

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCC-ceeeeeeeeecCCceEEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHR-NLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~  377 (623)
                      +|.+.+.||+|+||.||+|... +++.||||+++....  ......+..|.+++..+.|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999875 578999999975432  22344678899999988765 5888999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            999999999888653    3588999999999999999999999   999999999999999999999999999874322


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .. .......||+.|+|||++.+..++.++||||+||++|||+||+.||......       +....... ..       
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~-~~-------  217 (324)
T cd05587         154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQSIME-HN-------  217 (324)
T ss_pred             CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHc-CC-------
Confidence            21 2233456999999999999999999999999999999999999999643221       11111111 10       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKM-----SEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  575 (623)
                         ..++.....++.+++.+||..+|.+|++.     .+++++
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 ---VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               11122234678899999999999999986     566554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=309.98  Aligned_cols=248  Identities=29%  Similarity=0.455  Sum_probs=198.8

Q ss_pred             CceeccCCeEEEEEEeCC----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|.+..    +..+|+|.++.........++..|+.+++.+.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999997632    36899999986654445567999999999999999999999876 4568999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|.+++...    ..+++..+..++.|++.||+|||..   +++||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999763    2689999999999999999999999   99999999999999999999999999998765433322


Q ss_pred             ee--ccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          463 TT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       463 ~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      ..  ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+..........         
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-------~~~~~~~~~~~~---------  216 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-------AEVIAMLESGER---------  216 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcCCc---------
Confidence            11  1223568999999998899999999999999999998 9999864321       111111111110         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                       ...+...+..+.+++.+||..+|++||++.++++.|++.
T Consensus       217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             011222346789999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.4e-37  Score=320.00  Aligned_cols=268  Identities=21%  Similarity=0.301  Sum_probs=201.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|.+.+.||+|+||.||+|... +++.||+|.++..........+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888899999999999999875 68899999997655444445688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            975 888877653   34588999999999999999999999   99999999999999999999999999997644322


Q ss_pred             Cceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH--------HHHHHhhcCc
Q 006968          460 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--------WVKKLHQEGK  530 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~  530 (623)
                      . ......++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+.......        +.........
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            2 1223457899999998865 4678999999999999999999999964332111100000        0000000000


Q ss_pred             cccccccccCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          531 LSQMVDKDLKG----NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       531 ~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ....-.+....    ........++.+++.+|+..||.+|||+.|++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  287 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA  287 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence            00000000000    00011245688999999999999999999998854

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.8e-37  Score=310.00  Aligned_cols=251  Identities=25%  Similarity=0.456  Sum_probs=202.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      .+|.+.+.||+|+||.||+|.+.++..+|+|.++...  ....+|.+|+++++++.|||++++++++......++|+||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            4577789999999999999998778899999986543  23457899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            999999998753   23588999999999999999999999   999999999999999999999999999876543322


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .......++.+|+|||.+.+..++.++||||||+++|||++ |+.||.....       ...........   ....+  
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~---~~~~~--  223 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETINAGF---RLYKP--  223 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHhCCC---CCCCC--
Confidence            22222335678999999988889999999999999999998 8988863221       11111111100   11111  


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                           ...+..+.+++.+||..+|++|||+.+++++|
T Consensus       224 -----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         224 -----RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                 11246799999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-37  Score=311.96  Aligned_cols=250  Identities=28%  Similarity=0.418  Sum_probs=196.2

Q ss_pred             CceeccCCeEEEEEEeCC-Cc--EEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFSD-GA--LVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|...+ +.  .+|+|.++..........+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999998753 43  57889887544344456789999999999 799999999999999999999999999


Q ss_pred             CChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          383 GSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       383 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      |+|.+++.....            ....+++.++..++.|++.||+|||+.   +++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999975321            123588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcC
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      ++.......  .......+..|+|||++....++.++||||||+++|||++ |+.||.....       .+.........
T Consensus       158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~  228 (270)
T cd05047         158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYEKLPQGY  228 (270)
T ss_pred             Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HHHHHHHhCCC
Confidence            986322111  1111224567999999988889999999999999999997 9999853211       11111111110


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .          ...+.....++.+++.+|+..+|.+|||+.++++.|++
T Consensus       229 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         229 R----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             C----------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            0          01111234678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=308.68  Aligned_cols=249  Identities=32%  Similarity=0.449  Sum_probs=204.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|.+.+.||+|+||.||+|.. .|+.||+|.++....  ...++..|+.+++.++|+||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            5678889999999999999987 488999999976543  4567899999999999999999999999899999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||.++.......
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            9999999997642  23689999999999999999999999   999999999999999999999999999986632211


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                          ...++..|+|||.+....++.++||||||+++||+++ |+.||......       + +......+         .
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~-~~~~~~~~---------~  216 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------D-VVPHVEKG---------Y  216 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------H-HHHHHhcC---------C
Confidence                2235678999999988889999999999999999997 98888532211       1 11111111         0


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....+...+.++.+++.+||..+|++|||+.+++++|+.
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            111122234778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.4e-37  Score=310.78  Aligned_cols=254  Identities=24%  Similarity=0.298  Sum_probs=201.3

Q ss_pred             CCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      +|+..++||+|+||.||+|.. .++..||+|.+...........+..|+++++++.||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577889999999999999986 4688999999875443344557899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|..+.        .+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++......  
T Consensus        82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            999986542        367889999999999999999999   9999999999999999999999999999765432  


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                       ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..............+...... ...     +.+.
T Consensus       149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~  221 (279)
T cd06619         149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-EDP-----PVLP  221 (279)
T ss_pred             -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-cCC-----CCCC
Confidence             123346899999999999889999999999999999999999998643221111111111111110 100     0110


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         ......++.+++.+|+..+|++||++.+++++-.-
T Consensus       222 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~  256 (279)
T cd06619         222 ---VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI  256 (279)
T ss_pred             ---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence               11123578999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.6e-37  Score=316.20  Aligned_cols=259  Identities=24%  Similarity=0.386  Sum_probs=205.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      .++|...+.||+|+||.||+|...      ++..||+|.++.........+|.+|+.+++++.||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            356888999999999999999853      46789999987654444456799999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 006968          374 LLVYPYMPNGSVASRLRDHIH------------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN  435 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N  435 (623)
                      ++|+||+++|+|.+++.....                  ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            999999999999999975321                  123478999999999999999999999   99999999999


Q ss_pred             eEECCCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccc
Q 006968          436 ILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAAN  513 (623)
Q Consensus       436 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~  513 (623)
                      |+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....  
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--  238 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--  238 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            99999999999999998765432211 1122235678999999988899999999999999999998 7778753211  


Q ss_pred             cccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          514 QRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                           .++..... .+....         .+...+.++.+++.+|++.+|++|||+.|+++.|+.
T Consensus       239 -----~~~~~~~~-~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 -----EEVIYYVR-DGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -----HHHHHHHh-cCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                 12222221 111110         112234678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.4e-37  Score=313.15  Aligned_cols=254  Identities=25%  Similarity=0.400  Sum_probs=202.5

Q ss_pred             CCCcCCceeccCCeEEEEEEeCC-C---cEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSD-G---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .|.+.+.||+|+||.||+|.... +   ..||||.++.........+|..|+.+++.++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778999999999999998753 3   3699999876543444567999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...   ...+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+|++|||++.....
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999998754   34689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCcee--eccc--cccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          458 RDSHVT--TAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       458 ~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ......  ....  .+..|+|||.+.+..++.++||||||+++||+++ |+.||......    ....++   .....  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~i---~~~~~--  229 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINAI---EQDYR--  229 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHHH---HcCCc--
Confidence            322111  1111  2457999999998899999999999999999886 99998632211    111111   11100  


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                              ...+...+..+.+++.+||..+|.+||++.+|+..|+.
T Consensus       230 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         230 --------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                    01112334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-37  Score=324.30  Aligned_cols=259  Identities=26%  Similarity=0.371  Sum_probs=200.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEe------CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecC-Cc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE-NE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~~  372 (623)
                      ++|.+.+.||+|+||.||+|..      .+++.||||+++..........+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5788999999999999999973      347899999997654333445688999999999 689999999988654 45


Q ss_pred             eEEEEecccCCChhhhhhhccC----------------------------------------------------------
Q 006968          373 RLLVYPYMPNGSVASRLRDHIH----------------------------------------------------------  394 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  394 (623)
                      .++||||+++|+|.++++....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999999865311                                                          


Q ss_pred             -----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc-eeecccc
Q 006968          395 -----GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRG  468 (623)
Q Consensus       395 -----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g  468 (623)
                           ....+++.++.+++.|+++||+|||++   +|+||||||+||+++.++.+||+|||++......... ......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                 012478899999999999999999999   9999999999999999999999999999765332211 1122335


Q ss_pred             ccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHH
Q 006968          469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE  547 (623)
Q Consensus       469 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (623)
                      +..|+|||.+.+..++.++||||||+++|||++ |..|+......      ...... ...+...         ..+...
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~-~~~~~~~---------~~~~~~  307 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRR-LKEGTRM---------RAPDYT  307 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHH-HhccCCC---------CCCCCC
Confidence            678999999988899999999999999999997 88887532211      011111 1111100         001112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          548 LEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       548 ~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ..++.+++..||..+|++|||+.+|+++|+.
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            3568999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-38  Score=331.67  Aligned_cols=255  Identities=18%  Similarity=0.219  Sum_probs=197.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||++... +|+.||||++.....  ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888999999999999999864 689999999865432  122346788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999999999998753    4688999999999999999999999   999999999999999999999999999864321


Q ss_pred             CCCc----------------------------------------------eeeccccccccccccccccCCCCCccchhh
Q 006968          458 RDSH----------------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFG  491 (623)
Q Consensus       458 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S  491 (623)
                      ....                                              ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            1000                                              001245999999999999989999999999


Q ss_pred             HHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCC---CC
Q 006968          492 FGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHR---PK  568 (623)
Q Consensus       492 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps  568 (623)
                      |||++|||++|+.||.......       .............     +..  ......++.+++.+|+. +|.+|   ++
T Consensus       234 lGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~-----~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHE-------TYRKIINWRETLY-----FPD--DIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHH-------HHHHHHccCCccC-----CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999999996432211       1111111000000     000  01123568899999997 66664   69


Q ss_pred             HHHHHHHhh
Q 006968          569 MSEVLKMLE  577 (623)
Q Consensus       569 ~~evl~~L~  577 (623)
                      +.|++++-.
T Consensus       299 ~~~~l~hp~  307 (377)
T cd05629         299 AHEIKSHPF  307 (377)
T ss_pred             HHHHhcCCC
Confidence            999988643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.7e-37  Score=320.00  Aligned_cols=258  Identities=29%  Similarity=0.401  Sum_probs=203.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC--------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCC
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN  371 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  371 (623)
                      .+|.+.+.||+|+||.||+|...        .+..||+|.++..........+..|++++.++ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            56788899999999999999742        24579999987654334455788999999999 6999999999999888


Q ss_pred             ceEEEEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD  439 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~  439 (623)
                      ..++||||+++|+|.+++.....            ....+++.++.+++.|++.||.|||++   +++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            99999999999999999976421            124589999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccc
Q 006968          440 EDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGV  517 (623)
Q Consensus       440 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~  517 (623)
                      .++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....      
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------  242 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------  242 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH------
Confidence            99999999999998654322211 112224567999999988889999999999999999999 8888753221      


Q ss_pred             hHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       .+...... .+...         ..+...+.++.+++.+|+..+|++|||+.++++.|+.
T Consensus       243 -~~~~~~~~-~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~  292 (314)
T cd05099         243 -EELFKLLR-EGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK  292 (314)
T ss_pred             -HHHHHHHH-cCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence             11111111 11100         1122234678899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.5e-37  Score=312.97  Aligned_cols=263  Identities=27%  Similarity=0.397  Sum_probs=200.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-----CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec--CCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~  373 (623)
                      ..|.+.+.||+|+||.||++..+     ++..||+|.++... ......|.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            46778899999999999999742     57899999986543 2334578999999999999999999998754  3468


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++|+||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence            8999999999999998753   23589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCcee--eccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccccc-------c-cchHHHHH
Q 006968          454 LLDHRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ-------R-GVMLDWVK  523 (623)
Q Consensus       454 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-------~-~~~~~~~~  523 (623)
                      ..........  ....++..|+|||.+.+..++.++||||||+++|||++|..++........       . ......+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            7644322111  112234569999999888899999999999999999998876532211000       0 00000000


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ...         ............+.++.+++.+||..+|++|||+.+|++.|+..
T Consensus       237 ~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELL---------KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHH---------hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            100         00001011222346799999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-37  Score=320.35  Aligned_cols=248  Identities=23%  Similarity=0.306  Sum_probs=197.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      +|.+.+.||+|+||.||+|... ++..||||+++.....  .....+..|..++... .|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999875 5789999999764322  2233467788888776 5899999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            999999999888653    3588999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......       ........ ..       
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~~~i~~-~~-------  217 (323)
T cd05616         154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIME-HN-------  217 (323)
T ss_pred             CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHHHHHHh-CC-------
Confidence            21 2233456999999999999999999999999999999999999999743221       11111111 11       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKM-----SEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  575 (623)
                         ..++.....++.+++.+|++.+|.+|++.     .++.++
T Consensus       218 ---~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         218 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence               01222234678999999999999999984     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-38  Score=328.68  Aligned_cols=252  Identities=27%  Similarity=0.452  Sum_probs=211.6

Q ss_pred             CcCCceeccCCeEEEEEEeC-C----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          304 SAKNILGRGGFGIVYKGCFS-D----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       304 ~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ...++||+|+||+||||.+- +    +-+||+|++..........++++|+-.|.++.|||+++|+|+|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34578999999999999873 3    34799999988887778889999999999999999999999997765 889999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      ||+.|+|.+|++.+   +..+.-...+.|..|||+||.|||++   +++||||..+|||+..-..+||.|||+++.+.+.
T Consensus       778 ~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999986   45788899999999999999999999   9999999999999999999999999999988766


Q ss_pred             CCceeec-cccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          459 DSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       459 ~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ....... ..-.+.|||-|.+....++.++|||||||++||++| |..|++....        +         ++.+.+.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------~---------eI~dlle  914 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------E---------EIPDLLE  914 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------H---------HhhHHHh
Confidence            5444332 234578999999999999999999999999999998 7888764321        1         1222222


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ..-+-.-++.+..++..++.+||..|++.||+++++...+...
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            2222233566778999999999999999999999998877663

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-37  Score=306.61  Aligned_cols=248  Identities=27%  Similarity=0.450  Sum_probs=200.4

Q ss_pred             CceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCChh
Q 006968          307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVA  386 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~  386 (623)
                      ++||+|+||.||++...+++.||+|.++..........+..|+++++++.|+||+++++++...+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999987799999999876544434567999999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCcee-ec
Q 006968          387 SRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-TA  465 (623)
Q Consensus       387 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~  465 (623)
                      +++...   ...+++.....++.+++.|++|||++   +++||||+|+||+++.++.++|+|||++........... ..
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            998753   23588999999999999999999999   999999999999999999999999999986543222111 11


Q ss_pred             cccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCC
Q 006968          466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD  544 (623)
Q Consensus       466 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  544 (623)
                      ..++..|+|||.+.+..++.++||||||+++|||+| |..||......       ........ .         .....+
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~-~---------~~~~~~  217 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIES-G---------YRMPAP  217 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhc-C---------CCCCCC
Confidence            224567999999988899999999999999999999 78787532211       11111110 0         011112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       545 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ...+.++.+++.+|+..+|++|||+.|+++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            234568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-37  Score=308.36  Aligned_cols=251  Identities=32%  Similarity=0.480  Sum_probs=205.2

Q ss_pred             CceeccCCeEEEEEEeCC----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|...+    +..||+|.++..........+.+|++.+..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999754    8899999998765444466899999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          383 GSVASRLRDHIHG-----RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       383 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ++|.+++......     ...+++..+..++.|++.||+|||++   +++||||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875221     35799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          458 RDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       458 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ... .......++..|+|||.+....++.++||||+|+++|||++ |..||.....       .+....... +.     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~-~~-----  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLRK-GY-----  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHc-CC-----
Confidence            331 12233457889999999988889999999999999999999 5888864321       111111111 10     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                          ....+...+.++.+++.+|+..+|++|||+.|++++|+
T Consensus       225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                11112233578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.3e-37  Score=327.95  Aligned_cols=252  Identities=22%  Similarity=0.249  Sum_probs=195.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .|...+.||+|+||.||+|... +++.||+|++.....  ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999864 688999999975432  1223468899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            99999999998753    3588999999999999999999999   9999999999999999999999999997533110


Q ss_pred             C----------------------------------------------CceeeccccccccccccccccCCCCCccchhhH
Q 006968          459 D----------------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF  492 (623)
Q Consensus       459 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~Sl  492 (623)
                      .                                              ........||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              000123468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---H
Q 006968          493 GILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK---M  569 (623)
Q Consensus       493 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~  569 (623)
                      ||++|||++|+.||........       ........       .............+..+++.+|+ .+|++|++   +
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~-------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLET-------QMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHH-------HHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999999974332111       11111000       00000001112355677777765 49999987   8


Q ss_pred             HHHHHH
Q 006968          570 SEVLKM  575 (623)
Q Consensus       570 ~evl~~  575 (623)
                      .+++++
T Consensus       300 ~ei~~h  305 (382)
T cd05625         300 DEIKAH  305 (382)
T ss_pred             HHHhcC
Confidence            888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.4e-38  Score=323.28  Aligned_cols=239  Identities=26%  Similarity=0.338  Sum_probs=193.6

Q ss_pred             CceeccCCeEEEEEEe----CCCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEeccc
Q 006968          307 NILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP  381 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  381 (623)
                      +.||+|+||.||++..    .+|+.||+|+++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    35889999999754322 233457889999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      +|+|.+++...    ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++....... .
T Consensus        82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~  153 (318)
T cd05582          82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K  153 (318)
T ss_pred             CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence            99999988652    4689999999999999999999999   99999999999999999999999999997654332 2


Q ss_pred             eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCC
Q 006968          462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG  541 (623)
Q Consensus       462 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  541 (623)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......       ........ ...          
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~~~i~~-~~~----------  215 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETMTMILK-AKL----------  215 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-------HHHHHHHc-CCC----------
Confidence            233456999999999999888999999999999999999999999643211       11111111 110          


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006968          542 NFDRIELEEMVQVALLCTQFNPLHRPKMSE  571 (623)
Q Consensus       542 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e  571 (623)
                      .++......+.+++.+||+.||++||++.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            112223467889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.2e-37  Score=313.32  Aligned_cols=249  Identities=24%  Similarity=0.301  Sum_probs=196.1

Q ss_pred             eeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCCh
Q 006968          309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV  385 (623)
Q Consensus       309 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  385 (623)
                      ||+|+||.||++... +|+.||+|.+......  .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999875 5899999998653322  2234567799999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeec
Q 006968          386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA  465 (623)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  465 (623)
                      .+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~  153 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ  153 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence            9888653  234589999999999999999999999   99999999999999999999999999998664322  2233


Q ss_pred             cccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCH
Q 006968          466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDR  545 (623)
Q Consensus       466 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (623)
                      ..|+..|+|||++.+..++.++||||+||++|||++|+.||........   .....+.... ..        ... ...
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~-~~--------~~~-~~~  220 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---KEELKRRTLE-DE--------VKF-EHQ  220 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---HHHHHHHhhc-cc--------ccc-ccc
Confidence            4589999999999988899999999999999999999999863221100   1111111110 00        000 001


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          546 IELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       546 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ....++.+++.+||+.||++||++.|+++.+.
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            23467899999999999999999988765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.4e-37  Score=309.22  Aligned_cols=254  Identities=24%  Similarity=0.286  Sum_probs=200.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            5688899999999999999996 468899999986543 22344678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999998864    24689999999999999999999999   99999999999999999999999999998664322


Q ss_pred             Cceeeccccccccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      . ......|+..|+|||.+.   ...++.++||||||+++|||++|+.|+..........       ... ..   ....
T Consensus       161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~-~~---~~~~  228 (267)
T cd06646         161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMS-KS---NFQP  228 (267)
T ss_pred             c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eee-cC---CCCC
Confidence            1 122345889999999884   3457889999999999999999999985322111000       000 00   0000


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      +...  .....+..+.+++.+||..+|++|||+.+++++|
T Consensus       229 ~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         229 PKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1110  0112346789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.4e-38  Score=330.20  Aligned_cols=255  Identities=22%  Similarity=0.239  Sum_probs=197.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|... +++.||||++.....  ......+.+|++++++++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888999999999999999865 589999999865332  122346889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            999999999998753    3588899999999999999999999   999999999999999999999999999753310


Q ss_pred             CC------------------------------------------CceeeccccccccccccccccCCCCCccchhhHHHH
Q 006968          458 RD------------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL  495 (623)
Q Consensus       458 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvi  495 (623)
                      ..                                          ........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                          000113469999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHH
Q 006968          496 LLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRP---KMSEV  572 (623)
Q Consensus       496 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP---s~~ev  572 (623)
                      +|||++|+.||.......       ...........   ......    .....++.+++.+|+ .+|.+|+   ++.++
T Consensus       234 lyell~G~~Pf~~~~~~~-------~~~~i~~~~~~---~~~~~~----~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         234 LYEMLVGQPPFLADTPAE-------TQLKVINWETT---LHIPSQ----AKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             eeehhhCCCCCCCCCHHH-------HHHHHhccCcc---ccCCCC----CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            999999999997433211       11111100000   000000    112345677777766 4999999   89999


Q ss_pred             HHHhh
Q 006968          573 LKMLE  577 (623)
Q Consensus       573 l~~L~  577 (623)
                      +++-.
T Consensus       299 l~h~~  303 (376)
T cd05598         299 KAHPF  303 (376)
T ss_pred             hCCCC
Confidence            88743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.6e-37  Score=308.65  Aligned_cols=254  Identities=23%  Similarity=0.398  Sum_probs=204.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .++|.+.+.||+|+||.||+|...++..+|+|.++...  .....|.+|+++++.++|+||+++.+++.. ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            35788899999999999999998788889999886532  234578999999999999999999999877 778999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||.+.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          82 MAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            99999999997632  34588999999999999999999998   99999999999999999999999999998665433


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ........++..|+|||++....++.++|+||||+++|++++ |+.||......    ....+.   . .+.        
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~---~-~~~--------  220 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRAL---E-RGY--------  220 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHHHH---h-CCC--------
Confidence            222223345678999999998889999999999999999999 88888632211    011111   1 110        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       ........+.++.+++.+|+..+|++||++.++.+.|++
T Consensus       221 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 -RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             001112234678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.7e-37  Score=316.81  Aligned_cols=243  Identities=25%  Similarity=0.336  Sum_probs=193.0

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhh-cCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|... +|+.||+|.++....  ......+..|..++.. ..||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 588999999976432  2233456777777765 4899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05620          81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence            9999888653    4688999999999999999999999   99999999999999999999999999987432222 22


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......       ........ .      .+.    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~-~------~~~----  214 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRV-D------TPH----  214 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh-C------CCC----
Confidence            34456999999999999999999999999999999999999999643211       11111111 0      011    


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKMS-EVLKM  575 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~~  575 (623)
                      ++.....++.+++.+||..||++||++. ++.++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            1112336788999999999999999984 66544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.8e-37  Score=308.28  Aligned_cols=255  Identities=26%  Similarity=0.372  Sum_probs=194.1

Q ss_pred             CceeccCCeEEEEEEeCC---CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCC
Q 006968          307 NILGRGGFGIVYKGCFSD---GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG  383 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  383 (623)
                      +.||+|+||.||+|...+   +..+|+|.++..........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998643   46799999876544444557899999999999999999999999989999999999999


Q ss_pred             ChhhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          384 SVASRLRDHIH-GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       384 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      +|.++++.... .....++..+..++.|++.|++|||+.   +++||||||+||+++.++++||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999976432 233567888899999999999999999   99999999999999999999999999997543322211


Q ss_pred             -eeccccccccccccccccC-------CCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          463 -TTAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       463 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.||........       ...... +....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~-~~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-------LTYTVR-EQQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-------HHHHhh-cccCC
Confidence             1223467889999998642       35789999999999999996 9999864322110       000011 11111


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ..++.+.    ......+.+++..|+ .+|++|||+.+|+..|+
T Consensus       230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1112211    112356788999999 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-37  Score=316.82  Aligned_cols=258  Identities=20%  Similarity=0.244  Sum_probs=199.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||++... +++.||+|++++...  ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36888999999999999999975 589999999975321  122345888999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999999753   34588999999999999999999999   999999999999999999999999999976654


Q ss_pred             CCCceeecccccccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ..........||+.|+|||++..     ..++.++|||||||++|||++|+.||.....       .+............
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~  227 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKEHF  227 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCcc
Confidence            33333333469999999999863     4578899999999999999999999963221       11112211111100


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCC--CCCCHHHHHHHhh
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPL--HRPKMSEVLKMLE  577 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~--~RPs~~evl~~L~  577 (623)
                      ..     ... ....+.++.+++.+|+..+++  .||++.+++++-.
T Consensus       228 ~~-----~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~  268 (331)
T cd05597         228 QF-----PPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF  268 (331)
T ss_pred             cC-----CCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence            00     000 011345678888887755443  4889999988743

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.7e-37  Score=308.51  Aligned_cols=251  Identities=19%  Similarity=0.287  Sum_probs=204.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      +|++.+.||+|+||.||++... ++..+|+|.++..........+..|+.+++.++||||+++++++..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999875 688999999865444444567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.+++....  ...+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.++++|||.+........
T Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            9999999886532  34578999999999999999999999   999999999999999999999999999976643222


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                       ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....       ........ .+...        
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~-~~~~~--------  218 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLILKVC-QGSYK--------  218 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHHHHh-cCCCC--------
Confidence             22334588999999999888899999999999999999999999963221       11111111 11111        


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ..+......+.+++.+||+.||++|||+.+++..
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 -PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             1122234568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.9e-37  Score=311.13  Aligned_cols=256  Identities=22%  Similarity=0.375  Sum_probs=203.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .+|.+.+.||+|+||.||+|...+    ...||||.............+..|+.+++.+.||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999998643    347999998755433445579999999999999999999998865 567899


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++...
T Consensus        85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999999753   23589999999999999999999998   99999999999999999999999999998665


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ...........++..|+|||.+....++.++||||||+++||+++ |+.||......    ....   ........    
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~---~~~~~~~~----  227 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIG---RIENGERL----  227 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHH---HHHcCCcC----
Confidence            433222223335578999999988889999999999999999986 99998643221    0111   11111111    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG  580 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  580 (623)
                            ..+...+.++.+++.+|+..+|.+|||+.++++.|++..
T Consensus       228 ------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         228 ------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  112223467899999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-37  Score=315.12  Aligned_cols=262  Identities=26%  Similarity=0.406  Sum_probs=203.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-----CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC--Cce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~  373 (623)
                      ..|.+.+.||+|+||.||++.+     .++..||+|.++..........+.+|+++++.++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467889999999999999974     257889999987654444455799999999999999999999998765  568


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            8999999999999998653   23589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCc--eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccc--------ccccchHHHHH
Q 006968          454 LLDHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAA--------NQRGVMLDWVK  523 (623)
Q Consensus       454 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~--------~~~~~~~~~~~  523 (623)
                      .+......  ......++..|+|||.+.+..++.++||||||+++|||++++.|.......        ........++.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76543221  122344677899999998888999999999999999999987764321110        00000111111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .. ..+..         ...+...+.++.+++.+|++.+|++|||+.++++.|++
T Consensus       238 ~~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         238 VL-EEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HH-HcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            11 11110         01112234689999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-36  Score=313.17  Aligned_cols=242  Identities=26%  Similarity=0.351  Sum_probs=192.7

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhh-cCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|... +++.||||+++....  ......+..|..++.. ..||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 578999999976432  2233456777878775 4899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....... ..
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05619          81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence            9999988753    3588999999999999999999999   99999999999999999999999999987532222 22


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||......       +.........       +.    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~-------~~----  214 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDN-------PC----  214 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC-------CC----
Confidence            33456899999999999889999999999999999999999999643211       1111111110       11    


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKMS-EVLK  574 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  574 (623)
                      ++.....++.+++.+||..+|++||++. ++.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            1122336688999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.9e-37  Score=312.93  Aligned_cols=256  Identities=26%  Similarity=0.423  Sum_probs=202.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      .+|...+.||+|+||.||++...      ++..+|+|.++... ......|.+|+++++.+.|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            46777899999999999999632      46689999886433 334557999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc
Q 006968          375 LVYPYMPNGSVASRLRDHIH-----------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE  443 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  443 (623)
                      +++||+++|+|.+++.....           ....+++..++.++.|++.|++|||+.   +++||||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            99999999999999976421           113589999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHH
Q 006968          444 AVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDW  521 (623)
Q Consensus       444 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  521 (623)
                      +||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......       +.
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~  233 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------EA  233 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------HH
Confidence            999999999765432211 1122235678999999998899999999999999999998 88888532211       11


Q ss_pred             HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          522 VKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ..........          ..+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus       234 ~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 IECITQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1111111000          111223467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.6e-37  Score=307.13  Aligned_cols=248  Identities=29%  Similarity=0.405  Sum_probs=200.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeee-cCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS-TENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~  379 (623)
                      .+|.+.+.||+|+||.||+|.. .|..||+|.++...   ....|..|+.++++++|+|++++++++. ..+..++|+||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            4688889999999999999977 57889999986432   3457899999999999999999999764 55678999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999987532  34589999999999999999999999   99999999999999999999999999987543221


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                          ....++..|+|||++....++.++||||||+++|||++ |+.|+....       ..+....... +         
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-------~~~~~~~~~~-~---------  215 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEK-G---------  215 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhc-C---------
Confidence                22335678999999988889999999999999999998 888875321       1111121111 1         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .........+..+.+++.+|++.+|++|||+.++++.|++
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         216 YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            0111122335778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.5e-37  Score=311.77  Aligned_cols=254  Identities=25%  Similarity=0.359  Sum_probs=199.7

Q ss_pred             HHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecC-----
Q 006968          298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE-----  370 (623)
Q Consensus       298 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-----  370 (623)
                      .+...|+..+.||+|+||.||+|... +++.||+|++....  .....+..|+.++.++ +||||+++++++...     
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            35667888899999999999999875 58899999986543  3345788999999988 699999999998653     


Q ss_pred             -CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          371 -NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       371 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                       ...++||||+++|+|.+++....  ...+++..+..++.|++.|++|||++   +|+||||||+||++++++.++|+||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence             45789999999999999987632  34689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      |++........ ......|+..|+|||++.     ...++.++|||||||++|||++|+.||......      ..... 
T Consensus       156 g~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~-  227 (272)
T cd06637         156 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFL-  227 (272)
T ss_pred             CCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHH-
Confidence            99986543222 223355899999999986     335788999999999999999999998632211      11100 


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .. .......        .....+.++.+++.+||..+|.+|||+.+++++
T Consensus       228 ~~-~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         228 IP-RNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             Hh-cCCCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            00 0110111        111234678999999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.4e-37  Score=315.34  Aligned_cols=264  Identities=23%  Similarity=0.308  Sum_probs=203.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|++.+.||+|+||.||++... ++..+|+|.++.........++.+|++++.+++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999865 58889999987543333345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++...    ..+++..+..++.|+++||.|||+.+  +++||||||+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999999753    45889999999999999999999732  8999999999999999999999999998754322 


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc--------
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL--------  531 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------  531 (623)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......    ...+..........        
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCccccccccCCccccc
Confidence              1233468899999999988889999999999999999999999986432111    00000000000000        


Q ss_pred             ------------cccccccc---CCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          532 ------------SQMVDKDL---KGNFD-RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       532 ------------~~~~~~~~---~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                                  .+..+...   ....+ .....++.+++.+||..+|++|||+.+++++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                        00000000   00000 113457899999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-37  Score=310.71  Aligned_cols=248  Identities=27%  Similarity=0.355  Sum_probs=204.2

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      +|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5778889999999999999975 689999999876544444567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|.+++...     .+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++|+|||+++.......
T Consensus        82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999998753     689999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                       ......++..|+|||.+.+..++.++||||||+++|+|+||+.||......       ....... ....     +   
T Consensus       154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~-~~~~-----~---  216 (274)
T cd06609         154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIP-KNNP-----P---  216 (274)
T ss_pred             -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhh-hcCC-----C---
Confidence             223345888999999999888999999999999999999999998633211       1111111 1111     1   


Q ss_pred             CCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          541 GNFDRI-ELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       541 ~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ..... .+..+.+++.+||..+|++|||+++++++
T Consensus       217 -~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         217 -SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             11111 34678999999999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.3e-37  Score=310.39  Aligned_cols=252  Identities=30%  Similarity=0.458  Sum_probs=199.9

Q ss_pred             CceeccCCeEEEEEEeCC-------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          307 NILGRGGFGIVYKGCFSD-------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +.||+|+||.||+|...+       +..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       3579999986544334556789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-----cEEEeeccc
Q 006968          380 MPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-----EAVVGDFGL  451 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~Dfgl  451 (623)
                      +++++|.+++.....   ....+++.++..++.|++.||+|||+.   +++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999976432   224588999999999999999999998   999999999999999877     899999999


Q ss_pred             ccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcC
Q 006968          452 AKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       452 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      +......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+.........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-------~~~~~~~~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-------QEVLQHVTAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-------HHHHHHHhcCC
Confidence            9765432211 1122235688999999999999999999999999999998 9999863221       11111111111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                                ....+...+..+.+++.+||..+|.+||++.++++.|++
T Consensus       231 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 ----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                      001122345778999999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.4e-37  Score=307.31  Aligned_cols=249  Identities=32%  Similarity=0.468  Sum_probs=200.6

Q ss_pred             CceeccCCeEEEEEEeCC--C--cEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFSD--G--ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|++|.||+|.+.+  +  ..||||.++..........+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998743  3  36999999776543445679999999999999999999999988 889999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc-
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-  461 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-  461 (623)
                      |+|.+++.....  ..+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++..+...... 
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999986432  4689999999999999999999999   9999999999999999999999999999876543222 


Q ss_pred             -eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          462 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       462 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......       +............       
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~-------  220 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------QILKKIDKEGERL-------  220 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcCCcC-------
Confidence             1123447789999999988899999999999999999999 99998632221       1112111111100       


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                        ..+...+..+.+++.+|+..+|++||++.++++.|.
T Consensus       221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              011223467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-38  Score=292.84  Aligned_cols=254  Identities=25%  Similarity=0.364  Sum_probs=203.8

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccc-------hHHHHHHHHHHhhc-CCCceeeeeeeeec
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-------EVQFQTEVETISLA-VHRNLLRLCGFCST  369 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l-~H~niv~l~~~~~~  369 (623)
                      -...|...+.||+|..++|-+...+ +|..+|+|++........       ..+-.+|+.+|+++ .||+|+++.+++.+
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            4456788899999999999888765 688999999864332211       12356799999987 69999999999999


Q ss_pred             CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                      +...++|+|.|+.|.|.++|...    -.++++..++|+.|+.+|++|||..   .||||||||+|||+|++.++||+||
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            99999999999999999999764    4699999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeecccccccccccccccc------CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      |++..+.++.  .....+||++|+|||.+..      ..|+..+|+||+|||||.|+.|.+||..-..      +.  +-
T Consensus       168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------ml--ML  237 (411)
T KOG0599|consen  168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------ML--ML  237 (411)
T ss_pred             ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------HH--HH
Confidence            9999887654  3567889999999999853      3578899999999999999999999852110      00  11


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ....+|.+.      +...--.+...+..+++.+||++||.+|.|++|++++
T Consensus       238 R~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  238 RMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            111122211      0111112345778999999999999999999999875

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.8e-37  Score=312.47  Aligned_cols=249  Identities=26%  Similarity=0.348  Sum_probs=202.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      .|+..+.||+|+||.||+|... ++..||+|.++..........+.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3555678999999999999865 578999999875543444557899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|.+++..     ..+++..+..++.|+++|+.|||++   +++|+||+|+||++++++.++++|||++........
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999988853     3589999999999999999999999   999999999999999999999999999976543221


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                       ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+......       .+....          .....
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~----------~~~~~  218 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-------RVLFLI----------PKNSP  218 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-------hHHhhh----------hcCCC
Confidence             122345788999999999888999999999999999999999998632210       001100          00111


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .......+.++.+++.+|+..+|++||++.+++++-
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            112223456789999999999999999999999863

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-37  Score=321.22  Aligned_cols=242  Identities=24%  Similarity=0.263  Sum_probs=190.4

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHH-HHhhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVE-TISLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|... +|+.||+|++......  .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999865 6899999999654321  22334556655 46778999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~  152 (325)
T cd05604          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT  152 (325)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence            999888864    34689999999999999999999999   99999999999999999999999999987532221 22


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......       +....... ...      .+   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~~~~-~~~------~~---  215 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDNILH-KPL------VL---  215 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHHHHc-CCc------cC---
Confidence            33456999999999999999999999999999999999999999643211       11111111 110      01   


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                       .......+.+++.+|+..+|.+||++.+.++
T Consensus       216 -~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         216 -RPGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             -CCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence             1122366889999999999999998864433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.6e-37  Score=308.97  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=206.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ..|+..+.||+|+||.||+|... ++..||+|.++..........+.+|+.+++++.||||+++++++.+.+..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35667789999999999999875 58899999987554444456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++..     ..+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.......
T Consensus        84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            999999998864     2588899999999999999999999   99999999999999999999999999997664332


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      . ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......       ...          ......
T Consensus       156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~----------~~~~~~  217 (277)
T cd06640         156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-------VLF----------LIPKNN  217 (277)
T ss_pred             c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-------Hhh----------hhhcCC
Confidence            2 2233457889999999988889999999999999999999999986322110       000          001111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ........+..+.+++.+||..+|++||++.+++++-.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF  255 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence            12334456678999999999999999999999988643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7.9e-37  Score=305.12  Aligned_cols=250  Identities=25%  Similarity=0.342  Sum_probs=204.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC-CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|+..+.||+|+||.||+|...+ +..+|+|.++....   ..++.+|++++++++||||+++++++......++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            568888999999999999999864 78999999865432   56799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          80 CGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            9999999998653   34689999999999999999999999   99999999999999999999999999998765432


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+........   .    ...   .   ......+
T Consensus       154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~----~~~---~---~~~~~~~  219 (256)
T cd06612         154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---I----FMI---P---NKPPPTL  219 (256)
T ss_pred             c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---h----hhh---c---cCCCCCC
Confidence            2 22234478899999999988999999999999999999999999864322110   0    000   0   0000000


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ..+.....++.+++.+|++.+|++|||+.|++++
T Consensus       220 --~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         220 --SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             --CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence              1122334678999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.9e-37  Score=318.43  Aligned_cols=256  Identities=18%  Similarity=0.237  Sum_probs=198.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||++..+ +++.||+|.+.+...  ......+..|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888999999999999999976 478899999864321  122335788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.++++..   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999999763   23689999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCceeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ..........||+.|+|||++.     ...++.++|||||||++|||++|+.||.....       .+............
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~  227 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKERF  227 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCccc
Confidence            3333333456999999999986     34678999999999999999999999963221       11122221111000


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLH--RPKMSEVLKM  575 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~  575 (623)
                           .... .....+.++.+++.+|+..++.+  |+++.+++++
T Consensus       228 -----~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 -----QFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -----cCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                 0000 01123466788888888654444  7899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=296.69  Aligned_cols=255  Identities=23%  Similarity=0.299  Sum_probs=204.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++.|++.+.||+|.|+.||+.... +|+.+|+|++..... ..+.+++.+|+.+-+.++||||+++...+.+....++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            356778899999999999998764 688999998754332 235667899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEeecccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFGLAKL  454 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfgla~~  454 (623)
                      |+|+|+.|..-+-..    ..+++..+...+.||+++|.|+|.+   +|||||+||+|+++..   ..-+|++|||+|..
T Consensus        90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999987655432    3578899999999999999999999   9999999999999963   34589999999998


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ++  ........+||++|||||++...+|+..+|||+.|||+|-|+.|..||...+...        +.+....+.    
T Consensus       163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--------lye~I~~g~----  228 (355)
T KOG0033|consen  163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYEQIKAGA----  228 (355)
T ss_pred             eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--------HHHHHhccc----
Confidence            87  3445556779999999999999999999999999999999999999997422110        111111111    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                        -++.+.+-....++..+++.+||..||.+|.|+.|.+++-+
T Consensus       229 --yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  229 --YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW  269 (355)
T ss_pred             --cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence              11122222334467899999999999999999999887644

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.3e-37  Score=310.02  Aligned_cols=258  Identities=26%  Similarity=0.375  Sum_probs=203.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|...+.||+|+||.||+|..+      +...||+|.+...........+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999864      346799998865432223457999999999999999999999999989999


Q ss_pred             EEEecccCCChhhhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          375 LVYPYMPNGSVASRLRDHIHGR-----PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                      +||||+++|+|.+++.......     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997653221     2689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhc
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      |++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||.....       ...+.... .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~-~  233 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQ-A  233 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHH-c
Confidence            9987543322222233346778999999988888999999999999999999 7778753211       11111111 1


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      +....        ..+...+..+.+++.+||+.+|++|||+.|++++|+
T Consensus       234 ~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11110        111123467999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.9e-37  Score=319.85  Aligned_cols=245  Identities=24%  Similarity=0.279  Sum_probs=191.4

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHH-HHhhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVE-TISLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|... +++.||+|++......  .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999875 5788999999754321  22234444544 56788999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|.+++...    ..+.+..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~  152 (325)
T cd05602          81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT  152 (325)
T ss_pred             CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence            9999988752    3578888999999999999999999   99999999999999999999999999997543222 22


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......       +........ ..          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~-~~----------~  214 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNK-PL----------Q  214 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-------HHHHHHHhC-Cc----------C
Confidence            33456999999999999999999999999999999999999999632211       111111111 00          1


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      +.......+.+++.+|++.+|.+||++.+.+..+.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~  249 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK  249 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence            11123467889999999999999999875444333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.9e-37  Score=312.30  Aligned_cols=250  Identities=20%  Similarity=0.308  Sum_probs=202.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .+|...+.||+|+||.||+|... ++..||+|.+...... ....+.+|+.+++.+.||||+++++++......++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            46888899999999999999864 6889999998754432 345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++..     ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            999999998864     2578999999999999999999999   99999999999999999999999999988654332


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .. .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||......       .+.......+. ..      
T Consensus       171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-~~------  235 (296)
T cd06654         171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGT-PE------  235 (296)
T ss_pred             cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHHHHhcCCC-CC------
Confidence            21 22345889999999998888999999999999999999999999643221       11111111110 00      


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ...+......+.+++.+||..+|++|||+.+++++
T Consensus       236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             -CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence             01122334678899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.2e-37  Score=319.21  Aligned_cols=261  Identities=28%  Similarity=0.372  Sum_probs=205.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC--------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCC
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN  371 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  371 (623)
                      .+|.+.+.||+|+||.||+|...        ++..||+|.++.........++.+|++++.++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999742        12469999987544344456789999999999 7999999999999999


Q ss_pred             ceEEEEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD  439 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~  439 (623)
                      ..++++||+++|+|.+++.....            ....+++.++..++.|++.||+|||++   +|+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence            99999999999999999975321            123589999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccc
Q 006968          440 EDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGV  517 (623)
Q Consensus       440 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~  517 (623)
                      .++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....      
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------  242 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------  242 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence            99999999999998654322211 122234568999999999899999999999999999998 7888753211      


Q ss_pred             hHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCC
Q 006968          518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGL  581 (623)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  581 (623)
                       .++...... +..         ...+...+.++.+++.+|+..+|++|||+.++++.|+....
T Consensus       243 -~~~~~~~~~-~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         243 -EELFKLLKE-GHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             -HHHHHHHHc-CCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence             122222211 110         01112234678999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.4e-37  Score=315.82  Aligned_cols=271  Identities=22%  Similarity=0.290  Sum_probs=203.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|.+.+.||+|+||.||+|... ++..||+|.++..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888899999999999999875 58899999997654444445678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      ++ ++|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            97 5888888653   34588999999999999999999999   99999999999999999999999999997643322


Q ss_pred             CceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHH--------HHHhhcCc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV--------KKLHQEGK  530 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~  530 (623)
                      . ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+.........        ........
T Consensus       159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence            1 12233478899999988653 57889999999999999999999997443211110000000        00000000


Q ss_pred             cccccccccCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          531 LSQMVDKDLKGN----FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       531 ~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ....-.+.....    ........+.+++.+|+..||.+|||+.|++++-.-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            000000000000    0111235678999999999999999999999865443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.5e-37  Score=307.35  Aligned_cols=256  Identities=22%  Similarity=0.329  Sum_probs=200.6

Q ss_pred             HHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       297 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      +.+++++.....||+|+||.||+|... ++..||+|.++... ......+.+|+.+++.++|+||+++++++..++..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            345566666778999999999999864 57889999986543 2334578999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCcEEEeecccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPAL--DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLA  452 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfgla  452 (623)
                      |+||+++++|.++++...   ..+  ++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.++|+|||++
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999999999997642   234  7888999999999999999999   9999999999999986 678999999998


Q ss_pred             cccCCCCCceeeccccccccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      ........ ......|+..|+|||.+....  ++.++||||||+++|+|++|+.|+........    ..+....     
T Consensus       157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----~~~~~~~-----  226 (268)
T cd06624         157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----AMFKVGM-----  226 (268)
T ss_pred             eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----hHhhhhh-----
Confidence            76543222 222335789999999986643  78899999999999999999999863221100    0000000     


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                            ......++.....++.+++.+||+.+|++|||+.|++++
T Consensus       227 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         227 ------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                  000111223344678999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-36  Score=318.46  Aligned_cols=192  Identities=24%  Similarity=0.330  Sum_probs=165.8

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ...+|.+.+.||+|+||.||+|... ++..||+|.....       ....|+.++++++||||+++++++...+..++|+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            4467999999999999999999975 5788999975332       2356899999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+ .++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       137 e~~-~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        137 PHY-SSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             Ecc-CCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            999 46888888653   34689999999999999999999999   999999999999999999999999999975332


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL  506 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~  506 (623)
                      .  .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       210 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 A--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             C--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            2  1223456899999999999999999999999999999999976665

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.3e-37  Score=307.57  Aligned_cols=256  Identities=25%  Similarity=0.351  Sum_probs=203.6

Q ss_pred             CCCcCCceeccCCeEEEEEEeCC--CcEEEEEEeccccc---------ccchHHHHHHHHHHhh-cCCCceeeeeeeeec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSD--GALVAVKRLKDYNI---------AGGEVQFQTEVETISL-AVHRNLLRLCGFCST  369 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~  369 (623)
                      +|++.+.||+|+||.||+|....  +..+|+|.+.....         .....++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999764  78899999854321         1122357788888864 799999999999999


Q ss_pred             CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCcEEEee
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGD  448 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~D  448 (623)
                      .+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .   +++||||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999986544445679999999999999999999996 5   899999999999999999999999


Q ss_pred             cccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc
Q 006968          449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      ||.+.......  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....       ......... 
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~-  227 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLATKIVE-  227 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHHHHhh-
Confidence            99998755432  23344588999999999988899999999999999999999999863221       111111111 


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      +.....        .....+.++.+++.+||+.||++||++.|+.+++++
T Consensus       228 ~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         228 AVYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             ccCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            111100        011234678999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.5e-37  Score=316.45  Aligned_cols=250  Identities=23%  Similarity=0.282  Sum_probs=195.8

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|... +++.||+|+++.....  .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999875 5789999999764322  2234578899998887 699999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  152 (327)
T cd05617          81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT  152 (327)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence            9998887643    3689999999999999999999999   99999999999999999999999999987532211 22


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...++..........          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~----------~  221 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILEKPI----------R  221 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHHhCCC----------C
Confidence            33456999999999999999999999999999999999999999642211111 111222221111110          1


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKM------SEVLKM  575 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~~  575 (623)
                      ++...+..+.+++.+||..||++|+++      .+++++
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            122233668899999999999999984      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-38  Score=323.86  Aligned_cols=248  Identities=27%  Similarity=0.427  Sum_probs=206.5

Q ss_pred             cCCceeccCCeEEEEEEeCC--C--cEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          305 AKNILGRGGFGIVYKGCFSD--G--ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       305 ~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ..++||+|.||+|++|.|+.  |  -.||||.++.........+|++|+.+|-+++|||+++|||...+ ....||+|++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            45789999999999999863  4  46999999887766667789999999999999999999999977 6788999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      +.|+|.+.|+.  .....+-......++.|||.||.||.++   ++|||||..+|+|+-....+||+|||+.+-+...+.
T Consensus       193 plGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  193 PLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             ccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            99999999997  3456788999999999999999999999   999999999999999998999999999998876654


Q ss_pred             ceee--ccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          461 HVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       461 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ....  ...-.+.|.|||.+....++.++|||+|||++|||+| |+.||..-..       ...+          +.+|.
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------~qIL----------~~iD~  330 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------IQIL----------KNIDA  330 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------HHHH----------Hhccc
Confidence            4332  2234578999999999999999999999999999999 5667753221       1111          22222


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .-.-.-++.+++.+++++..||..+|.+|||+..|.+.
T Consensus       331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            22222356678999999999999999999999999743

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.3e-37  Score=306.24  Aligned_cols=249  Identities=31%  Similarity=0.438  Sum_probs=192.6

Q ss_pred             CceeccCCeEEEEEEeC----CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeee-cCCceEEEEeccc
Q 006968          307 NILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS-TENERLLVYPYMP  381 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~~  381 (623)
                      +.||+|+||.||+|...    ++..||+|++...........+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    245799999864333333457889999999999999999999875 4556889999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      +|+|.+++...   ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999999753   23467888899999999999999999   9999999999999999999999999999765432211


Q ss_pred             ---eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCC-CCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          462 ---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR-ALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       462 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                         ......++..|+|||.+.+..++.++||||||+++|||++|+. |+....       ..+...........      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~~~------  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-------SFDITVYLLQGRRL------  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHhcCCCC------
Confidence               1122345778999999988889999999999999999999654 553211       11222222111100      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                          ..+...+..+.+++.+||..+|++||++.++++.|++
T Consensus       222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                0111224678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-37  Score=309.42  Aligned_cols=254  Identities=30%  Similarity=0.449  Sum_probs=200.8

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchH-HHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEV-QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      |+..+.||+|+||+||++... +++.||+|++.......... ...+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999976 46789999998765433222 3456999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|.+++..    ...+++..+..++.|+++||++||+.   +|+|+||||+||+++.++.++|+|||.+.... ...
T Consensus        81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN  152 (260)
T ss_dssp             TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred             ccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence            99999999983    34689999999999999999999999   99999999999999999999999999997642 222


Q ss_pred             ceeeccccccccccccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .......++..|+|||.+. +...+.++||||+|+++|+|++|+.|+......+..    ........ .....    ..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~----~~~~~~~~-~~~~~----~~  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL----EIIEKILK-RPLPS----SS  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH----HHHHHHHH-THHHH----HT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhh----hhhhhccc-ccccc----cc
Confidence            3344556899999999998 788999999999999999999999999744111111    11111000 00000    00


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .  .......++.+++.+||+.||++||++.+++++
T Consensus       224 ~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 Q--QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             T--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             c--ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0  000012789999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.6e-37  Score=341.21  Aligned_cols=260  Identities=21%  Similarity=0.290  Sum_probs=202.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|... +|+.||+|+++.....  ....+|.+|+++++.++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47888999999999999999875 5899999999754322  22456899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          378 PYMPNGSVASRLRDHIHG-------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      ||+++|+|.+++......       ....++..+.+++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998753211       23467888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC-----------------ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccc
Q 006968          451 LAKLLDHRDS-----------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN  513 (623)
Q Consensus       451 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~  513 (623)
                      +++.......                 .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                 01112459999999999999999999999999999999999999996422110


Q ss_pred             cccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhc
Q 006968          514 QRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRP-KMSEVLKMLEG  578 (623)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~  578 (623)
                      .     ..      ....   .++.-.. .....+..+.+++.+|+..||++|| +++++.+.|+.
T Consensus       239 i-----~~------~~~i---~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 I-----SY------RDVI---LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             h-----hh------hhhc---cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0     00      0000   0000000 0112346688999999999999995 56667776665

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-37  Score=309.51  Aligned_cols=255  Identities=25%  Similarity=0.431  Sum_probs=203.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCc----EEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      .+|.+.+.||+|+||.||+|... +|.    .||+|.++..........+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46778899999999999999864 233    6999988765544445678999999999999999999999987 78899


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      |+||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            99999999999998764   33589999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCcee-eccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ........ ....++..|+|||.+....++.++||||||+++||+++ |+.||.....       .++..... .+..  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~-~~~~--  229 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------VEIPDLLE-KGER--  229 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHh-CCCC--
Confidence            54332221 11224568999999988889999999999999999999 9999864322       11111111 1110  


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                             ...+..+...+.+++.+||..+|++||++.++++.|++.
T Consensus       230 -------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         230 -------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                   011122335788999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.9e-37  Score=310.16  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=200.9

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      |+..+.||+|+||.||++... +++.||||.+.......  ....+..|+.+++.++|+|++++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999875 68899999986543222  234578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999999886532  23589999999999999999999998   99999999999999999999999999987654322


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .  .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......    ..+........  ..       
T Consensus       157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~----~~~~~~~~~~~--~~-------  221 (285)
T cd05630         157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKE--VQ-------  221 (285)
T ss_pred             c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc----hHHHHHhhhhh--hh-------
Confidence            1  223458999999999999999999999999999999999999996422110    00001111000  00       


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHh
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPK-----MSEVLKML  576 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~L  576 (623)
                       ..+......++.+++.+||+.||++|||     +.|++++-
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~  262 (285)
T cd05630         222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP  262 (285)
T ss_pred             -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence             0111223456889999999999999999     88888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-36  Score=309.42  Aligned_cols=263  Identities=23%  Similarity=0.319  Sum_probs=204.8

Q ss_pred             HHHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeee--
Q 006968          293 FKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCS--  368 (623)
Q Consensus       293 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~--  368 (623)
                      ++.+..+.++|++.+.||+|+||.||++... +++.+|+|.++...  ....++..|+.++..+ +||||+++++++.  
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            4455567789999999999999999999875 58899999886432  2235678899999998 6999999999874  


Q ss_pred             ---cCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEE
Q 006968          369 ---TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       369 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                         .++..++||||+++++|.++++........+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence               34568999999999999998876544456789999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCCceeecccccccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH
Q 006968          446 VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD  520 (623)
Q Consensus       446 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  520 (623)
                      |+|||++........ ......|+..|+|||++..     ..++.++||||+||++|||++|+.|+........      
T Consensus       165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------  237 (286)
T cd06638         165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------  237 (286)
T ss_pred             EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------
Confidence            999999986643222 2223458999999998753     4478899999999999999999999864321110      


Q ss_pred             HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      . ..... .......+       +.....++.+++.+||+.+|++|||+.|++++.
T Consensus       238 ~-~~~~~-~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         238 L-FKIPR-NPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             H-hhccc-cCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            0 00000 00000101       111235689999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.3e-36  Score=302.34  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=191.8

Q ss_pred             ceeccCCeEEEEEEeCCC---cEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCC
Q 006968          308 ILGRGGFGIVYKGCFSDG---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS  384 (623)
Q Consensus       308 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  384 (623)
                      .||+|+||.||+|...++   ..+++|.++..........|.+|+.+++.++||||+++++++......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975433   35667776654433445679999999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC-Ccee
Q 006968          385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVT  463 (623)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~  463 (623)
                      |.++++.........++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999986533344577888899999999999999999   99999999999999999999999999986432211 1112


Q ss_pred             ecccccccccccccccc-------CCCCCccchhhHHHHHHHHHhC-CCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          464 TAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELITG-QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       464 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ ..|+.....       .+.+...... ......
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~-~~~~~~  230 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKD-QQVKLF  230 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhh-cccccC
Confidence            23457889999998753       2457899999999999999975 557643221       1222222211 112223


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ++.+...    ....+.+++..|| .+|++||++.+|++.|.
T Consensus       231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3333322    2356788999999 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-36  Score=306.47  Aligned_cols=253  Identities=26%  Similarity=0.376  Sum_probs=191.3

Q ss_pred             ceeccCCeEEEEEEeCC---CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCC
Q 006968          308 ILGRGGFGIVYKGCFSD---GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS  384 (623)
Q Consensus       308 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  384 (623)
                      .||+|+||.||+|...+   ...+|+|.++..........|.+|+..++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   457888987654433445578999999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce-
Q 006968          385 VASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-  462 (623)
Q Consensus       385 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  462 (623)
                      |.+++...... ....++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999765322 23457888999999999999999999   99999999999999999999999999987543322111 


Q ss_pred             eecccccccccccccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          463 TTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||......       +.......... ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~-~~~  230 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQD-IKL  230 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhccC-ccC
Confidence            122335678999998743       356889999999999999999 67777532211       11112111111 111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ..+..    +...+..+.+++..|+ .||++|||+++|++.|
T Consensus       231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            11111    2223456778888898 5999999999999987

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-36  Score=324.97  Aligned_cols=261  Identities=21%  Similarity=0.277  Sum_probs=196.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .+|.+.+.||+|+||.||+|... .++.||||...       ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46888999999999999999976 47889999642       22467899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      + .++|.+++...   ...++|..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       242 ~-~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 Y-RSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            9 47888888653   23699999999999999999999999   99999999999999999999999999998654332


Q ss_pred             Cc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccccccc----chHHHHHHHhhc-Ccccc
Q 006968          460 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRG----VMLDWVKKLHQE-GKLSQ  533 (623)
Q Consensus       460 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~  533 (623)
                      .. ......||..|+|||++.+..++.++|||||||++|||++|..++..........    .....+...... .....
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            21 2234569999999999999999999999999999999999887653221111111    111111111000 00000


Q ss_pred             ccc------------cccCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          534 MVD------------KDLKGNFD-------RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       534 ~~~------------~~~~~~~~-------~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...            ......+.       ......+.+++.+||+.||++|||+.|++++
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000            00000000       0112467889999999999999999999986

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.9e-37  Score=310.95  Aligned_cols=263  Identities=27%  Similarity=0.397  Sum_probs=205.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-----CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec--CCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~  373 (623)
                      +.|...+.||+|+||.||+|.+.     ++..||||.++..........|.+|+++++.+.||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35677789999999999999863     3689999999765433245679999999999999999999999877  5578


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||.+.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            9999999999999999764   23589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCce--eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccc--------cchHHHHH
Q 006968          454 LLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQR--------GVMLDWVK  523 (623)
Q Consensus       454 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~  523 (623)
                      .........  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.........        .....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            765332211  11223556799999998889999999999999999999999987542221100        00111111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ....          ......+..++.++.+++.+||+.+|++|||+.||+++|+..
T Consensus       238 ~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKE----------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHc----------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111          111111223347799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.2e-37  Score=314.18  Aligned_cols=255  Identities=26%  Similarity=0.449  Sum_probs=200.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCc----EEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ++|...+.||+|+||.||+|... +|.    .||+|.++.........++.+|+.+++.+.||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45777889999999999999864 343    57999887554333345788999999999999999999998754 5679


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ++||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence            99999999999998754   33588999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+ .......+... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~-~~~~~~~~~~~-  230 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------RE-IPDLLEKGERL-  230 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHHCCCCC-
Confidence            5332221 122335678999999998899999999999999999998 8888853211       01 11111111100 


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                              ..+..++..+.+++.+||..+|++||++.++++.|+..
T Consensus       231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                    01112335788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=313.13  Aligned_cols=254  Identities=23%  Similarity=0.309  Sum_probs=213.0

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCC-CcEEEEEEecccccccc--hHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGG--EVQFQTEVETISLAV-HRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~l  375 (623)
                      ...|++.+.||+|.||.||++..+. |+.+|+|.+++......  ...+.+|+.+|+++. |||||.+.+++.+....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            4568888999999999999999864 99999999987665433  357899999999998 9999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC----CcEEEeeccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED----FEAVVGDFGL  451 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~Dfgl  451 (623)
                      |||++.||.|.+.+...     .+++..+..++.|++.+++|||+.   +|+||||||+|+|+...    +.+|++|||+
T Consensus       114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999999875     299999999999999999999999   99999999999999743    4799999999


Q ss_pred             ccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      +.....  .......+||+.|+|||++....|+..+||||+||++|.|++|.+||........   ..     ....+++
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~---~~-----~i~~~~~  255 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI---FL-----AILRGDF  255 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH---HH-----HHHcCCC
Confidence            998776  4456677899999999999999999999999999999999999999974332111   00     1111111


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                            .+....-........+++..|+..||.+|+|+.++++|-+
T Consensus       256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence                  1222223344678899999999999999999999999754

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.5e-37  Score=310.34  Aligned_cols=266  Identities=24%  Similarity=0.298  Sum_probs=195.1

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhc---CCCceeeeeeeeec-----CC
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLA---VHRNLLRLCGFCST-----EN  371 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~H~niv~l~~~~~~-----~~  371 (623)
                      +|++.+.||+|+||.||+|... +|+.||+|.++...... ....+.+|+.+++.+   .||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999875 68999999987543222 223566777777655   69999999998754     24


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL  451 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  451 (623)
                      ..++||||++ ++|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            5789999997 58888886532  24589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      ++......  ......||..|+|||++.+..++.++||||+||++|||++|++||..............+..........
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            98664322  2233458899999999998899999999999999999999999986433221111111110000000000


Q ss_pred             ------ccccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          532 ------SQMVDKDLKG---NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       532 ------~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                            .....+....   ........++.+++.+|++.||++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  0000000000   0111234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-36  Score=305.10  Aligned_cols=253  Identities=27%  Similarity=0.388  Sum_probs=205.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeec--CCceEEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST--ENERLLVY  377 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~  377 (623)
                      +|++.+.||+|+||.||++... +|..||+|.++..... .....+..|+++++.++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999864 6889999998754332 234468899999999999999999998754  34578999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH-----EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      ||+++++|.+++.........+++..++.++.|++.||.|||     +.   +++||||+|+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999876555567999999999999999999999     66   9999999999999999999999999999


Q ss_pred             cccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.....       ....... ..+.. 
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~-~~~~~-  227 (265)
T cd08217         158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLASKI-KEGKF-  227 (265)
T ss_pred             ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHHHHH-hcCCC-
Confidence            876543321 2334589999999999988899999999999999999999999874321       1111111 11111 


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                              ...+...+..+.+++.+|++.+|++||++.+|+++
T Consensus       228 --------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 --------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                    12233345788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.6e-37  Score=317.18  Aligned_cols=238  Identities=24%  Similarity=0.267  Sum_probs=188.4

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHH-HHhhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVE-TISLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      ++||+|+||.||+|... +|+.||+|++......  .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 6889999998654321  22334555654 57889999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++..    ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (321)
T cd05603          81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET  152 (321)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence            999888764    34588899999999999999999999   99999999999999999999999999987532222 22


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....       ......... ..          ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~-~~----------~~  214 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILH-KP----------LQ  214 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhc-CC----------CC
Confidence            3345689999999999988999999999999999999999999964321       111111111 10          01


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKMS  570 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~  570 (623)
                      ++.....++.+++.+|++.+|.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1222346789999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-36  Score=319.19  Aligned_cols=266  Identities=21%  Similarity=0.270  Sum_probs=197.7

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCC-----
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-----  371 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----  371 (623)
                      ..++|.+.+.||+|+||.||++... +|..||||+++.... ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999874 589999999965432 223456889999999999999999999886443     


Q ss_pred             -ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          372 -ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       372 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                       ..++||||+++ +|...+..      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence             46999999965 56555532      478899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch--------HHH-
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM--------LDW-  521 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~--------~~~-  521 (623)
                      +++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........        ..+ 
T Consensus       169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            99754322  1223346899999999999999999999999999999999999999743321100000        000 


Q ss_pred             ------HHHHhhcC-ccc-----cccccc-c--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          522 ------VKKLHQEG-KLS-----QMVDKD-L--KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       522 ------~~~~~~~~-~~~-----~~~~~~-~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                            +..+.... ...     +....- .  ..........++.+++.+||..||++|||+.|++++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                  01110000 000     000000 0  0001112245789999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.2e-36  Score=308.72  Aligned_cols=255  Identities=23%  Similarity=0.324  Sum_probs=198.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHH-HhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++.........++..|+.. ++...||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888899999999999999975 6999999999765444445566667765 566789999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |++ |+|.+++.........+++..++.++.|++.||+|||+++  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 7888888765444567999999999999999999999853  8999999999999999999999999999865432


Q ss_pred             CCceeecccccccccccccccc----CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      .  ......|+..|+|||.+.+    ..++.++|+||||+++|||++|+.||.....      ..+.+..... +.... 
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~~~-  227 (283)
T cd06617         158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PFQQLKQVVE-EPSPQ-  227 (283)
T ss_pred             c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CHHHHHHHHh-cCCCC-
Confidence            1  1222457889999998865    4468899999999999999999999853211      0111111111 10000 


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          +.   ....+.++.+++.+||..+|++||++.+++++
T Consensus       228 ----~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         228 ----LP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ----CC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00   11234678999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.2e-36  Score=306.10  Aligned_cols=252  Identities=26%  Similarity=0.340  Sum_probs=199.6

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      |...+.||+|+||+||+|... +++.||+|.+.......  ....+.+|+++++.++|+|++++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556788999999999999875 68899999986543222  234578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            99999998886532  34699999999999999999999999   99999999999999999999999999997654322


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                        ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||........   ...+.... ....  .      
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~-~~~~--~------  222 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRV-LETE--E------  222 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhh-hccc--c------
Confidence              12334589999999999988999999999999999999999999964321100   00111111 1010  0      


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPK-----MSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  575 (623)
                        .+....+.++.+++..|++.+|++||+     +.+++++
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 --VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             --ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence              111223456889999999999999999     6677664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.5e-37  Score=309.80  Aligned_cols=259  Identities=23%  Similarity=0.314  Sum_probs=206.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|++.+.||+|+||+||++... +|..||+|++...........+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46777899999999999999875 58899999987554444456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++...    ..+++.....++.+++.||.|||+.+  +++||||+|+||++++++.++|+|||++.......
T Consensus        85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          85 MDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             CCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            9999999888652    36899999999999999999999732  89999999999999999999999999987543221


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccccc----ccchHHHHHHHhhcCcccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ----RGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  535 (623)
                         .....|+..|+|||++.+..++.++|||||||++|+|++|+.||........    .....++........      
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  229 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------  229 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence               2234689999999999888899999999999999999999999974332111    011112222221111      


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .+.+.   ....+.++.+++.+|++.||++|||+.|++++..
T Consensus       230 ~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         230 PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            00110   1124467899999999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1e-36  Score=309.57  Aligned_cols=268  Identities=21%  Similarity=0.269  Sum_probs=199.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|.+.+.||+|+||.||+|... ++..||+|.++...... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999875 68999999986543222 235688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      ++ ++|.+++.... ....+++..+..++.|+++||+|||+.   +|+||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 68888886532 235689999999999999999999999   99999999999999999999999999997654332


Q ss_pred             CceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHH--------HHHhhcCc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV--------KKLHQEGK  530 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~  530 (623)
                      . ......+++.|+|||.+.+. .++.++||||||+++|||+||+.||................        ........
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            1 12233478899999988654 56889999999999999999999986432211100000000        00000000


Q ss_pred             cccccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKDLKG---NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .....+.....   ........++.+++.+||..||++|||+.+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00000000000   0011124677899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.6e-36  Score=304.34  Aligned_cols=240  Identities=22%  Similarity=0.350  Sum_probs=188.0

Q ss_pred             CceeccCCeEEEEEEeCC-------------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          307 NILGRGGFGIVYKGCFSD-------------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      +.||+|+||.||+|...+             ...||+|.+.... ......|.+|+.+++.++||||+++++++..+...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            468999999999998532             2358999876533 23345688899999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc-------EEE
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE-------AVV  446 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~kl  446 (623)
                      ++||||+++|+|..++...   ...+++..+.+++.|+++||+|||+.   +|+||||||+|||++.++.       +++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence            9999999999999888653   34689999999999999999999999   9999999999999987664       899


Q ss_pred             eecccccccCCCCCceeeccccccccccccccc-cCCCCCccchhhHHHHHHHHH-hCCCCCCcccccccccchHHHHHH
Q 006968          447 GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI-TGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       447 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      +|||++......     ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......       +.. .
T Consensus       154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~-~  220 (262)
T cd05077         154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EKE-R  220 (262)
T ss_pred             CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HHH-H
Confidence            999998754322     2234788999999886 467899999999999999998 577776532110       000 0


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .. .+...      .    ......++.+++.+||+.||++||++.+|++.|+
T Consensus       221 ~~-~~~~~------~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         221 FY-EGQCM------L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HH-hcCcc------C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            00 01000      0    0112357889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.2e-37  Score=316.01  Aligned_cols=242  Identities=23%  Similarity=0.309  Sum_probs=193.3

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  377 (623)
                      +|+..+.||+|+||.||+|... +|+.||+|+++....  ......+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677889999999999999865 689999999975432  222345778888888775 577888999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            999999999988653    4689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......       ........ ..       
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~-~~-------  217 (323)
T cd05615         154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------ELFQSIME-HN-------  217 (323)
T ss_pred             CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh-CC-------
Confidence            21 2233456899999999999889999999999999999999999999643211       11111111 11       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKM  569 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~  569 (623)
                         ..++.....++.+++.+|+..+|.+|++.
T Consensus       218 ---~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 ---VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               01122234678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.8e-36  Score=302.65  Aligned_cols=252  Identities=31%  Similarity=0.459  Sum_probs=202.6

Q ss_pred             CCcCCceeccCCeEEEEEEeCC-----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          303 FSAKNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      |++.+.||.|+||.||++...+     +..||+|.++..........+..|+.++..+.|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999999753     48899999976554435668999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++.....  ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999999876421  1289999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..........++..|+|||.+.+..++.++||||+|+++++|++ |+.|+.....       ......... +..     
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~-~~~-----  222 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLEYLKK-GYR-----  222 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhc-CCC-----
Confidence            43222222336789999999988889999999999999999998 7777753211       111111111 110     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                          ...+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 ----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                011122457799999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.6e-36  Score=301.48  Aligned_cols=252  Identities=23%  Similarity=0.360  Sum_probs=201.3

Q ss_pred             CCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc-----cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-----GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      +|...+.||+|+||.||+|...+|+.+|||.++.....     .....+.+|++++++++|+||+++++++...+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            46778999999999999999888999999998643221     1224588999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      +||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+|+||+|+||++++++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999998753    3578999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCC-----CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          457 HRD-----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       457 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      ...     ........|+..|+|||++.+..++.++||||||+++|+|++|+.||...+..      ............ 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~-  226 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL------AAMFYIGAHRGL-  226 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH------HHHHHhhhccCC-
Confidence            211     11122345889999999999888999999999999999999999999632211      000000000011 


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          .+.    .+.....++.+++.+||..+|.+||++.+++++
T Consensus       227 ----~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 ----MPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ----CCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                111    122234678999999999999999999999763

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-36  Score=319.84  Aligned_cols=253  Identities=19%  Similarity=0.275  Sum_probs=196.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|+..+.||+|+||.||++... +++.||+|+++....  ......+..|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999875 589999999975332  222346788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            999999999998753    4689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCC----------------------------------ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCC
Q 006968          458 RDS----------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ  503 (623)
Q Consensus       458 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~  503 (623)
                      ...                                  .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            110                                  0112346999999999999999999999999999999999999


Q ss_pred             CCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 006968          504 RALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK---MSEVLKM  575 (623)
Q Consensus       504 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~  575 (623)
                      .||......       ............ ..+.+    ..  ....++.+++.+++. +|++|++   +.+++++
T Consensus       234 ~Pf~~~~~~-------~~~~~i~~~~~~-~~~p~----~~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         234 PPFCSETPQ-------ETYRKVMNWKET-LVFPP----EV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCCHH-------HHHHHHHcCCCc-eecCC----CC--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            999643221       111111110000 00011    00  123567788888764 9999985   6677665

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.3e-36  Score=310.90  Aligned_cols=196  Identities=24%  Similarity=0.324  Sum_probs=160.9

Q ss_pred             CCceeccCCeEEEEEEeC---CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec--CCceEEEEecc
Q 006968          306 KNILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENERLLVYPYM  380 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~  380 (623)
                      .++||+|+||+||+|...   ++..||+|.++...   ....+.+|+.++++++||||+++++++..  ....++++||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999864   46789999986532   23457889999999999999999998854  45678999998


Q ss_pred             cCCChhhhhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----CCCCcEEEeeccc
Q 006968          381 PNGSVASRLRDHIH-----GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGL  451 (623)
Q Consensus       381 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Dfgl  451 (623)
                      . ++|.+++.....     ....+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            5 578877754321     123589999999999999999999999   99999999999999    4567899999999


Q ss_pred             ccccCCCCCc--eeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCc
Q 006968          452 AKLLDHRDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF  508 (623)
Q Consensus       452 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~  508 (623)
                      ++........  ......||+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            9876543221  2234568999999999876 4589999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5e-36  Score=304.19  Aligned_cols=251  Identities=24%  Similarity=0.303  Sum_probs=198.3

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEeccc
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP  381 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  381 (623)
                      |++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+++++.++|||++++++++..++..++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            566788999999999999976 47889999985432 2334568899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      +++|..++...   ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++....... .
T Consensus        86 ~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~  158 (282)
T cd06643          86 GGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q  158 (282)
T ss_pred             CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence            99998887652   34689999999999999999999999   99999999999999999999999999987653322 1


Q ss_pred             eeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          462 VTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       462 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ......++..|+|||++.     +..++.++|||||||++|||++|+.||.....       .+.+........ ...  
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~--  228 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEP-PTL--  228 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------HHHHHHHhhcCC-CCC--
Confidence            223345899999999984     34567899999999999999999999863221       011111111100 000  


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                           ..+...+.++.+++.+||+.+|.+||++.+++++-
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence                 01122346789999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.4e-36  Score=308.94  Aligned_cols=251  Identities=20%  Similarity=0.300  Sum_probs=203.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ..+|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            36788899999999999999986 4799999999865432 334568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            9999999998864     3578999999999999999999999   9999999999999999999999999999765443


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.........       ......+        .
T Consensus       169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-------~~~~~~~--------~  232 (297)
T cd06656         169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIATNG--------T  232 (297)
T ss_pred             ccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-------eeeccCC--------C
Confidence            222 22345889999999999888999999999999999999999999643221100       0000000        0


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .....+...+..+.+++.+||..+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0001122334668899999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.7e-36  Score=301.42  Aligned_cols=252  Identities=25%  Similarity=0.359  Sum_probs=205.4

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|+..+.||+|+||.||.+... ++..+++|.+..... .....++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4778899999999999998864 588999999865432 33445789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++....  ...+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999987642  34689999999999999999999998   99999999999999999999999999998764433


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      . ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....       .+....... +....      
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~-~~~~~------  220 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKIVQ-GNYTP------  220 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHc-CCCCC------
Confidence            2 22334589999999999888889999999999999999999999863221       111222111 11111      


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                         .....+.++.+++.+||..+|.+||++.++++++
T Consensus       221 ---~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 ---VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ---CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence               1122346789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=319.41  Aligned_cols=244  Identities=25%  Similarity=0.374  Sum_probs=202.7

Q ss_pred             ceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCChh
Q 006968          308 ILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVA  386 (623)
Q Consensus       308 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~  386 (623)
                      +||+|.||+||.|... +...+|||.+..... ...+-+..|+.+-++++|.|||+.+|.|.+.+..-+.||-++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            6999999999999975 466799999965543 23345889999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCcEEEeecccccccCCCCCcee
Q 006968          387 SRLRDHIHGRPAL--DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVT  463 (623)
Q Consensus       387 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~  463 (623)
                      +.|+...   +++  .+.++-.+.+||++||.|||++   .|||||||-+|||++ -.|.+||+|||.++.+.. -...+
T Consensus       661 sLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~T  733 (1226)
T KOG4279|consen  661 SLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCT  733 (1226)
T ss_pred             HHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccc
Confidence            9998754   355  7888899999999999999999   999999999999997 678999999999988753 34566


Q ss_pred             eccccccccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCC
Q 006968          464 TAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG  541 (623)
Q Consensus       464 ~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  541 (623)
                      ..+-||..|||||++..+  .|+.++|||||||++.||.||++||..-.......      -   +.|-      -....
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM------F---kVGm------yKvHP  798 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM------F---KVGM------YKVHP  798 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh------h---hhcc------eecCC
Confidence            677799999999999775  47889999999999999999999997432211100      0   0011      11233


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          542 NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       542 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                      ..+....++...++.+|..+||.+||+++++++
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            456777889999999999999999999999976

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.5e-36  Score=318.62  Aligned_cols=266  Identities=20%  Similarity=0.260  Sum_probs=198.4

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecC------
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTE------  370 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------  370 (623)
                      ..++|...+.||+|+||.||++... .++.||||+++..... .....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999864 5889999998754322 2345678899999999999999999988543      


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      ...++||||+++ ++...+..      .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence            346999999965 66666543      478999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH--------HH-
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--------DW-  521 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~-  521 (623)
                      +++.....  .......||..|+|||++.+..++.++|||||||++|||++|+.||.............        ++ 
T Consensus       165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865432  12234468999999999999899999999999999999999999996432211100000        00 


Q ss_pred             ------HHHHhhc-Ccccccccc-----cc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          522 ------VKKLHQE-GKLSQMVDK-----DL---KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       522 ------~~~~~~~-~~~~~~~~~-----~~---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                            +...... ........+     ..   ..........++.+++.+|+..||++|||+.|++++-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp  312 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP  312 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence                  0111000 000000000     00   0011112246789999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.4e-36  Score=301.88  Aligned_cols=251  Identities=23%  Similarity=0.340  Sum_probs=201.8

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeec-CCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST-ENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e  378 (623)
                      +|++.+.||+|++|.||++... +++.||+|.+...... .....+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999875 5789999998654322 234468899999999999999999988764 445789999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|.+++....  ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            999999999997632  34589999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      .. ......+++.|+|||.+.+..++.++||||||+++++|++|+.||...+.       ........ .+..       
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~-~~~~-------  219 (257)
T cd08223         156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRII-EGKL-------  219 (257)
T ss_pred             CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHH-hcCC-------
Confidence            22 22334588999999999999999999999999999999999999863221       11111111 1111       


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ...+.....++.+++.+|++.+|++|||+.+++++
T Consensus       220 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 --PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             --CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              11223344679999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.2e-36  Score=304.22  Aligned_cols=252  Identities=24%  Similarity=0.309  Sum_probs=199.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +.|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            56888899999999999999875 48899999986542 33345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|..++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        91 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          91 CPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            9999998887653   23589999999999999999999999   99999999999999999999999999987543221


Q ss_pred             Cceeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      . ......++..|+|||++.     ...++.++|||||||++|||++|+.|+.....       ......... ...   
T Consensus       165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~-~~~---  232 (292)
T cd06644         165 Q-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAK-SEP---  232 (292)
T ss_pred             c-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhc-CCC---
Confidence            1 122345788999999984     34568899999999999999999999863221       111111111 100   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        +..  ..+...+.++.+++.+||..+|++||++.+++++
T Consensus       233 --~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         233 --PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             --ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence              000  0112234578899999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.9e-36  Score=303.21  Aligned_cols=250  Identities=26%  Similarity=0.413  Sum_probs=200.9

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccc--------hHHHHHHHHHHhhcCCCceeeeeeeeecCCc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG--------EVQFQTEVETISLAVHRNLLRLCGFCSTENE  372 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  372 (623)
                      +|.+...||+|+||.||+|... ++..||+|.+........        ...+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667889999999999999864 588999999865432211        1357889999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++|+||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            99999999999999999753    3588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCc-----eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh
Q 006968          453 KLLDHRDSH-----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       453 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      +........     ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......       .-+.... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~-  225 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIFKIG-  225 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHHHHh-
Confidence            876532111     112235788999999999888999999999999999999999999642210       0011100 


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                           ....    ...+...+..+.+++.+||+.+|++||++.+++++
T Consensus       226 -----~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         226 -----ENAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -----ccCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                 0111    11222345778999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-36  Score=322.09  Aligned_cols=261  Identities=22%  Similarity=0.271  Sum_probs=198.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC---CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||++...   .+..||+|.+...      ..+.+|++++++++||||+++++++...+..++||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            56899999999999999999753   3678999988643      24568999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      |++. ++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus       166 e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        166 PKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             hhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9995 688888743    34689999999999999999999999   999999999999999999999999999976554


Q ss_pred             CCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC-cccc--
Q 006968          458 RDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG-KLSQ--  533 (623)
Q Consensus       458 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--  533 (623)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....+...... ....  
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            322 222345699999999999999999999999999999999999999864332211111111111100000 0000  


Q ss_pred             ---------ccccccCCCC--C-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          534 ---------MVDKDLKGNF--D-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       534 ---------~~~~~~~~~~--~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                               .........+  +     .....++.+++.+||..||++|||+.|++.+
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                     0000000000  0     1123567889999999999999999999986

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.9e-36  Score=305.82  Aligned_cols=250  Identities=20%  Similarity=0.322  Sum_probs=203.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .+|+..+.||.|+||.||+|.. .+|+.||+|.+.... ......+.+|+++++.++||||+++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4688889999999999999986 468999999986543 23355788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|..++..     ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          98 LAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             cCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            999999998864     2589999999999999999999999   99999999999999999999999999988654432


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||......       .......... ....     
T Consensus       170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-------~~~~~~~~~~-~~~~-----  235 (296)
T cd06655         170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATNG-TPEL-----  235 (296)
T ss_pred             cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcC-Cccc-----
Confidence            21 22345889999999998888999999999999999999999999643321       1111111111 0000     


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ..+...+..+.+++.+||..+|++||++.+++++
T Consensus       236 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         236 --QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             --CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence              0112234678899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.6e-36  Score=303.68  Aligned_cols=263  Identities=22%  Similarity=0.251  Sum_probs=205.5

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC--CceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e  378 (623)
                      +|...+.||.|++|.||++... +++.+|+|.+..........++.+|++++++++||||+++++++...  +..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5777899999999999999975 58899999997654444456799999999999999999999988653  46899999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999998876444456689999999999999999999999   9999999999999999999999999998754332


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ..   ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||......  .....+....... ...... ...
T Consensus       159 ~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~-~~~~~~-~~~  231 (287)
T cd06621         159 LA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVN-MPNPEL-KDE  231 (287)
T ss_pred             cc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhc-CCchhh-ccC
Confidence            21   2344788999999999889999999999999999999999999744221  1111122111111 011111 000


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ..  .....+..+.+++.+||..+|.+|||+.|++++-
T Consensus       232 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         232 PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence            00  0012346789999999999999999999999854

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=309.58  Aligned_cols=267  Identities=21%  Similarity=0.309  Sum_probs=203.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|++.+.||+|+||.||+|... +++.||+|+++..... .....+.+|+++++.++|+||+++++++..++..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6888899999999999999876 5889999998754322 2345789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      ++++.+..+...    ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          82 VERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            998776655543    34589999999999999999999999   99999999999999999999999999998766544


Q ss_pred             CceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHH--------HHHhhcCc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV--------KKLHQEGK  530 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~  530 (623)
                      ........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.........        ........
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence            3233445678999999999887 78999999999999999999999986432211000000000        00000000


Q ss_pred             ccc--ccccc----cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQ--MVDKD----LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~--~~~~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...  ..+..    ....++...+.++.+++.+||..+|++|||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            000  00000    0001222235789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.6e-36  Score=306.26  Aligned_cols=261  Identities=26%  Similarity=0.370  Sum_probs=203.7

Q ss_pred             cCHHHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeee
Q 006968          291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCS  368 (623)
Q Consensus       291 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~  368 (623)
                      .++.++..+...|++.+.||+|+||.||+|... +++.||+|++....  ....++..|+.++.++ +|+||+++++++.
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            455666667788999999999999999999974 68899999985432  2334678899999888 6999999999985


Q ss_pred             c------CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 006968          369 T------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF  442 (623)
Q Consensus       369 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  442 (623)
                      .      .+..+++|||+++|+|.+++....  ...+++..+..++.|++.|++|||+.   +|+||||+|+||++++++
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            3      456799999999999999987643  33578889999999999999999999   999999999999999999


Q ss_pred             cEEEeecccccccCCCCCceeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccc
Q 006968          443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGV  517 (623)
Q Consensus       443 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  517 (623)
                      .++|+|||++........ ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||.........  
T Consensus       159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--  235 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--  235 (282)
T ss_pred             CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh--
Confidence            999999999876543221 122345889999999886     345788999999999999999999998632211110  


Q ss_pred             hHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                           .... ..     .....   .....+.++.+++.+||+.||.+|||+.|++++
T Consensus       236 -----~~~~-~~-----~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         236 -----FLIP-RN-----PPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -----hhHh-hC-----CCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                 0000 00     00000   112234679999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=301.08  Aligned_cols=254  Identities=25%  Similarity=0.302  Sum_probs=204.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|++.+.||+|+||.||+|... +++.+|+|.++..... ....+.+|++++++++||||+++++++...+..+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            57888899999999999999875 5788999999754322 456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||+|+||++++++.+||+|||.+.......
T Consensus        82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            9999999988753   24689999999999999999999999   99999999999999999999999999997654322


Q ss_pred             CceeeccccccccccccccccC---CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      . ......++..|+|||.+.+.   .++.++||||||+++|||++|+.|+........       ...... ....   .
T Consensus       156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~~~~~-~~~~---~  223 (262)
T cd06613         156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LFLISK-SNFP---P  223 (262)
T ss_pred             h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHh-ccCC---C
Confidence            1 22334578899999999776   789999999999999999999999864321110       000100 1000   0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..  .......+.++.+++.+||..+|.+|||+.+|+.+
T Consensus       224 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         224 PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00  01123345779999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.2e-36  Score=317.09  Aligned_cols=265  Identities=20%  Similarity=0.258  Sum_probs=198.0

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecC------C
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------N  371 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~  371 (623)
                      .++|.+.+.||+|+||.||++... .++.||||+++.... ......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999865 588999999975432 22345688999999999999999999987543      3


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL  451 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  451 (623)
                      ..++||||+++ +|..++..      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            57999999965 67666643      478899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH--------HHHH
Q 006968          452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--------DWVK  523 (623)
Q Consensus       452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~  523 (623)
                      ++......  ......||..|+|||++.+..++.++|||||||++|||++|+.||...+.........        ++..
T Consensus       173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            98654322  2234468999999999999999999999999999999999999996433211100000        0000


Q ss_pred             H-------Hhhc-Cccc-----ccccccc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          524 K-------LHQE-GKLS-----QMVDKDL---KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       524 ~-------~~~~-~~~~-----~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .       .... ....     .......   ..........++.+++.+|+..||.+|||+.|++++-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp  319 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  319 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            0       0000 0000     0000000   0001111235788999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.4e-36  Score=305.35  Aligned_cols=263  Identities=25%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             CHHHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeec
Q 006968          292 TFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCST  369 (623)
Q Consensus       292 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~  369 (623)
                      +..++..++++|.+.+.||+|+||.||++... +++.+|+|++....  .....+.+|+.++.++ +|||++++++++..
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            34455556788999999999999999999874 68899999986432  2234678899999988 79999999999865


Q ss_pred             C-----CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcE
Q 006968          370 E-----NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA  444 (623)
Q Consensus       370 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  444 (623)
                      .     +..++|+||+++|+|.++++........+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999999876444455789999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeccccccccccccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH
Q 006968          445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML  519 (623)
Q Consensus       445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~  519 (623)
                      ||+|||++......... .....|+..|+|||.+...     .++.++|||||||++|||++|+.||........     
T Consensus       168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-----  241 (291)
T cd06639         168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-----  241 (291)
T ss_pred             EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-----
Confidence            99999998865432221 2234588999999987543     268899999999999999999999863221100     


Q ss_pred             HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          520 DWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        +.... ........+       +......+.+++.+||+.+|++||++.+++++
T Consensus       242 --~~~~~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 --LFKIP-RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             --HHHHh-cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence              01110 011111111       12233578999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.2e-36  Score=301.36  Aligned_cols=251  Identities=26%  Similarity=0.363  Sum_probs=195.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc----cchHHHHHHHHHHhhcCCCceeeeeeeeec--CCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA----GGEVQFQTEVETISLAVHRNLLRLCGFCST--ENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~  373 (623)
                      .+|...+.||+|+||.||+|... ++..||+|.++.....    .....+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999874 5899999998643221    122358889999999999999999998865  3567


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++++||+++++|.+++...    ..+++...+.++.|++.||+|||+.   +|+||||+|+||+++.++.++|+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            8999999999999998753    3588999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCC--ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          454 LLDHRDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       454 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      .......  .......++..|+|||.+.+..++.++||||||+++|||++|+.||.....       ...........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~~~~~--  225 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKIATQP--  225 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcCC--
Confidence            6543211  111234588999999999988899999999999999999999999863211       11111111000  


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                             ....++......+.+++ .||..+|++||+++||+++
T Consensus       226 -------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 -------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             -------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                   01122233345566666 6888999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-36  Score=306.72  Aligned_cols=255  Identities=22%  Similarity=0.346  Sum_probs=201.8

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      +|++.+.||+|+||.||++... +|..||+|.++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5778899999999999999976 689999999875433333457899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|..++.... ....+++..+..++.|++.||.|||+.+  +|+||||||+||+++.++.++|+|||++..+...  
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999998887532 1346899999999999999999999632  8999999999999999999999999998765322  


Q ss_pred             ceeeccccccccccccccccCC------CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                       ......++..|+|||.+.+..      ++.++|||||||++|+|++|+.||......    .....+.... .+.    
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~-~~~----  226 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA----NIFAQLSAIV-DGD----  226 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh----hHHHHHHHHh-hcC----
Confidence             122335788999999985543      478999999999999999999998632210    0011111110 010    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                           ....+.....++.+++.+|+..+|++||++.+++++-
T Consensus       227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~  263 (286)
T cd06622         227 -----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP  263 (286)
T ss_pred             -----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence                 1112333557789999999999999999999998853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-36  Score=303.17  Aligned_cols=253  Identities=24%  Similarity=0.313  Sum_probs=201.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|++.+.||+|+||.||+|... ++..||+|.++... ......|..|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            356888899999999999999875 68999999986532 2334578899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999998753   34689999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CCceeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      .. ......++..|+|||.+.     ...++.++||||||+++|||++|+.||......       ..+..... .... 
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~-  226 (280)
T cd06611         157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVLLKILK-SEPP-  226 (280)
T ss_pred             cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHHHHHhc-CCCC-
Confidence            22 222345889999999875     344678999999999999999999998632211       11111111 1000 


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          .+  ..+...+.++.+++.+||..+|.+||++.+++++
T Consensus       227 ----~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 ----TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ----Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                00  0112234678899999999999999999999886

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3e-36  Score=300.92  Aligned_cols=247  Identities=29%  Similarity=0.409  Sum_probs=198.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|.+.+.||+|+||.||++.. +++.||+|.++...   ....+.+|+.+++.++|||++++++++.. +..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECC
Confidence            4578889999999999999975 67889999986532   34578999999999999999999999865 4579999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|.+++....  ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            9999999997642  34589999999999999999999998   99999999999999999999999999987543221 


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                         .....+..|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+....... +.         
T Consensus       155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~-~~---------  214 (254)
T cd05083         155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KEVKECVEK-GY---------  214 (254)
T ss_pred             ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HHHHHHHhC-CC---------
Confidence               12224568999999988899999999999999999998 8888863221       111111111 10         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ........+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            111112234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.1e-36  Score=300.54  Aligned_cols=258  Identities=28%  Similarity=0.402  Sum_probs=206.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|++.+.||.|+||.||+|... ++..+|+|+++..........+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36888999999999999999864 68899999997655444556789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.++++.... ...+++.....++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999976432 24689999999999999999999999   99999999999999999999999999997765433


Q ss_pred             Cc---eeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          460 SH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       460 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ..   ......|+..|+|||.+... .++.++|+||||+++|||++|+.||.......   ......    ...      
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~----~~~------  223 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTL----QND------  223 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHh----cCC------
Confidence            22   22334588999999998776 78999999999999999999999986332210   111111    100      


Q ss_pred             ccccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          536 DKDLKGNF-DRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       536 ~~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .+.+.... ....+.++.+++.+|+..+|++||++.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00111100 11334678999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6e-36  Score=304.00  Aligned_cols=264  Identities=22%  Similarity=0.280  Sum_probs=200.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|+..+.||+|+||.||+|... +|+.||+|++...... .....+.+|+++++.++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888899999999999999976 5899999998654322 233468899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|..++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999888777653    23589999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH----------hh
Q 006968          459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL----------HQ  527 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~  527 (623)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.   ........          ..
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhcc
Confidence            22 2223457889999999866 4578999999999999999999999864332111   10110000          00


Q ss_pred             cCc-cccccccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          528 EGK-LSQMVDKDLKGNFD-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       528 ~~~-~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ... ......+......+     ...+..+.+++.+||+.+|++||++.|++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            000 00000000000000     1124678999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.9e-36  Score=304.62  Aligned_cols=239  Identities=23%  Similarity=0.335  Sum_probs=186.0

Q ss_pred             ceeccCCeEEEEEEeCC-------------------------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceee
Q 006968          308 ILGRGGFGIVYKGCFSD-------------------------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR  362 (623)
Q Consensus       308 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~  362 (623)
                      .||+|+||.||+|....                         ...||+|.+.... ......|.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            59999999999997421                         2358999986543 223446888999999999999999


Q ss_pred             eeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 006968          363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF  442 (623)
Q Consensus       363 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  442 (623)
                      +++++......++||||+++|+|..++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence            999999999999999999999999988653   34688999999999999999999999   999999999999997643


Q ss_pred             -------cEEEeecccccccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHH-hCCCCCCcccccc
Q 006968          443 -------EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELI-TGQRALDFGRAAN  513 (623)
Q Consensus       443 -------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~ell-tg~~p~~~~~~~~  513 (623)
                             .+|++|||.+......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.......
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                   3799999988643221     12247788999998865 56799999999999999995 6888886322111


Q ss_pred             cccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          514 QRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                          ...+..   ...        ...    .....++.+++.+||+.+|++|||+.+|++.|.
T Consensus       230 ----~~~~~~---~~~--------~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 ----KERFYE---KKH--------RLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ----HHHHHH---hcc--------CCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                011111   000        011    111246889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5e-36  Score=303.35  Aligned_cols=248  Identities=26%  Similarity=0.365  Sum_probs=202.2

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      -|...+.||+|+||.||+|... ++..||+|.+...........+.+|+.++.+++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667789999999999999864 688999999865443444557889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|.+++..     ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            99999998864     3589999999999999999999999   999999999999999999999999999876543221


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                       ......++..|+|||.+.+...+.++|||||||++|+|++|+.|+.....       ..+..... ...         .
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~-~~~---------~  218 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MKVLFLIP-KNN---------P  218 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HHHHHHHh-cCC---------C
Confidence             12234578899999999888889999999999999999999999863211       01111111 110         1


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .......+.++.+++.+|+..+|.+||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11222334678999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.6e-36  Score=301.30  Aligned_cols=253  Identities=25%  Similarity=0.349  Sum_probs=205.9

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      +|+..+.||+|+||.||++... +++.||+|++..........++.+|+++++.+.||||+++++++..++..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677889999999999999976 589999999976554445567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      ++++|.+++....   ..+++.....++.|++.||+|||+ .   +++||||||+||++++++.++|+|||.+.......
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999999987642   568899999999999999999999 7   99999999999999999999999999987654322


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      ..   ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+......  .....+.+........         
T Consensus       156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~---------  221 (265)
T cd06605         156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPP---------  221 (265)
T ss_pred             hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCC---------
Confidence            11   155889999999999889999999999999999999999998643211  1112222222211110         


Q ss_pred             CCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRI-ELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ...+.. ...++.+++.+||..+|++|||+.+++.+
T Consensus       222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 -PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             -CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence             011111 45678999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.5e-36  Score=337.10  Aligned_cols=258  Identities=19%  Similarity=0.297  Sum_probs=201.1

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeec--CCceE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST--ENERL  374 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~  374 (623)
                      ...+|.+.+.||+|+||.||+|... ++..||+|.++..... .....|..|+.+++.++||||+++++++..  ....+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3468999999999999999999875 5788999998754332 234568999999999999999999998854  35689


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCeEECC----------
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD----PKIIHRDVKAANILLDE----------  440 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~Dlk~~NIll~~----------  440 (623)
                      +||||+++|+|.++|.........+++..++.|+.||+.||+|||+...    .+||||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999998754445579999999999999999999998521    25999999999999964          


Q ss_pred             -------CCcEEEeecccccccCCCCCceeecccccccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q 006968          441 -------DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDFGRA  511 (623)
Q Consensus       441 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~  511 (623)
                             .+.+||+|||++..+....  ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                   3348999999998654322  2234468999999999854  4578999999999999999999999963221


Q ss_pred             cccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          512 ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                            ....+..+....        .+.   ....+.++.+++..||..+|.+||++.|++.+
T Consensus       249 ------~~qli~~lk~~p--------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        249 ------FSQLISELKRGP--------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             ------HHHHHHHHhcCC--------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence                  112222211111        000   01123678999999999999999999999853

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.5e-36  Score=310.01  Aligned_cols=259  Identities=21%  Similarity=0.296  Sum_probs=194.6

Q ss_pred             cCCceecc--CCeEEEEEEeC-CCcEEEEEEecccccccc-hHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          305 AKNILGRG--GFGIVYKGCFS-DGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       305 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      +.++||+|  +||+||++... +|+.||+|+++....... ...+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  67899999874 689999999975543222 345778999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.+++..+.  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999987542  23589999999999999999999999   999999999999999999999999987543321111


Q ss_pred             c------eeecccccccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          461 H------VTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       461 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      .      ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......   ......     .+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~-----~~~~~  228 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKL-----NGTVP  228 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH---HHHHHh-----cCCcc
Confidence            0      0112246778999999876  458899999999999999999999996322110   000000     00000


Q ss_pred             ccc-------------------ccc-----------------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          533 QMV-------------------DKD-----------------LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       533 ~~~-------------------~~~-----------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ...                   +..                 ....+......++.+++.+||+.||++|||+.|++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p  308 (327)
T cd08227         229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  308 (327)
T ss_pred             ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence            000                   000                 00011222346789999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-36  Score=306.58  Aligned_cols=263  Identities=22%  Similarity=0.283  Sum_probs=197.3

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|+..+.||+|+||.||+|... +|+.||+|+++..... .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999975 6899999998654322 2234578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      ++ ++|.+++...   ...+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            96 5788777643   34689999999999999999999999   99999999999999999999999999998654332


Q ss_pred             CceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC------ccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG------KLS  532 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~  532 (623)
                      . ......++..|+|||.+.+. .++.++||||||+++|||+||+.|+........   ............      ...
T Consensus       154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07839         154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEESWPGVS  229 (284)
T ss_pred             C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH---HHHHHHHHhCCCChHHhHHhh
Confidence            2 12233478899999988664 468999999999999999999998643222110   011000000000      000


Q ss_pred             ccccc----ccCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          533 QMVDK----DLKG-----NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       533 ~~~~~----~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...+.    ....     ........++.+++.+||..||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            00000    0000     0111234678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.3e-36  Score=301.21  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=199.5

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc---------chHHHHHHHHHHhhcCCCceeeeeeeeecCC
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG---------GEVQFQTEVETISLAVHRNLLRLCGFCSTEN  371 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  371 (623)
                      +|...+.||+|+||.||+|... +|+.||+|.++......         ..+.+..|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667889999999999999864 68999999986422111         1235788999999999999999999999999


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL  451 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  451 (623)
                      ..++||||+++++|.++++..    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++++|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999998764    4689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCc-eeeccccccccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc
Q 006968          452 AKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       452 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      +......... ......|+..|+|||.+....  ++.++||||||+++||+++|+.|+.....      ... ...... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~-~~~~~~-  226 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAA-MFKLGN-  226 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHH-HHHhhc-
Confidence            9765432211 123345889999999987654  78999999999999999999999853211      001 111100 


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ......+..    ......+.++.+++.+|+..+|++|||+.+|+++
T Consensus       227 ~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         227 KRSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            111111111    1112235788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.3e-36  Score=301.35  Aligned_cols=253  Identities=23%  Similarity=0.303  Sum_probs=198.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|.+.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            46777889999999999999864 68899999987543 22334578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++...    ..+++.+...++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          88 CGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            9999999988653    4689999999999999999999999   99999999999999999999999999987654322


Q ss_pred             Cceeeccccccccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      . ......|+..|+|||.+.   ...++.++|||||||++|+|++|+.|+........       +..... ....   .
T Consensus       161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~~~~~~-~~~~---~  228 (267)
T cd06645         161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMTK-SNFQ---P  228 (267)
T ss_pred             c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------HHhhhc-cCCC---C
Confidence            1 223345899999999874   45678899999999999999999999853221100       000000 0000   0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      +....  ....+..+.+++.+|+..+|++||++.+++++
T Consensus       229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00100  00123568899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.8e-36  Score=307.87  Aligned_cols=267  Identities=22%  Similarity=0.330  Sum_probs=200.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++....... ....+.+|+++++.++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36788899999999999999986 58999999986543222 34568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|..+...    ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999988876653    23589999999999999999999999   9999999999999999999999999999865443


Q ss_pred             CCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH-------HHhhcCc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK-------KLHQEGK  530 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~  530 (623)
                      . .......++..|+|||++.+ ..++.++||||||+++|||++|+.||..............+..       .......
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            3 22233457899999998865 4568899999999999999999988863321110000000000       0000000


Q ss_pred             -cccccccccCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 -LSQMVDKDLKGN-----FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 -~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ......+.....     .....+..+.+++.+||..+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence             000000000000     011234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7e-36  Score=304.50  Aligned_cols=267  Identities=22%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|+..+.||+|+||.||+|... +++.||+|.++..........+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56888899999999999999975 68999999987544333334578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      ++ ++|.+++...   ...+++.....++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             CC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            97 4899888754   23689999999999999999999999   99999999999999999999999999987543221


Q ss_pred             Cceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccc-cchHH--------HHHHHhhcC
Q 006968          460 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQR-GVMLD--------WVKKLHQEG  529 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~--------~~~~~~~~~  529 (623)
                      . ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......... ....+        .........
T Consensus       158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence            1 1122346889999998865 45789999999999999999999998643211000 00000        000000000


Q ss_pred             cccc-----ccccccCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          530 KLSQ-----MVDKDLKGNFD-RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       530 ~~~~-----~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ....     .....+..... .....++.+++.+|+..+|++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            0000     00000000000 0012567899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=303.94  Aligned_cols=256  Identities=28%  Similarity=0.357  Sum_probs=202.2

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCC-----
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN-----  371 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~-----  371 (623)
                      ++++|++.+.||+|+||.||+|... +++.+++|.++....  ...++.+|+.+++++ .|+||+++++++....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4678999999999999999999975 578999999875432  345789999999998 6999999999997644     


Q ss_pred             -ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          372 -ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       372 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                       ..++||||+++++|.+++.........+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             48999999999999999876543456789999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      ++........ ......|+..|+|||.+..     ..++.++||||||+++|+|++|+.||.......      . ....
T Consensus       159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~-~~~~  230 (275)
T cd06608         159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------A-LFKI  230 (275)
T ss_pred             cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------H-HHHh
Confidence            9876543222 2233458899999998754     346789999999999999999999986321100      0 0111


Q ss_pred             hhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      . .....     .+  ..+.....++.+++.+||..||++|||+.+++++
T Consensus       231 ~-~~~~~-----~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         231 P-RNPPP-----TL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             h-ccCCC-----CC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0 01000     11  1112244678999999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.1e-36  Score=300.12  Aligned_cols=251  Identities=21%  Similarity=0.322  Sum_probs=203.5

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|+..+.||+|+||.||++... +|+.||+|.+..... .....++.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999865 688999999875432 22345789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++....  ...+++.....++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            99999999887532  23578999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      . ......|+..|+|||++.+...+.++||||||+++++|++|+.|+.....       .+.+..... +...       
T Consensus       156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~-~~~~-------  219 (256)
T cd08218         156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKIIR-GSYP-------  219 (256)
T ss_pred             h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHhc-CCCC-------
Confidence            2 12234478899999999888899999999999999999999999863221       111111111 1110       


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ..+.....++.+++.+||+.+|++||++.+|+++
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 --PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              1122234678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-35  Score=297.63  Aligned_cols=238  Identities=23%  Similarity=0.372  Sum_probs=189.3

Q ss_pred             CceeccCCeEEEEEEeCCCc-----------EEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          307 NILGRGGFGIVYKGCFSDGA-----------LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      +.||+|+||.||+|...+..           .|++|.++.....  ...|.+|+.+++.++||||+++++++.. +..++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            46999999999999986432           5888887654322  5678999999999999999999999988 78899


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-------cEEEee
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-------EAVVGD  448 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~kl~D  448 (623)
                      |+||+++|+|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++       .+||+|
T Consensus        78 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          78 VEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence            999999999999998642   2689999999999999999999999   999999999999999887       799999


Q ss_pred             cccccccCCCCCceeeccccccccccccccccC--CCCCccchhhHHHHHHHHHhC-CCCCCcccccccccchHHHHHHH
Q 006968          449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITG-QRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      ||++.....     .....++..|+|||++...  .++.++||||||+++|||++| ..|+......       .+....
T Consensus       152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-------~~~~~~  219 (259)
T cd05037         152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-------EKERFY  219 (259)
T ss_pred             CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-------hHHHHH
Confidence            999986543     1223467789999999776  789999999999999999994 6666532210       111111


Q ss_pred             hhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .....        .    +......+.+++.+||..+|.+|||+.++++.|+
T Consensus       220 ~~~~~--------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 QDQHR--------L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             hcCCC--------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            10000        0    0001167899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.8e-36  Score=306.37  Aligned_cols=263  Identities=23%  Similarity=0.316  Sum_probs=202.5

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|.+.+.||+|+||.||+|... +|..||+|+++.... ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999975 689999999976543 22345789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      + +++|.+++...   ...+++..++.++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 99999998754   24699999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc----------
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE----------  528 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  528 (623)
                      ........|+..|+|||.+.+. .++.++||||+|+++|||++|+++|.......    ...+.......          
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCCChHHHhhcc
Confidence            3223344589999999998654 46899999999999999999987775322111    11111000000          


Q ss_pred             --CccccccccccC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          529 --GKLSQMVDKDLK----GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       529 --~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        .....+......    .........++.+++.+|+..+|.+|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              000000000000    00011224788999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.8e-36  Score=299.12  Aligned_cols=249  Identities=27%  Similarity=0.396  Sum_probs=201.4

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc----cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA----GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      +|...+.||+|+||.||+|... ++..|++|.+......    .....+.+|+.+++.++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4667789999999999999976 7899999998653321    2335689999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      +||+++++|.+++...    ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999998753    3588999999999999999999999   99999999999999999999999999988654


Q ss_pred             CCCCceeeccccccccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ...  ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||.....       ..............   
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~---  221 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELP---  221 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCC---
Confidence            332  223445889999999987766 89999999999999999999999863221       11111111101111   


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                            .++......+.+++.+||..+|.+||++.+++.+
T Consensus       222 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         222 ------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                  1122234678899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7e-36  Score=311.94  Aligned_cols=263  Identities=25%  Similarity=0.302  Sum_probs=195.0

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecC------
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTE------  370 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------  370 (623)
                      ..++|.+.+.||+|+||.||+|... ++..||||+++..... .....+.+|+.++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999864 6889999998653222 2234578899999999999999999887533      


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      ...++++|++ +++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence            3568999988 7888877753     3589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH--------H
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--------W  521 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~  521 (623)
                      +++.....    .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......+.......        .
T Consensus       164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99865432    223458999999999876 5689999999999999999999999864322111000000        0


Q ss_pred             HHHHhhcC------ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          522 VKKLHQEG------KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       522 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ........      .........+...+ ......+.+++.+|+..||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000      00000000000000 0112457899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.7e-36  Score=329.34  Aligned_cols=267  Identities=19%  Similarity=0.271  Sum_probs=192.7

Q ss_pred             HHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCC------Cceeeeeeeee
Q 006968          296 LRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH------RNLLRLCGFCS  368 (623)
Q Consensus       296 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~~~~~  368 (623)
                      +.....+|.+.+.||+|+||+||+|... .++.||||+++...  .....+..|+.+++.++|      .+++++++++.
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3345678999999999999999999875 58899999996432  122345567777666654      45888999887


Q ss_pred             cC-CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCC----
Q 006968          369 TE-NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDF----  442 (623)
Q Consensus       369 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~----  442 (623)
                      .+ ++.++|||++ +++|.+++...    ..+++..+..++.|++.||+|||+ .   +||||||||+|||++.++    
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence            54 5688999988 77888888653    468999999999999999999997 5   999999999999998765    


Q ss_pred             ------------cEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccc
Q 006968          443 ------------EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR  510 (623)
Q Consensus       443 ------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~  510 (623)
                                  .+||+|||.+.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                        499999998764321    2334569999999999999999999999999999999999999997533


Q ss_pred             ccccccch--------HHHHHHH--------h-hcCccccccccc-c----C-CCC-CHHHHHHHHHHHHHccCCCCCCC
Q 006968          511 AANQRGVM--------LDWVKKL--------H-QEGKLSQMVDKD-L----K-GNF-DRIELEEMVQVALLCTQFNPLHR  566 (623)
Q Consensus       511 ~~~~~~~~--------~~~~~~~--------~-~~~~~~~~~~~~-~----~-~~~-~~~~~~~l~~l~~~cl~~~P~~R  566 (623)
                      .......+        ..|....        . ..+......++. +    . ... .......+.+++.+||..||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            21111000        0111100        0 000000000000 0    0 000 00113567899999999999999


Q ss_pred             CCHHHHHHHh
Q 006968          567 PKMSEVLKML  576 (623)
Q Consensus       567 Ps~~evl~~L  576 (623)
                      ||+.|+++|=
T Consensus       430 ~ta~e~L~Hp  439 (467)
T PTZ00284        430 LNARQMTTHP  439 (467)
T ss_pred             CCHHHHhcCc
Confidence            9999999853

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-36  Score=301.77  Aligned_cols=249  Identities=26%  Similarity=0.361  Sum_probs=200.6

Q ss_pred             CCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcC---CCceeeeeeeeecCCceEEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---HRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .|+..+.||+|+||.||+|.. .++..||+|.++.........++.+|+++++.++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999996 4689999999876544444567889999999886   999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.++++..     .+++.....++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999988642     689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      .... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||......       .+...      ......
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~~------~~~~~~  219 (277)
T cd06917         154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAMML------IPKSKP  219 (277)
T ss_pred             Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hhhhc------cccCCC
Confidence            3322 2334588999999988654 4688999999999999999999999633211       11100      000011


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      +.+...   ..+.++.+++.+||..||++||++.+++++
T Consensus       220 ~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         220 PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            111111   134678999999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-36  Score=303.80  Aligned_cols=240  Identities=20%  Similarity=0.353  Sum_probs=188.3

Q ss_pred             CceeccCCeEEEEEEeCC--------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          307 NILGRGGFGIVYKGCFSD--------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      +.||+|+||.||+|....        ...||+|.+.... ......+..|+.+++.+.||||+++++++..++..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            469999999999998642        2348888875432 2234568899999999999999999999999899999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc--------EEEeecc
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE--------AVVGDFG  450 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~Dfg  450 (623)
                      |+++|+|.++++..   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.        ++++|||
T Consensus        80 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          80 YVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence            99999999999754   23689999999999999999999999   9999999999999987765        5999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCC-CCCCcccccccccchHHHHHHHhhc
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQ-RALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      ++.....     .....++..|+|||.+.+. .++.++||||||+++|||++|. .|+......       .......  
T Consensus       154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-------~~~~~~~--  219 (258)
T cd05078         154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-------KKLQFYE--  219 (258)
T ss_pred             cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------HHHHHHH--
Confidence            8865432     1224578899999999764 5789999999999999999995 454321110       0111100  


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .          ...++.....++.+++.+||+.+|++|||++++++.|+
T Consensus       220 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 D----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             c----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0          01112222367899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.2e-35  Score=298.52  Aligned_cols=251  Identities=24%  Similarity=0.312  Sum_probs=196.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc----cchHHHHHHHHHHhhcCCCceeeeeeeeecC--Cce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA----GGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~  373 (623)
                      .+|.+.+.||+|+||.||+|... +|..||||.+......    .....+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999875 5899999998543211    1224678899999999999999999988653  457


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      +++|||+++++|.+++...    ..+++....+++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            8999999999999998753    3578899999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCC--ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          454 LLDHRDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       454 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      .......  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......      .. .......   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~-~~~~~~~---  224 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AA-IFKIATQ---  224 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HH-HHHHhcC---
Confidence            6542211  1122345889999999998888999999999999999999999998632111      00 0111000   


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                            ......+......+.+++.+|+. +|++||++.+++++
T Consensus       225 ------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         225 ------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                  01112234445678889999985 99999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=295.42  Aligned_cols=246  Identities=25%  Similarity=0.338  Sum_probs=207.9

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEeccc
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP  381 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  381 (623)
                      |.+.++||+|+||+||||.++ .|..||||.+..   ..+-+++..|+.++++++.|++|+.+|.+.....+++|||||.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            566789999999999999876 599999999864   3456678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      -|++.+.++..   +.++++..+..++...++||+|||..   .-||||||+.|||++-+|.+|++|||.|..+.+-. .
T Consensus       112 AGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A  184 (502)
T KOG0574|consen  112 AGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A  184 (502)
T ss_pred             CCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence            99999999865   56899999999999999999999998   88999999999999999999999999998765322 2


Q ss_pred             eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCC
Q 006968          462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG  541 (623)
Q Consensus       462 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  541 (623)
                      ....+.||+.|||||++..-.|..++||||+|+...||..|++|+..-.+..                 ..-++...-..
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-----------------AIFMIPT~PPP  247 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR-----------------AIFMIPTKPPP  247 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc-----------------eeEeccCCCCC
Confidence            2345679999999999999899999999999999999999999986322211                 11112222222


Q ss_pred             CC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          542 NF--DRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       542 ~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .|  ++.-+.++-+++..||..+|++|-|+.+++++
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            33  34456789999999999999999999999885

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-36  Score=308.49  Aligned_cols=253  Identities=25%  Similarity=0.282  Sum_probs=201.8

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      +|+..+.||+|+||.||+|... +++.||+|.+.......  ....+..|+++++.++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            6788899999999999999876 48999999997654332  34568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+.+++|.+++...  ....+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          82 YCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             ecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999998753  234689999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCc----------------------------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccc
Q 006968          459 DSH----------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR  510 (623)
Q Consensus       459 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~  510 (623)
                      ...                            ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            111                            0112357889999999998889999999999999999999999986432


Q ss_pred             ccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 006968          511 AANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK----MSEVLKM  575 (623)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs----~~evl~~  575 (623)
                      ...      .+....          .....-......+..+.+++.+|+..+|++|||    +.|++.+
T Consensus       237 ~~~------~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         237 RDE------TFSNIL----------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hHH------HHHHHh----------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            210      111111          111100001114578999999999999999999    6666664

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.5e-36  Score=307.77  Aligned_cols=196  Identities=24%  Similarity=0.326  Sum_probs=160.2

Q ss_pred             CCceeccCCeEEEEEEeC---CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec--CCceEEEEecc
Q 006968          306 KNILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENERLLVYPYM  380 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~  380 (623)
                      ...||+|+||.||+|...   ++..||+|.++...   ....+.+|++++++++||||+++++++..  +...++|+||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999864   35789999986532   23467899999999999999999998853  45678999998


Q ss_pred             cCCChhhhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----CCCCcEEEeeccc
Q 006968          381 PNGSVASRLRDHI-----HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGL  451 (623)
Q Consensus       381 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Dfgl  451 (623)
                      + ++|.+++....     .....+++..+..++.|++.||.|||+.   +|+||||||+||++    +.++.+||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            6 47777765321     1123588999999999999999999999   99999999999999    5667899999999


Q ss_pred             ccccCCCCCc--eeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCc
Q 006968          452 AKLLDHRDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF  508 (623)
Q Consensus       452 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~  508 (623)
                      ++........  ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            9876543221  1233458999999999876 4579999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.9e-35  Score=301.28  Aligned_cols=267  Identities=22%  Similarity=0.277  Sum_probs=198.6

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++.+|.+.+.||+|+||.||+|... +|..||+|+++..........+.+|+.+++.++|+||+++.+++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3467889999999999999999864 689999999976544444456789999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+. +++.+++...   ...+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9995 7777776543   23578888999999999999999999   999999999999999999999999999875433


Q ss_pred             CCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH-HH----------HHH
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD-WV----------KKL  525 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~-~~----------~~~  525 (623)
                      ... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||........  .+.. |.          ...
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         156 PSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhh
Confidence            221 12233478899999998754 578899999999999999999999964332100  0000 00          000


Q ss_pred             hhcCccccccc-cccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          526 HQEGKLSQMVD-KDLKGNFD-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       526 ~~~~~~~~~~~-~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ........... ........     ......+.+++.+|+..||++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            00000000000 00000000     0113578899999999999999999999764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-36  Score=295.40  Aligned_cols=253  Identities=25%  Similarity=0.280  Sum_probs=203.6

Q ss_pred             CCCcCCceeccCCeEEEEEEeCC-CcEEEEEEecccccccc--hHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGG--EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .|...+.||+|.-|+||++...+ +..+|+|++.+......  ..+.+.|-++|+.+.||.+..|++.++.+...++|||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            45567889999999999999864 68999999977654432  3367889999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC-
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH-  457 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~-  457 (623)
                      ||+||+|....+..  ....+++..++.++..++-||+|||..   |||.|||||+||||.++|++-|+||.++..... 
T Consensus       158 yCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             cCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999988764  356799999999999999999999999   999999999999999999999999998743310 


Q ss_pred             --------------------------------C-CC---------------------ceeeccccccccccccccccCCC
Q 006968          458 --------------------------------R-DS---------------------HVTTAVRGTVGHIAPEYLSTGQS  483 (623)
Q Consensus       458 --------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~  483 (623)
                                                      . ..                     ..+..++||-.|+|||++.+.-.
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 00                     01123568999999999999999


Q ss_pred             CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCC
Q 006968          484 SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNP  563 (623)
Q Consensus       484 ~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P  563 (623)
                      +.++|.|+|||++|||+.|+-||.......                .+..++-+.+.-.-....+..+.+||.+.|.+||
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP  376 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP  376 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchh----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence            999999999999999999999997543211                1112222222211122445788999999999999


Q ss_pred             CCCCC----HHHHHHH
Q 006968          564 LHRPK----MSEVLKM  575 (623)
Q Consensus       564 ~~RPs----~~evl~~  575 (623)
                      .+|-.    +.||-+|
T Consensus       377 ~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  377 SKRLGSKRGAAEIKRH  392 (459)
T ss_pred             hhhhccccchHHhhcC
Confidence            99988    7777653

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-35  Score=297.78  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=201.8

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|+..+.||+|+||.||+|... ++..||+|.++..... .....+..|+++++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999865 6899999998765432 2455789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            9999999998752    3578999999999999999999999   99999999999999999999999999998765433


Q ss_pred             Cceee---ccccccccccccccccCC---CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          460 SHVTT---AVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       460 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      .....   ...++..|+|||++....   .+.++||||||+++||+++|+.||...+..      ......... +.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~------~~~~~~~~~-~~---  223 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE------FQIMFHVGA-GH---  223 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch------HHHHHHHhc-CC---
Confidence            32221   345788999999998766   889999999999999999999999632210      011111100 10   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        .+.+..  .......+.+++.+||+.+|.+|||+.+++.+
T Consensus       224 --~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         224 --KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             --CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence              001110  01124667899999999999999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=315.83  Aligned_cols=242  Identities=24%  Similarity=0.281  Sum_probs=187.8

Q ss_pred             eeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhc---CCCceeeeeeeeecCCceEEEEecccC
Q 006968          309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLA---VHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       309 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      ||+|+||+||+|... +|+.||||++.......  ....+..|..++...   .||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999875 58999999986533221  223455677776655   699999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|..++..    ...+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||++....... ..
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~  152 (330)
T cd05586          81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT  152 (330)
T ss_pred             ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence            999988865    34689999999999999999999999   99999999999999999999999999987543222 22


Q ss_pred             eeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCC
Q 006968          463 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG  541 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  541 (623)
                      .....||..|+|||.+.+. .++.++|||||||++|||++|+.||.....       ........ .+..      .+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~-~~~~------~~~~  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIA-FGKV------RFPK  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHH-cCCC------CCCC
Confidence            3345699999999998754 479999999999999999999999964221       11111111 1110      0110


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 006968          542 NFDRIELEEMVQVALLCTQFNPLHRP----KMSEVLKM  575 (623)
Q Consensus       542 ~~~~~~~~~l~~l~~~cl~~~P~~RP----s~~evl~~  575 (623)
                         .....++.+++.+||..+|++||    ++.+++++
T Consensus       219 ---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         219 ---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence               11235678999999999999998    56666664

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-36  Score=301.26  Aligned_cols=253  Identities=21%  Similarity=0.308  Sum_probs=214.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .-|.+.+.||+|.|..|-+|.+- +|+.||||++.+.+... ....+.+|+..|+.++|||||++|.+..+...+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            34677789999999999998753 79999999998766543 23468999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE-CCCCcEEEeecccccccCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL-DEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~Dfgla~~~~~  457 (623)
                      +=.+|+|++|+..+.   ..+.+..+.+++.||..|+.|+|..   .+|||||||+||.+ .+-|-+|+.|||++..+.+
T Consensus        98 LGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             ecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999998763   4589999999999999999999999   89999999999965 5778999999999988776


Q ss_pred             CCCceeeccccccccccccccccCCCC-CccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      +..  ....+|+..|-|||++.+..|+ +++||||+|||+|-|++|+.||..+.+.                +.+..++|
T Consensus       172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLTmImD  233 (864)
T KOG4717|consen  172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLTMIMD  233 (864)
T ss_pred             cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhhhhhc
Confidence            543  4556799999999999999885 5789999999999999999999754332                12223334


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      -.+  .++.....+..+||..||..||++|.+.++|...-+-+
T Consensus       234 CKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  234 CKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             ccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence            333  35777789999999999999999999999998765543

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-35  Score=298.17  Aligned_cols=252  Identities=26%  Similarity=0.382  Sum_probs=207.3

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      +|++.+.||+|++|.||+|... +++.||||++...........+..|+..+.+++|+|++++++++...+..++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5788899999999999999986 499999999876543344567999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      ++++|.+++...    ..+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999763    468999999999999999999999 8   99999999999999999999999999998765433


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.....    ....+....... ...        
T Consensus       155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~-~~~--------  220 (264)
T cd06623         155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICD-GPP--------  220 (264)
T ss_pred             Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHhc-CCC--------
Confidence            22 2234578999999999998999999999999999999999999864321    011111111111 110        


Q ss_pred             CCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRI-ELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ...+.. .+..+.+++.+|+..+|++||++.+++++
T Consensus       221 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 -PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             111222 45789999999999999999999999884

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-35  Score=298.03  Aligned_cols=254  Identities=27%  Similarity=0.397  Sum_probs=202.2

Q ss_pred             CCCcCCceeccCCeEEEEEEe-CCCcEEEEEEeccccccc-----chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      +|+..+.||+|+||.||+|.. .+++.||+|.++......     ....+.+|++++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999986 468999999987543211     23468999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-cEEEeecccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKL  454 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~~  454 (623)
                      |+||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++ .+||+|||.+..
T Consensus        81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            99999999999998753    3688999999999999999999999   999999999999998776 599999999976


Q ss_pred             cCCCCCc---eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          455 LDHRDSH---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       455 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      .......   ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||........    ........     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~-----  224 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIA-----  224 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHh-----
Confidence            6543211   12234578999999999888899999999999999999999999863221111    11111100     


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          ........+.....++.+++.+|+..+|.+||++.+++++
T Consensus       225 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         225 ----SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ----ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                0011122333445778999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.1e-35  Score=299.88  Aligned_cols=256  Identities=26%  Similarity=0.357  Sum_probs=197.8

Q ss_pred             CCcCCceeccCCeEEEEEEeC----CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCC------
Q 006968          303 FSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------  371 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------  371 (623)
                      |.+.+.||+|+||.||+|...    ++..||||+++..... ....++.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556789999999999999853    3688999998654322 23456889999999999999999999886432      


Q ss_pred             ceEEEEecccCCChhhhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                      ..++++||+++|+|..++.....  ....+++....+++.|++.||+|||+.   +|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            24789999999999988754321  123578999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhh
Q 006968          450 GLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       450 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      |.++........ ......++..|++||.+....++.++||||||+++|||++ |+.||.....       .+.......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-------SEIYNYLIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-------HHHHHHHHc
Confidence            999865432211 1122335678999999988889999999999999999999 8888753221       111111111


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .....          .+...+..+.+++.+|++.+|++||++.++++.|++
T Consensus       231 ~~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 GNRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            11110          111234679999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.7e-36  Score=303.80  Aligned_cols=267  Identities=21%  Similarity=0.278  Sum_probs=200.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecC--CceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv  376 (623)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++...... ....+.+|+.++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999986 58899999997543322 233577899999999999999999998877  889999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||++ ++|.+++....   ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++....
T Consensus        85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            99997 58988887542   3689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH---------HHHHH--
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML---------DWVKK--  524 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~---------~~~~~--  524 (623)
                      ..... .....++..|+|||.+.+. ..+.++|+||||+++|||++|+.||.............         .|...  
T Consensus       158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            43221 2233478899999988654 46899999999999999999999986433211100000         01000  


Q ss_pred             Hhhc--CccccccccccCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          525 LHQE--GKLSQMVDKDLKGNFDRI-ELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       525 ~~~~--~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      +...  ..........+...++.. ....+.+++.+||+.+|++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0000  000001111111222222 35678899999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9.8e-36  Score=302.19  Aligned_cols=267  Identities=25%  Similarity=0.331  Sum_probs=201.7

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      +|+..+.||+|++|.||+|... +|..||||.++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999975 689999999976554444556788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++ +|.+++..... ...+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++++|||++........
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 88888865432 34689999999999999999999999   999999999999999999999999999976543221


Q ss_pred             ceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHH--------HHHhhcCcc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV--------KKLHQEGKL  531 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~  531 (623)
                       ......++..|++||.+.+. .++.++||||||+++|+|++|+.||.............+..        .........
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence             12233478899999988654 56889999999999999999999987443211111000000        000000000


Q ss_pred             cc----ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          532 SQ----MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       532 ~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..    ..+... ..+....+..+.+++.+|++.+|.+||++.+++++
T Consensus       235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         235 KPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00    000000 00111234678899999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.7e-36  Score=312.97  Aligned_cols=261  Identities=23%  Similarity=0.312  Sum_probs=201.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CC-----ceeeeeeeeecCCceE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HR-----NLLRLCGFCSTENERL  374 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~~~~  374 (623)
                      +|.+.++||+|+||.|-||... +++.||||+++....  -..+-..|+.+|..++ |.     |+|++++||.-.++.+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            7899999999999999999864 699999999986542  2334577999999887 43     8999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC--CCcEEEeecccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE--DFEAVVGDFGLA  452 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~Dfgla  452 (623)
                      ||+|.+ .-+|+++++.+.  ...++...++.++.||+.||..||+.   +|||+||||+||||.+  ...+||+|||.+
T Consensus       265 iVfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence            999998 569999998753  44699999999999999999999999   9999999999999974  347999999999


Q ss_pred             cccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH-------HHHHH
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD-------WVKKL  525 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~-------~~~~~  525 (623)
                      ......-   . ....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|......++...+.+       |+-..
T Consensus       339 c~~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  339 CFESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cccCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            8654322   2 45578899999999999999999999999999999999777754433332211111       11110


Q ss_pred             hhcCcccccccc---------------------------------ccC-------CCCCHHHHHHHHHHHHHccCCCCCC
Q 006968          526 HQEGKLSQMVDK---------------------------------DLK-------GNFDRIELEEMVQVALLCTQFNPLH  565 (623)
Q Consensus       526 ~~~~~~~~~~~~---------------------------------~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~  565 (623)
                      ..  +....++.                                 ...       .......-..+.+++.+|+.+||.+
T Consensus       415 ~~--~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  415 AK--KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             cc--ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence            00  00000000                                 000       0111133467899999999999999


Q ss_pred             CCCHHHHHHHh
Q 006968          566 RPKMSEVLKML  576 (623)
Q Consensus       566 RPs~~evl~~L  576 (623)
                      |+|+.|+++|=
T Consensus       493 R~tp~qal~Hp  503 (586)
T KOG0667|consen  493 RITPAQALNHP  503 (586)
T ss_pred             cCCHHHHhcCc
Confidence            99999998863

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-35  Score=296.20  Aligned_cols=250  Identities=26%  Similarity=0.429  Sum_probs=201.2

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|+..+.||+|+||.||++... +++.+|+|.+..... ......+..|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 688999999865432 22345789999999999999999999999988999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CcEEEeecccccccCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgla~~~~~~  458 (623)
                      +++++|.+++....  ...+++..+..++.+++.||+|||++   +++||||+|+||+++++ +.+|++|||.+......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999997632  34589999999999999999999999   99999999999999855 45799999999876433


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ..  .....++..|+|||.+.+...+.++||||||+++|+|++|+.||......       ........ +...      
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------~~~~~~~~-~~~~------  219 (256)
T cd08220         156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALVLKIMS-GTFA------  219 (256)
T ss_pred             cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-------HHHHHHHh-cCCC------
Confidence            21  22345889999999998888899999999999999999999998643211       11111111 1111      


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         ..+...+.++.+++.+||..+|.+|||+.|++++
T Consensus       220 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         220 ---PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ---CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence               1111234678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.6e-36  Score=302.99  Aligned_cols=257  Identities=25%  Similarity=0.339  Sum_probs=196.5

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|...+.||+|+||.||++... ++..||+|.+...........+..|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3455678999999999999875 589999999876544444567899999999996 99999999999999999999999


Q ss_pred             ccCCChhhhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          380 MPNGSVASRLRDH-IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       380 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      +. +++.++.... ......+++....+++.|++.||+|||+..  +++||||||+||+++.++.+||+|||++......
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            86 4555543221 112356899999999999999999999742  8999999999999999999999999999765432


Q ss_pred             CCceeeccccccccccccccccC---CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ..  .....|+..|+|||.+.+.   .++.++||||||+++|||++|+.||.....      ...-+..... +.     
T Consensus       162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~-~~-----  227 (288)
T cd06616         162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------VFDQLTQVVK-GD-----  227 (288)
T ss_pred             Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch------HHHHHhhhcC-CC-----
Confidence            21  1223488999999998776   688999999999999999999999863220      1111111110 00     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .+.+........+.++.+++.+||+.+|++|||+.+|+++
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111111122345679999999999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1e-35  Score=302.04  Aligned_cols=263  Identities=21%  Similarity=0.311  Sum_probs=198.5

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|+..+.||+|+||.||+|... +|..||||+++..... .....+..|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999875 6899999998654322 2234688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +. ++|.+++....  ...+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            95 68888886532  34689999999999999999999999   99999999999999999999999999987654332


Q ss_pred             CceeeccccccccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh-----------
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ-----------  527 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------  527 (623)
                      . ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||........   ..........           
T Consensus       155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCChhhhhhhhH
Confidence            2 122334688999999886644 58899999999999999999999864322111   1111100000           


Q ss_pred             ----cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          528 ----EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       528 ----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          .............. .......++.+++.+|++.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                00000000000000 001123567899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.9e-35  Score=301.19  Aligned_cols=255  Identities=21%  Similarity=0.271  Sum_probs=200.3

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      +|+..+.||+|+||.||++... .++.||+|.++....  ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6888899999999999999875 578999999875432  1223468899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+++.....
T Consensus        82 ~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          82 YVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999653    3689999999999999999999999   9999999999999999999999999998642110


Q ss_pred             C--------------CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH
Q 006968          459 D--------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       459 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      .              ........++..|+|||.+....++.++|+||||+++|||++|+.||.....       .++...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~~~  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQ  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence            0              0011123478899999999888899999999999999999999999863221       111222


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ..... ..   .+..    ....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       228 ~~~~~-~~---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         228 VISDD-IE---WPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHhcc-cC---CCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11111 00   0000    01234678999999999999999997666666655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.6e-35  Score=301.41  Aligned_cols=266  Identities=24%  Similarity=0.286  Sum_probs=199.3

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc----cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA----GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      +|...+.||+|+||.||+|... +|+.||||.++.....    .....+..|++++++++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999975 6899999999765432    1233567899999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+ +|+|.+++....   ..+++..+..++.|+++||+|||++   +|+||||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 999999987532   3689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH-----HhhcCc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK-----LHQEGK  530 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~  530 (623)
                      ..... .....++..|+|||.+.+ ..++.++||||||+++|||++|..+|..................     ......
T Consensus       154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            43222 222346788999998854 46789999999999999999997777532221110000000000     000000


Q ss_pred             cccccccccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKDLKGNF-----DRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .............     ......++.+++.+||+.+|++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000001     11234678999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=308.16  Aligned_cols=245  Identities=30%  Similarity=0.373  Sum_probs=197.7

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      |+..+.||.|+||.||.|... +.+.||||++.-....  ....++..|+..|.+++|||++.+.|+|-.+...+|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            334466999999999999864 6889999999644322  2344789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      | -|+-.+.+.-+   ..++.+..+..|..+.+.||+|||+.   +.||||||+.|||+++.|.||++|||.|....+  
T Consensus       108 C-lGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  108 C-LGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             H-hccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            9 46777777654   45789999999999999999999999   999999999999999999999999999987654  


Q ss_pred             Cceeeccccccccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                         ...++|||.|||||++.   .+.|+-|+||||+|++-.||...++|+.....      +.........+       .
T Consensus       179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQNe-------s  242 (948)
T KOG0577|consen  179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-------S  242 (948)
T ss_pred             ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHhcC-------C
Confidence               34577999999999885   46899999999999999999999999752211      11111111111       1


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      +.+.   ..+-...+..++..||+.-|.+|||..+++++
T Consensus       243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            1111   23345778999999999999999999888764

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.6e-35  Score=301.70  Aligned_cols=248  Identities=29%  Similarity=0.341  Sum_probs=197.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ..|...+.||+|+||.||+|... +|+.||+|.++.....  ....++.+|+++++.++||||+++.+++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45788899999999999999875 6899999998643322  22346889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||++ |++.+++...   ...+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9996 6777766543   23689999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCceeeccccccccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      .     ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+......       ........ ...   
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-------~~~~~~~~-~~~---  231 (307)
T cd06607         168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQ-NDS---  231 (307)
T ss_pred             C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-------HHHHHHhc-CCC---
Confidence            2     2345788999999874   356788999999999999999999998632211       11111111 000   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                        +.   ......+.++.+++.+||..+|++||++.+++.+.
T Consensus       232 --~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         232 --PT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             --CC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence              00   01223456789999999999999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.3e-35  Score=300.43  Aligned_cols=245  Identities=22%  Similarity=0.295  Sum_probs=197.0

Q ss_pred             CCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCC
Q 006968          306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS  384 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  384 (623)
                      ...||+|+||.||+|... ++..||+|.+.... ......+.+|+.++..+.||||+++++++..++..++|+||+++++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            357999999999999875 68999999986543 2334568899999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceee
Q 006968          385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT  464 (623)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  464 (623)
                      |..++..     ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++........ ...
T Consensus       105 L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~  175 (297)
T cd06659         105 LTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK  175 (297)
T ss_pred             HHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence            9887754     3589999999999999999999999   999999999999999999999999999876543222 223


Q ss_pred             ccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCC
Q 006968          465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD  544 (623)
Q Consensus       465 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  544 (623)
                      ...|+..|+|||.+.+..++.++||||||+++|||++|+.||......       .-+..... .....     ..  ..
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~-~~~~~-----~~--~~  240 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMKRLRD-SPPPK-----LK--NA  240 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhc-cCCCC-----cc--cc
Confidence            345889999999998888999999999999999999999998633211       11111111 10000     00  01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       545 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ......+.+++.+|+..+|++||++.+++++
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            1123568899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.5e-35  Score=300.57  Aligned_cols=247  Identities=22%  Similarity=0.314  Sum_probs=197.4

Q ss_pred             CcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          304 SAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       304 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      .....||+|+||.||++... ++..||||.+.... ......+.+|+..++.++||||+++++.+...+..++||||+++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            33467999999999999864 68899999986433 23345688999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      ++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++........ .
T Consensus       104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~  174 (292)
T cd06658         104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K  174 (292)
T ss_pred             CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence            999988753     2588999999999999999999999   999999999999999999999999999876543222 2


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....|+..|+|||...+..++.++||||||+++|||++|+.||......       ..+....      ......... 
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~------~~~~~~~~~-  240 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------QAMRRIR------DNLPPRVKD-  240 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH------hcCCCcccc-
Confidence            22345889999999998888999999999999999999999998632211       1111110      011111111 


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       .......+.+++.+|+..+|.+|||+.+++++
T Consensus       241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             11234578899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-35  Score=295.79  Aligned_cols=251  Identities=27%  Similarity=0.365  Sum_probs=206.4

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|++.+.||+|+||.||++... ++..+|+|.++..... .....+.+|+++++.++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999864 6889999998764422 2344678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++.........+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999977544456789999999999999999999999   9999999999999999999999999999876543 


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                        ......++..|++||.+.+..++.++|+||+|+++|||++|+.||......       .. ......+..        
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~-~~~~~~~~~--------  218 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DL-RYKVQRGKY--------  218 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HH-HHHHhcCCC--------
Confidence              222344788999999999989999999999999999999999998643221       00 111111111        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ...+.....++.+++.+|+..+|++||++.+++++
T Consensus       219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             11223445779999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.5e-35  Score=299.71  Aligned_cols=250  Identities=20%  Similarity=0.308  Sum_probs=201.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .+|.+.+.||+|+||.||+|... ++..||+|.+.... ......+..|+.+++.++|||++++++++...+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            57888899999999999999864 68899999986433 23345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++...     .+++..+..++.|++.||.|||++   +++||||+|+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999998652     478999999999999999999999   99999999999999999999999999987654432


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      . ......|++.|+|||.+....++.++||||||+++|++++|+.||.........       ......+.      +  
T Consensus       170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-------~~~~~~~~------~--  233 (293)
T cd06647         170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIATNGT------P--  233 (293)
T ss_pred             c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-------eehhcCCC------C--
Confidence            2 222345888999999998888999999999999999999999999643221110       00000000      0  


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...........+.+++.+||..+|++||++.+++.+
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            001122234678899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.9e-35  Score=301.14  Aligned_cols=246  Identities=26%  Similarity=0.339  Sum_probs=201.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||++... +++.||+|.++.....  .....+.+|+++++++.||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999875 5899999998654322  23456889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            999999999998753    4689999999999999999999998   999999999999999999999999999987644


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .    .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||......       ....... .+..      
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~-~~~~------  215 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKIL-EGKV------  215 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHh-cCCc------
Confidence            3    23345889999999998888899999999999999999999998643210       0011111 1110      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  575 (623)
                          .++......+.+++.+||..+|.+||     ++.|++++
T Consensus       216 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         216 ----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                11122246788999999999999999     77888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.3e-35  Score=293.27  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=207.7

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|.+.+.||+|+||.||++... ++..||+|++...... .....+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777899999999999999975 5899999999764432 3445789999999999999999999999988999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++.........+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999987544456799999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                       .......|++.|+|||......++.++||||+|+++++|++|+.|+.....       .+....... ...        
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~--------  220 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKILK-GQY--------  220 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHHhc-CCC--------
Confidence             223334588999999999888899999999999999999999999864321       111111111 111        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ...+.....++.+++.+||..+|++|||+.+++++
T Consensus       221 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 -PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             11122334678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-35  Score=298.87  Aligned_cols=263  Identities=21%  Similarity=0.238  Sum_probs=195.5

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecC--CceEEEEe
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTE--NERLLVYP  378 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e  378 (623)
                      |.+.+.||+|+||.||+|... ++..||+|+++............+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            556788999999999999865 689999999876543333445567888888885 99999999999877  88999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |++ |++.+++...   ...+++..+..++.|++.||+|||+.   +++||||+|+||+++. +.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            996 5888877653   24689999999999999999999999   9999999999999999 99999999999876433


Q ss_pred             CCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch--------HHHHHHHhhcC
Q 006968          459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM--------LDWVKKLHQEG  529 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~  529 (623)
                      ..  .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+.....        ..|........
T Consensus       153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            22  122447889999997644 56788999999999999999999999643321110000        01111110000


Q ss_pred             ccccccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          530 KLSQMVDKDLKG---NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       530 ~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ............   ......+.++.+++.+||+.+|++||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000000000000   0012335789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-34  Score=294.42  Aligned_cols=248  Identities=21%  Similarity=0.304  Sum_probs=199.4

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEeccc
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP  381 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  381 (623)
                      |...+.||+|++|.||++... +++.+|+|+++... ......+.+|+.+++.+.||||+++++++...+..++++||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            444578999999999999864 68899999986432 2334568899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      +++|.+++..     ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||.+........ 
T Consensus       100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648         100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            9999998875     2588999999999999999999999   999999999999999999999999998876543222 


Q ss_pred             eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCC
Q 006968          462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG  541 (623)
Q Consensus       462 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  541 (623)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....       .......... ..     +... 
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~~~~-~~-----~~~~-  236 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDN-LP-----PKLK-  236 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHhc-CC-----CCCc-
Confidence            22334588999999999888899999999999999999999999864221       1122222111 10     0010 


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          542 NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       542 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       .....+..+.+++.+||..+|++||++.+++++
T Consensus       237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             -ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence             011134679999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-34  Score=294.70  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=205.5

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .++.|+..+.||+|+||.||+|... ++..||+|+++....  ....+..|+++++.++|+|++++++++...+..++|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4466788889999999999999986 688999999975432  4567899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            9999999999998642   3699999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ... ......++..|++||.+.+..++.++||||||+++|+|++|+.|+......       ........ .......  
T Consensus       169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~~~--  237 (286)
T cd06614         169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFLITT-KGIPPLK--  237 (286)
T ss_pred             chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh-cCCCCCc--
Confidence            322 122334788999999998888999999999999999999999998632211       11111111 1111100  


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                           .....+..+.+++.+|++.+|.+||++.+++++-
T Consensus       238 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         238 -----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             -----chhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence                 1112346789999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=300.66  Aligned_cols=262  Identities=21%  Similarity=0.309  Sum_probs=197.7

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      |+..+.||+|++|.||+|... +|..||+|+++...... ....+..|+++++.++|||++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999875 69999999987543222 2346889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      + ++|.+++....  ...+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 68998886532  23689999999999999999999998   999999999999999999999999999976543222


Q ss_pred             ceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc-----------
Q 006968          461 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE-----------  528 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  528 (623)
                      . .....++..|+|||++.+. .++.++||||||+++|+|++|+.||........   .....+.....           
T Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ---LFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhhhhhc
Confidence            1 1222468899999987654 568899999999999999999999864332111   11111100000           


Q ss_pred             Cc----cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          529 GK----LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       529 ~~----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..    .......... .........+.+++.+|++.+|.+|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         231 PDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00    0000000000 0111223678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=299.60  Aligned_cols=266  Identities=24%  Similarity=0.335  Sum_probs=199.1

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccc-cccchHHHHHHHHHHhhcCCCceeeeeeeeecC--CceEEEEe
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLVYP  378 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e  378 (623)
                      |++.+.||+|+||.||+|... +|+.+|+|+++... .......+.+|+++++.++|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566789999999999999876 58999999997654 122334688999999999999999999999887  88999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++ +|.+++...   ...+++..++.++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9974 888877643   24689999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc--Ccccc--
Q 006968          459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE--GKLSQ--  533 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--  533 (623)
                      .........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............+........  .....  
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            3222333456888999997764 457899999999999999999999986433211110000000000000  00000  


Q ss_pred             ---------ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          534 ---------MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       534 ---------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                               .....+...+...++.++.+++.+||..+|.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                     000000001111125678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-35  Score=296.62  Aligned_cols=249  Identities=23%  Similarity=0.278  Sum_probs=203.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      +|++.+.||.|+||.||+|... ++..||+|.+......  .....+.+|++++++++||||+++++++.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999976 5899999999754322  234578999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|.+++...    ..+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||.+......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999998753    4689999999999999999999999   9999999999999999999999999998865443


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      .  ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+......     ..++.......          
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~----------  216 (258)
T cd05578         154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET----------  216 (258)
T ss_pred             c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc----------
Confidence            2  223345888999999998888999999999999999999999998743321     11111111110          


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHHH
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKM--SEVLK  574 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~--~evl~  574 (623)
                      .....+...+..+.+++.+||+.+|.+||++  +|+++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            0111222334788999999999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.8e-36  Score=309.28  Aligned_cols=244  Identities=27%  Similarity=0.413  Sum_probs=194.2

Q ss_pred             CCceeccCCeEEEEEEeC-CCcEEEEEEecccc---cccchHHHHHHHHHHhhcCCCceeeeeeeeecCCc--eEEEEec
Q 006968          306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN---IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE--RLLVYPY  379 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~--~~lv~e~  379 (623)
                      .++||+|+|-+||||.+. +|-.||--.++...   .......|..|+.+|+.++||||++++.++.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            468999999999999875 47677754443332   23334679999999999999999999999877655  7799999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCcEEEeecccccccCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~~  458 (623)
                      |..|+|..|..++.    ..+...+.+|+.||++||.|||++ .|+|||||||-+||+|+ ..|.|||+|.|+|...+..
T Consensus       125 ~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            99999999998863    588889999999999999999997 78999999999999998 4689999999999987654


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ..   ..+.|||.|||||.+. ..|...+||||||+.++||+|+..|+..-...      ....+++.. |.-...    
T Consensus       200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~------AQIYKKV~S-GiKP~s----  264 (632)
T KOG0584|consen  200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP------AQIYKKVTS-GIKPAA----  264 (632)
T ss_pred             cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH------HHHHHHHHc-CCCHHH----
Confidence            32   3367999999999876 88999999999999999999999998632211      122222221 211111    


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                          +......++.++|.+|+.. .++|||+.|+++
T Consensus       265 ----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  265 ----LSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----hhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                1111236789999999999 999999999987

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.3e-35  Score=294.71  Aligned_cols=251  Identities=22%  Similarity=0.340  Sum_probs=202.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|...+.||+|+||.||+|... +|..||+|.+...... .....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777899999999999999975 5889999998654322 2345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-cEEEeecccccccCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHR  458 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~  458 (623)
                      +++++|.+++....  ...+++..+..++.|+++||.|||+.   +++|+||+|+||++++++ .+|++|||.+......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            99999999987532  33589999999999999999999999   999999999999999875 4699999999876543


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      .. ......|++.|+|||...+..++.++||||||+++|||++|+.|+.....       .++...... +....     
T Consensus       156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~-----  221 (257)
T cd08225         156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQ-GYFAP-----  221 (257)
T ss_pred             cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhc-ccCCC-----
Confidence            22 22234588999999999888899999999999999999999999863221       112222111 11111     


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          .....+.++.+++.+|+..+|++|||+.+++++
T Consensus       222 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         222 ----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                111223678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=8.7e-35  Score=296.98  Aligned_cols=267  Identities=20%  Similarity=0.231  Sum_probs=196.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcC-CCceeeeeeeeecCCc-----
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAV-HRNLLRLCGFCSTENE-----  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~-----  372 (623)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++...... ....+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888899999999999999975 68999999986543222 2346888999999995 6999999999877665     


Q ss_pred             eEEEEecccCCChhhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCcEEEeecc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFG  450 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg  450 (623)
                      .++||||+++ +|.+++...... ...+++..++.++.|+++||.|||+.   +|+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 788888654322 34689999999999999999999999   9999999999999998 8899999999


Q ss_pred             cccccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc-
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE-  528 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  528 (623)
                      ++..+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........   ........... 
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LLHIFKLLGTPT  232 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHhCCCC
Confidence            99865432211 122346889999998865 4578999999999999999999999864322111   00100000000 


Q ss_pred             -Ccccccc---c----cccC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          529 -GKLSQMV---D----KDLK----GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       529 -~~~~~~~---~----~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       .......   +    +...    ....+....++.+++.+||..+|.+||++.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             0000000   0    0000    00011234678999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.4e-35  Score=293.82  Aligned_cols=244  Identities=25%  Similarity=0.293  Sum_probs=198.1

Q ss_pred             eeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCCh
Q 006968          309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV  385 (623)
Q Consensus       309 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  385 (623)
                      ||.|+||.||+|... ++..||+|.+......  .....+.+|+.+++.++||||+++++++.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999975 4899999999754322  3345789999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeec
Q 006968          386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA  465 (623)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  465 (623)
                      .+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            9999763    3588999999999999999999998   99999999999999999999999999998765432  2233


Q ss_pred             cccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCH
Q 006968          466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDR  545 (623)
Q Consensus       466 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (623)
                      ..++..|++||.+....++.++|+||+|+++|+|++|+.|+.....     ...........         ......++.
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~---------~~~~~~~~~  217 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILK---------GNGKLEFPN  217 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhc---------cCCCCCCCc
Confidence            4588999999999888899999999999999999999999964331     01112222111         011112222


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006968          546 IELEEMVQVALLCTQFNPLHRPK-----MSEVLKM  575 (623)
Q Consensus       546 ~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  575 (623)
                      ....++.+++.+||..+|++||+     ++|++++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            23578999999999999999999     7777764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-36  Score=302.60  Aligned_cols=253  Identities=22%  Similarity=0.318  Sum_probs=200.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccc-hHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ...|++.+.||+||.+.||++...+.+.+|+|++........ -..|..|++.|.+++ |.+||+|++|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            356888999999999999999988889999998765433322 335999999999995 999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||= +.+|..+|+...  ....+| .++.+..||+.|+.++|.+   ||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus       440 E~G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             ecc-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            974 568999998753  223445 7889999999999999999   9999999999999864 5899999999998876


Q ss_pred             CCCcee-eccccccccccccccccCC-----------CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          458 RDSHVT-TAVRGTVGHIAPEYLSTGQ-----------SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       458 ~~~~~~-~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      ...... ...+||+.||+||.+....           .+.++||||+|||+|+|+.|+.||....        -.|.   
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--------n~~a---  580 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--------NQIA---  580 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--------HHHH---
Confidence            655433 3567999999999985432           4678999999999999999999996211        0121   


Q ss_pred             hhcCccccccccccCCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIE-LEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          ++..+.++.-.-+|+... ..++.+++..||..||++|||..+++++
T Consensus       581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                233344443322332211 1339999999999999999999999984

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-36  Score=309.90  Aligned_cols=266  Identities=20%  Similarity=0.317  Sum_probs=196.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC-----Cce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~  373 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||+|.++..........+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467999999999999999999864 68999999987543333445688999999999999999999887543     357


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++|+||++ ++|..++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            99999996 477766653     3689999999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCCc--eeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          454 LLDHRDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       454 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      ........  ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+.........+.+... ..+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~-~~~~  233 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP-SQED  233 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-CHHH
Confidence            65432221  1123458899999998754 568899999999999999999999996432211000000000000 0000


Q ss_pred             cccccccc-------c--CCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKD-------L--KGNF-----DRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~-------~--~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...+.+..       .  ....     ......++.+++.+||+.+|++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000       0  0000     01124678999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.5e-34  Score=285.68  Aligned_cols=250  Identities=28%  Similarity=0.398  Sum_probs=204.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      +|...+.||+|++|.||++... ++..+++|+++.... .....+.+|++.++.++|+|++++++++...+..++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            3677889999999999999986 688999999976543 34567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|.+++....   ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||.+........
T Consensus        80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            9999999987642   4689999999999999999999998   999999999999999999999999999987654432


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                        .....++..|++||.+.....+.++||||||+++++|++|+.|+.....       ......... ........    
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~~~~----  219 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-------MKALFKIAT-NGPPGLRN----  219 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-------HHHHHHHHh-cCCCCcCc----
Confidence              2344588999999999888899999999999999999999999863321       011111110 11111110    


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         .......+.+++.+|+..||++|||+.+++++
T Consensus       220 ---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 ---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ---ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               11124678999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-35  Score=300.07  Aligned_cols=270  Identities=21%  Similarity=0.290  Sum_probs=198.5

Q ss_pred             CCCcCCceeccCCeEEEEEEeC---CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecC--CceE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS---DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERL  374 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~  374 (623)
                      +|.+.+.||+|+||.||+|...   ++..||+|.++....  ......+.+|+.++..++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4777889999999999999975   478999999976331  22234678899999999999999999999887  7899


Q ss_pred             EEEecccCCChhhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC----CCcEEEeec
Q 006968          375 LVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE----DFEAVVGDF  449 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~Df  449 (623)
                      +||||+++ ++.+++...... ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 677766544332 23789999999999999999999999   9999999999999999    999999999


Q ss_pred             ccccccCCCCC--ceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccc------hHH
Q 006968          450 GLAKLLDHRDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGV------MLD  520 (623)
Q Consensus       450 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~------~~~  520 (623)
                      |++........  .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...........      +..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322  112234578899999987664 578999999999999999999999975433221000      001


Q ss_pred             HHHHHh-----------hcCccccccccccCCCCC---------H--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          521 WVKKLH-----------QEGKLSQMVDKDLKGNFD---------R--IELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       521 ~~~~~~-----------~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .+..+.           .........+......++         .  ....++.+++.+|++.||++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            110000           000000000000000111         0  223578999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=307.87  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=199.1

Q ss_pred             CCcCCceeccCCeEEEEEEeCC-CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEeccc
Q 006968          303 FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP  381 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  381 (623)
                      |.++..||.|+||.||||..++ +-..|-|++. ......-.+|+-|+++|+.+.||+||+|++.|.-++.+++..|||.
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhc-ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            4456679999999999999775 4445566663 3334445679999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      ||-++..+-..   ...+.+.++.-+..|++.||.|||++   .|||||||+.|||++-+|.++|+|||.+..... ...
T Consensus       113 GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q  185 (1187)
T KOG0579|consen  113 GGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ  185 (1187)
T ss_pred             CchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence            99998887654   45799999999999999999999999   999999999999999999999999999864322 222


Q ss_pred             eeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          462 VTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       462 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ....+.||+.|||||+..     ..+|+.++||||||+++.||..+.+|...-.+      + ..+-++.. .....++.
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------M-RVllKiaK-SePPTLlq  257 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------M-RVLLKIAK-SEPPTLLQ  257 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------H-HHHHHHhh-cCCCcccC
Confidence            344567999999999874     45899999999999999999999999752211      1 11111111 11111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                             +..-...+.+++.+||..||..||++.+++++-.
T Consensus       258 -------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf  291 (1187)
T KOG0579|consen  258 -------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF  291 (1187)
T ss_pred             -------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence                   2333467899999999999999999999987643

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-35  Score=323.24  Aligned_cols=273  Identities=19%  Similarity=0.269  Sum_probs=190.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCC--CcEEEEEEe--------------ccc--ccccchHHHHHHHHHHhhcCCCcee
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSD--GALVAVKRL--------------KDY--NIAGGEVQFQTEVETISLAVHRNLL  361 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~~~--~~~~~~~~~~~e~~~l~~l~H~niv  361 (623)
                      ..+|.+.+.||+|+||+||++..+.  +..+++|.+              .+.  ........+.+|+.++++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999987532  222222211              000  0111234588999999999999999


Q ss_pred             eeeeeeecCCceEEEEecccCCChhhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 006968          362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHI-HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE  440 (623)
Q Consensus       362 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~  440 (623)
                      ++++++...+..++|+|++. ++|.+++.... ..........+..++.|++.||+|||++   +|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            99999999999999999984 57777765421 1122344667788999999999999999   9999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH
Q 006968          441 DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD  520 (623)
Q Consensus       441 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  520 (623)
                      ++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++...........+..
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            99999999999987754433333445699999999999999999999999999999999998854322111111111111


Q ss_pred             HHHHHhh-cCcc-------ccccccc-c---CCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          521 WVKKLHQ-EGKL-------SQMVDKD-L---KGNFDR-----IELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       521 ~~~~~~~-~~~~-------~~~~~~~-~---~~~~~~-----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .+..... ...+       .+.++.. +   ...++.     .....+.+++.+||..||++|||+.|++++-
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp  455 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP  455 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence            1110000 0000       0000000 0   000000     1124577889999999999999999999863

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.9e-34  Score=294.69  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=196.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC-CcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|.+.+.||+|+||.||+|...+ ++.||||.++..........+..|+.++.+.. ||||+++++++......++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567788999999999999999864 89999999976544444556777887776664 9999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |++ +++.+++...   ...+++..+..++.|++.||+|||+.+  +|+||||+|+||++++++.+||+|||++..+...
T Consensus        95 ~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            985 5676666542   237899999999999999999999732  8999999999999999999999999999765432


Q ss_pred             CCceeeccccccccccccccccCC----CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ...  ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||......      .+.+....... ....
T Consensus       169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-~~~~  239 (296)
T cd06618         169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEE-PPSL  239 (296)
T ss_pred             Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCC-CCCC
Confidence            221  2234788999999987654    788999999999999999999998632110      11111111111 0000


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                           .  .......++.+++.+||..+|++||++.+++++-.
T Consensus       240 -----~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         240 -----P--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             -----C--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence                 0  00113467899999999999999999999988754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=324.71  Aligned_cols=261  Identities=27%  Similarity=0.383  Sum_probs=211.0

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC----C----CcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeec
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS----D----GALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCST  369 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~  369 (623)
                      ..++..+.+.||+|.||.|++|...    .    ...||||.++......+.+.+..|+++|+.+ +|+||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3445556679999999999999853    1    4579999999877776777899999999988 59999999999999


Q ss_pred             CCceEEEEecccCCChhhhhhhcc---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHI---H-------GR--PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANIL  437 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIl  437 (623)
                      .+..++|+||+..|+|.++|+...   .       ..  ..++....+.++.|||.|++||++.   ++|||||..+|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEE
Confidence            999999999999999999998765   0       01  2489999999999999999999999   9999999999999


Q ss_pred             ECCCCcEEEeecccccccCCCCCceeecccc--ccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCccccccc
Q 006968          438 LDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQ  514 (623)
Q Consensus       438 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  514 (623)
                      +.++..+||+|||+|+............-.|  ...|||||.+....++.|+|||||||++|||+| |..|+..-.    
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~----  526 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP----  526 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC----
Confidence            9999999999999999765554444333223  456999999999999999999999999999999 555654210    


Q ss_pred             ccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          515 RGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                        ...+.+. ....|         .+...+..+..++.+++..||+.+|++||++.++.+.++.
T Consensus       527 --~~~~l~~-~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  527 --PTEELLE-FLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             --cHHHHHH-HHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence              0111111 11222         1222345567889999999999999999999999999988

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=291.02  Aligned_cols=251  Identities=24%  Similarity=0.318  Sum_probs=198.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccc----cccchHHHHHHHHHHhhcCCCceeeeeeeeecC--Cce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN----IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~  373 (623)
                      .+|.+.+.||+|+||.||+|... ++..||+|.+....    .......+.+|++++++++||||+++++++...  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999864 58999999875322    122234688999999999999999999998654  457


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++++||+++++|.+++...    ..+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            8999999999999988753    3588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC--CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          454 LLDHRD--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       454 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      ......  ........++..|+|||.+.+...+.++||||||+++|+|++|+.||......      .. +...      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~~------  221 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AA-IFKI------  221 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HH-HHHH------
Confidence            653211  11122345889999999998888899999999999999999999998632111      00 1111      


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         ........++.....++.+++.+|+. +|..||++.+++.+
T Consensus       222 ---~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         222 ---ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ---HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence               00111112333445779999999999 57999999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-34  Score=298.07  Aligned_cols=248  Identities=29%  Similarity=0.352  Sum_probs=196.7

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      |...+.||+|+||.||+|... ++..||+|.+......  .....+..|+++++.++|||++++++++..++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            566788999999999999864 6899999998654322  2234688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      ++ |++.+.+...   ...+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++...... 
T Consensus       107 ~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         107 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            96 5777776543   34689999999999999999999999   9999999999999999999999999998754322 


Q ss_pred             Cceeeccccccccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                          ....|+..|+|||.+.   .+.++.++|||||||++|||++|+.||.....       ..........+.      
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~------  241 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNES------  241 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhccC------
Confidence                2335888999999874   45688999999999999999999999853211       111111111111      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         ...........+.+++.+|++.+|.+||++.++++++..
T Consensus       242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence               000112234678999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.6e-35  Score=294.27  Aligned_cols=246  Identities=24%  Similarity=0.292  Sum_probs=190.1

Q ss_pred             ceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHh---hcCCCceeeeeeeeecCCceEEEEeccc
Q 006968          308 ILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETIS---LAVHRNLLRLCGFCSTENERLLVYPYMP  381 (623)
Q Consensus       308 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~---~l~H~niv~l~~~~~~~~~~~lv~e~~~  381 (623)
                      .||+|+||.||++... +++.+|+|.+.......  ....+.+|..++.   ...||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 58999999986543321  2233445544443   3479999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      +|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-  152 (279)
T cd05633          81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (279)
T ss_pred             CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence            99999988753    4699999999999999999999999   999999999999999999999999999875543221 


Q ss_pred             eeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          462 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       462 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                        ....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||........     ........      .    ..
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~------~----~~  215 (279)
T cd05633         153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTL------T----VN  215 (279)
T ss_pred             --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHHHHhh------c----CC
Confidence              22358999999998864 5678999999999999999999999964322110     11111100      0    01


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhc
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKMLEG  578 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L~~  578 (623)
                      ..++...+.++.+++.+|+..||++||     |+++++++-.-
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~  258 (279)
T cd05633         216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF  258 (279)
T ss_pred             cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence            112233446789999999999999999     69999887533

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.8e-35  Score=305.69  Aligned_cols=265  Identities=21%  Similarity=0.278  Sum_probs=198.6

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecC------
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------  370 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------  370 (623)
                      ...+|+..+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3477999999999999999999865 689999999864322 22334677899999999999999999988543      


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      ...++||||+. ++|.+.+..      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            35799999995 577777753      288899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch--------HHHH
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM--------LDWV  522 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~--------~~~~  522 (623)
                      +++.......  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+........        .++.
T Consensus       164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9987543221  23345789999999999999999999999999999999999998643321110000        0010


Q ss_pred             HH-------Hhhc-Cc-----ccccccccc----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          523 KK-------LHQE-GK-----LSQMVDKDL----KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       523 ~~-------~~~~-~~-----~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..       .... ..     ..+......    ..........++.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00       0000 00     001110000    000012335678899999999999999999999886

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.2e-35  Score=297.85  Aligned_cols=265  Identities=25%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCC-----
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-----  371 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----  371 (623)
                      ..++|++.+.||+|+||.||+|... +|+.||+|+++.... ......+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4578899999999999999999986 589999999975432 223346788999999999999999999987654     


Q ss_pred             -----ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 006968          372 -----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV  446 (623)
Q Consensus       372 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  446 (623)
                           ..++|+||+++ ++..++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence                 78999999976 676666543   34689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          447 GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       447 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      +|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||........    ...+...
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~----~~~~~~~  233 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ----LELISRL  233 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHH
Confidence            9999998765433222223346788999998865 3568899999999999999999999864322111    1111111


Q ss_pred             hhcC---cccccc--------cc------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          526 HQEG---KLSQMV--------DK------DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       526 ~~~~---~~~~~~--------~~------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ....   ....+.        +.      ...... ...+..+.+++.+||..+|.+||++.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000   000000        00      000000 1124678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.7e-35  Score=299.99  Aligned_cols=269  Identities=24%  Similarity=0.324  Sum_probs=198.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccc-hHHHHHHHHHHhhcCCCceeeeeeeeecC--CceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l  375 (623)
                      .++|++.+.||+|+||.||+|... +|+.||+|.++....... ...+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467889999999999999999975 589999999875432222 23567899999999999999999998754  46899


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||++ ++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            999996 5788887653   24689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH--------Hh
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK--------LH  526 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~  526 (623)
                      ...... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.............++...        ..
T Consensus       159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            543222 222335788999999865 45789999999999999999999999643321111101010000        00


Q ss_pred             hcCcccc--ccccccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          527 QEGKLSQ--MVDKDLKG--NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       527 ~~~~~~~--~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .......  .-......  ........++.+++.+|++.||++|||+.+++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            0000000  00000000  00011246678999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-34  Score=293.15  Aligned_cols=246  Identities=26%  Similarity=0.326  Sum_probs=194.2

Q ss_pred             eeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCCh
Q 006968          309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV  385 (623)
Q Consensus       309 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  385 (623)
                      ||+|+||+||++... +|+.||+|.+.....  ......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999864 689999999865332  22344578899999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeec
Q 006968          386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA  465 (623)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  465 (623)
                      .+++....  ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||.+......  .....
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG  153 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence            99987642  24689999999999999999999999   9999999999999999999999999998765432  12223


Q ss_pred             cccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCH
Q 006968          466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDR  545 (623)
Q Consensus       466 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (623)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||........    ...+..    ....      ....++.
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~----~~~~------~~~~~~~  219 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKR----RTLE------MAVEYPD  219 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHh----cccc------ccccCCc
Confidence            4578899999999888899999999999999999999999864322111    000000    0000      0111222


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006968          546 IELEEMVQVALLCTQFNPLHRP-----KMSEVLKM  575 (623)
Q Consensus       546 ~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  575 (623)
                      .....+.+++.+||+.+|.+||     ++.+++.+
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            2356789999999999999999     66667653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=274.06  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=197.3

Q ss_pred             cCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEEEecccC
Q 006968          305 AKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       305 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      ....||.|.-|.||++.+. .|...|||.+.......+.++++..+.++.... +|.||+.+|||..+...++.||.|. 
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence            3567999999999999976 589999999987766666667788888776665 8999999999999999999999984 


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      -.++.+++..   ..++++..+-++...+.+||.||.+++  +|+|||+||+|||+|+.|++|+||||++..+-+...  
T Consensus       175 ~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--  247 (391)
T KOG0983|consen  175 TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--  247 (391)
T ss_pred             HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence            3556666554   346888888999999999999999986  999999999999999999999999999977654433  


Q ss_pred             eecccccccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          463 TTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .+..+|-+.|||||.+..   ..|+-++||||||+.++||.||+.||.....      ..+.+..+..++.      +.+
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t------dFe~ltkvln~eP------P~L  315 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT------DFEVLTKVLNEEP------PLL  315 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc------cHHHHHHHHhcCC------CCC
Confidence            233458899999999964   4688899999999999999999999974221      1222333322211      122


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .+  ....+..+.+++..||..|+.+||...+++++
T Consensus       316 ~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  316 PG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             Cc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            21  11134678999999999999999999999885

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=291.10  Aligned_cols=264  Identities=20%  Similarity=0.269  Sum_probs=200.3

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      |...+.||+|++|.||+|... +|+.+|+|+++..... .....+..|++++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            556788999999999999875 6899999998754432 23456889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++ ++.+++...   ...+++..+..++.|+++||+|||+.   +|+|+||+|+||+++.++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            75 888887653   24689999999999999999999999   99999999999999999999999999998765433 


Q ss_pred             ceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc---
Q 006968          461 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD---  536 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  536 (623)
                      .......++..|+|||.+.+. ..+.++||||+|+++|+|++|+.||......+......+.+.... ........+   
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  231 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD-PEVWPKFTSLAR  231 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCc-hHhcccchhhhh
Confidence            122234478899999998776 789999999999999999999999864332111000000000000 000000000   


Q ss_pred             ---cccC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 ---KDLK-------GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ---~~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         ....       .........++.+++.+||..||.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence               0000       01112345789999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=291.56  Aligned_cols=265  Identities=24%  Similarity=0.328  Sum_probs=199.2

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEEEecc
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      |.+.+.||+|+||+||+|... +++.||||++.............+|+..+.+++ |||++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566789999999999999986 478999999876543333445667999999999 999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                       +|+|.+++....  ...+++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||.+........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             889998887642  24689999999999999999999999   999999999999999999999999999986543222


Q ss_pred             ceeeccccccccccccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch---------HHHHHHHhhcCc
Q 006968          461 HVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM---------LDWVKKLHQEGK  530 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~  530 (623)
                        .....++..|+|||.+. ...++.++|+||||++++||++|+.||......+.....         ..|.........
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              22345788999999874 455789999999999999999999998643221110000         011111111111


Q ss_pred             cccccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKDLKG---NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ....+......   .........+.+++.+||..+|++|||++|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            11110000000   0001114678999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.6e-34  Score=286.74  Aligned_cols=252  Identities=28%  Similarity=0.391  Sum_probs=205.1

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecC--CceEEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLVY  377 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~  377 (623)
                      +|...+.||+|++|.||+|... ++..|++|+++.... ......+.+|++++++++||||+++++.+...  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999986 689999999875442 12345789999999999999999999999888  8899999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999998764    2799999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      .... ......++..|+|||.+.....+.++||||||+++++|++|+.||.....      ....+....         .
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~---------~  218 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYKIG---------S  218 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHhcc---------c
Confidence            4321 12334588999999999888899999999999999999999999874331      111111111         0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .......+...+..+.+++.+|+..+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            011112223335789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.9e-34  Score=300.40  Aligned_cols=266  Identities=25%  Similarity=0.359  Sum_probs=197.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhc-CCCceeeeeeeeecC--CceE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE--NERL  374 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~--~~~~  374 (623)
                      .++|.+.+.||+|+||.||+|... +|+.+|+|++..... ......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467888899999999999999975 588999998854321 22334577899999999 999999999998653  3579


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +||||++ ++|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999997 5888887642     688999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCC----ceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHH-------
Q 006968          455 LDHRDS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV-------  522 (623)
Q Consensus       455 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------  522 (623)
                      ......    .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||................       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            643322    12233458899999998754 457889999999999999999999986432211110000000       


Q ss_pred             -HHHhhcCcccccccc----ccC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          523 -KKLHQEGKLSQMVDK----DLK--GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       523 -~~~~~~~~~~~~~~~----~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       .... ......+++.    ...  .......+.++.+++.+||+.+|.+|||+.+++++
T Consensus       237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIK-SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHH-hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence             0000 0000000100    000  00011135778999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-34  Score=296.04  Aligned_cols=267  Identities=19%  Similarity=0.255  Sum_probs=196.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|+..+.||+|++|.||+|... +|+.||+|.++..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999875 6889999998654322 223468899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCcEEEeecccccccCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~  457 (623)
                      |++ ++|.+++....  ...+++..+..++.|++.||+|||++   +++||||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            995 57877775432  23468889999999999999999999   9999999999999985 56799999999976543


Q ss_pred             CCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc------
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK------  530 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  530 (623)
                      ... ......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||......+.......+.... ....      
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  233 (294)
T PLN00009        156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTP-NEETWPGVTS  233 (294)
T ss_pred             Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-Chhhcccccc
Confidence            221 1223347889999998865 457899999999999999999999986433211100000000000 0000      


Q ss_pred             cccccc--cccCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVD--KDLKGN----FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~--~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ......  +.....    .......++.+++.+|++.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000000  000000    011123568899999999999999999999874

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.7e-34  Score=298.07  Aligned_cols=263  Identities=24%  Similarity=0.309  Sum_probs=194.2

Q ss_pred             Cceecc--CCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRG--GFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|  +||+||++... +|+.||+|+++...... ..+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456776  89999999874 79999999987543222 235688999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |++.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+..........
T Consensus        84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            99999988643  23588999999999999999999998   99999999999999999999999998654332111110


Q ss_pred             ------eeccccccccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH----------
Q 006968          463 ------TTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK----------  524 (623)
Q Consensus       463 ------~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----------  524 (623)
                            .....++..|+|||++.+.  .++.++||||||+++|||++|+.||........   .......          
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDITT  235 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccccc
Confidence                  0112245679999998764  468999999999999999999999864321110   0000000          


Q ss_pred             ----------------------HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          525 ----------------------LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       525 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                                            ...........+..+...........+.+++.+||..||++|||+.|++++-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence                                  00000000111111111122345678999999999999999999999987543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.3e-34  Score=293.17  Aligned_cols=253  Identities=23%  Similarity=0.314  Sum_probs=198.4

Q ss_pred             CCCcCCceeccCCeEEEEEEe----CCCcEEEEEEeccccc---ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCce
Q 006968          302 NFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNI---AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENER  373 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  373 (623)
                      +|++.+.||+|+||.||++..    .+|..||+|+++....   ......+..|+.++.++ .|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467789999999999999986    3689999999975332   12235678899999999 599999999999888899


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++|+||+++++|.+++...    ..+++..+..++.|+++||.|||+.   +++||||+|+||+++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999998753    3588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCceeeccccccccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      ..............|+..|+|||.+...  ..+.++||||||+++|+|++|+.|+......   .....+........  
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~--  228 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSE--  228 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc---ccHHHHHHHhhccC--
Confidence            7654333333345588999999998753  4678999999999999999999998642211   11112211111110  


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKM  575 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  575 (623)
                               ..++......+.+++.+|++.+|++||     ++.+++.+
T Consensus       229 ---------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 ---------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ---------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                     011222346788999999999999997     67777664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.5e-34  Score=289.54  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=199.2

Q ss_pred             CCCcCCceeccCCeEEEEEEeCC-CcEEEEEEeccccc----ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNI----AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      +|.+.+.||+|+||.||++.... +..+++|.++....    .....++..|+.+++.++||||+++++++...+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998753 45566666654221    22334577899999999999999999999998999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      +||+++++|.+++.........+++..++.++.|+++||.|||+.   +++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999999976544556799999999999999999999999   9999999999999975 569999999987654


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ... .......|+..|+|||...+..++.++|+||||+++|+|++|+.|+....       .......... +.      
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~-~~------  221 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVE-GP------  221 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHc-CC------
Confidence            322 12233457889999999988888999999999999999999999986321       1111111111 11      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         ....+...+.++.+++.+||..+|++||++.+++++
T Consensus       222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence               111233445788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-34  Score=289.89  Aligned_cols=245  Identities=24%  Similarity=0.332  Sum_probs=196.9

Q ss_pred             eeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCCh
Q 006968          309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV  385 (623)
Q Consensus       309 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  385 (623)
                      ||+|+||.||++... +|+.+|+|.++.....  .....+.+|++++++++||||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986 4999999998654332  3345688999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC-----
Q 006968          386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-----  460 (623)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----  460 (623)
                      .+++...    ..+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9998763    2689999999999999999999999   999999999999999999999999999876433211     


Q ss_pred             --ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          461 --HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       461 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                        .......++..|+|||.......+.++||||||+++|+|++|+.||.....       ......... +...      
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~------  219 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNILN-GKIE------  219 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhc-CCcC------
Confidence              122334578899999999888899999999999999999999999864321       111111111 1110      


Q ss_pred             cCCCCCHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRI--ELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~--~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                          .+..  .+..+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         220 ----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             ----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence                0111  24778999999999999999999666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.4e-34  Score=294.66  Aligned_cols=265  Identities=23%  Similarity=0.327  Sum_probs=194.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCc-----
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENE-----  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----  372 (623)
                      .++|+..+.||+|+||.||+|... +++.||||.+....... ....+.+|++++++++||||+++++++...+.     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357889999999999999999875 68999999986543222 23356789999999999999999999876543     


Q ss_pred             ---eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          373 ---RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       373 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                         .++||||+. ++|.+++...   ...+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence               499999996 4777777543   23689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCc---eeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          450 GLAKLLDHRDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       450 gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      |++.........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||........    ...+...
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~----~~~~~~~  239 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ----LTLISQL  239 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHH
Confidence            999865432221   11233478899999988664 468899999999999999999999864332111    0111111


Q ss_pred             hhc---Ccccc-----cccc-ccCCCC---------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          526 HQE---GKLSQ-----MVDK-DLKGNF---------DRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       526 ~~~---~~~~~-----~~~~-~~~~~~---------~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...   .....     ..+. ......         .......+.+++.+||..||.+|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000   00000     0000 000000         00112457799999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-35  Score=304.70  Aligned_cols=269  Identities=23%  Similarity=0.327  Sum_probs=204.5

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC------ceEE
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------ERLL  375 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~~~l  375 (623)
                      +...+.||+|+||.||+|+.+ .|+.||||.++........+.+.+|++++++++|+|||++++.-.+..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            344578999999999999954 799999999998776777778999999999999999999998765543      5789


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC--CCCc--EEEeeccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDFE--AVVGDFGL  451 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~--~kl~Dfgl  451 (623)
                      |||||.+|+|+..|.+-. ....+++...+.+..+++.||.|||++   +|+||||||.||++-  .+|+  .||+|||.
T Consensus        95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            999999999999998753 345699999999999999999999999   999999999999874  3343  69999999


Q ss_pred             ccccCCCCCceeeccccccccccccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          452 AKLLDHRDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      |+.+.++.  ....++||..|++||.+. .+.|+..+|.|||||++||.+||..||........... ..|.-.......
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~-~~~~~~tkkp~~  247 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE-IMWHIITKKPSG  247 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch-hhhhhhccCCCc
Confidence            99876544  566778999999999998 48899999999999999999999999964333211100 112111111111


Q ss_pred             cccccccccC------------CCCCHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHhhc
Q 006968          531 LSQMVDKDLK------------GNFDRIELEEMVQVALLCTQFNPLHRP--KMSEVLKMLEG  578 (623)
Q Consensus       531 ~~~~~~~~~~------------~~~~~~~~~~l~~l~~~cl~~~P~~RP--s~~evl~~L~~  578 (623)
                      +.-...+..+            ....+.....+-+++..++..+|++|-  .+.+....+.+
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d  309 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD  309 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence            1111111111            112334456677888888999999998  55555444433

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.6e-34  Score=292.44  Aligned_cols=256  Identities=24%  Similarity=0.313  Sum_probs=201.1

Q ss_pred             CCCcCCceeccCCeEEEEEEe----CCCcEEEEEEeccccc---ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCce
Q 006968          302 NFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNI---AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENER  373 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  373 (623)
                      +|.+.+.||+|+||.||++..    .++..||||.++....   ......+..|+.++.++ .||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999874    3578899999875432   12234688999999999 599999999999888899


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++|+|.+++...    ..+++..+..++.|+++||.|||+.   +++||||+|+||+++.++.++|+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999988652    3588999999999999999999998   99999999999999999999999999988


Q ss_pred             ccCCCCCceeeccccccccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      ..............|+..|+|||.+.+..  .+.++||||||+++|||++|+.||.......   ......+.....   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~---  227 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKS---  227 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHcc---
Confidence            75543333333455889999999987655  6889999999999999999999985322111   111111111110   


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                          ..    ..+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       228 ----~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 ----KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                01    1122233668899999999999999999888887765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-34  Score=284.79  Aligned_cols=249  Identities=28%  Similarity=0.433  Sum_probs=202.9

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|++.+.||+|++|.||+|... +++.||+|.+...... .....+.+|++++++++|||++++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777899999999999999875 5789999999765432 2345789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999998753    4689999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .. .....++..|+|||...+...+.++||||+|+++|+|++|+.|+.....      ... ...... ...        
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~-~~~~~~-~~~--------  216 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAA-LFRIVQ-DDH--------  216 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHH-HHHHhc-cCC--------
Confidence            32 2334588999999999888889999999999999999999999863221      000 011110 000        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ..++...+..+.+++.+||..+|++|||+.+++.+
T Consensus       217 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         217 -PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             -CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence             11122234678999999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-34  Score=299.79  Aligned_cols=253  Identities=22%  Similarity=0.351  Sum_probs=211.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccc-hHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ...|.+...||+|.|+.|..|... ++..||||.+.+...... ...+.+|+++|..+.|||||+++.+...+..+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            456888899999999999999875 699999999987665433 245899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||..+|.+.+|+..+    .......+..++.|+.+|++|||++   .|||||||+.|||++.+.++||+|||++..+..
T Consensus       135 eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  135 EYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999875    2345588889999999999999999   999999999999999999999999999988763


Q ss_pred             CCCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                        .......+|++.|.|||+..+..| ++++|+||+|+++|-|+.|..||+...-                    ..+-+
T Consensus       208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------------------k~Lr~  265 (596)
T KOG0586|consen  208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------------------KELRP  265 (596)
T ss_pred             --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------------------ccccc
Confidence              344566789999999999998766 7899999999999999999999984321                    11112


Q ss_pred             cccCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCC
Q 006968          537 KDLKGNF--DRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGL  581 (623)
Q Consensus       537 ~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  581 (623)
                      +.+.+.+  +.-...+..+++.+++..+|.+|++.+++.++-+-...
T Consensus       266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence            2222211  22334678899999999999999999999987665433

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=283.60  Aligned_cols=244  Identities=20%  Similarity=0.270  Sum_probs=188.7

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHH-hhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETI-SLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|... +|+.||||.++.....  .....+..|..++ ....|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999874 5899999998654321  1122344555444 455899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      ++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....     
T Consensus        82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            9999998753    3588999999999999999999999   999999999999999999999999999875432     


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....++..|+|||.+.+..++.++||||||+++|||++|..||......       ........ +...      ....
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~------~~~~  215 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILS-RRIN------WPEE  215 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHh-cccC------CCCc
Confidence            22345788999999998888899999999999999999999999632211       11111111 1100      0111


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .....+.++.+++.+||+.+|++||++.++.+.|
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            1122347789999999999999999776555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.7e-34  Score=289.14  Aligned_cols=244  Identities=22%  Similarity=0.313  Sum_probs=195.3

Q ss_pred             CceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCCh
Q 006968          307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV  385 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  385 (623)
                      ..||+|+||.||+|... +|..||||++.... ......+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            57999999999999874 68999999985432 23445689999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeec
Q 006968          386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA  465 (623)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  465 (623)
                      .+++..     ..+++.....++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++........ ....
T Consensus       105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~  175 (292)
T cd06657         105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS  175 (292)
T ss_pred             HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence            987753     2578999999999999999999999   999999999999999999999999999876543221 2233


Q ss_pred             cccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCH
Q 006968          466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDR  545 (623)
Q Consensus       466 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (623)
                      ..|+..|+|||.+.+..++.++||||+|+++|+|++|+.||......       ........      .....+..  ..
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~~~~~~~------~~~~~~~~--~~  240 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRD------NLPPKLKN--LH  240 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh------hCCcccCC--cc
Confidence            45889999999998888899999999999999999999998632211       11111110      00111100  01


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          546 IELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       546 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..+..+.+++.+||..+|.+||++.+++++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            123568899999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=320.99  Aligned_cols=259  Identities=22%  Similarity=0.307  Sum_probs=211.4

Q ss_pred             HHHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeec
Q 006968          293 FKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCST  369 (623)
Q Consensus       293 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~  369 (623)
                      ..+++...++|.+.++||+|+||.|..++.+ +++.+|+|++++....  ....-|..|..+|.....+-|+.+...|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4567777789999999999999999999975 5899999999874322  234568999999999999999999999999


Q ss_pred             CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                      +..+|+|||||+||+|...|..+.    .+++..++.++..|+.||.-||+.   |+|||||||+|||+|..|++||+||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            999999999999999999998752    689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeecccccccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      |.+-.+.....-.....+|||.|++||++..     +.|+..+|.||+||++|||+.|..||+...       +.+-.++
T Consensus       220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-------lveTY~K  292 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-------LVETYGK  292 (1317)
T ss_pred             hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-------HHHHHHH
Confidence            9998887555555566679999999999952     578999999999999999999999997322       1221222


Q ss_pred             HhhcCccccccccccCCCCC--HHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 006968          525 LHQEGKLSQMVDKDLKGNFD--RIELEEMVQVALLCTQFNPLHRPK---MSEVLKM  575 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~  575 (623)
                      +.....         .-.||  .+.+++..+||.+.+. +|+.|-.   +.++-.|
T Consensus       293 Im~hk~---------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  293 IMNHKE---------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             Hhchhh---------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            211111         11122  2245778888888775 7888877   8888665

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.9e-33  Score=282.82  Aligned_cols=250  Identities=23%  Similarity=0.273  Sum_probs=193.3

Q ss_pred             HHHHHHhcCCCcCCce--eccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeec
Q 006968          294 KELRAATSNFSAKNIL--GRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCST  369 (623)
Q Consensus       294 ~~l~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~  369 (623)
                      .+.....++|.+.+.+  |+|+||.||++..+ ++..+|+|.++......      .|+.....+ +||||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec
Confidence            3444455677777776  99999999999864 68899999986543221      122222222 69999999999999


Q ss_pred             CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-cEEEee
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGD  448 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~D  448 (623)
                      .+..++||||+++++|.+++...    ..+++..+..++.|+++||.|||+.   +++||||+|+||+++.++ .++|+|
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence            99999999999999999999753    3789999999999999999999999   999999999999999988 999999


Q ss_pred             cccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc
Q 006968          449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      ||++.......     ...++..|+|||++.+..++.++||||||+++|||++|+.||.......  -....+....  .
T Consensus       154 fg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--~  224 (267)
T PHA03390        154 YGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ--Q  224 (267)
T ss_pred             CccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh--c
Confidence            99987654321     2358899999999998899999999999999999999999997322111  0111121111  0


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 006968          529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK-MSEVLKM  575 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~  575 (623)
                      ..          ..........+.+++.+||+.+|.+||+ +++++++
T Consensus       225 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        225 KK----------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             cc----------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            00          0111234467899999999999999996 6998864

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.4e-34  Score=291.04  Aligned_cols=257  Identities=18%  Similarity=0.213  Sum_probs=183.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC----CcEEEEEEeccccccc-ch---------HHHHHHHHHHhhcCCCceeeeeee
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAG-GE---------VQFQTEVETISLAVHRNLLRLCGF  366 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~---------~~~~~e~~~l~~l~H~niv~l~~~  366 (623)
                      .+|.+.+.||+|+||.||+|...+    +..+|+|......... .+         .....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            578899999999999999998754    3456666543221110 00         112233344566789999999987


Q ss_pred             eecCC----ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 006968          367 CSTEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF  442 (623)
Q Consensus       367 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  442 (623)
                      +....    ..++++|++. .++.+.+...    ...++..+..++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            65443    3467777764 3555555432    2357888999999999999999999   999999999999999999


Q ss_pred             cEEEeecccccccCCCCCc------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccc-
Q 006968          443 EAVVGDFGLAKLLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQR-  515 (623)
Q Consensus       443 ~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~-  515 (623)
                      .++|+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... 
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999876432211      112345999999999999999999999999999999999999999743211100 


Q ss_pred             c-chHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          516 G-VMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       516 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      . ...++......         ....   ...++.++.+++..|+..+|++||++.++++.++
T Consensus       244 ~~~~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDFIKRLHE---------GKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHHHHHhhh---------hhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            0 00122222111         1100   1122477999999999999999999999998763

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=327.07  Aligned_cols=254  Identities=27%  Similarity=0.338  Sum_probs=205.4

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .+-++.-...||.|.||.||.|.. ++|+..|+|.++..... ...+.+.+|+.++..++|||+|+.+|+-...+..++.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            334566678999999999999985 57999999998765433 2334688999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      ||||++|+|.+.+..    ....++.....+..|++.|++|||++   |||||||||.||+++.+|.+|++|||.|..+.
T Consensus      1313 MEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence            999999999998875    33577788888999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCc---eeeccccccccccccccccCC---CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          457 HRDSH---VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       457 ~~~~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      .....   ......||+.|||||++.+..   -..+.||||+|||+.||+||++||...+.      -+..+..+ .-++
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy~V-~~gh 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMYHV-AAGH 1458 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHhHH-hccC
Confidence            54211   223457999999999997644   35688999999999999999999973222      11112221 1222


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .         .+++.....+-.+++.+|+..||++|.++.|++++
T Consensus      1459 ~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 K---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             C---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            2         23444466788999999999999999999988875

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.4e-34  Score=293.07  Aligned_cols=249  Identities=29%  Similarity=0.343  Sum_probs=196.2

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .|+..+.||+|+||.||+|... ++..||+|.+.....  .....++.+|+++++.++|+|++++.+++...+..++|+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999975 588999999864322  2223468899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+. |++.+++...   ...+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            996 6887777543   34589999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CCceeeccccccccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                           ....++..|+|||.+.   ...++.++|||||||++|+|++|+.|+.....       ......... +....  
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~-~~~~~--  233 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQ-NESPA--  233 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HHHHHHHhh-cCCCC--
Confidence                 2235788999999874   35678899999999999999999999853211       011111111 11100  


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                            .........+.+++.+||..+|++||++.+++++...
T Consensus       234 ------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         234 ------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             ------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence                  0112234678999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-34  Score=288.79  Aligned_cols=262  Identities=24%  Similarity=0.309  Sum_probs=195.6

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhc---CCCceeeeeeeeecCCc-----
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLA---VHRNLLRLCGFCSTENE-----  372 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~H~niv~l~~~~~~~~~-----  372 (623)
                      |++.+.||+|+||.||+|..+ ++..||+|+++...... ....+.+|+.++.++   .|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566789999999999999986 48999999997543322 233566788777655   59999999999987776     


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .+++|||+. ++|.+++....  ...+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||.+
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            899999996 58888886532  23589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ........  .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+.   ...+...........
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  229 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEE  229 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHh
Confidence            87643322  1223478899999999988999999999999999999999988864322111   111111110000000


Q ss_pred             ---------cccccccCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          533 ---------QMVDKDLKG---NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       533 ---------~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                               .........   .........+.+++.+||..||++||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                     000000000   0112334678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-33  Score=290.70  Aligned_cols=262  Identities=24%  Similarity=0.270  Sum_probs=192.5

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEecccc-cccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCC
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS  384 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  384 (623)
                      .+.+|.|+++.||++.. +++.||||+++... .......+.+|+++++.++||||+++++++...+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455555555666554 68999999997652 23344578999999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC----
Q 006968          385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS----  460 (623)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~----  460 (623)
                      |.+++....  ...+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||.+........    
T Consensus        86 l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          86 CEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999998643  23588999999999999999999999   999999999999999999999999998865432211    


Q ss_pred             --ceeeccccccccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH----hh-----
Q 006968          461 --HVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL----HQ-----  527 (623)
Q Consensus       461 --~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~-----  527 (623)
                        .......++..|+|||++...  .++.++||||||+++|||++|+.||........   ..+.....    ..     
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM---LLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCccccccCchh
Confidence              111233477889999998663  578899999999999999999999974322110   00000000    00     


Q ss_pred             --cCcccc----cccc----ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          528 --EGKLSQ----MVDK----DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       528 --~~~~~~----~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                        ......    ..+.    ............++.+++.+||..+|++|||+.+++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence              000000    0000    001112233456789999999999999999999998854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.9e-34  Score=298.62  Aligned_cols=268  Identities=20%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeec----CCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST----ENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~  374 (623)
                      .+|++.+.||+|+||.||+|... +|..||+|+++..... .....+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888999999999999999865 6899999998754322 234567889999999999999999998753    34679


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +|+||+. |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          85 VVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            9999995 688887754    34589999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCCc---eeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH--------HHH
Q 006968          455 LDHRDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--------DWV  522 (623)
Q Consensus       455 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~  522 (623)
                      .......   ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.............        ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5432211   1123468899999998865 468899999999999999999999996432211100000        000


Q ss_pred             HHHhhcCcccccccc-ccCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          523 KKLHQEGKLSQMVDK-DLKGNF-----DRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       523 ~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .... ...+....+. ......     ....+.++.+++.+||+.+|++|||+.+++.+-.
T Consensus       237 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  296 (334)
T cd07855         237 NRIG-SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF  296 (334)
T ss_pred             hhhc-hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence            0000 0000000000 000001     1123577999999999999999999999988643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-34  Score=299.57  Aligned_cols=266  Identities=21%  Similarity=0.295  Sum_probs=200.2

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCC-----ceE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-----ERL  374 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----~~~  374 (623)
                      +|.+.+.||+|+||.||+|... ++..||||++..... ......+.+|+++++.++||||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999975 489999999875432 333457899999999999999999999987765     789


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +||||++ ++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999997 578877764    23799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC--ceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHh-----
Q 006968          455 LDHRDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH-----  526 (623)
Q Consensus       455 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  526 (623)
                      ......  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.............+......     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            654431  122334578899999999887 789999999999999999999999864332111000000000000     


Q ss_pred             --hcCccccccc---cccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          527 --QEGKLSQMVD---KDLK---GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       527 --~~~~~~~~~~---~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ........+.   ....   .......+.++.+++.+||+.+|.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              0000000000   0000   00011134678999999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-34  Score=299.85  Aligned_cols=266  Identities=20%  Similarity=0.291  Sum_probs=197.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccc-cccchHHHHHHHHHHhhcCCCceeeeeeeeecC-----Cc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  372 (623)
                      ..+|.+.+.||+|+||.||+|... ++..||||.++... .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357888999999999999999864 68999999987532 222344678899999999999999999988644     34


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++|+||+. ++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999995 688887764    34689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH-------
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK-------  524 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------  524 (623)
                      ....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..................       
T Consensus       156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            8664332 12233457889999998765 46889999999999999999999998643211100000000000       


Q ss_pred             HhhcCccccc-------cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          525 LHQEGKLSQM-------VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       525 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..........       .+..... .....+.++.+++.+||+.+|++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            0000000000       0000000 011234678999999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.1e-34  Score=286.99  Aligned_cols=244  Identities=25%  Similarity=0.320  Sum_probs=188.4

Q ss_pred             ceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHH---HHhhcCCCceeeeeeeeecCCceEEEEeccc
Q 006968          308 ILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVE---TISLAVHRNLLRLCGFCSTENERLLVYPYMP  381 (623)
Q Consensus       308 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~---~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  381 (623)
                      .||+|+||.||+|... +++.||+|.+......  .....+..|..   .++...||||+++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 5889999998654322  11223444443   3444579999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      +|+|..++..    ...+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++|+|||++.......  
T Consensus        81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            9999988864    34699999999999999999999999   99999999999999999999999999987654322  


Q ss_pred             eeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          462 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       462 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                       .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||.........    . .......      ...   
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----~-~~~~~~~------~~~---  216 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----E-IDRMTLT------MAV---  216 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----H-HHHHhhc------cCC---
Confidence             1234589999999998754 6889999999999999999999999643221110    0 0000000      011   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKML  576 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L  576 (623)
                       ..+...+.++.+++.+|+..+|.+||     ++.+++++-
T Consensus       217 -~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~  256 (278)
T cd05606         217 -ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP  256 (278)
T ss_pred             -CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence             11222346789999999999999999     999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.4e-34  Score=294.08  Aligned_cols=266  Identities=21%  Similarity=0.285  Sum_probs=198.4

Q ss_pred             HHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeec-CCce
Q 006968          297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCST-ENER  373 (623)
Q Consensus       297 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~  373 (623)
                      ...+++|++.+.||+|+||.||+|... ++..||||++..... ......+..|++++..++||||+++.+++.. .+..
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346788999999999999999999865 789999998864322 2234568899999999999999999998865 5678


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++++||+ +++|..++..     ..+++.....++.|+++||+|||+.   +|+||||+|+||+++.++.++|+|||.+.
T Consensus        86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            9999998 5688877753     2578888999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch--------HHHHHH
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM--------LDWVKK  524 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~--------~~~~~~  524 (623)
                      .....    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............        .+|...
T Consensus       157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            54322    122347889999998765 56899999999999999999999998643321110000        011111


Q ss_pred             HhhcCccccccccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          525 LHQEGKLSQMVDKDLKGNFD-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ........-..........+     .....++.+++.+|++.+|++|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            10000000000000001111     1123678999999999999999999999775

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.4e-34  Score=287.48  Aligned_cols=250  Identities=25%  Similarity=0.351  Sum_probs=202.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|...+.||+|+||.||+|... +|..||+|++.....  ......+..|+++++++. ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999975 689999999875332  223456889999999998 99999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            9999999999998763    3699999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCC-------------------ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccc
Q 006968          457 HRDS-------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGV  517 (623)
Q Consensus       457 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  517 (623)
                      ....                   .......++..|+|||.......+.++||||||++++++++|+.|+.....      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------  227 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------  227 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------
Confidence            4321                   112234578899999999888899999999999999999999999874321      


Q ss_pred             hHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 006968          518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKM----SEVLKM  575 (623)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~----~evl~~  575 (623)
                       .........           ....++...+..+.+++.+||+.+|.+||++    .+++++
T Consensus       228 -~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         228 -YLTFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             -HHHHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence             000111110           0111222224678999999999999999999    777664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.7e-33  Score=289.95  Aligned_cols=245  Identities=29%  Similarity=0.380  Sum_probs=193.3

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      |...+.||+|+||.||+|... +|..||+|.+......  .....+..|+++++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999864 6889999998654322  2234688899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +. |++.+++...   ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||++.....  
T Consensus       103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            95 5777777543   34689999999999999999999999   999999999999999999999999999864322  


Q ss_pred             Cceeeccccccccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                         .....|+..|+|||.+.   ...++.++||||||+++|||++|+.|+.....       ...+....... ....  
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~-~~~~--  240 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQND-SPTL--  240 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcC-CCCC--
Confidence               12345888999999984   45678899999999999999999999863221       11111111111 1111  


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                            ........+.+++.+||+.+|.+||++.+++.+
T Consensus       241 ------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 ------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  111223568899999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-35  Score=276.54  Aligned_cols=249  Identities=26%  Similarity=0.340  Sum_probs=202.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccch--HHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGE--VQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .++|...++||+|.||.|..++-+ .|+.+|+|++++..+....  ..-+.|-.+|+..+||.+..+...|+..+.++.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            356788899999999999998865 6999999999886554322  2357788999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||..||.|.-+|.+    ...+++...+.+-..|+.||.|||++   +||.||+|-+|.|+|.||++||+|||+++.--
T Consensus       247 MeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999998888765    34689999999999999999999999   99999999999999999999999999997422


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                       .....+..++||+.|+|||++....|+..+|.|.+||++|||++|+.||...+...    +.+    +        ++-
T Consensus       320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----LFe----L--------Il~  382 (516)
T KOG0690|consen  320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----LFE----L--------ILM  382 (516)
T ss_pred             -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----HHH----H--------HHh
Confidence             23345677899999999999999999999999999999999999999997432211    000    0        000


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLK  574 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~  574 (623)
                      ..+  .++.....+...++...|..||++|.     .++||.+
T Consensus       383 ed~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  383 EDL--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             hhc--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            111  13334446678888999999999995     4555554

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-34  Score=288.13  Aligned_cols=264  Identities=27%  Similarity=0.344  Sum_probs=198.8

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      |+..+.||+|+||.||+|... +++.||+|.++.... ......+..|+.+++.++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999976 489999999976542 223456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      + ++|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||+|+||++++++.++|+|||.+........
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            7 58999987642   4689999999999999999999999   999999999999999999999999999986644322


Q ss_pred             ceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH---------HHHHHHhh---
Q 006968          461 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML---------DWVKKLHQ---  527 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~~---  527 (623)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.............         .|......   
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             12223467789999998776 78999999999999999999999986432211100000         00000000   


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...............+ ......+.+++.+||..+|++||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         233 KPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0000000000000001 1124679999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-35  Score=288.62  Aligned_cols=247  Identities=28%  Similarity=0.364  Sum_probs=200.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      +.|..-++||+|+||.||-.... +|+.+|.|.+.+....  .++.-.+.|-.+|.++..+.||.+-..|.+++.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45777899999999999998764 6999999988554332  23444678999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ..|.||+|.-+|.+.  +.+.+++..+..++.+|+.||++||..   +||.||+||.|||+|++|+++|+|.|+|..+..
T Consensus       265 tlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999998888765  346799999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      +...  ...+||.+|||||++.++.|+...|.||+||++|||+.|+.||.........    +-+.....+         
T Consensus       340 g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----eEvdrr~~~---------  404 (591)
T KOG0986|consen  340 GKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----EEVDRRTLE---------  404 (591)
T ss_pred             CCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----HHHHHHHhc---------
Confidence            5433  3347999999999999999999999999999999999999999622111100    001111000         


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPK  568 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs  568 (623)
                       -...++...+++..++....|..||++|-.
T Consensus       405 -~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  405 -DPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             -chhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence             012344445577888889999999999863

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.5e-34  Score=293.88  Aligned_cols=269  Identities=24%  Similarity=0.304  Sum_probs=194.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCC------
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTEN------  371 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------  371 (623)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....... ....+.+|+++++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467899999999999999999975 68999999986543222 2345788999999999999999999875433      


Q ss_pred             --ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          372 --ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       372 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                        ..++|+||+.+ ++...+...   ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++|+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              46999999964 666666542   34699999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCc----------eeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccch
Q 006968          450 GLAKLLDHRDSH----------VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM  518 (623)
Q Consensus       450 gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~  518 (623)
                      |+++........          ......+++.|+|||.+.+. .++.++||||||+++|||++|++||............
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999765432211          11223468889999987654 5789999999999999999999998643321111100


Q ss_pred             HHHHHHHhh-----cCcccccc----ccccCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          519 LDWVKKLHQ-----EGKLSQMV----DKDLKGNFD---RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       519 ~~~~~~~~~-----~~~~~~~~----~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .........     ........    .........   ......+.+++.+|+..+|++|||+.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            000000000     00000000    000000000   0112568899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.7e-34  Score=316.44  Aligned_cols=254  Identities=27%  Similarity=0.379  Sum_probs=187.0

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC-------
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-------  370 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-------  370 (623)
                      -..+|+..++||+||||.|||++.+ ||+.+|||++.............+|+.++++++|||||+++....+.       
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3467888899999999999999976 89999999997765444455689999999999999999975321000       


Q ss_pred             --------------------------------------------------------------------------------
Q 006968          371 --------------------------------------------------------------------------------  370 (623)
Q Consensus       371 --------------------------------------------------------------------------------  370 (623)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 006968          371 --------------------------------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL  418 (623)
Q Consensus       371 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L  418 (623)
                                                      ..+|+=||||+..++.+++++..-.   -.....++++.+|++||+|+
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHH
Confidence                                            0135667788777777776653211   14677899999999999999


Q ss_pred             HhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC----------------C-CCCceeeccccccccccccccccC
Q 006968          419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD----------------H-RDSHVTTAVRGTVGHIAPEYLSTG  481 (623)
Q Consensus       419 H~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~----------------~-~~~~~~~~~~gt~~y~aPE~~~~~  481 (623)
                      |++   |||||||||.||++|++..|||+|||+|....                . ......+..+||.-|+|||++.+.
T Consensus       714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            999   99999999999999999999999999998721                0 011123445699999999999765


Q ss_pred             ---CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHc
Q 006968          482 ---QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLC  558 (623)
Q Consensus       482 ---~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  558 (623)
                         .|+.|+|+||+|||++||+.   ||.-..   +....+.-++    .+.+..-      ..+.......-.++|.++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM---ERa~iL~~LR----~g~iP~~------~~f~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM---ERASILTNLR----KGSIPEP------ADFFDPEHPEEASLIRWL  854 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchH---HHHHHHHhcc----cCCCCCC------cccccccchHHHHHHHHH
Confidence               49999999999999999987   554211   1111111111    1221111      112223344567899999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 006968          559 TQFNPLHRPKMSEVLK  574 (623)
Q Consensus       559 l~~~P~~RPs~~evl~  574 (623)
                      ++.||.+|||+.|+++
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999986

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-33  Score=292.06  Aligned_cols=260  Identities=24%  Similarity=0.328  Sum_probs=191.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecC------Cc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------NE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~  372 (623)
                      .+|...+.||+|+||.||+|... +|+.||||+++.... ......+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            67888999999999999999864 689999999865332 22234688999999999999999999988654      24


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++|+||+.. +|..++.      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        95 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             EEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            6899999964 6655442      2588999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH--------HHH
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--------WVK  523 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~  523 (623)
                      +.....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............        +..
T Consensus       165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            764322    123357889999999866 4688999999999999999999999974322111000000        000


Q ss_pred             HHhhcC------ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          524 KLHQEG------KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       524 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ......      .........+...+ .....++.+++.+||+.||++||++.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000      00000000000000 1123568899999999999999999999875

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-33  Score=293.91  Aligned_cols=265  Identities=23%  Similarity=0.267  Sum_probs=196.0

Q ss_pred             cCCC-cCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccc-------------hHHHHHHHHHHhhcCCCceeeeee
Q 006968          301 SNFS-AKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-------------EVQFQTEVETISLAVHRNLLRLCG  365 (623)
Q Consensus       301 ~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------------~~~~~~e~~~l~~l~H~niv~l~~  365 (623)
                      ++|. +.+.||+|+||.||+|... +++.||||.++.......             ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4454 3467999999999999865 689999999865432221             124778999999999999999999


Q ss_pred             eeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEE
Q 006968          366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       366 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                      ++..++..++||||++ |+|.+++..    ...+++.....++.|++.||+|||+.   +|+||||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            9999999999999996 688888864    34589999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCC-------------CceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccc
Q 006968          446 VGDFGLAKLLDHRD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRA  511 (623)
Q Consensus       446 l~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~  511 (623)
                      |+|||++.......             ........++..|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999997654111             1111223467889999998764 468999999999999999999999864432


Q ss_pred             cccccchHHHHHHHhhcC---cccccc--------ccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          512 ANQRGVMLDWVKKLHQEG---KLSQMV--------DKDLKGN---FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~---~~~~~~--------~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ...    ...+.......   .+....        .......   .......++.+++.+|++.+|++|||+.|++.+-.
T Consensus       240 ~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        240 IDQ----LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             HHH----HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            111    11111100000   000000        0000000   01112467889999999999999999999997543

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-33  Score=291.70  Aligned_cols=270  Identities=24%  Similarity=0.280  Sum_probs=198.5

Q ss_pred             HHHHHHHhcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecC
Q 006968          293 FKELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE  370 (623)
Q Consensus       293 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~  370 (623)
                      ..++....++|.+.+.||+|+||.||+|.. .+|+.||+|+++.... ......+.+|+.++.+++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            455666788999999999999999999985 4689999999875321 22244678899999999999999999987543


Q ss_pred             ------CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcE
Q 006968          371 ------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA  444 (623)
Q Consensus       371 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  444 (623)
                            ...+++++++ +++|.+++..     ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence                  3467888876 7888887753     2589999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH---
Q 006968          445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD---  520 (623)
Q Consensus       445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~---  520 (623)
                      ||+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............   
T Consensus       160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999998764322    223457889999998866 5678899999999999999999999854322111000000   


Q ss_pred             -----HHHHHhhc--CccccccccccCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          521 -----WVKKLHQE--GKLSQMVDKDLKGNFD---RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       521 -----~~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                           ........  ......+.......+.   .....++.+++.+|+..+|.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                 00000000  0000000000000000   0123568899999999999999999999876

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-33  Score=290.07  Aligned_cols=263  Identities=24%  Similarity=0.310  Sum_probs=195.1

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCC-----
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-----  371 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-----  371 (623)
                      ..++|.+.+.||+|+||.||+|... +|..||||+++.... ......+.+|+.++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            3567999999999999999999854 689999999864322 222346889999999999999999999886543     


Q ss_pred             -ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          372 -ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       372 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                       ..++||||+ +++|.+++..     ..+++..++.++.|+++||+|||+.   +|+||||||+||+++.++.++++|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence             358999998 7788877753     3589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccc--------hHHH
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGV--------MLDW  521 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~--------~~~~  521 (623)
                      ++......    .....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||...........        ...+
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99865432    123357889999998876 4578999999999999999999999864322110000        0011


Q ss_pred             HHHHhhcCc------cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          522 VKKLHQEGK------LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       522 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .........      ........+. .........+.+++.+|+..||++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111000000      0000000000 0011223568899999999999999999999864

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=275.20  Aligned_cols=254  Identities=26%  Similarity=0.321  Sum_probs=196.0

Q ss_pred             CCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhh-cCCCceeeeeeeeecCCceEEEEecccCC
Q 006968          306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYMPNG  383 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~g  383 (623)
                      ...||.|+||+|+|-.++ .|+..|||+++......+.++++.|.+...+ -+.||||+++|.+..++..++.||.|. -
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence            456999999999998875 6999999999988776777789999887654 479999999999999999999999994 4


Q ss_pred             Chhhhhhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          384 SVASRLRD-HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       384 sL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |++.+-.. +.-++..+++.-.-+|+.-.+.||.||-+..  .|||||+||+|||+|..|.+|+||||++..+..+-  .
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--A  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--A  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH--H
Confidence            55543322 1223456888888999999999999999875  89999999999999999999999999997764322  2


Q ss_pred             eeccccccccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          463 TTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                      .+.-+|-..|||||.+...  .|+-+|||||+|++++|+.||+.|+.....      ..+-+.+++. ++...+.... .
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~~Vv~-gdpp~l~~~~-~  295 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLCQVVI-GDPPILLFDK-E  295 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHHHHHc-CCCCeecCcc-c
Confidence            2333578899999999643  478899999999999999999999863222      1222333322 2222111110 0


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         .......+.+++.-|+.+|-.+||...++.++
T Consensus       296 ---~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  296 ---CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ---ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence               12245779999999999999999999998763

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7e-34  Score=269.54  Aligned_cols=271  Identities=21%  Similarity=0.319  Sum_probs=199.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC-----CcEEEEEEecccccccc-hHHHHHHHHHHhhcCCCceeeeeeeeec-CCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCST-ENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~  373 (623)
                      ..|+....||+|+||.||||+-.+     ...+|+|.++......+ .....+|+.+++.++|||++.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            468889999999999999996432     23799999987643322 3467899999999999999999998877 7789


Q ss_pred             EEEEecccCCChhhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC----CcEEEee
Q 006968          374 LLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED----FEAVVGD  448 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~D  448 (623)
                      +|++||.+. +|...++.+... ...++.....+|+.||+.|+.|||++   =|+||||||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999976 777777655332 24688889999999999999999999   79999999999999877    8999999


Q ss_pred             cccccccCCCCCc--eeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCccccccccc--chHHHHH
Q 006968          449 FGLAKLLDHRDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRG--VMLDWVK  523 (623)
Q Consensus       449 fgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~--~~~~~~~  523 (623)
                      ||+++.+...-..  ....++.|..|.|||.+.+. .||.+.||||.|||+.||+|-++-|...+......  ...+-+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999998754332  23456689999999999874 68999999999999999999988876543322211  1111111


Q ss_pred             HHhh-c-----Ccccc---cccc-----ccC-CCCCH-----------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          524 KLHQ-E-----GKLSQ---MVDK-----DLK-GNFDR-----------IELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       524 ~~~~-~-----~~~~~---~~~~-----~~~-~~~~~-----------~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .+.. -     .+...   +.+-     .++ ..+..           ......++|+.++|..||.+|.|+++.+++
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            1100 0     00000   0000     000 00000           001237889999999999999999999875

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-33  Score=293.11  Aligned_cols=262  Identities=23%  Similarity=0.309  Sum_probs=192.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC---------
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE---------  370 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~---------  370 (623)
                      .+|.+.+.||.|+||.||+|... +|..||+|.+..... .....+.+|+++++.++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            57888999999999999999875 589999999865443 3445688999999999999999999776543         


Q ss_pred             -----CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCcE
Q 006968          371 -----NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEA  444 (623)
Q Consensus       371 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~  444 (623)
                           ...++|+||++ ++|.+++..     ..+++..++.++.|+++||.|||+.   +|+||||||+||+++ .++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 35789999997 588877753     2588999999999999999999999   999999999999998 45678


Q ss_pred             EEeecccccccCCCCCc--eeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHH
Q 006968          445 VVGDFGLAKLLDHRDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDW  521 (623)
Q Consensus       445 kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  521 (623)
                      |++|||++.........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||..........   ..
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~~  231 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ---LI  231 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH
Confidence            99999999865432211  1122347889999998654 567889999999999999999999996433211100   00


Q ss_pred             HHHHhh-----cC----ccccccc-cccCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          522 VKKLHQ-----EG----KLSQMVD-KDLKGN-----FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       522 ~~~~~~-----~~----~~~~~~~-~~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ......     ..    ....... ......     .......++.+++.+|+..||++|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            000000     00    0000000 000000     001123678899999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-33  Score=276.83  Aligned_cols=240  Identities=30%  Similarity=0.334  Sum_probs=194.9

Q ss_pred             eeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCCh
Q 006968          309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV  385 (623)
Q Consensus       309 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  385 (623)
                      ||+|+||.||++... +++.+|+|.++......  ....+..|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999975 58999999987654322  344789999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeec
Q 006968          386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA  465 (623)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  465 (623)
                      .+++...    ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~  152 (250)
T cd05123          81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT  152 (250)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence            9998753    3589999999999999999999998   99999999999999999999999999998654332 12334


Q ss_pred             cccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCH
Q 006968          466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDR  545 (623)
Q Consensus       466 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (623)
                      ..++..|++||...+...+.++|+||||+++|++++|+.||...+.       ......... ..          ..++.
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~-~~----------~~~~~  214 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILK-DP----------LRFPE  214 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhc-CC----------CCCCC
Confidence            4588899999999888889999999999999999999999964322       111111111 00          11222


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCH---HHHHH
Q 006968          546 IELEEMVQVALLCTQFNPLHRPKM---SEVLK  574 (623)
Q Consensus       546 ~~~~~l~~l~~~cl~~~P~~RPs~---~evl~  574 (623)
                      ..+.++.+++.+||..||++||++   .++++
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            224778999999999999999999   55544

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.1e-33  Score=290.21  Aligned_cols=264  Identities=23%  Similarity=0.298  Sum_probs=196.5

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCc----
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE----  372 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~----  372 (623)
                      ..++|...+.||+|+||.||+|... ++..||||++..... ......+.+|+.+++.++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3567889999999999999999975 588999999865321 2233457789999999999999999998766554    


Q ss_pred             --eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          373 --RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       373 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                        .++|+||+ +++|.+++..     ..+++..+..++.|+++||+|||+.   +|+||||+|+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 6788888764     3589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH--------H
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--------W  521 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~  521 (623)
                      ++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............+        +
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            99865432    223457889999998865 3678999999999999999999999864322111000000        0


Q ss_pred             HHHHhhcC--ccccccccccCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          522 VKKLHQEG--KLSQMVDKDLKGNFD---RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       522 ~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ........  .............+.   .....++.+++.+|+..+|++|||+.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00000000  000000000000010   1124678999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.3e-32  Score=286.01  Aligned_cols=266  Identities=21%  Similarity=0.250  Sum_probs=191.6

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-C--CcEEEEEEecccccc-cchHHHHHHHHHHhhc-CCCceeeeeeeeec----CCc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-D--GALVAVKRLKDYNIA-GGEVQFQTEVETISLA-VHRNLLRLCGFCST----ENE  372 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~  372 (623)
                      +|.+.+.||+|+||.||++... +  +..||+|+++..... .....+.+|+.++.++ .||||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999975 3  779999998643222 2245678899999998 59999999987533    245


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++++||+. ++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            788889885 688888754    34689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCc---eeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch--------HH
Q 006968          453 KLLDHRDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM--------LD  520 (623)
Q Consensus       453 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~--------~~  520 (623)
                      .........   ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||............        .+
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            865432211   1223458999999998765 46789999999999999999999998643321100000        01


Q ss_pred             HHHHHhhcCc--cccccccccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          521 WVKKLHQEGK--LSQMVDKDLKGNF---DRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       521 ~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      +.........  ........-...+   .......+.+++.+|++.+|++|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            1111100000  0000000000000   01123678999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=273.40  Aligned_cols=266  Identities=24%  Similarity=0.292  Sum_probs=215.4

Q ss_pred             HHHHHHHhcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeee
Q 006968          293 FKELRAATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF  366 (623)
Q Consensus       293 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~  366 (623)
                      ..++.....++....++-+|.||.||.|.|.      +.+.|-||.++...++-.-..+++|.-.+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3466666677888889999999999999764      3456888888776655555568889888888999999999999


Q ss_pred             eec-CCceEEEEecccCCChhhhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC
Q 006968          367 CST-ENERLLVYPYMPNGSVASRLRDHIH----GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED  441 (623)
Q Consensus       367 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  441 (623)
                      +.+ .+..+++|.++.-|+|..||.....    ....++..+...++.|++.|++|||.+   ++||.||..+|.+||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            865 4568999999999999999984432    234578888999999999999999999   99999999999999999


Q ss_pred             CcEEEeecccccccCCCCCceee-ccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchH
Q 006968          442 FEAVVGDFGLAKLLDHRDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVML  519 (623)
Q Consensus       442 ~~~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~  519 (623)
                      .++||+|=.+++.+-+.+++... .......||+||.+.+..|+..+|||||||++|||+| |+.|+..-++.+      
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------  506 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------  506 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence            99999999999988877766543 3346789999999999999999999999999999998 788876433321      


Q ss_pred             HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          520 DWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                        +..+..+|         .+-.-+-.++.++..++.-||...|++||+++|++.-|.+
T Consensus       507 --m~~ylkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  507 --MEHYLKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             --HHHHHhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence              11111112         1111233467999999999999999999999999998865

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.5e-32  Score=305.94  Aligned_cols=146  Identities=31%  Similarity=0.394  Sum_probs=130.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|... +++.||||+++......  ....+..|+.++..++||||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999976 68999999997543221  2346889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||..   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998753    3588999999999999999999999   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.5e-32  Score=271.24  Aligned_cols=219  Identities=22%  Similarity=0.212  Sum_probs=176.1

Q ss_pred             cCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCChhhhhh
Q 006968          312 GGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR  390 (623)
Q Consensus       312 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~  390 (623)
                      |.||.||++... +++.||+|+++...      .+..|...+....||||+++++++...+..++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999875 68999999987543      23345555555679999999999999999999999999999999987


Q ss_pred             hccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeecccccc
Q 006968          391 DHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV  470 (623)
Q Consensus       391 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~  470 (623)
                      ..    ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++++|||.+......    .....++.
T Consensus        78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~  146 (237)
T cd05576          78 KF----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN  146 (237)
T ss_pred             Hh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence            53    3589999999999999999999999   9999999999999999999999999988655432    12234577


Q ss_pred             ccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHH
Q 006968          471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEE  550 (623)
Q Consensus       471 ~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (623)
                      .|+|||.+....++.++||||+|+++|||++|+.|+.......               ..   ....    ..+......
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~---~~~~----~~~~~~~~~  204 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NT---HTTL----NIPEWVSEE  204 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------cc---cccc----CCcccCCHH
Confidence            8999999988889999999999999999999998865211100               00   0000    112223467


Q ss_pred             HHHHHHHccCCCCCCCCCH
Q 006968          551 MVQVALLCTQFNPLHRPKM  569 (623)
Q Consensus       551 l~~l~~~cl~~~P~~RPs~  569 (623)
                      +.+++.+|++.||++||++
T Consensus       205 ~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHccCCHHHhcCC
Confidence            8899999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=265.36  Aligned_cols=264  Identities=23%  Similarity=0.300  Sum_probs=202.2

Q ss_pred             CHHHHHHHhcCCCcCCceeccCCeEEEEEE-eCCCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeec
Q 006968          292 TFKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCST  369 (623)
Q Consensus       292 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~  369 (623)
                      ++.|+.+.++     +.||+|+|+.|.-++ ..+|..+|||++.+. ....+.+..+|++++.+.+ |+||++++.+|.+
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            3566665553     789999999998887 458999999999765 3455678899999999985 9999999999999


Q ss_pred             CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc---EEE
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE---AVV  446 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl  446 (623)
                      +...|||||-|.||.|..+++.+    ..+++..+.++..+|+.||.+||.+   ||.|||+||+|||-.+...   +||
T Consensus       148 d~~FYLVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             cceEEEEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence            99999999999999999998864    4689999999999999999999999   9999999999999875543   799


Q ss_pred             eecccccccCC--CC----Cceeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccc
Q 006968          447 GDFGLAKLLDH--RD----SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQR  515 (623)
Q Consensus       447 ~Dfgla~~~~~--~~----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~  515 (623)
                      +||.++.-+..  .-    .......+|+..|||||+..     ...|+.+.|.||+|||+|-|++|-+||...=.++..
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            99998764321  11    11223456899999999873     346789999999999999999999999642221110


Q ss_pred             ---cch----HHHHHHHhhcCccccccccccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          516 ---GVM----LDWVKKLHQEGKLSQMVDKDLKGNFDR----IELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       516 ---~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         +..    ..-+-.-.+++.+          +|+.    ..+.+..+++...+..++.+|-++.+++.+-+-
T Consensus       301 WdrGe~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~  364 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV  364 (463)
T ss_pred             ccCCCccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence               100    0111111111211          1233    234667889999999999999999999885443

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=241.92  Aligned_cols=266  Identities=20%  Similarity=0.272  Sum_probs=199.5

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccc-hHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +|...++||+|.||+|+||+.. +++.||+|+++-....++ .....+|+-+++.++|.|||++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4556688999999999999865 589999999986554333 33579999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +. -+|..|....   ++.++....+.++.|+++||.++|++   ++.|||+||.|.|++.+|+.|++|||+++.++-.-
T Consensus        83 cd-qdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CD-QDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hh-HHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            95 4677766543   45799999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccc-cchHHHHHHHhhcCc--ccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQR-GVMLDWVKKLHQEGK--LSQMV  535 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~  535 (623)
                      . .....+.|..|.+|.++.+. -|+...|+||-|||+.|+.....|...+.+...+ ..+...+....++.+  +.++.
T Consensus       156 r-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             E-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            2 33444579999999999875 5788999999999999999876665433221111 111111111111111  12222


Q ss_pred             ccccCCCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          536 DKDLKGNFDR---------IELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       536 ~~~~~~~~~~---------~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      |-....-|+.         .-...-.+++...+.-+|.+|.++++.+++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            2222222221         112345778888888999999999998875

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=8.1e-33  Score=261.23  Aligned_cols=250  Identities=23%  Similarity=0.285  Sum_probs=195.1

Q ss_pred             hcCCCcC-CceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeec----CCc
Q 006968          300 TSNFSAK-NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCST----ENE  372 (623)
Q Consensus       300 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~----~~~  372 (623)
                      +++|.+. ++||-|-.|.|-....+ +|+.+|+|++.+..      ...+|+++-... .|||||.++++|..    ...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            4455443 58999999999888765 68999999986532      346788776544 69999999998854    456


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC---CCCcEEEeec
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDF  449 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Df  449 (623)
                      +++|||.|+||.|.+.+.++  +..++++.++..|+.||+.|+.|||+.   +|.||||||+|+|..   .|..+||+||
T Consensus       134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence            78999999999999999875  356799999999999999999999999   999999999999997   4556899999


Q ss_pred             ccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      |+|+....  .......+-|+.|.|||++...+|+...|+||+||++|-|++|-+||.......-    .--++.....+
T Consensus       209 GFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai----spgMk~rI~~g  282 (400)
T KOG0604|consen  209 GFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SPGMKRRIRTG  282 (400)
T ss_pred             ccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC----ChhHHhHhhcc
Confidence            99986543  2233445679999999999999999999999999999999999999974322110    00011110001


Q ss_pred             ccccccccccCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          530 KLSQMVDKDLKGNFD----RIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .          -.|+    ...++...++|..+|..+|++|.|+.+++.+-
T Consensus       283 q----------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  283 Q----------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             C----------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            0          0122    23457788899999999999999999998754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=8e-32  Score=295.65  Aligned_cols=263  Identities=19%  Similarity=0.230  Sum_probs=173.0

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-C----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeee------e
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-D----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF------C  367 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~------~  367 (623)
                      ..++|++.+.||+|+||.||+|.+. +    +..||||+++....   ...+..|  .+....+.++..++..      +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4578999999999999999999975 4    68999999864321   1111111  1122222333322221      2


Q ss_pred             ecCCceEEEEecccCCChhhhhhhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 006968          368 STENERLLVYPYMPNGSVASRLRDHIH----------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV  431 (623)
Q Consensus       368 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  431 (623)
                      ......++|+||+++++|.+++.....                .........+..++.|++.||+|||+.   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            456678999999999999999865310                001122345668999999999999999   9999999


Q ss_pred             CCCCeEECC-CCcEEEeecccccccCCCCCceeeccccccccccccccccC----------------------CCCCccc
Q 006968          432 KAANILLDE-DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG----------------------QSSEKTD  488 (623)
Q Consensus       432 k~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  488 (623)
                      ||+|||++. ++.+||+|||+++.+............+++.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999985 57999999999987655444444556789999999965322                      2345679


Q ss_pred             hhhHHHHHHHHHhCCCCCCcccc------cccccchHHHHHHHhhcCccccccccccCCCC--CHHHHHHHHHHHHHccC
Q 006968          489 VFGFGILLLELITGQRALDFGRA------ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNF--DRIELEEMVQVALLCTQ  560 (623)
Q Consensus       489 v~SlGvil~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~  560 (623)
                      ||||||++|||+++..+.+....      .........|.......      ..+.....+  .........+++.+|++
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999997665431100      00000111221111100      000000000  00112345689999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 006968          561 FNPLHRPKMSEVLKM  575 (623)
Q Consensus       561 ~~P~~RPs~~evl~~  575 (623)
                      .||++|||+.|++++
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.6e-31  Score=286.07  Aligned_cols=265  Identities=20%  Similarity=0.211  Sum_probs=184.3

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEe-----------------CCCcEEEEEEeccccccc-------------chHHHHHH
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCF-----------------SDGALVAVKRLKDYNIAG-------------GEVQFQTE  348 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~e  348 (623)
                      ..++|.+.++||+|+||.||+|..                 .+++.||||+++......             ....+..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 235689999986432110             11224457


Q ss_pred             HHHHhhcCCCce-----eeeeeeeec--------CCceEEEEecccCCChhhhhhhccC--------------------C
Q 006968          349 VETISLAVHRNL-----LRLCGFCST--------ENERLLVYPYMPNGSVASRLRDHIH--------------------G  395 (623)
Q Consensus       349 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~  395 (623)
                      +.++.+++|.++     +++++||..        .+..++||||+++|+|.++++....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777777655     677787753        3568999999999999999875321                    0


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeeccccccccccc
Q 006968          396 RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP  475 (623)
Q Consensus       396 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP  475 (623)
                      ...++|..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++...............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            12357889999999999999999999   999999999999999999999999999976544322222223357899999


Q ss_pred             cccccCCC----------------------CCccchhhHHHHHHHHHhCCC-CCCccccc----cc-ccchHHHHHHHhh
Q 006968          476 EYLSTGQS----------------------SEKTDVFGFGILLLELITGQR-ALDFGRAA----NQ-RGVMLDWVKKLHQ  527 (623)
Q Consensus       476 E~~~~~~~----------------------~~~~Dv~SlGvil~elltg~~-p~~~~~~~----~~-~~~~~~~~~~~~~  527 (623)
                      |.+.....                      ..+.||||+||++++|++|.. |+.....-    .. ......|....  
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~--  457 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK--  457 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc--
Confidence            98854321                      234799999999999999875 55321110    00 00111121110  


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHh
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNP---LHRPKMSEVLKML  576 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~RPs~~evl~~L  576 (623)
                      ....    +  +  ...........+++.+++..+|   .+|+|+.|+++|-
T Consensus       458 ~~~~----~--~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp  501 (507)
T PLN03224        458 GQKY----D--F--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR  501 (507)
T ss_pred             ccCC----C--c--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence            0000    0  0  0111234678899999999766   6899999999863

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-32  Score=283.18  Aligned_cols=240  Identities=25%  Similarity=0.292  Sum_probs=193.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++.|.....+|.|+|+.|-++... +++..+||++.+..     .+-.+|+.++... .||||+++.+.+.+..+.++||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            566778888999999999888764 68889999997652     2335567666554 6999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE-CCCCcEEEeecccccccC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL-DEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~Dfgla~~~~  456 (623)
                      |++.++-+.+.+...     +.....+..|+.+++.|+.|||++   |+|||||||+|||+ ++.++++|+|||.++..+
T Consensus       396 e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             hhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            999999887777643     222267778999999999999999   99999999999999 589999999999999776


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..    ....+-|..|.|||++....+++++|+||||+++|+|++|+.||......      . -+.....         
T Consensus       468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~-ei~~~i~---------  527 (612)
T KOG0603|consen  468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------I-EIHTRIQ---------  527 (612)
T ss_pred             hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------H-HHHHhhc---------
Confidence            54    22334688999999999999999999999999999999999999743321      1 1111111         


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         .+.+....+.+..+|+.+||++||.+||+|.++..+
T Consensus       528 ---~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  528 ---MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ---CCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence               122234445778999999999999999999999775

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=276.91  Aligned_cols=250  Identities=22%  Similarity=0.285  Sum_probs=201.0

Q ss_pred             CCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCC
Q 006968          306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG  383 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  383 (623)
                      .++||+|.||+||-|+.+ +|+.||||++.+.... ..+.++..|+.+|+.+.||.||.+..-|++.+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            478999999999999975 7999999999765543 34567899999999999999999999999999999999999655


Q ss_pred             ChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEeecccccccCCCCC
Q 006968          384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~  460 (623)
                      -|.-.|...   .+.+++..-..++.||+.||.|||.+   +|+|+||||+|||+..   ..++||||||+|+.++..  
T Consensus       649 MLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--  720 (888)
T KOG4236|consen  649 MLEMILSSE---KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--  720 (888)
T ss_pred             HHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence            554444432   45788888899999999999999999   9999999999999964   357999999999998653  


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                      .-...++||+.|+|||++.++.|...-|+||.|||+|--++|.-||..+++.+++      +.      ...-+..    
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ------IQ------NAaFMyP----  784 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ------IQ------NAAFMYP----  784 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH------hh------ccccccC----
Confidence            3345678999999999999999999999999999999999999999754332111      00      0000111    


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ..--.+...+..++|...|++.-.+|-|..+-+.+.+-+
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq  823 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ  823 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence            111133456788999999999999999998887765543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1e-30  Score=257.93  Aligned_cols=239  Identities=30%  Similarity=0.382  Sum_probs=192.7

Q ss_pred             CCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCChhhhhhh
Q 006968          313 GFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD  391 (623)
Q Consensus       313 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  391 (623)
                      +||.||+|... +|+.+|+|++...........+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999986 48999999997654333256899999999999999999999999998999999999999999999875


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeeccccccc
Q 006968          392 HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG  471 (623)
Q Consensus       392 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~  471 (623)
                      .    ..+++..+..++.+++.++.|||+.   +++|+||+|+||++++++.++++|||.+.......  ......++..
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            3    2389999999999999999999999   99999999999999999999999999998765432  2334457889


Q ss_pred             cccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHH
Q 006968          472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEM  551 (623)
Q Consensus       472 y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  551 (623)
                      |++||.......+.++||||||+++++|++|..|+.....      ........ ........       ......+.++
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~------~~~~~~~~-~~~~~~~~-------~~~~~~~~~~  217 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ------LLELFKKI-GKPKPPFP-------PPEWKISPEA  217 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHH-hccCCCCc-------cccccCCHHH
Confidence            9999999888889999999999999999999999864211      01111111 11110000       0000034678


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 006968          552 VQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       552 ~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            99999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=267.50  Aligned_cols=242  Identities=25%  Similarity=0.330  Sum_probs=196.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccch--HHHHHHHHHHhhc-CCCceeeeeeeeecCCceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGE--VQFQTEVETISLA-VHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  375 (623)
                      ..+|....+||+|+||.|-+|.-+ +.+.+|||+++++.+.+..  +--+.|-++|+.. +-|.++++...+++.+.+|.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457889999999999999999865 4678999999876543322  1234566677665 57899999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+.||+|--+++..    +.+.+..+..++..||-||-+||++   +||.||||-+||++|.+|++||+|||+++.-
T Consensus       428 VMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999987777653    4577888999999999999999999   9999999999999999999999999999742


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      - -....+..++||+.|+|||++...+|+..+|.|||||++|||+.|++||+..+..+.   +             ..+.
T Consensus       501 i-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---F-------------~aI~  563 (683)
T KOG0696|consen  501 I-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---F-------------QAIM  563 (683)
T ss_pred             c-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---H-------------HHHH
Confidence            2 223456778999999999999999999999999999999999999999985433111   1             1111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRP  567 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP  567 (623)
                      +..  -.|+...+.+...+....+...|.+|.
T Consensus       564 ehn--vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  564 EHN--VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             Hcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            111  134555567888899999999999985

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=274.04  Aligned_cols=254  Identities=25%  Similarity=0.284  Sum_probs=210.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCc-EEEEEEecccccccch--HHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGA-LVAVKRLKDYNIAGGE--VQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~--~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++++.+..||-|+||.|-++..+... .+|+|.+++..+.+..  .....|-.+|...+.|.||++|.-|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34455677999999999998875433 4899999887665433  35788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      |-|-||.|...|++    ++.++..+.+.++..+.+|++|||++   +||.|||||+|.++|.+|.+||.|||+|+.+..
T Consensus       500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999999987    45789999999999999999999999   999999999999999999999999999998865


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      +  ..+.+++||+.|.|||++.++..+..+|.||+|+++|||++|.+||...++......++.        +     +| 
T Consensus       573 g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk--------G-----id-  636 (732)
T KOG0614|consen  573 G--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK--------G-----ID-  636 (732)
T ss_pred             C--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh--------h-----hh-
Confidence            4  456788999999999999999999999999999999999999999986554322211111        0     00 


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhhcC
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPK-----MSEVLKMLEGD  579 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~L~~~  579 (623)
                        .-.+++.......+++.+.+..+|.+|..     +.+|-+|-+-.
T Consensus       637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence              01234445567789999999999999975     77887776653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-31  Score=281.93  Aligned_cols=262  Identities=25%  Similarity=0.353  Sum_probs=208.7

Q ss_pred             cCHHHHHHHhcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeee
Q 006968          291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCS  368 (623)
Q Consensus       291 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~  368 (623)
                      ..++.+...+..|++.++||.|.+|.||+++. ++|+.+|+|++....  +...+...|.++++.. .|||++.++|++.
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            34445555677899999999999999999985 478999999986544  3344567888888876 6999999999985


Q ss_pred             c-----CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc
Q 006968          369 T-----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE  443 (623)
Q Consensus       369 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  443 (623)
                      .     ++.++||||||.+||..+++....  +..+.|..+..|+..++.|+.+||.+   .++|||||-.|||++.++.
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence            3     578999999999999999998876  56799999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccccccCCCCCceeeccccccccccccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCcccccccccch
Q 006968          444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM  518 (623)
Q Consensus       444 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~  518 (623)
                      +|+.|||++..+.... .......||+.|||||++...     .|+.++|+||+|++..||.-|.+|+....+       
T Consensus       162 VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------  233 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------  233 (953)
T ss_pred             EEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-------
Confidence            9999999998776433 334456699999999999643     467789999999999999999999853222       


Q ss_pred             HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          519 LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         ++.+..   +.....+.+.  -+..-..++.++|..|+..|-++||++.+++++
T Consensus       234 ---mraLF~---IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  234 ---MRALFL---IPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---hhhhcc---CCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence               111111   1111111111  134445789999999999999999999988763

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-32  Score=267.13  Aligned_cols=258  Identities=23%  Similarity=0.347  Sum_probs=197.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEeccccc--ccch----HHHHHHHHHHhhcCCCceeeeeeeeecC-C
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGE----VQFQTEVETISLAVHRNLLRLCGFCSTE-N  371 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~----~~~~~e~~~l~~l~H~niv~l~~~~~~~-~  371 (623)
                      .++|-..++||+|+|+.||||.. .+.+.||||+-.....  ....    +...+|..+-+.+.||.||++++|+.-+ +
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            45677788999999999999985 4678999998643222  1111    2357899999999999999999999754 5


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEee
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGD  448 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~D  448 (623)
                      ..+-|+||++|.+|+-||..+    .-++++.++.|+.||+.||.||.+. +|+|||-||||.|||+.+   -|.+||.|
T Consensus       542 sFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             cceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence            678999999999999999875    3589999999999999999999997 779999999999999853   47899999


Q ss_pred             cccccccCCCCCc------eeecccccccccccccccc----CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch
Q 006968          449 FGLAKLLDHRDSH------VTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM  518 (623)
Q Consensus       449 fgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~  518 (623)
                      ||+++.+......      .+....||..|++||.+.-    ...+.|+||||.|||+|..+.|+.||.......     
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-----  691 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-----  691 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-----
Confidence            9999998754332      3455679999999997743    356889999999999999999999997443211     


Q ss_pred             HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          519 LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                           .+..+..+....+-.+..  .+....+...+|.+||.+.-++|....++..
T Consensus       692 -----dILqeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  692 -----DILQENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             -----HHHhhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                 111111111111111111  1223466788999999999999998887754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=6e-32  Score=242.65  Aligned_cols=201  Identities=24%  Similarity=0.337  Sum_probs=170.8

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhh-cCCCceeeeeeeeecCCceEEEEecc
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ....+.||+|+||.|-+-.+. +|...|||+++..-..+..++.+.|+.+..+ ..+|.+|+++|........++.||.|
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            334567999999999887764 7999999999876655666678888887654 47999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      . -||+.+-+.....+..+++..+-+|+..+.+||.|||++.  .++|||+||+|||++.+|++|+||||.+-.+.++-.
T Consensus       128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA  204 (282)
T ss_pred             h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence            4 5888887777777888999999999999999999999986  899999999999999999999999999987654321


Q ss_pred             ceeecccccccccccccccc----CCCCCccchhhHHHHHHHHHhCCCCCCc
Q 006968          461 HVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQRALDF  508 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~elltg~~p~~~  508 (623)
                        .+.-.|-..|||||.+..    ..|+-|+||||+|+.+.||.+++.|++.
T Consensus       205 --kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  205 --KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             --HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence              122347788999998853    3688999999999999999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-32  Score=288.12  Aligned_cols=247  Identities=27%  Similarity=0.349  Sum_probs=187.6

Q ss_pred             CCcCCceeccCCe-EEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEecc
Q 006968          303 FSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       303 ~~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      |...+++|.|+-| .||+|.+ +|+.||||++-...    ..-..+|+..|+.- .|||||++++.-.+....|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            4556789999988 6799999 78999999985432    23457899999877 6999999999888999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---C--CcEEEeeccccccc
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---D--FEAVVGDFGLAKLL  455 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~Dfgla~~~  455 (623)
                       ..+|.+++...........-...+.+..|+++||++||+.   +||||||||.||||+.   +  ..++|+|||+++.+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             5699999976411111111144577889999999999998   9999999999999975   3  46899999999988


Q ss_pred             CCCCCce--eeccccccccccccccccCCCCCccchhhHHHHHHHHHhC-CCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          456 DHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG-QRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       456 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ..+....  .....||-||+|||++....-+..+||||+|||+|+.++| ++||...-.  .+..++      .....+.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl------~~~~~L~  733 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANIL------TGNYTLV  733 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhh------cCcccee
Confidence            7655433  3456799999999999998889999999999999999997 899963211  000000      0000000


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .     +..  ..++  +..+||.+|+.++|..||++.+|+.|
T Consensus       734 ~-----L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  734 H-----LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             e-----ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            0     000  1111  77899999999999999999999763

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9.7e-33  Score=254.57  Aligned_cols=268  Identities=24%  Similarity=0.348  Sum_probs=193.2

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecC--------C
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTE--------N  371 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--------~  371 (623)
                      .|....+||+|.||.||+|..+ +|+.||+|+.--.... .-...-.+|+++|..++|+|++.++..|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4555678999999999999875 5778899875322211 1123468999999999999999999988542        3


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL  451 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  451 (623)
                      ..++||.+++. +|.-.|.+.   ...++...+.+++.++..||.|+|..   .|+|||+|+.|+||+.++.+||+|||+
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            47999999976 666666653   34689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCc---eeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh
Q 006968          452 AKLLDHRDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       452 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      ++.+......   ..+..+.|..|.+||.+.+ ..|+++.|||+-|||+.||.||.+-+.......+...+.........
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            9876543322   2334456999999999876 46899999999999999999999887654432222111111111111


Q ss_pred             cCc-------ccccc--ccccCCCCCH--HH------HHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          528 EGK-------LSQMV--DKDLKGNFDR--IE------LEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       528 ~~~-------~~~~~--~~~~~~~~~~--~~------~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      +-+       +.+-+  .+--.+++..  ..      ..+.++++..++..||.+|+++.+++.+-
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            100       00000  0000111110  00      13678999999999999999999998753

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=262.35  Aligned_cols=264  Identities=21%  Similarity=0.278  Sum_probs=198.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-C-C----ceeeeeeeeecCCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-H-R----NLLRLCGFCSTENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H-~----niv~l~~~~~~~~~  372 (623)
                      +.+|.+...+|+|.||.|-..... .+..||||+++.-.  .-....+-|+++++++. + |    -+|.+.+++.-.++
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            578999999999999999998764 47899999997532  33445678999999994 2 2    36788899999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC------------
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE------------  440 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~------------  440 (623)
                      .++|+|.+ |-|+.++|...  +-.+++...++.|+.|+++++++||+.   +++|-||||+|||+.+            
T Consensus       166 iCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             eEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence            99999998 66999999864  345788999999999999999999999   9999999999999832            


Q ss_pred             --------CCcEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccc
Q 006968          441 --------DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAA  512 (623)
Q Consensus       441 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~  512 (623)
                              +..+||+|||.|.......    ...+.|..|.|||++.+-.++.++||||+||||.|+.||...|..-+..
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                    2458999999998754332    4456799999999999999999999999999999999999888643321


Q ss_pred             ccccchH--------HHHHHH-----hhcCcc-----------ccccccccC----CCCCHHHHHHHHHHHHHccCCCCC
Q 006968          513 NQRGVML--------DWVKKL-----HQEGKL-----------SQMVDKDLK----GNFDRIELEEMVQVALLCTQFNPL  564 (623)
Q Consensus       513 ~~~~~~~--------~~~~~~-----~~~~~~-----------~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~  564 (623)
                      +....+.        ..+...     -..+.+           ....+....    ..-...+..++.+|+..||.+||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            1100000        111111     000100           000000000    011234457899999999999999


Q ss_pred             CCCCHHHHHHH
Q 006968          565 HRPKMSEVLKM  575 (623)
Q Consensus       565 ~RPs~~evl~~  575 (623)
                      +|+|+.|++.+
T Consensus       396 ~RiTl~EAL~H  406 (415)
T KOG0671|consen  396 RRITLREALSH  406 (415)
T ss_pred             ccccHHHHhcC
Confidence            99999999875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-31  Score=250.53  Aligned_cols=250  Identities=23%  Similarity=0.296  Sum_probs=198.7

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchH-H-HHHHHHHHhhc-CCCceeeeeeeeecCCceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEV-Q-FQTEVETISLA-VHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~-~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  375 (623)
                      ..+|....+||+|+|..|-.+.+. +.+.+|+|++++.-..+++. + .+.|-.+..+. +||.+|.+..+|+++..++.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            457888999999999999999875 57889999998765443332 2 45566666544 79999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      |.||++||+|--++++    ...++++.++.+...|.-||.|||++   |||.||||-+|+|+|..|.+|+.|+|+++.-
T Consensus       329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999998666654    34689999999999999999999999   9999999999999999999999999999742


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      - .....+..++||+.|+|||.+.+..|...+|.|++||+++||+.|+.||+.-...+.+..-.+++-++..+..++   
T Consensus       402 l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---  477 (593)
T KOG0695|consen  402 L-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---  477 (593)
T ss_pred             C-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---
Confidence            2 233456778999999999999999999999999999999999999999985333222222234444433322211   


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRP  567 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP  567 (623)
                             .++..+.....++..-+.+||++|.
T Consensus       478 -------iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 -------IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -------ccceeehhhHHHHHHhhcCCcHHhc
Confidence                   2222334566788889999999984

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.6e-30  Score=263.39  Aligned_cols=214  Identities=25%  Similarity=0.350  Sum_probs=177.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .-|..++.||-|+||+|.++.. ++...+|.|.+++...-.  .......|..+|.....+-||+|+..|.+++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            3467788999999999999975 457789999997655322  2235788999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC-
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-  456 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~-  456 (623)
                      +|++||++-++|-+.    +.+.+..++.++..+..|+++.|..   |+|||||||+|||||.+|++||.|||++.-+. 
T Consensus       709 dYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             eccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence            999999999888763    4688999999999999999999999   99999999999999999999999999985331 


Q ss_pred             --------CCCCce--------------------------------eeccccccccccccccccCCCCCccchhhHHHHH
Q 006968          457 --------HRDSHV--------------------------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL  496 (623)
Q Consensus       457 --------~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil  496 (623)
                              .++...                                ....+||+.|+|||++....++.-+|.||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence                    111000                                0124599999999999999999999999999999


Q ss_pred             HHHHhCCCCCCcccccccccchHHH
Q 006968          497 LELITGQRALDFGRAANQRGVMLDW  521 (623)
Q Consensus       497 ~elltg~~p~~~~~~~~~~~~~~~~  521 (623)
                      |||+.|+.||-...+.........|
T Consensus       862 ~em~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             HHHhhCCCCccCCCCCcceeeeeeh
Confidence            9999999999765554443333444

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=249.01  Aligned_cols=268  Identities=24%  Similarity=0.327  Sum_probs=199.9

Q ss_pred             CcCCceeccCCeEEEEEEeC-CCcEEEEEEecccc-cccchHHHHHHHHHHhhcCCCceeeeeeeeecC-----CceEEE
Q 006968          304 SAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NERLLV  376 (623)
Q Consensus       304 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~~lv  376 (623)
                      +..+.||.|+||.||..... +|+.||.|++.... .-...+.+.+|+++|..++|.|++..++...-.     .+.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34578999999999999874 79999999985432 122345789999999999999999988776543     356788


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      +|.|. .+|    +...-....++-....-+..||++||+|||+.   +|.||||||.|.|++.+...||||||+++.-+
T Consensus       136 TELmQ-SDL----HKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  136 TELMQ-SDL----HKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHH-hhh----hheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence            89884 344    43334456788888999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH-------Hhhc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK-------LHQE  528 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~  528 (623)
                      ..+....+..+.|..|.|||.+.+. .|+...||||.|||+.||+.++..|....+..+...+.+.+..       ...+
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            6555545555678999999999874 6899999999999999999999888755444333333222211       1112


Q ss_pred             CccccccccccCC-C----C----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          529 GKLSQMVDKDLKG-N----F----DRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       529 ~~~~~~~~~~~~~-~----~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      |.-..++....+. .    |    +.....+-..+...++.+||+.|.+..+.+.++...
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~  347 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE  347 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence            2222222221111 0    1    112235677888999999999999999998877553

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=8e-30  Score=232.27  Aligned_cols=260  Identities=17%  Similarity=0.279  Sum_probs=194.7

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCC--ceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTEN--ERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~~l  375 (623)
                      .++|++.+.+|+|.|+.|+.|.. .+.+.++||+++...    .+.+.+|+++|..+. ||||+++++...++.  ...|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            45788889999999999999984 478899999998643    557899999999997 999999999987654  5689


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCcEEEeecccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLAKL  454 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfgla~~  454 (623)
                      |+||+.+.+....-       +.++...+..++.++++||.|+|+.   ||+|||+||.|+++|. .-..+|+|||+|..
T Consensus       113 iFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             HhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence            99999988755433       2477788899999999999999999   9999999999999995 45689999999998


Q ss_pred             cCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccc----------cchHHHHH
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQR----------GVMLDWVK  523 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~----------~~~~~~~~  523 (623)
                      +.++.....  .+.+..|..||.+.. ..|+..-|+|||||++..|+..+.||-.+.+..++          ..+..++.
T Consensus       183 YHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  183 YHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             cCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            876544322  235677889998865 45788899999999999999999999655432111          01112222


Q ss_pred             HHhhc--Ccccccccccc--------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          524 KLHQE--GKLSQMVDKDL--------KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       524 ~~~~~--~~~~~~~~~~~--------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ++...  ..+..++..-.        ...-......+..+++...|..|..+|||++|.+.+
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            21111  11111111100        000011123678999999999999999999999765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=4.1e-28  Score=233.33  Aligned_cols=212  Identities=36%  Similarity=0.528  Sum_probs=184.3

Q ss_pred             eeccCCeEEEEEEeCC-CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCChhh
Q 006968          309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVAS  387 (623)
Q Consensus       309 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  387 (623)
                      ||+|.+|.||++...+ ++.+++|++...........+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 899999999765432234679999999999999999999999999899999999999999999


Q ss_pred             hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCcEEEeecccccccCCCCCceeecc
Q 006968          388 RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLAKLLDHRDSHVTTAV  466 (623)
Q Consensus       388 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~  466 (623)
                      ++....   ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            987532   4689999999999999999999999   9999999999999999 89999999999986654321 12234


Q ss_pred             ccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCH
Q 006968          467 RGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDR  545 (623)
Q Consensus       467 ~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  545 (623)
                      .+...|++||..... ..+.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            478899999999877 888999999999999998                                              


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          546 IELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       546 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                         ..+.+++..|+..+|++||++.++++++
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence               3578899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-29  Score=238.39  Aligned_cols=262  Identities=22%  Similarity=0.275  Sum_probs=193.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccc-ccccchHHHHHHHHHHhhcCCCceeeeeeeeecC------Cc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDY-NIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------NE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~  372 (623)
                      .+|.....+|.|.- .|..|... .+++||+|++... ......++..+|..++..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666788898888 55555432 6899999987543 2233345678999999999999999999988532      45


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .|+||||| .++|...+..      .++-.++.+|..|++.|++|||+.   +|+||||||+||++..+..+||.|||+|
T Consensus        96 ~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence            79999999 5688877763      478889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH--------HHHHH
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--------DWVKK  524 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~  524 (623)
                      +.-+..  -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.+..++-....        +++.+
T Consensus       166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            864332  34556678999999999999889999999999999999999998876332211111100        11111


Q ss_pred             HhhcCc-------------cccc-cccccCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          525 LHQEGK-------------LSQM-VDKDLKG--NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       525 ~~~~~~-------------~~~~-~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      +...++             ..+. .|..+..  +.++.......+++.+||..+|++|-++.++++|
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            111110             0000 0111111  1122334567889999999999999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=8.5e-29  Score=252.34  Aligned_cols=198  Identities=24%  Similarity=0.329  Sum_probs=169.0

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-----chH--HHHHHHHHHhhcC---CCceeeeeeeee
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEV--QFQTEVETISLAV---HRNLLRLCGFCS  368 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~--~~~~e~~~l~~l~---H~niv~l~~~~~  368 (623)
                      ..+|...+.+|+|+||.|+.|.++ +...|+||.+.+...-.     +++  ..-.|+.+|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            346888999999999999999986 46779999987654311     111  2467999999997   999999999999


Q ss_pred             cCCceEEEEeccc-CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 006968          369 TENERLLVYPYMP-NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG  447 (623)
Q Consensus       369 ~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  447 (623)
                      +++.+|++||-.. +-+|.+++..    .+.+++..+.-|+.||+.|+++||+.   +|||||||-+|+.++.+|-+||+
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence            9999999999863 4477777765    46799999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCC
Q 006968          448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALD  507 (623)
Q Consensus       448 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~  507 (623)
                      |||.+.+...+   ....++||.+|.|||++.+..| +..-|||++|+++|.++....|+.
T Consensus       713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999876543   3445679999999999998877 667899999999999999988875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=3.7e-27  Score=229.94  Aligned_cols=199  Identities=31%  Similarity=0.444  Sum_probs=171.8

Q ss_pred             CCcCCceeccCCeEEEEEEeCC-CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEeccc
Q 006968          303 FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP  381 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  381 (623)
                      |...+.||+|++|.||++...+ ++.+|+|.+...........+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999865 899999999765432245678999999999999999999999999899999999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      +++|.+++.....   .+++.....++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999999876421   288999999999999999999999   9999999999999999999999999999876544311


Q ss_pred             eeecccccccccccccc-ccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 006968          462 VTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQRALD  507 (623)
Q Consensus       462 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltg~~p~~  507 (623)
                      ......++..|++||.. ....++.++|||+||++++||++|+.||+
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22334578899999998 66777889999999999999999999996

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.6e-27  Score=236.53  Aligned_cols=132  Identities=22%  Similarity=0.325  Sum_probs=111.0

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-----C---Cceeeeeeeeec-
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-----H---RNLLRLCGFCST-  369 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~~~~~~-  369 (623)
                      ..+|.+.++||-|.|++||++... +.+.||+|+.+...  .-.+.-+.||++|++++     |   ..||+|+++|.- 
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            367889999999999999999864 67899999997543  22345688999998884     2   369999999853 


Q ss_pred             ---CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 006968          370 ---ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL  438 (623)
Q Consensus       370 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll  438 (623)
                         +.+.+||+|++ |.+|..++....  -..++....++|+.||+.||.|||..|  +|||-||||+|||+
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence               46899999998 778988887643  345888999999999999999999998  99999999999999

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=3.1e-28  Score=252.22  Aligned_cols=253  Identities=24%  Similarity=0.269  Sum_probs=197.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ..+|+....+|+|.||.||||+.. .++..|||.++-.. .+...-.++|+-+++..+||||+.++|.+-..+..+++||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            356888899999999999999975 68999999997654 3344557889999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+.+|+|.+.-+-    ..++++-++....+...+|++|||+.   +-+|||||-.||++++.|.+|++|||.+..+..-
T Consensus        93 ycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             ecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence            9999998775543    56899999999999999999999999   8999999999999999999999999998766432


Q ss_pred             CCceeecccccccccccccc---ccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                       -.....+.||+.|||||+.   ..+.|..++|||+.|+...|+-.-++|...-.+.       .-+.-.. .    ...
T Consensus       166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmT-k----S~~  232 (829)
T KOG0576|consen  166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMT-K----SGF  232 (829)
T ss_pred             -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhh-c----cCC
Confidence             2234456799999999987   3567889999999999999998877775311110       0000000 0    111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                      ++.-... ...-.+.+.++++.|+..+|++||++..+++
T Consensus       233 qpp~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  233 QPPTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCcccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1110000 0112366888999999999999999977654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=3.5e-27  Score=233.98  Aligned_cols=265  Identities=23%  Similarity=0.344  Sum_probs=196.5

Q ss_pred             HHHHhcCCCcCCceeccCCeEEEEEEeC----CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecC
Q 006968          296 LRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE  370 (623)
Q Consensus       296 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~  370 (623)
                      .....+.|..+++||+|.|++||+|...    ..+.||+|.+.....   ......|+++|..+ .+.||+++.+++...
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            3445567888999999999999999864    367899999865442   34578999999888 599999999999999


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCcEEEeec
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDF  449 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Df  449 (623)
                      +...+|+||++.....++.+.       ++...+..++..+..||+++|.+   |||||||||+|+|.+. .+.-.|.||
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence            999999999999998888764       67889999999999999999999   9999999999999984 567899999


Q ss_pred             ccccccCCC-------C------------------------------------Cceeecccccccccccccccc-CCCCC
Q 006968          450 GLAKLLDHR-------D------------------------------------SHVTTAVRGTVGHIAPEYLST-GQSSE  485 (623)
Q Consensus       450 gla~~~~~~-------~------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~  485 (623)
                      |+|......       .                                    .......+||+||.|||++.. ...+.
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            999721100       0                                    000112459999999999865 56789


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCcccccccccchH--------HHHHHH-hhcCc--ccc----------------c-ccc
Q 006968          486 KTDVFGFGILLLELITGQRALDFGRAANQRGVML--------DWVKKL-HQEGK--LSQ----------------M-VDK  537 (623)
Q Consensus       486 ~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~~-~~~~~--~~~----------------~-~~~  537 (623)
                      ++||||.|||++.+++++.||-....  +...+.        .-+++. ...+.  +.+                + ...
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~d--d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~  335 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKD--DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES  335 (418)
T ss_pred             ccceeeccceeehhhccccccccCcc--ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence            99999999999999999999853322  111111        111111 11111  000                0 000


Q ss_pred             ccC--------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLK--------GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~--------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      -.+        .......+..+++++.+|+..||.+|.|+++.+++
T Consensus       336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            000        00011223578999999999999999999999885

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=4.6e-27  Score=236.82  Aligned_cols=274  Identities=21%  Similarity=0.237  Sum_probs=202.2

Q ss_pred             ccCHHHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC------CCceee
Q 006968          290 RYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV------HRNLLR  362 (623)
Q Consensus       290 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------H~niv~  362 (623)
                      ++.+.|+.  ..+|.+.-..|+|-|++|.+|... .|..||||+++.....  .+.=+.|+++|+++.      --|.++
T Consensus       423 rv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  423 RVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             EEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            44555554  478999999999999999999865 4889999999764332  223478999999985      337889


Q ss_pred             eeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-
Q 006968          363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-  441 (623)
Q Consensus       363 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-  441 (623)
                      ++..|.-.++++||+|-+ ..+|.+.|..+ +.+-.|.......++.|+.-||..|-..   +|+|.||||.|||+++. 
T Consensus       499 l~r~F~hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHhhhcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence            999999999999999987 56899999875 3345688999999999999999999998   99999999999999965 


Q ss_pred             CcEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHH
Q 006968          442 FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDW  521 (623)
Q Consensus       442 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  521 (623)
                      ..+||||||.|.......   .+.+..+..|.|||++.+-.|+...|+||.||.||||.||+..|...........+.+.
T Consensus       574 ~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             ceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            467999999998655432   22333466799999999999999999999999999999999888643221111000000


Q ss_pred             ----HHHHhhcCcc-ccccccc--------------------------------cC--CCCC---HHHHHHHHHHHHHcc
Q 006968          522 ----VKKLHQEGKL-SQMVDKD--------------------------------LK--GNFD---RIELEEMVQVALLCT  559 (623)
Q Consensus       522 ----~~~~~~~~~~-~~~~~~~--------------------------------~~--~~~~---~~~~~~l~~l~~~cl  559 (623)
                          -..+...+.+ .+-+|..                                +.  ..++   .....++.+|+..|+
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence                0001111100 0000100                                00  0122   233567899999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 006968          560 QFNPLHRPKMSEVLKM  575 (623)
Q Consensus       560 ~~~P~~RPs~~evl~~  575 (623)
                      ..||++|.|..|+++|
T Consensus       731 ~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  731 ILDPEKRITVNQALKH  746 (752)
T ss_pred             ccChhhcCCHHHHhcC
Confidence            9999999999999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.5e-26  Score=214.52  Aligned_cols=250  Identities=20%  Similarity=0.292  Sum_probs=183.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeee-eeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCG-FCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~-~~~~~~~~~lv~  377 (623)
                      +.|.+.+.+|+|.||.+-++.++ ..+.+++|-+....  ...++|.+|...--.+ .|.||+.-++ .|++.+.++.++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            45788899999999999999986 47789999987654  2356799998654444 5899998775 466778889999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC--CCCcEEEeeccccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDFEAVVGDFGLAKLL  455 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~Dfgla~~~  455 (623)
                      ||++.|+|.+-+..     ..+.+..-.+++.|+++|+.|+|++   ++||||||.+||||-  +...+|+||||..+..
T Consensus       102 E~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999998776654     3477888899999999999999999   999999999999984  4457999999998754


Q ss_pred             CCCCCceeeccccccccccccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      +.    ......-+..|.+||.....     ...+.+|||.||++++.++||+.|+..+.  .......+|+.....  .
T Consensus       174 g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~--~~d~~Y~~~~~w~~r--k  245 (378)
T KOG1345|consen  174 GT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS--IMDKPYWEWEQWLKR--K  245 (378)
T ss_pred             Cc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--ccCchHHHHHHHhcc--c
Confidence            32    11122245679999977543     24678999999999999999999997322  233344555543322  1


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                      ..     .++..+. ...+.+.++..+-+..+|++|=-..++-+
T Consensus       246 ~~-----~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  246 NP-----ALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             Cc-----cCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            11     1111111 12356788889999999999944444433

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=2.7e-26  Score=264.55  Aligned_cols=197  Identities=15%  Similarity=0.143  Sum_probs=140.0

Q ss_pred             hcCC-Cceeeeeeeee-------cCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 006968          354 LAVH-RNLLRLCGFCS-------TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK  425 (623)
Q Consensus       354 ~l~H-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  425 (623)
                      .+.| +||+++++++.       .....+.++||+ +++|.++|...   ...+++..++.++.||++||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3446 68888888872       234567888887 66999999742   34699999999999999999999999   9


Q ss_pred             eEecCCCCCCeEECCC-------------------CcEEEeecccccccCCCCC---------------ceeeccccccc
Q 006968          426 IIHRDVKAANILLDED-------------------FEAVVGDFGLAKLLDHRDS---------------HVTTAVRGTVG  471 (623)
Q Consensus       426 ivH~Dlk~~NIll~~~-------------------~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~  471 (623)
                      |+||||||+|||++..                   +.+|++|||+++.......               .......||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            9999999999999654                   4456666666653211000               00112357889


Q ss_pred             cccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHH
Q 006968          472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEM  551 (623)
Q Consensus       472 y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  551 (623)
                      |+|||++.+..++.++|||||||++|||++|..|+....         ..+......     ...+..     .....+.
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~~-----~~~~~~-----~~~~~~~  241 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRHR-----VLPPQI-----LLNWPKE  241 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHHh-----hcChhh-----hhcCHHH
Confidence            999999999999999999999999999999988764211         011111000     011110     0112345


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          552 VQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       552 ~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ..++.+||.++|.+||++.|++++-
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhch
Confidence            6788899999999999999998754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=6.2e-25  Score=206.30  Aligned_cols=166  Identities=20%  Similarity=0.177  Sum_probs=125.6

Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|.++++..   ...+++..++.++.|+++||+|||++   +      ||+||+++.++.+|+  ||++.......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            6888888753   34699999999999999999999998   5      999999999999999  99998654322   


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                         ..||+.|+|||++.+..++.++|||||||++|||+||+.||.......  .....+........       +.. ..
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~-------~~~-~~  130 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADD-------PRD-RS  130 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCC-------ccc-cc
Confidence               248999999999999999999999999999999999999986322110  01111111111000       000 00


Q ss_pred             CCHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          543 FDRIELE--EMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       543 ~~~~~~~--~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .......  ++.+++.+||..+|++||++.|+++++..
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            1112222  68999999999999999999999999865

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5.8e-25  Score=205.32  Aligned_cols=245  Identities=23%  Similarity=0.358  Sum_probs=188.1

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCC
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS  384 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  384 (623)
                      .-+|.+...|..|+|+++ |..+++|+++.... .....+|..|...|+.+.||||+.++|.|..+.+..++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            456888999999999995 55566788764432 2344579999999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEe--ecccccccCCCCCce
Q 006968          385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG--DFGLAKLLDHRDSHV  462 (623)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~--Dfgla~~~~~~~~~~  462 (623)
                      |++.|++.  ..-.++-.++.+++.++|+|++|||+. .|-|.---|.++.+++|++.+++|+  |--++..        
T Consensus       274 lynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq--------  342 (448)
T KOG0195|consen  274 LYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------  342 (448)
T ss_pred             HHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee--------
Confidence            99999863  344678889999999999999999996 3334445689999999999988875  2222111        


Q ss_pred             eeccccccccccccccccCCC---CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          463 TTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .....-.+.||+||.++..+.   -..+|+|||++++|||.|+..||..-.+.+..                .++.-..+
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------mkialegl  406 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------MKIALEGL  406 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------hhhhhccc
Confidence            111123678999999987654   35789999999999999999999743321110                01111223


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      +...++.....+.+++.-|+..||.+||.+..|+-.||.
T Consensus       407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            334455566789999999999999999999999988875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.6e-23  Score=215.39  Aligned_cols=168  Identities=23%  Similarity=0.238  Sum_probs=130.3

Q ss_pred             HHHhcCCCcCCceeccCCeEEEEEEeC--CCcEEEEEEeccccc----ccchHHHHHHHHHHhhcCCCceee-eeeeeec
Q 006968          297 RAATSNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNI----AGGEVQFQTEVETISLAVHRNLLR-LCGFCST  369 (623)
Q Consensus       297 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~-l~~~~~~  369 (623)
                      +....+|.+.+.||+|+||+||+|...  +++.||||++.....    ......|.+|++++++++|+|+++ +++    
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----   89 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----   89 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence            334578999999999999999999864  577889998753311    112446899999999999999985 443    


Q ss_pred             CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeEECCCCcEEEee
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV-KAANILLDEDFEAVVGD  448 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~D  448 (623)
                      .+..++||||+++++|.. +..       ..   ...++.++++||.|||+.   +|+|||| ||+|||++.++.+||+|
T Consensus        90 ~~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             cCCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence            246899999999999862 110       01   146788999999999999   9999999 99999999999999999


Q ss_pred             cccccccCCCCCce-------eeccccccccccccccccCC
Q 006968          449 FGLAKLLDHRDSHV-------TTAVRGTVGHIAPEYLSTGQ  482 (623)
Q Consensus       449 fgla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~  482 (623)
                      ||+|+.+.......       .....+++.|+|||.+...+
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence            99998765432111       13456888999999996543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=7.1e-23  Score=211.15  Aligned_cols=262  Identities=19%  Similarity=0.221  Sum_probs=195.5

Q ss_pred             CCCcCCceeccCCeEEEEEEeCCC--cEEEEEEecccccccchHHHHHHHHHHhhcCC----Cceeeeeeee-ecCCceE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSDG--ALVAVKRLKDYNIAGGEVQFQTEVETISLAVH----RNLLRLCGFC-STENERL  374 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~~~~-~~~~~~~  374 (623)
                      +|.+.+.||+|+||.||++...+.  ..+|+|.-......... .+..|..++..+.+    +++..+++.. ..+...+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            789999999999999999997553  47888887654333333 67888888888863    5788888888 4777889


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-----CcEEEeec
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-----FEAVVGDF  449 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~Df  449 (623)
                      +||+.+ |.+|.++.....  ...++..+...|+.|++.+|++||+.   |++||||||.|+++...     ..+.+.||
T Consensus        98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            999987 789999775543  46799999999999999999999999   99999999999999854     46899999


Q ss_pred             cccc--ccCCCCC-----c-e-eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH
Q 006968          450 GLAK--LLDHRDS-----H-V-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD  520 (623)
Q Consensus       450 gla~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  520 (623)
                      |+++  .+.....     . . .....||.+|.++....+...+.+.|+||++.++.|+..|..|+...........   
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---  248 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---  248 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---
Confidence            9998  3221111     1 1 2345699999999999999999999999999999999999999854332111100   


Q ss_pred             HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCCc
Q 006968          521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAE  583 (623)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  583 (623)
                       +...........         +....+.++.++...+-..+...+|....+...+++.....
T Consensus       249 -~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  249 -FEKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -HHHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence             111100000000         11122356667777777789999999999999987754443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=3.5e-21  Score=198.27  Aligned_cols=262  Identities=28%  Similarity=0.353  Sum_probs=198.7

Q ss_pred             CCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccc--hHHHHHHHHHHhhcCCC-ceeeeeeeeecCCceEEEEec
Q 006968          303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG--EVQFQTEVETISLAVHR-NLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~  379 (623)
                      |...+.||.|+||.||++...  ..+|+|.+........  ...+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999886  8899999977655443  66799999999999988 799999999777778999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-cEEEeecccccccCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHR  458 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~  458 (623)
                      +.++++.+++...... ..+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++.....
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999666543211 3688999999999999999999999   999999999999999988 7999999999865543


Q ss_pred             CCc-----eeecccccccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          459 DSH-----VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       459 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      ...     ......|+..|+|||.+..   ..+....|+||+|++++++++|..|+...............+..   ...
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~  232 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE---LPT  232 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh---cCC
Confidence            322     2355679999999999987   57889999999999999999999996543221000011111111   110


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       . .................+.+++..|+..+|..|.+..+....
T Consensus       233 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 -P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             0 000000100002223578889999999999999999987764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.87  E-value=3.9e-22  Score=236.23  Aligned_cols=154  Identities=38%  Similarity=0.673  Sum_probs=112.9

Q ss_pred             chHHHHHHHHHHhCCCCCcccCCCCCCCCCCCCcceeeeCCCCcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCC
Q 006968           32 NYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL  111 (623)
Q Consensus        32 ~~~~~~l~~~k~~~~~p~~~~~~w~~~~~~~c~w~gv~c~~~~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  111 (623)
                      ..|+.||++||+++.+|...+.+|+ .+.+||.|.||+|+..++|+.|+|++|+++|.++..|..+++|+.|+|++|+++
T Consensus        28 ~~~~~~l~~~~~~~~~~~~~~~~w~-~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~  106 (968)
T PLN00113         28 AEELELLLSFKSSINDPLKYLSNWN-SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS  106 (968)
T ss_pred             HHHHHHHHHHHHhCCCCcccCCCCC-CCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccC
Confidence            3689999999999999988899997 457899999999998789999999999999999999999999999999999999


Q ss_pred             CCCCCccC-CCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCC
Q 006968          112 GPIPASLG-KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK  188 (623)
Q Consensus       112 ~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  188 (623)
                      |.+|..+. ++++|++|+|++|+++|.+|.  +.+++|++|+|++|.+++.+|..++++++|+.|+|++|.+++.+|.
T Consensus       107 ~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~  182 (968)
T PLN00113        107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN  182 (968)
T ss_pred             CcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCCh
Confidence            88887655 677777777777766655543  2344444444444444444444444444444444444444444443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=7.1e-22  Score=181.96  Aligned_cols=255  Identities=18%  Similarity=0.218  Sum_probs=194.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCC-CceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH-RNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~  377 (623)
                      ..+|.+.+.||+|+||.+|.|.. .+|+.||||.=+...   ...++..|..+.+.++| ..|..+..|..+.....+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            35789999999999999999985 579999999865432   34468889999999975 56777788888888999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEeecccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFGLAKL  454 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfgla~~  454 (623)
                      +.+ |-+|.+.+.-.   ...++.++.+-++-|++.-++|+|.+   ++|||||||+|+|..-   -..+.++|||+|+.
T Consensus        91 dLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             ecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence            988 78998887654   34689999999999999999999999   9999999999999973   34688999999987


Q ss_pred             cCCCCCc------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc
Q 006968          455 LDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       455 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      +.+....      ......||.+|.+-....+.+.+.+.|+-|+|.++.++--|..||..-......             
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-------------  230 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-------------  230 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-------------
Confidence            7543322      223456999999998888888899999999999999999999999754332211             


Q ss_pred             CccccccccccCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          529 GKLSQMVDKDLKGNFD---RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .+...+.+..+....+   ...+.++.-.+..|-..--++-|...-+-+.++
T Consensus       231 QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  231 QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            1111122222211111   112467778888888888888887765555443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=3e-21  Score=185.63  Aligned_cols=255  Identities=18%  Similarity=0.245  Sum_probs=192.8

Q ss_pred             cCCCcCCceeccCCeEEEEEE-eCCCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      -.|.+.++||+|.||+.+.|+ +-++++||||.=..   ..+..++..|...++.+. .+.|-..+.|...+-+-.||+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr---kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR---KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccc---cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            368889999999999999998 34799999997432   223457889999998885 6899888888888888899999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-----CcEEEeeccccc
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-----FEAVVGDFGLAK  453 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~Dfgla~  453 (623)
                      .+ |-||.++..-+   +..++.++...+|.|++.-++|+|++   .+|.|||||+|+||..-     ..+.++|||+|+
T Consensus       105 LL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            98 77888877644   45799999999999999999999999   99999999999999743     348899999999


Q ss_pred             ccCCCCCce------eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh
Q 006968          454 LLDHRDSHV------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       454 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      .+.+.....      .....||.+||+-....+.+.+.+.|+-|+|-++++.+-|..||..-..... .      ..+..
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K------~kYeK  250 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-K------EKYEK  250 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-H------HHHHH
Confidence            886654332      2345699999999999999999999999999999999999999974322111 0      01111


Q ss_pred             cCccccccccccCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          528 EGKLSQMVDKDLKGNFD---RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .++      ........   ...+.++..-+...-+.+-.+-|...-+...+.+
T Consensus       251 IGe------~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d  298 (449)
T KOG1165|consen  251 IGE------TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD  298 (449)
T ss_pred             hcc------ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            121      11111111   1124566676666667777788887665554443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=2.1e-22  Score=220.55  Aligned_cols=257  Identities=19%  Similarity=0.232  Sum_probs=187.6

Q ss_pred             CcCCceeccCCeEEEEEEeC-CCcEEEEEEec----cccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          304 SAKNILGRGGFGIVYKGCFS-DGALVAVKRLK----DYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       304 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ...+++|.|++|.|+..... .....+.|.++    ...... ....+..|+-+-..+.|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999988777643 34444555433    111111 1112566777778889999998888777766666669


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++ +|..++...    ..+....+..++.|+..|++|+|+.   ||.|||+|++|+++..++.+||+|||.+..+.-
T Consensus       401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 999888753    3578888999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC---ceeeccccccccccccccccCCCCC-ccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          458 RDS---HVTTAVRGTVGHIAPEYLSTGQSSE-KTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       458 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ...   ......+|+..|+|||.+.+.+|.+ ..||||.|+++..|++|+.||..+...+...      .......+. .
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~-~  545 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQR-N  545 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhcccccc-c
Confidence            433   4556678999999999999998865 5799999999999999999997544322210      000000000 0


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ....  ........+.+...++.++++++|++|.|+++|++.=+
T Consensus       546 ~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  546 IFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             cccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence            0000  00112344577889999999999999999999987543

>PLN03150 hypothetical protein; Provisional

Probab=99.86  E-value=2.5e-21  Score=215.16  Aligned_cols=160  Identities=40%  Similarity=0.658  Sum_probs=126.5

Q ss_pred             CCCCchHHHHHHHHHHhCCCCCcccCCCCCCCCCCC-----CcceeeeCCC-----CcEEEEeCCCCCcccccCccccCC
Q 006968           28 PAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPC-----SWRMITCSPD-----GYVSALGLPSQSLSGTLSPWIGNL   97 (623)
Q Consensus        28 ~~~~~~~~~~l~~~k~~~~~p~~~~~~w~~~~~~~c-----~w~gv~c~~~-----~~v~~L~L~~n~l~~~~~~~~~~l   97 (623)
                      ......|..||+.+|+.+.+|..  .+|+.   +||     .|.||+|...     ..++.|+|++|+|+|.+|..++++
T Consensus       367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L  441 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL  441 (623)
T ss_pred             cccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence            34566789999999999977642  48953   566     6999999632     248889999999999999889899


Q ss_pred             CCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCC-CcccEEE
Q 006968           98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKI-ESLTLVD  176 (623)
Q Consensus        98 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~L~  176 (623)
                      ++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..+++|++|+.|+|++|+++|.+|..+..+ .++.   
T Consensus       442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~---  518 (623)
T PLN03150        442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA---  518 (623)
T ss_pred             CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCc---
Confidence            999999999999988888888889999999999999998888888888888888888888888888777543 1222   


Q ss_pred             CCCCcCcCcCCCCccccccccCCCCCCCCCCCCCC
Q 006968          177 LSYNNLSGSLPKISARTFKVTGNPLICGPKATNNC  211 (623)
Q Consensus       177 l~~N~l~~~~p~~~~~~~~~~~n~~~~~~~~~~~~  211 (623)
                                      .+++.+|+.+|+.+....|
T Consensus       519 ----------------~l~~~~N~~lc~~p~l~~C  537 (623)
T PLN03150        519 ----------------SFNFTDNAGLCGIPGLRAC  537 (623)
T ss_pred             ----------------eEEecCCccccCCCCCCCC
Confidence                            3456677777876544445

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=6.8e-21  Score=180.22  Aligned_cols=141  Identities=17%  Similarity=0.208  Sum_probs=109.0

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEeccccccc-c-------hHHH-----------------HHHHHHHhhcCCCce
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-G-------EVQF-----------------QTEVETISLAVHRNL  360 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~-------~~~~-----------------~~e~~~l~~l~H~ni  360 (623)
                      ...||+|+||.||+|...+|+.||||+++...... .       ...|                 ..|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46799999999999998889999999997543211 1       1122                 349999999988776


Q ss_pred             eeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCeEEC
Q 006968          361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL-HEQCDPKIIHRDVKAANILLD  439 (623)
Q Consensus       361 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlk~~NIll~  439 (623)
                      .....+..  ...++||||++++++......    ...+++.....++.|++.+|.|+ |+.   +|+||||||+||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            44333222  234899999998876544322    23688999999999999999999 687   999999999999998


Q ss_pred             CCCcEEEeecccccccC
Q 006968          440 EDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       440 ~~~~~kl~Dfgla~~~~  456 (623)
                       ++.++|+|||+|...+
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=1.6e-20  Score=196.35  Aligned_cols=215  Identities=23%  Similarity=0.358  Sum_probs=163.4

Q ss_pred             HhhcCCCceeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EecC
Q 006968          352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI-IHRD  430 (623)
Q Consensus       352 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-vH~D  430 (623)
                      |+.+.|.|+.+++|.+..+...+.|.+|+..|+|.+.+...   ...++|.....++++++.||+|||..   +| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            35678999999999999999999999999999999999873   45799999999999999999999998   55 8999


Q ss_pred             CCCCCeEECCCCcEEEeecccccccCCC-CCceeeccccccccccccccccC-------CCCCccchhhHHHHHHHHHhC
Q 006968          431 VKAANILLDEDFEAVVGDFGLAKLLDHR-DSHVTTAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGILLLELITG  502 (623)
Q Consensus       431 lk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvil~elltg  502 (623)
                      ++++|.++|....+|++|||+....... .........-..-|.|||.+...       ..+.+.||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999998876421 11111112234679999999764       147789999999999999999


Q ss_pred             CCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       503 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      +.||+..............++.     .....+.+.+...  .+...++..++..||..+|.+||++.+|-..++..
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9999753332222222222222     1111222222211  12334799999999999999999999998888764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=1.3e-20  Score=180.18  Aligned_cols=173  Identities=10%  Similarity=0.058  Sum_probs=133.0

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccch--------HHHHHHHHHHhhcCCCceeeeeeeeecC
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGE--------VQFQTEVETISLAVHRNLLRLCGFCSTE  370 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------~~~~~e~~~l~~l~H~niv~l~~~~~~~  370 (623)
                      ...+|...+++|.|+||.||.+.. ++..+|||.++........        ..+.+|+..+.++.||+|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            457899999999999999999766 6778999999765432211        1267899999999999999998875532


Q ss_pred             --------CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 006968          371 --------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF  442 (623)
Q Consensus       371 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  442 (623)
                              +..++||||++|.+|.++..        ++.    ....+++.++..+|..   +++|||++|+||+++.++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence                    35789999999999877632        222    2456999999999999   999999999999999988


Q ss_pred             cEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh
Q 006968          443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT  501 (623)
Q Consensus       443 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt  501 (623)
                       ++++|||...........             ..+.....+..++|+||||+.+..+..
T Consensus       173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence             999999988754321110             012334456678999999999876543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.2e-19  Score=172.44  Aligned_cols=141  Identities=18%  Similarity=0.186  Sum_probs=111.2

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEecccccccc-------------------------hHHHHHHHHHHhhcCCCce
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-------------------------EVQFQTEVETISLAVHRNL  360 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------~~~~~~e~~~l~~l~H~ni  360 (623)
                      ...||+|+||.||+|...+|+.||||+++.......                         ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            468999999999999987899999999976421100                         1123578899999999987


Q ss_pred             eeeeeeeecCCceEEEEecccCCChhhh-hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEE
Q 006968          361 LRLCGFCSTENERLLVYPYMPNGSVASR-LRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILL  438 (623)
Q Consensus       361 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll  438 (623)
                      .....+...  ..++||||++++++... +.     ...++......++.|++.++.++|+ .   +|+||||||.||++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            544443332  34899999998854433 32     2357788899999999999999999 8   99999999999999


Q ss_pred             CCCCcEEEeecccccccCC
Q 006968          439 DEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       439 ~~~~~~kl~Dfgla~~~~~  457 (623)
                      + ++.++|+|||++.....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            9 78999999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=2.1e-20  Score=204.14  Aligned_cols=258  Identities=23%  Similarity=0.247  Sum_probs=186.9

Q ss_pred             CCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHH---HHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF---QTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++...+.||++.|=.|.+|+.++|. |+||++-+....-.-..|   ..|++ ....+|||.+++.-.-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4566788999999999999998887 899998654433233334   44444 556789999999888777778889999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc--ccC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK--LLD  456 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~--~~~  456 (623)
                      |.. -+|++++..    ++-+...+.+.|+.|++.|+.-+|..   +|+|||||.+|||++.=+=+.|+||..-+  ++.
T Consensus       102 yvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence            984 477777764    55688888999999999999999999   99999999999999988788999998654  222


Q ss_pred             CCCCceeec----cccccccccccccccC-----------CCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHH
Q 006968          457 HRDSHVTTA----VRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLD  520 (623)
Q Consensus       457 ~~~~~~~~~----~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  520 (623)
                      .........    ...-..|+|||.+...           ..+++-||||+||++.||++ |+++|....-       ..
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-------~a  246 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-------LA  246 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-------Hh
Confidence            222222211    1233569999977541           14678899999999999988 5777752211       11


Q ss_pred             HHHHHhhcC-ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCCccchh
Q 006968          521 WVKKLHQEG-KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEA  587 (623)
Q Consensus       521 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~  587 (623)
                          +...+ ...+..-.       ..+...+.+++..|++.||.+|-++++.++.-.+..+++-+-.
T Consensus       247 ----Yr~~~~~~~e~~Le-------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~  303 (1431)
T KOG1240|consen  247 ----YRSGNADDPEQLLE-------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYS  303 (1431)
T ss_pred             ----HhccCccCHHHHHH-------hCcCccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHH
Confidence                00000 00000000       1111357899999999999999999999999999988887644

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=6.3e-19  Score=164.91  Aligned_cols=185  Identities=18%  Similarity=0.074  Sum_probs=137.7

Q ss_pred             CcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccc---hHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEEEec
Q 006968          304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG---EVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       304 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .+...|++|+||+||.+.. .+.+++.+.++....-..   ...|.+|+++|+++. |+++.+++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997765 678888888765443211   224789999999995 5789888886    457999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeEECCCCcEEEeecccccccCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV-KAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      +.|.+|...+..           ....++.|++.+|+++|+.   ||+|||| ||.|||++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999987643311           1134678999999999999   9999999 799999999999999999999865433


Q ss_pred             CCc----e--------eeccccccccccccccccC-CCC-CccchhhHHHHHHHHHhCCCCCC
Q 006968          459 DSH----V--------TTAVRGTVGHIAPEYLSTG-QSS-EKTDVFGFGILLLELITGQRALD  507 (623)
Q Consensus       459 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~SlGvil~elltg~~p~~  507 (623)
                      ...    .        ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.-
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            210    0        0112256777888754321 222 45688999999999999998764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=1.1e-18  Score=172.09  Aligned_cols=234  Identities=25%  Similarity=0.290  Sum_probs=149.5

Q ss_pred             CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccc--cccchHHHHHHHHHHhhcCC-----------Cceeeeee---
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN--IAGGEVQFQTEVETISLAVH-----------RNLLRLCG---  365 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~H-----------~niv~l~~---  365 (623)
                      +...+.||.|+++.||.+.+. +|+.+|||++....  .....+++.+|.-....+.+           .-++.+--   
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            445678999999999999986 58999999985443  22234466777655554332           11222110   


Q ss_pred             -----eeecCC--------ceEEEEecccCCChhhhhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 006968          366 -----FCSTEN--------ERLLVYPYMPNGSVASRLRD---HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHR  429 (623)
Q Consensus       366 -----~~~~~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  429 (623)
                           ++....        ..+++|+-+ -++|.+.+..   .......+....+..+..|+++.+++||+.   |++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                 111111        236677777 5677776542   222222355667788889999999999999   99999


Q ss_pred             CCCCCCeEECCCCcEEEeecccccccCCCCCceeeccccccccccccccccC--------CCCCccchhhHHHHHHHHHh
Q 006968          430 DVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG--------QSSEKTDVFGFGILLLELIT  501 (623)
Q Consensus       430 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~SlGvil~ellt  501 (623)
                      ||+|+|++++.+|.++|+||+.....+..    ......+..|.+||.....        .++.+.|.|++|+++|.|.+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999999987754321    1113356789999977442        46889999999999999999


Q ss_pred             CCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 006968          502 GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHR  566 (623)
Q Consensus       502 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R  566 (623)
                      |+.||+.........                    ..+. ... +.++.+..||..+|+.+|.+|
T Consensus       246 ~~lPf~~~~~~~~~~--------------------~~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPE--------------------WDFS-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSG--------------------GGGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCcccccc--------------------ccch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            999997543321110                    0122 223 667899999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=2e-18  Score=192.75  Aligned_cols=199  Identities=23%  Similarity=0.253  Sum_probs=161.0

Q ss_pred             HHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcC---CCceeeeeeeeecCC
Q 006968          295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---HRNLLRLCGFCSTEN  371 (623)
Q Consensus       295 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~  371 (623)
                      +.......|.+.+.||+|+||+||+|...+|+.||+|+=+....-    +|.-=.+++.+++   -+-|+++...+.-.+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence            344456778899999999999999999988999999997654422    2222233344444   345566666666778


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-------CCcE
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-------DFEA  444 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~~  444 (623)
                      .-+||+||.+.|+|.+++.    .....+|.-...++.|++.-+++||..   +||||||||+|++|..       ...+
T Consensus       768 ~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             cceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence            8899999999999999987    356789999999999999999999999   9999999999999952       3458


Q ss_pred             EEeecccccccCCC-CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCC
Q 006968          445 VVGDFGLAKLLDHR-DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR  504 (623)
Q Consensus       445 kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~  504 (623)
                      +|+|||.+-.+.-- +.......++|-.+-.+|...++.++.++|.|.++.+++-|+.|+.
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999999765432 2234566678999999999999999999999999999999999974

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=7.2e-20  Score=191.15  Aligned_cols=226  Identities=25%  Similarity=0.270  Sum_probs=180.6

Q ss_pred             ceeccCCeEEEEEE----eCCCcEEEEEEecccccccch-HHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEEEeccc
Q 006968          308 ILGRGGFGIVYKGC----FSDGALVAVKRLKDYNIAGGE-VQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMP  381 (623)
Q Consensus       308 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~  381 (623)
                      ++|+|.||.|+.+.    .+.|..+|.|++++....... .....|..++..++ ||.++++...+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999998764    235788999998765433222 24566888888887 9999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      +|.|...+..    ...++......+...++-+++++|+.   +|+|||+|++||+++.+|.+++.|||+++..-..+..
T Consensus        81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            9998877765    34577778888889999999999999   9999999999999999999999999999865433222


Q ss_pred             eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCC
Q 006968          462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG  541 (623)
Q Consensus       462 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  541 (623)
                           +||..|||||++.  .....+|.||||++++||+||..||..           +.++.+..           ...
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~-----------~~~  204 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILK-----------AEL  204 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhh-----------hcc
Confidence                 7999999999987  567789999999999999999999863           11222211           011


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006968          542 NFDRIELEEMVQVALLCTQFNPLHRPKM  569 (623)
Q Consensus       542 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~  569 (623)
                      .++........+++..+...+|..|--.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2455666778889999999999999755

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=2e-18  Score=169.94  Aligned_cols=196  Identities=20%  Similarity=0.233  Sum_probs=136.2

Q ss_pred             CCCceeeeeeeeecC---------------------------CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHH
Q 006968          356 VHRNLLRLCGFCSTE---------------------------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA  408 (623)
Q Consensus       356 ~H~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  408 (623)
                      +|||||++.++|.+.                           ...|+||.-++ .+|..|+-..     ..+...+.-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-----~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-----HRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-----CCchHHHHHHH
Confidence            599999998876431                           24578888774 4788877642     45666778899


Q ss_pred             HHHHHHHHHHHhCCCCCeEecCCCCCCeEEC--CCC--cEEEeecccccccCCCC---Cc--eeeccccccccccccccc
Q 006968          409 LGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDF--EAVVGDFGLAKLLDHRD---SH--VTTAVRGTVGHIAPEYLS  479 (623)
Q Consensus       409 ~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~kl~Dfgla~~~~~~~---~~--~~~~~~gt~~y~aPE~~~  479 (623)
                      .|+++|..|||.+   ||.|||+|++|||+.  +|+  ...|+|||.+-....-.   ..  -.....|.-.-||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   999999999999984  443  36799999875332100   00  111234777899999886


Q ss_pred             cCCC------CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHH
Q 006968          480 TGQS------SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQ  553 (623)
Q Consensus       480 ~~~~------~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  553 (623)
                      ..+-      -.|+|.|+.|.+.||+++...||..-.. .    .++ .+.+      .+.    .....+..++..+.+
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m----~L~-~r~Y------qe~----qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-M----LLD-TRTY------QES----QLPALPSRVPPVARQ  488 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-h----eec-hhhh------hhh----hCCCCcccCChHHHH
Confidence            5432      4589999999999999999999973111 0    000 0111      111    111233444567889


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHh
Q 006968          554 VALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       554 l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ++...++.||.+|++..-....|
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHH
Confidence            99999999999999986554443

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=1.1e-17  Score=159.61  Aligned_cols=136  Identities=18%  Similarity=0.211  Sum_probs=104.5

Q ss_pred             CcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhc-----CCCceeeeeeeeecCC---ceE-
Q 006968          304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-----VHRNLLRLCGFCSTEN---ERL-  374 (623)
Q Consensus       304 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~~~~~~~~---~~~-  374 (623)
                      ...+.||+|+||.||. .-.++.. +||++.... ......+.+|+.+++.+     .||||++++|++.++.   ..+ 
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            4467899999999996 2224444 699886543 22355789999999999     5799999999998763   333 


Q ss_pred             EEEec--ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCeEECC----CCcEEEe
Q 006968          375 LVYPY--MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL-LYLHEQCDPKIIHRDVKAANILLDE----DFEAVVG  447 (623)
Q Consensus       375 lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~  447 (623)
                      +|+||  +++|+|.+++.+.     .+++.  ..++.+++.++ +|||++   +|+||||||+|||++.    +..++|+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            78999  5579999999652     24544  35677888777 999999   9999999999999974    3479999


Q ss_pred             ecccc
Q 006968          448 DFGLA  452 (623)
Q Consensus       448 Dfgla  452 (623)
                      ||+-+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95444

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=1.2e-17  Score=163.52  Aligned_cols=145  Identities=14%  Similarity=0.118  Sum_probs=111.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEE--eCCCcEEEEEEeccccccc-----------------------chHHHHHHHHHHhh
Q 006968          300 TSNFSAKNILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAG-----------------------GEVQFQTEVETISL  354 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~  354 (623)
                      ...|.+.+.||+|+||.||+|.  ..+|+.||+|+++......                       ....+..|+..+.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3347888999999999999998  5689999999987543110                       01235689999999


Q ss_pred             cCCCc--eeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCC
Q 006968          355 AVHRN--LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK-IIHRDV  431 (623)
Q Consensus       355 l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dl  431 (623)
                      +.+..  +.+.+++    ...++||||+++++|..+...    ...........++.|++.++++||+.   + |+||||
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Di  175 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDL  175 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCC
Confidence            97533  3333432    245899999999887665422    22456667789999999999999999   8 999999


Q ss_pred             CCCCeEECCCCcEEEeecccccccC
Q 006968          432 KAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       432 k~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      ||+||+++ ++.++|+|||.+....
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhccC
Confidence            99999999 8899999999987544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=4.3e-17  Score=157.79  Aligned_cols=135  Identities=19%  Similarity=0.258  Sum_probs=114.0

Q ss_pred             CceeccCCeEEEEEEeCCCcEEEEEEeccccccc-------chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-------GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +.||+|++|.||+|.. +|..|+||+........       ....+.+|++++..+.|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 77889999875432211       123578899999999999998877777777889999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      ++|++|.+++...       .+ .+..++.+++.+|.++|+.   +++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988642       12 7889999999999999999   999999999999999 78999999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=4.1e-17  Score=156.22  Aligned_cols=146  Identities=20%  Similarity=0.137  Sum_probs=112.1

Q ss_pred             HHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc---------------------cchHHHHHHHHHHh
Q 006968          295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA---------------------GGEVQFQTEVETIS  353 (623)
Q Consensus       295 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~  353 (623)
                      ++......|.+.+.||+|+||.||++...+|+.||||+++.....                     .....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            333333447788999999999999999888999999987643210                     01123677888888


Q ss_pred             hcCCCc--eeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 006968          354 LAVHRN--LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV  431 (623)
Q Consensus       354 ~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  431 (623)
                      .+.|++  +.+.++    ....++||||+++++|......          .....++.+++.++.++|+.   +|+||||
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl  151 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL  151 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence            888874  334443    2456899999999998654321          23467889999999999998   9999999


Q ss_pred             CCCCeEECCCCcEEEeecccccccCC
Q 006968          432 KAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       432 k~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      +|.||++++++.++|+|||++.....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=6.2e-17  Score=155.13  Aligned_cols=131  Identities=20%  Similarity=0.287  Sum_probs=107.4

Q ss_pred             ceeccCCeEEEEEEeCCCcEEEEEEeccccccc-------chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-------GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       308 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      .||+|+||.||+|.+ +|..|++|.........       ....+.+|++++..+.|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 67889999865432111       1245778999999999988766555666677789999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      ++++|.+++....    .       .++.+++.+|.+||+.   +++|||++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988775421    0       7899999999999999   999999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=6.4e-17  Score=178.19  Aligned_cols=139  Identities=17%  Similarity=0.217  Sum_probs=112.4

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEe-cccccc------cchHHHHHHHHHHhhcCCCceeeeeeeeecCC
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRL-KDYNIA------GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN  371 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  371 (623)
                      ....|...+.||+|+||+||+|.+.+.. +++|+. .+....      .....+.+|++++..++|++++....++...+
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3445567889999999999999875443 444432 221111      11245889999999999999998888887777


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL  451 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  451 (623)
                      ..++||||+++++|.+++.            ....++.+++++|.|||+.   +++||||||+||++ .++.++|+|||+
T Consensus       410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence            8899999999999988875            3467899999999999999   99999999999999 677999999999


Q ss_pred             ccc
Q 006968          452 AKL  454 (623)
Q Consensus       452 a~~  454 (623)
                      ++.
T Consensus       474 a~~  476 (535)
T PRK09605        474 GKY  476 (535)
T ss_pred             ccc
Confidence            975

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.69  E-value=1.3e-17  Score=171.11  Aligned_cols=174  Identities=24%  Similarity=0.323  Sum_probs=128.6

Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL  451 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  451 (623)
                      ..++.|+++..++|.+||..... ....++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            57899999999999999975422 3457888999999999999999   6   899999999999999999999999999


Q ss_pred             ccccCCCC-----CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhC-CCCCCcccccccccchHHHHHHH
Q 006968          452 AKLLDHRD-----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG-QRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       452 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      ........     ....+...||..||+||.+.+..|+.|+||||+|++++|++.- ..+++                  
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------------  464 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------------  464 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------------
Confidence            87665433     1223445699999999999999999999999999999999881 11111                  


Q ss_pred             hhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEV  572 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev  572 (623)
                       ..+...++-+..+...+-.+. .+=..++.+++.+.|.+||++.+.
T Consensus       465 -r~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  465 -RIATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             -HHHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence             001111111111111110011 223578889999999999965554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=1.2e-16  Score=175.02  Aligned_cols=209  Identities=23%  Similarity=0.278  Sum_probs=142.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ..+|+.++.|..|+||.||...++ ..+.+|.|+= +...      +.+-  ++.....|.+|                 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l------ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL------ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccc-ccch------hhhc--cccccCCccee-----------------
Confidence            367888999999999999999876 3677888443 2211      1110  22222333333                 


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                          |+-...+...    +++..        +++.+++|||+.   +|+|||+||+|.+|+.-|.+|+.|||+.+..-..
T Consensus       136 ----gDc~tllk~~----g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 ----GDCATLLKNI----GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             ----chhhhhcccC----CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                3333333321    22221        337899999999   9999999999999999999999999998653211


Q ss_pred             C--------------CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH
Q 006968          459 D--------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       459 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      .              ......++||+.|+|||++...-|...+|.|++|+|+||.+-|+.||....+++..+..+..   
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd---  273 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD---  273 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh---
Confidence            1              01124568999999999999999999999999999999999999999765443322222110   


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK  568 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs  568 (623)
                         +..+.+- |        .....+..+++.+.|+.+|..|--
T Consensus       274 ---~i~wpE~-d--------ea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  274 ---DIEWPEE-D--------EALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             ---hcccccc-C--------cCCCHHHHHHHHHHHHhChHhhcc
Confidence               0111111 1        112367889999999999999943

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=3.3e-15  Score=135.85  Aligned_cols=135  Identities=18%  Similarity=0.126  Sum_probs=114.3

Q ss_pred             cCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCC--CceeeeeeeeecCCceEEEEecccC
Q 006968          305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH--RNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       305 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.+.||+|.++.||++...+ ..+++|..+....   ...+..|+..+..++|  .++.+++++....+..++++||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35679999999999999854 7899999865432   4578999999999976  5888999888888889999999988


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +.+..+           +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus        78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            775433           5567788899999999999997545799999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=1.5e-15  Score=144.07  Aligned_cols=137  Identities=20%  Similarity=0.223  Sum_probs=97.4

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEecccccccc-hHHH----------------------HHHHHHHhhcCCCc--e
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQF----------------------QTEVETISLAVHRN--L  360 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~----------------------~~e~~~l~~l~H~n--i  360 (623)
                      .+.||+|+||.||+|...+|+.||||+++....... ...+                      ..|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999988899999999875322111 1111                      24455555554332  2


Q ss_pred             eeeeeeeecCCceEEEEecccCCChhhh-hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEE
Q 006968          361 LRLCGFCSTENERLLVYPYMPNGSVASR-LRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILL  438 (623)
Q Consensus       361 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll  438 (623)
                      .+.++.    ...++||||++++.+... +....     .. .....++.+++.++.++|. .   +|+||||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            333332    346899999999653321 22110     11 5678899999999999999 7   99999999999999


Q ss_pred             CCCCcEEEeecccccccC
Q 006968          439 DEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       439 ~~~~~~kl~Dfgla~~~~  456 (623)
                      + ++.++++|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8899999999997544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=1.9e-14  Score=141.14  Aligned_cols=136  Identities=16%  Similarity=0.164  Sum_probs=105.1

Q ss_pred             CCcee-ccCCeEEEEEEeCCCcEEEEEEeccccc------------ccchHHHHHHHHHHhhcCCCce--eeeeeeeecC
Q 006968          306 KNILG-RGGFGIVYKGCFSDGALVAVKRLKDYNI------------AGGEVQFQTEVETISLAVHRNL--LRLCGFCSTE  370 (623)
Q Consensus       306 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~  370 (623)
                      ...|| .|+.|+||++.. ++..++||++.....            ......+.+|++++.++.|+++  .+.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 899999999987 477899998853211            1123457889999999998885  5667665432


Q ss_pred             Cc----eEEEEecccC-CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEE
Q 006968          371 NE----RLLVYPYMPN-GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       371 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                      ..    .++|+||+++ .+|.+++...     .++..    .+.+++.++.+||+.   ||+||||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            22    3599999997 6888887542     34443    356899999999999   999999999999999988999


Q ss_pred             Eeecccccc
Q 006968          446 VGDFGLAKL  454 (623)
Q Consensus       446 l~Dfgla~~  454 (623)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=9.5e-16  Score=168.34  Aligned_cols=255  Identities=24%  Similarity=0.300  Sum_probs=187.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC--CCcEEEEEEecccc-cccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv  376 (623)
                      ..|...+.||+|.|+.|-.....  ....+|+|.+.... ..........|..+-..+. |+|++++++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45677788999999999887653  34567777765443 1112223344666666665 99999999999999999999


Q ss_pred             EecccCCChhhhhh-hccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeEECCCC-cEEEeeccccc
Q 006968          377 YPYMPNGSVASRLR-DHIHGRPALDWARRKRIALGTARGLLYLH-EQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAK  453 (623)
Q Consensus       377 ~e~~~~gsL~~~l~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~  453 (623)
                      ++|..++++.+.+. ..   ....+......++.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus       100 ~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999887773 22   114555667788999999999999 77   999999999999999999 99999999998


Q ss_pred             ccCC--CCCceeecccc-ccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          454 LLDH--RDSHVTTAVRG-TVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       454 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      .+..  +........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++.......  ....|...-   +
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--~~~~~~~~~---~  248 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--RYSSWKSNK---G  248 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--cceeecccc---c
Confidence            7765  33334455668 9999999999884 557789999999999999999999986554332  111221110   0


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                      .....        ..........++..+++..+|..|.+.+++..
T Consensus       249 ~~~~~--------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  249 RFTQL--------PWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ccccC--------ccccCChhhhhcccccccCCchhccccccccc
Confidence            10010        11112245678888899899999999988854

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.53  E-value=4e-16  Score=136.96  Aligned_cols=130  Identities=27%  Similarity=0.443  Sum_probs=111.9

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|.|++|+|+ .+|+.+..|.+|+.|++++|+|. .+|.+++.+++|+.|+++-|++. .+|..|++++.|+.|||
T Consensus        33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl  109 (264)
T KOG0617|consen   33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence            37899999999999 88999999999999999999999 78999999999999999999999 99999999999999999


Q ss_pred             cccccCC-CCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCCCC
Q 006968          154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPK  206 (623)
Q Consensus       154 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~  206 (623)
                      .+|+++. .+|..|..++.|+.|+|+.|.|.-.+|+...    +.+.+..|.++..|.
T Consensus       110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lpk  167 (264)
T KOG0617|consen  110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLPK  167 (264)
T ss_pred             cccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCcH
Confidence            9999864 6788888888888888888888865555433    456666676665543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.47  E-value=4.1e-13  Score=143.18  Aligned_cols=147  Identities=22%  Similarity=0.225  Sum_probs=102.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEeccccccc---------------------------------------c
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG---------------------------------------G  341 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------~  341 (623)
                      ..|+ .+.||+|++|.||+|++++|+.||||+.+......                                       .
T Consensus       118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            3444 46899999999999999999999999986432000                                       0


Q ss_pred             hHHHHHHHHHHhhcC----CCceeeeeeee-ecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHH-HH
Q 006968          342 EVQFQTEVETISLAV----HRNLLRLCGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR-GL  415 (623)
Q Consensus       342 ~~~~~~e~~~l~~l~----H~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L  415 (623)
                      +.+|..|...+.+++    |.+-+.+-..+ ......++||||++|++|.++......   ..   .+..++..++. .+
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l  270 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFL  270 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHH
Confidence            113555655555442    33333332333 223457999999999999887653211   12   23456666665 47


Q ss_pred             HHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       416 ~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ..+|..   |++|+|++|.||+++.++.++++|||++..+..
T Consensus       271 ~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       271 NQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            788988   999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=2.9e-13  Score=130.99  Aligned_cols=204  Identities=20%  Similarity=0.276  Sum_probs=142.7

Q ss_pred             HhhcCCCceeeeeeeeecC-----CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006968          352 ISLAVHRNLLRLCGFCSTE-----NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI  426 (623)
Q Consensus       352 l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  426 (623)
                      +-++.|-|||++..|+.+.     ....+++|||..|++..+|++.......+......++..||..||.|||+ |.|+|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence            3455699999999988543     35689999999999999999876667788888999999999999999999 48899


Q ss_pred             EecCCCCCCeEECCCCcEEEeeccccccc---CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCC
Q 006968          427 IHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ  503 (623)
Q Consensus       427 vH~Dlk~~NIll~~~~~~kl~Dfgla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~  503 (623)
                      +|+++.-+-|++..++-+|++--.-...-   ............+-++|.|||.-.....+..+|||+||+-..||.-+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            99999999999999988887522111100   000011111223668999999877778888999999999999998876


Q ss_pred             CCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          504 RALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       504 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .-............         ........+...+           =...+..|+...|..||+|.+++.|.
T Consensus       280 iq~tnseS~~~~ee---------~ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  280 IQSTNSESKVEVEE---------NIANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eccCCCcceeehhh---------hhhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence            54221111100000         0000001111111           13467789999999999999987654

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.35  E-value=8.5e-14  Score=122.45  Aligned_cols=129  Identities=27%  Similarity=0.442  Sum_probs=113.2

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCC-CCCCccccCCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-GEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l  153 (623)
                      +++.|++.+|+|+ .+|..++.++.|+.|+++-|++. .+|..|+.++.|+.|||+.|+++ ..+|+.|.-++.|+.|+|
T Consensus        57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl  134 (264)
T KOG0617|consen   57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL  134 (264)
T ss_pred             hhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence            6888999999998 79999999999999999999998 88999999999999999999987 468999999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPKA  207 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~~  207 (623)
                      +.|.|. .+|..+++|++|+.|.+..|.+- ++|...+     +.+.+.||++.-.|+.
T Consensus       135 ~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppe  191 (264)
T KOG0617|consen  135 GDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPE  191 (264)
T ss_pred             cCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChh
Confidence            999999 89999999999999999999988 4554333     5678889988666553

>PLN03150 hypothetical protein; Provisional

Probab=99.34  E-value=1.7e-12  Score=144.74  Aligned_cols=94  Identities=39%  Similarity=0.636  Sum_probs=90.1

Q ss_pred             CcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECC
Q 006968           99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLS  178 (623)
Q Consensus        99 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~  178 (623)
                      .++.|+|++|.++|.+|..++++++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..+++|++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCcCcCCCCccc
Q 006968          179 YNNLSGSLPKISAR  192 (623)
Q Consensus       179 ~N~l~~~~p~~~~~  192 (623)
                      +|+|+|.+|..+..
T Consensus       499 ~N~l~g~iP~~l~~  512 (623)
T PLN03150        499 GNSLSGRVPAALGG  512 (623)
T ss_pred             CCcccccCChHHhh
Confidence            99999999986553

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.33  E-value=1.6e-12  Score=140.11  Aligned_cols=148  Identities=19%  Similarity=0.167  Sum_probs=95.1

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeCC-CcEEEEEEecccccc---------------------------------c----
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIA---------------------------------G----  340 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------------------~----  340 (623)
                      ....|+. +.||+|++|.||+|.+++ |+.||||+.+.....                                 +    
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456776 789999999999999987 999999999743100                                 0    


Q ss_pred             --chHHHHHHHHHHhhcC----CCceeeeeeeeec-CCceEEEEecccCCChhhhh--hhccCCCCCCCHHHHHHHHHHH
Q 006968          341 --GEVQFQTEVETISLAV----HRNLLRLCGFCST-ENERLLVYPYMPNGSVASRL--RDHIHGRPALDWARRKRIALGT  411 (623)
Q Consensus       341 --~~~~~~~e~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i  411 (623)
                        .+.+|.+|..-+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.+.-  .........+.......++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence              0113444554444442    3333333333322 35678999999999987642  2110000112222222333333


Q ss_pred             HHHHHHHHhCCCCCeEecCCCCCCeEECCCC----cEEEeecccccccCC
Q 006968          412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDFGLAKLLDH  457 (623)
Q Consensus       412 a~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfgla~~~~~  457 (623)
                             +..   |++|+|+||.||+++.++    .+++.|||++..+..
T Consensus       277 -------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   345   999999999999999888    999999999987754

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.31  E-value=8.4e-14  Score=137.78  Aligned_cols=123  Identities=28%  Similarity=0.419  Sum_probs=101.8

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCcccc-CCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG-DLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l  153 (623)
                      +++.||..+|-|+ ++|+.++.+.+|.-|+|..|+|. .+| +|.++..|.+|+++.|+|+ .+|.+.+ .+++|..|||
T Consensus       184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL  259 (565)
T KOG0472|consen  184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL  259 (565)
T ss_pred             HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence            4556666666665 78888888888888888888888 677 6888888888888888888 8888766 7899999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc---ccccccCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA---RTFKVTGNPLI  202 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~---~~~~~~~n~~~  202 (623)
                      ..|+++ .+|+.++-|++|++||+|+|.+++.++++..   +.+.+.|||+.
T Consensus       260 RdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr  310 (565)
T KOG0472|consen  260 RDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLR  310 (565)
T ss_pred             cccccc-cCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCchH
Confidence            999998 8899999999999999999999987777655   66778899874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=2.8e-12  Score=134.76  Aligned_cols=248  Identities=21%  Similarity=0.173  Sum_probs=177.7

Q ss_pred             CCCcCCceec--cCCeEEEEEEe---CCCcEEEEEEeccccc-ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceE
Q 006968          302 NFSAKNILGR--GGFGIVYKGCF---SDGALVAVKRLKDYNI-AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       302 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  374 (623)
                      .|...+.+|.  |.+|.||++..   .++..+|+|+-+.... ......=.+|......+ .|+|.++....+.+.+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556678999  99999999986   3688899998543322 11122224566555555 4999999888888899999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCeEECCC-CcEEEeec
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR----GLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDF  449 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Df  449 (623)
                      +-+|++. .+|..+-+..   ...+.....+.+..+..+    |+.++|+.   +++|-|+||.||+...+ ...+++||
T Consensus       195 iqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            9999884 6777766543   123566677777778888    99999999   99999999999999999 88999999


Q ss_pred             ccccccCCCCCc----eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          450 GLAKLLDHRDSH----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       450 gla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      |+...+....-.    ......|...|++||.. ++.++...|+|++|.++.+-.++.+.....-       ...|... 
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-------~~~W~~~-  338 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK-------NSSWSQL-  338 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC-------CCCcccc-
Confidence            999888765422    22233578899999986 5577899999999999999999987764320       0011110 


Q ss_pred             hhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                            ....   +..++-.....++...+..+++.+|..|++.+.+..
T Consensus       339 ------r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  339 ------RQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ------cccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                  0000   111111112345566889999999999999987754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=8.6e-12  Score=116.06  Aligned_cols=131  Identities=20%  Similarity=0.142  Sum_probs=96.9

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCcee-eeeeeeecCCceEEEEecccCCC
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL-RLCGFCSTENERLLVYPYMPNGS  384 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~gs  384 (623)
                      .+.++.|.++.||++... +..|++|.......  ....+..|+.++..+.+.+++ +++.+.  ....++||||+++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence            356889999999999874 77899999754421  233568899999888765554 344433  334689999999987


Q ss_pred             hhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC--DPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +...  .          .....++.+++++|+.||...  ..+++|||++|.||+++ ++.++++|||.+..
T Consensus        78 l~~~--~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTE--D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            6542  0          011345678999999999982  22369999999999999 66899999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.26  E-value=1.4e-10  Score=123.10  Aligned_cols=165  Identities=20%  Similarity=0.246  Sum_probs=123.9

Q ss_pred             CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHH
Q 006968          323 SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWA  402 (623)
Q Consensus       323 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~  402 (623)
                      .++.+|.|+..+.... .......+-++.++.++||||++++.....++..|+|+|-+.  -|..++.+       +...
T Consensus        35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~  104 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE  104 (690)
T ss_pred             ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence            4688899988865543 223346778889999999999999999999999999999874  34555554       2345


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeeccccccccccccccccCC
Q 006968          403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ  482 (623)
Q Consensus       403 ~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  482 (623)
                      .....+.||+.||.+||+.|  +++|++|.-..|+++..|+.||++|.++........ ......---.|..|+.+....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            56677889999999999776  999999999999999999999999998865432211 111111223466676543222


Q ss_pred             CCCccchhhHHHHHHHHHhC
Q 006968          483 SSEKTDVFGFGILLLELITG  502 (623)
Q Consensus       483 ~~~~~Dv~SlGvil~elltg  502 (623)
                        -..|.|-||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.26  E-value=5.3e-13  Score=137.84  Aligned_cols=132  Identities=31%  Similarity=0.357  Sum_probs=114.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .+..|+|+.|+++..-..++.+|+.|+.|+||+|.|...-++.+.-+.+|+.||||+|+|+..-+++|..|..|++|+|+
T Consensus       270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs  349 (873)
T KOG4194|consen  270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS  349 (873)
T ss_pred             ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence            68999999999998778899999999999999999998889999999999999999999997677789999999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc--------ccccccCCCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--------RTFKVTGNPLICGPK  206 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--------~~~~~~~n~~~~~~~  206 (623)
                      +|++...-...|..+++|+.|||++|.|++.|-+...        +.+.|.||++...+.
T Consensus       350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~k  409 (873)
T KOG4194|consen  350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPK  409 (873)
T ss_pred             ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecch
Confidence            9999865556788899999999999999987776422        567888888766543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=2e-10  Score=111.82  Aligned_cols=143  Identities=20%  Similarity=0.257  Sum_probs=110.1

Q ss_pred             CceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCC--ceeeeeeeeecC---CceEEEEeccc
Q 006968          307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR--NLLRLCGFCSTE---NERLLVYPYMP  381 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~~~---~~~~lv~e~~~  381 (623)
                      +.|+.|.++.||++...+|..+++|.............+..|.++++.+.+.  ++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            5689999999999998777899999976543222345688999999998763  456677776653   36689999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC---------------------------------------  422 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------------  422 (623)
                      +.++.+.+..     ..++...+..++.+++++|.+||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9887665431     24677778888888888888888521                                       


Q ss_pred             --------------CCCeEecCCCCCCeEECC--CCcEEEeecccccc
Q 006968          423 --------------DPKIIHRDVKAANILLDE--DFEAVVGDFGLAKL  454 (623)
Q Consensus       423 --------------~~~ivH~Dlk~~NIll~~--~~~~kl~Dfgla~~  454 (623)
                                    ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          246899999999999998  66689999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.19  E-value=3.9e-10  Score=105.89  Aligned_cols=138  Identities=16%  Similarity=0.159  Sum_probs=98.5

Q ss_pred             CceeccCCeEEEEEEeCC-------CcEEEEEEeccccc---------------------ccchHHH----HHHHHHHhh
Q 006968          307 NILGRGGFGIVYKGCFSD-------GALVAVKRLKDYNI---------------------AGGEVQF----QTEVETISL  354 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~----~~e~~~l~~  354 (623)
                      ..||.|.-+.||.|...+       +..+|||+.+....                     ......+    .+|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653       47999999853210                     0011122    378888888


Q ss_pred             cCC--CceeeeeeeeecCCceEEEEecccCCChhh-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecC
Q 006968          355 AVH--RNLLRLCGFCSTENERLLVYPYMPNGSVAS-RLRDHIHGRPALDWARRKRIALGTARGLLYL-HEQCDPKIIHRD  430 (623)
Q Consensus       355 l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~D  430 (623)
                      +..  -++-+.+++    ...++||||+.++.+.. .+++     ..++......+..+++.+|.++ |..   ++||||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            753  344455543    56789999997654321 2322     2345556677889999999999 777   999999


Q ss_pred             CCCCCeEECCCCcEEEeecccccccCC
Q 006968          431 VKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       431 lk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      |++.||+++ ++.+.|+|||.+....+
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            999999997 46899999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=3e-11  Score=127.15  Aligned_cols=248  Identities=21%  Similarity=0.194  Sum_probs=173.6

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC--CCcEEEEEEecccccccchHH-HHHHHHHHhhc-CCCceeeeeeeeecCCceE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQ-FQTEVETISLA-VHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  374 (623)
                      -..+|..+..||.|.|+.|++...+  ++..+++|.+.........+. -..|+.+...+ .|.++++....+......+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            4567888999999999999998754  578899998865433222222 24555555544 5888888777776777778


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CcEEEeeccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAK  453 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgla~  453 (623)
                      +=-||++++++......    ...++...++++..|++.++.++|+.   .++|+|+||+||++..+ +.-+++|||.+.
T Consensus       343 ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             CchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence            99999999987766532    23577888899999999999999998   99999999999999986 778899999986


Q ss_pred             ccCCCCCceeecccccccc-ccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          454 LLDHRDSHVTTAVRGTVGH-IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      .+.-.   .......+..| .+++......+..+.|+||||.-+.|.+++..-.....         .|          .
T Consensus       416 ~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---------~~----------~  473 (524)
T KOG0601|consen  416 RLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---------QS----------L  473 (524)
T ss_pred             cccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccc---------cc----------e
Confidence            42211   11111123334 35666666778899999999999999999875332110         00          0


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .+....+. ..+.. ..++..+...+..+++..||.+.++..+.+
T Consensus       474 ~i~~~~~p-~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  474 TIRSGDTP-NLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             eeeccccc-CCCch-HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            00001010 11111 256777888899999999999998876554

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.14  E-value=3.3e-12  Score=132.76  Aligned_cols=124  Identities=31%  Similarity=0.499  Sum_probs=70.5

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCC-CCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+..|.+++|+|. .+-+.++.|+.|+.+++..|++. ..+|..+..|..|++||||+|++. ..|..+..-.++-.|+|
T Consensus        56 kLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNL  133 (1255)
T KOG0444|consen   56 KLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNL  133 (1255)
T ss_pred             hhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEc
Confidence            4555566666665 34445555556666666665553 235555666666666666666666 56666666666666666


Q ss_pred             cccccCCCCCcc-cCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCC
Q 006968          154 NNNSLTGSCPES-LSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPL  201 (623)
Q Consensus       154 ~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~  201 (623)
                      |+|+|. +||.. |.+|+.|-+||||+|+|...+|....    +++.+++||+
T Consensus       134 S~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL  185 (1255)
T KOG0444|consen  134 SYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPL  185 (1255)
T ss_pred             ccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChh
Confidence            666665 44443 34556666666666666644444321    4555566654

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.10  E-value=7.5e-12  Score=130.16  Aligned_cols=130  Identities=29%  Similarity=0.426  Sum_probs=94.5

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      ++..+|||.|+|. .+|..+.++.+|+.|+||+|+|+ .+....+.+.+|++|+||+|+++ .+|+.++.|++|+.|++.
T Consensus       223 NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n  299 (1255)
T KOG0444|consen  223 NLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYAN  299 (1255)
T ss_pred             hhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhc
Confidence            5777888888887 78888888888888888888887 55556667777888888888887 778888888888888887


Q ss_pred             ccccC-CCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCCCCC
Q 006968          155 NNSLT-GSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPKAT  208 (623)
Q Consensus       155 ~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~~~  208 (623)
                      +|+++ .-+|..|++|.+|+.+.+++|+|. .+|+..-     +.+.++.|.++..|...
T Consensus       300 ~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaI  358 (1255)
T KOG0444|consen  300 NNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAI  358 (1255)
T ss_pred             cCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhh
Confidence            77764 246777777777777777777776 4444322     45666677666665543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.10  E-value=2.2e-09  Score=110.63  Aligned_cols=170  Identities=20%  Similarity=0.243  Sum_probs=129.5

Q ss_pred             CeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec----CCceEEEEecccCC-Chhh
Q 006968          314 FGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST----ENERLLVYPYMPNG-SVAS  387 (623)
Q Consensus       314 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~~g-sL~~  387 (623)
                      -.+.||+... ||..|..|+++........ .-..-+++++++.|+|+|++..++..    +...++||+|+++. +|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3578998754 8999999999654433221 12455788899999999999988863    45689999999874 7776


Q ss_pred             hhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          388 RLRDHIH-----------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       388 ~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      +-.....           +....++..+|.++.|+..||.++|+.   |+..+-|.+++|+++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            6543211           223467899999999999999999999   99999999999999999999999999887665


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRA  505 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p  505 (623)
                      ....               |.+   ..-.+-|.=.||.+++.|.||..-
T Consensus       445 ~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            4331               111   112467899999999999999643

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=5.4e-11  Score=109.44  Aligned_cols=105  Identities=34%  Similarity=0.474  Sum_probs=42.4

Q ss_pred             cEEEEeCCCCCcccccCcccc-CCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccc-cCCCCccchh
Q 006968           75 YVSALGLPSQSLSGTLSPWIG-NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSL-GDLGNLNYLR  152 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~  152 (623)
                      +++.|+|++|+|+. +. .++ .+++|+.|+|++|+|+. ++ .+..+++|++|+|++|+|+ .+++.+ ..+++|++|+
T Consensus        20 ~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   20 KLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY   94 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred             cccccccccccccc-cc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence            57889999999983 43 465 58899999999999994 44 5888999999999999999 676555 4689999999


Q ss_pred             ccccccCCCC-CcccCCCCcccEEECCCCcCcC
Q 006968          153 LNNNSLTGSC-PESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       153 l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      |++|+|...- -..+..+++|+.|+|.+|+++.
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             CcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            9999997421 1456788999999999998873

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.09  E-value=8.5e-12  Score=123.78  Aligned_cols=112  Identities=33%  Similarity=0.505  Sum_probs=87.7

Q ss_pred             ccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCC
Q 006968           89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSK  168 (623)
Q Consensus        89 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  168 (623)
                      .+|..++.+++|+.|+|+||-+. .+|..++.+..|+.||||+|+|. .+|..+-.+..|+.+-.++|++...-|..+.+
T Consensus       426 fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~n  503 (565)
T KOG0472|consen  426 FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKN  503 (565)
T ss_pred             cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhh
Confidence            45556778888899999988887 78888888888999999999888 88887777777777777778887555556888


Q ss_pred             CCcccEEECCCCcCcCcCCCCcc----ccccccCCCCC
Q 006968          169 IESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLI  202 (623)
Q Consensus       169 l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~  202 (623)
                      +.+|+.|||.+|.+...+|.+..    +.+.+.||||.
T Consensus       504 m~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  504 MRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            88888888888888855554433    56778888874

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.09  E-value=1.6e-10  Score=119.73  Aligned_cols=131  Identities=24%  Similarity=0.251  Sum_probs=101.5

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .+.+|||++|.|+..-+..|.++++|++++|.+|.++ .+|........|+.|+|.+|.|+..-.+++..++.|+.||||
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            5788999999999988899999999999999999999 788755556669999999999986666778888888999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK  206 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~  206 (623)
                      .|.|+..--..|..-.++++|+|++|+|+..--+.|.     ..+.|+.|.+...|.
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~  214 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQ  214 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCH
Confidence            9988844444566667888888888888743322222     345667777655543

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.08  E-value=9.2e-12  Score=135.39  Aligned_cols=123  Identities=37%  Similarity=0.579  Sum_probs=110.2

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCC-ccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .++.|+|.+|.|+...-+.|.+..+|+.|+|++|+|. .+|+ .+.++..|+.|+||+|+|+ .+|..+.++..|++|..
T Consensus       360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a  437 (1081)
T KOG0618|consen  360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA  437 (1081)
T ss_pred             HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence            6899999999999988888999999999999999999 5665 5788999999999999999 99999999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcC-cCCCCcc----ccccccCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKISA----RTFKVTGNPL  201 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~----~~~~~~~n~~  201 (623)
                      .+|++. ..| .+..++.|+.+|+|.|+|+. .+|....    +.++++||.+
T Consensus       438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            999999 888 89999999999999999983 4443322    6789999985

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.06  E-value=2.2e-09  Score=97.30  Aligned_cols=132  Identities=20%  Similarity=0.284  Sum_probs=98.7

Q ss_pred             CceeccCCeEEEEEEeCCCcEEEEEE-ecccccccc------hHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          307 NILGRGGFGIVYKGCFSDGALVAVKR-LKDYNIAGG------EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~~------~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ..+++|+-+.+|.+.+. |..+++|. +++......      ...-.+|..++.+++--.|---.=|..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999774 44455654 332222111      12356788888888755555555566778889999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      ++|-.|.+.+...           ...++..+-.-+.-||..   +|+|+||.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999888888653           245666777778889999   999999999999998774 99999999974

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.04  E-value=2.7e-11  Score=120.16  Aligned_cols=143  Identities=27%  Similarity=0.383  Sum_probs=120.0

Q ss_pred             CCcceeeeCCC---CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecC-CCCCCCC
Q 006968           63 CSWRMITCSPD---GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN-NKFTGEI  138 (623)
Q Consensus        63 c~w~gv~c~~~---~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~  138 (623)
                      |+-.|++--|.   ...+.|+|..|+|+...+..|+.+++|+.||||+|+|+-.-|++|.+|.+|..|-|.+ |+|+ .+
T Consensus        53 Cr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l  131 (498)
T KOG4237|consen   53 CRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DL  131 (498)
T ss_pred             ccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hh
Confidence            55555544442   4789999999999977778999999999999999999988899999999998886666 9999 55


Q ss_pred             C-ccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCC-Cc-----cccccccCCCCCCCCCC
Q 006968          139 P-DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK-IS-----ARTFKVTGNPLICGPKA  207 (623)
Q Consensus       139 p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~-----~~~~~~~~n~~~~~~~~  207 (623)
                      | +.|++|.+|+.|.+.-|++.-.....|..|++|..|.|-.|.+. .++. .+     .+.+.++-|++.|.|..
T Consensus       132 ~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL  206 (498)
T KOG4237|consen  132 PKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNL  206 (498)
T ss_pred             hhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccccccc
Confidence            5 56899999999999999999667788999999999999999998 3333 22     27788999999998764

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.99  E-value=5.7e-11  Score=113.71  Aligned_cols=124  Identities=32%  Similarity=0.465  Sum_probs=101.5

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      -+++|||++|.|+ .+..+..-++.++.|+||.|.|.. + ..+..|++|+.||||+|.++ .+-++-..|.+.++|.|+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            4788999999998 788888888999999999999983 3 34888999999999999999 777777788899999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCc--------CcCCCCccccccccCCCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLS--------GSLPKISARTFKVTGNPLICGPK  206 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--------~~~p~~~~~~~~~~~n~~~~~~~  206 (623)
                      .|.|.. + ..+.+|-+|..||+++|+|.        |.+|.+  ..+.+.+||+.-.+.
T Consensus       361 ~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCL--E~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  361 QNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCL--ETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHH--HHHhhcCCCccccch
Confidence            999973 3 46888889999999999987        344432  567788898755443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.98  E-value=6.6e-09  Score=93.61  Aligned_cols=144  Identities=17%  Similarity=0.212  Sum_probs=104.6

Q ss_pred             cCCceeccCCeEEEEEEeCCCcEEEEEE-eccccccc------chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          305 AKNILGRGGFGIVYKGCFSDGALVAVKR-LKDYNIAG------GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       305 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ...++-+|+-+.|+++.+ .|+...||. +.+.....      ...+-.+|.+.+.++.--.|.--.-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            467889999999999988 577766664 33322111      2335678999998876545544444566667778999


Q ss_pred             ecccC-CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---cEEEeeccccc
Q 006968          378 PYMPN-GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---EAVVGDFGLAK  453 (623)
Q Consensus       378 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~Dfgla~  453 (623)
                      ||+++ .++.+++......  .........++..+-+.+.-||..   +|+||||..+||++..++   .+.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99976 4888888765332  223333367888888999999999   999999999999997654   35899999986


Q ss_pred             c
Q 006968          454 L  454 (623)
Q Consensus       454 ~  454 (623)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            5

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.96  E-value=2.3e-10  Score=126.61  Aligned_cols=250  Identities=17%  Similarity=0.180  Sum_probs=171.3

Q ss_pred             HHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       298 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ...+.+.+.+-+-+|.++.+..+.-. .|...++|.........  .......+-.++-..+||-++....-+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            45566777788889999999887633 35445555543322111  1112233333333345676665555444566789


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      |+++|..+++|...|+..    +..+..-.+..+..+..+++|||..   .+.|+|++|.|.+...++..++.|||....
T Consensus       881 L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             hhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence            999999999999988763    3456666667777888999999998   799999999999999999999999984322


Q ss_pred             cCC---------------------CCC---------ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCC
Q 006968          455 LDH---------------------RDS---------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR  504 (623)
Q Consensus       455 ~~~---------------------~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~  504 (623)
                      ..-                     ...         .......||+.|.+||...+......+|.|++|++++|.++|..
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            110                     000         00123458999999999999999999999999999999999999


Q ss_pred             CCCcccccccccchHHHHHHHhhcCccccccccccC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006968          505 ALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK-GNFDRIELEEMVQVALLCTQFNPLHRPKMS  570 (623)
Q Consensus       505 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~  570 (623)
                      ||........                +..+...... ...+.....+..+++...+..+|.+|-.+.
T Consensus      1034 p~na~tpq~~----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQI----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcchhhh----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9974433211                1111111111 112334456778889999999999998776

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.91  E-value=1.7e-08  Score=100.19  Aligned_cols=142  Identities=14%  Similarity=0.073  Sum_probs=101.9

Q ss_pred             CceeccCCeEEEEEEeCCCcEEEEEEecccccc----------cchHHHHHHHHHHhhcCCCce--eeeeeeeec-----
Q 006968          307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA----------GGEVQFQTEVETISLAVHRNL--LRLCGFCST-----  369 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~-----  369 (623)
                      +.+-......|.+..+ +|+.+.||+.......          .....+.+|...+.++...+|  .+.+++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444455777766 6788999987543211          111247889988888754333  344555532     


Q ss_pred             CCceEEEEecccCC-ChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-------C
Q 006968          370 ENERLLVYPYMPNG-SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-------D  441 (623)
Q Consensus       370 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~  441 (623)
                      ...-++|+|++++. +|.+++....  ..+.+......++.+++..+.-||..   ||+|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23468999999886 8888886432  12455677789999999999999999   9999999999999975       4


Q ss_pred             CcEEEeecccccc
Q 006968          442 FEAVVGDFGLAKL  454 (623)
Q Consensus       442 ~~~kl~Dfgla~~  454 (623)
                      ..+.++||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6789999998863

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.90  E-value=2.4e-10  Score=118.39  Aligned_cols=102  Identities=33%  Similarity=0.548  Sum_probs=50.5

Q ss_pred             EEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccc
Q 006968           76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN  155 (623)
Q Consensus        76 v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  155 (623)
                      ++.|||+.|+++ .+|..+..|+ |+.|.+++|+++ .+|+.++.+..|..||.+.|++. .+|..++.+.+|+.|++..
T Consensus       123 lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrR  198 (722)
T KOG0532|consen  123 LTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRR  198 (722)
T ss_pred             HHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhh
Confidence            444555555555 4454444443 555555555555 45555555555555555555555 4555555555554444444


Q ss_pred             cccCCCCCcccCCCCcccEEECCCCcCc
Q 006968          156 NSLTGSCPESLSKIESLTLVDLSYNNLS  183 (623)
Q Consensus       156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~  183 (623)
                      |++. .+|+.++.| .|..||+|.|+++
T Consensus       199 n~l~-~lp~El~~L-pLi~lDfScNkis  224 (722)
T KOG0532|consen  199 NHLE-DLPEELCSL-PLIRLDFSCNKIS  224 (722)
T ss_pred             hhhh-hCCHHHhCC-ceeeeecccCcee
Confidence            4444 344444432 2444444444444

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.90  E-value=9.9e-09  Score=96.08  Aligned_cols=127  Identities=23%  Similarity=0.286  Sum_probs=81.7

Q ss_pred             EEEEEEeCCCcEEEEEEecccccc--------------------c-----chHHHHHHHHHHhhcCCCc--eeeeeeeee
Q 006968          316 IVYKGCFSDGALVAVKRLKDYNIA--------------------G-----GEVQFQTEVETISLAVHRN--LLRLCGFCS  368 (623)
Q Consensus       316 ~Vy~~~~~~~~~vavK~~~~~~~~--------------------~-----~~~~~~~e~~~l~~l~H~n--iv~l~~~~~  368 (623)
                      .||.|...+|..+|||+.+.....                    .     ......+|.+.|.++..-.  +-+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999989999999998532100                    0     0123577999999987663  44555432 


Q ss_pred             cCCceEEEEeccc--CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCeEECCCCcEE
Q 006968          369 TENERLLVYPYMP--NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY-LHEQCDPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       369 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                         ...+||||++  |..+ ..|...     .++......++.+++..+.. +|..   ||+|||+++.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~-~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPL-PRLKDV-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEG-GCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccch-hhHHhc-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               4679999998  4443 334332     11133456677778776666 4677   99999999999999988 999


Q ss_pred             EeecccccccC
Q 006968          446 VGDFGLAKLLD  456 (623)
Q Consensus       446 l~Dfgla~~~~  456 (623)
                      |+|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999987544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.89  E-value=2.4e-10  Score=113.51  Aligned_cols=88  Identities=26%  Similarity=0.336  Sum_probs=64.3

Q ss_pred             CCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccc
Q 006968          120 KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTF  194 (623)
Q Consensus       120 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~  194 (623)
                      .|++|+.|+|++|+|++.-+.+|..+..|++|.|..|+|...-...|.++..|+.|+|.+|+|+..-|..|.     ..+
T Consensus       272 ~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l  351 (498)
T KOG4237|consen  272 KLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTL  351 (498)
T ss_pred             hcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeee
Confidence            566667777777777766667777777777777777777644445677788888888888888877776654     567


Q ss_pred             cccCCCCCCCCCC
Q 006968          195 KVTGNPLICGPKA  207 (623)
Q Consensus       195 ~~~~n~~~~~~~~  207 (623)
                      ++.+|||.|.|..
T Consensus       352 ~l~~Np~~CnC~l  364 (498)
T KOG4237|consen  352 NLLSNPFNCNCRL  364 (498)
T ss_pred             ehccCcccCccch
Confidence            7888888887653

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.89  E-value=9.5e-10  Score=83.21  Aligned_cols=58  Identities=47%  Similarity=0.656  Sum_probs=24.1

Q ss_pred             cceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccc
Q 006968          100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS  157 (623)
Q Consensus       100 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  157 (623)
                      |++|+|++|+|+...+..|.++++|++|+|++|+++...|..|..+++|++|++++|+
T Consensus         3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            4444444444443333344444444444444444443333334444444444444443

...

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.88  E-value=7.6e-10  Score=101.86  Aligned_cols=113  Identities=35%  Similarity=0.547  Sum_probs=36.7

Q ss_pred             CCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccC-CCCCccEEEecCCCCCCCCCccccCCCCccchhccccccC
Q 006968           81 LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG-KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT  159 (623)
Q Consensus        81 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  159 (623)
                      |..+.|. .++ .+.+...+++|+|++|+|+ .+ +.++ .+.+|+.||||+|+|+ .++ .+..+++|++|+|++|+|+
T Consensus         4 lt~~~i~-~~~-~~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~   77 (175)
T PF14580_consen    4 LTANMIE-QIA-QYNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS   77 (175)
T ss_dssp             ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred             ccccccc-ccc-ccccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence            3444444 233 3456668999999999999 44 3576 5899999999999999 665 5888999999999999999


Q ss_pred             CCCCccc-CCCCcccEEECCCCcCcCcCCCCc---c----ccccccCCCC
Q 006968          160 GSCPESL-SKIESLTLVDLSYNNLSGSLPKIS---A----RTFKVTGNPL  201 (623)
Q Consensus       160 ~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~~~---~----~~~~~~~n~~  201 (623)
                       .+++.+ ..+++|+.|+|++|+|.. +-++.   .    ..+++.|||+
T Consensus        78 -~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv  125 (175)
T PF14580_consen   78 -SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRVLSLEGNPV  125 (175)
T ss_dssp             -S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--EEE-TT-GG
T ss_pred             -ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcceeeccCCcc
Confidence             565555 468999999999999984 22211   1    5678889986

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.88  E-value=1.9e-09  Score=74.81  Aligned_cols=40  Identities=48%  Similarity=0.933  Sum_probs=31.0

Q ss_pred             chHHHHHHHHHHhCC-CCCcccCCCCCCC-CCCCCcceeeeC
Q 006968           32 NYEVVALVAVKNNLH-DPYNVLENWDITS-VDPCSWRMITCS   71 (623)
Q Consensus        32 ~~~~~~l~~~k~~~~-~p~~~~~~w~~~~-~~~c~w~gv~c~   71 (623)
                      +.|+.||++||+++. +|...+.+|+.++ .+||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            568999999999998 5778999998764 899999999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.87  E-value=7.7e-09  Score=116.45  Aligned_cols=117  Identities=26%  Similarity=0.437  Sum_probs=85.0

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  .+|+.|+|++|++. .+|..+.  ++|+.|+|+
T Consensus       200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls  270 (754)
T PRK15370        200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF  270 (754)
T ss_pred             CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence            6888888888888 5666553  58888899888888 5676554  47888888888888 7787764  478888888


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc--ccccccCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPLIC  203 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~~~  203 (623)
                      +|+|+ .+|..+.  ++|+.|+|++|+|++.++....  ..+++++|.+..
T Consensus       271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp~sL~~L~Ls~N~Lt~  318 (754)
T PRK15370        271 HNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSLTA  318 (754)
T ss_pred             CCccC-ccccccC--CCCcEEECCCCccccCcccchhhHHHHHhcCCcccc
Confidence            88888 5777664  4788888888888853222221  445666666543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.86  E-value=1.2e-09  Score=82.62  Aligned_cols=61  Identities=49%  Similarity=0.685  Sum_probs=55.4

Q ss_pred             CCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcC
Q 006968          122 EKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL  182 (623)
Q Consensus       122 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  182 (623)
                      ++|++|+|++|+|+...+..|..+++|++|++++|+++...|..|..+++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5799999999999955456889999999999999999977778999999999999999986

...

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.84  E-value=3.6e-09  Score=118.48  Aligned_cols=71  Identities=32%  Similarity=0.417  Sum_probs=44.4

Q ss_pred             CccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----cccccc
Q 006968          123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVT  197 (623)
Q Consensus       123 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~  197 (623)
                      +|+.|+|++|+|+ .+|...   ++|+.|+|++|+|+ .+|...   .+|+.|+|++|+|+ .+|..+.     ..++++
T Consensus       383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            5667777777777 455432   45677777777777 455432   35667777777777 4554322     456777


Q ss_pred             CCCCC
Q 006968          198 GNPLI  202 (623)
Q Consensus       198 ~n~~~  202 (623)
                      +|++.
T Consensus       454 ~N~Ls  458 (788)
T PRK15387        454 GNPLS  458 (788)
T ss_pred             CCCCC
Confidence            77764

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.83  E-value=2e-08  Score=112.68  Aligned_cols=36  Identities=19%  Similarity=0.468  Sum_probs=21.8

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCC
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIP  115 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  115 (623)
                      +++.|+|++|+|+ .+|..   +++|++|+|++|+|+ .+|
T Consensus       223 ~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP  258 (788)
T PRK15387        223 HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLP  258 (788)
T ss_pred             CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-ccc
Confidence            4666777777766 34432   456666677666666 344

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.80  E-value=8.4e-09  Score=116.12  Aligned_cols=97  Identities=29%  Similarity=0.465  Sum_probs=52.6

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+|+ .+|..+.  .+|+.|+|++|++. .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|+
T Consensus       221 nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls  291 (754)
T PRK15370        221 NIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVY  291 (754)
T ss_pred             CCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECC
Confidence            5777777777777 4555442  35666666666665 4555443  35666666666665 4555443  355555555


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCc
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLS  183 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  183 (623)
                      +|+|+ .+|..+.  ++|+.|++++|+|+
T Consensus       292 ~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt  317 (754)
T PRK15370        292 DNSIR-TLPAHLP--SGITHLNVQSNSLT  317 (754)
T ss_pred             CCccc-cCcccch--hhHHHHHhcCCccc
Confidence            55555 3443332  23444444444444

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.78  E-value=6.2e-10  Score=121.43  Aligned_cols=104  Identities=28%  Similarity=0.428  Sum_probs=92.5

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|+.|+|.......+.++..|++|+||+|+++ .+|..+.++..|++|...+|++. .+| .+..++.|+.+|||
T Consensus       384 hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS  460 (1081)
T KOG0618|consen  384 HLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLS  460 (1081)
T ss_pred             ceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecc
Confidence            7999999999998444467889999999999999999 89999999999999999999999 899 89999999999999


Q ss_pred             ccccCC-CCCcccCCCCcccEEECCCCcC
Q 006968          155 NNSLTG-SCPESLSKIESLTLVDLSYNNL  182 (623)
Q Consensus       155 ~N~l~~-~~p~~~~~l~~L~~L~l~~N~l  182 (623)
                      .|+|+. .+|..... ++|++|||++|.-
T Consensus       461 ~N~L~~~~l~~~~p~-p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  461 CNNLSEVTLPEALPS-PNLKYLDLSGNTR  488 (1081)
T ss_pred             cchhhhhhhhhhCCC-cccceeeccCCcc
Confidence            999974 34544433 8999999999983

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=3.1e-09  Score=113.56  Aligned_cols=150  Identities=17%  Similarity=0.290  Sum_probs=104.0

Q ss_pred             HHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce--------eecccccccccccccccc
Q 006968          409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV--------TTAVRGTVGHIAPEYLST  480 (623)
Q Consensus       409 ~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~  480 (623)
                      .+++.|+.|+|...  ++||++|.|++|.++..+..||+.|+.+..........        .........|.|||++..
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34559999999874  89999999999999999999999999886544322111        111224567999999999


Q ss_pred             CCCCCccchhhHHHHHHHHHhCCCC-CCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHcc
Q 006968          481 GQSSEKTDVFGFGILLLELITGQRA-LDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCT  559 (623)
Q Consensus       481 ~~~~~~~Dv~SlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  559 (623)
                      ...+.++|+||+|+++|.+..|..+ +.....      ...        .......+..-...+....+.++.+-+.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~------~~~--------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGG------LLS--------YSFSRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCC------cch--------hhhhhcccccccccccccCcHHHHHHHHHHh
Confidence            8899999999999999999954444 332111      000        0111111111111223344578899999999


Q ss_pred             CCCCCCCCCHHHHHH
Q 006968          560 QFNPLHRPKMSEVLK  574 (623)
Q Consensus       560 ~~~P~~RPs~~evl~  574 (623)
                      ..++.-||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998777643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.69  E-value=1.7e-07  Score=90.20  Aligned_cols=137  Identities=21%  Similarity=0.148  Sum_probs=95.4

Q ss_pred             CCcCCceeccCCeEEEEEEeCCCcEEEEEEeccccc---------------------ccchHHHHHHHHHHhhcCCC--c
Q 006968          303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI---------------------AGGEVQFQTEVETISLAVHR--N  359 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~e~~~l~~l~H~--n  359 (623)
                      ..+.+.||-|.-+.||.|...+|.++|||.-+....                     .-......+|.+.|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            456689999999999999999999999997532110                     01122457788888887544  4


Q ss_pred             eeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC
Q 006968          360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD  439 (623)
Q Consensus       360 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~  439 (623)
                      +.+.++    .+...+||||+++--|...         +++......++..|.+-+...-..   ||||||+++-||+++
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCccc----cccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence            444443    3567899999988553321         112333344444555555555566   999999999999999


Q ss_pred             CCCcEEEeeccccccc
Q 006968          440 EDFEAVVGDFGLAKLL  455 (623)
Q Consensus       440 ~~~~~kl~Dfgla~~~  455 (623)
                      +||.+.++||--+...
T Consensus       237 ~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         237 EDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cCCCEEEEeCcccccC
Confidence            9999999999877643

>PLN03210 Resistant to P

Probab=98.68  E-value=5.2e-08  Score=116.93  Aligned_cols=125  Identities=25%  Similarity=0.292  Sum_probs=86.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|+|. .++..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..++++++|+.|+++
T Consensus       612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~  689 (1153)
T PLN03210        612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS  689 (1153)
T ss_pred             CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence            5777777777776 5666677777788888877655556664 6777778888887776555777777778888888887


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc--ccccccCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPLI  202 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~~  202 (623)
                      +|..-+.+|..+ ++++|+.|+|++|...+.+|....  +.+.+.+|.+.
T Consensus       690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~  738 (1153)
T PLN03210        690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE  738 (1153)
T ss_pred             CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCccc
Confidence            765444677655 677788888877766666665433  44566666643

syringae 6; Provisional

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.67  E-value=2.3e-09  Score=111.30  Aligned_cols=109  Identities=26%  Similarity=0.426  Sum_probs=100.6

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      -+..|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|..++.| .|..||+|
T Consensus       144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfS  219 (722)
T KOG0532|consen  144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFS  219 (722)
T ss_pred             cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecc
Confidence            4788899999998 89999999999999999999999 78999999999999999999999 899999955 59999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK  188 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  188 (623)
                      +|+++ .+|-.|.+|+.|++|-|.+|.|+..+..
T Consensus       220 cNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAq  252 (722)
T KOG0532|consen  220 CNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQ  252 (722)
T ss_pred             cCcee-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence            99999 9999999999999999999999954433

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.62  E-value=4.4e-09  Score=100.96  Aligned_cols=116  Identities=24%  Similarity=0.267  Sum_probs=93.7

Q ss_pred             cceeeeCCC-----CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCC
Q 006968           65 WRMITCSPD-----GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP  139 (623)
Q Consensus        65 w~gv~c~~~-----~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  139 (623)
                      ..-++|-..     ..+..|+|+.|+|.. +. .+..|.+|+.||||+|.++ .+-.+=-+|.+.+.|.|+.|.|. .+ 
T Consensus       293 ~N~I~~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~L-  367 (490)
T KOG1259|consen  293 GNLITQIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TL-  367 (490)
T ss_pred             ccchhhhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hh-
Confidence            344556432     479999999999983 33 3888999999999999999 45555567889999999999998 44 


Q ss_pred             ccccCCCCccchhccccccCCC-CCcccCCCCcccEEECCCCcCcCc
Q 006968          140 DSLGDLGNLNYLRLNNNSLTGS-CPESLSKIESLTLVDLSYNNLSGS  185 (623)
Q Consensus       140 ~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~  185 (623)
                      +.++.|-+|..||+++|+|... --..+++|+.|+.|.|.+|.|++.
T Consensus       368 SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  368 SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            4678888999999999999731 124799999999999999999964

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.62  E-value=2.2e-06  Score=86.70  Aligned_cols=260  Identities=15%  Similarity=0.159  Sum_probs=152.4

Q ss_pred             cCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeee------eecCC-ceEEE
Q 006968          305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGF------CSTEN-ERLLV  376 (623)
Q Consensus       305 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~------~~~~~-~~~lv  376 (623)
                      ....||+|+-+.+|-.-  +-...+-|+++......    -.+.++.|... .||-+-.-+.+      .-..+ ...+.
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAA----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecc--hhhchhheeecCCCchH----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            45779999999998642  11223447665433211    12233344333 46544321111      01112 24566


Q ss_pred             EecccCCChhhhhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          377 YPYMPNGSVASRLRD---HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      |..+++..=-..+.+   ...+-+..+|...++.+..+|.+.+.||..   |.+-||+.++|+|+.+++.+.+.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            776655421111111   122234579999999999999999999999   99999999999999999999998755433


Q ss_pred             ccCCCCCceeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhC-CCCCCcccccccccchHHHHHHHhh
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITG-QRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      ..  .........+|...|.+||.-.     +...+...|-|.+||++++++.| ++||..-..........+   .-..
T Consensus       166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia  240 (637)
T COG4248         166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIA  240 (637)
T ss_pred             ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhh
Confidence            22  1223344556899999999765     23447789999999999999887 999974221111000000   0000


Q ss_pred             cCccccccccc--c---CCCCC-HHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHhhc
Q 006968          528 EGKLSQMVDKD--L---KGNFD-RIELEEMVQVALLCTQFN--PLHRPKMSEVLKMLEG  578 (623)
Q Consensus       528 ~~~~~~~~~~~--~---~~~~~-~~~~~~l~~l~~~cl~~~--P~~RPs~~evl~~L~~  578 (623)
                      .+.+...-+..  +   ....+ .--+..+..+..+|....  +.-|||++..+..|..
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            11111111110  0   00111 111245666777887654  4689999988877665

>PRK09902 hypothetical protein; Provisional

Probab=98.61  E-value=1e-06  Score=83.00  Aligned_cols=139  Identities=19%  Similarity=0.122  Sum_probs=103.2

Q ss_pred             eeccCCeEEEEEEeCCCcEEEEEEecccc----c-ccchHHHHHHHHHHhhcCCCc--eeeeeeeee-c----CCceEEE
Q 006968          309 LGRGGFGIVYKGCFSDGALVAVKRLKDYN----I-AGGEVQFQTEVETISLAVHRN--LLRLCGFCS-T----ENERLLV  376 (623)
Q Consensus       309 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~-~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~-~----~~~~~lv  376 (623)
                      -|+||-+.|++..+ +|..+-+|+-...-    . +-++..|.+|...+.++..-+  +.+.. ++. .    .-.-+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            36688889999877 45578889864211    1 346678999999999886433  33444 332 1    1235799


Q ss_pred             EecccC-CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc--EEEeeccccc
Q 006968          377 YPYMPN-GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE--AVVGDFGLAK  453 (623)
Q Consensus       377 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~Dfgla~  453 (623)
                      +|-+++ -+|.+++.+..  ..+.+...+..++.+++..++-||..   |+.|+|+.+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997754 48888876531  23567788889999999999999999   9999999999999986666  9999998876


Q ss_pred             c
Q 006968          454 L  454 (623)
Q Consensus       454 ~  454 (623)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.56  E-value=4.2e-07  Score=87.31  Aligned_cols=107  Identities=19%  Similarity=0.237  Sum_probs=83.1

Q ss_pred             hHHHHHHHHHHhhcCCCc--eeeeeeeeecC----CceEEEEecccCC-ChhhhhhhccCCCCCCCHHHHHHHHHHHHHH
Q 006968          342 EVQFQTEVETISLAVHRN--LLRLCGFCSTE----NERLLVYPYMPNG-SVASRLRDHIHGRPALDWARRKRIALGTARG  414 (623)
Q Consensus       342 ~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~  414 (623)
                      .....+|...+..+....  ..+.+++....    ...++|+|++++. +|.+++....    ..+......++.+++..
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL  130 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence            335788888887775433  34555665442    2348999999884 7888887632    25667788999999999


Q ss_pred             HHHHHhCCCCCeEecCCCCCCeEECCCC---cEEEeeccccccc
Q 006968          415 LLYLHEQCDPKIIHRDVKAANILLDEDF---EAVVGDFGLAKLL  455 (623)
Q Consensus       415 L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~Dfgla~~~  455 (623)
                      ++-||..   ||+|+|++++|||++.+.   .+.++||+-++..
T Consensus       131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999   999999999999999887   7999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.56  E-value=5.7e-09  Score=107.62  Aligned_cols=111  Identities=26%  Similarity=0.346  Sum_probs=84.0

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCC---cceEEeecCCCCC----CCCCccCCC-CCccEEEecCCCCCCC----CCcc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTK---LQSVLLQNNAILG----PIPASLGKL-EKLQTLDLSNNKFTGE----IPDS  141 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~  141 (623)
                      .+++.|+|++|.+.+..+..+..+..   |++|+|++|++++    .+...+..+ ++|+.|+|++|.+++.    ++..
T Consensus        81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~  160 (319)
T cd00116          81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA  160 (319)
T ss_pred             CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence            47999999999988766666666655   9999999998873    233445666 8899999999998843    3445


Q ss_pred             ccCCCCccchhccccccCC----CCCcccCCCCcccEEECCCCcCcC
Q 006968          142 LGDLGNLNYLRLNNNSLTG----SCPESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       142 ~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      +..+++|++|+|++|.+++    .++..+..+++|+.|+|++|.+++
T Consensus       161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  207 (319)
T cd00116         161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD  207 (319)
T ss_pred             HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence            6677889999999998884    234455666789999999998874

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.53  E-value=1.8e-09  Score=92.05  Aligned_cols=113  Identities=22%  Similarity=0.359  Sum_probs=87.2

Q ss_pred             eCCCCcEEEEeCCCCCcccccCccc---cCCCCcceEEeecCCCCCCCCCccCC-CCCccEEEecCCCCCCCCCccccCC
Q 006968           70 CSPDGYVSALGLPSQSLSGTLSPWI---GNLTKLQSVLLQNNAILGPIPASLGK-LEKLQTLDLSNNKFTGEIPDSLGDL  145 (623)
Q Consensus        70 c~~~~~v~~L~L~~n~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l  145 (623)
                      |...-.+-.++|+++.|- .+++..   .....|+.++|++|.+. .+|+.|.. .+.++.|+|++|+|+ .+|..+..+
T Consensus        23 cedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam   99 (177)
T KOG4579|consen   23 CEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAM   99 (177)
T ss_pred             hHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhh
Confidence            443334566788888775 555543   44556677799999998 56666654 458899999999999 899999999


Q ss_pred             CCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCC
Q 006968          146 GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP  187 (623)
Q Consensus       146 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  187 (623)
                      +.|+.|++++|.|. ..|..+..|.+|..|+..+|.+. ++|
T Consensus       100 ~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid  139 (177)
T KOG4579|consen  100 PALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EID  139 (177)
T ss_pred             HHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCc
Confidence            99999999999998 77888888999999999888877 444

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=4.7e-07  Score=97.46  Aligned_cols=146  Identities=21%  Similarity=0.236  Sum_probs=95.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc---------------------c------------------c
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA---------------------G------------------G  341 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~------------------~  341 (623)
                      ..|+ .+.|+.++-|.||+|++++|+.||||+.+..-..                     .                  .
T Consensus       126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            3444 3689999999999999999999999998632110                     0                  1


Q ss_pred             hHHHHHHHHHHhhcC-----CCceeeeeeeee-cCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHH-
Q 006968          342 EVQFQTEVETISLAV-----HRNLLRLCGFCS-TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG-  414 (623)
Q Consensus       342 ~~~~~~e~~~l~~l~-----H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-  414 (623)
                      +-++.+|..-+.+++     .+++ ++=..|. -.+...|+|||++|-.+.+...-..   ...+.+   .++..++++ 
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k---~ia~~~~~~f  277 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRK---ELAELLVRAF  277 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHH---HHHHHHHHHH
Confidence            113455555554442     2333 2222232 3467899999999988887743221   224422   233333221 


Q ss_pred             HHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       415 L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      +..+-..   |+.|.|.+|.||+++.++.+.+.|||+...+.+
T Consensus       278 ~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         278 LRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2233334   999999999999999999999999999877654

>PLN03210 Resistant to P

Probab=98.49  E-value=3.4e-07  Score=110.01  Aligned_cols=123  Identities=22%  Similarity=0.239  Sum_probs=97.0

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|++.++.+. .+|..| .+.+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|+
T Consensus       590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~  665 (1153)
T PLN03210        590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLS  665 (1153)
T ss_pred             ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEec
Confidence            4777777777776 677766 5788999999999988 6788888899999999998765557774 7889999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPL  201 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~  201 (623)
                      +|.....+|..+.++++|+.|++++|..-+.+|....    +.++++||..
T Consensus       666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~  716 (1153)
T PLN03210        666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSR  716 (1153)
T ss_pred             CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence            8876668899999999999999998766666775432    4566776653

syringae 6; Provisional

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.48  E-value=1.6e-08  Score=104.31  Aligned_cols=128  Identities=30%  Similarity=0.428  Sum_probs=92.8

Q ss_pred             cEEEEeCCCCCccc----ccCccccCC-CCcceEEeecCCCCCC----CCCccCCCCCccEEEecCCCCCCC----CCcc
Q 006968           75 YVSALGLPSQSLSG----TLSPWIGNL-TKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTGE----IPDS  141 (623)
Q Consensus        75 ~v~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~  141 (623)
                      +++.|++++|++++    .+...+..+ ++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+++.    ++..
T Consensus       109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~  188 (319)
T cd00116         109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG  188 (319)
T ss_pred             cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence            48999999998873    344456667 8899999999998843    344566778899999999998842    3445


Q ss_pred             ccCCCCccchhccccccCCC----CCcccCCCCcccEEECCCCcCcCc--------CCC--CccccccccCCCCC
Q 006968          142 LGDLGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSGS--------LPK--ISARTFKVTGNPLI  202 (623)
Q Consensus       142 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~--------~p~--~~~~~~~~~~n~~~  202 (623)
                      +..+++|+.|+|++|.+++.    ++..+..+++|+.|++++|.+++.        ++.  ...+.+++++|.+.
T Consensus       189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~  263 (319)
T cd00116         189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT  263 (319)
T ss_pred             HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence            56677999999999988743    344567788899999999998851        111  11255677777653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.44  E-value=7.3e-08  Score=102.61  Aligned_cols=101  Identities=40%  Similarity=0.520  Sum_probs=49.7

Q ss_pred             EeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCC-CccEEEecCCCCCCCCCccccCCCCccchhccccc
Q 006968           79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLE-KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS  157 (623)
Q Consensus        79 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  157 (623)
                      |+++.|.+.. ....+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+
T Consensus        98 l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~  174 (394)
T COG4886          98 LDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND  174 (394)
T ss_pred             eecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence            4444444431 1222333445555555555555 4444444442 5555555555555 454455555555555555555


Q ss_pred             cCCCCCcccCCCCcccEEECCCCcCc
Q 006968          158 LTGSCPESLSKIESLTLVDLSYNNLS  183 (623)
Q Consensus       158 l~~~~p~~~~~l~~L~~L~l~~N~l~  183 (623)
                      ++ .+|.....+++|+.|++++|+++
T Consensus       175 l~-~l~~~~~~~~~L~~L~ls~N~i~  199 (394)
T COG4886         175 LS-DLPKLLSNLSNLNNLDLSGNKIS  199 (394)
T ss_pred             hh-hhhhhhhhhhhhhheeccCCccc
Confidence            55 44444434555555555555555

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.43  E-value=1.3e-06  Score=83.31  Aligned_cols=157  Identities=23%  Similarity=0.283  Sum_probs=100.5

Q ss_pred             cccCHHHHHHHhcCCCcCCcee---ccCCeEEEEEEeCCCcEEEEEEeccccccc------------------chHH---
Q 006968          289 KRYTFKELRAATSNFSAKNILG---RGGFGIVYKGCFSDGALVAVKRLKDYNIAG------------------GEVQ---  344 (623)
Q Consensus       289 ~~~~~~~l~~~~~~~~~~~~lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------~~~~---  344 (623)
                      ...++..+....++..+.+..|   +|.-+.||+|...++..+|||+++.....-                  +..+   
T Consensus        33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            4456777777777777777655   555668999998889999999996432210                  0000   


Q ss_pred             --HHHHHHHHhhcCC--CceeeeeeeeecCCceEEEEecccCCC-hhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 006968          345 --FQTEVETISLAVH--RNLLRLCGFCSTENERLLVYPYMPNGS-VASRLRDHIHGRPALDWARRKRIALGTARGLLYLH  419 (623)
Q Consensus       345 --~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH  419 (623)
                        ...|..-|.++..  =.+-+-+++    ....|||||+.... -.-.|.+     .++.......+..++++.+.-|-
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHH
Confidence              1234444444321  112222222    24579999986541 1111221     12333356677788888888888


Q ss_pred             hCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       420 ~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ..+  ++||+||+.-|||+. ++.+.|+|||-|....+
T Consensus       184 ~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         184 KEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             Hhc--CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence            733  999999999999999 78999999999876543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.41  E-value=5e-09  Score=111.45  Aligned_cols=124  Identities=31%  Similarity=0.439  Sum_probs=92.6

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCcc-ccCCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDS-LGDLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l  153 (623)
                      .+...+.+.|.|. ....++.-++.|+.|||++|+++..  +.+..|+.|.+|||+.|+|. .+|.- ...+ +|+.|.|
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence            4666777778887 5666777788899999999999865  37888899999999999998 67653 2233 4899999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCc--CCCCcc----ccccccCCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGS--LPKISA----RTFKVTGNPLICGP  205 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~----~~~~~~~n~~~~~~  205 (623)
                      +||.++..  ..+.+|++|+.|||++|-|++-  +-.+..    ..+.|.|||+-|.+
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            99988843  4688889999999999988852  111111    55778899987765

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.40  E-value=2.1e-08  Score=85.58  Aligned_cols=109  Identities=18%  Similarity=0.244  Sum_probs=87.7

Q ss_pred             CcEEEEeCCCCCcccccCcccc-CCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchh
Q 006968           74 GYVSALGLPSQSLSGTLSPWIG-NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR  152 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  152 (623)
                      .+++.++|++|++. ..|+.|. .++.++.|+|++|.|+ .+|..+..++.|+.|++++|.|. ..|..+..|.+|-.|+
T Consensus        53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld  129 (177)
T KOG4579|consen   53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD  129 (177)
T ss_pred             ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence            37999999999998 4565554 4568999999999999 78999999999999999999999 8999999999999999


Q ss_pred             ccccccCCCCCcccCCCCcccEEECCCCcCcCcC
Q 006968          153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSL  186 (623)
Q Consensus       153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  186 (623)
                      ..+|.+. .+|-.+..-+.+-..++.+|.+.+.-
T Consensus       130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~  162 (177)
T KOG4579|consen  130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDET  162 (177)
T ss_pred             CCCCccc-cCcHHHhccccHHHHHhcCCcccccC
Confidence            9999998 66655433333344445555555443

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.34  E-value=7.1e-06  Score=79.86  Aligned_cols=141  Identities=13%  Similarity=0.149  Sum_probs=84.4

Q ss_pred             CceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCce--eeeeeeeecCCceEEEEecccCCC
Q 006968          307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL--LRLCGFCSTENERLLVYPYMPNGS  384 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~~~~~lv~e~~~~gs  384 (623)
                      ..||+|..+.||+.   .|..+++|..+...   ......+|.++++.+..-.+  .+.+++....+...+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999984   35567788876432   23456889999988764333  466777767777889999998863


Q ss_pred             -hhhhhh--------------h---ccCCC--CCCCHHHHHH-HHH----------HHH-HHHHHHHhC-CCCCeEecCC
Q 006968          385 -VASRLR--------------D---HIHGR--PALDWARRKR-IAL----------GTA-RGLLYLHEQ-CDPKIIHRDV  431 (623)
Q Consensus       385 -L~~~l~--------------~---~~~~~--~~l~~~~~~~-i~~----------~ia-~~L~~LH~~-~~~~ivH~Dl  431 (623)
                       +...+.              .   ..+.-  .......... +..          .+. ....+|... ..+.++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             211110              0   00100  0111111000 000          001 112222221 1346789999


Q ss_pred             CCCCeEECCCCcEEEeecccccc
Q 006968          432 KAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       432 k~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999888 99999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.34  E-value=1.7e-07  Score=99.74  Aligned_cols=125  Identities=30%  Similarity=0.515  Sum_probs=103.4

Q ss_pred             cEEEEeCCCCCcccccCccccCCC-CcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLT-KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+..|++.+|.++ .+++....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus       117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l  193 (394)
T COG4886         117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL  193 (394)
T ss_pred             ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence            6899999999999 7888888885 9999999999999 77778999999999999999999 89888889999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLIC  203 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~  203 (623)
                      ++|+++ .+|..+..+..|+.|.+++|++...+.....    ..+.+.+|++.+
T Consensus       194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~  246 (394)
T COG4886         194 SGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED  246 (394)
T ss_pred             cCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee
Confidence            999999 8888777777899999999964433332221    334467777655

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=4.5e-06  Score=89.63  Aligned_cols=144  Identities=19%  Similarity=0.186  Sum_probs=92.2

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEecccccc------------------------------------cchHHHHHHH
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA------------------------------------GGEVQFQTEV  349 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------------------------~~~~~~~~e~  349 (623)
                      .+.||.-+.|.||+|++++|+.||||+-+..-..                                    ..+.+|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            4679999999999999999999999997532100                                    1122456665


Q ss_pred             HHHhhc----CCCce---eeeeeeee-cCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 006968          350 ETISLA----VHRNL---LRLCGFCS-TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ  421 (623)
Q Consensus       350 ~~l~~l----~H~ni---v~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~  421 (623)
                      +-..+.    +|-+.   |.+=.++. -.....|+||||+|..+.+.-.-.   ...++...+   +..+.++  |++..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i---~~~l~~~--~~~qI  317 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID---KRGISPHDI---LNKLVEA--YLEQI  317 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH---HcCCCHHHH---HHHHHHH--HHHHH
Confidence            544333    45551   11222222 235689999999998776653221   113444433   3333332  33332


Q ss_pred             CCCCeEecCCCCCCeEECC----CCcEEEeecccccccCC
Q 006968          422 CDPKIIHRDVKAANILLDE----DFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       422 ~~~~ivH~Dlk~~NIll~~----~~~~kl~Dfgla~~~~~  457 (623)
                      ...|++|+|-+|-||+++.    ++.+.+-|||+...+.+
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3338999999999999993    67899999999876654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.21  E-value=1e-05  Score=76.56  Aligned_cols=138  Identities=13%  Similarity=0.123  Sum_probs=90.4

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHH---------HHHHHHHHhhcCCC---ceeeeeee
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ---------FQTEVETISLAVHR---NLLRLCGF  366 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~~e~~~l~~l~H~---niv~l~~~  366 (623)
                      ...+|...+++.......|.+-.. +|..+++|..+..... .++.         ..+++..+.+++..   ....++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            345677777788777777777666 6788999988654322 1211         23344444444322   22232222


Q ss_pred             eec-----CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC
Q 006968          367 CST-----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED  441 (623)
Q Consensus       367 ~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  441 (623)
                      ...     ....+++|||++|..|.+...        ++.    .++..+.+++.-+|..   |+.|+|.+|.|++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence            221     234579999999987655432        222    2445677889999999   99999999999999965


Q ss_pred             CcEEEeecccccc
Q 006968          442 FEAVVGDFGLAKL  454 (623)
Q Consensus       442 ~~~kl~Dfgla~~  454 (623)
                       .++++||+..+.
T Consensus       172 -~i~iID~~~k~~  183 (229)
T PF06176_consen  172 -GIRIIDTQGKRM  183 (229)
T ss_pred             -cEEEEECccccc
Confidence             599999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.18  E-value=8.5e-07  Score=61.59  Aligned_cols=35  Identities=49%  Similarity=0.790  Sum_probs=14.2

Q ss_pred             ccEEEecCCCCCCCCCccccCCCCccchhccccccC
Q 006968          124 LQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT  159 (623)
Q Consensus       124 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  159 (623)
                      |++|+|++|+|+ .+|+.+++|++|+.|+|++|+|+
T Consensus         3 L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    3 LEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             -SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             ceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            444444444444 33333444444444444444443

...

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.17  E-value=3.3e-07  Score=97.21  Aligned_cols=185  Identities=18%  Similarity=0.137  Sum_probs=133.6

Q ss_pred             CcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCc-eeeeeeeeecCCceEEEEecccC
Q 006968          304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN-LLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       304 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      ..-+-.++|+++++||.+-...+...++.+...      ....-++++|.+++||| .+..++-+..++..+++++++.+
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            334557899999999986533333445555332      34567889999999999 66767777777888999999987


Q ss_pred             C-ChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc
Q 006968          383 G-SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH  461 (623)
Q Consensus       383 g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  461 (623)
                      + +...-+.   .....+...+...+..--+++++|+|+.   .=+|+|    ||+..+ +..+..||+....+....  
T Consensus       319 ~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--  385 (829)
T KOG0576|consen  319 GRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--  385 (829)
T ss_pred             CccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--
Confidence            7 2211111   1112344445556666778899999987   568998    777665 588999999988766543  


Q ss_pred             eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 006968          462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD  507 (623)
Q Consensus       462 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~  507 (623)
                      ......+++.++|||+.....+..+.|+|+.|+--.++.-|-+|-.
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            3344568999999999999999999999999988778877776643

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.15  E-value=1.4e-06  Score=60.51  Aligned_cols=37  Identities=41%  Similarity=0.619  Sum_probs=30.0

Q ss_pred             CCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCC
Q 006968           98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT  135 (623)
Q Consensus        98 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  135 (623)
                      ++|++|+|++|+|+ .+|..+++|++|++|+|++|+|+
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            47888999999998 57767889999999999999888

...

>PLN02876 acyl-CoA dehydrogenase

Probab=98.11  E-value=3.3e-05  Score=89.76  Aligned_cols=149  Identities=13%  Similarity=0.195  Sum_probs=92.8

Q ss_pred             CCceeccCCeEEEEEEeCCC---cEEEEEEecccccccchHHHHHHHHHHhhcC-CCce--eeeeeeeecC---CceEEE
Q 006968          306 KNILGRGGFGIVYKGCFSDG---ALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNL--LRLCGFCSTE---NERLLV  376 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lv  376 (623)
                      .+.++.|.++.+|+....++   ..+++|+............+.+|.++++.+. |.++  .+++++|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45688999999999877554   4677787654332333456889999999985 6665  6777887654   467899


Q ss_pred             EecccCCChhhh-----------------------hhhccCC-------CCCCCH--HHHHHHH---------------H
Q 006968          377 YPYMPNGSVASR-----------------------LRDHIHG-------RPALDW--ARRKRIA---------------L  409 (623)
Q Consensus       377 ~e~~~~gsL~~~-----------------------l~~~~~~-------~~~l~~--~~~~~i~---------------~  409 (623)
                      |||+++..+.+.                       |+.....       ..+..+  .+...+.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999987653221                       1110000       001111  0111111               1


Q ss_pred             HHHHHHHHHHhCCC--------CCeEecCCCCCCeEECCC-Cc-EEEeecccccc
Q 006968          410 GTARGLLYLHEQCD--------PKIIHRDVKAANILLDED-FE-AVVGDFGLAKL  454 (623)
Q Consensus       410 ~ia~~L~~LH~~~~--------~~ivH~Dlk~~NIll~~~-~~-~kl~Dfgla~~  454 (623)
                      .+.+.+.+|..+..        +.+||+|+++.||+++.+ .. .-|.||+++..
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            23344667754321        359999999999999853 34 46999998764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	623
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-133
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-131
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-46
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-46
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-42
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-41
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-38
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-22
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-22
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-22
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-22
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-22
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-22
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-22
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-22
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-22
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-22
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-22
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-21
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-21
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-21
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-21
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-21
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-10
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		8e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-09
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-08
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-06
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		9e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-05
3soa_A	444	Full-Length Human Camkii Length = 444		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  471 bits (1211), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 233/341 (68%), Positives = 272/341 (79%), Gaps = 5/341 (1%)
Query: 264 RYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS 323
           R +  Q  FFDV  + DPEV LG LKR++ +EL+ A+ NFS KNILGRGGFG VYKG  +
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 324 DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383
           DG LVAVKRLK+    GGE+QFQTEVE IS+AVHRNLLRL GFC T  ERLLVYPYM NG
Sbjct: 61  DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443
           SVAS LR+    +P LDW +R+RIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE+FE
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 180
Query: 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           AVVGDFGLAKL+D++D HV  AVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ
Sbjct: 181 AVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 240
Query: 504 RALDFGRAANQRGVM-LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
           RA D  R AN   VM LDWVK L +E KL  +VD DL+GN+   E+E+++QVALLCTQ +
Sbjct: 241 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 300
Query: 563 PLHRPKMSEVLKMLEGDGLAEKWEASQKIETPR----YRTH 599
           P+ RPKMSEV++MLEGDGLAE+WE  QK E  R    Y TH
Sbjct: 301 PMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPTH 341

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  464 bits (1193), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 226/325 (69%), Positives = 264/325 (81%), Gaps = 1/325 (0%)
Query: 272 FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVK 331
           FFDV  + DPEV LG LKR++ +EL+ A+ NF  KNILGRGGFG VYKG  +DG LVAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 332 RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD 391
           RLK+    GGE+QFQTEVE IS+AVHRNLLRL GFC T  ERLLVYPYM NGSVAS LR+
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 392 HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451
               +P LDW +R+RIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE+FEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511
           AKL+D++D HV  AVRG +GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQRA D  R 
Sbjct: 181 AKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 512 ANQRGVM-LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMS 570
           AN   VM LDWVK L +E KL  +VD DL+GN+   E+E+++QVALLCTQ +P+ RPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 571 EVLKMLEGDGLAEKWEASQKIETPR 595
           EV++MLEGDGLAE+WE  QK E  R
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFR 325

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  184 bits (466), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 113/293 (38%), Positives = 168/293 (57%), Gaps = 14/293 (4%)
Query: 290 RYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEV 349
           R    +L  AT+NF  K ++G G FG VYKG   DGA VA+KR +    + G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEI 86
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP----ALDWARRK 405
           ET+S   H +L+ L GFC   NE +L+Y YM NG+    L+ H++G      ++ W +R 
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN----LKRHLYGSDLPTMSMSWEQRL 142
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTT 464
            I +G ARGL YLH +    IIHRDVK+ NILLDE+F   + DFG++K     D +H+  
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXX 199
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
            V+GT+G+I PEY   G+ +EK+DV+ FG++L E++  + A+       +   + +W  +
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVE 258
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            H  G+L Q+VD +L        L +    A+ C   +   RP M +VL  LE
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  182 bits (461), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 112/293 (38%), Positives = 168/293 (57%), Gaps = 14/293 (4%)
Query: 290 RYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEV 349
           R    +L  AT+NF  K ++G G FG VYKG   DGA VA+KR +    + G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEI 86
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP----ALDWARRK 405
           ET+S   H +L+ L GFC   NE +L+Y YM NG+    L+ H++G      ++ W +R 
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN----LKRHLYGSDLPTMSMSWEQRL 142
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL-LDHRDSHVTT 464
            I +G ARGL YLH +    IIHRDVK+ NILLDE+F   + DFG++K   +   +H+  
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXX 199
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
            V+GT+G+I PEY   G+ +EK+DV+ FG++L E++  + A+       +   + +W  +
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPREMVNLAEWAVE 258
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            H  G+L Q+VD +L        L +    A+ C   +   RP M +VL  LE
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  170 bits (430), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 112/306 (36%), Positives = 168/306 (54%), Gaps = 19/306 (6%)
Query: 282 EVSLGHLKRYTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAVKRLK- 334
           EVS      ++F EL+  T+NF  +      N +G GGFG+VYKG + +   VAVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAA 64
Query: 335 --DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH 392
             D      + QF  E++ ++   H NL+ L GF S  ++  LVY YMPNGS+  RL   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS-C 123
Query: 393 IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452
           + G P L W  R +IA G A G+ +LHE      IHRD+K+ANILLDE F A + DFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 453 KLLDHRDSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511
           +  +     V  + + GT  ++APE L  G+ + K+D++ FG++LLE+ITG  A+D  R 
Sbjct: 181 RASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 512 ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSE 571
              + ++    +   +E  +   +DK +  + D   +E M  VA  C       RP + +
Sbjct: 240 P--QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 572 VLKMLE 577
           V ++L+
Sbjct: 297 VQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (428), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 112/306 (36%), Positives = 167/306 (54%), Gaps = 19/306 (6%)
Query: 282 EVSLGHLKRYTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAVKRLK- 334
           EVS      ++F EL+  T+NF  +      N +G GGFG+VYKG + +   VAVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAA 64
Query: 335 --DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH 392
             D      + QF  E++ ++   H NL+ L GF S  ++  LVY YMPNGS+  RL   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS-C 123
Query: 393 IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452
           + G P L W  R +IA G A G+ +LHE      IHRD+K+ANILLDE F A + DFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 453 KLLDHRDSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511
           +  +     V    + GT  ++APE L  G+ + K+D++ FG++LLE+ITG  A+D  R 
Sbjct: 181 RASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 512 ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSE 571
              + ++    +   +E  +   +DK +  + D   +E M  VA  C       RP + +
Sbjct: 240 P--QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 572 VLKMLE 577
           V ++L+
Sbjct: 297 VQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  167 bits (423), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 111/305 (36%), Positives = 166/305 (54%), Gaps = 19/305 (6%)
Query: 283 VSLGHLKRYTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAVKRLK-- 334
           VS      ++F EL+  T+NF  +      N +G GGFG+VYKG + +   VAVK+L   
Sbjct: 1   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAM 59
Query: 335 -DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI 393
            D      + QF  E++ ++   H NL+ L GF S  ++  LVY YMPNGS+  RL   +
Sbjct: 60  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS-CL 118
Query: 394 HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
            G P L W  R +IA G A G+ +LHE      IHRD+K+ANILLDE F A + DFGLA+
Sbjct: 119 DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 175
Query: 454 LLDHRDSHVTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAA 512
             +     V    + GT  ++APE L  G+ + K+D++ FG++LLE+ITG  A+D  R  
Sbjct: 176 ASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP 234
Query: 513 NQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEV 572
             + ++    +   +E  +   +DK +  + D   +E M  VA  C       RP + +V
Sbjct: 235 --QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 291
Query: 573 LKMLE 577
            ++L+
Sbjct: 292 QQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 107/297 (36%), Positives = 159/297 (53%), Gaps = 19/297 (6%)
Query: 291 YTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAVKRLK---DYNIAGG 341
           ++F EL+  T+NF  +      N  G GGFG+VYKG + +   VAVK+L    D      
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 342 EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDW 401
           + QF  E++  +   H NL+ L GF S  ++  LVY Y PNGS+  RL   + G P L W
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLS-CLDGTPPLSW 123
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
             R +IA G A G+ +LHE      IHRD+K+ANILLDE F A + DFGLA+  +     
Sbjct: 124 HXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 462 VTTA-VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD 520
           V  + + GT  + APE L  G+ + K+D++ FG++LLE+ITG  A+D  R    + ++  
Sbjct: 181 VXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLDI 237
Query: 521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
             +   +E  +   +DK    + D   +E    VA  C       RP + +V ++L+
Sbjct: 238 KEEIEDEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ YL  + 
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYLASK- 171
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +   ++   H  T  +  V  +A E L 
Sbjct: 172 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 229
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 230 TQKFTTKSDVWSFGVLLWELMT 251

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ YL  + 
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYLASK- 144
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +   ++   H  T  +  V  +A E L 
Sbjct: 145 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 203 TQKFTTKSDVWSFGVLLWELMT 224

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ YL  + 
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYLASK- 170
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +   ++   H  T  +  V  +A E L 
Sbjct: 171 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMT 250

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ YL  + 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYLASK- 152
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +   ++   H  T  +  V  +A E L 
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ YL  + 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYLASK- 152
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +   ++   H  T  +  V  +A E L 
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ YL  + 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYLASK- 151
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +   ++   H  T  +  V  +A E L 
Sbjct: 152 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 209
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMT 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ YL  + 
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYLASK- 147
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +   ++   H  T  +  V  +A E L 
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMT 227

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ YL  + 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYLASK- 151
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS---HVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +  ++    H  T  +  V  +A E L 
Sbjct: 152 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMT 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ YL  + 
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYLASK- 149
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +   ++   H  T  +  V  +A E L 
Sbjct: 150 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 207
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMT 229

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ YL  + 
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYLASK- 150
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +   ++   H  T  +  V  +A E L 
Sbjct: 151 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 76/202 (37%), Positives = 106/202 (52%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ +L  + 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFLASK- 153
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHR-DS-HVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +LD   DS H  T  +  V  +A E L 
Sbjct: 154 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ +L  + 
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFLASK- 211
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD---SHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +  ++    H  T  +  V  +A E L 
Sbjct: 212 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMT 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ +L  + 
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFLASK- 150
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD---SHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +  ++    H  T  +  V  +A E L 
Sbjct: 151 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT 230

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 108/204 (52%), Gaps = 5/204 (2%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEV-QFQTEVETISLAVHRNL 360
           + + K  +G G FG V++  +  G+ VAVK L + +     V +F  EV  +    H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           +   G  +      +V  Y+  GS+  RL      R  LD  RR  +A   A+G+ YLH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
           + +P I+HRD+K+ N+L+D+ +   V DFGL++L          A  GT   +APE L  
Sbjct: 156 R-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA-GTPEWMAPEVLRD 213
Query: 481 GQSSEKTDVFGFGILLLELITGQR 504
             S+EK+DV+ FG++L EL T Q+
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQ 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ +L  + 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFLASK- 152
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD---SHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +  ++    H  T  +  V  +A E L 
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ +L  + 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFLASK- 152
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD---SHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +  ++    H  T  +  V  +A E L 
Sbjct: 153 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ +L  + 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFLASK- 153
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD---SHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +  ++    H  T  +  V  +A E L 
Sbjct: 154 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMT 233

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 308 ILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           ++GRG FG VY G    +DG  +  AVK L      G   QF TE   +    H N+L L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 364 CGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
            G C  +E   L+V PYM +G + + +R+  H     D        L  A+G+ +L  + 
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFLASK- 157
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD---SHVTTAVRGTVGHIAPEYLS 479
             K +HRD+ A N +LDE F   V DFGLA+ +  ++    H  T  +  V  +A E L 
Sbjct: 158 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
           T + + K+DV+ FG+LL EL+T
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMT 237

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 109/204 (53%), Gaps = 5/204 (2%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEV-QFQTEVETISLAVHRNL 360
           + + K  +G G FG V++  +  G+ VAVK L + +     V +F  EV  +    H N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           +   G  +      +V  Y+  GS+  RL      R  LD  RR  +A   A+G+ YLH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
           + +P I+HR++K+ N+L+D+ +   V DFGL++L         +A  GT   +APE L  
Sbjct: 156 R-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRD 213
Query: 481 GQSSEKTDVFGFGILLLELITGQR 504
             S+EK+DV+ FG++L EL T Q+
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQ 237

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 143/299 (47%), Gaps = 52/299 (17%)
Query: 299 ATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAG---GEV-------QFQT 347
           A +    +  +G+GGFG+V+KG    D ++VA+K L    I G   GE        +FQ 
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL----ILGDSEGETEMIEKFQEFQR 72
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           EV  +S   H N+++L G     N   +V  ++P G +  RL D  H    + W+ + R+
Sbjct: 73  EVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRL 127
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANIL---LDEDFE--AVVGDFGLAKLLDHRDSHV 462
            L  A G+ Y+  Q +P I+HRD+++ NI    LDE+    A V DFGL++    +  H 
Sbjct: 128 MLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHS 182
Query: 463 TTAVRGTVGHIAPEYLSTGQSS--EKTDVFGFGILLLELITGQRALD---FGRAANQRGV 517
            + + G    +APE +   + S  EK D + F ++L  ++TG+   D   +G+       
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------- 235
Query: 518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            + ++  + +EG L   + +D            +  V  LC   +P  RP  S ++K L
Sbjct: 236 -IKFINMIREEG-LRPTIPEDCP--------PRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 142/299 (47%), Gaps = 52/299 (17%)
Query: 299 ATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAG---GEV-------QFQT 347
           A +    +  +G+GGFG+V+KG    D ++VA+K L    I G   GE        +FQ 
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL----ILGDSEGETEMIEKFQEFQR 72
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           EV  +S   H N+++L G     N   +V  ++P G +  RL D  H    + W+ + R+
Sbjct: 73  EVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRL 127
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANIL---LDEDFE--AVVGDFGLAKLLDHRDSHV 462
            L  A G+ Y+  Q +P I+HRD+++ NI    LDE+    A V DFG ++    +  H 
Sbjct: 128 MLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHS 182
Query: 463 TTAVRGTVGHIAPEYLSTGQSS--EKTDVFGFGILLLELITGQRALD---FGRAANQRGV 517
            + + G    +APE +   + S  EK D + F ++L  ++TG+   D   +G+       
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------- 235
Query: 518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            + ++  + +EG L   + +D            +  V  LC   +P  RP  S ++K L
Sbjct: 236 -IKFINMIREEG-LRPTIPEDCP--------PRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 142/299 (47%), Gaps = 52/299 (17%)
Query: 299 ATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAG---GEV-------QFQT 347
           A +    +  +G+GGFG+V+KG    D ++VA+K L    I G   GE        +FQ 
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL----ILGDSEGETEMIEKFQEFQR 72
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           EV  +S   H N+++L G     N   +V  ++P G +  RL D  H    + W+ + R+
Sbjct: 73  EVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRL 127
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANIL---LDEDFE--AVVGDFGLAKLLDHRDSHV 462
            L  A G+ Y+  Q +P I+HRD+++ NI    LDE+    A V DF L++    +  H 
Sbjct: 128 MLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHS 182
Query: 463 TTAVRGTVGHIAPEYLSTGQSS--EKTDVFGFGILLLELITGQRALD---FGRAANQRGV 517
            + + G    +APE +   + S  EK D + F ++L  ++TG+   D   +G+       
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------- 235
Query: 518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            + ++  + +EG L   + +D            +  V  LC   +P  RP  S ++K L
Sbjct: 236 -IKFINMIREEG-LRPTIPEDCP--------PRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 75
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 133
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 234
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 75
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 133
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLA 190
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 234
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 139/293 (47%), Gaps = 25/293 (8%)
Query: 286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQ 344
           GH+    + +     ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  
Sbjct: 1   GHMSP-NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-- 57
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
           F  E   +    H NL++L G C+ E    ++  +M  G++   LR+    R  ++    
Sbjct: 58  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVL 115
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
             +A   +  + YL ++     IHRD+ A N L+ E+    V DFGL++L+         
Sbjct: 116 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPA 172
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
             +  +   APE L+  + S K+DV+ FG+LL E+ T      +G +    G+ L     
Sbjct: 173 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL----- 220
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                ++ ++++KD +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 221 ----SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 75
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 133
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 234
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 71
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 129
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 130 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLA 186
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 230
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 231 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 71
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 129
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 130 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLA 186
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 230
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 231 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 74
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 132
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 133 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 233
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 70
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 128
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 229
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/201 (36%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 76
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST+ +  +V  +    S    L  H+H      +  +   IA  TARG+ YLH +    I
Sbjct: 77  STKPQLAIVTQWCEGSS----LYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA +      SH    + G++  +APE +    S  
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQ 210

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 70
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 128
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 229
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 75
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 133
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 234
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 139/293 (47%), Gaps = 25/293 (8%)
Query: 286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQ 344
           GH+    + +     ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  
Sbjct: 1   GHMSP-NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-- 57
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
           F  E   +    H NL++L G C+ E    ++  +M  G++   LR+    R  ++    
Sbjct: 58  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVL 115
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
             +A   +  + YL ++     IHRD+ A N L+ E+    V DFGL++L+         
Sbjct: 116 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 172
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
             +  +   APE L+  + S K+DV+ FG+LL E+ T      +G +    G+ L     
Sbjct: 173 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL----- 220
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                ++ ++++KD +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 221 ----SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 72
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 130
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 131 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 187
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 231
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 232 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 134/278 (48%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 83
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  ++      +A   +  + YL 
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 141
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 142 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 198
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 199 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 242
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 243 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 280

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G FG VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  +       +A   +  + YL 
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 126
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 127 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLA 183
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T   +   G   +Q                + ++++KD 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ----------------VYELLEKDY 227
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 228 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 133/278 (47%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 70
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  +       +A   +  + YL 
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 128
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 229
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 133/278 (47%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 75
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  +       +A   +  + YL 
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 133
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 190
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 234
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 235 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 133/278 (47%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 70
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  +       +A   +  + YL 
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 128
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 229
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 133/278 (47%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 70
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  +       +A   +  + YL 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 128
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 229
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 133/278 (47%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 70
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  +       +A   +  + YL 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 128
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L          ++ ++++KD 
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDL---------SQVYELLEKDY 229
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  +       +A   +  + YL 
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 126
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 127 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLA 183
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T   +   G   +Q                + ++++KD 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ----------------VYELLEKDY 227
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 228 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 82/327 (25%), Positives = 148/327 (45%), Gaps = 41/327 (12%)
Query: 255 IVVGLLVWLRY---RHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGR 311
           +  GL+  L Y   + N+   + V+  YD              +     ++ + K+ LG 
Sbjct: 185 VADGLITTLHYPAPKRNKPTIYGVSPNYD--------------KWEMERTDITMKHKLGG 230
Query: 312 GGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE 370
           G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H NL++L G C+ E
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVCTRE 288
Query: 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRD 430
               ++  +M  G++   LR+    R  +       +A   +  + YL ++     IHR+
Sbjct: 289 PPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRN 343
Query: 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
           + A N L+ E+    V DFGL++L+           +  +   APE L+  + S K+DV+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 491 GFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEE 550
            FG+LL E+ T      +G +    G+ L          ++ ++++KD +        E+
Sbjct: 404 AFGVLLWEIAT------YGMSP-YPGIDLS---------QVYELLEKDYRMERPEGCPEK 447
Query: 551 MVQVALLCTQFNPLHRPKMSEVLKMLE 577
           + ++   C Q+NP  RP  +E+ +  E
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 82/327 (25%), Positives = 149/327 (45%), Gaps = 41/327 (12%)
Query: 255 IVVGLLVWLRY---RHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGR 311
           +  GL+  L Y   + N+   + V+  YD              +     ++ + K+ LG 
Sbjct: 224 VADGLITTLHYPAPKRNKPTVYGVSPNYD--------------KWEMERTDITMKHKLGG 269
Query: 312 GGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE 370
           G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H NL++L G C+ E
Sbjct: 270 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVCTRE 327
Query: 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRD 430
               ++  +M  G++   LR+    R  ++      +A   +  + YL ++     IHR+
Sbjct: 328 PPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRN 382
Query: 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
           + A N L+ E+    V DFGL++L+           +  +   APE L+  + S K+DV+
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 442
Query: 491 GFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEE 550
            FG+LL E+ T      +G +    G+ L          ++ ++++KD +        E+
Sbjct: 443 AFGVLLWEIAT------YGMSPYP-GIDLS---------QVYELLEKDYRMERPEGCPEK 486
Query: 551 MVQVALLCTQFNPLHRPKMSEVLKMLE 577
           + ++   C Q+NP  RP  +E+ +  E
Sbjct: 487 VYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/201 (36%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST+ +  +V  +    S    L  H+H      +  +   IA  TARG+ YLH +    I
Sbjct: 89  STKPQLAIVTQWCEGSS----LYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA        SH    + G++  +APE +    S  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/201 (36%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST  +  +V  +    S    L  H+H      +  +   IA  TARG+ YLH +    I
Sbjct: 89  STAPQLAIVTQWCEGSS----LYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA        SH    + G++  +APE +    S  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 24/278 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 68
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  +       +A   +  + YL 
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 126
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHRD+ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 127 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLA 183
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T   +   G   +Q                + ++++KD 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ----------------VYELLEKDY 227
Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +        E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 228 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 79
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 134
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 194
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 195 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 234
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 235 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 267

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 83
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 138
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 199 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 238
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 239 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 85
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 140
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 200
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 201 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 240
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 241 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 273

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 132
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 193 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 232
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 86
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 141
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 201
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 202 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 241
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 242 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 274

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 78
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 133
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 193
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 194 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 233
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 234 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 266

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 132
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 193 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 232
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           LG G FG V+ G +++   VAVK LK   ++   VQ F  E   +    H  L+RL    
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
           + E    ++  YM  GS+   L+    G+  L   +    +   A G+ Y+  +     I
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYI 132
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD++AAN+L+ E     + DFGLA++++  +       +  +   APE ++ G  + K+
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 488 DVFGFGILLLELIT 501
           DV+ FGILL E++T
Sbjct: 193 DVWSFGILLYEIVT 206

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 132
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 193 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 232
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 83
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 138
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 199 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 238
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 239 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 87
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 142
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 202
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 203 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 242
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 243 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 275

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 82
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 137
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 197
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 198 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 237
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 238 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 270

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 117/234 (50%), Gaps = 30/234 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLK---DYNIAGGEVQFQTEVETISLAVH 357
           +  + + I+G GGFG VY+  F  G  VAVK  +   D +I+      + E +  ++  H
Sbjct: 7   AELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLR-DHIHGRPALDWARRKRIALGTARGLL 416
            N++ L G C  E    LV  +   G +   L    I     ++WA      +  ARG+ 
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA------VQIARGMN 119
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFE--------AVVGDFGLAKLLDHRDSHVTTAVRG 468
           YLH++    IIHRD+K++NIL+ +  E          + DFGLA+   HR + ++ A  G
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-HRTTKMSAA--G 176
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ---RALD-----FGRAANQ 514
               +APE +     S+ +DV+ +G+LL EL+TG+   R +D     +G A N+
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST+ +  +V  +    S    L  H+H      +  +   IA  TA+G+ YLH +    I
Sbjct: 78  STKPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA +      SH    + G++  +APE +       
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST+ +  +V  +    S    L  H+H      +  +   IA  TA+G+ YLH +    I
Sbjct: 73  STKPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA +      SH    + G++  +APE +       
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 74
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST+ +  +V  +    S    L  H+H      +  +   IA  TA+G+ YLH +    I
Sbjct: 75  STKPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA +      SH    + G++  +APE +       
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQ 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST+ +  +V  +    S    L  H+H      +  +   IA  TA+G+ YLH +    I
Sbjct: 78  STKPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA +      SH    + G++  +APE +       
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 72
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 127
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 187
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 188 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 227
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 228 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 131/291 (45%), Gaps = 50/291 (17%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY G +   +L VAVK LK+  +   E  F  E   +    H N
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 89
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    +V  YMP G++   LR+            R+ +   TA  LLY+ 
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRE----------CNREEV---TAVVLLYMA 136
Query: 420 EQCDPKI--------IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
            Q    +        IHRD+ A N L+ E+    V DFGL++L+           +  + 
Sbjct: 137 TQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK 196
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
             APE L+    S K+DV+ FG+LL E+ T      +G +    G+             L
Sbjct: 197 WTAPESLAYNTFSIKSDVWAFGVLLWEIAT------YGMSPYP-GI------------DL 237
Query: 532 SQMVDKDLKGNFDRIELEE-----MVQVALLCTQFNPLHRPKMSEVLKMLE 577
           SQ+ D   KG   R+E  E     + ++   C +++P  RP  +E  +  E
Sbjct: 238 SQVYDLLEKGY--RMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFE 286

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 99
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST+ +  +V  +    S    L  H+H      +  +   IA  TA+G+ YLH +    I
Sbjct: 100 STKPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA +      SH    + G++  +APE +       
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 100
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST+ +  +V  +    S    L  H+H      +  +   IA  TA+G+ YLH +    I
Sbjct: 101 STKPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA +      SH    + G++  +APE +       
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST  +  +V  +    S    L  H+H      +  +   IA  TA+G+ YLH +    I
Sbjct: 73  STAPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA +      SH    + G++  +APE +       
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 130/293 (44%), Gaps = 50/293 (17%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG+VY+G   D         VAVK + +       ++F  E   +      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPALDWARRKRIALGTARGLL 416
           L G  S     L+V   M +G + S LR      ++  GRP        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TV 470
           YL+ +   K +HRD+ A N ++  DF   +GDFG+      RD + T   R        V
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT-----RDIYETAYYRKGGKGLLPV 196
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ--RGVMLDWVKKLHQE 528
             +APE L  G  +  +D++ FG++L E+ +          A Q  +G+  + V K   +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQPYQGLSNEQVLKFVMD 247
Query: 529 GKLSQMVDKDLKGNFDRIE--LEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD 579
           G           G  D+ +   E +  +  +C QFNP  RP   E++ +L+ D
Sbjct: 248 G-----------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 121/272 (44%), Gaps = 32/272 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G G FG+V+ G + +   VA+K +K+ +++  E  F  E E +    H  L++L G C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS--EDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    LV+ +M +G ++  LR     R          + L    G+ YL E C   +IH
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+ E+    V DFG+ + +       +T  +  V   +PE  S  + S K+D
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD---- 544
           V+ FG+L+ E+ +                      K+  E + +  V +D+   F     
Sbjct: 207 VWSFGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKP 246
Query: 545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           R+    + Q+   C +  P  RP  S +L+ L
Sbjct: 247 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST+ +  +V  +    S    L  H+H      +  +   IA  TA+G+ YLH +    I
Sbjct: 73  STKPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA        SH    + G++  +APE +       
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG+VY+G   D         VAVK + +       ++F  E   +      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPALDWARRKRIALGTARGLL 416
           L G  S     L+V   M +G + S LR      ++  GRP        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TV 470
           YL+ +   K +HRD+ A N ++  DF   +GDFG+      RD + T   R        V
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLPV 196
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK 530
             +APE L  G  +  +D++ FG++L E IT      +   +N++      V K   +G 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQ------VLKFVMDG- 248
Query: 531 LSQMVDKDLKGNFDRIE--LEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD 579
                     G  D+ +   E +  +  +C QFNP  RP   E++ +L+ D
Sbjct: 249 ----------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 73
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 128
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           R+++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 188
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 189 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 228
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 229 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 261

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG+V  G +     VAVK +K+ +++  E +F  E +T+    H  L++  G CS
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  Y+ NG + + LR H  G   L+ ++   +      G+ +L      + IH
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 429 RDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTT-AVRGTVGHIAPEYLSTGQSSEK 486
           RD+ A N L+D D    V DFG+ + +LD  D +V++   +  V   APE     + S K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 487 TDVFGFGILLLELIT 501
           +DV+ FGIL+ E+ +
Sbjct: 186 SDVWAFGILMWEVFS 200

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 92
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST+ +  +V  +    S    L  H+H      +  +   IA  TA+G+ YLH +    I
Sbjct: 93  STKPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA        SH    + G++  +APE +       
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 100
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKI 426
           ST+ +  +V  +    S    L  H+H      +  +   IA  TA+G+ YLH +    I
Sbjct: 101 STKPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA        SH    + G++  +APE +       
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 484 -SEKTDVFGFGILLLELITGQ 503
            S ++DV+ FGI+L EL+TGQ
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           LG G FG V+ G +++   VAVK LK   ++   VQ F  E   +    H  L+RL    
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
           + E    ++  +M  GS+   L+    G+  L   +    +   A G+ Y+  +     I
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYI 131
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD++AAN+L+ E     + DFGLA++++  +       +  +   APE ++ G  + K+
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 488 DVFGFGILLLELIT 501
           +V+ FGILL E++T
Sbjct: 192 NVWSFGILLYEIVT 205

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 42/289 (14%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG+VY+G   D         VAVK + +       ++F  E   +      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPALDWARRKRIALGTARGLL 416
           L G  S     L+V   M +G + S LR      ++  GRP        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG--TVGHIA 474
           YL+ +   K +HRD+ A N ++  DF   +GDFG+ + +   D       +G   V  +A
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX-XRKGGKGLLPVRWMA 200
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ--RGVMLDWVKKLHQEGKLS 532
           PE L  G  +  +D++ FG++L E+ +          A Q  +G+  + V K   +G   
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQPYQGLSNEQVLKFVMDG--- 248
Query: 533 QMVDKDLKGNFDRIE--LEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD 579
                   G  D+ +   E +  +  +C QFNP  RP   E++ +L+ D
Sbjct: 249 --------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 130/293 (44%), Gaps = 50/293 (17%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG+VY+G   D         VAVK + +       ++F  E   +      +++R
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPALDWARRKRIALGTARGLL 416
           L G  S     L+V   M +G + S LR      ++  GRP        ++A   A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TV 470
           YL+ +   K +HRD+ A N ++  DF   +GDFG+      RD + T   R        V
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLPV 195
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ--RGVMLDWVKKLHQE 528
             +APE L  G  +  +D++ FG++L E+ +          A Q  +G+  + V K   +
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQPYQGLSNEQVLKFVMD 246
Query: 529 GKLSQMVDKDLKGNFDRIE--LEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD 579
           G           G  D+ +   E +  +  +C QFNP  RP   E++ +L+ D
Sbjct: 247 G-----------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 288

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 42/289 (14%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG+VY+G   D         VAVK + +       ++F  E   +      +++R
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPALDWARRKRIALGTARGLL 416
           L G  S     L+V   M +G + S LR      ++  GRP        ++A   A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG--TVGHIA 474
           YL+ +   K +HRD+ A N ++  DF   +GDFG+ + +   D       +G   V  +A
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX-XRKGGKGLLPVRWMA 197
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ--RGVMLDWVKKLHQEGKLS 532
           PE L  G  +  +D++ FG++L E+ +          A Q  +G+  + V K   +G   
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQPYQGLSNEQVLKFVMDG--- 245
Query: 533 QMVDKDLKGNFDRIE--LEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD 579
                   G  D+ +   E +  +  +C QFNP  RP   E++ +L+ D
Sbjct: 246 --------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 286

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 134/307 (43%), Gaps = 42/307 (13%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQ 344
           Y   E   +    +    LG+G FG+VY+G   D         VAVK + +       ++
Sbjct: 7   YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPA 398
           F  E   +      +++RL G  S     L+V   M +G + S LR      ++  GRP 
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
                  ++A   A G+ YL+ +   K +HRD+ A N ++  DF   +GDFG+ + +   
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 183
Query: 459 DSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ-- 514
           D       +G   V  +APE L  G  +  +D++ FG++L E+ +          A Q  
Sbjct: 184 DX-XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------LAEQPY 233
Query: 515 RGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE--LEEMVQVALLCTQFNPLHRPKMSEV 572
           +G+  + V K   +G           G  D+ +   E +  +  +C QFNP  RP   E+
Sbjct: 234 QGLSNEQVLKFVMDG-----------GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 282
Query: 573 LKMLEGD 579
           + +L+ D
Sbjct: 283 VNLLKDD 289

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 32/272 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G G FG+V+ G + +   VA+K +++   A  E  F  E E +    H  L++L G C 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    LV+ +M +G ++  LR     R          + L    G+ YL E C   +IH
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+ E+    V DFG+ + +       +T  +  V   +PE  S  + S K+D
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD---- 544
           V+ FG+L+ E+ +                      K+  E + +  V +D+   F     
Sbjct: 190 VWSFGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKP 229
Query: 545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           R+    + Q+   C +  P  RP  S +L+ L
Sbjct: 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 125/273 (45%), Gaps = 32/273 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G  G V+ G ++    VAVK LK  +++     F  E   +    H+ L+RL     
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
           T+    ++  YM NGS+   L+     +  ++  +   +A   A G+ ++ E+     IH
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEER---NYIH 132
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ G  + K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE- 547
           V+ FGILL E++T  R                    +   G  +  V ++L+  +  +  
Sbjct: 193 VWSFGILLTEIVTHGR--------------------IPYPGMTNPEVIQNLERGYRMVRP 232
Query: 548 ---LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 32/272 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G G FG+V+ G + +   VA+K +++   A  E  F  E E +    H  L++L G C 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    LV+ +M +G ++  LR     R          + L    G+ YL E C   +IH
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+ E+    V DFG+ + +       +T  +  V   +PE  S  + S K+D
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD---- 544
           V+ FG+L+ E+ +                      K+  E + +  V +D+   F     
Sbjct: 185 VWSFGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKP 224
Query: 545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           R+    + Q+   C +  P  RP  S +L+ L
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 31/285 (10%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGA-----LVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           S  + + ++G G FG VYKG     +      VA+K LK        V F  E   +   
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N++RL G  S     +++  YM NG++   LR+       L      R   G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGM 160
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHI 473
            YL    +   +HRD+ A NIL++ +    V DFGL+++L  D   ++ T+  +  +   
Sbjct: 161 KYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLS 532
           APE +S  + +  +DV+ FGI++ E++T G+R   +   +N      + +K ++   +L 
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSNH-----EVMKAINDGFRLP 270
Query: 533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
             +D              + Q+ + C Q     RPK ++++ +L+
Sbjct: 271 TPMDCP----------SAIYQLMMQCWQQERARRPKFADIVSILD 305

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 32/272 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G G FG+V+ G + +   VA+K +++   A  E  F  E E +    H  L++L G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    LV+ +M +G ++  LR     R          + L    G+ YL E C   +IH
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+ E+    V DFG+ + +       +T  +  V   +PE  S  + S K+D
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD---- 544
           V+ FG+L+ E+ +                      K+  E + +  V +D+   F     
Sbjct: 187 VWSFGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKP 226
Query: 545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           R+    + Q+   C +  P  RP  S +L+ L
Sbjct: 227 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 137/302 (45%), Gaps = 51/302 (16%)
Query: 306 KNILGRGGFGIVYKG-CFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           K  LG G FG V+   C++     D  LVAVK LKD  +A  +  FQ E E ++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEH 78
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDH-------IHGRP-----ALDWARRKRI 407
           +++  G C   +  ++V+ YM +G +   LR H       + G+P      L  ++   I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
           A   A G++YL  Q     +HRD+   N L+  +    +GDFG++     RD + T   R
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS-----RDVYSTDYYR 190
Query: 468 GTVGH-------IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD 520
              GH       + PE +   + + ++DV+ FG++L E+ T      +G+          
Sbjct: 191 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT------YGKQP-------- 235
Query: 521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG 580
           W +  + E  + + + +       R+  +E+  V L C Q  P  R  + E+ K+L   G
Sbjct: 236 WFQLSNTE--VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293
Query: 581 LA 582
            A
Sbjct: 294 KA 295

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/315 (26%), Positives = 142/315 (45%), Gaps = 36/315 (11%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
           + F D +   DP  ++        KEL A  +N S   ++G G FG V  G         
Sbjct: 20  RTFVDPHTFEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
             VA+K LK          F  E   +    H N++RL G  +     ++V  YM NGS+
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445
            S LR H      +      R   G A G+ YL    D   +HRD+ A NIL++ +    
Sbjct: 134 DSFLRKHDAQFTVIQLVGMLR---GIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 446 VGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-G 502
           V DFGLA++L  D   ++ T   +  +   +PE ++  + +  +DV+ +GI+L E+++ G
Sbjct: 188 VSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
           +R   +   +NQ     D +K + +  +L   +D              + Q+ L C Q +
Sbjct: 248 ERP--YWEMSNQ-----DVIKAVDEGYRLPPPMDCP----------AALYQLMLDCWQKD 290
Query: 563 PLHRPKMSEVLKMLE 577
             +RPK  +++ +L+
Sbjct: 291 RNNRPKFEQIVSILD 305

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG+VY+G   D         VAVK + +       ++F  E   +      +++R
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPALDWARRKRIALGTARGLL 416
           L G  S     L+V   M +G + S LR      ++  GRP        ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TV 470
           YL+ +   K +HR++ A N ++  DF   +GDFG+      RD + T   R        V
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLPV 196
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK 530
             +APE L  G  +  +D++ FG++L E IT      +   +N++      V K   +G 
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQ------VLKFVMDG- 248
Query: 531 LSQMVDKDLKGNFDRIE--LEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD 579
                     G  D+ +   E +  +  +C QFNP  RP   E++ +L+ D
Sbjct: 249 ----------GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/315 (26%), Positives = 142/315 (45%), Gaps = 36/315 (11%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
           + F D +   DP  ++        KEL A  +N S   ++G G FG V  G         
Sbjct: 20  RTFVDPHTYEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
             VA+K LK          F  E   +    H N++RL G  +     ++V  YM NGS+
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445
            S LR H      +      R   G A G+ YL    D   +HRD+ A NIL++ +    
Sbjct: 134 DSFLRKHDAQFTVIQLVGMLR---GIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 446 VGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-G 502
           V DFGL+++L  D   ++ T   +  +   +PE ++  + +  +DV+ +GI+L E+++ G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
           +R   +   +NQ     D +K + +  +L   +D              + Q+ L C Q +
Sbjct: 248 ERP--YWEMSNQ-----DVIKAVDEGYRLPPPMDCP----------AALYQLMLDCWQKD 290
Query: 563 PLHRPKMSEVLKMLE 577
             +RPK  +++ +L+
Sbjct: 291 RNNRPKFEQIVSILD 305

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 88/347 (25%), Positives = 149/347 (42%), Gaps = 62/347 (17%)
Query: 255 IVVGLLVWLRYRHNQQI-----FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNIL 309
           +V+ L V+ R R+N ++     +  VN +Y     +     Y   E   A    +    L
Sbjct: 1   LVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADV-----YVPDEWEVAREKITMSREL 55
Query: 310 GRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           G+G FG+VY+G  + G +       VA+K + +       ++F  E   +      +++R
Sbjct: 56  GQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPAL---DWARRKRIALGTARGLL 416
           L G  S     L++   M  G + S LR     +   P L     ++  ++A   A G+ 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TV 470
           YL+     K +HRD+ A N ++ EDF   +GDFG+      RD + T   R        V
Sbjct: 175 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLPV 226
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ--RGVMLDWVKKLHQE 528
             ++PE L  G  +  +DV+ FG++L E+ T          A Q  +G+  + V +   E
Sbjct: 227 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQPYQGLSNEQVLRFVME 277
Query: 529 GKLSQMVDK--DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
           G L    D   D+           + ++  +C Q+NP  RP   E++
Sbjct: 278 GGLLDKPDNCPDM-----------LFELMRMCWQYNPKMRPSFLEII 313

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 131/296 (44%), Gaps = 42/296 (14%)
Query: 286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF 345
           G L    +KE+         + ++GRG FG+V K  +     VA+K+++          F
Sbjct: 1   GSLHMIDYKEIEV-------EEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAF 49
Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDW---A 402
             E+  +S   H N+++L G C   N   LV  Y   GS    L + +HG   L +   A
Sbjct: 50  IVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGS----LYNVLHGAEPLPYYTAA 103
Query: 403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSH 461
                 L  ++G+ YLH      +IHRD+K  N+LL      + + DFG A  +    +H
Sbjct: 104 HAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---TH 160
Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD-FGRAANQRGVMLD 520
           +T   +G+   +APE       SEK DVF +GI+L E+IT ++  D  G  A +    + 
Sbjct: 161 MTNN-KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IM 215
Query: 521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           W         L + + K ++    R            C   +P  RP M E++K++
Sbjct: 216 WAVHNGTRPPLIKNLPKPIESLMTR------------CWSKDPSQRPSMEEIVKIM 259

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG+VY+G   D         VAVK + +       ++F  E   +      +++R
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPALDWARRKRIALGTARGLL 416
           L G  S     L+V   M +G + S LR      ++  GRP        ++A   A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TV 470
           YL+ +   K +HR++ A N ++  DF   +GDFG+      RD + T   R        V
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLPV 197
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK 530
             +APE L  G  +  +D++ FG++L E IT      +   +N++      V K   +G 
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQ------VLKFVMDG- 249
Query: 531 LSQMVDKDLKGNFDRIE--LEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD 579
                     G  D+ +   E +  +  +C QFNP  RP   E++ +L+ D
Sbjct: 250 ----------GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 290

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS--PESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  GS+   L+D   GR AL       +A   A G+ Y+        IH
Sbjct: 75  -EEPIYIVTEYMNKGSLLDFLKDG-EGR-ALKLPNLVDMAAQVAAGMAYIERM---NYIH 128
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+++ANIL+       + DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL+T  R
Sbjct: 189 VWSFGILLTELVTKGR 204

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 84/315 (26%), Positives = 142/315 (45%), Gaps = 36/315 (11%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
           + F D +   DP  ++        KEL A  +N S   ++G G FG V  G         
Sbjct: 20  RTFVDPHTFEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
             VA+K LK          F  E   +    H N++RL G  +     ++V  YM NGS+
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445
            S LR H      +      R   G A G+ YL    D   +HRD+ A NIL++ +    
Sbjct: 134 DSFLRKHDAQFTVIQLVGMLR---GIASGMKYL---SDMGFVHRDLAARNILINSNLVCK 187
Query: 446 VGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-G 502
           V DFGL+++L  D   ++ T   +  +   +PE ++  + +  +DV+ +GI+L E+++ G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
           +R   +   +NQ     D +K + +  +L   +D              + Q+ L C Q +
Sbjct: 248 ERP--YWEMSNQ-----DVIKAVDEGYRLPPPMDCP----------AALYQLMLDCWQKD 290
Query: 563 PLHRPKMSEVLKMLE 577
             +RPK  +++ +L+
Sbjct: 291 RNNRPKFEQIVSILD 305

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 18/217 (8%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVET 351
           + E+ A+    S +  +G G FG VYKG +     VAVK LK  +    + Q F+ EV  
Sbjct: 30  YWEIEASEVMLSTR--IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAV 85
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIALG 410
           +    H N+L   G+ + +N  ++           S L  H+H +       +   IA  
Sbjct: 86  LRKTRHVNILLFMGYMTKDNLAIVT-----QWCEGSSLYKHLHVQETKFQMFQLIDIARQ 140
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGT 469
           TA+G+ YLH +    IIHRD+K+ NI L E     +GDFGLA +      S       G+
Sbjct: 141 TAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGS 197
Query: 470 VGHIAPEYLSTGQS---SEKTDVFGFGILLLELITGQ 503
           V  +APE +    +   S ++DV+ +GI+L EL+TG+
Sbjct: 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 32/291 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
           KEL A  +N S   ++G G FG V  G           VA+K LK          F  E 
Sbjct: 11  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    H N++RL G  +     ++V  YM NGS+ S LR H      +      R   
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR--- 125
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVR 467
           G A G+ YL    D   +HRD+ A NIL++ +    V DFGL+++L  D   ++ T   +
Sbjct: 126 GIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH 526
             +   +PE ++  + +  +DV+ +GI+L E+++ G+R   +   +NQ     D +K + 
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ-----DVIKAVD 235
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +L   +D              + Q+ L C Q +  +RPK  +++ +L+
Sbjct: 236 EGYRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 276

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 32/291 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
           KEL A  +N S   ++G G FG V  G           VA+K LK          F  E 
Sbjct: 28  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 85
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    H N++RL G  +     ++V  YM NGS+ S LR H      +      R   
Sbjct: 86  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR--- 142
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVR 467
           G A G+ YL    D   +HRD+ A NIL++ +    V DFGL+++L  D   ++ T   +
Sbjct: 143 GIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH 526
             +   +PE ++  + +  +DV+ +GI+L E+++ G+R   +   +NQ     D +K + 
Sbjct: 200 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ-----DVIKAVD 252
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +L   +D              + Q+ L C Q +  +RPK  +++ +L+
Sbjct: 253 EGYRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 293

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 32/272 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G G FG+V+ G + +   VA+K +++   A  E  F  E E +    H  L++L G C 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    LV  +M +G ++  LR     R          + L    G+ YL E C   +IH
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+ E+    V DFG+ + +       +T  +  V   +PE  S  + S K+D
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD---- 544
           V+ FG+L+ E+ +                      K+  E + +  V +D+   F     
Sbjct: 188 VWSFGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKP 227
Query: 545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           R+    + Q+   C +  P  RP  S +L+ L
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 32/291 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
           KEL A  +N S   ++G G FG V  G           VA+K LK          F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    H N++RL G  +     ++V  YM NGS+ S LR H      +      R   
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR--- 154
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVR 467
           G A G+ YL    D   +HRD+ A NIL++ +    V DFGL+++L  D   ++ T   +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH 526
             +   +PE ++  + +  +DV+ +GI+L E+++ G+R   +   +NQ     D +K + 
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ-----DVIKAVD 264
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +L   +D              + Q+ L C Q +  +RPK  +++ +L+
Sbjct: 265 EGYRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 32/291 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
           KEL A  +N S   ++G G FG V  G           VA+K LK          F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    H N++RL G  +     ++V  YM NGS+ S LR H      +      R   
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR--- 154
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVR 467
           G A G+ YL    D   +HRD+ A NIL++ +    V DFGL+++L  D   ++ T   +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH 526
             +   +PE ++  + +  +DV+ +GI+L E+++ G+R   +   +NQ     D +K + 
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ-----DVIKAVD 264
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +L   +D              + Q+ L C Q +  +RPK  +++ +L+
Sbjct: 265 EGYRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 84/315 (26%), Positives = 142/315 (45%), Gaps = 36/315 (11%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
           + F D +   DP  ++        KEL A  +N S   ++G G FG V  G         
Sbjct: 20  RTFVDPHTFEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
             VA+K LK          F  E   +    H N++RL G  +     ++V  YM NGS+
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445
            S LR H      +      R   G A G+ YL    D   +HRD+ A NIL++ +    
Sbjct: 134 DSFLRKHDAQFTVIQLVGMLR---GIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 446 VGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-G 502
           V DFGL+++L  D   ++ T   +  +   +PE ++  + +  +DV+ +GI+L E+++ G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
           +R   +   +NQ     D +K + +  +L   +D              + Q+ L C Q +
Sbjct: 248 ERP--YWEMSNQ-----DVIKAVDEGYRLPPPMDCP----------AALYQLMLDCWQKD 290
Query: 563 PLHRPKMSEVLKMLE 577
             +RPK  +++ +L+
Sbjct: 291 RNNRPKFEQIVSILD 305

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 35/276 (12%)
Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           + ++GRG FG+V K  +     VA+K+++          F  E+  +S   H N+++L G
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDW---ARRKRIALGTARGLLYLHEQC 422
            C   N   LV  Y   GS    L + +HG   L +   A      L  ++G+ YLH   
Sbjct: 69  ACL--NPVCLVMEYAEGGS----LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 423 DPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              +IHRD+K  N+LL      + + DFG A  +    +H+T   +G+   +APE     
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KGSAAWMAPEVFEGS 178
Query: 482 QSSEKTDVFGFGILLLELITGQRALD-FGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK 540
             SEK DVF +GI+L E+IT ++  D  G  A +    + W         L + + K ++
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAVHNGTRPPLIKNLPKPIE 234
Query: 541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
               R            C   +P  RP M E++K++
Sbjct: 235 SLMTR------------CWSKDPSQRPSMEEIVKIM 258

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 32/291 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
           KEL A  +N S   ++G G FG V  G           VA+K LK          F  E 
Sbjct: 38  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 95
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    H N++RL G  +     ++V  YM NGS+ S LR H      +      R   
Sbjct: 96  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR--- 152
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVR 467
           G A G+ YL    D   +HRD+ A NIL++ +    V DFGL+++L  D   ++ T   +
Sbjct: 153 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH 526
             +   +PE ++  + +  +DV+ +GI+L E+++ G+R   +   +NQ     D +K + 
Sbjct: 210 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ-----DVIKAVD 262
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +L   +D              + Q+ L C Q +  +RPK  +++ +L+
Sbjct: 263 EGYRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 303

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/315 (26%), Positives = 141/315 (44%), Gaps = 36/315 (11%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
           + F D +   DP  ++        KEL A  +N S   ++G G FG V  G         
Sbjct: 20  RTFVDPHTFEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
             VA+K LK          F  E   +    H N++RL G  +     ++V  YM NGS+
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445
            S LR H      +      R   G A G+ YL    D   +HRD+ A NIL++ +    
Sbjct: 134 DSFLRKHDAQFTVIQLVGMLR---GIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 446 VGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-G 502
           V DFGL ++L  D   ++ T   +  +   +PE ++  + +  +DV+ +GI+L E+++ G
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
           +R   +   +NQ     D +K + +  +L   +D              + Q+ L C Q +
Sbjct: 248 ERP--YWEMSNQ-----DVIKAVDEGYRLPPPMDCP----------AALYQLMLDCWQKD 290
Query: 563 PLHRPKMSEVLKMLE 577
             +RPK  +++ +L+
Sbjct: 291 RNNRPKFEQIVSILD 305

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK  N++     F  E + +    H  L++L    S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  GS+   L+  + G+  L   +   +A   A G+ Y+        +H
Sbjct: 251 -EEPIYIVTEYMSKGSLLDFLKGEM-GK-YLRLPQLVDMAAQIASGMAYVERM---NYVH 304
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ E+    V DFGL +L++  +       +  +   APE    G+ + K+D
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL T  R
Sbjct: 365 VWSFGILLTELTTKGR 380

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  GS+   L+  + G+  L   +   +A   A G+ Y+        +H
Sbjct: 73  -EEPIYIVTEYMSKGSLLDFLKGEM-GK-YLRLPQLVDMAAQIASGMAYVERM---NYVH 126
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL T  R
Sbjct: 187 VWSFGILLTELTTKGR 202

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  GS+   L+  + G+  L   +   +A   A G+ Y+        +H
Sbjct: 84  -EEPIYIVIEYMSKGSLLDFLKGEM-GK-YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL T  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARGLLYLHEQCDPKI 426
            E    +V  YM  GS    L D + G     L   +   +A   A G+ Y+        
Sbjct: 74  -EEPIXIVTEYMSKGS----LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 487 TDVFGFGILLLELITGQR 504
           +DV+ FGILL EL T  R
Sbjct: 186 SDVWSFGILLTELTTKGR 203

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  GS+   L+  + G+  L   +   +A   A G+ Y+        +H
Sbjct: 75  -EEPIYIVTEYMSKGSLLDFLKGEM-GK-YLRLPQLVDMAAQIASGMAYVERM---NYVH 128
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL T  R
Sbjct: 189 VWSFGILLTELTTKGR 204

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  GS+   L+  + G+  L   +   +A   A G+ Y+        +H
Sbjct: 84  -EEPIYIVIEYMSKGSLLDFLKGEM-GK-YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL T  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  GS+   L+  + G+  L   +   +A   A G+ Y+        +H
Sbjct: 84  -EEPIYIVTEYMSKGSLLDFLKGEM-GK-YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL T  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  GS+   L+  + G+  L   +   +A   A G+ Y+        +H
Sbjct: 84  -EEPIYIVTEYMSKGSLLDFLKGEM-GK-YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL T  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARGLLYLHEQCDPKI 426
            E    +V  YM  GS    L D + G     L   +   +A   A G+ Y+        
Sbjct: 77  -EEPIYIVTEYMSKGS----LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 128
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 487 TDVFGFGILLLELITGQR 504
           +DV+ FGILL EL T  R
Sbjct: 189 SDVWSFGILLTELTTKGR 206

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 309 LGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           LG G FG V   C+       G +VAVK LK+         +Q E+E +    H ++++ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 364 CGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
            G C  + E+   LV  Y+P GS    LRD++  R  +  A+    A     G+ YLH Q
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGS----LRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLS 479
                IHR + A N+LLD D    +GDFGLAK +   H    V       V   APE L 
Sbjct: 131 ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 187
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
             +    +DV+ FG+ L EL+T
Sbjct: 188 ECKFYYASDVWSFGVTLYELLT 209

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  GS+   L+  + G+  L   +   +A   A G+ Y+        +H
Sbjct: 84  -EEPIYIVCEYMSKGSLLDFLKGEM-GK-YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL T  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 309 LGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           LG G FG V   C+       G +VAVK LK+         +Q E+E +    H ++++ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 364 CGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
            G C  + E+   LV  Y+P GS    LRD++  R  +  A+    A     G+ YLH Q
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGS----LRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQ 131
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLS 479
                IHR + A N+LLD D    +GDFGLAK +   H    V       V   APE L 
Sbjct: 132 ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 188
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
             +    +DV+ FG+ L EL+T
Sbjct: 189 ECKFYYASDVWSFGVTLYELLT 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 49  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 163
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 118/272 (43%), Gaps = 32/272 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G G FG+V+ G + +   VA+K +++   A  E  F  E E +    H  L++L G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    LV+ +M +G ++  LR     R          + L    G+ YL E     +IH
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE---ASVIH 126
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+ E+    V DFG+ + +       +T  +  V   +PE  S  + S K+D
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD---- 544
           V+ FG+L+ E+ +                      K+  E + +  V +D+   F     
Sbjct: 187 VWSFGVLMWEVFSE--------------------GKIPYENRSNSEVVEDISTGFRLYKP 226
Query: 545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           R+    + Q+   C +  P  RP  S +L+ L
Sbjct: 227 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 18  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 132
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 16  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 130
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 131 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 188 TESKFSVASDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 17  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 131
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 132 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 189 TESKFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 22  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 136
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 137 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 194 TESKFSVASDVWSFGVVLYELFT 216

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY     +   + A+K L    +  AG E Q + EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   K+IHRD+K  N+LL    E  + DFG +    H  S    A+ GT+ ++ P
Sbjct: 122 SYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPP 175
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 18  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 132
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARGLLYLHEQCDPKI 426
            E    +V  YM  GS    L D + G     L   +   +A   A G+ Y+        
Sbjct: 250 -EEPIYIVTEYMSKGS----LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 487 TDVFGFGILLLELITGQR 504
           +DV+ FGILL EL T  R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 25  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 139
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 140 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 197 TESKFSVASDVWSFGVVLYELFT 219

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARGLLYLHEQCDPKI 426
            E    +V  YM  GS    L D + G     L   +   +A   A G+ Y+        
Sbjct: 250 -EEPIYIVTEYMSKGS----LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 487 TDVFGFGILLLELITGQR 504
           +DV+ FGILL EL T  R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G V   L+         D  R       
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITE 121
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTL 175
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 21  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 135
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 136 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 23  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 137
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 138 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 195 TESKFSVASDVWSFGVVLYELFT 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 36  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 150
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 151 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 24  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 138
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 139 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 196 TESKFSVASDVWSFGVVLYELFT 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 36  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 150
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 151 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 117
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTL 171
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARGLLYLHEQCDPKI 426
            E    +V  YM  GS    L D + G     L   +   +A   A G+ Y+        
Sbjct: 333 -EEPIYIVTEYMSKGS----LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 487 TDVFGFGILLLELITGQR 504
           +DV+ FGILL EL T  R
Sbjct: 445 SDVWSFGILLTELTTKGR 462

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 142
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+
Sbjct: 143 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTL 196
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  GS+   L+  + G+  L   +   +A   A G+ Y+        +H
Sbjct: 84  -EEPIYIVTEYMSKGSLLDFLKGEM-GK-YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL T  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARGLLYLHEQCDPKI 426
            E    +V  YM  GS    L D + G     L   +   +A   A G+ Y+        
Sbjct: 250 -EEPIYIVGEYMSKGS----LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 487 TDVFGFGILLLELITGQR 504
           +DV+ FGILL EL T  R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 306 KNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLL 361
           ++++G G FG V K       L    A+KR+K+Y        F  E+E +  L  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDH--IHGRPALDWARRK----------RIAL 409
            L G C       L   Y P+G++   LR    +   PA   A               A 
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRG 468
             ARG+ YL ++   + IHRD+ A NIL+ E++ A + DFGL++    ++ +V  T  R 
Sbjct: 140 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 193
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE 528
            V  +A E L+    +  +DV+ +G+LL E+++       G          +  +KL Q 
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYEKLPQG 247
Query: 529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL----KMLE 577
            +L + ++ D          +E+  +   C +  P  RP  +++L    +MLE
Sbjct: 248 YRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 290

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 119
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTL 173
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 309 LGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           LG G FG V   C+       G +VAVK LK          ++ E++ +    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 364 CGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
            G C  + E+   LV  Y+P GS    LRD++  R ++  A+    A     G+ YLH Q
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGS----LRDYL-PRHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD--HRDSHVTTAVRGTVGHIAPEYLS 479
                IHR++ A N+LLD D    +GDFGLAK +   H    V       V   APE L 
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
             +    +DV+ FG+ L EL+T
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 131/306 (42%), Gaps = 52/306 (16%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEV 343
           Y   E   A    +    LG+G FG+VY+G  + G +       VA+K + +       +
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPAL- 399
           +F  E   +      +++RL G  S     L++   M  G + S LR     +   P L 
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 400 --DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
               ++  ++A   A G+ YL+     K +HRD+ A N ++ EDF   +GDFG+      
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT----- 185
Query: 458 RDSHVTTAVRG------TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511
           RD + T   R        V  ++PE L  G  +  +DV+ FG++L E+ T          
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------L 236
Query: 512 ANQ--RGVMLDWVKKLHQEGKLSQMVDK--DLKGNFDRIELEEMVQVALLCTQFNPLHRP 567
           A Q  +G+  + V +   EG L    D   D+           + ++  +C Q+NP  RP
Sbjct: 237 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-----------LFELMRMCWQYNPKMRP 285
Query: 568 KMSEVL 573
              E++
Sbjct: 286 SFLEII 291

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 306 KNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLL 361
           ++++G G FG V K       L    A+KR+K+Y        F  E+E +  L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDH--IHGRPALDWARRK----------RIAL 409
            L G C       L   Y P+G++   LR    +   PA   A               A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRG 468
             ARG+ YL ++   + IHRD+ A NIL+ E++ A + DFGL++    ++ +V  T  R 
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE 528
            V  +A E L+    +  +DV+ +G+LL E+++       G          +  +KL Q 
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYEKLPQG 257
Query: 529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL----KMLE 577
            +L + ++ D          +E+  +   C +  P  RP  +++L    +MLE
Sbjct: 258 YRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  G +   L+  + G+  L   +   +A   A G+ Y+        +H
Sbjct: 84  -EEPIYIVMEYMSKGCLLDFLKGEM-GK-YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL T  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 121
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTL 175
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 309 LGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           LG G FG V   C+       G +VAVK LK          ++ E++ +    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 364 CGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
            G C  + E+   LV  Y+P GS    LRD++  R ++  A+    A     G+ YLH Q
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGS----LRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD--HRDSHVTTAVRGTVGHIAPEYLS 479
                IHR++ A N+LLD D    +GDFGLAK +   H    V       V   APE L 
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
             +    +DV+ FG+ L EL+T
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G V   L+         D  R       
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITE 121
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLXGTL 175
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 18  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 77
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 78  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 133
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+
Sbjct: 134 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTL 187
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARGLLYLHEQCDPKI 426
            E    +V  YM  GS    L D + G     L   +   ++   A G+ Y+        
Sbjct: 81  -EEPIYIVTEYMNKGS----LLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 487 TDVFGFGILLLELITGQR 504
           +DV+ FGILL EL T  R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARGLLYLHEQCDPKI 426
            E    +V  YM  GS    L D + G     L   +   ++   A G+ Y+        
Sbjct: 81  -EEPIYIVTEYMNKGS----LLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 487 TDVFGFGILLLELITGQR 504
           +DV+ FGILL EL T  R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    +V  YM  G +   L+  + G+  L   +   +A   A G+ Y+        +H
Sbjct: 84  -EEPIYIVTEYMSKGCLLDFLKGEM-GK-YLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL EL T  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 134/305 (43%), Gaps = 41/305 (13%)
Query: 291 YTFKELRAATSNFSAK---------NILGRGGFGIVYKGCFS----DGALVAVKRLKDYN 337
           +TF++   A   F+ +          ++G G FG V  G           VA+K LK   
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 338 IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP 397
                  F +E   +    H N++ L G  +     +++  +M NGS+ S LR +     
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 398 ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-- 455
            +      R   G A G+ YL    D   +HRD+ A NIL++ +    V DFGL++ L  
Sbjct: 134 VIQLVGMLR---GIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 187
Query: 456 DHRDSHVTTAVRGTVG--HIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAA 512
           D  D   T+A+ G +     APE +   + +  +DV+ +GI++ E+++ G+R   +    
Sbjct: 188 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMT 245
Query: 513 NQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEV 572
           NQ     D +  + Q+ +L   +D              + Q+ L C Q +  HRPK  ++
Sbjct: 246 NQ-----DVINAIEQDYRLPPPMDCP----------SALHQLMLDCWQKDRNHRPKFGQI 290
Query: 573 LKMLE 577
           +  L+
Sbjct: 291 VNTLD 295

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 119
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTL 173
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPP 175
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 18  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 132
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 131/306 (42%), Gaps = 52/306 (16%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEV 343
           Y   E   A    +    LG+G FG+VY+G  + G +       VA+K + +       +
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPAL- 399
           +F  E   +      +++RL G  S     L++   M  G + S LR     +   P L 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 400 --DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
               ++  ++A   A G+ YL+     K +HRD+ A N ++ EDF   +GDFG+      
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT----- 178
Query: 458 RDSHVTTAVRG------TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511
           RD + T   R        V  ++PE L  G  +  +DV+ FG++L E+ T          
Sbjct: 179 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------L 229
Query: 512 ANQ--RGVMLDWVKKLHQEGKLSQMVDK--DLKGNFDRIELEEMVQVALLCTQFNPLHRP 567
           A Q  +G+  + V +   EG L    D   D+           + ++  +C Q+NP  RP
Sbjct: 230 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-----------LFELMRMCWQYNPKMRP 278
Query: 568 KMSEVL 573
              E++
Sbjct: 279 SFLEII 284

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 105/240 (43%), Gaps = 31/240 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           S+     +LG+G FG   K    + G ++ +K L  ++    +  F  EV+ +    H N
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPN 68
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +L+  G    +     +  Y+  G++   ++      P   W++R   A   A G+ YLH
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP---WSQRVSFAKDIASGMAYLH 125
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL-------------LDHRDSHVTTAV 466
                 IIHRD+ + N L+ E+   VV DFGLA+L             L   D      V
Sbjct: 126 SM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG--------QRALDFGRAANQRGVM 518
            G    +APE ++     EK DVF FGI+L E+I           R +DFG   N RG +
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--LNVRGFL 240

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 121
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTL 175
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 131/306 (42%), Gaps = 52/306 (16%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEV 343
           Y   E   A    +    LG+G FG+VY+G  + G +       VA+K + +       +
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPAL- 399
           +F  E   +      +++RL G  S     L++   M  G + S LR     +   P L 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 400 --DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
               ++  ++A   A G+ YL+     K +HRD+ A N ++ EDF   +GDFG+      
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT----- 178
Query: 458 RDSHVTTAVRG------TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511
           RD + T   R        V  ++PE L  G  +  +DV+ FG++L E+ T          
Sbjct: 179 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------L 229
Query: 512 ANQ--RGVMLDWVKKLHQEGKLSQMVDK--DLKGNFDRIELEEMVQVALLCTQFNPLHRP 567
           A Q  +G+  + V +   EG L    D   D+           + ++  +C Q+NP  RP
Sbjct: 230 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-----------LFELMRMCWQYNPKMRP 278
Query: 568 KMSEVL 573
              E++
Sbjct: 279 SFLEII 284

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 21  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H      +D  +  +      +G+ YL  
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAE---RIDHIKLLQYTSQICKGMEYLGT 135
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 136 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL- 361
           LG+G FG V + C  D      GALVAVK+L+ ++    +  FQ E++ +  A+H + + 
Sbjct: 15  LGKGNFGSV-ELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILK-ALHSDFIV 71
Query: 362 --RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
             R   +     E  LV  Y+P+G +   L+ H   R  LD +R    +    +G+ YL 
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLG 128
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL--LDHRDSHVTTAVRGTVGHIAPEY 477
            +   + +HRD+ A NIL++ +    + DFGLAKL  LD     V    +  +   APE 
Sbjct: 129 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES 185
Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           LS    S ++DV+ FG++L EL T
Sbjct: 186 LSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 120
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ P
Sbjct: 121 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPP 174
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 117
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTL 171
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 121
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTL 175
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 116
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTL 170
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 32/291 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
           KEL A  +N S   ++G G FG V  G           VA+K LK          F  E 
Sbjct: 11  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    H N++RL G  +     ++V   M NGS+ S LR H      +      R   
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR--- 125
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVR 467
           G A G+ YL    D   +HRD+ A NIL++ +    V DFGL+++L  D   ++ T   +
Sbjct: 126 GIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH 526
             +   +PE ++  + +  +DV+ +GI+L E+++ G+R   +   +NQ     D +K + 
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ-----DVIKAVD 235
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +L   +D              + Q+ L C Q +  +RPK  +++ +L+
Sbjct: 236 EGYRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 276

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 132/302 (43%), Gaps = 44/302 (14%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEV 343
           Y   E   A    +    LG+G FG+VY+G  + G +       VA+K + +       +
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPAL- 399
           +F  E   +      +++RL G  S     L++   M  G + S LR     +   P L 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 400 --DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
               ++  ++A   A G+ YL+     K +HRD+ A N ++ EDF   +GDFG+ + +  
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 184
Query: 458 RDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ- 514
            D +     +G   V  ++PE L  G  +  +DV+ FG++L E+ T          A Q 
Sbjct: 185 TD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP 234
Query: 515 -RGVMLDWVKKLHQEGKLSQMVDK--DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSE 571
            +G+  + V +   EG L    D   D+           + ++  +C Q+NP  RP   E
Sbjct: 235 YQGLSNEQVLRFVMEGGLLDKPDNCPDM-----------LFELMRMCWQYNPKMRPSFLE 283
Query: 572 VL 573
           ++
Sbjct: 284 II 285

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 21  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  ++P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 135
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHRD+   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 136 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 305 AKNILGRGGFGIVYKGCFSDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           +  ++G+G FG+VY G + D A      A+K L           F  E   +    H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 361 LRLCG-FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG--TARGLLY 417
           L L G     E    ++ PYM +G +   +R      P  +   +  I+ G   ARG+ Y
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-----PQRNPTVKDLISFGLQVARGMEY 139
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT---VGHIA 474
           L EQ   K +HRD+ A N +LDE F   V DFGLA+ +  R+ +     R     V   A
Sbjct: 140 LAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT 501
            E L T + + K+DV+ FG+LL EL+T
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 141/315 (44%), Gaps = 36/315 (11%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS----DG 325
           + F D +   DP  ++        KEL A  +N S   ++G G FG V  G         
Sbjct: 20  RTFVDPHTFEDPTQTVHEFA----KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
             VA+K LK          F  E   +    H N++RL G  +     ++V   M NGS+
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 133
Query: 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445
            S LR H      +      R   G A G+ YL    D   +HRD+ A NIL++ +    
Sbjct: 134 DSFLRKHDAQFTVIQLVGMLR---GIASGMKYL---SDMGAVHRDLAARNILINSNLVCK 187
Query: 446 VGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-G 502
           V DFGL+++L  D   ++ T   +  +   +PE ++  + +  +DV+ +GI+L E+++ G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
           +R   +   +NQ     D +K + +  +L   +D              + Q+ L C Q +
Sbjct: 248 ERP--YWEMSNQ-----DVIKAVDEGYRLPPPMDCP----------AALYQLMLDCWQKD 290
Query: 563 PLHRPKMSEVLKMLE 577
             +RPK  +++ +L+
Sbjct: 291 RNNRPKFEQIVSILD 305

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTELCGTLDYLPP 175
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 125
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ P
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPP 179
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 132/309 (42%), Gaps = 58/309 (18%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEV 343
           Y   E   A    +    LG+G FG+VY+G  + G +       VA+K + +       +
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---- 399
           +F  E   +      +++RL G  S     L++   M  G + S LR     RPA+    
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL---RPAMANNP 130
Query: 400 -----DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454
                  ++  ++A   A G+ YL+     K +HRD+ A N ++ EDF   +GDFG+   
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-- 185
Query: 455 LDHRDSHVTTAVRG------TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508
              RD + T   R        V  ++PE L  G  +  +DV+ FG++L E+ T       
Sbjct: 186 ---RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------- 235
Query: 509 GRAANQ--RGVMLDWVKKLHQEGKLSQMVDK--DLKGNFDRIELEEMVQVALLCTQFNPL 564
              A Q  +G+  + V +   EG L    D   D+           + ++  +C Q+NP 
Sbjct: 236 --LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-----------LFELMRMCWQYNPK 282
Query: 565 HRPKMSEVL 573
            RP   E++
Sbjct: 283 MRPSFLEII 291

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 32/291 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
           KEL A  +N S   ++G G FG V  G           VA+K LK          F  E 
Sbjct: 40  KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    H N++RL G  +     ++V   M NGS+ S LR H      +      R   
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR--- 154
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVR 467
           G A G+ YL    D   +HRD+ A NIL++ +    V DFGL+++L  D   ++ T   +
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH 526
             +   +PE ++  + +  +DV+ +GI+L E+++ G+R   +   +NQ     D +K + 
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ-----DVIKAVD 264
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +L   +D              + Q+ L C Q +  +RPK  +++ +L+
Sbjct: 265 EGYRLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 131/302 (43%), Gaps = 44/302 (14%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEV 343
           Y   E   A    +    LG+G FG+VY+G  + G +       VA+K + +       +
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPAL- 399
           +F  E   +      +++RL G  S     L++   M  G + S LR     +   P L 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 400 --DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
               ++  ++A   A G+ YL+     K +HRD+ A N ++ EDF   +GDFG+ + +  
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 458 RDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ- 514
            D       +G   V  ++PE L  G  +  +DV+ FG++L E+ T          A Q 
Sbjct: 185 TDXXRKGG-KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP 234
Query: 515 -RGVMLDWVKKLHQEGKLSQMVDK--DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSE 571
            +G+  + V +   EG L    D   D+           + ++  +C Q+NP  RP   E
Sbjct: 235 YQGLSNEQVLRFVMEGGLLDKPDNCPDM-----------LFELMRMCWQYNPKMRPSFLE 283
Query: 572 VL 573
           ++
Sbjct: 284 II 285

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTXLCGTLDYLPP 175
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 124
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S    A+ GT+ ++ P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPP 178
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S    A+ GT+ ++ P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPP 175
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPP 175
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 130/304 (42%), Gaps = 48/304 (15%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEV 343
           Y   E   A    +    LG+G FG+VY+G  + G +       VA+K + +       +
Sbjct: 2   YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPAL- 399
           +F  E   +      +++RL G  S     L++   M  G + S LR     +   P L 
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 400 --DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
               ++  ++A   A G+ YL+     K +HRD+ A N  + EDF   +GDFG+      
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMT----- 172
Query: 458 RDSHVTTAVRG------TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511
           RD + T   R        V  ++PE L  G  +  +DV+ FG++L E+ T          
Sbjct: 173 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------L 223
Query: 512 ANQ--RGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKM 569
           A Q  +G+  + V +   EG L    D     N   + LE M     +C Q+NP  RP  
Sbjct: 224 AEQPYQGLSNEQVLRFVMEGGLLDKPD-----NCPDMLLELM----RMCWQYNPKMRPSF 274
Query: 570 SEVL 573
            E++
Sbjct: 275 LEII 278

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 133/305 (43%), Gaps = 50/305 (16%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEV 343
           Y   E   A    +    LG+G FG+VY+G  + G +       VA+K + +       +
Sbjct: 5   YVPDEWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---- 399
           +F  E   +      +++RL G  S     L++   M  G + S LR     RPA+    
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL---RPAMANNP 120
Query: 400 -----DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454
                  ++  ++A   A G+ YL+     K +HRD+ A N ++ EDF   +GDFG+ + 
Sbjct: 121 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 177
Query: 455 LDHRDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAA 512
           +   D +     +G   V  ++PE L  G  +  +DV+ FG++L E+ T          A
Sbjct: 178 IYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LA 227
Query: 513 NQ--RGVMLDWVKKLHQEGKLSQMVDK--DLKGNFDRIELEEMVQVALLCTQFNPLHRPK 568
            Q  +G+  + V +   EG L    D   D+           + ++  +C Q+NP  RP 
Sbjct: 228 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM-----------LFELMRMCWQYNPKMRPS 276
Query: 569 MSEVL 573
             E++
Sbjct: 277 FLEII 281

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 307 NILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
            +LG G FG VYKG +  +G  V    A+K L +       V+F  E   ++   H +L+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTARGLLYL 418
           RL G C +   +L V   MP+G +   + +H   I  +  L+W       +  A+G++YL
Sbjct: 104 RLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWC------VQIAKGMMYL 156
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-AVRGTVGHIAPEY 477
            E+   +++HRD+ A N+L+       + DFGLA+LL+  +        +  +  +A E 
Sbjct: 157 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           +   + + ++DV+ +G+ + EL+T
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 307 NILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
            +LG G FG VYKG +  +G  V    A+K L +       V+F  E   ++   H +L+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTARGLLYL 418
           RL G C +   +L V   MP+G +   + +H   I  +  L+W       +  A+G++YL
Sbjct: 81  RLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWC------VQIAKGMMYL 133
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-AVRGTVGHIAPEY 477
            E+   +++HRD+ A N+L+       + DFGLA+LL+  +        +  +  +A E 
Sbjct: 134 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           +   + + ++DV+ +G+ + EL+T
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 130/296 (43%), Gaps = 40/296 (13%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEVQFQT 347
           E   A    +    LG+G FG+VY+G  + G +       VA+K + +       ++F  
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPAL---DW 401
           E   +      +++RL G  S     L++   M  G + S LR     +   P L     
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
           ++  ++A   A G+ YL+     K +HRD+ A N ++ EDF   +GDFG+ + +   D  
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 462 VTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ--RGV 517
                +G   V  ++PE L  G  +  +DV+ FG++L E+ T          A Q  +G+
Sbjct: 180 RKGG-KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQPYQGL 229
Query: 518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
             + V +   EG L      D   N   + LE M     +C Q+NP  RP   E++
Sbjct: 230 SNEQVLRFVMEGGLL-----DKPDNCPDMLLELM----RMCWQYNPKMRPSFLEII 276

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 118
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ P
Sbjct: 119 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPP 172
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 130/302 (43%), Gaps = 52/302 (17%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEVQFQT 347
           E   A    +    LG+G FG+VY+G  + G +       VA+K + +       ++F  
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLN 68
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPAL---DW 401
           E   +      +++RL G  S     L++   M  G + S LR     +   P L     
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
           ++  ++A   A G+ YL+     K +HRD+ A N ++ EDF   +GDFG+      RD +
Sbjct: 129 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-----RDIY 180
Query: 462 VTTAVRG------TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ- 514
            T   R        V  ++PE L  G  +  +DV+ FG++L E+ T          A Q 
Sbjct: 181 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP 231
Query: 515 -RGVMLDWVKKLHQEGKLSQMVDK--DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSE 571
            +G+  + V +   EG L    D   D+           + ++  +C Q+NP  RP   E
Sbjct: 232 YQGLSNEQVLRFVMEGGLLDKPDNCPDM-----------LFELMRMCWQYNPKMRPSFLE 280
Query: 572 VL 573
           ++
Sbjct: 281 II 282

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 131/298 (43%), Gaps = 44/298 (14%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEVQFQT 347
           E   A    +    LG+G FG+VY+G  + G +       VA+K + +       ++F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPAL---DW 401
           E   +      +++RL G  S     L++   M  G + S LR     +   P L     
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
           ++  ++A   A G+ YL+     K +HRD+ A N ++ EDF   +GDFG+ + +   D +
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-Y 180
Query: 462 VTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ--RGV 517
                +G   V  ++PE L  G  +  +DV+ FG++L E+ T          A Q  +G+
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQPYQGL 231
Query: 518 MLDWVKKLHQEGKLSQMVDK--DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
             + V +   EG L    D   D+           + ++  +C Q+NP  RP   E++
Sbjct: 232 SNEQVLRFVMEGGLLDKPDNCPDM-----------LFELMRMCWQYNPKMRPSFLEII 278

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G FG V + C  D      G +VAVK+L+ ++       F+ E+E +    H N+++
Sbjct: 19  LGKGNFGSV-EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+ YL  
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 133
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + IHR++   NIL++ +    +GDFGL K+L  D     V       +   APE L
Sbjct: 134 K---RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
           +  + S  +DV+ FG++L EL T
Sbjct: 191 TESKFSVASDVWSFGVVLYELFT 213

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 118
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + +FG +    H  S   T + GT+
Sbjct: 119 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTTLCGTL 172
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 119
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + +FG +    H  S   T + GT+
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTTLCGTL 173
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLAVHR 358
           +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S   H 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N+LRL G+        L+  Y P G+V   L+         D  R        A  L Y 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELANALSYC 128
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           H +   ++IHRD+K  N+LL  + E  + DFG +    H  S   T + GT+ ++ PE +
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMI 182
Query: 479 STGQSSEKTDVFGFGILLLELITG 502
                 EK D++  G+L  E + G
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 131/293 (44%), Gaps = 43/293 (14%)
Query: 306 KNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLL 361
           ++++G G FG V K       L    A+KR+K+Y        F  E+E +  L  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDH--IHGRPALDWARRK----------RIAL 409
            L G C       L   Y P+G++   LR    +   PA   A               A 
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRG 468
             ARG+ YL ++   + IHR++ A NIL+ E++ A + DFGL++    ++ +V  T  R 
Sbjct: 147 DVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 200
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE 528
            V  +A E L+    +  +DV+ +G+LL E+++       G          +  +KL Q 
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYEKLPQG 254
Query: 529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL----KMLE 577
            +L + ++ D          +E+  +   C +  P  RP  +++L    +MLE
Sbjct: 255 YRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 297

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 117
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDTLCGTL 171
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 118
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+
Sbjct: 119 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTL 172
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
           LG G FG+V +G +         VAVK LK   ++  E    F  EV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L G   T   ++ V    P GS+  RLR H  G   L      R A+  A G+ YL  + 
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKH-QGHFLL--GTLSRYAVQVAEGMGYLESK- 134
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV--GHIAPEYLST 480
             + IHRD+ A N+LL       +GDFGL + L   D H        V     APE L T
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 481 GQSSEKTDVFGFGILLLELIT 501
              S  +D + FG+ L E+ T
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 119
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTL 173
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K+ + A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             S   H N+LRL G+        L+  Y P G+V   L+         D  R       
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 142
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            A  L Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+
Sbjct: 143 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTL 196
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            ++ PE +      EK D++  G+L  E + G+
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
           LG G FG+V +G +         VAVK LK   ++  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L G   T   ++ V    P GS+  RLR H  G   L      R A+  A G+ YL  + 
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKH-QGHFLL--GTLSRYAVQVAEGMGYLESK- 130
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV--GHIAPEYLST 480
             + IHRD+ A N+LL       +GDFGL + L   D H        V     APE L T
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 481 GQSSEKTDVFGFGILLLELIT 501
              S  +D + FG+ L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
           LG G FG+V +G +         VAVK LK   ++  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L G   T   ++ V    P GS+  RLR H  G   L      R A+  A G+ YL  + 
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKH-QGHFLL--GTLSRYAVQVAEGMGYLESK- 130
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV--GHIAPEYLST 480
             + IHRD+ A N+LL       +GDFGL + L   D H        V     APE L T
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 481 GQSSEKTDVFGFGILLLELIT 501
              S  +D + FG+ L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
           LG G FG+V +G +         VAVK LK   ++  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L G   T   ++ V    P GS+  RLR H  G   L      R A+  A G+ YL  + 
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKH-QGHFLL--GTLSRYAVQVAEGMGYLESK- 130
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV--GHIAPEYLST 480
             + IHRD+ A N+LL       +GDFGL + L   D H        V     APE L T
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 481 GQSSEKTDVFGFGILLLELIT 501
              S  +D + FG+ L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 309 LGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           LG G FG V   C+       G +VAVK LK          ++ E++ +    H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 364 CGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
            G C         LV  Y+P GS    LRD++  R ++  A+    A     G+ YLH Q
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGS----LRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLS 479
                IHRD+ A N+LLD D    +GDFGLAK +   H    V       V   APE L 
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
             +    +DV+ FG+ L EL+T
Sbjct: 211 EYKFYYASDVWSFGVTLYELLT 232

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 20/204 (9%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL- 361
           LG+G FG V + C  D      GALVAVK+L+ ++    +  FQ E++ +  A+H + + 
Sbjct: 18  LGKGNFGSV-ELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILK-ALHSDFIV 74
Query: 362 --RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
             R   +        LV  Y+P+G +   L+ H   R  LD +R    +    +G+ YL 
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLG 131
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-HRDSHVTTAV-RGTVGHIAPEY 477
            +   + +HRD+ A NIL++ +    + DFGLAKLL   +D +V     +  +   APE 
Sbjct: 132 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           LS    S ++DV+ FG++L EL T
Sbjct: 189 LSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
           LG G FG+V +G +         VAVK LK   ++  E    F  EV  +    HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L G   T   ++ V    P GS+  RLR H  G   L      R A+  A G+ YL  + 
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKH-QGHFLL--GTLSRYAVQVAEGMGYLESK- 140
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV--GHIAPEYLST 480
             + IHRD+ A N+LL       +GDFGL + L   D H        V     APE L T
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 481 GQSSEKTDVFGFGILLLELIT 501
              S  +D + FG+ L E+ T
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLK-DYNIAGGEVQF-QTEVET 351
           +++    +F    +LG+G FG V+   F       A+K LK D  +   +V+    E   
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 352 ISLAVHRNLL--RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
           +SLA     L    C F + EN    V  Y+  G +      HI      D +R    A 
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMY----HIQSCHKFDLSRATFYAA 126
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
               GL +LH +    I++RD+K  NILLD+D    + DFG+ K     D+  T    GT
Sbjct: 127 EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNEFCGT 182
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
             +IAPE L   + +   D + FG+LL E++ GQ
Sbjct: 183 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
           LG G FG+V +G +         VAVK LK   ++  E    F  EV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L G   T   ++ V    P GS+  RLR H  G   L      R A+  A G+ YL  + 
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKH-QGHFLL--GTLSRYAVQVAEGMGYLESK- 134
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV--GHIAPEYLST 480
             + IHRD+ A N+LL       +GDFGL + L   D H        V     APE L T
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 481 GQSSEKTDVFGFGILLLELIT 501
              S  +D + FG+ L E+ T
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 108/237 (45%), Gaps = 42/237 (17%)
Query: 287 HLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFS-----DGALVAVKRLKDYNIAG 340
           H+KR+          N   K  LG G FG V+   C++     D  LVAVK LKD +   
Sbjct: 9   HIKRH----------NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DN 57
Query: 341 GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH-------I 393
               F  E E ++   H ++++  G C   +  ++V+ YM +G +   LR H        
Sbjct: 58  ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA 117
Query: 394 HGRPALDWARRK--RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451
            G P  +  + +   IA   A G++YL  Q     +HRD+   N L+ E+    +GDFG+
Sbjct: 118 EGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGM 174
Query: 452 AKLLDHRDSHVTTAVRGTVGH-------IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           +     RD + T   R   GH       + PE +   + + ++DV+  G++L E+ T
Sbjct: 175 S-----RDVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLR 362
           LG G FG+V +G +         VAVK LK   ++  E    F  EV  +    HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L G   T   ++ V    P GS+  RLR H  G   L      R A+  A G+ YL  + 
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKH-QGHFLL--GTLSRYAVQVAEGMGYLESK- 140
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV--GHIAPEYLST 480
             + IHRD+ A N+LL       +GDFGL + L   D H        V     APE L T
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 481 GQSSEKTDVFGFGILLLELIT 501
              S  +D + FG+ L E+ T
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 20/204 (9%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL- 361
           LG+G FG V + C  D      GALVAVK+L+ ++    +  FQ E++ +  A+H + + 
Sbjct: 31  LGKGNFGSV-ELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILK-ALHSDFIV 87
Query: 362 --RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
             R   +        LV  Y+P+G +   L+ H   R  LD +R    +    +G+ YL 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLG 144
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-HRDSHVTTAV-RGTVGHIAPEY 477
            +   + +HRD+ A NIL++ +    + DFGLAKLL   +D +V     +  +   APE 
Sbjct: 145 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           LS    S ++DV+ FG++L EL T
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 20/204 (9%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL- 361
           LG+G FG V + C  D      GALVAVK+L+ ++    +  FQ E++ +  A+H + + 
Sbjct: 19  LGKGNFGSV-ELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILK-ALHSDFIV 75
Query: 362 --RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
             R   +        LV  Y+P+G +   L+ H   R  LD +R    +    +G+ YL 
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLG 132
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-HRDSHVTTAV-RGTVGHIAPEY 477
            +   + +HRD+ A NIL++ +    + DFGLAKLL   +D +V     +  +   APE 
Sbjct: 133 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 189
Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           LS    S ++DV+ FG++L EL T
Sbjct: 190 LSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 121
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+ ++ P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLDYLPP 175
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 13/208 (6%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLA 355
           A  +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N+LRL G+        L+  Y P G+V   L+         D  R        A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 124
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            Y H +   ++IHRD+K  N+LL    E  + DFG +    H  S     + GT+ ++ P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDYLPP 178
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +      EK D++  G+L  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLK-DYNIAGGEVQF-QTEVET 351
           +++    +F    +LG+G FG V+   F       A+K LK D  +   +V+    E   
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 352 ISLAVHRNLL--RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
           +SLA     L    C F + EN    V  Y+  G +      HI      D +R    A 
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMY----HIQSCHKFDLSRATFYAA 125
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
               GL +LH +    I++RD+K  NILLD+D    + DFG+ K     D+  T    GT
Sbjct: 126 EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGT 181
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
             +IAPE L   + +   D + FG+LL E++ GQ
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G+G FG V  G +  G  VAVK +K+   A     F  E   ++   H NL++L G   
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 256
Query: 369 TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
            E   L +V  YM  GS+   LR    GR  L      + +L     + YL        +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 311
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+ A N+L+ ED  A V DFGL K            V+ T    APE L   + S K+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 367
Query: 488 DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           DV+ FGILL E+ +      FGR    R  + D V ++ +  K+
Sbjct: 368 DVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKM 405

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+   ++    VAVK +K  +++     F  E   +    H  L++L    +
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    ++  +M  GS+   L+     +  L   +    +   A G+ ++ ++     IH
Sbjct: 81  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 134
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+       + DFGLA++++  +       +  +   APE ++ G  + K+D
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 194
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL+E++T  R
Sbjct: 195 VWSFGILLMEIVTYGR 210

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G+G FG V  G +  G  VAVK +K+   A     F  E   ++   H NL++L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 369 TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
            E   L +V  YM  GS+   LR    GR  L      + +L     + YL        +
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 124
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+ A N+L+ ED  A V DFGL K            V+ T    APE L   + S K+
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 180
Query: 488 DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           DV+ FGILL E+ +      FGR    R  + D V ++ +  K+
Sbjct: 181 DVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKM 218

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G+G FG V  G +  G  VAVK +K+   A     F  E   ++   H NL++L G   
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 369 TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
            E   L +V  YM  GS+   LR    GR  L      + +L     + YL        +
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 139
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+ A N+L+ ED  A V DFGL K            V+ T    APE L   + S K+
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 195
Query: 488 DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           DV+ FGILL E+ +      FGR    R  + D V ++ +  K+
Sbjct: 196 DVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKM 233

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLAVHR 358
           +F     LG+G FG VY         + A+K L    +  AG E Q + EVE  S   H 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N+LRL G+        L+  Y P G+V   L+         D  R        A  L Y 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELANALSYC 128
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           H +   ++IHRD+K  N+LL  + E  + DFG +    H  S     + GT+ ++ PE +
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRDTLCGTLDYLPPEMI 182
Query: 479 STGQSSEKTDVFGFGILLLELITG 502
                 EK D++  G+L  E + G
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G+G FG V  G +  G  VAVK +K+   A     F  E   ++   H NL++L G   
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 369 TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
            E   L +V  YM  GS+   LR    GR  L      + +L     + YL        +
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 130
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+ A N+L+ ED  A V DFGL K            V+ T    APE L     S K+
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREAAFSTKS 186
Query: 488 DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           DV+ FGILL E+ +      FGR    R  + D V ++ +  K+
Sbjct: 187 DVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKM 224

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 306 KNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           + ++G G FG V  G           VA+K LK          F +E   +    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
            L G  +     +++  +M NGS+ S LR +      +      R   G A G+ YL   
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL--- 125
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVG--HIAPEY 477
            D   +HR + A NIL++ +    V DFGL++ L  D  D   T+A+ G +     APE 
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 478 LSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD 536
           +   + +  +DV+ +GI++ E+++ G+R   +    NQ     D +  + Q+ +L   +D
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTNQ-----DVINAIEQDYRLPPPMD 238
Query: 537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                         + Q+ L C Q +  HRPK  +++  L+
Sbjct: 239 CP----------SALHQLMLDCWQKDRNHRPKFGQIVNTLD 269

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 25/285 (8%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           ++  + ++G G   +V    C      VA+KR+          +   E++ +S   H N+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHI-----HGRPALDWARRKRIALGTARGL 415
           +        ++E  LV   +  GSV   ++ HI     H    LD +    I      GL
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL----DHRDSHVTTAVRGTVG 471
            YLH+      IHRDVKA NILL ED    + DFG++  L    D   + V     GT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 472 HIAPEYLSTGQSSE-KTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK 530
            +APE +   +  + K D++ FGI  +EL TG  A  + +    + +ML      +    
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTL---QNDPPS 241
Query: 531 LSQMV-DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
           L   V DK++   + +    +M+    LC Q +P  RP  +E+L+
Sbjct: 242 LETGVQDKEMLKKYGK-SFRKMIS---LCLQKDPEKRPTAAELLR 282

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+   ++    VAVK +K  +++     F  E   +    H  L++L    +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    ++  +M  GS+   L+     +  L   +    +   A G+ ++ ++     IH
Sbjct: 254 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+       + DFGLA++++  +       +  +   APE ++ G  + K+D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL+E++T  R
Sbjct: 368 VWSFGILLMEIVTYGR 383

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-KRI--------- 407
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++    R+         
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 408 ----ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV- 462
                   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN 215
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K   +    VAVK LK            +E+E + +   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARRKR----------- 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P L+++               
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGN----LREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 407 ---IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
               A   ARG+ YL  +   K IHRD+ A N+L+ ED    + DFGLA+ + H D +  
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+LL E+ T
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-----------KR 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++             K 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 407 IALGT---ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
           +   T   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNIA--GGEVQFQTEVETISLAVHR 358
           +F     LG+G FG VY         + A+K L    +   G E Q + E+E  S   H 
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N+LR+  +        L+  + P G +   L+ H  GR   D  R        A  L Y 
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GR--FDEQRSATFMEELADALHYC 131
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           HE+   K+IHRD+K  N+L+    E  + DFG +    H  S     + GT+ ++ PE +
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDYLPPEMI 185
Query: 479 STGQSSEKTDVFGFGILLLELITGQRALD 507
                 EK D++  G+L  E + G    D
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/312 (24%), Positives = 140/312 (44%), Gaps = 39/312 (12%)
Query: 282 EVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKD 335
           EV   H ++   K +R           LG G FG V + C  D      G  VAVK LK 
Sbjct: 12  EVDPTHFEKRFLKRIRD----------LGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKP 60
Query: 336 YNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLVYPYMPNGSVASRLRDHI 393
            +        + E+E +    H N+++  G C+ +  N   L+  ++P+GS+   L  + 
Sbjct: 61  ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN- 119
Query: 394 HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
             +  ++  ++ + A+   +G+ YL  +   + +HRD+ A N+L++ + +  +GDFGL K
Sbjct: 120 --KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174
Query: 454 LL--DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511
            +  D     V       V   APE L   +    +DV+ FG+ L EL+T   +      
Sbjct: 175 AIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS-----D 229
Query: 512 ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHR 566
           ++   + L  +   H +  ++++V+   +G   R+       +E+ Q+   C +F P +R
Sbjct: 230 SSPMALFLKMIGPTHGQMTVTRLVNTLKEGK--RLPCPPNCPDEVYQLMRKCWEFQPSNR 287
Query: 567 PKMSEVLKMLEG 578
                +++  E 
Sbjct: 288 TSFQNLIEGFEA 299

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K   +    VAVK LK            +E+E + +   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARRKR----------- 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P L+++               
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGN----LREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 407 ---IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
               A   ARG+ YL  +   K IHRD+ A N+L+ ED    + DFGLA+ + H D +  
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+LL E+ T
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K   +    VAVK LK            +E+E + +   H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARRKR----------- 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P L+++               
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGN----LREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 407 ---IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
               A   ARG+ YL  +   K IHRD+ A N+L+ ED    + DFGLA+ + H D +  
Sbjct: 145 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+LL E+ T
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 25/285 (8%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           ++  + ++G G   +V    C      VA+KR+          +   E++ +S   H N+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHI-----HGRPALDWARRKRIALGTARGL 415
           +        ++E  LV   +  GSV   ++ HI     H    LD +    I      GL
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL----DHRDSHVTTAVRGTVG 471
            YLH+      IHRDVKA NILL ED    + DFG++  L    D   + V     GT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 472 HIAPEYLSTGQSSE-KTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK 530
            +APE +   +  + K D++ FGI  +EL TG  A  + +    + +ML      +    
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTL---QNDPPS 246
Query: 531 LSQMV-DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
           L   V DK++   + +    +M+    LC Q +P  RP  +E+L+
Sbjct: 247 LETGVQDKEMLKKYGK-SFRKMIS---LCLQKDPEKRPTAAELLR 287

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K   +    VAVK LK            +E+E + +   H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARRKR----------- 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P L+++               
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGN----LREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 407 ---IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
               A   ARG+ YL  +   K IHRD+ A N+L+ ED    + DFGLA+ + H D +  
Sbjct: 193 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+LL E+ T
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNIA--GGEVQFQTEVETISLAVHR 358
           +F     LG+G FG VY         + A+K L    +   G E Q + E+E  S   H 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N+LR+  +        L+  + P G +   L+ H  GR   D  R        A  L Y 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GR--FDEQRSATFMEELADALHYC 130
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           HE+   K+IHRD+K  N+L+    E  + DFG +    H  S     + GT+ ++ PE +
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDYLPPEMI 184
Query: 479 STGQSSEKTDVFGFGILLLELITGQRALD 507
                 EK D++  G+L  E + G    D
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K   +    VAVK LK            +E+E + +   H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARRKR----------- 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P L+++               
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGN----LREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 407 ---IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
               A   ARG+ YL  +   K IHRD+ A N+L+ ED    + DFGLA+ + H D +  
Sbjct: 141 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+LL E+ T
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 88/331 (26%), Positives = 147/331 (44%), Gaps = 62/331 (18%)
Query: 280 DPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLK 334
           DP      +    FKE     +      +LG G FG V+KG +     S    V +K ++
Sbjct: 15  DPSEKANKVLARIFKE-----TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE 69
Query: 335 DYNIAGGEVQFQTEVETISLAV----HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
           D +   G   FQ   + + LA+    H +++RL G C   + +L V  Y+P GS+   +R
Sbjct: 70  DKS---GRQSFQAVTDHM-LAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVR 124
Query: 391 DHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450
            H   R AL         +  A+G+ YL E     ++HR++ A N+LL    +  V DFG
Sbjct: 125 QH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFG 178
Query: 451 LAKLLDHRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509
           +A LL   D  +  +  +  +  +A E +  G+ + ++DV+ +G+ + EL+T      FG
Sbjct: 179 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT------FG 232
Query: 510 RAANQRGVMLDWVKKLHQEG-KLSQ----------------MVDKDLKGNFDRIELEEMV 552
            A    G+ L  V  L ++G +L+Q                M+D++++  F         
Sbjct: 233 -AEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKE------- 284
Query: 553 QVALLCTQFNPLHR-PKMSEVLKMLEGDGLA 582
               L  +F  + R P    V+K   G G+A
Sbjct: 285 ----LANEFTRMARDPPRYLVIKRESGPGIA 311

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K   +    VAVK LK            +E+E + +   H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARRKR----------- 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P L+++               
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGN----LREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 407 ---IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
               A   ARG+ YL  +   K IHRD+ A N+L+ ED    + DFGLA+ + H D +  
Sbjct: 144 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+LL E+ T
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-----------KR 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++             K 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 407 IALGT---ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
           +   T   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-KRI--------- 407
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++    R+         
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 408 ----ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
                   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK 215
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K   +    VAVK LK            +E+E + +   H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARRKR----------- 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P L++                
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGN----LREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 407 ---IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
               A   ARG+ YL  +   K IHRD+ A N+L+ ED    + DFGLA+ + H D +  
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+LL E+ T
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-----------KR 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++             K 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 407 IALGT---ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
           +   T   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-----------KR 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++             K 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 407 IALGT---ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
           +   T   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-----------KR 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++             K 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 407 IALGT---ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHV 462
           +   T   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D    
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K   +    VAVK LK            +E+E + +   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARRKR----------- 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P L++                
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGN----LREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 407 ---IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
               A   ARG+ YL  +   K IHRD+ A N+L+ ED    + DFGLA+ + H D +  
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+LL E+ T
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 140/304 (46%), Gaps = 57/304 (18%)
Query: 307 NILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV----H 357
            +LG G FG V+KG +     S    V +K ++D +   G   FQ   + + LA+    H
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHM-LAIGSLDH 74
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            +++RL G C   + +L V  Y+P GS+   +R H   R AL         +  A+G+ Y
Sbjct: 75  AHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYY 130
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-TAVRGTVGHIAPE 476
           L E     ++HR++ A N+LL    +  V DFG+A LL   D  +  +  +  +  +A E
Sbjct: 131 LEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG-KLSQ-- 533
            +  G+ + ++DV+ +G+ + EL+T      FG A    G+ L  V  L ++G +L+Q  
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMT------FG-AEPYAGLRLAEVPDLLEKGERLAQPQ 240
Query: 534 --------------MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHR-PKMSEVLKMLEG 578
                         M+D++++  F             L  +F  + R P    V+K   G
Sbjct: 241 ICTIDVYMVMVKCWMIDENIRPTFKE-----------LANEFTRMARDPPRYLVIKRESG 289
Query: 579 DGLA 582
            G+A
Sbjct: 290 PGIA 293

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
           +++S F     LG G +  VYKG   + G  VA+K +K  +  G       E+  +    
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP------ALDWARRKRIALG 410
           H N++RL     TEN+  LV+ +M N      L+ ++  R        L+    K     
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDND-----LKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
             +GL + HE    KI+HRD+K  N+L+++  +  +GDFGLA+      +  ++ V  T+
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TL 172
Query: 471 GHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
            + AP+ L   ++ S   D++  G +L E+ITG+
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-----------KR 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++             K 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 407 IALGT---ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
           +   T   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 37/226 (16%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTE--VETISLAVHRN 359
           N     ++GRG +G VYKG   D   VAVK     N       F  E  +  + L  H N
Sbjct: 14  NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDN 68
Query: 360 LLRLCG-----FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           + R              E LLV  Y PNGS+   L  H       DW    R+A    RG
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRG 123
Query: 415 LLYLH------EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHR------DSH 461
           L YLH      +   P I HRD+ + N+L+  D   V+ DFGL+ +L  +R      + +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 462 VTTAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGILLLELI 500
              +  GT+ ++APE L           + ++ D++  G++  E+ 
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 96/215 (44%), Gaps = 12/215 (5%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLK-DYNIAGGEVQF-QTEVETIS 353
           R    NF    +LG+G FG V      + G L AVK LK D  +   +V+   TE   +S
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
           LA +   L     C    +RL       NG     L  HI      D AR +  A     
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGH 472
            L++LH   D  II+RD+K  N+LLD +    + DFG+ K  +   + VTTA   GT  +
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDY 190
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
           IAPE L         D +  G+LL E++ G    +
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 127/270 (47%), Gaps = 33/270 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 85  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 137
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 138 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 193
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEG 529
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q  
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQPP 252
Query: 530 ----------KLSQMVDKDLKGNFDRIELE 549
                     +   M+D D +  F  + +E
Sbjct: 253 ICTIDVYMIMRKCWMIDADSRPKFRELIIE 282

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-----------KR 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++             K 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 407 IALGT---ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
           +   T   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  
Sbjct: 146 LVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK 202
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 132/285 (46%), Gaps = 29/285 (10%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG V + C  D      G  VAVK LK  +        + E+E +    H N+++
Sbjct: 17  LGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 363 LCGFCSTE--NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             G C+ +  N   L+  ++P+GS+   L  +   +  ++  ++ + A+   +G+ YL  
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS 132
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
           +   + +HRD+ A N+L++ + +  +GDFGL K +  D     V       V   APE L
Sbjct: 133 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
              +    +DV+ FG+ L EL+T   +      ++   + L  +   H +  ++++V+  
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLTYCDS-----DSSPMALFLKMIGPTHGQMTVTRLVNTL 244
Query: 539 LKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLEG 578
            +G   R+       +E+ Q+   C +F P +R     +++  E 
Sbjct: 245 KEGK--RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 287

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 118/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L++   MP G +   +R+H   I  +  L+W       +  A
Sbjct: 79  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 131
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 132 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 187
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 244

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 118/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L++   MP G +   +R+H   I  +  L+W       +  A
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 128
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 129 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 184
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-----------KR 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++             K 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 407 IALGT---ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
           +   T   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  
Sbjct: 148 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 204
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 118/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L++   MP G +   +R+H   I  +  L+W       +  A
Sbjct: 75  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 183
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 240

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-----------KR 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++             K 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 407 IALGT---ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
           +   T   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARR-----------KR 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P ++++             K 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGN----LREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 407 IALGT---ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
           +   T   ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  
Sbjct: 151 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 207
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 8/193 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG+V  G +     VA+K +K+ +++  E +F  E + +    H  L++L G C+
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    ++  YM NG + + LR+  H        +   +       + YL  +   + +H
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+++     V DFGL++ +   +   +   +  V    PE L   + S K+D
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 489 VFGFGILLLELIT 501
           ++ FG+L+ E+ +
Sbjct: 204 IWAFGVLMWEIYS 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 118/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L++   MP G +   +R+H   I  +  L+W       +  A
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQ-LMPFGXLLDYVREHKDNIGSQYLLNWC------VQIA 128
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 129 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 184
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 241

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 118/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L++   MP G +   +R+H   I  +  L+W       +  A
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 185
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 242

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 118/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L++   MP G +   +R+H   I  +  L+W       +  A
Sbjct: 78  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 186
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 243

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 127/270 (47%), Gaps = 33/270 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 186
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEG 529
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q  
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQPP 245
Query: 530 ----------KLSQMVDKDLKGNFDRIELE 549
                     +   M+D D +  F  + +E
Sbjct: 246 ICTIDVYMIMRKCWMIDADSRPKFRELIIE 275

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 185
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 242

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 183
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 240

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 127/270 (47%), Gaps = 33/270 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 183
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEG 529
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q  
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQPP 242
Query: 530 ----------KLSQMVDKDLKGNFDRIELE 549
                     +   M+D D +  F  + +E
Sbjct: 243 ICTIDVYMIMRKCWMIDADSRPKFRELIIE 272

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 114/246 (46%), Gaps = 36/246 (14%)
Query: 276 NDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFS-----DGALVA 329
           N QY  +  + H+KR           +   K  LG G FG V+   C +     D  LVA
Sbjct: 26  NPQYFSDACVHHIKR----------RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVA 75
Query: 330 VKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
           VK LK+ + +  +  FQ E E +++  H++++R  G C+     L+V+ YM +G +   L
Sbjct: 76  VKALKEASESARQ-DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134
Query: 390 RDHIHGRPALDWARRKRIALG-------------TARGLLYLHEQCDPKIIHRDVKAANI 436
           R   HG  A   A  + +A G              A G++YL        +HRD+   N 
Sbjct: 135 RS--HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNC 189
Query: 437 LLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL 495
           L+ +     +GDFG+++ +   D + V       +  + PE +   + + ++DV+ FG++
Sbjct: 190 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249
Query: 496 LLELIT 501
           L E+ T
Sbjct: 250 LWEIFT 255

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQ-LMPFGXLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 183
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 240

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 100 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 152
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 153 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 208
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 265

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 186
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 243

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 32/291 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
           KE+ A  S  + + ++G G FG V  G           VA+K LK          F  E 
Sbjct: 17  KEIEA--SCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEA 74
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    H N++ L G  +     ++V  YM NGS+ + L+ +      +      R   
Sbjct: 75  SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR--- 131
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVR 467
           G + G+ YL    D   +HRD+ A NIL++ +    V DFGL+++L  D   ++ T   +
Sbjct: 132 GISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 188
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH 526
             +   APE ++  + +  +DV+ +GI++ E+++ G+R   +    NQ     D +K + 
Sbjct: 189 IPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP--YWEMTNQ-----DVIKAVE 241
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +L   +D              + Q+ L C Q     RPK  E++ ML+
Sbjct: 242 EGYRLPSPMDCPAA----------LYQLMLDCWQKERNSRPKFDEIVNMLD 282

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K    +   VAVK LKD           +E+E + +   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDH----------IHGRPALDWARRKRIA- 408
           ++ L G C+ +    ++  Y   G++   LR            I+  P      +  ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 409 -LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAV 466
               ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D    TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           R  V  +APE L     + ++DV+ FG+L+ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++F     LGRGGFG+V++     D    A+KR++  N      +   EV+ ++   H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSV--------ASRLRDHIHGRPALDWARRK---RIA 408
           ++R       +N    + P  P   +           L+D ++GR  ++   R     I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT----- 463
           L  A  + +LH +    ++HRD+K +NI    D    VGDFGL   +D  +   T     
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 464 ------TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 500
                 T   GT  +++PE +     S K D+F  G++L EL+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
           LG G FG V         K   +    VAVK LK            +E+E + +   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARRKR----------- 406
           ++ L G C+ +    ++  Y   G+    LR+++  R  P L+++               
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGN----LREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 407 ---IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHV 462
               A   ARG+ YL  +   K IHRD+ A N+L+ ED    + DFGLA+ + H D    
Sbjct: 152 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           TT  R  V  +APE L     + ++DV+ FG+LL E+ T
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 69  DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 121
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 122 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 177
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 234

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 130
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 186
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 243

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 81  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 133
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 134 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 189
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 246

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 8/193 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG+V  G +     VA+K +K+ +++  E +F  E + +    H  L++L G C+
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    ++  YM NG + + LR+  H        +   +       + YL  +   + +H
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+++     V DFGL++ +   +   +   +  V    PE L   + S K+D
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 489 VFGFGILLLELIT 501
           ++ FG+L+ E+ +
Sbjct: 204 IWAFGVLMWEIYS 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 190
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 247

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 8/193 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG+V  G +     VA+K +K+ +++  E +F  E + +    H  L++L G C+
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    ++  YM NG + + LR+  H        +   +       + YL  +   + +H
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+++     V DFGL++ +   +   +   +  V    PE L   + S K+D
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 489 VFGFGILLLELIT 501
           ++ FG+L+ E+ +
Sbjct: 189 IWAFGVLMWEIYS 201

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 309 LGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           +G G FG V++        +    +VAVK LK+   A  +  FQ E   ++   + N+++
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 363 LCGFCSTENERLLVYPYMPNG--------------------SVASRLRDHIHGRPALDWA 402
           L G C+      L++ YM  G                     +++R R    G P L  A
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462
            +  IA   A G+ YL E+   K +HRD+   N L+ E+    + DFGL++ +   D + 
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 463 TTAVRGT-VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
                   +  + PE +   + + ++DV+ +G++L E+ +
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 8/193 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG+V  G +     VA+K +K+ +++  E +F  E + +    H  L++L G C+
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    ++  YM NG + + LR+  H        +   +       + YL  +   + +H
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLH 127
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+++     V DFGL++ +   +   +   +  V    PE L   + S K+D
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 187
Query: 489 VFGFGILLLELIT 501
           ++ FG+L+ E+ +
Sbjct: 188 IWAFGVLMWEIYS 200

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 125/293 (42%), Gaps = 36/293 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
           +N      LG G FG V +         D  L VAVK LK    A  +    +E++ +S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR-------DHIHGRPALDWARRKR 406
           L  H N++ L G C+     L++  Y   G + + LR       D   GRP L+      
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP-LELRDLLH 156
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTA 465
            +   A+G+ +L  +     IHRDV A N+LL     A +GDFGLA+ +++  +  V   
Sbjct: 157 FSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 213
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQR-GVMLDWVKK 524
            R  V  +APE +     + ++DV+ +GILL E+        F    N   G++++    
Sbjct: 214 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI--------FSLGLNPYPGILVN---- 261
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                K  ++V    +        + +  +   C    P HRP   ++   L+
Sbjct: 262 ----SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 310

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +GRG FG V+ G   +D  LVAVK  ++      + +F  E   +    H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL-----GTARGLLYLHEQC 422
           + +    +V   +  G   + LR         + AR +   L       A G+ YL  +C
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT--------EGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-----APEY 477
               IHRD+ A N L+ E     + DFG+++     ++    A  G +  +     APE 
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEA 286
Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           L+ G+ S ++DV+ FGILL E  +
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 137/303 (45%), Gaps = 39/303 (12%)
Query: 291 YTFKELRAATSNFSAK---------NILGRGGFGIVYKGCFS----DGALVAVKRLKDYN 337
           +TF++   A   F+ +          ++G G FG V  G           VA+K LK   
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 338 IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP 397
                  F +E   +    H N++ L G  +     +++  YM NGS+ + LR +  GR 
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN-DGRF 128
Query: 398 ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-- 455
            +   +   +  G   G+ YL    D   +HRD+ A NIL++ +    V DFG++++L  
Sbjct: 129 TV--IQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQ 514
           D   ++ T   +  +   APE ++  + +  +DV+ +GI++ E+++ G+R   +   +NQ
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQ 241
Query: 515 RGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
                D +K + +  +L   +D  +           + Q+ L C Q     RPK  +++ 
Sbjct: 242 -----DVIKAIEEGYRLPPPMDCPIA----------LHQLMLDCWQKERSDRPKFGQIVN 286
Query: 575 MLE 577
           ML+
Sbjct: 287 MLD 289

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 8/193 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG+V  G +     VA+K +K+ +++  E +F  E + +    H  L++L G C+
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    ++  YM NG + + LR+  H        +   +       + YL  +   + +H
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLH 134
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+++     V DFGL++ +   +   +   +  V    PE L   + S K+D
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 194
Query: 489 VFGFGILLLELIT 501
           ++ FG+L+ E+ +
Sbjct: 195 IWAFGVLMWEIYS 207

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 112/243 (46%), Gaps = 37/243 (15%)
Query: 292 TFKELRAATSNFSAKNI-----LGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAG 340
            FK L      F  KN+     LG G FG V K         +    VAVK LK+ N + 
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASP 67
Query: 341 GEVQ-FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA- 398
            E++   +E   +    H ++++L G CS +   LL+  Y   GS+   LR+     P  
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 399 -----------LDWARRKRIALG--------TARGLLYLHEQCDPKIIHRDVKAANILLD 439
                      LD    + + +G         ++G+ YL E    K++HRD+ A NIL+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVA 184
Query: 440 EDFEAVVGDFGLAKLLDHRDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 498
           E  +  + DFGL++ +   DS+V  +  R  V  +A E L     + ++DV+ FG+LL E
Sbjct: 185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 499 LIT 501
           ++T
Sbjct: 245 IVT 247

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 8/193 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG+V  G +     VA+K +K+ +++  E +F  E + +    H  L++L G C+
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    ++  YM NG + + LR+  H        +   +       + YL  +   + +H
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+++     V DFGL++ +   +   +   +  V    PE L   + S K+D
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 489 VFGFGILLLELIT 501
           ++ FG+L+ E+ +
Sbjct: 184 IWAFGVLMWEIYS 196

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +GRG FG V+ G   +D  LVAVK  ++      + +F  E   +    H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL-----GTARGLLYLHEQC 422
           + +    +V   +  G   + LR         + AR +   L       A G+ YL  +C
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT--------EGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-----APEY 477
               IHRD+ A N L+ E     + DFG+++     ++    A  G +  +     APE 
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEA 286
Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           L+ G+ S ++DV+ FGILL E  +
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 128/302 (42%), Gaps = 36/302 (11%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
           +N      LG G FG V +         D  L VAVK LK    A  +    +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR-------DHIHGRPALDWARRKR 406
           L  H N++ L G C+     L++  Y   G + + LR       D   GRP L+      
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP-LELRDLLH 164
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTA 465
            +   A+G+ +L  +     IHRDV A N+LL     A +GDFGLA+ +++  +  V   
Sbjct: 165 FSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQR-GVMLDWVKK 524
            R  V  +APE +     + ++DV+ +GILL E+        F    N   G++++    
Sbjct: 222 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI--------FSLGLNPYPGILVN---- 269
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEK 584
                K  ++V    +        + +  +   C    P HRP   ++   L+     ++
Sbjct: 270 ----SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 325
Query: 585 WE 586
            E
Sbjct: 326 RE 327

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 72  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 124
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
            G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 125 EGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 180
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 237

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 8/193 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG+V  G +     VA+K +K+ +++  E +F  E + +    H  L++L G C+
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            +    ++  YM NG + + LR+  H        +   +       + YL  +   + +H
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD+ A N L+++     V DFGL++ +   +   +   +  V    PE L   + S K+D
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 489 VFGFGILLLELIT 501
           ++ FG+L+ E+ +
Sbjct: 189 IWAFGVLMWEIYS 201

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 114/261 (43%), Gaps = 22/261 (8%)
Query: 297 RAATSNFSAKNILGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           + +  +F     LG G FG V+      +G   A+K LK   +   +    T  E + L+
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 356 V--HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR-DHIHGRPALDWARRKRIALGTA 412
           +  H  ++R+ G      +  ++  Y+  G + S LR       P       K  A    
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-----KFYAAEVC 116
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
             L YLH +    II+RD+K  NILLD++    + DFG AK +      VT  + GT  +
Sbjct: 117 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDY 169
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS 532
           IAPE +ST   ++  D + FGIL+ E++ G               M  + K L+ E +  
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF------YDSNTMKTYEKILNAELRFP 223
Query: 533 QMVDKDLKGNFDRIELEEMVQ 553
              ++D+K    R+   ++ Q
Sbjct: 224 PFFNEDVKDLLSRLITRDLSQ 244

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 134/291 (46%), Gaps = 32/291 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
           KE+ A  S    + ++G G FG V  G           VA+K LK          F +E 
Sbjct: 3   KEIDA--SCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 60
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    H N++ L G  +     +++  YM NGS+ + LR +  GR  +   +   +  
Sbjct: 61  SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN-DGRFTV--IQLVGMLR 117
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVR 467
           G   G+ YL    D   +HRD+ A NIL++ +    V DFG++++L  D   ++ T   +
Sbjct: 118 GIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH 526
             +   APE ++  + +  +DV+ +GI++ E+++ G+R   +   +NQ     D +K + 
Sbjct: 175 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQ-----DVIKAIE 227
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +L   +D  +           + Q+ L C Q     RPK  +++ ML+
Sbjct: 228 EGYRLPPPMDCPIA----------LHQLMLDCWQKERSDRPKFGQIVNMLD 268

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 127/270 (47%), Gaps = 33/270 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L++   MP G +   +R+H   I  +  L+W       +  A
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  + ++ H     +  +
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 185
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEG 529
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q  
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQPP 244
Query: 530 ----------KLSQMVDKDLKGNFDRIELE 549
                     +   M+D D +  F  + +E
Sbjct: 245 ICTIDVYMIMRKCWMIDADSRPKFRELIIE 274

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L++   MP G +   +R+H   I  +  L+W       +  A
Sbjct: 79  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 131
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  + ++ H     +  +
Sbjct: 132 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 187
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 244

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 111/243 (45%), Gaps = 37/243 (15%)
Query: 292 TFKELRAATSNFSAKNI-----LGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAG 340
            FK L      F  KN+     LG G FG V K         +    VAVK LK+ N + 
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASP 67
Query: 341 GEVQ-FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA- 398
            E++   +E   +    H ++++L G CS +   LL+  Y   GS+   LR+     P  
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 399 -----------LDWARRKRIALG--------TARGLLYLHEQCDPKIIHRDVKAANILLD 439
                      LD    + + +G         ++G+ YL E    K++HRD+ A NIL+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVA 184
Query: 440 EDFEAVVGDFGLAKLLDHRDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 498
           E  +  + DFGL++ +   DS V  +  R  V  +A E L     + ++DV+ FG+LL E
Sbjct: 185 EGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 499 LIT 501
           ++T
Sbjct: 245 IVT 247

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +L  G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 183
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 240

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L++   MP G +   +R+H   I  +  L+W       +  A
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  + ++ H     +  +
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 185
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 242

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 117/238 (49%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +L  G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L++   MP G +   +R+H   I  +  L+W       +  A
Sbjct: 82  DNPHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 190
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 247

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 134/291 (46%), Gaps = 32/291 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
           KE+ A  S    + ++G G FG V  G           VA+K LK          F +E 
Sbjct: 9   KEIDA--SCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 66
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    H N++ L G  +     +++  YM NGS+ + LR +  GR  +   +   +  
Sbjct: 67  SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN-DGRFTV--IQLVGMLR 123
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVR 467
           G   G+ YL    D   +HRD+ A NIL++ +    V DFG++++L  D   ++ T   +
Sbjct: 124 GIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 180
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH 526
             +   APE ++  + +  +DV+ +GI++ E+++ G+R   +   +NQ     D +K + 
Sbjct: 181 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQ-----DVIKAIE 233
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +L   +D  +           + Q+ L C Q     RPK  +++ ML+
Sbjct: 234 EGYRLPPPMDCPIA----------LHQLMLDCWQKERSDRPKFGQIVNMLD 274

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 129/281 (45%), Gaps = 32/281 (11%)
Query: 306 KNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           + ++G G FG V +G         + VA+K LK         +F +E   +    H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           RL G  +     +++  +M NG++ S LR +      +      R   G A G+ YL E 
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYLAEM 135
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR--DSHVTTAVRGTVG--HIAPEY 477
                +HRD+ A NIL++ +    V DFGL++ L+    D   T+++ G +     APE 
Sbjct: 136 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 478 LSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD 536
           ++  + +  +D + +GI++ E+++ G+R   +   +NQ     D +  + Q+ +L    D
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERP--YWDMSNQ-----DVINAIEQDYRLPPPPD 245
Query: 537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                         + Q+ L C Q +   RP+  +V+  L+
Sbjct: 246 CPTS----------LHQLMLDCWQKDRNARPRFPQVVSALD 276

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 129/291 (44%), Gaps = 32/291 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEV 349
           KEL A  S    + ++G G FG V  G           VA+K LK          F  E 
Sbjct: 38  KELDA--SCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEA 95
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    H N++ L G  +     ++V  +M NG++ + LR H      +      R   
Sbjct: 96  SIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR--- 152
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVR 467
           G A G+ YL    D   +HRD+ A NIL++ +    V DFGL++++  D    + TT  +
Sbjct: 153 GIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH 526
             V   APE +   + +  +DV+ +GI++ E+++ G+R   +   +NQ     D +K + 
Sbjct: 210 IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQ-----DVIKAIE 262
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +L   +D              + Q+ L C Q     RPK  +++ +L+
Sbjct: 263 EGYRLPAPMDCPAG----------LHQLMLDCWQKERAERPKFEQIVGILD 303

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+  L++        +   E   ++  
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 109 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 161
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 162 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 217
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 274

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 307 NILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA--VHRNLLRL 363
            I  RG FG V+K    +D   V +  L+D         +Q+E E  S     H NLL+ 
Sbjct: 21  EIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQ------SWQSEREIFSTPGMKHENLLQF 74
Query: 364 CGF----CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
                   + E E  L+  +   GS+   L+ +I     + W     +A   +RGL YLH
Sbjct: 75  IAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYLH 129
Query: 420 EQC--------DPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTV 470
           E           P I HRD K+ N+LL  D  AV+ DFGLA +    +    T    GT 
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 471 GHIAPEYLSTGQSSE-----KTDVFGFGILLLELITGQRALD 507
            ++APE L    + +     + D++  G++L EL++  +A D
Sbjct: 190 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 126/270 (46%), Gaps = 33/270 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 129
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  + ++ H     +  +
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 185
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEG 529
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q  
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQPP 244
Query: 530 ----------KLSQMVDKDLKGNFDRIELE 549
                     +   M+D D +  F  + +E
Sbjct: 245 ICTIDVYMIMRKCWMIDADSRPKFRELIIE 274

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  + ++ H     +  +
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 183
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 240

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 133/315 (42%), Gaps = 38/315 (12%)
Query: 279 YDPEVSLGHLKRYTFKELRAAT-SNFSAKNILGRGGFGIVYKGCFS------DGALVAVK 331
           Y+P  S    K  +  +L+     N +    LG G FG VY+G  S          VAVK
Sbjct: 9   YNPNYSFAG-KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 67
Query: 332 RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD 391
            L +      E+ F  E   IS   H+N++R  G       R ++   M  G + S LR+
Sbjct: 68  TLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE 127
Query: 392 HIHGRP----ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEA 444
               RP    +L       +A   A G  YL E      IHRD+ A N LL        A
Sbjct: 128 -TRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 183
Query: 445 VVGDFGLAKLLDHRDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            +GDFG+A+ + +R S+          V  + PE    G  + KTD + FG+LL E+ + 
Sbjct: 184 KIGDFGMARDI-YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS- 241
Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
              + +   +NQ   +L++V      G++     K+  G   RI    M Q    C Q  
Sbjct: 242 LGYMPYPSKSNQE--VLEFVTS---GGRMDP--PKNCPGPVYRI----MTQ----CWQHQ 286
Query: 563 PLHRPKMSEVLKMLE 577
           P  RP  + +L+ +E
Sbjct: 287 PEDRPNFAIILERIE 301

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +L  G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFGLAKLL  + ++ H     +  +
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPI 190
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 247

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 133/315 (42%), Gaps = 38/315 (12%)
Query: 279 YDPEVSLGHLKRYTFKELRAAT-SNFSAKNILGRGGFGIVYKGCFS------DGALVAVK 331
           Y+P  S    K  +  +L+     N +    LG G FG VY+G  S          VAVK
Sbjct: 9   YNPNYSFAG-KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 67
Query: 332 RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD 391
            L +      E+ F  E   IS   H+N++R  G       R ++   M  G + S LR+
Sbjct: 68  TLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE 127
Query: 392 HIHGRP----ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEA 444
               RP    +L       +A   A G  YL E      IHRD+ A N LL        A
Sbjct: 128 -TRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 183
Query: 445 VVGDFGLAKLLDHRDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            +GDFG+A+ + +R S+          V  + PE    G  + KTD + FG+LL E+ + 
Sbjct: 184 KIGDFGMARDI-YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS- 241
Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
              + +   +NQ   +L++V      G++     K+  G   RI    M Q    C Q  
Sbjct: 242 LGYMPYPSKSNQE--VLEFVTS---GGRMDP--PKNCPGPVYRI----MTQ----CWQHQ 286
Query: 563 PLHRPKMSEVLKMLE 577
           P  RP  + +L+ +E
Sbjct: 287 PEDRPNFAIILERIE 301

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 133/315 (42%), Gaps = 38/315 (12%)
Query: 279 YDPEVSLGHLKRYTFKELRAAT-SNFSAKNILGRGGFGIVYKGCFS------DGALVAVK 331
           Y+P  S    K  +  +L+     N +    LG G FG VY+G  S          VAVK
Sbjct: 15  YNPNYSFAG-KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 73
Query: 332 RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD 391
            L +      E+ F  E   IS   H+N++R  G       R ++   M  G + S LR+
Sbjct: 74  TLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE 133
Query: 392 HIHGRP----ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEA 444
               RP    +L       +A   A G  YL E      IHRD+ A N LL        A
Sbjct: 134 -TRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 189
Query: 445 VVGDFGLAKLLDHRDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            +GDFG+A+ + +R S+          V  + PE    G  + KTD + FG+LL E+ + 
Sbjct: 190 KIGDFGMARDI-YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS- 247
Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
              + +   +NQ   +L++V      G++     K+  G   RI    M Q    C Q  
Sbjct: 248 LGYMPYPSKSNQE--VLEFVTS---GGRMDP--PKNCPGPVYRI----MTQ----CWQHQ 292
Query: 563 PLHRPKMSEVLKMLE 577
           P  RP  + +L+ +E
Sbjct: 293 PEDRPNFAIILERIE 307

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 30/286 (10%)
Query: 298 AATSNFSAKNILGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLA 355
           +   ++     +G G +G   K    SDG ++  K L   ++   E Q   +EV  +   
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 356 VHRNLLRLCG--FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
            H N++R        T     +V  Y   G +AS +      R  LD     R+      
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 414 GLLYLHEQCD--PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
            L   H + D    ++HRD+K AN+ LD      +GDFGLA++L+H  S   T V GT  
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPY 181
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           +++PE ++    +EK+D++  G LL EL           A +Q+                
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQK---------------- 222
Query: 532 SQMVDKDLKGNFDRIEL---EEMVQVALLCTQFNPLHRPKMSEVLK 574
            ++  K  +G F RI     +E+ ++          HRP + E+L+
Sbjct: 223 -ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG VY+G  S          VAVK L +      E+ F  E   IS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP----ALDWARRKRIALGTARGLLYL 418
             G       R ++   M  G + S LR+    RP    +L       +A   A G  YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 419 HEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHI 473
            E      IHRD+ A N LL        A +GDFG+A+ + +R S+          V  +
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVKWM 227
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
            PE    G  + KTD + FG+LL E+ +    + +   +NQ   +L++V      G++  
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTS---GGRMDP 281
Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K+  G   RI    M Q    C Q  P  RP  + +L+ +E
Sbjct: 282 --PKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 315

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 23/238 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +  +G  V    A+K L++        +   E   ++  
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTA 412
            + ++ RL G C T   +L+    MP G +   +R+H   I  +  L+W       +  A
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 134
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           +G+ YL    D +++HRD+ A N+L+       + DFG AKLL  + ++ H     +  +
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPI 190
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQ 527
             +A E +     + ++DV+ +G+ + EL+T G +  D G  A++   +L+  ++L Q
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGERLPQ 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG VY+G  S          VAVK L +      E+ F  E   IS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP----ALDWARRKRIALGTARGLLYL 418
             G       R ++   M  G + S LR+    RP    +L       +A   A G  YL
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 419 HEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHI 473
            E      IHRD+ A N LL        A +GDFG+A+ + +R S+          V  +
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVKWM 227
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
            PE    G  + KTD + FG+LL E+ +    + +   +NQ   +L++V      G++  
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTS---GGRMDP 281
Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K+  G   RI    M Q    C Q  P  RP  + +L+ +E
Sbjct: 282 --PKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 315

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 30/286 (10%)
Query: 298 AATSNFSAKNILGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLA 355
           +   ++     +G G +G   K    SDG ++  K L   ++   E Q   +EV  +   
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 356 VHRNLLRLCG--FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
            H N++R        T     +V  Y   G +AS +      R  LD     R+      
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 414 GLLYLHEQCD--PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
            L   H + D    ++HRD+K AN+ LD      +GDFGLA++L+H D+    A  GT  
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPY 181
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           +++PE ++    +EK+D++  G LL EL           A +Q+                
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQK---------------- 222
Query: 532 SQMVDKDLKGNFDRIEL---EEMVQVALLCTQFNPLHRPKMSEVLK 574
            ++  K  +G F RI     +E+ ++          HRP + E+L+
Sbjct: 223 -ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG VY+G  S          VAVK L +      E+ F  E   IS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP----ALDWARRKRIALGTARGLLYL 418
             G       R ++   M  G + S LR+    RP    +L       +A   A G  YL
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 419 HEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHI 473
            E      IHRD+ A N LL        A +GDFG+A+ + +R S+          V  +
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVKWM 212
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
            PE    G  + KTD + FG+LL E+ +    + +   +NQ   +L++V      G++  
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTS---GGRMDP 266
Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K+  G   RI    M Q    C Q  P  RP  + +L+ +E
Sbjct: 267 --PKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 300

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG VY+G  S          VAVK L +      E+ F  E   IS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP----ALDWARRKRIALGTARGLLYL 418
             G       R ++   M  G + S LR+    RP    +L       +A   A G  YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 419 HEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHI 473
            E      IHRD+ A N LL        A +GDFG+A+ + +R S+          V  +
Sbjct: 172 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVKWM 227
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
            PE    G  + KTD + FG+LL E+ +    + +   +NQ   +L++V      G++  
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTS---GGRMDP 281
Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K+  G   RI    M Q    C Q  P  RP  + +L+ +E
Sbjct: 282 --PKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 315

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 133/315 (42%), Gaps = 38/315 (12%)
Query: 279 YDPEVSLGHLKRYTFKELRAAT-SNFSAKNILGRGGFGIVYKGCFS------DGALVAVK 331
           Y+P  S    K  +  +L+     N +    LG G FG VY+G  S          VAVK
Sbjct: 9   YNPNYSFAG-KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 67
Query: 332 RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD 391
            L +      E+ F  E   IS   H+N++R  G       R ++   M  G + S LR+
Sbjct: 68  TLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE 127
Query: 392 HIHGRP----ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEA 444
               RP    +L       +A   A G  YL E      IHRD+ A N LL        A
Sbjct: 128 -TRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 183
Query: 445 VVGDFGLAKLLDHRDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            +GDFG+A+ + +R S+          V  + PE    G  + KTD + FG+LL E+ + 
Sbjct: 184 KIGDFGMAQDI-YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS- 241
Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
              + +   +NQ   +L++V      G++     K+  G   RI    M Q    C Q  
Sbjct: 242 LGYMPYPSKSNQE--VLEFVTS---GGRMDP--PKNCPGPVYRI----MTQ----CWQHQ 286
Query: 563 PLHRPKMSEVLKMLE 577
           P  RP  + +L+ +E
Sbjct: 287 PEDRPNFAIILERIE 301

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 13/215 (6%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEV--QFQTEVETIS 353
           R    ++   + LG G FG V  G     G  VAVK L    I   +V  + + E++ + 
Sbjct: 12  RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK 71
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
           L  H ++++L    ST ++  +V  Y+  G     L D+I     LD    +R+      
Sbjct: 72  LFRHPHIIKLYQVISTPSDIFMVMEYVSGGE----LFDYICKNGRLDEKESRRLFQQILS 127
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           G+ Y H      ++HRD+K  N+LLD    A + DFGL+ ++   D        G+  + 
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRXSCGSPNYA 182
Query: 474 APEYLSTG-QSSEKTDVFGFGILLLELITGQRALD 507
           APE +S    +  + D++  G++L  L+ G    D
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 14/226 (6%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISLAVHR 358
           +F   N+LG+G F  VY+      G  VA+K + K      G VQ  Q EV+      H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           ++L L  +    N   LV     NG +   L++ +  +P  +   R  +      G+LYL
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMH-QIITGMLYL 128
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEY 477
           H      I+HRD+  +N+LL  +    + DFGLA  L    + H T    GT  +I+PE 
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEI 183
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN--QRGVMLDW 521
            +      ++DV+  G +   L+ G+   D     N   + V+ D+
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG VY+G  S          VAVK L +      E+ F  E   IS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP----ALDWARRKRIALGTARGLLYL 418
             G       R ++   M  G + S LR+    RP    +L       +A   A G  YL
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 419 HEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHI 473
            E      IHRD+ A N LL        A +GDFG+A+ + +R S+          V  +
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVKWM 212
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
            PE    G  + KTD + FG+LL E+ +    + +   +NQ   +L++V      G++  
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTS---GGRMDP 266
Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K+  G   RI    M Q    C Q  P  RP  + +L+ +E
Sbjct: 267 --PKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 300

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG VY+G  S          VAVK L +      E+ F  E   IS   H+N++R
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP----ALDWARRKRIALGTARGLLYL 418
             G       R ++   M  G + S LR+    RP    +L       +A   A G  YL
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 419 HEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHI 473
            E      IHRD+ A N LL        A +GDFG+A+ + +R S+          V  +
Sbjct: 149 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVKWM 204
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
            PE    G  + KTD + FG+LL E+ +    + +   +NQ   +L++V      G++  
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTS---GGRMDP 258
Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K+  G   RI    M Q    C Q  P  RP  + +L+ +E
Sbjct: 259 --PKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 292

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 15/212 (7%)
Query: 297 RAATSNFSAKNILGRGGFGIVY---KGCFSD-GALVAVKRLKDYNI-AGGEVQFQTEVET 351
           +A  S+F    +LG+G FG V+   K    D G L A+K LK   +     V+ + E + 
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
           ++   H  +++L     TE +  L+  ++  G + +RL   +           K      
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAEL 139
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTAVRGTV 470
           A GL +LH      II+RD+K  NILLDE+    + DFGL+K  +DH     +    GTV
Sbjct: 140 ALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC--GTV 194
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            ++APE ++    S   D + +G+L+ E++TG
Sbjct: 195 EYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG VY+G  S          VAVK L +      E+ F  E   IS   H+N++R
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP----ALDWARRKRIALGTARGLLYL 418
             G       R ++   M  G + S LR+    RP    +L       +A   A G  YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 419 HEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHI 473
            E      IHRD+ A N LL        A +GDFG+A+ + +R S+          V  +
Sbjct: 174 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVKWM 229
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
            PE    G  + KTD + FG+LL E+ +    + +   +NQ   +L++V      G++  
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTS---GGRMDP 283
Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K+  G   RI    M Q    C Q  P  RP  + +L+ +E
Sbjct: 284 --PKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 317

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGA-LVAVKRLKDYNIA--GGEVQFQTEVETISLAVHR 358
           +F     LG+G FG VY         +VA+K L    I   G E Q + E+E  +   H 
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N+LRL  +        L+  Y P G +   L+         D  R   I    A  L+Y 
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC----TFDEQRTATIMEELADALMYC 139
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           H +   K+IHRD+K  N+LL    E  + DFG +    H  S     + GT+ ++ PE +
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFGWSV---HAPSLRRKTMCGTLDYLPPEMI 193
Query: 479 STGQSSEKTDVFGFGILLLELITG 502
                +EK D++  G+L  EL+ G
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 309 LGRGGFGIVYKG-CFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG V+   C +     D  LVAVK LK+ + +  +  FQ E E +++  H++++R
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 84
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG------------ 410
             G C+     L+V+ YM +G +   LR   HG  A   A  + +A G            
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRS--HGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 411 -TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRG 468
             A G++YL        +HRD+   N L+ +     +GDFG+++ +   D + V      
Sbjct: 143 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
            +  + PE +   + + ++DV+ FG++L E+ T
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 15/226 (6%)
Query: 286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGG 341
           G   R   +E+ A  S    + I+G G  G V  G           VA+K LK       
Sbjct: 36  GRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 342 EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDW 401
              F +E   +    H N++RL G  +     ++V  YM NGS+ + LR H      +  
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRD 459
               R   G   G+ YL    D   +HRD+ A N+L+D +    V DFGL+++L  D   
Sbjct: 154 VGMLR---GVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
           ++ TT  +  +   APE ++    S  +DV+ FG+++ E++  G+R
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 129/281 (45%), Gaps = 32/281 (11%)
Query: 306 KNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           + ++G G FG V +G         + VA+K LK         +F +E   +    H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           RL G  +     +++  +M NG++ S LR +      +      R   G A G+ YL E 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYLAEM 137
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR--DSHVTTAVRGTVG--HIAPEY 477
                +HRD+ A NIL++ +    V DFGL++ L+    D   T+++ G +     APE 
Sbjct: 138 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 478 LSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD 536
           ++  + +  +D + +GI++ E+++ G+R   +   +NQ     D +  + Q+ +L    D
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERP--YWDMSNQ-----DVINAIEQDYRLPPPPD 247
Query: 537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                         + Q+ L C Q +   RP+  +V+  L+
Sbjct: 248 CPTS----------LHQLMLDCWQKDRNARPRFPQVVSALD 278

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG VYK    + +++A  ++ D         +  E++ ++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            EN   ++  +   G+V + + +    RP L  ++ + +   T   L YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL--ERP-LTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 429 RDVKAANILLDEDFEAVVGDFGLA----KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           RD+KA NIL   D +  + DFG++    + +  RDS +     GT   +APE +    S 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 213
Query: 485 E-----KTDVFGFGILLLEL 499
           +     K DV+  GI L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 309 LGRGGFGIVYKG-CFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG V+   C +     D  LVAVK LK+ + +  +  FQ E E +++  H++++R
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 78
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG------------ 410
             G C+     L+V+ YM +G +   LR   HG  A   A  + +A G            
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRS--HGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 411 -TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRG 468
             A G++YL        +HRD+   N L+ +     +GDFG+++ +   D + V      
Sbjct: 137 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
            +  + PE +   + + ++DV+ FG++L E+ T
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 133/315 (42%), Gaps = 38/315 (12%)
Query: 279 YDPEVSLGHLKRYTFKELRAAT-SNFSAKNILGRGGFGIVYKGCFS------DGALVAVK 331
           Y+P  S    K  +  +L+     N +    LG G FG VY+G  S          VAVK
Sbjct: 35  YNPNYSFAG-KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 93
Query: 332 RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD 391
            L +      E+ F  E   IS   H+N++R  G       R ++   M  G + S LR+
Sbjct: 94  TLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRE 153
Query: 392 HIHGRP----ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEA 444
               RP    +L       +A   A G  YL E      IHRD+ A N LL        A
Sbjct: 154 -TRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 209
Query: 445 VVGDFGLAKLLDHRDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            +GDFG+A+ + +R S+          V  + PE    G  + KTD + FG+LL E+ + 
Sbjct: 210 KIGDFGMARDI-YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS- 267
Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
              + +   +NQ   +L++V      G++     K+  G   RI    M Q    C Q  
Sbjct: 268 LGYMPYPSKSNQE--VLEFVTS---GGRMDP--PKNCPGPVYRI----MTQ----CWQHQ 312
Query: 563 PLHRPKMSEVLKMLE 577
           P  RP  + +L+ +E
Sbjct: 313 PEDRPNFAIILERIE 327

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 125/306 (40%), Gaps = 40/306 (13%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
           +N      LG G FG V +         D  L VAVK LK    A  +    +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALG 410
           L  H N++ L G C+     L++  Y   G + + LR     +   PA   A     +  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN----STA 161
Query: 411 TARGLLYLHEQ--------CDPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSH 461
           + R LL+   Q             IHRDV A N+LL     A +GDFGLA+ +++  +  
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQR-GVMLD 520
           V    R  V  +APE +     + ++DV+ +GILL E+        F    N   G++++
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI--------FSLGLNPYPGILVN 273
Query: 521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG 580
                    K  ++V    +        + +  +   C    P HRP   ++   L+   
Sbjct: 274 --------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325
Query: 581 LAEKWE 586
             ++ E
Sbjct: 326 QEDRRE 331

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG VYK    + +++A  ++ D         +  E++ ++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            EN   ++  +   G+V + + +    RP L  ++ + +   T   L YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL--ERP-LTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 429 RDVKAANILLDEDFEAVVGDFGLA----KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           RD+KA NIL   D +  + DFG++    + +  RDS +     GT   +APE +    S 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-----GTPYWMAPEVVMCETSK 213
Query: 485 E-----KTDVFGFGILLLEL 499
           +     K DV+  GI L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 110/243 (45%), Gaps = 37/243 (15%)
Query: 292 TFKELRAATSNFSAKNI-----LGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAG 340
            FK L      F  KN+     LG G FG V K         +    VAVK LK+ N + 
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-NASP 67
Query: 341 GEVQ-FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA- 398
            E++   +E   +    H ++++L G CS +   LL+  Y   GS+   LR+     P  
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 399 -----------LDWARRKRIALG--------TARGLLYLHEQCDPKIIHRDVKAANILLD 439
                      LD    + + +G         ++G+ YL E     ++HRD+ A NIL+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVA 184
Query: 440 EDFEAVVGDFGLAKLLDHRDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 498
           E  +  + DFGL++ +   DS V  +  R  V  +A E L     + ++DV+ FG+LL E
Sbjct: 185 EGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 499 LIT 501
           ++T
Sbjct: 245 IVT 247

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 38/287 (13%)
Query: 307 NILGRGGFGIVYKGCF--SDGA--LVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLL 361
            ILG G FG V +G     DG    VAVK +K  N +  E++ F +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 362 RLCGFCSTENER-----LLVYPYMPNGSV-----ASRLRDHIHGRPALDWARRKRIALGT 411
           RL G C   + +     +++ P+M  G +      SRL     G   +      +  +  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDI 156
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-RGTV 470
           A G+ YL  +     +HRD+ A N +L +D    V DFGL+K +   D +    + +  V
Sbjct: 157 ALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK 530
             IA E L+    + K+DV+ FG+ + E+ T  R +       Q   M D++   H   +
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMT-PYPGVQNHEMYDYLLHGH---R 267
Query: 531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           L Q  D           L+E+ ++   C + +PL RP  S +   LE
Sbjct: 268 LKQPEDC----------LDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL--AVHRNLLRLCG 365
           +  RG FG V+K    +   VAVK     +    +  +Q E E  SL    H N+L+  G
Sbjct: 31  VKARGRFGCVWKAQLLN-EYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 366 F----CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
                 S + +  L+  +   GS++  L+ ++     + W     IA   ARGL YLHE 
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHED 140
Query: 422 C-------DPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHI 473
                    P I HRD+K+ N+LL  +  A + DFGLA K    + +  T    GT  ++
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 474 APEYLSTGQSSE-----KTDVFGFGILLLELITGQRALD 507
           APE L    + +     + D++  G++L EL +   A D
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 117/277 (42%), Gaps = 35/277 (12%)
Query: 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           F+    +G+G FG V+KG  +    +VA+K +            Q E+  +S      + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           +  G    + +  ++  Y+  GS    L         LD  +   I     +GL YLH +
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 143
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              K IHRD+KAAN+LL E  E  + DFG+A  L        T V GT   +APE +   
Sbjct: 144 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 199
Query: 482 QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD--- 538
               K D++  GI  +EL  G+                    +LH   K+  ++ K+   
Sbjct: 200 AYDSKADIWSLGITAIELARGEPPHS----------------ELHPM-KVLFLIPKNNPP 242
Query: 539 -LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
            L+GN+ +  L+E V+    C    P  RP   E+LK
Sbjct: 243 TLEGNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 275

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 117/277 (42%), Gaps = 35/277 (12%)
Query: 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           F+    +G+G FG V+KG  +    +VA+K +            Q E+  +S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           +  G    + +  ++  Y+  GS    L         LD  +   I     +GL YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 123
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              K IHRD+KAAN+LL E  E  + DFG+A  L        T V GT   +APE +   
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 179
Query: 482 QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD--- 538
               K D++  GI  +EL  G+                    +LH   K+  ++ K+   
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHS----------------ELHP-MKVLFLIPKNNPP 222
Query: 539 -LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
            L+GN+ +  L+E V+    C    P  RP   E+LK
Sbjct: 223 TLEGNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 255

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 15/226 (6%)
Query: 286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGG 341
           G   R   +E+ A  S    + I+G G  G V  G           VA+K LK       
Sbjct: 36  GRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 342 EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDW 401
              F +E   +    H N++RL G  +     ++V  YM NGS+ + LR H      +  
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRD 459
               R   G   G+ YL    D   +HRD+ A N+L+D +    V DFGL+++L  D   
Sbjct: 154 VGMLR---GVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
           +  TT  +  +   APE ++    S  +DV+ FG+++ E++  G+R
Sbjct: 208 AXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 126/305 (41%), Gaps = 38/305 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
           +N      LG G FG V +         D  L VAVK LK    A  +    +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRK----- 405
           L  H N++ L G C+     L++  Y   G + + LR     +   PA   A        
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 406 --RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHV 462
               +   A+G+ +L  +     IHRDV A N+LL     A +GDFGLA+ +++  +  V
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQR-GVMLDW 521
               R  V  +APE +     + ++DV+ +GILL E+        F    N   G++++ 
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI--------FSLGLNPYPGILVN- 273
Query: 522 VKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGL 581
                   K  ++V    +        + +  +   C    P HRP   ++   L+    
Sbjct: 274 -------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326
Query: 582 AEKWE 586
            ++ E
Sbjct: 327 EDRRE 331

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 120/288 (41%), Gaps = 44/288 (15%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG VY+G  S          VAVK L +      E+ F  E   IS   H+N++R
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP----ALDWARRKRIALGTARGLLYL 418
             G       R ++   M  G + S LR+    RP    +L       +A   A G  YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 419 HEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTTAVRG------T 469
            E      IHRD+ A N LL        A +GDFG+A     RD +     R        
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-----RDIYRAGYYRKGGCAMLP 249
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG 529
           V  + PE    G  + KTD + FG+LL E+ +    + +   +NQ   +L++V      G
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTS---GG 303
Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           ++     K+  G   RI    M Q    C Q  P  RP  + +L+ +E
Sbjct: 304 RMDP--PKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 341

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 309 LGRGGFGIVYKGCFSDGAL---VAVK------RLKDYNIAGGEVQFQTEVETISLAVHRN 359
           LG GG   VY     D  L   VA+K      R K+  +     +F+ EV   S   H+N
Sbjct: 19  LGGGGMSTVY--LAEDTILNIKVAIKAIFIPPREKEETLK----RFEREVHNSSQLSHQN 72
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           ++ +      ++   LV  Y+   +++  +  H  G  ++D A           G+ + H
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAIN--FTNQILDGIKHAH 128
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
              D +I+HRD+K  NIL+D +    + DFG+AK L       T  V GTV + +PE   
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
              + E TD++  GI+L E++ G+
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 120/288 (41%), Gaps = 44/288 (15%)
Query: 309 LGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG VY+G  S          VAVK L +      E+ F  E   IS   H+N++R
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP----ALDWARRKRIALGTARGLLYL 418
             G       R ++   M  G + S LR+    RP    +L       +A   A G  YL
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRE-TRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 419 HEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTTAVRG------T 469
            E      IHRD+ A N LL        A +GDFG+A     RD +     R        
Sbjct: 175 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-----RDIYRAGYYRKGGCAMLP 226
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG 529
           V  + PE    G  + KTD + FG+LL E+ +    + +   +NQ   +L++V      G
Sbjct: 227 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-LGYMPYPSKSNQE--VLEFVTS---GG 280
Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           ++     K+  G   RI    M Q    C Q  P  RP  + +L+ +E
Sbjct: 281 RMDP--PKNCPGPVYRI----MTQ----CWQHQPEDRPNFAIILERIE 318

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 30/286 (10%)
Query: 298 AATSNFSAKNILGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLA 355
           +   ++     +G G +G   K    SDG ++  K L   ++   E Q   +EV  +   
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 356 VHRNLLRLCG--FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
            H N++R        T     +V  Y   G +AS +      R  LD     R+      
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 414 GLLYLHEQCD--PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
            L   H + D    ++HRD+K AN+ LD      +GDFGLA++L+H D        GT  
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DEDFAKEFVGTPY 181
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           +++PE ++    +EK+D++  G LL EL           A +Q+                
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQK---------------- 222
Query: 532 SQMVDKDLKGNFDRIEL---EEMVQVALLCTQFNPLHRPKMSEVLK 574
            ++  K  +G F RI     +E+ ++          HRP + E+L+
Sbjct: 223 -ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 125/306 (40%), Gaps = 49/306 (16%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
           +N      LG G FG V +         D  L VAVK LK    A  +    +E++ +S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR--------------------DHI 393
           L  H N++ L G C+     L++  Y   G + + LR                    D  
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 394 HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
            GRP L+       +   A+G+ +L  +     IHRDV A N+LL     A +GDFGLA+
Sbjct: 151 DGRP-LELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR 206
Query: 454 -LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAA 512
            +++  +  V    R  V  +APE +     + ++DV+ +GILL E+        F    
Sbjct: 207 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI--------FSLGL 258
Query: 513 NQR-GVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSE 571
           N   G++++         K  ++V    +        + +  +   C    P HRP   +
Sbjct: 259 NPYPGILVN--------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ 310
Query: 572 VLKMLE 577
           +   L+
Sbjct: 311 ICSFLQ 316

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG VYK    + +++A  ++ D         +  E++ ++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            EN   ++  +   G+V + + +    RP L  ++ + +   T   L YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL--ERP-LTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 429 RDVKAANILLDEDFEAVVGDFGLA----KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           RD+KA NIL   D +  + DFG++    + +  RD  +     GT   +APE +    S 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-----GTPYWMAPEVVMCETSK 213
Query: 485 E-----KTDVFGFGILLLEL 499
           +     K DV+  GI L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LG G FG V+   ++    VAVK +K  +++     F  E   +    H  L++L    +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
            E    ++  +M  GS+   L+     +  L   +    +   A G+ ++ ++     IH
Sbjct: 248 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 301
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
           RD++AANIL+       + DFGLA++            +  +   APE ++ G  + K+D
Sbjct: 302 RDLRAANILVSASLVCKIADFGLARV----------GAKFPIKWTAPEAINFGSFTIKSD 351
Query: 489 VFGFGILLLELITGQR 504
           V+ FGILL+E++T  R
Sbjct: 352 VWSFGILLMEIVTYGR 367

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 9/202 (4%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR--LCG 365
            LG+GGF   ++   +D   V   ++   ++       Q E  ++ +++HR+L    + G
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 81
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
           F     +   V+  +      S L  H   R AL     +        G  YLH     +
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---R 137
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
           +IHRD+K  N+ L+ED E  +GDFGLA  +++ D      + GT  +IAPE LS    S 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 486 KTDVFGFGILLLELITGQRALD 507
           + DV+  G ++  L+ G+   +
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 9/202 (4%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR--LCG 365
            LG+GGF   ++   +D   V   ++   ++       Q E  ++ +++HR+L    + G
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 81
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
           F     +   V+  +      S L  H   R AL     +        G  YLH     +
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---R 137
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
           +IHRD+K  N+ L+ED E  +GDFGLA  +++ D      + GT  +IAPE LS    S 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 486 KTDVFGFGILLLELITGQRALD 507
           + DV+  G ++  L+ G+   +
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 297 RAATSNFSAKNILGRGGFGIVY---KGCFSDG-ALVAVKRLKDYNI-AGGEVQFQTEVET 351
           +A  S F    +LG+G FG V+   K   SD   L A+K LK   +     V+ + E + 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
           +    H  +++L     TE +  L+  ++  G + +RL   +           + +    
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-------MFTEEDVKFYL 132
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTAVRGTV 470
           A   L L       II+RD+K  NILLDE+    + DFGL+K  +DH     +    GTV
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTV 190
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            ++APE ++    ++  D + FG+L+ E++TG
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 121/276 (43%), Gaps = 23/276 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVH 357
           +NF  +  +GRG F  VY+  C  DG  VA+K+++ +++  A        E++ +    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK-RIALGTARGLL 416
            N+++       +NE  +V      G + SR+  H   +  L   R   +  +     L 
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           ++H +   +++HRD+K AN+ +       +GD GL +    + +   + V GT  +++PE
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 206
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD 536
            +     + K+D++  G LL E+   Q    +G   N    +    KK+ Q        D
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMN----LYSLCKKIEQCDYPPLPSD 261
Query: 537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEV 572
                       EE+ Q+  +C   +P  RP ++ V
Sbjct: 262 H---------YSEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 9/202 (4%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR--LCG 365
            LG+GGF   ++   +D   V   ++   ++       Q E  ++ +++HR+L    + G
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 103
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
           F     +   V+  +      S L  H   R AL     +        G  YLH     +
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---R 159
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
           +IHRD+K  N+ L+ED E  +GDFGLA  +++ D      + GT  +IAPE LS    S 
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 486 KTDVFGFGILLLELITGQRALD 507
           + DV+  G ++  L+ G+   +
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFE 240

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 9/202 (4%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR--LCG 365
            LG+GGF   ++   +D   V   ++   ++       Q E  ++ +++HR+L    + G
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 85
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
           F     +   V+  +      S L  H   R AL     +        G  YLH     +
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---R 141
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
           +IHRD+K  N+ L+ED E  +GDFGLA  +++ D      + GT  +IAPE LS    S 
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 486 KTDVFGFGILLLELITGQRALD 507
           + DV+  G ++  L+ G+   +
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFE 222

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 9/202 (4%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR--LCG 365
            LG+GGF   ++   +D   V   ++   ++       Q E  ++ +++HR+L    + G
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 105
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
           F     +   V+  +      S L  H   R AL     +        G  YLH     +
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---R 161
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
           +IHRD+K  N+ L+ED E  +GDFGLA  +++ D      + GT  +IAPE LS    S 
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 486 KTDVFGFGILLLELITGQRALD 507
           + DV+  G ++  L+ G+   +
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 307 NILGRGGFGIVYKGCF-SDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
            +LG G FG VYKG +  DG      VA+K L++        +   E   ++      + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTARGLLYL 418
           RL G C T   +L V   MP G +   +R++   +  +  L+W       +  A+G+ YL
Sbjct: 83  RLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWC------MQIAKGMSYL 135
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEY 477
               D +++HRD+ A N+L+       + DFGLA+LLD  ++       +  +  +A E 
Sbjct: 136 E---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           +   + + ++DV+ +G+ + EL+T
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 118/278 (42%), Gaps = 37/278 (13%)
Query: 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           F+    +G+G FG V+KG  +    +VA+K +            Q E+  +S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           +  G    + +  ++  Y+  GS    L         LD  +   I     +GL YLH +
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 138
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-TAVRGTVGHIAPEYLST 480
              K IHRD+KAAN+LL E  E  + DFG+A  L   D+ +      GT   +APE +  
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD-- 538
                K D++  GI  +EL  G+                    +LH   K+  ++ K+  
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHS----------------ELHP-MKVLFLIPKNNP 236
Query: 539 --LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
             L+GN+ +  L+E V+    C    P  RP   E+LK
Sbjct: 237 PTLEGNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 270

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 297 RAATSNFSAKNILGRGGFGIVY---KGCFSDG-ALVAVKRLKDYNI-AGGEVQFQTEVET 351
           +A  S F    +LG+G FG V+   K   SD   L A+K LK   +     V+ + E + 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
           +    H  +++L     TE +  L+  ++  G + +RL   +           + +    
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-------MFTEEDVKFYL 132
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTAVRGTV 470
           A   L L       II+RD+K  NILLDE+    + DFGL+K  +DH     +    GTV
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTV 190
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            ++APE ++    ++  D + FG+L+ E++TG
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 9/198 (4%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR--LCG 365
            LG+GGF   ++   +D   V   ++   ++       Q E  ++ +++HR+L    + G
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVG 79
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
           F     +   V+  +      S L  H   R AL     +        G  YLH     +
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---R 135
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
           +IHRD+K  N+ L+ED E  +GDFGLA  +++ D      + GT  +IAPE LS    S 
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY-DGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 486 KTDVFGFGILLLELITGQ 503
           + DV+  G ++  L+ G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 15/212 (7%)
Query: 297 RAATSNFSAKNILGRGGFGIVY---KGCFSDG-ALVAVKRLKDYNI-AGGEVQFQTEVET 351
           +A  S F    +LG+G FG V+   K   SD   L A+K LK   +     V+ + E + 
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
           +    H  +++L     TE +  L+  ++  G + +RL   +           + +    
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-------MFTEEDVKFYL 133
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTAVRGTV 470
           A   L L       II+RD+K  NILLDE+    + DFGL+K  +DH     +    GTV
Sbjct: 134 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTV 191
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            ++APE ++    ++  D + FG+L+ E++TG
Sbjct: 192 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 118/278 (42%), Gaps = 37/278 (13%)
Query: 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           F+    +G+G FG V+KG  +    +VA+K +            Q E+  +S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           +  G    + +  ++  Y+  GS    L         LD  +   I     +GL YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 123
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-TAVRGTVGHIAPEYLST 480
              K IHRD+KAAN+LL E  E  + DFG+A  L   D+ +      GT   +APE +  
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD-- 538
                K D++  GI  +EL  G+                    +LH   K+  ++ K+  
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHS----------------ELHP-MKVLFLIPKNNP 221
Query: 539 --LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
             L+GN+ +  L+E V+    C    P  RP   E+LK
Sbjct: 222 PTLEGNYSK-PLKEFVEA---CLNKEPSFRPTAKELLK 255

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/309 (24%), Positives = 127/309 (41%), Gaps = 44/309 (14%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS- 353
           +N      LG G FG V +         D  L VAVK LK    A  +    +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK-------- 405
           L  H N++ L G C+     L++  Y   G + + LR      P L+++           
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRK--RPPGLEYSYNPSHNPEEQL 163
Query: 406 ------RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHR 458
                   +   A+G+ +L  +     IHRDV A N+LL     A +GDFGLA+ +++  
Sbjct: 164 SSRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQR-GV 517
           +  V    R  V  +APE +     + ++DV+ +GILL E+        F    N   G+
Sbjct: 221 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI--------FSLGLNPYPGI 272
Query: 518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +++         K  ++V    +        + +  +   C    P HRP   ++   L+
Sbjct: 273 LVN--------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 324
Query: 578 GDGLAEKWE 586
                ++ E
Sbjct: 325 EQAQEDRRE 333

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 41/276 (14%)
Query: 309 LGRGGFG--IVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCG 365
           +G G FG  I+ K    DG    +K +    ++  E +  + EV  ++   H N+++   
Sbjct: 32  IGEGSFGKAILVKST-EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDH----IHGRPALDWARRKRIALGTARGLLYLHEQ 421
                    +V  Y   G +  R+             LDW  +  +AL       ++H  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK------HVH-- 142
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
            D KI+HRD+K+ NI L +D    +GDFG+A++L+     +  A  GT  +++PE     
Sbjct: 143 -DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-TVELARACIGTPYYLSPEICENK 200
Query: 482 QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG 541
             + K+D++  G +L EL T + A + G   N                    +V K + G
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--------------------LVLKIISG 240
Query: 542 NFDRIELEEMVQVALLCTQF---NPLHRPKMSEVLK 574
           +F  + L     +  L +Q    NP  RP ++ +L+
Sbjct: 241 SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 296 LRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETIS 353
           LR     F    ++G G +G VYKG     G L A+K +   ++ G E +  + E+  + 
Sbjct: 19  LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLK 75
Query: 354 -LAVHRNLLRLCGFCSTEN------ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
             + HRN+    G    +N      +  LV  +   GSV   +++        +W     
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AY 133
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
           I     RGL +LH+    K+IHRD+K  N+LL E+ E  + DFG++  LD       T +
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 190
Query: 467 RGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELITG 502
            GT   +APE ++  ++ +     K+D++  GI  +E+  G
Sbjct: 191 -GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 14/214 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQ--FQTEVETISL 354
           A   N+     LG G FG V     +  G  VA+K +    +A  ++Q   + E+  + L
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 60
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
             H ++++L     +++E ++V  Y  N      L D+I  R  +     +R        
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-----ELFDYIVQRDKMSEQEARRFFQQIISA 115
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           + Y H     KI+HRD+K  N+LLDE     + DFGL+ ++   D +      G+  + A
Sbjct: 116 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAA 170
Query: 475 PEYLSTG-QSSEKTDVFGFGILLLELITGQRALD 507
           PE +S    +  + DV+  G++L  ++  +   D
Sbjct: 171 PEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 14/214 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQ--FQTEVETISL 354
           A   N+     LG G FG V     +  G  VA+K +    +A  ++Q   + E+  + L
Sbjct: 11  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 70
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
             H ++++L     +++E ++V  Y  N      L D+I  R  +     +R        
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-----ELFDYIVQRDKMSEQEARRFFQQIISA 125
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           + Y H     KI+HRD+K  N+LLDE     + DFGL+ ++   D +      G+  + A
Sbjct: 126 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAA 180
Query: 475 PEYLSTG-QSSEKTDVFGFGILLLELITGQRALD 507
           PE +S    +  + DV+  G++L  ++  +   D
Sbjct: 181 PEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 14/214 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQ--FQTEVETISL 354
           A   N+     LG G FG V     +  G  VA+K +    +A  ++Q   + E+  + L
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 64
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
             H ++++L     +++E ++V  Y  N      L D+I  R  +     +R        
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-----ELFDYIVQRDKMSEQEARRFFQQIISA 119
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           + Y H     KI+HRD+K  N+LLDE     + DFGL+ ++   D +      G+  + A
Sbjct: 120 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAA 174
Query: 475 PEYLSTG-QSSEKTDVFGFGILLLELITGQRALD 507
           PE +S    +  + DV+  G++L  ++  +   D
Sbjct: 175 PEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 14/214 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQ--FQTEVETISL 354
           A   N+     LG G FG V     +  G  VA+K +    +A  ++Q   + E+  + L
Sbjct: 10  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 69
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
             H ++++L     +++E ++V  Y  N      L D+I  R  +     +R        
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-----ELFDYIVQRDKMSEQEARRFFQQIISA 124
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           + Y H     KI+HRD+K  N+LLDE     + DFGL+ ++   D +      G+  + A
Sbjct: 125 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAA 179
Query: 475 PEYLSTG-QSSEKTDVFGFGILLLELITGQRALD 507
           PE +S    +  + DV+  G++L  ++  +   D
Sbjct: 180 PEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 13/223 (5%)
Query: 284 SLGHLKRYTFKELRAATSN-FSAKNILGRGGFGIVYKGCFSDGA-LVAVKRLKDYNIAGG 341
           S+ HL+ +  +  R      F+  + +G+G FG VYKG  +    +VA+K +        
Sbjct: 1   SMAHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDE 60
Query: 342 EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDW 401
               Q E+  +S      + R  G      +  ++  Y+  GS    L+        L+ 
Sbjct: 61  IEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPG-----PLEE 115
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
                I     +GL YLH +   + IHRD+KAAN+LL E  +  + DFG+A  L   D+ 
Sbjct: 116 TYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQ 170
Query: 462 VT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           +      GT   +APE +       K D++  GI  +EL  G+
Sbjct: 171 IKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 110/228 (48%), Gaps = 40/228 (17%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           +F    ++G GGFG V+K     DG    ++R+K YN    E     EV+ ++   H N+
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVK-YNNEKAE----REVKALAKLDHVNI 67
Query: 361 LRLCGFC--------STENERLLVYPYMP-NGSVASR-------LRDHIHGRPALD-WAR 403
           +   G C         T ++ L    Y P N   +SR       ++     +  L+ W  
Sbjct: 68  VHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 126
Query: 404 RKR-------IAL----GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452
           ++R       +AL       +G+ Y+H +   K+IHRD+K +NI L +  +  +GDFGL 
Sbjct: 127 KRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 500
             L  ++    T  +GT+ +++PE +S+    ++ D++  G++L EL+
Sbjct: 184 TSL--KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 40/291 (13%)
Query: 309 LGRGGFGIV-----YKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
           LG G FG V     Y    SD A+ VAVK LK            +E++ +S L  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 362 RLCGFCSTENERLLVYPYMPNGSVAS---RLRDHI---HGRPAL--------DWARRKRI 407
            L G C+     L++  Y   G + +   R RD        PA+        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-V 466
           +   A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     
Sbjct: 174 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH 526
           R  V  +APE +     + ++DV+ +GI L EL +       G ++   G+ +D      
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LG-SSPYPGMPVD------ 277
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K  +M+ +  +         EM  +   C   +PL RP   ++++++E
Sbjct: 278 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 10/202 (4%)
Query: 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           F+    +G+G FG V+KG  +    +VA+K +            Q E+  +S      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           +  G     ++  ++  Y+  GS    LR         D  +   +     +GL YLH +
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE 139
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              K IHRD+KAAN+LL E  +  + DFG+A  L        T V GT   +APE +   
Sbjct: 140 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 195
Query: 482 QSSEKTDVFGFGILLLELITGQ 503
               K D++  GI  +EL  G+
Sbjct: 196 AYDSKADIWSLGITAIELAKGE 217

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 71
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 72  --HCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 129 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC- 184
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 185 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 40/291 (13%)
Query: 309 LGRGGFGIV-----YKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
           LG G FG V     Y    SD A+ VAVK LK            +E++ +S L  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 362 RLCGFCSTENERLLVYPYMPNGSVAS---RLRDHI---HGRPAL--------DWARRKRI 407
            L G C+     L++  Y   G + +   R RD        PA+        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-V 466
           +   A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     
Sbjct: 174 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH 526
           R  V  +APE +     + ++DV+ +GI L EL +       G ++   G+ +D      
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LG-SSPYPGMPVD------ 277
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K  +M+ +  +         EM  +   C   +PL RP   ++++++E
Sbjct: 278 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 71
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 72  --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 129 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC- 184
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 185 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL--LRLC 364
             LG+GGF   Y+    D   V   ++   ++       Q E  +  +A+H++L    + 
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLK--PHQKEKMSTEIAIHKSLDNPHVV 105
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           GF     +   VY  +      S L  H   R A+     +     T +G+ YLH     
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELH-KRRKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           ++IHRD+K  N+ L++D +  +GDFGLA  ++  D      + GT  +IAPE L     S
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKTLCGTPNYIAPEVLCKKGHS 220
Query: 485 EKTDVFGFGILLLELITGQ 503
            + D++  G +L  L+ G+
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 35  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 90
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 91  --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 147
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 148 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC- 203
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 204 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 71
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 72  --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 129 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC- 184
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 185 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGC--FSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAV 356
           ++FS   I+GRGGFG VY GC     G + A+K L  K   +  GE     E   +SL  
Sbjct: 189 NDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 357 HRNLLRLCGFC-------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    C F         T ++   +   M  G +   L  H         A  +  A 
Sbjct: 248 TGD----CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAA 299
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
               GL ++H +    +++RD+K ANILLDE     + D GLA     +  H +    GT
Sbjct: 300 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 470 VGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            G++APE L  G + + + D F  G +L +L+ G 
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGC--FSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAV 356
           ++FS   I+GRGGFG VY GC     G + A+K L  K   +  GE     E   +SL  
Sbjct: 189 NDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 357 HRNLLRLCGFC-------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    C F         T ++   +   M  G +   L  H         A  +  A 
Sbjct: 248 TGD----CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAA 299
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
               GL ++H +    +++RD+K ANILLDE     + D GLA     +  H +    GT
Sbjct: 300 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 470 VGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            G++APE L  G + + + D F  G +L +L+ G 
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 28  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 83
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 84  --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 141 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC- 196
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 197 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 17  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 72
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 73  --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 129
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 130 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC- 185
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 186 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 24  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 79
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 80  --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 136
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 137 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC- 192
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 193 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGC--FSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAV 356
           ++FS   I+GRGGFG VY GC     G + A+K L  K   +  GE     E   +SL  
Sbjct: 189 NDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 357 HRNLLRLCGFC-------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    C F         T ++   +   M  G +   L  H         A  +  A 
Sbjct: 248 TGD----CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAA 299
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
               GL ++H +    +++RD+K ANILLDE     + D GLA     +  H +    GT
Sbjct: 300 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 353
Query: 470 VGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            G++APE L  G + + + D F  G +L +L+ G 
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 20  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 75
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 76  --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 132
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 133 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC- 188
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 189 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEV--QFQTEVETIS 353
           R    ++   + LG G FG V  G     G  VAVK L    I   +V  + + E++ + 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGT 411
           L  H ++++L    ST  +  +V  Y+  G     L D+I  HGR     ARR    + +
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGE----LFDYICKHGRVEEMEARRLFQQILS 122
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
           A    + H      ++HRD+K  N+LLD    A + DFGL+ ++   D        G+  
Sbjct: 123 AVDYCHRH-----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSCGSPN 175
Query: 472 HIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALD 507
           + APE +S    +  + D++  G++L  L+ G    D
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL--LRLC 364
             LG+GGF   Y+    D   V   ++   ++       Q E  +  +A+H++L    + 
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLK--PHQKEKMSTEIAIHKSLDNPHVV 105
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           GF     +   VY  +      S L  H   R A+     +     T +G+ YLH     
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELH-KRRKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           ++IHRD+K  N+ L++D +  +GDFGLA  ++  D      + GT  +IAPE L     S
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKXLCGTPNYIAPEVLCKKGHS 220
Query: 485 EKTDVFGFGILLLELITGQ 503
            + D++  G +L  L+ G+
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 13/222 (5%)
Query: 285 LGHLKRYTFKELRAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEV 343
           LG ++   +K+       +  +++LG G F  ++         LVA+K +    + G E 
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG 61
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR 403
             + E+  +    H N++ L     +     L+   +  G     L D I  +       
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG----ELFDRIVEKGFYTERD 117
Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANIL---LDEDFEAVVGDFGLAKLLDHRDS 460
             R+       + YLH   D  I+HRD+K  N+L   LDED + ++ DFGL+K+ D    
Sbjct: 118 ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PG 172
Query: 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            V +   GT G++APE L+    S+  D +  G++   L+ G
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGC--FSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAV 356
           ++FS   I+GRGGFG VY GC     G + A+K L  K   +  GE     E   +SL  
Sbjct: 188 NDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 246
Query: 357 HRNLLRLCGFC-------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
             +    C F         T ++   +   M  G +   L  H         A  +  A 
Sbjct: 247 TGD----CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAA 298
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
               GL ++H +    +++RD+K ANILLDE     + D GLA     +  H +    GT
Sbjct: 299 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 352
Query: 470 VGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            G++APE L  G + + + D F  G +L +L+ G 
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 387

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 40/291 (13%)
Query: 309 LGRGGFGIV-----YKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
           LG G FG V     Y    SD A+ VAVK LK            +E++ +S L  H N++
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 362 RLCGFCSTENERLLVYPYMPNGSVAS---RLRDHI---HGRPAL--------DWARRKRI 407
            L G C+     L++  Y   G + +   R RD        PA+        D       
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-V 466
           +   A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     
Sbjct: 167 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH 526
           R  V  +APE +     + ++DV+ +GI L EL +       G ++   G+ +D      
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LG-SSPYPGMPVD------ 270
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K  +M+ +  +         EM  +   C   +PL RP   ++++++E
Sbjct: 271 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 40/291 (13%)
Query: 309 LGRGGFGIV-----YKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
           LG G FG V     Y    SD A+ VAVK LK            +E++ +S L  H N++
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 362 RLCGFCSTENERLLVYPYMPNGSVAS---RLRDHI---HGRPAL--------DWARRKRI 407
            L G C+     L++  Y   G + +   R RD        PA+        D       
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-V 466
           +   A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     
Sbjct: 169 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH 526
           R  V  +APE +     + ++DV+ +GI L EL +       G ++   G+ +D      
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LG-SSPYPGMPVD------ 272
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K  +M+ +  +         EM  +   C   +PL RP   ++++++E
Sbjct: 273 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 285 LGHLKRYTFKELRAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEV 343
           LG ++   +K+       +  +++LG G F  ++         LVA+K +    + G E 
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG 61
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL--RDHIHGRPALDW 401
             + E+  +    H N++ L     +     L+   +  G +  R+  +     R A   
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA--- 118
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANIL---LDEDFEAVVGDFGLAKLLDHR 458
               R+       + YLH   D  I+HRD+K  N+L   LDED + ++ DFGL+K+ D  
Sbjct: 119 ---SRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-- 170
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
              V +   GT G++APE L+    S+  D +  G++   L+ G
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 141/294 (47%), Gaps = 56/294 (19%)
Query: 302 NFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHR 358
           +F  K++LG G  G IVY+G F D   VAVKR+  + ++ A  EVQ   E +      H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADREVQLLRESDE-----HP 78
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR--RKRIAL--GTARG 414
           N++R   FC TE +R   + Y+     A+ L++++  +   D+A    + I L   T  G
Sbjct: 79  NVIRY--FC-TEKDR--QFQYIAIELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSG 130
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDE-----DFEAVVGDFGLAKLL---DHRDSHVTTAV 466
           L +LH      I+HRD+K  NIL+         +A++ DFGL K L    H  S   + V
Sbjct: 131 LAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR-RSGV 186
Query: 467 RGTVGHIAPEYLSTGQSSEKT---DVFGFGILLLELITGQRALDFGRAANQRGVML---D 520
            GT G IAPE LS       T   D+F  G +   +I+ + +  FG++  ++  +L    
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS-EGSHPFGKSLQRQANILLGAC 245
Query: 521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
            +  LH E K   ++ ++L        +E+M+ +       +P  RP    VLK
Sbjct: 246 SLDCLHPE-KHEDVIAREL--------IEKMIAM-------DPQKRPSAKHVLK 283

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 28  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 83
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 84  --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 141 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC- 196
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 197 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 71
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 72  --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 129 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC- 184
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 185 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 285 LGHLKRYTFKELRAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEV 343
           LG ++   +K+       +  +++LG G F  ++         LVA+K +    + G E 
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG 61
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL--RDHIHGRPALDW 401
             + E+  +    H N++ L     +     L+   +  G +  R+  +     R A   
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA--- 118
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANIL---LDEDFEAVVGDFGLAKLLDHR 458
               R+       + YLH   D  I+HRD+K  N+L   LDED + ++ DFGL+K+ D  
Sbjct: 119 ---SRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-- 170
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
              V +   GT G++APE L+    S+  D +  G++   L+ G
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 40/291 (13%)
Query: 309 LGRGGFGIV-----YKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
           LG G FG V     Y    SD A+ VAVK LK            +E++ +S L  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 362 RLCGFCSTENERLLVYPYMPNGSVAS---RLRDHI---HGRPAL--------DWARRKRI 407
            L G C+     L++  Y   G + +   R RD        PA+        D       
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-V 466
           +   A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  ++V     
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH 526
           R  V  +APE +     + ++DV+ +GI L EL +       G ++   G+ +D      
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS------LG-SSPYPGMPVD------ 254
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              K  +M+ +  +         EM  +   C   +PL RP   ++++++E
Sbjct: 255 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 303 FSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQ---TEVETISLAVHR 358
           FS    +G G FG VY      +  +VA+K++  Y+      ++Q    EV  +    H 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N ++  G    E+   LV  Y   GS +  L   +H +P L       +  G  +GL YL
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYC-LGSASDLLE--VHKKP-LQEVEIAAVTHGALQGLAYL 170
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY- 477
           H      +IHRDVKA NILL E     +GDFG A ++   +  V     GT   +APE  
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 222
Query: 478 --LSTGQSSEKTDVFGFGILLLEL 499
             +  GQ   K DV+  GI  +EL
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 29  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 84
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 85  --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 141
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 142 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC- 197
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 198 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 105
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 106 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 163 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC- 218
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 219 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 303 FSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQ---TEVETISLAVHR 358
           FS    +G G FG VY      +  +VA+K++  Y+      ++Q    EV  +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N ++  G    E+   LV  Y   GS +  L   +H +P L       +  G  +GL YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLE--VHKKP-LQEVEIAAVTHGALQGLAYL 131
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY- 477
           H      +IHRDVKA NILL E     +GDFG A ++   +  V     GT   +APE  
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 478 --LSTGQSSEKTDVFGFGILLLEL 499
             +  GQ   K DV+  GI  +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL--LRLC 364
             LG+GGF   Y+    D   V   ++   ++       Q E  +  +A+H++L    + 
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLK--PHQKEKMSTEIAIHKSLDNPHVV 89
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           GF     +   VY  +      S L  H   R A+     +     T +G+ YLH     
Sbjct: 90  GFHGFFEDDDFVYVVLEICRRRSLLELH-KRRKAVTEPEARYFMRQTIQGVQYLHNN--- 145
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           ++IHRD+K  N+ L++D +  +GDFGLA  ++  D      + GT  +IAPE L     S
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTPNYIAPEVLCKKGHS 204
Query: 485 EKTDVFGFGILLLELITGQ 503
            + D++  G +L  L+ G+
Sbjct: 205 FEVDIWSLGCILYTLLVGK 223

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 21  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 76
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 77  --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 133
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 134 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC- 189
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 190 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL--LRLC 364
             LG+GGF   Y+    D   V   ++   ++       Q E  +  +A+H++L    + 
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLK--PHQKEKMSTEIAIHKSLDNPHVV 105
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           GF     +   VY  +      S L  H   R A+     +     T +G+ YLH     
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELH-KRRKAVTEPEARYFMRQTIQGVQYLHNN--- 161
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           ++IHRD+K  N+ L++D +  +GDFGLA  ++  D      + GT  +IAPE L     S
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTPNYIAPEVLCKKGHS 220
Query: 485 EKTDVFGFGILLLELITGQ 503
            + D++  G +L  L+ G+
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 44  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 99
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 100 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 156
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 157 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC- 212
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 213 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  FC  ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 151
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 152 YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 208
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 209 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 253

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 105
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 106 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 163 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC- 218
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 219 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEV--QFQTEVETIS 353
           R    ++   + LG G FG V  G     G  VAVK L    I   +V  + + E++ + 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGT 411
           L  H ++++L    ST  +  +V  Y+  G     L D+I  HGR     ARR    + +
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGE----LFDYICKHGRVEEMEARRLFQQILS 122
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
           A    + H      ++HRD+K  N+LLD    A + DFGL+ ++   D        G+  
Sbjct: 123 AVDYCHRH-----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRDSCGSPN 175
Query: 472 HIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALD 507
           + APE +S    +  + D++  G++L  L+ G    D
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 52  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 107
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 108 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 164
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 165 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC- 220
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 221 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 95  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 150
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 151 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 207
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 208 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC- 263
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 264 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+    D G LVA+K+ L+D      E+Q   +++    
Sbjct: 54  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 109
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 110 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 166
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVR 467
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 167 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC- 222
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
            +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 223 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 303 FSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           F  K  LG G F  +V     + G L AVK +    + G E   + E+  +    H N++
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRL--RDHIHGRPALDWARRKRIALGTARGLLYLH 419
            L     + N   LV   +  G +  R+  +     + A    R+          + YLH
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ------VLDAVYYLH 137
Query: 420 EQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
                 I+HRD+K  N+L    DE+ + ++ DFGL+K+    D  V +   GT G++APE
Sbjct: 138 RMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD--VMSTACGTPGYVAPE 192
Query: 477 YLSTGQSSEKTDVFGFGILLLELITG 502
            L+    S+  D +  G++   L+ G
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/325 (23%), Positives = 131/325 (40%), Gaps = 56/325 (17%)
Query: 281 PEVSLGHLKRYTFKELRAATSNFSAK-----------NILGRGGFGIVYKGCFSDGA--- 326
           PE++L  L   +F    + TS F  +            ++G+G FG VY G +       
Sbjct: 2   PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIR 61
Query: 327 LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVA 386
           L+ ++R  +  +      F+ EV       H N++   G C +     ++       ++ 
Sbjct: 62  LIDIERDNEDQLKA----FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 387 SRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV 446
           S +RD    +  LD  + ++IA    +G+ YLH +    I+H+D+K+ N+  D   + V+
Sbjct: 118 SVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYDNG-KVVI 170
Query: 447 GDFGL----AKLLDHRDSHVTTAVRGTVGHIAPEY---LSTGQSSEK------TDVFGFG 493
            DFGL      L   R         G + H+APE    LS     +K      +DVF  G
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230
Query: 494 ILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIEL-EEMV 552
            +  EL                    +W  K      +   +   +K N  +I + +E+ 
Sbjct: 231 TIWYELHAR-----------------EWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEIS 273
Query: 553 QVALLCTQFNPLHRPKMSEVLKMLE 577
            + L C  F    RP  ++++ MLE
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 303 FSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           +  +++LG G F  ++         LVA+K +    + G E   + E+  +    H N++
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRL--RDHIHGRPALDWARRKRIALGTARGLLYLH 419
            L     +     L+   +  G +  R+  +     R A       R+       + YLH
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA------SRLIFQVLDAVKYLH 133
Query: 420 EQCDPKIIHRDVKAANIL---LDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
              D  I+HRD+K  N+L   LDED + ++ DFGL+K+ D     V +   GT G++APE
Sbjct: 134 ---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGYVAPE 188
Query: 477 YLSTGQSSEKTDVFGFGILLLELITG 502
            L+    S+  D +  G++   L+ G
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 298 AATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS 353
           A +  F  ++ LGRG   IVY    KG     AL  +K+  D  I       +TE+  + 
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV------RTEIGVLL 103
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL--RDHIHGRPALDWARRKRIALGT 411
              H N+++L     T  E  LV   +  G +  R+  + +   R A D  ++       
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------I 157
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFGLAKLLDHRDSHVTTAVRG 468
              + YLHE     I+HRD+K  N+L      D    + DFGL+K+++H+   +   V G
Sbjct: 158 LEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCG 212
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           T G+ APE L       + D++  GI+   L+ G
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
           A  +     ILG G FG VY+G ++    +   VAVK  K       + +F +E   +  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 355 AVHRNLLRLCGFCSTENERLLV--YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
             H ++++L G    E   +++  YPY   G    R ++ +     + ++      L   
Sbjct: 66  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQIC 119
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           + + YL        +HRD+   NIL+       +GDFGL++ ++  D +  +  R  +  
Sbjct: 120 KAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 176
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS 532
           ++PE ++  + +  +DV+ F + + E+      L FG+          W++     G L 
Sbjct: 177 MSPESINFRRFTTASDVWMFAVCMWEI------LSFGKQP------FFWLENKDVIGVLE 224
Query: 533 QMVDKDLKGNFDRIELEEMVQVALL-----CTQFNPLHRPKMSEVL 573
                  KG  DR+   ++    L      C  ++P  RP+ +E++
Sbjct: 225 -------KG--DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 261

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
           A  +     ILG G FG VY+G ++    +   VAVK  K       + +F +E   +  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 355 AVHRNLLRLCGFCSTENERLLV--YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
             H ++++L G    E   +++  YPY   G    R ++ +     + ++      L   
Sbjct: 82  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQIC 135
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           + + YL        +HRD+   NIL+       +GDFGL++ ++  D +  +  R  +  
Sbjct: 136 KAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 192
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS 532
           ++PE ++  + +  +DV+ F + + E+      L FG+          W++     G L 
Sbjct: 193 MSPESINFRRFTTASDVWMFAVCMWEI------LSFGKQP------FFWLENKDVIGVLE 240
Query: 533 QMVDKDLKGNFDRIELEEMVQVALL-----CTQFNPLHRPKMSEVL 573
                  KG  DR+   ++    L      C  ++P  RP+ +E++
Sbjct: 241 -------KG--DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 277

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 108/229 (47%), Gaps = 24/229 (10%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNL 360
           +F   + LG G  G+V+K       LV  ++L    I      Q   E++ +       +
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 361 LRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARG 414
           +   G   ++ E  +   +M  GS+      A R+ + I G+          +++   +G
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKG 135
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHI 473
           L YL E+   KI+HRDVK +NIL++   E  + DFG++ +L+D     +  +  GT  ++
Sbjct: 136 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 189
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
           +PE L     S ++D++  G+ L+E+  G+  +  G  +     +LD++
Sbjct: 190 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYI 238

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 105/240 (43%), Gaps = 51/240 (21%)
Query: 296 LRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
           LR A S+F    +LG+G FG V K   + D    A+K+++       E +  T +  + L
Sbjct: 2   LRYA-SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVML 55
Query: 355 AV----------------HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA 398
                              RN ++       ++   +   Y  NG+    L D IH    
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGT----LYDLIHSE-N 110
Query: 399 LDWARRK--RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
           L+  R +  R+       L Y+H Q    IIHRD+K  NI +DE     +GDFGLAK + 
Sbjct: 111 LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNV- 166
Query: 457 HR---------------DSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI 500
           HR                 ++T+A+ GT  ++A E L  TG  +EK D++  GI+  E+I
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 18/234 (7%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-------EVQFQTEVE 350
           ATS +     +G G +G VYK      G  VA+K ++  N   G       EV     +E
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP--ALDWARRKRIA 408
                 H N++RL   C+T      +   +    V   LR ++   P   L     K + 
Sbjct: 62  AFE---HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG 468
               RGL +LH  C   I+HRD+K  NIL+       + DFGLA++  ++ +     V  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV-- 173
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
           T+ + APE L     +   D++  G +  E+   +        A+Q G + D +
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
           A  +     ILG G FG VY+G ++    +   VAVK  K       + +F +E   +  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 355 AVHRNLLRLCGFCSTENERLLV--YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
             H ++++L G    E   +++  YPY   G    R ++ +     + ++      L   
Sbjct: 70  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQIC 123
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           + + YL        +HRD+   NIL+       +GDFGL++ ++  D +  +  R  +  
Sbjct: 124 KAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS 532
           ++PE ++  + +  +DV+ F + + E+      L FG+          W++     G L 
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEI------LSFGKQP------FFWLENKDVIGVLE 228
Query: 533 QMVDKDLKGNFDRIELEEMVQVALL-----CTQFNPLHRPKMSEVL 573
                  KG  DR+   ++    L      C  ++P  RP+ +E++
Sbjct: 229 -------KG--DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELV 265

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 113/267 (42%), Gaps = 32/267 (11%)
Query: 264 RYRHNQQI-FFDVNDQYDPEVSLGHLKRYTFK-ELRAATSNFSAKNILGRGGFGIVYK-- 319
           ++R+  Q+    V    D E      + Y +  +      N     +LG G FG V    
Sbjct: 6   QFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNAT 65
Query: 320 --GCFSDGA--LVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLLRLCGFCSTENERL 374
             G    G    VAVK LK+   +       +E++ ++ L  H N++ L G C+      
Sbjct: 66  AYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 125
Query: 375 LVYPYMPNGSVASRLRD--HIHGRPALDWARRKRI-----------------ALGTARGL 415
           L++ Y   G + + LR          +++  +KR+                 A   A+G+
Sbjct: 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 185
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTAVRGTVGHIA 474
            +L  +     +HRD+ A N+L+       + DFGLA+ ++   +  V    R  V  +A
Sbjct: 186 EFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 242
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT 501
           PE L  G  + K+DV+ +GILL E+ +
Sbjct: 243 PESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 18/234 (7%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-------EVQFQTEVE 350
           ATS +     +G G +G VYK      G  VA+K ++  N   G       EV     +E
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP--ALDWARRKRIA 408
                 H N++RL   C+T      +   +    V   LR ++   P   L     K + 
Sbjct: 62  AFE---HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG 468
               RGL +LH  C   I+HRD+K  NIL+       + DFGLA++  ++ +     V  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-- 173
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
           T+ + APE L     +   D++  G +  E+   +        A+Q G + D +
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 22/220 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLK-DYNIAGGEVQFQTEVET 351
           R   ++F+   +LG+G FG V     KG      L A+K LK D  I   +V+  T VE 
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKVMLADRKGT---EELYAIKILKKDVVIQDDDVEC-TMVEK 70
Query: 352 ISLAVHRN---LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             LA+      L +L     T +    V  Y+  G     L  HI         +    A
Sbjct: 71  RVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGD----LMYHIQQVGKFKEPQAVFYA 126
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-AVR 467
              + GL +LH++    II+RD+K  N++LD +    + DFG+ K  +H    VTT    
Sbjct: 127 AEISIGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFC 181
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
           GT  +IAPE ++     +  D + +G+LL E++ GQ   D
Sbjct: 182 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 126
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 187 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 224

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G G +G+VYK   S G +VA+KR++ D    G       E+  +    H N++ L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
            +E    LV+ +M       ++ D    +  L  ++ K       RG+ + H+    +I+
Sbjct: 89  HSERCLTLVFEFMEKD--LKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQH---RIL 141
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL-STGQSSEK 486
           HRD+K  N+L++ D    + DFGLA+         T  V  T+ + AP+ L  + + S  
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTS 200
Query: 487 TDVFGFGILLLELITGQ 503
            D++  G +  E+ITG+
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 186 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 223

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G G +G+VYK   S G +VA+KR++ D    G       E+  +    H N++ L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
            +E    LV+ +M       ++ D    +  L  ++ K       RG+ + H+    +I+
Sbjct: 89  HSERCLTLVFEFMEKD--LKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQH---RIL 141
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL-STGQSSEK 486
           HRD+K  N+L++ D    + DFGLA+         T  V  T+ + AP+ L  + + S  
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTS 200
Query: 487 TDVFGFGILLLELITGQ 503
            D++  G +  E+ITG+
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 186 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQEYSDWKEK 223

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           R    +++   ++G G FG+VY+    D G LVA+K+     +  G+     E++ +   
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFKNRELQIMRKL 70
Query: 356 VHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
            H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K    
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRG 468
              R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+     
Sbjct: 130 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-- 184
Query: 469 TVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
           +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 16/227 (7%)
Query: 302 NFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVHR 358
           +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 359 NLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
             ++L  F   ++E+L     Y  NG     L  +I    + D    +         L Y
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGC----LLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPE 476
           LH +    IIHRD+K  NILL+ED    + DFG AK+L          +  GT  +++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
            L+   +S+ +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 248

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 122/275 (44%), Gaps = 37/275 (13%)
Query: 309 LGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLC-G 365
           +GRG F  VYKG  ++  + VA   L+D  +   E Q F+ E E +    H N++R    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 366 FCSTENER---LLVYPYMPNGSVASRLRDHIHGRPAL--DWARRKRIALGTARGLLYLHE 420
           + ST   +   +LV     +G++ + L+     +  +   W R+        +GL +LH 
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQFLHT 147
Query: 421 QCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           +  P IIHRD+K  NI +     +V +GD GLA L   + +    AV GT    APE   
Sbjct: 148 RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPEXYE 203
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             +  E  DV+ FG   LE  T +      + A Q                + + V   +
Sbjct: 204 E-KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQ----------------IYRRVTSGV 246
Query: 540 K-GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
           K  +FD++ + E+ ++   C + N   R  + ++L
Sbjct: 247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 186 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 223

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNL 360
           +F   + LG G  G+V+K       LV  ++L    I      Q   E++ +       +
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 361 LRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARG 414
           +   G   ++ E  +   +M  GS+      A R+ + I G+          +++   +G
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKG 178
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHI 473
           L YL E+   KI+HRDVK +NIL++   E  + DFG++ +L+D     +  +  GT  ++
Sbjct: 179 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 232
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           +PE L     S ++D++  G+ L+E+  G+
Sbjct: 233 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 302 NFSAKNILGRGGFGIVYKGCF--SDGALV--AVKRLKDYNIAGGEVQ-FQTEVETISLAV 356
            F+   +LG+G FG V +      DG+ V  AVK LK   IA  +++ F  E   +    
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 357 HRNLLRLCGFCSTENER------LLVYPYMPNGSV-----ASRLRDHIHGRPALDWARRK 405
           H ++ +L G       +      +++ P+M +G +     ASR+ ++    P     R  
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR-- 141
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-T 464
              +  A G+ YL  +     IHRD+ A N +L ED    V DFGL++ +   D +    
Sbjct: 142 -FMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           A +  V  +A E L+    +  +DV+ FG+ + E++T
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 126/279 (45%), Gaps = 59/279 (21%)
Query: 305 AKNILGRGGFG-IVYKGCFSDGALVAVKR-LKDY-NIAGGEVQFQTEVETISLAVHRNLL 361
           ++ ILG G  G +V++G F  G  VAVKR L D+ +IA  E++  TE +      H N++
Sbjct: 19  SEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVI 72
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR-----IAL--GTARG 414
           R   +CS   +R L   Y+        L+D +  +   D   + +     I+L    A G
Sbjct: 73  RY--YCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 415 LLYLHEQCDPKIIHRDVKAANILLD-------------EDFEAVVGDFGLAKLLDHRDSH 461
           + +LH     KIIHRD+K  NIL+              E+   ++ DFGL K LD   S 
Sbjct: 128 VAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 462 VTTAVR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGILLLELIT-GQRAL--DF 508
             T +    GT G  APE L    +       +   D+F  G +   +++ G+      +
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 509 GRAAN-QRGVM-LDWVKKLHQEG-------KLSQMVDKD 538
            R +N  RG+  LD +K LH           +SQM+D D
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 186 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 223

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 18/234 (7%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-------EVQFQTEVE 350
           ATS +     +G G +G VYK      G  VA+K ++  N   G       EV     +E
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP--ALDWARRKRIA 408
                 H N++RL   C+T      +   +    V   LR ++   P   L     K + 
Sbjct: 62  AFE---HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG 468
               RGL +LH  C   I+HRD+K  NIL+       + DFGLA++  ++ +     V  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV-- 173
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
           T+ + APE L     +   D++  G +  E+   +        A+Q G + D +
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           R    +++   ++G G FG+VY+    D G LVA+K+     +  G+     E++ +   
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFKNRELQIMRKL 70
Query: 356 VHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
            H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K    
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRG 468
              R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+     
Sbjct: 130 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 184
Query: 469 TVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
           +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L          A  GT  +++P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP 201
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 246

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 125/300 (41%), Gaps = 59/300 (19%)
Query: 302 NFSAKNI-----LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETIS-- 353
           +F+A+++     +GRG +G V K      G ++AVKR++       + Q   +++ +   
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS 77
Query: 354 ------LAVHRNLLRL--CGFC----STENERLLVYPYMPNGSVASRLRDHIHGRPALDW 401
                 +  +  L R   C  C    ST  ++   Y Y     V   + + I G+     
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV---IPEEILGK----- 129
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
                I L T + L +L E    KIIHRD+K +NILLD      + DFG++  L   DS 
Sbjct: 130 -----ITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSI 180
Query: 462 VTTAVRGTVGHIAPEYLSTGQSSE----KTDVFGFGILLLELITGQRALDFGRAANQRGV 517
             T   G   ++APE +    S +    ++DV+  GI L EL TG            R  
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG------------RFP 228
Query: 518 MLDWVKKLHQEGKLSQMVDKD---LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
              W     Q   L+Q+V  D   L  + +R      +    LC   +   RPK  E+LK
Sbjct: 229 YPKWNSVFDQ---LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNL 360
           +F   + LG G  G+V+K       LV  ++L    I      Q   E++ +       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 361 LRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARG 414
           +   G   ++ E  +   +M  GS+      A R+ + I G+          +++   +G
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKG 116
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHI 473
           L YL E+   KI+HRDVK +NIL++   E  + DFG++ +L+D     +  +  GT  ++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 170
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           +PE L     S ++D++  G+ L+E+  G+
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           R    +++   ++G G FG+VY+    D G LVA+K+     +  G+     E++ +   
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQGKAFKNRELQIMRKL 70
Query: 356 VHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
            H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K    
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRG 468
              R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+     
Sbjct: 130 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 184
Query: 469 TVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQ 503
           +  + APE +      +   DV+  G +L EL+ GQ
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 186 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 223

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+   ++  H N+++  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 126
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 187 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 224

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 126
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 187 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 224

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 126
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 187 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 224

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 126
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 187 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 224

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 186 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 223

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 21/237 (8%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG----------EVQFQT 347
           ATS +     +G G +G VYK      G  VA+K ++  N  GG          EV    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP--ALDWARRK 405
            +E      H N++RL   C+T      +   +    V   LR ++   P   L     K
Sbjct: 67  RLEAFE---HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
            +     RGL +LH  C   I+HRD+K  NIL+       + DFGLA++  ++ +   T 
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTP 178
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
           V  T+ + APE L     +   D++  G +  E+   +        A+Q G + D +
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNL 360
           +F   + LG G  G+V+K       LV  ++L    I      Q   E++ +       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 361 LRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARG 414
           +   G   ++ E  +   +M  GS+      A R+ + I G+          +++   +G
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKG 116
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHI 473
           L YL E+   KI+HRDVK +NIL++   E  + DFG++ +L+D     +  +  GT  ++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 170
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           +PE L     S ++D++  G+ L+E+  G+
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 111/246 (45%), Gaps = 17/246 (6%)
Query: 290 RYTFKELRAATSN-FSAKNILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAG--GEVQ 344
           ++ + E +  T N F    +LG+GGFG V   C   + G + A K+L+   I    GE  
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWA 402
              E + +     R ++ L     T++   LV   M  G     L+ HI+  G+     A
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD----LKFHIYHMGQAGFPEA 286
Query: 403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462
           R    A     GL  LH +   +I++RD+K  NILLD+     + D GLA  +   +   
Sbjct: 287 RAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQT 341
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
                GTVG++APE +   + +   D +  G LL E+I GQ      +   +R  +   V
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 401
Query: 523 KKLHQE 528
           K++ +E
Sbjct: 402 KEVPEE 407

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 111/246 (45%), Gaps = 17/246 (6%)
Query: 290 RYTFKELRAATSN-FSAKNILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAG--GEVQ 344
           ++ + E +  T N F    +LG+GGFG V   C   + G + A K+L+   I    GE  
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWA 402
              E + +     R ++ L     T++   LV   M  G     L+ HI+  G+     A
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD----LKFHIYHMGQAGFPEA 286
Query: 403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462
           R    A     GL  LH +   +I++RD+K  NILLD+     + D GLA  +   +   
Sbjct: 287 RAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQT 341
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
                GTVG++APE +   + +   D +  G LL E+I GQ      +   +R  +   V
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 401
Query: 523 KKLHQE 528
           K++ +E
Sbjct: 402 KEVPEE 407

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNL 360
           +F   + LG G  G+V+K       LV  ++L    I      Q   E++ +       +
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 361 LRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARG 414
           +   G   ++ E  +   +M  GS+      A R+ + I G+          +++   +G
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKG 143
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L YL E+   KI+HRDVK +NIL++   E  + DFG++  L   DS   + V GT  +++
Sbjct: 144 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMS 198
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           PE L     S ++D++  G+ L+E+  G+
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 302 NFSAKNILGRGGFGIV-YKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           N+     +G+G F  V        G  VAVK +    +    +Q    EV  + +  H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TE    LV  Y   G V   L    HGR     AR K   + +A  + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSA--VQYCH 130
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++    I+HRD+KA N+LLD D    + DFG +      +   T    G+  + APE L 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPE-LF 184
Query: 480 TGQSSE--KTDVFGFGILLLELITGQRALD 507
            G+  +  + DV+  G++L  L++G    D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           N+     +G+G F  V        G  VAVK +    +    +Q    EV  + +  H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TE    LV  Y   G V   L    HGR     AR K   + +A  + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSA--VQYCH 130
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++    I+HRD+KA N+LLD D    + DFG +      +   T    G+  + APE L 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPE-LF 184
Query: 480 TGQSSE--KTDVFGFGILLLELITGQRALD 507
            G+  +  + DV+  G++L  L++G    D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNL 360
           +F   + LG G  G+V+K       LV  ++L    I      Q   E++ +       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 361 LRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARG 414
           +   G   ++ E  +   +M  GS+      A R+ + I G+          +++   +G
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKG 116
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHI 473
           L YL E+   KI+HRDVK +NIL++   E  + DFG++ +L+D     +  +  GT  ++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 170
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           +PE L     S ++D++  G+ L+E+  G+
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 186 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 223

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 186 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 223

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNL 360
           +F   + LG G  G+V+K       LV  ++L    I      Q   E++ +       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 361 LRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARG 414
           +   G   ++ E  +   +M  GS+      A R+ + I G+          +++   +G
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKG 116
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHI 473
           L YL E+   KI+HRDVK +NIL++   E  + DFG++ +L+D     +  +  GT  ++
Sbjct: 117 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 170
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           +PE L     S ++D++  G+ L+E+  G+
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 186 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 223

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNL 360
           +F   + LG G  G+V+K       LV  ++L    I      Q   E++ +       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 361 LRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARG 414
           +   G   ++ E  +   +M  GS+      A R+ + I G+          +++   +G
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKG 116
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHI 473
           L YL E+   KI+HRDVK +NIL++   E  + DFG++ +L+D     +  +  GT  ++
Sbjct: 117 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 170
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           +PE L     S ++D++  G+ L+E+  G+
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 124
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 185 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 222

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 186 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 223

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 14/210 (6%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           N+     +G+G F  V        G  VAVK +    +    +Q    EV  + +  H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TE    LV  Y   G V   L    HGR     AR K   + +A  + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSA--VQYCH 130
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++    I+HRD+KA N+LLD D    + DFG +      +     A  G   + APE L 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPE-LF 184
Query: 480 TGQSSE--KTDVFGFGILLLELITGQRALD 507
            G+  +  + DV+  G++L  L++G    D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 70  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 124
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 125 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 181
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 182 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 226

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G FG V++G +    +    VA+K  K+        +F  E  T+    H ++++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   TEN   ++      G + S L+   +   +LD A     A   +  L YL  +   
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK--- 130
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           + +HRD+ A N+L+  +    +GDFGL++ ++    +  +  +  +  +APE ++  + +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 485 EKTDVFGFGILLLELI 500
             +DV+ FG+ + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 125
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 186 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 223

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 126
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 187 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 224

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 126
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 187 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 224

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +G V       ++ A VAVK +            + E+    +  H N+++  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
               N + L   Y   G +  R+   I G P  D    +R       G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGI 126
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SS 484
            HRD+K  N+LLDE     + DFGLA +  + +   +   + GT+ ++APE L   +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E  DV+  GI+L  ++ G+  L + + ++      DW +K
Sbjct: 187 EPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWKEK 224

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 308 ILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           +LG+G +GIVY G   S+   +A+K + + +    +     E+       H+N+++  G 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR---GLLYLHEQCD 423
            S      +    +P GS+++ LR      P  D    + I   T +   GL YLH   D
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWG--PLKD--NEQTIGFYTKQILEGLKYLH---D 140
Query: 424 PKIIHRDVKAANILLDEDFEAV--VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
            +I+HRD+K  N+L++  +  V  + DFG +K L   +   T    GT+ ++APE +  G
Sbjct: 141 NQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKG 198
Query: 482 QS--SEKTDVFGFGILLLELITGQ 503
                +  D++  G  ++E+ TG+
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLA 355
           R      +    +G+G +G V++G +  G  VAVK     +    +  F +TE+    L 
Sbjct: 4   RTVARQVALVECVGKGRYGEVWRGLWH-GESVAVKIFSSRD---EQSWFRETEIYNTVLL 59
Query: 356 VHRNLLRLCGFCSTE-------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
            H N+L   GF +++        +  L+  Y  +GS+   L+     R  L+     R+A
Sbjct: 60  RHDNIL---GFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQ-----RQTLEPHLALRLA 111
Query: 409 LGTARGLLYLH-----EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
           +  A GL +LH      Q  P I HRD K+ N+L+  + +  + D GLA +      ++ 
Sbjct: 112 VSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLD 171
Query: 464 TAVRGTVG---HIAPEYLSTG------QSSEKTDVFGFGILLLEL 499
                 VG   ++APE L         +S + TD++ FG++L E+
Sbjct: 172 IGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 123
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 124 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 180
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 181 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 225

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK----DYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G +G+VYK   + G   A+K+++    D  I    ++   E+  +    H N+++L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLY 66
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
               T+   +LV+ ++       +L D   G   L+    K   L    G+ Y H   D 
Sbjct: 67  DVIHTKKRLVLVFEHLDQD--LKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL-STGQS 483
           +++HRD+K  N+L++ + E  + DFGLA+         T  V  T+ + AP+ L  + + 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 484 SEKTDVFGFGILLLELITG 502
           S   D++  G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK----DYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G +G+VYK   + G   A+K+++    D  I    ++   E+  +    H N+++L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLY 66
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
               T+   +LV+ ++       +L D   G   L+    K   L    G+ Y H   D 
Sbjct: 67  DVIHTKKRLVLVFEHLDQD--LKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL-STGQS 483
           +++HRD+K  N+L++ + E  + DFGLA+         T  V  T+ + AP+ L  + + 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 484 SEKTDVFGFGILLLELITG 502
           S   D++  G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF---SDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G FG V++G +    + AL VA+K  K+        +F  E  T+    H ++++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   TEN   ++      G + S L+   +   +LD A     A   +  L YL  +   
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK--- 130
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           + +HRD+ A N+L+  +    +GDFGL++ ++    +  +  +  +  +APE ++  + +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 485 EKTDVFGFGILLLELI 500
             +DV+ FG+ + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 143
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L          +  GT  +++P
Sbjct: 144 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 200
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 245

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 123 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 179
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 224

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 34/229 (14%)
Query: 283 VSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG- 341
           ++LG LK   F+++            LG G  G+V+K       LV  ++L    I    
Sbjct: 1   MALGELKDDDFEKISE----------LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI 50
Query: 342 EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHG 395
             Q   E++ +       ++   G   ++ E  +   +M  GS+      A R+ + I G
Sbjct: 51  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 110
Query: 396 RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KL 454
           +          +++   +GL YL E+   KI+HRDVK +NIL++   E  + DFG++ +L
Sbjct: 111 K----------VSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 158
Query: 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           +D     +     GT  +++PE L     S ++D++  G+ L+E+  G+
Sbjct: 159 ID----EMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF---SDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G FG V++G +    + AL VA+K  K+        +F  E  T+    H ++++L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   TEN   ++      G + S L+   +   +LD A     A   +  L YL  +   
Sbjct: 106 GVI-TENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK--- 158
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           + +HRD+ A N+L+  +    +GDFGL++ ++    +  +  +  +  +APE ++  + +
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 485 EKTDVFGFGILLLELI 500
             +DV+ FG+ + E++
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 34/225 (15%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLA 355
           R    + +    +G+G +G V++G +  G  VAVK     +    +  F +TE+    + 
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVML 59
Query: 356 VHRNLLRLCGFCSTE-------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
            H N+L   GF +++        +  L+  Y   GS+   L+        LD     RI 
Sbjct: 60  RHENIL---GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIV 111
Query: 409 LGTARGLLYLH-----EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
           L  A GL +LH      Q  P I HRD+K+ NIL+ ++ +  + D GLA +     + + 
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 464 TAVRGTVG---HIAPEYLSTG------QSSEKTDVFGFGILLLEL 499
                 VG   ++APE L          S ++ D++ FG++L E+
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 16/227 (7%)
Query: 302 NFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVHR 358
           +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 359 NLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
             ++L  F   ++E+L     Y  NG     L  +I    + D    +         L Y
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPE 476
           LH +    IIHRD+K  NILL+ED    + DFG AK+L          +  GT  +++PE
Sbjct: 149 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
            L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 249

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF---SDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G FG V++G +    + AL VA+K  K+        +F  E  T+    H ++++L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   TEN   ++      G + S L+   +   +LD A     A   +  L YL  +   
Sbjct: 75  GVI-TENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK--- 127
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           + +HRD+ A N+L+  +    +GDFGL++ ++    +  +  +  +  +APE ++  + +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 485 EKTDVFGFGILLLELI 500
             +DV+ FG+ + E++
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 67  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 121
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 122 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 178
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 179 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 223

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 309 LGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G FG V++G +    +    VA+K  K+        +F  E  T+    H ++++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   TEN   ++      G + S L+     + +LD A     A   +  L YL  +   
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLSTGQ 482
           + +HRD+ A N+L+  +    +GDFGL++ ++  DS    A +G   +  +APE ++  +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTXXKASKGKLPIKWMAPESINFRR 188
Query: 483 SSEKTDVFGFGILLLELI 500
            +  +DV+ FG+ + E++
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 104/240 (43%), Gaps = 51/240 (21%)
Query: 296 LRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
           LR A S+F    +LG+G FG V K   + D    A+K+++       E +  T +  + L
Sbjct: 2   LRYA-SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVML 55
Query: 355 AV----------------HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA 398
                              RN ++       ++   +   Y  N +    L D IH    
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRT----LYDLIHSE-N 110
Query: 399 LDWARRK--RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
           L+  R +  R+       L Y+H Q    IIHRD+K  NI +DE     +GDFGLAK + 
Sbjct: 111 LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNV- 166
Query: 457 HR---------------DSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI 500
           HR                 ++T+A+ GT  ++A E L  TG  +EK D++  GI+  E+I
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF---SDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G FG V++G +    + AL VA+K  K+        +F  E  T+    H ++++L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   TEN   ++      G + S L+   +   +LD A     A   +  L YL  +   
Sbjct: 80  GVI-TENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK--- 132
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           + +HRD+ A N+L+  +    +GDFGL++ ++    +  +  +  +  +APE ++  + +
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 485 EKTDVFGFGILLLELI 500
             +DV+ FG+ + E++
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           N+     +G+G F  V        G  VAVK +    +    +Q    EV  + +  H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TE    LV  Y   G V   L  H        W + K  A    R ++   
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-------GWMKEKE-ARAKFRQIVSAV 119
Query: 420 EQCDPK-IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           + C  K I+HRD+KA N+LLD D    + DFG +      +   T    G+  + APE L
Sbjct: 120 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPE-L 176
Query: 479 STGQSSE--KTDVFGFGILLLELITGQRALD 507
             G+  +  + DV+  G++L  L++G    D
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 308 ILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           +LG+G +GIVY G   S+   +A+K + + +    +     E+       H+N+++  G 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 73
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR---GLLYLHEQCD 423
            S      +    +P GS+++ LR      P  D    + I   T +   GL YLH   D
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWG--PLKD--NEQTIGFYTKQILEGLKYLH---D 126
Query: 424 PKIIHRDVKAANILLDEDFEAV--VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
            +I+HRD+K  N+L++  +  V  + DFG +K L   +   T    GT+ ++APE +  G
Sbjct: 127 NQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKG 184
Query: 482 QS--SEKTDVFGFGILLLELITGQ 503
                +  D++  G  ++E+ TG+
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGK 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G FG V++G +    +    VA+K  K+        +F  E  T+    H ++++L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   TEN   ++      G + S L+   +   +LD A     A   +  L YL  +   
Sbjct: 83  GVI-TENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK--- 135
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           + +HRD+ A N+L+  +    +GDFGL++ ++    +  +  +  +  +APE ++  + +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 485 EKTDVFGFGILLLELI 500
             +DV+ FG+ + E++
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF---SDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G FG V++G +    + AL VA+K  K+        +F  E  T+    H ++++L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   TEN   ++      G + S L+   +   +LD A     A   +  L YL  +   
Sbjct: 81  GVI-TENPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK--- 133
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           + +HRD+ A N+L+  +    +GDFGL++ ++    +  +  +  +  +APE ++  + +
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 485 EKTDVFGFGILLLELI 500
             +DV+ FG+ + E++
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK----DYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G +G+VYK   + G   A+K+++    D  I    ++   E+  +    H N+++L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIVKLY 66
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
               T+   +LV+ ++       +L D   G   L+    K   L    G+ Y H   D 
Sbjct: 67  DVIHTKKRLVLVFEHLDQD--LKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL-STGQS 483
           +++HRD+K  N+L++ + E  + DFGLA+         T  +  T+ + AP+ L  + + 
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKY 178
Query: 484 SEKTDVFGFGILLLELITG 502
           S   D++  G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 302 NFSAKNILGRGGFGIV-YKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           N+     +G+G F  V        G  VAV+ +    +    +Q    EV  + +  H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TE    LV  Y   G V   L    HGR     AR K   + +A  + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSA--VQYCH 130
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++    I+HRD+KA N+LLD D    + DFG +      +   T    G+  + APE L 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPE-LF 184
Query: 480 TGQSSE--KTDVFGFGILLLELITGQRALD 507
            G+  +  + DV+  G++L  L++G    D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 34/225 (15%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLA 355
           R      +    +G+G +G V++G +  G  VAVK     +    +  F +TE+    + 
Sbjct: 4   RTVAHQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVML 59
Query: 356 VHRNLLRLCGFCSTE-------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
            H N+L   GF +++        +  L+  Y   GS+   L+        LD     RI 
Sbjct: 60  RHENIL---GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIV 111
Query: 409 LGTARGLLYLH-----EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
           L  A GL +LH      Q  P I HRD+K+ NIL+ ++ +  + D GLA +     + + 
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 464 TAVRGTVG---HIAPEYLSTG------QSSEKTDVFGFGILLLEL 499
                 VG   ++APE L          S ++ D++ FG++L E+
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG G FG VYK    + GAL A K ++  +    E  +  E+E ++   H  +++L G  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 77
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG--RPALDWARRKRIALGTARGLLYLHEQCDPK 425
             + +  ++  + P G+V + + +   G   P +    R+ +       L +LH +   +
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLHSK---R 129
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLA----KLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
           IIHRD+KA N+L+  + +  + DFG++    K L  RDS + T        +  E +   
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 482 QSSEKTDVFGFGILLLEL 499
               K D++  GI L+E+
Sbjct: 190 PYDYKADIWSLGITLIEM 207

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 128
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 129 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 185
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 186 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 248

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG G FG VYK    + GAL A K ++  +    E  +  E+E ++   H  +++L G  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 85
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHG--RPALDWARRKRIALGTARGLLYLHEQCDPK 425
             + +  ++  + P G+V + + +   G   P +    R+ +       L +LH +   +
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLHSK---R 137
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLA----KLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
           IIHRD+KA N+L+  + +  + DFG++    K L  RDS + T        +  E +   
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 482 QSSEKTDVFGFGILLLEL 499
               K D++  GI L+E+
Sbjct: 198 PYDYKADIWSLGITLIEM 215

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 34/225 (15%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLA 355
           R      +    +G+G +G V++G +  G  VAVK     +    +  F +TE+    + 
Sbjct: 33  RTVARQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVML 88
Query: 356 VHRNLLRLCGFCSTE-------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
            H N+L   GF +++        +  L+  Y   GS+   L+        LD     RI 
Sbjct: 89  RHENIL---GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIV 140
Query: 409 LGTARGLLYLH-----EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
           L  A GL +LH      Q  P I HRD+K+ NIL+ ++ +  + D GLA +     + + 
Sbjct: 141 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 200
Query: 464 TAVRGTVG---HIAPEYLSTG------QSSEKTDVFGFGILLLEL 499
                 VG   ++APE L          S ++ D++ FG++L E+
Sbjct: 201 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 248

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 7/200 (3%)
Query: 307 NILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VH-RNLLRL 363
            +LGRGGFG V+     + G L A K+L    +   +      VE   LA VH R ++ L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
                T+ +  LV   M  G +   + +     P     R          GL +LH++  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
             II+RD+K  N+LLD+D    + D GLA  L    +  T    GT G +APE L   + 
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 484 SEKTDVFGFGILLLELITGQ 503
               D F  G+ L E+I  +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 143
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 144 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 200
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 245

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 303 FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           +  K  LG GGFG V +    D G  VA+K+ +         ++  E++ +    H N++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 362 RL------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
                       +  +  LL   Y   G +   L +       L     + +    +  L
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSAL 135
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVG---DFGLAKLLDHRDSHVTTAVRGTVGH 472
            YLHE    +IIHRD+K  NI+L    + ++    D G AK LD     + T   GT+ +
Sbjct: 136 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQY 190
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
           +APE L   + +   D + FG L  E ITG R
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 147
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 148 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 204
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 249

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 246

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 7/200 (3%)
Query: 307 NILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VH-RNLLRL 363
            +LGRGGFG V+     + G L A K+L    +   +      VE   LA VH R ++ L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
                T+ +  LV   M  G +   + +     P     R          GL +LH++  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
             II+RD+K  N+LLD+D    + D GLA  L    +  T    GT G +APE L   + 
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 484 SEKTDVFGFGILLLELITGQ 503
               D F  G+ L E+I  +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 303 FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           +  K  LG GGFG V +    D G  VA+K+ +         ++  E++ +    H N++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 362 RL------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
                       +  +  LL   Y   G +   L +       L     + +    +  L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSAL 134
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVG---DFGLAKLLDHRDSHVTTAVRGTVGH 472
            YLHE    +IIHRD+K  NI+L    + ++    D G AK LD     + T   GT+ +
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQY 189
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
           +APE L   + +   D + FG L  E ITG R
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 127/289 (43%), Gaps = 41/289 (14%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 362 RLCGFCSTENERLLV-YPYMPNGSVASRLR----DHIHGRPA------LDWARRKRIALG 410
            L G C+     L+V   +   G++++ LR    + +  +P       L        +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRGT 469
            A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +      V     R  
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKLHQ 527
           +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L +
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL-K 265
Query: 528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 266 EGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 328 VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVAS 387
           VAVK +            + E+    +  H N+++  G     N + L   Y   G +  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 388 RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 447
           R+   I G P  D    +R       G++YLH      I HRD+K  N+LLDE     + 
Sbjct: 94  RIEPDI-GMPEPD---AQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS 146
Query: 448 DFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRA 505
           DFGLA +  + +   +   + GT+ ++APE L   +  +E  DV+  GI+L  ++ G+  
Sbjct: 147 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-- 204
Query: 506 LDFGRAANQRGVMLDWVKK 524
           L + + ++      DW +K
Sbjct: 205 LPWDQPSDSCQEYSDWKEK 223

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 248

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 17/229 (7%)
Query: 302 NFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVHR 358
           +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 359 NLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
             ++L  F   ++E+L     Y  NG     L  +I    + D    +         L Y
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPE 476
           LH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL 525
            L+   + + +D++  G ++ +L+ G   L   RA N+ G++   + KL
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAG---LPPFRAGNE-GLIFAKIIKL 249

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 246

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 7/200 (3%)
Query: 307 NILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VH-RNLLRL 363
            +LGRGGFG V+     + G L A K+L    +   +      VE   LA VH R ++ L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
                T+ +  LV   M  G +   + +     P     R          GL +LH++  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
             II+RD+K  N+LLD+D    + D GLA  L    +  T    GT G +APE L   + 
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 484 SEKTDVFGFGILLLELITGQ 503
               D F  G+ L E+I  +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 16/227 (7%)
Query: 302 NFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVHR 358
           +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H 
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 359 NLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
             ++L  F   ++E+L     Y  NG     L  +I    + D    +         L Y
Sbjct: 96  FFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 150
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPE 476
           LH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++PE
Sbjct: 151 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
            L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 251

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 7/200 (3%)
Query: 307 NILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VH-RNLLRL 363
            +LGRGGFG V+     + G L A K+L    +   +      VE   LA VH R ++ L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
                T+ +  LV   M  G +   + +     P     R          GL +LH++  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
             II+RD+K  N+LLD+D    + D GLA  L    +  T    GT G +APE L   + 
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 484 SEKTDVFGFGILLLELITGQ 503
               D F  G+ L E+I  +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 126/287 (43%), Gaps = 39/287 (13%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 362 RLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHG--------RPALDWARRKRIALGTA 412
            L G C+     L+V   +   G++++ LR   +         +  L        +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRGTVG 471
           +G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R  + 
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKLHQEG 529
            +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L +EG
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFXRRL-KEG 263
Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
              +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 264 TRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 14/210 (6%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           N+  +  +G+G F  V        G  VAVK +    +    +Q    EV  + +  H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TE    LV  Y   G V   L    HGR     AR K   + +A  + Y H
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSA--VQYCH 131
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++    I+HRD+KA N+LLD D    + DFG +      +   T    G+  + APE L 
Sbjct: 132 QKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC--GSPPYAAPE-LF 185
Query: 480 TGQSSE--KTDVFGFGILLLELITGQRALD 507
            G+  +  + DV+  G++L  L++G    D
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 104/229 (45%), Gaps = 17/229 (7%)
Query: 302 NFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVHR 358
           +F    ILG G F  +V     +     A+K L K + I   +V + T E + +S   H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 359 NLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
             ++L  F   ++E+L     Y  NG     L  +I    + D    +         L Y
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPE 476
           LH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL 525
            L+   + + +D++  G ++ +L+ G   L   RA N+ G++   + KL
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNE-GLIFAKIIKL 249

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 39/221 (17%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           +F    ++G GGFG V+K     DG    +KR+K YN    E     EV+ ++   H N+
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAE----REVKALAKLDHVNI 66
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH---------GRPALD-WARRKR---- 406
           +   G           + Y P  S  +  R              +  L+ W  ++R    
Sbjct: 67  VHYNGCWDG-------FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 407 ---IAL----GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
              +AL       +G+ Y+H +   K+I+RD+K +NI L +  +  +GDFGL   L +  
Sbjct: 120 DKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 500
               +  +GT+ +++PE +S+    ++ D++  G++L EL+
Sbjct: 177 KRXRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 80/180 (44%), Gaps = 12/180 (6%)
Query: 29  AGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSG 88
           AG  Y  +    +K   H   N+LE   I S      R+ T +P        + S+   G
Sbjct: 568 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ--LNRLSTRNP------CNITSRVYGG 619
Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXX 148
             SP   N   +  + +  N + G IP  +G +  L  L+L +N  +G IPD +GD    
Sbjct: 620 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 679
Query: 149 XXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-RTF---KVTGNPLICG 204
                      G  P+++S +  LT +DLS NNLSG +P++    TF   K   NP +CG
Sbjct: 680 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 739

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G FG V++G +    +    VA+K  K+        +F  E  T+    H ++++L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   TEN   ++      G + S L+     + +LD A     A   +  L YL  +   
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           + +HRD+ A N+L+  +    +GDFGL++ ++    +  +  +  +  +APE ++  + +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 485 EKTDVFGFGILLLELI 500
             +DV+ FG+ + E++
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 309 LGRGGFGIVYKGCF---SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           LG G FG V +G +        VA+K LK         +   E + +    +  ++RL G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
            C  E   L++   M  G    +    +  R  +  +    +    + G+ YL E+    
Sbjct: 78  VCQAEA--LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAVRGTVGHIAPEYLSTGQS 483
            +HRD+ A N+LL     A + DFGL+K L   DS+ T  +A +  +   APE ++  + 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 484 SEKTDVFGFGILLLELIT-GQR 504
           S ++DV+ +G+ + E ++ GQ+
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQK 212

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 14/210 (6%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           N+     +G+G F  V        G  VAVK +    +    +Q    EV    +  H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TE    LV  Y   G V   L    HGR     AR K   + +A  + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLV--AHGRXKEKEARAKFRQIVSA--VQYCH 130
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++    I+HRD+KA N+LLD D    + DFG +      +     A  G   + APE L 
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPE-LF 184
Query: 480 TGQSSE--KTDVFGFGILLLELITGQRALD 507
            G+  +  + DV+  G++L  L++G    D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNL 360
           +F   + LG G  G+V K       L+  ++L    I      Q   E++ +       +
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 361 LRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARG 414
           +   G   ++ E  +   +M  GS+      A R+ + I G+          +++   RG
Sbjct: 77  VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK----------VSIAVLRG 126
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHI 473
           L YL E+   +I+HRDVK +NIL++   E  + DFG++ +L+D     +  +  GT  ++
Sbjct: 127 LAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 180
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           APE L     S ++D++  G+ L+EL  G+
Sbjct: 181 APERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G FG V++G +    +    VA+K  K+        +F  E  T+    H ++++L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   TEN   ++      G + S L+     + +LD A     A   +  L YL  +   
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           + +HRD+ A N+L+       +GDFGL++ ++    +  +  +  +  +APE ++  + +
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 485 EKTDVFGFGILLLELI 500
             +DV+ FG+ + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           +G+G +G V+ G +  G  VAVK    +         +TE+    L  H N+L   GF +
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVF--FTTEEASWFRETEIYQTVLMRHENIL---GFIA 98
Query: 369 TE-------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE- 420
            +        +  L+  Y  NGS+   L+        LD     ++A  +  GL +LH  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 421 ----QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK--LLDHRDSHVTTAVR-GTVGHI 473
               Q  P I HRD+K+ NIL+ ++    + D GLA   + D  +  +    R GT  ++
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 474 APEYLSTG------QSSEKTDVFGFGILLLEL 499
            PE L         QS    D++ FG++L E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 126/287 (43%), Gaps = 39/287 (13%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 362 RLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHG--------RPALDWARRKRIALGTA 412
            L G C+     L+V   +   G++++ LR   +         +  L        +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRGTVG 471
           +G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R  + 
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKLHQEG 529
            +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L +EG
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL-KEG 263
Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
              +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 264 TRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 18/218 (8%)
Query: 297 RAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLK-DYNIAGGEVQF-QTEVE 350
           R   ++F+   +LG+G FG V     KG      L AVK LK D  I   +V+    E  
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 351 TISLAVHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
            ++L      L     C    +RL  V  Y+  G     L  HI              A 
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD----LMYHIQQVGRFKEPHAVFYAA 128
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
             A GL +L  +    II+RD+K  N++LD +    + DFG+ K  +  D   T    GT
Sbjct: 129 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKXFCGT 184
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
             +IAPE ++     +  D + FG+LL E++ GQ   +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 309 LGRGGFGIV--YKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG GGF  V   +G   DG   A+KR+  +     E + Q E +   L  H N+LRL  +
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNILRLVAY 94
Query: 367 CSTE----NERLLVYPYMPNGSV---ASRLRD--HIHGRPALDWARRKRIALGTARGLLY 417
           C  E    +E  L+ P+   G++     RL+D  +      + W     + LG  RGL  
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW-----LLLGICRGLEA 149
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-----------TAV 466
           +H +      HRD+K  NILL ++ + V+ D G    ++    HV             A 
Sbjct: 150 IHAK---GYAHRDLKPTNILLGDEGQPVLMDLG---SMNQACIHVEGSRQALTLQDWAAQ 203
Query: 467 RGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELITGQRALDF 508
           R T+ + APE  S        E+TDV+  G +L  ++ G+   D 
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 14/210 (6%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           N+     +G+G F  V        G  VAV+ +    +    +Q    EV  + +  H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TE    LV  Y   G V   L    HGR     AR K   + +A  + Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSA--VQYCH 130
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++    I+HRD+KA N+LLD D    + DFG +      +        G+  + APE L 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFCGSPPYAAPE-LF 184
Query: 480 TGQSSE--KTDVFGFGILLLELITGQRALD 507
            G+  +  + DV+  G++L  L++G    D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 80/180 (44%), Gaps = 12/180 (6%)
Query: 29  AGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSG 88
           AG  Y  +    +K   H   N+LE   I S      R+ T +P        + S+   G
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ--LNRLSTRNP------CNITSRVYGG 622
Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXX 148
             SP   N   +  + +  N + G IP  +G +  L  L+L +N  +G IPD +GD    
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682
Query: 149 XXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-RTF---KVTGNPLICG 204
                      G  P+++S +  LT +DLS NNLSG +P++    TF   K   NP +CG
Sbjct: 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           N+     +G+G F  V        G  VA+K +    +    +Q    EV  + +  H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TE    L+  Y   G V   L    HGR     AR K   + +A  + Y H
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLV--AHGRMKEKEARSKFRQIVSA--VQYCH 131
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++   +I+HRD+KA N+LLD D    + DFG +   +        A  G   + APE L 
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDAFCGAPPYAAPE-LF 185
Query: 480 TGQSSE--KTDVFGFGILLLELITGQRALD 507
            G+  +  + DV+  G++L  L++G    D
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 16/228 (7%)
Query: 301 SNFSAKNILGRGGFGI-VYKGCFSDGALVAVKRL-KDYNIAGGEVQFQT-EVETISLAVH 357
            +F    ILG G F   V     +     A+K L K + I   +V + T E + +S   H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 358 RNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
              ++L  F   ++E+L     Y  NG     L  +I    + D    +         L 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAP 475
           YLH +    IIHRD+K  NILL+ED    + DFG AK+L             GT  +++P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           E L+   + + +D++  G ++ +L+ G   L   RA N+  +    +K
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAG---LPPFRAGNEYLIFQKIIK 246

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 362 RLCGFCSTENERLLV-YPYMPNGSVASRLR----DHIHGRPALDWARRKRIAL------- 409
            L G C+     L+V   +   G++++ LR    + +  + A +   +  + L       
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 410 -GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VR 467
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R
Sbjct: 157 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKL 525
             +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL 266
Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 267 -KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LG G +  VYKG    +D  LVA+K ++  +  G       EV  +    H N++ L   
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
             TE    LV+ Y+ +  +   L D       ++    K       RGL Y H Q   K+
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG----TVGHIAPE-YLSTG 481
           +HRD+K  N+L++E  E  + DFGLA     R   + T        T+ +  P+  L + 
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLA-----RAKSIPTKTYDNEVVTLWYRPPDILLGST 176
Query: 482 QSSEKTDVFGFGILLLELITGQ 503
             S + D++G G +  E+ TG+
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGR 198

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 123/275 (44%), Gaps = 55/275 (20%)
Query: 305 AKNILGRGGFG-IVYKGCFSDGALVAVKR-LKDY-NIAGGEVQFQTEVETISLAVHRNLL 361
           ++ ILG G  G +V++G F  G  VAVKR L D+ +IA  E++  TE +      H N++
Sbjct: 37  SEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVI 90
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR-----IAL--GTARG 414
           R   +CS   +R L   Y+        L+D +  +   D   + +     I+L    A G
Sbjct: 91  RY--YCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 145
Query: 415 LLYLHEQCDPKIIHRDVKAANILLD-------------EDFEAVVGDFGLAKLLDHRDSH 461
           + +LH     KIIHRD+K  NIL+              E+   ++ DFGL K LD     
Sbjct: 146 VAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 462 VTTAVR---GTVGHIAPEYLSTGQSSEKT---DVFGFGILLLELIT-GQRAL--DFGRAA 512
               +    GT G  APE L        T   D+F  G +   +++ G+      + R +
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 513 N-QRGVM-LDWVKKLHQEG-------KLSQMVDKD 538
           N  RG+  LD +K LH           +SQM+D D
Sbjct: 263 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 297

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLCGF 366
           +G+G FG V++G +  G  VAVK          E  +  E E     +  H N+L   GF
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENIL---GF 62
Query: 367 CSTEN-------ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
            + +N       +  LV  Y  +GS+   L      R  +      ++AL TA GL +LH
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 117
Query: 420 -----EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--- 471
                 Q  P I HRD+K+ NIL+ ++    + D GLA   D     +  A    VG   
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 472 HIAPEYLSTG------QSSEKTDVFGFGILLLEL 499
           ++APE L         +S ++ D++  G++  E+
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 27/220 (12%)
Query: 296 LRAATSNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIA--GGEVQFQTEV 349
           L+    ++    ++GRG FG V    +K   +   + A+K L  + +        F  E 
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHK---ASQKVYAMKLLSKFEMIKRSDSAFFWEER 126
Query: 350 ETISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           + ++ A    +++L  FC+ ++++ L  V  YMP G + + + ++        WA+    
Sbjct: 127 DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAK---- 177
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAV 466
              TA  +L L       +IHRDVK  N+LLD+     + DFG    +D     H  TAV
Sbjct: 178 -FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV 236
Query: 467 RGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITG 502
            GT  +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 237 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 123/275 (44%), Gaps = 55/275 (20%)
Query: 305 AKNILGRGGFG-IVYKGCFSDGALVAVKR-LKDY-NIAGGEVQFQTEVETISLAVHRNLL 361
           ++ ILG G  G +V++G F  G  VAVKR L D+ +IA  E++  TE +      H N++
Sbjct: 37  SEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVI 90
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR-----IAL--GTARG 414
           R   +CS   +R L   Y+        L+D +  +   D   + +     I+L    A G
Sbjct: 91  RY--YCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 145
Query: 415 LLYLHEQCDPKIIHRDVKAANILLD-------------EDFEAVVGDFGLAKLLDHRDSH 461
           + +LH     KIIHRD+K  NIL+              E+   ++ DFGL K LD     
Sbjct: 146 VAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 462 VTTAVR---GTVGHIAPEYLSTGQSSEKT---DVFGFGILLLELIT-GQRAL--DFGRAA 512
               +    GT G  APE L        T   D+F  G +   +++ G+      + R +
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 513 N-QRGVM-LDWVKKLHQEG-------KLSQMVDKD 538
           N  RG+  LD +K LH           +SQM+D D
Sbjct: 263 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 297

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 303 FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           F     LG G +G VYK    + G +VA+K++    +     +   E+  +      +++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEISIMQQCDSPHVV 87
Query: 362 RLCGFCSTENERLLVYPYMPNGSVAS--RLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +  G      +  +V  Y   GSV+   RLR+       L       I   T +GL YLH
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLH 142
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
                + IHRD+KA NILL+ +  A + DFG+A  L    +     + GT   +APE + 
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI-GTPFWMAPEVIQ 198
Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
               +   D++  GI  +E+  G+
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLCGF 366
           +G+G FG V++G +  G  VAVK          E  +  E E     +  H N+L   GF
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENIL---GF 101
Query: 367 CSTEN-------ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
            + +N       +  LV  Y  +GS+   L      R  +      ++AL TA GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 420 -----EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--- 471
                 Q  P I HRD+K+ NIL+ ++    + D GLA   D     +  A    VG   
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 472 HIAPEYLSTG------QSSEKTDVFGFGILLLEL 499
           ++APE L         +S ++ D++  G++  E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 362 RLCGFCSTENERLLV-YPYMPNGSVASRLR----DHIHGRPALDWARRKRIAL------- 409
            L G C+     L+V   +   G++++ LR    + +  + A +   +  + L       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 410 -GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VR 467
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKL 525
             +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL 264
Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 265 -KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 124/279 (44%), Gaps = 59/279 (21%)
Query: 305 AKNILGRGGFG-IVYKGCFSDGALVAVKR-LKDY-NIAGGEVQFQTEVETISLAVHRNLL 361
           ++ ILG G  G +V++G F  G  VAVKR L D+ +IA  E++  TE +      H N++
Sbjct: 19  SEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVI 72
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR-----IAL--GTARG 414
           R   +CS   +R L   Y+        L+D +  +   D   + +     I+L    A G
Sbjct: 73  RY--YCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 415 LLYLHEQCDPKIIHRDVKAANILLD-------------EDFEAVVGDFGLAKLLDHRDSH 461
           + +LH     KIIHRD+K  NIL+              E+   ++ DFGL K LD     
Sbjct: 128 VAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 184
Query: 462 VTTAVR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGILLLELIT-GQRAL--DF 508
               +    GT G  APE L    +       +   D+F  G +   +++ G+      +
Sbjct: 185 FRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 509 GRAAN-QRGVM-LDWVKKLHQEG-------KLSQMVDKD 538
            R +N  RG+  LD +K LH           +SQM+D D
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G FG V++G +    +    VA+K  K+        +F  E  T+    H ++++L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G   TEN   ++      G + S L+     + +LD A     A   +  L YL  +   
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           + +HRD+ A N+L+       +GDFGL++ ++    +  +  +  +  +APE ++  + +
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 485 EKTDVFGFGILLLELI 500
             +DV+ FG+ + E++
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 18/218 (8%)
Query: 297 RAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLK-DYNIAGGEVQF-QTEVE 350
           R   ++F+   +LG+G FG V     KG      L AVK LK D  I   +V+    E  
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 351 TISLAVHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
            ++L      L     C    +RL  V  Y+  G     L  HI              A 
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD----LMYHIQQVGRFKEPHAVFYAA 449
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
             A GL +L  +    II+RD+K  N++LD +    + DFG+ K  +  D   T    GT
Sbjct: 450 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKXFCGT 505
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
             +IAPE ++     +  D + FG+LL E++ GQ   +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 300 TSNFSAKNILGRGGFG--IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV- 356
           +  +  + +LG+G FG  I+ K   + G   AVK      I+  +V+ +T+ E++   V 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKV-----ISKRQVKQKTDKESLLREVQ 78
Query: 357 ------HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
                 H N+++L  F   +    LV      G     L D I  R         RI   
Sbjct: 79  LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQ 134
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
              G+ Y+H+    KI+HRD+K  N+LL+   +D    + DFGL+   +   S       
Sbjct: 135 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKI 189
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           GT  +IAPE L  G   EK DV+  G++L  L++G
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLCGF 366
           +G+G FG V++G +  G  VAVK          E  +  E E     +  H N+L   GF
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENIL---GF 63
Query: 367 CSTEN-------ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
            + +N       +  LV  Y  +GS+   L      R  +      ++AL TA GL +LH
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 118
Query: 420 -----EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--- 471
                 Q  P I HRD+K+ NIL+ ++    + D GLA   D     +  A    VG   
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 178
Query: 472 HIAPEYLSTG------QSSEKTDVFGFGILLLEL 499
           ++APE L         +S ++ D++  G++  E+
Sbjct: 179 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLCGF 366
           +G+G FG V++G +  G  VAVK          E  +  E E     +  H N+L   GF
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENIL---GF 68
Query: 367 CSTEN-------ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
            + +N       +  LV  Y  +GS+   L      R  +      ++AL TA GL +LH
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 123
Query: 420 -----EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--- 471
                 Q  P I HRD+K+ NIL+ ++    + D GLA   D     +  A    VG   
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 183
Query: 472 HIAPEYLSTG------QSSEKTDVFGFGILLLEL 499
           ++APE L         +S ++ D++  G++  E+
Sbjct: 184 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLCGF 366
           +G+G FG V++G +  G  VAVK          E  +  E E     +  H N+L   GF
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENIL---GF 65
Query: 367 CSTEN-------ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
            + +N       +  LV  Y  +GS+   L      R  +      ++AL TA GL +LH
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 120
Query: 420 -----EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--- 471
                 Q  P I HRD+K+ NIL+ ++    + D GLA   D     +  A    VG   
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 180
Query: 472 HIAPEYLSTG------QSSEKTDVFGFGILLLEL 499
           ++APE L         +S ++ D++  G++  E+
Sbjct: 181 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           N+     +G+G F  V        G  VA+K +    +    +Q    EV  + +  H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TE    L+  Y   G V   L    HGR     AR K   + +A  + Y H
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLV--AHGRMKEKEARSKFRQIVSA--VQYCH 128
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++   +I+HRD+KA N+LLD D    + DFG +          T    G+  + APE L 
Sbjct: 129 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC--GSPPYAAPE-LF 182
Query: 480 TGQSSE--KTDVFGFGILLLELITGQRALD 507
            G+  +  + DV+  G++L  L++G    D
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 300 TSNFSAKNILGRGGFG--IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV- 356
           +  +  + +LG+G FG  I+ K   + G   AVK      I+  +V+ +T+ E++   V 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVK-----VISKRQVKQKTDKESLLREVQ 84
Query: 357 ------HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
                 H N+++L  F   +    LV      G     L D I  R         RI   
Sbjct: 85  LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQ 140
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
              G+ Y+H+    KI+HRD+K  N+LL+   +D    + DFGL+   +   S       
Sbjct: 141 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKI 195
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           GT  +IAPE L  G   EK DV+  G++L  L++G
Sbjct: 196 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLCGF 366
           +G+G FG V++G +  G  VAVK          E  +  E E     +  H N+L   GF
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENIL---GF 88
Query: 367 CSTEN-------ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
            + +N       +  LV  Y  +GS+   L      R  +      ++AL TA GL +LH
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 143
Query: 420 -----EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--- 471
                 Q  P I HRD+K+ NIL+ ++    + D GLA   D     +  A    VG   
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 203
Query: 472 HIAPEYLSTG------QSSEKTDVFGFGILLLEL 499
           ++APE L         +S ++ D++  G++  E+
Sbjct: 204 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 24/235 (10%)
Query: 273 FDVNDQYDPE-VSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAV 330
           FD+  QY P+ V + H              ++     LG G FG+V++    + G   A 
Sbjct: 31  FDIWKQYYPQPVEIKH---------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 81
Query: 331 KRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
           K +   + +  E   + E++T+S+  H  L+ L      +NE +++Y +M  G +  ++ 
Sbjct: 82  KFVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 140
Query: 391 DHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVVGD 448
           D  H + + D A          +GL ++HE      +H D+K  NI+       E  + D
Sbjct: 141 DE-HNKMSEDEA--VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLID 194
Query: 449 FGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           FGL   LD + S  VTT   GT    APE          TD++  G+L   L++G
Sbjct: 195 FGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 30/238 (12%)
Query: 273 FDVNDQYDPE-VSLGH---LKRYTFKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGAL 327
           FD+  QY P+ V + H   L  Y   E             LG G FG+V++    + G  
Sbjct: 137 FDIWKQYYPQPVEIKHDHVLDHYDIHEE------------LGTGAFGVVHRVTERATGNN 184
Query: 328 VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVAS 387
            A K +   + +  E   + E++T+S+  H  L+ L      +NE +++Y +M  G +  
Sbjct: 185 FAAKFVMTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 243
Query: 388 RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAV 445
           ++ D  H + + D A          +GL ++HE      +H D+K  NI+       E  
Sbjct: 244 KVADE-HNKMSEDEA--VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELK 297
Query: 446 VGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           + DFGL   LD + S  VTT   GT    APE          TD++  G+L   L++G
Sbjct: 298 LIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 362 RLCGFCSTENERLLVY-PYMPNGSVASRLR----DHIHGRPALDWARRKRIAL------- 409
            L G C+     L+V   +   G++++ LR    + +  + A +   +  + L       
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 410 -GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VR 467
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKL 525
             +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL 255
Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 256 -KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 362 RLCGFCSTENERLLV-YPYMPNGSVASRLR----DHIHGRPALDWARRKRIAL------- 409
            L G C+     L+V   +   G++++ LR    + +  + A +   +  + L       
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 410 -GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VR 467
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R
Sbjct: 192 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKL 525
             +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL 301
Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 302 -KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 362 RLCGFCSTENERLLVY-PYMPNGSVASRLR----DHIHGRPALDWARRKRIAL------- 409
            L G C+     L+V   +   G++++ LR    + +  + A +   +  + L       
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 410 -GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VR 467
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     R
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKL 525
             +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL 255
Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 256 -KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 43/291 (14%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 362 RLCGFCSTENERLLV-YPYMPNGSVASRLR----DHIHGRPALDWARRKRIAL------- 409
            L G C+     L+V   +   G++++ LR    + +  + A +   +  + L       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 410 -GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VR 467
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +      V     R
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKL 525
             +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL 264
Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 265 -KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 389 LRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448
           LRD +H    +   R   +     + L + H+     IIHRDVK ANIL+       V D
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANILISATNAVKVVD 159
Query: 449 FGLAKLLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           FG+A+ +    + V  T AV GT  +++PE         ++DV+  G +L E++TG+
Sbjct: 160 FGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 42/290 (14%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 362 RLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHG-----------RPALDWARRKRIAL 409
            L G C+     L+V   +   G++++ LR   +            +  L        + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRG 468
             A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +      V     R 
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKLH 526
            +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL- 264
Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 265 KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 389 LRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448
           LRD +H    +   R   +     + L + H+     IIHRDVK ANI++       V D
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMD 159
Query: 449 FGLAKLLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           FG+A+ +    + V  T AV GT  +++PE         ++DV+  G +L E++TG+
Sbjct: 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 300 TSNFSAKNILGRGGFG--IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV- 356
           +  +  + +LG+G FG  I+ K   + G   AVK      I+  +V+ +T+ E++   V 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKV-----ISKRQVKQKTDKESLLREVQ 102
Query: 357 ------HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
                 H N+++L  F   +    LV      G     L D I  R         RI   
Sbjct: 103 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQ 158
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
              G+ Y+H+    KI+HRD+K  N+LL+   +D    + DFGL+   +   S       
Sbjct: 159 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKI 213
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           GT  +IAPE L  G   EK DV+  G++L  L++G
Sbjct: 214 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 43/291 (14%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 362 RLCGFCSTENERLLVY-PYMPNGSVASRLR----DHIHGRPALDWARRKRIAL------- 409
            L G C+     L+V   +   G++++ LR    + +  + A +   +  + L       
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 410 -GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VR 467
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +      V     R
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKL 525
             +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL 255
Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 256 -KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 389 LRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448
           LRD +H    +   R   +     + L + H+     IIHRDVK ANI++       V D
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMD 159
Query: 449 FGLAKLLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           FG+A+ +    + V  T AV GT  +++PE         ++DV+  G +L E++TG+
Sbjct: 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 300 TSNFSAKNILGRGGFG--IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV- 356
           +  +  + +LG+G FG  I+ K   + G   AVK      I+  +V+ +T+ E++   V 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKV-----ISKRQVKQKTDKESLLREVQ 101
Query: 357 ------HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
                 H N+++L  F   +    LV      G     L D I  R         RI   
Sbjct: 102 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQ 157
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
              G+ Y+H+    KI+HRD+K  N+LL+   +D    + DFGL+   +   S       
Sbjct: 158 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKI 212
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           GT  +IAPE L  G   EK DV+  G++L  L++G
Sbjct: 213 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 106/232 (45%), Gaps = 35/232 (15%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKD--YNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           LG+G +GIV+K      G +VAVK++ D   N    +  F+  +    L+ H N++ L  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 366 FCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
               +N+R   LV+ YM    + + +R +I     L+   ++ +     + + YLH    
Sbjct: 77  VLRADNDRDVYLVFDYM-ETDLHAVIRANI-----LEPVHKQYVVYQLIKVIKYLHSGG- 129
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHR-------------------DSHVT 463
             ++HRD+K +NILL+ +    V DFGL++  ++ R                   D  + 
Sbjct: 130 --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 464 TAVRGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
           T    T  + APE  L + + ++  D++  G +L E++ G+         NQ
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 389 LRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448
           LRD +H    +   R   +     + L + H+     IIHRDVK ANI++       V D
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMD 159
Query: 449 FGLAKLLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           FG+A+ +    + V  T AV GT  +++PE         ++DV+  G +L E++TG+
Sbjct: 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 43/291 (14%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 362 RLCGFCSTENERLLV-YPYMPNGSVASRLR----DHIHGRPALDWARRKRIAL------- 409
            L G C+     L+V   +   G++++ LR    + +  + A +   +  + L       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 410 -GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTAVR 467
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +    D       R
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKL 525
             +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL 264
Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 265 -KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 309 LGRGGFGIVYKGCF---SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           LG G FG V +G +        VA+K LK         +   E + +    +  ++RL G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
            C  E   L++   M  G    +    +  R  +  +    +    + G+ YL E+    
Sbjct: 404 VCQAEA--LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 456
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAVRGTVGHIAPEYLSTGQS 483
            +HR++ A N+LL     A + DFGL+K L   DS+ T  +A +  +   APE ++  + 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 484 SEKTDVFGFGILLLELIT-GQR 504
           S ++DV+ +G+ + E ++ GQ+
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQK 538

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 389 LRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448
           LRD +H    +   R   +     + L + H+     IIHRDVK ANI++       V D
Sbjct: 103 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMD 159
Query: 449 FGLAKLLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           FG+A+ +    + V  T AV GT  +++PE         ++DV+  G +L E++TG+
Sbjct: 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 43/291 (14%)
Query: 309 LGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLL 361
           LGRG FG ++    F     +    VAVK LK+           +E++  I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 362 RLCGFCSTENERLLV-YPYMPNGSVASRLR----DHIHGRPALDWARRKRIAL------- 409
            L G C+     L+V   +   G++++ LR    + +  + A +   +  + L       
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 410 -GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VR 467
              A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +      V     R
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKKL 525
             +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++L
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRRL 255
Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
            +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 256 -KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 127/294 (43%), Gaps = 45/294 (15%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVET 351
           FK+L     NF  K  L     G ++KG +  +  +V V +++D++       F  E   
Sbjct: 9   FKQL-----NFLTK--LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSR-DFNEECPR 60
Query: 352 ISLAVHRNLLRLCGFCSTEN--ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
           + +  H N+L + G C +       L+  +MP GS+ + L +  +    +D ++  + AL
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFAL 118
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
             ARG+ +LH   +P I    + + ++++DED  A +       + D + S  +      
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARIS------MADVKFSFQSPGRMYA 171
Query: 470 VGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAANQR---GVMLDWVK 523
              +APE L       +    D++ F +LL EL+T  R + F   +N      V L+ ++
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT--REVPFADLSNMEIGMKVALEGLR 229
Query: 524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                G +S  V K +K                +C   +P  RPK   ++ +LE
Sbjct: 230 PTIPPG-ISPHVSKLMK----------------ICMNEDPAKRPKFDMIVPILE 266

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 106/235 (45%), Gaps = 41/235 (17%)
Query: 296 LRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
           LR A S+F    +LG+G FG V K   + D    A+K+++        +   +EV  ++ 
Sbjct: 2   LRYA-SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL--SEVXLLAS 58
Query: 355 AVHRNLLRLCGFCSTENERLLVYP----------YMPNGSVASR-LRDHIHGRPALDWAR 403
             H+ ++R   + +    R  V P          ++      +R L D IH    L+  R
Sbjct: 59  LNHQYVVRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE-NLNQQR 115
Query: 404 RK--RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR--- 458
            +  R+       L Y+H Q    IIHR++K  NI +DE     +GDFGLAK + HR   
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNV-HRSLD 171
Query: 459 ------------DSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI 500
                         ++T+A+ GT  ++A E L  TG  +EK D +  GI+  E I
Sbjct: 172 ILKLDSQNLPGSSDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 389 LRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448
           LRD +H    +   R   +     + L + H+     IIHRDVK ANI++       V D
Sbjct: 120 LRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMD 176
Query: 449 FGLAKLLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           FG+A+ +    + V  T AV GT  +++PE         ++DV+  G +L E++TG+
Sbjct: 177 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
           +S+F  K++LG G +G+V        G +VA+K+++ ++     ++   E++ +    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N++ +      ++       Y+    + + L   I  +  L     +     T R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVL 128
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR---DSHVTTAVRGTVGHI-- 473
           H      +IHRD+K +N+L++ + +  V DFGLA+++D     +S  T    G V  +  
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 474 ----APE-YLSTGQSSEKTDVFGFGILLLELI 500
               APE  L++ + S   DV+  G +L EL 
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 118
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 174
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 127
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  L
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 127
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  L
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 120
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  L
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 119
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  L
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 120
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  L
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 11/209 (5%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHR 358
            NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N+++L     TEN+  LV+ ++            + G P       K       +GL + 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 123
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-Y 477
           H     +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  
Sbjct: 124 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEIL 179
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQRAL 506
           L     S   D++  G +  E++T +RAL
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 120
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  L
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 119
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  L
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 24/253 (9%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G G  GIV      S G LVAVK++        E+ F  EV  +    H N++ +    
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 217
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  ++  G++   +    H R  ++  +   + L   + L  LH Q    +I
Sbjct: 218 LVGDELWVVMEFLEGGALTDIV---THTR--MNEEQIAAVCLAVLQALSVLHAQG---VI 269
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ +ILL  D    + DFG    +          V GT   +APE +S      + 
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 328
Query: 488 DVFGFGILLLELITGQRALDFGRAANQ-----RGVMLDWVKKLHQEGKLSQMVDKDLKGN 542
           D++  GI+++E++ G+    F     +     R  +   +K LH+       V   LKG 
Sbjct: 329 DIWSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHK-------VSPSLKGF 380
Query: 543 FDRIELEEMVQVA 555
            DR+ + +  Q A
Sbjct: 381 LDRLLVRDPAQRA 393

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
           +S+F  K++LG G +G+V        G +VA+K+++ ++     ++   E++ +    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N++ +      ++       Y+    + + L   I  +  L     +     T R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVL 128
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR---DSHVTTAVRGTVGHI-- 473
           H      +IHRD+K +N+L++ + +  V DFGLA+++D     +S  T    G   ++  
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 474 ----APE-YLSTGQSSEKTDVFGFGILLLELI 500
               APE  L++ + S   DV+  G +L EL 
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 14/224 (6%)
Query: 282 EVSLGHLKRYTFKELRAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG 340
           EVSL   K       R   + F    +LG+G FG ++     + G   A+K LK   I  
Sbjct: 138 EVSLAKPKH------RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA 191
Query: 341 GEVQFQTEVETISLAVHRN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL 399
            +    T  E   L   R+  L    +    ++RL       NG     L  H+      
Sbjct: 192 KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVF 248
Query: 400 DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
              R +         L YLH   +  +++RD+K  N++LD+D    + DFGL K    +D
Sbjct: 249 SEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKD 305
Query: 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
                   GT  ++APE L         D +G G+++ E++ G+
Sbjct: 306 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +    +V    +     + N    + +   E   +    +  ++R+ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRD--HIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           G C  E+  +LV      G +   L+   H+  +  ++   +       + G+ YL E  
Sbjct: 95  GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLEES- 146
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L   +++      G   V   APE ++ 
Sbjct: 147 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
            + S K+DV+ FG+L+ E  + GQ+
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +    +V    +     + N    + +   E   +    +  ++R+ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRD--HIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           G C  E+  +LV      G +   L+   H+  +  ++   +       + G+ YL E  
Sbjct: 95  GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLEES- 146
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L   +++      G   V   APE ++ 
Sbjct: 147 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
            + S K+DV+ FG+L+ E  + GQ+
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 14/224 (6%)
Query: 282 EVSLGHLKRYTFKELRAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG 340
           EVSL   K       R   + F    +LG+G FG ++     + G   A+K LK   I  
Sbjct: 135 EVSLAKPKH------RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA 188
Query: 341 GEVQFQTEVETISLAVHRN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL 399
            +    T  E   L   R+  L    +    ++RL       NG     L  H+      
Sbjct: 189 KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVF 245
Query: 400 DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
              R +         L YLH   +  +++RD+K  N++LD+D    + DFGL K    +D
Sbjct: 246 SEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKD 302
Query: 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
                   GT  ++APE L         D +G G+++ E++ G+
Sbjct: 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 19/225 (8%)
Query: 302 NFSAKNILGRGGFG---IVYKGCFSDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISLAV 356
           +F     +G+G FG   IV K       + A+K + K   +   EV+    E++ +    
Sbjct: 16  HFEILRAIGKGSFGKVCIVQKN--DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H  L+ L      E +  +V   +  G +   L+ ++H +        K         L 
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET----VKLFICELVMALD 129
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           YL  Q   +IIHRD+K  NILLDE     + DF +A +L  R++ +TT   GT  ++APE
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITTMA-GTKPYMAPE 184
Query: 477 YLSTGQS---SEKTDVFGFGILLLELITGQRALDFGRAANQRGVM 518
             S+ +    S   D +  G+   EL+ G+R      + + + ++
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLSFCH 120
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  L
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVH 357
           + N+  K  LG+G F +V +    + G   A K +    ++  + Q  + E        H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N++RL      E+   LV+  +  G     L + I  R     A            + Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
            H      I+HR++K  N+LL    +     + DFGLA  ++  DS       GT G+++
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLS 175
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE L     S+  D++  G++L  L+ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 80/345 (23%), Positives = 136/345 (39%), Gaps = 91/345 (26%)
Query: 309 LGRGGFG-IVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
           LGRG FG +V    F          VAVK LK+   A       TE++ ++ +  H N++
Sbjct: 35  LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 362 RLCGFCSTENERLLV-YPYMPNGSVASRLRD-------------HIHGR-----PALDWA 402
            L G C+ +   L+V   Y   G++++ L+              H+  +     P L+  
Sbjct: 95  NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPKKEKMEPGLEQG 154
Query: 403 RRKRI---------------------------------------------ALGTARGLLY 417
           ++ R+                                             +   ARG+ +
Sbjct: 155 KKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEF 214
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRGTVGHIAPE 476
           L  +   K IHRD+ A NILL E+    + DFGLA+ +     +V     R  +  +APE
Sbjct: 215 LSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPE 271
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD 536
            +     S K+DV+ +G+LL E+ +       G  +   GV +D              + 
Sbjct: 272 SIFDKIYSTKSDVWSYGVLLWEIFS------LG-GSPYPGVQMD--------EDFCSRLR 316
Query: 537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGL 581
           + ++         E+ Q+ L C   +P  RP+ +E+++ L GD L
Sbjct: 317 EGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL-GDLL 360

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +    +V    +     + N    + +   E   +    +  ++R+ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRD--HIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           G C  E+  +LV      G +   L+   H+  +  ++   +       + G+ YL E  
Sbjct: 93  GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLEES- 144
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L   +++      G   V   APE ++ 
Sbjct: 145 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 202
Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
            + S K+DV+ FG+L+ E  + GQ+
Sbjct: 203 YKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 17/213 (7%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
           +S+F  K++LG G +G+V        G +VA+K+++ ++     ++   E++ +    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N++ +      ++       Y+    + + L   I  +  L     +     T R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVL 128
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH----------RDSHVTTAVRG 468
           H      +IHRD+K +N+L++ + +  V DFGLA+++D           + S +T  V  
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV-A 184
Query: 469 TVGHIAPE-YLSTGQSSEKTDVFGFGILLLELI 500
           T  + APE  L++ + S   DV+  G +L EL 
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +    +V    +     + N    + +   E   +    +  ++R+ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRD--HIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           G C  E+  +LV      G +   L+   H+  +  ++   +       + G+ YL E  
Sbjct: 75  GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLEES- 126
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L   +++      G   V   APE ++ 
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
            + S K+DV+ FG+L+ E  + GQ+
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 303 FSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVET--ISLAVHRN 359
           +  +  LG G FG V     +     VA+K +    +   ++  + E E   + L  H +
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L    +T  + ++V  Y         L D+I  +  +     +R        + Y H
Sbjct: 71  IIKLYDVITTPTDIVMVIEY-----AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH 125
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
                KI+HRD+K  N+LLD++    + DFGL+ ++   D +      G+  + APE ++
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVIN 180
Query: 480 TG-QSSEKTDVFGFGILLLELITGQRALD 507
               +  + DV+  GI+L  ++ G+   D
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +    +V    +     + N    + +   E   +    +  ++R+ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRD--HIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           G C  E+  +LV      G +   L+   H+  +  ++   +       + G+ YL E  
Sbjct: 79  GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLEES- 130
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L   +++      G   V   APE ++ 
Sbjct: 131 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 188
Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
            + S K+DV+ FG+L+ E  + GQ+
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 21/236 (8%)
Query: 299 ATSNFSAKNILGRGGFGIVYKG--CFSDGALVAVKRLKDYNIAGG-------EVQFQTEV 349
           A   +     +G G +G V+K     + G  VA+KR++      G       EV     +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 350 ETISLAVHRNLLRLCGFCS---TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
           ET     H N++RL   C+   T+ E  L   +       +   D +   P +     K 
Sbjct: 69  ETFE---HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKD 124
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
           +     RGL +LH     +++HRD+K  NIL+    +  + DFGLA++   +     T+V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSV 179
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
             T+ + APE L     +   D++  G +  E+   +         +Q G +LD +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 304 SAKNILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           S   ILG G FG V+K C   + G  +A K +K   +   E + + E+  ++   H NL+
Sbjct: 92  SKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLI 149
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR-RKRIALGTARGLLYLHE 420
           +L     ++N+ +LV  Y+  G +  R+ D  +    LD     K+I      G+ ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC----EGIRHMHQ 205
Query: 421 QCDPKIIHRDVKAANIL-LDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
                I+H D+K  NIL ++ D + + + DFGLA+    R+        GT   +APE +
Sbjct: 206 MY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--GTPEFLAPEVV 260
Query: 479 STGQSSEKTDVFGFGILLLELITG 502
           +    S  TD++  G++   L++G
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 303 FSAKNILGRGGFGIVYK----GCFSDGALVAVKRLKDYNI---AGGEVQFQTEVETISLA 355
           F    +LG+GG+G V++       + G + A+K LK   I   A      + E   +   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL-RDHIHGR-PALDWARRKRIALGTAR 413
            H  ++ L     T  +  L+  Y+  G +  +L R+ I     A  +     +ALG   
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG--- 135
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
              +LH++    II+RD+K  NI+L+      + DFGL K   H D  VT    GT+ ++
Sbjct: 136 ---HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH-DGTVTHTFCGTIEYM 188
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITG 502
           APE L     +   D +  G L+ +++TG
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G G  GIV      S G LVAVK++        E+ F  EV  +    H N++ +    
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 95
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  ++  G++   +    H R  ++  +   + L   + L  LH Q    +I
Sbjct: 96  LVGDELWVVMEFLEGGALTDIV---THTR--MNEEQIAAVCLAVLQALSVLHAQG---VI 147
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ +ILL  D    + DFG    +          V GT   +APE +S      + 
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 206
Query: 488 DVFGFGILLLELITGQ 503
           D++  GI+++E++ G+
Sbjct: 207 DIWSLGIMVIEMVDGE 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +    +V    +     + N    + +   E   +    +  ++R+ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRD--HIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           G C  E+  +LV      G +   L+   H+  +  ++   +       + G+ YL E  
Sbjct: 85  GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLEES- 136
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L   +++      G   V   APE ++ 
Sbjct: 137 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
            + S K+DV+ FG+L+ E  + GQ+
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK 219

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVH 357
           + N+  K  LG+G F +V +    + G   A K +    ++  + Q  + E        H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N++RL      E+   LV+  +  G     L + I  R     A            + Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
            H      I+HR++K  N+LL    +     + DFGLA  ++  DS       GT G+++
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLS 175
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE L     S+  D++  G++L  L+ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP--ALDWARRKRIALGTARG 414
           H N+++L     TEN+  LV+ ++     +  L+D +       +     K       +G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-----SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + A
Sbjct: 118 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 173
Query: 475 PE-YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
           PE  L     S   D++  G +  E++T +RAL
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           R+   NF     +G G  GIV      S G LVAVK++        E+ F  EV  +   
Sbjct: 19  RSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDY 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N++ +       +E  +V  ++  G++   +    H R  ++  +   + L   + L
Sbjct: 75  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTR--MNEEQIAAVCLAVLQAL 129
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
             LH Q    +IHRD+K+ +ILL  D    + DFG    +          V GT   +AP
Sbjct: 130 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAP 185
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
           E +S      + D++  GI+++E++ G+
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP--ALDWARRKRIALGTARG 414
           H N+++L     TEN+  LV+ ++     +  L+D +       +     K       +G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-----SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + A
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 174
Query: 475 PE-YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
           PE  L     S   D++  G +  E++T +RAL
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G G  GIV      S G LVAVK++        E+ F  EV  +    H N++ +    
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 97
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  ++  G++   +    H R  ++  +   + L   + L  LH Q    +I
Sbjct: 98  LVGDELWVVMEFLEGGALTDIV---THTR--MNEEQIAAVCLAVLQALSVLHAQG---VI 149
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ +ILL  D    + DFG    +          V GT   +APE +S      + 
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 208
Query: 488 DVFGFGILLLELITGQ 503
           D++  GI+++E++ G+
Sbjct: 209 DIWSLGIMVIEMVDGE 224

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 119
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  L
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVH 357
           + N+  K  LG+G F +V +    + G   A K +    ++  + Q  + E        H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N++RL      E+   LV+  +  G     L + I  R     A            + Y
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
            H      I+HR++K  N+LL    +     + DFGLA  ++  DS       GT G+++
Sbjct: 120 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLS 174
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE L     S+  D++  G++L  L+ G
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 297 RAATSNFSAKNILGRGGFGIVYK----GCFSDGALVAVKRLKDYNIA-GGEVQFQTEVET 351
           +    NF    +LG G +G V+          G L A+K LK   I    +    T  E 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 352 ISLAVHRN---LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR-- 406
             L   R    L+ L     TE +  L+  Y+  G + + L            ++R+R  
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL------------SQRERFT 157
Query: 407 ---IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
              + +     +L L       II+RD+K  NILLD +   V+ DFGL+K     ++   
Sbjct: 158 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217
Query: 464 TAVRGTVGHIAPEYLSTGQS--SEKTDVFGFGILLLELITG 502
               GT+ ++AP+ +  G S   +  D +  G+L+ EL+TG
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 8/209 (3%)
Query: 297 RAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           R   + F    +LG+G FG ++     + G   A+K LK   I   +    T  E   L 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 356 VHRN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
             R+  L    +    ++RL       NG     L  H+         R +         
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSA 120
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L YLH + +  +++RD+K  N++LD+D    + DFGL K    +D        GT  ++A
Sbjct: 121 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLA 177
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           PE L         D +G G+++ E++ G+
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +    +V    +     + N    + +   E   +    +  ++R+ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRD--HIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           G C  E+  +LV      G +   L+   H+  +  ++   +       + G+ YL E  
Sbjct: 73  GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLEES- 124
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L   +++      G   V   APE ++ 
Sbjct: 125 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 182
Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
            + S K+DV+ FG+L+ E  + GQ+
Sbjct: 183 YKFSSKSDVWSFGVLMWEAFSYGQK 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 8/209 (3%)
Query: 297 RAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           R   + F    +LG+G FG ++     + G   A+K LK   I   +    T  E   L 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 356 VHRN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
             R+  L    +    ++RL       NG     L  H+         R +         
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSA 122
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L YLH + +  +++RD+K  N++LD+D    + DFGL K    +D        GT  ++A
Sbjct: 123 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLA 179
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           PE L         D +G G+++ E++ G+
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 24/253 (9%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G G  GIV      S G LVAVK++        E+ F  EV  +    H N++ +    
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 140
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  ++  G++   +    H R  ++  +   + L   + L  LH Q    +I
Sbjct: 141 LVGDELWVVMEFLEGGALTDIV---THTR--MNEEQIAAVCLAVLQALSVLHAQG---VI 192
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ +ILL  D    + DFG    +          V GT   +APE +S      + 
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 251
Query: 488 DVFGFGILLLELITGQRALDFGRAANQRGVML-----DWVKKLHQEGKLSQMVDKDLKGN 542
           D++  GI+++E++ G+    F     +   M+       +K LH+       V   LKG 
Sbjct: 252 DIWSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHK-------VSPSLKGF 303
Query: 543 FDRIELEEMVQVA 555
            DR+ + +  Q A
Sbjct: 304 LDRLLVRDPAQRA 316

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 303 FSAKNILGRGGFGIVYK----GCFSDGALVAVKRLKDYNI---AGGEVQFQTEVETISLA 355
           F    +LG+GG+G V++       + G + A+K LK   I   A      + E   +   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL-RDHIHGR-PALDWARRKRIALGTAR 413
            H  ++ L     T  +  L+  Y+  G +  +L R+ I     A  +     +ALG   
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG--- 135
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
              +LH++    II+RD+K  NI+L+      + DFGL K   H D  VT    GT+ ++
Sbjct: 136 ---HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH-DGTVTHXFCGTIEYM 188
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITG 502
           APE L     +   D +  G L+ +++TG
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 294 KELRAATSNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIA--GGEVQFQT 347
           ++LR    ++    ++GRG FG V    +K   S   + A+K L  + +        F  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRK 405
           E + ++ A    +++L  F + +++R L  V  YMP G + + + ++        WAR  
Sbjct: 124 ERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WAR-- 176
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
                TA  +L L        IHRDVK  N+LLD+     + DFG    ++         
Sbjct: 177 ---FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 466 VRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQ 503
             GT  +I+PE L +    G    + D +  G+ L E++ G 
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 275

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 294 KELRAATSNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIA--GGEVQFQT 347
           ++LR    ++    ++GRG FG V    +K   S   + A+K L  + +        F  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWE 118
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRK 405
           E + ++ A    +++L  F + +++R L  V  YMP G + + + ++        WAR  
Sbjct: 119 ERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WAR-- 171
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
                TA  +L L        IHRDVK  N+LLD+     + DFG    ++         
Sbjct: 172 ---FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 466 VRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQ 503
             GT  +I+PE L +    G    + D +  G+ L E++ G 
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 54/241 (22%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNI------------------AG 340
           + ++ K+ +G+G +G+V K  ++  D    A+K L    +                   G
Sbjct: 13  NQYTLKDEIGKGSYGVV-KLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 341 GEVQFQTEVETISLAV-------HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI 393
           G +Q +  +E +   +       H N+++L       NE  L   YM        + + +
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YM--------VFELV 120
Query: 394 HGRPALDWARRKRIALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445
           +  P ++    K ++   AR        G+ YLH Q   KIIHRD+K +N+L+ ED    
Sbjct: 121 NQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIK 177
Query: 446 VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITG 502
           + DFG++      D+ ++  V GT   +APE LS  +   S +  DV+  G+ L   + G
Sbjct: 178 IADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 503 Q 503
           Q
Sbjct: 237 Q 237

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G+G  G VY     + G  VA++++        E+    E+  +    + N++      
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDSY 86
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  Y+  GS+   + +       +D  +   +     + L +LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ NILL  D    + DFG    +    S  +T V GT   +APE ++      K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 488 DVFGFGILLLELITGQ 503
           D++  GI+ +E+I G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 294 KELRAATSNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIA--GGEVQFQT 347
           ++LR    ++    ++GRG FG V    +K   S   + A+K L  + +        F  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRK 405
           E + ++ A    +++L  F + +++R L  V  YMP G + + + ++        WAR  
Sbjct: 124 ERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WAR-- 176
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
                TA  +L L        IHRDVK  N+LLD+     + DFG    ++         
Sbjct: 177 ---FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 466 VRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQ 503
             GT  +I+PE L +    G    + D +  G+ L E++ G 
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 275

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 8/209 (3%)
Query: 297 RAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           R   + F    +LG+G FG ++     + G   A+K LK   I   +    T  E   L 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 356 VHRN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
             R+  L    +    ++RL       NG     L  H+         R +         
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSA 121
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L YLH + +  +++RD+K  N++LD+D    + DFGL K    +D        GT  ++A
Sbjct: 122 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYLA 178
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           PE L         D +G G+++ E++ G+
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G G  GIV      S G LVAVK++        E+ F  EV  +    H N++ +    
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 90
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  ++  G++   +    H R  ++  +   + L   + L  LH Q    +I
Sbjct: 91  LVGDELWVVMEFLEGGALTDIV---THTR--MNEEQIAAVCLAVLQALSVLHAQG---VI 142
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ +ILL  D    + DFG    +          V GT   +APE +S      + 
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 201
Query: 488 DVFGFGILLLELITGQ 503
           D++  GI+++E++ G+
Sbjct: 202 DIWSLGIMVIEMVDGE 217

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 21/236 (8%)
Query: 299 ATSNFSAKNILGRGGFGIVYKG--CFSDGALVAVKRLKDYNIAGG-------EVQFQTEV 349
           A   +     +G G +G V+K     + G  VA+KR++      G       EV     +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 350 ETISLAVHRNLLRLCGFCS---TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
           ET     H N++RL   C+   T+ E  L   +       +   D +   P +     K 
Sbjct: 69  ETFE---HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKD 124
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
           +     RGL +LH     +++HRD+K  NIL+    +  + DFGLA++   +     T+V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSV 179
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
             T+ + APE L     +   D++  G +  E+   +         +Q G +LD +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVH 357
           + N+  K  LG+G F +V +    + G   A K +    ++  + Q  + E        H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N++RL      E+   LV+  +  G     L + I  R     A            + Y
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
            H      I+HR++K  N+LL    +     + DFGLA  ++  DS       GT G+++
Sbjct: 144 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLS 198
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE L     S+  D++  G++L  L+ G
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 21/236 (8%)
Query: 299 ATSNFSAKNILGRGGFGIVYKG--CFSDGALVAVKRLKDYNIAGG-------EVQFQTEV 349
           A   +     +G G +G V+K     + G  VA+KR++      G       EV     +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 350 ETISLAVHRNLLRLCGFCS---TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
           ET     H N++RL   C+   T+ E  L   +       +   D +   P +     K 
Sbjct: 69  ETFE---HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKD 124
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
           +     RGL +LH     +++HRD+K  NIL+    +  + DFGLA++   +     T+V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSV 179
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
             T+ + APE L     +   D++  G +  E+   +         +Q G +LD +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +    +V    +     + N    + +   E   +    +  ++R+ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRD--HIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           G C  E+  +LV      G +   L+   H+  +  ++   +       + G+ YL E  
Sbjct: 79  GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLEES- 130
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L  D       T  +  V   APE ++ 
Sbjct: 131 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINY 188
Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
            + S K+DV+ FG+L+ E  + GQ+
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 15/213 (7%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP--ALDWARRKRIALGTARG 414
           H N+++L     TEN+  LV+ ++        L+D +       +     K       +G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-----HQDLKDFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + A
Sbjct: 116 LAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRA 171
Query: 475 PE-YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
           PE  L     S   D++  G +  E++T +RAL
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 300 TSNFSAKNILGRGGFG--IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV- 356
           +  +  + +LG+G FG  I+ K   + G   AVK      I+  +V+ +T+ E++   V 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKV-----ISKRQVKQKTDKESLLREVQ 78
Query: 357 ------HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
                 H N+ +L  F   +    LV      G     L D I  R         RI   
Sbjct: 79  LLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQ 134
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
              G+ Y H+    KI+HRD+K  N+LL+   +D    + DFGL+   +   S       
Sbjct: 135 VLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKXKDKI 189
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           GT  +IAPE L  G   EK DV+  G++L  L++G
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 120
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 119
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 117
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPE 173
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPL---PLIKSYLFQLLQGLA 120
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 107/236 (45%), Gaps = 19/236 (8%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG GG G+V+    +D    VA+K++   +    +   + E++ I    H N++++    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEIL 77
Query: 368 STENERL---------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
                +L         L   Y+    + + L + +   P L+   R        RGL Y+
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR-LFMYQLLRGLKYI 136
Query: 419 HEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--HIAP 475
           H      ++HRD+K AN+ ++ ED    +GDFGLA+++D   SH      G V   + +P
Sbjct: 137 HSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP 193
Query: 476 E-YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK 530
              LS    ++  D++  G +  E++TG+          Q  ++L+ +  +H+E +
Sbjct: 194 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 119
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 117
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPE 173
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 117
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPE 173
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 119
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 118
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 121
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 177
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +    +V    +     + N    + +   E   +    +  ++R+ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRD--HIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           G C  E+  +LV      G +   L+   H+  +  ++   +       + G+ YL E  
Sbjct: 437 GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLEES- 488
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L   +++      G   V   APE ++ 
Sbjct: 489 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546
Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
            + S K+DV+ FG+L+ E  + GQ+
Sbjct: 547 YKFSSKSDVWSFGVLMWEAFSYGQK 571

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 120
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 119
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE  L
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILL 175
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR--NLLRLCG 365
           +G G  G V+K  F   G ++AVK+++         +   +++ + L  H    +++  G
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV-LKSHDCPYIVQCFG 91
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
              T  +  +    M  G+ A +L+  + G   +      ++ +   + L YL E+    
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLKEK--HG 145
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
           +IHRDVK +NILLDE  +  + DFG++ +L+D +    +    G   ++APE +     +
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAYMAPERIDPPDPT 202
Query: 485 E-----KTDVFGFGILLLELITGQ 503
           +     + DV+  GI L+EL TGQ
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQ 226

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 117
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 120
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 118
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G FG V KG +    +V    +     + N    + +   E   +    +  ++R+ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRD--HIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           G C  E+  +LV      G +   L+   H+  +  ++   +       + G+ YL E  
Sbjct: 438 GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLEES- 489
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L   +++      G   V   APE ++ 
Sbjct: 490 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 547
Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
            + S K+DV+ FG+L+ E  + GQ+
Sbjct: 548 YKFSSKSDVWSFGVLMWEAFSYGQK 572

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQT----EVETISLAVHRNLLRL 363
           +LG+G FG V K C  D        +K  N A  + +  +    EVE +    H N+++L
Sbjct: 29  MLGKGSFGEVLK-C-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
                  +   +V      G     L D I  R         RI      G+ Y+H+   
Sbjct: 87  FEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 424 PKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
             I+HRD+K  NILL   ++D +  + DFGL+     +++ +   + GT  +IAPE L  
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRI-GTAYYIAPEVLR- 196
Query: 481 GQSSEKTDVFGFGILLLELITG 502
           G   EK DV+  G++L  L++G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/318 (22%), Positives = 137/318 (43%), Gaps = 32/318 (10%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRL--KDYNIAGGEVQFQTEVETISLA 355
           +   +    ++G G +G+V K    D G +VA+K+    D +    ++  + E++ +   
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQL 81
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARG 414
            H NL+ L   C  +    LV+ +     V   + D +   P  LD+   ++       G
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           + + H      IIHRD+K  NIL+ +     + DFG A+ L      V      T  + A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRA 192
Query: 475 PEYL-STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL---HQE-- 528
           PE L    +  +  DV+  G L+ E+  G+         +Q   ++  +  L   HQE  
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252
Query: 529 --------GKLSQMVDKD-LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK--MLE 577
                    +L ++ +++ L+  + ++  E ++ +A  C   +P  RP  +E+L     +
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPKLS-EVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
Query: 578 GDGLAEKWEASQKIETPR 595
            DG AE++    +++  +
Sbjct: 312 MDGFAERFSQELQLKVQK 329

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 302 NFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV- 356
           N+  K ILGRG   +V    +K    + A+  +      + +  EVQ   E     + + 
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 357 -----HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
                H N+++L     T     LV+  M  G     L D++  +  L     ++I    
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIMRAL 133
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
              +  LH+     I+HRD+K  NILLD+D    + DFG +  LD  +     +V GT  
Sbjct: 134 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LRSVCGTPS 188
Query: 472 HIAPEYLSTGQSS------EKTDVFGFGILLLELITG 502
           ++APE +    +       ++ D++  G+++  L+ G
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 118
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 119
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE  L
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV-VTLWYRAPEILL 175
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)
Query: 302 NFSAKNILGRGGFGIVY--KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
            F    +LG G F  V+  K   + G L A+K +K  + A  +   + E+  +    H N
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHEN 67
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           ++ L     +     LV   +  G     L D I  R          +       + YLH
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGVYTEKDASLVIQQVLSAVKYLH 123
Query: 420 EQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           E     I+HRD+K  N+L    +E+ + ++ DFGL+K+     + + +   GT G++APE
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPE 177
Query: 477 YLSTGQSSEKTDVFGFGILLLELITG 502
            L+    S+  D +  G++   L+ G
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 121
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE  L
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+ +++ D    G       E+  +    H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 120
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  L
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 176
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 11/208 (5%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+ +++ D    G       E+  +    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++            + G P       K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFCH 119
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YL 478
                +++HRD+K  N+L++ +    + DFGLA+         T  V  T+ + APE  L
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175
Query: 479 STGQSSEKTDVFGFGILLLELITGQRAL 506
                S   D++  G +  E++T +RAL
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 309 LGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G  GIV   C +     G  VAVK++        E+ F  EV  +    H N++ + 
Sbjct: 53  IGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHDNVVDMY 108
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
                 +E  +V  ++  G++   +    H R  ++  +   + L   R L YLH Q   
Sbjct: 109 SSYLVGDELWVVMEFLEGGALTDIV---THTR--MNEEQIATVCLSVLRALSYLHNQ--- 160
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
            +IHRD+K+ +ILL  D    + DFG    +  ++      + GT   +APE +S     
Sbjct: 161 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKXLVGTPYWMAPEVISRLPYG 219
Query: 485 EKTDVFGFGILLLELITGQ 503
            + D++  GI+++E+I G+
Sbjct: 220 TEVDIWSLGIMVIEMIDGE 238

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
            N+  K ILGRG   +V    +K    + A+  +      + +  EVQ   E     + +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 357 ------HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
                 H N+++L     T     LV+  M  G     L D++  +  L     ++I   
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIMRA 119
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
               +  LH+     I+HRD+K  NILLD+D    + DFG +  LD  +      V GT 
Sbjct: 120 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTP 174
Query: 471 GHIAPEYLSTGQSS------EKTDVFGFGILLLELITG 502
            ++APE +    +       ++ D++  G+++  L+ G
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQT----EVETISLAVHRNLLRL 363
           +LG+G FG V K C  D        +K  N A  + +  +    EVE +    H N+++L
Sbjct: 29  MLGKGSFGEVLK-C-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
                  +   +V      G     L D I  R         RI      G+ Y+H+   
Sbjct: 87  FEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 424 PKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
             I+HRD+K  NILL   ++D +  + DFGL+     +++ +   + GT  +IAPE L  
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRI-GTAYYIAPEVLR- 196
Query: 481 GQSSEKTDVFGFGILLLELITG 502
           G   EK DV+  G++L  L++G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 11/210 (5%)
Query: 297 RAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQ-TEVETIS 353
           +   ++F    +LG+G FG ++     + G   A+K L K+  IA  EV    TE   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
              H  L  L     T +    V  Y   G +      H+         R +        
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF----HLSRERVFTEERARFYGAEIVS 116
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
            L YLH +    +++RD+K  N++LD+D    + DFGL K     D        GT  ++
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYL 172
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           APE L         D +G G+++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 11/210 (5%)
Query: 297 RAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQ-TEVETIS 353
           +   ++F    +LG+G FG ++     + G   A+K L K+  IA  EV    TE   + 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
              H  L  L     T +    V  Y   G +      H+         R +        
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF----HLSRERVFTEERARFYGAEIVS 121
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
            L YLH +    +++RD+K  N++LD+D    + DFGL K     D        GT  ++
Sbjct: 122 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYL 177
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           APE L         D +G G+++ E++ G+
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 11/210 (5%)
Query: 297 RAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQ-TEVETIS 353
           +   ++F    +LG+G FG ++     + G   A+K L K+  IA  EV    TE   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
              H  L  L     T +    V  Y   G     L  H+         R +        
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGE----LFFHLSRERVFTEERARFYGAEIVS 116
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
            L YLH +    +++RD+K  N++LD+D    + DFGL K     D        GT  ++
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYL 172
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           APE L         D +G G+++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQT----EVETISLAVHRNLLRL 363
           +LG+G FG V K C  D        +K  N A  + +  +    EVE +    H N+++L
Sbjct: 29  MLGKGSFGEVLK-C-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
                  +   +V      G     L D I  R         RI      G+ Y+H+   
Sbjct: 87  FEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 424 PKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
             I+HRD+K  NILL   ++D +  + DFGL+     +++ +   + GT  +IAPE L  
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRI-GTAYYIAPEVLR- 196
Query: 481 GQSSEKTDVFGFGILLLELITG 502
           G   EK DV+  G++L  L++G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 11/210 (5%)
Query: 297 RAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQ-TEVETIS 353
           +   ++F    +LG+G FG ++     + G   A+K L K+  IA  EV    TE   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
              H  L  L     T +    V  Y   G     L  H+         R +        
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGE----LFFHLSRERVFTEERARFYGAEIVS 116
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
            L YLH +    +++RD+K  N++LD+D    + DFGL K     D        GT  ++
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYL 172
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           APE L         D +G G+++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 11/210 (5%)
Query: 297 RAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQ-TEVETIS 353
           +   ++F    +LG+G FG ++     + G   A+K L K+  IA  EV    TE   + 
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
              H  L  L     T +    V  Y   G     L  H+         R +        
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGE----LFFHLSRERVFTEERARFYGAEIVS 119
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
            L YLH +    +++RD+K  N++LD+D    + DFGL K     D        GT  ++
Sbjct: 120 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYL 175
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           APE L         D +G G+++ E++ G+
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
            N+  K ILGRG   +V    +K    + A+  +      + +  EVQ   E     + +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 357 ------HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
                 H N+++L     T     LV+  M  G     L D++  +  L     ++I   
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIMRA 132
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
               +  LH+     I+HRD+K  NILLD+D    + DFG +  LD  +      V GT 
Sbjct: 133 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTP 187
Query: 471 GHIAPEYLSTGQSS------EKTDVFGFGILLLELITG 502
            ++APE +    +       ++ D++  G+++  L+ G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 11/211 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
           +  NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L     TEN+  LV+ ++            + G P       K       +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLA 120
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           + H     +++HRD+K  N+L++ +    + DFGLA+            V  T+ + APE
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 477 -YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
             L     S   D++  G +  E++T +RAL
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 11/210 (5%)
Query: 297 RAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQ-TEVETIS 353
           +   ++F    +LG+G FG ++     + G   A+K L K+  IA  EV    TE   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
              H  L  L     T +    V  Y   G +      H+         R +        
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF----HLSRERVFTEERARFYGAEIVS 116
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
            L YLH +    +++RD+K  N++LD+D    + DFGL K     D        GT  ++
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYL 172
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           APE L         D +G G+++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G+G  G VY     + G  VA++++        E+    E+  +    + N++      
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDSY 87
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  Y+  GS+   + +       +D  +   +     + L +LH     ++I
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HR++K+ NILL  D    + DFG    +    S  +T V GT   +APE ++      K 
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 488 DVFGFGILLLELITGQ 503
           D++  GI+ +E+I G+
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 11/210 (5%)
Query: 297 RAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQ-TEVETIS 353
           +   ++F    +LG+G FG ++     + G   A+K L K+  IA  EV    TE   + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
              H  L  L     T +    V  Y   G +      H+         R +        
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF----HLSRERVFTEERARFYGAEIVS 116
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
            L YLH +    +++RD+K  N++LD+D    + DFGL K     D        GT  ++
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYL 172
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           APE L         D +G G+++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G+G  G VY     + G  VA++++        E+    E+  +    + N++      
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDSY 87
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  Y+  GS+   + +       +D  +   +     + L +LH     ++I
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ NILL  D    + DFG    +    S  +  V GT   +APE ++      K 
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 488 DVFGFGILLLELITGQ 503
           D++  GI+ +E+I G+
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G+G  G VY     + G  VA++++        E+    E+  +    + N++      
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDSY 86
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  Y+  GS+   + +       +D  +   +     + L +LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ NILL  D    + DFG    +    S  +  V GT   +APE ++      K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 488 DVFGFGILLLELITGQ 503
           D++  GI+ +E+I G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLK---------DYNIAG 340
           KE +   S F  +  LG G +G V     K   S+ A+  +K+ +         + NI  
Sbjct: 30  KEGKIGESYFKVRK-LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEK 88
Query: 341 GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALD 400
              +   E+  +    H N+++L      +    LV  +   G     L + I  R   D
Sbjct: 89  FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFD 144
Query: 401 WARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED---FEAVVGDFGLAKLLDH 457
                 I      G+ YLH+     I+HRD+K  NILL+         + DFGL+     
Sbjct: 145 ECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-S 200
Query: 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           +D  +   + GT  +IAPE L   + +EK DV+  G+++  L+ G
Sbjct: 201 KDYKLRDRL-GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/122 (36%), Positives = 64/122 (52%), Gaps = 15/122 (12%)
Query: 393 IHG-RPALDWARRKRIALGTAR----GLLYLHEQCDPKIIHRDVKAANILL--DEDFEAV 445
           IHG R +LD+ +R+++     R     L YLH Q    I HRD+K  N L   ++ FE  
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 446 VGDFGLAK---LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS--EKTDVFGFGILLLELI 500
           + DFGL+K    L++ + +  T   GT   +APE L+T   S   K D +  G+LL  L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 501 TG 502
            G
Sbjct: 271 MG 272

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 13/158 (8%)
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           EV  + L  H N+++L  F   +    LV      G     L D I  R   +      I
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVI 141
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTT 464
                 G+ YLH+     I+HRD+K  N+LL   ++D    + DFGL+ + +++      
Sbjct: 142 IKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MK 196
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
              GT  +IAPE L   +  EK DV+  G++L  L+ G
Sbjct: 197 ERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAG 233

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     +G G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  YMP G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G+G  G VY     + G  VA++++        E+    E+  +    + N++      
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNPNIVNYLDSY 86
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
              +E  +V  Y+  GS+   + +       +D  +   +     + L +LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           HRD+K+ NILL  D    + DFG    +    S  +  V GT   +APE ++      K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 488 DVFGFGILLLELITGQ 503
           D++  GI+ +E+I G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     +G G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  YMP G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 297 RAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNI--AGGEVQFQTEVETIS 353
            A  S+F    ++G+G FG ++     ++    AVK L+   I     E    +E   + 
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 354 LAV-HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
             V H  L+ L     T ++   V  Y+  G     L  H+         R +  A   A
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGG----ELFYHLQRERCFLEPRARFYAAEIA 149
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL-LDHRDSHVTTAVRGTVG 471
             L YLH      I++RD+K  NILLD     V+ DFGL K  ++H  +  T+   GT  
Sbjct: 150 SALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPE 204
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           ++APE L         D +  G +L E++ G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGXV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYV-ATRWY 193
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYV-ATRWY 193
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 147 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYV-ATRWY 199
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 184
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 302 NFSAKNILGRGGFGIVYKGCF-SDGALVAVK-------RLKDYNIAGGEVQFQTEVETIS 353
            +  K+++GRG   +V +    + G   AVK       RL    +   EV+  T  ET  
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLE--EVREATRRETHI 152
Query: 354 L---AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
           L   A H +++ L     + +   LV+  M  G     L D++  + AL     + I   
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE----LFDYLTEKVALSEKETRSIMRS 208
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
               + +LH      I+HRD+K  NILLD++ +  + DFG +  L+  +      + GT 
Sbjct: 209 LLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTP 263
Query: 471 GHIAPEYLSTGQSS------EKTDVFGFGILLLELITG 502
           G++APE L            ++ D++  G++L  L+ G
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 193
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 135 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 187
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 147 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 199
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 133 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 185
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 148 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 200
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 134 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 186
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 148 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 200
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    E++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y P G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+++D+     V DFGLAK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 190
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    E++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y P G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+++D+     V DFGLAK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 190
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 148 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 200
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 184
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 195
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 133 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 185
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 146 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 198
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 141 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 193
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 142 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 194
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGYV-ATRWY 190
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 12/211 (5%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF---QTEVETISLAV- 356
            +F    ++GRG +  V          +   R+    +   +      QTE      A  
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H  L+ L     TE+    V  Y+  G     L  H+  +  L     +  +   +  L 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGD----LMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           YLHE+    II+RD+K  N+LLD +    + D+G+ K    R    T+   GT  +IAPE
Sbjct: 168 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPE 223
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALD 507
            L         D +  G+L+ E++ G+   D
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 184
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 159 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 211
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 142 RGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGYV-ATRWY 194
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 156 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 208
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 155 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 207
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 138 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 190
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 156 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 208
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 155 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 207
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 142 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 194
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 142 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 194
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 24  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 83
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 84  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 139
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 140 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLA 192
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 101/234 (43%), Gaps = 28/234 (11%)
Query: 284 SLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKD-YNIAGG 341
           +L  LK  +F         +     +G G +G+V        G  VA+K++ + +++   
Sbjct: 38  NLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN 97
Query: 342 EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS----------VASRLRD 391
             +   E++ +    H N++ +         + ++ P +P G           + S L  
Sbjct: 98  AKRTLRELKILKHFKHDNIIAI---------KDILRPTVPYGEFKSVYVVLDLMESDLHQ 148
Query: 392 HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451
            IH    L     +       RGL Y+H     ++IHRD+K +N+L++E+ E  +GDFG+
Sbjct: 149 IIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 205
Query: 452 AKLL---DHRDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELIT 501
           A+ L        +  T    T  + APE  LS  + ++  D++  G +  E++ 
Sbjct: 206 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 71/163 (43%), Gaps = 9/163 (5%)
Query: 346 QTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
           QTE      A  H  L+ L     TE+    V  Y+  G     L  H+  +  L     
Sbjct: 57  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD----LMFHMQRQRKLPEEHA 112
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
           +  +   +  L YLHE+    II+RD+K  N+LLD +    + D+G+ K    R    T+
Sbjct: 113 RFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS 168
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
              GT  +IAPE L         D +  G+L+ E++ G+   D
Sbjct: 169 XFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 71/163 (43%), Gaps = 9/163 (5%)
Query: 346 QTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
           QTE      A  H  L+ L     TE+    V  Y+  G     L  H+  +  L     
Sbjct: 68  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD----LMFHMQRQRKLPEEHA 123
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
           +  +   +  L YLHE+    II+RD+K  N+LLD +    + D+G+ K    R    T+
Sbjct: 124 RFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS 179
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
              GT  +IAPE L         D +  G+L+ E++ G+   D
Sbjct: 180 XFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 71/163 (43%), Gaps = 9/163 (5%)
Query: 346 QTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
           QTE      A  H  L+ L     TE+    V  Y+  G     L  H+  +  L     
Sbjct: 53  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD----LMFHMQRQRKLPEEHA 108
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
           +  +   +  L YLHE+    II+RD+K  N+LLD +    + D+G+ K    R    T+
Sbjct: 109 RFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS 164
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
              GT  +IAPE L         D +  G+L+ E++ G+   D
Sbjct: 165 XFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETIS 353
           E+RA   +      +G G +G V        GA VA+K+L  Y     E+  +     + 
Sbjct: 22  EVRAVYRDLQP---VGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELR 76
Query: 354 LAVHRNLLRLCGFCS--TENERL-------LVYPYMPNGSVASRLRDHIHGRPALDWARR 404
           L  H     + G     T +E L       LV P+M  G+   +L  H      L   R 
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH----EKLGEDRI 130
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
           + +     +GL Y+H      IIHRD+K  N+ ++ED E  + DFGLA+     DS +  
Sbjct: 131 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXG 184
Query: 465 AVRGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
            V  T  + APE  L+  + ++  D++  G ++ E+ITG+
Sbjct: 185 XV-VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +T  V  T  +
Sbjct: 165 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 217
Query: 473 IAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            APE +        T D++  G ++ EL+TG+
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 23/172 (13%)
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-V 466
           +   A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKK 524
           R  +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRR 308
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           L +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 309 L-KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 86/226 (38%), Gaps = 24/226 (10%)
Query: 306 KNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           + +L  GGF  VY+      G   A+KRL            Q       L+ H N+++ C
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 365 GFCSTENER-------LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
              S   E         L+   +  G +   L+  +  R  L      +I   T R + +
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR---------- 467
           +H Q  P IIHRD+K  N+LL       + DFG A  + H   +  +A R          
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 468 -GTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGQRALDFG 509
             T  +  PE +   S     EK D++  G +L  L   Q   + G
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + D+GLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 23/172 (13%)
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-V 466
           +   A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     
Sbjct: 197 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKK 524
           R  +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRR 306
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           L +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 307 L-KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 23/172 (13%)
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-V 466
           +   A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     
Sbjct: 204 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKK 524
           R  +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRR 313
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           L +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 314 L-KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 23/172 (13%)
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-V 466
           +   A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V     
Sbjct: 206 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--WVKK 524
           R  +  +APE +     + ++DV+ FG+LL E+ +       G A+   GV +D  + ++
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG-ASPYPGVKIDEEFCRR 315
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
           L +EG   +  D             EM Q  L C    P  RP  SE+++ L
Sbjct: 316 L-KEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     +G G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 71/188 (37%), Gaps = 34/188 (18%)
Query: 324 DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383
           D   V ++R+  ++      Q Q     + L +   L R        N R          
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR---------- 155
Query: 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443
                L D  HG           I +  A  + +LH +    ++HRD+K +NI    D  
Sbjct: 156 ---CSLEDREHGVCL-------HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDV 202
Query: 444 AVVGDFGLAKLLDHRDSHVTTAV--------RGTVG---HIAPEYLSTGQSSEKTDVFGF 492
             VGDFGL   +D  +   T            G VG   +++PE +     S K D+F  
Sbjct: 203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262
Query: 493 GILLLELI 500
           G++L EL+
Sbjct: 263 GLILFELL 270

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 104/236 (44%), Gaps = 32/236 (13%)
Query: 284 SLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKD-YNIAGG 341
           +L  LK  +F         +     +G G +G+V        G  VA+K++ + +++   
Sbjct: 37  NLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN 96
Query: 342 EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS----------VASRLRD 391
             +   E++ +    H N++ +         + ++ P +P G           + S L  
Sbjct: 97  AKRTLRELKILKHFKHDNIIAI---------KDILRPTVPYGEFKSVYVVLDLMESDLHQ 147
Query: 392 HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451
            IH    L     +       RGL Y+H     ++IHRD+K +N+L++E+ E  +GDFG+
Sbjct: 148 IIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204
Query: 452 AKLL-----DHRDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELIT 501
           A+ L     +H+  +  T    T  + APE  LS  + ++  D++  G +  E++ 
Sbjct: 205 ARGLCTSPAEHQ--YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 102/240 (42%), Gaps = 39/240 (16%)
Query: 284 SLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRL--------KD 335
           +L +L +Y  KE     +++     L +G F  +   C  D    A+K+         +D
Sbjct: 15  NLIYLNKYV-KEKDKYINDYRIIRTLNQGKFNKII-LCEKDNKFYALKKYEKSLLEKKRD 72
Query: 336 Y--------NIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVAS 387
           +        +I      F+ E++ I+   +   L   G  +  +E  ++Y YM N S+  
Sbjct: 73  FTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSIL- 131
Query: 388 RLRDHIHGRPALDWARRKRIALGTARGLL--------YLHEQCDPKIIHRDVKAANILLD 439
           +  ++      LD      I +   + ++        Y+H +    I HRDVK +NIL+D
Sbjct: 132 KFDEYFF---VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMD 186
Query: 440 EDFEAVVGDFGLAK-LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE--KTDVFGFGILL 496
           ++    + DFG ++ ++D +        RGT   + PE+ S   S    K D++  GI L
Sbjct: 187 KNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG V      + G   A+K L    +    +++     + I  A
Sbjct: 39  AHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y P G + S LR    GR +   AR    A      
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR     AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR     AR    A      
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR     AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG V      + G   A+K L    +    +++     + I  A
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 146
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 147 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 199
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +G G  GIV   C +     G  VAVK +        E+ F  EV  +    H N++ + 
Sbjct: 53  IGEGSTGIV---CLAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHFNVVEMY 108
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
                  E  ++  ++  G++       I  +  L+  +   +     + L YLH Q   
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTD-----IVSQVRLNEEQIATVCEAVLQALAYLHAQ--- 160
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
            +IHRD+K+ +ILL  D    + DFG    +  +D      + GT   +APE +S    +
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 485 EKTDVFGFGILLLELITGQ 503
            + D++  GI+++E++ G+
Sbjct: 220 TEVDIWSLGIMVIEMVDGE 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y P G + S LR    GR +   AR    A      
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+++D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +   V  T  +
Sbjct: 156 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGXV-ATRWY 208
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGL +   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y P G + S LR    GR +   AR    A      
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+++D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG V      + G   A+K L    +    +++     + I  A
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +   V  T  +
Sbjct: 159 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGYV-ATRWY 211
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG V      + G   A+K L    +    +++     + I  A
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +   V  T  +
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFV-ATRWY 184
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +   V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG V      + G   A+K L    +    +++     + I  A
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H D  +   V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG V      + G   A+K L    +    +++     + I  A
Sbjct: 59  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 174
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 175 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 227
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG V      + G   A+K L    +    +++     + I  A
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+P G + S LR    GR     AR    A      
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARF--YAAQIVLT 146
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 147 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 199
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y P G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+++D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 110/265 (41%), Gaps = 39/265 (14%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKR-LKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           +G+G FG V+K      G  VA+K+ L +    G  +    E++ + L  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 367 CSTENERLLVYPY-MPNGSVASRLRDHIHGRPAL--------DWARRKRIALGTARGLLY 417
           C T+       PY    GS+        H    L          +  KR+      GL Y
Sbjct: 86  CRTK-----ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK---LLDHRDSHVTTAVRGTVGHIA 474
           +H     KI+HRD+KAAN+L+  D    + DFGLA+   L  +   +       T+ +  
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 475 PE-YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
           PE  L         D++G G ++ E+ T             R  ++    + HQ   +SQ
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT-------------RSPIMQGNTEQHQLALISQ 244
Query: 534 M---VDKDLKGNFDRIELEEMVQVA 555
           +   +  ++  N D  EL E +++ 
Sbjct: 245 LCGSITPEVWPNVDNYELYEKLELV 269

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y P G + S LR    GR     AR    A      
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFXEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+++D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y P G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+++D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKD-------YNIAGGEVQFQTEVETISLAVHRNL 360
           +G G +G+V+K    D G +VA+K+  +         IA  E++   +++      H NL
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK------HPNL 64
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           + L      +    LV+ Y  + +V   L  +  G P       K I   T + + + H+
Sbjct: 65  VNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPE---HLVKSITWQTLQAVNFCHK 120
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL----DHRDSHVTTAVRGTVGHIAPE 476
                 IHRDVK  NIL+ +     + DFG A+LL    D+ D  V T       + +PE
Sbjct: 121 H---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE 172
Query: 477 YL-STGQSSEKTDVFGFGILLLELITG 502
            L    Q     DV+  G +  EL++G
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 39/274 (14%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKR-LKDYNIAGGEVQFQTEVETISLAVH 357
            S +     +G+G FG V+K      G  VA+K+ L +    G  +    E++ + L  H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 358 RNLLRLCGFCSTENERLLVYPY-MPNGSVASRLRDHIHGRPAL--------DWARRKRIA 408
            N++ L   C T+       PY    GS+        H    L          +  KR+ 
Sbjct: 77  ENVVNLIEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 131
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK---LLDHRDSHVTTA 465
                GL Y+H     KI+HRD+KAAN+L+  D    + DFGLA+   L  +   +    
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 466 VRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
              T+ +  PE  L         D++G G ++ E+ T             R  ++    +
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-------------RSPIMQGNTE 235
Query: 525 LHQEGKLSQM---VDKDLKGNFDRIELEEMVQVA 555
            HQ   +SQ+   +  ++  N D  EL E +++ 
Sbjct: 236 QHQLALISQLCGSITPEVWPNVDNYELYEKLELV 269

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           ++G G FG+V++    +   VA+K+ L+D      E+Q    V+      H N++ L  F
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK------HPNVVDLKAF 100
Query: 367 CSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
             +  ++       LV  Y+P  +V    R +   +  +     K       R L Y+H 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 421 QCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL- 478
                I HRD+K  N+LLD     + + DFG AK+L   + +V+     +  + APE + 
Sbjct: 160 I---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC--SRYYRAPELIF 214
Query: 479 STGQSSEKTDVFGFGILLLELITGQ 503
                +   D++  G ++ EL+ GQ
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 39/274 (14%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKR-LKDYNIAGGEVQFQTEVETISLAVH 357
            S +     +G+G FG V+K      G  VA+K+ L +    G  +    E++ + L  H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 358 RNLLRLCGFCSTENERLLVYPY-MPNGSVASRLRDHIHGRPAL--------DWARRKRIA 408
            N++ L   C T+       PY    GS+        H    L          +  KR+ 
Sbjct: 76  ENVVNLIEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK---LLDHRDSHVTTA 465
                GL Y+H     KI+HRD+KAAN+L+  D    + DFGLA+   L  +   +    
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 466 VRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
              T+ +  PE  L         D++G G ++ E+ T             R  ++    +
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-------------RSPIMQGNTE 234
Query: 525 LHQEGKLSQM---VDKDLKGNFDRIELEEMVQVA 555
            HQ   +SQ+   +  ++  N D  EL E +++ 
Sbjct: 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELV 268

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 13/208 (6%)
Query: 300 TSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVH 357
           T  +     +G+G F +V +      G   A K +    ++  + Q  + E     L  H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N++RL    S E    LV+  +  G     L + I  R     A            +L+
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
            H+     ++HRD+K  N+LL    +     + DFGLA +    D        GT G+++
Sbjct: 119 CHQM---GVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLS 174
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE L      +  D++  G++L  L+ G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---HRNLLRLC 364
           LG G F I  K          AVK      I    ++  T+ E  +L +   H N+++L 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVK------IISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIH-GRPALDWARRKRIALGTARGLLYLHEQCD 423
                +    LV   +  G +  R++   H       +  RK ++      + ++H   D
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHMH---D 124
Query: 424 PKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
             ++HRD+K  N+L    +++ E  + DFG A+L    +  + T    T+ + APE L+ 
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQ 183
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
               E  D++  G++L  +++GQ
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQ 206

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H    +T  V  T  +
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV-ATRWY 195
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H    +T  V  T  +
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV-ATRWY 195
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSDGAL--VAVKRLKDYNIAGGEVQ-------FQT 347
           +A    +     LG G  G V K  F       VA+K +     A G  +        +T
Sbjct: 5   KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 63
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           E+E +    H  ++++  F   E+   +V   M  G     L D + G   L  A  K  
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGE----LFDKVVGNKRLKEATCKLY 118
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTT 464
                  + YLHE     IIHRD+K  N+LL   +ED    + DFG +K+L   ++ +  
Sbjct: 119 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 173
Query: 465 AVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITG 502
            + GT  ++APE L    T   +   D +  G++L   ++G
Sbjct: 174 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+   H    +T  V  T  +
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV-ATRWY 195
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y P G + S LR    GR     AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFXEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+++D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSDGAL--VAVKRLKDYNIAGGEVQ-------FQT 347
           +A    +     LG G  G V K  F       VA+K +     A G  +        +T
Sbjct: 6   KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           E+E +    H  ++++  F   E+   +V   M  G     L D + G   L  A  K  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGE----LFDKVVGNKRLKEATCKLY 119
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTT 464
                  + YLHE     IIHRD+K  N+LL   +ED    + DFG +K+L   ++ +  
Sbjct: 120 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 174
Query: 465 AVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITG 502
            + GT  ++APE L    T   +   D +  G++L   ++G
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DF LA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSDGAL--VAVKRLKDYNIAGGEVQ-------FQT 347
           +A    +     LG G  G V K  F       VA+K +     A G  +        +T
Sbjct: 6   KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           E+E +    H  ++++  F   E+   +V   M  G     L D + G   L  A  K  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGE----LFDKVVGNKRLKEATCKLY 119
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTT 464
                  + YLHE     IIHRD+K  N+LL   +ED    + DFG +K+L   ++ +  
Sbjct: 120 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 174
Query: 465 AVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITG 502
            + GT  ++APE L    T   +   D +  G++L   ++G
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSDGAL--VAVKRLKDYNIAGGEVQ-------FQT 347
           +A    +     LG G  G V K  F       VA+K +     A G  +        +T
Sbjct: 6   KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           E+E +    H  ++++  F   E+   +V   M  G     L D + G   L  A  K  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGE----LFDKVVGNKRLKEATCKLY 119
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTT 464
                  + YLHE     IIHRD+K  N+LL   +ED    + DFG +K+L   ++ +  
Sbjct: 120 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 174
Query: 465 AVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITG 502
            + GT  ++APE L    T   +   D +  G++L   ++G
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  +  FGLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   M        L D I  R AL     +
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERM---EPVQDLFDFITERGALQEELAR 117
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 118 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 171
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 39/274 (14%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKR-LKDYNIAGGEVQFQTEVETISLAVH 357
            S +     +G+G FG V+K      G  VA+K+ L +    G  +    E++ + L  H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA---------LDWARRKRIA 408
            N++ L   C T+       PY    +    + D      A            +  KR+ 
Sbjct: 77  ENVVNLIEICRTKAS-----PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 131
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK---LLDHRDSHVTTA 465
                GL Y+H     KI+HRD+KAAN+L+  D    + DFGLA+   L  +   +    
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 466 VRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
              T+ +  PE  L         D++G G ++ E+ T             R  ++    +
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-------------RSPIMQGNTE 235
Query: 525 LHQEGKLSQM---VDKDLKGNFDRIELEEMVQVA 555
            HQ   +SQ+   +  ++  N D  EL E +++ 
Sbjct: 236 QHQLALISQLCGSITPEVWPNVDNYELYEKLELV 269

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG V      + G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    +   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 35/252 (13%)
Query: 275 VNDQYDPEVSLGHLKRYTFKEL---------RAATSNFSAKNILGRGGFGIVYKGCFSDG 325
           +N+  +  +SL   K + F +L         +A    +     LG G  G V K  F   
Sbjct: 114 LNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV-KLAFERK 172
Query: 326 AL--VAVKRLKDYNIAGGEVQ-------FQTEVETISLAVHRNLLRLCGFCSTENERLLV 376
               VA++ +     A G  +        +TE+E +    H  ++++  F   E+   +V
Sbjct: 173 TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIV 231
Query: 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANI 436
              M  G     L D + G   L  A  K         + YLHE     IIHRD+K  N+
Sbjct: 232 LELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENV 284
Query: 437 LL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL---STGQSSEKTDVF 490
           LL   +ED    + DFG +K+L   ++ +   + GT  ++APE L    T   +   D +
Sbjct: 285 LLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 342
Query: 491 GFGILLLELITG 502
             G++L   ++G
Sbjct: 343 SLGVILFICLSG 354

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGCFSDGAL--VAVKRLKDYNIAGGEVQ-------FQT 347
           +A    +     LG G  G V K  F       VA+K +     A G  +        +T
Sbjct: 12  KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 70
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           E+E +    H  ++++  F   E+   +V   M  G     L D + G   L  A  K  
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGE----LFDKVVGNKRLKEATCKLY 125
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTT 464
                  + YLHE     IIHRD+K  N+LL   +ED    + DFG +K+L   ++ +  
Sbjct: 126 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 180
Query: 465 AVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITG 502
            + GT  ++APE L    T   +   D +  G++L   ++G
Sbjct: 181 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG V      + G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    +   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + D GLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG V      + G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    +   +N  L +V  Y+P G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 14/206 (6%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEV---QFQTEVETISLAVHRN 359
           F  K  LG G FG V+        L  V  +K  N    +V   Q + E+E +    H N
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERV--IKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           ++++       +   +V      G +  R+        AL       +       L Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 420 EQCDPKIIHRDVKAANILLDE---DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
            Q    ++H+D+K  NIL  +        + DFGLA+L    D H T A  GT  ++APE
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAA-GTALYMAPE 196
Query: 477 YLSTGQSSEKTDVFGFGILLLELITG 502
                 +  K D++  G+++  L+TG
Sbjct: 197 VFKRDVTF-KCDIWSAGVVMYFLLTG 221

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + D GLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 35/252 (13%)
Query: 275 VNDQYDPEVSLGHLKRYTFKEL---------RAATSNFSAKNILGRGGFGIVYKGCFSDG 325
           +N+  +  +SL   K + F +L         +A    +     LG G  G V K  F   
Sbjct: 100 LNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV-KLAFERK 158
Query: 326 AL--VAVKRLKDYNIAGGEVQ-------FQTEVETISLAVHRNLLRLCGFCSTENERLLV 376
               VA++ +     A G  +        +TE+E +    H  ++++  F   E+   +V
Sbjct: 159 TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIV 217
Query: 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANI 436
              M  G     L D + G   L  A  K         + YLHE     IIHRD+K  N+
Sbjct: 218 LELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENV 270
Query: 437 LL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL---STGQSSEKTDVF 490
           LL   +ED    + DFG +K+L   ++ +   + GT  ++APE L    T   +   D +
Sbjct: 271 LLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 328
Query: 491 GFGILLLELITG 502
             G++L   ++G
Sbjct: 329 SLGVILFICLSG 340

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 25  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 140
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+DE     V DFG AK +  R    T  + GT  ++A
Sbjct: 141 FEYLHSL---DLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 193
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG V      + G   A+K L    +    +++     + I  A
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y P G + S LR    GR +   AR    A      
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+++D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+  D       T    T  +
Sbjct: 134 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE----MTGYVATRWY 186
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+ G+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 35/196 (17%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           +GL Y+H      ++HRD+K  N+ ++ED E  + DFGLA+   H D+ +T  V  T  +
Sbjct: 155 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWY 207
Query: 473 IAPEY-LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--------DWVK 523
            APE  LS    ++  D++  G ++ E++TG+         +Q   +L        ++V+
Sbjct: 208 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267
Query: 524 KLHQEGKLS--QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL-KMLEGDG 580
           KL+ +   S  Q + +  + +F               TQ  P   P+ +++L KMLE D 
Sbjct: 268 KLNDKAAKSYIQSLPQTPRKDF---------------TQLFPRASPQAADLLEKMLELD- 311
Query: 581 LAEKWEASQKIETPRY 596
           + ++  A+Q +  P +
Sbjct: 312 VDKRLTAAQALTHPFF 327

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 35/196 (17%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           +GL Y+H      ++HRD+K  N+ ++ED E  + DFGLA+   H D+ +T  V  T  +
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYV-VTRWY 189
Query: 473 IAPEY-LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--------DWVK 523
            APE  LS    ++  D++  G ++ E++TG+         +Q   +L        ++V+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 524 KLHQEGKLS--QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL-KMLEGDG 580
           KL+ +   S  Q + +  + +F               TQ  P   P+ +++L KMLE D 
Sbjct: 250 KLNDKAAKSYIQSLPQTPRKDF---------------TQLFPRASPQAADLLEKMLELD- 293
Query: 581 LAEKWEASQKIETPRY 596
           + ++  A+Q +  P +
Sbjct: 294 VDKRLTAAQALTHPFF 309

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 118
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 119 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 172
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + D GLA+   H D  +T  V  T  +
Sbjct: 136 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLAR---HTDDEMTGYV-ATRWY 188
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 132
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 133 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 186
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 187 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 146
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 147 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 200
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 132
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 133 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 186
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 187 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR A   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFAEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 117
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 118 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 171
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+  D       T    T  +
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----MTGYVATRWY 194
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+ G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 146
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 147 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 200
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 22/222 (9%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVE 350
           K++R    +F    ++GRG FG V      +   V A+K L  + +        F+ E +
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNG---SVASRLRDHIHGRPALDWARRKRI 407
            +     + +  L      +N   LV  Y   G   ++ S+  D +    A  +     I
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG-LAKLLDHRDSHVTTAV 466
           A+ +   L Y         +HRD+K  NIL+D +    + DFG   KL++      + AV
Sbjct: 187 AIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 467 RGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQ 503
            GT  +I+PE L       G+   + D +  G+ + E++ G+
Sbjct: 238 -GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 145
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 146 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 199
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 19/220 (8%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVE 350
            KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 351 TISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
              + + +       ++RL  +    +  +L+   +        L D I  R AL     
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELA 117
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVT 463
           +         + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V 
Sbjct: 118 RSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VY 171
Query: 464 TAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
           T   GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 15/200 (7%)
Query: 309 LGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCG 365
           LG+G F +V + C     G   A K +    ++  + Q  + E     L  H N++RL  
Sbjct: 30  LGKGAFSVVRR-CVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
             S E    L++  +  G     L + I  R     A            +L+ H+     
Sbjct: 89  SISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCHQM---G 141
Query: 426 IIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
           ++HRD+K  N+LL    +     + DFGLA  ++  +        GT G+++PE L    
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 483 SSEKTDVFGFGILLLELITG 502
             +  D++  G++L  L+ G
Sbjct: 201 YGKPVDLWACGVILYILLVG 220

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 145
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 146 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 199
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 19/220 (8%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVE 350
            KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 351 TISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
              + + +       ++RL  +    +  +L+   +        L D I  R AL     
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELA 117
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVT 463
           +         + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V 
Sbjct: 118 RSFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VY 171
Query: 464 TAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
           T   GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 146
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 147 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 200
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 145
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 146 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 199
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+  D       T    T  +
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE----MTGYVATRWY 194
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            APE  L+    ++  D++  G ++ EL+ G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 146
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 147 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 200
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 201 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 145
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 146 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 199
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 200 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 133
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 134 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 187
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 24  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 83
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 84  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 140
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 141 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 194
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 195 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 133
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 134 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 187
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 152
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 153 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 206
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 133
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 134 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 187
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 188 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGA------LVAVKRLKDYNIAGGE 342
           K+   KE+  +   F  +  LG   FG VYKG     A       VA+K LKD       
Sbjct: 16  KQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR 73
Query: 343 VQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL------------R 390
            +F+ E    +   H N++ L G  + +    +++ Y  +G +   L             
Sbjct: 74  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133
Query: 391 DHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450
           D    + AL+      +    A G+ YL       ++H+D+   N+L+ +     + D G
Sbjct: 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLG 190
Query: 451 LAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           L + +   D + +       +  +APE +  G+ S  +D++ +G++L E+ +
Sbjct: 191 LFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 160
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 161 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 214
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 215 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIA----GGEVQFQTEV 349
           ++++    +   + LG G F  VYK    +   +VA+K++K  + +    G       E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
           + +    H N++ L      ++   LV+ +M    +   ++D+      L  +  K   L
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDN---SLVLTPSHIKAYML 119
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
            T +GL YLH+     I+HRD+K  N+LLDE+    + DFGLAK     +      V  T
Sbjct: 120 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-T 175
Query: 470 VGHIAPEYLSTGQS-SEKTDVFGFGILLLELI 500
             + APE L   +      D++  G +L EL+
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 160
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 161 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 214
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 215 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVET 351
           KE     S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V  
Sbjct: 49  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 108
Query: 352 ISLAVHR------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             + + +       ++RL  +    +  +L+   +        L D I  R AL     +
Sbjct: 109 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELAR 165
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTT 464
                    + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T
Sbjct: 166 SFFWQVLEAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYT 219
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
              GT  +  PE++   +   ++  V+  GILL +++ G
Sbjct: 220 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 21/221 (9%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETI 352
           K+  A  + +    +LG+GGFG V+ G   +D   VA+K +    + G      +    +
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 353 SLAV---------HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR 403
            +A+         H  ++RL  +  T+   +LV   +     A  L D+I  +  L    
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV---LERPLPAQDLFDYITEKGPLGEGP 140
Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHV 462
            +         + + H +    ++HRD+K  NIL+D     A + DFG   LL H + + 
Sbjct: 141 SRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPY- 195
Query: 463 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITG 502
            T   GT  +  PE++S  Q  +    V+  GILL +++ G
Sbjct: 196 -TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 39  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 154
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 155 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 33  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR     AR    A      
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARF--YAAQIVLT 148
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 149 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 201
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 59  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 174
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK    R    T  + GT  ++A
Sbjct: 175 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGATWTLCGTPEYLA 227
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR     AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR     AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 133 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR     AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 140 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 196
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+++D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 141 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 197
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 198 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 132 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 188
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 189 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 67/322 (20%), Positives = 130/322 (40%), Gaps = 53/322 (16%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVK---RLKDYNIAGGEVQFQTEVE 350
           KE++    +F    ++GRG FG V        A+V +K   R+    I   + +     E
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEV--------AVVKMKNTERIYAMKILN-KWEMLKRAE 133
Query: 351 TISLAVHRNLLRLCGFCS----------TENERLLVYPYMPNG---SVASRLRDHIHGRP 397
           T      R++L + G C            EN   LV  Y   G   ++ S+  D +    
Sbjct: 134 TACFREERDVL-VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM 192
Query: 398 ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
           A  +     +A+ +   L Y         +HRD+K  N+LLD +    + DFG    ++ 
Sbjct: 193 ARFYIGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMND 243
Query: 458 RDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFGRAA 512
             +  ++   GT  +I+PE L       G+   + D +  G+ + E++ G+         
Sbjct: 244 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 303
Query: 513 NQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEV 572
              G +++  ++      ++ + +          E ++++Q  L+C++   L +  + + 
Sbjct: 304 ETYGKIMNHEERFQFPSHVTDVSE----------EAKDLIQ-RLICSRERRLGQNGIEDF 352
Query: 573 LKMLEGDGLAEKWEASQKIETP 594
            K    +GL   WE  + +E P
Sbjct: 353 KKHAFFEGL--NWENIRNLEAP 372

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 133 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 309 LGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LGRG +G+V K      G ++AVKR++    +  + +   +++     V       C F 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD------CPFT 112
Query: 368 ST-------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
            T       E +  +    M + S+    +  I     +      +IA+   + L +LH 
Sbjct: 113 VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY--- 477
           +    +IHRDVK +N+L++   +  + DFG++  L   DS   T   G   ++APE    
Sbjct: 172 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTIDAGCKPYMAPERINP 227
Query: 478 -LSTGQSSEKTDVFGFGILLLEL 499
            L+    S K+D++  GI ++EL
Sbjct: 228 ELNQKGYSVKSDIWSLGITMIEL 250

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 24/228 (10%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGA------LVAVKRLKDYNIAGGEVQFQ 346
            KE+  +   F  +  LG   FG VYKG     A       VA+K LKD        +F+
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 347 TEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL------------RDHIH 394
            E    +   H N++ L G  + +    +++ Y  +G +   L             D   
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 395 GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454
            + AL+      +    A G+ YL       ++H+D+   N+L+ +     + D GL + 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 455 LDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
           +   D + +       +  +APE +  G+ S  +D++ +G++L E+ +
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 59  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR     AR    A      
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARF--YAAQIVLT 174
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 175 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 227
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHR 358
           S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V    + + +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 359 ------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
                  ++RL  +    +  +L+   +        L D I  R AL     +       
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
             + + H   +  ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T   GT  
Sbjct: 121 EAVRHCH---NXGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYTDFDGTRV 174
Query: 472 HIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
           +  PE++   +   ++  V+  GILL +++ G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 67/322 (20%), Positives = 130/322 (40%), Gaps = 53/322 (16%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVK---RLKDYNIAGGEVQFQTEVE 350
           KE++    +F    ++GRG FG V        A+V +K   R+    I   + +     E
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEV--------AVVKMKNTERIYAMKILN-KWEMLKRAE 117
Query: 351 TISLAVHRNLLRLCGFCS----------TENERLLVYPYMPNG---SVASRLRDHIHGRP 397
           T      R++L + G C            EN   LV  Y   G   ++ S+  D +    
Sbjct: 118 TACFREERDVL-VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM 176
Query: 398 ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
           A  +     +A+ +   L Y         +HRD+K  N+LLD +    + DFG    ++ 
Sbjct: 177 ARFYIGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMND 227
Query: 458 RDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFGRAA 512
             +  ++   GT  +I+PE L       G+   + D +  G+ + E++ G+         
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 287
Query: 513 NQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEV 572
              G +++  ++      ++ + +          E ++++Q  L+C++   L +  + + 
Sbjct: 288 ETYGKIMNHEERFQFPSHVTDVSE----------EAKDLIQ-RLICSRERRLGQNGIEDF 336
Query: 573 LKMLEGDGLAEKWEASQKIETP 594
            K    +GL   WE  + +E P
Sbjct: 337 KKHAFFEGL--NWENIRNLEAP 356

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 143 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 77/189 (40%), Gaps = 35/189 (18%)
Query: 37  ALVAVKNNLHDPYNVLENWDITSVDPC--SWRMITCSPDGY--------VSALGLPS--- 83
           AL+ +K +L +P   L +W + + D C  +W  + C  D          +S L LP    
Sbjct: 10  ALLQIKKDLGNP-TTLSSW-LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP 67
Query: 84  -------------------QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL 124
                               +L G + P I  LT+L  + + +  + G IP  L +++ L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 125 QTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESL-TLVDLSYNNLS 183
            TLD S N  +G +P S+                +G+ P+S      L T + +S N L+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 184 GSLPKISAR 192
           G +P   A 
Sbjct: 188 GKIPPTFAN 196

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHR 358
           S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V    + + +
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 359 ------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
                  ++RL  +    +  +L+   +        L D I  R AL     +       
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVL 123
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
             + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T   GT  
Sbjct: 124 EAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYTDFDGTRV 177
Query: 472 HIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
           +  PE++   +   ++  V+  GILL +++ G
Sbjct: 178 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHR 358
           S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V    + + +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 359 ------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
                  ++RL  +    +  +L+   +        L D I  R AL     +       
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
             + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T   GT  
Sbjct: 121 EAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYTDFDGTRV 174
Query: 472 HIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
           +  PE++   +   ++  V+  GILL +++ G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ ++  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV--TTAVRGTV 470
           RGL Y+H      ++HRD+K +N+L++   +  + DFGLA++ D    H    T    T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHR 358
           S +    +LG GGFG VY G   SD   VA+K ++   I+  GE+   T V    + + +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 359 ------NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
                  ++RL  +    +  +L+   +        L D I  R AL     +       
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
             + + H  C   ++HRD+K  NIL+D +  E  + DFG   LL  +D+ V T   GT  
Sbjct: 121 EAVRHCH-NC--GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDT-VYTDFDGTRV 174
Query: 472 HIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
           +  PE++   +   ++  V+  GILL +++ G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT   +A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEALA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE + +   ++  D +  G+L+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 85/212 (40%), Gaps = 21/212 (9%)
Query: 300 TSNFSAKNILGRGGFGIVYK------GCFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS 353
           T  +     LG+G F +V +      G      ++  K+L     A    + + E     
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS----ARDHQKLEREARICR 65
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
           L  H N++RL    S E    L++  +  G     L + I  R     A           
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILE 121
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGTV 470
            +L+ H+     ++HR++K  N+LL    +     + DFGLA  ++  +        GT 
Sbjct: 122 AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTP 177
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           G+++PE L      +  D++  G++L  L+ G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 90/226 (39%), Gaps = 43/226 (19%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
           E R      + +  LGRG FG V+             R+KD         FQ  V+ + L
Sbjct: 66  EYREEVHWMTHQPRLGRGSFGEVH-------------RMKDKQTG-----FQCAVKKVRL 107
Query: 355 AVHR--NLLRLCGFCST----------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWA 402
            V R   L+   G  S           E   + ++  +  G    +L   +   P     
Sbjct: 108 EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---- 163
Query: 403 RRKRIALGTA-RGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLL--DHR 458
            R    LG A  GL YLH +   +I+H DVKA N+LL  D   A + DFG A  L  D  
Sbjct: 164 DRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 220
Query: 459 DSHVTTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
              + T   + GT  H+APE +       K D++    ++L ++ G
Sbjct: 221 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 23/213 (10%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-------GALVAVKRLKDYNIAGGEVQFQTEVETI 352
           T ++     LG+G F +V + C            ++  K+L     A    + + E    
Sbjct: 30  TDDYQLFEELGKGAFSVV-RRCVKKTPTQEYAAKIINTKKLS----ARDHQKLEREARIC 84
Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
            L  H N++RL    S E    LV+  +  G     L + I  R     A          
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIHQIL 140
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGT 469
             + ++H+     I+HRD+K  N+LL    +     + DFGLA +    +        GT
Sbjct: 141 ESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGT 196
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            G+++PE L      +  D++  G++L  L+ G
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 12/145 (8%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQFQTEVETIS---- 353
           T+ F     +G G FG V+K C    DG + A+KR K      G V  Q  +  +     
Sbjct: 6   TTEFHELEKIGSGEFGSVFK-CVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAV 62
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
           L  H +++R     + ++  L+   Y   GS+A  + ++         A  K + L   R
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 414 GLLYLHEQCDPKIIHRDVKAANILL 438
           GL Y+H      ++H D+K +NI +
Sbjct: 123 GLRYIHSMS---LVHMDIKPSNIFI 144

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 12/145 (8%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQFQTEVETIS---- 353
           T+ F     +G G FG V+K C    DG + A+KR K      G V  Q  +  +     
Sbjct: 8   TTEFHELEKIGSGEFGSVFK-CVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAV 64
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
           L  H +++R     + ++  L+   Y   GS+A  + ++         A  K + L   R
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 414 GLLYLHEQCDPKIIHRDVKAANILL 438
           GL Y+H      ++H D+K +NI +
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFI 146

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 12/145 (8%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQFQTEVETIS---- 353
           T+ F     +G G FG V+K C    DG + A+KR K      G V  Q  +  +     
Sbjct: 8   TTEFHELEKIGSGEFGSVFK-CVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAV 64
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
           L  H +++R     + ++  L+   Y   GS+A  + ++         A  K + L   R
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 414 GLLYLHEQCDPKIIHRDVKAANILL 438
           GL Y+H      ++H D+K +NI +
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFI 146

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 12/145 (8%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQFQTEVETIS---- 353
           T+ F     +G G FG V+K C    DG + A+KR K      G V  Q  +  +     
Sbjct: 10  TTEFHELEKIGSGEFGSVFK-CVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAV 66
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
           L  H +++R     + ++  L+   Y   GS+A  + ++         A  K + L   R
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 414 GLLYLHEQCDPKIIHRDVKAANILL 438
           GL Y+H      ++H D+K +NI +
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFI 148

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 409 LGTA-RGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLLDH----RDSHV 462
           LG A  GL YLH +   +I+H DVKA N+LL  D   A + DFG A  L      +D   
Sbjct: 172 LGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLT 228
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
              + GT  H+APE +       K DV+    ++L ++ G
Sbjct: 229 GDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 15/200 (7%)
Query: 309 LGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCG 365
           LG+G F +V + C     G   A K +    ++  + Q  + E     L  H N++RL  
Sbjct: 12  LGKGAFSVVRR-CMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
             S E    LV+  +  G     L + I  R     A            + + H      
Sbjct: 71  SISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILESVNHCHLN---G 123
Query: 426 IIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
           I+HRD+K  N+LL    +     + DFGLA +    D        GT G+++PE L    
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 483 SSEKTDVFGFGILLLELITG 502
             +  D++  G++L  L+ G
Sbjct: 183 YGKPVDMWACGVILYILLVG 202

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 307 NILGRGGFGIVYKGCFS--DGALVAVK--RLKDYNIAGG--EVQFQTEVETISLAVHRNL 360
            ++G+G F +V + C +   G   AVK   +  +  + G      + E     +  H ++
Sbjct: 30  EVIGKGAFSVVRR-CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           + L    S++    +V+ +M    +       I  R    +   + +A    R +L    
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFE----IVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 421 QC-DPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAP 475
            C D  IIHRDVK  N+LL   +      +GDFG+A  L   +S +    R GT   +AP
Sbjct: 145 YCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--ESGLVAGGRVGTPHFMAP 202
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITG 502
           E +      +  DV+G G++L  L++G
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 11/201 (5%)
Query: 309 LGRGGFGIVYKGCFSDG-ALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           +G G +G V+K    +   +VA+KR++ D +  G       E+  +    H+N++RL   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
             ++ +  LV+ +        +  D  +G   LD    K       +GL + H +    +
Sbjct: 70  LHSDKKLTLVFEFCDQD--LKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ-SSE 485
           +HRD+K  N+L++ + E  + DFGLA+          +A   T+ +  P+ L   +  S 
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 486 KTDVFGFGILLLELITGQRAL 506
             D++  G +  EL    R L
Sbjct: 182 SIDMWSAGCIFAELANAARPL 202

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 14/208 (6%)
Query: 298 AATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
           A    F     LG G FG ++       G   A+K L    +    +++     + I  A
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
           V+   L    F   +N  L +V  Y+  G + S LR    GR +   AR    A      
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARF--YAAQIVLT 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  + GT  ++A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           P  + +   ++  D +  G+L+ E+  G
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 309 LGRGGFGIVYKGCFSD--GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           LGRG F +V + C S   G   A K LK     G + + +   E   L + ++  R+   
Sbjct: 37  LGRGKFAVV-RQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 367 CST-EN--ERLLVYPYMPNGSVAS----RLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
               EN  E +L+  Y   G + S     L + +     +      R+      G+ YLH
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI------RLIKQILEGVYYLH 148
Query: 420 EQCDPKIIHRDVKAANILLDEDF---EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           +     I+H D+K  NILL   +   +  + DFG+++ + H  +     + GT  ++APE
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELREIMGTPEYLAPE 203
Query: 477 YLSTGQSSEKTDVFGFGILLLELIT 501
            L+    +  TD++  GI+   L+T
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 84/211 (39%), Gaps = 15/211 (7%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQ-FQTEVETISL 354
           + T  +     LG+G F +V + C     G   A K +    ++  + Q  + E     L
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRR-CMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRL 59
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
             H N++RL    S E    LV+  +  G     L + I  R     A            
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILES 115
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGTVG 471
           + + H      I+HRD+K  N+LL    +     + DFGLA +    D        GT G
Sbjct: 116 VNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           +++PE L      +  D++  G++L  L+ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 25/214 (11%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG---------GEVQFQTEV 349
           +  +S  + LG G FG V+     +    V VK +K   +           G+V    E+
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL--EI 80
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI-- 407
             +S   H N++++      +    LV   M        L   I   P LD      I  
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLV---MEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
            L +A G L L +     IIHRD+K  NI++ EDF   + DFG A  L+      T    
Sbjct: 138 QLVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-- 190
Query: 468 GTVGHIAPEYL-STGQSSEKTDVFGFGILLLELI 500
           GT+ + APE L        + +++  G+ L  L+
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 90/226 (39%), Gaps = 43/226 (19%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
           E R      + +  +GRG FG V+             R+KD         FQ  V+ + L
Sbjct: 68  EYREEVHWMTHQPRVGRGSFGEVH-------------RMKDKQTG-----FQCAVKKVRL 109
Query: 355 AVHR--NLLRLCGFCST----------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWA 402
            V R   L+   G  S           E   + ++  +  G    +L   +   P     
Sbjct: 110 EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---- 165
Query: 403 RRKRIALGTA-RGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLL--DHR 458
            R    LG A  GL YLH +   +I+H DVKA N+LL  D   A + DFG A  L  D  
Sbjct: 166 DRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 222
Query: 459 DSHVTTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
              + T   + GT  H+APE +       K D++    ++L ++ G
Sbjct: 223 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 90/226 (39%), Gaps = 43/226 (19%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
           E R      + +  +GRG FG V+             R+KD         FQ  V+ + L
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVH-------------RMKDKQTG-----FQCAVKKVRL 93
Query: 355 AVHR--NLLRLCGFCST----------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWA 402
            V R   L+   G  S           E   + ++  +  G    +L   +   P     
Sbjct: 94  EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---- 149
Query: 403 RRKRIALGTA-RGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLL--DHR 458
            R    LG A  GL YLH +   +I+H DVKA N+LL  D   A + DFG A  L  D  
Sbjct: 150 DRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 459 DSHVTTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
              + T   + GT  H+APE +       K D++    ++L ++ G
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +        T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTV 470
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +        T 
Sbjct: 140 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 471 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + APE +   +   K+ D++  G +L E+++ +
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 10/168 (5%)
Query: 302 NFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH 357
           N+  K+++GRG +G VY    K    + A+  V R+ +  I    +    E+  ++    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKS 86
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
             ++RL      E+       Y+      S L+        L     K I      G  +
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-HRDSHVTT 464
           +HE     IIHRD+K AN LL++D    + DFGLA+ ++  +D H+  
Sbjct: 147 IHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVN 191

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 97/245 (39%), Gaps = 22/245 (8%)
Query: 294 KELRAATSNFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLKDYN-IAGGEVQ-FQTEVE 350
           KE+R    +F    ++GRG F  +        G + A+K +  ++ +  GEV  F+ E +
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNG---SVASRLRDHIHGRPALDWARRKRI 407
            +     R + +L      EN   LV  Y   G   ++ S+  + I    A  +     +
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM 173
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
           A+ +   L Y         +HRD+K  NILLD      + DFG    L    +  +    
Sbjct: 174 AIDSVHRLGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 468 GTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD 520
           GT  +++PE L         G    + D +  G+   E+  GQ        A   G ++ 
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284
Query: 521 WVKKL 525
           + + L
Sbjct: 285 YKEHL 289

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 51/100 (51%), Gaps = 9/100 (9%)
Query: 409 LGTA-RGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLL--DHRDSHVTT 464
           LG A  GL YLH +   +I+H DVKA N+LL  D   A + DFG A  L  D     + T
Sbjct: 191 LGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLT 247
Query: 465 A--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
              + GT  H+APE +       K DV+    ++L ++ G
Sbjct: 248 GDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 85/202 (42%), Gaps = 20/202 (9%)
Query: 309 LGRGGFG--IVYKGCFSDGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLC 364
           LG G +G  ++ K   + GA  A+K +K  ++           EV  +    H N+++L 
Sbjct: 29  LGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
            F   +    LV      G     L D I  R          I      G  YLH+    
Sbjct: 88  EFFEDKRNYYLVMEVYRGGE----LFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH--- 140
Query: 425 KIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAPEYLST 480
            I+HRD+K  N+LL+    D    + DFGL+    H +       R GT  +IAPE L  
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERLGTAYYIAPEVLRK 197
Query: 481 GQSSEKTDVFGFGILLLELITG 502
            +  EK DV+  G++L  L+ G
Sbjct: 198 -KYDEKCDVWSCGVILYILLCG 218

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 25/242 (10%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R     F  + + G+G FG V  G   S G  VA+K+ ++D      E+Q   ++  +  
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH- 77
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR---------K 405
             H N+++L  +  T  ER     Y+    V   + D +H R   ++ RR         K
Sbjct: 78  --HPNIVQLQSYFYTLGERDRRDIYL--NVVMEYVPDTLH-RCCRNYYRRQVAPPPILIK 132
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLAKLLDHRDSHVTT 464
                  R +  LH      + HRD+K  N+L++E D    + DFG AK L   + +V  
Sbjct: 133 VFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV-- 189
Query: 465 AVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           A   +  + APE +   Q  +   D++  G +  E++ G+      R  N  G + + V+
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF---RGDNSAGQLHEIVR 246
Query: 524 KL 525
            L
Sbjct: 247 VL 248

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 85/202 (42%), Gaps = 20/202 (9%)
Query: 309 LGRGGFG--IVYKGCFSDGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLC 364
           LG G +G  ++ K   + GA  A+K +K  ++           EV  +    H N+++L 
Sbjct: 12  LGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
            F   +    LV      G     L D I  R          I      G  YLH+    
Sbjct: 71  EFFEDKRNYYLVMEVYRGGE----LFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH--- 123
Query: 425 KIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAPEYLST 480
            I+HRD+K  N+LL+    D    + DFGL+    H +       R GT  +IAPE L  
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERLGTAYYIAPEVLRK 180
Query: 481 GQSSEKTDVFGFGILLLELITG 502
            +  EK DV+  G++L  L+ G
Sbjct: 181 -KYDEKCDVWSCGVILYILLCG 201

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 67/309 (21%), Positives = 129/309 (41%), Gaps = 46/309 (14%)
Query: 283 VSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGE 342
           V LG    Y F+ +      +S    +G GG   V++       + A+K +   N+   +
Sbjct: 11  VDLGTENLY-FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV---NLEEAD 66
Query: 343 VQ----FQTEVETIS-LAVHRN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR 396
            Q    ++ E+  ++ L  H + ++RL  +  T+     +Y  M  G++   L   +  +
Sbjct: 67  NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKK 121
Query: 397 PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
            ++D   RK         +  +H+     I+H D+K AN L+ +    ++ DFG+A  + 
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQ 177
Query: 457 HRDSHVTTAVR-GTVGHIAPEYLSTGQSSEKT-----------DVFGFGILLLELITGQR 504
              + V    + GTV ++ PE +    SS +            DV+  G +L  +  G+ 
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 505 ALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPL 564
              F +  NQ       + KLH       ++D + +  F  I  +++  V   C + +P 
Sbjct: 238 P--FQQIINQ-------ISKLH------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 282
Query: 565 HRPKMSEVL 573
            R  + E+L
Sbjct: 283 QRISIPELL 291

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 417 YLHEQCDPKIIHRDVKAANIL-LDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           YLH Q    ++HRD+K +NIL +DE        + DFG AK L   +  + T    T   
Sbjct: 136 YLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANF 191
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           +APE L      E  D++  GILL  ++ G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 11/201 (5%)
Query: 309 LGRGGFGIVYKGCFSDG-ALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           +G G +G V+K    +   +VA+KR++ D +  G       E+  +    H+N++RL   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
             ++ +  LV+ +        +  D  +G   LD    K       +GL + H +    +
Sbjct: 70  LHSDKKLTLVFEFCDQD--LKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ-SSE 485
           +HRD+K  N+L++ + E  + +FGLA+          +A   T+ +  P+ L   +  S 
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 486 KTDVFGFGILLLELITGQRAL 506
             D++  G +  EL    R L
Sbjct: 182 SIDMWSAGCIFAELANAGRPL 202

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 417 YLHEQCDPKIIHRDVKAANIL-LDEDFEAV---VGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           YLH Q    ++HRD+K +NIL +DE        + DFG AK L   +  + T    T   
Sbjct: 136 YLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANF 191
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           +APE L      E  D++  GILL  ++ G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 417 YLHEQCDPKIIHRDVKAANIL-LDE--DFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           YLH Q    ++HRD+K +NIL +DE  + E++ + DFG AK L   +  + T    T   
Sbjct: 131 YLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TANF 186
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           +APE L         D++  G+LL  ++TG
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 5/104 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
           LD  R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-- 177
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            S + T    T  + APE +      E  D++  G+++ E+I G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 5/104 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
           LD  R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-- 177
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            S + T    T  + APE +      E  D++  G+++ E+I G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           ++ +N +GRG +G V K     G  +  A K++  Y +   + +F+ E+E +    H N+
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNI 85
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           +RL        +  LV      G +  R+   +H R     +   RI       + Y H+
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGELFERV---VHKR-VFRESDAARIMKDVLSAVAYCHK 141
Query: 421 QCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
                + HRD+K  N L      D    + DFGLA     +   +     GT  +++P+ 
Sbjct: 142 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSPQV 196
Query: 478 LSTGQSSEKTDVFGFGILLLELITG 502
           L  G    + D +  G+++  L+ G
Sbjct: 197 LE-GLYGPECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALV--AVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           ++ +N +GRG +G V K     G  +  A K++  Y +   + +F+ E+E +    H N+
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNI 68
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           +RL        +  LV      G +  R+   +H R     +   RI       + Y H+
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERV---VHKR-VFRESDAARIMKDVLSAVAYCHK 124
Query: 421 QCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
                + HRD+K  N L      D    + DFGLA     +   +     GT  +++P+ 
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSPQV 179
Query: 478 LSTGQSSEKTDVFGFGILLLELITG 502
           L  G    + D +  G+++  L+ G
Sbjct: 180 LE-GLYGPECDEWSAGVMMYVLLCG 203

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 23/233 (9%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQT------- 347
           EL A  S ++ +  +  G +G V  G  S+G  VA+KR+ +    G  V   +       
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 348 ---EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
              E+  ++   H N+L L        E  +   Y+    + + L   IH +  +     
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV--ISP 133
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
           + I       LL LH   +  ++HRD+   NILL ++ +  + DF LA+  D  D++ T 
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTH 192
Query: 465 AVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELITGQRALDFGRAANQRG 516
            V     + APE +   +   K  D++  G ++ E+        F R A  RG
Sbjct: 193 YVTHR-WYRAPELVMQFKGFTKLVDMWSAGCVMAEM--------FNRKALFRG 236

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 309 LGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LGRG +G+V K      G ++AVKR++    +  + +   +++     V       C F 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD------CPFT 68
Query: 368 ST-------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
            T       E +  +    M + S+    +  I     +      +IA+   + L +LH 
Sbjct: 69  VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY--- 477
           +    +IHRDVK +N+L++   +  + DFG++  L   D        G   ++APE    
Sbjct: 128 KL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINP 183
Query: 478 -LSTGQSSEKTDVFGFGILLLEL 499
            L+    S K+D++  GI ++EL
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 23/233 (9%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQT------- 347
           EL A  S ++ +  +  G +G V  G  S+G  VA+KR+ +    G  V   +       
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 348 ---EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
              E+  ++   H N+L L        E  +   Y+    + + L   IH +  +     
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV--ISP 133
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
           + I       LL LH   +  ++HRD+   NILL ++ +  + DF LA+  D  D++ T 
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTH 192
Query: 465 AVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELITGQRALDFGRAANQRG 516
            V     + APE +   +   K  D++  G ++ E+        F R A  RG
Sbjct: 193 YVTHR-WYRAPELVMQFKGFTKLVDMWSAGCVMAEM--------FNRKALFRG 236

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 67/309 (21%), Positives = 128/309 (41%), Gaps = 46/309 (14%)
Query: 283 VSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGE 342
           V LG    Y F+ +      +S    +G GG   V++       + A+K +   N+   +
Sbjct: 11  VDLGTENLY-FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV---NLEEAD 66
Query: 343 VQ----FQTEVETIS-LAVHRN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR 396
            Q    ++ E+  ++ L  H + ++RL  +  T+     +Y  M  G++   L   +  +
Sbjct: 67  NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKK 121
Query: 397 PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
            ++D   RK         +  +H+     I+H D+K AN L+ +    ++ DFG+A  + 
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQ 177
Query: 457 HRDSHVTTAVR-GTVGHIAPEYLSTGQSSEKT-----------DVFGFGILLLELITGQR 504
                V    + GTV ++ PE +    SS +            DV+  G +L  +  G+ 
Sbjct: 178 PDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 505 ALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPL 564
              F +  NQ       + KLH       ++D + +  F  I  +++  V   C + +P 
Sbjct: 238 P--FQQIINQ-------ISKLH------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 282
Query: 565 HRPKMSEVL 573
            R  + E+L
Sbjct: 283 QRISIPELL 291

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 21/155 (13%)
Query: 309 LGRGGFGIVYKGCFS-DGALVAVKRLK----DYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           LG G +G VYK   +     VA+KR++    +  + G  ++   EV  +    HRN++ L
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---EVSLLKELQHRNIIEL 98
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
                  +   L++ Y  N      L+ ++   P +     K        G+ + H +  
Sbjct: 99  KSVIHHNHRLHLIFEYAEND-----LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR-- 151
Query: 424 PKIIHRDVKAANILL-----DEDFEAVVGDFGLAK 453
            + +HRD+K  N+LL      E     +GDFGLA+
Sbjct: 152 -RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/289 (21%), Positives = 122/289 (42%), Gaps = 45/289 (15%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ----FQTEVETIS-LAVH 357
           +S    +G GG   V++       + A+K +   N+   + Q    ++ E+  ++ L  H
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYV---NLEEADNQTLDSYRNEIAYLNKLQQH 70
Query: 358 RN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
            + ++RL  +  T+     +Y  M  G++   L   +  + ++D   RK         + 
Sbjct: 71  SDKIIRLYDYEITDQ---YIYMVMECGNI--DLNSWLKKKKSIDPWERKSYWKNMLEAVH 125
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAP 475
            +H+     I+H D+K AN L+ +    ++ DFG+A  +    + V    + GTV ++ P
Sbjct: 126 TIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPP 181
Query: 476 EYLSTGQSSEKT-----------DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E +    SS +            DV+  G +L  +  G+    F +  NQ       + K
Sbjct: 182 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQ-------ISK 232
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
           LH       ++D + +  F  I  +++  V   C + +P  R  + E+L
Sbjct: 233 LH------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 5/104 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
           LD  R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 177
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            S + T    T  + APE +      E  D++  G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 52/115 (45%), Gaps = 30/115 (26%)
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS------------- 460
           G+ Y+H      I+HRD+K AN L+++D    V DFGLA+ +D+ ++             
Sbjct: 168 GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 461 -------HVTTAVRGTVGHI------APEYLSTGQS-SEKTDVFGFGILLLELIT 501
                  H     R   GH+      APE +   ++ +E  DV+  G +  EL+ 
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 5/104 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
           LD  R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+     
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 178
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            S + T    T  + APE +      E  D++  G ++ E+I G
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 55/132 (41%), Gaps = 10/132 (7%)
Query: 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433
           L+V   +  G + SR++D   G  A        I       + YLH      I HRDVK 
Sbjct: 97  LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 151
Query: 434 ANILLDEDFEAVV---GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
            N+L        +    DFG AK     +S  T     T  ++APE L   +  +  D++
Sbjct: 152 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMW 209
Query: 491 GFGILLLELITG 502
             G+++  L+ G
Sbjct: 210 SLGVIMYILLCG 221

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 55/132 (41%), Gaps = 10/132 (7%)
Query: 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433
           L+V   +  G + SR++D   G  A        I       + YLH      I HRDVK 
Sbjct: 96  LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 150
Query: 434 ANILLDEDFEAVV---GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
            N+L        +    DFG AK     +S  T     T  ++APE L   +  +  D++
Sbjct: 151 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMW 208
Query: 491 GFGILLLELITG 502
             G+++  L+ G
Sbjct: 209 SLGVIMYILLCG 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 55/132 (41%), Gaps = 10/132 (7%)
Query: 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433
           L+V   +  G + SR++D   G  A        I       + YLH      I HRDVK 
Sbjct: 95  LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 149
Query: 434 ANILLDEDFEAVV---GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
            N+L        +    DFG AK     +S  T     T  ++APE L   +  +  D++
Sbjct: 150 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMW 207
Query: 491 GFGILLLELITG 502
             G+++  L+ G
Sbjct: 208 SLGVIMYILLCG 219

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 307 NILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLRL 363
            +LG G +  V +G  S  +G   AVK ++          F+ EVET+     ++N+L L
Sbjct: 19  ELLGEGAYAKV-QGAVSLQNGKEYAVKIIEKQAGHSRSRVFR-EVETLYQCQGNKNILEL 76
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
             F   +    LV+  +  GS+ +    HI  +   +     R+    A  L +LH +  
Sbjct: 77  IEFFEDDTRFYLVFEKLQGGSILA----HIQKQKHFNEREASRVVRDVAAALDFLHTK-- 130
Query: 424 PKIIHRDVKAANILLD--EDFEAV-VGDFGLAKLLDHRDS-------HVTTAVRGTVGHI 473
             I HRD+K  NIL +  E    V + DF L   +   +S        +TT   G+  ++
Sbjct: 131 -GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC-GSAEYM 188
Query: 474 APEYLS--TGQSS---EKTDVFGFGILLLELITG 502
           APE +   T Q++   ++ D++  G++L  +++G
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 5/104 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
           LD  R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 177
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            S + T    T  + APE +      E  D++  G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 74/168 (44%), Gaps = 10/168 (5%)
Query: 302 NFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH 357
           N+  K+++GRG +G VY    K    + A+  V R+ +  I    +    E+  ++    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKS 84
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
             ++RL      ++       Y+      S L+        L     K I      G  +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-HRDSHVTT 464
           +HE     IIHRD+K AN LL++D    V DFGLA+ ++  +D+++  
Sbjct: 145 IHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 55/132 (41%), Gaps = 10/132 (7%)
Query: 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433
           L+V   +  G + SR++D   G  A        I       + YLH      I HRDVK 
Sbjct: 105 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 159
Query: 434 ANILLDEDFEAVV---GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
            N+L        +    DFG AK     +S  T     T  ++APE L   +  +  D++
Sbjct: 160 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMW 217
Query: 491 GFGILLLELITG 502
             G+++  L+ G
Sbjct: 218 SLGVIMYILLCG 229

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 417 YLHEQCDPKIIHRDVKAANIL-LDE--DFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           YLH Q    ++HRD+K +NIL +DE  + E++ + DFG AK L   +  + T    T   
Sbjct: 131 YLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TANF 186
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           +APE L         D++  G+LL   +TG
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 55/132 (41%), Gaps = 10/132 (7%)
Query: 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433
           L+V   +  G + SR++D   G  A        I       + YLH      I HRDVK 
Sbjct: 89  LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 143
Query: 434 ANILLDEDFEAVV---GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
            N+L        +    DFG AK     +S  T     T  ++APE L   +  +  D++
Sbjct: 144 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMW 201
Query: 491 GFGILLLELITG 502
             G+++  L+ G
Sbjct: 202 SLGVIMYILLCG 213

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/289 (21%), Positives = 122/289 (42%), Gaps = 45/289 (15%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ----FQTEVETIS-LAVH 357
           +S    +G GG   V++       + A+K +   N+   + Q    ++ E+  ++ L  H
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYV---NLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 358 RN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
            + ++RL  +  T+     +Y  M  G++   L   +  + ++D   RK         + 
Sbjct: 115 SDKIIRLYDYEITDQ---YIYMVMECGNI--DLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAP 475
            +H+     I+H D+K AN L+ +    ++ DFG+A  +    + V    + GTV ++ P
Sbjct: 170 TIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPP 225
Query: 476 EYLSTGQSSEKT-----------DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E +    SS +            DV+  G +L  +  G+    F +  NQ       + K
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQ-------ISK 276
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
           LH       ++D + +  F  I  +++  V   C + +P  R  + E+L
Sbjct: 277 LH------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 55/132 (41%), Gaps = 10/132 (7%)
Query: 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433
           L+V   +  G + SR++D   G  A        I       + YLH      I HRDVK 
Sbjct: 90  LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 144
Query: 434 ANILLDEDFEAVV---GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
            N+L        +    DFG AK     +S  T     T  ++APE L   +  +  D++
Sbjct: 145 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMW 202
Query: 491 GFGILLLELITG 502
             G+++  L+ G
Sbjct: 203 SLGVIMYILLCG 214

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 55/132 (41%), Gaps = 10/132 (7%)
Query: 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433
           L+V   +  G + SR++D   G  A        I       + YLH      I HRDVK 
Sbjct: 91  LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 145
Query: 434 ANILLDEDFEAVV---GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
            N+L        +    DFG AK     +S  T     T  ++APE L   +  +  D++
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMW 203
Query: 491 GFGILLLELITG 502
             G+++  L+ G
Sbjct: 204 SLGVIMYILLCG 215

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 63/289 (21%), Positives = 123/289 (42%), Gaps = 45/289 (15%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ----FQTEVETIS-LAVH 357
           +S    +G GG   V++       + A+K +   N+   + Q    ++ E+  ++ L  H
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYV---NLEEADNQTLDSYRNEIAYLNKLQQH 66
Query: 358 RN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
            + ++RL  +  T+     +Y  M  G++   L   +  + ++D   RK         + 
Sbjct: 67  SDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVH 121
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHIAP 475
            +H+     I+H D+K AN L+ +    ++ DFG+A ++     S V  +  GTV ++ P
Sbjct: 122 TIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPP 177
Query: 476 EYLSTGQSSEKT-----------DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E +    SS +            DV+  G +L  +  G+    F +  NQ       + K
Sbjct: 178 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQ-------ISK 228
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
           LH       ++D + +  F  I  +++  V   C + +P  R  + E+L
Sbjct: 229 LH------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 5/104 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
           LD  R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-- 177
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            S + T    T  + APE +      E  D++  G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 55/132 (41%), Gaps = 10/132 (7%)
Query: 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433
           L+V   +  G + SR++D   G  A        I       + YLH      I HRDVK 
Sbjct: 141 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 195
Query: 434 ANILLDEDFEAVV---GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
            N+L        +    DFG AK     +S  T     T  ++APE L   +  +  D++
Sbjct: 196 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMW 253
Query: 491 GFGILLLELITG 502
             G+++  L+ G
Sbjct: 254 SLGVIMYILLCG 265

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/289 (21%), Positives = 122/289 (42%), Gaps = 45/289 (15%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ----FQTEVETIS-LAVH 357
           +S    +G GG   V++       + A+K +   N+   + Q    ++ E+  ++ L  H
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYV---NLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 358 RN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
            + ++RL  +  T+     +Y  M  G++   L   +  + ++D   RK         + 
Sbjct: 68  SDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAP 475
            +H+     I+H D+K AN L+ +    ++ DFG+A  +    + V    + GTV ++ P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 476 EYLSTGQSSEKT-----------DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E +    SS +            DV+  G +L  +  G+    F +  NQ       + K
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQ-------ISK 229
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
           LH       ++D + +  F  I  +++  V   C + +P  R  + E+L
Sbjct: 230 LH------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 55/132 (41%), Gaps = 10/132 (7%)
Query: 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433
           L+V   +  G + SR++D   G  A        I       + YLH      I HRDVK 
Sbjct: 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 189
Query: 434 ANILLDEDFEAVV---GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
            N+L        +    DFG AK     +S  T     T  ++APE L   +  +  D++
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMW 247
Query: 491 GFGILLLELITG 502
             G+++  L+ G
Sbjct: 248 SLGVIMYILLCG 259

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 5/104 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
           LD  R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 177
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            S + T    T  + APE +      E  D++  G ++ E+I G
Sbjct: 178 TSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 5/104 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
           LD  R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 177
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            S + T    T  + APE +      E  D++  G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 5/104 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
           LD  R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-- 177
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            S + T    T  + APE +      E  D++  G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 55/132 (41%), Gaps = 10/132 (7%)
Query: 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433
           L+V   +  G + SR++D   G  A        I       + YLH      I HRDVK 
Sbjct: 91  LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 145
Query: 434 ANILLDEDFEAVV---GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
            N+L        +    DFG AK     +S  T     T  ++APE L   +  +  D++
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSCDMW 203
Query: 491 GFGILLLELITG 502
             G+++  L+ G
Sbjct: 204 SLGVIMYILLCG 215

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/205 (21%), Positives = 88/205 (42%), Gaps = 29/205 (14%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
           LGRG FGIV++   +      + +         +V  + E+  +++A HRN+L L     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP---- 424
           +  E ++++ ++    +  R+        A +   R+ ++        Y+H+ C+     
Sbjct: 72  SMEELVMIFEFISGLDIFERI-----NTSAFELNEREIVS--------YVHQVCEALQFL 118
Query: 425 ---KIIHRDVKAANILLDEDFEAVVG--DFGLAKLLDHRDSH--VTTAVRGTVGHIAPEY 477
               I H D++  NI+      + +   +FG A+ L   D+   + TA      + APE 
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE----YYAPEV 174
Query: 478 LSTGQSSEKTDVFGFGILLLELITG 502
                 S  TD++  G L+  L++G
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 42/85 (49%), Gaps = 6/85 (7%)
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L +LH Q    ++H DVK ANI L       +GDFGL  L++   +       G   ++A
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMA 224
Query: 475 PEYLSTGQSSEKTDVFGFGILLLEL 499
           PE L  G      DVF  G+ +LE+
Sbjct: 225 PELLQ-GSYGTAADVFSLGLTILEV 248

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 5/104 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
           LD  R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-- 177
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            S + T    T  + APE +      E  D++  G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 12/198 (6%)
Query: 309 LGRGGFGIVYKGCFSD--GALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           +G G  GIV    F    G  VAVK+L + +       +   E+  +    H+N++ L  
Sbjct: 30  IGSGAQGIVC-AAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 88
Query: 366 -FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
            F   +        Y+    + + L   IH    LD  R   +      G+ +LH     
Sbjct: 89  VFTPQKTLEEFQDVYLVMELMDANLCQVIHME--LDHERMSYLLYQMLCGIKHLH---SA 143
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
            IIHRD+K +NI++  D    + DFGLA+      + + T    T  + APE +      
Sbjct: 144 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAS--TNFMMTPYVVTRYYRAPEVILGMGYK 201
Query: 485 EKTDVFGFGILLLELITG 502
           E  D++  G ++ EL+ G
Sbjct: 202 ENVDIWSVGCIMGELVKG 219

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 62/289 (21%), Positives = 122/289 (42%), Gaps = 45/289 (15%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ----FQTEVETIS-LAVH 357
           +S    +G GG   V++       + A+K +   N+   + Q    ++ E+  ++ L  H
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYV---NLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 358 RN-LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
            + ++RL  +  T+     +Y  M  G++   L   +  + ++D   RK         + 
Sbjct: 115 SDKIIRLYDYEITDQ---YIYMVMECGNI--DLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAP 475
            +H+     I+H D+K AN L+ +    ++ DFG+A  +    + V    + GTV ++ P
Sbjct: 170 TIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPP 225
Query: 476 EYLSTGQSSEKT-----------DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
           E +    SS +            DV+  G +L  +  G+    F +  NQ       + K
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQ-------ISK 276
Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
           LH       ++D + +  F  I  +++  V   C + +P  R  + E+L
Sbjct: 277 LH------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	623
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	0.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-148
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-135
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-78
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-61
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-55
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-49
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-46
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-35
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-34
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-26
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-37
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-25
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-23
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-33
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-33
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-32
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-31
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-31
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-31
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-30
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-30
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-29
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-29
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-26
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-26
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-09
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-11
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-24
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-23
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-22
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-22
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-09
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-04
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-15
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-20
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-08
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-18
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-18
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-18
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-17
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-17
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-14
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-09
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-09
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-04
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-16
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-09
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-15
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-15
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-04
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-04
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-10
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-10
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-08
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-07
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-08
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-08
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-09
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-13
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-07
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-05
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-13
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-09
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-12
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-06
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-12
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-09
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-10
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-11
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-11
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-10
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-07
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-11
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-11
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-08
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-08
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-10
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-10
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-10
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-07
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-07
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-06
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-07
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-04
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-06
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-07
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-05
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-09
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-05
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-05
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	2e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	7e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  586 bits (1514), Expect = 0.0
 Identities = 230/325 (70%), Positives = 269/325 (82%), Gaps = 1/325 (0%)

Query: 272 FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVK 331
           FFDV  + DPEV LG LKR++ +EL+ A+ NFS KNILGRGGFG VYKG  +DG LVAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60

Query: 332 RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD 391
           RLK+    GGE+QFQTEVE IS+AVHRNLLRL GFC T  ERLLVYPYM NGSVAS LR+
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120

Query: 392 HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451
               +P LDW +R+RIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE+FEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180

Query: 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511
           AKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQRA D  R 
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240

Query: 512 ANQRGVML-DWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMS 570
           AN   VML DWVK L +E KL  +VD DL+GN+   E+E+++QVALLCTQ +P+ RPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300

Query: 571 EVLKMLEGDGLAEKWEASQKIETPR 595
           EV++MLEGDGLAE+WE  QK E  R
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFR 325

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  430 bits (1107), Expect = e-148
 Identities = 114/314 (36%), Positives = 172/314 (54%), Gaps = 21/314 (6%)

Query: 277 DQYDPEVSLGHLKRYTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAV 330
           +    EVS      ++F EL+  T+NF  +      N +G GGFG+VYKG   +   VAV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59

Query: 331 KRLK---DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVAS 387
           K+L    D      + QF  E++ ++   H NL+ L GF S  ++  LVY YMPNGS+  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 388 RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 447
           RL   + G P L W  R +IA G A G+ +LHE      IHRD+K+ANILLDE F A + 
Sbjct: 120 RLSC-LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS 175

Query: 448 DFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL 506
           DFGLA+  +    + +T+ + GT  ++APE L  G+ + K+D++ FG++LLE+ITG  A+
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV 234

Query: 507 DFGRAANQRGVMLDWVKKLHQE-GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLH 565
           D  R      ++LD  +++  E   +   +DK +  + D   +E M  VA  C       
Sbjct: 235 DEHREPQ---LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNK 290

Query: 566 RPKMSEVLKMLEGD 579
           RP + +V ++L+  
Sbjct: 291 RPDIKKVQQLLQEM 304

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  396 bits (1020), Expect = e-135
 Identities = 113/296 (38%), Positives = 167/296 (56%), Gaps = 14/296 (4%)

Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTE 348
            R    +L  AT+NF  K ++G G FG VYKG   DGA VA+KR      + G  +F+TE
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP-ESSQGIEEFETE 85

Query: 349 VETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA----LDWARR 404
           +ET+S   H +L+ L GFC   NE +L+Y YM NG+    L+ H++G       + W +R
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN----LKRHLYGSDLPTMSMSWEQR 141

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL-LDHRDSHVT 463
             I +G ARGL YLH +    IIHRDVK+ NILLDE+F   + DFG++K   +   +H++
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198

Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           T V+GT+G+I PEY   G+ +EK+DV+ FG++L E++  + A+           + +W  
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAV 257

Query: 524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD 579
           + H  G+L Q+VD +L        L +    A+ C   +   RP M +VL  LE  
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  249 bits (638), Expect = 5e-78
 Identities = 71/309 (22%), Positives = 115/309 (37%), Gaps = 38/309 (12%)

Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
            L   +       +  RG FG V+K        VAVK     +      Q + EV ++  
Sbjct: 18  NLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ--SWQNEYEVYSLPG 74

Query: 355 AVHRNLLRLCGFC----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             H N+L+  G      S + +  L+  +   GS    L D +     + W     IA  
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGS----LSDFLKANV-VSWNELCHIAET 129

Query: 411 TARGLLYLHE-------QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHV 462
            ARGL YLHE          P I HRD+K+ N+LL  +  A + DFGLA   +  + +  
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 463 TTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGV 517
           T    GT  ++APE L         +  + D++  G++L EL +   A D          
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM--- 246

Query: 518 MLDWVKKLHQEGKLSQMVDKDLKGNFD---------RIELEEMVQVALLCTQFNPLHRPK 568
            L + +++ Q   L  M +  +                 +  + +    C   +   R  
Sbjct: 247 -LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 569 MSEVLKMLE 577
              V + + 
Sbjct: 306 AGCVGERIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  206 bits (527), Expect = 2e-61
 Identities = 72/338 (21%), Positives = 118/338 (34%), Gaps = 51/338 (15%)

Query: 292 TFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVET 351
              E      N     ++GRG +G VYKG   D   VAVK     N       F  E   
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNI 58

Query: 352 ISLAV--HRNLLRLCGFC-----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
             + +  H N+ R              E LLV  Y PNGS    L  ++      DW   
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGS----LXKYLS-LHTSDWVSS 113

Query: 405 KRIALGTARGLLYLHE------QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH- 457
            R+A    RGL YLH          P I HRD+ + N+L+  D   V+ DFGL+  L   
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 458 ------RDSHVTTAVRGTVGHIAPEYL-------STGQSSEKTDVFGFGILLLELITGQR 504
                  + +   +  GT+ ++APE L           + ++ D++  G++  E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 505 ALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNF----------DRIELEEMVQV 554
            L  G +       + +  ++        M     +             + + +  + + 
Sbjct: 234 DLFPGESVP--EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291

Query: 555 ALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIE 592
              C   +   R       + +    L   WE ++ + 
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMA--ELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  200 bits (510), Expect = 2e-59
 Identities = 77/284 (27%), Positives = 126/284 (44%), Gaps = 43/284 (15%)

Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLC 364
           K  +G G FG V++  +  G+ VAVK L + +     V  F  EV  +    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQ 421
           G  +      +V  Y+  GS    L   +H    R  LD  RR  +A   A+G+ YLH  
Sbjct: 101 GAVTQPPNLSIVTEYLSRGS----LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
            +P I+HR++K+ N+L+D+ +   V DFGL++L        + +  GT   +APE L   
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS-TFLSSKSAAGTPEWMAPEVLRDE 214

Query: 482 QSSEKTDVFGFGILLLELITGQ---RALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
            S+EK+DV+ FG++L EL T Q     L+  +                     + +  K 
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV-------------------AAVGFKC 255

Query: 539 LKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                 R+E+      ++  +   C    P  RP  + ++ +L 
Sbjct: 256 K-----RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  191 bits (488), Expect = 3e-56
 Identities = 73/281 (25%), Positives = 119/281 (42%), Gaps = 43/281 (15%)

Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           + ++GRG FG+V K  +     VA+K+++  +       F  E+  +S   H N+++L G
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLYG 68

Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGR---PALDWARRKRIALGTARGLLYLHEQC 422
            C   N   LV  Y   GS    L + +HG    P    A      L  ++G+ YLH   
Sbjct: 69  ACL--NPVCLVMEYAEGGS----LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 423 DPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              +IHRD+K  N+LL      + + DFG A  +        T  +G+   +APE     
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGS 178

Query: 482 QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKG 541
             SEK DVF +GI+L E+IT ++                + +      ++   V      
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKP---------------FDEIGGPAFRIMWAVHNGT-- 221

Query: 542 NFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              R  L     + +  +   C   +P  RP M E++K++ 
Sbjct: 222 ---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  190 bits (486), Expect = 3e-56
 Identities = 72/295 (24%), Positives = 126/295 (42%), Gaps = 56/295 (18%)

Query: 306 KNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEV------QFQTEVETISLAVHR 358
           +  +G+GGFG+V+KG    D ++VA+K L   +  G         +FQ EV  +S   H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLY 417
           N+++L G     N   +V  ++P G     L   +  +   + W+ + R+ L  A G+ Y
Sbjct: 84  NIVKLYGLMH--NPPRMVMEFVPCGD----LYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAV-----VGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           +    +P I+HRD+++ NI L    E       V DFGL++       H  + + G    
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192

Query: 473 IAPEYLSTGQS--SEKTDVFGFGILLLELITGQ---RALDFGRAANQRGVMLDWVKKLHQ 527
           +APE +   +   +EK D + F ++L  ++TG+       +G+      +          
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI---------- 242

Query: 528 EGKLSQMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                   ++ L     R  +       +  V  LC   +P  RP  S ++K L 
Sbjct: 243 -------REEGL-----RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (482), Expect = 9e-56
 Identities = 74/291 (25%), Positives = 121/291 (41%), Gaps = 52/291 (17%)

Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLK---DYNIAGGEVQFQTEVETISLAVHRNLLR 362
           + I+G GGFG VY+  +  G  VAVK  +   D +I+      + E +  ++  H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L G C  E    LV  +   G     L   + G+  +        A+  ARG+ YLH++ 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGP----LNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEA 125

Query: 423 DPKIIHRDVKAANILLDEDFEAV--------VGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
              IIHRD+K++NIL+ +  E          + DFGLA+           +  G    +A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMA 182

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQ---RALDFGRAANQRGVMLDWVKKLHQEGKL 531
           PE +     S+ +DV+ +G+LL EL+TG+   R +D    A                   
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------------------- 223

Query: 532 SQMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
             +    L      + +     E   ++   C   +P  RP  + +L  L 
Sbjct: 224 YGVAMNKL-----ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  189 bits (481), Expect = 3e-55
 Identities = 69/286 (24%), Positives = 109/286 (38%), Gaps = 36/286 (12%)

Query: 306 KNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
             +LG+G FG   K      G ++ +K L  ++    +  F  EV+ +    H N+L+  
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G    +     +  Y+  G++   ++          W++R   A   A G+ YLH     
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM--- 127

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-------------HRDSHVTTAVRGTVG 471
            IIHRD+ + N L+ E+   VV DFGLA+L+                D      V G   
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
            +APE ++     EK DVF FGI+L E+I    A D           L+    L +    
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPRTMDFGLNVRGFLDRY--C 244

Query: 532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                                 + + C   +P  RP   ++   LE
Sbjct: 245 PPNCPPSFF------------PITVRCCDLDPEKRPSFVKLEHWLE 278

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  182 bits (465), Expect = 3e-53
 Identities = 58/288 (20%), Positives = 109/288 (37%), Gaps = 52/288 (18%)

Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLC 364
              L     G ++KG +  G  + VK LK  + +  + + F  E   + +  H N+L + 
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 365 GFCSTENERLL--VYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLLYLHE 420
           G C +        +  +MP GS    L + +H      +D ++  + AL  ARG+ +LH 
Sbjct: 74  GACQSPPAPHPTLITHWMPYGS----LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH- 128

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
             +P I    + + ++++DED  A +    +        S  +         +APE L  
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQK 182

Query: 481 GQS---SEKTDVFGFGILLLELITGQ---RALDFGRAANQRGVMLDWVKKLHQEGKLSQM 534
                     D++ F +LL EL+T +     L                          ++
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-------------------MKV 223

Query: 535 VDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
             + L     R  +       + ++  +C   +P  RPK   ++ +LE
Sbjct: 224 ALEGL-----RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  183 bits (466), Expect = 3e-53
 Identities = 79/278 (28%), Positives = 123/278 (44%), Gaps = 34/278 (12%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
           +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGR-PALDWARRKRIALGTARGLLYLHEQCDPKI 426
           +      +V  +    S    L  H+H      +  +   IA  TARG+ YLH +    I
Sbjct: 90  TAPQ-LAIVTQWCEGSS----LYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SI 141

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHR-DSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           IHRD+K+ NI L ED    +GDFGLA        SH    + G++  +APE +    S  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 484 -SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN 542
            S ++DV+ FGI+L EL+TGQ               L +    +++  +  +    L  +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ---------------LPYSNINNRDQIIEMVGRGSLSPD 246

Query: 543 FDRIEL---EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
             ++     + M ++   C +     RP    +L  +E
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  180 bits (458), Expect = 8e-52
 Identities = 61/291 (20%), Positives = 112/291 (38%), Gaps = 49/291 (16%)

Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLC 364
             ++G+G FG VY G +     VA++ +        +++ F+ EV       H N++   
Sbjct: 38  GELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGR-PALDWARRKRIALGTARGLLYLHEQCD 423
           G C +     ++       +    L   +      LD  + ++IA    +G+ YLH +  
Sbjct: 96  GACMSPPHLAIITSLCKGRT----LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK-- 149

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH----RDSHVTTAVRGTVGHIAPEYLS 479
             I+H+D+K+ N+  D   + V+ DFGL  +       R         G + H+APE + 
Sbjct: 150 -GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 480 TGQS---------SEKTDVFGFGILLLELITGQ---RALDFGRAANQRGVMLDWVKKLHQ 527
                        S+ +DVF  G +  EL   +   +                       
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII--------------- 252

Query: 528 EGKLSQMVDKDLKGNFDRIEL-EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                  +   +K N  +I + +E+  + L C  F    RP  ++++ MLE
Sbjct: 253 -----WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  175 bits (446), Expect = 3e-50
 Identities = 67/300 (22%), Positives = 111/300 (37%), Gaps = 44/300 (14%)

Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLC 364
             +G+G +G V++G +  G  VAVK     +    E  +  E E  +  +  H N+L   
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFI 68

Query: 365 GFCSTEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
               T      +  L+  Y   GS    L D++     LD     RI L  A GL +LH 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGS----LYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 421 -----QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV---TTAVRGTVGH 472
                Q  P I HRD+K+ NIL+ ++ +  + D GLA +     + +        GT  +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 473 IAPE------YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH 526
           +APE       +    S ++ D++ FG++L E+     +               +   + 
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG-----IVEDYKPPFYDVVP 238

Query: 527 QEGKLSQM----VDKDL-----KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            +     M                 F    L  + ++   C   NP  R     + K L 
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  176 bits (447), Expect = 4e-50
 Identities = 67/300 (22%), Positives = 105/300 (35%), Gaps = 44/300 (14%)

Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLC 364
             +G+G +G V+ G +  G  VAVK       A     +  E E     +  H N+L   
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA----SWFRETEIYQTVLMRHENILGFI 97

Query: 365 GFCSTENER----LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
                         L+  Y  NGS    L D++     LD     ++A  +  GL +LH 
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGS----LYDYLK-STTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 421 -----QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV---TTAVRGTVGH 472
                Q  P I HRD+K+ NIL+ ++    + D GLA       + V        GT  +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 473 IAPE------YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH 526
           + PE        +  QS    D++ FG++L E+     +             L +   + 
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG-----IVEEYQLPYHDLVP 267

Query: 527 QEGKLSQMVDKDLKGN---------FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            +     M +                    L +M ++   C   NP  R     V K L 
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  174 bits (443), Expect = 2e-49
 Identities = 72/297 (24%), Positives = 119/297 (40%), Gaps = 38/297 (12%)

Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLC 364
             +G+G FG V++G +  G  VAVK          E  +  E E     +  H N+L   
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102

Query: 365 GFCSTEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
              + +N    +  LV  Y  +GS    L D+++ R  +      ++AL TA GL +LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGS----LFDYLN-RYTVTVEGMIKLALSTASGLAHLHM 157

Query: 421 -----QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT---TAVRGTVGH 472
                Q  P I HRD+K+ NIL+ ++    + D GLA   D     +        GT  +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 473 IAPEYL------STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH 526
           +APE L         +S ++ D++  G++  E+    R    G   + +    D V    
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR--RCSIGGIHEDYQLPYYDLVPSDP 275

Query: 527 QEGKLSQMV-DKDL-----KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              ++ ++V ++ L             L  M ++   C   N   R     + K L 
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  165 bits (421), Expect = 1e-46
 Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 8/162 (4%)

Query: 34  EVVALVAVKNNLHDPYNVLENWDI-TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGT 89
           +  AL+ +K +L +P   L +W   T     +W  + C  D     V+ L L   +L   
Sbjct: 7   DKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65

Query: 90  --LSPWIGNLTKLQSVLLQN-NAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
             +   + NL  L  + +   N ++GPIP ++ KL +L  L +++   +G IPD L  + 
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 147 NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
            L  L  + N+L+G+ P S+S + +L  +    N +SG++P 
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  133 bits (336), Expect = 8e-35
 Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 2/110 (1%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L +   ++SG +  ++  +  L ++    NA+ G +P S+  L  L  +    N+ +G I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165

Query: 139 PDSLGDLGNL-NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           PDS G    L   + ++ N LTG  P + + + +L  VDLS N L G   
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDAS 214

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  131 bits (332), Expect = 3e-34
 Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 6/124 (4%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
            L+G + P   NL  L  V L  N + G      G  +  Q + L+ N    ++   +G 
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGL 242

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI----SARTFKVTGNP 200
             NLN L L NN + G+ P+ L++++ L  +++S+NNL G +P+              N 
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302

Query: 201 LICG 204
            +CG
Sbjct: 303 CLCG 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  108 bits (273), Expect = 2e-26
 Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 4/105 (3%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
            L G  S   G+    Q + L  N++   +   +G  + L  LDL NN+  G +P  L  
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNN-LSGS-LP 187
           L  L+ L ++ N+L G  P+    ++   +   + N  L GS LP
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLP 310

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  146 bits (371), Expect = 5e-39
 Identities = 68/288 (23%), Positives = 114/288 (39%), Gaps = 42/288 (14%)

Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
            +      +GRG FG V+ G   +D  LVAVK  ++      + +F  E   +    H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           ++RL G C+ +    +V   +  G   + LR        L      ++    A G+ YL 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLE 230

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIA 474
            +     IHRD+ A N L+ E     + DFG+++         +       V+ T    A
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----A 283

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM 534
           PE L+ G+ S ++DV+ FGILL E  +       G +      +              Q 
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFS------LGASPYPN--L-----------SNQQT 324

Query: 535 VDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            +   KG   R+       + + ++   C  + P  RP  S + + L+
Sbjct: 325 REFVEKGG--RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  144 bits (366), Expect = 5e-39
 Identities = 64/287 (22%), Positives = 122/287 (42%), Gaps = 29/287 (10%)

Query: 306 KNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
              LG G FG V    +     + G  VAVK LK  +        + E+E +    H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 361 LRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           ++  G C+ +      L+  ++P+GS+   L  +   +  ++  ++ + A+   +G+ YL
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYL 142

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI---AP 475
             +   + +HRD+ A N+L++ + +  +GDFGL K +   D    T        +   AP
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAP 198

Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV 535
           E L   +    +DV+ FG+ L EL+T      +  + +    +   +            +
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT------YCDSDSSPMALFLKMIGPTHGQMTVTRL 252

Query: 536 DKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              LK    R+       +E+ Q+   C +F P +R     +++  E
Sbjct: 253 VNTLKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  139 bits (353), Expect = 4e-37
 Identities = 71/290 (24%), Positives = 113/290 (38%), Gaps = 37/290 (12%)

Query: 306 KNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
              LG G FG V   C+       G +VAVK LK          ++ E++ +    H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 361 LRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           ++  G C         LV  Y+P GS+   L  H     ++  A+    A     G+ YL
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYL 150

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGH 472
           H Q     IHRD+ A N+LLD D    +GDFGLAK +     +      G          
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY--- 204

Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS 532
            APE L   +    +DV+ FG+ L EL+T         ++         +  + Q     
Sbjct: 205 -APECLKEYKFYYASDVWSFGVTLYELLT------HCDSSQSPPTKFLELIGIAQGQMTV 257

Query: 533 QMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
             + + L+    R+        E+  +   C +     RP    ++ +L+
Sbjct: 258 LRLTELLERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  139 bits (353), Expect = 5e-37
 Identities = 77/312 (24%), Positives = 131/312 (41%), Gaps = 41/312 (13%)

Query: 306 KNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
            + LG+G FG V    +     + GALVAVK+L+  +    +  FQ E++ +       +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-SGPDQQRDFQREIQILKALHSDFI 86

Query: 361 LRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           ++  G       +   LV  Y+P+G +   L+ H   R  LD +R    +    +G+ YL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYL 143

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGH 472
             +   + +HRD+ A NIL++ +    + DFGLAKLL     +      G          
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY--- 197

Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS 532
            APE LS    S ++DV+ FG++L EL T      +   +         +    ++    
Sbjct: 198 -APESLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGCERDVPAL 250

Query: 533 QMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEA 587
             + + L+    R+        E+ ++  LC   +P  RP  S +   L+       W  
Sbjct: 251 SRLLELLEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD-----MLWSG 304

Query: 588 SQKIETPRYRTH 599
           S+  ET  +  H
Sbjct: 305 SRGCETHAFTAH 316

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  137 bits (348), Expect = 1e-36
 Identities = 65/277 (23%), Positives = 110/277 (39%), Gaps = 37/277 (13%)

Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEV-QFQTEVETISLAVHRNLLRLCG 365
            +GRG F  VYKG        VA   L+D  +   E  +F+ E E +    H N++R   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 366 FC---STENERLLVYP-YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
                    + +++    M +G++ + L+        +     +       +GL +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 422 CDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
             P IIHRD+K  NI +     +V +GD GLA L     +    AV GT   +APE    
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204

Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK---LSQMVDK 537
               E  DV+ FG+ +LE+ T +         ++        +++    K     ++   
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDKVAIP 257

Query: 538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
           ++K     IE          C + N   R  + ++L 
Sbjct: 258 EVK-EI--IE---------GCIRQNKDERYSIKDLLN 282

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  137 bits (348), Expect = 1e-36
 Identities = 81/286 (28%), Positives = 118/286 (41%), Gaps = 44/286 (15%)

Query: 307 NILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
            ++GRG FG VY G   D        AVK L      G   QF TE   +    H N+L 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 363 LCGFCS-TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           L G C  +E   L+V PYM +G + + +R+                 L  A+G+ YL  +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK 147

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-----APE 476
              K +HRD+ A N +LDE F   V DFGLA+ +  ++ +  +    T   +     A E
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALE 202

Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-----ANQRGVMLDWVKKLHQEGKL 531
            L T + + K+DV+ FG+LL EL+T       G               D    L Q  +L
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTF-----DITVYLLQGRRL 251

Query: 532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            Q               + + +V L C       RP  SE++  + 
Sbjct: 252 LQPEYC----------PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  136 bits (345), Expect = 3e-36
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 35/290 (12%)

Query: 306 KNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQ---FQTEVETISLAVH 357
              LG+G FG V    +     + G +VAVK+L+       E     F+ E+E +    H
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQH 70

Query: 358 RNLLRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            N+++  G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGM 127

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-- 473
            YL  +   + IHRD+   NIL++ +    +GDFGL K+L   D             I  
Sbjct: 128 EYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFW 183

Query: 474 -APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS 532
            APE L+  + S  +DV+ FG++L EL T        ++ +     +  +    Q   + 
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIV 238

Query: 533 QMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
             + + LK N  R+       +E+  +   C   N   RP   ++   ++
Sbjct: 239 FHLIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  135 bits (343), Expect = 6e-36
 Identities = 76/287 (26%), Positives = 113/287 (39%), Gaps = 44/287 (15%)

Query: 306 KNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
             ++G+G FG+VY G + D A      A+K L           F  E   +    H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 362 RLCGFCSTENERLL-VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
            L G           + PYM +G +   +R     +            L  ARG+ YL E
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAE 142

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-----AP 475
           Q   K +HRD+ A N +LDE F   V DFGLA+ +  R+    +  +     +     A 
Sbjct: 143 Q---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKWTAL 197

Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-----ANQRGVMLDWVKKLHQEGK 530
           E L T + + K+DV+ FG+LL EL+T       G               D    L Q  +
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT------RGAPPYRHIDPF-----DLTHFLAQGRR 246

Query: 531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           L Q               + + QV   C + +P  RP    ++  +E
Sbjct: 247 LPQPEYC----------PDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  139 bits (352), Expect = 7e-36
 Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 28/273 (10%)

Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
             LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
             +E    +V  YM  GS+   L+        L   +   +A   A G+ Y+        
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 301

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

Query: 487 TDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRI 546
           +DV+ FGILL EL T       GR      V  + + ++ +  ++               
Sbjct: 362 SDVWSFGILLTELTT------KGRVPYPGMVNREVLDQVERGYRM------------PCP 403

Query: 547 EL--EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               E +  +   C +  P  RP    +   LE
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  136 bits (344), Expect = 8e-36
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 35/290 (12%)

Query: 306 KNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQ---FQTEVETISLAVH 357
              LG+G FG V    +     + G +VAVK+L+       E     F+ E+E +    H
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQH 101

Query: 358 RNLLRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            N+++  G C +   R   L+  Y+P GS+   L+ H   +  +D  +  +      +G+
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGM 158

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-- 473
            YL  +   + IHRD+   NIL++ +    +GDFGL K+L   D             I  
Sbjct: 159 EYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFW 214

Query: 474 -APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS 532
            APE L+  + S  +DV+ FG++L EL T        ++ +     +  +    Q   + 
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIE-----KSKSPPAEFMRMIGNDKQGQMIV 269

Query: 533 QMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
             + + LK N  R+       +E+  +   C   N   RP   ++   ++
Sbjct: 270 FHLIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  142 bits (360), Expect = 1e-35
 Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 16/167 (9%)

Query: 76  VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT 135
            +   + S+   G  SP   N   +  + +  N + G IP  +G +  L  L+L +N  +
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669

Query: 136 GEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-RTF 194
           G IPD +GDL  LN L L++N L G  P+++S +  LT +DLS NNLSG +P++    TF
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729

Query: 195 KVT---GNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHR 238
                  NP +CG             PL        D      +SH 
Sbjct: 730 PPAKFLNNPGLCGY------------PLPRCDPSNADGYAHHQRSHH 764

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  139 bits (353), Expect = 8e-35
 Identities = 42/104 (40%), Positives = 57/104 (54%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
             +G + P + N ++L S+ L  N + G IP+SLG L KL+ L L  N   GEIP  L  
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           +  L  L L+ N LTG  P  LS   +L  + LS N L+G +PK
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  138 bits (351), Expect = 1e-34
 Identities = 38/104 (36%), Positives = 59/104 (56%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
            L G +   +  +  L++++L  N + G IP+ L     L  + LSNN+ TGEIP  +G 
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           L NL  L+L+NNS +G+ P  L    SL  +DL+ N  +G++P 
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  135 bits (341), Expect = 3e-33
 Identities = 43/103 (41%), Positives = 67/103 (65%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
            LSGT+   +G+L+KL+ + L  N + G IP  L  ++ L+TL L  N  TGEIP  L +
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
             NLN++ L+NN LTG  P+ + ++E+L ++ LS N+ SG++P
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  130 bits (330), Expect = 7e-32
 Identities = 42/112 (37%), Positives = 60/112 (53%), Gaps = 2/112 (1%)

Query: 79  LGLPSQSLSGTLSPWIGN--LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG 136
           L L S + SG + P +       LQ + LQNN   G IP +L    +L +L LS N  +G
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSG 432

Query: 137 EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
            IP SLG L  L  L+L  N L G  P+ L  +++L  + L +N+L+G +P 
Sbjct: 433 TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  130 bits (329), Expect = 8e-32
 Identities = 49/219 (22%), Positives = 86/219 (39%), Gaps = 59/219 (26%)

Query: 27  SPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPD------------- 73
               +  E+  L++ K+ L D  N+L +W  ++ +PC++  +TC  D             
Sbjct: 6   PSQSLYREIHQLISFKDVLPDK-NLLPDWS-SNKNPCTFDGVTCRDDKVTSIDLSSKPLN 63

Query: 74  ---------------------------GYVSALG---------LPSQSLSGTLSP--WIG 95
                                      G VS            L   SLSG ++    +G
Sbjct: 64  VGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLG 123

Query: 96  NLTKLQSVLLQNNAILGPIPASLG-KLEKLQTLDLSNNKFTGEIPDSL---GDLGNLNYL 151
           + + L+ + + +N +  P   S G KL  L+ LDLS N  +G            G L +L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
            ++ N ++G     +S+  +L  +D+S NN S  +P + 
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLG 220

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  127 bits (321), Expect = 9e-31
 Identities = 44/113 (38%), Positives = 57/113 (50%), Gaps = 3/113 (2%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L +    LSG  S  I   T+L+ + + +N  +GPIP     L+ LQ L L+ NKFTGEI
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEI 285

Query: 139 PDSL-GDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
           PD L G    L  L L+ N   G+ P        L  + LS NN SG LP  +
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  124 bits (313), Expect = 8e-30
 Identities = 36/111 (32%), Positives = 62/111 (55%), Gaps = 4/111 (3%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L + S + S  + P++G+ + LQ + +  N + G    ++    +L+ L++S+N+F G I
Sbjct: 205 LDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLS-KIESLTLVDLSYNNLSGSLPK 188
           P     L +L YL L  N  TG  P+ LS   ++LT +DLS N+  G++P 
Sbjct: 264 PPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  121 bits (307), Expect = 5e-29
 Identities = 37/104 (35%), Positives = 54/104 (51%), Gaps = 4/104 (3%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
            L+G +   + N T L  + L NN + G IP  +G+LE L  L LSNN F+G IP  LGD
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
             +L +L LN N   G+ P ++ K        ++ N ++G    
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYV 576

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  121 bits (306), Expect = 7e-29
 Identities = 41/111 (36%), Positives = 56/111 (50%), Gaps = 4/111 (3%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGE 137
           L + S    G + P    L  LQ + L  N   G IP  L G  + L  LDLS N F G 
Sbjct: 252 LNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309

Query: 138 IPDSLGDLGNLNYLRLNNNSLTGSCP-ESLSKIESLTLVDLSYNNLSGSLP 187
           +P   G    L  L L++N+ +G  P ++L K+  L ++DLS+N  SG LP
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  120 bits (302), Expect = 2e-28
 Identities = 37/113 (32%), Positives = 64/113 (56%), Gaps = 4/113 (3%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGE 137
           L L      G + P+ G+ + L+S+ L +N   G +P  +L K+  L+ LDLS N+F+GE
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358

Query: 138 IPDSLGDL-GNLNYLRLNNNSLTGSCPESLSKI--ESLTLVDLSYNNLSGSLP 187
           +P+SL +L  +L  L L++N+ +G    +L +    +L  + L  N  +G +P
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  109 bits (275), Expect = 4e-25
 Identities = 21/112 (18%), Positives = 52/112 (46%), Gaps = 2/112 (1%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL--GPIPASLGKLEKLQTLDLSNNKFTG 136
             + +  ++G    +I N    +      N +   G     L +L      ++++  + G
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 622

Query: 137 EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
               +  + G++ +L ++ N L+G  P+ +  +  L +++L +N++SGS+P 
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  103 bits (260), Expect = 3e-23
 Identities = 22/112 (19%), Positives = 42/112 (37%), Gaps = 6/112 (5%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L L + S SG +   +G+   L  + L  N   G IPA++ K     +  ++ N   G+ 
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKR 574

Query: 139 PDSLGDLGNLNYLRL--NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
              + + G         N     G   E L+++ +    +++     G    
Sbjct: 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  136 bits (345), Expect = 1e-35
 Identities = 80/286 (27%), Positives = 116/286 (40%), Gaps = 44/286 (15%)

Query: 307 NILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
            ++GRG FG VY G   D        AVK L      G   QF TE   +    H N+L 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 363 LCGFCS-TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           L G C  +E   L+V PYM +G + + +R+                 L  A+G+ +L  +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK 211

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-----APE 476
              K +HRD+ A N +LDE F   V DFGLA+ +  ++         T   +     A E
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALE 266

Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-----ANQRGVMLDWVKKLHQEGKL 531
            L T + + K+DV+ FG+LL EL+T       G               D    L Q  +L
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTF-----DITVYLLQGRRL 315

Query: 532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            Q               + + +V L C       RP  SE++  + 
Sbjct: 316 LQPEYC----------PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  135 bits (342), Expect = 2e-35
 Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 22/215 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +          VA+K L++        +   E   ++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            + ++ RL G C   +   L+   MP G +   +R+H   +  +         +  A+G+
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTV 470
            YL ++   +++HRD+ A N+L+       + DFGLAKLL   +           ++   
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM- 186

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
              A E +     + ++DV+ +G+ + EL+T G +
Sbjct: 187 ---ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (350), Expect = 4e-35
 Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 28/273 (10%)

Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
             LG+G FG V+ G ++    VA+K LK   ++     F  E + +    H  L++L   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
             +E    +V  YM  GS+   L+        L   +   +A   A G+ Y+        
Sbjct: 331 V-SEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 384

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    G+ + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444

Query: 487 TDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRI 546
           +DV+ FGILL EL T       GR      V  + + ++ +  ++               
Sbjct: 445 SDVWSFGILLTELTT------KGRVPYPGMVNREVLDQVERGYRM------------PCP 486

Query: 547 EL--EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               E +  +   C +  P  RP    +   LE
Sbjct: 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  133 bits (338), Expect = 5e-35
 Identities = 71/328 (21%), Positives = 123/328 (37%), Gaps = 63/328 (19%)

Query: 306 KNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNL 360
             +LG+G FG V +            VAVK LK   IA  +++ F  E   +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 361 LRLCGFCSTENER------LLVYPYMPNGSVASRLRDHIHGR--PALDWARRKRIALGTA 412
            +L G       +      +++ P+M +G + + L     G     L      R  +  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VR 467
            G+ YL  +     IHRD+ A N +L ED    V DFGL++ +   D +         V+
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-----ANQRGVMLDWV 522
                 A E L+    +  +DV+ FG+ + E++T       G+       N         
Sbjct: 205 WL----ALESLADNLYTVHSDVWAFGVTMWEIMT------RGQTPYAGIENA-------- 246

Query: 523 KKLHQEGKLSQMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                     ++ +  + GN  R++      EE+  +   C   +P  RP  + +   LE
Sbjct: 247 ----------EIYNYLIGGN--RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294

Query: 578 GDGLAEKWEASQKIETPRYRTHEKRYSD 605
              +          + P Y   E+ +  
Sbjct: 295 --NILGHLSVLSTSQDPLYINIERAHHH 320

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  132 bits (334), Expect = 1e-34
 Identities = 73/299 (24%), Positives = 121/299 (40%), Gaps = 60/299 (20%)

Query: 306 KNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNL 360
             ILG G FG V +G           VAVK +K  N +  E++ F +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 361 LRLCGFCSTEN-----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK--RIALGTAR 413
           +RL G C   +     + +++ P+M  G + + L              +   +  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRG 468
           G+ YL  +     +HRD+ A N +L +D    V DFGL+K +   D +         V+ 
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-----ANQRGVMLDWVK 523
                A E L+    + K+DV+ FG+ + E+ T       G        N          
Sbjct: 216 I----AIESLADRVYTSKSDVWAFGVTMWEIAT------RGMTPYPGVQNH--------- 256

Query: 524 KLHQEGKLSQMVDKDLKGNFDRIE-----LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                    +M D  L G+  R++     L+E+ ++   C + +PL RP  S +   LE
Sbjct: 257 ---------EMYDYLLHGH--RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  136 bits (344), Expect = 1e-34
 Identities = 74/283 (26%), Positives = 129/283 (45%), Gaps = 34/283 (12%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G        VAVK LK+  +     +F  E   +    H N
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 277

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  +       +A   +  + YL 
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 335

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           ++     IHR++ A N L+ E+    V DFGL++L+           +  +   APE L+
Sbjct: 336 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 392

Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+LL E+ T      +G +    G+ L  V +L ++           
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIAT------YGMSPYP-GIDLSQVYELLEKD---------- 435

Query: 540 KGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                R+E      E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 436 ----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  132 bits (333), Expect = 3e-34
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 22/215 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
           +      +LG G FG V+KG +          V +K ++D +           +  I   
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H +++RL G C   +   LV  Y+P GS+   +R H   R AL         +  A+G+
Sbjct: 73  DHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGM 128

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTV 470
            YL E     ++HR++ A N+LL    +  V DFG+A LL   D  +  +     ++   
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM- 184

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
              A E +  G+ + ++DV+ +G+ + EL+T G  
Sbjct: 185 ---ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  130 bits (330), Expect = 6e-34
 Identities = 54/282 (19%), Positives = 119/282 (42%), Gaps = 29/282 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGE--VQFQTEVETISLAVH 357
           +NF  +  +GRG F  VY+  C  DG  VA+K+++ +++   +       E++ +    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N+++       +NE  +V      G ++  ++     +  +      +  +     L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
           +H +   +++HRD+K AN+ +       +GD GL +    + +   + V GT  +++PE 
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207

Query: 478 LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK 537
           +     + K+D++  G LL E+   Q                        +  L  +  K
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYG------------------DKMNLYSLCKK 249

Query: 538 DLKGNFDRIELE----EMVQVALLCTQFNPLHRPKMSEVLKM 575
             + ++  +  +    E+ Q+  +C   +P  RP ++ V  +
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (328), Expect = 1e-33
 Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 22/215 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGA-----LVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +          VA+K L++        +   E   ++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            + ++ RL G C   +   L+   MP G +   +R+H   +  +         +  A+G+
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTV 470
            YL ++   +++HRD+ A N+L+       + DFGLAKLL   +           ++   
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM- 186

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
              A E +     + ++DV+ +G+ + EL+T G +
Sbjct: 187 ---ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  127 bits (321), Expect = 4e-33
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           S  +    +G G FG+V+ G + +   VA+K +++  ++  E  F  E E +    H  L
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKL 65

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           ++L G C  +    LV  +M +G ++  LR     R          + L    G+ YL E
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIAP 475
                +IHRD+ A N L+ E+    V DFG+ + +   D + ++      V+      +P
Sbjct: 123 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA----SP 174

Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT 501
           E  S  + S K+DV+ FG+L+ E+ +
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFS 200

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  127 bits (322), Expect = 4e-33
 Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
            + +    LG G FG+V  G +     VA+K +K+ +++  E +F  E + +    H  L
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKL 81

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           ++L G C+ +    ++  YM NG + + LR+    R      +   +       + YL  
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIAP 475
           +   + +HRD+ A N L+++     V DFGL++ +   D + ++      VR +     P
Sbjct: 139 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWS----PP 190

Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT 501
           E L   + S K+D++ FG+L+ E+ +
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYS 216

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  126 bits (320), Expect = 4e-33
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 18/206 (8%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
              +    LG G FG+V  G +     VAVK +K+ +++  E +F  E +T+    H  L
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKL 65

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           ++  G CS E    +V  Y+ NG + + LR H      L+ ++   +      G+ +L  
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES 122

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIAP 475
               + IHRD+ A N L+D D    V DFG+ + +   D +V++      V+ +    AP
Sbjct: 123 H---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWS----AP 174

Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT 501
           E     + S K+DV+ FGIL+ E+ +
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFS 200

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  127 bits (321), Expect = 4e-33
 Identities = 76/286 (26%), Positives = 119/286 (41%), Gaps = 36/286 (12%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRN 359
           ++     +G G +G   K    SDG ++  K L   ++   E Q   +EV  +    H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 360 LLRLCG-FCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
           ++R         N  L +V  Y   G +AS +      R  LD     R+       L  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 418 LHEQCDP--KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            H + D    ++HRD+K AN+ LD      +GDFGLA++L+H  S   T V GT  +++P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185

Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV 535
           E ++    +EK+D++  G LL EL        F  A +                   ++ 
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP--F-TAFS-----------------QKELA 225

Query: 536 DKDLKGNFDRI------ELEEMVQVALLCTQFNPLHRPKMSEVLKM 575
            K  +G F RI      EL E++            HRP + E+L+ 
Sbjct: 226 GKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILEN 268

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  127 bits (321), Expect = 4e-33
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 21/209 (10%)

Query: 306 KNILGRGGFGIVYKGCFSDGA---LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
              LG G FG V +G +        VA+K LK         +   E + +    +  ++R
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L G C  E   +LV      G +   L      R  +  +    +    + G+ YL E+ 
Sbjct: 75  LIGVCQAEA-LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK- 129

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGHIAPE 476
               +HRD+ A N+LL     A + DFGL+K L   DS+ T    G           APE
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APE 183

Query: 477 YLSTGQSSEKTDVFGFGILLLELIT-GQR 504
            ++  + S ++DV+ +G+ + E ++ GQ+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  130 bits (330), Expect = 7e-33
 Identities = 68/279 (24%), Positives = 120/279 (43%), Gaps = 40/279 (14%)

Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
             LG G FG V+   ++    VAVK +K  +++     F  E   +    H  L++L   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251

Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
             T+    ++  +M  GS+   L+            +    +   A G+ ++ ++     
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI---APEYLSTGQS 483
           IHRD++AANIL+       + DFGLA+++   + +  TA  G    I   APE ++ G  
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSF 362

Query: 484 SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNF 543
           + K+DV+ FGILL+E++T      +GR     G+    V +  + G              
Sbjct: 363 TIKSDVWSFGILLMEIVT------YGRIPYP-GMSNPEVIRALERG-------------- 401

Query: 544 DRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            R+       EE+  + + C +  P  RP    +  +L+
Sbjct: 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  127 bits (321), Expect = 1e-32
 Identities = 65/299 (21%), Positives = 121/299 (40%), Gaps = 60/299 (20%)

Query: 306 KNILGRGGFGIVYKGCFSDGA------LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
              LG+G FG+VY+G             VA+K + +       ++F  E   +      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDH------IHGRPALDWARRKRIALGTAR 413
           ++RL G  S     L++   M  G + S LR                 ++  ++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           G+ YL+     K +HRD+ A N ++ EDF   +GDFG+ + +   D       +G  G +
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLL 202

Query: 474 -----APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-----ANQRGVMLDWVK 523
                +PE L  G  +  +DV+ FG++L E+ T               +N+         
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGLSNE--------- 247

Query: 524 KLHQEGKLSQMVDKDLKGNFDRIE-----LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                    Q++   ++G    ++      + + ++  +C Q+NP  RP   E++  ++
Sbjct: 248 ---------QVLRFVMEGG--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  126 bits (318), Expect = 1e-32
 Identities = 47/215 (21%), Positives = 91/215 (42%), Gaps = 24/215 (11%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLAV 356
            +     ILG G FG VY+G +++       VAVK  K       + +F +E   +    
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H ++++L G    E    ++    P G +   L  +   + +L        +L   + + 
Sbjct: 72  HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMA 127

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TV 470
           YL        +HRD+   NIL+       +GDFGL++ ++  D     A           
Sbjct: 128 YLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE--DEDYYKASVTRLPIKWM- 181

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
              +PE ++  + +  +DV+ F + + E+++ G++
Sbjct: 182 ---SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  125 bits (317), Expect = 1e-32
 Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 24/208 (11%)

Query: 308 ILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
            +G G FG V++G +         VA+K  K+        +F  E  T+    H ++++L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
            G   TEN   ++      G + S L+     + +LD A     A   +  L YL  +  
Sbjct: 82  IGVI-TENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-- 135

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGHIAPEY 477
            + +HRD+ A N+L+  +    +GDFGL++ ++  DS    A +G           APE 
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWM----APES 188

Query: 478 LSTGQSSEKTDVFGFGILLLELIT-GQR 504
           ++  + +  +DV+ FG+ + E++  G +
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVK 216

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  126 bits (319), Expect = 2e-32
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 21/210 (10%)

Query: 306 KNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
           + I+G G  G V  G           VA+K LK          F +E   +    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
           RL G  +     ++V  YM NGS+ + LR H          +   +  G   G+ YL + 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGHIAP 475
                +HRD+ A N+L+D +    V DFGL+++L+       T   G      T    AP
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223

Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
           E ++    S  +DV+ FG+++ E++  G+R
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  127 bits (320), Expect = 2e-32
 Identities = 62/284 (21%), Positives = 117/284 (41%), Gaps = 41/284 (14%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRN 359
            +     +G G FG         DG    +K +    ++  E +  + EV  ++   H N
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-----ALDWARRKRIALGTARG 414
           +++            +V  Y   G +  R+     G        LDW  +          
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQ------ICLA 137

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L ++H++   KI+HRD+K+ NI L +D    +GDFG+A++L+         + GT  +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM 534
           PE       + K+D++  G +L EL T + A  F  A + + ++L               
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA--F-EAGSMKNLVL--------------- 235

Query: 535 VDKDLKGNFDRIEL---EEMVQVALLCTQFNPLHRPKMSEVLKM 575
             K + G+F  + L    ++  +     + NP  RP ++ +L+ 
Sbjct: 236 --KIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  127 bits (320), Expect = 4e-32
 Identities = 71/303 (23%), Positives = 121/303 (39%), Gaps = 59/303 (19%)

Query: 306 KNILGRGGFGIVYKG--------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAV 356
              LG G FG V              +   VAVK LKD           +E+E +  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK----------- 405
           H+N++ L G C+ +    ++  Y   G++   LR          +   +           
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 406 -RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
                  ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  T
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 465 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML 519
                 V+      APE L     + ++DV+ FG+L+ E+ T       G +    G+ +
Sbjct: 263 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYP-GIPV 311

Query: 520 DWVKKLHQEGKLSQMVDKDLKGNFDRIE-----LEEMVQVALLCTQFNPLHRPKMSEVLK 574
           + + KL +EG               R++       E+  +   C    P  RP   ++++
Sbjct: 312 EELFKLLKEGH--------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

Query: 575 MLE 577
            L+
Sbjct: 358 DLD 360

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  128 bits (324), Expect = 4e-32
 Identities = 80/284 (28%), Positives = 115/284 (40%), Gaps = 42/284 (14%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
                   +G+G FG V  G +  G  VAVK +K+        Q F  E   ++   H N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN----DATAQAFLAEASVMTQLRHSN 247

Query: 360 LLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           L++L G    E   L +V  YM  GS+   LR    GR  L      + +L     + YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
                   +HRD+ A N+L+ ED  A V DFGL K            V+ T    APE L
Sbjct: 306 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEAL 358

Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
              + S K+DV+ FGILL E+ +      FGR    R  +            L  +V + 
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS------FGRVPYPR--I-----------PLKDVVPRV 399

Query: 539 LKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            KG   +++        +  V   C   +   RP   ++ + LE
Sbjct: 400 EKG--YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  124 bits (313), Expect = 5e-32
 Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 26/208 (12%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
                   +G+G FG V  G +  G  VAVK +K+        Q F  E   ++   H N
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSN 75

Query: 360 LLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           L++L G    E   L +V  YM  GS+   LR    GR  L      + +L     + YL
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL 133

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHI 473
                   +HRD+ A N+L+ ED  A V DFGL      +++  T       V+ T    
Sbjct: 134 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWT---- 181

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELIT 501
           APE L   + S K+DV+ FGILL E+ +
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYS 209

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  124 bits (314), Expect = 5e-32
 Identities = 69/217 (31%), Positives = 92/217 (42%), Gaps = 24/217 (11%)

Query: 301 SNFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEVQ--FQTEVETISL 354
            +      LG G FG+V +G +         VAVK LK   ++  E    F  EV  +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
             HRNL+RL G   T     +V    P GS+  RLR H   +         R A+  A G
Sbjct: 78  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEG 133

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------ 468
           + YL  +   + IHRD+ A N+LL       +GDFGL + L   D H             
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190

Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
                APE L T   S  +D + FG+ L E+ T GQ 
Sbjct: 191 C----APESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  125 bits (316), Expect = 6e-32
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 22/216 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGA-----LVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           S  + + ++G G FG VYKG     +      VA+K LK        V F  E   +   
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N++RL G  S     +++  YM NG++   LR+           +   +  G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGM 160

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTTA-----VRGT 469
            YL        +HRD+ A NIL++ +    V DFGL+++L D  ++  TT+     +R T
Sbjct: 161 KYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217

Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
               APE +S  + +  +DV+ FGI++ E++T G+R
Sbjct: 218 ----APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  125 bits (316), Expect = 7e-32
 Identities = 71/303 (23%), Positives = 121/303 (39%), Gaps = 59/303 (19%)

Query: 306 KNILGRGGFGIVYKG--------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAV 356
              LG G FG V              +   VAVK LKD           +E+E +  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK----------- 405
           H+N++ L G C+ +    ++  Y   G++   LR          +   +           
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 406 -RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
                  ARG+ YL  Q   K IHRD+ A N+L+ E+    + DFGLA+ +++ D +  T
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 465 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML 519
                 V+      APE L     + ++DV+ FG+L+ E+ T       G +    G+ +
Sbjct: 217 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT------LGGSPYP-GIPV 265

Query: 520 DWVKKLHQEGKLSQMVDKDLKGNFDRIE-----LEEMVQVALLCTQFNPLHRPKMSEVLK 574
           + + KL +EG               R++       E+  +   C    P  RP   ++++
Sbjct: 266 EELFKLLKEGH--------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

Query: 575 MLE 577
            L+
Sbjct: 312 DLD 314

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  123 bits (312), Expect = 8e-32
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 14/204 (6%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
                   LG G FG V+ G ++    VAVK LK  +++     F  E   +    H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRL 70

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           +RL     T+    ++  YM NGS+   L+        L   +   +A   A G+ ++ E
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI---APEY 477
           +     IHRD++AANIL+ +     + DFGLA+L++  +    TA  G    I   APE 
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEA 181

Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
           ++ G  + K+DV+ FGILL E++T
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  124 bits (314), Expect = 9e-32
 Identities = 75/298 (25%), Positives = 125/298 (41%), Gaps = 57/298 (19%)

Query: 306 KNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
           ++++G G FG V K       L    A+KR+K+Y        F  E+E +  L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK------------RIAL 409
            L G C       L   Y P+G++   LR          +A                 A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
             ARG+ YL ++   + IHRD+ A NIL+ E++ A + DFGL+     R   V   V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS-----RGQEV--YVKKT 199

Query: 470 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-----ANQRGVML 519
           +G +     A E L+    +  +DV+ +G+LL E+++       G               
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCA----- 248

Query: 520 DWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +KL Q  +L + ++ D          +E+  +   C +  P  RP  +++L  L 
Sbjct: 249 ELYEKLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQILVSLN 296

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  128 bits (324), Expect = 1e-31
 Identities = 59/249 (23%), Positives = 100/249 (40%), Gaps = 15/249 (6%)

Query: 262 WLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGC 321
                  + +  D +    P      LK       R   +   A   LG G FG V +G 
Sbjct: 299 ITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKR--DNLLIADIELGCGNFGSVRQGV 356

Query: 322 FSDGA---LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378
           +        VA+K LK         +   E + +    +  ++RL G C      +LV  
Sbjct: 357 YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 415

Query: 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438
               G +   L      R  +  +    +    + G+ YL E+     +HR++ A N+LL
Sbjct: 416 MAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLL 469

Query: 439 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLSTGQSSEKTDVFGFGILL 496
                A + DFGL+K L   DS+ T    G   +   APE ++  + S ++DV+ +G+ +
Sbjct: 470 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529

Query: 497 LELIT-GQR 504
            E ++ GQ+
Sbjct: 530 WEALSYGQK 538

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  123 bits (310), Expect = 1e-31
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 44/288 (15%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++ + K+ LG G +G VY+G +   +L VAVK LK+  +     +F  E   +    H N
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L G C+ E    ++  +M  G++   LR+    R  +       +A   +  + YL 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 128

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIA 474
           ++     IHRD+ A N L+ E+    V DFGL++L+   D++   A     ++ T    A
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWT----A 180

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-----ANQRGVMLDWVKKLHQEG 529
           PE L+  + S K+DV+ FG+LL E+ T      +G +                + L ++ 
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLS-----QVYELLEKDY 229

Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           ++ +               E++ ++   C Q+NP  RP  +E+ +  E
Sbjct: 230 RMERPEGC----------PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  123 bits (311), Expect = 1e-31
 Identities = 60/298 (20%), Positives = 110/298 (36%), Gaps = 47/298 (15%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++F     LGRGGFG+V++     D    A+KR++  N      +   EV+ ++   H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 360 LLRLCGFCSTENERLLVYP------------YMPNGSVASRLRDHIHGRPALDWARRKRI 407
           ++R       +N    + P                 ++   +          + +    I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHI 123

Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
            L  A  + +LH +    ++HRD+K +NI    D    VGDFGL   +D  +   T    
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 468 -----------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRG 516
                      GT  +++PE +     S K D+F  G++L EL+       F     +  
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-----FSTQMERVR 235

Query: 517 VMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
            +      + +  K   +  +             MVQ        +P+ RP+   +++
Sbjct: 236 TL----TDV-RNLKFPPLFTQKYP------CEYVMVQ---DMLSPSPMERPEAINIIE 279

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  129 bits (325), Expect = 2e-31
 Identities = 59/279 (21%), Positives = 117/279 (41%), Gaps = 37/279 (13%)

Query: 308 ILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
            +G G FG V++G +         VA+K  K+        +F  E  T+    H ++++L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
            G   TEN   ++      G + S L+     + +LD A     A   +  L YL  +  
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK-- 510

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA----VRGTVGHIAPEYLS 479
            + +HRD+ A N+L+  +    +GDFGL++ ++    +  +     ++      APE ++
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 565

Query: 480 TGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
             + +  +DV+ FG+ + E++  G +   F    N      D + ++    +L    +  
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNN-----DVIGRIENGERLPMPPNC- 617

Query: 539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                       +  +   C  ++P  RP+ +E+   L 
Sbjct: 618 ---------PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  122 bits (309), Expect = 2e-31
 Identities = 60/293 (20%), Positives = 115/293 (39%), Gaps = 51/293 (17%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
            +F    ++G GGFG V+K     DG    +KR     +     + + EV+ ++   H N
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR-----VKYNNEKAEREVKALAKLDHVN 65

Query: 360 LLRLCGFCSTENERLLVYP----------------YMPNGSVASRLRDHIHGRPALDWAR 403
           ++   G     +                       +   G++   +      +     A 
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
              +     +G+ Y+H +   K+I+RD+K +NI L +  +  +GDFGL   L +      
Sbjct: 126 E--LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
           +   GT+ +++PE +S+    ++ D++  G++L EL+           A +       ++
Sbjct: 181 SK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------CDTAFETSKFFTDLR 232

Query: 524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML 576
                G +S + DK  K          ++Q         P  RP  SE+L+ L
Sbjct: 233 D----GIISDIFDKKEK---------TLLQ---KLLSKKPEDRPNTSEILRTL 269

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  124 bits (314), Expect = 2e-31
 Identities = 78/342 (22%), Positives = 126/342 (36%), Gaps = 64/342 (18%)

Query: 306 KNILGRGGFGIVYKG--------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAV 356
              LG G FG V             +    VAVK LK            +E+E +  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR---------- 406
           H+N++ L G C+ +    ++  Y   G++   L+          +               
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 407 --IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
              A   ARG+ YL  +   K IHRD+ A N+L+ ED    + DFGLA+ + H D +  T
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 465 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML 519
                 V+      APE L     + ++DV+ FG+LL E+ T       G +    GV +
Sbjct: 251 TNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT------LGGSPYP-GVPV 299

Query: 520 DWVKKLHQEGKLSQMVDKDLKGNFDRIE-----LEEMVQVALLCTQFNPLHRPKMSEVLK 574
           + + KL +EG               R++       E+  +   C    P  RP   ++++
Sbjct: 300 EELFKLLKEGH--------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

Query: 575 MLEGDGLAEKWEASQKIETPRYRTHEKRYSDFIEESSLVIEA 616
            L+          +   E   Y  H     D     +L    
Sbjct: 346 DLDRI-----VALTSNQEMGYYHHHHHHDYDIPTTENLYFNG 382

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  122 bits (309), Expect = 4e-31
 Identities = 67/308 (21%), Positives = 116/308 (37%), Gaps = 69/308 (22%)

Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHR 358
              LGRG FG V +         +    VAVK LK+           +E++ +  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 359 NLLRLCGFCSTENE-RLLVYPYMPNGSVASRLRDHIHGRPALDWARRK------------ 405
           N++ L G C+      +++  +   G++++ LR   +       A               
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
             +   A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V   
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 466 -----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR------AANQ 514
                ++      APE +     + ++DV+ FG+LL E+ +       G         ++
Sbjct: 209 DARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDE 258

Query: 515 RGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE-----LEEMVQVALLCTQFNPLHRPKM 569
                             +   +  +G   R+        EM Q  L C    P  RP  
Sbjct: 259 ------------------EFCRRLKEGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 298

Query: 570 SEVLKMLE 577
           SE+++ L 
Sbjct: 299 SELVEHLG 306

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  123 bits (311), Expect = 5e-31
 Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 38/288 (13%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
           +N S   ++G G FG V  G     +     VA+K LK          F  E   +    
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N++RL G  +     ++V  YM NGS+ S LR H          +   +  G A G+ 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TV 470
           YL +      +HRD+ A NIL++ +    V DFGL ++L+       T   G      T 
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT- 217

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEG 529
              +PE ++  + +  +DV+ +GI+L E+++ G+R   +   +NQ     D +K + +  
Sbjct: 218 ---SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ-----DVIKAVDEGY 267

Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +L   +D              + Q+ L C Q +  +RPK  +++ +L+
Sbjct: 268 RLPPPMDCP----------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  121 bits (306), Expect = 6e-31
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 23/208 (11%)

Query: 308 ILGRGGFGIVYKGCFSDGAL---VAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRL 363
            LG G FG V KG +    +   VAVK LK + N    + +   E   +    +  ++R+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
            G C  E+  +LV      G     L  ++     +       +    + G+ YL E   
Sbjct: 84  IGICEAES-WMLVMEMAELGP----LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES-- 136

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGHIAPEY 477
              +HRD+ A N+LL     A + DFGL+K L   +++      G           APE 
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APEC 191

Query: 478 LSTGQSSEKTDVFGFGILLLELIT-GQR 504
           ++  + S K+DV+ FG+L+ E  + GQ+
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  122 bits (308), Expect = 7e-31
 Identities = 76/327 (23%), Positives = 117/327 (35%), Gaps = 60/327 (18%)

Query: 278 QYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGA------LVAVK 331
            ++P                    N +    LG G FG VY+G  S          VAVK
Sbjct: 7   HHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 66

Query: 332 RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD 391
            L +      E+ F  E   IS   H+N++R  G       R ++   M  G + S LR+
Sbjct: 67  TLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRE 126

Query: 392 H---IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAV 445
                    +L       +A   A G  YL E      IHRD+ A N LL        A 
Sbjct: 127 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183

Query: 446 VGDFGLAKLLDHRDSHVTTAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELI 500
           +GDFG+A+ +           +G    +      PE    G  + KTD + FG+LL E+ 
Sbjct: 184 IGDFGMARDIYRAS----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

Query: 501 TGQRALDFGRA-----ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE-----LEE 550
           +       G       +NQ                  ++++    G   R++        
Sbjct: 240 S------LGYMPYPSKSNQ------------------EVLEFVTSGG--RMDPPKNCPGP 273

Query: 551 MVQVALLCTQFNPLHRPKMSEVLKMLE 577
           + ++   C Q  P  RP  + +L+ +E
Sbjct: 274 VYRIMTQCWQHQPEDRPNFAIILERIE 300

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  121 bits (306), Expect = 8e-31
 Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 63/303 (20%)

Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           K  LG G FG V+           D  LVAVK LKD  +A     FQ E E ++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQREAELLTNLQHEH 78

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR------------- 406
           +++  G C   +  ++V+ YM +G +   LR H    P        +             
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH---GPDAMILVDGQPRQAKGELGLSQM 135

Query: 407 --IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
             IA   A G++YL  Q     +HRD+   N L+  +    +GDFG+++ +   D +   
Sbjct: 136 LHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192

Query: 465 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-----ANQ 514
                 +R       PE +   + + ++DV+ FG++L E+ T      +G+      +N 
Sbjct: 193 GHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNT 242

Query: 515 RGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
                + ++ + Q   L +               +E+  V L C Q  P  R  + E+ K
Sbjct: 243 -----EVIECITQGRVLERPRVCP----------KEVYDVMLGCWQREPQQRLNIKEIYK 287

Query: 575 MLE 577
           +L 
Sbjct: 288 ILH 290

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  121 bits (306), Expect = 9e-31
 Identities = 71/292 (24%), Positives = 111/292 (38%), Gaps = 35/292 (11%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           ++     LG GGF  V       DG   A+KR+  +     E + Q E +   L  H N+
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNI 88

Query: 361 LRLCGFCSTE----NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           LRL  +C  E    +E  L+ P+   G++ + +         L   +   + LG  RGL 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR--------G 468
            +H        HRD+K  NILL ++ + V+ D G              A+          
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 469 TVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL 525
           T+ + APE  S        E+TDV+  G +L  ++ G+   D      Q+G  +    + 
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD---MVFQKGDSVALAVQN 262

Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                 S      L        L  M+ V       +P  RP +  +L  LE
Sbjct: 263 QLSIPQSPRHSSALW-QL----LNSMMTV-------DPHQRPHIPLLLSQLE 302

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (303), Expect = 2e-30
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 10/201 (4%)

Query: 308 ILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           +LG+G +GIVY G        +A+K + + +    +     E+       H+N+++  G 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87

Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
            S      +    +P GS+++ LR    G    +             GL YLH+    +I
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143

Query: 427 IHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
           +HRD+K  N+L++     + + DFG +K L   +    T   GT+ ++APE +  G    
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202

Query: 484 SEKTDVFGFGILLLELITGQR 504
            +  D++  G  ++E+ TG+ 
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  120 bits (303), Expect = 2e-30
 Identities = 58/303 (19%), Positives = 106/303 (34%), Gaps = 62/303 (20%)

Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
              LG   FG VYKG             VA+K LKD        +F+ E    +   H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR------------- 406
           ++ L G  + +    +++ Y  +G +   L       P  D                   
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMR---SPHSDVGSTDDDRTVKSALEPPDF 130

Query: 407 --IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
             +    A G+ YL       ++H+D+   N+L+ +     + D GL + +   D +   
Sbjct: 131 VHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187

Query: 465 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR-----AANQ 514
                 +R      APE +  G+ S  +D++ +G++L E+ +      +G       +NQ
Sbjct: 188 GNSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS------YGLQPYCGYSNQ 237

Query: 515 RGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
             V+    + +     L    D              +  + + C    P  RP+  ++  
Sbjct: 238 D-VV----EMIRNRQVLPCPDDCP----------AWVYALMIECWNEFPSRRPRFKDIHS 282

Query: 575 MLE 577
            L 
Sbjct: 283 RLR 285

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  121 bits (305), Expect = 2e-30
 Identities = 51/219 (23%), Positives = 82/219 (37%), Gaps = 23/219 (10%)

Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVK--RLKDYNIAGGEVQFQTEVE 350
            E R      + +  +GRG FG V++      G   AVK  RL+ +           E+ 
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELV 102

Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             +      ++ L G         +    +  GS+   ++        L   R       
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK---QMGC-LPEDRALYYLGQ 158

Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTA---- 465
              GL YLH +   +I+H DVKA N+LL  D     + DFG A  L       +      
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
           + GT  H+APE +       K D++    ++L ++ G  
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  120 bits (304), Expect = 2e-30
 Identities = 68/307 (22%), Positives = 112/307 (36%), Gaps = 66/307 (21%)

Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHR 358
              LG G FG V +              VAVK LK            +E++ +S L  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK------------- 405
           N++ L G C+     L++  Y   G + + LR     R +   ++               
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK---RDSFICSKTSPAIMEDDELALDL 144

Query: 406 ----RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
                 +   A+G+ +L  +     IHRD+ A NILL       + DFGLA     RD  
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA-----RDIK 196

Query: 462 VTTAVRGTVGHI------APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQR 515
             +               APE +     + ++DV+ +GI L EL +   +   G   + +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 516 GVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMS 570
                   K+ +EG               R+        EM  +   C   +PL RP   
Sbjct: 257 ------FYKMIKEGF--------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296

Query: 571 EVLKMLE 577
           ++++++E
Sbjct: 297 QIVQLIE 303

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  120 bits (303), Expect = 2e-30
 Identities = 66/282 (23%), Positives = 94/282 (33%), Gaps = 40/282 (14%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--- 356
            +F   + LG G +G V+K     DG L AVKR         +   +   E  S      
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQ 115

Query: 357 HRNLLRLCGFCS-TENERLLVYPYM--PNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
           H   +RL    +  E   L  Y        S+         G   L  A+       T  
Sbjct: 116 HPCCVRL--EQAWEEGGIL--YLQTELCGPSLQQHCEAW--GAS-LPEAQVWGYLRDTLL 168

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
            L +LH Q    ++H DVK ANI L       +GDFGL   L    +       G   ++
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYM 223

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
           APE L  G      DVF  G+ +LE+         G                       Q
Sbjct: 224 APELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEG-------------------WQQ 263

Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM 575
           +    L   F      E+  V ++  + +P  R     +L +
Sbjct: 264 LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  120 bits (304), Expect = 3e-30
 Identities = 66/299 (22%), Positives = 114/299 (38%), Gaps = 54/299 (18%)

Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHR 358
              LG G FG V +              VAVK LK    A  +    +E++ +S L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH----------IHGRPALDWARRKRIA 408
           N++ L G C+     L++  Y   G + + LR                           +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA--- 465
              A+G+ +L  +     IHRDV A N+LL     A +GDFGLA+ + +  +++      
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 466 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK 523
             V+      APE +     + ++DV+ +GILL E+ +       G      G++++   
Sbjct: 228 LPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYP-GILVN--- 273

Query: 524 KLHQEGKLSQMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                   S+       G   ++       + +  +   C    P HRP   ++   L+
Sbjct: 274 --------SKFYKLVKDGY--QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  119 bits (300), Expect = 3e-30
 Identities = 59/305 (19%), Positives = 101/305 (33%), Gaps = 65/305 (21%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQ-TEVETIS-LAV 356
           T+ F     +G G FG V+K     DG + A+KR K       + Q    EV   + L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 357 HRNLLRLCGFCSTENERLLVY-PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
           H +++R       E++ +L+   Y   GS+A  + ++         A  K + L   RGL
Sbjct: 70  HSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVV-------------------GDFGLAKLLD 456
            Y+H      ++H D+K +NI +                           GD G    + 
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 457 HRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQR 515
                      G    +A E L    +   K D+F   + ++     +     G      
Sbjct: 186 SPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------ 234

Query: 516 GVMLDWVKKLHQEGKLSQMVDKDLKGNFDRI------ELEEMVQVALLCTQFNPLHRPKM 569
                                +  +G   RI      E  E+++   +    +P  RP  
Sbjct: 235 -----------------DQWHEIRQGRLPRIPQVLSQEFTELLK---VMIHPDPERRPSA 274

Query: 570 SEVLK 574
             ++K
Sbjct: 275 MALVK 279

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  119 bits (301), Expect = 1e-29
 Identities = 84/374 (22%), Positives = 130/374 (34%), Gaps = 88/374 (23%)

Query: 259 LLVWLRYRHNQQIFFDVNDQY----------DPEVSLGHLKR----------YTFKELRA 298
           +  +  + H+        + Y           PE  L  L+           Y F    +
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTS 60

Query: 299 AT--------SNFSAKNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQ 344
           +          N +    LG G FG VY+G             VAVK L +      E+ 
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120

Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDW 401
           F  E   IS   H+N++R  G       R ++   M  G + S LR+         +L  
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180

Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHR 458
                +A   A G  YL E      IHRD+ A N LL        A +GDFG+A+ +   
Sbjct: 181 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237

Query: 459 DSHVTTAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-- 511
                   +G    +      PE    G  + KTD + FG+LL E+ +       G    
Sbjct: 238 G----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------LGYMPY 287

Query: 512 ---ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE-----LEEMVQVALLCTQFNP 563
              +NQ   +L++V                  G   R++        + ++   C Q  P
Sbjct: 288 PSKSNQE--VLEFVT----------------SGG--RMDPPKNCPGPVYRIMTQCWQHQP 327

Query: 564 LHRPKMSEVLKMLE 577
             RP  + +L+ +E
Sbjct: 328 EDRPNFAIILERIE 341

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  118 bits (299), Expect = 1e-29
 Identities = 66/315 (20%), Positives = 107/315 (33%), Gaps = 77/315 (24%)

Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHR 358
             +LG G FG V                VAVK LK+   +       +E++ ++ L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR------------ 406
           N++ L G C+      L++ Y   G + + LR         +     +            
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 407 -------IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
                   A   A+G+ +L  +     +HRD+ A N+L+       + DFGLA     RD
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA-----RD 221

Query: 460 SHVTTAVRGTVGHI------APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR--- 510
               +               APE L  G  + K+DV+ +GILL E+ +       G    
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS------LGVNPY 275

Query: 511 ---AANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE-----LEEMVQVALLCTQFN 562
                +          KL Q G               +++      EE+  +   C  F+
Sbjct: 276 PGIPVDAN------FYKLIQNGF--------------KMDQPFYATEEIYIIMQSCWAFD 315

Query: 563 PLHRPKMSEVLKMLE 577
              RP    +   L 
Sbjct: 316 SRKRPSFPNLTSFLG 330

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  118 bits (297), Expect = 2e-29
 Identities = 69/307 (22%), Positives = 119/307 (38%), Gaps = 72/307 (23%)

Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           K  LG G FG V+           D  LVAVK LK+ + +     FQ E E +++  H++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTMLQHQH 104

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR------------- 406
           ++R  G C+     L+V+ YM +G +   LR H    P                      
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH---GPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 407 -IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
            +A   A G++YL        +HRD+   N L+ +     +GDFG+++ +   D      
Sbjct: 162 AVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YY 214

Query: 466 VRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-----ANQR 515
             G    +      PE +   + + ++DV+ FG++L E+ T      +G+      +N  
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT------YGKQPWYQLSNT- 267

Query: 516 GVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIEL-----EEMVQVALLCTQFNPLHRPKMS 570
                            + +D   +G    +E       E+  +   C Q  P  R  + 
Sbjct: 268 -----------------EAIDCITQGR--ELERPRACPPEVYAIMRGCWQREPQQRHSIK 308

Query: 571 EVLKMLE 577
           +V   L+
Sbjct: 309 DVHARLQ 315

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  116 bits (293), Expect = 3e-29
 Identities = 54/299 (18%), Positives = 107/299 (35%), Gaps = 57/299 (19%)

Query: 301 SNFSAKNILGRGGFGIVYKG--------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI 352
            +      LG+G F  ++KG               V +K L   +    E  F      +
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEAASMM 66

Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
           S   H++L+   G C   +E +LV  ++  GS+ + L+ +   +  ++   +  +A   A
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLA 123

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV--------VGDFGLAKLLDHRDSHVTT 464
             + +L E     +IH +V A NILL  + +          + D G++  +      +  
Sbjct: 124 AAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQE 179

Query: 465 AVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRA-----ANQRGVM 518
            +        PE +   ++ +  TD + FG  L E+ +       G        +Q    
Sbjct: 180 RIPWV----PPECIENPKNLNLATDKWSFGTTLWEICS------GGDKPLSALDSQ---- 225

Query: 519 LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
              ++      +L               +  E+  +   C  + P HRP    +++ L 
Sbjct: 226 -RKLQFYEDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  115 bits (290), Expect = 1e-28
 Identities = 77/313 (24%), Positives = 125/313 (39%), Gaps = 74/313 (23%)

Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
              LG G FG V K         +    VAVK LK+           +E   +    H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT-------- 411
           +++L G CS +   LL+  Y   GS+   LR+     P    +   R +           
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 412 ------------ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
                       ++G+ YL E    K++HRD+ A NIL+ E  +  + DFGL++ +   D
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 460 SHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA--- 511
           S+V  +     V+      A E L     + ++DV+ FG+LL E++T       G     
Sbjct: 205 SYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGNPYP 254

Query: 512 --ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE-----LEEMVQVALLCTQFNPL 564
               +R  + + +K                 G+  R+E      EEM ++ L C +  P 
Sbjct: 255 GIPPER--LFNLLK----------------TGH--RMERPDNCSEEMYRLMLQCWKQEPD 294

Query: 565 HRPKMSEVLKMLE 577
            RP  +++ K LE
Sbjct: 295 KRPVFADISKDLE 307

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  115 bits (289), Expect = 1e-28
 Identities = 74/305 (24%), Positives = 120/305 (39%), Gaps = 56/305 (18%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
            S+F    +LG+G FG V K     D    A+K+++            +EV  ++   H+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK--LSTILSEVMLLASLNHQ 62

Query: 359 NLLRLCG-FCSTENERLLVYP------------YMPNGSVASRLRDHIH-GRPALDWARR 404
            ++R    +    N    +              Y  NG+    L D IH           
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGT----LYDLIHSENLNQQRDEY 118

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH------- 457
            R+       L Y+H Q    IIHRD+K  NI +DE     +GDFGLAK +         
Sbjct: 119 WRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 458 -------RDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGQRALDFG 509
                     ++T+A+ GT  ++A E L  TG  +EK D++  GI+  E+I       F 
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FS 229

Query: 510 RAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKM 569
               +  ++    KKL       + V  +   +FD  +++   ++  L    +P  RP  
Sbjct: 230 TGMERVNIL----KKL-------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA 278

Query: 570 SEVLK 574
             +L 
Sbjct: 279 RTLLN 283

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  115 bits (291), Expect = 1e-28
 Identities = 64/316 (20%), Positives = 116/316 (36%), Gaps = 80/316 (25%)

Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
              +G G FG V++        +    +VAVK LK+   A  +  FQ E   ++   + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK-------------- 405
           +++L G C+      L++ YM  G +   LR      P    +                 
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM---SPHTVCSLSHSDLSTRARVSSPGP 168

Query: 406 ---------RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
                     IA   A G+ YL E+   K +HRD+   N L+ E+    + DFGL++ + 
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225

Query: 457 HRDSHVTTAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511
             D             I      PE +   + + ++DV+ +G++L E+ +      +G  
Sbjct: 226 SAD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------YGLQ 275

Query: 512 -----ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIE-----LEEMVQVALLCTQF 561
                A++                  +++     GN   +        E+  +  LC   
Sbjct: 276 PYYGMAHE------------------EVIYYVRDGN--ILACPENCPLELYNLMRLCWSK 315

Query: 562 NPLHRPKMSEVLKMLE 577
            P  RP    + ++L+
Sbjct: 316 LPADRPSFCSIHRILQ 331

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (294), Expect = 2e-28
 Identities = 69/292 (23%), Positives = 101/292 (34%), Gaps = 52/292 (17%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHRN 359
           +F  K++LG G  G +      D   VAVKR+  + ++ A  EVQ   E        H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRE-----SDEHPN 79

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           ++R          + +        ++   +         L+      +   T  GL +LH
Sbjct: 80  VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLH 135

Query: 420 EQCDPKIIHRDVKAANILLDEDFE-----AVVGDFGLAKLLDHRDS--HVTTAVRGTVGH 472
                 I+HRD+K  NIL+          A++ DFGL K L          + V GT G 
Sbjct: 136 SL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 473 IAPEYLSTGQS---SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG 529
           IAPE LS       +   D+F  G +   +I+       G                H  G
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE------GS---------------HPFG 231

Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALL-------CTQFNPLHRPKMSEVLK 574
           K  Q     L G      L       ++           +P  RP    VLK
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  111 bits (281), Expect = 2e-27
 Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 33/208 (15%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+GGF   ++        + A K      L   +      +   E+       H++++ 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 79

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR--------G 414
             GF    +   +V       S+    +            RRK +    AR        G
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHK------------RRKALTEPEARYYLRQIVLG 127

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH     ++IHRD+K  N+ L+ED E  +GDFGLA  +++          GT  +IA
Sbjct: 128 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIA 183

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE LS    S + DV+  G ++  L+ G
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVG 211

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  112 bits (283), Expect = 2e-27
 Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 33/208 (15%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+GGF   ++        + A K      L   +      +   E+       H++++ 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 105

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR--------G 414
             GF    +   +V       S+    +            RRK +    AR        G
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHK------------RRKALTEPEARYYLRQIVLG 153

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
             YLH     ++IHRD+K  N+ L+ED E  +GDFGLA  +++          GT  +IA
Sbjct: 154 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIA 209

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE LS    S + DV+  G ++  L+ G
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVG 237

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  112 bits (281), Expect = 2e-27
 Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 19/216 (8%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHR 358
            ++  + ++G G   +V    C      VA+KR+ +       +     E++ +S   H 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHP 73

Query: 359 NLLRLCGFCS-TENERL-LVYPYMPNGSVASRLRD-HIHGRPALDWARRKRIAL---GTA 412
           N++    + S    + L LV   +  GSV   ++     G           IA       
Sbjct: 74  NIVSY--YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT-VG 471
            GL YLH+      IHRDVKA NILL ED    + DFG++  L          VR T VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 472 H---IAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
               +APE +   +    K D++ FGI  +EL TG 
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (278), Expect = 4e-27
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVH 357
              F+    +G+G FG V+KG       +VA+K + D   A  E++  Q E+  +S    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDS 79

Query: 358 RNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
             + +  G    ++ +L ++  Y+  GS      D +   P LD  +   I     +GL 
Sbjct: 80  PYVTKYYG-SYLKDTKLWIIMEYLGGGSA----LDLLEPGP-LDETQIATILREILKGLD 133

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           YLH +   K IHRD+KAAN+LL E  E  + DFG+A  L        T V GT   +APE
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 189

Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
            +       K D++  GI  +EL  G+
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGE 216

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  109 bits (274), Expect = 1e-26
 Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 16/202 (7%)

Query: 309 LGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEV---QFQTEVETISLAVHRNLLR 362
           LG GG   VY     D  L   VA+K +        E    +F+ EV   S   H+N++ 
Sbjct: 19  LGGGGMSTVYLA--EDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           +      ++   LV  Y+   +    L ++I     L              G+ + H+  
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPT----LSEYIESHGPLSVDTAINFTNQILDGIKHAHDM- 130

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
             +I+HRD+K  NIL+D +    + DFG+AK L       T  V GTV + +PE      
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 483 SSEKTDVFGFGILLLELITGQR 504
           + E TD++  GI+L E++ G+ 
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEP 210

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  108 bits (272), Expect = 2e-26
 Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 32/208 (15%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG+G F  VY+      G  VA+K      +    +     + Q EV+      H ++L 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM---VQRVQNEVKIHCQLKHPSILE 75

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR--------G 414
           L  +    N   LV     NG     +  ++         R K  +   AR        G
Sbjct: 76  LYNYFEDSNYVYLVLEMCHNGE----MNRYLK-------NRVKPFSENEARHFMHQIITG 124

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           +LYLH      I+HRD+  +N+LL  +    + DFGLA  L        T   GT  +I+
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYIS 180

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE  +      ++DV+  G +   L+ G
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIG 208

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  110 bits (277), Expect = 2e-26
 Identities = 49/219 (22%), Positives = 80/219 (36%), Gaps = 23/219 (10%)

Query: 300 TSNFSAKNILGRG--GFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLA 355
              +    ++G+G      V        G  V V+R+     +   V F Q E+    L 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL---GTA 412
            H N++        +NE  +V  +M  GS    +  H              IA    G  
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG-LAKLLDH--RDSHVTTAVRGT 469
           + L Y+H       +HR VKA++IL+  D +  +        ++ H  R   V    + +
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 470 VGHI---APEYLSTGQS--SEKTDVFGFGILLLELITGQ 503
           V  +   +PE L         K+D++  GI   EL  G 
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  110 bits (275), Expect = 2e-26
 Identities = 42/233 (18%), Positives = 76/233 (32%), Gaps = 31/233 (13%)

Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQT 347
            E +  +      ++LG G F  VY+    D           +K  K  N     +  Q 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ- 116

Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR---- 403
            +E +  ++    ++       +N  +LV      G+    L + I+             
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT----LLNAINLYKNTPEKVMPQG 172

Query: 404 -RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL-----------DEDFEAVVGDFGL 451
                A+     +  +H+    +IIH D+K  N +L           D      + D G 
Sbjct: 173 LVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 452 AKLLD-HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           +  +       + TA   T G    E LS    + + D FG    +  ++ G 
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  108 bits (271), Expect = 2e-26
 Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 13/205 (6%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVH 357
            +F     LG+G FG VY         ++A+K L    +  AG E Q + EVE  S   H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N+LRL G+        L+  Y P G+V   L+     +   D  R        A  L Y
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK--FDEQRTATYITELANALSY 124

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
            H +   ++IHRD+K  N+LL    E  + DFG +               GT+ ++ PE 
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLC--GTLDYLPPEM 178

Query: 478 LSTGQSSEKTDVFGFGILLLELITG 502
           +      EK D++  G+L  E + G
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVG 203

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (277), Expect = 3e-26
 Identities = 30/233 (12%), Positives = 61/233 (26%), Gaps = 40/233 (17%)

Query: 308 ILGRGGFGIVYKGC-FSDGALVAVK---------------------------RLKDYNIA 339
           +LG+       +      G    V                             +K+   A
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 340 GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--ERLLVYPYM--PNGSVASRLRDHIHG 395
              ++F    + +     + ++R+           R  +YP M     +    L  H   
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 396 RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455
             +L    R ++ L   R L  LH      ++H  ++  +I+LD+     +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 456 DHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQ 503
                             A   L          +   D +  G+ +  +    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  108 bits (272), Expect = 3e-26
 Identities = 58/301 (19%), Positives = 115/301 (38%), Gaps = 39/301 (12%)

Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQT 347
           +   F+ +      +S    +G GG   V++       + A+K +         +  ++ 
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75

Query: 348 EVETISLAVHRNL--LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
           E+  ++     +   +RL  +  T+    +V     N  + S L+            +  
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK--KKSIDPWERK-- 130

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTT 464
                    +  +H+     I+H D+K AN L+ +     + DFG+A  +     S V  
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186

Query: 465 AVRGTVGHIAPEYL-----------STGQSSEKTDVFGFGILLLELITGQRALDFGRAAN 513
           +  GTV ++ PE +           S  + S K+DV+  G +L  +  G+    F +  N
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIIN 244

Query: 514 QRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
           Q       + KLH       ++D + +  F  I  +++  V   C + +P  R  + E+L
Sbjct: 245 Q-------ISKLH------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

Query: 574 K 574
            
Sbjct: 292 A 292

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  109 bits (273), Expect = 4e-26
 Identities = 27/242 (11%), Positives = 54/242 (22%), Gaps = 40/242 (16%)

Query: 295 ELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVK--RLKDYNIAGGEVQFQTEVET 351
            L            L  G   +V+           A+K   +   N      +       
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 352 ISLAVHRNLLRLCGFC--------------------------STENERLLVYPYMP--NG 383
            +  +  +                                        LL+ P       
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443
            + S L      R          +     R    L  +    ++H      N+ +  D  
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGR 232

Query: 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELIT 501
            ++GD         +      A    V +   E+L  ST   +   + +  G+ +  +  
Sbjct: 233 LMLGDVSAL----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288

Query: 502 GQ 503
             
Sbjct: 289 LF 290

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  109 bits (273), Expect = 4e-26
 Identities = 57/285 (20%), Positives = 110/285 (38%), Gaps = 43/285 (15%)

Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNL--LRL 363
             +G GG   V++       + A+K +         +  ++ E+  ++     +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 364 CGFCSTENERLLVYPYM--PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
             +  T+     +Y  M   N  + S L+            +           +  +H+ 
Sbjct: 75  YDYEITDQY---IYMVMECGNIDLNSWLKK--KKSIDPWERK--SYWKNMLEAVHTIHQH 127

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTTAVRGTVGHIAPEYL-- 478
               I+H D+K AN L+ +     + DFG+A  +     S V  +  GTV ++ PE +  
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 479 ---------STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG 529
                    S  + S K+DV+  G +L  +  G+    F +  NQ       + KLH   
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQ-------ISKLH--- 231

Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
               ++D + +  F  I  +++  V   C + +P  R  + E+L 
Sbjct: 232 ---AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  107 bits (269), Expect = 9e-26
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 26/210 (12%)

Query: 309 LGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEV---QFQTEVETISLAVHRNLLR 362
           LG GG   V+     D      VAVK L+  ++A       +F+ E +  +   H  ++ 
Sbjct: 20  LGFGGMSEVHLA--RDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 363 L--CGFCSTENERLLVYPYMP----NGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           +   G            PY+     +G     LRD +H    +   R   +     + L 
Sbjct: 77  VYDTG---EAETPAGPLPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQALN 130

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHIA 474
           + H+     IIHRDVK ANI++       V DFG+A+ +    + VT   AV GT  +++
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQR 504
           PE         ++DV+  G +L E++TG+ 
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  110 bits (278), Expect = 9e-26
 Identities = 25/126 (19%), Positives = 46/126 (36%), Gaps = 7/126 (5%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
                 +     L+ L+ + +  N+      P    +L  L  LDLS  +     P +  
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI------SARTFKVT 197
            L +L  L +++N+           + SL ++D S N++  S  +       S     +T
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551

Query: 198 GNPLIC 203
            N   C
Sbjct: 552 QNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 99.7 bits (249), Expect = 4e-22
 Identities = 18/100 (18%), Positives = 36/100 (36%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
            L    S    +  +LQ + L    I      +   L  L TL L+ N        +   
Sbjct: 39  PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
           L +L  L     +L       +  +++L  +++++N +  
Sbjct: 99  LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 98.9 bits (247), Expect = 8e-22
 Identities = 22/110 (20%), Positives = 47/110 (42%), Gaps = 5/110 (4%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLG 143
            +          L+ LQ ++     +       +G L+ L+ L++++N     ++P+   
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLV----DLSYNNLSGSLPKI 189
           +L NL +L L++N +       L  +  + L+    DLS N ++   P  
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 98.6 bits (246), Expect = 8e-22
 Identities = 24/110 (21%), Positives = 39/110 (35%), Gaps = 1/110 (0%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L L    +         +L+ L +++L  N I      +   L  LQ L           
Sbjct: 57  LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 139 PDSLGDLGNLNYLRLNNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLP 187
              +G L  L  L + +N +     PE  S + +L  +DLS N +     
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 98.2 bits (245), Expect = 1e-21
 Identities = 23/105 (21%), Positives = 39/105 (37%), Gaps = 2/105 (1%)

Query: 85  SLSGTLSP-WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
           S      P     L  L  + L    +    P +   L  LQ L++S+N F         
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 515

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIE-SLTLVDLSYNNLSGSLP 187
            L +L  L  + N +  S  + L     SL  ++L+ N+ + +  
Sbjct: 516 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 97.4 bits (243), Expect = 2e-21
 Identities = 24/103 (23%), Positives = 43/103 (41%), Gaps = 2/103 (1%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIPDSLGDLGN 147
           T+S     L +L+ +  Q++ +      S    L  L  LD+S+             L +
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446

Query: 148 LNYLRLNNNSLTGS-CPESLSKIESLTLVDLSYNNLSGSLPKI 189
           L  L++  NS   +  P+  +++ +LT +DLS   L    P  
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 95.1 bits (237), Expect = 1e-20
 Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 6/111 (5%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
           +L+   +  IG+L  L+ + + +N I    +P     L  L+ LDLS+NK        L 
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170

Query: 144 DLGNLNY----LRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
            L  +      L L+ N +    P +  +I  L  + L  N  S ++ K  
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTC 220

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 92.0 bits (229), Expect = 1e-19
 Identities = 19/90 (21%), Positives = 33/90 (36%)

Query: 98  TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
              +++ L  N +      S     +LQ LDLS  +       +   L +L+ L L  N 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 158 LTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           +      + S + SL  +     NL+    
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLEN 117

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 89.3 bits (222), Expect = 9e-19
 Identities = 23/108 (21%), Positives = 42/108 (38%), Gaps = 4/108 (3%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
           S  G  +    +L  L+ + L  N +   G    S      L+ LDLS N     +  + 
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392

Query: 143 GDLGNLNYLRLNNNSLTGSCPES-LSKIESLTLVDLSYNNLSGSLPKI 189
             L  L +L   +++L      S    + +L  +D+S+ +   +   I
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 67.7 bits (166), Expect = 6e-12
 Identities = 29/126 (23%), Positives = 41/126 (32%), Gaps = 23/126 (18%)

Query: 86  LSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT---------- 135
               +      LT + S  L +  I              Q L+L N KF           
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSL 327

Query: 136 ---------GEIPDSLGDLGNLNYLRLNNNSLT--GSCPESLSKIESLTLVDLSYNNLSG 184
                    G    S  DL +L +L L+ N L+  G C +S     SL  +DLS+N +  
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387

Query: 185 SLPKIS 190
                 
Sbjct: 388 MSSNFL 393

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 14/97 (14%), Positives = 31/97 (31%), Gaps = 4/97 (4%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEK-LQTLDLSNNKFTGEIP--DS 141
           +     +     L  LQ +    N I+      L      L  L+L+ N F         
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564

Query: 142 LGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLS 178
           L  + +   L +    +  + P     +  +  ++++
Sbjct: 565 LQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 16/91 (17%), Positives = 25/91 (27%), Gaps = 2/91 (2%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
           NLT  +  L   +  L  I      L  + +  L +         S        +L L N
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVN 313

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSL 186
                     L  ++ LT       N    +
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 16/109 (14%), Positives = 32/109 (29%), Gaps = 10/109 (9%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGE------IPDS 141
            + P      +L  + L+NN     +    +  L  L+   L   +F  E         +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 142 LGDLGNLNYLRLNNNSLTGS---CPESLSKIESLTLVDLSYNNLSGSLP 187
           L  L NL         L        +  + + +++   L    +     
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 17/121 (14%), Positives = 36/121 (29%), Gaps = 13/121 (10%)

Query: 85  SLSGTLSP-WIGNLTKLQSVLLQNNAILG------PIPASLGKLEKLQTLDLS---NNKF 134
             S  +    I  L  L+   L                ++L  L  L   +      + +
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270

Query: 135 TGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
             +I D    L N++   L + ++     +  S       ++L         P +  ++ 
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQ-FPTLKLKSL 327

Query: 195 K 195
           K
Sbjct: 328 K 328

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  108 bits (270), Expect = 1e-25
 Identities = 32/238 (13%), Positives = 67/238 (28%), Gaps = 51/238 (21%)

Query: 308 ILGRGGFGIVYKGC-FSDGALVAVK---------------------------RLKDYNIA 339
           +LG+       +      G    V                             +K+   A
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 340 GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--ERLLVYPYM--PNGSVASRLRDHIHG 395
              ++F    + +     + ++R+           R  +YP M     +    L  H   
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 396 RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455
             +L    R ++ L   R L  LH      ++H  ++  +I+LD+     +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQS-----------SEKTDVFGFGILLLELITG 502
             R          + G   PE  +   +           +   D +  G+++  +   
Sbjct: 257 GAR-----VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  107 bits (269), Expect = 2e-25
 Identities = 54/283 (19%), Positives = 107/283 (37%), Gaps = 39/283 (13%)

Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNL--LRL 363
             +G GG   V++       + A+K +         +  ++ E+  ++     +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
             +  T+    +V     N  + S L+            +           +  +H+   
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERK--SYWKNMLEAVHTIHQH-- 174

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTTAVRGTVGHIAPEYLS--- 479
             I+H D+K AN L+ +     + DFG+A  +     S V  +  G V ++ PE +    
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 480 --------TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
                     + S K+DV+  G +L  +  G+    F +  NQ       + KLH     
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQ-------ISKLH----- 278

Query: 532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
             ++D + +  F  I  +++  V   C + +P  R  + E+L 
Sbjct: 279 -AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  109 bits (275), Expect = 2e-25
 Identities = 41/205 (20%), Positives = 74/205 (36%), Gaps = 27/205 (13%)

Query: 309 LGRGGFGIVYKGCFSDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           +  GG G +Y     D  +    V +K L     A  +     E + ++  VH +++++ 
Sbjct: 88  IAHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 365 GFCSTENERLLVYPYM-----PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
            F    +       Y+        S    L+     +  +  A      L     L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQS----LKRSKGQKLPVAEAIA--YLLEILPALSYLH 199

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
                 +++ D+K  NI+L E+ +  + D G    ++         + GT G  APE + 
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IV 249

Query: 480 TGQSSEKTDVFGFGILLLELITGQR 504
               +  TD++  G  L  L     
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLP 274

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  109 bits (275), Expect = 3e-25
 Identities = 25/121 (20%), Positives = 44/121 (36%), Gaps = 9/121 (7%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT--- 135
                     T      NL  L  V + N   L  +P  L  L ++Q ++++ N+     
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289

Query: 136 -----GEIPDSLGDLGNLNYLRLNNNSL-TGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
                 +          +  + +  N+L T     SL K++ L +++  YN L G LP  
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF 349

Query: 190 S 190
            
Sbjct: 350 G 350

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  104 bits (262), Expect = 1e-23
 Identities = 21/115 (18%), Positives = 42/115 (36%), Gaps = 10/115 (8%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL--------GPIPASLGKLEKLQTLDLS 130
           + + +      L  ++  L ++Q + +  N  +            A     EK+Q + + 
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313

Query: 131 NNKF-TGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
            N   T  +  SL  +  L  L    N L G    +      L  ++L+YN ++ 
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEGK-LPAFGSEIKLASLNLAYNQITE 367

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  100 bits (252), Expect = 2e-22
 Identities = 20/111 (18%), Positives = 41/111 (36%), Gaps = 14/111 (12%)

Query: 94  IGNLTKLQSVLLQNNAI-------LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
             +++ + ++    N I         P+  +  K   + +++LSNN+ +    +      
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457

Query: 147 NLNYLRLNNNSLTG-------SCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
            L+ + L  N LT           E+      LT +DL +N L+       
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR 508

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 99.3 bits (248), Expect = 5e-22
 Identities = 21/103 (20%), Positives = 41/103 (39%), Gaps = 2/103 (1%)

Query: 87  SGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
           +  +   +  + KL  +    N + G +P + G   KL +L+L+ N+ T    +  G   
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTE 377

Query: 147 NLNYLRLNNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPK 188
            +  L   +N L           +  ++ +D SYN +     K
Sbjct: 378 QVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGK 420

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 95.9 bits (239), Expect = 7e-21
 Identities = 23/113 (20%), Positives = 41/113 (36%), Gaps = 9/113 (7%)

Query: 80  GLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG--- 136
            +  ++    L P       + S+ L NN I             L +++L  N  T    
Sbjct: 416 SVDGKNFDP-LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK 474

Query: 137 ----EIPDSLGDLGNLNYLRLNNNSLTGSCPE-SLSKIESLTLVDLSYNNLSG 184
               +  ++  +   L  + L  N LT    +   + +  L  +DLSYN+ S 
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK 527

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 95.5 bits (238), Expect = 9e-21
 Identities = 20/137 (14%), Positives = 45/137 (32%), Gaps = 29/137 (21%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGP-------------------IPASLG 119
           +G  S +++  +S  +  LTKL+   + N+  +                           
Sbjct: 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWD 246

Query: 120 KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT--------GSCPESLSKIES 171
            L+ L  +++ N     ++P  L  L  +  + +  N                     E 
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306

Query: 172 LTLVDLSYNNL-SGSLP 187
           + ++ + YNNL +  + 
Sbjct: 307 IQIIYIGYNNLKTFPVE 323

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 95.1 bits (237), Expect = 1e-20
 Identities = 17/113 (15%), Positives = 36/113 (31%), Gaps = 6/113 (5%)

Query: 76  VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT 135
           +    + S     ++        K   +   +N I   +  ++ +L KL+   + N+ F 
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFV 219

Query: 136 GEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
            E      +  N  Y +                ++ LT V++        LP 
Sbjct: 220 AENICEAWENENSEYAQQYKTE-----DLKWDNLKDLTDVEVYNCPNLTKLPT 267

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 93.2 bits (232), Expect = 5e-20
 Identities = 23/193 (11%), Positives = 55/193 (28%), Gaps = 43/193 (22%)

Query: 36  VALVAVKNNLHDP--------YNVLENWDITSVDPCSWRM---ITCSPDGYVSALGLPSQ 84
           +AL  + + L+               NW+  + +   W     ++ + +G V+ L L   
Sbjct: 33  LALKEIWDALNGKNWSQQGFGTQPGANWN-FNKELDMWGAQPGVSLNSNGRVTGLSLEGF 91

Query: 85  SLSGTLSPWIGNLTKL----------------------------QSVLLQNNAILGPIPA 116
             SG +   IG LT+L                            +               
Sbjct: 92  GASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVD 151

Query: 117 SLGKLE--KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTL 174
              + +   L    ++++     I  S         +   +N++T    +++ ++  L  
Sbjct: 152 YDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQ 210

Query: 175 VDLSYNNLSGSLP 187
             +  +       
Sbjct: 211 FYMGNSPFVAENI 223

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 92.8 bits (231), Expect = 6e-20
 Identities = 16/108 (14%), Positives = 43/108 (39%), Gaps = 8/108 (7%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTG------- 136
            ++   + + G   +++++   +N +   P       +  +  +D S N+          
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423

Query: 137 EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
            +  +     N++ + L+NN ++    E  S    L+ ++L  N L+ 
Sbjct: 424 PLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 88.2 bits (219), Expect = 2e-18
 Identities = 17/101 (16%), Positives = 31/101 (30%), Gaps = 10/101 (9%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN------NKFTGEIPDSLGDLGN 147
              L  L  + L  N+     P        L+   + N      N+   E P+ +    +
Sbjct: 509 ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567

Query: 148 LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           L  L++ +N +     +    I  L   D+  N        
Sbjct: 568 LTQLQIGSNDIRKVNEKITPNISVL---DIKDNPNISIDLS 605

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 14/101 (13%), Positives = 29/101 (28%), Gaps = 9/101 (8%)

Query: 89  TLSPWIGNLTKLQS------VLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
                  N + L+          Q N  L   P  +     L  L + +N     + + +
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585

Query: 143 GDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
               N++ L + +N         +       +  L Y+   
Sbjct: 586 --TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 82.0 bits (203), Expect = 2e-16
 Identities = 28/190 (14%), Positives = 52/190 (27%), Gaps = 35/190 (18%)

Query: 34  EVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPW 93
            V   ++        Y  L+           W            AL   + S  G  +  
Sbjct: 17  IVPIKLSRTAEYIKDYLALKEI---------WD-----------ALNGKNWSQQGFGTQP 56

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
             N    + + +           SL    ++  L L     +G +PD++G L  L  L L
Sbjct: 57  GANWNFNKELDMWGA----QPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLAL 112

Query: 154 NNNSLTG----SCPESLSKIESLTLVDLSYNNLSGSLPKISAR-------TFKVTGNPLI 202
            ++          P+ +S   S         +   +      R          +  +P  
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172

Query: 203 CGPKATNNCT 212
              K ++  T
Sbjct: 173 KSIKKSSRIT 182

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 63.5 bits (155), Expect = 9e-11
 Identities = 8/81 (9%), Positives = 18/81 (22%), Gaps = 3/81 (3%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
                          I     L  + + +N I   +   +     +  LD+ +N      
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISID 603

Query: 139 PDSLGDLGNLNYLRLNNNSLT 159
              +          L  +   
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ 624

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  104 bits (262), Expect = 6e-25
 Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 20/204 (9%)

Query: 309 LGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEV---QFQTEVETISLAVHRNLLR 362
           +GRGG G VY+    D      VA+K + +  ++   V   + Q E  T       +++ 
Sbjct: 42  VGRGGMGDVYEA--EDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           +  F   + +  +    +        L   +  +  L   R   I       L   H   
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHIAPEYLST 480
                HRDVK  NIL+  D  A + DFG+A      D  +T      GT+ ++APE  S 
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSE 209

Query: 481 GQSSEKTDVFGFGILLLELITGQR 504
             ++ + D++    +L E +TG  
Sbjct: 210 SHATYRADIYALTCVLYECLTGSP 233

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  104 bits (261), Expect = 1e-24
 Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 36/220 (16%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK----------------DYNIAGGEVQFQTEVETI 352
           L +G F  +   C  D    A+K+ +                  +I      F+ E++ I
Sbjct: 39  LNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
           +   +   L   G  +  +E  ++Y YM N S    +         LD      I +   
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDS----ILKFDEYFFVLDKNYTCFIPIQVI 153

Query: 413 R--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
           +           Y+H + +  I HRDVK +NIL+D++    + DFG ++ +   D  +  
Sbjct: 154 KCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKG 209

Query: 465 AVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITG 502
           +  GT   + PE+ S     +  K D++  GI L  +   
Sbjct: 210 SR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  103 bits (260), Expect = 1e-24
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 29/237 (12%)

Query: 284 SLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGE 342
               L       LR     F    ++G G +G VYKG     G L A+K +   ++ G E
Sbjct: 7   PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDE 63

Query: 343 VQ-FQTEVETIS-LAVHRNLLR-----LCGFCSTENERL-LVYPYMPNGSVASRLRDHIH 394
            +  + E+  +   + HRN+       +       +++L LV  +   GSV   +++   
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123

Query: 395 GRPALDWARRKRIAL---GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451
                +W     IA       RGL +LH+    K+IHRD+K  N+LL E+ E  + DFG+
Sbjct: 124 NTLKEEW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 175

Query: 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELITGQ 503
           +  LD       T + GT   +APE ++  ++ +     K+D++  GI  +E+  G 
Sbjct: 176 SAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  101 bits (255), Expect = 3e-24
 Identities = 58/197 (29%), Positives = 89/197 (45%), Gaps = 13/197 (6%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLRLCG 365
           LG+G FG VY      +  ++A+K L    +    V  Q + E+E  S   H N+LR+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
           +        L+  + P G +   L+ H  GR   D  R        A  L Y HE+   K
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKH--GR--FDEQRSATFMEELADALHYCHER---K 134

Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
           +IHRD+K  N+L+    E  + DFG +    H  S     + GT+ ++ PE +      E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMCGTLDYLPPEMIEGKTHDE 191

Query: 486 KTDVFGFGILLLELITG 502
           K D++  G+L  E + G
Sbjct: 192 KVDLWCAGVLCYEFLVG 208

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  105 bits (263), Expect = 6e-24
 Identities = 69/299 (23%), Positives = 108/299 (36%), Gaps = 42/299 (14%)

Query: 302 NFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
            +  K  LG GGFG V +      G  VA+K+ +         ++  E++ +    H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 361 LRLCGFCSTENE------RLLVYPYMPNGSVASRLRDHI--HGRPAL---DWARR--KRI 407
           +          +       LL   Y   G     LR ++              R     I
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGD----LRKYLNQFENCCGLKEGPIRTLLSDI 130

Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTT 464
           +      L YLHE    +IIHRD+K  NI+L    + +   + D G AK LD      T 
Sbjct: 131 SSA----LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTE 182

Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR--------ALDFGRAANQRG 516
            V GT+ ++APE L   + +   D + FG L  E ITG R            G+   +  
Sbjct: 183 FV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241

Query: 517 VMLDWVKKLHQEGKLSQMV-DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
             +     L    K S ++   +        +LE  +Q  L    ++   R    +   
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQNPN 297

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  102 bits (255), Expect = 9e-24
 Identities = 64/299 (21%), Positives = 118/299 (39%), Gaps = 48/299 (16%)

Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG G  G+V+K      G ++A K +          Q   E++ +       ++   G  
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 368 STENERLLVYPYMPNGSVAS------RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
            ++ E  +   +M  GS+        R+ + I G+          +++   +GL YL E+
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKGLTYLREK 150

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              KI+HRDVK +NIL++   E  + DFG++  L   DS   + V GT  +++PE L   
Sbjct: 151 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGT 205

Query: 482 QSSEKTDVFGFGILLLELITGQ--------RALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
             S ++D++  G+ L+E+  G+        + L+        G   +   +    G+   
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265

Query: 534 MVDKDLKGNFDRIELEEMV---QVALL---------------CTQFNPLHRPKMSEVLK 574
               D +      EL + +       L               C   NP  R  + +++ 
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  100 bits (252), Expect = 9e-24
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 11/205 (5%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
              ++    +G+G  G VY     + G  VA++++ +      +     E+  +    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N++         +E  +V  Y+  GS    L D +     +D  +   +     + L +L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETC-MDEGQIAAVCRECLQALEFL 132

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           H     ++IHRD+K+ NILL  D    + DFG    +    S  +T V GT   +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188

Query: 479 STGQSSEKTDVFGFGILLLELITGQ 503
           +      K D++  GI+ +E+I G+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE 213

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  103 bits (258), Expect = 1e-23
 Identities = 59/234 (25%), Positives = 92/234 (39%), Gaps = 45/234 (19%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHR 358
           +   ++ ILG G  G V       G  VAVKR+     +IA  E++  TE        H 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE-----SDDHP 69

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR-------KRIALGT 411
           N++R     +T+    +      N +    L+D +  +   D   +         +    
Sbjct: 70  NVIRYYCSETTDRFLYIALELC-NLN----LQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLD-------------EDFEAVVGDFGLAKLLDHR 458
           A G+ +LH     KIIHRD+K  NIL+              E+   ++ DFGL K LD  
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 459 DSHVTTAVR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGILLLELITG 502
            S   T +    GT G  APE L    +       +   D+F  G +   +++ 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  100 bits (252), Expect = 1e-23
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 13/206 (6%)

Query: 300 TSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
              F     LG G +G VYK      G +VA+K++    +     +   E+  +      
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSP 84

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLY 417
           ++++  G      +  +V  Y   GSV+    D I  R   L       I   T +GL Y
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTEDEIATILQSTLKGLEY 140

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
           LH     + IHRD+KA NILL+ +  A + DFG+A  L    +   T + GT   +APE 
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196

Query: 478 LSTGQSSEKTDVFGFGILLLELITGQ 503
           +     +   D++  GI  +E+  G+
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  100 bits (250), Expect = 3e-23
 Identities = 55/219 (25%), Positives = 83/219 (37%), Gaps = 28/219 (12%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLRLCGF 366
           L  GGF  VY+      G   A+KRL              EV  +  L+ H N+++ C  
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK-NRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 367 CSTENER-------LLVYPYMPNGSVASRL-RDHIHGRPALDWARRKRIALGTARGLLYL 418
            S   E         L+   +  G +   L +    G  + D   +  I   T R + ++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCRAVQHM 152

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----------VR 467
           H Q  P IIHRD+K  N+LL       + DFG A  + H   +  +A             
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 468 GTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELITGQ 503
            T  +  PE +    +    EK D++  G +L  L   Q
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 44/224 (19%), Positives = 78/224 (34%), Gaps = 35/224 (15%)

Query: 302 NFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
            +   +ILG+G    V++G     G L A+K   + +          E E +    H+N+
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 361 LRLCGFCSTENERL--LVYPYMPNGSVASRLRDHI--HGRPAL---DWARR--KRIALGT 411
           ++L         R   L+  + P GS    L   +                  + +    
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGS----LYTVLEEPSNAYGLPESEFLIVLRDVV--- 122

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
             G+ +L E     I+HR++K  NI+     D      + DFG A+ L+  D    +   
Sbjct: 123 -GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY- 176

Query: 468 GTVGHIAPEYLSTGQS--------SEKTDVFGFGILLLELITGQ 503
           GT  ++ P+                   D++  G+      TG 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 14/228 (6%)

Query: 284 SLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGE 342
           S G LK    +       +      +GRG +G V K      G ++AVKR+    +   E
Sbjct: 5   SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKE 63

Query: 343 V-QFQTEVETI-SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-L 399
             Q   +++ +   +    +++  G    E +  +    M + S     +         +
Sbjct: 64  QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVI 122

Query: 400 DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
                 +I L T + L +L E    KIIHRD+K +NILLD      + DFG++  L    
Sbjct: 123 PEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180

Query: 460 SHVTTAVRGTVGHIAPEYLSTGQS----SEKTDVFGFGILLLELITGQ 503
           +    A  G   ++APE +    S      ++DV+  GI L EL TG+
Sbjct: 181 AKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 16/208 (7%)

Query: 303 FSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNL 360
           +     LG G FG VYK      GAL A K ++    +  E++ +  E+E ++   H  +
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYI 78

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           ++L G    + +  ++  + P G+V + + +   G   L   + + +       L +LH 
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHS 135

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
           +   +IIHRD+KA N+L+  + +  + DFG++           + + GT   +APE +  
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMC 191

Query: 481 GQSSE-----KTDVFGFGILLLELITGQ 503
               +     K D++  GI L+E+   +
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIE 219

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =   99 bits (249), Expect = 8e-23
 Identities = 46/224 (20%), Positives = 81/224 (36%), Gaps = 35/224 (15%)

Query: 302 NFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
            +   +ILG+G    V++G     G L A+K   + +          E E +    H+N+
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 361 LRLCGFCSTENERL--LVYPYMPNGSVASRLRDHI--HGRPAL---DWARR--KRIALGT 411
           ++L         R   L+  + P GS    L   +                  + +  G 
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGS----LYTVLEEPSNAYGLPESEFLIVLRDVVGG- 124

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVV--GDFGLAKLLDHRDSHVTTAVR 467
              + +L E     I+HR++K  NI+    ED ++V    DFG A+ L+  D    +   
Sbjct: 125 ---MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY- 176

Query: 468 GTVGHIAPEYLSTGQS--------SEKTDVFGFGILLLELITGQ 503
           GT  ++ P+                   D++  G+      TG 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 98.6 bits (246), Expect = 8e-23
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 11/205 (5%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
                +   +G G  GIV        G  VAVK + D            EV  +    H 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHF 102

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N++ +        E  ++  ++  G+    L D +     L+  +   +     + L YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGA----LTDIVSQVR-LNEEQIATVCEAVLQALAYL 157

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           H Q    +IHRD+K+ +ILL  D    + DFG    +        + V GT   +APE +
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVI 213

Query: 479 STGQSSEKTDVFGFGILLLELITGQ 503
           S    + + D++  GI+++E++ G+
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGE 238

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  100 bits (250), Expect = 4e-22
 Identities = 24/120 (20%), Positives = 40/120 (33%), Gaps = 11/120 (9%)

Query: 81  LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG---- 136
                          NL  L  V L N   +  +P  L  L +LQ+L+++ N+       
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533

Query: 137 -----EIPDSLGDLGNLNYLRLNNNSLTGSCPE-SLSKIESLTLVDLSYNNLSGSLPKIS 190
                 + D       +    +  N+L       SL K+  L L+D  +N +   L    
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFG 592

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 91.1 bits (226), Expect = 4e-19
 Identities = 25/125 (20%), Positives = 38/125 (30%), Gaps = 28/125 (22%)

Query: 88  GTLSPWIGNLTKLQSVLLQNNAI-------------------LGPIPASLGKLEKLQTLD 128
             +S  I  LTKLQ +   N+                           S   L+ L  ++
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497

Query: 129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTG---------SCPESLSKIESLTLVDLSY 179
           L N     ++PD L DL  L  L +  N                +       + +  + Y
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557

Query: 180 NNLSG 184
           NNL  
Sbjct: 558 NNLEE 562

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 86.5 bits (214), Expect = 1e-17
 Identities = 25/109 (22%), Positives = 45/109 (41%), Gaps = 4/109 (3%)

Query: 82  PSQSLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPD 140
             ++    L+       K+Q   +  N +   P  ASL K+ KL  LD  +NK      +
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLE 589

Query: 141 SLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
           + G    L  L+L+ N +     +  +  + +  +  S+N L   +P I
Sbjct: 590 AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNI 637

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 86.1 bits (213), Expect = 1e-17
 Identities = 22/123 (17%), Positives = 47/123 (38%), Gaps = 15/123 (12%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAI-------LGPIPASLGKLEKLQTLDLSN 131
           + L    +    +      + + +++L NN +       L P   +      L T+DL  
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRF 737

Query: 132 NKFTGEIPDSL--GDLGNLNYLRLNNNSLTG--SCPESLSKIESLTL---VDLSYNNLSG 184
           NK T  + D      L  L+ + ++ N  +   + P + S++++  +    D   N +  
Sbjct: 738 NKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILR 796

Query: 185 SLP 187
             P
Sbjct: 797 QWP 799

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 85.3 bits (211), Expect = 2e-17
 Identities = 18/124 (14%), Positives = 39/124 (31%), Gaps = 17/124 (13%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL------SNNKFTGEIPDSLGDLGN 147
              L  L ++ +  N      P       +L+   +        N+   + P  +    +
Sbjct: 749 ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807

Query: 148 LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL-SGSLP------KISARTFKVTGNP 200
           L  L++ +N +     E L+    L ++D++ N   S  +       +            
Sbjct: 808 LIQLQIGSNDIR-KVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

Query: 201 LICG 204
            I G
Sbjct: 865 DIRG 868

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 83.4 bits (206), Expect = 8e-17
 Identities = 20/137 (14%), Positives = 42/137 (30%), Gaps = 20/137 (14%)

Query: 76  VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT 135
           +    +        +        K   +    N  +  I  ++ +L KLQ +  +N+ FT
Sbjct: 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR-ITFISKAIQRLTKLQIIYFANSPFT 461

Query: 136 G-------------------EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVD 176
                                   S  +L +L  + L N       P+ L  +  L  ++
Sbjct: 462 YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521

Query: 177 LSYNNLSGSLPKISART 193
           ++ N    +    +  T
Sbjct: 522 IACNRGISAAQLKADWT 538

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 83.0 bits (205), Expect = 1e-16
 Identities = 21/106 (19%), Positives = 36/106 (33%), Gaps = 13/106 (12%)

Query: 94  IGNLTKLQSVLLQNNAILG-----PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
             ++  + SV    N I              K     T+ LS N+      +       +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699

Query: 149 NYLRLNNNSLT-------GSCPESLSKIESLTLVDLSYNNLSGSLP 187
           + + L+NN +T            +      LT +DL +N L+ SL 
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLS 744

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 81.8 bits (202), Expect = 3e-16
 Identities = 23/103 (22%), Positives = 39/103 (37%), Gaps = 5/103 (4%)

Query: 91  SPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG-DLGNLN 149
           S  +  + KL  +   +N  +  +  + G   KL  L L  N+   EIP+        + 
Sbjct: 566 SASLQKMVKLGLLDCVHNK-VRHLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622

Query: 150 YLRLNNNSLTGSCPE-SLSKIESLTLVDLSYNNLSGSLPKISA 191
            L  ++N L       +   +  +  VD SYN +      IS 
Sbjct: 623 GLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISC 665

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 81.5 bits (201), Expect = 3e-16
 Identities = 16/107 (14%), Positives = 42/107 (39%), Gaps = 8/107 (7%)

Query: 89  TLSPWIG-NLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
            +         +++ +   +N +   P   +   +  + ++D S NK   E  +    + 
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668

Query: 147 -----NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
                N + + L+ N +     E  +    ++ + LS N ++ S+P+
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPE 714

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 81.1 bits (200), Expect = 4e-16
 Identities = 24/106 (22%), Positives = 36/106 (33%), Gaps = 9/106 (8%)

Query: 91  SPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-------GEIPDSLG 143
           S          +V L  N I             + T+ LSNN  T            +  
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725

Query: 144 DLGNLNYLRLNNNSLTGSCPE-SLSKIESLTLVDLSYNNLSGSLPK 188
           +   L  + L  N LT    +   + +  L+ +D+SYN  S S P 
Sbjct: 726 NTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPT 770

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 80.3 bits (198), Expect = 8e-16
 Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 10/106 (9%)

Query: 92  PWIGNLTKLQSVLLQNNAILGPIPASLGK-LEKLQTLDLSNNKFTGEIPD--SLGDLGNL 148
              G   KL  + L  N I   IP       ++++ L  S+NK    IP+  +   +  +
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM 646

Query: 149 NYLRLNNNSLTG-----SCPESLSKIESLTLVDLSYNNLSGSLPKI 189
             +  + N +       SC     K  + + V LSYN +     ++
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 75.3 bits (185), Expect = 3e-14
 Identities = 25/177 (14%), Positives = 55/177 (31%), Gaps = 18/177 (10%)

Query: 29  AGINYEVVALVAVKNNLH-----------DPYNVLENWDITSVDPCSWRM---ITCSPDG 74
           A    +  AL A+   L            +      NW+  + +   W     +    +G
Sbjct: 265 AEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNG 323

Query: 75  YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKF 134
            V+ L L      G +   IG LT+L+ +    ++          +       +   ++ 
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383

Query: 135 TGEIP-DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
                   L     LN   L  +++  +    +  I+  + + L    +     +I+
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNLTNRIT 438

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 73.4 bits (180), Expect = 1e-13
 Identities = 22/196 (11%), Positives = 52/196 (26%), Gaps = 27/196 (13%)

Query: 36  VALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIG 95
           + L      + D   +   W+        +   T +               +     W  
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINN--------------TIHSLNW-- 302

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
                 +   + +         L    ++  L L+     G +PD++G L  L  L    
Sbjct: 303 ------NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGT 356

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVF 215
           +S T S      +  +  + +   + +     K+      +  +  +       +     
Sbjct: 357 HSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF-----LDYDQRLNLSDLLQDAINRN 411

Query: 216 PEPLSLPPNGLKDQSD 231
           PE   +  +      D
Sbjct: 412 PEMKPIKKDSRISLKD 427

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 70.7 bits (173), Expect = 7e-13
 Identities = 25/170 (14%), Positives = 52/170 (30%), Gaps = 26/170 (15%)

Query: 77  SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG 136
             + +  + +       +     LQ  + +N  +      S   L+  Q +    N+ T 
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ-IGNLTNRITF 439

Query: 137 EIPDSLGDLGNLNYLRLNNNSLTGSC-------------------PESLSKIESLTLVDL 177
            I  ++  L  L  +   N+  T                        S S ++ LT V+L
Sbjct: 440 -ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498

Query: 178 SYNNLSGSLPK-ISA----RTFKVTGNPLICGPKATNNCTAVFPEPLSLP 222
                   LP  +      ++  +  N  I   +   + T +  +  + P
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 12/87 (13%), Positives = 25/87 (28%), Gaps = 5/87 (5%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-GE 137
                  +       I     L  + + +N I   +   L    +L  LD+++N     +
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISID 843

Query: 138 IPDSLGDLGNLNY-LRLNNNSLTGSCP 163
           +      +    Y L  +       C 
Sbjct: 844 VTSVCPYIEAGMYVLLYDKTQDIRGCD 870

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 95.4 bits (238), Expect = 6e-22
 Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 15/203 (7%)

Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEV-QFQTEVETISLAV--HRNLLRLC 364
           LGRG +G+V K      G ++AVKR+    +   E  +   +++ IS+        +   
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLD-ISMRTVDCPFTVTFY 72

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
           G    E +  +    M + S+    +  I     +      +IA+   + L +LH +   
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-- 129

Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS- 483
            +IHRDVK +N+L++   +  + DFG++  L   D        G   ++APE ++   + 
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 484 ---SEKTDVFGFGILLLELITGQ 503
              S K+D++  GI ++EL   +
Sbjct: 188 KGYSVKSDIWSLGITMIELAILR 210

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 95.7 bits (238), Expect = 1e-21
 Identities = 45/211 (21%), Positives = 83/211 (39%), Gaps = 40/211 (18%)

Query: 379 YMPNGSVASRLRDHIHGRPALDWARRK---RIALGTARGLLYLHEQCDPKIIHRDVKAAN 435
                +    L+D ++ R +L+         I +  A  + +LH +    ++HRD+K +N
Sbjct: 142 LCRKEN----LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSN 194

Query: 436 ILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-----------GTVGHIAPEYLSTGQSS 484
           I    D    VGDFGL   +D  +   T               GT  +++PE +     S
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254

Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFD 544
            K D+F  G++L EL+       F     +R  ++  V+      K   +  +       
Sbjct: 255 HKVDIFSLGLILFELLYS-----FS-TQMERVRIITDVRN----LKFPLLFTQKYP---- 300

Query: 545 RIELEEMVQVALLCTQFNPLHRPKMSEVLKM 575
             +   MVQ        +P  RP+ +++++ 
Sbjct: 301 --QEHMMVQ---DMLSPSPTERPEATDIIEN 326

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 17/72 (23%), Positives = 32/72 (44%), Gaps = 1/72 (1%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
           ++F     +GRGGFG+V++     D    A+KR++  N      +   EV+ ++   H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 360 LLRLCGFCSTEN 371
           ++R         
Sbjct: 66  IVRYFNAWLETP 77

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 63/210 (30%), Positives = 90/210 (42%), Gaps = 18/210 (8%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLAV 356
              FS    +G G FG VY      +  +VA+K++      +  + Q    EV  +    
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N ++  G    E+   LV  Y   GS +  L  H   +  L       +  G  +GL 
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLA 168

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           YLH      +IHRDVKA NILL E     +GDFG A ++   +S V     GT   +APE
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 220

Query: 477 YLSTGQSSE---KTDVFGFGILLLELITGQ 503
            +      +   K DV+  GI  +EL   +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK 250

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 98.1 bits (245), Expect = 1e-21
 Identities = 34/137 (24%), Positives = 55/137 (40%), Gaps = 4/137 (2%)

Query: 54  NWDITSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAI 110
                  D CS   +T  PD     ++ L L    L    +      ++L S+ +  N I
Sbjct: 3   TVSHEVAD-CSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 111 LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIE 170
               P    KL  L+ L+L +N+ +     +     NL  L L +NS+         K +
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 171 SLTLVDLSYNNLSGSLP 187
           +L  +DLS+N LS +  
Sbjct: 122 NLITLDLSHNGLSSTKL 138

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 98.1 bits (245), Expect = 1e-21
 Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 2/113 (1%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L L S S+    +        L ++ L +N +      +  +LE LQ L LSNNK     
Sbjct: 102 LHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161

Query: 139 PDSLGDLGN--LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
            + L    N  L  L L++N +    P     I  L  + L+   L  SL + 
Sbjct: 162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 97.8 bits (244), Expect = 2e-21
 Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 14/137 (10%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNN--------AILGPIPASLGKLEKLQTLDLSNNKFTG 136
           +++      +  L KL+ + LQ+N        A  G     L  L  L  L+L +N F  
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550

Query: 137 EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI------S 190
              +   DL  L  + L  N+L        +   SL  ++L  N ++    K+      +
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610

Query: 191 ARTFKVTGNPLICGPKA 207
                +  NP  C  ++
Sbjct: 611 LTELDMRFNPFDCTCES 627

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 96.6 bits (241), Expect = 4e-21
 Identities = 22/116 (18%), Positives = 44/116 (37%), Gaps = 4/116 (3%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
           ++S         L  L+ + LQ+N +      +      L  L L +N       +    
Sbjct: 60  TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNP 200
             NL  L L++N L+ +   +  ++E+L  + LS N +      + +    +  N 
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA----LKSEELDIFANS 171

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 94.3 bits (235), Expect = 3e-20
 Identities = 21/111 (18%), Positives = 41/111 (36%), Gaps = 1/111 (0%)

Query: 81  LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD 140
           L   +  G    ++  L+ L  + L++N            L +L+ +DL  N        
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578

Query: 141 SLGDLGNLNYLRLNNNSLTGSCPESLSKIE-SLTLVDLSYNNLSGSLPKIS 190
              +  +L  L L  N +T    +       +LT +D+ +N    +   I+
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA 629

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 91.2 bits (227), Expect = 3e-19
 Identities = 27/108 (25%), Positives = 45/108 (41%), Gaps = 3/108 (2%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIPDSLG 143
            +S   S     L  L+ + L  N I   +       LE +  + LS NK+     +S  
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451

Query: 144 DLGNLNYLRLNNNSLTG--SCPESLSKIESLTLVDLSYNNLSGSLPKI 189
            + +L  L L   +L    S P     + +LT++DLS NN++     +
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 90.8 bits (226), Expect = 3e-19
 Identities = 30/105 (28%), Positives = 42/105 (40%), Gaps = 2/105 (1%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
            LS          T L  + L +N+I         K + L TLDLS+N  +     +   
Sbjct: 84  ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIE--SLTLVDLSYNNLSGSLP 187
           L NL  L L+NN +     E L      SL  ++LS N +    P
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP 188

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 87.4 bits (217), Expect = 3e-18
 Identities = 33/110 (30%), Positives = 43/110 (39%), Gaps = 5/110 (4%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG--KLEKLQTLDLSNNKFTGEIPDSL 142
            LS T       L  LQ +LL NN I       L       L+ L+LS+N+     P   
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191

Query: 143 GDLGNLNYLRLNNNSLTGSCPESLSKIE---SLTLVDLSYNNLSGSLPKI 189
             +G L  L LNN  L  S  E L       S+  + LS + LS +    
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 87.0 bits (216), Expect = 5e-18
 Identities = 24/113 (21%), Positives = 44/113 (38%), Gaps = 4/113 (3%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNN--KFTG 136
             +   SL          L  L+ + +++N I G        L  L+ L LSN+      
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369

Query: 137 EIPDSLGDLGN--LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
              ++   L +  L+ L L  N ++    ++ S +  L ++DL  N +   L 
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 86.6 bits (215), Expect = 6e-18
 Identities = 28/122 (22%), Positives = 44/122 (36%), Gaps = 11/122 (9%)

Query: 79  LGLPSQSLSGTLSPWIGNL--TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG 136
           L L +  LS T +     L  T L  + L  N +      S   L +L+   L  N    
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286

Query: 137 EIPDSLGDLGNLNYLRLNNN---------SLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
               SL  L N+ YL L  +         SL      S   ++ L  +++  N++ G   
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346

Query: 188 KI 189
            +
Sbjct: 347 NM 348

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 85.4 bits (212), Expect = 1e-17
 Identities = 26/114 (22%), Positives = 41/114 (35%), Gaps = 10/114 (8%)

Query: 86  LSGTLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
                      +  LQ ++L+  A+  +   P+    L  L  LDLSNN       D L 
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501

Query: 144 DLGNLNYLRLNNNSLT--------GSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
            L  L  L L +N+L         G     L  +  L +++L  N       ++
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 85.4 bits (212), Expect = 2e-17
 Identities = 28/121 (23%), Positives = 49/121 (40%), Gaps = 10/121 (8%)

Query: 85  SLSGTLSPWIG---NLTKLQSVLLQNNAILGPIPASLGKLE--KLQTLDLSNNKFTGEIP 139
            L  +L+  +      T ++++ L N+ +      +   L+   L  LDLS N       
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

Query: 140 DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG-----SLPKISARTF 194
           DS   L  L Y  L  N++      SL  + ++  ++L  +         SLPKI   +F
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325

Query: 195 K 195
           +
Sbjct: 326 Q 326

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 83.5 bits (207), Expect = 7e-17
 Identities = 24/110 (21%), Positives = 40/110 (36%), Gaps = 5/110 (4%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAI-LGPIPASLGK---LEKLQTLDLSNNKFTGEIPD 140
            + G  S     L  L+ + L N+   L  +            L  L+L+ NK +    D
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399

Query: 141 SLGDLGNLNYLRLNNNSLTGSCP-ESLSKIESLTLVDLSYNNLSGSLPKI 189
           +   LG+L  L L  N +      +    +E++  + LSYN         
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 78.9 bits (195), Expect = 2e-15
 Identities = 23/116 (19%), Positives = 47/116 (40%), Gaps = 13/116 (11%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNN---------AILGPIPASLGKLEKLQTLDLSNNKFT 135
           ++    S  +  L  ++ + L+ +         ++      S   L+ L+ L++ +N   
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342

Query: 136 GEIPDSLGDLGNLNYLRLNNN--SLTGSCPESLS--KIESLTLVDLSYNNLSGSLP 187
           G   +    L NL YL L+N+  SL     E+        L +++L+ N +S    
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 95.2 bits (237), Expect = 1e-20
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 24/213 (11%)

Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQF-QTEVETISL 354
           + F    +LG+GGFG V     +     G + A K+L K              E + +  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240

Query: 355 AVHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGT 411
              R ++ L  +     + L LV   M  G     L+ HI+  G+     AR    A   
Sbjct: 241 VNSRFVVSLA-YAYETKDALCLVLTLMNGGD----LKFHIYHMGQAGFPEARAVFYAAEI 295

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
             GL  LH +   +I++RD+K  NILLD+     + D GLA  +    +       GTVG
Sbjct: 296 CCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVG 350

Query: 472 HIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
           ++APE +   +    + D +  G LL E+I GQ
Sbjct: 351 YMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQ 382

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 94.8 bits (236), Expect = 1e-20
 Identities = 62/219 (28%), Positives = 89/219 (40%), Gaps = 33/219 (15%)

Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQF-QTEVETISL 354
             F    +LGRGGFG V+    K     G L A K+L K         Q    E + ++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241

Query: 355 AVHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
              R ++ L  +       L LV   M  G     +R HI+                 A 
Sbjct: 242 VHSRFIVSL-AYAFETKTDLCLVMTIMNGGD----IRYHIYNVDE----DNPGFQEPRAI 292

Query: 414 --------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
                   GL +LH++    II+RD+K  N+LLD+D    + D GLA  L    +     
Sbjct: 293 FYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349

Query: 466 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
             GT G +APE L  G+  + + D F  G+ L E+I  +
Sbjct: 350 A-GTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAAR 386

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 29/224 (12%)

Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEV-QFQTEVET 351
           +  +A  ++      +G G  G V+K  F   G ++AVK++   +    E  +   +++ 
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDV 76

Query: 352 I-SLAVHRNLLRLCGFCSTENERLLVYPYMPNGS------VASRLRDHIHGRPALDWARR 404
           +        +++  G   T  +  +    M   +      +   + + I G+        
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK-------- 128

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
             + +   + L YL E+    +IHRDVK +NILLDE  +  + DFG++  L    +   +
Sbjct: 129 --MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS 184

Query: 465 AVRGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELITGQ 503
           A  G   ++APE +     ++     + DV+  GI L+EL TGQ
Sbjct: 185 A--GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.0 bits (236), Expect = 2e-20
 Identities = 63/240 (26%), Positives = 97/240 (40%), Gaps = 29/240 (12%)

Query: 272 FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAV 330
            F    Q+       HL    F   R          I+GRGGFG VY    +D G + A+
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHR----------IIGRGGFGEVYGCRKADTGKMYAM 219

Query: 331 KRL-KDYNIAGGEVQF-QTE---VETISLAVHRNLLRLCGFCSTENERL-LVYPYMPNGS 384
           K L K              E   +  +S      ++ +  +     ++L  +   M  G 
Sbjct: 220 KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGD 278

Query: 385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA 444
               L  H+        A  +  A     GL ++H +    +++RD+K ANILLDE    
Sbjct: 279 ----LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV 331

Query: 445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            + D GLA     +  H   +V GT G++APE L  G + + + D F  G +L +L+ G 
Sbjct: 332 RISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 93.9 bits (234), Expect = 3e-20
 Identities = 25/127 (19%), Positives = 47/127 (37%), Gaps = 6/127 (4%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIPDSLG 143
           +           LT L ++ +  N+      ++       L  LDLS  +          
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI-----SARTFKVTG 198
            L  L  L +++N+L        +++ SL+ +D S+N +  S   +     S   F +T 
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554

Query: 199 NPLICGP 205
           N + C  
Sbjct: 555 NSVACIC 561

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.9 bits (208), Expect = 4e-17
 Identities = 22/105 (20%), Positives = 38/105 (36%), Gaps = 8/105 (7%)

Query: 80  GLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP 139
            L S S S        N ++LQ + L    I      +   L  L  L L+ N      P
Sbjct: 46  ILKSYSFS--------NFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP 97

Query: 140 DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
            S   L +L  L      L       + ++ +L  +++++N +  
Sbjct: 98  GSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.9 bits (208), Expect = 4e-17
 Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 13/137 (9%)

Query: 68  ITCSPDGYVSALGLPS-QSLS------GTLSPWIGNLTKLQSVLLQNNAILGPIPAS-LG 119
           ++ S     S LG  S + L         +S     L +LQ +  Q++ +      S   
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421

Query: 120 KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGS-CPESLSKIESLTLVDLS 178
            LEKL  LD+S      +       L +LN L++  NS   +      +   +LT +DLS
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481

Query: 179 YNNLSGSLPKISARTFK 195
              L      IS   F 
Sbjct: 482 KCQLEQ----ISWGVFD 494

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 78.9 bits (195), Expect = 2e-15
 Identities = 26/116 (22%), Positives = 43/116 (37%), Gaps = 6/116 (5%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
            L+   S  IG L  L+ + + +N I    +PA    L  L  +DLS N       + L 
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174

Query: 144 DLGNLN----YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
            L         L ++ N +     ++   I  L  + L  N  S ++ K   +   
Sbjct: 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLA 229

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 27/106 (25%), Positives = 41/106 (38%), Gaps = 4/106 (3%)

Query: 87  SGTLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
            G++S     L  L  + L  NA+   G    S      L+ LDLS N     +  +   
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397

Query: 145 LGNLNYLRLNNNSLTGSCPES-LSKIESLTLVDLSYNNLSGSLPKI 189
           L  L +L   +++L      S    +E L  +D+SY N       I
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 70.8 bits (174), Expect = 5e-13
 Identities = 25/95 (26%), Positives = 37/95 (38%), Gaps = 5/95 (5%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG--NLNYLR 152
            +L  L+S+ L  N     I      L  L  LDLS N  +     S  DLG  +L +L 
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382

Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           L+ N        +   +E L  +D  ++ L     
Sbjct: 383 LSFNGAIIM-SANFMGLEELQHLDFQHSTLKRVTE 416

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 67.0 bits (164), Expect = 9e-12
 Identities = 17/100 (17%), Positives = 39/100 (39%), Gaps = 4/100 (4%)

Query: 88  GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGN 147
           G+L+P I  +  + +    +  +   +P  +      + +DLS N        S  +   
Sbjct: 2   GSLNPCIEVVPNI-TYQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 148 LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           L +L L+   +     ++   +  L+ + L+ N +    P
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP 97

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.9 bits (156), Expect = 8e-11
 Identities = 26/116 (22%), Positives = 38/116 (32%), Gaps = 8/116 (6%)

Query: 87  SGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL----QTLDLSNNKFTGEIPDSL 142
           S  L  +  NLT L  V L  N I       L  L +      +LD+S N     I D  
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQA 200

Query: 143 GDLGNLNYLRLNNNSLTGSCPE-SLSKIESLTLVDLSYNNLSG--SLPKISARTFK 195
                L+ L L  N  + +  +  L  +  L +  L         +L        +
Sbjct: 201 FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 58.1 bits (141), Expect = 5e-09
 Identities = 13/99 (13%), Positives = 26/99 (26%), Gaps = 7/99 (7%)

Query: 94  IGNLTKLQSVLL--QNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
           +  L  +                      L  +  + L+         + +        L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSL 312

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
            +    L       L  ++SL    L+ N  S S  K++
Sbjct: 313 SIIRCQLKQFPTLDLPFLKSL---TLTMNKGSISFKKVA 348

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 23/111 (20%), Positives = 31/111 (27%), Gaps = 12/111 (10%)

Query: 87  SGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDL 145
              L     N     S+ +  N I   I     +  KL  L L  N  +  I    L +L
Sbjct: 170 VNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNL 228

Query: 146 GNLNYLRLNNNSLTG---------SCPESLSKIESLTLVDLSYNNLSGSLP 187
             L+  RL                S  E L  +       L+Y N      
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF-RLTYTNDFSDDI 278

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 14/99 (14%), Positives = 27/99 (27%), Gaps = 10/99 (10%)

Query: 94  IGNLTKLQSVLLQNNAILG------PIPASLGKLEKLQT--LDLSNNKFTGEIPDSLGDL 145
           + NL  L    L               P+ +  L  +      L+      +       L
Sbjct: 225 LQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL 284

Query: 146 GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
            N++ + L   S+     E + K      + +    L  
Sbjct: 285 ANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ 321

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 92.1 bits (229), Expect = 4e-20
 Identities = 61/247 (24%), Positives = 102/247 (41%), Gaps = 37/247 (14%)

Query: 282 EVSLGH--LKRYTFKELRAATSNFSAKNI---------LGRGGFGIVYKGCF--SDGALV 328
           E++L     K + F +L     +   K +         LG G  G V    F       V
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL-AFERKTCKKV 163

Query: 329 AVKRLKDYNIAGGEVQ-------FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381
           A++ +     A G  +        +TE+E +    H  ++++  F   E+   +V   M 
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELME 222

Query: 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--- 438
            G     L D + G   L  A  K         + YLHE     IIHRD+K  N+LL   
Sbjct: 223 GGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 275

Query: 439 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGIL 495
           +ED    + DFG +K+L   ++ +   + GT  ++APE L +  +   +   D +  G++
Sbjct: 276 EEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333

Query: 496 LLELITG 502
           L   ++G
Sbjct: 334 LFICLSG 340

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 92.5 bits (230), Expect = 5e-20
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 15/210 (7%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVH 357
           +  +     LG G +G V            A+K ++  +++         EV  + L  H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N+++L  F   +    LV      G     L D I  R   +      I      G+ Y
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151

Query: 418 LHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           LH+     I+HRD+K  N+LL   ++D    + DFGL+ + +  +        GT  +IA
Sbjct: 152 LHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIA 206

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQR 504
           PE L   +  EK DV+  G++L  L+ G  
Sbjct: 207 PEVLR-KKYDEKCDVWSIGVILFILLAGYP 235

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 90.5 bits (225), Expect = 2e-19
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 16/209 (7%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGE--VQFQTEVETISLAV 356
           +  +  + +LG+G FG V        G   AVK +    +           EV+ +    
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L  F   +    LV      G     L D I  R         RI      G+ 
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGIT 140

Query: 417 YLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           Y+H+    KI+HRD+K  N+LL    +D    + DFGL+   +   S       GT  +I
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYI 195

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITG 502
           APE L  G   EK DV+  G++L  L++G
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSG 223

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 49/199 (24%), Positives = 78/199 (39%), Gaps = 21/199 (10%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK--------RLKDYNIAGGEVQFQTEV 349
             N+  K ILGRG   +V + C         AVK              +         EV
Sbjct: 16  YENYEPKEILGRGVSSVVRR-CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74

Query: 350 ETI-SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
           + +  ++ H N+++L     T     LV+  M  G     L D++  +  L     ++I 
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIM 130

Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG 468
                 +  LH+     I+HRD+K  NILLD+D    + DFG +  LD     +     G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVC-G 185

Query: 469 TVGHIAPEYLSTGQSSEKT 487
           T  ++APE +    +    
Sbjct: 186 TPSYLAPEIIECSMNDNHP 204

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 29/210 (13%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISL----AVHR 358
           LG+GGFG V+ G   +D   VA+K     R+  ++     V    EV  +        H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARR--KRIALGTARG 414
            ++RL  +  T+   +LV            L D+I   G      +R    ++       
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQ---DLFDYITEKGPLGEGPSRCFFGQVV----AA 151

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           + + H +    ++HRD+K  NIL+D       + DFG   LL   D   T    GT  + 
Sbjct: 152 IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GTRVYS 205

Query: 474 APEYLSTGQ-SSEKTDVFGFGILLLELITG 502
            PE++S  Q  +    V+  GILL +++ G
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCG 235

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 87.6 bits (217), Expect = 6e-19
 Identities = 57/253 (22%), Positives = 85/253 (33%), Gaps = 55/253 (21%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK----RLKDYNIAGGEVQFQTEVETIS 353
              +  K  +G+G +G+V          A+ A+K                + +TEV  + 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRV-AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83

Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
              H N+ RL      E    LV      G +  +L   I            +  +    
Sbjct: 84  KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 414 ------------------------------------GLLYLHEQCDPKIIHRDVKAANIL 437
                                                L YLH Q    I HRD+K  N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFL 200

Query: 438 L--DEDFEAVVGDFGLAKLLDHRDSH----VTTAVRGTVGHIAPEYLSTGQSS--EKTDV 489
              ++ FE  + DFGL+K     ++     +TT   GT   +APE L+T   S   K D 
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDA 259

Query: 490 FGFGILLLELITG 502
           +  G+LL  L+ G
Sbjct: 260 WSAGVLLHLLLMG 272

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 89.3 bits (222), Expect = 8e-19
 Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 9/118 (7%)

Query: 94  IGNLTKLQSVLLQNNAILGPI---PASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNY 150
              L  LQ + LQ N           SL  L +L+ L LS    +     +   L  +N+
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504

Query: 151 LRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI-----SARTFKVTGNPLIC 203
           + L++N LT S  E+LS ++ + L +L+ N++S  LP +       RT  +  NPL C
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGIYL-NLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 85.5 bits (212), Expect = 1e-17
 Identities = 18/102 (17%), Positives = 37/102 (36%), Gaps = 2/102 (1%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
            L       +     L+ +      I       L   + L++L L +N  +         
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLV--DLSYNNLSG 184
              L  L   NN++     E +S ++  T +  +L+ N+++G
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 84.7 bits (210), Expect = 3e-17
 Identities = 17/91 (18%), Positives = 30/91 (32%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
              L  L  + L    I      +     +L TL L+ N        +L     L +L  
Sbjct: 53  FSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
               ++      L   ++L  + L  N++S 
Sbjct: 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISS 143

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 83.9 bits (208), Expect = 4e-17
 Identities = 19/125 (15%), Positives = 43/125 (34%), Gaps = 7/125 (5%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            +  +L +++L  N ++     +L   + L+ L       +      L +   L  L L 
Sbjct: 78  QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS-------GSLPKISARTFKVTGNPLICGPKA 207
           +N ++          E L ++D   N +         SL + +  +  + GN +      
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPG 197

Query: 208 TNNCT 212
             +  
Sbjct: 198 AFDSA 202

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.4 bits (204), Expect = 1e-16
 Identities = 25/109 (22%), Positives = 43/109 (39%), Gaps = 2/109 (1%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
             +  + +S  +   +  ++ ++S+ LQ +        +      LQ LDL+    + E+
Sbjct: 236 EDMDDEDISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           P  L  L  L  L L+ N     C  S S   SLT + +  N     L 
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.4 bits (204), Expect = 1e-16
 Identities = 18/100 (18%), Positives = 32/100 (32%), Gaps = 7/100 (7%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
           +   L+      N +      +  +L  L  LDL+  +      D+      L+ L L  
Sbjct: 34  STECLE---FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTA 90

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           N L      +LS  ++L  +      +S     I      
Sbjct: 91  NPLIFMAETALSGPKALKHLFFIQTGISS----IDFIPLH 126

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.4 bits (204), Expect = 1e-16
 Identities = 25/102 (24%), Positives = 43/102 (42%), Gaps = 2/102 (1%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
                 S      + LQ + L    +   +P+ L  L  L+ L LS NKF      S  +
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASN 323

Query: 145 LGNLNYLRLNNNSLTGS-CPESLSKIESLTLVDLSYNNLSGS 185
             +L +L +  N+         L  +E+L  +DLS++++  S
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.0 bits (203), Expect = 2e-16
 Identities = 20/102 (19%), Positives = 44/102 (43%), Gaps = 1/102 (0%)

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
              +   +  +  L +L+ ++L    +      +   L+ +  +DLS+N+ T    ++L 
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGS 185
            L  + YL L +N ++   P  L  +     ++L  N L  +
Sbjct: 522 HLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.0 bits (203), Expect = 2e-16
 Identities = 25/115 (21%), Positives = 45/115 (39%), Gaps = 8/115 (6%)

Query: 85  SLSGTLSPW-IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDS 141
           +    L    + NL  L+ + L ++ I         L  L  LQ+L+LS N+      ++
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395

Query: 142 LGDLGNLNYLRLNNNSLTGSCPES-LSKIESLTLVDLSYNNLSGSLPKISARTFK 195
             +   L  L L    L     +S    +  L +++LS++ L       S + F 
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI----SSEQLFD 446

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.4 bits (199), Expect = 5e-16
 Identities = 27/115 (23%), Positives = 47/115 (40%), Gaps = 7/115 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI---PDSLGDLGNLNY 150
             NL  L+ + L ++ +          L  LQ L+L  N F        +SL  LG L  
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480

Query: 151 LRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG----SLPKISARTFKVTGNPL 201
           L L+   L+     + + ++ +  VDLS+N L+     +L  +      +  N +
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 77.7 bits (192), Expect = 4e-15
 Identities = 21/115 (18%), Positives = 37/115 (32%), Gaps = 8/115 (6%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
                 +       +L+ + L    +      +    L  L+ L+LS++           
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446

Query: 144 DLGNLNYLRLNNNSLTG---SCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
            L  L +L L  N           SL  +  L ++ LS+ +LS     I    F 
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS----IDQHAFT 497

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 70.4 bits (173), Expect = 7e-13
 Identities = 24/119 (20%), Positives = 37/119 (31%), Gaps = 9/119 (7%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQ--TLDLSNNKFTGEIPDSL 142
            +S    P      KL+ +  QNNAI       +  L++    +L+L+ N     I    
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGA 198

Query: 143 GDLGNLNYLRLNNNSLTGSCPESLS--KIESLTLVDLSYNNLSGSLPKISARTFKVTGN 199
            D      L            + L    I+SL L      +       IS   F+    
Sbjct: 199 FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE----DISPAVFEGLCE 253

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 17/105 (16%), Positives = 31/105 (29%), Gaps = 5/105 (4%)

Query: 88  GTLSPWIGNLTKLQSVLLQNNAILGPIPASLG--KLEKLQTLDLSNNKFTGEIPDSLGDL 145
             + P   +    QS+       L  I   L    ++ L      +       P     L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251

Query: 146 GNLN--YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
             ++   + L  +        +      L  +DL+  +LS  LP 
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPS 295

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 16/69 (23%), Positives = 30/69 (43%), Gaps = 1/69 (1%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
             +L  +  V L +N +      +L  L+ +  L+L++N  +  +P  L  L     + L
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554

Query: 154 NNNSLTGSC 162
             N L  +C
Sbjct: 555 RQNPLDCTC 563

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.0 bits (216), Expect = 9e-19
 Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 21/222 (9%)

Query: 282 EVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIA 339
            V +  + +   +     T  +  K  +G G + +  + C   +     AVK +      
Sbjct: 3   TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKR-CIHKATNMEFAVKIIDKSKRD 61

Query: 340 GGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA 398
             E     E+E +     H N++ L           +V   M  G     L D I  +  
Sbjct: 62  PTE-----EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE----LLDKILRQKF 112

Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAV-VGDFGLAKL 454
                   +     + + YLH Q    ++HRD+K +NIL      + E++ + DFG AK 
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169

Query: 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 496
           L   +  + T    T   +APE L         D++  G+LL
Sbjct: 170 LRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 15/208 (7%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVH 357
              ++   +LG+G FG V K          AVK +   +    +      EVE +    H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N+++L       +   +V      G     L D I  R         RI      G+ Y
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 418 LHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           +H+     I+HRD+K  NILL   ++D +  + DFGL+     +++ +   + GT  +IA
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYYIA 191

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
           PE L  G   EK DV+  G++L  L++G
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSG 218

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.5 bits (217), Expect = 1e-18
 Identities = 50/224 (22%), Positives = 92/224 (41%), Gaps = 26/224 (11%)

Query: 294 KELRAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQ-FQT 347
           K++R    +F    ++GRG FG V     K       + A+K L K   +   E   F+ 
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFRE 123

Query: 348 EVETISLAVHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWAR--R 404
           E + +     + +  L  +   ++  L LV  Y   G + + L      R   + AR   
Sbjct: 124 ERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYL 181

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
             + +     +  +H+      +HRD+K  NIL+D +    + DFG    L    +  ++
Sbjct: 182 AEMVIA----IDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234

Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELITGQ 503
              GT  +I+PE L   +  +       D +  G+ + E++ G+
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 29/209 (13%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHR--NL 360
           LG GGFG VY G   SD   VA+K     R+ D+       +   EV  +         +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 361 LRLCGFCSTENERLLVYPY-MPNGSVASRLRDHI--HGRPALDWARR--KRIALGTARGL 415
           +RL  +    +  +L+     P       L D I   G    + AR    ++       +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQD----LFDFITERGALQEELARSFFWQVL----EAV 162

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
            + H      ++HRD+K  NIL+D +   + + DFG   LL  +D+  T    GT  +  
Sbjct: 163 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTRVYSP 216

Query: 475 PEYLSTGQ-SSEKTDVFGFGILLLELITG 502
           PE++   +       V+  GILL +++ G
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 18/211 (8%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
              F  K  LG G FG V+     S G    +K +          Q + E+E +    H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR----G 414
           N++++       +   +V      G     L + I    A   A  +       +     
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 415 LLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
           L Y H Q    ++H+D+K  NIL           + DFGLA+L    D H T A  GT  
Sbjct: 137 LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAA-GTAL 191

Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           ++APE       + K D++  G+++  L+TG
Sbjct: 192 YMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 45/197 (22%), Positives = 77/197 (39%), Gaps = 19/197 (9%)

Query: 306 KNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLR 362
              LG G F I  K C         AVK +     A      Q E+  +     H N+++
Sbjct: 16  DKPLGEGSFSICRK-CVHKKSNQAFAVKIISKRMEA----NTQKEITALKLCEGHPNIVK 70

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L      +    LV   +  G     L + I  +          I       + ++H+  
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGE----LFERIKKKKHFSETEASYIMRKLVSAVSHMHDV- 125

Query: 423 DPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
              ++HRD+K  N+L    +++ E  + DFG A+L    +  + T    T+ + APE L+
Sbjct: 126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLN 182

Query: 480 TGQSSEKTDVFGFGILL 496
                E  D++  G++L
Sbjct: 183 QNGYDESCDLWSLGVIL 199

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 3/101 (2%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN-NKFTGEIPDSLGDLGN 147
            L P I +L KL+ + L+    L   P   G    L+ L L + +     +P  +  L  
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQ 278

Query: 148 LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           L  L L         P  ++++ +  ++ +   +L   L +
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 20/102 (19%), Positives = 40/102 (39%), Gaps = 5/102 (4%)

Query: 89  TLSPWIGNLT--KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
             +  + + T     ++ L++   L   P    +L  LQ + +       E+PD++    
Sbjct: 70  ATADLLEDATQPGRVALELRSVP-LPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127

Query: 147 NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
            L  L L  N L  + P S++ +  L  + +        LP+
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 81.5 bits (202), Expect = 5e-17
 Identities = 27/109 (24%), Positives = 48/109 (44%), Gaps = 12/109 (11%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG----- 143
            L   +     L+++ L  N  L  +PAS+  L +L+ L +       E+P+ L      
Sbjct: 118 ELPDTMQQFAGLETLTLARNP-LRALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 144 ----DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
                L NL  LRL    +  S P S++ +++L  + +  + LS +L  
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP 223

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 26/108 (24%), Positives = 44/108 (40%), Gaps = 2/108 (1%)

Query: 81  LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD 140
           LP    S   S     L  LQS+ L+   I   +PAS+  L+ L++L + N+  +  +  
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGP 223

Query: 141 SLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           ++  L  L  L L   +   + P        L  + L   +   +LP 
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 15/81 (18%), Positives = 32/81 (39%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L L   +      P  G    L+ ++L++ + L  +P  + +L +L+ LDL        +
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293

Query: 139 PDSLGDLGNLNYLRLNNNSLT 159
           P  +  L     + +  +   
Sbjct: 294 PSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 19/125 (15%), Positives = 34/125 (27%), Gaps = 8/125 (6%)

Query: 68  ITCSPDGYVSALGLPSQSLSG--TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQ 125
           +  S   +  + G  +    G   L P+   L++ Q     +                 Q
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS-AWRQANSNNPQ 59

Query: 126 TLDLSNNKFTGEIPDSLGDL--GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
               +         D L D        L L +  L    P+   ++  L  + +    L 
Sbjct: 60  IETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117

Query: 184 GSLPK 188
             LP 
Sbjct: 118 -ELPD 121

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.5 bits (212), Expect = 5e-18
 Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 28/226 (12%)

Query: 294 KELRAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEV-QFQT 347
           KE+R    +F    ++GRG F  V     K     G + A+K + K   +  GEV  F+ 
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFRE 110

Query: 348 EVETISLAVHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWAR--R 404
           E + +     R + +L  F   +   L LV  Y   G + + L      R   + AR   
Sbjct: 111 ERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYL 168

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
             I +     +  +H       +HRD+K  NILLD      + DFG    L    +  + 
Sbjct: 169 AEIVMA----IDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221

Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFG-------FGILLLELITGQ 503
              GT  +++PE L        T  +G        G+   E+  GQ
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 85.2 bits (211), Expect = 5e-18
 Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 20/198 (10%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVK-------RLKDYNIAGGEVQFQTEVET 351
              +  K+++GRG   +V +    + G   AVK       RL    +       + E   
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH- 151

Query: 352 I--SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
           I   +A H +++ L     + +   LV+  M  G     L D++  + AL     + I  
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE----LFDYLTEKVALSEKETRSIMR 207

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
                + +LH      I+HRD+K  NILLD++ +  + DFG +  L+     +     GT
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELC-GT 262

Query: 470 VGHIAPEYLSTGQSSEKT 487
            G++APE L         
Sbjct: 263 PGYLAPEILKCSMDETHP 280

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 86.3 bits (214), Expect = 6e-18
 Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 26/219 (11%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLK------------DYNIAGGEVQFQ 346
             ++     LG G +G V      +  +  A+K +K            + NI     +  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 347 TEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
            E+  +    H N+++L      +    LV  +   G     L + I  R   D      
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAAN 150

Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVT 463
           I      G+ YLH+     I+HRD+K  NILL   +      + DFGL+      D  + 
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKLR 206

Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
             + GT  +IAPE L   + +EK DV+  G+++  L+ G
Sbjct: 207 DRL-GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 83.8 bits (208), Expect = 8e-18
 Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 33/218 (15%)

Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQF-QTEVETISL 354
            +F    ILG G F  V         +     A+K L K + I   +V +   E + +S 
Sbjct: 30  EDFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86

Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR- 413
             H   ++L      + +      Y  NG +   +R            +         R 
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR------------KIGSFDETCTRF 134

Query: 414 -------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA- 465
                   L YLH +    IIHRD+K  NILL+ED    + DFG AK+L           
Sbjct: 135 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
             GT  +++PE L+   + + +D++  G ++ +L+ G 
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 21/207 (10%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAV 356
              ++   +LG+G FG V K C         AVK +   +    +      EVE +    
Sbjct: 21  AERYNIVCMLGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
           H N+++L       +   +V      G     L D I  R         RI      G+ 
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVFSGIT 135

Query: 417 YLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
           Y+H+     I+HRD+K  NILL   ++D +  + DFGL+      ++ +   + GT  +I
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYI 190

Query: 474 APEYLSTGQSSEKTDVFGFG----ILL 496
           APE L  G   EK DV+  G    ILL
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILL 216

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 84.3 bits (209), Expect = 9e-18
 Identities = 50/221 (22%), Positives = 81/221 (36%), Gaps = 34/221 (15%)

Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEV--- 343
             Y   E            ++G+G F +V + C     G   AVK +             
Sbjct: 24  DVYELCE------------VIGKGPFSVVRR-CINRETGQQFAVKIVDVAKFTSSPGLST 70

Query: 344 -QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWA 402
              + E     +  H +++ L    S++    +V+ +M        L   I  R    + 
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFV 126

Query: 403 RRKRIALGTARGLL----YLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLL 455
             + +A    R +L    Y H+     IIHRDVK   +LL   +      +G FG+A  L
Sbjct: 127 YSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183

Query: 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 496
                     V GT   +APE +      +  DV+G G++L
Sbjct: 184 GESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 29/113 (25%), Positives = 52/113 (46%), Gaps = 11/113 (9%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + NL++L  + +  N I       +  L KL+ L++ +N+ +      L +L  LN L L
Sbjct: 239 LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS-----GSLPKISARTFKVTGNPL 201
           NNN L     E +  + +LT + LS N+++      SL K+   +       +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKM--DSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 81.8 bits (203), Expect = 5e-17
 Identities = 24/90 (26%), Positives = 43/90 (47%), Gaps = 4/90 (4%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + +LTKL+ + + +N I       L  L +L +L L+NN+   E  + +G L NL  L L
Sbjct: 261 VKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           + N +T      L+ +  +   D +   + 
Sbjct: 319 SQNHITDI--RPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 75.7 bits (187), Expect = 6e-15
 Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 7/97 (7%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           I NLT L S+ L  N I    P  L  L  L       N+ T   P  + ++  LN L++
Sbjct: 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
            NN +T      L+ +  LT +++  N +S  +  + 
Sbjct: 229 GNNKITDL--SPLANLSQLTWLEIGTNQIS-DINAVK 262

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 74.1 bits (183), Expect = 2e-14
 Identities = 23/91 (25%), Positives = 39/91 (42%), Gaps = 5/91 (5%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + NLTK+ S+ L  N  L    + L  +  L  L ++ +K     P  + +L +L  L L
Sbjct: 128 LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
           N N +       L+ + SL       N ++ 
Sbjct: 185 NYNQIEDI--SPLASLTSLHYFTAYVNQITD 213

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 73.7 bits (182), Expect = 3e-14
 Identities = 20/94 (21%), Positives = 38/94 (40%), Gaps = 5/94 (5%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + NL KL ++ +  N I     ++L  L  L+ L L+ +  +      L +L  +  L L
Sbjct: 84  LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNL 139

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
             N         LS +  L  + ++ + +    P
Sbjct: 140 GANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP 172

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 71.4 bits (176), Expect = 1e-13
 Identities = 23/123 (18%), Positives = 50/123 (40%), Gaps = 11/123 (8%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
              L  +  +++    +   I   +  L  L+ L+L+ N+ T   P  L +L  L  L +
Sbjct: 40  QEELESITKLVVAGEKVAS-IQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYI 95

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPKATN 209
             N +T     +L  + +L  + L+ +N+S  +  ++      +  +  N  +      +
Sbjct: 96  GTNKITD--ISALQNLTNLRELYLNEDNIS-DISPLANLTKMYSLNLGANHNLSDLSPLS 152

Query: 210 NCT 212
           N T
Sbjct: 153 NMT 155

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 68.3 bits (168), Expect = 1e-12
 Identities = 22/90 (24%), Positives = 39/90 (43%), Gaps = 6/90 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
             +L +    +LQ  ++   +     +LE +  L ++  K    I   +  L NL YL L
Sbjct: 18  DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNL 73

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           N N +T      LS +  LT + +  N ++
Sbjct: 74  NGNQITD--ISPLSNLVKLTNLYIGTNKIT 101

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 57.9 bits (141), Expect = 3e-09
 Identities = 11/88 (12%), Positives = 29/88 (32%), Gaps = 6/88 (6%)

Query: 100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
             ++      I    P     L +     L     T  +     +L ++  L +    + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 160 GSCPESLSKIESLTLVDLSYNNLSGSLP 187
               + +  + +L  ++L+ N ++   P
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQITDISP 83

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 47/210 (22%), Positives = 82/210 (39%), Gaps = 21/210 (10%)

Query: 300 TSNFSAK----NILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQ-FQTEVETIS 353
            + F+ +      LG+G F +V +      G   A   +    ++  + Q  + E     
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
           L  H N++RL    S E    L++  +  G     L + I  R     A           
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILE 121

Query: 414 GLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
            +L+ H+     ++HR++K  N+LL    +     + DFGLA  ++           GT 
Sbjct: 122 AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTP 177

Query: 471 GHIAPEYLSTGQSSEKTDVFGFG----ILL 496
           G+++PE L      +  D++  G    ILL
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILL 207

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 51/234 (21%), Positives = 90/234 (38%), Gaps = 19/234 (8%)

Query: 277 DQYDPEVSLGHLKRYTFKELRAATSNFSAK----NILGRGGFGIVYKGCF--SDGALVAV 330
           + YD        K+Y  + +     +          LG G FG+V++ C   + G +   
Sbjct: 24  NDYDKFYE-DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR-CVEKATGRVFVA 81

Query: 331 KRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
           K +            + E+  ++   H  L+ L      + E +L+  ++  G +  R+ 
Sbjct: 82  KFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140

Query: 391 DHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVVGD 448
              +     +     R A     GL ++HE     I+H D+K  NI+    +     + D
Sbjct: 141 AEDYKMSEAEVINYMRQACE---GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIID 194

Query: 449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
           FGLA  L+  D  V      T    APE +        TD++  G+L   L++G
Sbjct: 195 FGLATKLNP-DEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 49/217 (22%), Positives = 86/217 (39%), Gaps = 27/217 (12%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK-----RLKDYNIAGGEVQFQTEVETI 352
              +     LG G F IV K C   S G   A K     + +         + + EV  +
Sbjct: 11  EDFYDIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69

Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---DWARRKRIAL 409
              +H N++ L        + +L+   +  G     L D +  + +L   +     +  L
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQIL 125

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAV-VGDFGLAKLLDHRDSHVTTA 465
               G+ YLH +   KI H D+K  NI+L   +     + + DFGLA  ++         
Sbjct: 126 D---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNI 178

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
             GT   +APE ++      + D++  G++   L++G
Sbjct: 179 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 81.8 bits (203), Expect = 3e-17
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 33/217 (15%)

Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQ 346
           K + F E            +LG G F  V+        G L A+K +K  + A  +   +
Sbjct: 9   KTFIFME------------VLGSGAFSEVFL-VKQRLTGKLFALKCIKK-SPAFRDSSLE 54

Query: 347 TEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
            E+  +    H N++ L     +     LV   +  G     L D I  R          
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASL 110

Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVT 463
           +       + YLHE     I+HRD+K  N+L    +E+ + ++ DFGL+K+    +  ++
Sbjct: 111 VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMS 165

Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFG----ILL 496
           TA  GT G++APE L+    S+  D +  G    ILL
Sbjct: 166 TAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 54/229 (23%), Positives = 88/229 (38%), Gaps = 53/229 (23%)

Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
            +F     +G+G FG V             + A+K + K   +   EV+     E     
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVR-NVFKE----- 65

Query: 356 VHRNLLR------LCG--FCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
               +++      L    +   + E + +V   +  G     LR H+         +   
Sbjct: 66  --LQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGD----LRYHLQ--------QNVH 111

Query: 407 IALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
               T +         L YL  Q   +IIHRD+K  NILLDE     + DF +A +L   
Sbjct: 112 FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168

Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKT---DVFGFGILLLELITGQR 504
               T A  GT  ++APE  S+ + +  +   D +  G+   EL+ G+R
Sbjct: 169 TQITTMA--GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 32/218 (14%)

Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-F 345
             Y  KE             LG+G F +V + C   + G   A K +    ++  + Q  
Sbjct: 29  DNYDVKE------------ELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKL 75

Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
           + E        H N++RL      E+   LV+  +  G     L + I  R     A   
Sbjct: 76  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS 131

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHV 462
                    + Y H      I+HR++K  N+LL    +     + DFGLA  ++  DS  
Sbjct: 132 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEA 186

Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG----ILL 496
                GT G+++PE L     S+  D++  G    ILL
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 24/211 (11%)

Query: 300 TSNFSAK----NILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-FQTEVETI 352
           ++ FS        LG+G F +V + C   + G   A K +    ++  + Q  + E    
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 59

Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
               H N++RL      E+   LV+  +  G     L + I  R     A          
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQIL 115

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
             + Y H      I+HR++K  N+LL    +     + DFGLA  ++  DS       GT
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGT 170

Query: 470 VGHIAPEYLSTGQSSEKTDVFGFG----ILL 496
            G+++PE L     S+  D++  G    ILL
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 80.7 bits (200), Expect = 6e-17
 Identities = 65/279 (23%), Positives = 101/279 (36%), Gaps = 45/279 (16%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG G +G V           VAVK +            + E+    +  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 368 STENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK---RIALGTARGLLYLHEQC 422
              N + L   Y   G     L D I          A+R     +A     G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGI- 124

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH--RDSHVTTAVRGTVGHIAPEYLS- 479
              I HRD+K  N+LLDE     + DFGLA +  +  R+  +     GT+ ++APE L  
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181

Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
               +E  DV+  GI+L  ++ G   L +                  Q     Q      
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG--ELPW-----------------DQPSDSCQEYSDWK 222

Query: 540 KGNFDRIELEEMVQVA--LLCT--QFNPLHRPKMSEVLK 574
           +        +++      LL      NP  R  + ++ K
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 67/282 (23%), Positives = 119/282 (42%), Gaps = 56/282 (19%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           +G+G F  V        G  VA+K     +L   ++     +   EV  + +  H N+++
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ----KLFREVRIMKILNHPNIVK 78

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARGLLYLHE 420
           L     TE    L+  Y   G     + D++  HGR     AR K   + +A  + Y H+
Sbjct: 79  LFEVIETEKTLYLIMEYASGG----EVFDYLVAHGRMKEKEARSKFRQIVSA--VQYCHQ 132

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
           +    I+HRD+KA N+LLD D    + DFG +         +     G   + APE    
Sbjct: 133 KR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC-GAPPYAAPELFQ- 186

Query: 481 GQSSE--KTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
           G+  +  + DV+  G++L  L++G  +L F                      L ++ ++ 
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSG--SLPF------------------DGQNLKELRERV 226

Query: 539 LKGNFDRI------ELEEMVQVALLCTQFNPLHRPKMSEVLK 574
           L+G + RI      + E +++  L     NP+ R  + +++K
Sbjct: 227 LRGKY-RIPFYMSTDCENLLKRFL---VLNPIKRGTLEQIMK 264

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 80.3 bits (199), Expect = 7e-17
 Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 27/217 (12%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK-----RLKDYNIAGGEVQFQTEVETI 352
             ++     LG G F IV K C     G   A K     RL          + + EV  +
Sbjct: 4   EDHYEMGEELGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---DWARRKRIAL 409
               H N++ L      + + +L+   +  G     L D +  + +L   +  +  +  L
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQIL 118

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGLAKLLDHRDSHVTTA 465
               G+ YLH +   +I H D+K  NI+L      +    + DFG+A  ++   +     
Sbjct: 119 D---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNI 171

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
             GT   +APE ++      + D++  G++   L++G
Sbjct: 172 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 82.1 bits (203), Expect = 8e-17
 Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 37/228 (16%)

Query: 294 KELRAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQ-FQT 347
           ++LR    ++    ++GRG FG V     K       + A+K L K   I   +   F  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWE 118

Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           E + ++ A    +++L      +    +V  YMP G + + +                 +
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-------------NYDV 165

Query: 408 ALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
               AR         L  +H       IHRDVK  N+LLD+     + DFG    ++   
Sbjct: 166 PEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222

Query: 460 SHVTTAVRGTVGHIAPEYLSTGQSSEK----TDVFGFGILLLELITGQ 503
                   GT  +I+PE L +           D +  G+ L E++ G 
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 80.8 bits (200), Expect = 9e-17
 Identities = 47/194 (24%), Positives = 71/194 (36%), Gaps = 23/194 (11%)

Query: 306 KNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLR 362
           +++LG G    V   C         AVK ++         +   EVE +     HRN+L 
Sbjct: 18  EDVLGEGAHARVQT-CINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLE 75

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L  F   E+   LV+  M  GS    +  HIH R   +      +    A  L +LH + 
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGS----ILSHIHKRRHFNELEASVVVQDVASALDFLHNK- 130

Query: 423 DPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHV-------TTAVRGTVGH 472
              I HRD+K  NIL    ++     + DF L   +               T   G+  +
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEY 187

Query: 473 IAPEYLSTGQSSEK 486
           +APE +        
Sbjct: 188 MAPEVVEAFSEEAS 201

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 81.3 bits (201), Expect = 1e-16
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 14/205 (6%)

Query: 302 NFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
             S   ILG G FG V+K C   + G  +A K +K   +   E + + E+  ++   H N
Sbjct: 90  TVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHAN 147

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           L++L     ++N+ +LV  Y+  G +  R+ D  +    LD     +       G+ ++H
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMH 204

Query: 420 EQCDPKIIHRDVKAANILL--DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
           +     I+H D+K  NIL    +  +  + DFGLA+    R+  +     GT   +APE 
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFLAPEV 259

Query: 478 LSTGQSSEKTDVFGFGILLLELITG 502
           ++    S  TD++  G++   L++G
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSG 284

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 49/217 (22%), Positives = 86/217 (39%), Gaps = 27/217 (12%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK-----RLKDYNIAGGEVQFQTEVETI 352
              +     LG G F IV K C   S G   A K     + +         + + EV  +
Sbjct: 11  EDFYDIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69

Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---DWARRKRIAL 409
              +H N++ L        + +L+   +  G     L D +  + +L   +     +  L
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQIL 125

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAV-VGDFGLAKLLDHRDSHVTTA 465
               G+ YLH +   KI H D+K  NI+L   +     + + DFGLA  ++         
Sbjct: 126 D---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNI 178

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
             GT   +APE ++      + D++  G++   L++G
Sbjct: 179 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 24/114 (21%), Positives = 48/114 (42%), Gaps = 6/114 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI-PDSLGDLGNLNYLRLN 154
           +L  L  + + +             L  L+ L ++ N F     PD   +L NL +L L+
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS----GSLPKISA-RTFKVTGNPLIC 203
              L    P + + + SL +++++ N L     G   ++++ +   +  NP  C
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 23/129 (17%), Positives = 42/129 (32%), Gaps = 4/129 (3%)

Query: 58  TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI 114
            +   C        PD        L L    L    S    +  +LQ + L    I    
Sbjct: 10  ITYQ-CMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68

Query: 115 PASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTL 174
             +   L  L TL L+ N        +   L +L  L     +L       +  +++L  
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128

Query: 175 VDLSYNNLS 183
           +++++N + 
Sbjct: 129 LNVAHNLIQ 137

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 75.5 bits (186), Expect = 2e-14
 Identities = 25/109 (22%), Positives = 46/109 (42%), Gaps = 6/109 (5%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIPDSLGDLGN 147
           T+S     L +L+ +  Q++ +      S    L  L  LD+S+             L +
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446

Query: 148 LNYLRLNNNSLTGS-CPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           L  L++  NS   +  P+  +++ +LT +DLS   L     ++S   F 
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE----QLSPTAFN 491

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 24/108 (22%), Positives = 48/108 (44%), Gaps = 9/108 (8%)

Query: 93  WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-GEIPDSLGDLGNLNYL 151
               L+ LQ ++     +       +G L+ L+ L++++N     ++P+   +L NL +L
Sbjct: 95  AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154

Query: 152 RLNNNSLTGSCPESLSKIESLTLV----DLSYNNLSGSLPKISARTFK 195
            L++N +       L  +  + L+    DLS N ++     I    FK
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN----FIQPGAFK 198

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 1/95 (1%)

Query: 96  NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            L+ L+ + +  N+           +L  L  LDLS  +     P +   L +L  L + 
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMA 502

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
           +N L         ++ SL  + L  N    S P+I
Sbjct: 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 29/115 (25%), Positives = 48/115 (41%), Gaps = 6/115 (5%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGE 137
           L     +L+   +  IG+L  L+ + + +N I    +P     L  L+ LDLS+NK    
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164

Query: 138 IPDSLGDLGNLNY----LRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
               L  L  +      L L+ N +    P +  +I  L  + L  N  S ++ K
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMK 218

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 63.6 bits (155), Expect = 9e-11
 Identities = 19/80 (23%), Positives = 30/80 (37%), Gaps = 1/80 (1%)

Query: 85  SLSGTLSPWI-GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
           S      P I   L  L  + L    +    P +   L  LQ L++++N+          
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515

Query: 144 DLGNLNYLRLNNNSLTGSCP 163
            L +L  + L+ N    SCP
Sbjct: 516 RLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 27/93 (29%), Positives = 42/93 (45%), Gaps = 8/93 (8%)

Query: 97  LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156
               Q + L N       P    KL+ L+ L  ++NK       S  DL +L +L L+ N
Sbjct: 303 NFGWQHLELVNCKFGQ-FPT--LKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRN 357

Query: 157 SLT--GSCPESLSKIESLTLVDLSYNNLSGSLP 187
            L+  G C +S     SL  +DLS+N +  ++ 
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS 389

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 12/109 (11%)

Query: 94  IGNLTKLQSVL----LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNL 148
           +  L ++  +     L  N +   I     K  +L  L L NN  +  +    +  L  L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227

Query: 149 NYLRL------NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA 191
              RL      N  +L      +L  + +LT+ +     L   L  I  
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 14/105 (13%), Positives = 30/105 (28%), Gaps = 10/105 (9%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDL------SNNKFTGEIPDS 141
            + P      +L  + L+NN     +    +  L  L+   L      +          +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 142 LGDLGNLNYLRLNNNSLTGSC---PESLSKIESLTLVDLSYNNLS 183
           L  L NL         L        +  + + +++   L    + 
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 15/107 (14%), Positives = 32/107 (29%), Gaps = 5/107 (4%)

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
           +    +    + NLT  +  L   +  L  I      L  + +  L +      + D   
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY 302

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
           +     +L L N          L  ++ L     + N    +  ++ 
Sbjct: 303 NF-GWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAFSEVD 345

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 16/66 (24%), Positives = 27/66 (40%), Gaps = 9/66 (13%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR--L 153
           +L+ LQ + + +N +         +L  LQ + L  N +    P        ++YL   L
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR-------IDYLSRWL 544

Query: 154 NNNSLT 159
           N NS  
Sbjct: 545 NKNSQK 550

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 48/202 (23%), Positives = 79/202 (39%), Gaps = 27/202 (13%)

Query: 306 KNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
           K +LG G  G V + CF    G   A+K L D   A  EV    +      +   +++ +
Sbjct: 34  KQVLGLGVNGKVLE-CFHRRTGQKCALKLLYDSPKARQEVDHHWQ-----ASGGPHIVCI 87

Query: 364 CGFCSTENER----LLVYPYMPNGSVASRLRDHIHGRPALDWARRK--RIALGTARGLLY 417
                  +      L++   M  G     L   I  R    +  R+   I       + +
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGE----LFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143

Query: 418 LHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           LH      I HRDVK  N+L    ++D    + DFG AK      + + T    T  ++A
Sbjct: 144 LHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPC-YTPYYVA 197

Query: 475 PEYLSTGQSSEKTDVFGFGILL 496
           PE L   +  +  D++  G+++
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIM 219

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 46/216 (21%), Positives = 78/216 (36%), Gaps = 31/216 (14%)

Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQT 347
           + YT +              +GRG +G V            A K++  Y +   + +F+ 
Sbjct: 9   QYYTLEN------------TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQ 55

Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           E+E +    H N++RL        +  LV      G     L + +  +     +   RI
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARI 111

Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTT 464
                  + Y H+     + HRD+K  N L      D    + DFGLA         +  
Sbjct: 112 MKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMR 166

Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFG----ILL 496
              GT  +++P+ L  G    + D +  G    +LL
Sbjct: 167 TKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLL 201

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 51/208 (24%), Positives = 79/208 (37%), Gaps = 27/208 (12%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVK-----RLKDYNIAGGEV--QFQTEVETISLAVHRNL 360
           LG G FG V+          V VK     ++ +          +   E+  +S   H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK--RIALGTARGLL 416
           +++      +    LV     +G     L   I  H R     A     ++         
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLVSAVG---- 144

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           YL  +    IIHRD+K  NI++ EDF   + DFG A  L  R     T   GT+ + APE
Sbjct: 145 YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEYCAPE 199

Query: 477 YLSTGQSSE--KTDVFGFGILLLELITG 502
            L  G      + +++  G+ L  L+  
Sbjct: 200 VLM-GNPYRGPELEMWSLGVTLYTLVFE 226

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 81.8 bits (202), Expect = 2e-16
 Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 14/230 (6%)

Query: 277 DQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLK 334
           D Y  ++   +  +    +      ++     LG G FG+V++     + G   A K + 
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR-VTERATGNNFAAKFVM 191

Query: 335 DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH 394
             + +  E   + E++T+S+  H  L+ L      +NE +++Y +M  G +  ++ D  +
Sbjct: 192 TPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250

Query: 395 GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV--GDFGLA 452
                +     R       GL ++HE      +H D+K  NI+        +   DFGL 
Sbjct: 251 KMSEDEAVEYMRQVCK---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLT 304

Query: 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
             LD + S V     GT    APE          TD++  G+L   L++G
Sbjct: 305 AHLDPKQS-VKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.9 bits (190), Expect = 2e-16
 Identities = 17/97 (17%), Positives = 39/97 (40%), Gaps = 2/97 (2%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           I     ++ + + N       P  +  L  L+ L +     T +   +L  L +L  L +
Sbjct: 62  IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
           ++++   S    ++ +  +  +DLSYN     +  + 
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLK 156

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 69.6 bits (171), Expect = 8e-14
 Identities = 18/91 (19%), Positives = 34/91 (37%), Gaps = 3/91 (3%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +  LT L  + + ++A    I   +  L K+ ++DLS N    +I   L  L  L  L +
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNI 166

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
             + +       +     L  +      + G
Sbjct: 167 QFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 8/97 (8%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
              +  L  + L N  +  L      +     ++ L ++N   T   P  +  L NL  L
Sbjct: 40  EAQMNSLTYITLANINVTDLTG----IEYAHNIKDLTINNIHATNYNP--ISGLSNLERL 93

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           R+    +T     +LS + SLTL+D+S++    S+  
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.1 bits (136), Expect = 3e-09
 Identities = 14/93 (15%), Positives = 35/93 (37%), Gaps = 7/93 (7%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
                 + LL  ++    I  +  ++  L  + L+N   T ++   +    N+  L +NN
Sbjct: 21  TFKAYLNGLLGQSST-ANI--TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
              T      +S + +L  + +   +++     
Sbjct: 76  IHATNY--NPISGLSNLERLRIMGKDVTSDKIP 106

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 63/265 (23%), Positives = 106/265 (40%), Gaps = 38/265 (14%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG G +G V           VAVK +            + E+    +  H N+++  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 368 STENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK---RIALGTARGLLYLHEQC 422
              N + L   Y   G     L D I          A+R     +A     G++YLH   
Sbjct: 75  REGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGI- 124

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH--RDSHVTTAVRGTVGHIAPEYLS- 479
              I HRD+K  N+LLDE     + DFGLA +  +  R+  +     GT+ ++APE L  
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181

Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK---------KLHQEGK 530
               +E  DV+  GI+L  ++ G   L + + ++      DW +         K+     
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG--ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239

Query: 531 --LSQMVDKDLKGNFDRIELEEMVQ 553
             L +++ ++      RI + ++ +
Sbjct: 240 ALLHKILVENPS---ARITIPDIKK 261

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 19/205 (9%)

Query: 309 LGRGGFGIVYKGCFSD-GALVAVK---RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           LG G +G V +   S+     AVK   + K   I  GE   + E++ +    H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 365 GFCSTENER--LLVYPYMPNGSVASRLRDHI-HGRPALDWARRKRIALGTARGLLYLHEQ 421
                E ++   +V  Y   G     + D +   R  +  A      L    GL YLH Q
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFPVCQAHGYFCQL--IDGLEYLHSQ 128

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR--DSHVTTAVRGTVGHIAPEYLS 479
               I+H+D+K  N+LL       +   G+A+ L     D    T+ +G+     PE  +
Sbjct: 129 ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEIAN 184

Query: 480 TGQ--SSEKTDVFGFGILLLELITG 502
                S  K D++  G+ L  + TG
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTG 209

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 26/222 (11%)

Query: 297 RAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R     F  + + G+G FG V  G   S G  VA+K+ ++D      E+Q    ++ +++
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAV 75

Query: 355 AVHRNLLRLCGFCSTENER-------LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
             H N+++L  +  T  ER        +V  Y+P+ ++    R++   + A      K  
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134

Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVTTAV 466
                R +  LH      + HRD+K  N+L++  D    + DFG AK L   + +V    
Sbjct: 135 LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193

Query: 467 ----RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
               R      APE +   Q  +   D++  G +  E++ G+
Sbjct: 194 SRYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 79.8 bits (197), Expect = 4e-16
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 30/221 (13%)

Query: 297 RAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
           R    +++   ++G G FG+VY+      G LVA+K+ L+D      E+Q   +++    
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 105

Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
             H N++RL  F  +  E+       LV  Y+P  +V    R +   +  L     K   
Sbjct: 106 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 162

Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAV- 466
               R L Y+H      I HRD+K  N+LLD D   + + DFG AK L   + +V+    
Sbjct: 163 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219

Query: 467 ---RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
              R      APE +      +   DV+  G +L EL+ GQ
Sbjct: 220 RYYR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 27/217 (12%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK-----RLKDYNIAGGEVQFQTEVETI 352
              +     LG G F +V K C   S G   A K     R K           + EV  +
Sbjct: 10  DDYYDTGEELGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68

Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---DWARRKRIAL 409
               H N++ L      + + +L+   +  G     L D +  + +L   +     +  L
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQIL 124

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGLAKLLDHRDSHVTTA 465
               G+ YLH     +I H D+K  NI+L           + DFGLA  +D   +     
Sbjct: 125 N---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI 177

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
             GT   +APE ++      + D++  G++   L++G
Sbjct: 178 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 26/212 (12%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-------FQTEVE 350
              +     LG G  G V    F       VA+K +     A G  +        +TE+E
Sbjct: 9   RDEYIMSKTLGSGACGEVKL-AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67

Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
            +    H  ++++  F   E+   +V   M  G     L D + G   L  A  K     
Sbjct: 68  ILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQ 122

Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
               + YLHE     IIHRD+K  N+LL   +ED    + DFG +K+L   ++ +   + 
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLC 177

Query: 468 GTVGHIAPEYLSTGQS---SEKTDVFGFGILL 496
           GT  ++APE L +  +   +   D +  G++L
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 28/204 (13%), Positives = 55/204 (26%), Gaps = 44/204 (21%)

Query: 309 LGRGGFGIVYKGCFSDGAL---VAVKRLK-DYNIAGGEVQ-FQTEVETISLAVHRNLLRL 363
            G       ++    D AL   VA+  +     +    +Q   +    +S      + R+
Sbjct: 39  HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
                T    L+V  ++  GS    L++     P+   A R       A      H    
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGS----LQEVADTSPSPVGAIR--AMQSLAAAADAAHRA-- 148

Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
             +       + + +  D + V+         + +                         
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQ------------------------- 182

Query: 484 SEKTDVFGFGILLLELITGQRALD 507
               D+ G G  L  L+  +  L 
Sbjct: 183 ---DDIRGIGASLYALLVNRWPLP 203

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 36/217 (16%)

Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISL 354
             F     LG G FG V     K     G   A+K L K   +   +++    E   +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97

Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR- 413
                L++L       +   +V  Y+  G + S LR            R  R +   AR 
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145

Query: 414 -------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
                     YLH      +I+RD+K  N+L+D+     V DFG AK +  R    T  +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTL 198

Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            GT   +APE + +   ++  D +  G+L+ E+  G 
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 79.9 bits (196), Expect = 1e-15
 Identities = 66/394 (16%), Positives = 118/394 (29%), Gaps = 103/394 (26%)

Query: 264 RYRHNQQIFFDVNDQYDPEVSLGHLKRY-TFKELRAATSNF-SAKNIL--GRGGFGIVYK 319
            Y   +   ++ N  +       ++ R   + +LR A      AKN+L  G  G G   K
Sbjct: 111 MYIEQRDRLYNDNQVFAK----YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K 163

Query: 320 GCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL----- 374
                   VA+     Y +   + +   ++  ++L            C++    L     
Sbjct: 164 TW------VALDVCLSYKV---QCKMDFKIFWLNL----------KNCNSPETVLEMLQK 204

Query: 375 LVYPYMPNGSV----ASRLRDHIHGRPALDWARRKRIALGT---ARGLLYLHEQCDPKII 427
           L+Y   PN +     +S ++  IH           R  L +      LL L    + K  
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIH-----SIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG-TVGHIAPEYLSTGQSSEK 486
                         F     +     LL  R   VT  +   T  HI+ ++ S   + ++
Sbjct: 260 ------------NAF-----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302

Query: 487 T-DVFG--FGI--------------LLLELITGQRALDF-GRAANQRGVMLDWVKKLHQE 528
              +                       L +I  +   D      N + V  D +  +  E
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNPRRLSII-AESIRDGLATWDNWKHVNCDKLTTI-IE 360

Query: 529 GKLSQMVDKDLKGNFDRIE-LEEMVQV--ALLCTQFNPLHRPKMSEVLKMLEGDGLAEKW 585
             L+ +   + +  FDR+        +   LL   +  + +  +  V+  L    L EK 
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420

Query: 586 EASQKIETP------------RYRTHEK---RYS 604
                I  P             Y  H      Y+
Sbjct: 421 PKESTISIPSIYLELKVKLENEYALHRSIVDHYN 454

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.5 bits (117), Expect = 3e-06
 Identities = 72/442 (16%), Positives = 134/442 (30%), Gaps = 142/442 (32%)

Query: 8   FW-------RVGFLVLALIDICY--------ATLSPAGINYEVVALVAVKNNL--HDPYN 50
           FW           ++  L  + Y         +   + I   + ++ A    L    PY 
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244

Query: 51  ----VLEN-WDITSVDP----CSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQ 101
               VL N  +  + +     C  +++  +    V+     + +   +L      LT  +
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSC--KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302

Query: 102 SV-LLQNNAILGPIPASLGKLEKLQT--LDLSNNKFTGEIPDSLGDLGNL--NYLRLNNN 156
              LL     L   P  L   E L T    LS       I +S+ D      N+  +N +
Sbjct: 303 VKSLLLK--YLDCRPQDL-PREVLTTNPRRLS------IIAESIRDGLATWDNWKHVNCD 353

Query: 157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFP 216
            LT             T+++ S N L    P    + F                  +VFP
Sbjct: 354 KLT-------------TIIESSLNVLE---PAEYRKMFD--------------RL-SVFP 382

Query: 217 EPLSLPPNGLK---------DQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWLRYR- 266
               +P   L          D      K H+ ++       +   +       ++L  + 
Sbjct: 383 PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI-----PSIYLELKV 437

Query: 267 --------HNQQI-------FFDVNDQYDPEVS------LG-HLKR-------------- 290
                   H   +        FD +D   P +       +G HLK               
Sbjct: 438 KLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF 497

Query: 291 --YTF--KELRAATSNFSAK----NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGE 342
             + F  +++R  ++ ++A     N L +  F   YK    D      + +         
Sbjct: 498 LDFRFLEQKIRHDSTAWNASGSILNTLQQLKF---YKPYICDNDPKYERLVNAI------ 548

Query: 343 VQFQTEVETISL-AVHRNLLRL 363
           + F  ++E   + + + +LLR+
Sbjct: 549 LDFLPKIEENLICSKYTDLLRI 570

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 5e-05
 Identities = 67/497 (13%), Positives = 134/497 (26%), Gaps = 167/497 (33%)

Query: 12  GFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITC- 70
            FL+  +        S     Y     +  ++ L++   V   ++++ + P   ++    
Sbjct: 92  KFLMSPIKTEQRQP-SMMTRMY-----IEQRDRLYNDNQVFAKYNVSRLQP-YLKLRQAL 144

Query: 71  ---SPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVL----LQNNAILGPIP-----ASL 118
               P   V   G+      G      G   K  + +      +  +   +       +L
Sbjct: 145 LELRPAKNVLIDGVL-----G-----SG---K--TWVALDVCLSYKVQCKMDFKIFWLNL 189

Query: 119 GK-------LEKLQTL-------DLSNNKFTGEIPDSLGDL-GNLNYL---RLNNNSL-- 158
                    LE LQ L         S +  +  I   +  +   L  L   +   N L  
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249

Query: 159 -------------TGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICG- 204
                          SC           L+   +  ++  L   +A T  ++ +      
Sbjct: 250 LLNVQNAKAWNAFNLSCK---------ILLTTRFKQVTDFL--SAATTTHISLDHHSMTL 298

Query: 205 -PKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWL 263
            P       ++  + L   P  L  +  +    +   +++      +    I  GL  W 
Sbjct: 299 TPDEV---KSLLLKYLDCRPQDLPREVLTT---NPRRLSI---IAES----IRDGLATWD 345

Query: 264 RYRHNQQIFFDVNDQYDP--EVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGC 321
            ++H         D+     E SL  L+   ++++      F            +     
Sbjct: 346 NWKHVN------CDKLTTIIESSLNVLEPAEYRKM------FDR--------LSV----- 380

Query: 322 FSDGALVAVKRLKDY--NIAGGEVQ-FQTEVETISLA----------VHRNLLRLCGFCS 368
           F   A +    L     ++   +V     ++   SL           +    L L     
Sbjct: 381 FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK--VK 438

Query: 369 TENE----RLLV--YP----YMPNGSVASRLRD----HI--HGRPA-------------- 398
            ENE    R +V  Y     +  +  +   L      HI  H +                
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL 498

Query: 399 -LDWARRKRIALGTARG 414
              +  +K     TA  
Sbjct: 499 DFRFLEQKIRHDSTAWN 515

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 25/118 (21%), Positives = 46/118 (38%), Gaps = 14/118 (11%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
            +SP +  LT L ++ L  N +    P  +  L+ L  L L  N  +   P  +  L  L
Sbjct: 279 NISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKL 333

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS-----GSLPKISARTFKVTGNPL 201
             L   NN ++     SL+ + ++  +   +N +S      +L +I      +     
Sbjct: 334 QRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRI--TQLGLNDQAW 387

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + NLT L+ + + +N +       L KL  L++L  +NN+ +   P  LG L NL+ L L
Sbjct: 173 LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           N N L      +L+ + +LT +DL+ N +S   P
Sbjct: 229 NGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 76.2 bits (188), Expect = 7e-15
 Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 6/94 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +G LT L  + L  N +       L  L  L  LDL+NN+ +   P  L  L  L  L+L
Sbjct: 217 LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 272

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
             N ++      L+ + +LT ++L+ N L    P
Sbjct: 273 GANQISNI--SPLAGLTALTNLELNENQLEDISP 304

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 7/94 (7%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + NLTKL  +L+ NN I    P  L  L  L  L L NN+ T   P  L +L NLN L L
Sbjct: 86  LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLEL 141

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           ++N+++     +LS + SL  +    N ++   P
Sbjct: 142 SSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP 172

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 21/99 (21%), Positives = 43/99 (43%), Gaps = 5/99 (5%)

Query: 92  PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
             + NLT +  +   +N I    P  L  L ++  L L++  +T    +   ++   N +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
           +    +L    P ++S   S T  D+++N  S    ++S
Sbjct: 405 KNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVS 440

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 72.7 bits (179), Expect = 9e-14
 Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 7/91 (7%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + NLT L  + L NN I    P  L  L  L  L+LS+N  +     +L  L +L  L  
Sbjct: 108 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF 163

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
            N        + L+ + +L  +D+S N +S 
Sbjct: 164 GNQVTD---LKPLANLTTLERLDISSNKVSD 191

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 71.9 bits (177), Expect = 2e-13
 Identities = 23/106 (21%), Positives = 46/106 (43%), Gaps = 8/106 (7%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
             L   +++ T+S    +L ++ ++      I       +  L  L  ++ SNN+ T   
Sbjct: 29  TVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDIT 84

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
           P  L +L  L  + +NNN +       L+ + +LT + L  N ++ 
Sbjct: 85  P--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD 126

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 70.4 bits (173), Expect = 6e-13
 Identities = 16/91 (17%), Positives = 32/91 (35%), Gaps = 6/91 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
              L +    +L    +   +      L+++ TL            D +  L NL  +  
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINF 75

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
           +NN LT      L  +  L  + ++ N ++ 
Sbjct: 76  SNNQLTDI--TPLKNLTKLVDILMNNNQIAD 104

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 61.9 bits (151), Expect = 3e-10
 Identities = 13/83 (15%), Positives = 29/83 (34%), Gaps = 6/83 (7%)

Query: 102 SVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGS 161
           + + Q+  I          L +     L     T  +     DL  +  L+ +   +   
Sbjct: 6   ATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS- 60

Query: 162 CPESLSKIESLTLVDLSYNNLSG 184
             + +  + +LT ++ S N L+ 
Sbjct: 61  -IDGVEYLNNLTQINFSNNQLTD 82

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 78.4 bits (193), Expect = 2e-15
 Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 3/94 (3%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
             N  + +   + ++++   + +       ++ LDLS N  +      L     L  L L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           ++N L       L  + +L  +DL+ N +   L 
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL 96

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 11/117 (9%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
             +   SL   L+    +   ++ + L  N +     A L    KL+ L+LS+N    E 
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
            D L  L  L  L LNNN +       L    S+  +  + NN+S    ++S    +
Sbjct: 74  LD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS----RVSCSRGQ 120

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 19/124 (15%), Positives = 41/124 (33%), Gaps = 9/124 (7%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
              KL+++ L +N +   +         +  + L NNK    I  +L    NL +  L  
Sbjct: 189 VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVF 215
           N             ++  +  ++      ++ K++ +  +    P +        C    
Sbjct: 247 NGFHCGTLRDF-FSKNQRVQTVAKQ----TVKKLTGQNEEECTVPTL--GHYGAYCCEDL 299

Query: 216 PEPL 219
           P P 
Sbjct: 300 PAPF 303

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 18/90 (20%), Positives = 35/90 (38%), Gaps = 8/90 (8%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + +L+ L+++ L NN +       L     ++TL  +NN  +  +  S         + L
Sbjct: 76  LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYL 127

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            NN +T            +  +DL  N + 
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 67.6 bits (165), Expect = 4e-12
 Identities = 19/96 (19%), Positives = 39/96 (40%), Gaps = 5/96 (5%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +     ++++   NN I   +  S    +  + + L+NNK T       G    + YL L
Sbjct: 95  LLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151

Query: 154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPK 188
             N +   +  E  +  ++L  ++L YN +   +  
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 13/149 (8%), Positives = 40/149 (26%), Gaps = 10/149 (6%)

Query: 52  LENWDITSVDPCSWRMITCSPDGYVSALGLPSQS---LSGTLSPWIGNLTKLQSVLLQNN 108
            +N  + +V   + + +T   +   +   L            +P+   L  L+       
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318

Query: 109 AI----LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP- 163
           +        +        + + +D    ++   I            L     +L      
Sbjct: 319 SGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN 378

Query: 164 --ESLSKIESLTLVDLSYNNLSGSLPKIS 190
              + ++++      +    L  +  + S
Sbjct: 379 GRRAHAELDGTLQQAVGQIELQHATEEQS 407

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 7/126 (5%), Positives = 25/126 (19%), Gaps = 6/126 (4%)

Query: 81  LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL-----QTLDLSNNKFT 135
           +  Q++           T                     +L  L       L    ++  
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE 326

Query: 136 GEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
             +     +      +            +   + ++   ++     L   +        +
Sbjct: 327 -RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385

Query: 196 VTGNPL 201
           + G   
Sbjct: 386 LDGTLQ 391

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.8 bits (106), Expect = 6e-05
 Identities = 12/58 (20%), Positives = 22/58 (37%), Gaps = 4/58 (6%)

Query: 138 IPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           I +   +       ++ ++SL  +         ++  +DLS N LS     ISA    
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ----ISAADLA 55

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 3/94 (3%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
             N  + +   + ++++   + +       ++ LDLS N  +      L     L  L L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           ++N L       L  + +L  +DL+ N +   L 
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL 96

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 11/117 (9%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
             +   SL   L+    +   ++ + L  N +     A L    KL+ L+LS+N    E 
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73

Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
            D L  L  L  L LNNN +       L    S+  +  + NN+S    ++S    +
Sbjct: 74  LD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS----RVSCSRGQ 120

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 19/133 (14%), Positives = 39/133 (29%), Gaps = 10/133 (7%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
            +   +    KL+++ L +N +   +         +  + L NNK    I  +L    NL
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKAT 208
            +  L  N             ++  +  ++   +   L   +     V            
Sbjct: 240 EHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHY-----G 292

Query: 209 NNCTAVFPEPLSL 221
             C    P P + 
Sbjct: 293 AYCCEDLPAPFAD 305

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 68.5 bits (168), Expect = 9e-13
 Identities = 19/96 (19%), Positives = 39/96 (40%), Gaps = 5/96 (5%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +     ++++   NN I   +  S    +  + + L+NNK T       G    + YL L
Sbjct: 95  LLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151

Query: 154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPK 188
             N +   +  E  +  ++L  ++L YN +   +  
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 19/90 (21%), Positives = 36/90 (40%), Gaps = 8/90 (8%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + +L+ L+++ L NN +       L     ++TL  +NN  +  +  S G       + L
Sbjct: 76  LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYL 127

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            NN +T            +  +DL  N + 
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 12/58 (20%), Positives = 23/58 (39%), Gaps = 4/58 (6%)

Query: 138 IPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           I +   +       ++ ++SL  +         ++  +DLS N LS    +ISA    
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS----QISAADLA 55

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 29/217 (13%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISLAVHR 358
              ++   ++G G FG+V++    +   VA+K+ L+D      E+Q    V+      H 
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK------HP 92

Query: 359 NLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
           N++ L  F  +  ++       LV  Y+P  +V    R +   +  +     K       
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL 151

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAV----R 467
           R L Y+H      I HRD+K  N+LLD     + + DFG AK+L   + +V+       R
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208

Query: 468 GTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
                 APE +    + +   D++  G ++ EL+ GQ
Sbjct: 209 ------APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 47/228 (20%)

Query: 301 SNFSAKNILGRGGFGIVY---KGCFSD-GALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
            NF    +LG G +G V+   K    D G L A+K L K   +   +    T  E     
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE----- 108

Query: 356 VHRNLLRLCG---------FCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             R +L             +      +L L+  Y+  G + + L             +R+
Sbjct: 109 --RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS------------QRE 154

Query: 406 RIALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
           R      +         L +LH+     II+RD+K  NILLD +   V+ DFGL+K    
Sbjct: 155 RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211

Query: 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV--FGFGILLLELITGQ 503
            ++       GT+ ++AP+ +  G S     V  +  G+L+ EL+TG 
Sbjct: 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 25/206 (12%)

Query: 309 LGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-FQTEVETI-SLAVHRNLLRLC 364
           LGRG F +V + C   S G   A K LK              E+  +        ++ L 
Sbjct: 37  LGRGKFAVVRQ-CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-----LDWARRKRIALGTARGLLYLH 419
                 +E +L+  Y   G     +        A      D  R  +  L    G+ YLH
Sbjct: 96  EVYENTSEIILILEYAAGGE----IFSLCLPELAEMVSENDVIRLIKQILE---GVYYLH 148

Query: 420 EQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
           +     I+H D+K  NILL       +  + DFG+++ + H    +   + GT  ++APE
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-ACELREIM-GTPEYLAPE 203

Query: 477 YLSTGQSSEKTDVFGFGILLLELITG 502
            L+    +  TD++  GI+   L+T 
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTH 229

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 37/224 (16%)

Query: 297 RAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVET 351
           +A  S F    +LG+G FG V+            L A+K L K        V+ + E + 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79

Query: 352 ISLAVHRNLLRLCGFCS--TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
           +    H  +++L    +  TE  +L L+  ++  G     L   +         +     
Sbjct: 80  LVEVNHPFIVKL--HYAFQTE-GKLYLILDFLRGGD----LFTRLS--------KEVMFT 124

Query: 409 LGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460
               +         L +LH      II+RD+K  NILLDE+    + DFGL+K       
Sbjct: 125 EEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHE 180

Query: 461 HVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
               +  GTV ++APE +   +   ++ D + FG+L+ E++TG 
Sbjct: 181 KKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGT 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.1 bits (192), Expect = 3e-15
 Identities = 71/247 (28%), Positives = 102/247 (41%), Gaps = 24/247 (9%)

Query: 267 HNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIV----YKGCF 322
              +I        +   +            R   ++F+   +LG+G FG V     KG  
Sbjct: 307 ERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG-- 364

Query: 323 SDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRN---LLRLCGFCSTENERL-LVY 377
               L AVK L KD  I   +V+  T VE   LA+      L +L   C    +RL  V 
Sbjct: 365 -TDELYAVKILKKDVVIQDDDVE-CTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVM 421

Query: 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANIL 437
            Y+  G     L  HI              A   A GL +L  +    II+RD+K  N++
Sbjct: 422 EYVNGGD----LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVM 474

Query: 438 LDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILL 496
           LD +    + DFG+ K  +  D   T    GT  +IAPE +   Q   K+ D + FG+LL
Sbjct: 475 LDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLL 532

Query: 497 LELITGQ 503
            E++ GQ
Sbjct: 533 YEMLAGQ 539

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 19/172 (11%)

Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTA 465
            +   A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     +V    
Sbjct: 198 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL 525
            R  +  +APE +     + ++DV+ FG+LL E+ +   +   G   ++     ++ ++L
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRL 309

Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            +  ++                  EM Q  L C    P  RP  SE+++ L 
Sbjct: 310 KEGTRMRAPDYTT----------PEMYQTMLDCWHGEPSQRPTFSELVEHLG 351

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 65/296 (21%), Positives = 114/296 (38%), Gaps = 75/296 (25%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVK-------------------------RLKDYNIAGGE 342
           +G+G +G+V      +D    A+K                                 G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 343 VQFQTEVETISLAVHRNLLRLCGF----CSTENERLLVYPYMPNGSVASRLRDHIHGRPA 398
            Q   E+  +    H N+++L          E+   +V+  +  G V             
Sbjct: 81  EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV------------- 125

Query: 399 LDWARRKRIALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450
           ++    K ++   AR        G+ YLH Q   KIIHRD+K +N+L+ ED    + DFG
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQ---- 503
           ++      D+ ++  V GT   +APE LS  +   S +  DV+  G+ L   + GQ    
Sbjct: 183 VSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

Query: 504 ----RALDFGRAANQRGVMLDWVKKLHQEGK--LSQMVDKDLKGNFDRIELEEMVQ 553
                 L   +  +Q     D    + ++ K  +++M+DK+ +    RI + E+  
Sbjct: 242 DERIMCL-HSKIKSQALEFPDQP-DIAEDLKDLITRMLDKNPE---SRIVVPEIKL 292

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 76.3 bits (188), Expect = 6e-15
 Identities = 47/202 (23%), Positives = 77/202 (38%), Gaps = 26/202 (12%)

Query: 306 KNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
             +LG G  G V +  F        A+K L+D   A  EV+          +   +++R+
Sbjct: 67  SQVLGLGINGKVLQ-IFNKRTQEKFALKMLQDCPKARREVELHWR-----ASQCPHIVRI 120

Query: 364 CGFC----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK--RIALGTARGLLY 417
                   +     L+V   +  G     L   I  R    +  R+   I       + Y
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 418 LHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           LH      I HRDVK  N+L      +    + DFG AK      + +TT    T  ++A
Sbjct: 177 LHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-HNSLTTPC-YTPYYVA 231

Query: 475 PEYLSTGQSSEKTDVFGFGILL 496
           PE L   +  +  D++  G+++
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIM 253

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 75.3 bits (186), Expect = 6e-15
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 36/217 (16%)

Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISL 354
            +F     LG G FG V+    +    +G   A+K L K+  +   +V+    E   +S+
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR- 413
             H  ++R+ G      +  ++  Y+  G + S LR            + +R     A+ 
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR------------KSQRFPNPVAKF 110

Query: 414 -------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
                   L YLH +    II+RD+K  NILLD++    + DFG AK +       T  +
Sbjct: 111 YAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTL 163

Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            GT  +IAPE +ST   ++  D + FGIL+ E++ G 
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 76.3 bits (188), Expect = 7e-15
 Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 24/213 (11%)

Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
           + F    +LG+G FG V     K     G   A+K L K+  +A  EV   T  E   L 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQ 203

Query: 356 VHRN--LLRLCGFCS--TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
             R+  L  L    S  T +    V  Y   G     L  H+         R +      
Sbjct: 204 NSRHPFLTAL--KYSFQTHDRLCFVMEYANGGE----LFFHLSRERVFSEDRARFYGAEI 257

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
              L YLH + +  +++RD+K  N++LD+D    + DFGL K    +D        GT  
Sbjct: 258 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE 314

Query: 472 HIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
           ++APE L       +  D +G G+++ E++ G+
Sbjct: 315 YLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 346

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 74.5 bits (184), Expect = 8e-15
 Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 33/224 (14%)

Query: 299 ATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISL-- 354
           ATS +     +G G +G VYK      G  VA+K ++  N  GG      + V  ++L  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 355 ----AVHRNLLRLCGFCSTENERL-----LVYPYMPNGSVASRLRDHI--HGRPALDWAR 403
                 H N++RL   C+T          LV+ ++        LR ++     P L    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-----QDLRTYLDKAPPPGLPAET 121

Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL--LDHRDSH 461
            K +     RGL +LH      I+HRD+K  NIL+       + DFGLA++       + 
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

Query: 462 --VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
             VT   R      APE L     +   D++  G +  E+   +
Sbjct: 179 VVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 58/219 (26%), Positives = 86/219 (39%), Gaps = 38/219 (17%)

Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQT 347
             +  +              LGRG   IVY+          A+K LK       +   +T
Sbjct: 53  DFFEVES------------ELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRT 97

Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---DWARR 404
           E+  +    H N+++L     T  E  LV   +  G     L D I  +      D A  
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE----LFDRIVEKGYYSERDAADA 153

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSH 461
            +  L     + YLHE     I+HRD+K  N+L      D    + DFGL+K+++H    
Sbjct: 154 VKQILE---AVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVL 206

Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG----ILL 496
           + T   GT G+ APE L       + D++  G    ILL
Sbjct: 207 MKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 22/116 (18%), Positives = 47/116 (40%), Gaps = 8/116 (6%)

Query: 92  PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
            W+ N   L  V L  N +   +     K+++L+ L +SNN+    +      +  L  L
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS----GSLPKISARTFKVTGNPLIC 203
            L++N L      +  + + L  + L +N++      +   +  +   ++ N   C
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTL--KNLTLSHNDWDC 353

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 20/118 (16%), Positives = 44/118 (37%), Gaps = 6/118 (5%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           + +  Q+           L   + V  +N+ +     A L    +++ L+L++ +   EI
Sbjct: 26  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84

Query: 139 P-DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
              +      +  L +  N++    P     +  LT++ L  N+LS     +    F 
Sbjct: 85  DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS----SLPRGIFH 138

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 20/101 (19%), Positives = 36/101 (35%), Gaps = 4/101 (3%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            +  +++ + L +  I      +      +Q L +  N      P    ++  L  L L 
Sbjct: 66  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
            N L+            LT + +S NNL     +I   TF+
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLE----RIEDDTFQ 162

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 22/94 (23%), Positives = 40/94 (42%), Gaps = 4/94 (4%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
               +L  + LQ+N +       L     L  +DLS N+    +      +  L  L ++
Sbjct: 223 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           NN L  +       I +L ++DLS+N+L   + +
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 312

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 63.5 bits (155), Expect = 7e-11
 Identities = 21/101 (20%), Positives = 45/101 (44%), Gaps = 12/101 (11%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            N  KL ++ + NN +      +      LQ L LS+N+ T  +  SL  + +L +  ++
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVS 194

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
            N L+     +L+   ++  +D S+N+++     +      
Sbjct: 195 YNLLS-----TLAIPIAVEELDASHNSIN----VVRGPVNV 226

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 30/106 (28%), Positives = 46/106 (43%), Gaps = 3/106 (2%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
           N+  L  ++L+ N +            KL TL +SNN       D+     +L  L+L++
Sbjct: 115 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 174

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201
           N LT      LS I SL   ++SYN LS     I+      + N +
Sbjct: 175 NRLTHV---DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI 217

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 60.4 bits (147), Expect = 7e-10
 Identities = 16/90 (17%), Positives = 37/90 (41%), Gaps = 5/90 (5%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
            L+ +   +  L+ + L +N +L  +  +  + ++L+ L L +N     +   L     L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 341

Query: 149 NYLRLNNNSLTGSCPESL-SKIESLTLVDL 177
             L L++N    +   +L   +    + D 
Sbjct: 342 KNLTLSHNDWDCNSLRALFRNVARPAVDDA 371

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 6/94 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +     ++ +   +N+I   +   +    +L  L L +N  T +    L +   L  + L
Sbjct: 201 LAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDL 255

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           + N L         K++ L  + +S N L  +L 
Sbjct: 256 SYNELEKIMYHPFVKMQRLERLYISNNRLV-ALN 288

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 9/100 (9%), Positives = 26/100 (26%), Gaps = 4/100 (4%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
                  V +               L   + +   N+         L     +  L LN+
Sbjct: 19  YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 78

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
             +      + +   ++  + + +N +      +    F+
Sbjct: 79  LQIEEIDTYAFAYAHTIQKLYMGFNAIR----YLPPHVFQ 114

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 11/88 (12%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
             T LQ++ L +N +   +  SL  +  L   ++S N  +     +L     +  L  ++
Sbjct: 163 ATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASH 214

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
           NS+         ++  L    L +NNL+
Sbjct: 215 NSINVVRGPVNVELTIL---KLQHNNLT 239

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 10/82 (12%), Positives = 24/82 (29%), Gaps = 4/82 (4%)

Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
           I ++L        + +               L N   +   N+++       L     + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 174 LVDLSYNNLSGSLPKISARTFK 195
           L++L+   +     +I    F 
Sbjct: 73  LLNLNDLQIE----EIDTYAFA 90

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 45/212 (21%), Positives = 82/212 (38%), Gaps = 25/212 (11%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAV 356
              +     LGRG FGIV++ C   S       K +K   + G +    + E+  +++A 
Sbjct: 4   YEKYMIAEDLGRGEFGIVHR-CVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIAR 59

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA----LDWARRKRIALGTA 412
           HRN+L L     +  E ++++ ++        + + I+         +            
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCE-- 113

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
             L +LH      I H D++  NI+          + +FG A+ L   D+          
Sbjct: 114 -ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAP 167

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
            + APE       S  TD++  G L+  L++G
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 44/223 (19%)

Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
            NF    +LG+G FG V     K     G L AVK L KD  +   +V+  T  E   L+
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVE-CTMTEKRILS 78

Query: 356 VHRN---LLRLCGFCS--TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
           + RN   L +L  FC   T  +RL  V  ++  G     L  HI         + +R   
Sbjct: 79  LARNHPFLTQL--FCCFQTP-DRLFFVMEFVNGGD----LMFHIQ--------KSRRFDE 123

Query: 410 GTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
             AR         L++LH++    II+RD+K  N+LLD +    + DFG+ K     +  
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGV 179

Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            T    GT  +IAPE L          D +  G+LL E++ G 
Sbjct: 180 TTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 66/222 (29%), Positives = 96/222 (43%), Gaps = 42/222 (18%)

Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
            +F    +LG+G FG V    +K         A+K L KD  +   +V+  T VE   L+
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVE-CTMVEKRVLS 72

Query: 356 VHRN---LLRLCGFCS--TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
           +      L  +  FC+  T+     V  Y+  G     L  HI            +  L 
Sbjct: 73  LAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGD----LMYHIQ--------SCHKFDLS 118

Query: 411 TAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462
            A         GL +LH +    I++RD+K  NILLD+D    + DFG+ K  +      
Sbjct: 119 RATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAK 174

Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
           T    GT  +IAPE L  GQ    + D + FG+LL E++ GQ
Sbjct: 175 TNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQ 215

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 27/205 (13%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG V  G     G  VAVK     +++  ++ G   + + E++ + L  H ++++
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG---KIKREIQNLKLFRHPHIIK 75

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK--RIALGTARGLLYL 418
           L    ST  +  +V  Y+  G     L D+I  HGR     ARR   +I         Y 
Sbjct: 76  LYQVISTPTDFFMVMEYVSGG----ELFDYICKHGRVEEMEARRLFQQILSAVD----YC 127

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           H      ++HRD+K  N+LLD    A + DFGL+ ++      + T+  G+  + APE +
Sbjct: 128 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVI 182

Query: 479 S-TGQSSEKTDVFGFGILLLELITG 502
           S    +  + D++  G++L  L+ G
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCG 207

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 75.7 bits (186), Expect = 2e-14
 Identities = 22/116 (18%), Positives = 47/116 (40%), Gaps = 8/116 (6%)

Query: 92  PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
            W+ N   L  V L  N +   +     K+++L+ L +SNN+    +      +  L  L
Sbjct: 248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS----GSLPKISARTFKVTGNPLIC 203
            L++N L      +  + + L  + L +N++      +   +  +   ++ N   C
Sbjct: 307 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTL--KNLTLSHNDWDC 359

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 71.9 bits (176), Expect = 2e-13
 Identities = 21/126 (16%), Positives = 45/126 (35%), Gaps = 6/126 (4%)

Query: 70  CSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129
              D     + +  Q+           L   + V  +N+ +     A L    +++ L+L
Sbjct: 23  LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 82

Query: 130 SNNKFTGEIP-DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           ++ +   EI   +      +  L +  N++    P     +  LT++ L  N+LS     
Sbjct: 83  NDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS----S 137

Query: 189 ISARTF 194
           +    F
Sbjct: 138 LPRGIF 143

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 69.2 bits (169), Expect = 2e-12
 Identities = 20/101 (19%), Positives = 36/101 (35%), Gaps = 4/101 (3%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            +  +++ + L +  I      +      +Q L +  N      P    ++  L  L L 
Sbjct: 72  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
            N L+            LT + +S NNL     +I   TF+
Sbjct: 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLE----RIEDDTFQ 168

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 22/94 (23%), Positives = 40/94 (42%), Gaps = 4/94 (4%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
               +L  + LQ+N +       L     L  +DLS N+    +      +  L  L ++
Sbjct: 229 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 286

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
           NN L  +       I +L ++DLS+N+L   + +
Sbjct: 287 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 318

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 32/108 (29%), Positives = 47/108 (43%), Gaps = 7/108 (6%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDS-LGDLGNLNYLRLN 154
           N+  L  ++L+ N +            KL TL +SNN     I D       +L  L+L+
Sbjct: 121 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-RTFKVTGNPL 201
           +N LT     SL  I SL   ++SYN LS +L    A      + N +
Sbjct: 180 SNRLT-HVDLSL--IPSLFHANVSYNLLS-TLAIPIAVEELDASHNSI 223

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 16/93 (17%), Positives = 38/93 (40%), Gaps = 5/93 (5%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
            L+ +   +  L+ + L +N +L  +  +  + ++L+ L L +N     +   L     L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 347

Query: 149 NYLRLNNNSLTGSCPESL-SKIESLTLVDLSYN 180
             L L++N    +   +L   +    + D   +
Sbjct: 348 KNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 17/90 (18%), Positives = 35/90 (38%), Gaps = 5/90 (5%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +     ++ +   +N+I   +   +    +L  L L +N  T +    L +   L  + L
Sbjct: 207 LAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDL 261

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           + N L         K++ L  + +S N L 
Sbjct: 262 SYNELEKIMYHPFVKMQRLERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 58.0 bits (140), Expect = 5e-09
 Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 11/88 (12%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
             T LQ++ L +N +   +  SL  +  L   ++S N  +     +L     +  L  ++
Sbjct: 169 ATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASH 220

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
           NS+         ++  L    L +NNL+
Sbjct: 221 NSINVVRGPVNVELTIL---KLQHNNLT 245

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 9/100 (9%), Positives = 26/100 (26%), Gaps = 4/100 (4%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
                  V +               L   + +   N+         L     +  L LN+
Sbjct: 25  YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 84

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
             +      + +   ++  + + +N +      +    F+
Sbjct: 85  LQIEEIDTYAFAYAHTIQKLYMGFNAIR----YLPPHVFQ 120

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 10/85 (11%), Positives = 24/85 (28%), Gaps = 4/85 (4%)

Query: 111 LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIE 170
              I ++L        + +               L N   +   N+++       L    
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75

Query: 171 SLTLVDLSYNNLSGSLPKISARTFK 195
            + L++L+   +     +I    F 
Sbjct: 76  QVELLNLNDLQIE----EIDTYAFA 96

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 73.7 bits (182), Expect = 2e-14
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 36/218 (16%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-------EVQFQTEVETIS 353
             +     +G G +G+VYK   S G +VA+KR++      G       E+    E+    
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--- 77

Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIALGTA 412
              H N++ L     +E    LV+ +M        L+  +      L  ++ K       
Sbjct: 78  ---HPNIVSLIDVIHSERCLTLVFEFME-----KDLKKVLDENKTGLQDSQIKIYLYQLL 129

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-----R 467
           RG+ + H+    +I+HRD+K  N+L++ D    + DFGLA+         T  V     R
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186

Query: 468 GTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
                 AP+ L  S   S+   D++  G +  E+ITG+
Sbjct: 187 ------APDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 30/115 (26%), Positives = 51/115 (44%), Gaps = 9/115 (7%)

Query: 96  NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            L  LQ + LQ+NA+   +P  +   L  L  L L  N+ +     +   L +L+ L L+
Sbjct: 127 GLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK------ISARTFKVTGNPLIC 203
            N +    P +   +  L  + L  NNLS +LP        + +  ++  NP +C
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVC 239

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 26/102 (25%), Positives = 43/102 (42%), Gaps = 7/102 (6%)

Query: 96  NLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRL 153
            L  L+ + L +NA L  +  +    L +L TL L       E+       L  L YL L
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
            +N+L     ++   + +LT + L  N +S     +  R F+
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRIS----SVPERAFR 174

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 24/100 (24%), Positives = 38/100 (38%), Gaps = 5/100 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRLN 154
               L  + L +N +     A+   L  L+ LDLS+N     +   +   LG L+ L L+
Sbjct: 54  ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
              L    P     + +L  + L  N L      +   TF
Sbjct: 114 RCGLQELGPGLFRGLAALQYLYLQDNALQ----ALPDDTF 149

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 59.2 bits (144), Expect = 8e-10
 Identities = 21/98 (21%), Positives = 32/98 (32%), Gaps = 5/98 (5%)

Query: 98  TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
              Q + L  N I     AS      L  L L +N        +   L  L  L L++N+
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 158 -LTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
            L    P +   +  L  + L    L     ++    F
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQ----ELGPGLF 125

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 22/67 (32%), Positives = 30/67 (44%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L  L  +LL  N +    P +   L +L TL L  N  +    ++L  L  L YLRLN+
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234

Query: 156 NSLTGSC 162
           N     C
Sbjct: 235 NPWVCDC 241

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 19/81 (23%), Positives = 31/81 (38%), Gaps = 5/81 (6%)

Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
           +P  +      Q + L  N+ +     S     NL  L L++N L      + + +  L 
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 174 LVDLSYNNLSGSLPKISARTF 194
            +DLS N     L  +   TF
Sbjct: 84  QLDLSDNAQ---LRSVDPATF 101

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.3 bits (181), Expect = 3e-14
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 39/222 (17%)

Query: 301 SNFSAKNILGRGGFGIVY---KGCFSD-GALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
             F    +LG+GG+G V+   K   ++ G + A+K L K   +   +    T+ E   L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 356 VHRN--LLRLCGFCS--TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
             ++  ++ L    +  T   +L L+  Y+  G     L   +         R       
Sbjct: 77  EVKHPFIVDL--IYAFQTG-GKLYLILEYLSGGE----LFMQLE--------REGIFMED 121

Query: 411 TAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462
           TA          L +LH++    II+RD+K  NI+L+      + DFGL K     D  V
Sbjct: 122 TACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTV 177

Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
           T    GT+ ++APE L       +  D +  G L+ +++TG 
Sbjct: 178 THTFCGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGA 218

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 41/221 (18%)

Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
           ++F    +LG+G FG V     K     G   A+K L K+  IA  EV   T  E+  L 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVA-HTVTESRVLQ 60

Query: 356 VHRN--LLRLCGFCS--TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
             R+  L  L    +  T +    V  Y   G     L  H+         R +      
Sbjct: 61  NTRHPFLTAL--KYAFQTHDRLCFVMEYANGGE----LFFHLS--------RERVFTEER 106

Query: 412 AR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
           AR         L YLH +    +++RD+K  N++LD+D    + DFGL K     D    
Sbjct: 107 ARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATM 162

Query: 464 TAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
               GT  ++APE L       +  D +G G+++ E++ G+
Sbjct: 163 KTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 202

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 49/227 (21%), Positives = 84/227 (37%), Gaps = 49/227 (21%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVE----T---- 351
             +     LG G +G VYK         VA+KR++           + E E    T    
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR----------LEHEEEGVPGTAIRE 83

Query: 352 ISL---AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
           +SL     HRN++ L       +   L++ Y       + L+ ++   P +     K   
Sbjct: 84  VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFL 138

Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG-----DFGLAKLL---DHRDS 460
                G+ + H +   + +HRD+K  N+LL     +        DFGLA+       + +
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195

Query: 461 H--VTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
           H  +T   R       PE L  S   S+   D++    +  E++   
Sbjct: 196 HEIITLWYR------PPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 29/115 (25%), Positives = 48/115 (41%), Gaps = 11/115 (9%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L  L+ + L    I   +P  L  L  L+ L++S N F    P S   L +L  L + N
Sbjct: 194 GLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS-------GSLPKISARTFKVTGNPLIC 203
           + ++     +   + SL  ++L++NNLS         L  +      +  NP  C
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYL--VELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 21/98 (21%), Positives = 34/98 (34%), Gaps = 4/98 (4%)

Query: 98  TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
           +  + + L  N I      +   L  L+ L L  N        +   L +LN L L +N 
Sbjct: 75  SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134

Query: 158 LTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           LT     +   +  L  + L  N +      I +  F 
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIE----SIPSYAFN 168

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 24/101 (23%), Positives = 43/101 (42%), Gaps = 7/101 (6%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN-NKFTGEIPDSLGDLGNLNYLRLN 154
            L+KL+ + L+NN I      +  ++  L  LDL    K       +   L NL YL L 
Sbjct: 145 YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
             ++      +L+ +  L  +++S N+      +I   +F 
Sbjct: 205 MCNIKD--MPNLTPLVGLEELEMSGNHFP----EIRPGSFH 239

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 19/91 (20%), Positives = 39/91 (42%)

Query: 92  PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
           P +  L  L+ + +  N      P S   L  L+ L + N++ +    ++   L +L  L
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
            L +N+L+    +  + +  L  + L +N  
Sbjct: 272 NLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 19/97 (19%), Positives = 38/97 (39%), Gaps = 7/97 (7%)

Query: 99  KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL 158
           +   V+     +   +P  +      + L+L  N       D+   L +L  L+L  NS+
Sbjct: 55  QFSKVVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 159 TGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
                 + + + SL  ++L  N L+     I +  F+
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT----VIPSGAFE 144

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 54.0 bits (130), Expect = 8e-08
 Identities = 15/67 (22%), Positives = 28/67 (41%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L+ L+ + + N+ +      +   L  L  L+L++N  +    D    L  L  L L++
Sbjct: 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH 299

Query: 156 NSLTGSC 162
           N     C
Sbjct: 300 NPWNCDC 306

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 29/154 (18%), Positives = 60/154 (38%), Gaps = 14/154 (9%)

Query: 57  ITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA 116
           I ++   S++ +       +  L +       T++P       L S+ + +  +      
Sbjct: 188 INAIRDYSFKRLY-----RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL 242

Query: 117 SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVD 176
           ++  L  L+ L+LS N  +      L +L  L  ++L    L    P +   +  L +++
Sbjct: 243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN 302

Query: 177 LSYNNLS-------GSLPKISARTFKVTGNPLIC 203
           +S N L+        S+  +   T  +  NPL C
Sbjct: 303 VSGNQLTTLEESVFHSVGNL--ETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 70.5 bits (173), Expect = 6e-13
 Identities = 21/103 (20%), Positives = 44/103 (42%), Gaps = 4/103 (3%)

Query: 93  WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
            + +L  L  + L++  I      S  +L +L+ L++S+  +   +  +     NL  L 
Sbjct: 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLS 230

Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           + + +LT     ++  +  L  ++LSYN +S     I      
Sbjct: 231 ITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS----TIEGSMLH 269

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 21/103 (20%), Positives = 44/103 (42%), Gaps = 2/103 (1%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNYLRLN 154
           +L  L+S+ + +N ++     +   L  L+ L L     T  IP  +L  L  L  LRL 
Sbjct: 126 DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR 184

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVT 197
           + ++      S  ++  L ++++S+     ++         +T
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 26/99 (26%), Positives = 40/99 (40%), Gaps = 4/99 (4%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
           NL  L+++ L++N +          L  L  LD+S NK    +     DL NL  L + +
Sbjct: 78  NLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
           N L      + S + SL  + L   NL+     I     
Sbjct: 138 NDLVYISHRAFSGLNSLEQLTLEKCNLT----SIPTEAL 172

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 27/142 (19%), Positives = 48/142 (33%), Gaps = 26/142 (18%)

Query: 54  NWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGP 113
           +    +V  C  +     P+G      +P+                L    L  N I   
Sbjct: 10  SAQDRAVL-CHRKRFVAVPEG------IPT------------ETRLLD---LGKNRIKTL 47

Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
                     L+ L+L+ N  +   P +  +L NL  L L +N L        + + +LT
Sbjct: 48  NQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLT 107

Query: 174 LVDLSYNNLSGSLPKISARTFK 195
            +D+S N +      +    F+
Sbjct: 108 KLDISENKIV----ILLDYMFQ 125

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 16/100 (16%), Positives = 35/100 (35%), Gaps = 4/100 (4%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L  L+ + L+   +      +L  L  L  L L +         S   L  L  L +++
Sbjct: 150 GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
                +   +     +LT + +++ NL+     +     +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT----AVPYLAVR 245

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 19/67 (28%), Positives = 30/67 (44%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L +LQ + L    +    P +   L  L+ L++S N+ T         +GNL  L L++
Sbjct: 270 ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329

Query: 156 NSLTGSC 162
           N L   C
Sbjct: 330 NPLACDC 336

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 72.6 bits (179), Expect = 5e-14
 Identities = 69/221 (31%), Positives = 98/221 (44%), Gaps = 40/221 (18%)

Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
           ++F+   +LG+G FG V     KG      L AVK L KD  I   +V+  T VE   LA
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVE-CTMVEKRVLA 75

Query: 356 VHRN---LLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
           +      L +L   C    +RL  V  Y+  G     L  HI         +  R     
Sbjct: 76  LPGKPPFLTQL-HSCFQTMDRLYFVMEYVNGGD----LMYHIQ--------QVGRFKEPH 122

Query: 412 AR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
           A         GL +L  +    II+RD+K  N++LD +    + DFG+ K  +  D   T
Sbjct: 123 AVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTT 178

Query: 464 TAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
               GT  +IAPE +   Q   K+ D + FG+LL E++ GQ
Sbjct: 179 KTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQ 218

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 72.6 bits (179), Expect = 6e-14
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 14/165 (8%)

Query: 295 ELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETI 352
           ++++    +   + LG G F  VYK    +   +VA+K++K  + +  +    +T +  I
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 353 SL---AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIA 408
            L     H N++ L      ++   LV+ +M      + L   I      L  +  K   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFME-----TDLEVIIKDNSLVLTPSHIKAYM 118

Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
           L T +GL YLH+     I+HRD+K  N+LLDE+    + DFGLAK
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 72.7 bits (179), Expect = 6e-14
 Identities = 62/223 (27%), Positives = 91/223 (40%), Gaps = 44/223 (19%)

Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
           S+F    ++G+G FG V     K    +    AVK L K   +   E +     E   L 
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEK-HIMSERNVLL 93

Query: 356 VHRN---LLRLCGFCS--TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
            +     L+ L    S  T  ++L  V  Y+  G     L  H+         R +    
Sbjct: 94  KNVKHPFLVGL--HFSFQTA-DKLYFVLDYINGGE----LFYHLQ--------RERCFLE 138

Query: 410 GTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
             AR         L YLH      I++RD+K  NILLD     V+ DFGL K  +   + 
Sbjct: 139 PRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNS 194

Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            T+   GT  ++APE L   Q  ++T D +  G +L E++ G 
Sbjct: 195 TTSTFCGTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGL 236

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.2 bits (180), Expect = 6e-14
 Identities = 58/257 (22%), Positives = 99/257 (38%), Gaps = 44/257 (17%)

Query: 267 HNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVY----KGCF 322
            N      +    + E    + +            +F    ++GRG +  V     K   
Sbjct: 18  ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKK-- 75

Query: 323 SDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRN---LLRLCGFCS--TENERL-L 375
               + A++ + K+      ++    + E        N   L+ L       TE  RL  
Sbjct: 76  -TDRIYAMRVVKKELVNDDEDID-WVQTEKHVFEQASNHPFLVGL--HSCFQTE-SRLFF 130

Query: 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR--------GLLYLHEQCDPKII 427
           V  Y+  G     L  H+         R++++    AR         L YLHE+    II
Sbjct: 131 VIEYVNGGD----LMFHMQ--------RQRKLPEEHARFYSAEISLALNYLHER---GII 175

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
           +RD+K  N+LLD +    + D+G+ K    R    T+   GT  +IAPE L  G+    +
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEIL-RGEDYGFS 233

Query: 488 -DVFGFGILLLELITGQ 503
            D +  G+L+ E++ G+
Sbjct: 234 VDWWALGVLMFEMMAGR 250

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 72.6 bits (179), Expect = 6e-14
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 44/223 (19%)

Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
            +F    ++GRG +  V     K       + A+K + K+      ++    + E     
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDID-WVQTEKHVFE 64

Query: 356 VHRN---LLRLCGFCS--TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
              N   L+ L       TE  RL  V  Y+  G     L  H+         R++++  
Sbjct: 65  QASNHPFLVGL--HSCFQTE-SRLFFVIEYVNGGD----LMFHMQ--------RQRKLPE 109

Query: 410 GTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
             AR         L YLHE+    II+RD+K  N+LLD +    + D+G+ K    R   
Sbjct: 110 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGD 165

Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
            T+   GT  +IAPE L  G+    + D +  G+L+ E++ G+
Sbjct: 166 TTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGR 207

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 73.6 bits (181), Expect = 7e-14
 Identities = 25/150 (16%), Positives = 53/150 (35%), Gaps = 7/150 (4%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
             NLT LQ++ + N      I       L  L  L++           SL  + ++++L 
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178

Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSG------SLPKISARTFKVTGNPLICGPK 206
           L+ +            + S+  ++L   NL+        + ++S+   K+     +   +
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238

Query: 207 ATNNCTAVFPEPLSLPPNGLKDQSDSGTKS 236
           + N    +    L L      D + +G   
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGD 268

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 25/102 (24%), Positives = 45/102 (44%), Gaps = 6/102 (5%)

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDS 141
                  S   G    LQ+++L  N +  +      L  L+ L +LD+S N F   +PDS
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDS 405

Query: 142 LGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
                 + +L L++  +       + +  +L ++D+S NNL 
Sbjct: 406 CQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNNNLD 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 70.5 bits (173), Expect = 6e-13
 Identities = 27/134 (20%), Positives = 48/134 (35%), Gaps = 33/134 (24%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L  L S+ +  N    P+P S    EK++ L+LS+      +   +     L  L ++N
Sbjct: 385 TLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSN 440

Query: 156 NSLTGSCPESLSKIE-------------------SLTLVDLSYNNLS-------GSLPKI 189
           N+L  S    L +++                    L ++ +S N L          L  +
Sbjct: 441 NNLD-SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499

Query: 190 SARTFKVTGNPLIC 203
             +   +  NP  C
Sbjct: 500 --QKIWLHTNPWDC 511

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 22/89 (24%), Positives = 37/89 (41%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
           G    ++S+ L  N I       L     LQ L L +++      D+   LG+L +L L+
Sbjct: 23  GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           +N L+         + SL  ++L  N   
Sbjct: 83  DNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.1 bits (164), Expect = 7e-12
 Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 1/98 (1%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +     LQ ++L+++ I      +   L  L+ LDLS+N  +       G L +L YL L
Sbjct: 46  LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105

Query: 154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
             N             + +L  + +        + +I 
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 19/155 (12%), Positives = 47/155 (30%), Gaps = 17/155 (10%)

Query: 52  LENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGN-------------LT 98
              +  + +   S+  +       +    +     +                        
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV 286

Query: 99  KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL 158
            ++ + +    +   +      LEK++ + + N+K           L +L +L L+ N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346

Query: 159 TGSCPES---LSKIESLTLVDLSYNNLSGSLPKIS 190
                ++        SL  + LS N+L  S+ K  
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTG 380

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 20/88 (22%), Positives = 34/88 (38%), Gaps = 6/88 (6%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
                L+ + + NN  L      L    +LQ L +S NK    +PD+      L  ++++
Sbjct: 428 CIPQTLEVLDVSNNN-LDSFSLFL---PRLQELYISRNKLK-TLPDASL-FPVLLVMKIS 481

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNL 182
            N L         ++ SL  + L  N  
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 15/68 (22%), Positives = 27/68 (39%), Gaps = 2/68 (2%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L +LQ + +  N +   +P +      L  + +S N+           L +L  + L+ 
Sbjct: 449 FLPRLQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506

Query: 156 NSLTGSCP 163
           N    SCP
Sbjct: 507 NPWDCSCP 514

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.8 bits (114), Expect = 7e-06
 Identities = 9/112 (8%), Positives = 30/112 (26%), Gaps = 11/112 (9%)

Query: 93  WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
            + ++  +  + L  +     +      L  ++ L+L +          L      + ++
Sbjct: 167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226

Query: 153 LNNNSLTG----------SCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
                 +                + ++  +   D + N L G      +   
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL-GDFNPSESDVV 277

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 15/74 (20%), Positives = 26/74 (35%), Gaps = 7/74 (9%)

Query: 122 EKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNN 181
           +     D  +  FT  IP  L     +  L L+ N +T      L    +L ++ L  + 
Sbjct: 5   DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61

Query: 182 LSGSLPKISARTFK 195
           ++     I    F 
Sbjct: 62  IN----TIEGDAFY 71

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 74.1 bits (182), Expect = 7e-14
 Identities = 37/201 (18%), Positives = 66/201 (32%), Gaps = 30/201 (14%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASL-----GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN 149
                L+ + L  N +       L       L  LQ L L++N      P     L  L 
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507

Query: 150 YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI--SARTFKVTGNPLICG--- 204
            L LN+N LT      L    +L ++D+S N L    P +  S     +T N  IC    
Sbjct: 508 GLSLNSNRLTVLSHNDLPA--NLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565

Query: 205 --------------PKATNNCTAVFPEPLS----LPPNGLKDQSDSGTKSHRVAVALGAS 246
                              +   V+P+  S       +      +   KS + ++ +  +
Sbjct: 566 STFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCT 625

Query: 247 FGAAFFVIIVVGLLVWLRYRH 267
                F++ ++ +  +  +  
Sbjct: 626 VTLTLFLMTILTVTKFRGFCF 646

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.4 bits (175), Expect = 5e-13
 Identities = 29/128 (22%), Positives = 55/128 (42%), Gaps = 9/128 (7%)

Query: 69  TCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLD 128
           +CS DG ++       +L+         L   + +LL  N I     +S   LE+LQ L+
Sbjct: 1   SCSFDGRIAFYR--FCNLTQVPQ----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54

Query: 129 LSNNKFTGEI-PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           L +      I  ++  +L NL  L L ++ +    P++   +  L  + L +  LS ++ 
Sbjct: 55  LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV- 113

Query: 188 KISARTFK 195
            +    F+
Sbjct: 114 -LKDGYFR 120

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 69.8 bits (171), Expect = 2e-12
 Identities = 22/88 (25%), Positives = 36/88 (40%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L  L+ + L  N I      +   L+ LQ L+LS N        +   L  + Y+ L  
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
           N +     ++   +E L  +DL  N L+
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 68.3 bits (167), Expect = 4e-12
 Identities = 25/91 (27%), Positives = 41/91 (45%), Gaps = 3/91 (3%)

Query: 96  NLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            L +LQ + L +      I   +   L  L+ LDL ++K     PD+   L +L  LRL 
Sbjct: 46  FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105

Query: 155 NNSLTGSC--PESLSKIESLTLVDLSYNNLS 183
              L+ +         +++LT +DLS N + 
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 68.3 bits (167), Expect = 4e-12
 Identities = 23/112 (20%), Positives = 39/112 (34%), Gaps = 5/112 (4%)

Query: 93  WIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGNLN 149
               L  L  + L    +            L+ L  LDLS N+     +  S G L +L 
Sbjct: 92  AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK 151

Query: 150 YLRLNNNSLTGSCPESLSKIESLTL--VDLSYNNLSGSLPKISARTFKVTGN 199
            +  ++N +   C   L  ++  TL    L+ N+L   +     +      N
Sbjct: 152 SIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN 203

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 64.8 bits (158), Expect = 5e-11
 Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 9/114 (7%)

Query: 93  WIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG--NLN 149
           +  NL  L  + L  N I    +  S GKL  L+++D S+N+        L  L    L+
Sbjct: 118 YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS 177

Query: 150 YLRLNNNSLTGSCPESLSKIE------SLTLVDLSYNNLSGSLPKISARTFKVT 197
           +  L  NSL         K         L ++D+S N  +  +    +     +
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 64.4 bits (157), Expect = 6e-11
 Identities = 21/99 (21%), Positives = 42/99 (42%), Gaps = 4/99 (4%)

Query: 97  LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156
            + ++ + L +  +          L+ L+ L+L+ NK      ++   L NL  L L+ N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324

Query: 157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
            L      +   +  +  +DL  N+++     I  +TFK
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIA----IIQDQTFK 359

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 11/103 (10%)

Query: 100 LQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSL-GDLGNLNYLRLNNNS 157
              + L  N +    I   L ++  LQ L L+ N+F+    D    +  +L  L L  N 
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462

Query: 158 LTGS-----CPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           L  +     C +    +  L ++ L++N L+     +    F 
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLN----SLPPGVFS 501

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 17/103 (16%), Positives = 38/103 (36%), Gaps = 6/103 (5%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG--NLNYLR 152
           GN   +      +NAI      SL     +       +       ++   L   ++ +L 
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272

Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           L++  +          ++ L +++L+YN ++    KI+   F 
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKIN----KIADEAFY 311

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 10/89 (11%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L KLQ++ L++NA+      ++  +  +  + LS NK       +L      N + L+ 
Sbjct: 360 FLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSE 410

Query: 156 NSLTGSCPES-LSKIESLTLVDLSYNNLS 183
           N L        L ++  L ++ L+ N  S
Sbjct: 411 NRLENLDILYFLLRVPHLQILILNQNRFS 439

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.4 bits (176), Expect = 8e-14
 Identities = 47/225 (20%), Positives = 87/225 (38%), Gaps = 45/225 (20%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVE----T----I 352
            +     +G G +G V+K        +VA+KR++             + E    +    I
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR----------LDDDDEGVPSSALREI 52

Query: 353 SL---AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIA 408
            L     H+N++RL     ++ +  LV+ +         L+ +       LD    K   
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFL 107

Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-- 466
               +GL + H +    ++HRD+K  N+L++ + E  + +FGLA+         +  V  
Sbjct: 108 FQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT 164

Query: 467 ---RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQRAL 506
              R       P+ L  +   S+   D++  G +  EL    R L
Sbjct: 165 LWYR------PPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPL 202

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 72.9 bits (179), Expect = 8e-14
 Identities = 29/115 (25%), Positives = 48/115 (41%), Gaps = 11/115 (9%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L+ L+ + L    +   IP  L  L KL  LDLS N  +   P S   L +L  L +  
Sbjct: 183 GLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS-------GSLPKISARTFKVTGNPLIC 203
           + +      +   ++SL  ++L++NNL+         L  +      +  NP  C
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL--ERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 25/98 (25%), Positives = 35/98 (35%), Gaps = 4/98 (4%)

Query: 98  TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
           T  + + L  N I      S   L  L+ L LS N        +   L NLN L L +N 
Sbjct: 64  TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123

Query: 158 LTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           LT     +   +  L  + L  N +      I +  F 
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIE----SIPSYAFN 157

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 7/101 (6%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRLN 154
            L+KL+ + L+NN I      +  ++  L+ LDL   K    I   +   L NL YL L 
Sbjct: 134 YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
             +L      +L+ +  L  +DLS N+LS     I   +F+
Sbjct: 194 MCNLRE--IPNLTPLIKLDELDLSGNHLS----AIRPGSFQ 228

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 21/91 (23%), Positives = 39/91 (42%)

Query: 92  PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
           P +  L KL  + L  N +    P S   L  LQ L +  ++      ++  +L +L  +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
            L +N+LT    +  + +  L  + L +N  
Sbjct: 261 NLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 18/97 (18%), Positives = 37/97 (38%), Gaps = 7/97 (7%)

Query: 99  KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL 158
           +   V+      L  +P  +      + L+L  N+      +S   L +L  L+L+ N +
Sbjct: 44  QFSKVICVRKN-LREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 159 TGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
                 + + + +L  ++L  N L+     I    F 
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT----TIPNGAFV 133

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 29/171 (16%), Positives = 51/171 (29%), Gaps = 33/171 (19%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L  LQ + +  + I      +   L+ L  ++L++N  T    D    L +L  + L++
Sbjct: 229 GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHH 288

Query: 156 NSLTGSC-------------------------PESLSKIESLTLVDLSYNNLSGSLPKIS 190
           N    +C                         P +L       + +L  N  +   P I 
Sbjct: 289 NPWNCNCDILWLSWWIKDMAPSNTACCARCNTPPNLKG---RYIGELDQNYFTCYAPVIV 345

Query: 191 ARTFKVTGNPLICGPKATNNCTAVFPEPLS--LPPNGLKDQSDSGTKSHRV 239
                +    +  G  A   C A         + PNG      +      V
Sbjct: 346 EPPADLN---VTEGMAAELKCRASTSLTSVSWITPNGTVMTHGAYKVRIAV 393

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 24/211 (11%)

Query: 302 NFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
            +   + LG G +  VYKG       LVA+K ++  +  G       EV  +    H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIALGTARGLLYLH 419
           + L     TE    LV+ Y+        L+ ++      ++    K       RGL Y H
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLD-----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-----RGTVGHIA 474
            Q   K++HRD+K  N+L++E  E  + DFGLA+            V     R       
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR------P 168

Query: 475 PEYL--STGQSSEKTDVFGFGILLLELITGQ 503
           P+ L  ST  S++  D++G G +  E+ TG+
Sbjct: 169 PDILLGSTDYSTQ-IDMWGVGCIFYEMATGR 198

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 26/113 (23%), Positives = 40/113 (35%), Gaps = 9/113 (7%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP----D 140
           +    L  W+     L+ + +     L      +     L TLDLS+N   GE       
Sbjct: 138 AWLAELQQWL--KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195

Query: 141 SLGDLGNLNYLRLNNN---SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
                  L  L L N    + +G C    +    L  +DLS+N+L  +    S
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 32/124 (25%), Positives = 49/124 (39%), Gaps = 10/124 (8%)

Query: 75  YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKL--EKLQTLDLSNN 132
            V A  +PS+ L G L   +  ++ LQ + L+N  + G  P  L +     L  L+L N 
Sbjct: 74  TVRAARIPSRILFGALR--VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131

Query: 133 KFTGEIPDSLGDLGN-----LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
            +       L +L       L  L +          E +    +L+ +DLS N   G   
Sbjct: 132 SWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

Query: 188 KISA 191
            ISA
Sbjct: 191 LISA 194

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 23/103 (22%), Positives = 42/103 (40%), Gaps = 6/103 (5%)

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
           ++ SG  S       +LQ + L +N++       S     +L +L+LS      ++P  L
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272

Query: 143 GDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGS 185
                L+ L L+ N L  +   S  ++  +  + L  N    S
Sbjct: 273 PA--KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 26/131 (19%), Positives = 48/131 (36%), Gaps = 15/131 (11%)

Query: 76  VSALGLPSQSLSGTLSPWIGNLT--KLQSVLLQNNAILGPIPASLGKL-----EKLQTLD 128
           +  L L +  ++GT  P +   T   L  + L+N +      A L +L       L+ L 
Sbjct: 97  LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLS 155

Query: 129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGS-------CPESLSKIESLTLVDLSYNN 181
           ++         + +     L+ L L++N   G        CP     ++ L L +     
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215

Query: 182 LSGSLPKISAR 192
            SG    ++A 
Sbjct: 216 PSGVCSALAAA 226

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 20/106 (18%), Positives = 36/106 (33%), Gaps = 4/106 (3%)

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIP-ASLGKLEKLQTLDLSNNKFTGEIPDS- 141
             L        G    L+ +L + +          + K   L+ L +   +    I    
Sbjct: 29  NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88

Query: 142 --LGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGS 185
             +  +  L  L L N  +TG+ P  L +     L  L+  N+S +
Sbjct: 89  LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 70.2 bits (173), Expect = 2e-13
 Identities = 50/221 (22%), Positives = 93/221 (42%), Gaps = 44/221 (19%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVE----T----IS 353
            +     +G G +G+VYK   + G   A+K+++           + E E    T    IS
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR----------LEKEDEGIPSTTIREIS 52

Query: 354 L---AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIAL 409
           +     H N+++L     T+   +LV+ ++        L+  +      L+    K   L
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLL 107

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV--- 466
               G+ Y H++   +++HRD+K  N+L++ + E  + DFGLA+         T  +   
Sbjct: 108 QLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164

Query: 467 --RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
             R      AP+ L  S   S+   D++  G +  E++ G 
Sbjct: 165 WYR------APDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT 198

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 27/205 (13%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
           LG G FG V  G     G  VAVK     +++  ++ G   + + E++ + L  H ++++
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG---KIRREIQNLKLFRHPHIIK 80

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK--RIALGTARGLLYL 418
           L    ST ++  +V  Y+  G     L D+I  +GR     +RR   +I  G      Y 
Sbjct: 81  LYQVISTPSDIFMVMEYVSGG----ELFDYICKNGRLDEKESRRLFQQILSGVD----YC 132

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           H      ++HRD+K  N+LLD    A + DFGL+ ++      + T+  G+  + APE +
Sbjct: 133 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVI 187

Query: 479 S-TGQSSEKTDVFGFGILLLELITG 502
           S    +  + D++  G++L  L+ G
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCG 212

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 50/223 (22%), Positives = 86/223 (38%), Gaps = 37/223 (16%)

Query: 301 SNFSAKNILGRGGFGIVYKG--CFSDGALVAVKRLKDYNIAGG-------EVQFQTEVET 351
             +     +G G +G V+K     + G  VA+KR++      G       EV        
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--- 67

Query: 352 ISLAVHRNLLRLCGFCSTENERL-----LVYPYMPNGSVASRLRDHI--HGRPALDWARR 404
           +    H N++RL   C+           LV+ ++        L  ++     P +     
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETI 122

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL--LDHRDSH- 461
           K +     RGL +LH     +++HRD+K  NIL+    +  + DFGLA++       +  
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179

Query: 462 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
            VT   R      APE L     +   D++  G +  E+   +
Sbjct: 180 VVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 25/207 (12%)

Query: 307 NILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQT--EVETISLAVHRNLLRL 363
            ++G G +G+V K      G +VA+K+  + +     V+     E++ +    H NL+ L
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRHENLVNL 89

Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLYLHEQC 422
              C  +    LV+ ++        + D +   P  LD+   ++       G+ + H   
Sbjct: 90  LEVCKKKKRWYLVFEFVD-----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-----RGTVGHIAPEY 477
              IIHRD+K  NIL+ +     + DFG A+ L          V     R      APE 
Sbjct: 144 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR------APEL 195

Query: 478 L-STGQSSEKTDVFGFGILLLELITGQ 503
           L    +  +  DV+  G L+ E+  G+
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.3 bits (174), Expect = 3e-13
 Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 4/91 (4%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +  L  +  + L +N +   +P +L  L  L+ L  S+N     +   + +L  L  L L
Sbjct: 459 LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLL 515

Query: 154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLS 183
            NN L   +  + L     L L++L  N+L 
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 66.3 bits (161), Expect = 1e-11
 Identities = 25/132 (18%), Positives = 50/132 (37%), Gaps = 15/132 (11%)

Query: 93  WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
                  ++ + L +  +   +   L +L  +  LDLS+N+    +P +L  L  L  L+
Sbjct: 436 LKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQ 492

Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLS--------GSLPKISARTFKVTGNPLICG 204
            ++N+L  +    ++ +  L  + L  N L          S P++      + GN L   
Sbjct: 493 ASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRL--VLLNLQGNSLCQE 548

Query: 205 PKATNNCTAVFP 216
                    + P
Sbjct: 549 EGIQERLAEMLP 560

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 51.7 bits (123), Expect = 5e-07
 Identities = 20/85 (23%), Positives = 32/85 (37%), Gaps = 4/85 (4%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGN 147
            L P +  L  L+ +   +NA+   +   +  L +LQ L L NN+         L     
Sbjct: 477 ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534

Query: 148 LNYLRLNNNSLTGSCPESLSKIESL 172
           L  L L  NSL         ++  +
Sbjct: 535 LVLLNLQGNSLC-QEEGIQERLAEM 558

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 37/233 (15%)

Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQT---- 347
             EL A  S ++ +  +  G +G V  G  S+G  VA+KR+ +    G  V         
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 348 -----EVETISLAVHRNLLRLCG-FCSTENERL----LVYPYMPNGSVASRLRDHIH-GR 396
                E+  ++   H N+L L   F   E   +    LV   M      + L   IH  R
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQR 128

Query: 397 PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
             +     +        GL  LHE     ++HRD+   NILL ++ +  + DF LA+   
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDT 185

Query: 457 HRDSHVTTAV-----RGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
             D++ T  V     R      APE  +     ++  D++  G ++ E+   +
Sbjct: 186 A-DANKTHYVTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 35/202 (17%), Positives = 66/202 (32%), Gaps = 19/202 (9%)

Query: 58  TSVDPCSWRMITCSPD--GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIP 115
            +   C  R +   P+   +V+ + L   S++         L  LQ + ++       I 
Sbjct: 13  YNAI-CINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR 71

Query: 116 A-SLGKLEKLQTLDLSNNKFTGEIPDS-LGDLGNLNYLRLNNNSLTGSC--PESLSKIES 171
             +   L  L  L L  N+F  ++       L NL  L L   +L G+         + S
Sbjct: 72  NNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS 130

Query: 172 LTLVDLSYNNLS--------GSLPKISARTFKVTGNPLICGPKAT-NNCTAVFPEPLSLP 222
           L ++ L  NN+          ++ +       +T N +    +    N        L L 
Sbjct: 131 LEMLVLRDNNIKKIQPASFFLNMRRF--HVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS 188

Query: 223 PNGLKDQSDSGTKSHRVAVALG 244
              L+D ++      +      
Sbjct: 189 SITLQDMNEYWLGWEKCGNPFK 210

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 32/170 (18%), Positives = 58/170 (34%), Gaps = 16/170 (9%)

Query: 43  NNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWI-GNLTKLQ 101
           +N ++  +   + +    D  +++ +  S    V    L    +   L   +  + T L+
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASG---VKTCDLSKSKIF-ALLKSVFSHFTDLE 302

Query: 102 SVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTG 160
            + L  N I   I   +   L  L  L+LS N           +L  L  L L+ N +  
Sbjct: 303 QLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA 361

Query: 161 SCPESLSKIESLTLVDLSYNNLS-------GSLPKISARTFKVTGNPLIC 203
              +S   + +L  + L  N L          L  +      +  NP  C
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQ--KIWLHTNPWDC 409

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 23/73 (31%), Positives = 33/73 (45%), Gaps = 4/73 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
           NL KL+ + L  N I   +   S   L  L+ L L  N+    +PD + D L +L  + L
Sbjct: 345 NLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 402

Query: 154 NNNSLTGSCPESL 166
           + N    SCP   
Sbjct: 403 HTNPWDCSCPRID 415

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 25/104 (24%), Positives = 44/104 (42%), Gaps = 13/104 (12%)

Query: 96  NLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG--NLNYL 151
            LT L+ ++L++N I  + P       + +   LDL+ NK      + L +    +   L
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASF-FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185

Query: 152 RLNNNSLTGSCPESLSKIE--------SLTLVDLSYNNLSGSLP 187
           RL++ +L       L   +        S+T +DLS N    S+ 
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA 229

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 16/107 (14%), Positives = 31/107 (28%), Gaps = 16/107 (14%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN-----Y 150
            L+ +    +    +      +  K   + TLDLS N F   +     D           
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245

Query: 151 LRLNNNSLTGSCPESLSKIE----------SLTLVDLSYNNLSGSLP 187
           L  + N  +     +    +           +   DLS + +  +L 
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL 291

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 69.5 bits (171), Expect = 5e-13
 Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 37/213 (17%)

Query: 307 NILGRGGFGIVYKGCFSD-GALVAVK--RLKDYN-----IAGGEVQFQTEVETISLAVHR 358
             +G G +G+V+K    D G +VA+K     + +     IA  E++   +++      H 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK------HP 62

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLY 417
           NL+ L      +    LV+ Y         +   +      +     K I   T + + +
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCD-----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-----RGTVGH 472
            H+      IHRDVK  NIL+ +     + DFG A+LL     +    V     R     
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR----- 169

Query: 473 IAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
            +PE L   T       DV+  G +  EL++G 
Sbjct: 170 -SPELLVGDTQYGPP-VDVWAIGCVFAELLSGV 200

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 55/203 (27%), Positives = 80/203 (39%), Gaps = 25/203 (12%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G G FG+           LVAVK ++        VQ   E+       H N++R     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIVRFKEVI 85

Query: 368 STENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK---RIALGTARGLLYLHEQC 422
            T     ++  Y   G     L + I   GR + D AR      ++     G+ Y H   
Sbjct: 86  LTPTHLAIIMEYASGGE----LYERICNAGRFSEDEARFFFQQLLS-----GVSYCHSM- 135

Query: 423 DPKIIHRDVKAANILLDEDFEAV--VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS- 479
             +I HRD+K  N LLD        + DFG +K      S   + V GT  +IAPE L  
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV-GTPAYIAPEVLLR 191

Query: 480 TGQSSEKTDVFGFGILLLELITG 502
                +  DV+  G+ L  ++ G
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVG 214

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 6/100 (6%)

Query: 96  NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            LT L S+LL +N +   I + +   +  L+ LDLS+N           DL  L  L L 
Sbjct: 62  RLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
           NN +      +   +  L  + LS N +S    +      
Sbjct: 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQIS----RFPVELI 156

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 28/112 (25%), Positives = 42/112 (37%), Gaps = 22/112 (19%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP----DSLGDLGNLNYL 151
           +L  L+ +LL NN I+     +   + +LQ L LS N+ +   P         L  L  L
Sbjct: 110 DLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLL 168

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLIC 203
            L++N L       L K+ +     L  +N                 NPL C
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHN-----------------NPLEC 203

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 45/228 (19%)

Query: 298 AATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVE-----T 351
           +++S F     LG G +  VYKG   + G  VA+K +K             + E     T
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK------------LDSEEGTPST 49

Query: 352 ----ISL---AVHRNLLRLCGFCSTENERLLVYPYMPN--GSVASRLRDHIHGRPALDWA 402
               ISL     H N++RL     TEN+  LV+ +M N               R  L+  
Sbjct: 50  AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG-LELN 108

Query: 403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462
             K       +GL + HE    KI+HRD+K  N+L+++  +  +GDFGLA+      +  
Sbjct: 109 LVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165

Query: 463 TTAV-----RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
           ++ V     R      AP+ L  S   S+   D++  G +L E+ITG+
Sbjct: 166 SSEVVTLWYR------APDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 24/203 (11%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQT--EVETISLAVHRNLLRLCG 365
           LG G FG V     +     VA+K +    +   ++  +   E+  + L  H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK--RIALGTARGLLYLHEQ 421
             +T  + ++V  Y         L D+I    R   D  RR   +I         Y H  
Sbjct: 77  VITTPTDIVMVIEY-----AGGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCHRH 127

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
              KI+HRD+K  N+LLD++    + DFGL+ ++    + + T+  G+  + APE ++ G
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTSC-GSPNYAAPEVIN-G 181

Query: 482 QSSE--KTDVFGFGILLLELITG 502
           +     + DV+  GI+L  ++ G
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVG 204

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 56/240 (23%), Positives = 89/240 (37%), Gaps = 67/240 (27%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVE----T---- 351
           S +     +G+G FG V+K      G  VA+K++            + E E    T    
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL----------MENEKEGFPITALRE 66

Query: 352 ISL---AVHRNLLRLCGFCSTENERL--------LVYPYMPNGSVASRLRDH------IH 394
           I +     H N++ L   C T+            LV+ +           +H       +
Sbjct: 67  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC----------EHDLAGLLSN 116

Query: 395 GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454
                  +  KR+      GL Y+H     KI+HRD+KAAN+L+  D    + DFGLA+ 
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173

Query: 455 ----LDHRDSHVTTAV-----RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
                + + +  T  V     R       PE L           D++G G ++ E+ T  
Sbjct: 174 FSLAKNSQPNRYTNRVVTLWYR------PPELLLGERDYGPP-IDLWGAGCIMAEMWTRS 226

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 24/113 (21%), Positives = 40/113 (35%), Gaps = 12/113 (10%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
            L     +L  +      NN +       L  L  L T+   NN     +PD      +L
Sbjct: 209 KLPDLPLSLESIV---AGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SL 259

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201
             L + +N LT   PE    +  L + +  ++ LS   P +       + N +
Sbjct: 260 EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNL--YYLNASSNEI 309

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 30/126 (23%), Positives = 44/126 (34%), Gaps = 14/126 (11%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
            L     +L  +      NN  L  +P  L  L  L  +   NN    ++PD      +L
Sbjct: 167 KLPDLPPSLEFIA---AGNNQ-LEELP-ELQNLPFLTAIYADNNSLK-KLPDL---PLSL 217

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI--SARTFKVTGNPLICGPK 206
             +   NN L       L  +  LT +    N L  +LP +  S     V  N L   P+
Sbjct: 218 ESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPE 274

Query: 207 ATNNCT 212
              + T
Sbjct: 275 LPQSLT 280

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 66.6 bits (163), Expect = 8e-12
 Identities = 25/112 (22%), Positives = 44/112 (39%), Gaps = 19/112 (16%)

Query: 90  LSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDL---- 145
           ++P   + T LQ  L  ++  L  +P     ++       + +++    P   G+     
Sbjct: 3   INPRNVSNTFLQEPLRHSSN-LTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 146 ---------GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
                       + L LNN  L+ S PE    +ESL     S N+L+  LP+
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPE 108

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 25/127 (19%), Positives = 43/127 (33%), Gaps = 25/127 (19%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L L +  LS +L     +L  L       N+ L  +P     L+ L   + +    +   
Sbjct: 76  LELNNLGLS-SLPELPPHLESLV---ASCNS-LTELPELPQSLKSLLVDNNNLKALSDLP 130

Query: 139 P---------------DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           P                 L +   L  + ++NNSL    P+    +E +       N L 
Sbjct: 131 PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE 186

Query: 184 GSLPKIS 190
             LP++ 
Sbjct: 187 -ELPELQ 192

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 28/115 (24%), Positives = 40/115 (34%), Gaps = 24/115 (20%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKL--------------EKLQTLDLSNNKF 134
            L     +LT L       +  L  +P +L  L                L+ L++SNNK 
Sbjct: 271 DLPELPQSLTFLDVSENIFSG-LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL 329

Query: 135 TGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
             E+P        L  L  + N L    PE    ++ L    + YN L    P I
Sbjct: 330 I-ELPAL---PPRLERLIASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDI 375

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 18/110 (16%), Positives = 36/110 (32%), Gaps = 22/110 (20%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLE-------------KLQTLDLSNNK 133
            +     NL +L    ++ N +     IP S+  L               L+ L +  N 
Sbjct: 351 EVPELPQNLKQLH---VEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNP 407

Query: 134 FTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
              E PD      ++  LR+N+  +      +    + L      +++  
Sbjct: 408 LR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 21/121 (17%), Positives = 32/121 (26%), Gaps = 28/121 (23%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDL--- 145
            L      L +L       N  L  +P     L   + L +  N    E PD    +   
Sbjct: 331 ELPALPPRLERLI---ASFNH-LAEVPELPQNL---KQLHVEYNPLR-EFPDIPESVEDL 382

Query: 146 -------------GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISAR 192
                         NL  L +  N L    P+    +E L    ++   +          
Sbjct: 383 RMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHET 438

Query: 193 T 193
           T
Sbjct: 439 T 439

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 26/100 (26%), Positives = 43/100 (43%), Gaps = 5/100 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L  L +++L NN I      +   L KLQ L +S N    EIP +L    +L  LR+++
Sbjct: 76  GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHD 132

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           N +        S + ++  +++  N L  S        F 
Sbjct: 133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENS--GFEPGAFD 170

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 30/108 (27%), Positives = 44/108 (40%), Gaps = 7/108 (6%)

Query: 95  GNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
                L  + L +N I   I    L +  KL  L L +N+       SL  L  L  L L
Sbjct: 190 DLPETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201
           +NN L+   P  L  ++ L +V L  NN++    K+    F   G  +
Sbjct: 249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNIT----KVGVNDFCPVGFGV 291

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 19/101 (18%), Positives = 34/101 (33%), Gaps = 10/101 (9%)

Query: 97  LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI--PDSLGDLGNLNYLRLN 154
            + L  + + +N I          L  +  +++  N        P +   L  LNYLR++
Sbjct: 122 PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRIS 180

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
              LTG   +    +  L    L +N +      I      
Sbjct: 181 EAKLTGIPKDLPETLNEL---HLDHNKIQ----AIELEDLL 214

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 11/94 (11%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDS-------LGDLGNL 148
            L  L+ + L NN +   +PA L  L+ LQ + L  N  T ++  +              
Sbjct: 239 FLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296

Query: 149 NYLRLNNNSLTGSC--PESLSKIESLTLVDLSYN 180
           N + L NN +      P +   +     +     
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 7/96 (7%)

Query: 100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
           L+ V   +   L  +P  +        LDL NN  +    D    L +L  L L NN ++
Sbjct: 35  LRVVQCSDLG-LKAVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91

Query: 160 GSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
               ++ S +  L  + +S N+L     +I      
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV----EIPPNLPS 123

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 14/77 (18%), Positives = 26/77 (33%), Gaps = 10/77 (12%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPAS-------LGKLEKLQTLDLSNNKFT-GEI-P 139
            +   + +L  LQ V L  N I   +  +         K      + L NN     E+ P
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313

Query: 140 DSLGDLGNLNYLRLNNN 156
            +   + +   ++  N 
Sbjct: 314 ATFRCVTDRLAIQFGNY 330

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 47/244 (19%), Positives = 80/244 (32%), Gaps = 50/244 (20%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKR-------------------------L 333
           +  +S    LG G FGIV +      G   A+K+                         L
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65

Query: 334 KDY------NIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL--LVYPYMPNGSV 385
            DY                   +        N        +    +   ++  Y+P+ ++
Sbjct: 66  VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124

Query: 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEA 444
              L+  I    ++             R + ++H      I HRD+K  N+L++ +D   
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTL 181

Query: 445 VVGDFGLAKLLDHRDSHVTTAV----RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLEL 499
            + DFG AK L   +  V        R      APE  L   + +   D++  G +  EL
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLWSIGCVFGEL 235

Query: 500 ITGQ 503
           I G+
Sbjct: 236 ILGK 239

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 24/116 (20%), Positives = 49/116 (42%), Gaps = 13/116 (11%)

Query: 96  NLTKLQSVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            +  LQ + +  N++            + L +L++S+N  T  I   L     +  L L+
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLH 429

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS-------GSLPKISARTFKVTGNPLIC 203
           +N +  S P+ + K+E+L  ++++ N L          L  +  +   +  NP  C
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSL--QKIWLHTNPWDC 482

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 29/134 (21%), Positives = 43/134 (32%), Gaps = 26/134 (19%)

Query: 58  TSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPAS 117
             VD  S   +   P        L                T L    +  N I     + 
Sbjct: 3   FLVD-RSKNGLIHVPKD------LSQ------------KTTILN---ISQNYISELWTSD 40

Query: 118 LGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDL 177
           +  L KL+ L +S+N+              L YL L++N L      S     +L  +DL
Sbjct: 41  ILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDL 97

Query: 178 SYNNLSGSLPKISA 191
           S+N    +LP    
Sbjct: 98  SFNAFD-ALPICKE 110

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 20/113 (17%), Positives = 44/113 (38%), Gaps = 5/113 (4%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
                             ++    +   NN +   +  + G L +L+TL L  N+   E+
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363

Query: 139 PDSLG---DLGNLNYLRLNNNSLTGSCPESL-SKIESLTLVDLSYNNLSGSLP 187
                    + +L  L ++ NS++    +   S  +SL  +++S N L+ ++ 
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 26/133 (19%), Positives = 39/133 (29%), Gaps = 3/133 (2%)

Query: 95  GNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN-YLR 152
                L+ + L  NA    PI    G + +L+ L LS           +  L      L 
Sbjct: 87  HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146

Query: 153 LNNNSLTGSCPESLSKIESLTL-VDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNC 211
           L         PE L    + +L +    N     +  +S +T        I      N C
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206

Query: 212 TAVFPEPLSLPPN 224
           +        L  N
Sbjct: 207 SYFLSILAKLQTN 219

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 16/95 (16%), Positives = 32/95 (33%), Gaps = 1/95 (1%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
           +L  L    + ++    P          +   + + +            +    +L  +N
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
           N LT +  E+   +  L  + L  N L   L KI+
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLK-ELSKIA 367

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 21/68 (30%), Positives = 36/68 (52%), Gaps = 3/68 (4%)

Query: 97  LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNYLRLNN 155
             +++ + L +N I   IP  + KLE LQ L++++N+    +PD     L +L  + L+ 
Sbjct: 420 PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHT 477

Query: 156 NSLTGSCP 163
           N    SCP
Sbjct: 478 NPWDCSCP 485

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 22/151 (14%), Positives = 44/151 (29%), Gaps = 8/151 (5%)

Query: 50  NVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNL---TKLQSVLLQ 106
           N+    +          +     +  +S L L +   +      I  L   T +    + 
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255

Query: 107 NNAILGPI-----PASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGS 161
           N  + G +       S   L+ L    + ++ F            N+N      +     
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315

Query: 162 CPESLSKIESLTLVDLSYNNLSGSLPKISAR 192
                SKI     +D S N L+ ++ +    
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGH 346

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 24/132 (18%), Positives = 44/132 (33%), Gaps = 14/132 (10%)

Query: 96  NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
           +LTKLQ + + N      I       L  L+ L++  +      P SL  + N+++L L+
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG----SLPKISARTFK---------VTGNPL 201
                      +    S+  ++L   +L       L      +           +T   L
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266

Query: 202 ICGPKATNNCTA 213
               K  N  + 
Sbjct: 267 FQVMKLLNQISG 278

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 18/123 (14%), Positives = 44/123 (35%), Gaps = 18/123 (14%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG----EIP----DSLGDLGN 147
           ++  +  ++L     +  +   +     ++ L+L +         E+     +SL     
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255

Query: 148 LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG-------SLPKISARTFKVTGNP 200
              +++ + SL     + L++I  L  ++ S N L          L  +  +   +  NP
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSL--QKIWLHTNP 312

Query: 201 LIC 203
             C
Sbjct: 313 WDC 315

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 23/122 (18%), Positives = 41/122 (33%), Gaps = 29/122 (23%)

Query: 96  NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFT------------------- 135
           +L  L+ + L  N  L  + +S    L  L  L+L  N +                    
Sbjct: 98  SLGSLEHLDLSYNY-LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156

Query: 136 ------GEIPD-SLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
                  +I       L  L  L ++ + L    P+SL  I++++ + L        L +
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLE 215

Query: 189 IS 190
           I 
Sbjct: 216 IF 217

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 17/85 (20%), Positives = 34/85 (40%), Gaps = 3/85 (3%)

Query: 80  GLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP 139
                 LS   +  +      ++V + + ++   +   L ++  L  L+ S N+    +P
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VP 293

Query: 140 DS-LGDLGNLNYLRLNNNSLTGSCP 163
           D     L +L  + L+ N    SCP
Sbjct: 294 DGIFDRLTSLQKIWLHTNPWDCSCP 318

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 50.5 bits (121), Expect = 9e-07
 Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 7/114 (6%)

Query: 81  LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD 140
           + S S   + +    +  +       + + L  IP+ L   E +++LDLSNN+ T     
Sbjct: 14  IISLSKEESSNQASLSCDRNGICKGSSGS-LNSIPSGL--TEAVKSLDLSNNRITYISNS 70

Query: 141 SLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
            L    NL  L L +N +     +S S + SL  +DLSYN LS     +S+  F
Sbjct: 71  DLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS----NLSSSWF 120

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 17/158 (10%)

Query: 58  TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPWI-GNLTKLQSVLLQNNAILGP 113
             VD C  + +T  P      ++ + L   ++   + P       KL+ + L NN  +  
Sbjct: 14  NIVD-CRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQ-ISE 70

Query: 114 IPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNNSLTGSCPESLSKIES 171
           +   +   L  L +L L  NK T E+P SL + L +L  L LN N +     ++   + +
Sbjct: 71  LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN 129

Query: 172 LTLVDLSYNNLSGSLPK------ISARTFKVTGNPLIC 203
           L L+ L  N L  ++ K       + +T  +  NP IC
Sbjct: 130 LNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFIC 166

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 16/68 (23%), Positives = 24/68 (35%), Gaps = 2/68 (2%)

Query: 96  NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            L  LQ +LL  N  +  +   +   L  L  L L +NK       +   L  +  + L 
Sbjct: 102 GLFSLQLLLLNANK-INCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA 160

Query: 155 NNSLTGSC 162
            N     C
Sbjct: 161 QNPFICDC 168

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 9/106 (8%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L  L  + L  N+I      SL     L+ L L+NNK   ++P  L D   +  + L+N
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272

Query: 156 NSLTG------SCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           N+++         P   +K  S + V L  N +     +I   TF+
Sbjct: 273 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW--EIQPSTFR 316

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 33/105 (31%), Positives = 44/105 (41%), Gaps = 7/105 (6%)

Query: 95  GNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           G    L  + L  N I   + A SL  L  L  L LS N  +     SL +  +L  L L
Sbjct: 189 GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTG 198
           NNN L    P  L+  + + +V L  NN+S     I +  F   G
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS----AIGSNDFCPPG 287

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 23/102 (22%), Positives = 44/102 (43%), Gaps = 9/102 (8%)

Query: 96  NLTKLQSVLLQNNAI-LGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
            L ++  V L  N +    I   +   ++KL  + +++   T  IP  L    +L  L L
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHL 199

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           + N +T     SL  + +L  + LS+N++S     +   +  
Sbjct: 200 DGNKITKVDAASLKGLNNLAKLGLSFNSIS----AVDNGSLA 237

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 27/95 (28%), Positives = 39/95 (41%), Gaps = 7/95 (7%)

Query: 100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
              + LQNN I          L+ L TL L NNK +   P +   L  L  L L+ N L 
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113

Query: 160 GSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
              PE + K  +L  + +  N ++    K+    F
Sbjct: 114 -ELPEKMPK--TLQELRVHENEIT----KVRKSVF 141

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 17/101 (16%), Positives = 37/101 (36%), Gaps = 9/101 (8%)

Query: 97  LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI--PDSLGDLGNLNYLRLN 154
              LQ + +  N I     +    L ++  ++L  N          +   +  L+Y+R+ 
Sbjct: 120 PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           + ++T         +  L    L  N ++    K+ A + K
Sbjct: 180 DTNITTIPQGLPPSLTEL---HLDGNKIT----KVDAASLK 213

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 11/94 (11%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDS-------LGDLGNL 148
           N   L+ + L NN ++  +P  L   + +Q + L NN  +  I  +            + 
Sbjct: 238 NTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASY 295

Query: 149 NYLRLNNNSLTGSC--PESLSKIESLTLVDLSYN 180
           + + L +N +      P +   +     V L   
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 26/96 (27%), Positives = 40/96 (41%), Gaps = 7/96 (7%)

Query: 100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
           L+ V   +   L  +P  L        LDL NNK T        +L NL+ L L NN ++
Sbjct: 33  LRVVQCSDLG-LEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 160 GSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
              P + + +  L  + LS N L     ++  +  K
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLK----ELPEKMPK 121

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 15/76 (19%), Positives = 25/76 (32%), Gaps = 8/76 (10%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAI------LGPIPASLGKLEKLQTLDLSNNKFT-GEI-PD 140
            +   + +   +Q V L NN I          P    K      + L +N     EI P 
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313

Query: 141 SLGDLGNLNYLRLNNN 156
           +   +     ++L N 
Sbjct: 314 TFRCVYVRAAVQLGNY 329

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 34/159 (21%), Positives = 64/159 (40%), Gaps = 18/159 (11%)

Query: 58  TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPWIG--NLTKLQSVLLQNNAILG 112
           T+VD CS + +   P+    Y + L L +   +  L        L +L+ +   NN I  
Sbjct: 14  TTVD-CSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD 71

Query: 113 PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNNSLTGSCPESLSKIES 171
               +      +  + L++N+    +   +   L +L  L L +N +T    +S   + S
Sbjct: 72  IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSS 130

Query: 172 LTLVDLSYNNLSG-------SLPKISARTFKVTGNPLIC 203
           + L+ L  N ++        +L  +S  T  +  NP  C
Sbjct: 131 VRLLSLYDNQITTVAPGAFDTLHSLS--TLNLLANPFNC 167

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 17/69 (24%), Positives = 33/69 (47%), Gaps = 4/69 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
            L  L++++L++N  +  +   S   L  ++ L L +N+ T  +     D L +L+ L L
Sbjct: 103 GLESLKTLMLRSNR-ITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNL 160

Query: 154 NNNSLTGSC 162
             N    +C
Sbjct: 161 LANPFNCNC 169

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 34/135 (25%), Positives = 52/135 (38%), Gaps = 35/135 (25%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL-----------------QTLDLSN 131
           +L      L +L    + +N  L  +P    +L KL                 + L +S 
Sbjct: 175 SLPMLPSGLQELS---VSDNQ-LASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSG 230

Query: 132 NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK--- 188
           N+ T  +P    +L  L    ++ N LT S P   S + SL    +  N L+  LP+   
Sbjct: 231 NRLT-SLPVLPSELKELM---VSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLI 281

Query: 189 --ISARTFKVTGNPL 201
              S  T  + GNPL
Sbjct: 282 HLSSETTVNLEGNPL 296

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 21/116 (18%), Positives = 37/116 (31%), Gaps = 10/116 (8%)

Query: 97  LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156
                 + +  +  L  +P  L     + TL + +N  T  +P        L  L ++ N
Sbjct: 39  NNGNAVLNVGESG-LTTLPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVSGN 91

Query: 157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCT 212
            LT S P     +  L++      +L      +      + GN L   P       
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALPSGL--CKLWIFGNQLTSLPVLPPGLQ 144

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 27/124 (21%), Positives = 42/124 (33%), Gaps = 25/124 (20%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
           L +P  +L+ +L      L  L+   +  N  L  +P     L +L             +
Sbjct: 66  LVIPDNNLT-SLPALPPELRTLE---VSGNQ-LTSLPVLPPGLLELSIFSNPLTHLP-AL 119

Query: 139 PDSLGDL--------------GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
           P  L  L                L  L +++N L  S P   S++  L       N L+ 
Sbjct: 120 PSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT- 174

Query: 185 SLPK 188
           SLP 
Sbjct: 175 SLPM 178

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 26/113 (23%), Positives = 45/113 (39%), Gaps = 14/113 (12%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
           +L      L +L    + +N +   +PA   +L KL      NN+ T  +P        L
Sbjct: 135 SLPVLPPGLQELS---VSDNQLAS-LPALPSELCKL---WAYNNQLT-SLPML---PSGL 183

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201
             L +++N L  S P   S++  L   +    +L      +  +   V+GN L
Sbjct: 184 QELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGL--KELIVSGNRL 233

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 15/91 (16%), Positives = 30/91 (32%), Gaps = 4/91 (4%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
           +L      L  L    +  N  L  +P SL  L    T++L  N  +     +L ++ + 
Sbjct: 255 SLPMLPSGLLSLS---VYRNQ-LTRLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSY 179
                       +   +  +  +L L    +
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALHLAAADW 341

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 27/139 (19%), Positives = 51/139 (36%), Gaps = 18/139 (12%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + + T+L  +  Q   I   +   L +  KL  L L+N + T E+   +     L  L  
Sbjct: 293 VTHNTQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSC 346

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTA 213
            N  +       + KI +L     +      ++PK +     +T            +   
Sbjct: 347 VNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVS-------PDLLD 396

Query: 214 VFPEPLSLPP--NGLKDQS 230
            F  P+++ P   G+ DQ+
Sbjct: 397 QFGNPMNIEPGDGGVYDQA 415

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 21/99 (21%), Positives = 38/99 (38%), Gaps = 10/99 (10%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
                +   T+L ++    N I       + + + L  L+   N  T ++   L     L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKI---TELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQL 214

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
            +L  ++N LT      ++ +  LT  D S N L+  L 
Sbjct: 215 TFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELD 249

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 60.5 bits (147), Expect = 7e-10
 Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 9/90 (10%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           I  LT L  ++  +N I   +   L +   L  L   +NK T  +   +  L  L YL  
Sbjct: 60  IEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNC 113

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           + N LT      +S+   LT ++ + N L+
Sbjct: 114 DTNKLTKL---DVSQNPLLTYLNCARNTLT 140

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 8/99 (8%)

Query: 85  SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
            +  T +     L  L S+   N++I   +   + KL  L  L  ++N  T  +   L  
Sbjct: 29  EMQATDTISEEQLATLTSLDCHNSSITD-MTG-IEKLTGLTKLICTSNNIT-TLD--LSQ 83

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
             NL YL  ++N LT      ++ +  LT ++   N L+
Sbjct: 84  NTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT 119

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 22/94 (23%), Positives = 35/94 (37%), Gaps = 9/94 (9%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +   T L  +   +N +   +   +  L KL  L+   NK T ++   +     L YL  
Sbjct: 81  LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNC 134

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
             N+LT      +S    LT +D   N     L 
Sbjct: 135 ARNTLT---EIDVSHNTQLTELDCHLNKKITKLD 165

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 18/90 (20%), Positives = 28/90 (31%), Gaps = 8/90 (8%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +  LT+L       N +   +  S   L KL TL         EI   L     L Y + 
Sbjct: 229 VTPLTQLTYFDCSVNPL-TELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQA 282

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
                       ++    L L+D     ++
Sbjct: 283 EGCRKI--KELDVTHNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 17/114 (14%), Positives = 38/114 (33%), Gaps = 18/114 (15%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
           +     L  +    N +  +      +    +L  LD   NK   ++   +     L  L
Sbjct: 123 VSQNPLLTYLNCARNTLTEI-----DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTL 175

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS----GSLPKISARTFKVTGNPL 201
             + N +T      +S+ + L  ++   NN++        ++       + N L
Sbjct: 176 DCSFNKITEL---DVSQNKLLNRLNCDTNNITKLDLNQNIQL--TFLDCSSNKL 224

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 20/88 (22%), Positives = 36/88 (40%), Gaps = 6/88 (6%)

Query: 100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
             S +     +      S  +L  L +LD  N+  T ++   +  L  L  L   +N++T
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77

Query: 160 GSCPESLSKIESLTLVDLSYNNLSGSLP 187
                 LS+  +LT +    N L+ +L 
Sbjct: 78  T---LDLSQNTNLTYLACDSNKLT-NLD 101

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 17/101 (16%), Positives = 35/101 (34%), Gaps = 7/101 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + + TKL+S+   N  I      S+GK+  L     +  +    +P       +L     
Sbjct: 335 VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVS 391

Query: 154 NNN-SLTG---SCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
            +     G   +       +       +++ NLS   P ++
Sbjct: 392 PDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVT 432

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 23/116 (19%), Positives = 36/116 (31%), Gaps = 27/116 (23%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL-----------------QTLDLSN 131
            L      L  +      NN  L  +P     LE L                 + LD+S 
Sbjct: 134 MLPELPALLEYIN---ADNNQ-LTMLPELPTSLEVLSVRNNQLTFLPELPESLEALDVST 189

Query: 132 NKFTGEIPDSLGDLGNL----NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           N     +P       +      + R   N +T   PE++  ++    + L  N LS
Sbjct: 190 NLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS 243

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 27/129 (20%), Positives = 45/129 (34%), Gaps = 12/129 (9%)

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
                          K        N  +  +   L  + +   L L+    +  +PD+L 
Sbjct: 23  SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLP 79

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI--SARTFKVTGNPL 201
               +  L +  N+L  S PE  + +E L   D   N LS +LP++  S +   V  N L
Sbjct: 80  P--QITVLEITQNALI-SLPELPASLEYL---DACDNRLS-TLPELPASLKHLDVDNNQL 132

Query: 202 ICGPKATNN 210
              P+    
Sbjct: 133 TMLPELPAL 141

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 32/99 (32%), Positives = 44/99 (44%), Gaps = 16/99 (16%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
           TL     +L  L    + NN  L  +P     LE +   +  NN+ T  +P+      +L
Sbjct: 114 TLPELPASLKHLD---VDNNQ-LTMLPELPALLEYI---NADNNQLT-MLPEL---PTSL 162

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
             L + NN LT   PE     ESL  +D+S N L  SLP
Sbjct: 163 EVLSVRNNQLT-FLPELP---ESLEALDVSTNLLE-SLP 196

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 14/104 (13%), Positives = 27/104 (25%), Gaps = 7/104 (6%)

Query: 89  TLSPWIGNLTKLQSVL----LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
           +L          +        + N I   IP ++  L+   T+ L +N  +  I +SL  
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQ 252

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
                         +    +         L D        +   
Sbjct: 253 QTAQPDYHGPRIYFS--MSDGQQNTLHRPLADAVTAWFPENKQS 294

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 38/159 (23%), Positives = 57/159 (35%), Gaps = 24/159 (15%)

Query: 306 KNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
             +LG G  G V +  F        A+K L+D   A  EV+          +   +++R+
Sbjct: 23  SQVLGLGINGKVLQ-IFNKRTQEKFALKMLQDCPKARREVELHWR-----ASQCPHIVRI 76

Query: 364 CGFC----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK--RIALGTARGLLY 417
                   +     L+V   +  G     L   I  R    +  R+   I       + Y
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 418 LHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAK 453
           LH      I HRDVK  N+L      +    + DFG AK
Sbjct: 133 LHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 23/114 (20%), Positives = 46/114 (40%), Gaps = 10/114 (8%)

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSL 142
            ++S         L +L+ +  Q++ +      S+   L  L  LD+S+           
Sbjct: 91  ITMSSNFL----GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146

Query: 143 GDLGNLNYLRL-NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
             L +L  L++  N+      P+  +++ +LT +DLS   L     ++S   F 
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE----QLSPTAFN 196

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 24/98 (24%), Positives = 44/98 (44%), Gaps = 7/98 (7%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT--GEIPDSLGDLGNLNYLRL 153
           + T+L+   L++N +         KL +L  L LS+N  +  G    S     +L YL L
Sbjct: 29  SATRLE---LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA 191
           + N +  +   +   +E L  +D  ++NL   + + S 
Sbjct: 86  SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSV 121

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 1/89 (1%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L  L  + L    +    P +   L  LQ L++S+N F          L +L  L  + 
Sbjct: 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232

Query: 156 NSLTGSCPESLSKI-ESLTLVDLSYNNLS 183
           N +  S  + L     SL  ++L+ N+ +
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 6/89 (6%)

Query: 101 QSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT- 159
             +   +   L  +P  +        L+L +NK           L  L  L L++N L+ 
Sbjct: 10  TEIRCNSKG-LTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 160 -GSCPESLSKIESLTLVDLSYNNLSGSLP 187
            G C +S     SL  +DLS+N +  ++ 
Sbjct: 67  KGCCSQSDFGTTSLKYLDLSFNGVI-TMS 94

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 17/69 (24%), Positives = 25/69 (36%), Gaps = 1/69 (1%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDL-GNLNYLRLN 154
           +L+ LQ + + +N            L  LQ LD S N         L     +L +L L 
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 256

Query: 155 NNSLTGSCP 163
            N    +C 
Sbjct: 257 QNDFACTCE 265

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 48/224 (21%)

Query: 309 LGRGGFGIVYKGCFSD---GALVAVKRLKDYNI---AGGEVQFQTEVETISLAVHRNLLR 362
           +GRG +G VYK    D       A+K+++   I   A  E+    E++      H N++ 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELK------HPNVIS 82

Query: 363 LCG-FCSTENERL-LVYPYMPNGSVASRLRDHIHGRPA-----LDWARRKRIALGTARGL 415
           L   F S  + ++ L++ Y  +  +   ++ H   +       L     K +      G+
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAV----VGDFGLA-------KLLDHRDSHVTT 464
            YLH      ++HRD+K ANIL+  +        + D G A       K L   D  V T
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198

Query: 465 AVRGTVGHI---APEYL--STGQSSEKTDVFGFGILLLELITGQ 503
                       APE L  +   +    D++  G +  EL+T +
Sbjct: 199 --------FWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTSE 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 64.7 bits (157), Expect = 5e-11
 Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 10/92 (10%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
           + NL  L  + L  N I  L      L  L+KL++L L +N  + +I + L  L  L  L
Sbjct: 83  LTNLKNLGWLFLDENKIKDLSS----LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESL 136

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            L NN +T      LS++  L  + L  N +S
Sbjct: 137 YLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 61.3 bits (148), Expect = 5e-10
 Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 6/90 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + +L +L+S+ L NN I       L +L KL TL L +N+ + +I   L  L  L  L L
Sbjct: 127 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYL 182

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           + N ++     +L+ +++L +++L      
Sbjct: 183 SKNHIS--DLRALAGLKNLDVLELFSQECL 210

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 10/92 (10%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
           I  L  +  + L  N +  + P    L  L+ L  L L  NK   ++  SL DL  L  L
Sbjct: 61  IQYLPNVTKLFLNGNKLTDIKP----LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSL 114

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            L +N ++      L  +  L  + L  N ++
Sbjct: 115 SLEHNGIS--DINGLVHLPQLESLYLGNNKIT 144

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 23/92 (25%), Positives = 41/92 (44%), Gaps = 10/92 (10%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
              L  +  ++  N+ I  +      +  L  +  L L+ NK T +I   L +L NL +L
Sbjct: 39  QNELNSIDQIIANNSDIKSVQG----IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWL 92

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            L+ N +      SL  ++ L  + L +N +S
Sbjct: 93  FLDENKIK--DLSSLKDLKKLKSLSLEHNGIS 122

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 56.3 bits (135), Expect = 2e-08
 Identities = 16/88 (18%), Positives = 35/88 (39%), Gaps = 6/88 (6%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
              +     L+  ++   +     +L  +  +  +N+     +   +  L N+  L LN 
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
           N LT   P  L+ +++L  + L  N + 
Sbjct: 75  NKLTDIKP--LTNLKNLGWLFLDENKIK 100

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 11/86 (12%), Positives = 33/86 (38%), Gaps = 10/86 (11%)

Query: 100 LQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
           +   +  +  I  + P         +    +L     T  +     +L +++ +  NN+ 
Sbjct: 1   MGETITVSTPIKQIFPDD----AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD 54

Query: 158 LTGSCPESLSKIESLTLVDLSYNNLS 183
           +     + +  + ++T + L+ N L+
Sbjct: 55  IKSV--QGIQYLPNVTKLFLNGNKLT 78

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 20/90 (22%), Positives = 39/90 (43%), Gaps = 4/90 (4%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +  LTKLQ++ L  N I      +L  L+ L  L+L + +   +  +   +L   N ++ 
Sbjct: 171 LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 228

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            + SL    PE +S        ++ ++   
Sbjct: 229 TDGSLV--TPEIISDDGDYEKPNVKWHLPE 256

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 6/90 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +  LT LQ + + N  +    P  L  L KL TL   +NK + +I   L  L NL  + L
Sbjct: 147 LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHL 202

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            NN ++      L+   +L +V L+   ++
Sbjct: 203 KNNQISDV--SPLANTSNLFIVTLTNQTIT 230

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 25/115 (21%), Positives = 47/115 (40%), Gaps = 13/115 (11%)

Query: 92  PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
             +  L+ LQ + L  N I   I   L  L  LQ L + N + + ++   L +L  L  L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTL 178

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS-----GSLPKISARTFKVTGNPL 201
           + ++N ++      L+ + +L  V L  N +S      +   +      +T   +
Sbjct: 179 KADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPLANTSNL--FIVTLTNQTI 229

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 22/90 (24%), Positives = 42/90 (46%), Gaps = 6/90 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +  L  L  + L++N I    P  L  L K+  L+LS N     +  ++  L ++  L L
Sbjct: 59  VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDL 114

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            +  +T   P  L+ + +L ++ L  N ++
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQIT 142

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 19/88 (21%), Positives = 32/88 (36%), Gaps = 6/88 (6%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L     +    + +   +      L+ + TL       T  I   +  L NL  L L +
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
           N +T      L  +  +T ++LS N L 
Sbjct: 73  NQITD--LAPLKNLTKITELELSGNPLK 98

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 17/90 (18%), Positives = 41/90 (45%), Gaps = 6/90 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
             +L  + ++      +   I   +  L  L  L+L +N+ T ++   L +L  +  L L
Sbjct: 37  QADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELEL 92

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           + N L      +++ ++S+  +DL+   ++
Sbjct: 93  SGNPLKN--VSAIAGLQSIKTLDLTSTQIT 120

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 4/90 (4%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + +L  L  V L+NN I    P  L     L  + L+N   T +      +L   N ++ 
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKG 248

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            + +     P ++S   +    +L++N  S
Sbjct: 249 PSGAPI--APATISDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 14/80 (17%), Positives = 27/80 (33%), Gaps = 6/80 (7%)

Query: 104 LLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP 163
           + Q  AI    P     L     +    +  T  +     DL  +  L      +T    
Sbjct: 3   ITQPTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI-- 56

Query: 164 ESLSKIESLTLVDLSYNNLS 183
           E +  + +L  ++L  N ++
Sbjct: 57  EGVQYLNNLIGLELKDNQIT 76

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 51/220 (23%), Positives = 80/220 (36%), Gaps = 36/220 (16%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQT---------EV 349
              +     +G G  GIV           VA+K+L           FQ          E+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75

Query: 350 ETISLAVHRNLLRL------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR 403
             +    H+N++ L              +  +V   M      + L   I     LD  R
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQME--LDHER 128

Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
              +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+      S + 
Sbjct: 129 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMM 183

Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
           T    T  + APE +      E  D++  G ++ E+I G 
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 19/96 (19%), Positives = 43/96 (44%), Gaps = 5/96 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRL 153
           NL  +  + +  +  L  + + S   L K+  +++ N +    I  D+L +L  L +L +
Sbjct: 53  NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112

Query: 154 NNNSLTGSCPE--SLSKIESLTLVDLSYNNLSGSLP 187
            N  L    P+   +   +   +++++ N    S+P
Sbjct: 113 FNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 22/98 (22%), Positives = 44/98 (44%), Gaps = 6/98 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASL--GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
           + +      + + +N  +  IP +   G   +  TL L NN FT  +     +   L+ +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184

Query: 152 RL-NNNSLTGSCPESLSKIES-LTLVDLSYNNLSGSLP 187
            L  N  LT    ++   + S  +L+D+S  +++ +LP
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP 221

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 22/106 (20%), Positives = 43/106 (40%), Gaps = 13/106 (12%)

Query: 96  NLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGN-LNYLR 152
            L  L+ + + N  +   P    +   +    L++++N +   IP ++   L N    L+
Sbjct: 103 ELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162

Query: 153 LNNNSLTGSCPE---SLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
           L NN  T S      + +K++++    L+ N     L  I    F 
Sbjct: 163 LYNNGFT-SVQGYAFNGTKLDAV---YLNKNKY---LTVIDKDAFG 201

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 19/70 (27%), Positives = 26/70 (37%), Gaps = 5/70 (7%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASL--GKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
           ++  +  N TKL +V L  N  L  I      G       LD+S    T  +P     L 
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LE 226

Query: 147 NLNYLRLNNN 156
           +L  L   N 
Sbjct: 227 HLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 14/74 (18%), Positives = 29/74 (39%), Gaps = 6/74 (8%)

Query: 124 LQTLDLSNNKFTGEIP-DSLGDLGNLNYLRLN-NNSLTGSCPESLSKIESLTLVDLSYNN 181
            QTL L        IP  +  +L N++ + ++ + +L      S   +  +T +++    
Sbjct: 33  TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 182 LSGSLPKISARTFK 195
              +L  I     K
Sbjct: 92  ---NLTYIDPDALK 102

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 34/202 (16%), Positives = 75/202 (37%), Gaps = 31/202 (15%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVET------I 352
              +  ++++G G +G V +     +  +VA+K++           F+  ++       I
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--------VFEDLIDCKRILREI 103

Query: 353 SL---AVHRNLLRLCGFCSTENERL-----LVYPYMPNGSVASRLRDHIHGRPALDWARR 404
           ++     H +++++      ++        +V          S  +        L     
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-----SDFKKLFRTPVYLTELHI 158

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
           K +      G+ Y+H      I+HRD+K AN L+++D    V DFGLA+ +D+ ++  + 
Sbjct: 159 KTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 465 AVRGTVGHIAPEYLSTGQSSEK 486
                              + K
Sbjct: 216 LPISPREDDMNLVTFPHTKNLK 237

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 26/107 (24%), Positives = 49/107 (45%), Gaps = 13/107 (12%)

Query: 96  NLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGNLNYLR 152
            L+ LQ ++     +  L   P   G L+ L+ L++++N     ++P+   +L NL +L 
Sbjct: 98  GLSSLQKLVAVETNLASLENFPI--GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155

Query: 153 LNNNSLTGSCPESLSKIESLTLV----DLSYNNLSGSLPKISARTFK 195
           L++N +       L  +  + L+    DLS N ++     I    FK
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN----FIQPGAFK 198

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 19/100 (19%), Positives = 36/100 (36%), Gaps = 5/100 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
           +  +LQ + L    I   I       L  L TL L+ N        +   L +L  L   
Sbjct: 50  SFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
             +L       +  +++L  +++++N +  S        F
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQ-SFK--LPEYF 145

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 24/89 (26%), Positives = 34/89 (38%), Gaps = 5/89 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQ----TLDLSNNKFTGEIPDSLGDLGNLNYL 151
           NLT L+ + L +N I       L  L ++     +LDLS N     I         L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYN 180
            L+ N L         ++ SL  + L  N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 16/72 (22%), Positives = 26/72 (36%), Gaps = 5/72 (6%)

Query: 96  NLTKLQSVL----LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
            L ++  +     L  N +   I     K  +L+ L L  N+           L +L  +
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKI 229

Query: 152 RLNNNSLTGSCP 163
            L+ N    SCP
Sbjct: 230 WLHTNPWDCSCP 241

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 28/92 (30%), Positives = 43/92 (46%), Gaps = 10/92 (10%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
           + NL  L  + L  N +  L      L  L+KL++L L +N  + +I + L  L  L  L
Sbjct: 86  LANLKNLGWLFLDENKVKDLSS----LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESL 139

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            L NN +T      LS++  L  + L  N +S
Sbjct: 140 YLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 169

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 6/90 (6%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           + +L +L+S+ L NN I       L +L KL TL L +N+ + +I   L  L  L  L L
Sbjct: 130 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYL 185

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           + N ++     +L+ +++L +++L      
Sbjct: 186 SKNHISD--LRALAGLKNLDVLELFSQECL 213

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 10/92 (10%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
           I  L  +  + L  N +  + P    L  L+ L  L L  NK   ++  SL DL  L  L
Sbjct: 64  IQYLPNVTKLFLNGNKLTDIKP----LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSL 117

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            L +N ++      L  +  L  + L  N ++
Sbjct: 118 SLEHNGIS--DINGLVHLPQLESLYLGNNKIT 147

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 23/92 (25%), Positives = 41/92 (44%), Gaps = 10/92 (10%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
              L  +  ++  N+ I  +      +  L  +  L L+ NK T +I   L +L NL +L
Sbjct: 42  QNELNSIDQIIANNSDIKSVQG----IQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWL 95

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            L+ N +      SL  ++ L  + L +N +S
Sbjct: 96  FLDENKVK--DLSSLKDLKKLKSLSLEHNGIS 125

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 16/88 (18%), Positives = 35/88 (39%), Gaps = 6/88 (6%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
              +     L+  ++   +     +L  +  +  +N+     +   +  L N+  L LN 
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
           N LT   P  L+ +++L  + L  N + 
Sbjct: 78  NKLTDIKP--LANLKNLGWLFLDENKVK 103

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 8/92 (8%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
           +  LTKLQ++ L  N I  L      L  L+ L  L+L + +   +  +   +L   N +
Sbjct: 174 LAGLTKLQNLYLSKNHISDLRA----LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           +  + SL    PE +S        ++ ++   
Sbjct: 230 KNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 10/80 (12%), Positives = 29/80 (36%), Gaps = 6/80 (7%)

Query: 104 LLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP 163
           +     I            +    +L     T  +     +L +++ +  NN+ +     
Sbjct: 8   ITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-- 61

Query: 164 ESLSKIESLTLVDLSYNNLS 183
           + +  + ++T + L+ N L+
Sbjct: 62  QGIQYLPNVTKLFLNGNKLT 81

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 32/122 (26%), Positives = 50/122 (40%), Gaps = 10/122 (8%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LG 146
           +L      L  L  + +  N +   +P      L +LQ L L  N+    +P  L     
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148

Query: 147 NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK-----ISARTFKVTGNPL 201
            L  L L NN+LT      L+ +E+L  + L  N+L  ++PK            + GNP 
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

Query: 202 IC 203
           +C
Sbjct: 208 LC 209

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 23/92 (25%), Positives = 32/92 (34%), Gaps = 6/92 (6%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            +     V       L  +P  L   +    L LS N        +L     L  L L+ 
Sbjct: 8   KVASHLEVNCDKRN-LTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
             LT    +    +  L  +DLS+N L  SLP
Sbjct: 65  AELTK--LQVDGTLPVLGTLDLSHNQLQ-SLP 93

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 54/254 (21%), Positives = 90/254 (35%), Gaps = 39/254 (15%)

Query: 269 QQIFFDVNDQYDPEVSLGHLKRYTFKELRAA---TSNFSAKNILGRGGFGIVYKG-CFSD 324
           Q     +   Y+   S    + Y+ +   +       +     +G G  GIV        
Sbjct: 27  QVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL 86

Query: 325 GALVAVKRLKDYNIAGGEVQFQT---------EVETISLAVHRNLLRL------CGFCST 369
              VA+K+L           FQ          E+  +    H+N++ L            
Sbjct: 87  DRNVAIKKLSR--------PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138

Query: 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHR 429
             +  LV   M      + L   I     LD  R   +      G+ +LH      IIHR
Sbjct: 139 FQDVYLVMELMD-----ANLCQVIQME--LDHERMSYLLYQMLCGIKHLH---SAGIIHR 188

Query: 430 DVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 489
           D+K +NI++  D    + DFGLA+      S + T    T  + APE +      E  D+
Sbjct: 189 DLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246

Query: 490 FGFGILLLELITGQ 503
           +  G ++ E++  +
Sbjct: 247 WSVGCIMGEMVRHK 260

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 59.6 bits (145), Expect = 9e-10
 Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 48/226 (21%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQT---------EV 349
            + +     +G G +G V        GA VA+K+L           FQ+         E+
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75

Query: 350 ETISLAVHRNLLRL------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR 403
             +    H N++ L              +  LV P+M      + L   +     L   R
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHEK-LGEDR 129

Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
            + +     +GL Y+H      IIHRD+K  N+ ++ED E  + DFGLA+     DS +T
Sbjct: 130 IQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMT 183

Query: 464 TAV-----RGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
             V     R      APE  L+  + ++  D++  G ++ E+ITG+
Sbjct: 184 GYVVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 60.3 bits (146), Expect = 9e-10
 Identities = 26/127 (20%), Positives = 58/127 (45%), Gaps = 12/127 (9%)

Query: 84  QSLSGTLSPWIGNLTKLQSVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
           ++     +    N++ L+++ +  N++       +    E +  L+LS+N  TG +   L
Sbjct: 390 KNFFKV-ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448

Query: 143 GDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK------ISARTFKV 196
                +  L L+NN +  S P+ ++ +++L  ++++ N L  S+P        S +   +
Sbjct: 449 --PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWL 504

Query: 197 TGNPLIC 203
             NP  C
Sbjct: 505 HDNPWDC 511

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 19/91 (20%), Positives = 38/91 (41%), Gaps = 8/91 (8%)

Query: 96  NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            L++L+ + L +N  +  +   +    + L+ LD+S+N+    I      + +L +L L+
Sbjct: 74  FLSELRVLRLSHN-RIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLS 129

Query: 155 NNSLTGSCPES--LSKIESLTLVDLSYNNLS 183
            N      P       +  LT + LS     
Sbjct: 130 FNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR 159

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 16/89 (17%), Positives = 30/89 (33%), Gaps = 1/89 (1%)

Query: 105 LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPE 164
           ++N   L    A      ++    LS +              +  +L    N  T S  +
Sbjct: 312 VKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQ 371

Query: 165 SLSKIESLTLVDLSYNNLSGSLPKISART 193
             S ++ L  + L  N L  +  K++  T
Sbjct: 372 GCSTLKRLQTLILQRNGLK-NFFKVALMT 399

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 20/162 (12%), Positives = 45/162 (27%), Gaps = 11/162 (6%)

Query: 44  NLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSV 103
           +L      L + +   +      +        V+   + +                ++ +
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281

Query: 104 LLQNNAILGPIP-----ASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL 158
            + N  I   I       S   L+ L    + N  F             +N   L+ +  
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341

Query: 159 TG---SCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVT 197
                 CP S S    L   + + N  + S+ +  +   ++ 
Sbjct: 342 PFIHMVCPPSPSSFTFL---NFTQNVFTDSVFQGCSTLKRLQ 380

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 16/74 (21%), Positives = 29/74 (39%), Gaps = 7/74 (9%)

Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
           +P         + L LS N  +      +  L  L  LRL++N +           + L 
Sbjct: 50  LPPRT------KALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE 103

Query: 174 LVDLSYNNLSGSLP 187
            +D+S+N L  ++ 
Sbjct: 104 YLDVSHNRLQ-NIS 116

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.9 bits (106), Expect = 6e-05
 Identities = 23/95 (24%), Positives = 35/95 (36%), Gaps = 2/95 (2%)

Query: 95  GNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG-NLNYLR 152
             +  L+ + L  N     P+    G L KL  L LS  KF       +  L  +   L 
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177

Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           L +  + G   ESL    +  L  + + N   S+ 
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 6/72 (8%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNYLRLN 154
            +  L    L NN  +  IP  +  L+ LQ L++++N+    +PD     L +L Y+ L+
Sbjct: 451 KVKVLD---LHNNR-IMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505

Query: 155 NNSLTGSCPESL 166
           +N    +CP   
Sbjct: 506 DNPWDCTCPGIR 517

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 49/137 (35%), Positives = 69/137 (50%), Gaps = 13/137 (9%)

Query: 58  TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPWI-GNLTKLQSVLLQNNAILGP 113
            SVD CS + +T  P         L L S  LS +L       LTKL+ + L +N  L  
Sbjct: 19  NSVD-CSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNK-LQT 75

Query: 114 IPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNNSLTGSCPESL-SKIE 170
           +PA +  +L+ L+TL +++NK    +P  + D L NL  LRL+ N L  S P  +   + 
Sbjct: 76  LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLT 133

Query: 171 SLTLVDLSYNNLSGSLP 187
            LT + L YN L  SLP
Sbjct: 134 KLTYLSLGYNELQ-SLP 149

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 30/116 (25%), Positives = 46/116 (39%), Gaps = 11/116 (9%)

Query: 96  NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
            L  L  + L  N +   +P  +   L KL  L L  N+    +P  + D L +L  LRL
Sbjct: 107 QLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRL 164

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK------ISARTFKVTGNPLIC 203
            NN L      +  K+  L  + L  N L   +P+         +  ++  NP  C
Sbjct: 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWDC 219

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 34/113 (30%), Positives = 50/113 (44%), Gaps = 9/113 (7%)

Query: 79  LGLPSQSLSGTLSPWI-GNLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTG 136
           L L    L  TL   I   L  L+++ + +N  L  +P  +  +L  L  L L  N+   
Sbjct: 66  LYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK-LQALPIGVFDQLVNLAELRLDRNQLK- 122

Query: 137 EIPDSLGD-LGNLNYLRLNNNSLTGSCPESL-SKIESLTLVDLSYNNLSGSLP 187
            +P  + D L  L YL L  N L  S P+ +  K+ SL  + L  N L   +P
Sbjct: 123 SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVP 173

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 22/72 (30%), Positives = 32/72 (44%), Gaps = 2/72 (2%)

Query: 96  NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
            LT L+ + L NN  L  +P     KL +L+TL L NN+       +   L  L  L+L 
Sbjct: 155 KLTSLKELRLYNNQ-LKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213

Query: 155 NNSLTGSCPESL 166
            N    +C   +
Sbjct: 214 ENPWDCTCNGII 225

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 52/226 (23%), Positives = 93/226 (41%), Gaps = 49/226 (21%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT---------EV 349
              + +   +G G +G V        G  VA+K+L           FQ+         E+
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74

Query: 350 ETISLAVHRNLLRL------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR 403
             +    H N++ L              +  LV P+M      + L+  +  +      +
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGLK--FSEEK 127

Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
            + +     +GL Y+H      ++HRD+K  N+ ++ED E  + DFGLA+   H D+ +T
Sbjct: 128 IQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMT 181

Query: 464 TAV-----RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
             V     R      APE  LS    ++  D++  G ++ E++TG+
Sbjct: 182 GYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.4 bits (140), Expect = 3e-09
 Identities = 34/218 (15%), Positives = 56/218 (25%), Gaps = 45/218 (20%)

Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVK--RLKDYNIAGGEVQFQTE 348
             F      T        +G G FG V++   +D   VA+K   ++  ++  G  Q   E
Sbjct: 11  VPFSHCLP-TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 349 --VETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD--------------- 391
             +  I ++   +LL       TE    L   +   GS    L                 
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 392 ----------------------HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHR 429
                                           A  K I       L         +  HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHR 186

Query: 430 DVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
           D+   N+LL +     +      K        +  ++ 
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 48/243 (19%), Positives = 87/243 (35%), Gaps = 53/243 (21%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVET------I 352
             N+  K+++GRG +G VY     +    VA+K++           F+  ++       I
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------MFEDLIDCKRILREI 76

Query: 353 SL---AVHRNLLRLCGFCSTENERL-----LVYPYMPNGSVASRLRDHIHGRPALDWARR 404
           ++        ++RL      ++        +V          S L+        L     
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-----SDLKKLFKTPIFLTEEHI 131

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
           K I      G  ++HE     IIHRD+K AN LL++D    V DFGLA+ ++        
Sbjct: 132 KTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 465 AVRGTVGHI---------------------APEYLSTGQS-SEKTDVFGFGILLLELITG 502
                                         APE +   ++ ++  D++  G +  EL+  
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248

Query: 503 QRA 505
            ++
Sbjct: 249 LQS 251

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.2 bits (140), Expect = 3e-09
 Identities = 33/174 (18%), Positives = 52/174 (29%), Gaps = 25/174 (14%)

Query: 63  CSW-RMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGK 120
                 + C+ DG + +L      L G           L  + ++N   L  +    L  
Sbjct: 7   PHGSSGLRCTRDGALDSL----HHLPG--------AENLTELYIENQQHLQHLELRDLRG 54

Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180
           L +L+ L +  +      PD+      L+ L L+ N+L  S      +  SL  + LS N
Sbjct: 55  LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

Query: 181 ------NLSGSLPKISARTFKVTGNPLICGPKATNNCTAVF----PEPLSLPPN 224
                  L             V    L C  +             P      PN
Sbjct: 114 PLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPN 167

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 42/223 (18%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT---------EV 349
              +   + +G G +G V     +  G  VAVK+L           FQ+         E+
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79

Query: 350 ETISLAVHRNLLRL------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR 403
             +    H N++ L             N+  LV   M      + L + +  +  L    
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQK-LTDDH 133

Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR--DSH 461
            + +     RGL Y+H      IIHRD+K +N+ ++ED E  + DFGLA+          
Sbjct: 134 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV 190

Query: 462 VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
            T   R      APE  L+    ++  D++  G ++ EL+TG+
Sbjct: 191 ATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.8 bits (135), Expect = 4e-09
 Identities = 26/116 (22%), Positives = 49/116 (42%), Gaps = 15/116 (12%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +  L   + + L  N I   I +SL  +E L+ L L  N    +I +       L  L +
Sbjct: 44  LSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS--------GSLPKISARTFKVTGNPL 201
           + N +  +    + K+ +L ++ +S N ++         +L K+      + GNPL
Sbjct: 101 SYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL--EDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.9 bits (117), Expect = 9e-07
 Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 6/90 (6%)

Query: 96  NLTKLQSVLLQN--NAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
             T+ + V L      I   + A+L  L+  + L LS N    +I  SL  + NL  L L
Sbjct: 21  VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSL 77

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
             N +        +  ++L  + +SYN ++
Sbjct: 78  GRNLIK-KIENLDAVADTLEELWISYNQIA 106

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 25/83 (30%), Positives = 34/83 (40%), Gaps = 9/83 (10%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFT--GEIPDSLGD 144
            +         L+ + +  N I  L      + KL  L+ L +SNNK T  GEI D L  
Sbjct: 84  KIENLDAVADTLEELWISYNQIASLSG----IEKLVNLRVLYMSNNKITNWGEI-DKLAA 138

Query: 145 LGNLNYLRLNNNSLTGSCPESLS 167
           L  L  L L  N L     E+ +
Sbjct: 139 LDKLEDLLLAGNPLYNDYKENNA 161

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 53/238 (22%), Positives = 92/238 (38%), Gaps = 51/238 (21%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETI------ 352
              +     LG+G +GIV+K      G +VAVK++ D         FQ   +        
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------AFQNSTDAQRTFREI 59

Query: 353 ----SLAVHRNLLRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
                L+ H N++ L      +N+R   LV+ YM      + L   I     L+   ++ 
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-----TDLHAVIRANI-LEPVHKQY 113

Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
           +     + + YLH      ++HRD+K +NILL+ +    V DFGL++   +         
Sbjct: 114 VVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 467 RGTVGHI--------------------APEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
                +                     APE L      ++  D++  G +L E++ G+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 28/109 (25%), Positives = 47/109 (43%), Gaps = 23/109 (21%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPA-----------------SLGKLEKLQTLDLSNNKF 134
           + +LTKL+ + +  N +  L  IP+                 SL  L+ L+ L + NNK 
Sbjct: 81  LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKL 140

Query: 135 TGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
              I   LG L  L  L L+ N +T      L++++ +  +DL+     
Sbjct: 141 K-SI-VMLGFLSKLEVLDLHGNEIT--NTGGLTRLKKVNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 15/94 (15%), Positives = 33/94 (35%), Gaps = 7/94 (7%)

Query: 90  LSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN 149
           + P    L       L   ++   +     +L  +Q  +  N+     +   +    NL 
Sbjct: 12  VFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLK 66

Query: 150 YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            L L++N ++      L  +  L  + ++ N L 
Sbjct: 67  ELHLSHNQIS--DLSPLKDLTKLEELSVNRNRLK 98

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 11/92 (11%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
              L+ +Q+    N+ I       +     L+ L LS+N+ + ++   L DL  L  L +
Sbjct: 37  QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSV 92

Query: 154 NNNSLTGSCPESLSKIESLTLV--DLSYNNLS 183
           N N L      +L+ I S  L    L  N L 
Sbjct: 93  NRNRLK-----NLNGIPSACLSRLFLDNNELR 119

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 19/91 (20%), Positives = 35/91 (38%), Gaps = 8/91 (8%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
           + +L  L+ + ++NN +  +      LG L KL+ LDL  N+ T      L  L  +N++
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVM----LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWI 177

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
            L          +   ++     V       
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 21/97 (21%), Positives = 38/97 (39%), Gaps = 5/97 (5%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +G L+KL+ + L  N I       L +L+K+  +DL+  K   E      +L   N ++ 
Sbjct: 146 LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKD 203

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
            +       P  +S   S     +    L     ++S
Sbjct: 204 PDGRWI--SPYYISNGGSYVDGCVL-WELPVYTDEVS 237

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 56.9 bits (138), Expect = 7e-09
 Identities = 59/236 (25%), Positives = 91/236 (38%), Gaps = 55/236 (23%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVK---------------------RLKDYN 337
            S +     LG GG G+V+    +D    VA+K                     RL   N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 338 IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP 397
           I         +V  I       L    G  +  N   +V  YM      + L + +   P
Sbjct: 70  I--------VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLANVLEQGP 116

Query: 398 ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLD 456
            L     +       RGL Y+H      ++HRD+K AN+ ++ ED    +GDFGLA+++D
Sbjct: 117 -LLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 457 HRDSH--------VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
              SH        VT   R      +P   LS    ++  D++  G +  E++TG+
Sbjct: 173 PHYSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 54.6 bits (132), Expect = 8e-09
 Identities = 34/135 (25%), Positives = 52/135 (38%), Gaps = 20/135 (14%)

Query: 58  TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPW--IGNLTKLQSVLLQNNAILG 112
           T+VD C+ R +   P     + + L L    L   +S     G L  L  + L+ N  L 
Sbjct: 11  TTVD-CTGRGLKEIPRDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRN-QLT 67

Query: 113 PIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNNSLTGSCPE----SL 166
            I  +       +Q L L  NK   EI + +   L  L  L L +N ++          L
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHL 125

Query: 167 SKIESLTLVDLSYNN 181
           + + SL L     +N
Sbjct: 126 NSLTSLNL----ASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 16/69 (23%), Positives = 32/69 (46%), Gaps = 4/69 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
             + +Q + L  N  +  I   +   L +L+TL+L +N+ +  +     + L +L  L L
Sbjct: 76  GASHIQELQLGENK-IKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNL 133

Query: 154 NNNSLTGSC 162
            +N    +C
Sbjct: 134 ASNPFNCNC 142

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 56.8 bits (137), Expect = 9e-09
 Identities = 16/94 (17%), Positives = 32/94 (34%), Gaps = 3/94 (3%)

Query: 96  NLTKLQSVLLQNNAILGPIPA-SLGKL-EKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +  +   + +Q+N  +  I   S   L  +   L L+ N        +            
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           +NN+L     +         ++D+S   +  SLP
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIH-SLP 218

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 6/94 (6%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRL- 153
           N  +L+        +      +      L+ +++S N     I  D   +L  L+ +R+ 
Sbjct: 31  NAIELR---FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
             N+L    PE+   + +L  + +S   +   LP
Sbjct: 88  KANNLLYINPEAFQNLPNLQYLLISNTGIK-HLP 120

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 22/108 (20%), Positives = 36/108 (33%), Gaps = 9/108 (8%)

Query: 96  NLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNYLRL 153
           NL KL  + ++    L  I       L  LQ L +SN      +PD           L +
Sbjct: 77  NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDI 135

Query: 154 N-NNSLTGSCPESLSKIES-LTLVDLSYNNLSGSLPKISARTFKVTGN 199
             N ++      S   +     ++ L+ N +     +I    F  T  
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQ----EIHNSAFNGTQL 179

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 16/91 (17%), Positives = 28/91 (30%), Gaps = 5/91 (5%)

Query: 98  TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRLNNN 156
            +   + L  N I     ++    +  +     NN    E+P D          L ++  
Sbjct: 154 FESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRT 212

Query: 157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
            +       L  ++ L     S  NL   LP
Sbjct: 213 RIHSLPSYGLENLKKLRA--RSTYNLK-KLP 240

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 56.5 bits (137), Expect = 9e-09
 Identities = 45/228 (19%), Positives = 91/228 (39%), Gaps = 48/228 (21%)

Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT---------EV 349
              ++  + +G G +G+V     +     VA+K++           F+          E+
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---------FEHQTYCQRTLREI 76

Query: 350 ETISLAVHRNLLRLCG-FCSTENERL----LVYPYMPNGSVASRLRDHIHGRPALDWARR 404
           + +    H N++ +     +   E++    +V   M      + L   +  +  L     
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLLKTQH-LSNDHI 130

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH--- 461
                   RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++ D    H   
Sbjct: 131 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 462 -----VTTAVRGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
                 T   R      APE  L++   ++  D++  G +L E+++ +
Sbjct: 188 LTEYVATRWYR------APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 15/102 (14%)

Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
           R +  LH      +IHRD+K +N+L++ + +  V DFGLA+++D   +   +   G    
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE-SAADNSEPTGQQSG 178

Query: 473 I----------APEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
           +          APE  L++ + S   DV+  G +L EL   +
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 31/139 (22%), Positives = 59/139 (42%), Gaps = 16/139 (11%)

Query: 56  DITSVDPCSWRMITCSP--DGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGP 113
           +    +    + +T +   +   S   + + +        I  L  ++ + L  N +   
Sbjct: 20  ETIKAN-LKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKL--- 75

Query: 114 IPASLG---KLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNNSLTGSCPESL-SK 168
               +    +L  L  L L+ N+    +P+ + D L NL  L L  N L  S P+ +  K
Sbjct: 76  --HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDK 131

Query: 169 IESLTLVDLSYNNLSGSLP 187
           + +LT ++L++N L  SLP
Sbjct: 132 LTNLTYLNLAHNQLQ-SLP 149

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 27/90 (30%), Positives = 41/90 (45%), Gaps = 11/90 (12%)

Query: 97  LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNN 155
           LT L  + L +N +         KL  L  LDLS N+    +P+ + D L  L  LRL  
Sbjct: 132 LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQ 190

Query: 156 NSLTGSCPE----SLSKIESLTLVDLSYNN 181
           N L  S P+     L+ ++ + L    ++N
Sbjct: 191 NQLK-SVPDGVFDRLTSLQYIWL----HDN 215

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.8 bits (122), Expect = 8e-08
 Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 3/89 (3%)

Query: 96  NLTKLQSVLLQNNAI-LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
             + ++ ++L N+    G +     + E+L+ L   N   T  I + L  L  L  L L+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           +N ++G       K  +LT ++LS N + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 49.3 bits (118), Expect = 3e-07
 Identities = 25/90 (27%), Positives = 43/90 (47%), Gaps = 7/90 (7%)

Query: 94  IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
                +L+ +   N  +  +  +P    KL KL+ L+LS+N+ +G +        NL +L
Sbjct: 38  TDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93

Query: 152 RLNNNSLTG-SCPESLSKIESLTLVDLSYN 180
            L+ N +   S  E L K+E+L  +DL   
Sbjct: 94  NLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 21/67 (31%), Positives = 30/67 (44%), Gaps = 1/67 (1%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGNLNYLR 152
           +  L KL+ + L +N + G +     K   L  L+LS NK       + L  L NL  L 
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119

Query: 153 LNNNSLT 159
           L N  +T
Sbjct: 120 LFNCEVT 126

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 4/88 (4%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            + +L  VL    +  G I     +   L+ L L N      +  +L  L  L  L L+ 
Sbjct: 25  AVREL--VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
           N + G       K+ +LT ++LS N L 
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 3/99 (3%)

Query: 83  SQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
            +S  G +         L+ + L N  ++    ++L KL KL+ L+LS N+  G +    
Sbjct: 34  CKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGLDMLA 91

Query: 143 GDLGNLNYLRLNNNSLTG-SCPESLSKIESLTLVDLSYN 180
             L NL +L L+ N L   S  E L K+E L  +DL   
Sbjct: 92  EKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 22/68 (32%), Positives = 30/68 (44%), Gaps = 3/68 (4%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT--GEIPDSLGDLGNLNYL 151
           +  L KL+ + L  N I G +     KL  L  L+LS NK      + + L  L  L  L
Sbjct: 67  LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSL 125

Query: 152 RLNNNSLT 159
            L N  +T
Sbjct: 126 DLFNCEVT 133

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 29/103 (28%), Positives = 45/103 (43%), Gaps = 11/103 (10%)

Query: 85  SLSGTLSPWIGNL----TKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEI 138
            L G   P I NL     +  ++   +N I  L   P     L +L+TL ++NN+     
Sbjct: 25  DLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNNNRICRIG 80

Query: 139 PDSLGDLGNLNYLRLNNNSLTG-SCPESLSKIESLTLVDLSYN 180
                 L +L  L L NNSL      + L+ ++SLT + +  N
Sbjct: 81  EGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 5/89 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGK-LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
           N  + + + L+   I  P+  +LG  L++   +D S+N+   ++ D    L  L  L +N
Sbjct: 17  NAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVN 72

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           NN +          +  LT + L+ N+L 
Sbjct: 73  NNRICRIGEGLDQALPDLTELILTNNSLV 101

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 5/88 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
           +LT+L  + L  N +   +P+ +  +L KL+ L L+ N+    IP    D L NL  L L
Sbjct: 105 HLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSL 162

Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNN 181
           + N L      +  ++  L  + L + N
Sbjct: 163 STNQLQSVPHGAFDRLGKLQTITL-FGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 26/88 (29%), Positives = 36/88 (40%), Gaps = 3/88 (3%)

Query: 101 QSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTG 160
           + + LQ+  +     A+   L KL  L+L  N+          DL  L  L L NN L  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96

Query: 161 SCPESL-SKIESLTLVDLSYNNLSGSLP 187
           S P  +   +  L  + L  N L  SLP
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLK-SLP 123

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 29/72 (40%), Positives = 34/72 (47%), Gaps = 4/72 (5%)

Query: 97  LTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLN 154
           LTKL+ + L  N  L  IPA    KL  LQTL LS N+    +P    D LG L  + L 
Sbjct: 130 LTKLKELRLNTNQ-LQSIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLF 187

Query: 155 NNSLTGSCPESL 166
            N    S  E L
Sbjct: 188 GNQFDCSRCEIL 199

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 12/90 (13%)

Query: 97  LTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
           LT+L  + L  N  L  +P+++  +L  L+ L +  NK T E+P  +  L +L +L L+ 
Sbjct: 87  LTQLTVLDLGTNQ-LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQ 144

Query: 156 NSLTGSCPE----SLSKIESLTLVDLSYNN 181
           N L  S P      LS +    L    + N
Sbjct: 145 NQLK-SIPHGAFDRLSSLTHAYL----FGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 28/99 (28%), Positives = 38/99 (38%), Gaps = 17/99 (17%)

Query: 98  TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT----GEIPDSLGDLGNLNYLRL 153
           T  Q + L +N I    P     L  L+ L L +N+      G + DS   L  L  L L
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDS---LTQLTVLDL 95

Query: 154 NNNSLTGSCPE----SLSKIESLTLVDLSYNNLSGSLPK 188
             N LT   P      L     L  + +  N L+  LP+
Sbjct: 96  GTNQLT-VLPSAVFDRLVH---LKELFMCCNKLT-ELPR 129

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 43/219 (19%), Positives = 77/219 (35%), Gaps = 34/219 (15%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI------ 352
             ++     LGRG +  V++    ++   V VK LK             + +        
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------KKKIKREIKIL 84

Query: 353 -SLAVHRNLLRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
            +L    N++ L         R   LV+ ++ N    +  +        L     +    
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNN----TDFKQLY---QTLTDYDIRFYMY 137

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVTTAVRG 468
              + L Y H      I+HRDVK  N+++D E  +  + D+GLA+       +    V  
Sbjct: 138 EILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-A 192

Query: 469 TVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRAL 506
           +     PE L   Q      D++  G +L  +I  +   
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 49/236 (20%), Positives = 79/236 (33%), Gaps = 69/236 (29%)

Query: 308 ILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
            LG G F  V+       +   VA+K ++           + E+          LL+   
Sbjct: 26  KLGWGHFSTVWL-AKDMVNNTHVAMKIVR--GDKVYTEAAEDEI---------KLLQRV- 72

Query: 366 FCSTENERLLVYPYMPNGSVASRLRDH--------IH--------GRPALDWARR----- 404
                N+           +   +L DH        +H        G   L   ++     
Sbjct: 73  -----NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 127

Query: 405 ------KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE------DFEAVVGDFGLA 452
                 K+I+     GL Y+H +C   IIH D+K  N+L++         +  + D G A
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

Query: 453 KLLDHRDSHVTTAV-----RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
              D    H T ++     R      +PE L         D++    L+ ELITG 
Sbjct: 186 CWYDE---HYTNSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 50.0 bits (118), Expect = 1e-06
 Identities = 17/101 (16%), Positives = 36/101 (35%), Gaps = 13/101 (12%)

Query: 96  NLTKLQSVLLQNNAILGPIPASL------GKLEKLQTLDLSNNKFTGEIPDSLGD---LG 146
           NL KL   +   +                 +   L+ L + + +    + +   +   L 
Sbjct: 220 NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279

Query: 147 NLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLS 183
            L  + ++   LT        + + KI+ L  +++ YN LS
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 50.0 bits (118), Expect = 1e-06
 Identities = 14/81 (17%), Positives = 33/81 (40%), Gaps = 7/81 (8%)

Query: 95  GNLTKLQSVLLQNNAILGPIPASLGK---LEKLQTLDLSNNKFTGE----IPDSLGDLGN 147
                L+ + + +      +     +   L +L+T+D+S    T E    + D +  + +
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308

Query: 148 LNYLRLNNNSLTGSCPESLSK 168
           L ++ +  N L+    + L K
Sbjct: 309 LKFINMKYNYLSDEMKKELQK 329

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 30/137 (21%), Positives = 46/137 (33%), Gaps = 41/137 (29%)

Query: 97  LTKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG------ 146
           L + Q V L +  +       I ++L     L  L+L +N         LGD+G      
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN--------ELGDVGVHCVLQ 78

Query: 147 -------NLNYLRLNNNSLTGSC----PESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
                   +  L L N  LTG+       +L  + +L  + LS N L  +          
Sbjct: 79  GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA---------- 128

Query: 196 VTGNPLICGPKATNNCT 212
             G  L+C       C 
Sbjct: 129 --GLQLLCEGLLDPQCR 143

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 48.0 bits (115), Expect = 6e-06
 Identities = 25/101 (24%), Positives = 45/101 (44%), Gaps = 13/101 (12%)

Query: 98  TKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDLG-NL 148
            K+Q + LQN  +     G + ++L  L  LQ L LS+N         + + L D    L
Sbjct: 85  CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144

Query: 149 NYLRLNNNSLTGSCPESLSKI----ESLTLVDLSYNNLSGS 185
             L+L   SL+ +  E L+ +         + +S N+++ +
Sbjct: 145 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA 185

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.7 bits (109), Expect = 3e-05
 Identities = 22/101 (21%), Positives = 43/101 (42%), Gaps = 13/101 (12%)

Query: 98  TKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDLG-NL 148
           ++L+++ +    I     G +   L   E L+ L L+ N+   E    + ++L + G  L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315

Query: 149 NYLRLNNNSLTGSCPESLSKI----ESLTLVDLSYNNLSGS 185
             L + + S T +C    S +      L  + +S N L  +
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.3 bits (108), Expect = 4e-05
 Identities = 14/67 (20%), Positives = 29/67 (43%), Gaps = 5/67 (7%)

Query: 124 LQTLDLSNNKFTGE-IPDSLGDLGNLNYLRLNNNSLTGSCPESLSKI----ESLTLVDLS 178
           +Q+LD+   + +     + L  L     +RL++  LT +  + +S       +L  ++L 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 179 YNNLSGS 185
            N L   
Sbjct: 65  SNELGDV 71

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 19/103 (18%), Positives = 37/103 (35%), Gaps = 13/103 (12%)

Query: 96  NLTKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGE-----IPDSLGDLG 146
           +  +L+++ L++  +       +   +     L+ L L +NK          P  L    
Sbjct: 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS 256

Query: 147 NLNYLRLNNNSLTGSCPESLSKI----ESLTLVDLSYNNLSGS 185
            L  L +    +T      L ++    ESL  + L+ N L   
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 39/156 (25%)

Query: 58  TSVDPCSWRMITCSPDGY---VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAI---- 110
           T+V+ C  +  T  P G     + L L + SL    +     LT L  + L  N +    
Sbjct: 10  TTVE-CYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLP 68

Query: 111 -------------------LGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLN 149
                              L  +P  +  KL +L+ L L+ N+    +PD + D L  L 
Sbjct: 69  NGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLK 127

Query: 150 YLRLNNNSLTGSCPE----SLSKIESLTLVDLSYNN 181
            LRL  N L  S P+     L+ ++ + L    ++N
Sbjct: 128 DLRLYQNQLK-SVPDGVFDRLTSLQYIWL----HDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 26/96 (27%), Positives = 42/96 (43%), Gaps = 11/96 (11%)

Query: 98  TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNN 156
            +   + L+ N++         +L  L  L L  NK    +P+ + + L +L YL L+ N
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86

Query: 157 SLTGSCPE----SLSKIESLTLVDLSYNNLSGSLPK 188
            L  S P      L++   L  + L+ N L  SLP 
Sbjct: 87  QLQ-SLPNGVFDKLTQ---LKELALNTNQLQ-SLPD 117

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 35/168 (20%), Positives = 56/168 (33%), Gaps = 34/168 (20%)

Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G GGFG++Y     +     A   +K      G        E   L  ++ + +     
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG----PLFSE---LKFYQRVAKKDCIK 97

Query: 368 STENERLLVYPYMPN----GSVASRLRDH------IHGRPALD--WARRKRIALGT---- 411
                + L Y  +P     G    + R +        G   L     +       T    
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLG-IDLQKISGQNGTFKKSTVLQL 156

Query: 412 ARGLL----YLHEQCDPKIIHRDVKAANILLDEDFEAVV--GDFGLAK 453
              +L    Y+HE      +H D+KAAN+LL       V   D+GL+ 
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 33/176 (18%), Positives = 60/176 (34%), Gaps = 47/176 (26%)

Query: 309 LGRGGFGIVYKGC---------FSDGALVAVK----------RLKDYNIAGGEVQFQTEV 349
             R   GI+Y+                  ++K              +  A   +Q     
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 350 ETISLAVHRNLLRLCGFCSTENE-RLLVYPYM-PNGSVASRLRDHIHGRPALDWARRKRI 407
           +  S      +    GF   +++ R LV P +  +      L+       ALD + +  +
Sbjct: 110 KLYSTP-LLAIPTCMGFGVHQDKYRFLVLPSLGRS------LQS------ALDVSPKHVL 156

Query: 408 ALGT----ARGLL----YLHEQCDPKIIHRDVKAANILLDEDFEAVV--GDFGLAK 453
           +  +    A  LL    +LHE      +H +V A NI +D + ++ V    +G A 
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.5 bits (106), Expect = 2e-05
 Identities = 29/89 (32%), Positives = 40/89 (44%), Gaps = 11/89 (12%)

Query: 98  TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNN 156
           T  Q + L +N I    P    +L +L  LDL NN+ T  +P  + D L  L  L LN+N
Sbjct: 30  TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88

Query: 157 SLTGSCPE----SLSKIESLTLVDLSYNN 181
            L  S P     +L  +  + L     NN
Sbjct: 89  QLK-SIPRGAFDNLKSLTHIWL----LNN 112

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 23/105 (21%), Positives = 39/105 (37%), Gaps = 15/105 (14%)

Query: 94  IGNLTKLQSVLLQNNAI-----LGPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGD 144
             +   L +V +  N I        +   L   ++L+ LDL +N FT      +  +L  
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242

Query: 145 LGNLNYLRLNNNSLTGSCPESLSKI------ESLTLVDLSYNNLS 183
             NL  L LN+  L+     ++           L  + L YN + 
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 23/116 (19%), Positives = 37/116 (31%), Gaps = 27/116 (23%)

Query: 94  IGNLTKLQSVLLQNNAI----------LGPIPASLGKLEKLQTLDLSNNKFTGE----IP 139
           I +   L+     +             L  +  +L K  KL T+ LS+N F       + 
Sbjct: 56  IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115

Query: 140 DSLGDLGNLNYLRLNNNSLTGSCPESLSKI-------------ESLTLVDLSYNNL 182
           D L     L +L L+NN L       +++                L  +    N L
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 18/108 (16%), Positives = 38/108 (35%), Gaps = 19/108 (17%)

Query: 94  IGNLTKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDL 145
           +   + ++   L+ +AI       + A L + + ++ + LS N    E    + +++   
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 146 GNLNYLRLNNNSLTGSCPE----------SLSKIESLTLVDLSYNNLS 183
            +L     ++        E          +L K   L  V LS N   
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 22/75 (29%), Positives = 35/75 (46%), Gaps = 8/75 (10%)

Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
           IP  +        L L  N+FT  +P  L +  +L  + L+NN ++    +S S +  L 
Sbjct: 29  IPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81

Query: 174 LVDLSYNNLSGSLPK 188
            + LSYN L   +P 
Sbjct: 82  TLILSYNRLR-CIPP 95

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 20/69 (28%), Positives = 34/69 (49%), Gaps = 4/69 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
           N+T+L +++L  N  L  IP      L+ L+ L L  N  +  +P+   + L  L++L +
Sbjct: 76  NMTQLLTLILSYNR-LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAI 133

Query: 154 NNNSLTGSC 162
             N L   C
Sbjct: 134 GANPLYCDC 142

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 31/89 (34%), Positives = 39/89 (43%), Gaps = 11/89 (12%)

Query: 98  TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNN 156
           T  Q + L NN I    P     L  LQ L  ++NK T  IP  + D L  L  L LN+N
Sbjct: 33  TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91

Query: 157 SLTGSCPE----SLSKIESLTLVDLSYNN 181
            L  S P     +L  +  + L    YNN
Sbjct: 92  HLK-SIPRGAFDNLKSLTHIYL----YNN 115

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 36/179 (20%), Positives = 59/179 (32%), Gaps = 53/179 (29%)

Query: 309 LGRGGFGIVYKGCFSDGALVAVKR-----------------LKDYNIAGGEVQFQTEVET 351
           +G+GGFG +Y    +    V                     LK Y  A          E 
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKP-------EQ 95

Query: 352 ISLAVHRNLLRLCGFCS-----TENERLLVYPYMPNGSVASRLRDHIHGRP---ALDWAR 403
           I   +    L+  G          ++    Y +M    +  R      G       +   
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRF-----GSDLQKIYEANA 146

Query: 404 RK-------RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV--GDFGLAK 453
           ++       +++L     L Y+HE      +H D+KA+N+LL+      V   D+GLA 
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 22/73 (30%), Positives = 37/73 (50%), Gaps = 6/73 (8%)

Query: 96  NLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFT--GEIPDSLGDLGNLNYL 151
           N+ +L S+ L NN +  L  + + + K   L+ L+LS N+     E+ D +  L  L  L
Sbjct: 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSEREL-DKIKGL-KLEEL 225

Query: 152 RLNNNSLTGSCPE 164
            L+ NSL  +  +
Sbjct: 226 WLDGNSLCDTFRD 238

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 30/151 (19%), Positives = 44/151 (29%), Gaps = 59/151 (39%)

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILL-------------------------- 438
           K+I     +GL YLH +C  +IIH D+K  NILL                          
Sbjct: 149 KKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206

Query: 439 -----------------------DEDFEAVVGDFGLAKLLDHRDSHV--TTAVRGTVGHI 473
                                   E  +  + D G A  +    +    T   R      
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR------ 260

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQR 504
           + E L     +   D++    +  EL TG  
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDY 291

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 24/79 (30%), Positives = 33/79 (41%), Gaps = 15/79 (18%)

Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPE----SLSKI 169
           IP+S         L+L +NK           L  L  L L+ N +  S P+     L+K 
Sbjct: 26  IPSSA------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK- 77

Query: 170 ESLTLVDLSYNNLSGSLPK 188
             LT++ L  N L  SLP 
Sbjct: 78  --LTILYLHENKLQ-SLPN 93

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 17/103 (16%), Positives = 36/103 (34%), Gaps = 18/103 (17%)

Query: 98  TKLQSVLLQNNAILGPIPAS-LGKL-----EKLQTLDLSNNKFTGE----IPDSLGDLGN 147
             + S+ L  N + G    + L  +       + +L+L  N   G     +      L +
Sbjct: 196 ASVTSLDLSANLL-GLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254

Query: 148 LNYLRLNNNSLTGSCPE-------SLSKIESLTLVDLSYNNLS 183
           L  + L+ + +     E       +   I+ + LVD +   + 
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 41.2 bits (97), Expect = 7e-04
 Identities = 21/93 (22%), Positives = 34/93 (36%), Gaps = 14/93 (15%)

Query: 105 LQNNAILGP----IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDL-----GNLNYLRLNN 155
           +     L P    +         + +LDLS N         L         ++  L L+ 
Sbjct: 1   MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60

Query: 156 NSLTGSCPESLSKI-----ESLTLVDLSYNNLS 183
           NSL     + L +I      ++T ++LS N LS
Sbjct: 61  NSLGFKNSDELVQILAAIPANVTSLNLSGNFLS 93

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 51/244 (20%), Positives = 90/244 (36%), Gaps = 38/244 (15%)

Query: 276 NDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRL 333
           ND YD +           ++       +   +++G+G FG V K  +   +   VA+K +
Sbjct: 34  NDGYDDDN--YDYIVKNGEKW---MDRYEIDSLIGKGSFGQVVK-AYDRVEQEWVAIKII 87

Query: 334 KD----YNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM-PNGSVASR 388
           K+     N A  EV+    +      +   ++ L       N   LV+  +  N      
Sbjct: 88  KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN------ 141

Query: 389 LRDHI--HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV- 445
           L D +       +     ++ A      LL+L    +  IIH D+K  NILL     +  
Sbjct: 142 LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI 200

Query: 446 -VGDFGLAKLLDHRDSHVTTAV-----RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 499
            + DFG +         +   +     R      +PE L         D++  G +L+E+
Sbjct: 201 KIVDFGSSC---QLGQRIYQYIQSRFYR------SPEVLLGMPYDLAIDMWSLGCILVEM 251

Query: 500 ITGQ 503
            TG+
Sbjct: 252 HTGE 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	623
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.88
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.88
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.87
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.84
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.83
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.81
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.8
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.79
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.75
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.73
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.72
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.71
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.71
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.7
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.7
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.69
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.69
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.68
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.67
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.67
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.66
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.65
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.65
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.64
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.63
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.63
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.62
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.61
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.6
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.6
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.6
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.59
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.59
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.59
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.59
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.59
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.59
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.58
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.58
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.58
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.58
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.58
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.58
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.57
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.57
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.57
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.57
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.56
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.56
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.56
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.55
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.55
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.54
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.53
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.53
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.53
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.53
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.52
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.52
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.52
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.51
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.51
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.51
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.5
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.49
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.48
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.48
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.48
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.48
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.48
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.48
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.48
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.47
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.47
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.47
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.47
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.47
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.46
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.45
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.45
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.45
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.45
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.44
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.44
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.43
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.43
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.43
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.41
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.4
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.4
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.4
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.4
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.4
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.39
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.38
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.38
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.37
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.36
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.36
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.36
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.34
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.33
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.32
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.31
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.31
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.3
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.3
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.3
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.29
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.29
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.26
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.26
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.24
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.23
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.2
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.19
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.19
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.16
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.16
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.12
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.1
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.05
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.05
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.9
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.85
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.84
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.73
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.71
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.68
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.65
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.58
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.48
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.46
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.45
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.35
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.3
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.29
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.29
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.23
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.23
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.14
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.05
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.03
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.0
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.96
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.91
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.71
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.69
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.63
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.59
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.53
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.49
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.42
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.4
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.33
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.32
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.31
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.22
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.13
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.09
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.03
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.0
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.99
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.87
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.79
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.75
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.47
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.47
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.26
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	96.21
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	96.07
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.04
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.75
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	95.51
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	94.96
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.29
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.05
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	89.81
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	87.6
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.19
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.35
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.76
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	81.3

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.1e-55  Score=444.92  Aligned_cols=257  Identities=21%  Similarity=0.308  Sum_probs=212.3

Q ss_pred             CCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ++.+.+.||+|+||+||+|.+.      +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4556788999999999999863      4688999999876555556789999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc
Q 006968          376 VYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE  443 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  443 (623)
                      ||||+++|+|.++|+....            ....++|..+.+|+.|||+||+|||++   +||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            9999999999999975321            124699999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHH
Q 006968          444 AVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDW  521 (623)
Q Consensus       444 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  521 (623)
                      +||+|||+++....... .......||++|||||++.++.++.++|||||||++|||+| |+.||.....       .+.
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------~~~  256 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDV  256 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------HHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence            99999999987644322 23345679999999999999999999999999999999999 8999864321       112


Q ss_pred             HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          522 VKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      +..+. .+..         ...+..++.++.+++.+||+.||++||||.||+++|+.
T Consensus       257 ~~~i~-~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          257 VEMIR-NRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHHHH-TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHH-cCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            22221 1211         11233455789999999999999999999999999986

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.4e-55  Score=440.74  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=211.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||+++... ....++|.+|++++++++|||||+++|+|.+++..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            46778899999999999999863      47889999997543 334567999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhcc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEE
Q 006968          375 LVYPYMPNGSVASRLRDHI---------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                      +||||+++|+|.++|+...         .....++|.++..++.|+|+||+|||++   +||||||||+|||+++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence            9999999999999997642         2245799999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHH
Q 006968          446 VGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       446 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      |+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.....       .+.+.
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~~  241 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIE  241 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence            99999998765433322 233469999999999999999999999999999999999 8999964321       12222


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .+.. +..         ...+..++.++.+++.+||+.||++||||.||++.|++
T Consensus       242 ~i~~-~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          242 CITQ-GRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             HHHH-TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHc-CCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2222 211         11233345789999999999999999999999999976

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.8e-54  Score=441.96  Aligned_cols=257  Identities=26%  Similarity=0.413  Sum_probs=205.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||+++... ....++|.+|++++++++|||||+++|+|.+++..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45667789999999999999864      47899999997543 334567999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc
Q 006968          375 LVYPYMPNGSVASRLRDHIH-----------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE  443 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  443 (623)
                      +||||+++|+|.++++....           ...+++|.++..|+.|+|+||+|||++   +||||||||+|||+++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence            99999999999999986432           134699999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHH
Q 006968          444 AVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDW  521 (623)
Q Consensus       444 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  521 (623)
                      +||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.....       .+.
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~  269 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------TEA  269 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------HHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence            99999999987654332 23345679999999999999999999999999999999999 8999964321       112


Q ss_pred             HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          522 VKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      +..+....+          ...+..++.++.+++.+||+.||++||||.||+++|+.
T Consensus       270 ~~~i~~g~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~  316 (329)
T 4aoj_A          270 IDCITQGRE----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA  316 (329)
T ss_dssp             HHHHHHTCC----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHHcCCC----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            222222111          11233345789999999999999999999999999987

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-53  Score=431.91  Aligned_cols=257  Identities=29%  Similarity=0.422  Sum_probs=202.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +++.+.+.||+|+||+||+|.+++  .||||+++..... .....|.+|++++++++|||||+++|+|.. +..++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            567788999999999999998743  5999999754332 334579999999999999999999998864 578999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.++|+..   ...++|..+..|+.|+|+||+|||++   +||||||||+|||+++++.+||+|||+|+......
T Consensus       113 ~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          113 CEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999754   34699999999999999999999999   99999999999999999999999999998765432


Q ss_pred             -Cceeecccccccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          460 -SHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       460 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                       .......+||+.|||||++.+   +.++.++|||||||++|||+||+.||......       ..+......+..    
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~~~~----  255 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGRGYA----  255 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHTTCC----
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCC----
Confidence             223445679999999999864   45899999999999999999999999643211       111122221111    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .+.+ ...+..++.++.+++.+||+.||++||||.||+++|+.
T Consensus       256 ~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          256 SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1111 11223345789999999999999999999999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-51  Score=421.89  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=208.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +.|+..+.||+|+||+||+|... +|+.||||+++... ......+.+|+++++.++|||||++++++.+++..||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            45888899999999999999975 69999999997544 33455689999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++..     ..+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+|||+|+.+....
T Consensus       153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            999999999875     2599999999999999999999999   99999999999999999999999999998775432


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                       ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.....       .+.+..+.....      +.+
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~~------~~~  290 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNLP------PRL  290 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSSC------CCC
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCCC------CCC
Confidence             234456799999999999999999999999999999999999999964322       111222211110      011


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .  .....+.++.+++.+||..||++|||+.|++++
T Consensus       291 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          291 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             S--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             C--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0  112234678999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.9e-53  Score=434.88  Aligned_cols=267  Identities=25%  Similarity=0.360  Sum_probs=216.8

Q ss_pred             HHHHHHHhcCCCcCCceeccCCeEEEEEEeCC------CcEEEEEEecccccccchHHHHHHHHHHhhcCC-Cceeeeee
Q 006968          293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVH-RNLLRLCG  365 (623)
Q Consensus       293 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~  365 (623)
                      ..+++...++|++.+.||+|+||+||+|.+..      ++.||||+++.........+|.+|++++.++.| ||||+++|
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            34444556789999999999999999998632      468999999876655556689999999999976 89999999


Q ss_pred             eeecC-CceEEEEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 006968          366 FCSTE-NERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVK  432 (623)
Q Consensus       366 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  432 (623)
                      +|..+ +..++|||||++|+|.++|+....            ....++|..+..++.|||+||+|||++   +|||||||
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK  212 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  212 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence            99764 568999999999999999976422            134589999999999999999999999   99999999


Q ss_pred             CCCeEECCCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCccc
Q 006968          433 AANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGR  510 (623)
Q Consensus       433 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~  510 (623)
                      |+|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999976544333 3445679999999999999999999999999999999998 899996422


Q ss_pred             ccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          511 AANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ..      ....+.+ ..+.         ....+..++.++.+++.+||+.||++|||+.||+++|+.
T Consensus       293 ~~------~~~~~~i-~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          293 ID------EEFCRRL-KEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             CS------HHHHHHH-HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH------HHHHHHH-HcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            11      1111222 1121         111223345779999999999999999999999999976

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-51  Score=419.81  Aligned_cols=266  Identities=24%  Similarity=0.338  Sum_probs=201.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC----ceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN----ERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~lv  376 (623)
                      ++|.+.+.||+|+||+||+|.+ +|+.||||+++...  .....+..|+..+.+++|||||+++|+|..++    ..++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            4577789999999999999998 68999999996532  11222345666667889999999999997654    57999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ-----CDPKIIHRDVKAANILLDEDFEAVVGDFGL  451 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  451 (623)
                      |||+++|+|.++|+..     .++|..+.+++.|+++||+|||++     +.++||||||||+|||++.++++||+|||+
T Consensus        80 ~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            9999999999999763     599999999999999999999986     356899999999999999999999999999


Q ss_pred             ccccCCCCCce---eeccccccccccccccccC------CCCCccchhhHHHHHHHHHhCCCCCCccccccc-------c
Q 006968          452 AKLLDHRDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITGQRALDFGRAANQ-------R  515 (623)
Q Consensus       452 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-------~  515 (623)
                      |+.........   ....+||+.|||||++.+.      .++.++|||||||++|||+||+.|+........       .
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            98775543322   2345799999999998754      467899999999999999999888753221110       0


Q ss_pred             cchHHHHHHHhhcCccccccccccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          516 GVMLDWVKKLHQEGKLSQMVDKDLKGNF-DRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ......+......+..    ++.+.... ....+..+.+++.+||+.||++||||.||++.|+.
T Consensus       235 ~~~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             SCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             cchHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            0111222222222211    12221111 23456789999999999999999999999999976

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.9e-52  Score=429.47  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=204.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|.+.+.||+|+||+||+|... +|+.||||+++..... .....|.+|++++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999975 6999999999765433 234579999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.+++...  ....+++..++.++.|++.||+|||++   +||||||||+|||++.++.+||+|||+|+.+...
T Consensus       104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999753  234679999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      . ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.....       .+.+..+.. +...     .
T Consensus       179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~-~~~~-----~  244 (350)
T 4b9d_A          179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLVLKIIS-GSFP-----P  244 (350)
T ss_dssp             H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHH-TCCC-----C
T ss_pred             c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHc-CCCC-----C
Confidence            1 223456799999999999999999999999999999999999999974322       122222222 1111     1


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          .+...+.++.+++.+||..||++|||+.|++++
T Consensus       245 ----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          245 ----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                112234678999999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.4e-51  Score=419.40  Aligned_cols=250  Identities=22%  Similarity=0.238  Sum_probs=204.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +.|...+.||+|+||+||+|... +|+.||||+++...      ...+|+.+++.++|||||++++++.+++..++||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45777889999999999999975 69999999997543      235799999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-cEEEeecccccccCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHR  458 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~  458 (623)
                      +++|+|.++++..    ..+++..+..++.|++.||+|||++   +||||||||+|||++.++ .+||+|||+|+.+...
T Consensus       132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            9999999999864    4699999999999999999999999   999999999999999987 6999999999977543


Q ss_pred             CCc----eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          459 DSH----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       459 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ...    .....+||+.|||||++.+..++.++|||||||++|||+||+.||......   ....    .+.......  
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~----~i~~~~~~~--  275 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCL----KIASEPPPI--  275 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHH----HHHHSCCGG--
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHH----HHHcCCCCc--
Confidence            221    123457999999999999999999999999999999999999999643221   1111    111111100  


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                        .    .++...+.++.+++.+||..||++|||+.|++++|..
T Consensus       276 --~----~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          276 --R----EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             --G----GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --h----hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence              0    1122334678999999999999999999999998865

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.3e-51  Score=409.40  Aligned_cols=246  Identities=26%  Similarity=0.396  Sum_probs=198.1

Q ss_pred             CcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeec----CCceEEEE
Q 006968          304 SAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCST----ENERLLVY  377 (623)
Q Consensus       304 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~  377 (623)
                      ...+.||+|+||+||+|.+. ++..||||++....... ....|.+|++++++++|||||++++++.+    ++..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45678999999999999975 58999999997654332 34569999999999999999999999864    34579999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEECC-CCcEEEeecccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLDE-DFEAVVGDFGLAKL  454 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~-~~~~kl~Dfgla~~  454 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +  |+||||||+|||++. ++.+||+|||+|+.
T Consensus       109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            999999999999864    4699999999999999999999998   6  999999999999984 78999999999986


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ...   ......+||+.|||||++.+ .++.++|||||||++|||+||+.||.....      .......+. .+.....
T Consensus       182 ~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~-~~~~~~~  250 (290)
T 3fpq_A          182 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVT-SGVKPAS  250 (290)
T ss_dssp             CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHT-TTCCCGG
T ss_pred             CCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHH-cCCCCCC
Confidence            432   23445679999999998865 699999999999999999999999963221      111122221 1111111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .+        ...+.++.+++.+||..||++|||+.|+++|
T Consensus       251 ~~--------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          251 FD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CC--------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11        1122568899999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.7e-52  Score=418.47  Aligned_cols=249  Identities=23%  Similarity=0.313  Sum_probs=209.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||++++...  ......+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999975 699999999975432  233457899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            999999999999864    4699999999999999999999999   999999999999999999999999999998754


Q ss_pred             CC-CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      .. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....       .+....+.. +..     
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~-~~~-----  251 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------GLIFAKIIK-LEY-----  251 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-TCC-----
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHc-CCC-----
Confidence            33 2344567899999999999999999999999999999999999999964322       111222211 111     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                       .    ++...+.++.+++.+||..||++|||+.|++.
T Consensus       252 -~----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          252 -D----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             -C----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             -C----CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence             1    12223467899999999999999999998754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.7e-50  Score=422.91  Aligned_cols=250  Identities=22%  Similarity=0.299  Sum_probs=209.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +.|+..+.||+|+||.||+|... +|+.||||+++... ......+.+|+.+|+.++|||||++++++.+++..||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            56889999999999999999975 69999999997544 33455789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      |++|+|.+++...     .+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+|||+|+.+....
T Consensus       230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            9999999998752     589999999999999999999999   99999999999999999999999999998775433


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      . .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....       .+.+..+.....      +.+
T Consensus       302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~~------~~~  367 (423)
T 4fie_A          302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNLP------PRL  367 (423)
T ss_dssp             C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCC------CCC
T ss_pred             c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCCC------CCC
Confidence            2 34456799999999999999999999999999999999999999964322       111222211110      111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .  .....+.++.+++.+||..||++|||+.|++++
T Consensus       368 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          368 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             S--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             c--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1  111224678999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.8e-50  Score=417.39  Aligned_cols=319  Identities=70%  Similarity=1.127  Sum_probs=266.9

Q ss_pred             cCCCCCCccccCcccccCHHHHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhh
Q 006968          275 VNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL  354 (623)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~  354 (623)
                      .....++....+....+++.++....++|.+.+.||+|+||.||+|...+|+.||||+++..........+.+|+++++.
T Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~   83 (326)
T 3uim_A            4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM   83 (326)
T ss_dssp             -----------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGT
T ss_pred             CCcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHh
Confidence            34445566667778899999999999999999999999999999999888999999999876555555579999999999


Q ss_pred             cCCCceeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 006968          355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAA  434 (623)
Q Consensus       355 l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~  434 (623)
                      ++||||+++++++...+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+
T Consensus        84 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~  163 (326)
T 3uim_A           84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA  163 (326)
T ss_dssp             CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred             ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence            99999999999999999999999999999999999887666667999999999999999999999988889999999999


Q ss_pred             CeEECCCCcEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccc-c
Q 006968          435 NILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAA-N  513 (623)
Q Consensus       435 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~-~  513 (623)
                      ||+++.++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||+..... .
T Consensus       164 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  243 (326)
T 3uim_A          164 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND  243 (326)
T ss_dssp             GEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred             hEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence            999999999999999999987655555556667999999999998889999999999999999999999999743322 2


Q ss_pred             cccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCCccchhhhccCC
Q 006968          514 QRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIET  593 (623)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~~~~~  593 (623)
                      ......+|+.............+......+....+..+.+++.+||+.||++|||+.||+++|++..+.+.|......+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~  323 (326)
T 3uim_A          244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEM  323 (326)
T ss_dssp             SCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-------
T ss_pred             cchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHHh
Confidence            33445577777777777788888888888889999999999999999999999999999999999999888877654443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-50  Score=403.25  Aligned_cols=247  Identities=22%  Similarity=0.371  Sum_probs=192.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|++.+.||+|+||+||+|... +|+.||||++++....  .....+.+|++++++++|||||++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999874 6999999999765432  23457999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+ +|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 68999998763    4699999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..  .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.....       ....+.... +..     
T Consensus       165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~~~~~i~~-~~~-----  229 (275)
T 3hyh_A          165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PVLFKNISN-GVY-----  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-TCC-----
T ss_pred             CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHc-CCC-----
Confidence            32  2345679999999999988776 5899999999999999999999964221       122222221 111     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       .    ++...+.++.+++.+||+.||++|||+.|++++
T Consensus       230 -~----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          230 -T----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             -C----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             -C----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             1    122234678999999999999999999999885

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.9e-51  Score=411.59  Aligned_cols=249  Identities=26%  Similarity=0.328  Sum_probs=199.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC----CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ++|++.+.||+|+||+||+|...    +++.||||++++.... .....+.+|++++++++|||||++++++.+++..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56999999999999999999852    4789999999764432 234468899999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            99999999999999864    4699999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      .... ......+||+.|||||++.+..++.++||||+||++|||+||+.||.....       .+.+..+.. +..    
T Consensus       177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~-~~~----  243 (304)
T 3ubd_A          177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KETMTMILK-AKL----  243 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-CCC----
T ss_pred             cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HHHHHHHHc-CCC----
Confidence            4332 223456799999999999999999999999999999999999999974322       112222221 111    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKM-----SEVLKM  575 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  575 (623)
                            .++...+.++.+++.+||+.||++|||+     +|+++|
T Consensus       244 ------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 ------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             ------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                  1122234678999999999999999984     677664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.5e-49  Score=399.37  Aligned_cols=252  Identities=22%  Similarity=0.327  Sum_probs=190.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC--------
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--------  371 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--------  371 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||+++..........+.+|++++++++|||||++++++...+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45889999999999999999975 699999999976554444567999999999999999999999986543        


Q ss_pred             ----ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 006968          372 ----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG  447 (623)
Q Consensus       372 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  447 (623)
                          ..++||||+++|+|.+++.... .....++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                3689999999999999997642 123467788899999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCCc-----------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccccccc
Q 006968          448 DFGLAKLLDHRDSH-----------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRG  516 (623)
Q Consensus       448 Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~  516 (623)
                      |||+|+.+......           .....+||+.|||||++.+..|+.++|||||||++|||++   ||.....     
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----
Confidence            99999877543221           1234569999999999999999999999999999999996   6642110     


Q ss_pred             chHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          517 VMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ....+.... .......         .........+++.+||+.||++|||+.|++++
T Consensus       233 -~~~~~~~~~-~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          233 -RVRTLTDVR-NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             -HHHHHHHHH-TTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHHHHHHh-cCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             011111111 1111100         11223456789999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=391.93  Aligned_cols=262  Identities=19%  Similarity=0.283  Sum_probs=201.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeec------CCc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST------ENE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~  372 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||+++..... .....+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            56899999999999999999975 6999999999754432 234568899999999999999999998753      367


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .|+||||++ |+|.+++..    ...+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+|||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999995 678888865    35799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC---CceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc
Q 006968          453 KLLDHRD---SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       453 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      +.+....   .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+..    ..+...  .
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l----~~I~~~--~  279 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL----QLIMMV--L  279 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH----HHHHHH--H
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH----HHHHHh--c
Confidence            8764322   2233456799999999998775 5699999999999999999999999743321111    101000  0


Q ss_pred             Ccccc-ccc-----------cccCC--CCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          529 GKLSQ-MVD-----------KDLKG--NFD-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       529 ~~~~~-~~~-----------~~~~~--~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      +.... ...           ..+..  ..+     .....++.+++.+||..||++|||+.|+++|=
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  346 (398)
T 4b99_A          280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP  346 (398)
T ss_dssp             CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred             CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence            10000 000           00000  000     01235788999999999999999999998863

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.9e-46  Score=381.90  Aligned_cols=282  Identities=39%  Similarity=0.682  Sum_probs=240.9

Q ss_pred             CHHHHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC
Q 006968          292 TFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN  371 (623)
Q Consensus       292 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  371 (623)
                      ++.++...+++|...+.||+|+||.||+|...+|+.||||++.... ......+.+|+.+++.++||||+++++++...+
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            3344455678999999999999999999998889999999986543 334567999999999999999999999999999


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL  451 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  451 (623)
                      ..++||||+++|+|.+++.........+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999976544445699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCC-CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          452 AKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       452 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      ++...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .......|.......+.
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS-SCCCHHHHTHHHHTTTC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH-HHHHHHHHhhhcccccc
Confidence            98654322 22233445899999999999899999999999999999999999999754332 22334466666666667


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      +...+++..........+..+.+++.+||+.||++|||+.|++++|+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  312 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY  312 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            777778777777888899999999999999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.8e-46  Score=386.20  Aligned_cols=198  Identities=23%  Similarity=0.385  Sum_probs=170.4

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC----CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCce
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENER  373 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  373 (623)
                      ..++|++.+.||+|+||+||+|..+    +++.||||++....   ...++.+|++++..+ .||||+++++++.+.+..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            4578999999999999999999753    47889999986532   345688999999988 699999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CcEEEeecccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLA  452 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgla  452 (623)
                      ++||||+++|+|.+++.       .+++..++.++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+|
T Consensus        96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            99999999999999884       388999999999999999999999   99999999999999876 79999999999


Q ss_pred             cccCCCCC---------------------------ceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCC
Q 006968          453 KLLDHRDS---------------------------HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQR  504 (623)
Q Consensus       453 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~  504 (623)
                      +.......                           ......+||+.|+|||++.+. .++.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            86543211                           112345699999999999775 58999999999999999999999


Q ss_pred             CCCcc
Q 006968          505 ALDFG  509 (623)
Q Consensus       505 p~~~~  509 (623)
                      ||..+
T Consensus       246 Pf~~~  250 (361)
T 4f9c_A          246 PFYKA  250 (361)
T ss_dssp             SSSCC
T ss_pred             CCCCC
Confidence            99643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.7e-45  Score=400.65  Aligned_cols=252  Identities=25%  Similarity=0.290  Sum_probs=202.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHH---HHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTE---VETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e---~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|++.++||+|+||.||+|... +|+.||||++++....  .....+.+|   +.+++.++|||||++++++.+++..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            56899999999999999999975 6999999999754321  222233444   56667789999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +||||++||+|.++|...    ..+++..++.++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.
T Consensus       269 lVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999864    4699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      +....   ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||.......    .....+.... ..   
T Consensus       342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~----~~~i~~~i~~-~~---  410 (689)
T 3v5w_A          342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLT-MA---  410 (689)
T ss_dssp             CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC----HHHHHHHHHH-CC---
T ss_pred             cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhhcC-CC---
Confidence            65432   345679999999999965 579999999999999999999999996432211    1111111111 11   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhh
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK-----MSEVLKMLE  577 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~L~  577 (623)
                             ..++...+.++.+++.+||..||++|++     +.||++|-.
T Consensus       411 -------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf  452 (689)
T 3v5w_A          411 -------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  452 (689)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred             -------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence                   1122223467899999999999999998     788877543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-44  Score=397.54  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=208.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++... ......+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            57999999999999999999975 69999999997543 23345689999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC--CcEEEeecccccccCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED--FEAVVGDFGLAKLLDH  457 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~Dfgla~~~~~  457 (623)
                      +++|+|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+..
T Consensus       236 ~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          236 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             cCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            9999999998643   34699999999999999999999999   99999999999999854  8999999999998764


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ..  .....+||+.|||||++.+..|+.++||||+||++|||++|+.||......       +.+..+... ..  .+..
T Consensus       310 ~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~~~~~i~~~-~~--~~~~  377 (573)
T 3uto_A          310 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSC-DW--NMDD  377 (573)
T ss_dssp             TS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTT-CC--CCCS
T ss_pred             CC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHhC-CC--CCCc
Confidence            32  344567999999999999999999999999999999999999999743221       112222111 10  0011


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...    ...+.++.+++.+||..||++|||+.|+++|
T Consensus       378 ~~~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          378 SAF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             GGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111    1123678899999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.6e-42  Score=354.66  Aligned_cols=283  Identities=39%  Similarity=0.659  Sum_probs=231.6

Q ss_pred             cccccCHHHHHHHhcCCCcC------CceeccCCeEEEEEEeCCCcEEEEEEeccccc---ccchHHHHHHHHHHhhcCC
Q 006968          287 HLKRYTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAVKRLKDYNI---AGGEVQFQTEVETISLAVH  357 (623)
Q Consensus       287 ~~~~~~~~~l~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~H  357 (623)
                      ....+++.++..++.+|...      +.||+|+||.||+|.. +++.||||++.....   ......+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45678999999999999887      8999999999999987 688999999875432   2234578999999999999


Q ss_pred             CceeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 006968          358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANIL  437 (623)
Q Consensus       358 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIl  437 (623)
                      |||+++++++...+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            999999999999999999999999999999997542 245699999999999999999999999   9999999999999


Q ss_pred             ECCCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccccccc
Q 006968          438 LDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRG  516 (623)
Q Consensus       438 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~  516 (623)
                      ++.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.......   
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---  241 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ---  241 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS---
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH---
Confidence            999999999999999876543322 2334569999999998865 58899999999999999999999997543321   


Q ss_pred             chHHHHHHHhhc-CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          517 VMLDWVKKLHQE-GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       517 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ....+....... ..+...+++.+. ..+...+..+.+++.+||+.+|++|||+.+++++|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          242 LLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             BTTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            222333332222 223344444432 35677788999999999999999999999999999873

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.4e-43  Score=372.26  Aligned_cols=258  Identities=28%  Similarity=0.402  Sum_probs=211.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEe--------CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCC
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF--------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN  371 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  371 (623)
                      ++|.+.+.||+|+||.||+|..        .++..||||+++..........+.+|+.+++.+ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            6788899999999999999985        245689999997665444456799999999999 8999999999999999


Q ss_pred             ceEEEEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD  439 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~  439 (623)
                      ..++||||+++|+|.+++.....            ....+++..+..++.|++.||+|||++   +|+||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence            99999999999999999986432            123589999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccc
Q 006968          440 EDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGV  517 (623)
Q Consensus       440 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~  517 (623)
                      .++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......    .
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----~  313 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----E  313 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----G
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----H
Confidence            9999999999999876543322 2233457889999999999999999999999999999999 99998643221    1


Q ss_pred             hHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ..   ... ..+.         ....+...+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus       314 ~~---~~~-~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          314 LF---KLL-KEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             HH---HHH-HTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH---HHH-hcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11   111 1111         111222334679999999999999999999999999986

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-42  Score=353.85  Aligned_cols=251  Identities=20%  Similarity=0.305  Sum_probs=208.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ..+|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            35799999999999999999986 468999999997544 3345678999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            99999999999753     589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      .. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......       .........+....     
T Consensus       170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~~~-----  236 (297)
T 3fxz_A          170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPEL-----  236 (297)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSCCC-----
T ss_pred             cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCC-----
Confidence            33 233456999999999999999999999999999999999999999643221       11111111111110     


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus       237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 ---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               1122234678999999999999999999999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=360.70  Aligned_cols=254  Identities=27%  Similarity=0.450  Sum_probs=208.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.... ......|.+|++++++++||||+++++++..++..++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            56888999999999999999975 68999999985432 33456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            9999999999864   34699999999999999999999999   99999999999999999999999999998765432


Q ss_pred             Cce-------------eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccc-c-chHHHHHH
Q 006968          460 SHV-------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQR-G-VMLDWVKK  524 (623)
Q Consensus       460 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~-~-~~~~~~~~  524 (623)
                      ...             .....||+.|+|||++.+..++.++||||||+++|||++|..|+......... . ......  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--  240 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--  240 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--
Confidence            211             11456999999999999999999999999999999999999998643221111 0 011111  


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                                 +...    +...+.++.+++.+||+.||++|||+.++++.|+.
T Consensus       241 -----------~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~  279 (310)
T 3s95_A          241 -----------DRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET  279 (310)
T ss_dssp             -----------HHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----------cccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                       1111    11223568899999999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=365.03  Aligned_cols=255  Identities=26%  Similarity=0.395  Sum_probs=208.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC----CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .+|.+.+.||+|+||.||+|.+.    .+..||||+++..........|.+|+.+++.++||||+++++++...+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56788899999999999999974    35569999998655445566799999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.++++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       129 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             eeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999753   34699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCc--eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          457 HRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       457 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      .....  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......       +.........    
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~~~~~~~~~----  271 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------DVISSVEEGY----  271 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHHHHHTTC----
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcCC----
Confidence            43322  2223346788999999998999999999999999999999 99998643221       1112211111    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                            ....+...+.++.+++.+||..||++|||+.+|++.|+.
T Consensus       272 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~  310 (325)
T 3kul_A          272 ------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA  310 (325)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                  111122334779999999999999999999999999987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.3e-43  Score=352.46  Aligned_cols=256  Identities=27%  Similarity=0.434  Sum_probs=213.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .++|.+.+.||+|+||.||+|...++..||||+++....  ...++.+|++++.+++||||+++++++...+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            357888999999999999999998888999999976432  346789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            9999999999764   23589999999999999999999999   99999999999999999999999999998766544


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......       ...........   .    
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~---~----  224 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------EVVLKVSQGHR---L----  224 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTCC---C----
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-------HHHHHHHcCCC---C----
Confidence            433444557788999999998899999999999999999999 99998643221       11111111110   0    


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG  580 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  580 (623)
                         ..+...+..+.+++.+||+.||++|||+.+++++|+...
T Consensus       225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          225 ---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             ---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             ---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence               011122367899999999999999999999999998843

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-43  Score=354.37  Aligned_cols=253  Identities=26%  Similarity=0.428  Sum_probs=210.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|.+.+.||+|+||.||+|...+++.||+|+++...  ....++.+|++++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            5688889999999999999999889999999997643  23567999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           88 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            999999999753   34689999999999999999999999   999999999999999999999999999987654332


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......       +.........          
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-------~~~~~~~~~~----------  224 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGF----------  224 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTC----------
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhcCc----------
Confidence            23334457788999999998999999999999999999999 99998643221       1112211110          


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....+...+.++.+++.+||+.||++|||+.+++++|++
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence            111122234678999999999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.8e-42  Score=353.56  Aligned_cols=263  Identities=21%  Similarity=0.282  Sum_probs=214.6

Q ss_pred             cccCHHHHHHHhcC----------CCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCC
Q 006968          289 KRYTFKELRAATSN----------FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH  357 (623)
Q Consensus       289 ~~~~~~~l~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H  357 (623)
                      ..+++++++.+++.          |...+.||+|+||.||+|... +|+.||||+++... ......+.+|+.+++.++|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence            45778888887765          666778999999999999976 79999999997543 3345678999999999999


Q ss_pred             CceeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 006968          358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANIL  437 (623)
Q Consensus       358 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIl  437 (623)
                      |||+++++++...+..++||||+++|+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  173 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL  173 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence            9999999999999999999999999999998864     3589999999999999999999999   9999999999999


Q ss_pred             ECCCCcEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccc
Q 006968          438 LDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGV  517 (623)
Q Consensus       438 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  517 (623)
                      ++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....      
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------  246 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------  246 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------
T ss_pred             ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence            99999999999999987654322 23445699999999999999999999999999999999999999964322      


Q ss_pred             hHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                       ........... ...     +.  .....+.++.+++.+||..||++|||+.|++++-
T Consensus       247 -~~~~~~~~~~~-~~~-----~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          247 -VQAMKRLRDSP-PPK-----LK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             -HHHHHHHHHSS-CCC-----CT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             -HHHHHHHhcCC-CCC-----cC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence             11112211111 000     00  0112236789999999999999999999999853

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.2e-44  Score=374.72  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=209.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|.+. +++.||||.++.........+|.+|++++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            357888899999999999999986 7899999999765433344578999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.++++..   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       193 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999864   23589999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCcee-eccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          459 DSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       459 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..... ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......       . +......+.      
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~-~~~~~~~~~------  332 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------Q-TREFVEKGG------  332 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------H-HHHHHHTTC------
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHcCC------
Confidence            21111 11235778999999998899999999999999999998 99998643211       1 111111111      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         ....+...+.++.+++.+||+.||++|||+.++++.|++
T Consensus       333 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          333 ---RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence               111222334678999999999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5e-42  Score=353.14  Aligned_cols=271  Identities=17%  Similarity=0.227  Sum_probs=216.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC--ceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--ERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999976 489999999986655555677899999999999999999999987655  779999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----CCCCcEEEeeccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGLAK  453 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Dfgla~  453 (623)
                      ||+++|+|.+++..... ...+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+++
T Consensus        89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999986432 23499999999999999999999999   99999999999999    788889999999998


Q ss_pred             ccCCCCCceeeccccccccccccccc--------cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLS--------TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      .......  .....||+.|+|||++.        +..++.++||||||+++|||++|+.||.........   ...+...
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~  239 (319)
T 4euu_A          165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKI  239 (319)
T ss_dssp             ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC---HHHHHHH
T ss_pred             ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh---HHHHHHH
Confidence            7654332  23456999999999986        577899999999999999999999999643322221   1122222


Q ss_pred             hhcC---ccccc---------ccc--ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 006968          526 HQEG---KLSQM---------VDK--DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG  580 (623)
Q Consensus       526 ~~~~---~~~~~---------~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  580 (623)
                      ....   .....         +..  .....+.......+.+++.+||+.||++|||+.|++++..+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            1111   11100         000  1122446778889999999999999999999999999998743

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.7e-43  Score=358.42  Aligned_cols=258  Identities=29%  Similarity=0.432  Sum_probs=202.0

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ...+|.+.+.||+|+||.||+|.. +|+.||||++....... ....+.+|++++++++||||+++++++...+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            346788899999999999999987 68899999997654332 2346899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+||+|||+++..
T Consensus       114 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             ECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             ecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            9999999999997531 112489999999999999999999999   8  999999999999999999999999999864


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      .... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......       +..........     
T Consensus       190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~~-----  256 (309)
T 3p86_A          190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-------QVVAAVGFKCK-----  256 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHHSCC-----
T ss_pred             cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCC-----
Confidence            4322 2233456999999999999999999999999999999999999999643221       11111111111     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                          ....+...+.++.+++.+||+.||++|||+.++++.|+.
T Consensus       257 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~  295 (309)
T 3p86_A          257 ----RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP  295 (309)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                011222334678999999999999999999999999976

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.3e-43  Score=370.90  Aligned_cols=256  Identities=28%  Similarity=0.418  Sum_probs=199.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC----CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .+|.+.+.||+|+||.||+|...    ++..||||+++.........+|.+|+.++++++||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57889999999999999999874    57789999997654444556799999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.++++..   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       125 ~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          125 TEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999753   34699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCce--eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          457 HRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       457 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ......  .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.....       .+...... .+    
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------~~~~~~i~-~~----  266 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------QDVIKAVD-EG----  266 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------HHHHHHHH-TT----
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH-cC----
Confidence            432221  122235778999999999999999999999999999998 9999863321       11111111 11    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                           .....+...+.++.+++.+||+.||++||++.+|++.|+..
T Consensus       267 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          267 -----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             -----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                 01111223347799999999999999999999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.5e-43  Score=360.71  Aligned_cols=250  Identities=22%  Similarity=0.358  Sum_probs=207.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ..+|.+.+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35788999999999999999997 47999999999765432 23456889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            999999999999764    3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeccccccccccccccccCCCC-CccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..  .....+||+.|+|||++.+..++ .++||||+||++|||++|+.||.....       ......... +..     
T Consensus       167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~-~~~-----  231 (328)
T 3fe3_A          167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KELRERVLR-GKY-----  231 (328)
T ss_dssp             SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-CCC-----
T ss_pred             CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh-CCC-----
Confidence            32  23455799999999999887765 799999999999999999999974321       111111111 111     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                           ..+...+.++.+++.+||..||.+|||+.|++++-
T Consensus       232 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~  266 (328)
T 3fe3_A          232 -----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR  266 (328)
T ss_dssp             -----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred             -----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence                 11122346788999999999999999999998863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.6e-43  Score=368.83  Aligned_cols=269  Identities=26%  Similarity=0.374  Sum_probs=214.4

Q ss_pred             cCHHHHHHHhcCCCcCCceeccCCeEEEEEEe------CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeee
Q 006968          291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRL  363 (623)
Q Consensus       291 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l  363 (623)
                      +...++....++|.+.+.||+|+||.||+|.+      .+++.||||+++..........+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34445555678899999999999999999973      246899999998655444556799999999999 78999999


Q ss_pred             eeeeecCCc-eEEEEecccCCChhhhhhhccCC-----------------------------------------------
Q 006968          364 CGFCSTENE-RLLVYPYMPNGSVASRLRDHIHG-----------------------------------------------  395 (623)
Q Consensus       364 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------  395 (623)
                      ++++...+. .++||||+++|+|.+++......                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987554 89999999999999999764321                                               


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          396 ---------------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       396 ---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                                     ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           12289999999999999999999999   999999999999999999999999999986644322


Q ss_pred             -ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          461 -HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       461 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                       .......||+.|+|||++.+..++.++||||||+++|||+| |+.||.......      ....... .+..       
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~-~~~~-------  314 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLK-EGTR-------  314 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHH-HTCC-------
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHH-cCCC-------
Confidence             23344568999999999999999999999999999999998 999986432211      1111111 1110       


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                        ...+...+.++.+++.+||+.||++|||+.|++++|+.
T Consensus       315 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          315 --MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence              11122234678999999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=370.68  Aligned_cols=258  Identities=28%  Similarity=0.364  Sum_probs=210.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|.+.+.||+|+||.||+|.+.      ++..||||+++..........+.+|+.++++++||||+++++++...+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56888999999999999999853      467899999976555555667999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---cEEEee
Q 006968          375 LVYPYMPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---EAVVGD  448 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~D  448 (623)
                      +||||+++|+|.+++.....   ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            99999999999999987532   234699999999999999999999999   999999999999999555   599999


Q ss_pred             cccccccCCC-CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHh
Q 006968          449 FGLAKLLDHR-DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLH  526 (623)
Q Consensus       449 fgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  526 (623)
                      ||+++..... .........||+.|+|||.+.+..++.++|||||||++|||++ |+.||.....       .+......
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------~~~~~~i~  300 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEFVT  300 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHH
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence            9999754322 1122334558999999999999999999999999999999998 9999864322       11122221


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....          ...+...+..+.+++.+||+.||++|||+.+|+++|+.
T Consensus       301 ~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          301 SGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCC----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1111          11122234678999999999999999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4e-43  Score=361.83  Aligned_cols=267  Identities=25%  Similarity=0.334  Sum_probs=206.9

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC----ceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN----ERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~l  375 (623)
                      ..+|++.+.||+|+||.||+|... ++.||||+++...  .....+..|+.++++++||||+++++++....    ..++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            467889999999999999999874 8999999996542  22345677899999999999999999997754    3699


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEecCCCCCCeEECCCCcEEEee
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ-------CDPKIIHRDVKAANILLDEDFEAVVGD  448 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------~~~~ivH~Dlk~~NIll~~~~~~kl~D  448 (623)
                      ||||+++|+|.++++..     .+++..+..++.|++.||+|||+.       +.++|+||||||+|||++.++.+||+|
T Consensus       100 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            99999999999999763     499999999999999999999986       244899999999999999999999999


Q ss_pred             cccccccCCCCCc-eeecccccccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCccccccccc------
Q 006968          449 FGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRG------  516 (623)
Q Consensus       449 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~------  516 (623)
                      ||+++........ ......||+.|+|||++.+     ..++.++||||||+++|||+||+.||..........      
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            9999876543322 2334569999999999976     345678999999999999999999997533221111      


Q ss_pred             ---chHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          517 ---VMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       517 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         ...++..... .......+.....   ....+.++.+++.+||+.||++|||+.||++.|+.
T Consensus       255 ~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          255 QHPSLEDMQEVVV-HKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             SSCCHHHHHHHHT-TSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCchhhhhhhhh-cccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               0111111111 1111111111111   22456779999999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.3e-43  Score=352.91  Aligned_cols=254  Identities=22%  Similarity=0.375  Sum_probs=208.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .++|.+.+.||+|+||.||+|.+.++..||||+++....  ...++.+|++++.+++||||+++++++...+..++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            467888999999999999999998888999999976432  356799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            9999999999763   23599999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......       +.........         
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~---------  238 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQGL---------  238 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTC---------
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-------HHHHHHhccc---------
Confidence            222333447788999999998899999999999999999998 99998643221       1111111110         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       ....+...+..+.+++.+||+.+|++|||+.+++++|++
T Consensus       239 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          239 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence             011112223678999999999999999999999999976

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=366.01  Aligned_cols=260  Identities=28%  Similarity=0.365  Sum_probs=212.9

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC--------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecC
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE  370 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~  370 (623)
                      .++|.+.+.||+|+||.||+|...        ++..||||+++.........++.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            367888999999999999999852        34689999998765444556799999999999 899999999999999


Q ss_pred             CceEEEEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL  438 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll  438 (623)
                      +..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            999999999999999999986532            124599999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCccccccccc
Q 006968          439 DEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRG  516 (623)
Q Consensus       439 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~  516 (623)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....     
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-----  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999987654332 22334457899999999999999999999999999999999 9999864321     


Q ss_pred             chHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          517 VMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                        .+....... +..         ...+...+.++.+++.+||+.||++|||+.||+++|+..
T Consensus       300 --~~~~~~~~~-~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          300 --EELFKLLKE-GHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             --HHHHHHHHT-TCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHHHHHc-CCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              111222211 111         111122346789999999999999999999999999873

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.6e-42  Score=355.76  Aligned_cols=259  Identities=30%  Similarity=0.415  Sum_probs=211.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe------CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      .++|.+.+.||+|+||.||+|..      .++..||||+++..........+.+|+++++.++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46788899999999999999985      245889999997655444456789999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 006968          374 LLVYPYMPNGSVASRLRDHIH--------------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA  433 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~  433 (623)
                      ++||||+++|+|.+++.....                    ....+++..++.++.|+++||+|||++   +|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            999999999999999986432                    123489999999999999999999999   999999999


Q ss_pred             CCeEECCCCcEEEeecccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccc
Q 006968          434 ANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRA  511 (623)
Q Consensus       434 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~  511 (623)
                      +||+++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998765433222 233457889999999998899999999999999999999 9999864332


Q ss_pred             cccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          512 ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ..    ....   . ..+.         ....+...+.++.+++.+||+.||++|||+.+++++|+.
T Consensus       259 ~~----~~~~---~-~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          259 ER----LFNL---L-KTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             GG----HHHH---H-HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH----HHHH---h-hcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            11    1111   1 1111         011122234679999999999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-42  Score=358.75  Aligned_cols=255  Identities=25%  Similarity=0.429  Sum_probs=201.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCc----EEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ++|...+.||+|+||.||+|.+. +++    .||+|.++..........|.+|+.++++++||||+++++++... ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence            56888999999999999999864 344    46888887655555667899999999999999999999999875 4789


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      |+||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999999864   34699999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......    ...    ....+.   
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~----~~~~~~---  236 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISS----ILEKGE---  236 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHH----HHHTTC---
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHH----HHHcCC---
Confidence            544332 2233457889999999999999999999999999999999 999997432211    111    111111   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                            ....+...+.++.+++.+||+.+|++|||+.+++++|+..
T Consensus       237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                  1111223346789999999999999999999999999874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-42  Score=361.80  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=212.5

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCc
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE  372 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  372 (623)
                      ..++|.+.+.||+|+||.||+|...      +++.||||+++..........|.+|+.++++++||||+++++++...+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            4567899999999999999999874      3488999999865544445679999999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHG--------------------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVK  432 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  432 (623)
                      .++||||+++|+|.+++......                    ...+++..++.++.|+++||+|||++   +|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            99999999999999999864221                    25799999999999999999999999   99999999


Q ss_pred             CCCeEECCCCcEEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCccc
Q 006968          433 AANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGR  510 (623)
Q Consensus       433 ~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~  510 (623)
                      |+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999986643222 22234458899999999998899999999999999999999 999986432


Q ss_pred             ccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          511 AANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      .       .+..... ..+...         ..+...+.++.+++.+||+.||++|||+.+++++|++.
T Consensus       282 ~-------~~~~~~~-~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~  333 (343)
T 1luf_A          282 H-------EEVIYYV-RDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  333 (343)
T ss_dssp             H-------HHHHHHH-HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             h-------HHHHHHH-hCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence            1       1111111 112111         11222346789999999999999999999999999884

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.4e-42  Score=357.79  Aligned_cols=255  Identities=23%  Similarity=0.316  Sum_probs=204.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57899999999999999999876 78999999997655444456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+....
T Consensus        87 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           87 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             CCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999998864    34699999999999999999999999   99999999999999999999999999998654322


Q ss_pred             C-ceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          460 S-HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       460 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      . .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........  ....|.    .......    
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~----~~~~~~~----  229 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWK----EKKTYLN----  229 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHH----TTCTTST----
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHh----cccccCC----
Confidence            1 22334569999999999987765 7899999999999999999999974332111  111111    1110000    


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                           .......++.+++.+||..||++|||+.|++++-.
T Consensus       230 -----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~  264 (323)
T 3tki_A          230 -----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (323)
T ss_dssp             -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             -----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence                 01122367889999999999999999999988644

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-42  Score=350.78  Aligned_cols=256  Identities=21%  Similarity=0.354  Sum_probs=197.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCC----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      .++|.+.+.||+|+||.||+|....    +..||+|+++..........+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            3578889999999999999998742    56799999876544444567999999999999999999999984 567899


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence            99999999999999764   34689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......    .   .........    
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----~---~~~i~~~~~----  235 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----V---IGRIENGER----  235 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----H---HHHHHTTCC----
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH----H---HHHHHcCCC----
Confidence            5543333344457889999999998899999999999999999997 899986432211    1   111111110    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                            ...+...+..+.+++.+||+.||++|||+.|++++|+..
T Consensus       236 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          236 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  011223346789999999999999999999999999873

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.5e-42  Score=346.90  Aligned_cols=259  Identities=24%  Similarity=0.324  Sum_probs=205.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+.......  ....+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            57889999999999999999865 68999999986543322  2356899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           91 EYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999764    3699999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ..........||+.|+|||.+.+..++.++||||||+++|||++|+.||......       ........ ..... ...
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~-~~~~~-~~~  234 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQ-DSVPN-VTT  234 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHS-SCCCC-HHH
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhh-ccCCC-cch
Confidence            4434444566999999999999999999999999999999999999999743221       11111111 11110 001


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhcC
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRP-KMSEVLKMLEGD  579 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~~  579 (623)
                      ..    ....+..+.+++.+|++.||++|| ++.++.+.|+..
T Consensus       235 ~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          235 DV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             hc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            11    122346789999999999999998 899999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-42  Score=377.78  Aligned_cols=257  Identities=27%  Similarity=0.411  Sum_probs=213.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCC-CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ..+|.+.+.||+|+||.||+|.+.. +..||||.++...  ....+|.+|+.++++++||||++++++|...+..++|||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            3568888999999999999999864 8899999997643  235679999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.++++...  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       297 ~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          297 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             CCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             ccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            999999999998642  34689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .........+++.|+|||.+....++.++||||||+++|||++ |+.||......    .....   +..          
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~~~~~---~~~----------  434 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYEL---LEK----------  434 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHH---HHT----------
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHH---HHc----------
Confidence            3333333456789999999998999999999999999999999 88998643221    11111   111          


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG  580 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  580 (623)
                      ......+..++.++.+++.+||+.||++|||+.+|++.|+...
T Consensus       435 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            1111222334578999999999999999999999999998854

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.9e-41  Score=354.05  Aligned_cols=255  Identities=20%  Similarity=0.246  Sum_probs=208.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-----chHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      .+.|.+.+.||+|+||.||+|... +|+.||+|.++......     ....+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            367889999999999999999975 68999999997654322     245789999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC----cEEEeec
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDF  449 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Df  449 (623)
                      ++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999865    34699999999999999999999999   999999999999998877    7999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      |++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......       +....+.. .
T Consensus       164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-------~~~~~i~~-~  233 (361)
T 2yab_A          164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANITA-V  233 (361)
T ss_dssp             SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHT-T
T ss_pred             CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh-c
Confidence            9998765432  234456999999999999989999999999999999999999999643221       11111111 1


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ..  ..+....    ...+.++.+++.+||..||++|||+.|++++-.
T Consensus       234 ~~--~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  275 (361)
T 2yab_A          234 SY--DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (361)
T ss_dssp             CC--CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             CC--CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence            00  0000000    112367899999999999999999999987644

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.2e-43  Score=376.12  Aligned_cols=255  Identities=23%  Similarity=0.390  Sum_probs=210.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .++|.+.+.||+|+||.||+|.+.++..||||+++...  .....|.+|+.++++++||||+++++++. .+..++||||
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            46788899999999999999999889999999997643  34668999999999999999999999986 6678999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.++++...  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       264 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          264 MAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             cCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            99999999997532  23578999999999999999999999   99999999999999999999999999998765332


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ........++..|+|||.+....++.++||||||+++|||+| |+.||.....       .+....+.....        
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~--------  403 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALERGYR--------  403 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHHTCC--------
T ss_pred             eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC--------
Confidence            222233446789999999998999999999999999999999 9999864221       111222211111        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                        ...+...+.++.+++.+||+.||++|||+.+|++.|++.
T Consensus       404 --~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          404 --MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence              111223457899999999999999999999999999884

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.9e-42  Score=349.28  Aligned_cols=260  Identities=25%  Similarity=0.355  Sum_probs=202.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhh--cCCCceeeeeeeeec----CCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL--AVHRNLLRLCGFCST----ENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~~----~~~~  373 (623)
                      .++|.+.+.||+|+||.||+|.. +|+.||||+++..    ....+..|.+++..  ++||||+++++++..    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46788999999999999999988 7899999998653    34456777777766  789999999998654    3457


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeEECCCCcEE
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH--------EQCDPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                      ++||||+++|+|.++++.     ..+++..+..++.|++.||+|||        +.   +|+||||||+|||++.++.+|
T Consensus        82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred             EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence            999999999999999954     36999999999999999999999        77   999999999999999999999


Q ss_pred             EeecccccccCCCCCce---eeccccccccccccccccC------CCCCccchhhHHHHHHHHHhC----------CCCC
Q 006968          446 VGDFGLAKLLDHRDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITG----------QRAL  506 (623)
Q Consensus       446 l~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltg----------~~p~  506 (623)
                      |+|||+++.........   .....||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999998765443322   2234699999999999876      455799999999999999999          7777


Q ss_pred             CcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          507 DFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ........   ....+............+..   ..+....+.++.+++.+||+.||++|||+.||++.|+.
T Consensus       234 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          234 YDVVPNDP---SFEDMRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TTTSCSSC---CHHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccCCCCc---chhhhhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            53222111   11111221111111111100   11233567889999999999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.5e-42  Score=353.84  Aligned_cols=251  Identities=23%  Similarity=0.274  Sum_probs=208.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|++.+.||+|+||.||+|... +|+.||+|++++...  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57888999999999999999975 689999999976432  233456889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        85 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999998763    3689999999999999999999999   999999999999999999999999999986432


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......... +..      
T Consensus       158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~-~~~------  222 (337)
T 1o6l_A          158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILM-EEI------  222 (337)
T ss_dssp             TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-CCC------
T ss_pred             CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-------HHHHHHHHc-CCC------
Confidence            22 233456799999999999999999999999999999999999999964321       111111111 110      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhh
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKMLE  577 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L~  577 (623)
                          .++...+.++.+++.+||..||++||     ++.|++++-.
T Consensus       223 ----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~  263 (337)
T 1o6l_A          223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence                11222346789999999999999999     8999988643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.7e-42  Score=362.32  Aligned_cols=266  Identities=20%  Similarity=0.275  Sum_probs=213.3

Q ss_pred             HHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecC
Q 006968          294 KELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE  370 (623)
Q Consensus       294 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~  370 (623)
                      .+++...++|.+.+.||+|+||.||+|... +++.||+|++++...  ......+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            445556678999999999999999999976 589999999975322  12234588999999999999999999999999


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      +..++||||+++|+|.++++..     .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence            9999999999999999998753     589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCC----CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHh
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH  526 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  526 (623)
                      +++.............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||......       +....+.
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~  286 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIM  286 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHH
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------hHHHHHH
Confidence            99876654433444667999999999997655    789999999999999999999999743221       1111111


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhhcCCC
Q 006968          527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLH--RPKMSEVLKMLEGDGL  581 (623)
Q Consensus       527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~L~~~~~  581 (623)
                      ....  ..   ....  ....+.++.+++.+||..+|++  ||++.||++|-.-..+
T Consensus       287 ~~~~--~~---~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          287 NHKN--SL---TFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             THHH--HC---CCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             hccc--cc---cCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            1000  00   0000  0012367899999999999998  9999999997655443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.5e-42  Score=367.69  Aligned_cols=266  Identities=18%  Similarity=0.231  Sum_probs=213.0

Q ss_pred             HHHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeec
Q 006968          293 FKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCST  369 (623)
Q Consensus       293 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~  369 (623)
                      +.+++...++|++.++||+|+||+||+|... +++.||||++++....  .....+.+|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4455566789999999999999999999986 4789999999753221  223348999999999999999999999999


Q ss_pred             CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                      .+..++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999999999763   34699999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      |+++.............+||+.|+|||++.     ...++.++|||||||++|||++|+.||........       ...
T Consensus       220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-------~~~  292 (437)
T 4aw2_A          220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGK  292 (437)
T ss_dssp             TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHH
T ss_pred             hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-------HHh
Confidence            999876655444445567999999999987     56789999999999999999999999974332111       111


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHhh
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLH--RPKMSEVLKMLE  577 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~L~  577 (623)
                      +.....  ...-+....    ..+.++.+++.+||..+|++  ||++.|++++-.
T Consensus       293 i~~~~~--~~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf  341 (437)
T 4aw2_A          293 IMNHKE--RFQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPF  341 (437)
T ss_dssp             HHTHHH--HCCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred             hhhccc--cccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence            110000  000000001    12367889999999988888  999999998644

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-42  Score=357.76  Aligned_cols=257  Identities=27%  Similarity=0.420  Sum_probs=204.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCc----EEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ++|.+.+.||+|+||.||+|.+. ++.    .||+|.+...........+.+|+.+++.++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            56888899999999999999864 344    388888865544444556889999999999999999999986 567899


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence            99999999999999754   34689999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ...... ......||..|+|||.+.+..++.++||||||+++|||++ |+.||......    ....   .. ..+..  
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~---~~-~~~~~--  235 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPD---LL-EKGER--  235 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----HHHH---HH-HTTCB--
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----HHHH---HH-HcCCC--
Confidence            544332 2344568889999999999999999999999999999999 99999743221    1111   11 11110  


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCC
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGL  581 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  581 (623)
                             ...+...+.++.+++.+||..||++|||+.+++++|+....
T Consensus       236 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          236 -------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                   01111223467899999999999999999999999988533

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.2e-42  Score=353.42  Aligned_cols=267  Identities=24%  Similarity=0.326  Sum_probs=193.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467899999999999999999875 6899999999765544445678999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          379 YMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |++ |+|.+++.....  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 699999876422  224589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC---ccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG---KLS  532 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~  532 (623)
                      .... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........    ...+.......   ...
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ----LKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCTTTCG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCChhHhh
Confidence            3322 2234468999999999876 4689999999999999999999999974332111    11111110000   000


Q ss_pred             cc-----cccccC----C--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          533 QM-----VDKDLK----G--------NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       533 ~~-----~~~~~~----~--------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..     ..+...    .        ........++.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            00     000000    0        0001123578999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.2e-42  Score=349.26  Aligned_cols=264  Identities=21%  Similarity=0.313  Sum_probs=201.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|.+.+.||+|+||.||+|...+|+.||||+++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            468889999999999999999988999999999754422 2235688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            975 888888753   34689999999999999999999999   99999999999999999999999999998765332


Q ss_pred             Cceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc--Ccccc---
Q 006968          460 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE--GKLSQ---  533 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---  533 (623)
                      . ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........   .....+.....  .....   
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhc
Confidence            2 2233458999999999876 4589999999999999999999999974332111   11111110000  00000   


Q ss_pred             --ccccccC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          534 --MVDKDLK-------GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       534 --~~~~~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ..++...       ..+....+.++.+++.+||+.||++|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              0000000       00111234678899999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.7e-42  Score=353.77  Aligned_cols=265  Identities=22%  Similarity=0.280  Sum_probs=202.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||+||+|...+|+.||||+++...... ....+.+|++++++++||||+++++++..++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            36788999999999999999999889999999997544322 23568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++ +|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       100 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9974 788777653   34699999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc---ccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL---SQM  534 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  534 (623)
                      .. ......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||........    ...+.........   ...
T Consensus       173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ----LPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH----HHHHHHHHCCCCTTTSGGG
T ss_pred             cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHHCCCChHHhhhh
Confidence            22 2333468999999999876 5689999999999999999999999974332211    1111111110000   000


Q ss_pred             c------ccccC--CCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          535 V------DKDLK--GNF-----DRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       535 ~------~~~~~--~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .      +....  ...     ......++.+++.+||..||++|||+.|++++-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  302 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP  302 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence            0      00000  000     011235788999999999999999999999853

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-42  Score=358.10  Aligned_cols=262  Identities=26%  Similarity=0.380  Sum_probs=209.3

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEe------CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCC
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN  371 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  371 (623)
                      ..++|.+.+.||+|+||.||+|..      .++..||||+++..........+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            346789999999999999999986      246789999998655444556799999999999 8999999999999999


Q ss_pred             ceEEEEecccCCChhhhhhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHG-------------------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVK  432 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  432 (623)
                      ..++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||+.   +|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence            999999999999999999764321                   13489999999999999999999999   99999999


Q ss_pred             CCCeEECCCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCccc
Q 006968          433 AANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGR  510 (623)
Q Consensus       433 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~  510 (623)
                      |+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999999866543322 2334457889999999999999999999999999999998 999986432


Q ss_pred             ccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          511 AANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ...      . .......+         .....+...+.++.+++.+||+.||.+|||+.+++++|+..
T Consensus       280 ~~~------~-~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          280 VDA------N-FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             CSH------H-HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cHH------H-HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            111      1 11111111         11111222347799999999999999999999999999874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-41  Score=354.53  Aligned_cols=256  Identities=20%  Similarity=0.286  Sum_probs=206.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc----ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI----AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      +.|.+.+.||+|+||.||+|... +|+.||||+++....    ......+.+|+.+++.++||||+++++++...+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            56889999999999999999875 689999999864321    1235679999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc---EEEeecccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE---AVVGDFGLA  452 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~Dfgla  452 (623)
                      ||||+++|+|.+++.........+++..+..++.|++.||+|||++   +|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            9999999999988876544455689999999999999999999999   9999999999999986654   999999999


Q ss_pred             cccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ........ +...
T Consensus       181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~-~~~~  250 (351)
T 3c0i_A          181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIK-GKYK  250 (351)
T ss_dssp             EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHH-TCCC
T ss_pred             eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHc-CCCC
Confidence            87654322 23345699999999999999999999999999999999999999964221        11111111 1110


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ..+....    ..+.++.+++.+||..||++|||+.|++++
T Consensus       251 --~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          251 --MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0000000    123678999999999999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.6e-42  Score=352.93  Aligned_cols=260  Identities=27%  Similarity=0.391  Sum_probs=211.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe------CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~  372 (623)
                      .++|.+.+.||+|+||.||+|..      .++..||||+++..........+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            36788899999999999999984      357899999998655444556799999999999 99999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 006968          373 RLLVYPYMPNGSVASRLRDHIH--------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL  438 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll  438 (623)
                      .++||||+++|+|.+++.....              ....+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            9999999999999999986432              123589999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCccccccccc
Q 006968          439 DEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRG  516 (623)
Q Consensus       439 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~  516 (623)
                      +.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.......   
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  255 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---  255 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---
Confidence            99999999999999876544332 2233457889999999999999999999999999999999 999986432111   


Q ss_pred             chHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          517 VMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                         .. ........         ....+...+.++.+++.+||+.||.+|||+.|++++|++
T Consensus       256 ---~~-~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          256 ---KF-YKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             ---HH-HHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HH-HHHhccCC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence               11 11111110         011112234678999999999999999999999999976

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.2e-42  Score=371.58  Aligned_cols=255  Identities=27%  Similarity=0.380  Sum_probs=204.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .++|.+.+.||+|+||.||+|.+.++..||||+++...  ....+|.+|++++++++||||+++++++.. +..++||||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            35688889999999999999999888889999997643  235679999999999999999999999876 678999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       260 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          260 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            99999999997532  23589999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ........++..|+|||.+....++.++||||||+++|||++ |+.||.....       .+....+....         
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~---------  398 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGY---------  398 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTC---------
T ss_pred             eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC---------
Confidence            333334457889999999999999999999999999999999 8999863221       11122221111         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                       ....+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus       399 -~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~  438 (452)
T 1fmk_A          399 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  438 (452)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             1112233457899999999999999999999999999884

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-41  Score=347.82  Aligned_cols=254  Identities=20%  Similarity=0.233  Sum_probs=207.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|... ++..||+|.++...  .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            367889999999999999999975 58899999986432  334568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC--CCcEEEeecccccccC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE--DFEAVVGDFGLAKLLD  456 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~Dfgla~~~~  456 (623)
                      |+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.  ++.+||+|||++....
T Consensus        82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            99999999998653   34689999999999999999999999   9999999999999997  7899999999998765


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ...  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....       .+.......... .  .+
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~-~--~~  223 (321)
T 1tki_A          156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEY-T--FD  223 (321)
T ss_dssp             TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCC-C--CC
T ss_pred             CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHcCCC-C--CC
Confidence            432  23445699999999999988899999999999999999999999964322       111222211110 0  00


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ....    ...+.++.+++.+||..||++|||+.|++++-.
T Consensus       224 ~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          224 EEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             HHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             hhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence            0000    012367899999999999999999999998543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-42  Score=344.77  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=210.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|.+.+.||+|+||.||+|...++..||+|+++....  ....+.+|++++++++||||+++++++...+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            56888899999999999999998899999999976542  3467999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        86 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           86 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             TTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            999999999764   34689999999999999999999999   999999999999999999999999999987643222


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....       ............         
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~i~~~~~---------  223 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFR---------  223 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC---------
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHHHHHHhcCCc---------
Confidence            22233457789999999998899999999999999999999 8999864321       111122111100         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       ...+...+..+.+++.+||+.||++|||+.+++++|++
T Consensus       224 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          224 -LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  261 (267)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             01112234678999999999999999999999999976

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5e-42  Score=354.62  Aligned_cols=253  Identities=21%  Similarity=0.316  Sum_probs=201.7

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC-------
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-------  371 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-------  371 (623)
                      .++|++.+.||+|+||.||+|... +|+.||||+++..........+.+|++++++++||||+++++++.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            356889999999999999999986 799999999986554555678999999999999999999999885543       


Q ss_pred             --------------------------------------------------ceEEEEecccCCChhhhhhhccCCCCCCCH
Q 006968          372 --------------------------------------------------ERLLVYPYMPNGSVASRLRDHIHGRPALDW  401 (623)
Q Consensus       372 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  401 (623)
                                                                        ..++||||+++|+|.+++.... .....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence                                                              2799999999999999998643 2345678


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC-----------ceeecccccc
Q 006968          402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-----------HVTTAVRGTV  470 (623)
Q Consensus       402 ~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~  470 (623)
                      ..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            88999999999999999999   999999999999999999999999999987765421           1123346999


Q ss_pred             ccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHH
Q 006968          471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEE  550 (623)
Q Consensus       471 ~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  550 (623)
                      .|+|||.+.+..++.++||||||+++|||++|..|+...         ....... .......         .......+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------~~~~~~~-~~~~~~~---------~~~~~~~~  301 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------VRIITDV-RNLKFPL---------LFTQKYPQ  301 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------HHHHHHH-HTTCCCH---------HHHHHCHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------HHHHHHh-hccCCCc---------ccccCChh
Confidence            999999999999999999999999999999987765310         0011111 0111000         01223466


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          551 MVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       551 l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      +.+++.+||+.||++|||+.|++++
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhhc
Confidence            7899999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.2e-42  Score=349.57  Aligned_cols=262  Identities=25%  Similarity=0.404  Sum_probs=203.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-----CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec--CCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~  373 (623)
                      ++|++.+.||+|+||.||+|.+     .+++.||||+++... ......+.+|++++++++||||+++++++..  ....
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            5788899999999999999984     368999999997543 2334578999999999999999999999854  3568


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            9999999999999999764   23589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCc--eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccc-------cccc-hHHHHH
Q 006968          454 LLDHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN-------QRGV-MLDWVK  523 (623)
Q Consensus       454 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-------~~~~-~~~~~~  523 (623)
                      ........  ......++..|+|||.+.+..++.++||||||+++|||++|..|+.......       .... ....+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            76543221  2233457788999999999999999999999999999999999986432110       0000 000111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....         .......+...+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus       243 ~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          243 ELLK---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  288 (295)
T ss_dssp             HHHH---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHh---------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            1111         111111233345789999999999999999999999999976

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-41  Score=366.80  Aligned_cols=249  Identities=29%  Similarity=0.404  Sum_probs=204.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC-ceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-ERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|.+ .|+.||||+++...   ....|.+|+.++++++||||+++++++...+ ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            35688889999999999999998 47899999997643   3567999999999999999999999987655 7899999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.++++...  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       268 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             CCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            999999999998642  33579999999999999999999999   9999999999999999999999999999854322


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                          .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......    .   ...+.. +        
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----~---~~~i~~-~--------  402 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----V---VPRVEK-G--------  402 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----H---HHHHHT-T--------
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----H---HHHHHc-C--------
Confidence                122357889999999999999999999999999999998 999986432211    1   111111 1        


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       .....+..++.++.+++.+||+.||++|||+.++++.|++
T Consensus       403 -~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          403 -YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence             1111223345789999999999999999999999999976

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=346.69  Aligned_cols=254  Identities=19%  Similarity=0.260  Sum_probs=206.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-----chHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|.+.+.||+|+||.||+|... +|..||||+++......     ....+.+|+.+++.++||||+++++++...+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            56888999999999999999975 68999999997654321     3457899999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC----cEEEeecc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDFG  450 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfg  450 (623)
                      +||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999865    34699999999999999999999999   999999999999999887    79999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      +++......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......       +......... 
T Consensus       164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~-  233 (326)
T 2y0a_A          164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVN-  233 (326)
T ss_dssp             TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHTC-
T ss_pred             CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHHhcC-
Confidence            998765332  223456999999999999899999999999999999999999999643221       1111111110 


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ..  ......    ...+..+.+++.+||..||++|||+.|++++-.
T Consensus       234 ~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  274 (326)
T 2y0a_A          234 YE--FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW  274 (326)
T ss_dssp             CC--CCHHHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             CC--cCcccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            00  000000    112367889999999999999999999998643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=342.94  Aligned_cols=250  Identities=24%  Similarity=0.339  Sum_probs=197.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-------------------------chHHHHHHHHHHhh
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-------------------------GEVQFQTEVETISL  354 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------------------~~~~~~~e~~~l~~  354 (623)
                      ++|.+.+.||+|+||.||+|... +++.||||+++......                         ....+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57889999999999999999874 68999999997543211                         12468999999999


Q ss_pred             cCCCceeeeeeeeec--CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 006968          355 AVHRNLLRLCGFCST--ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVK  432 (623)
Q Consensus       355 l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  432 (623)
                      ++||||+++++++..  .+..++||||+++++|.+++.     ...+++..+..++.|++.||+|||+.   +|+|||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            999999999999986  567899999999999887653     24699999999999999999999999   99999999


Q ss_pred             CCCeEECCCCcEEEeecccccccCCCCCceeeccccccccccccccccCC---CCCccchhhHHHHHHHHHhCCCCCCcc
Q 006968          433 AANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALDFG  509 (623)
Q Consensus       433 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~  509 (623)
                      |+||+++.++.+||+|||+++....... ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999987654332 234456999999999997655   378899999999999999999999632


Q ss_pred             cccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          510 RAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..       ..+...... .....    ...    ...+.++.+++.+||+.||++|||+.|++++
T Consensus       244 ~~-------~~~~~~~~~-~~~~~----~~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          244 RI-------MCLHSKIKS-QALEF----PDQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SH-------HHHHHHHHH-CCCCC----CSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             cH-------HHHHHHHhc-ccCCC----CCc----cccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            21       111121111 11100    001    1123678999999999999999999999764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.7e-42  Score=345.51  Aligned_cols=255  Identities=21%  Similarity=0.392  Sum_probs=204.7

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCC----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      .++|.+.+.||+|+||.||+|.+.+    +..||||.++..........+.+|+.+++.++||||+++++++.. +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4678889999999999999998642    346999999866544456679999999999999999999999864 46789


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999999764   34689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......    ..   .........   
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~~---~~~~~~~~~---  233 (281)
T 3cc6_A          164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VI---GVLEKGDRL---  233 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----HH---HHHHHTCCC---
T ss_pred             ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----HH---HHHhcCCCC---
Confidence            5543333344557889999999998899999999999999999998 999996432211    11   111111110   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                             ..+...+..+.+++.+||+.||++|||+.|++++|++
T Consensus       234 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          234 -------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence                   1112234678999999999999999999999999987

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.1e-41  Score=350.16  Aligned_cols=258  Identities=17%  Similarity=0.182  Sum_probs=207.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .+|.+.+.||+|+||.||+|.. .+|+.||||+++...   ....+.+|+++++.+ +||||+++++++...+..++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            5788899999999999999996 478999999986543   234688999999999 99999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc-----EEEeeccccc
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE-----AVVGDFGLAK  453 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~Dfgla~  453 (623)
                      |+ +++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||+++
T Consensus        86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99 99999999864   34799999999999999999999999   9999999999999998887     9999999998


Q ss_pred             ccCCCCCc------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh
Q 006968          454 LLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       454 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      .+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......    ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~  234 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT----LKERYQKIGD  234 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS----HHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc----HHHHHHHHHh
Confidence            76543321      1235579999999999999999999999999999999999999997532211    1111111110


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ... .. ....+..    ..+ ++.+++..||+.||.+||++.+|.+.|++.
T Consensus       235 ~~~-~~-~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          235 TKR-AT-PIEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HHH-HS-CHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hhc-cC-CHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            000 00 0000000    123 799999999999999999999999999863

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.7e-42  Score=343.01  Aligned_cols=253  Identities=27%  Similarity=0.397  Sum_probs=195.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc---cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA---GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|.+ .|+.||||+++.....   .....+.+|+++++.++||||+++++++..++..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            5788899999999999999997 4899999998754322   22357899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC--------CCcEEEeec
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE--------DFEAVVGDF  449 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------~~~~kl~Df  449 (623)
                      ||+++++|.+++..     ..+++..+..++.|++.||+|||++...+|+||||||+||+++.        ++.+||+||
T Consensus        86 e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999998853     36899999999999999999999992112999999999999986        678999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      |++.......   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......       ........ .
T Consensus       161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~-~  229 (271)
T 3dtc_A          161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAYGVAM-N  229 (271)
T ss_dssp             CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHT-S
T ss_pred             Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHhhhc-C
Confidence            9998654332   22346899999999999999999999999999999999999999643221       11111111 1


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .        .....+...+.++.+++.+||+.||++|||+.|++++|+.
T Consensus       230 ~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          230 K--------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             C--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             C--------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            1        1111222334679999999999999999999999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.8e-41  Score=352.70  Aligned_cols=259  Identities=22%  Similarity=0.291  Sum_probs=205.7

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  375 (623)
                      .++|.+.++||+|+||.||+|... +++.||||++++.....  ....+..|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357889999999999999999976 58899999998654322  233578899999877 89999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       131 V~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            99999999999999764    3699999999999999999999999   9999999999999999999999999999853


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccccc-ccchHHHHHHHhhcCccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ-RGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.+.........   
T Consensus       204 ~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  279 (396)
T 4dc2_A          204 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  279 (396)
T ss_dssp             CCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred             ccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence            322 2234556799999999999999999999999999999999999999964322111 11111222221111111   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHh
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKM------SEVLKML  576 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~~L  576 (623)
                             .++...+.++.+++.+||+.||++||++      .|++++-
T Consensus       280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp  320 (396)
T 4dc2_A          280 -------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP  320 (396)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred             -------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence                   1222234678999999999999999995      6676643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-41  Score=353.01  Aligned_cols=259  Identities=27%  Similarity=0.387  Sum_probs=210.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC--------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecC
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE  370 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~  370 (623)
                      .++|.+.+.||+|+||.||+|...        ++..||||+++..........+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467889999999999999999863        46789999997655444456789999999999 899999999999999


Q ss_pred             CceEEEEecccCCChhhhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHG------------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL  438 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll  438 (623)
                      +..++||||+++|+|.+++......            ...+++..++.++.|++.||+|||+.   +|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            9999999999999999999864321            23489999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCccccccccc
Q 006968          439 DEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRG  516 (623)
Q Consensus       439 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~  516 (623)
                      +.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....     
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----  265 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  265 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence            99999999999999876543322 2233457889999999988889999999999999999999 9999864321     


Q ss_pred             chHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          517 VMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                        .+....... +..         ...+...+.++.+++.+||+.+|.+|||+.|+++.|+.
T Consensus       266 --~~~~~~~~~-~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  315 (334)
T 2pvf_A          266 --EELFKLLKE-GHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  315 (334)
T ss_dssp             --HHHHHHHHH-TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHHHHHHhc-CCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence              111111111 110         01112234678999999999999999999999999987

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-41  Score=352.04  Aligned_cols=249  Identities=20%  Similarity=0.323  Sum_probs=204.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|.. .+|+.||||+++....  ......+.+|+.+++.++||||+++++++..++..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788999999999999999997 4789999999965422  222346899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+ +|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        89 E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             CCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             ECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            999 78999888763    3699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..  .....+||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||........                ...+..
T Consensus       161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~  222 (336)
T 3h4j_B          161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNS  222 (336)
T ss_dssp             SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCS
T ss_pred             Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHc
Confidence            32  2234569999999999988776 7899999999999999999999964321111                000000


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .  ....+...+.++.+++.+||..||.+|||+.|++++-.
T Consensus       223 ~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          223 C--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             S--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             C--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence            0  01122233467899999999999999999999987543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.1e-41  Score=339.91  Aligned_cols=254  Identities=22%  Similarity=0.261  Sum_probs=202.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|.+.+.||+|+||.||+|... ++..||+|++...........+.+|++++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            56888999999999999999875 68999999998766555667899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCcEEEeecccccccC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfgla~~~~  456 (623)
                      +++|+|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999976543346799999999999999999999999   99999999999999   456789999999998654


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ...  ......||+.|+|||.+. ..++.++||||||+++|||++|+.||......       +............... 
T Consensus       179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~-  247 (285)
T 3is5_A          179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-------EVQQKATYKEPNYAVE-  247 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCCCC--
T ss_pred             Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-------HHHhhhccCCcccccc-
Confidence            332  233456899999999875 56899999999999999999999999643211       1111111111100000 


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         ...    .+.++.+++.+||+.||++|||+.|++++
T Consensus       248 ---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          248 ---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               001    23678899999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.7e-41  Score=342.07  Aligned_cols=252  Identities=30%  Similarity=0.514  Sum_probs=203.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccch------HHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGE------VQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      ++|.+.+.||+|+||.||+|... +++.||||++.........      ..+.+|+.++++++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            67888999999999999999974 7899999998654433221      57899999999999999999999986554  


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEECCCCc-----EEE
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLDEDFE-----AVV  446 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~-----~kl  446 (623)
                      ++||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +  |+||||||+||+++.++.     +||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            7999999999999988653   34699999999999999999999999   8  999999999999988776     999


Q ss_pred             eecccccccCCCCCceeeccccccccccccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH
Q 006968          447 GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       447 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      +|||+++....    ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||......     .......
T Consensus       171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~  241 (287)
T 4f0f_A          171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-----KIKFINM  241 (287)
T ss_dssp             CCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-----HHHHHHH
T ss_pred             CCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-----HHHHHHH
Confidence            99999975332    234456999999999983  456789999999999999999999999643221     1111222


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....+         .....+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus       242 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          242 IREEG---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HhccC---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            21111         1112223334789999999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.5e-42  Score=345.55  Aligned_cols=257  Identities=28%  Similarity=0.421  Sum_probs=213.9

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ...+|.+.+.||+|+||.||+|... ++..||+|.++...  .....+.+|++++++++||||+++++++...+..++||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            3467888999999999999999986 48899999997543  34567899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        89 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             ECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999999764  235699999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......    ...   ....         
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----~~~---~~~~---------  227 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYE---LLEK---------  227 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HHH---HHHT---------
T ss_pred             CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH---HHhc---------
Confidence            54444445567889999999998999999999999999999999 999986432211    111   1111         


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                       ......+...+.++.+++.+||..||++|||+.++++.|+..
T Consensus       228 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          228 -DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence             111111222346799999999999999999999999999873

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.1e-41  Score=343.94  Aligned_cols=266  Identities=20%  Similarity=0.258  Sum_probs=202.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|.+.+.||+|+||+||+|... +|+.||||+++...... ....+.+|+.++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888999999999999999975 68999999997654332 23578899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++ ++.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9975 555555442   34699999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCceeeccccccccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc--Ccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE--GKLSQMV  535 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  535 (623)
                      .. ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+........  ......+.....  .......
T Consensus       155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGG
T ss_pred             cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhc
Confidence            22 233456899999999997765 79999999999999999999988643221110  111111111000  0000000


Q ss_pred             ---c---------cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          536 ---D---------KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       536 ---~---------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                         +         .............++.+++.+||+.||++|||+.|++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  284 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence               0         0000011123346789999999999999999999998853

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=357.68  Aligned_cols=254  Identities=20%  Similarity=0.282  Sum_probs=205.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||+|+++..... .....+.+|+++++.++||||+++++++.+++..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            467999999999999999999864 6899999999765432 23456899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC---CCCcEEEeecccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKL  454 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Dfgla~~  454 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++   .++.+||+|||++..
T Consensus        90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999998763    4699999999999999999999999   999999999999998   467899999999987


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....       .+....... +... .
T Consensus       163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~-~~~~-~  232 (444)
T 3soa_A          163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------HRLYQQIKA-GAYD-F  232 (444)
T ss_dssp             CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHH-TCCC-C
T ss_pred             ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHh-CCCC-C
Confidence            654332 23345699999999999999999999999999999999999999964321       111111111 1110 0


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..+     .....+.++.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 PSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             Ccc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            000     011224678999999999999999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4e-42  Score=350.81  Aligned_cols=262  Identities=26%  Similarity=0.402  Sum_probs=207.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-----CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC--Cce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~  373 (623)
                      ..|++.+.||+|+||.||+|.+     .+++.||||+++..........+.+|+++++.++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999984     368999999998665555567899999999999999999999999876  668


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence            9999999999999999664   34699999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCc--eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccc--------ccccchHHHHH
Q 006968          454 LLDHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAA--------NQRGVMLDWVK  523 (623)
Q Consensus       454 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~--------~~~~~~~~~~~  523 (623)
                      ........  ......||..|+|||.+.+..++.++||||||+++|||++|+.|+......        ...........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            77654332  223455888999999999999999999999999999999999986432110        00000001111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ... .+         .....+...+.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       255 ~~~-~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          255 TLK-EG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHH-TT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHh-cc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            111 11         1111223344789999999999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.7e-41  Score=350.14  Aligned_cols=253  Identities=21%  Similarity=0.305  Sum_probs=205.7

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .++|.+.+.||+|+||.||+|... +|..||+|+++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999875 6899999999765432 23356889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC---CcEEEeecccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED---FEAVVGDFGLAKL  454 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Dfgla~~  454 (623)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.+   +.+||+|||++..
T Consensus       108 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          108 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999988865    34689999999999999999999999   99999999999999865   4599999999987


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....       ......... +...  
T Consensus       181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~-~~~~--  248 (362)
T 2bdw_A          181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKA-GAYD--  248 (362)
T ss_dssp             CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-TCCC--
T ss_pred             ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHh-CCCC--
Confidence            65332  23345699999999999998999999999999999999999999964321       111111111 1110  


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          .........+.++.+++.+||..||++|||+.|++++
T Consensus       249 ----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0000001224678999999999999999999999876

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=353.52  Aligned_cols=251  Identities=27%  Similarity=0.348  Sum_probs=202.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~l  375 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||||++++...  ......+.+|..++..+ +||||+++++++...+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999975 589999999976432  22344678899999988 69999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       102 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999764    3699999999999999999999999   9999999999999999999999999999854


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......       +....+.... .    
T Consensus       175 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~-~----  241 (353)
T 3txo_A          175 ICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDE-V----  241 (353)
T ss_dssp             CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC-C----
T ss_pred             ccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC-C----
Confidence            322 22344567999999999999989999999999999999999999999743221       1112221111 0    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHh
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKM------SEVLKML  576 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~~L  576 (623)
                            .++.....++.+++.+||..||++||++      .|++++-
T Consensus       242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp  282 (353)
T 3txo_A          242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP  282 (353)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred             ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence                  1122234678999999999999999998      7787753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=348.46  Aligned_cols=246  Identities=26%  Similarity=0.300  Sum_probs=195.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|+..+.||+|+||+||+|... +|+.||||++...... .....+..|+..+..+ +||||+++++++...+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999986 7999999998654322 2233456666666555 8999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+ +++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999 77999988765   34699999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ..  ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....         | ... ..+...    +
T Consensus       210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~-~~~-~~~~~~----~  271 (311)
T 3p1a_A          210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------W-QQL-RQGYLP----P  271 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------H-HHH-TTTCCC----H
T ss_pred             CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------H-HHH-hccCCC----c
Confidence            32  2334569999999999875 789999999999999999999777642211         1 111 111111    1


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .+.    ...+.++.+++.+||+.||++|||+.|++++
T Consensus       272 ~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          272 EFT----AGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             HHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            111    1123678999999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.9e-41  Score=341.95  Aligned_cols=259  Identities=17%  Similarity=0.201  Sum_probs=208.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|.+.+.||+|+||.||+|.. .+|+.||||+++...   ....+.+|+.++..+ +|+|++++++++......++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            5788999999999999999996 479999999986533   234688999999999 79999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc-----EEEeeccccc
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE-----AVVGDFGLAK  453 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~Dfgla~  453 (623)
                      |+ +++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||+++
T Consensus        87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99 99999999864   34599999999999999999999999   9999999999999987776     9999999998


Q ss_pred             ccCCCCCc------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh
Q 006968          454 LLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       454 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      ........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............ ..+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~  238 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQ  238 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH-HHHHhhcc
Confidence            76543321      234456999999999999999999999999999999999999999753321111111 11111111


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ......     +..    ..+.++.+++.+||+.||++|||+.+|++.|++.
T Consensus       239 ~~~~~~-----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          239 STPLRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HSCHHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CccHHH-----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            111111     111    1236789999999999999999999999999873

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-41  Score=347.80  Aligned_cols=248  Identities=26%  Similarity=0.326  Sum_probs=206.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++++...  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888999999999999999975 699999999975432  223456889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        86 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999763    4689999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .    ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ........... .      
T Consensus       159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~-~------  220 (318)
T 1fot_A          159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAE-L------  220 (318)
T ss_dssp             C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCC-C------
T ss_pred             c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-C------
Confidence            2    3345699999999999999999999999999999999999999964322       11112221111 0      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhh
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKMLE  577 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L~  577 (623)
                          .++.....++.+++.+|+..||++||     ++.+++++-.
T Consensus       221 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~  261 (318)
T 1fot_A          221 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  261 (318)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             ----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence                11222346789999999999999999     8999987643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=364.76  Aligned_cols=265  Identities=22%  Similarity=0.248  Sum_probs=211.0

Q ss_pred             CHHHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeee
Q 006968          292 TFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCS  368 (623)
Q Consensus       292 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~  368 (623)
                      .+.+.+...++|++.+.||+|+||.||+|... +|+.||||++++....  .....+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455556788999999999999999999975 6999999999753321  22345889999999999999999999999


Q ss_pred             cCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 006968          369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD  448 (623)
Q Consensus       369 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  448 (623)
                      +.+..++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence            999999999999999999999864   23689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCceeeccccccccccccccc-------cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHH
Q 006968          449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS-------TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDW  521 (623)
Q Consensus       449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  521 (623)
                      ||+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.||.......       .
T Consensus       206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~  278 (412)
T 2vd5_A          206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-------T  278 (412)
T ss_dssp             CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------H
T ss_pred             chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-------H
Confidence            9999877654443344567999999999997       3578999999999999999999999997433211       1


Q ss_pred             HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHh
Q 006968          522 VKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHR---PKMSEVLKML  576 (623)
Q Consensus       522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps~~evl~~L  576 (623)
                      ...+.....  ....+..    ....+.++.+++.+||. +|++|   |++.|++++-
T Consensus       279 ~~~i~~~~~--~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          279 YGKIVHYKE--HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             HHHHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             HHHHHhccc--CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence            111111000  0000101    11224678999999999 99998   6999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.5e-42  Score=356.41  Aligned_cols=261  Identities=26%  Similarity=0.374  Sum_probs=210.5

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeCC------CcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCC
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN  371 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  371 (623)
                      ..++|.+.+.||+|+||.||+|....      +..||+|.++..........+.+|+.+++.+ +||||+++++++...+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45789999999999999999998642      3489999997665444556799999999999 8999999999999999


Q ss_pred             ceEEEEecccCCChhhhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIH----------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED  441 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  441 (623)
                      ..++||||+++|+|.+++.....          ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence            99999999999999999975321          134589999999999999999999999   99999999999999999


Q ss_pred             CcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchH
Q 006968          442 FEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVML  519 (623)
Q Consensus       442 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~  519 (623)
                      +.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |..||.......      
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------  274 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------  274 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------
Confidence            99999999999865433322 2233457889999999998999999999999999999999 888986422111      


Q ss_pred             HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          520 DWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       ........+.         ....+...+..+.+++.+||+.||.+|||+.|++++|++
T Consensus       275 -~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          275 -KFYKLVKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             -HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence             1111111111         001112224678999999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7e-42  Score=351.94  Aligned_cols=266  Identities=26%  Similarity=0.382  Sum_probs=207.3

Q ss_pred             CCcCCceeccCCeEEEEEEeC-----CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC--CceEE
Q 006968          303 FSAKNILGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLL  375 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~l  375 (623)
                      |.+.+.||+|+||.||++.+.     +++.||||+++..........+.+|++++++++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            478899999999999998753     58899999998665444456799999999999999999999999874  56899


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|.+++...     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999999999999753     489999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCc--eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ......  ......+|..|+|||.+.+..++.++||||||+++|||++|+.||.........  ...+...........+
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE--LIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HHCSCCHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh--hhcccccchhHHHHHH
Confidence            654332  223445888999999999989999999999999999999999998643211000  0000000000000111


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .+........+...+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT  307 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            111111122233345789999999999999999999999999976

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-41  Score=347.53  Aligned_cols=254  Identities=22%  Similarity=0.292  Sum_probs=195.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCce----
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENER----  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~----  373 (623)
                      ++|.+.+.||+|+||.||+|.. .+++.||||+++......  ....+.+|+.++++++||||+++++++......    
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            6788999999999999999996 478999999997653322  234689999999999999999999998765443    


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        92 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            9999999999999999763    3689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCc--eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          454 LLDHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       454 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      ........  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......       ............
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~  237 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPI  237 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCC
Confidence            76543222  223456899999999999999999999999999999999999999643221       111111111111


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..   .....    ..+.++.+++.+||+.||++||++.+++.+
T Consensus       238 ~~---~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          238 PP---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             CH---HHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             Cc---ccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence            10   00011    123678999999999999999987777654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=343.72  Aligned_cols=254  Identities=24%  Similarity=0.364  Sum_probs=207.1

Q ss_pred             cCCCcCC-ceeccCCeEEEEEEeC---CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKN-ILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||||+++..........+.+|+++++.++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455555 8999999999999863   57889999998754444556799999999999999999999999 45678999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999998753   34699999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCCce--eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          457 HRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       457 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ......  .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......       +....... +.   
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~i~~-~~---  230 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQ-GK---  230 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHT-TC---
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHhc-CC---
Confidence            433322  223346899999999988889999999999999999999 99998643221       11111111 11   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                            ....+...+.++.+++.+||+.+|++||++.+++++|+.
T Consensus       231 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  269 (287)
T 1u59_A          231 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  269 (287)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                  011222334789999999999999999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.8e-41  Score=349.54  Aligned_cols=260  Identities=26%  Similarity=0.359  Sum_probs=194.1

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeCC-C---cEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFSD-G---ALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      ..++|.+.+.||+|+||.||+|.... +   ..||||+++.... ......+.+|++++++++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34679999999999999999998754 2   2799999976432 23355799999999999999999999999876655


Q ss_pred             ------EEEEecccCCChhhhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEE
Q 006968          374 ------LLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       374 ------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                            ++||||+++|+|.+++.....  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence                  999999999999999976432  223689999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHH
Q 006968          446 VGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       446 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      |+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......       ...
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~  250 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------IYN  250 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHH
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-------HHH
Confidence            9999999876543322 2223447889999999999999999999999999999999 899986432211       111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .......          ...+...+.++.+++.+||+.||++|||+.++++.|++
T Consensus       251 ~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  295 (323)
T 3qup_A          251 YLIGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN  295 (323)
T ss_dssp             HHHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1111111          11122234679999999999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-41  Score=351.54  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=202.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC-----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ++|...+.||+|+||.||+|....     +..||||+++..........+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456778999999999999998642     346999999765544445679999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999763   34699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCc--eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          456 DHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       456 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ......  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+........... 
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~~~-  269 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRL-  269 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCC-
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHCCCcC-
Confidence            543221  1222346789999999998999999999999999999999 9999863221       1111222111111 


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                               ..+...+.++.+++.+||+.+|++||++.+++++|+..
T Consensus       270 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          270 ---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             ---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                     11222346789999999999999999999999999873

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-41  Score=340.30  Aligned_cols=250  Identities=22%  Similarity=0.349  Sum_probs=203.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecC--CceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~--~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|.+ +++.||||+++..... .....|.+|+.++++++||||+++++++...  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            5688899999999999999998 4899999999765432 2345799999999999999999999999877  7789999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||+.   +  |+||||||+||+++.++.++|+|||++...
T Consensus        89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999999763  233689999999999999999999998   7  999999999999999999999999987643


Q ss_pred             CCCCCceeeccccccccccccccccCCCCC---ccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSE---KTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ..      ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||......       +........+.  
T Consensus       164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~--  228 (271)
T 3kmu_A          164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVALEGL--  228 (271)
T ss_dssp             SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHHSCC--
T ss_pred             cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHhcCC--
Confidence            32      2235899999999998765544   799999999999999999999643221       11111111111  


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                             ....+...+.++.+++.+||+.||++|||+.++++.|+.
T Consensus       229 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          229 -------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                   111222234679999999999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.9e-42  Score=351.99  Aligned_cols=267  Identities=24%  Similarity=0.384  Sum_probs=214.5

Q ss_pred             HHHHHhcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeee
Q 006968          295 ELRAATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS  368 (623)
Q Consensus       295 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~  368 (623)
                      ++....++|.+.+.||+|+||.||+|...      ++..||||.++..........+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            33445678999999999999999999864      378899999976554445567999999999999999999999999


Q ss_pred             cCCceEEEEecccCCChhhhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 006968          369 TENERLLVYPYMPNGSVASRLRDHI------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF  442 (623)
Q Consensus       369 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  442 (623)
                      ..+..++||||+++|+|.+++....      .....+++..+..++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence            9999999999999999999997532      1124579999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHH
Q 006968          443 EAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLD  520 (623)
Q Consensus       443 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  520 (623)
                      .+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~  248 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQ  248 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-------HH
Confidence            9999999999865432221 1223346889999999999999999999999999999999 8888864321       11


Q ss_pred             HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCC
Q 006968          521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGL  581 (623)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  581 (623)
                      ....... +...         ..+...+..+.+++.+||+.||++|||+.|++++|++...
T Consensus       249 ~~~~~~~-~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 VLRFVME-GGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHT-TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHc-CCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1122111 1111         1112234678999999999999999999999999988533

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.6e-41  Score=342.32  Aligned_cols=254  Identities=28%  Similarity=0.424  Sum_probs=208.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .++|.+.+.||+|+||.||+|...++..||||.++...  .....+.+|+++++.++||||+++++++. .+..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            35788899999999999999999888899999997543  23567999999999999999999999986 4568999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            99999999987531  12589999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+..........        
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~--------  228 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYR--------  228 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC--------
T ss_pred             cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HHHHHHHhcccC--------
Confidence            333334457889999999988889999999999999999999 8999864321       111122111110        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                        ...+...+.++.+++.+|++.||++|||+.++++.|++
T Consensus       229 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  266 (279)
T 1qpc_A          229 --MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (279)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence              01112234678999999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.9e-42  Score=350.44  Aligned_cols=268  Identities=25%  Similarity=0.357  Sum_probs=213.9

Q ss_pred             CHHHHHHHhcCCCcCCceeccCCeEEEEEEe------CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeee
Q 006968          292 TFKELRAATSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLC  364 (623)
Q Consensus       292 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~  364 (623)
                      ...++....++|.+.+.||+|+||.||+|..      .+++.||||+++..........+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3444445567899999999999999999974      357899999998655444456799999999999 799999999


Q ss_pred             eeeecCC-ceEEEEecccCCChhhhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 006968          365 GFCSTEN-ERLLVYPYMPNGSVASRLRDHIHG------------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV  431 (623)
Q Consensus       365 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl  431 (623)
                      +++...+ ..++||||+++|+|.+++......            ...+++..+..++.|++.||.|||+.   +|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence            9987654 489999999999999999864321            12389999999999999999999999   9999999


Q ss_pred             CCCCeEECCCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcc
Q 006968          432 KAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG  509 (623)
Q Consensus       432 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~  509 (623)
                      ||+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999999999999999999876543332 2334557899999999999999999999999999999998 99998643


Q ss_pred             cccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          510 RAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ...      ............      .    ..+...+.++.+++.+||+.||.+|||+.|++++|+.
T Consensus       255 ~~~------~~~~~~~~~~~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  307 (316)
T 2xir_A          255 KID------EEFCRRLKEGTR------M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  307 (316)
T ss_dssp             CCS------HHHHHHHHHTCC------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             chh------HHHHHHhccCcc------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            211      111111111111      0    1111234678999999999999999999999999987

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.9e-41  Score=348.01  Aligned_cols=257  Identities=23%  Similarity=0.298  Sum_probs=204.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|.+.+.||+|+||.||+|... +++.||+|++++.....  ....+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56888999999999999999975 58999999997654332  234578899999887 899999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999999763    3689999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccccc-ccchHHHHHHHhhcCcccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ-RGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+.........    
T Consensus       162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~----  236 (345)
T 3a8x_A          162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----  236 (345)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred             CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence            222 234456799999999999999999999999999999999999999964221110 00111111111111111    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKM------SEVLKM  575 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~~  575 (623)
                            .++...+.++.+++.+||..||++||++      .|++++
T Consensus       237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          237 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             ------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                  1222234678999999999999999995      677664

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=348.78  Aligned_cols=255  Identities=25%  Similarity=0.426  Sum_probs=201.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCc----EEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      .+|.+.+.||+|+||.||+|.+. +++    .||+|.++..........+.+|+.+++.++||||+++++++... ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence            57889999999999999999864 344    46888886655555677899999999999999999999999865 4889


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      |+||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        94 v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999999864   34699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......    ...   .. ..+.   
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~---~~-~~~~---  236 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISS---IL-EKGE---  236 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHH---HH-HTTC---
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHH---HH-HcCC---
Confidence            543222 2233447889999999999999999999999999999999 999997433211    111   11 1111   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                            ....+...+.++.+++.+||..||.+|||+.|+++.|+..
T Consensus       237 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          237 ------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  1111222346789999999999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.5e-42  Score=358.54  Aligned_cols=266  Identities=16%  Similarity=0.180  Sum_probs=203.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCC------CcEEEEEEeccccccc----------chHHHHHHHHHHhhcCCCceeee
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAG----------GEVQFQTEVETISLAVHRNLLRL  363 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~H~niv~l  363 (623)
                      .++|.+.+.||+|+||.||+|.+.+      ++.||||++.......          ....+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578999999999999999998754      4789999986543110          01124456666778889999999


Q ss_pred             eeeeecC----CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC
Q 006968          364 CGFCSTE----NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD  439 (623)
Q Consensus       364 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~  439 (623)
                      ++++...    ...++||||+ +++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            9998764    4479999999 99999999763   34699999999999999999999999   999999999999999


Q ss_pred             --CCCcEEEeecccccccCCCCCc------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q 006968          440 --EDFEAVVGDFGLAKLLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA  511 (623)
Q Consensus       440 --~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~  511 (623)
                        .++.+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999876432211      11334599999999999999999999999999999999999999974221


Q ss_pred             cccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          512 ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      .   .....+..... ...+..++++.+..   ...+.++.+++..||+.+|++||++.+|++.|++.
T Consensus       267 ~---~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 D---PKYVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             C---HHHHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             C---HHHHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            1   11111111111 11223333332211   11236789999999999999999999999998874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=350.15  Aligned_cols=251  Identities=24%  Similarity=0.304  Sum_probs=205.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|... +++.||+|+++....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888999999999999999875 588999999975432  233457889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999875    34699999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCceeecccccccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ..  ......||+.|+|||++..   ..++.++|||||||++|||++|+.||.......    ............     
T Consensus       168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~~~~~~-----  236 (384)
T 4fr4_A          168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTFETTV-----  236 (384)
T ss_dssp             TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHHHHHHCC-----
T ss_pred             CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhhcc-----
Confidence            32  3345679999999999964   458999999999999999999999996432211    111111111110     


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK-MSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~  575 (623)
                            ..++...+.++.+++.+||..||++||+ +.++.++
T Consensus       237 ------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          237 ------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             ------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                  1122233467899999999999999998 7777664

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.3e-41  Score=348.20  Aligned_cols=263  Identities=23%  Similarity=0.232  Sum_probs=203.3

Q ss_pred             HHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc----ccchHHHHHHHHHHhhcCCCceeeeeeeeecCC
Q 006968          297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI----AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN  371 (623)
Q Consensus       297 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  371 (623)
                      ....++|.+.+.||+|+||.||+|... ++..||+|+++....    ......+.+|++++++++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            445678999999999999999999874 688999999975431    234457999999999999999999999999999


Q ss_pred             ceEEEEecccCCChhhhhhhccCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHG------------------------------------RPALDWARRKRIALGTARGL  415 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~L  415 (623)
                      ..++||||+++|+|.+++......                                    ...+++..++.++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998632111                                    11246778889999999999


Q ss_pred             HHHHhCCCCCeEecCCCCCCeEECCCC--cEEEeecccccccCCCC---Cceeecccccccccccccccc--CCCCCccc
Q 006968          416 LYLHEQCDPKIIHRDVKAANILLDEDF--EAVVGDFGLAKLLDHRD---SHVTTAVRGTVGHIAPEYLST--GQSSEKTD  488 (623)
Q Consensus       416 ~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D  488 (623)
                      +|||+.   +|+||||||+||+++.++  .+||+|||+++.+....   ........||+.|+|||.+.+  ..++.++|
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999   999999999999998776  89999999998654322   112344569999999999865  67899999


Q ss_pred             hhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 006968          489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK  568 (623)
Q Consensus       489 v~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs  568 (623)
                      |||||+++|||++|+.||......       +............  ..+.     ....+.++.+++.+||..||++|||
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCF--ENPN-----YNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCT--TSGG-----GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhccccc--CCcc-----cccCCHHHHHHHHHHcCCChhHCCC
Confidence            999999999999999999643221       1112221111100  0000     0112367899999999999999999


Q ss_pred             HHHHHHHh
Q 006968          569 MSEVLKML  576 (623)
Q Consensus       569 ~~evl~~L  576 (623)
                      +.|++++-
T Consensus       325 ~~~~l~hp  332 (345)
T 3hko_A          325 AMRALQHP  332 (345)
T ss_dssp             HHHHHHSH
T ss_pred             HHHHhcCh
Confidence            99999853

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-40  Score=349.55  Aligned_cols=254  Identities=20%  Similarity=0.273  Sum_probs=207.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            357999999999999999999875 68999999987543 2234578999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC--CCcEEEeecccccccC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE--DFEAVVGDFGLAKLLD  456 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~Dfgla~~~~  456 (623)
                      |+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.  ++.+||+|||+++...
T Consensus       129 ~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          129 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            99999999988753   34699999999999999999999999   9999999999999974  5779999999998765


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .+.+........   ..+
T Consensus       203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~---~~~  270 (387)
T 1kob_A          203 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDW---EFD  270 (387)
T ss_dssp             TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCC---CCC
T ss_pred             CCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC---CCC
Confidence            432  23344699999999999999999999999999999999999999974322       111222211110   011


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ...    ....+.++.+++.+||..||++|||+.|++++-
T Consensus       271 ~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          271 EDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             SST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             ccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence            111    112346789999999999999999999999863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6e-41  Score=345.93  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=182.3

Q ss_pred             CCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEEEecccCC
Q 006968          306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPNG  383 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g  383 (623)
                      .+.||+|+||.||+|... +|+.||||+++..    ....+.+|+.++..+. ||||+++++++.+.+..++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            478999999999999975 6899999999653    3456889999999997 999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---cEEEeecccccccCCCCC
Q 006968          384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---EAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~  460 (623)
                      +|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++   .+||+|||+++.......
T Consensus        92 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  164 (325)
T 3kn6_A           92 ELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ  164 (325)
T ss_dssp             BHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence            999999763    4699999999999999999999999   999999999999997665   899999999986654322


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                       ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............+....... +...      ..
T Consensus       165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~-~~~~------~~  236 (325)
T 3kn6_A          165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-GDFS------FE  236 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT-TCCC------CC
T ss_pred             -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc-CCCC------CC
Confidence             233456899999999999999999999999999999999999999754332222222222222211 1110      00


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .......+.++.+++.+||..||++|||+.|++++
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            00001234678999999999999999999999765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-41  Score=355.51  Aligned_cols=270  Identities=17%  Similarity=0.230  Sum_probs=214.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC--ceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--ERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56888999999999999999976 589999999986655555667899999999999999999999997655  679999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----CCCCcEEEeeccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGLAK  453 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Dfgla~  453 (623)
                      ||+++|+|.+++..... ...+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999976432 23499999999999999999999999   99999999999999    788889999999998


Q ss_pred             ccCCCCCceeecccccccccccccccc--------CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      ......  ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||.........   .+.+...
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~---~~~~~~~  239 (396)
T 4eut_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKI  239 (396)
T ss_dssp             ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC---HHHHHHH
T ss_pred             EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch---HHHHHHH
Confidence            765432  2234569999999999865        56788999999999999999999999643222111   1222222


Q ss_pred             hhcCc---cccc---------cc--cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          526 HQEGK---LSQM---------VD--KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       526 ~~~~~---~~~~---------~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      .....   ....         +.  ......+.......+.+++.+||..||++|||+.|+++.+++.
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            22111   0000         00  0112234577888999999999999999999999999998773

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-41  Score=352.11  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=206.0

Q ss_pred             HHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCce
Q 006968          298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENER  373 (623)
Q Consensus       298 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  373 (623)
                      ...++|.+.+.||+|+||.||+|... +|+.||||+++....  ......+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            35678999999999999999999975 689999999976432  23345678899999876 899999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        94 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            9999999999999999763    3689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......       +....+....    
T Consensus       167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~----  234 (345)
T 1xjd_A          167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDN----  234 (345)
T ss_dssp             CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC----
T ss_pred             hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHhCC----
Confidence            643222 2244567999999999999999999999999999999999999999643221       1112211111    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMS-EVLKM  575 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~~  575 (623)
                         .    .++...+.++.+++.+||..||++||++. +++++
T Consensus       235 ---~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          235 ---P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             ---C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ---C----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence               1    11222346789999999999999999997 66553

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=376.67  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=202.1

Q ss_pred             CCcCC-ceeccCCeEEEEEEeC---CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          303 FSAKN-ILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       303 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      +.+.+ .||+|+||.||+|.+.   ++..||||+++.........+|.+|++++++++||||+++++++.. +..++|||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            33334 7999999999999864   4678999999876545556789999999999999999999999976 56899999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       416 ~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          416 MAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             CCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             eCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999753   45699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcee--eccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          459 DSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       459 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      .....  ....+++.|+|||++.+..++.++|||||||++|||++ |+.||......       +....+.. +.     
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~-~~-----  556 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQ-GK-----  556 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------HHHHHHHT-TC-----
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHc-CC-----
Confidence            32222  22335689999999999999999999999999999998 99999643221       11111111 11     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                          ....+..++.++.+++.+||..+|++||++.+|++.|+.
T Consensus       557 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          557 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                111223345789999999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-41  Score=355.69  Aligned_cols=254  Identities=31%  Similarity=0.431  Sum_probs=193.9

Q ss_pred             CCCcCCceeccCCeEEEEEEeC--C--CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec-CCceEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS--D--GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST-ENERLLV  376 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv  376 (623)
                      .|.+.+.||+|+||.||+|.+.  +  +..||||.++.........+|.+|+.++++++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4666789999999999999863  2  246899999765544556689999999999999999999998754 5678999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.++++..   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999753   34689999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCCc---eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          457 HRDSH---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       457 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      .....   ......+|+.|+|||.+.+..++.++||||||+++|||+| |.+||......    ....   ... .+.. 
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~----~~~~---~~~-~~~~-  314 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITV---YLL-QGRR-  314 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS----CHHH---HHH-TTCC-
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH----HHHH---HHH-cCCC-
Confidence            33221   1233457889999999999999999999999999999999 56666532211    1111   111 1110 


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                              ...+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       315 --------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~  352 (373)
T 3c1x_A          315 --------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  352 (373)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                    01112234678999999999999999999999999987

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.6e-41  Score=350.72  Aligned_cols=248  Identities=22%  Similarity=0.272  Sum_probs=207.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||||+++....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999999999975 689999999975432  223456889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999999864    3589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .+....+.. +..      
T Consensus       194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~-~~~------  255 (350)
T 1rdq_E          194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVS-GKV------  255 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-CCC------
T ss_pred             C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHHHHHc-CCC------
Confidence            2    2345699999999999999999999999999999999999999964322       111222211 111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHhh
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPK-----MSEVLKMLE  577 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~L~  577 (623)
                          .++...+.++.+++.+||..||++||+     +.+++++-.
T Consensus       256 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~  296 (350)
T 1rdq_E          256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence                112223467899999999999999998     888887644

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.5e-40  Score=340.57  Aligned_cols=260  Identities=20%  Similarity=0.365  Sum_probs=200.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|.. .+|..||||+++.....  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4688899999999999999986 47899999999753322  23456899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++.........+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999986544456799999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....     .......... ........  
T Consensus       189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~-~~~~~~~~--  259 (310)
T 2wqm_A          189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIE-QCDYPPLP--  259 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHHHH-TTCSCCCC--
T ss_pred             CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHHhh-cccCCCCc--
Confidence            322 22334589999999999999999999999999999999999999863221     1112222221 11111111  


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                            ....+.++.+++.+||+.||++|||+.++++.|+.
T Consensus       260 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~  294 (310)
T 2wqm_A          260 ------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR  294 (310)
T ss_dssp             ------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                  11223678999999999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-41  Score=340.85  Aligned_cols=255  Identities=29%  Similarity=0.379  Sum_probs=202.9

Q ss_pred             CCCcCCceeccCCeEEEEEEeCC----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCce-EEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER-LLV  376 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-~lv  376 (623)
                      .|...+.||+|+||.||+|.+.+    +..||+|.++..........+.+|+.+++.++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            35566899999999999998532    3379999997655444556799999999999999999999999876655 999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+.+|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999763   35689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCC---CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          457 HRD---SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       457 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ...   ........+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.......   ....   .... +.   
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~---~~~~-~~---  245 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTH---FLAQ-GR---  245 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHH---HHHT-TC---
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHH---Hhhc-CC---
Confidence            322   112234458899999999999999999999999999999999666653221111   1111   1111 11   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                            ....+...+..+.+++.+||+.||.+|||+.++++.|++
T Consensus       246 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  284 (298)
T 3pls_A          246 ------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ  284 (298)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                  011122234678999999999999999999999999987

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=351.57  Aligned_cols=253  Identities=21%  Similarity=0.295  Sum_probs=198.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEeccccccc-chHHHHHHHHHHhhcCC--CceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVH--RNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H--~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|...+++.||||+++...... ....+.+|+.++.+++|  |||+++++++..++..++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            5688899999999999999999889999999997544322 23568999999999987  99999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      | +.+|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||+++....
T Consensus        89 e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             C-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             e-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            9 5688999999863    4689999999999999999999999   999999999999997 57899999999987654


Q ss_pred             CCCc-eeecccccccccccccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          458 RDSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       458 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      .... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....      ........
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~  233 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAI  233 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------HHHHHHHH
Confidence            3322 2334569999999999865           6788999999999999999999999963211      11111111


Q ss_pred             hhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                               ++......++.....++.+++.+||..||++|||+.|++++-.
T Consensus       234 ---------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          234 ---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             ---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ---------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence                     1111111222222367899999999999999999999998654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=345.60  Aligned_cols=262  Identities=25%  Similarity=0.312  Sum_probs=205.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeee----cCCceE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS----TENERL  374 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~----~~~~~~  374 (623)
                      .++|.+.+.||+|+||.||++.. .+|+.||||++.... ......+.+|+++++.++||||+++++++.    .....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            36788999999999999999997 478999999986532 234557899999999999999999999986    345789


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +||||+++|+|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999999987655567899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCc--------eeeccccccccccccccccCC---CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH
Q 006968          455 LDHRDSH--------VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       455 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      .......        ......||+.|+|||.+....   ++.++||||||+++|||++|+.||........  .....  
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~--  259 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALA--  259 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHH--
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHH--
Confidence            4321110        011234799999999987554   68999999999999999999999853211100  01100  


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG  580 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  580 (623)
                        ... .        .........+.++.+++.+||+.||.+|||+.+++++|+...
T Consensus       260 --~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          260 --VQN-Q--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             --HHC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             --hhc-c--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence              000 0        000111223467999999999999999999999999998843

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=337.92  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=184.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|.. .+|+.||||++.....  ......+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5688899999999999999987 4789999999965432  122357899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999998753   34689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........                .......
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~  227 (278)
T 3cok_A          165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LNKVVLA  227 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSS
T ss_pred             CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HHHHhhc
Confidence            322 22335689999999999988999999999999999999999999964322110                0000000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..  ..+...+.++.+++.+||+.||++|||+.+++++
T Consensus       228 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          228 DY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            00  1122234678999999999999999999999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=374.45  Aligned_cols=255  Identities=27%  Similarity=0.380  Sum_probs=209.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .++|.+.+.||+|+||.||+|.+.++..||||+++...  ....+|.+|++++++++||||+++++++.. +..++||||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            46688889999999999999999888889999997644  235679999999999999999999999876 678999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.++++...  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       343 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          343 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             hcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            99999999997532  23589999999999999999999999   99999999999999999999999999998764322


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      ........++..|+|||.+....++.++|||||||++|||++ |+.||.....       .+....+.....        
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~--------  482 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYR--------  482 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHHHHHTTCC--------
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC--------
Confidence            112223446789999999999999999999999999999999 8999863221       111222211111        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                        ...+..++.++.+++.+||+.||++|||+.+|++.|++.
T Consensus       483 --~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          483 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              111223447789999999999999999999999999884

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=346.06  Aligned_cols=252  Identities=23%  Similarity=0.302  Sum_probs=190.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|... +++.||||+++...   ....+.+|++++++++||||+++++++...+..++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            467889999999999999999986 58899999997543   34568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEeeccccccc
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFGLAKLL  455 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfgla~~~  455 (623)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++..
T Consensus       129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999998875    34689999999999999999999999   9999999999999975   889999999999865


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ........ .... . 
T Consensus       202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~-~~~~-~-  270 (349)
T 2w4o_A          202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILN-CEYY-F-  270 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHT-TCCC-C-
T ss_pred             Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHh-CCCc-c-
Confidence            4322  2334569999999999999999999999999999999999999996432210      01111111 1110 0 


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                          ........+.++.+++.+||..||++|||+.|++++-
T Consensus       271 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  307 (349)
T 2w4o_A          271 ----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP  307 (349)
T ss_dssp             ----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             ----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                0011112346789999999999999999999999853

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-40  Score=338.02  Aligned_cols=259  Identities=20%  Similarity=0.215  Sum_probs=200.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .++|.+.+.||+|+||.||+|... +++.||||+++......  ....+.+|+.++++++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999975 68999999997654322  235689999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999999864    3689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ...........|++.|+|||.+.+..++.++||||||+++|||++|+.||......        .+........ ..  .
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~-~~--~  254 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAI-PR--P  254 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCC-CC--G
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCC-CC--c
Confidence            44333334556999999999999999999999999999999999999999743221        1111111111 00  0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhcCC
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRP-KMSEVLKMLEGDG  580 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~~~  580 (623)
                      ...    ....+.++.+++.+||+.||++|| ++.++++.|+...
T Consensus       255 ~~~----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          255 STV----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             GGT----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             ccc----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence            011    112235789999999999999999 9999999998743

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.8e-41  Score=346.51  Aligned_cols=245  Identities=22%  Similarity=0.291  Sum_probs=204.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-------chHHHHHHHHHHhhcCCCceeeeeeeeecCC
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-------GEVQFQTEVETISLAVHRNLLRLCGFCSTEN  371 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  371 (623)
                      .++|.+.+.||+|+||.||+|... +++.||||+++......       ....+.+|+.++++++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            467999999999999999999864 68999999997654221       2335788999999999999999999999999


Q ss_pred             ceEEEEecccCC-ChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          372 ERLLVYPYMPNG-SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       372 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      ..++||||+.+| +|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999999777 999988753    4699999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      ++........  .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......                 
T Consensus       176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------  236 (335)
T 3dls_A          176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------  236 (335)
T ss_dssp             TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred             cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence            9987654332  234569999999999988776 88999999999999999999999632110                 


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                           ......  .+...+.++.+++.+||+.||++|||+.+++++-.
T Consensus       237 -----~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          237 -----VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             -----TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             -----HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence                 000000  01112367899999999999999999999999743

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-40  Score=344.09  Aligned_cols=253  Identities=23%  Similarity=0.269  Sum_probs=198.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe----CCCcEEEEEEecccccc---cchHHHHHHHHHHhhcCCCceeeeeeeeecCCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIA---GGEVQFQTEVETISLAVHRNLLRLCGFCSTENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  372 (623)
                      .++|.+.+.||+|+||.||+|..    .+|+.||+|+++.....   .....+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35788999999999999999986    47899999999765322   233457899999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++||||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            99999999999999999763    3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      +...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......       .....+... .  
T Consensus       169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~-~--  237 (327)
T 3a62_A          169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-------KTIDKILKC-K--  237 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHT-C--
T ss_pred             cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhC-C--
Confidence            7543222 2234456999999999999999999999999999999999999999743221       111221111 0  


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhc
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKMLEG  578 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L~~  578 (623)
                              ..++...+.++.+++.+||..||++||     ++.|++++-.-
T Consensus       238 --------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f  280 (327)
T 3a62_A          238 --------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF  280 (327)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred             --------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence                    011222346789999999999999999     78898886443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.4e-41  Score=341.28  Aligned_cols=255  Identities=31%  Similarity=0.439  Sum_probs=201.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeee-cCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS-TENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-~~~~~~l  375 (623)
                      .+|.+.+.||+|+||.||+|...+    +..||+|.++..........+.+|+.++++++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457788999999999999998642    33699999976554445567999999999999999999999864 5567899


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999753   34689999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCC---ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCC-CCCCcccccccccchHHHHHHHhhcCcc
Q 006968          456 DHRDS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ-RALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       456 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      .....   .......+|+.|+|||.+.+..++.++||||||+++|||++|+ +|+......    ...   ..... +. 
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~----~~~---~~~~~-~~-  249 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DIT---VYLLQ-GR-  249 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT----THH---HHHHT-TC-
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH----HHH---HHHhc-CC-
Confidence            44321   1223345788999999999999999999999999999999955 454422111    011   11111 11 


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                              ....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  288 (298)
T 3f66_A          250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  288 (298)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                    001112224678999999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-40  Score=340.42  Aligned_cols=266  Identities=25%  Similarity=0.337  Sum_probs=201.7

Q ss_pred             HHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhc--CCCceeeeeeeeecC----
Q 006968          297 RAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA--VHRNLLRLCGFCSTE----  370 (623)
Q Consensus       297 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l--~H~niv~l~~~~~~~----  370 (623)
                      ....++|.+.+.||+|+||.||+|... |+.||||++...    ....+..|.+++...  +||||+++++++...    
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            345578999999999999999999884 899999998643    234556666666554  899999999999876    


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeEECCCCcEE
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC-----DPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                      ...++||||+++|+|.++++..     .+++..++.++.|++.||+|||+.+     +++|+||||||+|||++.++.+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            6789999999999999999753     5899999999999999999999762     44899999999999999999999


Q ss_pred             EeecccccccCCCCCce---eeccccccccccccccccCCCCCc------cchhhHHHHHHHHHhC----------CCCC
Q 006968          446 VGDFGLAKLLDHRDSHV---TTAVRGTVGHIAPEYLSTGQSSEK------TDVFGFGILLLELITG----------QRAL  506 (623)
Q Consensus       446 l~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlGvil~elltg----------~~p~  506 (623)
                      |+|||+++.........   .....||+.|+|||++.+...+.+      +|||||||++|||+||          +.||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99999998765433221   124469999999999987766665      9999999999999999          4454


Q ss_pred             CcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          507 DFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .......   .......................   ....++.++.+++.+||+.||++|||+.||+++|+.
T Consensus       263 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          263 HDLVPSD---PSYEDMREIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             TTTSCSS---CCHHHHHHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hhhcCCC---CchhhhHHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence            3221111   11111122111111111111110   123567889999999999999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.2e-40  Score=336.70  Aligned_cols=261  Identities=19%  Similarity=0.215  Sum_probs=203.9

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeee-ecCCceEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC-STENERLLV  376 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv  376 (623)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++....   ...++.+|+++++.++|++++..++++ ...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            357899999999999999999996 478999999875433   234688999999999998888777666 566778999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCcEEEeeccccc
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAK  453 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfgla~  453 (623)
                      |||+ +++|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||+++
T Consensus        84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            9999 99999998753   34699999999999999999999999   99999999999999   788999999999998


Q ss_pred             ccCCCCCc------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh
Q 006968          454 LLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       454 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      ........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....................
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            76544321      223456999999999999999999999999999999999999999754332222222211111111


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                       ....     .....    .+.++.+++.+||+.||++|||+.++++.|++.
T Consensus       237 -~~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          237 -TPIE-----VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -SCHH-----HHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -chhh-----hhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence             0000     00111    136789999999999999999999999999874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.8e-40  Score=338.67  Aligned_cols=255  Identities=20%  Similarity=0.252  Sum_probs=207.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-----chHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||||.++......     ....+.+|+.+++.++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356889999999999999999975 68999999997654322     345799999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC----cEEEeec
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDF  449 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Df  449 (623)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            999999999999999975    34689999999999999999999999   999999999999999887    7999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      |++.......  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....       .+.........
T Consensus       164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~  234 (321)
T 2a2a_A          164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITSVS  234 (321)
T ss_dssp             TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTC
T ss_pred             ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcc
Confidence            9998765432  22345699999999999999999999999999999999999999964322       11111111110


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                       .  ..+.....    ..+..+.+++.+||..||++|||+.|++++-.
T Consensus       235 -~--~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~  275 (321)
T 2a2a_A          235 -Y--DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (321)
T ss_dssp             -C--CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred             -c--ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence             0  00111111    12367899999999999999999999998643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4e-41  Score=347.63  Aligned_cols=256  Identities=28%  Similarity=0.438  Sum_probs=204.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcE--EEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGAL--VAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|.+.+.||+|+||.||+|... +|..  ||||.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999875 4554  5999997655455566799999999999 899999999999999999999


Q ss_pred             EecccCCChhhhhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcE
Q 006968          377 YPYMPNGSVASRLRDHI------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA  444 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  444 (623)
                      |||+++|+|.+++....            .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999997642            2235799999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHH
Q 006968          445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      ||+|||+++......  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+...
T Consensus       182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYE  252 (327)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHH
T ss_pred             EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HHHHH
Confidence            999999997432211  1223347889999999988889999999999999999998 9999864321       11111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .... +         .....+...+.++.+++.+||..||++|||+.+++++|+.
T Consensus       253 ~~~~-~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          253 KLPQ-G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             HGGG-T---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             Hhhc-C---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1111 1         0111122234678999999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-41  Score=351.51  Aligned_cols=263  Identities=27%  Similarity=0.364  Sum_probs=209.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-----CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeee--cCCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS--TENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~  373 (623)
                      ++|.+.+.||+|+||.||+|.+     .++..||||+++... ......+.+|++++++++||||+++++++.  ..+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            5788899999999999999984     368899999997543 233456899999999999999999999886  45568


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence            9999999999999999764   23589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCce--eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccccc-------ccchHHHHHH
Q 006968          454 LLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ-------RGVMLDWVKK  524 (623)
Q Consensus       454 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~  524 (623)
                      .........  .....||..|+|||.+.+..++.++||||||+++|+|++|+.||........       .......+. 
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  254 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL-  254 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH-
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH-
Confidence            765443322  2234588889999999988899999999999999999999999864322100       000000011 


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                              +.+........+...+.++.+++.+||+.||++|||+.|++++|+..
T Consensus       255 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          255 --------ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             --------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             --------HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                    11111111222333457899999999999999999999999999884

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-40  Score=352.05  Aligned_cols=268  Identities=21%  Similarity=0.269  Sum_probs=204.2

Q ss_pred             hcCCCcCCceecc--CCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          300 TSNFSAKNILGRG--GFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ..+|++.+.||+|  +||.||+|... +|+.||||+++...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3578899999999  99999999986 69999999997654332 23468889999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.+...
T Consensus       104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999997642  34599999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCCC------ceeecccccccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHh-
Q 006968          456 DHRDS------HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH-  526 (623)
Q Consensus       456 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  526 (623)
                      .....      .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........   ......... 
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~  255 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVP  255 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH---HHHC------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHhcCCCC
Confidence            32111      11122368999999999987  6789999999999999999999999964322111   100000000 


Q ss_pred             ---h-----c-------------Ccccccccc---------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          527 ---Q-----E-------------GKLSQMVDK---------DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       527 ---~-----~-------------~~~~~~~~~---------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         .     .             .........         .....+......++.+++.+||+.||++|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence               0     0             000000000         00001122334679999999999999999999999876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=347.97  Aligned_cols=247  Identities=24%  Similarity=0.274  Sum_probs=196.8

Q ss_pred             CCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccCCC
Q 006968          306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS  384 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  384 (623)
                      .+.||+|+||.||+|... +|..||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            568999999999999874 689999999976432 345579999999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE--CCCCcEEEeecccccccCCCCCce
Q 006968          385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++.......  
T Consensus       173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--  244 (373)
T 2x4f_A          173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--  244 (373)
T ss_dssp             EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence            99988753   34689999999999999999999999   99999999999999  6778999999999987654332  


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN  542 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  542 (623)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......       +.+..+......   ......  
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~---~~~~~~--  312 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACRWD---LEDEEF--  312 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCC---SCSGGG--
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCC---CChhhh--
Confidence            23345999999999999999999999999999999999999999643321       112222111100   000000  


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          543 FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       543 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ...+.++.+++.+||..||++|||+.|++++
T Consensus       313 --~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          313 --QDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             --TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              1123678999999999999999999999984

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.5e-41  Score=343.42  Aligned_cols=252  Identities=29%  Similarity=0.440  Sum_probs=196.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|.+.+.||+|+||.||+|.+ .++.||||+++..   .....|.+|++++++++||||+++++++.  +..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            5688889999999999999988 4788999998643   34567999999999999999999999886  4589999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc-EEEeecccccccCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE-AVVGDFGLAKLLDHRD  459 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-~kl~Dfgla~~~~~~~  459 (623)
                      ++|+|.+++.... ....+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++...... 
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            9999999997542 1235789999999999999999999943239999999999999998886 799999999765422 


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                         .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......     .......... +..     +..
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~-~~~-----~~~  225 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRIMWAVHN-GTR-----PPL  225 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHHHHHHHT-TCC-----CCC
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHHHHHHhc-CCC-----CCc
Confidence               22345899999999999999999999999999999999999999642211     1111111111 111     111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                          ....+..+.+++.+||+.||++|||+.+++++|+.
T Consensus       226 ----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  260 (307)
T 2eva_A          226 ----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH  260 (307)
T ss_dssp             ----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence                11223678999999999999999999999999987

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.4e-40  Score=358.51  Aligned_cols=253  Identities=23%  Similarity=0.259  Sum_probs=199.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++....  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            356889999999999999999865 689999999975422  22334678999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+++..
T Consensus       227 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             ECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            9999999999999764    368999999999999999999998 7   9999999999999999999999999999864


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ........... .    
T Consensus       300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~-~----  366 (446)
T 4ejn_A          300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEE-I----  366 (446)
T ss_dssp             CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-C----
T ss_pred             cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHHhCC-C----
Confidence            3322 223446799999999999999999999999999999999999999964322       11111111111 0    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhc
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKMLEG  578 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L~~  578 (623)
                            .++...+.++.+++.+||+.||++||     ++.|++++-.-
T Consensus       367 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f  408 (446)
T 4ejn_A          367 ------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF  408 (446)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             ------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence                  11222346789999999999999999     99999986544

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-41  Score=343.01  Aligned_cols=258  Identities=25%  Similarity=0.349  Sum_probs=207.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeee--cCCceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCS--TENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~l  375 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||+|.++..... .....+.+|+.++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357888999999999999999975 6899999999754432 23456899999999999999999999874  4567899


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEecCCCCCCeEECCCCcEEEeecc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK-----IIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      ||||+++|+|.+++.........+++..++.++.|++.||+|||+.   +     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999999999987544455699999999999999999999998   7     9999999999999999999999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      ++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....       .+...... .+.
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~-~~~  232 (279)
T 2w5a_A          162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIR-EGK  232 (279)
T ss_dssp             HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHH-HTC
T ss_pred             hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHh-hcc
Confidence            9987654321 22334589999999999998999999999999999999999999874321       11111111 121


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ..         ..+...+.++.+++.+||+.||++|||+.|++++++.
T Consensus       233 ~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          233 FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            11         1112234678999999999999999999999998765

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-40  Score=336.49  Aligned_cols=259  Identities=30%  Similarity=0.435  Sum_probs=195.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ..+|.+.+.||+|+||.||+|...  ..||||+++..... .....|.+|++++++++||||+++++++ ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467889999999999999999864  35999999755432 2345689999999999999999999966 4567899999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus       100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A          100 WCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             ecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999998653   35699999999999999999999999   9999999999999999999999999999865432


Q ss_pred             C-Cceeeccccccccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          459 D-SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       459 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      . ........||+.|+|||.+.   +..++.++||||||+++|||++|+.||.......      . +......+.....
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~-~~~~~~~~~~~~~  246 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------Q-IIEMVGRGSLSPD  246 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------H-HHHHHHHTSCCCC
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------H-HHHHhcccccCcc
Confidence            2 22233456999999999986   5678889999999999999999999996432211      1 1111112211111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ..     ......+.++.+++.+||+.+|++|||+.++++.|++.
T Consensus       247 ~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          247 LS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             TT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            11     11223347799999999999999999999999999874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.1e-41  Score=336.03  Aligned_cols=255  Identities=23%  Similarity=0.326  Sum_probs=206.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|... +++.||||+++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            457889999999999999999975 6899999999765544556679999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+......
T Consensus        86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999998864    34689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CC-ceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          459 DS-HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       459 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      .. .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........  ....|    .......   .
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~----~~~~~~~---~  229 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDW----KEKKTYL---N  229 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHH----HTTCTTS---T
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHh----hhccccc---C
Confidence            21 12334568999999999987665 7899999999999999999999974332111  11111    1111000   0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                            .....+..+.+++.+||+.||++|||+.|++++-
T Consensus       230 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  263 (276)
T 2yex_A          230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (276)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             ------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence                  0112236788999999999999999999998753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.2e-41  Score=351.43  Aligned_cols=254  Identities=20%  Similarity=0.238  Sum_probs=195.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||++... +++.||||+++....  ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            367899999999999999999976 789999999975432  23568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc--EEEeecccccccC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE--AVVGDFGLAKLLD  456 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~Dfgla~~~~  456 (623)
                      |+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.  +||+|||+++...
T Consensus        97 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           97 YASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             eCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            99999999998763    3599999999999999999999999   9999999999999987765  9999999997433


Q ss_pred             CCCCceeeccccccccccccccccCCCCCc-cchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ..  .......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.......   .....+....... .    
T Consensus       170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~~~~~~~-~----  239 (361)
T 3uc3_A          170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR---DYRKTIQRILSVK-Y----  239 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC---CHHHHHHHHHTTC-C----
T ss_pred             cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH---HHHHHHHHHhcCC-C----
Confidence            22  12234469999999999988877655 899999999999999999997433211   1122222211111 0    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                        ....  ....+.++.+++.+||..||++|||+.|++++-
T Consensus       240 --~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          240 --SIPD--DIRISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             --CCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             --CCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence              0000  001236789999999999999999999999863

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1e-40  Score=347.46  Aligned_cols=252  Identities=23%  Similarity=0.293  Sum_probs=206.3

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  374 (623)
                      ..++|.+.+.||+|+||.||+|... +|+.||||+++....  ......+..|..++..+ +||||+++++++...+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3468999999999999999999986 488999999976432  23345688999999887 7999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        98 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            999999999999999764    3589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      .... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .+....+... ..   
T Consensus       171 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~-~~---  238 (353)
T 2i0e_A          171 NIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEH-NV---  238 (353)
T ss_dssp             CCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHC-CC---
T ss_pred             cccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhC-CC---
Confidence            4322 2234456799999999999999999999999999999999999999964322       1112222111 10   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHh
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK-----MSEVLKML  576 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~L  576 (623)
                             .++...+.++.+++.+||..||++||+     +.+++++-
T Consensus       239 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~  278 (353)
T 2i0e_A          239 -------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  278 (353)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred             -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence                   122233467899999999999999995     57787653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.7e-40  Score=335.10  Aligned_cols=260  Identities=19%  Similarity=0.216  Sum_probs=206.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeee-ecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC-STENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~-~~~~~~~lv~  377 (623)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++....   ...++.+|+.+++.++|++++..+.++ ...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            36789999999999999999996 579999999986543   234689999999999998877776666 5567789999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCcEEEeecccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKL  454 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfgla~~  454 (623)
                      ||+ +++|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++..
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999 99999999753   34699999999999999999999999   99999999999999   4888999999999987


Q ss_pred             cCCCCCc------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc
Q 006968          455 LDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       455 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      .......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..................... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  236 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-  236 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-
Confidence            6554321      123456999999999999999999999999999999999999999754332222222121111111 


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ....     .+...    .+.++.+++.+||+.||++|||+.++++.|++.
T Consensus       237 ~~~~-----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          237 TPIE-----VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             SCHH-----HHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             CchH-----HHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            0000     01111    236789999999999999999999999999873

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6e-41  Score=339.16  Aligned_cols=249  Identities=22%  Similarity=0.380  Sum_probs=202.0

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .++|.+.+.||+|+||.||+|... +++.||||+++.... .....++.+|+..+..+ +||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467889999999999999999976 799999999976432 23455788999999998 999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC---------------
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED---------------  441 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---------------  441 (623)
                      |||+++|+|.+++.........+++..++.++.|++.||+|||++   +|+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999987543345799999999999999999999999   99999999999999844               


Q ss_pred             ----CcEEEeecccccccCCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCccccccccc
Q 006968          442 ----FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRG  516 (623)
Q Consensus       442 ----~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~  516 (623)
                          ..+||+|||.+.......     ...||+.|+|||.+.+. .++.++||||||+++|||++|++++.....     
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-----  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence                479999999998765432     23489999999999765 566899999999999999999987642211     


Q ss_pred             chHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          517 VMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                          + ... ..+..     +.+    +...+.++.+++.+||+.||++|||+.|++++-
T Consensus       237 ----~-~~~-~~~~~-----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          237 ----W-HEI-RQGRL-----PRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             ----H-HHH-HTTCC-----CCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             ----H-HHH-HcCCC-----CCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence                1 111 11111     111    122336789999999999999999999998863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.9e-40  Score=340.84  Aligned_cols=269  Identities=25%  Similarity=0.318  Sum_probs=210.2

Q ss_pred             cCHHHHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhh--cCCCceeeeeeeee
Q 006968          291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL--AVHRNLLRLCGFCS  368 (623)
Q Consensus       291 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~H~niv~l~~~~~  368 (623)
                      .++..-....++|.+.+.||+|+||.||+|.. +|+.||||+++..    ....+.+|.+++..  ++||||+++++++.
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            34444455667899999999999999999998 6899999999643    34567889988887  78999999999998


Q ss_pred             cCC----ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCe
Q 006968          369 TEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH--------EQCDPKIIHRDVKAANI  436 (623)
Q Consensus       369 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlk~~NI  436 (623)
                      ..+    ..++||||+++|+|.+++...     .+++..++.++.|++.||+|||        +.   +|+||||||+||
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI  178 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI  178 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence            775    789999999999999999753     5899999999999999999999        66   999999999999


Q ss_pred             EECCCCcEEEeecccccccCCCCCc---eeeccccccccccccccccCC------CCCccchhhHHHHHHHHHhC-----
Q 006968          437 LLDEDFEAVVGDFGLAKLLDHRDSH---VTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELITG-----  502 (623)
Q Consensus       437 ll~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvil~elltg-----  502 (623)
                      +++.++.+||+|||++.........   ......||+.|+|||.+.+..      ++.++||||||+++|||++|     
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence            9999999999999999876544332   123446999999999987652      34689999999999999999     


Q ss_pred             -----CCCCCcccccccccchHHHHHHHhhcCccccccccccCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          503 -----QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN-FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       503 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                           +.||.......  .....+..... .....    +.+... .....+..+.+++.+||+.||++|||+.+|+++|
T Consensus       259 ~~~~~~~p~~~~~~~~--~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSD--PSVEEMRKVVC-EQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             BCCCCCCTTTTTSCSS--CCHHHHHHHHT-TSCCC----CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             cccccccCccccCcCc--ccHHHHHHHHH-HHHhC----CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence                 56665322111  11112222221 11111    111111 1235667899999999999999999999999999


Q ss_pred             hcC
Q 006968          577 EGD  579 (623)
Q Consensus       577 ~~~  579 (623)
                      +..
T Consensus       332 ~~i  334 (342)
T 1b6c_B          332 SQL  334 (342)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            873

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.9e-41  Score=341.80  Aligned_cols=254  Identities=26%  Similarity=0.358  Sum_probs=203.1

Q ss_pred             hcCCCcCC-ceeccCCeEEEEEEeC---CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          300 TSNFSAKN-ILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       300 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ..+|.+.+ .||+|+||.||+|.+.   ++..||||+++...... ...++.+|+++++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677777 9999999999999642   47889999997654322 245799999999999999999999999 567789


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        94 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            999999999999999763    3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCcee--eccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          455 LDHRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       455 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      .........  ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......       +..... ..+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~-~~~~~  238 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAML-EKGER  238 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHH-HTTCC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHH-HcCCC
Confidence            654433222  22346789999999988889999999999999999999 99998643221       111111 11111


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                               ...+...+.++.+++.+||+.||++|||+.++++.|++
T Consensus       239 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          239 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                     11122334779999999999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.9e-41  Score=354.11  Aligned_cols=253  Identities=21%  Similarity=0.282  Sum_probs=199.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc-cchHHHHHHHHHHhhcC--CCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAV--HRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|...+++.||||+++..... .....+.+|+.++.+++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458899999999999999999888999999999754332 23457899999999996  599999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      | +.+++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||+++.+..
T Consensus       136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9 5688999999863    3689999999999999999999999   999999999999996 57999999999987654


Q ss_pred             CCCc-eeecccccccccccccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          458 RDSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       458 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      .... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....      ....+...
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~~~  280 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAI  280 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------HHHHHHHH
Confidence            3322 2344569999999999865           4688999999999999999999999963211      11111111


Q ss_pred             hhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .         +......++...+.++.+++.+||..||++|||+.|++++-.
T Consensus       281 ~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  323 (390)
T 2zmd_A          281 I---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  323 (390)
T ss_dssp             H---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             h---------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence            1         111111122222467899999999999999999999998643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.3e-40  Score=330.95  Aligned_cols=253  Identities=21%  Similarity=0.301  Sum_probs=205.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||+|+++..... .....+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467899999999999999999875 5899999999765432 23356889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc---EEEeecccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE---AVVGDFGLAKL  454 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~Dfgla~~  454 (623)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999888764    3689999999999999999999999   9999999999999986655   99999999987


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      .....  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......       ........ +... .
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~-~~~~-~  226 (284)
T 3kk8_A          158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKA-GAYD-Y  226 (284)
T ss_dssp             CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH-TCCC-C
T ss_pred             cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-------HHHHHHHh-cccc-C
Confidence            65432  223456999999999999999999999999999999999999999643221       11111111 1110 0


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..+     .....+.++.+++.+||+.||++|||+.|++++
T Consensus       227 ~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          227 PSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             Cch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000     011223678999999999999999999999885

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=347.24  Aligned_cols=264  Identities=23%  Similarity=0.322  Sum_probs=197.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|.+.+.||+|+||.||+|... +++.||||+++..........+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888999999999999999976 68999999997654333333567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      ++ |+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            97 5888888764   34689999999999999999999999   99999999999999999999999999998654332


Q ss_pred             Cceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC---cccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG---KLSQMV  535 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  535 (623)
                      . ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........    ...+.......   ......
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ----LHFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTGG
T ss_pred             c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHhchhhh
Confidence            2 2233458999999999876 5689999999999999999999999975432211    11111111100   000000


Q ss_pred             cc---------ccCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          536 DK---------DLKGN----FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       536 ~~---------~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ..         .....    .......++.+++.+||+.||++|||+.|++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  283 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP  283 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence            00         00000    0011236788999999999999999999998854

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-40  Score=336.14  Aligned_cols=249  Identities=28%  Similarity=0.415  Sum_probs=202.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .++|.+.+.||+|+||.||+|... ++..||||++......  .....+.+|+.++++++||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467888999999999999999875 5789999998654322  2345689999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999999764    3589999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....       .+.........       
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~-------  223 (279)
T 3fdn_A          161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVE-------  223 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTC-------
T ss_pred             cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-------HHHHHHHHhCC-------
Confidence            22   22345689999999999999999999999999999999999999964321       11111111110       


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                          ..++...+..+.+++.+||+.||++|||+.|++++-
T Consensus       224 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          224 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             ----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                111222346788999999999999999999999863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-41  Score=349.54  Aligned_cols=258  Identities=23%  Similarity=0.290  Sum_probs=207.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEe----CCCcEEEEEEeccccc---ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNI---AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~  372 (623)
                      ++|.+.+.||+|+||.||+|..    .+|+.||||+++....   ......+.+|++++..+ .||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5788999999999999999987    3689999999975432   12344678899999999 69999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999764    3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      +..............||+.|+|||++.+  ..++.++|||||||++|||++|+.||........   ............ 
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~-  282 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKSE-  282 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHCC-
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---HHHHHHHHhccC-
Confidence            8765433334445679999999999985  3478999999999999999999999964322111   112222221111 


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhhcC
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKMLEGD  579 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L~~~  579 (623)
                                ..++...+..+.+++.+||..||++||     |+.|++++..-.
T Consensus       283 ----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          283 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             ----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence                      112222346788999999999999999     999999987653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-40  Score=359.42  Aligned_cols=248  Identities=24%  Similarity=0.399  Sum_probs=205.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|... +|+.||||+++.....  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888999999999999999975 7999999999754321  23456899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        96 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           96 EYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             ECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999865    34699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..  .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....       ......+.. +..     
T Consensus       169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~-~~~-----  233 (476)
T 2y94_A          169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PTLFKKICD-GIF-----  233 (476)
T ss_dssp             TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HHHHHHHHT-TCC-----
T ss_pred             cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhc-CCc-----
Confidence            32  2334569999999999988765 6899999999999999999999974321       111122111 110     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                           ..+.....++.+++.+||..||++|||+.|++++
T Consensus       234 -----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          234 -----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                 0111223678999999999999999999999984

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=340.34  Aligned_cols=267  Identities=25%  Similarity=0.300  Sum_probs=201.2

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccc----cchHHHHHHHHHHhhcC---CCceeeeeeeeecC
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA----GGEVQFQTEVETISLAV---HRNLLRLCGFCSTE  370 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~  370 (623)
                      ..++|.+.+.||+|+||+||+|.. .+|+.||||+++.....    .....+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999996 46899999999743321    12346778888877665   99999999999765


Q ss_pred             C-----ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEE
Q 006968          371 N-----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       371 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                      .     ..++||||+. |+|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence            5     4789999996 69999987642  23499999999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          446 VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       446 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      |+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ........
T Consensus       161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~  235 (308)
T 3g33_A          161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLI  235 (308)
T ss_dssp             ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHHH
T ss_pred             EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHh
Confidence            99999998764332  23445689999999999999999999999999999999999999964332211   11111111


Q ss_pred             hh--cCccccc---cccccCCC-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          526 HQ--EGKLSQM---VDKDLKGN-------FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       526 ~~--~~~~~~~---~~~~~~~~-------~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ..  .......   ....+...       .......++.+++.+||+.||++|||+.|++++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~  298 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS  298 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence            00  0000000   00000000       0012236789999999999999999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.9e-41  Score=348.57  Aligned_cols=249  Identities=29%  Similarity=0.363  Sum_probs=202.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      +.|...+.||+|+||.||+|.. .+|+.||||+++......  ....+.+|++++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999986 478999999997543222  2346899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||++ |+|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 6888887653   34699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeccccccccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      .     ....||+.|+|||++.   ...++.++||||||+++|||++|+.||.....       ...+........ ...
T Consensus       207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~~-~~~  273 (348)
T 1u5q_A          207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNES-PAL  273 (348)
T ss_dssp             B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCC-CCC
T ss_pred             C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCC-CCC
Confidence            2     2346999999999984   56789999999999999999999999864321       111222222111 111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .        ....+..+.+++.+||+.||++|||+.+++++..
T Consensus       274 ~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          274 Q--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             C--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             C--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            0        1122367889999999999999999999988644

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=337.60  Aligned_cols=268  Identities=21%  Similarity=0.238  Sum_probs=200.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||||++....... ....+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999975 58999999986544322 23468899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999888764    24589999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH--------HHHHHhhcC
Q 006968          459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--------WVKKLHQEG  529 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~  529 (623)
                      .. ......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||..............        +........
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            22 2234468999999999876 6689999999999999999999999975433211110000        000000000


Q ss_pred             ccccccccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          530 KLSQMVDKDLKGNFD-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .......+......+     ...+.++.+++.+||+.||++|||+.|++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  286 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP  286 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence            000000000000000     12245689999999999999999999999863

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-40  Score=339.88  Aligned_cols=250  Identities=27%  Similarity=0.375  Sum_probs=208.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +.|...+.||+|+||.||+|... +++.||||+++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56888999999999999999864 68999999997665555567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++++|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus       102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999864     3689999999999999999999999   99999999999999999999999999998765432


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      . ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......       ........ ..     .+.+
T Consensus       174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~-----~~~~  239 (303)
T 3a7i_A          174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPK-NN-----PPTL  239 (303)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHH-SC-----CCCC
T ss_pred             c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------HHHHHhhc-CC-----CCCC
Confidence            2 223456899999999999999999999999999999999999998643221       11111111 11     1111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ...    .+..+.+++.+||..||++|||+.+++++.
T Consensus       240 ~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          240 EGN----YSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CSS----CCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ccc----cCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            222    236789999999999999999999998854

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.7e-41  Score=345.52  Aligned_cols=259  Identities=27%  Similarity=0.368  Sum_probs=205.9

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe------CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      .++|.+.+.||+|+||.||+|.+      .++..||||+++.........++.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46788999999999999999984      247789999997655445566799999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEe
Q 006968          374 LLVYPYMPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVG  447 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~  447 (623)
                      ++||||+++|+|.+++.....   ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999987532   124589999999999999999999999   9999999999999994   4469999


Q ss_pred             ecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHH
Q 006968          448 DFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       448 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      |||++........ .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.....       .+.....
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------HHHHHHH
Confidence            9999986543322 22234457899999999998999999999999999999998 8899864321       1111221


Q ss_pred             hhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .....          ...+...+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus       259 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          259 TSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hcCCC----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            11111          01112234678999999999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-40  Score=361.39  Aligned_cols=257  Identities=24%  Similarity=0.299  Sum_probs=209.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|...+.||+|+||.||+|... +|+.||+|++++....  .....+..|+.++++++||||+++++++...+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888899999999999999975 6999999999754322  23456889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|..++.........+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999987654456799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ........... ..       
T Consensus       342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~---~~~~~~~~i~~-~~-------  409 (543)
T 3c4z_A          342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRVLE-QA-------  409 (543)
T ss_dssp             TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC---CHHHHHHHHHH-CC-------
T ss_pred             CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch---hHHHHHHHHhh-cc-------
Confidence            332 2334579999999999999999999999999999999999999997432211   11122222111 11       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKM-----SEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  575 (623)
                         ..++...+.++.+++.+||..||++||++     .+++++
T Consensus       410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence               01222334678999999999999999975     667654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.9e-40  Score=362.82  Aligned_cols=257  Identities=24%  Similarity=0.297  Sum_probs=209.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++....  ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888999999999999999975 699999999975432  23345688999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99999999999987642  34599999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........   .......... .       
T Consensus       338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~---~~~i~~~i~~-~-------  404 (576)
T 2acx_A          338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVKE-V-------  404 (576)
T ss_dssp             TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC---HHHHHHHHHH-C-------
T ss_pred             cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh---HHHHHHHhhc-c-------
Confidence            432  23345799999999999998999999999999999999999999974322111   1111111111 1       


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHhh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKMLE  577 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L~  577 (623)
                         ...++...+.++.+++.+||..||++||     ++.||+++-.
T Consensus       405 ---~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf  447 (576)
T 2acx_A          405 ---PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL  447 (576)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred             ---cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence               0112222346789999999999999999     7899987643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-40  Score=349.19  Aligned_cols=272  Identities=21%  Similarity=0.251  Sum_probs=207.2

Q ss_pred             cCHHHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-----CCceeeee
Q 006968          291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-----HRNLLRLC  364 (623)
Q Consensus       291 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~  364 (623)
                      +++.+-....++|.+.+.||+|+||.||+|... +++.||||+++...  .....+..|+.+++.+.     ||||++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            444444445678999999999999999999974 68999999996432  23446788999999886     99999999


Q ss_pred             eeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC----
Q 006968          365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE----  440 (623)
Q Consensus       365 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~----  440 (623)
                      +++...+..++||||+ +++|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.    
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence            9999999999999999 999999998642  33589999999999999999999999   9999999999999975    


Q ss_pred             ---------------------CCcEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHH
Q 006968          441 ---------------------DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL  499 (623)
Q Consensus       441 ---------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el  499 (623)
                                           ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                 789999999999865432    2345689999999999999999999999999999999


Q ss_pred             HhCCCCCCcccccccccchH--------HHHHHHhhcCcccccccc-----ccCCCC-------------C---HHHHHH
Q 006968          500 ITGQRALDFGRAANQRGVML--------DWVKKLHQEGKLSQMVDK-----DLKGNF-------------D---RIELEE  550 (623)
Q Consensus       500 ltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-----~~~~~~-------------~---~~~~~~  550 (623)
                      ++|+.||...........+.        .+........ .....+.     ......             +   ......
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTN-GSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSG-GGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhcc-CccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            99999997433211110000        1111110000 0000000     000000             0   001156


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          551 MVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       551 l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      +.+++.+||+.||++|||+.|++++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhcC
Confidence            7899999999999999999999865

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=342.00  Aligned_cols=267  Identities=27%  Similarity=0.404  Sum_probs=198.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHH--HhhcCCCceeeeeeeee-----cCCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVET--ISLAVHRNLLRLCGFCS-----TENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~H~niv~l~~~~~-----~~~~  372 (623)
                      .++|.+.+.||+|+||.||+|.. +++.||||+++...    ...+..|.++  +..++||||+++++++.     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            36788899999999999999987 78999999996432    3344555554  45689999999998543     2335


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCeEECCCCcEEE
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC------DPKIIHRDVKAANILLDEDFEAVV  446 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~kl  446 (623)
                      .++||||+++|+|.+++...     ..++..+..++.|+++||+|||+.+      .++|+||||||+|||++.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            68999999999999999753     4589999999999999999999873      348999999999999999999999


Q ss_pred             eecccccccCCCCC-------ceeecccccccccccccccc-------CCCCCccchhhHHHHHHHHHhCCCCCCccccc
Q 006968          447 GDFGLAKLLDHRDS-------HVTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELITGQRALDFGRAA  512 (623)
Q Consensus       447 ~Dfgla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~  512 (623)
                      +|||+++.+.....       .......||+.|+|||++.+       ..++.++||||||+++|||++|+.|+......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999987653221       12224469999999999976       45677999999999999999998877543321


Q ss_pred             ccccch----------HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          513 NQRGVM----------LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       513 ~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ......          ................+.....  .....+.++.+++.+||+.||++|||+.|+++.|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            111110          0111111111111111111111  123456789999999999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.4e-40  Score=335.37  Aligned_cols=253  Identities=21%  Similarity=0.336  Sum_probs=201.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC-C-------cEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD-G-------ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  372 (623)
                      ++|.+.+.||+|+||.||+|.... +       ..||+|+++... ......+.+|+.++++++||||+++++++..++.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            568889999999999999998643 3       579999996543 3345679999999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc--------E
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE--------A  444 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~  444 (623)
                      .++||||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence            99999999999999999864   23489999999999999999999999   9999999999999998887        9


Q ss_pred             EEeecccccccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH
Q 006968          445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      ||+|||++.....     .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+......      .....
T Consensus       161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~~~~~  229 (289)
T 4fvq_A          161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------QRKLQ  229 (289)
T ss_dssp             EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHH
T ss_pred             eeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch------HHHHH
Confidence            9999999875432     123458899999999987 77899999999999999999966554322111      11111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCCc
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAE  583 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  583 (623)
                      ........            +...+.++.+++.+||+.||++|||+.+++++|++..-+.
T Consensus       230 ~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          230 FYEDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             HHHTTCCC------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             HhhccCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            11111111            1111245789999999999999999999999998854443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.9e-41  Score=354.86  Aligned_cols=265  Identities=24%  Similarity=0.366  Sum_probs=192.0

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcC-CCceeeeeeeeecCC--ce
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAV-HRNLLRLCGFCSTEN--ER  373 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~--~~  373 (623)
                      ..++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++..+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999864 689999999865422 223456889999999997 999999999997544  68


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||++ |+|..+++.     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            99999997 688888875     2689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC--------------------Cceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCccccc
Q 006968          454 LLDHRD--------------------SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAA  512 (623)
Q Consensus       454 ~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~  512 (623)
                      .+....                    ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            654211                    112234579999999999976 67899999999999999999999999754322


Q ss_pred             ccccchHH--------------------HHHHHhhcCccccccccccCCCCC------------HHHHHHHHHHHHHccC
Q 006968          513 NQRGVMLD--------------------WVKKLHQEGKLSQMVDKDLKGNFD------------RIELEEMVQVALLCTQ  560 (623)
Q Consensus       513 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~l~~l~~~cl~  560 (623)
                      .....+..                    ............   .......++            .....++.+++.+||.
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIR---QSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC--------CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCccccccc---CCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            11111100                    000000000000   000000000            0123578999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 006968          561 FNPLHRPKMSEVLKM  575 (623)
Q Consensus       561 ~~P~~RPs~~evl~~  575 (623)
                      .||++|||+.|++++
T Consensus       315 ~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          315 FNPNKRISANDALKH  329 (388)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             cCcccCCCHHHHhCC
Confidence            999999999999887

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-40  Score=340.70  Aligned_cols=260  Identities=27%  Similarity=0.394  Sum_probs=197.4

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC----CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCC--
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--  371 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--  371 (623)
                      ..++|.+.+.||+|+||.||+|...    ++..||||+++..... .....+.+|+.++++++||||+++++++...+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            4567888999999999999999764    3458999999754332 23356899999999999999999999997654  


Q ss_pred             ---ceEEEEecccCCChhhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 006968          372 ---ERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV  446 (623)
Q Consensus       372 ---~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  446 (623)
                         ..++||||+++|+|.+++....  .....+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence               3499999999999999985432  2345799999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHH
Q 006968          447 GDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       447 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      +|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......    ..   ..
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~---~~  261 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE----MY---DY  261 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----HH---HH
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HH---HH
Confidence            999999876543221 2233457889999999999999999999999999999999 888886432211    11   11


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ... +..         ...+...+.++.+++.+||..||++|||+.+++++|+.
T Consensus       262 ~~~-~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          262 LLH-GHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK  305 (313)
T ss_dssp             HHT-TCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHc-CCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111 110         01122234679999999999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-39  Score=328.36  Aligned_cols=247  Identities=20%  Similarity=0.302  Sum_probs=203.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|... ++..||+|++..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            457889999999999999999975 478999999976442 345679999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCcEEEeeccccccc
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfgla~~~  455 (623)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           87 LCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             CCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            99999999988763    3589999999999999999999999   99999999999999   78899999999999876


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ....  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......       +....... +..    
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~----  224 (277)
T 3f3z_A          160 KPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------EVMLKIRE-GTF----  224 (277)
T ss_dssp             CTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH-CCC----
T ss_pred             cCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHh-CCC----
Confidence            5432  2334469999999999865 4899999999999999999999999643221       11111111 110    


Q ss_pred             ccccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          536 DKDLKGNFDR----IELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       536 ~~~~~~~~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                            .++.    ..+.++.+++.+||+.||++|||+.+++++
T Consensus       225 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          225 ------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             ------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0111    123678999999999999999999999764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.8e-40  Score=344.33  Aligned_cols=250  Identities=16%  Similarity=0.171  Sum_probs=203.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEE------eCCCcEEEEEEecccccccchHHHHHHHHHHhhcC---CCceeeeeeeeecC
Q 006968          300 TSNFSAKNILGRGGFGIVYKGC------FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---HRNLLRLCGFCSTE  370 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~  370 (623)
                      .++|.+.+.||+|+||.||+|.      ..+++.||||+++..    ...++..|++++..++   |+||+++++++...
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            4678899999999999999994      346889999999753    3456788888888776   99999999999999


Q ss_pred             CceEEEEecccCCChhhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---------
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIH-GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---------  440 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---------  440 (623)
                      +..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999976432 245799999999999999999999999   9999999999999998         


Q ss_pred             --CCcEEEeecccccccCC-CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccc
Q 006968          441 --DFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGV  517 (623)
Q Consensus       441 --~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  517 (623)
                        ++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence              89999999999976542 223344556799999999999999999999999999999999999999853221100   


Q ss_pred             hHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHhhc
Q 006968          518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHR-PKMSEVLKMLEG  578 (623)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-Ps~~evl~~L~~  578 (623)
                                      .....+.. ++  ....+.+++..|++.+|.+| |++.++.+.|++
T Consensus       294 ----------------~~~~~~~~-~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          294 ----------------KPEGLFRR-LP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             ----------------EECSCCTT-CS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             ----------------eechhccc-cC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                            01111111 11  24567889999999999998 678888887765

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=345.98  Aligned_cols=266  Identities=18%  Similarity=0.192  Sum_probs=199.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC----CCcEEEEEEeccccccc----------chHHHHHHHHHHhhcCCCceeeeeee
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAG----------GEVQFQTEVETISLAVHRNLLRLCGF  366 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~H~niv~l~~~  366 (623)
                      ++|.+.+.||+|+||.||+|...    ++..||||++.......          ....+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            56888999999999999999975    57889999987543210          12246778888999999999999999


Q ss_pred             eec----CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 006968          367 CST----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF  442 (623)
Q Consensus       367 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  442 (623)
                      +..    ....++||||+ +++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            877    67889999999 99999998764    2799999999999999999999999   999999999999999877


Q ss_pred             --cEEEeecccccccCCCCC------ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccccccc
Q 006968          443 --EAVVGDFGLAKLLDHRDS------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ  514 (623)
Q Consensus       443 --~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~  514 (623)
                        .+||+|||+++.+.....      .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... 
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-  267 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP-  267 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence              999999999987643211      11134569999999999999999999999999999999999999995321110 


Q ss_pred             ccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCC
Q 006968          515 RGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGL  581 (623)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  581 (623)
                        ............ .....+.....   ....+.++.+++.+||..||++|||+.+|++.|++..+
T Consensus       268 --~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 --VAVQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             --HHHHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             --HHHHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence              011111111110 11111110000   00123679999999999999999999999999988544

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.5e-41  Score=350.11  Aligned_cols=250  Identities=24%  Similarity=0.280  Sum_probs=195.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHH-HhhcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVET-ISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~-l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|.+.+.||+|+||.||+|... ++..||||++++.....  ....+..|..+ ++.++||||+++++++.+.+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            56888999999999999999976 58899999997654322  23456777776 5778999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       118 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          118 LDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999763    3688999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .+....+... ..     
T Consensus       191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~-~~-----  256 (373)
T 2r5t_A          191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNK-PL-----  256 (373)
T ss_dssp             CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------HHHHHHHHHS-CC-----
T ss_pred             cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhc-cc-----
Confidence            222 234456799999999999999999999999999999999999999964322       1111222111 10     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                           .++...+.++.+++.+||..||++||++.+.++.+
T Consensus       257 -----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          257 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             -----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence                 11122336789999999999999999985444333

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.1e-40  Score=347.94  Aligned_cols=253  Identities=22%  Similarity=0.271  Sum_probs=193.0

Q ss_pred             cCCCcC-CceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHh-hcCCCceeeeeeeeec----CCce
Q 006968          301 SNFSAK-NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLLRLCGFCST----ENER  373 (623)
Q Consensus       301 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~----~~~~  373 (623)
                      ++|.+. +.||+|+||.||+|... +|+.||||+++..      ..+.+|++++. ..+||||+++++++..    .+..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            456555 68999999999999875 6899999998642      35778888874 4589999999998865    5678


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEeecc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFG  450 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg  450 (623)
                      ++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus       135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence            9999999999999999763  234699999999999999999999999   9999999999999997   7899999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      +++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............+.    .+.
T Consensus       210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~  283 (400)
T 1nxk_A          210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQ  283 (400)
T ss_dssp             TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTC
T ss_pred             cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCc
Confidence            998654322  23345689999999999999999999999999999999999999975433221111111111    111


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ..      +........+.++.+++.+||..||++|||+.|++++-
T Consensus       284 ~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          284 YE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             CC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             cc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            10      00000112346789999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-39  Score=329.44  Aligned_cols=252  Identities=19%  Similarity=0.283  Sum_probs=202.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-----chHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||+|.++......     ....+.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999986 68999999997654322     3567999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC----cEEEeecc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDFG  450 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfg  450 (623)
                      +||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999763    3689999999999999999999999   999999999999999877    89999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      ++.......  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......       +....... ..
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~  227 (283)
T 3bhy_A          158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-------ETLTNISA-VN  227 (283)
T ss_dssp             TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHT-TC
T ss_pred             cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------HHHHHhHh-cc
Confidence            998764432  223445899999999999899999999999999999999999999643221       11111111 10


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .  ........    ..+..+.+++.+||..||++|||+.|++++
T Consensus       228 ~--~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          228 Y--DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             C--CCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             c--CCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            0  00000001    123678999999999999999999999884

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.7e-40  Score=335.35  Aligned_cols=246  Identities=24%  Similarity=0.388  Sum_probs=203.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec---------
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST---------  369 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~---------  369 (623)
                      ..+|.+.+.||+|+||.||+|... +|+.||+|+++...     ..+.+|++++++++||||+++++++..         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            457889999999999999999986 79999999997532     357899999999999999999998754         


Q ss_pred             -------CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 006968          370 -------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF  442 (623)
Q Consensus       370 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  442 (623)
                             ....++||||+++|+|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence                   345799999999999999997642  34689999999999999999999999   999999999999999999


Q ss_pred             cEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHH
Q 006968          443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV  522 (623)
Q Consensus       443 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  522 (623)
                      .+||+|||++........  .....||+.|+|||.+.+..++.++||||||+++|||++|..|+....         .+.
T Consensus       160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~  228 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFF  228 (284)
T ss_dssp             EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHH
T ss_pred             CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHH
Confidence            999999999987654322  233458999999999999999999999999999999999998874211         111


Q ss_pred             HHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          523 KKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      .... .+.        +...    .+.++.+++.+||+.||++|||+.|++++|+..
T Consensus       229 ~~~~-~~~--------~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          229 TDLR-DGI--------ISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             HHHH-TTC--------CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhh-ccc--------cccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1111 111        1111    235688999999999999999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-40  Score=370.78  Aligned_cols=247  Identities=26%  Similarity=0.378  Sum_probs=198.1

Q ss_pred             CceeccCCeEEEEEEeC---CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||.||+|.+.   .++.||||+++..... ....+|.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   4678999999765432 234679999999999999999999999964 568899999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCc-
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-  461 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-  461 (623)
                      |+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus       454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            9999999753    4689999999999999999999999   9999999999999999999999999999877543322 


Q ss_pred             -eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          462 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       462 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                       ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......       +....+ ..+.         
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i-~~~~---------  589 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAML-EKGE---------  589 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHH-HTTC---------
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHH-HcCC---------
Confidence             2233447789999999999999999999999999999998 99999643221       111111 1111         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....+...+.++.+++..||+.||++|||+.+|++.|++
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            111222345789999999999999999999999999976

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.3e-40  Score=343.60  Aligned_cols=253  Identities=21%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++....     ...+|++++.++ +||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            457899999999999999999975 689999999975432     345788888887 7999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC----CcEEEeeccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED----FEAVVGDFGLAK  453 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~Dfgla~  453 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||+.++    +.+||+|||+++
T Consensus        96 E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             CCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             eCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            999999999998753    4699999999999999999999999   99999999999998543    359999999998


Q ss_pred             ccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    ...+....+.. +... 
T Consensus       169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~i~~-~~~~-  241 (342)
T 2qr7_A          169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----TPEEILARIGS-GKFS-  241 (342)
T ss_dssp             ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----CHHHHHHHHHH-CCCC-
T ss_pred             cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----CHHHHHHHHcc-CCcc-
Confidence            7654332 234456899999999998888899999999999999999999999743211    11122222211 1111 


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                           +...+....+.++.+++.+||..||++|||+.+++++-
T Consensus       242 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          242 -----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             -----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             -----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence                 11111122346789999999999999999999998753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-40  Score=344.32  Aligned_cols=265  Identities=20%  Similarity=0.287  Sum_probs=194.6

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ..++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|++++++++||||+++++++...+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3467999999999999999999864 68999999997544322 234578999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE-----CCCCcEEEeeccc
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL-----DEDFEAVVGDFGL  451 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll-----~~~~~~kl~Dfgl  451 (623)
                      |||++ |+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||+     +.++.+||+|||+
T Consensus       112 ~e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            99997 5999988763    3589999999999999999999999   99999999999999     4555699999999


Q ss_pred             ccccCCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC-
Q 006968          452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG-  529 (623)
Q Consensus       452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  529 (623)
                      ++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........   ............ 
T Consensus       184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~  259 (329)
T 3gbz_A          184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---LFKIFEVLGLPDD  259 (329)
T ss_dssp             HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCT
T ss_pred             ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---HHHHHHHhCCCch
Confidence            987653322 23334589999999999774 489999999999999999999999974332111   111111110000 


Q ss_pred             -cccccc-----ccc---cCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          530 -KLSQMV-----DKD---LKGN-----FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       530 -~~~~~~-----~~~---~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ......     ...   ....     .......++.+++.+||+.||++|||+.|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence             000000     000   0000     001123678999999999999999999999885

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-40  Score=334.98  Aligned_cols=249  Identities=29%  Similarity=0.398  Sum_probs=197.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC-CceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-NERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|.. +|+.||||+++...   ....+.+|++++++++||||+++++++... +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            35788899999999999999987 58899999997532   355789999999999999999999987554 57899999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        96 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             cCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999997642  12378999999999999999999999   9999999999999999999999999999765432


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                          .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......       ....... +        
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~-~--------  230 (278)
T 1byg_A          171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEK-G--------  230 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTT-T--------
T ss_pred             ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhc-C--------
Confidence                122347889999999998899999999999999999998 999986432211       1111111 1        


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                       .....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       231 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          231 -YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence             0111222334678999999999999999999999999976

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.7e-41  Score=340.82  Aligned_cols=266  Identities=25%  Similarity=0.359  Sum_probs=188.7

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ..++|.+.+.||+|+||.||+|... +++.||||++..........++.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3468999999999999999999864 689999999876544444567899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          378 PYMPNGSVASRLRDHI----HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ||+++++|.+++....    .....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            9999999999987521    1234699999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC----ceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc
Q 006968          454 LLDHRDS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       454 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      .......    .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........      .....  .
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~--~  241 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTL--Q  241 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHH--T
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHh--c
Confidence            7643321    12234568999999999876 5689999999999999999999999974332111      01111  1


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...................+.++.+++.+||+.||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            11111000000001111223678999999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.3e-40  Score=337.52  Aligned_cols=256  Identities=22%  Similarity=0.276  Sum_probs=190.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHH-HHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .++|++.+.||+|+||.||+|... +|+.||||+++.........+ +.++...++.++||||+++++++..++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            367889999999999999999974 789999999976543333333 444555578889999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||++ |+|.+++.........+++..++.++.|++.||+|||+++  +|+||||||+||+++.++.+||+|||++.....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            9997 5888888765555668999999999999999999999843  899999999999999999999999999987654


Q ss_pred             CCCceeecccccccccccccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ...  .....||+.|+|||.+    .+..++.++||||||+++|||++|+.||.....      ....+......... .
T Consensus       163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-~  233 (290)
T 3fme_A          163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PFQQLKQVVEEPSP-Q  233 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------HHHHHHHHHHSCCC-C
T ss_pred             ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------hHHHHHHHhccCCC-C
Confidence            322  2334589999999996    556789999999999999999999999963221      11111221111111 1


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .        .....+.++.+++.+||+.||++|||+.|++++
T Consensus       234 ~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          234 L--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             C--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             c--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            0        111224678999999999999999999999873

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.9e-40  Score=344.92  Aligned_cols=267  Identities=21%  Similarity=0.281  Sum_probs=205.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|.+.+.||+|+||.||+|... ++..||+|+++..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56888999999999999999976 68999999997654444456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++...    ..+++..+..++.|++.||+|||+.+  +|+||||||+||+++.++.+||+|||++...... 
T Consensus       113 ~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            9999999999764    35899999999999999999999832  8999999999999999999999999999755321 


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH--------HHH---------
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--------DWV---------  522 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~---------  522 (623)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............        ...         
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence              2234468999999999999999999999999999999999999997433211100000        000         


Q ss_pred             -----HHHhhcCccccccc----cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          523 -----KKLHQEGKLSQMVD----KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       523 -----~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                           ..........+..+    ...........+.++.+++.+||..||++|||+.|++++-
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                 00000000000000    0000000112346789999999999999999999998753

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=339.55  Aligned_cols=262  Identities=24%  Similarity=0.387  Sum_probs=206.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-----CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC--ce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--ER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~--~~  373 (623)
                      ++|.+.+.||+|+||.||+|.+     .+|+.||||+++... ......+.+|++++++++||||+++++++...+  ..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            5688899999999999999984     368999999997542 334457999999999999999999999987644  78


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            9999999999999999864   34689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCce--eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccc-------cc-cchHHHHH
Q 006968          454 LLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN-------QR-GVMLDWVK  523 (623)
Q Consensus       454 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-------~~-~~~~~~~~  523 (623)
                      .........  .....++..|+|||.+.+..++.++||||||+++|||+||+.|+......-       .. ......+.
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            765443321  223347788999999998889999999999999999999999875321100       00 00000111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .....+         .....+...+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus       274 ~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          274 ELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhhcC---------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111111         1111122344779999999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.7e-40  Score=353.92  Aligned_cols=265  Identities=20%  Similarity=0.253  Sum_probs=196.0

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecC------C
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------N  371 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~  371 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            367999999999999999999865 689999999975432 22345688999999999999999999999654      3


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccc
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL  451 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  451 (623)
                      ..++||||++++ |.+.+..      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            569999999764 5555532      489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHH----------
Q 006968          452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDW----------  521 (623)
Q Consensus       452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----------  521 (623)
                      ++.....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+...          
T Consensus       211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9876532  2234456999999999999999999999999999999999999999754321111100000          


Q ss_pred             -----HHHHhhc-Cc-----cccccccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          522 -----VKKLHQE-GK-----LSQMVDKDLKGN---FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       522 -----~~~~~~~-~~-----~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                           .+..... ..     ........+...   .......++.+++.+||..||++|||+.|++++-
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence                 0000000 00     000000000000   0122356789999999999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.2e-40  Score=347.61  Aligned_cols=265  Identities=20%  Similarity=0.271  Sum_probs=200.0

Q ss_pred             HHHhcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC-----
Q 006968          297 RAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----  370 (623)
Q Consensus       297 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----  370 (623)
                      .....+|.+.+.||+|+||.||+|.. .+|+.||||++....     ....+|+++++.++||||+++++++...     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34567899999999999999999986 479999999986542     2234799999999999999999998443     


Q ss_pred             ---------------------------------CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 006968          371 ---------------------------------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY  417 (623)
Q Consensus       371 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~  417 (623)
                                                       ...++||||++ |+|.+.+.........+++..+..++.|+++||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             33789999997 58888887655556689999999999999999999


Q ss_pred             HHhCCCCCeEecCCCCCCeEEC-CCCcEEEeecccccccCCCCCceeeccccccccccccccccC-CCCCccchhhHHHH
Q 006968          418 LHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGIL  495 (623)
Q Consensus       418 LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvi  495 (623)
                      ||+.   +|+||||||+||+++ .++.+||+|||+++.......  .....||+.|+|||.+.+. .++.++||||+||+
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999   999999999999998 688999999999987654332  2344589999999998764 58999999999999


Q ss_pred             HHHHHhCCCCCCcccccccccchHHHHHHHh---------hcCccccc-----cccccCCCCCHHHHHHHHHHHHHccCC
Q 006968          496 LLELITGQRALDFGRAANQRGVMLDWVKKLH---------QEGKLSQM-----VDKDLKGNFDRIELEEMVQVALLCTQF  561 (623)
Q Consensus       496 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~-----~~~~~~~~~~~~~~~~l~~l~~~cl~~  561 (623)
                      +|||++|+.||......+..   ...+....         ........     ........++...+.++.+++.+||..
T Consensus       232 l~ell~g~~pf~~~~~~~~~---~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQL---VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            99999999999754322111   11111000         00000000     001111111222346789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 006968          562 NPLHRPKMSEVLKM  575 (623)
Q Consensus       562 ~P~~RPs~~evl~~  575 (623)
                      ||++|||+.|++++
T Consensus       309 dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          309 EPDLRINPYEAMAH  322 (383)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999999874

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-40  Score=343.52  Aligned_cols=269  Identities=25%  Similarity=0.292  Sum_probs=199.2

Q ss_pred             HHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc----chHHHHHHHHHHhhcCCCceeeeeeeeecCCc
Q 006968          298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG----GEVQFQTEVETISLAVHRNLLRLCGFCSTENE  372 (623)
Q Consensus       298 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  372 (623)
                      ...++|.+.+.||+|+||.||+|... +|+.||||+++......    ....+.+|+++++.++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999975 58999999997543221    12468899999999999999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++||||+++ +|.+++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             eEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            9999999976 888887653   34688999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc--C
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE--G  529 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~  529 (623)
                      +....... ......||+.|+|||.+.+. .++.++||||||+++|||++|.+||........   ...........  .
T Consensus       160 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          160 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEE  235 (346)
T ss_dssp             STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTT
T ss_pred             eeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChh
Confidence            87654322 23345689999999998764 578999999999999999999999864332111   11111111000  0


Q ss_pred             ccccc---ccccc---CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          530 KLSQM---VDKDL---KGNFD-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       530 ~~~~~---~~~~~---~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .....   .+...   ....+     ...+.++.+++.+||..||++|||+.|++++-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence            00000   00000   00001     122467999999999999999999999998754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.6e-39  Score=346.95  Aligned_cols=256  Identities=22%  Similarity=0.309  Sum_probs=194.2

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-------cchHHHHHHHHHHhhcCCCceeeeeeeeecC
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-------GGEVQFQTEVETISLAVHRNLLRLCGFCSTE  370 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~  370 (623)
                      ..++|.+.+.||+|+||.||+|... +++.||||+++.....       .....+.+|++++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            4578999999999999999999875 5899999999754321       122358899999999999999999999854 


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC---CcEEEe
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED---FEAVVG  447 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~  447 (623)
                      +..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.+   +.+||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            568999999999999888864    34699999999999999999999999   99999999999999754   459999


Q ss_pred             ecccccccCCCCCceeecccccccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH
Q 006968          448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       448 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      |||+++.....  .......||+.|+|||++.+   ..++.++||||||+++|||++|+.||.......   .....   
T Consensus       285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~~---  356 (419)
T 3i6u_A          285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQ---  356 (419)
T ss_dssp             CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC---CHHHH---
T ss_pred             ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH---HHHHH---
Confidence            99999876532  22344569999999999853   567889999999999999999999996432211   11111   


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                       ...+.... . +...    ...+.++.+++.+||+.||++|||+.|++++-.
T Consensus       357 -i~~~~~~~-~-~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  402 (419)
T 3i6u_A          357 -ITSGKYNF-I-PEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRHPW  402 (419)
T ss_dssp             -HHTTCCCC-C-HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             -HhcCCCCC-C-chhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence             11111100 0 0000    012367899999999999999999999998643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=345.63  Aligned_cols=260  Identities=18%  Similarity=0.192  Sum_probs=203.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC---------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceee---------
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD---------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR---------  362 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~---------  362 (623)
                      ++|.+.+.||+|+||.||+|....         ++.||||+++..      ..+.+|++++++++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            578899999999999999999763         789999998653      36889999999999999998         


Q ss_pred             ------eeeeeec-CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 006968          363 ------LCGFCST-ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN  435 (623)
Q Consensus       363 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N  435 (623)
                            +++++.. .+..++||||+ +++|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  5666655 67889999999 999999998642  24699999999999999999999999   99999999999


Q ss_pred             eEECCCC--cEEEeecccccccCCCCCc------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 006968          436 ILLDEDF--EAVVGDFGLAKLLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD  507 (623)
Q Consensus       436 Ill~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~  507 (623)
                      |+++.++  .+||+|||+++.+......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  8999999999876532211      1233469999999999999999999999999999999999999997


Q ss_pred             cccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          508 FGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ......  ............  ......+....   ....+.++.+++.+||..||++|||+.++++.|++.
T Consensus       270 ~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          270 NCLPNT--EDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             GGTTCH--HHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cCCcCH--HHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            432111  111122111111  11111111100   001236799999999999999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.1e-39  Score=332.99  Aligned_cols=257  Identities=21%  Similarity=0.256  Sum_probs=198.0

Q ss_pred             cCCCcC-CceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAK-NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      +.|.+. +.||+|+||.||+|... +++.||||+++... ......+.+|++++.++ +||||+++++++...+..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            457774 78999999999999864 68999999997543 33456789999999885 7999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc---EEEeecccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE---AVVGDFGLAKL  454 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~Dfgla~~  454 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||++..
T Consensus        91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999764    3689999999999999999999999   9999999999999998776   99999999976


Q ss_pred             cCCCCC------ceeecccccccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccc------
Q 006968          455 LDHRDS------HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGV------  517 (623)
Q Consensus       455 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~------  517 (623)
                      ......      .......||+.|+|||++..     ..++.++||||||+++|||++|+.||...........      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            542211      11223459999999999875     5678999999999999999999999975432111000      


Q ss_pred             --hHHHHHHHhhcCccccccccccCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          518 --MLDWVKKLHQEGKLSQMVDKDLKGNFDR----IELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       518 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                        ......... .+..          .++.    ..+.++.+++.+||..||++|||+.|++++-
T Consensus       244 ~~~~~~~~~i~-~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          244 ACQNMLFESIQ-EGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             HHHHHHHHHHH-HCCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             hHHHHHHHHHh-ccCc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence              001111111 1111          1111    1236789999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.3e-39  Score=334.49  Aligned_cols=259  Identities=22%  Similarity=0.254  Sum_probs=203.7

Q ss_pred             HHHhcCCCcC-CceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcC-CCceeeeeeeeecCCc
Q 006968          297 RAATSNFSAK-NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAV-HRNLLRLCGFCSTENE  372 (623)
Q Consensus       297 ~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~  372 (623)
                      ....+.|.+. +.||+|+||.||+|... +|+.||||+++..... .....+.+|+.++..++ ||||+++++++...+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3345567766 88999999999999875 6899999999764433 23567899999999985 6999999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEeec
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDF  449 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Df  449 (623)
                      .++||||+++|+|.+++...  ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            99999999999999998653  235699999999999999999999999   9999999999999997   789999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      |+++......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......       +.........
T Consensus       179 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~  249 (327)
T 3lm5_A          179 GMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------ETYLNISQVN  249 (327)
T ss_dssp             GGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTC
T ss_pred             ccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHHHhcc
Confidence            9998765332  223456999999999999999999999999999999999999999643221       1111111110


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                       .      ..........+..+.+++.+||..||++|||+.|++++-
T Consensus       250 -~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~  289 (327)
T 3lm5_A          250 -V------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS  289 (327)
T ss_dssp             -C------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred             -c------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence             0      001111112346789999999999999999999998763

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.9e-39  Score=326.81  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=198.6

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeec----CCceEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST----ENERLL  375 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~l  375 (623)
                      .|.+.+.||+|+||.||+|... ++..||+|.++..... .....+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4677788999999999999875 6889999999765432 234568999999999999999999998864    355899


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEEC-CCCcEEEeecccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLD-EDFEAVVGDFGLA  452 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~kl~Dfgla  452 (623)
                      ||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +  |+||||||+||+++ .++.+||+|||++
T Consensus       107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            99999999999999764    4689999999999999999999998   7  99999999999998 7899999999999


Q ss_pred             cccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ......   ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||.....      .......... +...
T Consensus       180 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~-~~~~  248 (290)
T 1t4h_A          180 TLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTS-GVKP  248 (290)
T ss_dssp             GGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTT-TCCC
T ss_pred             cccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHHHHHHHhc-cCCc
Confidence            764432   233456999999999886 4589999999999999999999999964222      1111222111 1111


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...+        ...+.++.+++.+||+.||++|||+.|++++
T Consensus       249 ~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          249 ASFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GGGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccC--------CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            1111        1122578999999999999999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7e-40  Score=338.96  Aligned_cols=267  Identities=21%  Similarity=0.320  Sum_probs=200.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||||++....... ....+.+|+.++++++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57888999999999999999975 58999999986544322 23457899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus       105 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          105 FVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             CCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             cCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999998887654    24599999999999999999999999   9999999999999999999999999999866433


Q ss_pred             CCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH--------HHHHHHhhcC
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--------DWVKKLHQEG  529 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~  529 (623)
                      .. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.............        .+........
T Consensus       178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            22 23345689999999999775 78999999999999999999999997543221110000        0000011111


Q ss_pred             ccccccccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          530 KLSQMVDKDLKGNFD-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .......+......+     ...+.++.+++.+||+.||++|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            111111111111111     1234779999999999999999999999874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.7e-41  Score=353.00  Aligned_cols=245  Identities=13%  Similarity=0.116  Sum_probs=191.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEeccccc--ccchHHHHHHH---HHHhhcCCCceeeee-------ee
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEV---ETISLAVHRNLLRLC-------GF  366 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~---~~l~~l~H~niv~l~-------~~  366 (623)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||+++....  ......+.+|+   +.++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35688889999999999999996 4699999999975432  22345789999   455566899999998       55


Q ss_pred             eecCC-----------------ceEEEEecccCCChhhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006968          367 CSTEN-----------------ERLLVYPYMPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQCDPKI  426 (623)
Q Consensus       367 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  426 (623)
                      +...+                 ..++||||+ +|+|.+++.....   ....+++..+..++.|++.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            55443                 278999999 6899999986321   122355788999999999999999999   99


Q ss_pred             EecCCCCCCeEECCCCcEEEeecccccccCCCCCceeeccccccccccccccccC-----------CCCCccchhhHHHH
Q 006968          427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGIL  495 (623)
Q Consensus       427 vH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGvi  495 (623)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986332    3345567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          496 LLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       496 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      +|||++|+.||.......                ....+.. .. ..+    +.++.+++.+||..||++|||+.|++++
T Consensus       303 l~elltg~~Pf~~~~~~~----------------~~~~~~~-~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          303 IYWIWCADLPITKDAALG----------------GSEWIFR-SC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHSSCCC------C----------------CSGGGGS-SC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHCCCCCccccccc----------------chhhhhh-hc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            999999999996322111                1111111 00 122    3678999999999999999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=341.34  Aligned_cols=252  Identities=25%  Similarity=0.323  Sum_probs=185.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeee--------cC
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCS--------TE  370 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~--------~~  370 (623)
                      .+|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++.++. ||||+++++++.        ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            57888999999999999999975 68999999985543 233457899999999996 999999999984        33


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEECCCCcEEEee
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLDEDFEAVVGD  448 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~D  448 (623)
                      ...++||||+. |+|.+++..... ...+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.+||+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            45799999995 799999876432 34699999999999999999999998   7  99999999999999999999999


Q ss_pred             cccccccCCCCCce-----------eecccccccccccccc---ccCCCCCccchhhHHHHHHHHHhCCCCCCccccccc
Q 006968          449 FGLAKLLDHRDSHV-----------TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ  514 (623)
Q Consensus       449 fgla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~  514 (623)
                      ||+++.........           .....||+.|+|||++   .+..++.++||||||+++|||++|+.||....... 
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-  260 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-  260 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence            99998765432211           1134589999999998   56678999999999999999999999996322110 


Q ss_pred             ccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          515 RGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                                         .................+.+++.+||+.||++|||+.|++++|+.
T Consensus       261 -------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  305 (337)
T 3ll6_A          261 -------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE  305 (337)
T ss_dssp             ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             -------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                               000000000111112457899999999999999999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.9e-40  Score=331.77  Aligned_cols=247  Identities=25%  Similarity=0.388  Sum_probs=205.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|... ++..||||++.....  ......+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888999999999999999975 578999999865432  223457899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999999764    3589999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ..   .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......       +....... ..      .
T Consensus       167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~-~~------~  229 (284)
T 2vgo_A          167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------ETHRRIVN-VD------L  229 (284)
T ss_dssp             SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHT-TC------C
T ss_pred             cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------HHHHHHhc-cc------c
Confidence            22   23456899999999999999999999999999999999999999643221       11111111 11      1


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          .++...+.++.+++.+||..||++|||+.+++++
T Consensus       230 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          230 ----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                1122234678999999999999999999999874

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-39  Score=329.48  Aligned_cols=249  Identities=22%  Similarity=0.343  Sum_probs=205.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|... +++.||+|++......  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            57888999999999999999976 5889999998754322  23456889999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++...    ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        95 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           95 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             ECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999988753    3689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......       +....... ...      
T Consensus       168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~------  232 (294)
T 2rku_A          168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKK-NEY------  232 (294)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHT-TCC------
T ss_pred             Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhh-ccC------
Confidence            222 233456899999999999988999999999999999999999999643221       11111111 110      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          ..+......+.+++.+||+.||++|||+.|++++
T Consensus       233 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                1112223678899999999999999999999874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5e-39  Score=329.78  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=201.3

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ..++|.+.+.||+|+||.||+|... +|+.||||.++...   ....+.+|+.++..++||||+++++++...+..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            4567999999999999999999875 58999999997532   3457899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus       104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            999999999998743   34689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......       .......... .....  
T Consensus       178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~--  246 (314)
T 3com_A          178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIFMIPTNP-PPTFR--  246 (314)
T ss_dssp             TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC-CCCCS--
T ss_pred             hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCC-CcccC--
Confidence            322 223446899999999999989999999999999999999999999643221       1111111111 00000  


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                           .+...+..+.+++.+||..||.+|||+.+++++
T Consensus       247 -----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          247 -----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             -----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -----CcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 111224678999999999999999999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.5e-40  Score=343.51  Aligned_cols=273  Identities=22%  Similarity=0.264  Sum_probs=201.9

Q ss_pred             CHHHHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccc----------hHHHHHHHHHHhhcCCCcee
Q 006968          292 TFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG----------EVQFQTEVETISLAVHRNLL  361 (623)
Q Consensus       292 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~l~H~niv  361 (623)
                      ...++....++|.+.+.||+|+||.||+|...+|..||||++........          ...+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            35677888899999999999999999999988899999999965432211          25789999999999999999


Q ss_pred             eeeeeeec-----CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 006968          362 RLCGFCST-----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANI  436 (623)
Q Consensus       362 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI  436 (623)
                      ++++++..     ....++||||++ |+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence            99999843     335799999997 6888887643   44699999999999999999999999   999999999999


Q ss_pred             EECCCCcEEEeecccccccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccc
Q 006968          437 LLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQR  515 (623)
Q Consensus       437 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~  515 (623)
                      +++.++.+||+|||+++......  ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.........
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999997543322  2334568999999999877 67899999999999999999999999753321111


Q ss_pred             cchHHHHHHHhhcCcc-----------ccccccccC---CC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          516 GVMLDWVKKLHQEGKL-----------SQMVDKDLK---GN----FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       516 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~---~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ...   . ........           ...+.....   ..    ........+.+++.+||+.||++|||+.|++++-.
T Consensus       244 ~~i---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          244 NKI---V-EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             HHH---H-HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHH---H-HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            000   0 00000000           000000000   00    01122367899999999999999999999998643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.2e-39  Score=335.76  Aligned_cols=257  Identities=21%  Similarity=0.328  Sum_probs=205.9

Q ss_pred             HHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-------chHHHHHHHHHHhhc-CCCceeeeeee
Q 006968          296 LRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-------GEVQFQTEVETISLA-VHRNLLRLCGF  366 (623)
Q Consensus       296 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l-~H~niv~l~~~  366 (623)
                      ......+|.+.+.||+|+||.||+|... +|+.||||+++......       ....+.+|+.++.++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445577999999999999999999985 69999999987543211       134578999999999 79999999999


Q ss_pred             eecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 006968          367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV  446 (623)
Q Consensus       367 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  446 (623)
                      +...+..++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999763    3689999999999999999999999   9999999999999999999999


Q ss_pred             eecccccccCCCCCceeecccccccccccccccc------CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH
Q 006968          447 GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD  520 (623)
Q Consensus       447 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  520 (623)
                      +|||++..+....  ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||.....       ..
T Consensus       242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~  312 (365)
T 2y7j_A          242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------IL  312 (365)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HH
T ss_pred             EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------HH
Confidence            9999998765432  2334569999999999863      3578999999999999999999999964221       11


Q ss_pred             HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          521 WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ....... +.... ..+.. .    ..+.++.+++.+||..||++|||+.|++++
T Consensus       313 ~~~~i~~-~~~~~-~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          313 MLRMIME-GQYQF-SSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHHHHH-TCCCC-CHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHh-CCCCC-CCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111111 11100 00000 0    113568999999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-39  Score=336.03  Aligned_cols=249  Identities=22%  Similarity=0.340  Sum_probs=205.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||++... +++.||+|++......  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            56888899999999999999975 5889999998754322  23456899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus       121 e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          121 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             CCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999988763    4689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....       .+....... ...      
T Consensus       194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~-~~~------  258 (335)
T 2owb_A          194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKK-NEY------  258 (335)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHH-TCC------
T ss_pred             Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHhc-CCC------
Confidence            322 23345689999999999998999999999999999999999999964321       111111111 110      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .    ++.....++.+++.+||+.||++|||+.|++++
T Consensus       259 ~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 S----IPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             C----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             C----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1    111223678899999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.5e-39  Score=331.73  Aligned_cols=254  Identities=22%  Similarity=0.314  Sum_probs=200.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            467889999999999999999986 58999999986543 3345678999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++++|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999998764   34589999999999999999999999   9999999999999999999999999997543211


Q ss_pred             CCceeecccccccccccccc-----ccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYL-----STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                       ........||+.|+|||.+     ....++.++||||||+++|||++|+.||.....       ............ ..
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~~  241 (302)
T 2j7t_A          171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSDP-PT  241 (302)
T ss_dssp             -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCC-CC
T ss_pred             -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHHHHhccCC-cc
Confidence             1112234589999999998     366789999999999999999999999874322       111112211111 11


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ..       .+...+.++.+++.+||+.||++|||+.+++++-
T Consensus       242 ~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  277 (302)
T 2j7t_A          242 LL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP  277 (302)
T ss_dssp             CS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred             cC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            10       1122246789999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=330.34  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=199.2

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      +|.....||+|+||.||+|... ++..||||.++... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            3445568999999999999964 68899999997643 333557899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCcEEEeecccccccCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~  459 (623)
                      ++++|.+++.... ....+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||++.......
T Consensus       102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            9999999998642 234578999999999999999999999   9999999999999987 8999999999998765322


Q ss_pred             CceeeccccccccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      . ......||+.|+|||.+.+..  ++.++||||||+++|||++|+.||.......     ........ ..     ..+
T Consensus       178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-~~-----~~~  245 (295)
T 2clq_A          178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGM-FK-----VHP  245 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHH-HC-----CCC
T ss_pred             C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhcc-cc-----ccc
Confidence            2 233456899999999987653  7899999999999999999999986322110     01111100 00     011


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          ..+...+.++.+++.+||+.||++|||+.+++++
T Consensus       246 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          246 ----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                1222334678999999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.3e-40  Score=335.81  Aligned_cols=256  Identities=30%  Similarity=0.420  Sum_probs=197.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC--CCc--EEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS--DGA--LVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|.+.+.||+|+||.||+|.+.  ++.  .||||+++....  ......+.+|++++++++||||+++++++...+ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            57888999999999999999853  333  699999875432  223457899999999999999999999997654 88


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +|+||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        97 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence            999999999999999864   24589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCce--eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          455 LDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       455 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      ........  .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....       .+...........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~  243 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEGER  243 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSCCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------HHHHHHHHccCCC
Confidence            65443322  223457889999999988889999999999999999999 9999864322       1122222211110


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                               ...+...+.++.+++.+||+.||++|||+.+++++|++.
T Consensus       244 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          244 ---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence                     011122347799999999999999999999999999873

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-39  Score=340.45  Aligned_cols=260  Identities=23%  Similarity=0.315  Sum_probs=195.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCC------c
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------E  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~  372 (623)
                      ++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+++++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            57888999999999999999974 6999999998654322 22456889999999999999999999997653      4


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++||||+ +++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus       105 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            69999999 8899999875     2589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHH--------HHH
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD--------WVK  523 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~  523 (623)
                      +.....    .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+..        +..
T Consensus       176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            875432    234568999999999877 6789999999999999999999999975432211100000        000


Q ss_pred             --------HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          524 --------KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       524 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                              .+..  .........+. ........++.+++.+||..||++|||+.|++++-
T Consensus       252 ~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp  309 (367)
T 1cm8_A          252 RLQSDEAKNYMK--GLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP  309 (367)
T ss_dssp             TCSCHHHHHHHH--HSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HhhhHHHHHHHH--hCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence                    0000  00000000110 01112346789999999999999999999999863

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3e-39  Score=333.93  Aligned_cols=260  Identities=18%  Similarity=0.255  Sum_probs=200.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeec--CCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCST--ENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lv  376 (623)
                      ++|.+.+.||+|+||.||+|.. .+++.||||+++..    ....+.+|++++++++ ||||+++++++..  ....++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            5688899999999999999986 47899999999743    3567899999999997 9999999999987  5678999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-cEEEeeccccccc
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLL  455 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~~~  455 (623)
                      |||+++++|.+++..       +++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|||+++..
T Consensus       112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            999999999988753       78999999999999999999999   999999999999999776 8999999999876


Q ss_pred             CCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccc-cc---------hHHHHHH
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQR-GV---------MLDWVKK  524 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~-~~---------~~~~~~~  524 (623)
                      .....  .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..         ..+++..
T Consensus       182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            54332  233468999999999877 67899999999999999999999999543221110 00         0011110


Q ss_pred             Hhhc----------CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          525 LHQE----------GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       525 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ....          ......+............+.++.+++.+||+.||++|||+.|++++-
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp  321 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP  321 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence            0000          000000001111111122357899999999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.9e-39  Score=329.14  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=203.2

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            357889999999999999999975 689999999975432 234568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCcEEEeeccccccc
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfgla~~~  455 (623)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           87 LVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             cCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999998763    3589999999999999999999999   99999999999999   78899999999999754


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ...   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....       ......... +...   
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~-~~~~---  225 (304)
T 2jam_A          160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------SKLFEKIKE-GYYE---  225 (304)
T ss_dssp             CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHH-CCCC---
T ss_pred             CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHc-CCCC---
Confidence            322   22334589999999999999999999999999999999999999964321       111111111 1110   


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         .........+.++.+++.+||..||++|||+.|++++
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          226 ---FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             ---CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ---CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               0111112234678999999999999999999999884

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8.6e-40  Score=329.01  Aligned_cols=248  Identities=23%  Similarity=0.400  Sum_probs=196.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||||+++....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888999999999999999976 699999999965432  223457899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           91 EYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             eccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999999764    3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ..  ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.....       ......... +..     
T Consensus       164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~-----  228 (276)
T 2h6d_A          164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKKIRG-GVF-----  228 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-CCC-----
T ss_pred             Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhc-Ccc-----
Confidence            32  2234458999999999987765 6899999999999999999999964221       111111111 110     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                           ..+.....++.+++.+||+.||++|||+.|++++
T Consensus       229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 0111223678999999999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.1e-39  Score=346.95  Aligned_cols=194  Identities=23%  Similarity=0.330  Sum_probs=153.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeec-----CCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST-----ENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-----~~~~  373 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+++++.++||||+++++++..     ....
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            67999999999999999999865 6899999998654322 234578999999999999999999999843     3568


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+ +|+|.+++..    ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence            9999998 5788888865    34699999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC--------------------------ceeecccccccccccccc-ccCCCCCccchhhHHHHHHHHHhC
Q 006968          454 LLDHRDS--------------------------HVTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITG  502 (623)
Q Consensus       454 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltg  502 (623)
                      .......                          ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            7643221                          122345689999999976 566799999999999999999994

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-39  Score=349.37  Aligned_cols=262  Identities=17%  Similarity=0.214  Sum_probs=205.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCC-CceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH-RNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|.+.+.||+|+||.||+|.. .+++.||||+++...   ...++..|++++..++| +++..+..++...+..++|||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC---SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc---ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            6789999999999999999996 469999999886543   23468899999999987 455566666677888899999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCcEEEeeccccccc
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfgla~~~  455 (623)
                      |+ +++|.+++...   ...+++..++.++.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||+++.+
T Consensus        84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99 99999999753   34699999999999999999999999   99999999999999   58899999999999876


Q ss_pred             CCCCCc------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          456 DHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       456 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+...... ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-~~~~  235 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-KVAT  235 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-HHHS
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-cccc
Confidence            544322      122556999999999999999999999999999999999999999753321111111111111 1111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCCCC
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLA  582 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  582 (623)
                      ....+.     ..    .+.++.+++..||+.+|++||++.+|++.|++....
T Consensus       236 ~~~~l~-----~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          236 SIEALC-----RG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             CHHHHH-----TT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cHHHHh-----cC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            111110     11    236789999999999999999999999999875333

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.9e-40  Score=368.43  Aligned_cols=256  Identities=22%  Similarity=0.361  Sum_probs=205.4

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC----CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      .++|.+.+.||+|+||.||+|.+.    .+..||||.++..........|.+|+.++++++||||+++++++. ++..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            467888999999999999999874    256799999876544444567999999999999999999999985 467899


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       468 v~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            99999999999999753   34689999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......       +...........   
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~~---  611 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERL---  611 (656)
T ss_dssp             CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHHTCCC---
T ss_pred             CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCCCC---
Confidence            5544333344557889999999998999999999999999999997 89998643221       112222111111   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                             ..+...+..+.+++.+||..||++|||+.++++.|+..
T Consensus       612 -------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          612 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   11223346789999999999999999999999999873

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.5e-39  Score=343.76  Aligned_cols=200  Identities=24%  Similarity=0.324  Sum_probs=166.9

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecC-----Cc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  372 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++..... .....+.+|+++++.++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            367999999999999999999875 5889999999754322 2345789999999999999999999999765     57


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++||||++ |+|.+++..    ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999986 699988865    34699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCc---------------------eeecccccccccccccc-ccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 006968          453 KLLDHRDSH---------------------VTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQRALD  507 (623)
Q Consensus       453 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltg~~p~~  507 (623)
                      +........                     ......||+.|+|||++ ....++.++||||+||++|||++|..|+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            876543211                     22456799999999986 56679999999999999999998655543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.6e-39  Score=336.90  Aligned_cols=260  Identities=20%  Similarity=0.294  Sum_probs=205.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccch----------------HHHHHHHHHHhhcCCCceeeee
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGE----------------VQFQTEVETISLAVHRNLLRLC  364 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------~~~~~e~~~l~~l~H~niv~l~  364 (623)
                      ++|.+.+.||+|+||.||+|.. +|+.||||++.........                ..+.+|+.++++++||||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            5788999999999999999999 9999999999754322211                6799999999999999999999


Q ss_pred             eeeecCCceEEEEecccCCChhhh------hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeE
Q 006968          365 GFCSTENERLLVYPYMPNGSVASR------LRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANIL  437 (623)
Q Consensus       365 ~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIl  437 (623)
                      +++...+..++||||+++|+|.++      +...  ....+++..++.++.|++.||+|||+ .   +|+||||||+||+
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            999999999999999999999998      4331  24579999999999999999999999 8   9999999999999


Q ss_pred             ECCCCcEEEeecccccccCCCCCceeeccccccccccccccccC-CCCC-ccchhhHHHHHHHHHhCCCCCCcccccccc
Q 006968          438 LDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSE-KTDVFGFGILLLELITGQRALDFGRAANQR  515 (623)
Q Consensus       438 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlGvil~elltg~~p~~~~~~~~~~  515 (623)
                      ++.++.+||+|||.+......   ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||......   
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred             EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence            999999999999999876433   33445699999999999877 5665 999999999999999999999743221   


Q ss_pred             cchHHHHHHHhhcCcccccc------ccccC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          516 GVMLDWVKKLHQEGKLSQMV------DKDLK---GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~------~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                         .+....... +....-.      .....   .......+.++.+++.+||+.||.+|||+.|++++-
T Consensus       259 ---~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp  324 (348)
T 2pml_X          259 ---VELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE  324 (348)
T ss_dssp             ---HHHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             ---HHHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence               111122111 1110000      00000   000122346789999999999999999999999853

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.9e-39  Score=337.08  Aligned_cols=265  Identities=19%  Similarity=0.278  Sum_probs=202.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC-----Cce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~  373 (623)
                      ..+|.+.+.||+|+||.||+|... ++..||||+++..........+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            357999999999999999999865 68899999997654444446789999999999999999999998654     368


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||++ |+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            99999997 5899888652     589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCce--eecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          454 LLDHRDSHV--TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       454 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      .........  .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+......   . ......
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~-~~~~~~  252 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---G-ILGSPS  252 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---H-HHCSCC
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---H-HhCCCC
Confidence            765332211  234569999999998754 458999999999999999999999997543322111111   0 000000


Q ss_pred             c---cccc--------cc-ccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          531 L---SQMV--------DK-DLKGNFD-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       531 ~---~~~~--------~~-~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .   ....        .. ......+     .....++.+++.+||+.||++|||+.|++++-.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  316 (364)
T 3qyz_A          253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  316 (364)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            0   0000        00 0000000     112367899999999999999999999998643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.1e-39  Score=350.77  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=206.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.....  ......+.+|+.++++++||||+++++++...+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357889999999999999999976 789999999965433  23456799999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCcEEEeeccccc
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAK  453 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~Dfgla~  453 (623)
                      |||+.+|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||+   +.++.+||+|||+++
T Consensus       105 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999988753    4699999999999999999999999   99999999999999   567899999999998


Q ss_pred             ccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      .......  .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....       .+.+..+.. +....
T Consensus       178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~-~~~~~  246 (484)
T 3nyv_A          178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDILKKVEK-GKYTF  246 (484)
T ss_dssp             HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-CCCCC
T ss_pred             Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHc-CCCCC
Confidence            7654332  334569999999999865 689999999999999999999999974322       111222221 11110


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .. +.     ....+.++.+++.+||..||++|||+.|++++-
T Consensus       247 ~~-~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          247 EL-PQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             CS-GG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             CC-cc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence            00 00     012246789999999999999999999998754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.4e-39  Score=339.54  Aligned_cols=265  Identities=25%  Similarity=0.335  Sum_probs=200.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeec--------C
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST--------E  370 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~  370 (623)
                      .+|.+.+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+++++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5788999999999999999997 47899999998654432 234568899999999999999999999876        3


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      +..++||||+++ +|.+.+...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            468999999975 777777643   34699999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC---ceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHh
Q 006968          451 LAKLLDHRDS---HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH  526 (623)
Q Consensus       451 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  526 (623)
                      +++.+.....   .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........    ...+....
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~  245 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ----LALISQLC  245 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHH
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHh
Confidence            9987653221   22234568999999999876 4579999999999999999999999975332111    11111111


Q ss_pred             hcC---cccccccccc-------CC-CCC-HH------HHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          527 QEG---KLSQMVDKDL-------KG-NFD-RI------ELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       527 ~~~---~~~~~~~~~~-------~~-~~~-~~------~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ...   .....-....       .. ... ..      ....+.+++.+||..||++|||+.|++++-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  313 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  313 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence            100   0000000000       00 000 00      124688999999999999999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.4e-39  Score=348.39  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=204.0

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .++|.+.+.||+|+||+||+|... +|+.||||+++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            367999999999999999999975 689999999965432 234567899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC---CCCcEEEeecccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKL  454 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Dfgla~~  454 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||+++.
T Consensus       101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            999999999988764    3689999999999999999999999   999999999999995   556799999999987


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      .....  ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....       .+....+.. +.....
T Consensus       174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~-~~~~~~  242 (486)
T 3mwu_A          174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVET-GKYAFD  242 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-TCCCSC
T ss_pred             CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh-CCCCCC
Confidence            65432  2334569999999999875 589999999999999999999999964322       112222211 111100


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      . +.     ....+.++.+++.+||..||++|||+.|++++-
T Consensus       243 ~-~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          243 L-PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             S-GG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             C-cc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence            0 00     011236789999999999999999999999863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.1e-40  Score=346.25  Aligned_cols=255  Identities=10%  Similarity=-0.001  Sum_probs=181.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHHHHHHhhc--CCCceeeee-------eeee
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLA--VHRNLLRLC-------GFCS  368 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l--~H~niv~l~-------~~~~  368 (623)
                      .+|...+.||+|+||.||+|... +|+.||||+++.....  .....+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888999999999999999975 7899999999875432  2234577885544444  699988754       3333


Q ss_pred             cC-----------------CceEEEEecccCCChhhhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 006968          369 TE-----------------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARR------KRIALGTARGLLYLHEQCDPK  425 (623)
Q Consensus       369 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~  425 (623)
                      ..                 ...++||||++ |+|.+++....   ..+.+..+      ..++.|++.||+|||++   +
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            22                 33799999998 89999998642   23455555      78889999999999999   9


Q ss_pred             eEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeecccccccccccccccc--CCCCCccchhhHHHHHHHHHhCC
Q 006968          426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQ  503 (623)
Q Consensus       426 ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~  503 (623)
                      |+||||||+|||++.++.+||+|||+++....    ......+|+.|+|||++.+  ..++.++|||||||++|||++|+
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999986542    2224457799999999987  67899999999999999999999


Q ss_pred             CCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          504 RALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       504 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .||...........         .....................+..+.+++.+||+.||++|||+.|++++
T Consensus       291 ~Pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          291 LPFGLVTPGIKGSW---------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             CSTTBCCTTCTTCC---------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCCcCcccccch---------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            99975422111000         0000000000111111112334789999999999999999999999764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=324.17  Aligned_cols=253  Identities=20%  Similarity=0.284  Sum_probs=200.7

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc---ccchHHHHHHHHHHhhcCCCceeeeeeeee--cCCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI---AGGEVQFQTEVETISLAVHRNLLRLCGFCS--TENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~  373 (623)
                      .++|.+.+.||+|+||.||+|... ++..||||+++....   ......+.+|+++++.++||||+++++++.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999975 688999999975432   234567999999999999999999999984  45678


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||++++ |.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999877 777776532  34699999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC-CceeeccccccccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          454 LLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       454 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      ...... ........||+.|+|||.+.+..  .+.++||||||+++|||++|+.||.....       ......... +.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~-~~  229 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFENIGK-GS  229 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHH-CC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHHHhc-CC
Confidence            765432 22334456999999999987644  37899999999999999999999974321       111122111 11


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .      .    ++...+..+.+++.+||..||++|||+.|++++-
T Consensus       230 ~------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          230 Y------A----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             C------C----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             C------C----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            1      1    1122346788999999999999999999999853

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-38  Score=348.89  Aligned_cols=253  Identities=23%  Similarity=0.308  Sum_probs=201.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc------------cchHHHHHHHHHHhhcCCCceeeeeee
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA------------GGEVQFQTEVETISLAVHRNLLRLCGF  366 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~H~niv~l~~~  366 (623)
                      .++|.+.+.||+|+||+||+|... ++..||||+++.....            .....+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467999999999999999999975 5889999999764322            234578999999999999999999999


Q ss_pred             eecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---c
Q 006968          367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---E  443 (623)
Q Consensus       367 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~  443 (623)
                      +...+..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999998764    3599999999999999999999999   999999999999999775   6


Q ss_pred             EEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH
Q 006968          444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       444 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      +||+|||++.......  ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.....       .+...
T Consensus       188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-------QDIIK  257 (504)
T ss_dssp             EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred             EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence            9999999998765432  233456999999999986 4689999999999999999999999974322       11222


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      .+.. +....  +....    ...+.++.+++.+||..||.+|||+.|++++-
T Consensus       258 ~i~~-~~~~~--~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          258 KVEK-GKYYF--DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             HHHH-CCCCC--CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHc-CCCCC--Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence            2221 11100  00000    01236789999999999999999999998854

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=334.34  Aligned_cols=259  Identities=25%  Similarity=0.368  Sum_probs=200.0

Q ss_pred             HHHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeec-
Q 006968          293 FKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCST-  369 (623)
Q Consensus       293 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~-  369 (623)
                      +.++....++|.+.+.||+|+||.||+|... +|+.||||++....  .....+.+|+.++.++ +||||+++++++.. 
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3344445678999999999999999999974 68999999986543  3356789999999998 79999999999976 


Q ss_pred             -----CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcE
Q 006968          370 -----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA  444 (623)
Q Consensus       370 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  444 (623)
                           .+..++||||+++|+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence                 467899999999999999998642  34689999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH
Q 006968          445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML  519 (623)
Q Consensus       445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~  519 (623)
                      ||+|||++........ ......||+.|+|||.+.     +..++.++||||||+++|+|++|+.||......       
T Consensus       169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------  240 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------  240 (326)
T ss_dssp             EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------
T ss_pred             EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------
Confidence            9999999986543221 223446899999999987     567899999999999999999999999643221       


Q ss_pred             HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          520 DWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ........ .......        ....+..+.+++.+||..||++|||+.+++++
T Consensus       241 ~~~~~~~~-~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          241 RALFLIPR-NPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHHHHHHH-SCCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhc-CccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11111111 1111111        11123678999999999999999999999984

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.8e-39  Score=365.52  Aligned_cols=251  Identities=23%  Similarity=0.288  Sum_probs=206.8

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~  374 (623)
                      ..++|.+.+.||+|+||.||+|... +++.||||++++...  ......+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4567999999999999999999975 588999999975432  23345678899999887 7999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +||||+++|+|..++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            999999999999999864    3699999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .+....+.. ..    
T Consensus       492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~-~~----  558 (674)
T 3pfq_A          492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIME-HN----  558 (674)
T ss_dssp             CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHS-SC----
T ss_pred             cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------HHHHHHHHh-CC----
Confidence            43222 234556799999999999999999999999999999999999999974322       111122211 11    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKM-----SEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  575 (623)
                            ..++...+.++.+++.+||..||++||++     .||+++
T Consensus       559 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          559 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             ------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                  11223344778999999999999999997     777664

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.2e-40  Score=347.37  Aligned_cols=264  Identities=22%  Similarity=0.304  Sum_probs=195.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCc------eE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE------RL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------~~  374 (623)
                      .+|.+.+.||+|+||.||+|...++..||+|++.....     ...+|+++++.++||||+++++++...+.      .+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            46888999999999999999988777799998864321     23479999999999999999999855433      78


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCcEEEeeccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAK  453 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfgla~  453 (623)
                      +||||++++ +...+.........+++..++.++.|++.||+|||+.   +|+||||||+|||++ .++.+||+|||+++
T Consensus       115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            999999765 4444443323345799999999999999999999999   999999999999999 79999999999998


Q ss_pred             ccCCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHH--------HHH
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDW--------VKK  524 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~  524 (623)
                      .......  .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+........        +..
T Consensus       191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            7644332  2345689999999998764 5899999999999999999999999754322111111110        000


Q ss_pred             Hhhc---CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          525 LHQE---GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       525 ~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ....   ..........+...+....+.++.+++.+||..||++|||+.|++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            0000   00000000000001112234689999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.3e-39  Score=336.22  Aligned_cols=274  Identities=22%  Similarity=0.268  Sum_probs=194.9

Q ss_pred             HHHHHHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCc
Q 006968          294 KELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE  372 (623)
Q Consensus       294 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~  372 (623)
                      .+.....++|.+.+.||+|+||.||+|... +|..||||++....  .....+.++++.+..++||||+++++++...+.
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            345667789999999999999999999975 68999999986543  223456788888899999999999999865433


Q ss_pred             -------eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCeEECC-CC
Q 006968          373 -------RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH--EQCDPKIIHRDVKAANILLDE-DF  442 (623)
Q Consensus       373 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~Dlk~~NIll~~-~~  442 (623)
                             .++||||+++ +|...+.........+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence                   7899999975 666666554445667999999999999999999999  77   9999999999999996 89


Q ss_pred             cEEEeecccccccCCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH--
Q 006968          443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--  519 (623)
Q Consensus       443 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~--  519 (623)
                      .+||+|||+++.......  .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.............  
T Consensus       170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  247 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV  247 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence            999999999987654332  2345689999999998664 48999999999999999999999997543221111110  


Q ss_pred             ------HHHHHHhhcCccccccccc------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          520 ------DWVKKLHQEGKLSQMVDKD------LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       520 ------~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                            .+..............+..      .........+.++.+++.+||+.||++|||+.|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                  1111111000000000000      0011112245789999999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-38  Score=348.09  Aligned_cols=252  Identities=22%  Similarity=0.345  Sum_probs=199.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .++|.+.+.||+|+||.||+|... ++..||||+++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            356889999999999999999975 689999999976543 233557899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEeecccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFGLAKL  454 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfgla~~  454 (623)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||++..
T Consensus       116 e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          116 ECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            999999999988764    3589999999999999999999999   9999999999999976   45599999999987


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      .....  ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.....       .+......... .. .
T Consensus       189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~-~~-~  256 (494)
T 3lij_A          189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QEILRKVEKGK-YT-F  256 (494)
T ss_dssp             CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC-CC-C
T ss_pred             CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-CC-C
Confidence            65432  233456999999999886 5689999999999999999999999974322       11222222111 10 0


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..+..     ...+.++.+++.+||..||.+|||+.|++++
T Consensus       257 ~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 DSPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CSGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             Cchhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            00000     1123678999999999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.1e-39  Score=344.84  Aligned_cols=262  Identities=25%  Similarity=0.333  Sum_probs=197.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC----C--ce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE----N--ER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~----~--~~  373 (623)
                      .+|...+.||+|+||.||+|... +|+.||||++....     ..+.+|+++++.++||||+++++++...    +  ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            35788899999999999999985 58999999986532     2235799999999999999999988532    1  25


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CcEEEeecccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLA  452 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgla  452 (623)
                      ++||||+++ ++.+.+.........+++..++.++.|+++||+|||+.   +|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999975 67666665434456799999999999999999999999   99999999999999965 56899999999


Q ss_pred             cccCCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHh-----
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH-----  526 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  526 (623)
                      +.+.....  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.   +...++...     
T Consensus       205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTRE  279 (420)
T ss_dssp             EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHH
T ss_pred             hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence            87654322  2345689999999998764 789999999999999999999999975432211   111111100     


Q ss_pred             ----hcCccccccccccCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          527 ----QEGKLSQMVDKDLKG-----NFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       527 ----~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                          ......+...+.+..     .+....+.++.+++.+||..||++|||+.|++++-
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence                001111111111100     01122346799999999999999999999998754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.4e-39  Score=337.59  Aligned_cols=265  Identities=20%  Similarity=0.242  Sum_probs=193.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCC------c
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------E  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~  372 (623)
                      ++|.+.+.||+|+||.||+|... +++.||||+++..... .....+.+|+.+++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            57889999999999999999865 6899999999754322 23456889999999999999999999997654      6


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++||||++ |+|.+++..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          105 VYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             eEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            799999997 477777753      488999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH--------H----
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--------D----  520 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~----  520 (623)
                      +.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............        +    
T Consensus       175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            865432  12334568999999999999999999999999999999999999997533211100000        0    


Q ss_pred             ---HHHHHhhc-Ccc-----ccccccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          521 ---WVKKLHQE-GKL-----SQMVDKDLKGN---FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       521 ---~~~~~~~~-~~~-----~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                         .+...... ...     ...........   .......++.+++.+||..||++|||+.|++++-.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  321 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  321 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence               00000000 000     00000000000   01233578999999999999999999999998643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.6e-39  Score=332.26  Aligned_cols=254  Identities=24%  Similarity=0.327  Sum_probs=197.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-------cchHHHHHHHHHHhhcCCCceeeeeeeeecCC
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-------GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN  371 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~  371 (623)
                      .++|.+.+.||+|+||.||+|... +++.||||+++.....       .....+.+|++++++++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            467999999999999999999875 5889999998654321       12335889999999999999999999987654


Q ss_pred             ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc---EEEee
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE---AVVGD  448 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~D  448 (623)
                       .++||||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             8999999999999998864    34689999999999999999999999   9999999999999987654   99999


Q ss_pred             cccccccCCCCCceeeccccccccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHH
Q 006968          449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      ||++......  .......||+.|+|||++.   ...++.++||||||+++|+|++|+.||.......   .....+.  
T Consensus       161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~--  233 (322)
T 2ycf_A          161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQIT--  233 (322)
T ss_dssp             CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHHHHH--
T ss_pred             Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHHHHH--
Confidence            9999876432  2223456899999999974   5678899999999999999999999996432211   1111111  


Q ss_pred             hhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                        .+....  .+....    ..+.++.+++.+||..||++|||+.+++++-
T Consensus       234 --~~~~~~--~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~  276 (322)
T 2ycf_A          234 --SGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRHP  276 (322)
T ss_dssp             --HTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             --hCcccc--Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence              111100  000001    1236789999999999999999999998753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.5e-39  Score=332.68  Aligned_cols=266  Identities=23%  Similarity=0.327  Sum_probs=202.6

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEe--CCCcEEEEEEeccccccc-chHHHHHHHHHHhhc---CCCceeeeeeeee----
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA---VHRNLLRLCGFCS----  368 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~H~niv~l~~~~~----  368 (623)
                      +.++|.+.+.||+|+||.||+|..  .+|+.||||+++...... ....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            357899999999999999999997  368899999997543222 233577888887766   8999999999987    


Q ss_pred             -cCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 006968          369 -TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG  447 (623)
Q Consensus       369 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  447 (623)
                       .....++||||++ |+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             5567899999997 69999997642  33589999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh
Q 006968          448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       448 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      |||+++.....  .......||..|+|||.+.+..++.++||||||+++|||++|+.||........   ....+.....
T Consensus       163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~  237 (326)
T 1blx_A          163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGL  237 (326)
T ss_dssp             SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred             cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCC
Confidence            99999865432  123345689999999999999999999999999999999999999974332111   0011111000


Q ss_pred             c--Ccccc-------ccccc---cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          528 E--GKLSQ-------MVDKD---LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       528 ~--~~~~~-------~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .  .....       .....   ....+....+..+.+++.+||..||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0  00000       00000   0001112234678999999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.6e-39  Score=332.95  Aligned_cols=258  Identities=24%  Similarity=0.302  Sum_probs=181.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHH-HHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVE-TISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|...+.||+|+||.||+|... +|+.||||+++.........++..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            67888999999999999999985 689999999976544344455666666 6778899999999999999999999999


Q ss_pred             cccCCChhhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          379 YMPNGSVASRLRDHI-HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      |+++ +|.+++.... .....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||+++....
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            9975 7877776421 12457899999999999999999999852  899999999999999999999999999986643


Q ss_pred             CCCceeecccccccccccccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ..  ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||........      .+      .....
T Consensus       179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~------~~~~~  244 (327)
T 3aln_A          179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QL------TQVVK  244 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------CCCCC
T ss_pred             cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HH------HHHhc
Confidence            32  12233589999999998    456789999999999999999999999964221100      00      00000


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...+.+........+.++.+++.+||..||++|||+.+++++
T Consensus       245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            011111111112234679999999999999999999999763

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.8e-39  Score=344.22  Aligned_cols=198  Identities=21%  Similarity=0.250  Sum_probs=171.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhc------CCCceeeeeeeeecCCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA------VHRNLLRLCGFCSTENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~H~niv~l~~~~~~~~~~  373 (623)
                      .+|.+.+.||+|+||.||+|... +++.||||+++...  ....++.+|+.+++.+      .|+||+++++++...+..
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            56889999999999999999875 58999999997532  2234677888888776      577999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc--EEEeeccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE--AVVGDFGL  451 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~Dfgl  451 (623)
                      ++||||+. ++|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            99999995 69999987642  34589999999999999999999999   9999999999999999887  99999999


Q ss_pred             ccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCccc
Q 006968          452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR  510 (623)
Q Consensus       452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~  510 (623)
                      +......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9764432    234568999999999999999999999999999999999999997543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2e-38  Score=322.73  Aligned_cols=253  Identities=23%  Similarity=0.291  Sum_probs=204.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--------cchHHHHHHHHHHhhcC-CCceeeeeeeeec
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--------GGEVQFQTEVETISLAV-HRNLLRLCGFCST  369 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~  369 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++.....        .....+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            467899999999999999999975 6899999999654311        12346889999999996 9999999999999


Q ss_pred             CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                      .+..++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999763    4689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      |++.......  ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||.....       .....
T Consensus       169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~  239 (298)
T 1phk_A          169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLR  239 (298)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred             cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------HHHHH
Confidence            9998765432  233456899999999885      45678999999999999999999999864321       11111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .... +....      ........+.++.+++.+||..||++|||+.|++++
T Consensus       240 ~~~~-~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          240 MIMS-GNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHHH-TCCCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHhc-CCccc------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            1111 11100      000011234678999999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.2e-39  Score=330.39  Aligned_cols=257  Identities=24%  Similarity=0.389  Sum_probs=200.1

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ..++|.+.+.||+|+||.||+|...+  .||+|+++..... .....+.+|+.++++++||||+++++++...+..++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35678899999999999999998753  4999998754322 23346888999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++ ++.+||+|||++.....
T Consensus       109 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             BCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             ecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            999999999999753   34689999999999999999999999   999999999999998 67999999999876532


Q ss_pred             CC----Cceeecccccccccccccccc---------CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH
Q 006968          458 RD----SHVTTAVRGTVGHIAPEYLST---------GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       458 ~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      ..    ........||+.|+|||.+..         ..++.++||||||+++|||++|+.||......       .....
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~  254 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------AIIWQ  254 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------HHHHH
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH
Confidence            11    112233458999999999864         35788999999999999999999999643221       11111


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcCC
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDG  580 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  580 (623)
                      .. .+........        ..+.++.+++.+||..||++|||+.++++.|+...
T Consensus       255 ~~-~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          255 MG-TGMKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             HH-TTCCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             hc-cCCCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            11 1111111111        12356889999999999999999999999998843

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.4e-39  Score=335.84  Aligned_cols=265  Identities=22%  Similarity=0.313  Sum_probs=200.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC-----Cce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~~  373 (623)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            367889999999999999999975 68999999997554444455788999999999999999999988654     678


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||++ |+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999997 689888875     2589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCc---------eeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH
Q 006968          454 LLDHRDSH---------VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       454 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      ........         ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........    ...+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~  236 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ----LLLIF  236 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHH
Confidence            76532211         1223468999999998754 6789999999999999999999999974332111    00000


Q ss_pred             HHhhcCc----cccccc-------cccC--CC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          524 KLHQEGK----LSQMVD-------KDLK--GN-----FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       524 ~~~~~~~----~~~~~~-------~~~~--~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .......    ......       ..+.  ..     .....+.++.+++.+||..||++|||+.|++++-.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY  308 (353)
T ss_dssp             HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence            0000000    000000       0000  00     00122467899999999999999999999998543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.8e-39  Score=337.07  Aligned_cols=259  Identities=22%  Similarity=0.269  Sum_probs=183.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecC------Cc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------NE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~  372 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||||+++.... ......+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            67889999999999999999864 689999999965432 22345688999999999999999999998654      56


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++|+||+ +++|.+++..     ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             EEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            79999999 7898888764     3699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc-
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK-  530 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  530 (623)
                      +.....    .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..........    .+........ 
T Consensus       180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~----~i~~~~g~p~~  251 (367)
T 2fst_X          180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK----LILRLVGTPGA  251 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHHHCSCCH
T ss_pred             cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHHHhCCCCH
Confidence            865432    234568999999999877 678999999999999999999999997543211111    0000000000 


Q ss_pred             --cccccc-------cccC--CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          531 --LSQMVD-------KDLK--GNFD-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       531 --~~~~~~-------~~~~--~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                        ...+..       ..+.  ....     ......+.+++.+||..||++|||+.|++++-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp  313 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  313 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence              000000       0000  0000     01236689999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8.6e-39  Score=338.97  Aligned_cols=264  Identities=20%  Similarity=0.241  Sum_probs=201.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC--------CCceeeeeeeee---
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--------HRNLLRLCGFCS---  368 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------H~niv~l~~~~~---  368 (623)
                      ++|.+.+.||+|+||.||+|... +++.||||+++...  .....+.+|+.+++.++        |+||+++++++.   
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            67999999999999999999864 68899999997432  23456889999999885        788999999987   


Q ss_pred             -cCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-----
Q 006968          369 -TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-----  442 (623)
Q Consensus       369 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----  442 (623)
                       .....++||||+ ++++.+++...  ....+++..++.++.|++.||+|||+++  +|+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence             556789999999 66776666543  2346999999999999999999999964  899999999999999775     


Q ss_pred             --------------------------------------------cEEEeecccccccCCCCCceeecccccccccccccc
Q 006968          443 --------------------------------------------EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL  478 (623)
Q Consensus       443 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~  478 (623)
                                                                  .+||+|||++......    .....||+.|+|||++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence                                                        7999999999876432    2334689999999999


Q ss_pred             ccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch--HHHHHHHhh--------cCcc-ccccccc---------
Q 006968          479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM--LDWVKKLHQ--------EGKL-SQMVDKD---------  538 (623)
Q Consensus       479 ~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~--------~~~~-~~~~~~~---------  538 (623)
                      .+..++.++|||||||++|||++|+.||............  ...+.....        .+.. .......         
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            9999999999999999999999999999753322111000  011111000        0000 0000000         


Q ss_pred             ----------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          539 ----------LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       539 ----------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                                -....+......+.+++.+||+.||++|||+.|++++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                      0012356677889999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.4e-39  Score=329.51  Aligned_cols=254  Identities=20%  Similarity=0.283  Sum_probs=197.7

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc-cchHHHHHHHHHHhhcC--CCceeeeeeeeecCCceEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAV--HRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~~~l  375 (623)
                      ..++|.+.+.||+|+||.||+|...+++.||||+++..... .....+.+|++++.+++  ||||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            34678899999999999999999988999999999754322 23457899999999997  5999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||| +.+++|.+++...    ..+++..+..++.|+++||.|||+.   +|+||||||+||++++ +.+||+|||++...
T Consensus       106 v~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            999 5688999999763    4689999999999999999999999   9999999999999964 79999999999876


Q ss_pred             CCCCCc-eeecccccccccccccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH
Q 006968          456 DHRDSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       456 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  523 (623)
                      ...... ......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||.....      ....+.
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~  250 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLH  250 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHH
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------HHHHHH
Confidence            543222 2234468999999999875           4678899999999999999999999963221      111111


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ...         +......++...+.++.+++.+||+.||++|||+.|++++-
T Consensus       251 ~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          251 AII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             HHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            111         11111112222246789999999999999999999998854

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.2e-38  Score=333.02  Aligned_cols=260  Identities=21%  Similarity=0.277  Sum_probs=195.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCce-----
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENER-----  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~-----  373 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||||+++...... ....+.+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            57888999999999999999875 68999999997543222 245688999999999999999999999877654     


Q ss_pred             -EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          374 -LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       374 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                       ++||||+. ++|.+++..      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus       122 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             EEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence             99999997 677777642      489999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC--
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG--  529 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  529 (623)
                      +.....    .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........   ...........  
T Consensus       192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~  264 (371)
T 4exu_A          192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGTE  264 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHH
T ss_pred             cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCcHH
Confidence            865432    234568999999999877 68899999999999999999999999743321110   01100000000  


Q ss_pred             ---ccc--------cccccccCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          530 ---KLS--------QMVDKDLKGNF---DRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       530 ---~~~--------~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                         ...        ..+.......+   ......++.+++.+||+.||++|||+.|++++-.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  326 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  326 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence               000        00000000000   0112467899999999999999999999998644

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.4e-38  Score=324.21  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=194.7

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec---------
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST---------  369 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~---------  369 (623)
                      .++|++.+.||+|+||.||+|... +|+.||||+++...  .....+.+|+.++++++||||+++++++..         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            457889999999999999999974 78999999996432  334578999999999999999999998754         


Q ss_pred             ----CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEE
Q 006968          370 ----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV  445 (623)
Q Consensus       370 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  445 (623)
                          .+..++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence                35678999999999999999763   34678899999999999999999999   999999999999999999999


Q ss_pred             EeecccccccCCCC-------------CceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccc
Q 006968          446 VGDFGLAKLLDHRD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRA  511 (623)
Q Consensus       446 l~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~  511 (623)
                      |+|||++.......             ........||+.|+|||.+.+. .++.++||||||+++|||++   |+.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            99999998664321             1122344589999999999764 68999999999999999998   4432111


Q ss_pred             cccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          512 ANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                            .......... .      ...+...++...+..+.+++.+||+.||++|||+.+++++-
T Consensus       234 ------~~~~~~~~~~-~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  285 (303)
T 1zy4_A          234 ------RVNILKKLRS-V------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG  285 (303)
T ss_dssp             ------HHHHHHHHHS-T------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred             ------HHHHHHhccc-c------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence                  1111121111 0      11112223333456789999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.1e-39  Score=340.00  Aligned_cols=269  Identities=20%  Similarity=0.258  Sum_probs=184.2

Q ss_pred             CCCc-CCceeccCCeEEEEEEeC---CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeee--cCCceEE
Q 006968          302 NFSA-KNILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS--TENERLL  375 (623)
Q Consensus       302 ~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~--~~~~~~l  375 (623)
                      .|.+ .++||+|+||.||+|...   ++..||||+++...   ....+.+|+.++++++||||+++++++.  .....++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            3554 458999999999999965   57899999997543   2346889999999999999999999994  4678899


Q ss_pred             EEecccCCChhhhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----CCCCcEEE
Q 006968          376 VYPYMPNGSVASRLRDHI-----HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVV  446 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl  446 (623)
                      ||||++ |+|.+++....     .....+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999996 57888776421     1123599999999999999999999999   99999999999999    67889999


Q ss_pred             eecccccccCCCCC--ceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCccccccc--ccchHHH
Q 006968          447 GDFGLAKLLDHRDS--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQ--RGVMLDW  521 (623)
Q Consensus       447 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~--~~~~~~~  521 (623)
                      +|||+++.......  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........  .....+.
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987654322  22334569999999999987 4589999999999999999999999964332100  0000011


Q ss_pred             HHHHhh-cC-----cccccc------------ccccCCCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006968          522 VKKLHQ-EG-----KLSQMV------------DKDLKGNFDR---------IELEEMVQVALLCTQFNPLHRPKMSEVLK  574 (623)
Q Consensus       522 ~~~~~~-~~-----~~~~~~------------~~~~~~~~~~---------~~~~~l~~l~~~cl~~~P~~RPs~~evl~  574 (623)
                      +..+.. -+     ....+.            ..........         ....++.+++.+||..||++|||+.|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111100 00     000000            0000000000         01356889999999999999999999998


Q ss_pred             Hhh
Q 006968          575 MLE  577 (623)
Q Consensus       575 ~L~  577 (623)
                      +-.
T Consensus       334 hp~  336 (405)
T 3rgf_A          334 DPY  336 (405)
T ss_dssp             SGG
T ss_pred             Chh
Confidence            654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.8e-38  Score=316.77  Aligned_cols=253  Identities=24%  Similarity=0.328  Sum_probs=203.8

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ..++|.+.+.||+|+||.||+|... +++.||||+++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            4467999999999999999999975 689999999975433 23456789999999999999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC---CcEEEeeccccc
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED---FEAVVGDFGLAK  453 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Dfgla~  453 (623)
                      +||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.+   +.+||+|||++.
T Consensus       100 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A          100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            9999999999988753    3589999999999999999999999   99999999999999754   479999999998


Q ss_pred             ccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      .......  .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.....       .+....... +....
T Consensus       173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~  241 (287)
T 2wei_A          173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVET-GKYAF  241 (287)
T ss_dssp             TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-CCCCC
T ss_pred             eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHc-CCCCC
Confidence            7654322  223458999999998865 489999999999999999999999964322       112222221 11110


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..  ...    ...+.++.+++.+||..||++|||+.|++++
T Consensus       242 ~~--~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          242 DL--PQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CS--GGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             Cc--hhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            00  000    1123678999999999999999999999984

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.1e-38  Score=324.83  Aligned_cols=259  Identities=19%  Similarity=0.276  Sum_probs=202.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEe--CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCc------eeeeeeeeecCCc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN------LLRLCGFCSTENE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~~  372 (623)
                      ++|.+.+.||+|+||.||+|..  .+++.||||+++...  .....+.+|+++++.++|++      ++++++++...+.
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            5788999999999999999986  368899999997532  23456888999998887654      9999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC------------
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE------------  440 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~------------  440 (623)
                      .++||||+ +++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||+++.            
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence            99999999 89999999764  234689999999999999999999999   9999999999999987            


Q ss_pred             -------CCcEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccc
Q 006968          441 -------DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN  513 (623)
Q Consensus       441 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~  513 (623)
                             ++.+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   668999999999864432    234568999999999999999999999999999999999999997543221


Q ss_pred             cccchHHHHHHHhh--------cCcccccc---------------------ccc-cCCCCCHHHHHHHHHHHHHccCCCC
Q 006968          514 QRGVMLDWVKKLHQ--------EGKLSQMV---------------------DKD-LKGNFDRIELEEMVQVALLCTQFNP  563 (623)
Q Consensus       514 ~~~~~~~~~~~~~~--------~~~~~~~~---------------------~~~-~~~~~~~~~~~~l~~l~~~cl~~~P  563 (623)
                      ..    ..+.....        ........                     .+. -..........++.+++.+||+.||
T Consensus       242 ~~----~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          242 HL----AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             HH----HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             HH----HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            11    11111000        00000000                     000 0001133456789999999999999


Q ss_pred             CCCCCHHHHHHH
Q 006968          564 LHRPKMSEVLKM  575 (623)
Q Consensus       564 ~~RPs~~evl~~  575 (623)
                      ++|||+.|++++
T Consensus       318 ~~Rpt~~ell~h  329 (339)
T 1z57_A          318 AKRITLREALKH  329 (339)
T ss_dssp             TTSCCHHHHTTS
T ss_pred             ccccCHHHHhcC
Confidence            999999999875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.7e-38  Score=327.07  Aligned_cols=258  Identities=21%  Similarity=0.274  Sum_probs=196.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCc------
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENE------  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~------  372 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||||+++...... ....+.+|+.+++.++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888899999999999999975 68999999997543222 23568899999999999999999999977654      


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++||||++ ++|.+++..      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence            499999997 687777642      489999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc---
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE---  528 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  528 (623)
                      +.....    .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........   .....+.....   
T Consensus       174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~  246 (353)
T 3coi_A          174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTE  246 (353)
T ss_dssp             TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHH
T ss_pred             cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence            865422    234468999999999877 6789999999999999999999999974332111   00111000000   


Q ss_pred             --------------CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          529 --------------GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       529 --------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                                    ..........+. ......+.++.+++.+||..||++|||+.|++++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  307 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  307 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence                          000000001111 11123357899999999999999999999998864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.2e-38  Score=331.82  Aligned_cols=265  Identities=19%  Similarity=0.255  Sum_probs=200.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcC-----------CCceeeeeeeee
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-----------HRNLLRLCGFCS  368 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~  368 (623)
                      .+|.+.+.||+|+||.||+|.. .+++.||||+++...  .....+.+|+.+++++.           ||||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            5788999999999999999996 468999999997432  23456888999998876           899999999987


Q ss_pred             cCC----ceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-----
Q 006968          369 TEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-----  439 (623)
Q Consensus       369 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-----  439 (623)
                      ..+    ..++||||+ +++|.+++....  ...+++..+..++.|++.||+|||+++  +|+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence            644    689999999 899999997643  345899999999999999999999953  899999999999994     


Q ss_pred             -CCCcEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch
Q 006968          440 -EDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM  518 (623)
Q Consensus       440 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~  518 (623)
                       ..+.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence             4458999999999876432    23346899999999999999999999999999999999999999743321111100


Q ss_pred             HHHHHHHhhcCcccc-----------ccc----------c---------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 006968          519 LDWVKKLHQEGKLSQ-----------MVD----------K---------DLKGNFDRIELEEMVQVALLCTQFNPLHRPK  568 (623)
Q Consensus       519 ~~~~~~~~~~~~~~~-----------~~~----------~---------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs  568 (623)
                      ..........+....           .+.          .         .-...++...+.++.+++.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            000000000010000           000          0         0011345677889999999999999999999


Q ss_pred             HHHHHHHh
Q 006968          569 MSEVLKML  576 (623)
Q Consensus       569 ~~evl~~L  576 (623)
                      +.|++++-
T Consensus       328 ~~ell~hp  335 (373)
T 1q8y_A          328 AGGLVNHP  335 (373)
T ss_dssp             HHHHHTCG
T ss_pred             HHHHhhCh
Confidence            99998853

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=324.74  Aligned_cols=262  Identities=23%  Similarity=0.304  Sum_probs=191.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeee-----------
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS-----------  368 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~-----------  368 (623)
                      ++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++.           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            57888999999999999999986 48999999986543 233457899999999999999999998873           


Q ss_pred             ---cCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCcE
Q 006968          369 ---TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEA  444 (623)
Q Consensus       369 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~  444 (623)
                         ..+..++||||++ |+|.+++..     ..+++..++.++.|++.||+|||+.   +|+||||||+||+++ +++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence               3467899999997 699988864     3689999999999999999999999   999999999999997 56799


Q ss_pred             EEeecccccccCCCCC--ceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHH
Q 006968          445 VVGDFGLAKLLDHRDS--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDW  521 (623)
Q Consensus       445 kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  521 (623)
                      ||+|||+++.......  .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.........   ...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~  237 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLI  237 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHH
Confidence            9999999987643221  12233457899999998865 67899999999999999999999999754321110   000


Q ss_pred             HHHHh---------hcCccccccccccCC-CC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          522 VKKLH---------QEGKLSQMVDKDLKG-NF-----DRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       522 ~~~~~---------~~~~~~~~~~~~~~~-~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .....         ............... ..     ....+.++.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            00000         000000000000000 00     01124678999999999999999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-38  Score=340.00  Aligned_cols=254  Identities=24%  Similarity=0.288  Sum_probs=188.6

Q ss_pred             CCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEecc
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      .|...+.||+|+||+||.+...+|+.||||++....    ...+.+|++++.++ +||||+++++++...+..++||||+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345568899999999987766689999999986532    34678999999876 8999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-------------CcE
Q 006968          381 PNGSVASRLRDHIHGRPA---LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-------------FEA  444 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-------------~~~  444 (623)
                      . |+|.+++.........   .++..+..++.|++.||+|||+.   +|+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 6999999764322111   23445678999999999999999   99999999999999654             489


Q ss_pred             EEeecccccccCCCCCc---eeecccccccccccccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCcccccc
Q 006968          445 VVGDFGLAKLLDHRDSH---VTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIT-GQRALDFGRAAN  513 (623)
Q Consensus       445 kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~  513 (623)
                      ||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999877643322   1234569999999999965       578999999999999999999 899986322110


Q ss_pred             cccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          514 QRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                           .....   .....     +..........+.++.+++.+||+.||++|||+.+++++-
T Consensus       248 -----~~i~~---~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp  297 (434)
T 2rio_A          248 -----SNIIR---GIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP  297 (434)
T ss_dssp             -----HHHHH---TCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             -----HHHhc---CCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence                 11111   00010     1111112455678899999999999999999999998753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-37  Score=328.61  Aligned_cols=200  Identities=25%  Similarity=0.299  Sum_probs=169.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CC-----ceeeeeeeeecCCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HR-----NLLRLCGFCSTENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~-----niv~l~~~~~~~~~  372 (623)
                      .++|.+.+.||+|+||.||+|... +++.||||+++...  ....++..|+.+++.++ |+     +|+++++++...+.
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            468999999999999999999875 68899999997432  22346778888888775 55     49999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC--CCCcEEEeecc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDFEAVVGDFG  450 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~Dfg  450 (623)
                      .++||||++ |+|.+++....  ...+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             eEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            999999995 59999997642  24589999999999999999999952 22899999999999995  57889999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG  509 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~  509 (623)
                      +++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             Cceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99876432    23456899999999999999999999999999999999999999754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=326.22  Aligned_cols=246  Identities=25%  Similarity=0.370  Sum_probs=194.0

Q ss_pred             HHhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-----chHHHHHHHHHHhhc----CCCceeeeeeee
Q 006968          298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLA----VHRNLLRLCGFC  367 (623)
Q Consensus       298 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l----~H~niv~l~~~~  367 (623)
                      ...++|.+.+.||+|+||.||+|... +++.||||+++......     ....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            34578999999999999999999864 68999999997543221     233467899999888    899999999999


Q ss_pred             ecCCceEEEEec-ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCcEE
Q 006968          368 STENERLLVYPY-MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAV  445 (623)
Q Consensus       368 ~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~k  445 (623)
                      ...+..++|+|| +.+++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++ .++.+|
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            999999999999 7899999999863    3589999999999999999999999   999999999999999 889999


Q ss_pred             EeecccccccCCCCCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH
Q 006968          446 VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       446 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      |+|||++.......   .....||..|+|||++.+..+ +.++||||||+++|||++|+.||.....             
T Consensus       181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------  244 (312)
T 2iwi_A          181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------------  244 (312)
T ss_dssp             ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------
T ss_pred             EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------------
Confidence            99999998765432   234558999999999877666 4589999999999999999999863211             


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      ... ...          .++.....++.+++.+||+.||++|||+.|++++-.
T Consensus       245 ~~~-~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          245 ILE-AEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             HHH-TCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             Hhh-hcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            000 000          111223467899999999999999999999998643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.1e-39  Score=329.34  Aligned_cols=244  Identities=23%  Similarity=0.369  Sum_probs=201.1

Q ss_pred             HhcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-----chHHHHHHHHHHhhcC--CCceeeeeeeeecC
Q 006968          299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAV--HRNLLRLCGFCSTE  370 (623)
Q Consensus       299 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~  370 (623)
                      ..++|.+.+.||+|+||.||+|... +++.||||+++......     ....+.+|+.++++++  ||||+++++++..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            3467999999999999999999864 68999999997654322     2245788999999996  59999999999999


Q ss_pred             CceEEEEecccC-CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCcEEEee
Q 006968          371 NERLLVYPYMPN-GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGD  448 (623)
Q Consensus       371 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~D  448 (623)
                      +..++|+||+.+ ++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++ +++.+||+|
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             CcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence            999999999976 8999998763    4689999999999999999999999   999999999999999 789999999


Q ss_pred             cccccccCCCCCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh
Q 006968          449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      ||+++.....   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....             ...
T Consensus       194 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~  257 (320)
T 3a99_A          194 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIR  257 (320)
T ss_dssp             CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHH
T ss_pred             Cccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhc
Confidence            9999876532   2234569999999999977665 6889999999999999999999963211             000


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                       +..      .....    .+.++.+++.+||..||++|||+.|++++-
T Consensus       258 -~~~------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~hp  295 (320)
T 3a99_A          258 -GQV------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP  295 (320)
T ss_dssp             -CCC------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             -ccc------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence             100      01111    236789999999999999999999998854

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=319.92  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=180.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHH-HHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|...+.||+|+||.||+|... +|+.||||+++.........+ +.++..+++.++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            56888899999999999999985 689999999976543333333 4444556788899999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      |+ ++.+..+....   ...+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.+||+|||++.....
T Consensus       105 ~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          105 LM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             cc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            99 44554444332   3468999999999999999999998 5   899999999999999999999999999976543


Q ss_pred             CCCceeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ..  ......||+.|+|||.+.     ...++.++||||||+++|||++|+.||.....      ..+.......... .
T Consensus       178 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~-~  248 (318)
T 2dyl_A          178 DK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------DFEVLTKVLQEEP-P  248 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHHSCC-C
T ss_pred             Cc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cHHHHHHHhccCC-C
Confidence            22  223345899999999984     45688999999999999999999999964221      1112222222111 0


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .     +..  ....+.++.+++.+||..||.+|||+.+++++
T Consensus       249 ~-----~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          249 L-----LPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             C-----CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             C-----CCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0     000  01123678999999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6e-38  Score=325.04  Aligned_cols=254  Identities=20%  Similarity=0.248  Sum_probs=174.0

Q ss_pred             hcCCCcC-CceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec----CCce
Q 006968          300 TSNFSAK-NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST----ENER  373 (623)
Q Consensus       300 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~  373 (623)
                      .++|.+. ++||+|+||.||+|... +|+.||||++....     ....+....+..+.||||+++++++..    ....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            4678874 46999999999999976 68999999986432     122223334567789999999999865    4458


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEeecc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFG  450 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg  450 (623)
                      ++||||+++|+|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            99999999999999998642  34699999999999999999999999   9999999999999986   4559999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      +++.....   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............   ... ..+.
T Consensus       177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~-~~~~  249 (336)
T 3fhr_A          177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRI-RLGQ  249 (336)
T ss_dssp             TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhh-hccc
Confidence            99865432   2234458999999999988889999999999999999999999996432211100000   000 0000


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                            ...........+.++.+++.+||+.||++|||+.|++++-
T Consensus       250 ------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          250 ------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             ------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                  0001001112346789999999999999999999999853

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.9e-37  Score=321.96  Aligned_cols=259  Identities=19%  Similarity=0.262  Sum_probs=199.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CC-cEEEEEEecccccccchHHHHHHHHHHhhcCCCc------eeeeeeeeecCCc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DG-ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN------LLRLCGFCSTENE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n------iv~l~~~~~~~~~  372 (623)
                      ++|.+.+.||+|+||.||+|... ++ ..||||+++...  .....+.+|+.+++.++|++      ++.+++++...+.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            67899999999999999999874 34 789999997432  23456888999999887766      8999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE--------------
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--------------  438 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll--------------  438 (623)
                      .++||||+ ++++.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||+              
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence            99999999 67777777653  234699999999999999999999999   99999999999999              


Q ss_pred             -----CCCCcEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccc
Q 006968          439 -----DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN  513 (623)
Q Consensus       439 -----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~  513 (623)
                           +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                 56789999999999864432    234569999999999999999999999999999999999999997433211


Q ss_pred             cccchHHHHHHHhhc--------C-ccccccccc---------------------cCCCCCHHHHHHHHHHHHHccCCCC
Q 006968          514 QRGVMLDWVKKLHQE--------G-KLSQMVDKD---------------------LKGNFDRIELEEMVQVALLCTQFNP  563 (623)
Q Consensus       514 ~~~~~~~~~~~~~~~--------~-~~~~~~~~~---------------------~~~~~~~~~~~~l~~l~~~cl~~~P  563 (623)
                      .    ...+......        . .........                     ...........++.+++.+||+.||
T Consensus       247 ~----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          247 H----LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             H----HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             H----HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            1    1111111000        0 000000000                     0001123345689999999999999


Q ss_pred             CCCCCHHHHHHH
Q 006968          564 LHRPKMSEVLKM  575 (623)
Q Consensus       564 ~~RPs~~evl~~  575 (623)
                      ++|||+.|++++
T Consensus       323 ~~Rpt~~e~l~h  334 (355)
T 2eu9_A          323 AQRITLAEALLH  334 (355)
T ss_dssp             TTSCCHHHHTTS
T ss_pred             hhCcCHHHHhcC
Confidence            999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-38  Score=350.90  Aligned_cols=261  Identities=23%  Similarity=0.323  Sum_probs=200.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec------CCc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST------ENE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~  372 (623)
                      ..+|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            367999999999999999999874 6899999999765444455679999999999999999999998765      667


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCc---EEEeec
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE---AVVGDF  449 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~Df  449 (623)
                      .++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            899999999999999998643 234689999999999999999999999   9999999999999997665   999999


Q ss_pred             ccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      |++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......      ..|........
T Consensus       169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~------~~~~~~i~~~~  240 (676)
T 3qa8_A          169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP------VQWHGKVREKS  240 (676)
T ss_dssp             CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH------HHSSTTCC---
T ss_pred             cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch------hhhhhhhhccc
Confidence            9998765433  233456999999999999999999999999999999999999999643211      11111000000


Q ss_pred             cc----cccccc--------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 006968          530 KL----SQMVDK--------DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEV  572 (623)
Q Consensus       530 ~~----~~~~~~--------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev  572 (623)
                      ..    ......        .....+....+..+.+++.+||..||++|||+.|+
T Consensus       241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            00    000000        11122345567889999999999999999999774

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=333.81  Aligned_cols=250  Identities=25%  Similarity=0.304  Sum_probs=187.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      .+|...+.||+|+||+||.....+|+.||||++.....    ..+.+|+++++.+ +||||+++++++...+..++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            46888899999999996655556899999999965332    2457899999998 799999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-----CCcEEEeecccccc
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-----DFEAVVGDFGLAKL  454 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~Dfgla~~  454 (623)
                      +. |+|.+++....   ....+..+..++.|++.||+|||+.   +|+||||||+|||++.     ...+||+|||+++.
T Consensus       100 ~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A          100 CA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            96 69999987642   2344455678999999999999999   9999999999999953     34688999999987


Q ss_pred             cCCCCC--ceeeccccccccccccccc---cCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhc
Q 006968          455 LDHRDS--HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       455 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      ......  .......||+.|+|||++.   ...++.++|||||||++|||++ |+.||.....        .........
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--------~~~~~~~~~  244 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--------RQANILLGA  244 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--------HHHHHHTTC
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--------HHHHHHhcc
Confidence            654322  2234456999999999997   4567889999999999999999 8888853211        001111111


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 006968          529 GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKML  576 (623)
Q Consensus       529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  576 (623)
                      ... ..    .  .........+.+++.+||+.||++|||+.|++++-
T Consensus       245 ~~~-~~----~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp  285 (432)
T 3p23_A          245 CSL-DC----L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP  285 (432)
T ss_dssp             CCC-TT----S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred             CCc-cc----c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence            110 00    0  01223456688999999999999999999999653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.6e-36  Score=306.90  Aligned_cols=228  Identities=13%  Similarity=0.045  Sum_probs=181.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+|.+.+.||+|+||.||+|... +|+.||||+++......  ....|.+|+..+.+++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56888999999999999999985 48999999997654322  2357899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++++|.+++...      .....+.+++.|++.||+|||++   +|+||||||+|||++.++.+||+++|       
T Consensus       111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999998542      35567889999999999999999   99999999999999999999998443       


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                                    |++       .++.++||||||+++|||+||+.||...........             .......
T Consensus       175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------------~~~~~~~  220 (286)
T 3uqc_A          175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------------AERDTAG  220 (286)
T ss_dssp             --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-------------CCBCTTS
T ss_pred             --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-------------HHHHhcc
Confidence                          333       367899999999999999999999975332111000             0000000


Q ss_pred             ccC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          538 DLK--GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       538 ~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ...  .......+.++.+++.+||+.||++| |+.|+++.|+..
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            000  00011234678999999999999999 999999999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.7e-37  Score=347.20  Aligned_cols=238  Identities=21%  Similarity=0.285  Sum_probs=191.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC--CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCc-----e
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE-----R  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~-----~  373 (623)
                      ++|.+.+.||+|+||.||+|.+.  +|+.||||++...........+.+|+.++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67899999999999999999975  5899999998754433445578999999999999999999999987655     6


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++++|.+++..      .+++..++.++.|++.||.|||++   +|+||||||+|||++.+ .+||+|||+++
T Consensus       160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence            999999999999877643      589999999999999999999999   99999999999999986 99999999998


Q ss_pred             ccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      .....     ....||+.|+|||++.+.. +.++|||||||++|+|++|..|+......                 ... 
T Consensus       230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------~~~-  285 (681)
T 2pzi_A          230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------GLP-  285 (681)
T ss_dssp             ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------SCC-
T ss_pred             hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------------ccc-
Confidence            76543     3346999999999987654 88999999999999999998887531110                 000 


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK-MSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~L~~  578 (623)
                            ...........+.+++.+||+.||++||+ +.++.+.|..
T Consensus       286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                  00001122367889999999999999995 5555555543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.2e-37  Score=326.34  Aligned_cols=244  Identities=14%  Similarity=0.078  Sum_probs=182.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEeccccccc--chHHHHHHHHHHhhcCC-Cceeeeee-----------
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVH-RNLLRLCG-----------  365 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H-~niv~l~~-----------  365 (623)
                      .+|...+.||+|+||.||+|.+ .+|+.||||+++......  ....|.+|+.+++.++| +|......           
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4566778999999999999995 469999999987433222  24578999999999987 32211111           


Q ss_pred             ----------eeec-----CCceEEEEecccCCChhhhhhhc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 006968          366 ----------FCST-----ENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTARGLLYLHEQCDPKII  427 (623)
Q Consensus       366 ----------~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv  427 (623)
                                ++..     ....+++|+++ +++|.+++...   ......+++..+..++.|+++||+|||++   +|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                      1111     12356777765 68999888532   22344688999999999999999999999   999


Q ss_pred             ecCCCCCCeEECCCCcEEEeecccccccCCCCCceeecccccccccccccc----------ccCCCCCccchhhHHHHHH
Q 006968          428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL----------STGQSSEKTDVFGFGILLL  497 (623)
Q Consensus       428 H~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~SlGvil~  497 (623)
                      ||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||++|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            9999999999999999999999999864422    344567 999999999          5566889999999999999


Q ss_pred             HHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          498 ELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       498 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ||++|+.||........                ...++...  ..+    +.++.+++.+||..||++|||+.+++++
T Consensus       309 elltg~~Pf~~~~~~~~----------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGG----------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHSSCCCCTTGGGSC----------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHCCCCCCCcchhhh----------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            99999999964322111                11111100  112    3679999999999999999999888653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-35  Score=302.45  Aligned_cols=227  Identities=21%  Similarity=0.283  Sum_probs=178.9

Q ss_pred             cCCCcC-CceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHH-hhcCCCceeeeeeeeec----CCce
Q 006968          301 SNFSAK-NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLRLCGFCST----ENER  373 (623)
Q Consensus       301 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~H~niv~l~~~~~~----~~~~  373 (623)
                      .+|.+. +.||+|+||.||+|... +++.||||+++.      ...+.+|++++ +..+||||+++++++..    ....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            456666 78999999999999874 689999999864      23577888888 56689999999999876    6678


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEeecc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFG  450 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg  450 (623)
                      ++||||+++|+|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            99999999999999998742  34699999999999999999999999   9999999999999998   7889999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      ++....                       +..++.++||||||+++|||++|+.||.........            ...
T Consensus       166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~  210 (299)
T 3m2w_A          166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGM  210 (299)
T ss_dssp             TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCS
T ss_pred             cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHH
Confidence            986532                       234677999999999999999999999643221100            000


Q ss_pred             cccccccccCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKDLKGNFD----RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ........  ...+    ...+.++.+++.+||+.||++|||+.|++++
T Consensus       211 ~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          211 KTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00000000  0111    1134679999999999999999999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1e-36  Score=315.91  Aligned_cols=241  Identities=14%  Similarity=0.146  Sum_probs=184.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEeccccc-------ccchHHHHHHHHHHhhcC---------CCceeee
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-------AGGEVQFQTEVETISLAV---------HRNLLRL  363 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~---------H~niv~l  363 (623)
                      .++|.+.+.||+|+||.||+|.. +|+.||||+++....       ......+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688899999999999999998 789999999976532       222357889999988886         5555555


Q ss_pred             e-----------------eeeec-------------CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHH
Q 006968          364 C-----------------GFCST-------------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR  413 (623)
Q Consensus       364 ~-----------------~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~  413 (623)
                      .                 +++..             .+..++||||+++|++.+.+..     ..+++..++.++.|++.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            4                 44443             6789999999999987766643     35899999999999999


Q ss_pred             HHHHHH-hCCCCCeEecCCCCCCeEECCCC--------------------cEEEeecccccccCCCCCceeecccccccc
Q 006968          414 GLLYLH-EQCDPKIIHRDVKAANILLDEDF--------------------EAVVGDFGLAKLLDHRDSHVTTAVRGTVGH  472 (623)
Q Consensus       414 ~L~~LH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y  472 (623)
                      ||+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....      ...||+.|
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y  243 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence            999999 88   999999999999999887                    8999999999876532      23699999


Q ss_pred             ccccccccCCCCCccchhhHHHH-HHHHHhCCCCCCcccccccccchHHHHHHH----hhcCccccccccccCCCCCHHH
Q 006968          473 IAPEYLSTGQSSEKTDVFGFGIL-LLELITGQRALDFGRAANQRGVMLDWVKKL----HQEGKLSQMVDKDLKGNFDRIE  547 (623)
Q Consensus       473 ~aPE~~~~~~~~~~~Dv~SlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  547 (623)
                      +|||++.+.. +.++||||++++ .+++++|..||..          ..|....    .......    ...........
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~----------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  308 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN----------VLWLHYLTDKMLKQMTFK----TKCNTPAMKQI  308 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH----------HHHHHHHHHHHHHTCCCS----SCCCSHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc----------hhhhhHHHHhhhhhhccC----cccchhhhhhc
Confidence            9999998766 899999998776 7888889998741          1121111    1110100    01111123456


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHH-HH
Q 006968          548 LEEMVQVALLCTQFNPLHRPKMSEVL-KM  575 (623)
Q Consensus       548 ~~~l~~l~~~cl~~~P~~RPs~~evl-~~  575 (623)
                      +.++.+++.+||+.|     |+.|++ ++
T Consensus       309 s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          309 KRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             CHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            788999999999866     999998 64

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=2.5e-29  Score=277.08  Aligned_cols=186  Identities=15%  Similarity=0.056  Sum_probs=130.0

Q ss_pred             eeccCCeEEEEEE-eCCCcEEEEEEeccccc---------ccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEEE
Q 006968          309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNI---------AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       309 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      .+.|++|.+..+. .-.|+.+|||++.+...         ....++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4555555555433 22488899999975421         12234699999999999 6999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||++|++|.++|...    .+++..   +|+.||+.||+|+|++   |||||||||+|||+++++.+||+|||+|+....
T Consensus       322 Eyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999763    356654   5889999999999999   999999999999999999999999999987654


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL  506 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~  506 (623)
                      ... .....+||++|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus       392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            322 2344679999999999865 5677899999999988876665443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.93  E-value=2.4e-26  Score=235.31  Aligned_cols=172  Identities=28%  Similarity=0.515  Sum_probs=158.1

Q ss_pred             CCCchHHHHHHHHHHhCCCCCcccCCCCCCCCCCCC--cceeeeCCC---CcEEEEeCCCCCccc--ccCccccCCCCcc
Q 006968           29 AGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCS--WRMITCSPD---GYVSALGLPSQSLSG--TLSPWIGNLTKLQ  101 (623)
Q Consensus        29 ~~~~~~~~~l~~~k~~~~~p~~~~~~w~~~~~~~c~--w~gv~c~~~---~~v~~L~L~~n~l~~--~~~~~~~~l~~L~  101 (623)
                      .|...|+.||++||+++.||. .+.+|+. +.+||.  |.||+|+..   ++|+.|+|++|+++|  .+|..|.++++|+
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~   79 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence            477889999999999999887 7899974 578998  999999864   799999999999999  9999999999999


Q ss_pred             eEEeec-CCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCC
Q 006968          102 SVLLQN-NAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN  180 (623)
Q Consensus       102 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  180 (623)
                      +|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|.+++.+|..+..+++|+.|+|++|
T Consensus        80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  159 (313)
T 1ogq_A           80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence            999994 9999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCcCCCCcc------ccccccCCCCC
Q 006968          181 NLSGSLPKISA------RTFKVTGNPLI  202 (623)
Q Consensus       181 ~l~~~~p~~~~------~~~~~~~n~~~  202 (623)
                      +++|.+|..+.      +.+++++|.+.
T Consensus       160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~  187 (313)
T 1ogq_A          160 RISGAIPDSYGSFSKLFTSMTISRNRLT  187 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred             cccCcCCHHHhhhhhcCcEEECcCCeee
Confidence            99998887543      45677787763

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=8.6e-27  Score=255.40  Aligned_cols=185  Identities=16%  Similarity=0.201  Sum_probs=146.7

Q ss_pred             CcCCceeccCCeEEEEEEeCCCcEEEEEEeccccccc-------chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-------GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       304 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ...+.||+|+||.||+|.. .+..+|+|+........       ..+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999955 67889999875432211       123589999999999999999777777778888999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++++|.+++..            +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999875            468999999999999999   9999999999999999  99999999999875


Q ss_pred             CCCCce------eecccccccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCC
Q 006968          457 HRDSHV------TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRAL  506 (623)
Q Consensus       457 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~  506 (623)
                      ......      .....||+.|+|||++..  ..|+..+|+|+..+-..+-+.++.++
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            432211      235679999999999976  56788899999999988888877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.2e-23  Score=211.41  Aligned_cols=154  Identities=12%  Similarity=0.047  Sum_probs=122.9

Q ss_pred             HHHHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc-----------------cchHHHHHHHHHHhhc
Q 006968          293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-----------------GGEVQFQTEVETISLA  355 (623)
Q Consensus       293 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l  355 (623)
                      +..+......|.+.+.||+|+||.||+|...+|+.||||.++.....                 .....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            34455555667788999999999999999977999999999643211                 1234689999999999


Q ss_pred             CCCceeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 006968          356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN  435 (623)
Q Consensus       356 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N  435 (623)
                      +  | +++.+++.. +..++||||+++|+|.+ +..          .....++.|++.||+|||+.   +|+||||||+|
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N  223 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN  223 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence            8  5 666665543 56799999999999888 421          12357999999999999999   99999999999


Q ss_pred             eEECCCCcEEEeecccccccCCCCCceeeccccccccccccccc
Q 006968          436 ILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS  479 (623)
Q Consensus       436 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~  479 (623)
                      ||++ ++.+||+|||+++.              +..|.|||++.
T Consensus       224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            9999 99999999999973              34578898874

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.88  E-value=2.5e-23  Score=238.75  Aligned_cols=154  Identities=28%  Similarity=0.418  Sum_probs=100.9

Q ss_pred             CCCCchHHHHHHHHHHhCCCCCcccCCCCCCCCCCCCcceeeeCCCCcEEEEeCCCCCcccc---cCcc-----------
Q 006968           28 PAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGT---LSPW-----------   93 (623)
Q Consensus        28 ~~~~~~~~~~l~~~k~~~~~p~~~~~~w~~~~~~~c~w~gv~c~~~~~v~~L~L~~n~l~~~---~~~~-----------   93 (623)
                      ..+.+.|+.||++||+++.||. .+++|+ .+.+||+|.||+|+ .++|+.|+|++++++|.   +|+.           
T Consensus         7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~-~~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~   83 (768)
T 3rgz_A            7 SQSLYREIHQLISFKDVLPDKN-LLPDWS-SNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLF   83 (768)
T ss_dssp             -CCHHHHHHHHHHHHTTCSCTT-SSTTCC-TTSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEE
T ss_pred             ccCCHHHHHHHHHHHhhCCCcc-cccCCC-CCCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccC
Confidence            3446779999999999999998 999997 56799999999998 78999999999999987   6654           


Q ss_pred             ------------ccCCCCcceEEeecCCCCCCCCC--ccCCCCCccEEEecCCCCCCCCCccc-cCCCCccchhcccccc
Q 006968           94 ------------IGNLTKLQSVLLQNNAILGPIPA--SLGKLEKLQTLDLSNNKFTGEIPDSL-GDLGNLNYLRLNNNSL  158 (623)
Q Consensus        94 ------------~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l  158 (623)
                                  |+++++|++|+|++|.++|.+|.  .++++++|++|||++|.+++.+|..+ .++++|++|+|++|++
T Consensus        84 ~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l  163 (768)
T 3rgz_A           84 LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI  163 (768)
T ss_dssp             CTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCC
T ss_pred             CcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCcc
Confidence                        44555555555555555555554  55555555555555555555555443 4455555555555555


Q ss_pred             CCCCCcc---cCCCCcccEEECCCCcCcC
Q 006968          159 TGSCPES---LSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       159 ~~~~p~~---~~~l~~L~~L~l~~N~l~~  184 (623)
                      ++..|..   +.++++|+.|++++|.+++
T Consensus       164 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~  192 (768)
T 3rgz_A          164 SGANVVGWVLSDGCGELKHLAISGNKISG  192 (768)
T ss_dssp             EEETHHHHHHTTCCTTCCEEECCSSEEES
T ss_pred             CCcCChhhhhhccCCCCCEEECCCCcccc
Confidence            4444433   3444444444444444443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.88  E-value=3.3e-23  Score=237.40  Aligned_cols=174  Identities=24%  Similarity=0.306  Sum_probs=152.3

Q ss_pred             CCCCchHHHHHHHHHHhCCCCCcccCCCCCCC----CCC--CCc------------ceeeeCCCCcEEEEeCCCCCcccc
Q 006968           28 PAGINYEVVALVAVKNNLHDPYNVLENWDITS----VDP--CSW------------RMITCSPDGYVSALGLPSQSLSGT   89 (623)
Q Consensus        28 ~~~~~~~~~~l~~~k~~~~~p~~~~~~w~~~~----~~~--c~w------------~gv~c~~~~~v~~L~L~~n~l~~~   89 (623)
                      .+....|+.||++||+++.+|     +|+.++    .+|  |+|            .||+|+..++|+.|+|++|+|+|.
T Consensus       264 ~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~  338 (876)
T 4ecn_A          264 TAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR  338 (876)
T ss_dssp             CCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEE
T ss_pred             cccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCc
Confidence            344556899999999999887     797654    466  999            999999888999999999999999


Q ss_pred             cCccccCCCCcceEEe-ecCCCCCC-------------------------------------------------------
Q 006968           90 LSPWIGNLTKLQSVLL-QNNAILGP-------------------------------------------------------  113 (623)
Q Consensus        90 ~~~~~~~l~~L~~L~L-~~N~l~~~-------------------------------------------------------  113 (623)
                      +|+.|++|++|++|+| ++|.++|.                                                       
T Consensus       339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~  418 (876)
T 4ecn_A          339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK  418 (876)
T ss_dssp             ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred             CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence            9999999999999999 77765544                                                       


Q ss_pred             ---------------------CCCccCCCCCccEEEecCCCCCC-----------------CCCcccc--CCCCccchhc
Q 006968          114 ---------------------IPASLGKLEKLQTLDLSNNKFTG-----------------EIPDSLG--DLGNLNYLRL  153 (623)
Q Consensus       114 ---------------------~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~L~l  153 (623)
                                           +|..|+++++|++|+|++|+|+|                 .+|..++  ++++|++|+|
T Consensus       419 ~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L  498 (876)
T 4ecn_A          419 KDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL  498 (876)
T ss_dssp             CCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred             cccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence                                 88899999999999999999998                 3999988  9999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCc-CcC-cCCCCc------------cccccccCCCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNN-LSG-SLPKIS------------ARTFKVTGNPLICGPK  206 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~~------------~~~~~~~~n~~~~~~~  206 (623)
                      ++|++.+.+|..|.++++|+.|+|++|+ |+| .+|..+            .+.+++++|.+...|.
T Consensus       499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~  565 (876)
T 4ecn_A          499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA  565 (876)
T ss_dssp             ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCC
T ss_pred             cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCC
Confidence            9999999999999999999999999998 998 777532            2567888888764443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.87  E-value=1.7e-22  Score=226.70  Aligned_cols=174  Identities=22%  Similarity=0.329  Sum_probs=151.7

Q ss_pred             CCchHHHHHHHHHHhCCCCC--------cccCCCCCCCCCCCCc---ceeeeCCCCcEEEEeCCCCCcccccCccccCCC
Q 006968           30 GINYEVVALVAVKNNLHDPY--------NVLENWDITSVDPCSW---RMITCSPDGYVSALGLPSQSLSGTLSPWIGNLT   98 (623)
Q Consensus        30 ~~~~~~~~l~~~k~~~~~p~--------~~~~~w~~~~~~~c~w---~gv~c~~~~~v~~L~L~~n~l~~~~~~~~~~l~   98 (623)
                      ....|+.||.+++.++.++.        ....+|+. +.+||.|   .||+|+..++|+.|+|++|+|+|.+|+.|++|+
T Consensus        27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~  105 (636)
T 4eco_A           27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLT  105 (636)
T ss_dssp             HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCT
T ss_pred             hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCc
Confidence            33458899999999986542        23458985 5899999   999999889999999999999999999999999


Q ss_pred             CcceEEeecCC---------------------------------------------------------------------
Q 006968           99 KLQSVLLQNNA---------------------------------------------------------------------  109 (623)
Q Consensus        99 ~L~~L~L~~N~---------------------------------------------------------------------  109 (623)
                      +|++|+|++|.                                                                     
T Consensus       106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~  185 (636)
T 4eco_A          106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD  185 (636)
T ss_dssp             TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred             cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence            99999999884                                                                     


Q ss_pred             ---------CCCCCCCccCCCCCccEEEecCCCCCCC-----------------CCcccc--CCCCccchhccccccCCC
Q 006968          110 ---------ILGPIPASLGKLEKLQTLDLSNNKFTGE-----------------IPDSLG--DLGNLNYLRLNNNSLTGS  161 (623)
Q Consensus       110 ---------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~  161 (623)
                               ++| +|..|+++++|++|+|++|+|+|.                 +|..++  ++++|++|+|++|++.|.
T Consensus       186 l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~  264 (636)
T 4eco_A          186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK  264 (636)
T ss_dssp             TTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSS
T ss_pred             hhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCcc
Confidence                     445 889999999999999999999986                 999999  999999999999999999


Q ss_pred             CCcccCCCCcccEEECCCCc-CcC-cCCCCc-----------cccccccCCCCCCCC
Q 006968          162 CPESLSKIESLTLVDLSYNN-LSG-SLPKIS-----------ARTFKVTGNPLICGP  205 (623)
Q Consensus       162 ~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~~-----------~~~~~~~~n~~~~~~  205 (623)
                      +|..|.++++|+.|+|++|+ ++| .+|...           .+.+++++|.+...+
T Consensus       265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip  321 (636)
T 4eco_A          265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP  321 (636)
T ss_dssp             CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCC
T ss_pred             ChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccC
Confidence            99999999999999999998 998 777632           256788999886444

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.84  E-value=1.1e-20  Score=184.10  Aligned_cols=148  Identities=22%  Similarity=0.260  Sum_probs=131.9

Q ss_pred             CCCCCCCcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEE
Q 006968           58 TSVDPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTL  127 (623)
Q Consensus        58 ~~~~~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  127 (623)
                      .+.+.|+|.+|.|+..          ..++.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|
T Consensus        14 ~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L   93 (229)
T 3e6j_A           14 PSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL   93 (229)
T ss_dssp             CTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEE
Confidence            3568899999999852          379999999999999889999999999999999999986666778999999999


Q ss_pred             EecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCC
Q 006968          128 DLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI  202 (623)
Q Consensus       128 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~  202 (623)
                      +|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+.     +.+.+.+|++.
T Consensus        94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A           94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred             ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence            99999999766677899999999999999999 8899999999999999999999977665443     56889999999


Q ss_pred             CCCC
Q 006968          203 CGPK  206 (623)
Q Consensus       203 ~~~~  206 (623)
                      |.+.
T Consensus       173 c~c~  176 (229)
T 3e6j_A          173 CECR  176 (229)
T ss_dssp             TTBG
T ss_pred             CCcc
Confidence            8764

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.83  E-value=1.7e-21  Score=200.48  Aligned_cols=178  Identities=19%  Similarity=0.253  Sum_probs=152.9

Q ss_pred             hccCCCCCchHHHHHHHHHHhC-CCCCcccCCCC---CCCCCCCCcceeeeCC---------CCcEEEEeCCCCCccccc
Q 006968           24 ATLSPAGINYEVVALVAVKNNL-HDPYNVLENWD---ITSVDPCSWRMITCSP---------DGYVSALGLPSQSLSGTL   90 (623)
Q Consensus        24 ~~~~~~~~~~~~~~l~~~k~~~-~~p~~~~~~w~---~~~~~~c~w~gv~c~~---------~~~v~~L~L~~n~l~~~~   90 (623)
                      ......+...++.||++||..+ .||.+.+.+|.   ..+.++|.|.|++|..         ..+|+.|+|++|+|+ .+
T Consensus        18 ~~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~l   96 (328)
T 4fcg_A           18 YFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QF   96 (328)
T ss_dssp             CCC--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SC
T ss_pred             eeeccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hc
Confidence            3345667788999999999998 57877788894   3467899999999952         368999999999999 88


Q ss_pred             CccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCC--
Q 006968           91 SPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSK--  168 (623)
Q Consensus        91 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--  168 (623)
                      |+.++++++|++|+|++|+++ .+|..++++++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+..  
T Consensus        97 p~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~  174 (328)
T 4fcg_A           97 PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD  174 (328)
T ss_dssp             CSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC
T ss_pred             ChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhcc
Confidence            999999999999999999999 89999999999999999999999 89999999999999999999998899988765  


Q ss_pred             -------CCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCC
Q 006968          169 -------IESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       169 -------l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~  205 (623)
                             +++|+.|+|++|+|+ .+|..+.     +.+++++|.+...+
T Consensus       175 ~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~  222 (328)
T 4fcg_A          175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALG  222 (328)
T ss_dssp             -CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCC
T ss_pred             chhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCc
Confidence                   999999999999999 6776443     56788888876433

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.81  E-value=5.7e-20  Score=177.74  Aligned_cols=146  Identities=23%  Similarity=0.314  Sum_probs=130.1

Q ss_pred             CCCCcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEec
Q 006968           61 DPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLS  130 (623)
Q Consensus        61 ~~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  130 (623)
                      ..|.|..|.|+..          ..++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus         9 C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls   88 (220)
T 2v9t_B            9 CTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLY   88 (220)
T ss_dssp             SEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECC
T ss_pred             CEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECC
Confidence            3478999999742          369999999999998777899999999999999999998889999999999999999


Q ss_pred             CCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCC
Q 006968          131 NNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       131 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~  205 (623)
                      +|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+.     +.+++++|++.|.+
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  168 (220)
T 2v9t_B           89 GNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC  168 (220)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence            9999955455578999999999999999988899999999999999999999988776544     56889999999976


Q ss_pred             C
Q 006968          206 K  206 (623)
Q Consensus       206 ~  206 (623)
                      .
T Consensus       169 ~  169 (220)
T 2v9t_B          169 H  169 (220)
T ss_dssp             G
T ss_pred             c
Confidence            4

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.80  E-value=1.4e-19  Score=175.00  Aligned_cols=146  Identities=20%  Similarity=0.285  Sum_probs=130.3

Q ss_pred             CCCCcceeeeCCC----------CcEEEEeCCCCCcccccC-ccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEe
Q 006968           61 DPCSWRMITCSPD----------GYVSALGLPSQSLSGTLS-PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL  129 (623)
Q Consensus        61 ~~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  129 (623)
                      .-|.|..+.|+..          ..++.|+|++|+|++..+ ..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus         9 C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L   88 (220)
T 2v70_A            9 CRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILL   88 (220)
T ss_dssp             CEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEEC
Confidence            3478889999742          258899999999998755 45899999999999999999888889999999999999


Q ss_pred             cCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCC
Q 006968          130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~  204 (623)
                      ++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+.     +.+++++|++.|.
T Consensus        89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A           89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred             CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence            99999977777899999999999999999988899999999999999999999998887654     5688999999997


Q ss_pred             CC
Q 006968          205 PK  206 (623)
Q Consensus       205 ~~  206 (623)
                      +.
T Consensus       169 c~  170 (220)
T 2v70_A          169 CY  170 (220)
T ss_dssp             GG
T ss_pred             Cc
Confidence            65

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.79  E-value=4.3e-19  Score=169.96  Aligned_cols=146  Identities=23%  Similarity=0.269  Sum_probs=127.4

Q ss_pred             CCCCcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEec
Q 006968           61 DPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLS  130 (623)
Q Consensus        61 ~~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  130 (623)
                      ..|.|.+|.|+..          .+++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus         5 C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls   84 (208)
T 2o6s_A            5 CSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS   84 (208)
T ss_dssp             CEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECC
Confidence            4478999999753          369999999999997777788999999999999999997767778999999999999


Q ss_pred             CCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCC
Q 006968          131 NNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       131 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~  205 (623)
                      +|+|++..+..+..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..+.     +.+++++|++.|.+
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  164 (208)
T 2o6s_A           85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC  164 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred             CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence            9999966666789999999999999999977777789999999999999999987765443     56889999998876


Q ss_pred             C
Q 006968          206 K  206 (623)
Q Consensus       206 ~  206 (623)
                      +
T Consensus       165 ~  165 (208)
T 2o6s_A          165 P  165 (208)
T ss_dssp             T
T ss_pred             C
Confidence            4

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=3e-19  Score=177.05  Aligned_cols=138  Identities=17%  Similarity=0.146  Sum_probs=106.2

Q ss_pred             CCcCCceeccCCeEEEEEEe-CCCcE--EEEEEeccccccc-----------------------chHHHHHHHHHHhhcC
Q 006968          303 FSAKNILGRGGFGIVYKGCF-SDGAL--VAVKRLKDYNIAG-----------------------GEVQFQTEVETISLAV  356 (623)
Q Consensus       303 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~  356 (623)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++......                       ....+.+|+..+.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998 68888  9999975432110                       0125789999999998


Q ss_pred             CCce--eeeeeeeecCCceEEEEecccC-C----ChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEe
Q 006968          357 HRNL--LRLCGFCSTENERLLVYPYMPN-G----SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH-EQCDPKIIH  428 (623)
Q Consensus       357 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH  428 (623)
                      |+++  ..++++    +..++||||+.+ |    +|.++...       .++..+..++.|++.||.||| +.   +|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8864  233332    367899999943 4    55544322       224466789999999999999 88   9999


Q ss_pred             cCCCCCCeEECCCCcEEEeecccccccC
Q 006968          429 RDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       429 ~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||||.|||++.  .++|+|||+|....
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccCC
Confidence            999999999998  99999999997643

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=1.2e-18  Score=164.65  Aligned_cols=146  Identities=23%  Similarity=0.308  Sum_probs=118.6

Q ss_pred             CCCCcceeeeCCC----------CcEEEEeCCCCCcccccCc-cccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEe
Q 006968           61 DPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSP-WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL  129 (623)
Q Consensus        61 ~~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  129 (623)
                      ..|.|+.+.|+..          ..++.|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus         6 C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   85 (192)
T 1w8a_A            6 CHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL   85 (192)
T ss_dssp             SEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEEC
Confidence            3478888888743          2789999999999876654 4889999999999999999888999999999999999


Q ss_pred             cCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCCC
Q 006968          130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGP  205 (623)
Q Consensus       130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~  205 (623)
                      ++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+-...    +...+.++...|..
T Consensus        86 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~  165 (192)
T 1w8a_A           86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred             CCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCC
Confidence            99999987778899999999999999999988899999999999999999999987653211    22234455555554


Q ss_pred             C
Q 006968          206 K  206 (623)
Q Consensus       206 ~  206 (623)
                      +
T Consensus       166 P  166 (192)
T 1w8a_A          166 P  166 (192)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.75  E-value=1.2e-18  Score=200.04  Aligned_cols=135  Identities=35%  Similarity=0.583  Sum_probs=125.5

Q ss_pred             EEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcccc
Q 006968           77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN  156 (623)
Q Consensus        77 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N  156 (623)
                      ..++++.|.++|.+|..++++++|++|+|++|+++|.+|..|+++++|+.|+|++|+|+|.+|..|+++++|+.|||++|
T Consensus       611 ~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N  690 (768)
T 3rgz_A          611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN  690 (768)
T ss_dssp             CCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred             cccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCC
Confidence            34567789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCCCCCCCCCc
Q 006968          157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPKATNNCT  212 (623)
Q Consensus       157 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~~~~~~~  212 (623)
                      +++|.+|..+..+++|+.|+|++|+|+|.+|....    ....+.||+.+||.+.. .|.
T Consensus       691 ~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~  749 (768)
T 3rgz_A          691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCD  749 (768)
T ss_dssp             CCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCC
T ss_pred             cccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCC
Confidence            99999999999999999999999999999998643    45678999999998765 675

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.73  E-value=8.1e-18  Score=166.09  Aligned_cols=130  Identities=23%  Similarity=0.227  Sum_probs=111.2

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  115 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG  115 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence            68899999999998888889999999999999999998888889999999999999999997667778899999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~  204 (623)
                      +|+|++..+..|..+++|+.|+|++|+|++..+..+.     +.+++++|.+...
T Consensus       116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A          116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            9999966666678899999999999999977765443     5678888887543

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.72  E-value=1.9e-19  Score=195.34  Aligned_cols=123  Identities=21%  Similarity=0.180  Sum_probs=75.6

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCcccc-CCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG-DLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l  153 (623)
                      .++.|+|++|.|++..+.   .+++|+.|+|++|.+++..|..|+++++|++|+|++|.|++.+|..+. .+++|+.|+|
T Consensus       100 ~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L  176 (487)
T 3oja_A          100 SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL  176 (487)
T ss_dssp             TCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred             CcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence            466666666666654443   345666677777777666666666666777777777777666666654 5666777777


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLI  202 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~  202 (623)
                      ++|.|++. | .+..+++|+.|+|++|.|++.+|.+..    +.+++++|.+.
T Consensus       177 s~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~  227 (487)
T 3oja_A          177 QYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV  227 (487)
T ss_dssp             TTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred             CCCccccc-c-ccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCc
Confidence            77766643 2 233466667777777766665554322    44566666654

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.71  E-value=2.1e-17  Score=153.83  Aligned_cols=127  Identities=27%  Similarity=0.308  Sum_probs=106.1

Q ss_pred             CCCcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecC
Q 006968           62 PCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN  131 (623)
Q Consensus        62 ~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  131 (623)
                      .|+|.+|.|+..          ..++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus         6 ~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             EEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             EeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            478999999752          3688999999999876667788899999999999999876667788899999999999


Q ss_pred             CCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCC
Q 006968          132 NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK  188 (623)
Q Consensus       132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  188 (623)
                      |+|++..+..+..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..|.
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            999966666788899999999999999865555578889999999999999887764

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.71  E-value=5.3e-17  Score=160.25  Aligned_cols=131  Identities=24%  Similarity=0.285  Sum_probs=118.8

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        59 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  138 (251)
T 3m19_A           59 TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL  138 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             ccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEEC
Confidence            37999999999999988888999999999999999999887888999999999999999999666667899999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~  204 (623)
                      ++|+|++..+..|..+++|+.|+|++|+|++.+|..+.     +.+++++|++.|.
T Consensus       139 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             cCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            99999976666899999999999999999987775543     5788999999887

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.70  E-value=8.5e-18  Score=171.67  Aligned_cols=131  Identities=27%  Similarity=0.458  Sum_probs=95.3

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|++++.+|..+..++ |++|+|++|++++.+|..|.++++|+.|+|++|++++.+|. +..+++|++|+|+
T Consensus       175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls  252 (313)
T 1ogq_A          175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR  252 (313)
T ss_dssp             TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred             cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence            455555555555555555555554 66666666666666666677777777777777777755554 6777888888888


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPKA  207 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~~  207 (623)
                      +|++++.+|..+..+++|+.|+|++|+|+|.+|....    +.+++.+|++.|+.+.
T Consensus       253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCC
Confidence            8888888888888888888888888888888887632    5678889998888654

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.70  E-value=3.5e-17  Score=154.52  Aligned_cols=127  Identities=20%  Similarity=0.333  Sum_probs=114.1

Q ss_pred             EEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCC-ccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccc
Q 006968           77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN  155 (623)
Q Consensus        77 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  155 (623)
                      +.|++++|+|+ .+|..+..  +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            68999999996 78876654  999999999999976664 489999999999999999988899999999999999999


Q ss_pred             cccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCCC
Q 006968          156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK  206 (623)
Q Consensus       156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~  206 (623)
                      |+|++..|..|..+++|+.|+|++|+|++.+|..+.     +.+++++|++.|.+.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            999988888899999999999999999998887654     568899999988764

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.69  E-value=8.8e-17  Score=160.45  Aligned_cols=129  Identities=27%  Similarity=0.321  Sum_probs=88.2

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|+
T Consensus        38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  117 (270)
T 2o6q_A           38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD  117 (270)
T ss_dssp             TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred             CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence            46677777777776555567777777777777777775444556677777777777777775555566777777777777


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC  203 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~  203 (623)
                      +|++++..|..|..+++|+.|+|++|.|++..+..+.     +.+++++|.+..
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  171 (270)
T 2o6q_A          118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR  171 (270)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence            7777766666677777777777777777765554332     456666666543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.69  E-value=1e-16  Score=160.13  Aligned_cols=131  Identities=22%  Similarity=0.244  Sum_probs=77.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|++|+|+
T Consensus        86 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  165 (272)
T 3rfs_A           86 NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLS  165 (272)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECC
Confidence            46666666666665555555666666666666666665555555666666666666666664444455666666666666


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~  205 (623)
                      +|++++..+..+..+++|+.|+|++|++++.+|..+.     +.+++.+|++.|.+
T Consensus       166 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  221 (272)
T 3rfs_A          166 YNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC  221 (272)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred             CCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence            6666655555556666666666666666655554322     34556666665544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=3.5e-17  Score=168.75  Aligned_cols=148  Identities=14%  Similarity=0.072  Sum_probs=103.4

Q ss_pred             HHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc-------------cchHHHHHHHHHHhhcCCCceee
Q 006968          296 LRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-------------GGEVQFQTEVETISLAVHRNLLR  362 (623)
Q Consensus       296 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~H~niv~  362 (623)
                      +.....-|.+.+.||+|+||.||+|...+|+.||||+++.....             .....+..++++.....|+|+.+
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            33333348899999999999999999989999999998643211             01112333333333344555554


Q ss_pred             eeeeeec------CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 006968          363 LCGFCST------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANI  436 (623)
Q Consensus       363 l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI  436 (623)
                      ++.....      ....++||||++++.|..+...          .....++.|++.+|.|||+.   +||||||||.||
T Consensus       170 L~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NI  236 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNI  236 (397)
T ss_dssp             HHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             HHhcCCCCCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHE
Confidence            4332211      1234799999998887654321          12356789999999999999   999999999999


Q ss_pred             EECCCC----------cEEEeecccccccC
Q 006968          437 LLDEDF----------EAVVGDFGLAKLLD  456 (623)
Q Consensus       437 ll~~~~----------~~kl~Dfgla~~~~  456 (623)
                      |+++++          .+.|+||+-+....
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccCC
Confidence            998776          38999999887543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.68  E-value=1.1e-16  Score=151.10  Aligned_cols=125  Identities=24%  Similarity=0.342  Sum_probs=85.7

Q ss_pred             EEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccc
Q 006968           78 ALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS  157 (623)
Q Consensus        78 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  157 (623)
                      .+++++|+|+ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            3555666666 4555442  46777777777777 566777777777777777777776656667777777777777777


Q ss_pred             cCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCCC
Q 006968          158 LTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK  206 (623)
Q Consensus       158 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~  206 (623)
                      |++..|..|..+++|+.|+|++|+|++..+..+.     +.+++++|++.|.+.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            7766666677777777777777777755554332     456677777777654

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=1.5e-16  Score=150.27  Aligned_cols=123  Identities=23%  Similarity=0.299  Sum_probs=111.1

Q ss_pred             CCCcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecC
Q 006968           62 PCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN  131 (623)
Q Consensus        62 ~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  131 (623)
                      .|.|..|.|+..          ..++.|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus         9 ~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~   87 (193)
T 2wfh_A            9 TCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY   87 (193)
T ss_dssp             EEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             EeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence            467788888642          37999999999998 7889999999999999999999988888999999999999999


Q ss_pred             CCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCc
Q 006968          132 NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGS  185 (623)
Q Consensus       132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  185 (623)
                      |+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus        88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            999987778899999999999999999966666799999999999999999853

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.67  E-value=6.8e-17  Score=168.39  Aligned_cols=141  Identities=26%  Similarity=0.323  Sum_probs=109.8

Q ss_pred             CCcceeeeCCC----------CcEEEEeCCCCCcccccCcccc-CCCCcceEEeecCCCCCCCCCccCCCCCccEEEecC
Q 006968           63 CSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIG-NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN  131 (623)
Q Consensus        63 c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  131 (623)
                      |.+..|.|...          ..++.|+|++|+|++..+..+. ++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            56777888642          3578899999999877777777 888999999999999877777888888999999999


Q ss_pred             CCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCc---c-----ccccccCCCCCC
Q 006968          132 NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS---A-----RTFKVTGNPLIC  203 (623)
Q Consensus       132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~---~-----~~~~~~~n~~~~  203 (623)
                      |+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+   .     +.+++++|.+..
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            99886666678888888888888888887777888888888888888888886444432   0     345666666543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.67  E-value=2.4e-16  Score=158.97  Aligned_cols=130  Identities=25%  Similarity=0.235  Sum_probs=79.3

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|+|+ .+|..+.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus        78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  156 (290)
T 1p9a_G           78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA  156 (290)
T ss_dssp             TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECC
Confidence            4666666666665 455566666666666666666665555666666666666666666665444555666666666666


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGP  205 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~  205 (623)
                      +|+|++..+..|..+++|+.|+|++|+|+..++..+.    +.+.+.+||+.|.|
T Consensus       157 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          157 NNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             TSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence            6666644334455666666666666666633222221    34556667766654

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.66  E-value=3.4e-16  Score=156.15  Aligned_cols=129  Identities=22%  Similarity=0.253  Sum_probs=81.1

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|+
T Consensus        62 ~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls  141 (270)
T 2o6q_A           62 KLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLG  141 (270)
T ss_dssp             TCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECC
Confidence            56777777777765444455667777777777777765555556666777777777777765555556666666677776


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC  203 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~  203 (623)
                      +|++++..+..|..+++|+.|+|++|++++..+..+.     +.+++++|.+..
T Consensus       142 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  195 (270)
T 2o6q_A          142 YNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR  195 (270)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCc
Confidence            6666644444466666666666666666655444322     445566665543

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.65  E-value=2.1e-16  Score=177.04  Aligned_cols=131  Identities=18%  Similarity=0.141  Sum_probs=116.0

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      ..++.|||++|+|++..+..|.++++|++|+|++|+|++..|.+|.+|++|++|+|++|+|++..+..|.++++|++|+|
T Consensus        52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L  131 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  131 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence            37999999999999877789999999999999999999888889999999999999999999655677999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcC-cCCCCcc-----ccccccCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~-----~~~~~~~n~~~~~  204 (623)
                      ++|++++..+..|+++++|+.|+|++|.+++ .+|..+.     +.+++++|.+...
T Consensus       132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~  188 (635)
T 4g8a_A          132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI  188 (635)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred             CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccc
Confidence            9999997766789999999999999999986 4565543     5678899987544

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.65  E-value=3.5e-16  Score=168.26  Aligned_cols=133  Identities=21%  Similarity=0.209  Sum_probs=123.6

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|++++.+|..++++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|++|+|+
T Consensus       276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  355 (455)
T 3v47_A          276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS  355 (455)
T ss_dssp             CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECC
T ss_pred             CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECC
Confidence            79999999999999999999999999999999999999889999999999999999999998888999999999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPKA  207 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~~  207 (623)
                      +|++++..|..|..+++|+.|+|++|+|++.++..+.     +.+++++|++.|.++.
T Consensus       356 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          356 YNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             CCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence            9999988899999999999999999999987665543     6789999999998763

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.64  E-value=2.6e-16  Score=158.34  Aligned_cols=128  Identities=23%  Similarity=0.267  Sum_probs=78.6

Q ss_pred             cEEEEeCCCCC-cccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           75 YVSALGLPSQS-LSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .++.|+|++|. +++..+..+.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..+..+++|++|+|
T Consensus        81 ~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  160 (285)
T 1ozn_A           81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL  160 (285)
T ss_dssp             TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEEC
Confidence            56666666665 55444566666666666666666666655666666666666666666666444445666666666666


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI  202 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~  202 (623)
                      ++|++++..+..+..+++|+.|+|++|.+++..|..+.     +.+++++|.+.
T Consensus       161 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  214 (285)
T 1ozn_A          161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS  214 (285)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCC
Confidence            66666644444566666666666666666655554432     34555555553

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.63  E-value=5e-16  Score=149.93  Aligned_cols=114  Identities=20%  Similarity=0.255  Sum_probs=107.6

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|
T Consensus        57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  136 (220)
T 2v70_A           57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL  136 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred             CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence            37999999999999888889999999999999999999888888999999999999999999888999999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP  187 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  187 (623)
                      ++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus       137 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          137 YDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             TTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            9999998889999999999999999999997654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.63  E-value=4.9e-16  Score=157.98  Aligned_cols=128  Identities=19%  Similarity=0.263  Sum_probs=74.5

Q ss_pred             cEEEEeCCCCCcccccC-ccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCC-CCCccccCCCCccchh
Q 006968           75 YVSALGLPSQSLSGTLS-PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGNLNYLR  152 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~  152 (623)
                      .++.|+|++|++++..+ ..+.++++|++|+|++|.+++..|..+.++++|++|+|++|.+++ .+|..+..+++|++|+
T Consensus       102 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  181 (306)
T 2z66_A          102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD  181 (306)
T ss_dssp             TCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred             CCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEE
Confidence            56666666666664433 355666666666666666665555556666666666666666654 3555666666666666


Q ss_pred             ccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCC
Q 006968          153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI  202 (623)
Q Consensus       153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~  202 (623)
                      |++|++++..|..+..+++|+.|+|++|++++..+..+.     +.+++++|++.
T Consensus       182 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  236 (306)
T 2z66_A          182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM  236 (306)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred             CCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence            666666655555566666666666666666554332221     34555555543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=1.3e-15  Score=141.64  Aligned_cols=128  Identities=21%  Similarity=0.239  Sum_probs=110.2

Q ss_pred             EEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccc
Q 006968           76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN  155 (623)
Q Consensus        76 v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  155 (623)
                      .+.+++++|+++ .+|..+  .++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            468999999998 566544  47999999999999977777889999999999999999966666789999999999999


Q ss_pred             cccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCCC
Q 006968          156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK  206 (623)
Q Consensus       156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~  206 (623)
                      |+|++..+..+..+++|+.|+|++|+|++.++..+.     +.+++++|++.|.++
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            999977777789999999999999999977665533     568899999988654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.62  E-value=9.2e-16  Score=141.36  Aligned_cols=129  Identities=24%  Similarity=0.253  Sum_probs=110.9

Q ss_pred             CcEEEEeCCCCCcc-cccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchh
Q 006968           74 GYVSALGLPSQSLS-GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR  152 (623)
Q Consensus        74 ~~v~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  152 (623)
                      .+++.|+|++|+++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            37999999999998 88999999999999999999999965  7899999999999999999987898888899999999


Q ss_pred             ccccccCCCC-CcccCCCCcccEEECCCCcCcCcCC---CCcc-----ccccccCCCCCCC
Q 006968          153 LNNNSLTGSC-PESLSKIESLTLVDLSYNNLSGSLP---KISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       153 l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p---~~~~-----~~~~~~~n~~~~~  204 (623)
                      |++|++++.. +..+..+++|+.|++++|++++..+   ..+.     +.+++.+|.....
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence            9999999532 2789999999999999999997665   2222     5567777765433

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.62  E-value=8e-16  Score=164.79  Aligned_cols=132  Identities=21%  Similarity=0.172  Sum_probs=111.9

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      ..++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  143 (440)
T 3zyj_A           64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL  143 (440)
T ss_dssp             TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred             CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence            46899999999999888899999999999999999999888889999999999999999999665667999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCC-Ccc-----ccccccCCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK-ISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-----~~~~~~~n~~~~~~  205 (623)
                      ++|++++..+..|..+++|+.|+|++|+..+.+|. .+.     +.+++++|.+...+
T Consensus       144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~  201 (440)
T 3zyj_A          144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP  201 (440)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC
T ss_pred             CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc
Confidence            99999976667889999999999998655555554 222     56778888775443

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.61  E-value=2.3e-15  Score=151.34  Aligned_cols=141  Identities=21%  Similarity=0.244  Sum_probs=120.2

Q ss_pred             CCcceeeeCCC---CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCC-CCCCC
Q 006968           63 CSWRMITCSPD---GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK-FTGEI  138 (623)
Q Consensus        63 c~w~gv~c~~~---~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~  138 (623)
                      |++.|++..+.   ..++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|. ++...
T Consensus        18 c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~   97 (285)
T 1ozn_A           18 CPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD   97 (285)
T ss_dssp             CCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCC
T ss_pred             cCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccC
Confidence            55555554432   479999999999998777889999999999999999998889999999999999999997 88666


Q ss_pred             CccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCC
Q 006968          139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC  203 (623)
Q Consensus       139 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~  203 (623)
                      |..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|++++..+..+.     +.+++++|.+..
T Consensus        98 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  167 (285)
T 1ozn_A           98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS  167 (285)
T ss_dssp             TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE
T ss_pred             HHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc
Confidence            88899999999999999999988788899999999999999999977666443     567888887643

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.60  E-value=1.7e-15  Score=162.84  Aligned_cols=131  Identities=18%  Similarity=0.129  Sum_probs=113.5

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  154 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL  154 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence            47999999999999988999999999999999999999888899999999999999999999666677999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCC-cc-----ccccccCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI-SA-----RTFKVTGNPLICG  204 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~-----~~~~~~~n~~~~~  204 (623)
                      ++|++++..+..|.++++|+.|+|++|+..+.+|.. +.     +.+++++|.+...
T Consensus       155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~  211 (452)
T 3zyi_A          155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM  211 (452)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred             CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence            999999666668999999999999996555555542 22     5678888877544

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.60  E-value=1.3e-15  Score=163.72  Aligned_cols=144  Identities=22%  Similarity=0.221  Sum_probs=123.4

Q ss_pred             CCCCcce--eeeCCC---------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCC-CCccCCCCCccEEE
Q 006968           61 DPCSWRM--ITCSPD---------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLD  128 (623)
Q Consensus        61 ~~c~w~g--v~c~~~---------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~  128 (623)
                      ..|.|.+  |.|+..         .+++.|+|++|.|++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus         6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~   85 (455)
T 3v47_A            6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK   85 (455)
T ss_dssp             -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred             ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence            3455544  777642         47999999999999988999999999999999999998665 56799999999999


Q ss_pred             ecCCCCCCCCCccccCCCCccchhccccccCCCCCcc--cCCCCcccEEECCCCcCcCcCCCC-cc-----ccccccCCC
Q 006968          129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPES--LSKIESLTLVDLSYNNLSGSLPKI-SA-----RTFKVTGNP  200 (623)
Q Consensus       129 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p~~-~~-----~~~~~~~n~  200 (623)
                      |++|++++..|..|+++++|++|+|++|++++.+|..  +..+++|+.|+|++|++++..|.. +.     +.+++++|.
T Consensus        86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~  165 (455)
T 3v47_A           86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK  165 (455)
T ss_dssp             CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred             CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence            9999999888999999999999999999999866655  999999999999999999987764 22     567889998


Q ss_pred             CCCC
Q 006968          201 LICG  204 (623)
Q Consensus       201 ~~~~  204 (623)
                      +...
T Consensus       166 l~~~  169 (455)
T 3v47_A          166 VKSI  169 (455)
T ss_dssp             BSCC
T ss_pred             cccc
Confidence            7543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.60  E-value=3.2e-15  Score=149.57  Aligned_cols=128  Identities=18%  Similarity=0.169  Sum_probs=107.2

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            58899999999997777788899999999999999987777788899999999999999997777888999999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcC-cCCCCcc-----ccccccCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKISA-----RTFKVTGNPLI  202 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~-----~~~~~~~n~~~  202 (623)
                      +|++++..+..+..+++|+.|+|++|.+++ .+|..+.     +.+++++|.+.
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~  162 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ  162 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC
Confidence            999987666678889999999999999886 3566543     55677777654

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.59  E-value=2.8e-15  Score=167.29  Aligned_cols=131  Identities=18%  Similarity=0.135  Sum_probs=114.5

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            47999999999999888889999999999999999999888889999999999999999999877999999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcC-cCCCCcc-----ccccccCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~-----~~~~~~~n~~~~~  204 (623)
                      ++|.+++..|..++++++|+.|+|++|.+++ .+|..+.     +.+++++|.+...
T Consensus       112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~  168 (606)
T 3vq2_A          112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI  168 (606)
T ss_dssp             TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEE
T ss_pred             cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceec
Confidence            9999987776889999999999999999986 6676554     5677888876543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.59  E-value=2.9e-15  Score=138.31  Aligned_cols=109  Identities=27%  Similarity=0.311  Sum_probs=96.7

Q ss_pred             EEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcccc
Q 006968           77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN  156 (623)
Q Consensus        77 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N  156 (623)
                      +.|++++|+|+ .+|..+  .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus        12 ~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            46777889998 577766  389999999999999888999999999999999999999666667899999999999999


Q ss_pred             ccCCCCCcccCCCCcccEEECCCCcCcCcCCC
Q 006968          157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPK  188 (623)
Q Consensus       157 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  188 (623)
                      +|++..+..|..+++|+.|+|++|+++...++
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence            99976666799999999999999999977664

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.59  E-value=3e-15  Score=144.51  Aligned_cols=111  Identities=25%  Similarity=0.262  Sum_probs=103.8

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|
T Consensus        56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  135 (220)
T 2v9t_B           56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL  135 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence            37999999999999988999999999999999999999666667899999999999999999888999999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      ++|+|++..+..|..+++|+.|+|++|++..
T Consensus       136 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            9999998777789999999999999999985

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.59  E-value=1.3e-15  Score=158.14  Aligned_cols=141  Identities=21%  Similarity=0.265  Sum_probs=117.2

Q ss_pred             CCCCCcceeeeCC------------CCcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEE
Q 006968           60 VDPCSWRMITCSP------------DGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTL  127 (623)
Q Consensus        60 ~~~c~w~gv~c~~------------~~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  127 (623)
                      ..+|.|.|+ |+.            ..+++.|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|
T Consensus        27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            456777776 542            1379999999999998777789999999999999999998888899999999999


Q ss_pred             EecCCCCCCCCCccccCCCCccchhccccccCCCCCc--ccCCCCcccEEECCCCc-CcCcCCCCcc-----ccccccCC
Q 006968          128 DLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPE--SLSKIESLTLVDLSYNN-LSGSLPKISA-----RTFKVTGN  199 (623)
Q Consensus       128 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~-l~~~~p~~~~-----~~~~~~~n  199 (623)
                      +|++|++++..+..+.++++|++|+|++|+++ .+|.  .+..+++|+.|++++|+ +++..|..+.     +.+++++|
T Consensus       106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n  184 (353)
T 2z80_A          106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS  184 (353)
T ss_dssp             ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred             ECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence            99999999544444899999999999999999 4555  78999999999999995 6655555443     56788888


Q ss_pred             CCC
Q 006968          200 PLI  202 (623)
Q Consensus       200 ~~~  202 (623)
                      .+.
T Consensus       185 ~l~  187 (353)
T 2z80_A          185 DLQ  187 (353)
T ss_dssp             TCC
T ss_pred             CcC
Confidence            764

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.59  E-value=2.9e-16  Score=178.13  Aligned_cols=124  Identities=27%  Similarity=0.374  Sum_probs=97.7

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|.|. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|++|++|++|+|+
T Consensus       225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~  301 (727)
T 4b8c_D          225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF  301 (727)
T ss_dssp             CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred             CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence            4667888888887 67777778888888888888888 77888888888888888888888 778888888888888888


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc------ccccccCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA------RTFKVTGNPLI  202 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~------~~~~~~~n~~~  202 (623)
                      +|.|+ .+|..|..|++|+.|+|++|+|+|.+|..+.      ..+.+.+|.+.
T Consensus       302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~  354 (727)
T 4b8c_D          302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPE  354 (727)
T ss_dssp             SSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             CCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCccc
Confidence            88887 7777788888888888888888887776553      12456677653

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.59  E-value=1.8e-15  Score=169.47  Aligned_cols=133  Identities=19%  Similarity=0.261  Sum_probs=121.5

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCC-CCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+..++++.|.+++..+..+..+++|+.|+|++|++. +.+|..|..+++|++|||++|+|++..|..|.++++|++|+|
T Consensus       446 ~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~L  525 (635)
T 4g8a_A          446 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM  525 (635)
T ss_dssp             TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEEC
Confidence            6888999999999999999999999999999999854 467889999999999999999999888999999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc------ccccccCCCCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA------RTFKVTGNPLICGPKA  207 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~------~~~~~~~n~~~~~~~~  207 (623)
                      ++|+|++..|..|..+++|+.|+|++|+|++.+|..+.      +.+++++|||.|.|..
T Consensus       526 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~  585 (635)
T 4g8a_A          526 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH  585 (635)
T ss_dssp             TTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred             CCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence            99999988888999999999999999999999887653      4578999999998763

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.58  E-value=7.8e-15  Score=146.43  Aligned_cols=129  Identities=27%  Similarity=0.346  Sum_probs=114.2

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|++++.  +.+.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|++|+|+
T Consensus        64 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  141 (272)
T 3rfs_A           64 NVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA  141 (272)
T ss_dssp             TCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECC
Confidence            799999999999963  478999999999999999998888889999999999999999997777778999999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~  205 (623)
                      +|++++..+..+..+++|+.|+|++|++++..|..+.     +.+++++|.+...+
T Consensus       142 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  197 (272)
T 3rfs_A          142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVP  197 (272)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccC
Confidence            9999977777789999999999999999987776543     66889999876443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.58  E-value=2.6e-15  Score=154.22  Aligned_cols=126  Identities=22%  Similarity=0.342  Sum_probs=110.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCC---------CCCccEEEecCCCCCCCCCccccCC
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK---------LEKLQTLDLSNNKFTGEIPDSLGDL  145 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---------l~~L~~L~Ls~N~l~~~~p~~~~~l  145 (623)
                      +++.|+|++|.++ .+|..++++++|++|+|++|++.+.+|..+..         +++|++|+|++|+|+ .+|..++.+
T Consensus       128 ~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l  205 (328)
T 4fcg_A          128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANL  205 (328)
T ss_dssp             TCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGC
T ss_pred             CCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCC
Confidence            7999999999999 88999999999999999999999899988765         999999999999999 899999999


Q ss_pred             CCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCC
Q 006968          146 GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC  203 (623)
Q Consensus       146 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~  203 (623)
                      ++|++|+|++|+++ .+|..+..+++|+.|+|++|++.+.+|..+.     +.+++++|++..
T Consensus       206 ~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~  267 (328)
T 4fcg_A          206 QNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL  267 (328)
T ss_dssp             TTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCC
T ss_pred             CCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchh
Confidence            99999999999999 4777899999999999999999998887654     567788877643

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.58  E-value=1.3e-15  Score=137.33  Aligned_cols=111  Identities=27%  Similarity=0.311  Sum_probs=102.3

Q ss_pred             cEEEEeCCCCCcc-cccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           75 YVSALGLPSQSLS-GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      +++.|+|++|+++ +.+|..+..+++|++|+|++|++++.  ..+.++++|++|+|++|++++.+|..+..+++|++|+|
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l   95 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL   95 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence            7999999999999 88999999999999999999999966  78999999999999999999879998889999999999


Q ss_pred             cccccCCC-CCcccCCCCcccEEECCCCcCcCcCC
Q 006968          154 NNNSLTGS-CPESLSKIESLTLVDLSYNNLSGSLP  187 (623)
Q Consensus       154 ~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p  187 (623)
                      ++|++++. .+..+..+++|+.|++++|++++..+
T Consensus        96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  130 (149)
T 2je0_A           96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND  130 (149)
T ss_dssp             TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred             CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence            99999963 34789999999999999999997655

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.58  E-value=5.3e-15  Score=149.08  Aligned_cols=129  Identities=24%  Similarity=0.199  Sum_probs=95.8

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      ..++.|+|++|+|++..+..|.++++|++|+|++|+|++. |. ...+++|++|+|++|+|+ .+|..+..+++|++|+|
T Consensus        31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l  107 (290)
T 1p9a_G           31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV  107 (290)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-EC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence            3688888888888877778888888888888888888753 33 267777888888888887 67777777788888888


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~  205 (623)
                      ++|+|++..|..|..+++|+.|+|++|+|++.++..+.     +.+++++|.+...+
T Consensus       108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~  164 (290)
T 1p9a_G          108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP  164 (290)
T ss_dssp             CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred             CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccC
Confidence            88888766566777778888888888888766555432     45677777765433

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.58  E-value=6.8e-15  Score=136.36  Aligned_cols=109  Identities=26%  Similarity=0.277  Sum_probs=96.7

Q ss_pred             EEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcccc
Q 006968           77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN  156 (623)
Q Consensus        77 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N  156 (623)
                      +.+++++|+|+ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            67899999997 7887764  89999999999999888999999999999999999999655556789999999999999


Q ss_pred             ccCCCCCcccCCCCcccEEECCCCcCcCcCCC
Q 006968          157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPK  188 (623)
Q Consensus       157 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  188 (623)
                      +|++..+..|..+++|+.|+|++|+|....++
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~  123 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD  123 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence            99966555699999999999999999966553

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.58  E-value=1.7e-15  Score=166.85  Aligned_cols=140  Identities=18%  Similarity=0.240  Sum_probs=120.8

Q ss_pred             CCCcceeeeCCC------------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEe
Q 006968           62 PCSWRMITCSPD------------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL  129 (623)
Q Consensus        62 ~c~w~gv~c~~~------------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  129 (623)
                      .|.|.|+ |+..            ..++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus         3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L   81 (549)
T 2z81_A            3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL   81 (549)
T ss_dssp             EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence            4888887 7521            37999999999999988999999999999999999999888899999999999999


Q ss_pred             cCCCCCCCCCccccCCCCccchhccccccCC-CCCcccCCCCcccEEECCCCcCcCcCCC-Ccc-----ccccccCCCCC
Q 006968          130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPK-ISA-----RTFKVTGNPLI  202 (623)
Q Consensus       130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-----~~~~~~~n~~~  202 (623)
                      ++|++++..|..|+++++|++|+|++|.+++ .+|..+.++++|+.|++++|.+.+.+|. .+.     +.+++++|.+.
T Consensus        82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~  161 (549)
T 2z81_A           82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR  161 (549)
T ss_dssp             TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred             CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence            9999997777779999999999999999986 4678899999999999999996666653 332     56778888764

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.57  E-value=7.5e-15  Score=140.30  Aligned_cols=126  Identities=23%  Similarity=0.222  Sum_probs=109.2

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|
T Consensus        52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  131 (208)
T 2o6s_A           52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL  131 (208)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence            37999999999999776777899999999999999999777777899999999999999999766667899999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCccccccccCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL  201 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~n~~  201 (623)
                      ++|++++..+..+..+++|+.|+|++|.+.+..|.+  +.+.+.+|.+
T Consensus       132 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l--~~L~~~~n~~  177 (208)
T 2o6s_A          132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI--RYLSEWINKH  177 (208)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTTT--HHHHHHHHHC
T ss_pred             CCCccceeCHHHhccCCCccEEEecCCCeecCCCCH--HHHHHHHHhC
Confidence            999999766667899999999999999999988754  3344444443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.57  E-value=5.4e-15  Score=160.05  Aligned_cols=141  Identities=16%  Similarity=0.169  Sum_probs=122.7

Q ss_pred             CcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCC
Q 006968           64 SWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK  133 (623)
Q Consensus        64 ~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  133 (623)
                      .|..|.|...          ..++.|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus        12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~   91 (477)
T 2id5_A           12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR   91 (477)
T ss_dssp             TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence            3667777632          378999999999998888999999999999999999998889999999999999999999


Q ss_pred             CCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCC
Q 006968          134 FTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       134 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~  204 (623)
                      +++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.+++..|..+.     +.+++++|.+...
T Consensus        92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  167 (477)
T 2id5_A           92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI  167 (477)
T ss_dssp             CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred             CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc
Confidence            9955556789999999999999999988888999999999999999999987776544     5677888876543

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.57  E-value=2.8e-15  Score=167.34  Aligned_cols=132  Identities=19%  Similarity=0.215  Sum_probs=90.4

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCC-CCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .++.|+|++|.+++..|..+.++++|++|+|++|++++ .+|..|.++++|++|+|++|++++..|..+..+++|++|+|
T Consensus       425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  504 (606)
T 3vq2_A          425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM  504 (606)
T ss_dssp             TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEEC
Confidence            56666777777766666667777777777777777765 35666777777777777777777666677777777777777


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc------ccccccCCCCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA------RTFKVTGNPLICGPKA  207 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~------~~~~~~~n~~~~~~~~  207 (623)
                      ++|++++..|..+..+++|+.|+|++|+|+. +|..+.      +.+++++|++.|.++.
T Consensus       505 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             CSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             CCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            7777776667777777777777777777773 333221      4456777777776653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.57  E-value=1.1e-14  Score=141.29  Aligned_cols=114  Identities=25%  Similarity=0.234  Sum_probs=104.7

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      ..++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|
T Consensus        64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L  142 (229)
T 3e6j_A           64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL  142 (229)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred             cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence            37999999999998666677899999999999999999777777899999999999999999 89999999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK  188 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  188 (623)
                      ++|+|++..+..|..+++|+.|+|++|.+++..+.
T Consensus       143 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  177 (229)
T 3e6j_A          143 DQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRD  177 (229)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBGG
T ss_pred             CCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcch
Confidence            99999976667899999999999999999987663

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.56  E-value=4.5e-15  Score=148.43  Aligned_cols=114  Identities=21%  Similarity=0.259  Sum_probs=84.8

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..+..+++|++|+|+
T Consensus        53 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  132 (276)
T 2z62_A           53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA  132 (276)
T ss_dssp             TCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred             CCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECc
Confidence            67778888888776666677777888888888888776666777777778888888777776555567777777777777


Q ss_pred             ccccCC-CCCcccCCCCcccEEECCCCcCcCcCCC
Q 006968          155 NNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPK  188 (623)
Q Consensus       155 ~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~  188 (623)
                      +|++++ .+|..+..+++|+.|+|++|++++..+.
T Consensus       133 ~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~  167 (276)
T 2z62_A          133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (276)
T ss_dssp             SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred             CCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence            777775 3577777777777777777777765443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.56  E-value=2.4e-15  Score=174.30  Aligned_cols=131  Identities=24%  Similarity=0.281  Sum_probs=94.1

Q ss_pred             cEEEEeCCCCCcccccCc-cccCCCCcceEEeecCCCC-----CCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCc
Q 006968           75 YVSALGLPSQSLSGTLSP-WIGNLTKLQSVLLQNNAIL-----GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL  148 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  148 (623)
                      +++.|+|++|++++..+. .+..+++|+.|+|++|.++     +..|..|.++++|+.|+|++|+|++..|..|..+++|
T Consensus       427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  506 (844)
T 3j0a_A          427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL  506 (844)
T ss_dssp             TCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSC
T ss_pred             ccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhh
Confidence            456666666666643332 3445666777777777765     3344567778888888888888887777778888888


Q ss_pred             cchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc--ccccccCCCCCCCCCC
Q 006968          149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPLICGPKA  207 (623)
Q Consensus       149 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~~~~~~~  207 (623)
                      +.|+|++|+|++..|..+.  ++|+.|+|++|+|++.+|..+.  ..+++++||+.|.|..
T Consensus       507 ~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          507 RGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             SEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred             heeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence            8888888888865555554  7888888888888888887654  5688999999998763

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.56  E-value=5.3e-15  Score=164.67  Aligned_cols=152  Identities=13%  Similarity=0.111  Sum_probs=110.2

Q ss_pred             ccCCCCCCCCCCCC----cceeeeCC------C-----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCC
Q 006968           51 VLENWDITSVDPCS----WRMITCSP------D-----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNA  109 (623)
Q Consensus        51 ~~~~w~~~~~~~c~----w~gv~c~~------~-----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  109 (623)
                      .+++|.. +.+||.    |.++.|..      .           ..++.|++++|.+++..+..+.++++|++|+|++|.
T Consensus         8 ~l~~~~~-~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~   86 (597)
T 3oja_B            8 NVKPRQP-EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ   86 (597)
T ss_dssp             ---CCCS-EECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSC
T ss_pred             cccCCCC-CCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCC
Confidence            4677863 455663    66655541      0           246778888888876555567778888888888888


Q ss_pred             CCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCC
Q 006968          110 ILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI  189 (623)
Q Consensus       110 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  189 (623)
                      +++..|..|.++++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|.++++|+.|+|++|.|++.+|..
T Consensus        87 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  166 (597)
T 3oja_B           87 IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT  166 (597)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred             CCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhh
Confidence            88777778888888888888888888777777888888888888888888544445688888888888888888777764


Q ss_pred             cc-----ccccccCCCCCC
Q 006968          190 SA-----RTFKVTGNPLIC  203 (623)
Q Consensus       190 ~~-----~~~~~~~n~~~~  203 (623)
                      +.     +.+++++|.+..
T Consensus       167 ~~~l~~L~~L~L~~N~l~~  185 (597)
T 3oja_B          167 FQATTSLQNLQLSSNRLTH  185 (597)
T ss_dssp             TTTCTTCCEEECTTSCCSB
T ss_pred             hhcCCcCcEEECcCCCCCC
Confidence            43     556777777643

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.55  E-value=2.2e-15  Score=153.10  Aligned_cols=141  Identities=22%  Similarity=0.246  Sum_probs=117.5

Q ss_pred             CCCCcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCC--CCCCccCCCCCccEEE
Q 006968           61 DPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILG--PIPASLGKLEKLQTLD  128 (623)
Q Consensus        61 ~~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~  128 (623)
                      ..|.|.+|.|+..          ..++.|+|++|+++...+..|.++++|++|+|++|+++.  ..|..+..+++|++|+
T Consensus         5 C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~   84 (306)
T 2z66_A            5 CSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD   84 (306)
T ss_dssp             CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred             CeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence            3479999999753          379999999999995545568999999999999999983  3366777899999999


Q ss_pred             ecCCCCCCCCCccccCCCCccchhccccccCCCCC-cccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCC
Q 006968          129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP-ESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI  202 (623)
Q Consensus       129 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~  202 (623)
                      |++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|+.|++++|.+++.+|..+.     +.+++++|.+.
T Consensus        85 Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  163 (306)
T 2z66_A           85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ  163 (306)
T ss_dssp             CCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred             CCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence            9999999 688889999999999999999986544 5788999999999999999988776543     56778888764

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.55  E-value=1e-14  Score=156.20  Aligned_cols=130  Identities=24%  Similarity=0.285  Sum_probs=89.4

Q ss_pred             cEEEEeCCCCCcccccCccc-------------------------cCCCCcceEEeecCCCCCCCCCccCCCCCccEEEe
Q 006968           75 YVSALGLPSQSLSGTLSPWI-------------------------GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL  129 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~-------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  129 (623)
                      +++.|+|++|.|++..+..|                         .++++|++|+|++|+++ .+| .+..+++|++|+|
T Consensus       137 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~L  214 (440)
T 3zyj_A          137 KLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDL  214 (440)
T ss_dssp             SCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEEC
T ss_pred             cCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEEC
Confidence            67888888888775444444                         44555555555556555 344 3566667777777


Q ss_pred             cCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCC
Q 006968          130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~  204 (623)
                      ++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+.     +.+++++||+.|.
T Consensus       215 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd  294 (440)
T 3zyj_A          215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN  294 (440)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred             CCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence            77777766677777777777777777777766677777778888888888888766655443     4577888888887


Q ss_pred             CC
Q 006968          205 PK  206 (623)
Q Consensus       205 ~~  206 (623)
                      |.
T Consensus       295 C~  296 (440)
T 3zyj_A          295 CD  296 (440)
T ss_dssp             ST
T ss_pred             CC
Confidence            64

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.54  E-value=2.5e-14  Score=147.10  Aligned_cols=140  Identities=24%  Similarity=0.324  Sum_probs=120.6

Q ss_pred             CCCcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecC
Q 006968           62 PCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN  131 (623)
Q Consensus        62 ~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  131 (623)
                      .|.|+.+.|+..          ..++.|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  111 (332)
T 2ft3_A           32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK  111 (332)
T ss_dssp             EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred             cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence            378999999742          3799999999999988888999999999999999999988899999999999999999


Q ss_pred             CCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCc--CcCCCCcc----ccccccCCCCCCC
Q 006968          132 NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS--GSLPKISA----RTFKVTGNPLICG  204 (623)
Q Consensus       132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~----~~~~~~~n~~~~~  204 (623)
                      |+++ .+|..+.  ++|++|+|++|++++..+..|..+++|+.|++++|.++  +..|..+.    +.+++++|.+...
T Consensus       112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l  187 (332)
T 2ft3_A          112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI  187 (332)
T ss_dssp             SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSC
T ss_pred             CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCcc
Confidence            9999 7888776  89999999999999766667999999999999999996  35555433    5677888876543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.53  E-value=6.9e-15  Score=143.80  Aligned_cols=128  Identities=21%  Similarity=0.268  Sum_probs=110.7

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCC-CCCCCCCccCCCCCccEEEecC-CCCCCCCCccccCCCCccch
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNA-ILGPIPASLGKLEKLQTLDLSN-NKFTGEIPDSLGDLGNLNYL  151 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L  151 (623)
                      ..++.|+|++|+|++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            479999999999998777799999999999999997 8866667899999999999999 99996666789999999999


Q ss_pred             hccccccCCCCCcccCCCCccc---EEECCCC-cCcCcCCCCcc-----c-cccccCCCCCC
Q 006968          152 RLNNNSLTGSCPESLSKIESLT---LVDLSYN-NLSGSLPKISA-----R-TFKVTGNPLIC  203 (623)
Q Consensus       152 ~l~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~~~-----~-~~~~~~n~~~~  203 (623)
                      +|++|++++ +|. +..+++|+   .|++++| .+++..+..+.     + .+++++|.+..
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~  170 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS  170 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCE
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcc
Confidence            999999995 776 88888888   9999999 99876665443     4 67788887753

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.53  E-value=1.7e-14  Score=161.03  Aligned_cols=130  Identities=18%  Similarity=0.136  Sum_probs=117.5

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      ..++.|+|++|+|++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  112 (606)
T 3t6q_A           33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF  112 (606)
T ss_dssp             TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred             CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence            47999999999999888999999999999999999999988999999999999999999999888999999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcC-cCCCCcc----ccccccCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKISA----RTFKVTGNPLIC  203 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~----~~~~~~~n~~~~  203 (623)
                      ++|++++..|..+.++++|+.|+|++|++++ .+|....    +.+++++|.+..
T Consensus       113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  167 (606)
T 3t6q_A          113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY  167 (606)
T ss_dssp             TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE
T ss_pred             cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccc
Confidence            9999997667889999999999999999997 4455433    567888887653

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.53  E-value=8.4e-15  Score=163.44  Aligned_cols=130  Identities=28%  Similarity=0.347  Sum_probs=69.0

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCC---CCCccCCCCCccEEEecCCCCCCCCCccccCCCCccch
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGP---IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL  151 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  151 (623)
                      .++.|+|++|.+++..|..+.++++|++|+|++|++++.   .+..+..+++|++|+|++|++++..|..|..+++|++|
T Consensus       426 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  505 (606)
T 3t6q_A          426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV  505 (606)
T ss_dssp             TCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             cCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEE
Confidence            344455555555444444455555555555555555431   12334555555555555555554445555555555555


Q ss_pred             hccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCC
Q 006968          152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       152 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~  205 (623)
                      +|++|++++..|..+.++++| .|+|++|++++.+|..+.     +.+++++|++.|.+
T Consensus       506 ~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  563 (606)
T 3t6q_A          506 DLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC  563 (606)
T ss_dssp             ECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred             ECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence            555555555555555555555 555555555555554322     44566666666654

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.53  E-value=1.8e-14  Score=154.71  Aligned_cols=130  Identities=24%  Similarity=0.276  Sum_probs=96.2

Q ss_pred             cEEEEeCCCCCcccccCcc-------------------------ccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEe
Q 006968           75 YVSALGLPSQSLSGTLSPW-------------------------IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL  129 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~-------------------------~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  129 (623)
                      +++.|+|++|+|++..+..                         |.++++|++|+|++|++++ +| .+..+++|++|+|
T Consensus       148 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~L  225 (452)
T 3zyi_A          148 KLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEM  225 (452)
T ss_dssp             TCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEEC
T ss_pred             CCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEEC
Confidence            6888888888887544434                         4455566666666666663 34 3667777777777


Q ss_pred             cCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCC
Q 006968          130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~  204 (623)
                      ++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+.     +.+++++|++.|.
T Consensus       226 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd  305 (452)
T 3zyi_A          226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD  305 (452)
T ss_dssp             TTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred             cCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence            77887777777888888888888888888877777888888888888888888866665543     5678888888887


Q ss_pred             CC
Q 006968          205 PK  206 (623)
Q Consensus       205 ~~  206 (623)
                      |.
T Consensus       306 C~  307 (452)
T 3zyi_A          306 CD  307 (452)
T ss_dssp             TT
T ss_pred             CC
Confidence            75

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.52  E-value=1.2e-14  Score=152.92  Aligned_cols=130  Identities=15%  Similarity=0.141  Sum_probs=106.5

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      ..++.|++++|.++...+..+.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus        45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  124 (390)
T 3o6n_A           45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  124 (390)
T ss_dssp             CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence            36788899999988544455788999999999999999777778999999999999999999777788899999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC  203 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~  203 (623)
                      ++|++++..+..|..+++|+.|+|++|++++..|..+.     +.+++++|.+..
T Consensus       125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  179 (390)
T 3o6n_A          125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH  179 (390)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred             CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence            99999844334468899999999999999987776443     567788887643

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.52  E-value=1.3e-14  Score=160.54  Aligned_cols=130  Identities=20%  Similarity=0.313  Sum_probs=65.3

Q ss_pred             EEEEeCCCCCcccccC-ccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCC-CCCCccccCCCCccchhc
Q 006968           76 VSALGLPSQSLSGTLS-PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-GEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        76 v~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l  153 (623)
                      ++.|+|++|.+++..+ ..+.++++|++|+|++|++++..|..+.++++|++|+|++|+++ +.+|..+..+++|++|+|
T Consensus       398 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l  477 (570)
T 2z63_A          398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL  477 (570)
T ss_dssp             CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred             CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEEC
Confidence            3334444444443333 23444555555555555555444555555555555555555554 345555555555555555


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~  205 (623)
                      ++|++++..|..+..+++|+.|+|++|++++.+|..+.     +.+++++|++.|.+
T Consensus       478 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  534 (570)
T 2z63_A          478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  534 (570)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred             CCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence            55555544455555555555555555555554444322     34455555555544

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.52  E-value=2.9e-14  Score=161.30  Aligned_cols=130  Identities=22%  Similarity=0.227  Sum_probs=108.0

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|+++++|++|+|
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            47899999999999877778899999999999999999888888888999999999999998444446888999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC  203 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~  203 (623)
                      ++|++++..|..|.++++|++|+|++|.+++.+|..+.     +.+++++|.+..
T Consensus       105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  159 (680)
T 1ziw_A          105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA  159 (680)
T ss_dssp             CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCC
T ss_pred             CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccc
Confidence            99999876677888999999999999999887776543     556777776643

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.51  E-value=4.3e-14  Score=145.18  Aligned_cols=139  Identities=23%  Similarity=0.359  Sum_probs=119.4

Q ss_pred             CCCcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecC
Q 006968           62 PCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN  131 (623)
Q Consensus        62 ~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  131 (623)
                      .|.|+.+.|+..          ..++.|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  109 (330)
T 1xku_A           30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK  109 (330)
T ss_dssp             EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence            468999999742          3789999999999987777999999999999999999988899999999999999999


Q ss_pred             CCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcC--cCCCCcc-----ccccccCCCCCC
Q 006968          132 NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG--SLPKISA-----RTFKVTGNPLIC  203 (623)
Q Consensus       132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~-----~~~~~~~n~~~~  203 (623)
                      |+++ .+|..+.  ++|++|++++|++++..+..+..+++|+.|++++|.++.  ..+..+.     +.+++++|.+..
T Consensus       110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~  185 (330)
T 1xku_A          110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  185 (330)
T ss_dssp             SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence            9999 7887765  799999999999997777789999999999999999963  4554433     557778887643

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.51  E-value=5e-15  Score=166.02  Aligned_cols=131  Identities=22%  Similarity=0.381  Sum_probs=119.5

Q ss_pred             CcEEEEeCCCCCcccc-----------------cCcccc--CCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCC-
Q 006968           74 GYVSALGLPSQSLSGT-----------------LSPWIG--NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK-  133 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-  133 (623)
                      .+++.|+|++|.|+|.                 +|..++  ++++|++|+|++|++.|.+|..|+++++|++|+|++|+ 
T Consensus       206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~  285 (636)
T 4eco_A          206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG  285 (636)
T ss_dssp             TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred             cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence            4799999999999996                 999999  99999999999999999999999999999999999999 


Q ss_pred             CCC-CCCccccCC------CCccchhccccccCCCCCc--ccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCC
Q 006968          134 FTG-EIPDSLGDL------GNLNYLRLNNNSLTGSCPE--SLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNP  200 (623)
Q Consensus       134 l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~  200 (623)
                      ++| .+|..++++      ++|++|+|++|+++ .+|.  .+.++++|+.|+|++|+++|.+|.+..    +.+++++|.
T Consensus       286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N~  364 (636)
T 4eco_A          286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQ  364 (636)
T ss_dssp             SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSSE
T ss_pred             CccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCCc
Confidence            998 899999887      99999999999999 8998  999999999999999999999993322    567888888


Q ss_pred             CCCCC
Q 006968          201 LICGP  205 (623)
Q Consensus       201 ~~~~~  205 (623)
                      +...+
T Consensus       365 l~~lp  369 (636)
T 4eco_A          365 ITEIP  369 (636)
T ss_dssp             EEECC
T ss_pred             ccccc
Confidence            76433

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.51  E-value=2.4e-14  Score=165.84  Aligned_cols=139  Identities=21%  Similarity=0.213  Sum_probs=106.7

Q ss_pred             CCcceeeeCCCCcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCC-CCccCCCCCccEEEecCCCCCCCCCcc
Q 006968           63 CSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLDLSNNKFTGEIPDS  141 (623)
Q Consensus        63 c~w~gv~c~~~~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~  141 (623)
                      |.|..|.+ -..+++.|+|++|.|++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|+|++..|..
T Consensus        14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~   92 (844)
T 3j0a_A           14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA   92 (844)
T ss_dssp             CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred             CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence            45666666 3457889999999998888888888888888888888666555 777888888888888888888777888


Q ss_pred             ccCCCCccchhccccccCCCCCcc--cCCCCcccEEECCCCcCcCcCCC-Ccc-----ccccccCCCCC
Q 006968          142 LGDLGNLNYLRLNNNSLTGSCPES--LSKIESLTLVDLSYNNLSGSLPK-ISA-----RTFKVTGNPLI  202 (623)
Q Consensus       142 ~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p~-~~~-----~~~~~~~n~~~  202 (623)
                      |+++++|++|+|++|.+++.+|..  |.++++|+.|+|++|.+++..|. .+.     +.+++++|.+.
T Consensus        93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~  161 (844)
T 3j0a_A           93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF  161 (844)
T ss_dssp             SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred             ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence            888888888888888888766654  78888888888888888776543 222     45666777653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.50  E-value=2.2e-14  Score=157.86  Aligned_cols=110  Identities=26%  Similarity=0.321  Sum_probs=102.1

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            58899999999996 676 999999999999999999 889999999999999999999995 77 89999999999999


Q ss_pred             ccccCCCC-CcccCCCCcccEEECCCCcCcCcCCCC
Q 006968          155 NNSLTGSC-PESLSKIESLTLVDLSYNNLSGSLPKI  189 (623)
Q Consensus       155 ~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~  189 (623)
                      +|+|++.. |..|..+++|+.|+|++|+|++.+|..
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence            99999776 999999999999999999999877643

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.49  E-value=6.5e-14  Score=129.20  Aligned_cols=105  Identities=24%  Similarity=0.260  Sum_probs=92.8

Q ss_pred             CcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECC
Q 006968           99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLS  178 (623)
Q Consensus        99 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~  178 (623)
                      ..+.|++++|+++ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            3578999999999 5887774  899999999999998889999999999999999999997777778999999999999


Q ss_pred             CCcCcCcCCCCcc-----ccccccCCCCCCCCC
Q 006968          179 YNNLSGSLPKISA-----RTFKVTGNPLICGPK  206 (623)
Q Consensus       179 ~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~  206 (623)
                      +|+|++..+..+.     +.+++++|++.|.+.
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            9999987776543     578999999999864

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.48  E-value=3.2e-14  Score=134.72  Aligned_cols=103  Identities=17%  Similarity=0.284  Sum_probs=55.5

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+++ .+| .+..+++|++|+|++|.++ . +..+..+++|++|+|++|++++..|..++.+++|++|+|+
T Consensus        45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls  120 (197)
T 4ezg_A           45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS  120 (197)
T ss_dssp             TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred             CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence            3555555555555 333 3555555555555555443 1 2245555555555555555555455555555555555555


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCc
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNN  181 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~  181 (623)
                      +|++++..|..+..+++|+.|+|++|.
T Consensus       121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~  147 (197)
T 4ezg_A          121 HSAHDDSILTKINTLPKVNSIDLSYNG  147 (197)
T ss_dssp             SSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred             CCccCcHhHHHHhhCCCCCEEEccCCC
Confidence            555554445555555555555555555

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.48  E-value=6.4e-14  Score=154.94  Aligned_cols=130  Identities=18%  Similarity=0.153  Sum_probs=102.8

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence            36888888888888777778888888888888888888777778888888888888888888666678888888888888


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcC-cCCCCcc-----ccccccCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKISA-----RTFKVTGNPLIC  203 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~-----~~~~~~~n~~~~  203 (623)
                      ++|++++..+..++++++|+.|+|++|.+++ .+|..+.     +.+++++|.+..
T Consensus       108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~  163 (570)
T 2z63_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS  163 (570)
T ss_dssp             TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCE
T ss_pred             cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccce
Confidence            8888885544468888888888888888876 4566443     556777777643

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.48  E-value=8.5e-14  Score=154.92  Aligned_cols=129  Identities=20%  Similarity=0.140  Sum_probs=113.0

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|.|++..|..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+++++|++|+|
T Consensus        75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  154 (597)
T 3oja_B           75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM  154 (597)
T ss_dssp             CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence            37999999999999988889999999999999999999988888999999999999999999554555799999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc--ccccccCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPLI  202 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~~  202 (623)
                      ++|.+++..|..|..+++|+.|+|++|.|++..+..+.  ..+++++|.+.
T Consensus       155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~  205 (597)
T 3oja_B          155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS  205 (597)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCS
T ss_pred             eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccc
Confidence            99999988888999999999999999999975433332  45667777653

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.48  E-value=7e-14  Score=154.52  Aligned_cols=131  Identities=21%  Similarity=0.306  Sum_probs=68.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCC--CCCccCCCCCccEEEecCCCCCCCCCcc-ccCCCCccch
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGP--IPASLGKLEKLQTLDLSNNKFTGEIPDS-LGDLGNLNYL  151 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L  151 (623)
                      .++.|+|++|++++.+|..++++++|++|+|++|++++.  +|..+.++++|++|+|++|++++.+|.. +..+++|++|
T Consensus       354 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L  433 (562)
T 3a79_B          354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL  433 (562)
T ss_dssp             CCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEE
T ss_pred             CceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEE
Confidence            466666666666665666666666666666666666542  2344555666666666666666534432 4444444444


Q ss_pred             hccccccCC---------------------CCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCC
Q 006968          152 RLNNNSLTG---------------------SCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       152 ~l~~N~l~~---------------------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~  205 (623)
                      +|++|++++                     .+|..+..+++|+.|+|++|+|++..+..+.     +.+++++|++.|.+
T Consensus       434 ~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c  513 (562)
T 3a79_B          434 NLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC  513 (562)
T ss_dssp             ECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred             ECCCCCCCcchhhhhcCcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence            444444443                     4444444555555555555555532222111     33455555555543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.48  E-value=1.2e-14  Score=159.32  Aligned_cols=136  Identities=25%  Similarity=0.412  Sum_probs=104.0

Q ss_pred             ccCCCCCCCCCCC-----Cccee-eeCCCCcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCc
Q 006968           51 VLENWDITSVDPC-----SWRMI-TCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL  124 (623)
Q Consensus        51 ~~~~w~~~~~~~c-----~w~gv-~c~~~~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  124 (623)
                      .+.+|.. +.+||     .|.|+ .|.. ++++.|+|++|+|++ +|..+  +++|++|+|++|+|+ .+|   ..+++|
T Consensus        32 ~l~~W~~-~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L  102 (571)
T 3cvr_A           32 AWDKWEK-QALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASL  102 (571)
T ss_dssp             HHHHHHT-TCCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred             HHHHHhc-cCCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCC
Confidence            4556753 46788     79999 7864 479999999999986 77766  378999999999998 677   457889


Q ss_pred             cEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc--ccccccCCCCC
Q 006968          125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPLI  202 (623)
Q Consensus       125 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~~  202 (623)
                      ++|+|++|+|++ +|. +.+  +|++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|....  +.+++++|.+.
T Consensus       103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~L~  173 (571)
T 3cvr_A          103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQLT  173 (571)
T ss_dssp             CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS
T ss_pred             CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCCCC
Confidence            999999999985 777 665  88888888888885 666   57888888888888886 554332  56777777765


Q ss_pred             CC
Q 006968          203 CG  204 (623)
Q Consensus       203 ~~  204 (623)
                      ..
T Consensus       174 ~l  175 (571)
T 3cvr_A          174 FL  175 (571)
T ss_dssp             CC
T ss_pred             Cc
Confidence            43

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.48  E-value=7e-14  Score=144.66  Aligned_cols=131  Identities=19%  Similarity=0.184  Sum_probs=104.2

Q ss_pred             CCcceeeeCCCCcEEEEeCCCC-CcccccCccccCCCCcceEEeec-CCCCCCCCCccCCCCCccEEEecCCCCCCCCCc
Q 006968           63 CSWRMITCSPDGYVSALGLPSQ-SLSGTLSPWIGNLTKLQSVLLQN-NAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD  140 (623)
Q Consensus        63 c~w~gv~c~~~~~v~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  140 (623)
                      |.|..|.|+           ++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|.
T Consensus         8 C~~~~v~~~-----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~   74 (347)
T 2ifg_A            8 HGSSGLRCT-----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD   74 (347)
T ss_dssp             SSSSCEECC-----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred             ccCCEEEcC-----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence            788777774           44 787 4888 99999999999996 999988788999999999999999999998888


Q ss_pred             cccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCC-cc-----ccccccCCCCCCCCCC
Q 006968          141 SLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI-SA-----RTFKVTGNPLICGPKA  207 (623)
Q Consensus       141 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~-----~~~~~~~n~~~~~~~~  207 (623)
                      .|.+|++|+.|+|++|+|++..+..+..++ |+.|+|++|+|.....-. +.     ....+..+.+.|..+.
T Consensus        75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            999999999999999999965555566555 999999999998542210 11     2233445666676543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.48  E-value=5.7e-14  Score=158.95  Aligned_cols=132  Identities=24%  Similarity=0.292  Sum_probs=97.6

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCC--------CCccCCCCCccEEEecCCCCCCCCCc-cccCC
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI--------PASLGKLEKLQTLDLSNNKFTGEIPD-SLGDL  145 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--------p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l  145 (623)
                      .++.|+|++|+|++..+..|.++++|++|+|++|++++..        +..|.++++|++|+|++|+|+ .+|. .|.++
T Consensus       481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l  559 (680)
T 1ziw_A          481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDL  559 (680)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTC
T ss_pred             CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccc
Confidence            5777777777777666666777777777777777776431        123677778888888888888 4554 57888


Q ss_pred             CCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc------ccccccCCCCCCCCCC
Q 006968          146 GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA------RTFKVTGNPLICGPKA  207 (623)
Q Consensus       146 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~------~~~~~~~n~~~~~~~~  207 (623)
                      ++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..|..+.      +.+++++||+.|.|..
T Consensus       560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            8888888888888865555677888888888888888877665332      5678899999998763

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.47  E-value=5.7e-14  Score=153.67  Aligned_cols=107  Identities=24%  Similarity=0.300  Sum_probs=63.1

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCC--CCCCccCCCCCccEEEecCCCCCCCCCcc-ccCCCCccch
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILG--PIPASLGKLEKLQTLDLSNNKFTGEIPDS-LGDLGNLNYL  151 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L  151 (623)
                      .++.|+|++|++++.+|..++++++|++|+|++|++++  .+|..+.++++|++|+|++|++++.+|.. +..+++|++|
T Consensus       325 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L  404 (520)
T 2z7x_B          325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL  404 (520)
T ss_dssp             CCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEE
T ss_pred             cccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEE
Confidence            56666666666666666666666666666666666664  34455666666666666666666545543 5555555555


Q ss_pred             hccccccCCCCCcccCCCCcccEEECCCCcCc
Q 006968          152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS  183 (623)
Q Consensus       152 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  183 (623)
                      +|++|++++.+|..+.  ++|+.|+|++|+|+
T Consensus       405 ~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~  434 (520)
T 2z7x_B          405 NMSSNILTDTIFRCLP--PRIKVLDLHSNKIK  434 (520)
T ss_dssp             ECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred             ECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence            5555555544444433  45555555555555

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.47  E-value=6.1e-14  Score=145.98  Aligned_cols=132  Identities=24%  Similarity=0.245  Sum_probs=114.9

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus        64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  143 (361)
T 2xot_A           64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL  143 (361)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence            37999999999999888889999999999999999999877888999999999999999999888899999999999999


Q ss_pred             cccccCCCCCcc-c---CCCCcccEEECCCCcCcCcCCCCcc-------ccccccCCCCCCCCC
Q 006968          154 NNNSLTGSCPES-L---SKIESLTLVDLSYNNLSGSLPKISA-------RTFKVTGNPLICGPK  206 (623)
Q Consensus       154 ~~N~l~~~~p~~-~---~~l~~L~~L~l~~N~l~~~~p~~~~-------~~~~~~~n~~~~~~~  206 (623)
                      ++|+|++ +|.. |   ..+++|+.|+|++|+|++..+..+.       +.+.+.+|++.|.|.
T Consensus       144 ~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          144 SQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             CSSCCCS-CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             CCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            9999995 5554 4   5799999999999999965443222       458899999999864

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.47  E-value=4.6e-14  Score=144.14  Aligned_cols=124  Identities=21%  Similarity=0.170  Sum_probs=74.4

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCcccc-CCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG-DLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l  153 (623)
                      .++.|+|++|+|++..+..   +++|++|+|++|++++..|..+..+++|++|+|++|++++..|..+. .+++|++|+|
T Consensus       100 ~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L  176 (317)
T 3o53_A          100 SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL  176 (317)
T ss_dssp             TCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred             CcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence            5666666666666544332   45666777777777665565666666777777777777655555553 5666777777


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLIC  203 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~  203 (623)
                      ++|.+++. | ....+++|+.|+|++|+|++.++.+..    +.+++++|.+..
T Consensus       177 ~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~  228 (317)
T 3o53_A          177 QYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL  228 (317)
T ss_dssp             TTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE
T ss_pred             CCCcCccc-c-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccc
Confidence            77766633 2 233466666666666666654444221    455666666543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.47  E-value=6.4e-14  Score=132.59  Aligned_cols=122  Identities=16%  Similarity=0.245  Sum_probs=105.6

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|.++  .++.+.++++|++|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++|++|+|+
T Consensus        67 ~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~  144 (197)
T 4ezg_A           67 NIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS  144 (197)
T ss_dssp             TCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred             CCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence            7999999999776  34578999999999999999998888999999999999999999998889999999999999999


Q ss_pred             ccc-cCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCC
Q 006968          155 NNS-LTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPL  201 (623)
Q Consensus       155 ~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~  201 (623)
                      +|. ++ .+| .+..+++|+.|++++|++++. +.+..    +.+++++|++
T Consensus       145 ~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~~l~~l~~L~~L~l~~N~i  193 (197)
T 4ezg_A          145 YNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-RGIEDFPKLNQLYAFSQTI  193 (197)
T ss_dssp             SCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-TTGGGCSSCCEEEECBC--
T ss_pred             CCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-HHhccCCCCCEEEeeCccc
Confidence            998 65 666 799999999999999999963 33221    5677888875

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.47  E-value=1.4e-13  Score=127.51  Aligned_cols=103  Identities=29%  Similarity=0.307  Sum_probs=90.6

Q ss_pred             ceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCC
Q 006968          101 QSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN  180 (623)
Q Consensus       101 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  180 (623)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            68999999997 7888775  89999999999999888999999999999999999999765566799999999999999


Q ss_pred             cCcCcCCCCcc-----ccccccCCCCCCCCC
Q 006968          181 NLSGSLPKISA-----RTFKVTGNPLICGPK  206 (623)
Q Consensus       181 ~l~~~~p~~~~-----~~~~~~~n~~~~~~~  206 (623)
                      +|++.++..+.     +.+++++|++.|.+.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            99977766443     568899999988764

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.46  E-value=2.8e-14  Score=163.60  Aligned_cols=130  Identities=22%  Similarity=0.295  Sum_probs=116.1

Q ss_pred             CcEEEEeCCCCCccc-----------------ccCcccc--CCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCC-
Q 006968           74 GYVSALGLPSQSLSG-----------------TLSPWIG--NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK-  133 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-  133 (623)
                      .+++.|+|++|+|+|                 .+|..++  ++++|++|+|++|++.+.+|..|+++++|+.|+|++|+ 
T Consensus       448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~  527 (876)
T 4ecn_A          448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG  527 (876)
T ss_dssp             TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred             CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence            479999999999998                 4999988  99999999999999999999999999999999999998 


Q ss_pred             CCC-CCCccccCCC-------CccchhccccccCCCCCc--ccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCC
Q 006968          134 FTG-EIPDSLGDLG-------NLNYLRLNNNSLTGSCPE--SLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGN  199 (623)
Q Consensus       134 l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n  199 (623)
                      |+| .+|..+++++       +|++|+|++|+++ .+|.  .|.++++|+.|+|++|+|+ .+|.+..    +.+++++|
T Consensus       528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~N  605 (876)
T 4ecn_A          528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN  605 (876)
T ss_dssp             SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCSS
T ss_pred             cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcCC
Confidence            998 8998777666       9999999999999 8998  8999999999999999999 8884332    56888999


Q ss_pred             CCCCCC
Q 006968          200 PLICGP  205 (623)
Q Consensus       200 ~~~~~~  205 (623)
                      .+...+
T Consensus       606 ~l~~lp  611 (876)
T 4ecn_A          606 QIEEIP  611 (876)
T ss_dssp             CCSCCC
T ss_pred             ccccch
Confidence            876433

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.45  E-value=2.1e-13  Score=143.50  Aligned_cols=128  Identities=21%  Similarity=0.188  Sum_probs=111.4

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCcc-ccCCCCccchh
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDS-LGDLGNLNYLR  152 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~  152 (623)
                      .+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|.. |.++++|++|+
T Consensus        69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~  147 (390)
T 3o6n_A           69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS  147 (390)
T ss_dssp             CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred             ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence            37999999999999888889999999999999999999888888999999999999999999 56655 68999999999


Q ss_pred             ccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc--ccccccCCCCC
Q 006968          153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPLI  202 (623)
Q Consensus       153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~~  202 (623)
                      |++|++++..|..+..+++|+.|++++|++++.....+.  +.+++++|.+.
T Consensus       148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~  199 (390)
T 3o6n_A          148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS  199 (390)
T ss_dssp             CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCS
T ss_pred             CCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeeccccccc
Confidence            999999988888899999999999999999965333222  45667777653

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.45  E-value=4.9e-14  Score=129.69  Aligned_cols=107  Identities=27%  Similarity=0.286  Sum_probs=97.3

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCC--ccccCCCCccchh
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP--DSLGDLGNLNYLR  152 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~  152 (623)
                      +++.|+|++|.|++.  ..+.++++|++|+|++|++++.+|..+.++++|++|+|++|+|++ +|  ..+..+++|++|+
T Consensus        50 ~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L~  126 (168)
T 2ell_A           50 NLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKSLD  126 (168)
T ss_dssp             GCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCEEE
T ss_pred             CCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCEEE
Confidence            799999999999976  789999999999999999998888888889999999999999995 44  7899999999999


Q ss_pred             ccccccCCCCC---cccCCCCcccEEECCCCcCcC
Q 006968          153 LNNNSLTGSCP---ESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       153 l~~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      |++|.+++..+   ..+..+++|+.|++++|.+..
T Consensus       127 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~  161 (168)
T 2ell_A          127 LFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE  161 (168)
T ss_dssp             CCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred             eeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence            99999995544   489999999999999999884

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.45  E-value=1.5e-14  Score=147.44  Aligned_cols=108  Identities=23%  Similarity=0.312  Sum_probs=51.8

Q ss_pred             EEEEeCCCCCc-ccccCcccc-------CCCCcceEEeecCCCCCCCCCcc--CCCCCccEEEecCCCCCCCCCccccCC
Q 006968           76 VSALGLPSQSL-SGTLSPWIG-------NLTKLQSVLLQNNAILGPIPASL--GKLEKLQTLDLSNNKFTGEIPDSLGDL  145 (623)
Q Consensus        76 v~~L~L~~n~l-~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l  145 (623)
                      ++.|+|++|.+ .+.+|..+.       ++++|++|+|++|++++.+|..+  ..+++|++|+|++|++++. |..++.+
T Consensus        65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l  143 (312)
T 1wwl_A           65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL  143 (312)
T ss_dssp             HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred             HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence            44445555555 233343333       44555555555555554444443  4455555555555555533 4444444


Q ss_pred             -----CCccchhccccccCCCCCcccCCCCcccEEECCCCcCcC
Q 006968          146 -----GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       146 -----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  184 (623)
                           ++|++|+|++|++++..|..|..+++|+.|+|++|+++|
T Consensus       144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  187 (312)
T 1wwl_A          144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG  187 (312)
T ss_dssp             HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCH
T ss_pred             HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCc
Confidence                 455555555555544444445555555555555555443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.45  E-value=8.4e-14  Score=150.63  Aligned_cols=130  Identities=22%  Similarity=0.193  Sum_probs=114.9

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|.|++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|
T Consensus        56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l  135 (477)
T 2id5_A           56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV  135 (477)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred             CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence            37999999999999988999999999999999999999766667899999999999999999888899999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC  203 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~  203 (623)
                      ++|.+++..|..|..+++|+.|+|++|++++..+..+.     +.+++.+|.+..
T Consensus       136 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~  190 (477)
T 2id5_A          136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA  190 (477)
T ss_dssp             CCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE
T ss_pred             CCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE
Confidence            99999988888999999999999999999976554332     567788887643

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.44  E-value=1.9e-13  Score=140.28  Aligned_cols=128  Identities=25%  Similarity=0.260  Sum_probs=91.2

Q ss_pred             CcEEEEeCCCCCccc--ccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccch
Q 006968           74 GYVSALGLPSQSLSG--TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL  151 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  151 (623)
                      ..++.|+|++|.++.  ..+..+.++++|++|+|++|+++ .+|..+.  ++|++|+|++|++++..|..+..+++|++|
T Consensus       145 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  221 (330)
T 1xku_A          145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKL  221 (330)
T ss_dssp             TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred             ccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence            368888888888853  66777888888888888888877 4565543  677777777777776667777777777777


Q ss_pred             hccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCC
Q 006968          152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       152 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~  205 (623)
                      +|++|.+++..+..+..+++|+.|+|++|+++ .+|..+.     +.+++++|++...+
T Consensus       222 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~  279 (330)
T 1xku_A          222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIG  279 (330)
T ss_dssp             ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCC
T ss_pred             ECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccC
Confidence            77777777666667777777777777777777 4444322     45667777765443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.44  E-value=3.6e-14  Score=144.65  Aligned_cols=128  Identities=19%  Similarity=0.195  Sum_probs=94.7

Q ss_pred             cEEEEeCCCCCcccccCccc--cCCCCcceEEeecCCCCCCCCCccCCC-----CCccEEEecCCCCCCCCCccccCCCC
Q 006968           75 YVSALGLPSQSLSGTLSPWI--GNLTKLQSVLLQNNAILGPIPASLGKL-----EKLQTLDLSNNKFTGEIPDSLGDLGN  147 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~  147 (623)
                      +++.|+|++|++++.+|..+  .++++|++|+|++|++++. |..+..+     ++|++|+|++|++++..|..|+.+++
T Consensus        96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~  174 (312)
T 1wwl_A           96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA  174 (312)
T ss_dssp             CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred             CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence            68888888888888888765  7888888888888888866 7777766     78888888888888766678888888


Q ss_pred             ccchhccccccCCC--CCccc--CCCCcccEEECCCCcCcC--cCCCC------ccccccccCCCCCC
Q 006968          148 LNYLRLNNNSLTGS--CPESL--SKIESLTLVDLSYNNLSG--SLPKI------SARTFKVTGNPLIC  203 (623)
Q Consensus       148 L~~L~l~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~--~~p~~------~~~~~~~~~n~~~~  203 (623)
                      |++|+|++|++.+.  +|..+  ..+++|+.|+|++|+|++  .++..      .-+.+++++|.+..
T Consensus       175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~  242 (312)
T 1wwl_A          175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD  242 (312)
T ss_dssp             CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCS
T ss_pred             CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCc
Confidence            88888888887654  23344  777888888888888873  22211      11567777777654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.43  E-value=1.1e-13  Score=140.86  Aligned_cols=110  Identities=20%  Similarity=0.102  Sum_probs=51.6

Q ss_pred             cEEEEeCCCCCcccccC----ccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCC--CC--ccccCCC
Q 006968           75 YVSALGLPSQSLSGTLS----PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE--IP--DSLGDLG  146 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p--~~~~~l~  146 (623)
                      .++.|+|++|++++..+    ..+..+++|++|+|++|++++..|..|.++++|++|||++|++.+.  ++  ..+..++
T Consensus       118 ~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~  197 (310)
T 4glp_A          118 ALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFP  197 (310)
T ss_dssp             CCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSC
T ss_pred             CCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCC
Confidence            45555555555554333    2233455555555555555544445555555555555555554421  11  1123444


Q ss_pred             CccchhccccccCCCCCc----ccCCCCcccEEECCCCcCcCc
Q 006968          147 NLNYLRLNNNSLTGSCPE----SLSKIESLTLVDLSYNNLSGS  185 (623)
Q Consensus       147 ~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~  185 (623)
                      +|++|+|++|+++ .+|.    .+..+++|+.|+|++|+|++.
T Consensus       198 ~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~  239 (310)
T 4glp_A          198 AIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRAT  239 (310)
T ss_dssp             CCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCC
T ss_pred             CCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCcc
Confidence            5555555555554 2222    123444555555555555544

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.43  E-value=9.4e-14  Score=144.08  Aligned_cols=127  Identities=18%  Similarity=0.196  Sum_probs=110.3

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCc--cccCCCCccch
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD--SLGDLGNLNYL  151 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L  151 (623)
                      .+++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++ .+|.  .+..+++|++|
T Consensus        76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L  154 (353)
T 2z80_A           76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL  154 (353)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEE
T ss_pred             CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEE
Confidence            47999999999999888889999999999999999999655555899999999999999999 5665  78999999999


Q ss_pred             hccccc-cCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCC
Q 006968          152 RLNNNS-LTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPL  201 (623)
Q Consensus       152 ~l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~  201 (623)
                      +|++|+ +++..|..+..+++|+.|++++|.+++..|..+.     +.+++++|.+
T Consensus       155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l  210 (353)
T 2z80_A          155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH  210 (353)
T ss_dssp             EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred             ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence            999994 7766678899999999999999999988777654     4567777764

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.43  E-value=1.7e-13  Score=149.98  Aligned_cols=130  Identities=18%  Similarity=0.261  Sum_probs=100.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCC--CCCccccCCCCccchh
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG--EIPDSLGDLGNLNYLR  152 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~  152 (623)
                      .++.|++++|++.+..  .+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++  .+|..+..+++|++|+
T Consensus       303 ~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~  380 (520)
T 2z7x_B          303 NIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD  380 (520)
T ss_dssp             CCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred             ceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEE
Confidence            5888888888876432  12578888888888888888788888888888888888888886  5667788888888888


Q ss_pred             ccccccCCCCCcc-cCCCCcccEEECCCCcCcCcCCCCcc---ccccccCCCCCCCCC
Q 006968          153 LNNNSLTGSCPES-LSKIESLTLVDLSYNNLSGSLPKISA---RTFKVTGNPLICGPK  206 (623)
Q Consensus       153 l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~~---~~~~~~~n~~~~~~~  206 (623)
                      |++|++++.+|.. +..+++|+.|+|++|++++.+|....   +.+++++|.+...+.
T Consensus       381 Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~~ip~  438 (520)
T 2z7x_B          381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPK  438 (520)
T ss_dssp             CCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCCCCCG
T ss_pred             CCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEECCCCcccccch
Confidence            8888888756654 77788888888888888877766542   567788887765443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.41  E-value=2e-13  Score=133.27  Aligned_cols=126  Identities=20%  Similarity=0.202  Sum_probs=107.9

Q ss_pred             CcEEEEeCCCCC-cccccCccccCCCCcceEEeec-CCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCcc--
Q 006968           74 GYVSALGLPSQS-LSGTLSPWIGNLTKLQSVLLQN-NAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN--  149 (623)
Q Consensus        74 ~~v~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~--  149 (623)
                      .+++.|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+|++|++++ +|. +..+++|+  
T Consensus        55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L  132 (239)
T 2xwt_C           55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF  132 (239)
T ss_dssp             TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred             CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence            379999999997 8876667899999999999998 99997777889999999999999999995 887 88888888  


Q ss_pred             -chhcccc-ccCCCCCcccCCCCccc-EEECCCCcCcCcCCC-Ccc----ccccccCCC-CC
Q 006968          150 -YLRLNNN-SLTGSCPESLSKIESLT-LVDLSYNNLSGSLPK-ISA----RTFKVTGNP-LI  202 (623)
Q Consensus       150 -~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~-~~~----~~~~~~~n~-~~  202 (623)
                       +|+|++| ++++..+..|..+++|+ .|++++|+++ .+|. .+.    +.+++++|+ +.
T Consensus       133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~  193 (239)
T 2xwt_C          133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT  193 (239)
T ss_dssp             EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCC
T ss_pred             cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcc
Confidence             9999999 99966666799999999 9999999999 4444 332    567888885 54

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.40  E-value=4.3e-13  Score=148.22  Aligned_cols=130  Identities=19%  Similarity=0.270  Sum_probs=111.5

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCC--CCCccccCCCCccchh
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG--EIPDSLGDLGNLNYLR  152 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~  152 (623)
                      .++.|++++|++....  ....+++|++|+|++|++++.+|..+.++++|++|+|++|++++  .+|..+.++++|++|+
T Consensus       332 ~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~  409 (562)
T 3a79_B          332 NIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD  409 (562)
T ss_dssp             CCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEE
T ss_pred             cceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEE
Confidence            5999999999986432  12689999999999999999999999999999999999999995  3356799999999999


Q ss_pred             ccccccCCCCCc-ccCCCCcccEEECCCCcCcCcCCCCcc---ccccccCCCCCCCCC
Q 006968          153 LNNNSLTGSCPE-SLSKIESLTLVDLSYNNLSGSLPKISA---RTFKVTGNPLICGPK  206 (623)
Q Consensus       153 l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~---~~~~~~~n~~~~~~~  206 (623)
                      |++|++++.+|. .+..+++|+.|+|++|++++.+|....   +.+++++|.+...+.
T Consensus       410 l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~  467 (562)
T 3a79_B          410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPK  467 (562)
T ss_dssp             CTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCT
T ss_pred             CCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhcCcCCEEECCCCcCcccCh
Confidence            999999985665 488899999999999999988776542   678899998875554

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.40  E-value=2.8e-13  Score=125.71  Aligned_cols=108  Identities=22%  Similarity=0.243  Sum_probs=92.0

Q ss_pred             cEEEEeCCCCCcccccCccccCCC-CcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLT-KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .++.|+|++|+++. ++. +..+. +|++|+|++|+|++.  ..|.++++|++|+|++|+|++..|..+..+++|++|+|
T Consensus        20 ~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   95 (176)
T 1a9n_A           20 RDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL   95 (176)
T ss_dssp             SCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred             CceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence            79999999999994 554 55555 999999999999965  67999999999999999999543344589999999999


Q ss_pred             cccccCCCCCc--ccCCCCcccEEECCCCcCcCcCCC
Q 006968          154 NNNSLTGSCPE--SLSKIESLTLVDLSYNNLSGSLPK  188 (623)
Q Consensus       154 ~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~  188 (623)
                      ++|+|+ .+|.  .+..+++|+.|++++|+++. +|.
T Consensus        96 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~  130 (176)
T 1a9n_A           96 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKH  130 (176)
T ss_dssp             CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STT
T ss_pred             CCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHh
Confidence            999997 6776  88999999999999999984 444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.40  E-value=1.3e-13  Score=149.23  Aligned_cols=128  Identities=23%  Similarity=0.259  Sum_probs=83.0

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCC----------------ccCCCCCccEEEecCCCCCCCC
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA----------------SLGKLEKLQTLDLSNNKFTGEI  138 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~----------------~~~~l~~L~~L~Ls~N~l~~~~  138 (623)
                      .++.|+|++|.|++..|  ++++++|++|+|++|.|++..+.                ....+++|+.|+|++|+|++..
T Consensus        59 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~~  136 (487)
T 3oja_A           59 KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLR  136 (487)
T ss_dssp             TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSGG
T ss_pred             CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCCCC
Confidence            57777777777776554  66666666666666666532110                0112455666777777777666


Q ss_pred             CccccCCCCccchhccccccCCCCCcccC-CCCcccEEECCCCcCcCcCCCCcc---ccccccCCCCCCC
Q 006968          139 PDSLGDLGNLNYLRLNNNSLTGSCPESLS-KIESLTLVDLSYNNLSGSLPKISA---RTFKVTGNPLICG  204 (623)
Q Consensus       139 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~---~~~~~~~n~~~~~  204 (623)
                      |..++.+++|+.|+|++|.+++.+|..+. .+++|+.|+|++|.|++..+....   +.+++++|.+...
T Consensus       137 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~  206 (487)
T 3oja_A          137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFM  206 (487)
T ss_dssp             GBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEE
T ss_pred             chhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCCC
Confidence            77777777777777777777776666665 677777777777777765433222   5567777776543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.40  E-value=8.9e-13  Score=135.45  Aligned_cols=125  Identities=22%  Similarity=0.275  Sum_probs=63.1

Q ss_pred             EEEEeCCCCCcccccCccccCCCCcceEEeecCCCC--CCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL--GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        76 v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      ++.|+|++|++++..+..|.++++|+.|+|++|.++  +..|..+..+ +|++|+|++|+++ .+|..+.  ++|++|+|
T Consensus       125 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l  200 (332)
T 2ft3_A          125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNELHL  200 (332)
T ss_dssp             CCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCCBC
T ss_pred             CCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-ccCcccc--CCCCEEEC
Confidence            444444444444333334555555555555555553  2344444444 3333333333333 2332222  45666666


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~  204 (623)
                      ++|.+++..|..+..+++|+.|+|++|++++..|..+.     +.+++++|.+...
T Consensus       201 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  256 (332)
T 2ft3_A          201 DHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRV  256 (332)
T ss_dssp             CSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBC
T ss_pred             CCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeec
Confidence            66666655555666666666666666666655543322     3455666655433

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.40  E-value=2.4e-13  Score=154.16  Aligned_cols=169  Identities=24%  Similarity=0.226  Sum_probs=107.1

Q ss_pred             CchHHHHHHHHHHhCCC-CCcccCCCCCCCCCCCCcceeeeCCC-----------------CcEEEEeCCCCCccc----
Q 006968           31 INYEVVALVAVKNNLHD-PYNVLENWDITSVDPCSWRMITCSPD-----------------GYVSALGLPSQSLSG----   88 (623)
Q Consensus        31 ~~~~~~~l~~~k~~~~~-p~~~~~~w~~~~~~~c~w~gv~c~~~-----------------~~v~~L~L~~n~l~~----   88 (623)
                      ...+..+|+++...... ....-.+|..+...++.|.+++++..                 ..+..++|+.|.|.+    
T Consensus       130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~  209 (727)
T 4b8c_D          130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDI  209 (727)
T ss_dssp             --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred             cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCcccc
Confidence            34466788888876632 22233457555556678888777542                 123344445555443    


Q ss_pred             -----ccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCC
Q 006968           89 -----TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP  163 (623)
Q Consensus        89 -----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  163 (623)
                           ..+..+..++.|+.|+|++|.+. .+|..+.++++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|
T Consensus       210 ~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp  286 (727)
T 4b8c_D          210 ENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLP  286 (727)
T ss_dssp             ------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCC
T ss_pred             ccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccC
Confidence                 33667889999999999999999 78888889999999999999999 99999999999999999999999 889


Q ss_pred             cccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCC
Q 006968          164 ESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC  203 (623)
Q Consensus       164 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~  203 (623)
                      ..|..|++|++|+|++|.|+ .+|..+.     +.+++++|++..
T Consensus       287 ~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~  330 (727)
T 4b8c_D          287 AELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK  330 (727)
T ss_dssp             SSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS
T ss_pred             hhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC
Confidence            99999999999999999998 6666443     678899999854

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.39  E-value=2.1e-13  Score=150.23  Aligned_cols=127  Identities=17%  Similarity=0.191  Sum_probs=109.9

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCC-CCCccccCCCCccchh
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGNLNYLR  152 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~  152 (623)
                      .+++.|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|+
T Consensus        50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  129 (549)
T 2z81_A           50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR  129 (549)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred             CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence            379999999999999888999999999999999999998777779999999999999999996 4678899999999999


Q ss_pred             ccccccCCCCC-cccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCC
Q 006968          153 LNNNSLTGSCP-ESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNP  200 (623)
Q Consensus       153 l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~  200 (623)
                      |++|.+.+.+| ..+..+++|+.|++++|++++.+|..+.     +.+++.+|.
T Consensus       130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~  183 (549)
T 2z81_A          130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE  183 (549)
T ss_dssp             EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSB
T ss_pred             CCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCc
Confidence            99999555665 6899999999999999999998877554     344555554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.38  E-value=6.1e-13  Score=131.89  Aligned_cols=120  Identities=24%  Similarity=0.332  Sum_probs=83.4

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+|++..+  +.++++|++|+|++|++++ +|. +.. ++|+.|+|++|++++ +| .+..+++|+.|+|+
T Consensus        64 ~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls  136 (263)
T 1xeu_A           64 NLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIR  136 (263)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECT
T ss_pred             CCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECC
Confidence            67778888888775443  7777888888888888774 443 223 778888888888774 43 57778888888888


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG  204 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~  204 (623)
                      +|++++ +| .+..+++|+.|+|++|++++. +.+..    +.+++++|++.+.
T Consensus       137 ~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          137 NNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             TSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred             CCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence            888874 33 577778888888888888765 32221    4566777776554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.38  E-value=1.8e-13  Score=139.32  Aligned_cols=130  Identities=15%  Similarity=0.149  Sum_probs=99.6

Q ss_pred             cEEEEeCCCCCcccccCccc--cCCCCcceEEeecCCCCCCCC----CccCCCCCccEEEecCCCCCCCCCccccCCCCc
Q 006968           75 YVSALGLPSQSLSGTLSPWI--GNLTKLQSVLLQNNAILGPIP----ASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL  148 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  148 (623)
                      +++.|+|++|++++..|..+  .++++|++|+|++|++++..|    ..+..+++|++|+|++|++++..|..++.+++|
T Consensus        92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L  171 (310)
T 4glp_A           92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL  171 (310)
T ss_dssp             CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred             ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence            48889999999988888887  888899999999999887655    344578889999999999987777888888999


Q ss_pred             cchhccccccCCC--C--CcccCCCCcccEEECCCCcCcCcCCC---C-----ccccccccCCCCCCC
Q 006968          149 NYLRLNNNSLTGS--C--PESLSKIESLTLVDLSYNNLSGSLPK---I-----SARTFKVTGNPLICG  204 (623)
Q Consensus       149 ~~L~l~~N~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~~p~---~-----~~~~~~~~~n~~~~~  204 (623)
                      ++|+|++|++.+.  +  +..+..+++|+.|+|++|+++...+.   .     .-+.+++++|.+...
T Consensus       172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~  239 (310)
T 4glp_A          172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRAT  239 (310)
T ss_dssp             CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCC
T ss_pred             CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCcc
Confidence            9999999987642  2  23346788899999999988732111   1     116678888887554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.37  E-value=1.1e-13  Score=124.46  Aligned_cols=104  Identities=25%  Similarity=0.249  Sum_probs=93.3

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCC-CCccccCCCCccchh
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE-IPDSLGDLGNLNYLR  152 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~  152 (623)
                      .+++.|+|++|+|++.  ..++++++|++|+|++|++++.+|..+.++++|++|+|++|++++. .|..+..+++|++|+
T Consensus        42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~  119 (149)
T 2je0_A           42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD  119 (149)
T ss_dssp             TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEE
T ss_pred             CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEe
Confidence            3799999999999976  7899999999999999999987898888899999999999999953 348899999999999


Q ss_pred             ccccccCCCCC---cccCCCCcccEEECCC
Q 006968          153 LNNNSLTGSCP---ESLSKIESLTLVDLSY  179 (623)
Q Consensus       153 l~~N~l~~~~p---~~~~~l~~L~~L~l~~  179 (623)
                      |++|.+++..+   ..+..+++|+.|++++
T Consensus       120 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A          120 LFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            99999996554   4789999999999874

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.36  E-value=1.6e-13  Score=127.25  Aligned_cols=105  Identities=24%  Similarity=0.306  Sum_probs=94.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCc--cccCCCCccchh
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD--SLGDLGNLNYLR  152 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~  152 (623)
                      +++.|+|++|+|++.  +.+.++++|++|+|++|+|++..|..+..+++|++|+|++|+|+ .+|.  .+..+++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            799999999999975  68999999999999999999654455689999999999999997 7887  899999999999


Q ss_pred             ccccccCCCCCcc----cCCCCcccEEECCCCcCc
Q 006968          153 LNNNSLTGSCPES----LSKIESLTLVDLSYNNLS  183 (623)
Q Consensus       153 l~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~  183 (623)
                      |++|.++ .+|..    +..+++|+.||+++|.+.
T Consensus       120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            9999998 67775    899999999999999876

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.36  E-value=1.4e-12  Score=131.42  Aligned_cols=120  Identities=28%  Similarity=0.417  Sum_probs=93.8

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|++++..+  +.++++|++|+|++|++++ +| .+..+++|++|+|++|++++ + +.+..+++|+.|+|+
T Consensus        69 ~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~  142 (291)
T 1h6t_A           69 NVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG  142 (291)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECC
T ss_pred             CCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEcc
Confidence            68888999998886544  8888889999999888885 44 48888888899999888884 4 467888888888888


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLIC  203 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~  203 (623)
                      +|++++.  ..+..+++|+.|+|++|++++..| +..    +.+++++|.+..
T Consensus       143 ~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~  192 (291)
T 1h6t_A          143 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD  192 (291)
T ss_dssp             SSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB
T ss_pred             CCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCC
Confidence            8888854  578888888888888888887654 221    557777877643

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.36  E-value=8.3e-13  Score=136.54  Aligned_cols=104  Identities=23%  Similarity=0.313  Sum_probs=93.1

Q ss_pred             ceEEeecC-CCCCCCCCccCCCCCccEEEecC-CCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECC
Q 006968          101 QSVLLQNN-AILGPIPASLGKLEKLQTLDLSN-NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLS  178 (623)
Q Consensus       101 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~  178 (623)
                      ..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            45789998 898 5888 99999999999996 99997777889999999999999999999888899999999999999


Q ss_pred             CCcCcCcCCCCcc----ccccccCCCCCCCCC
Q 006968          179 YNNLSGSLPKISA----RTFKVTGNPLICGPK  206 (623)
Q Consensus       179 ~N~l~~~~p~~~~----~~~~~~~n~~~~~~~  206 (623)
                      +|+|++.++..+.    +.+.+.+|++.|.|.
T Consensus        89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~  120 (347)
T 2ifg_A           89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCA  120 (347)
T ss_dssp             SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred             CCccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence            9999987776553    568899999999875

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.34  E-value=2.5e-12  Score=127.52  Aligned_cols=120  Identities=23%  Similarity=0.328  Sum_probs=101.6

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+|+ .++ .+..+++|++|+|++|+|++..|  +.++++|++|+|++|+++ .+|....  ++|+.|+|+
T Consensus        42 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~-~l~~~~~--~~L~~L~L~  114 (263)
T 1xeu_A           42 GVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLFLD  114 (263)
T ss_dssp             TCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCS-CCTTCCC--SSCCEEECC
T ss_pred             cCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccC-CcCcccc--CcccEEEcc
Confidence            7999999999998 456 78999999999999999996544  999999999999999999 4665433  999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG  204 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~  204 (623)
                      +|++++ ++ .+..+++|+.|+|++|+|++. |.+..    +.+++++|++...
T Consensus       115 ~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A          115 NNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             SSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC
T ss_pred             CCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch
Confidence            999995 44 699999999999999999975 43322    6688999987554

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.33  E-value=1.4e-12  Score=131.26  Aligned_cols=122  Identities=29%  Similarity=0.375  Sum_probs=104.1

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|.+++ ++ .+.++++|++|+|++|++++.  ..+..+++|+.|+|++|++++ + ..+..+++|++|+|
T Consensus        90 ~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L  163 (291)
T 1h6t_A           90 KNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSL  163 (291)
T ss_dssp             TTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEEC
T ss_pred             CCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEEc
Confidence            479999999999986 44 499999999999999999963  468999999999999999995 4 68999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG  204 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~  204 (623)
                      ++|++++..|  +..+++|+.|+|++|.|++ +|.+..    +.+++++|++.+.
T Consensus       164 ~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          164 EDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             CSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEEEEEECC
T ss_pred             cCCccccchh--hcCCCccCEEECCCCcCCC-ChhhccCCCCCEEECcCCcccCC
Confidence            9999996544  9999999999999999996 344322    5678888887553

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.32  E-value=1.4e-12  Score=132.57  Aligned_cols=123  Identities=25%  Similarity=0.367  Sum_probs=100.2

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|.|++. + .+.++++|++|+|++|++++ +|. +..+++|++|+|++|++++ ++. +..+++|++|+|
T Consensus        85 ~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l  158 (308)
T 1h6u_A           85 TKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSI  158 (308)
T ss_dssp             CSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEEC
T ss_pred             CCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEc
Confidence            4799999999999863 3 68899999999999999986 443 8899999999999999995 444 888999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGP  205 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~  205 (623)
                      ++|++++ ++. +..+++|+.|+|++|++++..+ +..    +.+++++|++...+
T Consensus       159 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~  211 (308)
T 1h6u_A          159 GNAQVSD-LTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVS  211 (308)
T ss_dssp             CSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCG
T ss_pred             cCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCccc
Confidence            9999985 444 8899999999999999986544 221    56788888875544

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.31  E-value=3.5e-12  Score=129.55  Aligned_cols=121  Identities=25%  Similarity=0.410  Sum_probs=96.5

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|++++..+  +.++++|++|+|++|++++ +| .+..+++|++|+|++|++++ +|. +..+++|++|+|+
T Consensus        64 ~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~  137 (308)
T 1h6u_A           64 NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLD  137 (308)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECC
T ss_pred             CCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECC
Confidence            78999999999986444  8889999999999999885 44 68889999999999999984 554 8889999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG  204 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~  204 (623)
                      +|++++..+  +..+++|+.|+|++|++++..+ +..    +.+++++|.+...
T Consensus       138 ~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~  188 (308)
T 1h6u_A          138 LNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDI  188 (308)
T ss_dssp             SSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC
T ss_pred             CCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcC
Confidence            999985433  8888999999999999986443 221    5677888876443

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.31  E-value=2.3e-12  Score=133.40  Aligned_cols=141  Identities=18%  Similarity=0.171  Sum_probs=101.3

Q ss_pred             CCcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCC-CccCCCCCccE-EEec
Q 006968           63 CSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIP-ASLGKLEKLQT-LDLS  130 (623)
Q Consensus        63 c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~Ls  130 (623)
                      |+|..|.|+..          ..++.|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|.. ++++
T Consensus         9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X            9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            78889999642          368888999998885555678888899999999988876665 46778887664 6677


Q ss_pred             CCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCC-CcCcCcCCCCcc------ccccccCCCCCC
Q 006968          131 NNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSY-NNLSGSLPKISA------RTFKVTGNPLIC  203 (623)
Q Consensus       131 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~------~~~~~~~n~~~~  203 (623)
                      +|+|+...|..|..+++|++|++++|++++..+..+....++..|++.+ |++....+..+.      ..+.+++|.+..
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~  168 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE  168 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred             CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence            7888866677888888899999998888866555666666777777755 455533333222      335667776643

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.30  E-value=4.7e-12  Score=140.14  Aligned_cols=120  Identities=29%  Similarity=0.415  Sum_probs=94.4

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+|++..+  +.++++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++ + +.+..|++|+.|+|+
T Consensus        66 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls  139 (605)
T 1m9s_A           66 NVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG  139 (605)
T ss_dssp             TCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECC
T ss_pred             CCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECC
Confidence            78889999999886554  8888899999999998885 44 68888888888888888884 4 458888888888888


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLIC  203 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~  203 (623)
                      +|+|++.  ..+..|++|+.|+|++|.|++.+| +..    +.+++++|.+..
T Consensus       140 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~  189 (605)
T 1m9s_A          140 NNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD  189 (605)
T ss_dssp             SSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB
T ss_pred             CCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCC
Confidence            8888854  578888888888888888887665 221    557778887644

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.30  E-value=6.5e-15  Score=139.62  Aligned_cols=109  Identities=22%  Similarity=0.273  Sum_probs=63.8

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|+|++ +| .+.++++|++|+|++|+++ .+|..+..+++|++|+|++|++++ +| .+..+++|++|+|+
T Consensus        49 ~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~  123 (198)
T 1ds9_A           49 ACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMS  123 (198)
T ss_dssp             TCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEES
T ss_pred             CCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECC
Confidence            46666666666664 44 5566666666666666666 455555555666666666666663 44 45566666666666


Q ss_pred             ccccCCCCC-cccCCCCcccEEECCCCcCcCcCCC
Q 006968          155 NNSLTGSCP-ESLSKIESLTLVDLSYNNLSGSLPK  188 (623)
Q Consensus       155 ~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~  188 (623)
                      +|++++..+ ..+..+++|+.|++++|++++.+|.
T Consensus       124 ~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~  158 (198)
T 1ds9_A          124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             EEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred             CCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence            666653211 2455666666666666666655443

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.30  E-value=2e-12  Score=131.88  Aligned_cols=120  Identities=20%  Similarity=0.197  Sum_probs=60.6

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|+|++..     ..++|++|+|++|++++..+..   +++|++|+|++|++++..|..+..+++|++|+|+
T Consensus        81 ~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls  152 (317)
T 3o53_A           81 TLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK  152 (317)
T ss_dssp             TCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECT
T ss_pred             CCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECC
Confidence            4555555555555322     2255555555555555433322   3455555555555554444455555555555555


Q ss_pred             ccccCCCCCcccC-CCCcccEEECCCCcCcCcCCCCcc---ccccccCCCCC
Q 006968          155 NNSLTGSCPESLS-KIESLTLVDLSYNNLSGSLPKISA---RTFKVTGNPLI  202 (623)
Q Consensus       155 ~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~---~~~~~~~n~~~  202 (623)
                      +|.+++..|..+. .+++|+.|+|++|.|++..+....   +.+++++|.+.
T Consensus       153 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~  204 (317)
T 3o53_A          153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA  204 (317)
T ss_dssp             TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCC
T ss_pred             CCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCC
Confidence            5555544444442 455555555555555543221111   34455555543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.29  E-value=3.2e-12  Score=132.04  Aligned_cols=122  Identities=20%  Similarity=0.309  Sum_probs=77.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|++++|.+++..+  +..+++|++|+|++|++++. |. +..+++|++|+|++|++++ + +.+..+++|++|+|+
T Consensus       200 ~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~  273 (347)
T 4fmz_A          200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVG  273 (347)
T ss_dssp             TCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECC
T ss_pred             ccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEcc
Confidence            56677777777765433  66677777777777777643 32 6667777777777777763 3 356667777777777


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~  204 (623)
                      +|++++ + +.+..+++|+.|++++|++++..|..+.     +.+++++|++...
T Consensus       274 ~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~  326 (347)
T 4fmz_A          274 SNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI  326 (347)
T ss_dssp             SSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred             CCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence            777764 3 3466667777777777777665554322     4566667765443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.29  E-value=1e-11  Score=136.09  Aligned_cols=114  Identities=28%  Similarity=0.402  Sum_probs=85.2

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. +.+  +|++|+|++|+|++ +|.   .+++|+.|+|+
T Consensus        81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls  148 (571)
T 3cvr_A           81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINAD  148 (571)
T ss_dssp             TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred             CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCC
Confidence            6888888888888 566   457888888888888886 776 655  88888888888885 766   57788888888


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc--ccccccCCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPLICGP  205 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~~~~~  205 (623)
                      +|+|++ +|.   .+++|+.|+|++|+|++ +|.+..  +.+++++|.+...+
T Consensus       149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l~~~L~~L~Ls~N~L~~lp  196 (571)
T 3cvr_A          149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPELPESLEALDVSTNLLESLP  196 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCC
T ss_pred             CCccCc-CCC---cCCCcCEEECCCCCCCC-cchhhCCCCEEECcCCCCCchh
Confidence            888884 665   56788888888888886 555321  45677777766443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.28  E-value=4.3e-12  Score=140.40  Aligned_cols=123  Identities=29%  Similarity=0.396  Sum_probs=104.8

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|.|++ ++ .+.++++|+.|+|++|+|++ + ..+..|++|+.|+|++|+|++ + ..+..|++|+.|+|
T Consensus        87 ~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L  160 (605)
T 1m9s_A           87 KNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSL  160 (605)
T ss_dssp             TTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEEC
T ss_pred             CCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEEC
Confidence            479999999999986 34 78999999999999999995 4 468999999999999999995 4 78999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGP  205 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~  205 (623)
                      ++|+|++..|  +..+++|+.|+|++|+|++. |.+..    +.+++++|++...+
T Consensus       161 s~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~p  213 (605)
T 1m9s_A          161 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKP  213 (605)
T ss_dssp             CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECCC
T ss_pred             cCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCCc
Confidence            9999997665  99999999999999999964 44322    56788888875543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.26  E-value=2.5e-12  Score=142.57  Aligned_cols=137  Identities=23%  Similarity=0.311  Sum_probs=96.1

Q ss_pred             cccCCCCCCCCCCCCcceeeeCC-------CCcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCC
Q 006968           50 NVLENWDITSVDPCSWRMITCSP-------DGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLE  122 (623)
Q Consensus        50 ~~~~~w~~~~~~~c~w~gv~c~~-------~~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  122 (623)
                      ...+.|. .+.+||.|+|..|..       ...++.|++++|+|+ .+|..+.  ++|++|+|++|+|+ .+|.   .++
T Consensus        10 ~~w~~W~-~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~   81 (622)
T 3g06_A           10 AVWSAWR-RAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP   81 (622)
T ss_dssp             CHHHHHH-HTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred             HHHHHHH-hcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence            3455675 345788887643321       125888889998888 7777665  78888888888888 5665   567


Q ss_pred             CccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc--ccccccCCC
Q 006968          123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNP  200 (623)
Q Consensus       123 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~  200 (623)
                      +|++|+|++|+|+ .+|.   .+++|++|+|++|++++ +|.   .+++|+.|++++|+|++ +|....  +.+++++|.
T Consensus        82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~l~~L~~L~Ls~N~  152 (622)
T 3g06_A           82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVLPPGLQELSVSDNQ  152 (622)
T ss_dssp             TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSC
T ss_pred             CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCCCCCCCEEECcCCc
Confidence            8888888888888 5776   66788888888888884 554   45677777777777775 333322  556677776


Q ss_pred             CCC
Q 006968          201 LIC  203 (623)
Q Consensus       201 ~~~  203 (623)
                      +..
T Consensus       153 l~~  155 (622)
T 3g06_A          153 LAS  155 (622)
T ss_dssp             CSC
T ss_pred             CCC
Confidence            544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=2.1e-11  Score=120.61  Aligned_cols=147  Identities=13%  Similarity=0.061  Sum_probs=113.8

Q ss_pred             HHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCceE
Q 006968          296 LRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERL  374 (623)
Q Consensus       296 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~  374 (623)
                      +......|.....++.|+++.||++.. +++.+++|+...... .....+.+|+++++.+. |..+.++++++...+..+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            444556788888888889999999976 468899999865321 22346889999999885 667788999998888999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ---------------------------------  421 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------  421 (623)
                      +||||++|.+|.+.+..         ......++.+++++|+.||+.                                 
T Consensus        87 lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            99999999998765321         112346788999999999981                                 


Q ss_pred             -----------------------CCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          422 -----------------------CDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       422 -----------------------~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                                             ..+.++|||+++.||+++++..+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   01468999999999999876556799999875

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.26  E-value=7.3e-12  Score=137.71  Aligned_cols=103  Identities=22%  Similarity=0.298  Sum_probs=91.5

Q ss_pred             CcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECC
Q 006968           99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLS  178 (623)
Q Consensus        99 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~  178 (623)
                      .|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            46789999999995 786 999999999999999999 999999999999999999999995 77 89999999999999


Q ss_pred             CCcCcCcC-CCCcc-----ccccccCCCCCCCCC
Q 006968          179 YNNLSGSL-PKISA-----RTFKVTGNPLICGPK  206 (623)
Q Consensus       179 ~N~l~~~~-p~~~~-----~~~~~~~n~~~~~~~  206 (623)
                      +|+|++.+ |..+.     +.+++++|++...++
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            99999886 76544     568899998755443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.24  E-value=8.6e-12  Score=134.38  Aligned_cols=103  Identities=29%  Similarity=0.433  Sum_probs=63.2

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|.+++..+  +.++++|++|+|++|++++..|  +..+++|+.|+|++|++++..|  +..+++|+.|+|+
T Consensus       244 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~  317 (466)
T 1o6v_A          244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLY  317 (466)
T ss_dssp             TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECC
T ss_pred             CCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECc
Confidence            56777777777765443  6666667777777776664332  6666666666666666664322  5566666666666


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCc
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGS  185 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  185 (623)
                      +|++++..|  +..+++|+.|++++|++++.
T Consensus       318 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          318 FNNISDISP--VSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             SSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred             CCcCCCchh--hccCccCCEeECCCCccCCc
Confidence            666665443  55556666666666666543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.23  E-value=8.1e-14  Score=132.01  Aligned_cols=126  Identities=24%  Similarity=0.315  Sum_probs=108.1

Q ss_pred             cEEEEeCCCCCcccccCc------cccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCc
Q 006968           75 YVSALGLPSQSLSGTLSP------WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL  148 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  148 (623)
                      .++.++|+.+.++|.+|.      .+.++++|++|+|++|++++ +| .+.++++|++|+|++|+|+ .+|..+..+++|
T Consensus        19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L   95 (198)
T 1ds9_A           19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL   95 (198)
T ss_dssp             CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred             cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence            677788888888888776      89999999999999999996 77 8999999999999999999 899988889999


Q ss_pred             cchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCC--CC---c-cccccccCCCCCCCC
Q 006968          149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP--KI---S-ARTFKVTGNPLICGP  205 (623)
Q Consensus       149 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~---~-~~~~~~~~n~~~~~~  205 (623)
                      ++|+|++|++++ +| .+..+++|+.|+|++|++++..+  .+   . -+.+++++|++.+.+
T Consensus        96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~  156 (198)
T 1ds9_A           96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY  156 (198)
T ss_dssp             SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHH
T ss_pred             CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccc
Confidence            999999999995 55 68899999999999999995322  11   1 167889999886653

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.20  E-value=7.1e-11  Score=126.56  Aligned_cols=116  Identities=26%  Similarity=0.332  Sum_probs=65.0

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|++++ +| .++++++|++|+|++|++++ +|..+   .+|++|+|++|++++ +| .++++++|++|+++
T Consensus       132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~  203 (454)
T 1jl5_A          132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD  203 (454)
T ss_dssp             TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred             CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence            45666666666654 44 36666666666666666663 44432   356666666666663 44 46666666666666


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLIC  203 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~  203 (623)
                      +|++++ +|...   ++|+.|++++|.++ .+|.+..    +.+++++|.+..
T Consensus       204 ~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~~  251 (454)
T 1jl5_A          204 NNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKT  251 (454)
T ss_dssp             SSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCSS
T ss_pred             CCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCCc
Confidence            666663 33322   35555566666555 4444221    446666776543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.19  E-value=5.9e-11  Score=127.26  Aligned_cols=99  Identities=26%  Similarity=0.347  Sum_probs=60.3

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+|++. | .++++++|++|+|++|++++ +|  ++.+++|++|+|++|+|++ +|  ++++++|++|+|+
T Consensus        43 ~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~  114 (457)
T 3bz5_A           43 TLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCD  114 (457)
T ss_dssp             TCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECC
Confidence            566666666666643 3 46666666666666666664 23  5666666666666666664 33  5666666666666


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      +|++++ +|  +..+++|+.|++++|+|++
T Consensus       115 ~N~l~~-l~--~~~l~~L~~L~l~~N~l~~  141 (457)
T 3bz5_A          115 TNKLTK-LD--VSQNPLLTYLNCARNTLTE  141 (457)
T ss_dssp             SSCCSC-CC--CTTCTTCCEEECTTSCCSC
T ss_pred             CCcCCe-ec--CCCCCcCCEEECCCCccce
Confidence            666664 33  5666666666666666665

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.19  E-value=2.9e-11  Score=130.23  Aligned_cols=123  Identities=31%  Similarity=0.398  Sum_probs=99.6

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      ..++.|+|++|++++.  +.+..+++|+.|+|++|++++..|  +..+++|+.|+|++|++++ +|. +..+++|+.|+|
T Consensus       221 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L  294 (466)
T 1o6v_A          221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLEL  294 (466)
T ss_dssp             TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEEC
T ss_pred             CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEc
Confidence            3689999999999863  468889999999999999986654  8889999999999999995 444 888999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc---ccccccCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA---RTFKVTGNPLICG  204 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~---~~~~~~~n~~~~~  204 (623)
                      ++|++++..|  +..+++|+.|+|++|++++..|-...   +.+++++|++...
T Consensus       295 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             CSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred             CCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence            9999986544  88899999999999999987662111   5677888877544

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.19  E-value=2.4e-11  Score=125.35  Aligned_cols=119  Identities=20%  Similarity=0.376  Sum_probs=85.1

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|+|++|.+++..+  +..+++|+.|++++|.+++..+  +..+++|++|+|++|++++ +|. +..+++|++|+|+
T Consensus       178 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~  251 (347)
T 4fmz_A          178 DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIG  251 (347)
T ss_dssp             TCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECC
T ss_pred             CCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECC
Confidence            67788888888775333  7778888888888888875433  7777888888888888874 444 7778888888888


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLI  202 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~  202 (623)
                      +|.+++ + +.+..+++|+.|++++|++++. |....    +.+++++|++.
T Consensus       252 ~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~  300 (347)
T 4fmz_A          252 TNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLG  300 (347)
T ss_dssp             SSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC
T ss_pred             CCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCC
Confidence            888874 3 4577788888888888888753 33221    55677777664

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.17  E-value=1e-10  Score=125.39  Aligned_cols=96  Identities=26%  Similarity=0.389  Sum_probs=59.5

Q ss_pred             CCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEEC
Q 006968           98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDL  177 (623)
Q Consensus        98 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l  177 (623)
                      ++|++|+|++|++++ +| .|+++++|++|+|++|++++ +|..+   ++|++|+|++|++++ +| .+..+++|+.|++
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l  202 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA  202 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence            456666666666664 55 46666667777777776663 55433   366666777776664 45 4667777777777


Q ss_pred             CCCcCcCcCCCCcc--ccccccCCCCC
Q 006968          178 SYNNLSGSLPKISA--RTFKVTGNPLI  202 (623)
Q Consensus       178 ~~N~l~~~~p~~~~--~~~~~~~n~~~  202 (623)
                      ++|++++ +|....  +.+++++|.+.
T Consensus       203 ~~N~l~~-l~~~~~~L~~L~l~~n~l~  228 (454)
T 1jl5_A          203 DNNSLKK-LPDLPLSLESIVAGNNILE  228 (454)
T ss_dssp             CSSCCSS-CCCCCTTCCEEECCSSCCS
T ss_pred             CCCcCCc-CCCCcCcccEEECcCCcCC
Confidence            7777765 333322  45666666654

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.16  E-value=1.2e-10  Score=124.81  Aligned_cols=118  Identities=25%  Similarity=0.287  Sum_probs=92.4

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|+|++. +  ++++++|++|+|++|+..+.+  .+..+++|++|+|++|++++ +|  +..+++|+.|++
T Consensus       127 ~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l  198 (457)
T 3bz5_A          127 PLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNC  198 (457)
T ss_dssp             TTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEEC
T ss_pred             CcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEEC
Confidence            4789999999999873 3  788888999999988766666  37888888888998888885 65  788888888888


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG  204 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~  204 (623)
                      ++|++++.   .+..+++|+.|++++|+|++ +| ...    +.+++++|++...
T Consensus       199 ~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~l~~~  248 (457)
T 3bz5_A          199 DTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLTEL  248 (457)
T ss_dssp             CSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSCCSCC
T ss_pred             cCCcCCee---ccccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCcCCCc
Confidence            88888854   37888888888888888887 45 211    5677888876543

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.16  E-value=5.4e-11  Score=117.28  Aligned_cols=137  Identities=14%  Similarity=0.073  Sum_probs=100.4

Q ss_pred             CCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCce--eeeeeeeecCCceEEEEec
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL--LRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~l~~~~~~~~~~~lv~e~  379 (623)
                      .+.+..+.+.|..+.||++...+|..+++|.....    ....+..|+.+++.+.+.++  .+++++...++..++||||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            44443333456679999998777888999997643    22457889999998865454  4588888877788999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC-------------------------------------  422 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------  422 (623)
                      ++|.++.  ...       .+   ...++.++++.|+.||+..                                     
T Consensus        97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            9998873  211       11   2356777888888888642                                     


Q ss_pred             ------------------CCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          423 ------------------DPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       423 ------------------~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                                        .+.++|||++|.||+++++..+.|+|||.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              12399999999999998776667999998753

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.12  E-value=2.6e-12  Score=134.94  Aligned_cols=110  Identities=21%  Similarity=0.273  Sum_probs=56.9

Q ss_pred             cEEEEeCCCCCccc----ccCccccCC---------CCcceEEeecCCCC-CCCC---CccCCCCCccEEEecCCCCC--
Q 006968           75 YVSALGLPSQSLSG----TLSPWIGNL---------TKLQSVLLQNNAIL-GPIP---ASLGKLEKLQTLDLSNNKFT--  135 (623)
Q Consensus        75 ~v~~L~L~~n~l~~----~~~~~~~~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--  135 (623)
                      +++.|+|++|+|++    .++..+..+         ++|++|+|++|+++ +.+|   ..+..+++|++|+|++|+|+  
T Consensus       123 ~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~  202 (386)
T 2ca6_A          123 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE  202 (386)
T ss_dssp             TCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH
T ss_pred             CCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHh
Confidence            45666666666542    233444444         55555555555554 2333   23445555555555555555  


Q ss_pred             C---CCCccccCCCCccchhccccccC----CCCCcccCCCCcccEEECCCCcCcC
Q 006968          136 G---EIPDSLGDLGNLNYLRLNNNSLT----GSCPESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       136 ~---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      |   .+|..+..+++|+.|+|++|.++    +.+|..+..+++|+.|+|++|.|++
T Consensus       203 g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~  258 (386)
T 2ca6_A          203 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  258 (386)
T ss_dssp             HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             HHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCch
Confidence            1   22334555555555555555553    3445555555555555555555553

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.10  E-value=3.2e-12  Score=131.37  Aligned_cols=134  Identities=18%  Similarity=0.192  Sum_probs=95.0

Q ss_pred             CCCCcceeeeCCCCcEEEEeCCCCCcccccCccccCC--CCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCC-
Q 006968           61 DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNL--TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE-  137 (623)
Q Consensus        61 ~~c~w~gv~c~~~~~v~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-  137 (623)
                      -|.+|.++.|++ ..++.|++++|.+.   +..+..+  ++++.|+|++|.+++..|. +.++++|++|+|++|.+++. 
T Consensus        35 vc~~W~~~~~~~-~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~  109 (336)
T 2ast_B           35 VCKRWYRLASDE-SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST  109 (336)
T ss_dssp             SCHHHHHHHTCS-TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred             HHHHHHHHhcCc-hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence            344788887763 35777888887776   3445566  7788888888888766554 55678888888888887755 


Q ss_pred             CCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCC-cCcCc-CCCCcc-----ccccccCC
Q 006968          138 IPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN-NLSGS-LPKISA-----RTFKVTGN  199 (623)
Q Consensus       138 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~-----~~~~~~~n  199 (623)
                      +|..+..+++|++|+|++|.+++..|..+..+++|+.|+|++| .+++. +|....     +.+++++|
T Consensus       110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~  178 (336)
T 2ast_B          110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC  178 (336)
T ss_dssp             HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred             HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence            7777778888888888888887777777778888888888888 56642 333221     45666666

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.09  E-value=3.6e-10  Score=117.26  Aligned_cols=142  Identities=14%  Similarity=0.200  Sum_probs=105.8

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEec--ccccccchHHHHHHHHHHhhcC--CCceeeeeeeeecC---CceEEEEe
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLK--DYNIAGGEVQFQTEVETISLAV--HRNLLRLCGFCSTE---NERLLVYP  378 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~e  378 (623)
                      .+.++.|.++.||+.... +..+++|+..  ..........+.+|..+++.+.  +..+.++++++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            467899999999999875 4678888875  3322223446889999999887  45577888888766   45899999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC------------------------------------  422 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------  422 (623)
                      |++|..+.+..      ...++...+..++.++++.|+.||...                                    
T Consensus       122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99988764321      124678888999999999999999731                                    


Q ss_pred             -------------------CCCeEecCCCCCCeEECCCCc--EEEeecccccc
Q 006968          423 -------------------DPKIIHRDVKAANILLDEDFE--AVVGDFGLAKL  454 (623)
Q Consensus       423 -------------------~~~ivH~Dlk~~NIll~~~~~--~kl~Dfgla~~  454 (623)
                                         .+.++|||+++.||+++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               247999999999999997753  68999999864

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.08  E-value=2.8e-10  Score=126.13  Aligned_cols=55  Identities=29%  Similarity=0.325  Sum_probs=35.3

Q ss_pred             CCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc--ccccccCCCCCCCC
Q 006968          146 GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPLICGP  205 (623)
Q Consensus       146 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~~~~~  205 (623)
                      ++|+.|+|++|+|++ +|   ..+++|+.|+|++|+|++ +|....  +.+++++|.+...+
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~~~~~L~~L~Ls~N~L~~lp  277 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPMLPSGLLSLSVYRNQLTRLP  277 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCCSCC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCcccccCcEEeCCCCCCCcCC
Confidence            567777777777773 55   345677777888877774 444322  55677777765443

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.08  E-value=1.2e-11  Score=128.72  Aligned_cols=128  Identities=21%  Similarity=0.235  Sum_probs=91.7

Q ss_pred             cEEEEeCCCCCcccccC----ccccCCC-CcceEEeecCCCCCCCCCccCCC-----CCccEEEecCCCCCCCCCccccC
Q 006968           75 YVSALGLPSQSLSGTLS----PWIGNLT-KLQSVLLQNNAILGPIPASLGKL-----EKLQTLDLSNNKFTGEIPDSLGD  144 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~  144 (623)
                      .++.|+|++|+|++..+    ..+.+++ +|++|+|++|++++..+..+..+     ++|++|+|++|++++..+..+..
T Consensus        23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~  102 (362)
T 3goz_A           23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK  102 (362)
T ss_dssp             TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence            48888888888887665    6677787 88888888888887766666664     88888888888888666654443


Q ss_pred             ----C-CCccchhccccccCCCCCcc----cCC-CCcccEEECCCCcCcCcCCCC----------ccccccccCCCCC
Q 006968          145 ----L-GNLNYLRLNNNSLTGSCPES----LSK-IESLTLVDLSYNNLSGSLPKI----------SARTFKVTGNPLI  202 (623)
Q Consensus       145 ----l-~~L~~L~l~~N~l~~~~p~~----~~~-l~~L~~L~l~~N~l~~~~p~~----------~~~~~~~~~n~~~  202 (623)
                          + ++|++|+|++|++++..+..    +.. .++|+.|+|++|.|+...+..          .-+.+++++|.+.
T Consensus       103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~  180 (362)
T 3goz_A          103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA  180 (362)
T ss_dssp             HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred             HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence                3 78888888888887655444    333 358888888888888432221          1255667777653

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.07  E-value=1.3e-11  Score=126.85  Aligned_cols=110  Identities=23%  Similarity=0.252  Sum_probs=89.6

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCC-CCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchh
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGP-IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR  152 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  152 (623)
                      ..++.|++++|.+++..+. +.++++|++|+|++|.+++. +|..+.++++|++|+|++|++++..|..++.+++|++|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            4688888888888876655 55788888889988888765 777788888888888888888888888888888888888


Q ss_pred             cccc-ccCC-CCCcccCCCCcccEEECCCC-cCcC
Q 006968          153 LNNN-SLTG-SCPESLSKIESLTLVDLSYN-NLSG  184 (623)
Q Consensus       153 l~~N-~l~~-~~p~~~~~l~~L~~L~l~~N-~l~~  184 (623)
                      |++| .+++ .++..+..+++|+.|++++| .+++
T Consensus       149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~  183 (336)
T 2ast_B          149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE  183 (336)
T ss_dssp             CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence            8888 6775 36666778888888888888 8875

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.06  E-value=7.8e-12  Score=131.23  Aligned_cols=130  Identities=22%  Similarity=0.291  Sum_probs=109.4

Q ss_pred             CcEEEEeCCCCCcc-cccC---ccccCCCCcceEEeecCCCC--C---CCCCccCCCCCccEEEecCCCCC----CCCCc
Q 006968           74 GYVSALGLPSQSLS-GTLS---PWIGNLTKLQSVLLQNNAIL--G---PIPASLGKLEKLQTLDLSNNKFT----GEIPD  140 (623)
Q Consensus        74 ~~v~~L~L~~n~l~-~~~~---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~  140 (623)
                      ..++.|+|++|+|+ +.++   ..+.++++|++|+|++|+++  |   ..|..+.++++|++|+|++|+|+    +.+|.
T Consensus       159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~  238 (386)
T 2ca6_A          159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  238 (386)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence            48999999999998 4455   57788999999999999998  3   35558899999999999999996    67899


Q ss_pred             cccCCCCccchhccccccCCC----CCccc--CCCCcccEEECCCCcCcC----cCCCCc------cccccccCCCCCC
Q 006968          141 SLGDLGNLNYLRLNNNSLTGS----CPESL--SKIESLTLVDLSYNNLSG----SLPKIS------ARTFKVTGNPLIC  203 (623)
Q Consensus       141 ~~~~l~~L~~L~l~~N~l~~~----~p~~~--~~l~~L~~L~l~~N~l~~----~~p~~~------~~~~~~~~n~~~~  203 (623)
                      .+..+++|++|+|++|.+++.    +|..+  +.+++|+.|+|++|.+++    .+|...      -+.+++++|++..
T Consensus       239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~  317 (386)
T 2ca6_A          239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  317 (386)
T ss_dssp             HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence            999999999999999999865    56677  448999999999999998    466533      1568899998754

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.05  E-value=1.1e-11  Score=128.94  Aligned_cols=113  Identities=22%  Similarity=0.221  Sum_probs=78.7

Q ss_pred             cEEEEeCCCCCcccccCccccCC-----CCcceEEeecCCCCCCCCCccC----CC-CCccEEEecCCCCCCCCCcccc-
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNL-----TKLQSVLLQNNAILGPIPASLG----KL-EKLQTLDLSNNKFTGEIPDSLG-  143 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~~p~~~~-  143 (623)
                      +++.|+|++|+|++..+..+..+     ++|++|+|++|++++..+..+.    .+ ++|++|+|++|+|++..+..+. 
T Consensus        52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  131 (362)
T 3goz_A           52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ  131 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence            68888888888887666666664     7888888888888766555433    33 7888888888888755554433 


Q ss_pred             ---C-CCCccchhccccccCCC----CCcccCCCC-cccEEECCCCcCcCcCC
Q 006968          144 ---D-LGNLNYLRLNNNSLTGS----CPESLSKIE-SLTLVDLSYNNLSGSLP  187 (623)
Q Consensus       144 ---~-l~~L~~L~l~~N~l~~~----~p~~~~~l~-~L~~L~l~~N~l~~~~p  187 (623)
                         . .++|++|+|++|.+++.    ++..+..++ +|+.|+|++|+|++..+
T Consensus       132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~  184 (362)
T 3goz_A          132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC  184 (362)
T ss_dssp             HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred             HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhH
Confidence               3 25788888888888753    333444554 78888888888876554

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.05  E-value=2.2e-10  Score=118.48  Aligned_cols=110  Identities=11%  Similarity=0.095  Sum_probs=93.0

Q ss_pred             EEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCc-cccCCCCccc-hhccc
Q 006968           78 ALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNY-LRLNN  155 (623)
Q Consensus        78 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~-L~l~~  155 (623)
                      .++-++++|+ .+|..+  .++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .|.++++|++ +.+++
T Consensus        13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~   89 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   89 (350)
T ss_dssp             EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred             EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence            4677899998 788766  46899999999999965556899999999999999999877775 6788998775 66778


Q ss_pred             cccCCCCCcccCCCCcccEEECCCCcCcCcCCCCc
Q 006968          156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS  190 (623)
Q Consensus       156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  190 (623)
                      |++++..|..|..+++|+.|++++|+|++..+..+
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~  124 (350)
T 4ay9_X           90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK  124 (350)
T ss_dssp             TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTT
T ss_pred             CcccccCchhhhhccccccccccccccccCCchhh
Confidence            99997778899999999999999999997665443

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.90  E-value=1e-09  Score=111.09  Aligned_cols=186  Identities=19%  Similarity=0.169  Sum_probs=120.7

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCc--eeeeeeeeecCC---ceEEEEec
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRN--LLRLCGFCSTEN---ERLLVYPY  379 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e~  379 (623)
                      .+.++.|.+..||+..    ..+++|+....   .....+.+|.++++.+. +..  +.+.+.+....+   ..++|||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999863    45888886432   23456889999998874 333  234444443332   34889999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ--------------------------------------  421 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------------------------------------  421 (623)
                      ++|.++......      .++..++..++.++++.++.||..                                      
T Consensus        98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999887653321      367777888888888888888861                                      


Q ss_pred             -----------------CCCCeEecCCCCCCeEECC--CCcEEEeecccccccCCCCCceeecc--------------cc
Q 006968          422 -----------------CDPKIIHRDVKAANILLDE--DFEAVVGDFGLAKLLDHRDSHVTTAV--------------RG  468 (623)
Q Consensus       422 -----------------~~~~ivH~Dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~--------------~g  468 (623)
                                       ..+.++|+|+++.||++++  ...+.|+||+.+..-.... ......              ..
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHH
Confidence                             1246899999999999998  4567899999986532210 000000              00


Q ss_pred             cccccc-ccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 006968          469 TVGHIA-PEYLSTGQSSEKTDVFGFGILLLELITGQRALD  507 (623)
Q Consensus       469 t~~y~a-PE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~  507 (623)
                      ..+... |+...  ......+.|+++.++|.+.+|..++.
T Consensus       251 ~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          251 HYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            001111 22211  11223589999999999999987763

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.85  E-value=4.9e-11  Score=117.08  Aligned_cols=125  Identities=21%  Similarity=0.222  Sum_probs=85.6

Q ss_pred             CCCCcceeeeCCCC-cEEEEeCCC---CCcccccCc-c-----------------------ccCCCCcce--EEeecCCC
Q 006968           61 DPCSWRMITCSPDG-YVSALGLPS---QSLSGTLSP-W-----------------------IGNLTKLQS--VLLQNNAI  110 (623)
Q Consensus        61 ~~c~w~gv~c~~~~-~v~~L~L~~---n~l~~~~~~-~-----------------------~~~l~~L~~--L~L~~N~l  110 (623)
                      ..|.|.|+.|++++ +|..+...+   ..+.+.+++ .                       |...+.|..  ++++.|+.
T Consensus        76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~  155 (267)
T 3rw6_A           76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR  155 (267)
T ss_dssp             HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSH
T ss_pred             HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHH
Confidence            35789999998754 565555544   233333321 1                       222233333  56666643


Q ss_pred             CCCCCC----ccCCCCCccEEEecCCCCCC--CCCccccCCCCccchhccccccCCCCCcccCCCC--cccEEECCCCcC
Q 006968          111 LGPIPA----SLGKLEKLQTLDLSNNKFTG--EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIE--SLTLVDLSYNNL  182 (623)
Q Consensus       111 ~~~~p~----~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l  182 (623)
                      . .++.    ...++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|+.|+|++|.+
T Consensus       156 ~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl  232 (267)
T 3rw6_A          156 S-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL  232 (267)
T ss_dssp             H-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred             H-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence            3 2222    22457899999999999997  5667888999999999999999964  3344444  999999999999


Q ss_pred             cCcCCC
Q 006968          183 SGSLPK  188 (623)
Q Consensus       183 ~~~~p~  188 (623)
                      ++.+|+
T Consensus       233 ~~~~~~  238 (267)
T 3rw6_A          233 CDTFRD  238 (267)
T ss_dssp             GGGCSS
T ss_pred             ccccCc
Confidence            988774

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.84  E-value=3.5e-11  Score=129.26  Aligned_cols=111  Identities=21%  Similarity=0.217  Sum_probs=74.4

Q ss_pred             cEEEEeCCCCCccccc-----CccccCCCCcceEEeecCCCCCC----CCCccCCCCCccEEEecCCCCCCCCCccccC-
Q 006968           75 YVSALGLPSQSLSGTL-----SPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-  144 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-  144 (623)
                      .++.|+|++|.+++..     +..+..+++|++|+|++|++++.    ++..+.++++|++|+|++|.+++..+..+.. 
T Consensus       228 ~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~  307 (461)
T 1z7x_W          228 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET  307 (461)
T ss_dssp             TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH
T ss_pred             CccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH
Confidence            6778888888777532     22233577788888888877743    5666667777888888888776544433332 


Q ss_pred             ----CCCccchhccccccCCC----CCcccCCCCcccEEECCCCcCcCc
Q 006968          145 ----LGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSGS  185 (623)
Q Consensus       145 ----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~  185 (623)
                          .++|++|+|++|.+++.    ++..+..+++|+.|+|++|.+++.
T Consensus       308 l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~  356 (461)
T 1z7x_W          308 LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA  356 (461)
T ss_dssp             HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH
T ss_pred             hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccc
Confidence                25777777777777654    455566677777777777777653

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.73  E-value=2.3e-10  Score=122.77  Aligned_cols=129  Identities=19%  Similarity=0.155  Sum_probs=101.8

Q ss_pred             CcEEEEeCCCCCcccc----cCccccCCCCcceEEeecCCCCCCCCCccCC-----CCCccEEEecCCCCCCC----CCc
Q 006968           74 GYVSALGLPSQSLSGT----LSPWIGNLTKLQSVLLQNNAILGPIPASLGK-----LEKLQTLDLSNNKFTGE----IPD  140 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~p~  140 (623)
                      .+++.|+|++|++++.    ++..+.++++|++|+|++|.+++..+..+..     .++|++|+|++|.+++.    +|.
T Consensus       256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~  335 (461)
T 1z7x_W          256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS  335 (461)
T ss_dssp             CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred             CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence            4799999999999874    6778888999999999999997543333332     36999999999999965    567


Q ss_pred             cccCCCCccchhccccccCCCCCcccCC-----CCcccEEECCCCcCcC----cCCCCcc-----ccccccCCCCC
Q 006968          141 SLGDLGNLNYLRLNNNSLTGSCPESLSK-----IESLTLVDLSYNNLSG----SLPKISA-----RTFKVTGNPLI  202 (623)
Q Consensus       141 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~----~~p~~~~-----~~~~~~~n~~~  202 (623)
                      .+..+++|++|+|++|.+++..+..+..     .++|+.|+|++|.+++    .+|..+.     +.+++++|++.
T Consensus       336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~  411 (461)
T 1z7x_W          336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG  411 (461)
T ss_dssp             HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence            7788899999999999998654444432     6799999999999985    5554322     66888998764

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.71  E-value=3.1e-10  Score=118.09  Aligned_cols=128  Identities=20%  Similarity=0.192  Sum_probs=89.9

Q ss_pred             CcEEEEeCCCCCcccccCccc-cCCCCcceEEeecCCCCCCCCCcc-----CCCCCccEEEecCCCCCC----CCCcccc
Q 006968           74 GYVSALGLPSQSLSGTLSPWI-GNLTKLQSVLLQNNAILGPIPASL-----GKLEKLQTLDLSNNKFTG----EIPDSLG  143 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~  143 (623)
                      ..++.|+|++|+|+......+ ..+++|+.|+|++|+|+..-...+     ...++|++|+|++|.|+.    .++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            378899999998875433333 346688899999998874433333     346789999999998874    2455567


Q ss_pred             CCCCccchhccccccCC----CCCcccCCCCcccEEECCCCcCcCc----CCCC-----ccccccccCCCC
Q 006968          144 DLGNLNYLRLNNNSLTG----SCPESLSKIESLTLVDLSYNNLSGS----LPKI-----SARTFKVTGNPL  201 (623)
Q Consensus       144 ~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~-----~~~~~~~~~n~~  201 (623)
                      .+++|++|+|++|.|++    .++..+..+++|+.|+|++|.|+..    ++..     .-+.+++++|++
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i  251 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL  251 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSC
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCC
Confidence            78889999999999874    2355677778899999999988742    1111     125677888875

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.68  E-value=9.5e-10  Score=114.37  Aligned_cols=111  Identities=21%  Similarity=0.254  Sum_probs=89.6

Q ss_pred             cEEEEeCCCCCcccccCccc-----cCCCCcceEEeecCCCCC----CCCCccCCCCCccEEEecCCCCCCC----CCcc
Q 006968           75 YVSALGLPSQSLSGTLSPWI-----GNLTKLQSVLLQNNAILG----PIPASLGKLEKLQTLDLSNNKFTGE----IPDS  141 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~  141 (623)
                      +++.|+|++|+|+......+     ...++|++|+|++|.|+.    .++..+..+++|++|||++|.|++.    ++..
T Consensus       127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~  206 (372)
T 3un9_A          127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ  206 (372)
T ss_dssp             TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred             hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence            69999999999986544444     346889999999999974    2455567889999999999999842    3566


Q ss_pred             ccCCCCccchhccccccCCC----CCcccCCCCcccEEECCCCcCcCc
Q 006968          142 LGDLGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSGS  185 (623)
Q Consensus       142 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~  185 (623)
                      +...++|++|+|++|.|++.    ++..+..+++|+.|+|++|.|+..
T Consensus       207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~  254 (372)
T 3un9_A          207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE  254 (372)
T ss_dssp             GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred             HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence            77889999999999999852    445566779999999999999853

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.65  E-value=2.9e-09  Score=104.43  Aligned_cols=80  Identities=28%  Similarity=0.392  Sum_probs=66.9

Q ss_pred             cCCCCcceEEeecCCCCC--CCCCccCCCCCccEEEecCCCCCCCCCccccCCC--CccchhccccccCCCCCc------
Q 006968           95 GNLTKLQSVLLQNNAILG--PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG--NLNYLRLNNNSLTGSCPE------  164 (623)
Q Consensus        95 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~------  164 (623)
                      .++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+.+.+|.      
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            568899999999999997  5567778899999999999999954  4455555  999999999999987763      


Q ss_pred             -ccCCCCcccEEE
Q 006968          165 -SLSKIESLTLVD  176 (623)
Q Consensus       165 -~~~~l~~L~~L~  176 (623)
                       .+..+++|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence             367788998886

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.48  E-value=6.3e-09  Score=96.93  Aligned_cols=110  Identities=15%  Similarity=0.194  Sum_probs=87.5

Q ss_pred             CcEEEEeCCCC-Cccc----ccCccccCCCCcceEEeecCCCCCC----CCCccCCCCCccEEEecCCCCCCC----CCc
Q 006968           74 GYVSALGLPSQ-SLSG----TLSPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTGE----IPD  140 (623)
Q Consensus        74 ~~v~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~  140 (623)
                      ..++.|+|++| .|..    .+...+...++|++|+|++|+|+..    +...+...++|++|+|++|.|+..    +..
T Consensus        36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~  115 (185)
T 1io0_A           36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE  115 (185)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence            37999999999 8875    3556677788999999999999742    344556678899999999999853    456


Q ss_pred             cccCCCCccchhc--cccccCCC----CCcccCCCCcccEEECCCCcCc
Q 006968          141 SLGDLGNLNYLRL--NNNSLTGS----CPESLSKIESLTLVDLSYNNLS  183 (623)
Q Consensus       141 ~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~  183 (623)
                      .+...++|++|+|  ++|.|+..    +...+...++|+.|+|++|.+.
T Consensus       116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            7778889999999  88999753    4455666789999999999886

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.45  E-value=2.3e-07  Score=94.75  Aligned_cols=100  Identities=15%  Similarity=0.104  Sum_probs=62.3

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCcc-EEEecCCCCCCCCCccccCCCCccchhc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQ-TLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .++.|+|++|+++...+..|.++++|+.|+|++| ++..-+.+|.+|++|+ .|+|++ +++..-+..|.+|++|+.|+|
T Consensus       227 ~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l  304 (329)
T 3sb4_A          227 NLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLA  304 (329)
T ss_dssp             TCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEE
T ss_pred             CCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEe
Confidence            5666666666666444456666666666666666 5544455666666666 666666 555333456666666666666


Q ss_pred             cccccCCCCCcccCCCCcccEEE
Q 006968          154 NNNSLTGSCPESLSKIESLTLVD  176 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~  176 (623)
                      ++|+++..-+..|.++++|+.|+
T Consensus       305 ~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          305 TGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             CSSCCCEECTTTTCTTCCCCEEE
T ss_pred             CCCccCccchhhhcCCcchhhhc
Confidence            66666644444666666666665

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.35  E-value=7.4e-07  Score=90.90  Aligned_cols=127  Identities=15%  Similarity=0.137  Sum_probs=88.1

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccC-----------------------------------
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG-----------------------------------  119 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----------------------------------  119 (623)
                      .++.|+|++ +++..-+..|.++++|+.|+|++|.+....+..|.                                   
T Consensus       102 ~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~  180 (329)
T 3sb4_A          102 TLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLET  180 (329)
T ss_dssp             TCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEE
T ss_pred             CCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccce
Confidence            688888888 78766667788888888888888875321111110                                   


Q ss_pred             -------------------------------------------CCCCccEEEecCCCCCCCCCccccCCCCccchhcccc
Q 006968          120 -------------------------------------------KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN  156 (623)
Q Consensus       120 -------------------------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N  156 (623)
                                                                 .+++|+.|+|++|+++..-+..|.++++|+.|+|++|
T Consensus       181 ~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n  260 (329)
T 3sb4_A          181 TIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN  260 (329)
T ss_dssp             EEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT
T ss_pred             eEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc
Confidence                                                       1678888899988888444456888889999999888


Q ss_pred             ccCCCCCcccCCCCccc-EEECCCCcCcCcCCCCcc-----ccccccCCCCCCC
Q 006968          157 SLTGSCPESLSKIESLT-LVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       157 ~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~  204 (623)
                       ++..-+..|.++++|+ .|++.+ +++..-+..+.     +.+.+.+|.+...
T Consensus       261 -i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I  312 (329)
T 3sb4_A          261 -LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTL  312 (329)
T ss_dssp             -CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEE
T ss_pred             -cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCcc
Confidence             7645556788888898 888887 66644444443     4456666665443

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.30  E-value=1.3e-08  Score=112.76  Aligned_cols=127  Identities=15%  Similarity=0.101  Sum_probs=79.5

Q ss_pred             cEEEEeCCCCCcccccCccccC-CCCcceEEee----cCCCCCC-----CCCccCCCCCccEEEecCC--CCCCCCCccc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGN-LTKLQSVLLQ----NNAILGP-----IPASLGKLEKLQTLDLSNN--KFTGEIPDSL  142 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~  142 (623)
                      +++.|+|+.|++++..+..++. +++|+.|+|+    .|++++.     ++..+.++++|++|+|+++  .+++..+..+
T Consensus       379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~  458 (592)
T 3ogk_B          379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI  458 (592)
T ss_dssp             TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHH
T ss_pred             cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHH
Confidence            5666777666666655555554 6777777775    5666642     2223555777777777643  3555544444


Q ss_pred             cC-CCCccchhccccccCC-CCCcccCCCCcccEEECCCCcCcCc-CCCCc-----cccccccCCCC
Q 006968          143 GD-LGNLNYLRLNNNSLTG-SCPESLSKIESLTLVDLSYNNLSGS-LPKIS-----ARTFKVTGNPL  201 (623)
Q Consensus       143 ~~-l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~-----~~~~~~~~n~~  201 (623)
                      +. +++|++|+|++|++++ .++..+..+++|+.|+|++|.|++. ++...     -+.+++++|++
T Consensus       459 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i  525 (592)
T 3ogk_B          459 GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA  525 (592)
T ss_dssp             HHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred             HHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence            43 7778888888888775 3455567778888888888887643 22211     15567777774

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.29  E-value=4.3e-06  Score=84.25  Aligned_cols=136  Identities=18%  Similarity=0.181  Sum_probs=92.0

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCC---ceeeeeeeee-cCCceEEEEeccc
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR---NLLRLCGFCS-TENERLLVYPYMP  381 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~  381 (623)
                      .+.++.|....||+.    |..+++|+...   ......+.+|.+++..+.+.   .+.+.+.++. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            356788888999997    56688887532   12345688999999998753   2445566663 4556789999999


Q ss_pred             CCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 006968          382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ----------------------------------------  421 (623)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------------  421 (623)
                      |..+......      .++......++.++++.|+.||+.                                        
T Consensus        97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9887653211      133444444555555555555532                                        


Q ss_pred             -----------------CCCCeEecCCCCCCeEECC---CCcE-EEeecccccc
Q 006968          422 -----------------CDPKIIHRDVKAANILLDE---DFEA-VVGDFGLAKL  454 (623)
Q Consensus       422 -----------------~~~~ivH~Dlk~~NIll~~---~~~~-kl~Dfgla~~  454 (623)
                                       ..+.++|+|+++.||+++.   ++.+ .|+||+.+..
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             2346799999999999997   4554 7999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.29  E-value=3.3e-06  Score=83.35  Aligned_cols=135  Identities=19%  Similarity=0.137  Sum_probs=95.1

Q ss_pred             ceeccCCe-EEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCceEEEEecccCCC
Q 006968          308 ILGRGGFG-IVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPNGS  384 (623)
Q Consensus       308 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gs  384 (623)
                      .+..|..| .||+.... ++..+++|+-...    ....+.+|...|+.+. +--+-++++++...+..++|||++++.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            45556666 69988765 4667899986532    2346788999988774 2235577888888889999999999988


Q ss_pred             hhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 006968          385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ-------------------------------------------  421 (623)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------------  421 (623)
                      +.+.....        ......+..+++..|+.||..                                           
T Consensus       107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            76654321        112234556666666666642                                           


Q ss_pred             ------------CCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          422 ------------CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       422 ------------~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                                  ..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                        012389999999999999877677999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.23  E-value=2.8e-06  Score=87.62  Aligned_cols=81  Identities=9%  Similarity=-0.058  Sum_probs=55.0

Q ss_pred             Cce-eccCCeEEEEEEeC-------CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcC-C--CceeeeeeeeecC---
Q 006968          307 NIL-GRGGFGIVYKGCFS-------DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAV-H--RNLLRLCGFCSTE---  370 (623)
Q Consensus       307 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-H--~niv~l~~~~~~~---  370 (623)
                      +.| +.|....+|+....       ++..+++|+......  ......+.+|..+++.+. +  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 78888999998764       267788998654320  101245788888888774 2  2456777777554   


Q ss_pred             CceEEEEecccCCChhh
Q 006968          371 NERLLVYPYMPNGSVAS  387 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~  387 (623)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35789999999877653

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.14  E-value=3.3e-07  Score=101.40  Aligned_cols=104  Identities=11%  Similarity=0.121  Sum_probs=64.6

Q ss_pred             cEEEEeCCCCC-ccc-ccCccccCCCCcceEEeecCCCCCC----CCCccCCCCCccEEEecCCCCC----CCCCccccC
Q 006968           75 YVSALGLPSQS-LSG-TLSPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFT----GEIPDSLGD  144 (623)
Q Consensus        75 ~v~~L~L~~n~-l~~-~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~  144 (623)
                      +++.|+|++|. ++. .++....++++|++|+|++|.+++.    ++..+.++++|++|+|++|.++    +.++..+.+
T Consensus       139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~  218 (592)
T 3ogk_B          139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN  218 (592)
T ss_dssp             GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred             cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence            37777777665 221 1222334667777777777777654    2333455677777777777776    234444556


Q ss_pred             CCCccchhccccccCCCCCcccCCCCcccEEECCC
Q 006968          145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSY  179 (623)
Q Consensus       145 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~  179 (623)
                      +++|+.|+|++|.+.+ +|..+..+++|+.|++++
T Consensus       219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~  252 (592)
T 3ogk_B          219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS  252 (592)
T ss_dssp             CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred             CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence            7777777777777763 556666666666666664

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.05  E-value=2.3e-05  Score=79.96  Aligned_cols=141  Identities=17%  Similarity=0.214  Sum_probs=79.9

Q ss_pred             CceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcC-----CCceeeee-e--eeecCCceEEEEe
Q 006968          307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-----HRNLLRLC-G--FCSTENERLLVYP  378 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv~l~-~--~~~~~~~~~lv~e  378 (623)
                      +.|+.|..+.||+....+| .+++|+....     ...+..|..++..+.     .|.++... |  +....+..+++|+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3466677899999987555 4889998642     223344555555442     24443311 1  1123567889999


Q ss_pred             cccCCChh--------------hhhhhccCCC----------CCCCHHHHH-----------------------------
Q 006968          379 YMPNGSVA--------------SRLRDHIHGR----------PALDWARRK-----------------------------  405 (623)
Q Consensus       379 ~~~~gsL~--------------~~l~~~~~~~----------~~l~~~~~~-----------------------------  405 (623)
                      |++|..+.              ..++......          ..-.|....                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              1122211100          012332211                             


Q ss_pred             --HHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          406 --RIALGTARGLLYLHE----------QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       406 --~i~~~ia~~L~~LH~----------~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                        .+...+..++.+|+.          ...+.++|||+++.||+++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              111223446667763          123489999999999999888889999999875

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.03  E-value=3e-07  Score=85.44  Aligned_cols=98  Identities=21%  Similarity=0.228  Sum_probs=78.6

Q ss_pred             ccccCccccCCCCcceEEeecC-CCCCC----CCCccCCCCCccEEEecCCCCCCC----CCccccCCCCccchhccccc
Q 006968           87 SGTLSPWIGNLTKLQSVLLQNN-AILGP----IPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDLGNLNYLRLNNNS  157 (623)
Q Consensus        87 ~~~~~~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~  157 (623)
                      ...+...+...++|++|+|++| .|...    +...+...++|++|+|++|+|+..    +...+...++|++|+|++|.
T Consensus        25 ~~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~  104 (185)
T 1io0_A           25 EETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNF  104 (185)
T ss_dssp             HHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSC
T ss_pred             HHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCc
Confidence            3345566778899999999999 88732    445667789999999999999842    34556667899999999999


Q ss_pred             cCCC----CCcccCCCCcccEEEC--CCCcCcC
Q 006968          158 LTGS----CPESLSKIESLTLVDL--SYNNLSG  184 (623)
Q Consensus       158 l~~~----~p~~~~~l~~L~~L~l--~~N~l~~  184 (623)
                      |+..    +...+...++|+.|+|  ++|.|+.
T Consensus       105 i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          105 ISGSGILALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             CCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             CCHHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence            9853    5667888899999999  8899984

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.00  E-value=6e-07  Score=92.51  Aligned_cols=107  Identities=15%  Similarity=0.218  Sum_probs=66.0

Q ss_pred             CcEEEEeCCCCC-cccccCccccCCCCcceEEeecCCCCCCCCCccC--CCCCccEEEecC--CCCCCC-----CCccc-
Q 006968           74 GYVSALGLPSQS-LSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG--KLEKLQTLDLSN--NKFTGE-----IPDSL-  142 (623)
Q Consensus        74 ~~v~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~-  142 (623)
                      .+++.|+|++|. +  .+++ + .+++|+.|+|..|.++......+.  .+++|+.|+|+.  |...|.     +...+ 
T Consensus       172 P~L~~L~L~g~~~l--~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~  247 (362)
T 2ra8_A          172 PLLNNLKIKGTNNL--SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS  247 (362)
T ss_dssp             TTCCEEEEECCBTC--BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred             CCCcEEEEeCCCCc--eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence            478888887763 3  2333 3 377888888888777633222332  677888888763  222211     11122 


Q ss_pred             -cCCCCccchhccccccCCCCCccc---CCCCcccEEECCCCcCcC
Q 006968          143 -GDLGNLNYLRLNNNSLTGSCPESL---SKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       143 -~~l~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~  184 (623)
                       ..+++|++|+|++|.+.+..+..+   ..+++|+.|+|+.|.|++
T Consensus       248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d  293 (362)
T 2ra8_A          248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD  293 (362)
T ss_dssp             TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred             cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence             246788888888888764333223   246788888888888875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.96  E-value=3.7e-05  Score=80.40  Aligned_cols=76  Identities=12%  Similarity=0.064  Sum_probs=49.4

Q ss_pred             CCceeccCCeEEEEEEeC-CCcEEEEEEeccccc------ccchHHHHHHHHHHhhcCC--Ccee-eeeeeeecCCceEE
Q 006968          306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI------AGGEVQFQTEVETISLAVH--RNLL-RLCGFCSTENERLL  375 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~H--~niv-~l~~~~~~~~~~~l  375 (623)
                      .+.||.|.++.||++... +++.++||.......      ......+..|.++++.+..  +..+ +++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999764 468899998653221      1123356788888887742  4444 44443  3456789


Q ss_pred             EEecccCC
Q 006968          376 VYPYMPNG  383 (623)
Q Consensus       376 v~e~~~~g  383 (623)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.94  E-value=1.1e-07  Score=105.29  Aligned_cols=63  Identities=16%  Similarity=0.205  Sum_probs=27.1

Q ss_pred             CCCCccEEEecCCCCCCCCCccccC-CCCccchhccccccCCCCCccc-CCCCcccEEECCCCcCc
Q 006968          120 KLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNNSLTGSCPESL-SKIESLTLVDLSYNNLS  183 (623)
Q Consensus       120 ~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~  183 (623)
                      ++++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.++
T Consensus       430 ~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~  494 (594)
T 2p1m_B          430 HCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG  494 (594)
T ss_dssp             HCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred             hCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence            344444444443 333333333333 4445555555555443222222 33455555555555543

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.91  E-value=3e-07  Score=101.72  Aligned_cols=89  Identities=13%  Similarity=0.158  Sum_probs=67.3

Q ss_pred             ccCCCCcceEEeecCCCCCCCCCccCC-CCCccEEEecCCCCCCCCCccc-cCCCCccchhccccccCCCCCc-ccCCCC
Q 006968           94 IGNLTKLQSVLLQNNAILGPIPASLGK-LEKLQTLDLSNNKFTGEIPDSL-GDLGNLNYLRLNNNSLTGSCPE-SLSKIE  170 (623)
Q Consensus        94 ~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~-~~~~l~  170 (623)
                      +.++++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++.... .+..++
T Consensus       428 ~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~  506 (594)
T 2p1m_B          428 VEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLE  506 (594)
T ss_dssp             HHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGG
T ss_pred             HhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCC
Confidence            45566777777755 555443444544 8899999999999987655555 6699999999999999654333 445689


Q ss_pred             cccEEECCCCcCc
Q 006968          171 SLTLVDLSYNNLS  183 (623)
Q Consensus       171 ~L~~L~l~~N~l~  183 (623)
                      +|+.|++++|+++
T Consensus       507 ~L~~L~l~~~~~~  519 (594)
T 2p1m_B          507 TMRSLWMSSCSVS  519 (594)
T ss_dssp             GSSEEEEESSCCB
T ss_pred             CCCEEeeeCCCCC
Confidence            9999999999985

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.71  E-value=0.0002  Score=71.90  Aligned_cols=139  Identities=17%  Similarity=0.150  Sum_probs=92.0

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcC---CCceeeeeeeeecCCceEEEEecccC
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---HRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      .+.|+.|.+..+|+... ++..+++|+....    ....+..|.+.|+.+.   ...+.++++++...+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            45689999999999886 5678889987542    2456888998888774   25677888888777889999999998


Q ss_pred             CChhh-----------hhhhccC-C-----------------CCCCCHHHHH---HHHH----------------HHHHH
Q 006968          383 GSVAS-----------RLRDHIH-G-----------------RPALDWARRK---RIAL----------------GTARG  414 (623)
Q Consensus       383 gsL~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------~ia~~  414 (623)
                      ..+..           .|+.... .                 ...-+|....   ++..                .+.+.
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            86521           1222211 0                 0012565432   1111                11111


Q ss_pred             -HHHHHh-CCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          415 -LLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       415 -L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                       ...|.. ...+.++|+|+.+.|++++.++ +.|.||+
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             123321 2356899999999999999887 8899974

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.69  E-value=5.7e-05  Score=79.02  Aligned_cols=122  Identities=14%  Similarity=0.114  Sum_probs=85.8

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCC-----CCCCccccCCCCcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-----GEIPDSLGDLGNLN  149 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~  149 (623)
                      .++.|+|+++ ++..-...|.+ .+|+.+.|. |+++..-+.+|.+|++|+.++|.+|.+.     ..-+..|.+|++|+
T Consensus       227 ~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~  303 (401)
T 4fdw_A          227 QLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLA  303 (401)
T ss_dssp             TCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCC
T ss_pred             CCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCC
Confidence            6788888764 66455566766 789999994 5566555778899999999999988775     24456788899999


Q ss_pred             chhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCC
Q 006968          150 YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPL  201 (623)
Q Consensus       150 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~  201 (623)
                      .++|. |.++..-...|.+|++|+.|+|.+| ++..-+..+.    +.+.+.+|..
T Consensus       304 ~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n~~  357 (401)
T 4fdw_A          304 RFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGTTP  357 (401)
T ss_dssp             EECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCSSC
T ss_pred             eEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCCCC
Confidence            99998 4476445567888899999999655 5532222222    4455666643

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.63  E-value=7.7e-06  Score=74.35  Aligned_cols=83  Identities=14%  Similarity=0.145  Sum_probs=43.1

Q ss_pred             CcceEEeecCCCCCCCCCccCCCCCccEEEecCCC-CCCCCCccccCC----CCccchhccccc-cCCCCCcccCCCCcc
Q 006968           99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK-FTGEIPDSLGDL----GNLNYLRLNNNS-LTGSCPESLSKIESL  172 (623)
Q Consensus        99 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~L  172 (623)
                      .|+.|||+++.|+..--..+.++++|+.|+|+++. |+..--..++.+    ++|++|+|+++. ++..--..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45666666665553322345556666666666653 543222334433    246666666653 543222234556666


Q ss_pred             cEEECCCCc
Q 006968          173 TLVDLSYNN  181 (623)
Q Consensus       173 ~~L~l~~N~  181 (623)
                      +.|+|+++.
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            666666653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.59  E-value=0.00031  Score=73.91  Aligned_cols=78  Identities=13%  Similarity=0.055  Sum_probs=47.8

Q ss_pred             CCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCceeeccc-cccccccccccccC---CCCCccchhhHHHHHHH
Q 006968          423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAPEYLSTG---QSSEKTDVFGFGILLLE  498 (623)
Q Consensus       423 ~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~-gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~e  498 (623)
                      .+.++|||+++.||+++.++ ++++||+.+..-.... ....... -...|.+|+.....   ......++......+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            34899999999999999876 9999999987532110 0000000 11346666654321   11223455677888888


Q ss_pred             HHhC
Q 006968          499 LITG  502 (623)
Q Consensus       499 lltg  502 (623)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.53  E-value=0.00028  Score=70.08  Aligned_cols=79  Identities=18%  Similarity=0.225  Sum_probs=55.6

Q ss_pred             CCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCC---ceeeeeeeeecCCceEEEEe
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR---NLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~---niv~l~~~~~~~~~~~lv~e  378 (623)
                      .....+.+|.|..+.||+....||+.|.||+..... ......|..|...|+.+.-.   -+.+++++    +..++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence            344567799999999999999999999999865432 22233578899998877422   23344443    23578999


Q ss_pred             cccCCCh
Q 006968          379 YMPNGSV  385 (623)
Q Consensus       379 ~~~~gsL  385 (623)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987653

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.49  E-value=0.00027  Score=73.81  Aligned_cols=105  Identities=13%  Similarity=0.101  Sum_probs=82.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.+.|.+ +++..-...|.++++|+.|+|.+| ++..-..+|.+ .+|+.++| .|.++..-+..|.++++|+.+++.
T Consensus       204 ~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~  279 (401)
T 4fdw_A          204 GIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTY  279 (401)
T ss_dssp             CCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEE
T ss_pred             ccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeC
Confidence            688888984 477666778999999999999976 56455567777 79999999 556774556789999999999999


Q ss_pred             ccccC-----CCCCcccCCCCcccEEECCCCcCcC
Q 006968          155 NNSLT-----GSCPESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       155 ~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      +|.+.     ..-+..|..|++|+.++|.+ .++.
T Consensus       280 ~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~  313 (401)
T 4fdw_A          280 GSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRI  313 (401)
T ss_dssp             SSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCE
T ss_pred             CccccCCcccEECHHHhhCCccCCeEEeCC-ceEE
Confidence            98875     24456789999999999984 4663

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.42  E-value=0.00049  Score=68.81  Aligned_cols=71  Identities=8%  Similarity=0.008  Sum_probs=44.0

Q ss_pred             CCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCce-eeeeeeeecCCceEEEEecc-cCC
Q 006968          306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLVYPYM-PNG  383 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~-~~g  383 (623)
                      .+.|+.|....+|+.     ..+++|+......  ......+|..+++.+....+ .++++++  .+..++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            577888999999998     4588888754311  11234567777776643233 3444443  44467899999 554


Q ss_pred             Ch
Q 006968          384 SV  385 (623)
Q Consensus       384 sL  385 (623)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.40  E-value=2.1e-05  Score=71.50  Aligned_cols=85  Identities=15%  Similarity=0.165  Sum_probs=67.1

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCC-CCCCCCCccCCC----CCccEEEecCCC-CCCCCCccccCCCCc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNA-ILGPIPASLGKL----EKLQTLDLSNNK-FTGEIPDSLGDLGNL  148 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L  148 (623)
                      +++.|||+++.|+..--..+.++++|+.|+|+++. |+..--..+..+    ++|++|+|+++. ++..--..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            69999999999987655678899999999999985 664322334543    479999999975 885544567889999


Q ss_pred             cchhccccc-cC
Q 006968          149 NYLRLNNNS-LT  159 (623)
Q Consensus       149 ~~L~l~~N~-l~  159 (623)
                      ++|+|+++. ++
T Consensus       142 ~~L~L~~c~~It  153 (176)
T 3e4g_A          142 KYLFLSDLPGVK  153 (176)
T ss_dssp             CEEEEESCTTCC
T ss_pred             CEEECCCCCCCC
Confidence            999999975 55

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.33  E-value=3.4e-05  Score=79.35  Aligned_cols=125  Identities=14%  Similarity=0.186  Sum_probs=82.0

Q ss_pred             CcEEEEeCCCCCcc---------cccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCcccc-
Q 006968           74 GYVSALGLPSQSLS---------GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG-  143 (623)
Q Consensus        74 ~~v~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-  143 (623)
                      .+++.|.+.++...         +.++..+..+++|+.|+|++|.-. .+|. + .+++|+.|+|..|.++......+. 
T Consensus       139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~  215 (362)
T 2ra8_A          139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILG  215 (362)
T ss_dssp             TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred             chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHH
Confidence            37888888665431         234556677899999999988422 3444 4 388999999999988754444444 


Q ss_pred             -CCCCccchhccc--cccCCC-----CCccc--CCCCcccEEECCCCcCcCcCCC-------Cc-cccccccCCCC
Q 006968          144 -DLGNLNYLRLNN--NSLTGS-----CPESL--SKIESLTLVDLSYNNLSGSLPK-------IS-ARTFKVTGNPL  201 (623)
Q Consensus       144 -~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~~~~p~-------~~-~~~~~~~~n~~  201 (623)
                       .+++|+.|+|+.  |...+.     +...+  ..+++|+.|+|++|.++...+.       .. .+.++++.|.+
T Consensus       216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L  291 (362)
T 2ra8_A          216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL  291 (362)
T ss_dssp             SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred             ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence             789999999863  332221     11223  3578999999999998743221       11 15677777654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.32  E-value=1.8e-05  Score=73.39  Aligned_cols=108  Identities=19%  Similarity=0.201  Sum_probs=61.2

Q ss_pred             cEEEEeCCCC-Cccc----ccCccccCCCCcceEEeecCCCCCC----CCCccCCCCCccEEEecCCCCCCC----CCcc
Q 006968           75 YVSALGLPSQ-SLSG----TLSPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTGE----IPDS  141 (623)
Q Consensus        75 ~v~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~  141 (623)
                      .++.|+|++| +|..    .+...+..-+.|+.|+|++|+|...    +.+.+..-+.|+.|+|++|+|+..    +-..
T Consensus        42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~a  121 (197)
T 1pgv_A           42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS  121 (197)
T ss_dssp             SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred             CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHH
Confidence            5777777764 6643    2344555566777777777777622    233344556677777777777632    2233


Q ss_pred             ccCCCCccchhccccc---cCC----CCCcccCCCCcccEEECCCCcC
Q 006968          142 LGDLGNLNYLRLNNNS---LTG----SCPESLSKIESLTLVDLSYNNL  182 (623)
Q Consensus       142 ~~~l~~L~~L~l~~N~---l~~----~~p~~~~~l~~L~~L~l~~N~l  182 (623)
                      +..-+.|++|+|++|.   +..    .+...+..-+.|+.|+++.|.+
T Consensus       122 L~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          122 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            4444567777776542   221    1233444556677777665543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.31  E-value=0.0016  Score=65.57  Aligned_cols=159  Identities=11%  Similarity=0.044  Sum_probs=88.6

Q ss_pred             cCHHHHHHHhcCCCcC-----CceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCc--eeee
Q 006968          291 YTFKELRAATSNFSAK-----NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN--LLRL  363 (623)
Q Consensus       291 ~~~~~l~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l  363 (623)
                      ++.+++......|...     +.|+.|....+|+....+| .+++|+.....   ....+..|..++..+....  +.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            4556666666666542     3466688889999987665 57889886521   1234566777776664222  2233


Q ss_pred             eee------eecCCceEEEEecccCCChhh--------------hhhhccCC---C--CC---CCHHHHHH---------
Q 006968          364 CGF------CSTENERLLVYPYMPNGSVAS--------------RLRDHIHG---R--PA---LDWARRKR---------  406 (623)
Q Consensus       364 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~---~--~~---l~~~~~~~---------  406 (623)
                      +..      ....+..+++++|++|..+..              .++.....   .  ..   ..|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      112356789999998865421              12211110   0  00   12332111         


Q ss_pred             ---HHHHHHHHHHHHHhC----CCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          407 ---IALGTARGLLYLHEQ----CDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       407 ---i~~~ia~~L~~LH~~----~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                         +...+.+.+++++..    ...+++|+|+.+.||+++++..+.|+||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               011244455666532    23479999999999999987556899999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.22  E-value=0.0016  Score=65.98  Aligned_cols=142  Identities=15%  Similarity=0.039  Sum_probs=72.6

Q ss_pred             CceeccCCeE-EEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCC--ceeeeeeeeecCCceEEEEecccCC
Q 006968          307 NILGRGGFGI-VYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR--NLLRLCGFCSTENERLLVYPYMPNG  383 (623)
Q Consensus       307 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~--niv~l~~~~~~~~~~~lv~e~~~~g  383 (623)
                      +.|+.|.... +|+....+|..+++|......    ...+..|+.++..+...  .+.+++.+....  -+++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence            4465555444 667765446777777654321    02345566666655322  244556554333  37899999776


Q ss_pred             Chhhhhhhcc---------------------C-CCCCCCHHHHH-------H-------------HHHHHHHHHHHHH--
Q 006968          384 SVASRLRDHI---------------------H-GRPALDWARRK-------R-------------IALGTARGLLYLH--  419 (623)
Q Consensus       384 sL~~~l~~~~---------------------~-~~~~l~~~~~~-------~-------------i~~~ia~~L~~LH--  419 (623)
                      .+.+++....                     . ....++.....       .             ....+...+..+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            6654432110                     0 01112221100       0             0011122223331  


Q ss_pred             -hCCCCCeEecCCCCCCeEECCC----CcEEEeecccccc
Q 006968          420 -EQCDPKIIHRDVKAANILLDED----FEAVVGDFGLAKL  454 (623)
Q Consensus       420 -~~~~~~ivH~Dlk~~NIll~~~----~~~kl~Dfgla~~  454 (623)
                       ....+.++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1124489999999999999875    6789999998865

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.13  E-value=0.0011  Score=69.79  Aligned_cols=72  Identities=18%  Similarity=0.223  Sum_probs=48.7

Q ss_pred             CceeccCCeEEEEEEeCC--------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCce-eeeeeeeecCCceEEEE
Q 006968          307 NILGRGGFGIVYKGCFSD--------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLVY  377 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~  377 (623)
                      +.|+.|....||+....+        +..+.+|+....   .....+..|..++..+...++ .++++.+..    .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            567788889999998753        578999988432   111456678888887753344 456665532    3899


Q ss_pred             ecccCCCh
Q 006968          378 PYMPNGSV  385 (623)
Q Consensus       378 e~~~~gsL  385 (623)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.09  E-value=0.0048  Score=62.18  Aligned_cols=159  Identities=16%  Similarity=0.098  Sum_probs=89.1

Q ss_pred             cCHHHHHHHhcCCCc-----CCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCc--eeee
Q 006968          291 YTFKELRAATSNFSA-----KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN--LLRL  363 (623)
Q Consensus       291 ~~~~~l~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l  363 (623)
                      .+.+++......|..     ...++ |....||+....+|+.+++|..+...  .....+..|..++..+....  +.++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecce
Confidence            444555444444432     23466 88889999877778789999986332  12345677888777664222  3344


Q ss_pred             eee-----eecCCceEEEEecccCCChhh-----------h---hhhccC-----CCCCCCHHHH----HHH--------
Q 006968          364 CGF-----CSTENERLLVYPYMPNGSVAS-----------R---LRDHIH-----GRPALDWARR----KRI--------  407 (623)
Q Consensus       364 ~~~-----~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~~-----~~~~l~~~~~----~~i--------  407 (623)
                      +..     ....+..+++|+|++|..+..           .   ++....     .....++...    ..+        
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            433     112345678999998754321           0   121111     1112333221    001        


Q ss_pred             -------HHHHHHHHHHHHhC----CCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          408 -------ALGTARGLLYLHEQ----CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       408 -------~~~ia~~L~~LH~~----~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                             ...+...++.+...    ....++|||+++.||+++ + .+.|+||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   11111223333321    234689999999999999 4 899999998754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.03  E-value=0.0022  Score=66.07  Aligned_cols=142  Identities=14%  Similarity=0.185  Sum_probs=82.6

Q ss_pred             CceeccCCeEEEEEEeC--------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCce-eeeeeeeecCCceEEEE
Q 006968          307 NILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLVY  377 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~  377 (623)
                      +.+..|-...+|+....        ++..+.+|+....  ......+.+|..+++.+.-..+ .++++++.+    .+|+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            45666888899998864        2478999986321  2234456789998887742223 456666543    3999


Q ss_pred             ecccCCChhhh-----------------hhhc-cCCCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 006968          378 PYMPNGSVASR-----------------LRDH-IHGRPALD--WARRKRIALGTAR-------------------GLLYL  418 (623)
Q Consensus       378 e~~~~gsL~~~-----------------l~~~-~~~~~~l~--~~~~~~i~~~ia~-------------------~L~~L  418 (623)
                      ||++|.+|..-                 |+.. ........  |.++.++..++..                   .+.+|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998654311                 1111 00011222  4455555544321                   23333


Q ss_pred             H----hC-CCCCeEecCCCCCCeEECCC----CcEEEeecccccc
Q 006968          419 H----EQ-CDPKIIHRDVKAANILLDED----FEAVVGDFGLAKL  454 (623)
Q Consensus       419 H----~~-~~~~ivH~Dlk~~NIll~~~----~~~kl~Dfgla~~  454 (623)
                      .    .. ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    21 23468999999999999876    7899999998863

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.00  E-value=0.00074  Score=58.28  Aligned_cols=55  Identities=22%  Similarity=0.245  Sum_probs=27.5

Q ss_pred             eEEeecCCCC-CCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcccccc
Q 006968          102 SVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL  158 (623)
Q Consensus       102 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l  158 (623)
                      .++.++++++ ..+|..+.  .+|++|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            5666666665 24454332  3456666666666632223344455555544444443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.99  E-value=0.00083  Score=57.95  Aligned_cols=56  Identities=20%  Similarity=0.270  Sum_probs=41.1

Q ss_pred             EEeCCCCCcc-cccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCC
Q 006968           78 ALGLPSQSLS-GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT  135 (623)
Q Consensus        78 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  135 (623)
                      .++.++++|+ ..+|..+  -++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5667777776 3456443  246888888888888665667778888888888888775

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.87  E-value=0.00015  Score=67.12  Aligned_cols=92  Identities=14%  Similarity=0.150  Sum_probs=70.0

Q ss_pred             cCccccCCCCcceEEeecC-CCCC----CCCCccCCCCCccEEEecCCCCCC----CCCccccCCCCccchhccccccCC
Q 006968           90 LSPWIGNLTKLQSVLLQNN-AILG----PIPASLGKLEKLQTLDLSNNKFTG----EIPDSLGDLGNLNYLRLNNNSLTG  160 (623)
Q Consensus        90 ~~~~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~  160 (623)
                      +...+.+-+.|++|+|++| +|..    .+-+.+..-+.|+.|+|++|+|..    .+...+..-+.|+.|+|++|.|..
T Consensus        33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~  112 (197)
T 1pgv_A           33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP  112 (197)
T ss_dssp             HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence            4444566789999999986 7763    144566778899999999999984    334455567899999999999985


Q ss_pred             ----CCCcccCCCCcccEEECCCCc
Q 006968          161 ----SCPESLSKIESLTLVDLSYNN  181 (623)
Q Consensus       161 ----~~p~~~~~l~~L~~L~l~~N~  181 (623)
                          .+-..+..-+.|+.|+|++|.
T Consensus       113 ~Ga~ala~aL~~N~tL~~L~L~n~~  137 (197)
T 1pgv_A          113 ELLARLLRSTLVTQSIVEFKADNQR  137 (197)
T ss_dssp             HHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred             HHHHHHHHHHhhCCceeEEECCCCc
Confidence                244567777889999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.79  E-value=0.0026  Score=65.49  Aligned_cols=73  Identities=7%  Similarity=-0.013  Sum_probs=43.2

Q ss_pred             CceeccCCeEEEEEEeCC---------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCce-eeeeeeeecCCceEEE
Q 006968          307 NILGRGGFGIVYKGCFSD---------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLV  376 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv  376 (623)
                      +.++.|....+|+....+         +..+++|+.....  ........|.++++.+...++ .++++..    .-++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence            457778888999988754         2678888875421  111134678888877753333 3555543    23789


Q ss_pred             EecccCCCh
Q 006968          377 YPYMPNGSV  385 (623)
Q Consensus       377 ~e~~~~gsL  385 (623)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.75  E-value=0.0076  Score=63.77  Aligned_cols=74  Identities=14%  Similarity=0.096  Sum_probs=47.5

Q ss_pred             CCceeccCCeEEEEEEeCC-CcEEEEEEecccccccchHHHHHHHHHHhhcCCCce-eeeeeeeecCCceEEEEecccCC
Q 006968          306 KNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLVYPYMPNG  383 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~g  383 (623)
                      .+.|+.|-...+|+....+ +..+++|+.....  .......+|..++..+...++ .++++.+.  +  .+|+||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            3567888889999998765 4788899874321  111123578888888865555 36666662  2  3599999875


Q ss_pred             Ch
Q 006968          384 SV  385 (623)
Q Consensus       384 sL  385 (623)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.47  E-value=0.02  Score=58.11  Aligned_cols=31  Identities=23%  Similarity=0.344  Sum_probs=27.7

Q ss_pred             CCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       424 ~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999988764

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.47  E-value=0.0057  Score=63.49  Aligned_cols=87  Identities=15%  Similarity=0.177  Sum_probs=44.6

Q ss_pred             ccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCc
Q 006968           92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIES  171 (623)
Q Consensus        92 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  171 (623)
                      ..|.++++|+.+.+. +.++..-..+|.++.+|+.++|.+| ++..-..+|.++++|+.+.|..+ ++..-..+|.++++
T Consensus       282 ~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~  358 (394)
T 4gt6_A          282 GAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTA  358 (394)
T ss_dssp             TTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTT
T ss_pred             cccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCC
Confidence            344555555555554 2333233345555666666666543 44222345556666666666433 44222345666666


Q ss_pred             ccEEECCCCc
Q 006968          172 LTLVDLSYNN  181 (623)
Q Consensus       172 L~~L~l~~N~  181 (623)
                      |+.+++.+|.
T Consensus       359 L~~i~~~~~~  368 (394)
T 4gt6_A          359 LNNIEYSGSR  368 (394)
T ss_dssp             CCEEEESSCH
T ss_pred             CCEEEECCce
Confidence            6666665543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.26  E-value=0.048  Score=50.72  Aligned_cols=103  Identities=16%  Similarity=0.072  Sum_probs=66.7

Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      -||.+.|...   +.++++.++|.++.|.+.+|.-+-.... . ..+=+.|..|++..+|.+.+.+ +.+.         
T Consensus        33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence            3788888876   5689999999999999999887732111 1 1223356899999999998864 1110         


Q ss_pred             eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 006968          463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRA  505 (623)
Q Consensus       463 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p  505 (623)
                          .....+.+||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                0123466888753 3456778899999999987764444

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=96.21  E-value=0.0063  Score=62.71  Aligned_cols=102  Identities=14%  Similarity=0.102  Sum_probs=56.1

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .+..+.+..+ +.......+.+++.|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.++++|+.+.+.
T Consensus       218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~  294 (379)
T 4h09_A          218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMD  294 (379)
T ss_dssp             SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEEC
T ss_pred             ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccccc
Confidence            3444555433 33333445566666666666654 44333445666666666666543 442233455666666666666


Q ss_pred             ccccCCCCCcccCCCCcccEEECCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSY  179 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~  179 (623)
                      +|.++..-...|.++.+|+.+.|..
T Consensus       295 ~~~i~~I~~~aF~~c~~L~~i~lp~  319 (379)
T 4h09_A          295 NSAIETLEPRVFMDCVKLSSVTLPT  319 (379)
T ss_dssp             CTTCCEECTTTTTTCTTCCEEECCT
T ss_pred             ccccceehhhhhcCCCCCCEEEcCc
Confidence            6666533344566666666666654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=96.07  E-value=0.0056  Score=63.60  Aligned_cols=87  Identities=14%  Similarity=0.054  Sum_probs=68.7

Q ss_pred             CccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCC
Q 006968           91 SPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIE  170 (623)
Q Consensus        91 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~  170 (623)
                      ...|.++++|+.+.+.++ ++..-..+|.++++|+.++|.++ ++..-..+|.++++|+.++|..| ++..-..+|.+++
T Consensus       290 ~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~  366 (394)
T 4fs7_A          290 EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCI  366 (394)
T ss_dssp             TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCT
T ss_pred             cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCC
Confidence            346778899999999866 66455678999999999999755 76344567899999999999877 6634456899999


Q ss_pred             cccEEECCCC
Q 006968          171 SLTLVDLSYN  180 (623)
Q Consensus       171 ~L~~L~l~~N  180 (623)
                      +|+.+++..|
T Consensus       367 ~L~~i~lp~~  376 (394)
T 4fs7_A          367 NLKKVELPKR  376 (394)
T ss_dssp             TCCEEEEEGG
T ss_pred             CCCEEEECCC
Confidence            9999998754

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.04  E-value=0.0061  Score=63.29  Aligned_cols=103  Identities=10%  Similarity=0.155  Sum_probs=70.2

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.+.++ ++++..-...|.++++|+.++|..| ++..-..+|.+|.+|+.+.|..+ ++..-..+|.++++|+.+++.
T Consensus       289 ~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~  365 (394)
T 4gt6_A          289 ALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYS  365 (394)
T ss_dssp             TCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEES
T ss_pred             ccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEEC
Confidence            45566664 4455445567889999999999865 66455678999999999999765 773445679999999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCc
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLS  183 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  183 (623)
                      +|....   ..+..+.+|+.+.+..|.+.
T Consensus       366 ~~~~~~---~~~~~~~~L~~i~i~~~~~~  391 (394)
T 4gt6_A          366 GSRSQW---NAISTDSGLQNLPVAPGSID  391 (394)
T ss_dssp             SCHHHH---HTCBCCCCC-----------
T ss_pred             Cceeeh---hhhhccCCCCEEEeCCCCEE
Confidence            987542   46778889999988877654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=95.51  E-value=0.013  Score=60.66  Aligned_cols=102  Identities=12%  Similarity=0.104  Sum_probs=76.1

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.+.+..+... .....|.++..|+.+.+..+.+.   ...|..+.+|+.+.+.+| ++..-..+|.++++|+.++|.
T Consensus       254 ~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp  328 (394)
T 4fs7_A          254 DLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLP  328 (394)
T ss_dssp             SCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCC
T ss_pred             cceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeC
Confidence            3555555554333 45567888899999998877654   246888999999999866 663445678999999999997


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCc
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLS  183 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  183 (623)
                      ++ ++..-..+|.++++|+.+++..| ++
T Consensus       329 ~~-v~~I~~~aF~~c~~L~~i~lp~~-l~  355 (394)
T 4fs7_A          329 YL-VEEIGKRSFRGCTSLSNINFPLS-LR  355 (394)
T ss_dssp             TT-CCEECTTTTTTCTTCCEECCCTT-CC
T ss_pred             Cc-ccEEhHHhccCCCCCCEEEECcc-cc
Confidence            55 66344568999999999999876 55

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=94.96  E-value=0.053  Score=55.62  Aligned_cols=89  Identities=12%  Similarity=0.041  Sum_probs=46.3

Q ss_pred             ccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCc
Q 006968           92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIES  171 (623)
Q Consensus        92 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  171 (623)
                      ..+...++|+.+.+..+ +...-...|.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|..+++
T Consensus       211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~  287 (379)
T 4h09_A          211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN  287 (379)
T ss_dssp             TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred             cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence            34445556666665544 22233345556666666666554 44233344555666666666433 33222334556666


Q ss_pred             ccEEECCCCcCc
Q 006968          172 LTLVDLSYNNLS  183 (623)
Q Consensus       172 L~~L~l~~N~l~  183 (623)
                      |+.+.+.+|.++
T Consensus       288 L~~i~l~~~~i~  299 (379)
T 4h09_A          288 LTKVVMDNSAIE  299 (379)
T ss_dssp             CCEEEECCTTCC
T ss_pred             cccccccccccc
Confidence            666666665555

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.29  E-value=0.12  Score=53.91  Aligned_cols=141  Identities=9%  Similarity=0.075  Sum_probs=82.8

Q ss_pred             CceeccCCeEEEEEEeCC--------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCce-eeeeeeeecCCceEEEE
Q 006968          307 NILGRGGFGIVYKGCFSD--------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLVY  377 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~  377 (623)
                      +.+..|-...+|+....+        +..+++|+.....  ....+..+|..+++.+.-.++ .++++.+.    -++|+
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            456667888999998753        5789999864321  112234678888877743233 34555332    37899


Q ss_pred             ecccCCChhhh-----------------hhhc-c-----C---CCCCCCHHHHHHHHHHH-------------------H
Q 006968          378 PYMPNGSVASR-----------------LRDH-I-----H---GRPALDWARRKRIALGT-------------------A  412 (623)
Q Consensus       378 e~~~~gsL~~~-----------------l~~~-~-----~---~~~~l~~~~~~~i~~~i-------------------a  412 (623)
                      ||++|.+|..-                 |+.. .     .   ...+--|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998654210                 1110 0     1   11122244444443322                   2


Q ss_pred             HHHHHHHh---------------------CCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          413 RGLLYLHE---------------------QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       413 ~~L~~LH~---------------------~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      ..+.+|..                     .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     11236899999999999 7788999999998863

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.05  E-value=0.094  Score=54.39  Aligned_cols=30  Identities=30%  Similarity=0.445  Sum_probs=25.2

Q ss_pred             CeEecCCCCCCeEE------CCCCcEEEeecccccc
Q 006968          425 KIIHRDVKAANILL------DEDFEAVVGDFGLAKL  454 (623)
Q Consensus       425 ~ivH~Dlk~~NIll------~~~~~~kl~Dfgla~~  454 (623)
                      .++|+|+.+.||++      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4566799999998863

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=89.81  E-value=0.14  Score=34.16  Aligned_cols=32  Identities=19%  Similarity=0.369  Sum_probs=18.5

Q ss_pred             ceeeeecchhhhHHHHHHHhhhhhheeecccc
Q 006968          238 RVAVALGASFGAAFFVIIVVGLLVWLRYRHNQ  269 (623)
Q Consensus       238 ~~~i~~~~~~g~~~~~~~~~~~l~~~~~r~~~  269 (623)
                      ...++.+++.|+++++++++..++++|+|+.+
T Consensus        10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           10 IPSIATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             SSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            34466666666666666555555555555443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=87.60  E-value=0.17  Score=33.67  Aligned_cols=31  Identities=23%  Similarity=0.315  Sum_probs=17.4

Q ss_pred             eeeeecchhhhHHHHHHHhhhhhheeecccc
Q 006968          239 VAVALGASFGAAFFVIIVVGLLVWLRYRHNQ  269 (623)
Q Consensus       239 ~~i~~~~~~g~~~~~~~~~~~l~~~~~r~~~  269 (623)
                      ..++.+++.|++++++++...++++|+|+.+
T Consensus        10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             ceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            3456666666666665555555555555543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.19  E-value=1.6  Score=40.39  Aligned_cols=116  Identities=11%  Similarity=0.085  Sum_probs=78.6

Q ss_pred             CCCceeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 006968          356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN  435 (623)
Q Consensus       356 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N  435 (623)
                      .||+.+.. .+-.+++...+.|+.-+.+  .+|-.     -...+...+++++..++....+++..     +|--++|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNH--TPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTS--EEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCccc--CCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence            58888765 4555566655656644322  22221     12478899999999999888777766     888999999


Q ss_pred             eEECCCCcEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 006968          436 ILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD  507 (623)
Q Consensus       436 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~  507 (623)
                      ++++.++.+++.-.|+-..+.                  |.     ..+...=.-.+=+++..+++++..|+
T Consensus       110 L~f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999998777643322                  11     11111123357788899999998875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.35  E-value=0.12  Score=54.55  Aligned_cols=61  Identities=5%  Similarity=-0.046  Sum_probs=17.6

Q ss_pred             cCCceeccCCeEEEEEEeCC-CcEEEE------EEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeee
Q 006968          305 AKNILGRGGFGIVYKGCFSD-GALVAV------KRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCS  368 (623)
Q Consensus       305 ~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~  368 (623)
                      +.+.||   ||.||+|.+.. ..+|||      |..+...... ....|.+|..++...+|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345676   99999999864 467899      7766533222 2346888999999999999999887653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.76  E-value=2.7  Score=38.97  Aligned_cols=115  Identities=16%  Similarity=0.150  Sum_probs=76.4

Q ss_pred             CCCceeeeeeeeecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCC
Q 006968          356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL-YLHEQCDPKIIHRDVKAA  434 (623)
Q Consensus       356 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~Dlk~~  434 (623)
                      .||.+  -...-.+++...+.|+.-+++.=...++       ..+...+++++.+++.... +++..     +|--++|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence            47777  3344456667777677554442222232       4788899999999988776 66654     88899999


Q ss_pred             CeEECCCCcEEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 006968          435 NILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD  507 (623)
Q Consensus       435 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~  507 (623)
                      ||++|.++.+++.-.|+-..+                  +|.-+     +..-=.-.+=+++..++.++..|+
T Consensus       114 NL~f~~~~~p~i~hRGi~~~l------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESL------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTB------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCcccC------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999877764332                  22211     111113357788888889888775

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=81.30  E-value=0.51  Score=31.31  Aligned_cols=28  Identities=18%  Similarity=0.341  Sum_probs=15.1

Q ss_pred             eecchhhhHHHHHHHhhhhhheeecccc
Q 006968          242 ALGASFGAAFFVIIVVGLLVWLRYRHNQ  269 (623)
Q Consensus       242 ~~~~~~g~~~~~~~~~~~l~~~~~r~~~  269 (623)
                      +.+.++|+++++++.+.+.+|+|||+.+
T Consensus        14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           14 IISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            4445555555555555555666655543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	623
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-63
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-61
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-60
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-50
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-41
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-10
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	7e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.001

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 2e-66
 Identities = 81/283 (28%), Positives = 126/283 (44%), Gaps = 28/283 (9%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
              +    +G G FG VYKG +     VAVK L        ++Q F+ EV  +    H N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYL 418
           +L   G+  T  +  +V  +    S    L  H+H      +  +   IA  TA+G+ YL
Sbjct: 66  ILLFMGYS-TAPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEY 477
           H +    IIHRD+K+ NI L ED    +GDFGLA +      SH    + G++  +APE 
Sbjct: 121 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 478 LSTGQS---SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM 534
           +        S ++DV+ FGI+L EL+TGQ         N R  ++  V + +    LS++
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKV 234

Query: 535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                         + M ++   C +     RP   ++L  +E
Sbjct: 235 RSN---------CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 6e-65
 Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 24/277 (8%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
                   LG G FG V+ G ++    VAVK LK  ++      F  E   +    H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           +RL     T+    ++  YM NGS+   L         L   +   +A   A G+ ++ E
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
           +     IHRD++AANIL+ +     + DFGLA+L++  +       +  +   APE ++ 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK 540
           G  + K+DV+ FGILL E++T  R    G    +                + Q +++  +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------------VIQNLERGYR 228

Query: 541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                   EE+ Q+  LC +  P  RP    +  +LE
Sbjct: 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  209 bits (534), Expect = 1e-63
 Identities = 66/304 (21%), Positives = 123/304 (40%), Gaps = 39/304 (12%)

Query: 291 YTFKELRAATSNFSAK---------NILGRGGFGIVYKGCF----SDGALVAVKRLKDYN 337
           +TF++   A   F+ +          ++G G FG V  G           VA+K LK   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 338 IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP 397
                  F +E   +    H N++ L G  +     +++  +M NGS+ S LR +     
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 398 ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
                +   +  G A G+ YL +      +HRD+ A NIL++ +    V DFGL++ L+ 
Sbjct: 127 ---VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 458 RDSHVTT----AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN 513
             S  T       +  +   APE +   + +  +DV+ +GI++ E+++      +     
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 514 QRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
                            +   +++D +          + Q+ L C Q +  HRPK  +++
Sbjct: 241 D----------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 574 KMLE 577
             L+
Sbjct: 285 NTLD 288

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 3e-63
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 26/278 (9%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           S  +    +G G FG+V+ G + +   VA+K +++  +   E  F  E E +    H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKL 62

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL-DWARRKRIALGTARGLLYLH 419
           ++L G C  +    LV+ +M +G     L D++  +  L        + L    G+ YL 
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
           E C   +IHRD+ A N L+ E+    V DFG+ + +       +T  +  V   +PE  S
Sbjct: 119 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FG+L+ E+ +  +     R+ ++                + + +    
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----------------VVEDISTGF 219

Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +    R+    + Q+   C +  P  RP  S +L+ L 
Sbjct: 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 1e-61
 Identities = 67/285 (23%), Positives = 122/285 (42%), Gaps = 29/285 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDG-----ALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           S  + + ++G G FG VYKG            VA+K LK        V F  E   +   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            H N++RL G  S     +++  YM NG++   LR+           +   +  G A G+
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGM 123

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHI 473
            YL        +HRD+ A NIL++ +    V DFGL+++L  D   ++ T+  +  +   
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
           APE +S  + +  +DV+ FGI++ E++T      +                     ++ +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----------------LSNHEVMK 224

Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG 578
            ++   +          + Q+ + C Q     RPK ++++ +L+ 
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-61
 Identities = 55/277 (19%), Positives = 110/277 (39%), Gaps = 24/277 (8%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
            + +    LG G FG+V  G +     VA+K +K+ ++   E +F  E + +    H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKL 61

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           ++L G C+ +    ++  YM NG +   L      R      +   +       + YL  
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
           +     +HRD+ A N L+++     V DFGL++ +   +   +   +  V    PE L  
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK 540
            + S K+D++ FG+L+ E+ +  +                         + ++ + + L+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERF----------------TNSETAEHIAQGLR 219

Query: 541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                +  E++  +   C       RP    +L  + 
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  203 bits (518), Expect = 3e-61
 Identities = 68/312 (21%), Positives = 122/312 (39%), Gaps = 46/312 (14%)

Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQ 346
              L    +N      +G G FG V++        +    +VAVK LK+   A  +  FQ
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 347 TEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH-------------- 392
            E   ++   + N+++L G C+      L++ YM  G +   LR                
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 393 ------IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV 446
                   G P L  A +  IA   A G+ YL E+   K +HRD+   N L+ E+    +
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181

Query: 447 GDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRA 505
            DFGL++ +   D           +  + PE +   + + ++DV+ +G++L E+ +    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 506 LDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLH 565
             +G A        + V    ++G +    +             E+  +  LC    P  
Sbjct: 242 PYYGMAH-------EEVIYYVRDGNILACPEN---------CPLELYNLMRLCWSKLPAD 285

Query: 566 RPKMSEVLKMLE 577
           RP    + ++L+
Sbjct: 286 RPSFCSIHRILQ 297

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 7e-61
 Identities = 70/301 (23%), Positives = 117/301 (38%), Gaps = 40/301 (13%)

Query: 301 SNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETIS- 353
           +  S    LG G FG V +              VAVK LK            +E++ +S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--------------GRPAL 399
           L  H N++ L G C+     L++  Y   G + + LR                     AL
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 400 DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
           D       +   A+G+ +L  +     IHRD+ A NILL       + DFGLA+ + +  
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 460 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM 518
           ++ V    R  V  +APE +     + ++DV+ +GI L EL +   +   G         
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-------- 251

Query: 519 LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG 578
                    + K  +M+ +  +         EM  +   C   +PL RP   ++++++E 
Sbjct: 252 -------PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 579 D 579
            
Sbjct: 305 Q 305

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 8e-61
 Identities = 69/277 (24%), Positives = 112/277 (40%), Gaps = 24/277 (8%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
            +   +  LG+G FG V+ G ++    VA+K LK   +      F  E + +    H  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 74

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           ++L     +E    +V  YM  GS+             L   +   +A   A G+ Y+  
Sbjct: 75  VQLYAVV-SEEPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
                 +HRD++AANIL+ E+    V DFGLA+L++  +       +  +   APE    
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK 540
           G+ + K+DV+ FGILL EL T  R    G    +                +   V++  +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERGYR 232

Query: 541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                   E +  +   C +  P  RP    +   LE
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (514), Expect = 8e-61
 Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 26/305 (8%)

Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT 347
               + +     ++ + K+ LG G +G VY+G +      VAVK LK+  +   E  F  
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62

Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
           E   +    H NL++L G C+ E    ++  +M  G++   L      R  +       +
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYM 120

Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
           A   +  + YL +      IHRD+ A N L+ E+    V DFGL++L+           +
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177

Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ 527
             +   APE L+  + S K+DV+ FG+LL E+ T   +   G   +Q             
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------- 224

Query: 528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEA 587
              + ++++KD +        E++ ++   C Q+NP  RP  +E+ +  E   + ++   
Sbjct: 225 ---VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE--TMFQESSI 279

Query: 588 SQKIE 592
           S ++E
Sbjct: 280 SDEVE 284

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 1e-60
 Identities = 66/294 (22%), Positives = 116/294 (39%), Gaps = 30/294 (10%)

Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
           +  +G+G FG V++G +  G  VAVK              + E+    +  H N+L    
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIA 64

Query: 366 FCSTEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
             + +N    +  LV  Y  +GS    L D+++    +      ++AL TA GL +LH +
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGS----LFDYLNRYT-VTVEGMIKLALSTASGLAHLHME 119

Query: 422 C-----DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV---TTAVRGTVGHI 473
                  P I HRD+K+ NIL+ ++    + D GLA   D     +        GT  ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 474 APEYLST------GQSSEKTDVFGFGILLLELITGQRALDF---GRAANQRGVMLDWVKK 524
           APE L         +S ++ D++  G++  E+             +      V  D   +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 525 LHQEGKLSQMVDKDLKGNFDRIE-LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
             ++    Q +  ++   +   E L  M ++   C   N   R     + K L 
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 6e-60
 Identities = 81/284 (28%), Positives = 116/284 (40%), Gaps = 32/284 (11%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVH 357
           +F    ++GRG FG VY G   D        AVK L      G   QF TE   +    H
Sbjct: 30  HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 358 RNLLRLCGFCS-TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
            N+L L G C  +E   L+V PYM +G + +      +              L  A+G+ 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN---FIRNETHNPTVKDLIGFGLQVAKGM- 143

Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD---SHVTTAVRGTVGHI 473
                   K +HRD+ A N +LDE F   V DFGLA+ +  ++    H  T  +  V  +
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
           A E L T + + K+DV+ FG+LL EL+T       G          D    L Q  +L Q
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTR------GAPPYPDVNTFDITVYLLQGRRLLQ 255

Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                          + + +V L C       RP  SE++  + 
Sbjct: 256 ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-59
 Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 31/291 (10%)

Query: 294 KELRAATSNFSAKNI-LGRGGFGIVYKGCF---SDGALVAVKRLKDYNIAGGEVQFQTEV 349
           K+L     N    +I LG G FG V +G +        VA+K LK         +   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIA 408
           + +    +  ++RL G C      +LV      G     L   + G R  +  +    + 
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP----LHKFLVGKREEIPVSNVAELL 115

Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAV 466
              + G+ YL E+     +HRD+ A N+LL     A + DFGL+K L   DS+ T  +A 
Sbjct: 116 HQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH 526
           +  +   APE ++  + S ++DV+ +G+ + E ++  +         +            
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------------ 220

Query: 527 QEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               +   +++  +         E+  +   C  +    RP    V + + 
Sbjct: 221 ----VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 4e-59
 Identities = 66/304 (21%), Positives = 112/304 (36%), Gaps = 45/304 (14%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETIS- 353
            N     +LG G FG V                VAVK LK+   +       +E++ ++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH------------------- 394
           L  H N++ L G C+      L++ Y   G + + LR                       
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 395 GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454
               L +      A   A+G+ +L  +     +HRD+ A N+L+       + DFGLA+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 455 LDHRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN 513
           +    ++V     R  V  +APE L  G  + K+DV+ +GILL E+ +       G    
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG---- 269

Query: 514 QRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
                      +  +    +++    K +      EE+  +   C  F+   RP    + 
Sbjct: 270 -----------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

Query: 574 KMLE 577
             L 
Sbjct: 319 SFLG 322

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 7e-59
 Identities = 60/306 (19%), Positives = 114/306 (37%), Gaps = 36/306 (11%)

Query: 296 LRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
           +     +F   + LG G  G+V+K      G ++A K +          Q   E++ +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
                ++   G   ++ E  +   +M  GS    L   +     +      ++++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGS----LDQVLKKAGRIPEQILGKVSIAVIKG 116

Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
           L YL E+   KI+HRDVK +NIL++   E  + DFG++  L      +  +  GT  +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMS 171

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQR--------ALDFGRAANQRGVMLDWVKKLH 526
           PE L     S ++D++  G+ L+E+  G+          L+        G   +   +  
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 527 QEGKLSQMVDKDLKGNFDRIEL------------------EEMVQVALLCTQFNPLHRPK 568
             G+       D +      EL                   E       C   NP  R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 569 MSEVLK 574
           + +++ 
Sbjct: 292 LKQLMV 297

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 9e-59
 Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 37/293 (12%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETIS-LAV 356
           ++   ++++G G FG V K       L    A+KR+K+Y        F  E+E +  L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARR 404
           H N++ L G C       L   Y P+G++   LR                    L   + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
              A   ARG+ YL +    + IHRD+ A NIL+ E++ A + DFGL++          T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184

Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
             R  V  +A E L+    +  +DV+ +G+LL E+++       G               
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------------- 229

Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                +L + + +  +        +E+  +   C +  P  RP  +++L  L 
Sbjct: 230 -MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 3e-58
 Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 30/282 (10%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
           ++     +G G +G   K    SDG ++  K L   ++   E Q   +EV  +    H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 360 LLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
           ++R            L  V  Y   G +AS +      R  LD     R+       L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 418 LHEQ--CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            H +      ++HRD+K AN+ LD      +GDFGLA++L+H D+    A  GT  +++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSP 183

Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV 535
           E ++    +EK+D++  G LL EL                                 ++ 
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMP--------------------PFTAFSQKELA 223

Query: 536 DKDLKGNFDRIEL---EEMVQVALLCTQFNPLHRPKMSEVLK 574
            K  +G F RI     +E+ ++          HRP + E+L+
Sbjct: 224 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 3e-58
 Identities = 74/278 (26%), Positives = 107/278 (38%), Gaps = 30/278 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
                   +G+G FG V  G +  G  VAVK +K+         F  E   ++   H NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 62

Query: 361 LRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           ++L G    E   L +V  YM  GS+   LR    GR  L      + +L     + YL 
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
                  +HRD+ A N+L+ ED  A V DFGL K             +  V   APE L 
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALR 173

Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
             + S K+DV+ FGILL E+ +  R                          +   V+K  
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRVEKGY 217

Query: 540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           K +        + +V   C   +   RP   ++ + LE
Sbjct: 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 6e-57
 Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 30/277 (10%)

Query: 307 NILGRGGFGIVYKGCFSD---GALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLR 362
             LG G FG V KG +        VAVK LK + N    + +   E   +    +  ++R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           + G C  E+  +LV      G     L  ++     +       +    + G+ YL E  
Sbjct: 73  MIGICEAES-WMLVMEMAELGP----LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 126

Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHIAPEYLST 480
               +HRD+ A N+LL     A + DFGL+K L   +++       +  V   APE ++ 
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK 540
            + S K+DV+ FG+L+ E  +  +    G   ++                ++ M++K  +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGER 228

Query: 541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                    EM  +  LC  ++  +RP  + V   L 
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-56
 Identities = 66/276 (23%), Positives = 115/276 (41%), Gaps = 31/276 (11%)

Query: 306 KNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRL 363
              +GRG F  VYKG  ++    VA   L+D  +   E Q F+ E E +    H N++R 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 364 CGFCST----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
                +    +   +LV   M +G+    L+ ++     +     +       +GL +LH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGT----LKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 420 EQCDPKIIHRDVKAANILL-DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
            +  P IIHRD+K  NI +        +GD GLA L     +    AV GT   +APE  
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMY 185

Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
              +  E  DV+ FG+ +LE+ T +                 + +  +      ++    
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYP---------------YSECQNAAQIYRRVTSGV 229

Query: 539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
              +FD++ + E+ ++   C + N   R  + ++L 
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 4e-55
 Identities = 72/321 (22%), Positives = 127/321 (39%), Gaps = 44/321 (13%)

Query: 272 FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF------SDG 325
           +F   D Y P+      ++ T                LG+G FG+VY+G           
Sbjct: 3   YFSAADVYVPDEWEVAREKITMSR------------ELGQGSFGMVYEGVAKGVVKDEPE 50

Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
             VA+K + +       ++F  E   +      +++RL G  S     L++   M  G +
Sbjct: 51  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 110

Query: 386 ASRLRDHIHG------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD 439
            S LR                 ++  ++A   A G+ YL+     K +HRD+ A N ++ 
Sbjct: 111 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 167

Query: 440 EDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 498
           EDF   +GDFG+ + +   D           V  ++PE L  G  +  +DV+ FG++L E
Sbjct: 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 227

Query: 499 LITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLC 558
           + T       G +        + V +   EG L    D            + + ++  +C
Sbjct: 228 IATLAEQPYQGLSN-------EQVLRFVMEGGLLDKPDN---------CPDMLFELMRMC 271

Query: 559 TQFNPLHRPKMSEVLKMLEGD 579
            Q+NP  RP   E++  ++ +
Sbjct: 272 WQYNPKMRPSFLEIISSIKEE 292

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 4e-55
 Identities = 61/283 (21%), Positives = 118/283 (41%), Gaps = 29/283 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           + F    +LG G FG VYKG +          VA+K L++        +   E   ++  
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            + ++ RL G C T   +L+    MP G +   L      +  +         +  A+G+
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQ-LMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIA 474
            YL ++   +++HRD+ A N+L+       + DFGLAKLL   +  +     +  +  +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM 534
            E +     + ++DV+ +G+ + EL+T       G  A++                +S +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSI 225

Query: 535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           ++K  +     I   ++  + + C   +   RPK  E++    
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-54
 Identities = 61/276 (22%), Positives = 103/276 (37%), Gaps = 25/276 (9%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           ++     LG G +G V           VAVK +            + E+    +  H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           ++  G     N + L   Y   G +     D I     +     +R       G++YLH 
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-HRDSHVTTAVRGTVGHIAPEYLS 479
                I HRD+K  N+LLDE     + DFGLA +   +    +   + GT+ ++APE L 
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 480 TGQ-SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
             +  +E  DV+  GI+L  ++ G+   D    + Q               + S   +K 
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---------------EYSDWKEKK 223

Query: 539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
              N  +      + +       NP  R  + ++ K
Sbjct: 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-54
 Identities = 70/277 (25%), Positives = 109/277 (39%), Gaps = 31/277 (11%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVH 357
            +F     LG+G FG VY         ++A+K L    +  AG E Q + EVE  S   H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
            N+LRL G+        L+  Y P G+    +   +      D  R        A  L Y
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSY 121

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
            H +   ++IHRD+K  N+LL    E  + DFG +    H  S   T + GT+ ++ PE 
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEM 175

Query: 478 LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK 537
           +      EK D++  G+L  E + G+   +             + +    E      V +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVEFTFPDFVTE 229

Query: 538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
             +             +     + NP  RP + EVL+
Sbjct: 230 GAR------------DLISRLLKHNPSQRPMLREVLE 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 4e-53
 Identities = 60/292 (20%), Positives = 118/292 (40%), Gaps = 31/292 (10%)

Query: 301 SNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
                   +G G FG V++G +         VA+K  K+        +F  E  T+    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGL 415
           H ++++L G   TEN   ++      G     LR  +  R  +LD A     A   +  L
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            YL  +   + +HRD+ A N+L+  +    +GDFGL++ ++    +  +  +  +  +AP
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV 535
           E ++  + +  +DV+ FG+ + E++        G   N     ++  ++L          
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP--- 235

Query: 536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEA 587
                          +  +   C  ++P  RP+ +E+   L    + E+ +A
Sbjct: 236 -------------PTLYSLMTKCWAYDPSRRPRFTELKAQLS--TILEEEKA 272

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  181 bits (460), Expect = 8e-53
 Identities = 76/301 (25%), Positives = 108/301 (35%), Gaps = 41/301 (13%)

Query: 280 DPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNI 338
           DP+V+        FK+       FS    +G G FG VY      +  +VA+K++     
Sbjct: 1   DPDVA-----ELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK 53

Query: 339 AGGEV--QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR 396
              E       EV  +    H N ++  G    E+   LV  Y    +           +
Sbjct: 54  QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA----SDLLEVHK 109

Query: 397 PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
             L       +  G  +GL YLH      +IHRDVKA NILL E     +GDFG A ++ 
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Query: 457 HRDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAAN 513
             +S V     GT   +APE +     GQ   K DV+  GI  +EL   +  L       
Sbjct: 167 PANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------ 215

Query: 514 QRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVL 573
                      ++    L  +   +          E        C Q  P  RP    +L
Sbjct: 216 ----------NMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

Query: 574 K 574
           K
Sbjct: 266 K 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 7e-52
 Identities = 70/298 (23%), Positives = 118/298 (39%), Gaps = 39/298 (13%)

Query: 301 SNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
                   LGRG FG V +         +    VAVK LK+           +E++ +  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 355 AVHR-NLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIH------------GRPALD 400
             H  N++ L G C+     L ++  +   G++++ LR   +             +  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 401 WARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460
                  +   A+G+ +L  +   K IHRD+ A NILL E     + DFGLA+ +     
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 461 HV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML 519
           +V     R  +  +APE +     + ++DV+ FG+LL E+ +   +   G   ++     
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 244

Query: 520 DWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
               +  +EG   +  D             EM Q  L C    P  RP  SE+++ L 
Sbjct: 245 -EFCRRLKEGTRMRAPDYT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 9e-52
 Identities = 76/284 (26%), Positives = 112/284 (39%), Gaps = 30/284 (10%)

Query: 302 NFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEV--QFQTEVETISLA 355
           +      LG G FG+V +G +         VAVK LK   ++  E    F  EV  +   
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
            HRNL+RL G   T   ++ V    P GS+  RLR H   +         R A+  A G+
Sbjct: 69  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGM 124

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH--VTTAVRGTVGHI 473
            YL  +     IHRD+ A N+LL       +GDFGL + L   D H  +    +      
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ 533
           APE L T   S  +D + FG+ L E+ T  +    G               L+    L +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG---------------LNGSQILHK 226

Query: 534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
           +  +  +        +++  V + C    P  RP    +   L 
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 1e-51
 Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 41/299 (13%)

Query: 301 SNFSAKNILGRGGFGIVYKG--------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI 352
                   LG G FG V             +    VAVK LK            +E+E +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 353 S-LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH------------IHGRPAL 399
             +  H+N++ L G C+ +    ++  Y   G++   L+               +    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 400 DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
                   A   ARG+ YL      K IHRD+ A N+L+ ED    + DFGLA+ + H D
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 460 SHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM 518
            +  T   R  V  +APE L     + ++DV+ FG+LL E+ T   +   G    +    
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245

Query: 519 LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
                       L +++ +  + +       E+  +   C    P  RP   ++++ L+
Sbjct: 246 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 5e-50
 Identities = 63/277 (22%), Positives = 106/277 (38%), Gaps = 39/277 (14%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG G FG VYK        L A K +   +    E  +  E++ ++   H N+++L    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 78

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
             EN   ++  +   G+V + + +       L  ++ + +   T   L YLH+    KII
Sbjct: 79  YYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KII 132

Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS---- 483
           HRD+KA NIL   D +  + DFG++           + + GT   +APE +    S    
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 191

Query: 484 -SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGN 542
              K DV+  GI L+E+   +                      H E    +++ K  K  
Sbjct: 192 YDYKADVWSLGITLIEMAEIEP--------------------PHHELNPMRVLLKIAKSE 231

Query: 543 FDRIEL-----EEMVQVALLCTQFNPLHRPKMSEVLK 574
              +                C + N   R   S++L+
Sbjct: 232 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-48
 Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 32/290 (11%)

Query: 292 TFKELRAATS------NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ 344
             ++LR+  S       ++    +G+G  G VY     + G  VA++++        E  
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-L 63

Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
              E+  +    + N++         +E  +V  Y+  GS    L D +      D  + 
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCM-DEGQI 118

Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
             +     + L +LH     ++IHRD+K+ NILL  D    + DFG    +    S  +T
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175

Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK 524
            V GT   +APE ++      K D++  GI+ +E+I G+         N    +      
Sbjct: 176 MV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALYLIATN 231

Query: 525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
              E +  + +    +                 C   +   R    E+L+
Sbjct: 232 GTPELQNPEKLSAIFR------------DFLNRCLDMDVEKRGSAKELLQ 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-46
 Identities = 59/282 (20%), Positives = 100/282 (35%), Gaps = 33/282 (11%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHR 358
           +F    ILG G F  V      +     A+K L+  +I           E + +S   H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
             ++L      + +      Y  NG     L  +I    + D    +         L YL
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEY 477
           H +    IIHRD+K  NILL+ED    + DFG AK+L          +  GT  +++PE 
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 478 LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK 537
           L+   + + +D++  G ++ +L+ G                        + G    +  K
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP--------------------PFRAGNEYLIFQK 221

Query: 538 DLKGNFDRIE--LEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            +K  +D  E    +   +       +   R    E+     
Sbjct: 222 IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  165 bits (419), Expect = 2e-46
 Identities = 72/361 (19%), Positives = 126/361 (34%), Gaps = 45/361 (12%)

Query: 273 FDVNDQYDP---EVSLGH-LKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGAL 327
           FD+  QY P   E+   H L  Y   E             LG G FG+V++    + G  
Sbjct: 6   FDIWKQYYPQPVEIKHDHVLDHYDIHEE------------LGTGAFGVVHRVTERATGNN 53

Query: 328 VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVAS 387
            A K +   + +  E   + E++T+S+  H  L+ L      +NE +++Y +M  G +  
Sbjct: 54  FAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112

Query: 388 RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAV 445
           ++ D       +             +GL ++HE      +H D+K  NI+       E  
Sbjct: 113 KVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELK 166

Query: 446 VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRA 505
           + DFGL   LD + S   T   GT    APE          TD++  G+L   L++G   
Sbjct: 167 LIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224

Query: 506 LDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLH 565
                  N    +         +  +       +         E+           +P  
Sbjct: 225 FG---GENDDETLR---NVKSCDWNMDDSAFSGIS--------EDGKDFIRKLLLADPNT 270

Query: 566 RPKMSEVLK---MLEGDGLAEKWEASQKIETPRYRTHEKRYSDFIEESSLVIEAMELSGP 622
           R  + + L+   +  G+      +      T    + + +Y  + E    +      S  
Sbjct: 271 RMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSL 330

Query: 623 R 623
           R
Sbjct: 331 R 331

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  158 bits (401), Expect = 7e-45
 Identities = 61/289 (21%), Positives = 103/289 (35%), Gaps = 39/289 (13%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK--------DYNIAGGEVQFQTEVETI 352
           N+  K ILGRG   +V +          AVK +            +         EV+ +
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 353 S-LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
             ++ H N+++L     T     LV+  M  G     L D++  +  L     ++I    
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIMRAL 119

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
              +  LH+     I+HRD+K  NILLD+D    + DFG +  LD         V GT  
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPS 174

Query: 472 HIAPEYLSTGQS------SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL 525
           ++APE +    +       ++ D++  G+++  L+ G            R  ML     +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLRMIM 228

Query: 526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
               +       D          + +  +        P  R    E L 
Sbjct: 229 SGNYQFGSPEWDDYS--------DTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (401), Expect = 2e-44
 Identities = 55/283 (19%), Positives = 100/283 (35%), Gaps = 21/283 (7%)

Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVET 351
           +K+       +  +++LG G F  V          LVA+K +    + G E   + E+  
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
           +    H N++ L     +     L+   +  G     L D I  +         R+    
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE----LFDRIVEKGFYTERDASRLIFQV 116

Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
              + YLH+        +        LDED + ++ DFGL+K+ D     V +   GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPG 174

Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           ++APE L+    S+  D +  G++   L+ G         A        + + L  E + 
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQILKAEYEF 228

Query: 532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
                 D+         +          + +P  R    + L+
Sbjct: 229 DSPYWDDIS--------DSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  158 bits (401), Expect = 5e-44
 Identities = 70/367 (19%), Positives = 129/367 (35%), Gaps = 52/367 (14%)

Query: 270 QIFFDVNDQYDP---EVSLGHL-KRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSD 324
           + + D+  +Y P   EV  G +   Y   E             LG G FG+V++    + 
Sbjct: 6   KFYEDIWKKYVPQPVEVKQGSVYDYYDILEE------------LGSGAFGVVHRCVEKAT 53

Query: 325 GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS 384
           G +   K +            + E+  ++   H  L+ L      + E +L+  ++  G 
Sbjct: 54  GRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112

Query: 385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDF 442
           +  R+         +  A           GL ++HE     I+H D+K  NI+ +  +  
Sbjct: 113 LFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKAS 166

Query: 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
              + DFGLA  L+     +      T    APE +        TD++  G+L   L++G
Sbjct: 167 SVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224

Query: 503 QRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFN 562
                            D ++ L    +     D+D   +       E         Q  
Sbjct: 225 LSPFA----------GEDDLETLQNVKRCDWEFDEDAFSSVS----PEAKDFIKNLLQKE 270

Query: 563 PLHRPKMSEVLKM--LEGDGLAEKWEASQKIETPRY----RTHEKRYSDFIEESSLVIEA 616
           P  R  + + L+   L+GD        + +I + RY    +  +++Y+D+      +   
Sbjct: 271 PRKRLTVHDALEHPWLKGD----HSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRI 326

Query: 617 MELSGPR 623
              S  R
Sbjct: 327 ANFSSLR 333

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 8e-43
 Identities = 63/293 (21%), Positives = 108/293 (36%), Gaps = 22/293 (7%)

Query: 299 ATSNFSAKNILGRGGFGIVYKG--CFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLA 355
           A   +     +G G +G V+K     + G  VA+KR++      G  +    EV  +   
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 356 V---HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALG 410
               H N++RL   C+           +    V   L  ++     P +     K +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
             RGL +LH     +++HRD+K  NIL+    +  + DFGLA++   + +  +  V  T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179

Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML---------DW 521
            + APE L     +   D++  G +  E+   +         +Q G +L         DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 522 VKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
            + +    +            F     E    + L C  FNP  R      L 
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-42
 Identities = 56/286 (19%), Positives = 104/286 (36%), Gaps = 19/286 (6%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
           NF     +G G +G+VYK      G +VA+K+++ D    G       E+  +    H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           +++L     TEN+  LV+ ++       +          +     K       +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
                 ++HRD+K  N+L++ +    + DFGLA+         T  V           L 
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL 539
               S   D++  G +  E++T +         +Q   +   +    +          D 
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 540 KGNFDRIELEEMVQV---------ALL--CTQFNPLHRPKMSEVLK 574
           K +F +   ++  +V         +LL     ++P  R      L 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-42
 Identities = 51/292 (17%), Positives = 109/292 (37%), Gaps = 21/292 (7%)

Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
              ++  + +G G +G+V       +   VA+K++  +       +   E++ +    H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
           N++ +           +   Y+    + + L   +  +  L             RGL Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPE 476
           H      ++HRD+K +N+LL+   +  + DFGLA++   DH  +   T    T  + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 477 YLSTGQ-SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV 535
            +   +  ++  D++  G +L E+++ +         +Q   +L  +    QE     + 
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 536 DKDLKGNFDRIEL-------------EEMVQVALLCTQFNPLHRPKMSEVLK 574
            K                         + + +      FNP  R ++ + L 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  153 bits (388), Expect = 5e-42
 Identities = 65/273 (23%), Positives = 101/273 (36%), Gaps = 32/273 (11%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAV-- 356
           +FS   I+GRGGFG VY       G + A+K L  K   +  GE     E   +SL    
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 357 -HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
               ++ +     T ++   +   M  G     L  H+        A  +  A     GL
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGD----LHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
            ++H +    +++RD+K ANILLDE     + D GLA     +  H +    GT G++AP
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174

Query: 476 EYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM 534
           E L  G +     D F  G +L +L+ G            +         L    +L   
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR---QHKTKDKHEIDRMTLTMAVELPDS 231

Query: 535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRP 567
              +L+   +               Q +   R 
Sbjct: 232 FSPELRSLLEG------------LLQRDVNRRL 252

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 2e-41
 Identities = 58/317 (18%), Positives = 110/317 (34%), Gaps = 30/317 (9%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LGRG FGIV++    S       K +K       +V  + E+  +++A HRN+L L    
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
            +  E ++++ ++    +  R+         L+              L +LH      I 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIG 124

Query: 428 HRDVKAANILLDEDFEAVV--GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
           H D++  NI+      + +   +FG A+ L   D+           + APE       S 
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182

Query: 486 KTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDR 545
            TD++  G L+  L++G                      ++ E    +   K++      
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYTFDEEAFKEIS----- 231

Query: 546 IELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGDGLAEKWEASQKIETPRYRTHEKRYSD 605
               E +             R   SE L+      L +K E          +     ++ 
Sbjct: 232 ---IEAMDFVDRLLVKERKSRMTASEALQH---PWLKQKIERVSTKVIRTLKHRRYYHTL 285

Query: 606 FIEESSLVIEAMELSGP 622
             ++ ++V+ A  +S  
Sbjct: 286 IKKDLNMVVSAARISCG 302

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-41
 Identities = 68/277 (24%), Positives = 108/277 (38%), Gaps = 30/277 (10%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISLAV-H 357
           +F    +LG+G FG V+           A+K L KD  +   +V+    E   +SLA  H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
             L  +     T+     V  Y+  G     L  HI      D +R    A     GL +
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGD----LMYHIQSCHKFDLSRATFYAAEIILGLQF 118

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
           LH +    I++RD+K  NILLD+D    + DFG+ K     D+   T   GT  +IAPE 
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174

Query: 478 LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK 537
           L   + +   D + FG+LL E++ GQ              +   ++         + ++K
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFH----GQDEEELFHSIRM--DNPFYPRWLEK 228

Query: 538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
           + K    +                 P  R  +   ++
Sbjct: 229 EAKDLLVK------------LFVREPEKRLGVRGDIR 253

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 5e-41
 Identities = 72/285 (25%), Positives = 116/285 (40%), Gaps = 24/285 (8%)

Query: 307 NILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIA----GGEVQFQTEVETISLAVHRNLL 361
           + LG G F  VYK    +   +VA+K++K  + +    G       E++ +    H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
            L      ++   LV+ +M                  L  +  K   L T +GL YLH+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
               I+HRD+K  N+LLDE+    + DFGLAK     +   T  V  T  + APE L   
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175

Query: 482 QS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE--GKLSQMVDKD 538
           +      D++  G +L EL+     L      +Q   + + +    +E    +  + D  
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 539 LKGNFDRIELEEMVQVA------LL--CTQFNPLHRPKMSEVLKM 575
              +F  I L  +   A      L+     FNP  R   ++ LKM
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  147 bits (372), Expect = 9e-41
 Identities = 63/280 (22%), Positives = 110/280 (39%), Gaps = 31/280 (11%)

Query: 308 ILGRGGFGIVYKG-CFSDGALVAVKRLK--DYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
           ILG GG   V+          VAVK L+          ++F+ E +  +   H  ++ + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 365 GFCSTENERL----LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
                E        +V  Y+   +    LRD +H    +   R   +     + L + H+
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV--TTAVRGTVGHIAPEYL 478
                IIHRDVK ANI++       V DFG+A+ +    + V  T AV GT  +++PE  
Sbjct: 130 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
                  ++DV+  G +L E++TG+         +   V     + + ++        + 
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVAY---QHVREDPIPPSARHEG 240

Query: 539 LKGNFDRIELEEMVQVALLCTQFNPLHRPK-MSEVLKMLE 577
           L          ++  V L     NP +R +  +E+   L 
Sbjct: 241 LS--------ADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (373), Expect = 1e-40
 Identities = 52/279 (18%), Positives = 91/279 (32%), Gaps = 29/279 (10%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           +G G FG +Y G   + G  VA+K      +     Q   E +   +      +    +C
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
             E +  ++   +   S+                     +A      + Y+H +     I
Sbjct: 72  GAEGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFI 125

Query: 428 HRDVKAANIL---LDEDFEAVVGDFGLAKLLDHRDSHV------TTAVRGTVGHIAPEYL 478
           HRDVK  N L     +     + DFGLAK      +H          + GT  + +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
              + S + D+   G +L+    G       +AA +R        +   E K+S  ++  
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-----ERISEKKMSTPIEVL 240

Query: 539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            KG        E       C       +P  S + ++  
Sbjct: 241 CKGY-----PSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  147 bits (372), Expect = 1e-40
 Identities = 50/285 (17%), Positives = 106/285 (37%), Gaps = 19/285 (6%)

Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNL 360
            +     +G G +G+VYK   + G   A+K+++ +    G       E+  +    H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           ++L     T+   +LV+ ++         +        L+    K   L    G+ Y H+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDL----KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
           +   +++HRD+K  N+L++ + E  + DFGLA+         T  +           + +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK 540
            + S   D++  G +  E++ G         A+Q   +   +   + +   +        
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 541 GNFDRIEL-----------EEMVQVALLCTQFNPLHRPKMSEVLK 574
            NF   E            E  + +     + +P  R    + L+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 64/297 (21%), Positives = 107/297 (36%), Gaps = 29/297 (9%)

Query: 297 RAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
           R    +++   ++G G FG+VY+      G LVA+K++        +     E++ +   
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 70

Query: 356 VHRNLLRLCGFCSTENER------LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
            H N++RL  F  +  E+       LV  Y+P        R +   +  L     K    
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMY 129

Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLLDHRDSHVTTAVRG 468
              R L Y+H      I HRD+K  N+LLD D     + DFG AK L   + +V+  +  
Sbjct: 130 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 185

Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD-------- 520
                          +   DV+  G +L EL+ GQ         +Q   ++         
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245

Query: 521 ---WVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
               +   + E K  Q+        F      E + +     ++ P  R    E   
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-39
 Identities = 62/325 (19%), Positives = 117/325 (36%), Gaps = 39/325 (12%)

Query: 308 ILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCG 365
           +LG G  G V +          A+K L+D        + + EVE    A    +++R+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72

Query: 366 FC----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
                 +     L+V   +  G + SR++D   G  A        I       + YLH  
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI 130

Query: 422 CDPKIIHRDVKAANILLDEDFE---AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
               I HRDVK  N+L           + DFG AK     +S  T     T  ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185

Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
              +  +  D++  G+++  L+ G               M   ++    E    +  +  
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

Query: 539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK---MLEGDGLAEKWEASQKIETPR 595
                     EE+  +     +  P  R  ++E +    +++   + +    + ++    
Sbjct: 246 ----------EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV---- 291

Query: 596 YRTHEKRYSDFIEESSLVIEAMELS 620
            +  ++R+ D  EE +  +  M + 
Sbjct: 292 LKEDKERWEDVKEEMTSALATMRVD 316

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  142 bits (360), Expect = 1e-38
 Identities = 63/270 (23%), Positives = 102/270 (37%), Gaps = 32/270 (11%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVH 357
            +F     LG G FG V+      +G   A+K LK   +   +       E   +S+  H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
             ++R+ G      +  ++  Y+        L   +           K  A      L Y
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
           LH +    II+RD+K  NILLD++    + DFG AK +          + GT  +IAPE 
Sbjct: 120 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEV 172

Query: 478 LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK 537
           +ST   ++  D + FGIL+ E++ G         +N         K L+ E +     ++
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFY---DSNTMKTYE---KILNAELRFPPFFNE 226

Query: 538 DLKGNFDRIELEEMVQVALLCTQFNPLHRP 567
           D+K    R                +   R 
Sbjct: 227 DVKDLLSR------------LITRDLSQRL 244

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  140 bits (354), Expect = 4e-38
 Identities = 44/288 (15%), Positives = 90/288 (31%), Gaps = 31/288 (10%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
           ++     +G G FG++++G    +   VA+K     + A    Q + E  T  L      
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTG 62

Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
           +    +   E    ++   +   S+   L                  A      +  +HE
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVG-----DFGLAKLLD------HRDSHVTTAVRGT 469
           +    +++RD+K  N L+              DFG+ K         H        + GT
Sbjct: 120 K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG 529
             +++       + S + D+   G + +  + G       +AA  +    + + +  Q  
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIGEKKQST 235

Query: 530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE 577
            L     ++L   F     EE  +             P    +  +  
Sbjct: 236 PL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-37
 Identities = 60/277 (21%), Positives = 99/277 (35%), Gaps = 43/277 (15%)

Query: 308 ILGRGGFGIVYKG-CFSDGALVAVKRLK-----DYNIAGGEVQFQTEVETISL--AVHRN 359
           +LG GGFG VY G   SD   VA+K ++     D+       +   EV  +    +    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
           ++RL  +    +  +L+            L D I  R AL     +         + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127

Query: 420 EQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
                 ++HRD+K  NIL+D +  E  + DFG   LL      V T   GT  +  PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWI 181

Query: 479 STGQ-SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK 537
              +       V+  GILL +++ G    +      +         ++    ++S     
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--------GQVFFRQRVS----- 228

Query: 538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
                       E   +   C    P  RP   E+  
Sbjct: 229 -----------SECQHLIRWCLALRPSDRPTFEEIQN 254

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 4e-36
 Identities = 52/301 (17%), Positives = 99/301 (32%), Gaps = 33/301 (10%)

Query: 288 LKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQF 345
           +++Y   E             +G G +G V+K        +VA+KR++ D +  G     
Sbjct: 1   MQKYEKLEK------------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA 48

Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
             E+  +    H+N++RL     ++ +  LV+ +          +        LD    K
Sbjct: 49  LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVK 104

Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
                  + L  L       ++HRD+K  N+L++ + E  + +FGLA+         +  
Sbjct: 105 SFL---FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161

Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKL 525
           V                 S   D++  G +  EL    R L  G   + +   +  +   
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221

Query: 526 HQEGKLSQMVDKDLKGNFDRIEL------------EEMVQVALLCTQFNPLHRPKMSEVL 573
             E +   M        +                      +     + NP+ R    E L
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

Query: 574 K 574
           +
Sbjct: 282 Q 282

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-35
 Identities = 52/276 (18%), Positives = 90/276 (32%), Gaps = 33/276 (11%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEV-----QFQTEVETISLAVHRNLLR 362
           LG G F +V K    S G   A K +K                + EV  +    H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
           L      + + +L+   +  G     L D +  + +L              G+ YLH   
Sbjct: 78  LHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 133

Query: 423 DPKIIHRDVKAANILLDED----FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
              I H D+K  NI+L +         + DFGLA  +D    +    + GT   +APE +
Sbjct: 134 ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEFVAPEIV 188

Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD 538
           +      + D++  G++   L++G               +     +   E          
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---------- 238

Query: 539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
               F                  +P  R  + + L+
Sbjct: 239 ---YFSNTS-ALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 3e-35
 Identities = 55/282 (19%), Positives = 99/282 (35%), Gaps = 23/282 (8%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           +G G +G V        GA VA+K+L + +       +   E+  +    H N++ L   
Sbjct: 26  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85

Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
            + +        +             +     L   R + +     +GL Y+H      I
Sbjct: 86  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---I 142

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           IHRD+K  N+ ++ED E  + DFGLA+     DS +T  V           L+  + ++ 
Sbjct: 143 IHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPEVILNWMRYTQT 199

Query: 487 TDVFGFGILLLELITGQRALDFGRAANQRGVM--------------LDWVKKLHQEGKLS 532
            D++  G ++ E+ITG+         +Q   +              L   +  +    L 
Sbjct: 200 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259

Query: 533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
           ++  KD             V +       +   R    E L 
Sbjct: 260 ELEKKDFASILTNAS-PLAVNLLEKMLVLDAEQRVTAGEALA 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 3e-35
 Identities = 58/302 (19%), Positives = 113/302 (37%), Gaps = 35/302 (11%)

Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHR 358
           S +     +G+G FG V+K      G  VA+K++  +    G  +    E++ + L  H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 359 NLLRLCGFCST--------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
           N++ L   C T        +    LV+ +  +           +       +  KR+   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL----AGLLSNVLVKFTLSEIKRVMQM 125

Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS---HVTTAVR 467
              GL   +     KI+HRD+KAAN+L+  D    + DFGLA+      +   +  T   
Sbjct: 126 LLNGL---YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 468 GTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV---- 522
            T+ +  PE L   +      D++G G ++ E+ T    +      +Q  ++        
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 523 ---------KKLHQEGKLSQMVDKDLKGNF-DRIELEEMVQVALLCTQFNPLHRPKMSEV 572
                     +L+++ +L +   + +K      +     + +       +P  R    + 
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 573 LK 574
           L 
Sbjct: 303 LN 304

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 6e-35
 Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 11/206 (5%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEV-QFQTEVETISLAVHR 358
           +F    +LG+G FG V      + G   A+K L K+  IA  EV    TE   +    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
            L  L     T +    V  Y   G     L  H+         R +      A  +  L
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYG---AEIVSAL 118

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
                  +++RD+K  N++LD+D    + DFGL K      +       GT  ++APE L
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVL 177

Query: 479 STGQSSEKTDVFGFGILLLELITGQR 504
                    D +G G+++ E++ G+ 
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (312), Expect = 8e-32
 Identities = 46/206 (22%), Positives = 75/206 (36%), Gaps = 14/206 (6%)

Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHR 358
            F     LG G FG V        G   A+K L    +   +       E   +      
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
            L++L       +   +V  Y+  G     +  H+           +  A        YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGG----EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
           H      +I+RD+K  N+L+D+     V DFG AK +  R       + GT   +APE +
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEII 210

Query: 479 STGQSSEKTDVFGFGILLLELITGQR 504
            +   ++  D +  G+L+ E+  G  
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 1e-30
 Identities = 64/276 (23%), Positives = 101/276 (36%), Gaps = 31/276 (11%)

Query: 302 NFSAKNILGRGGFGIVYKG----CFSDGALVAVKRLKDYNIAGGE---VQFQTEVETIS- 353
           NF    +LG G +G V+          G L A+K LK   I          +TE + +  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
           +     L+ L     TE +  L+  Y+  G     L  H+  R        +        
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGE----LFTHLSQRERFTEHEVQIYV---GE 137

Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
            +L L       II+RD+K  NILLD +   V+ DFGL+K     ++       GT+ ++
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 474 APEYLSTGQS--SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL 531
           AP+ +  G S   +  D +  G+L+ EL+TG     F     +        + L  E   
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPPY 255

Query: 532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRP 567
            Q +    K             +       +P  R 
Sbjct: 256 PQEMSALAK------------DLIQRLLMKDPKKRL 279

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  120 bits (301), Expect = 2e-30
 Identities = 57/334 (17%), Positives = 117/334 (35%), Gaps = 52/334 (15%)

Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSN---FSAKNILGRGGFGIVYKG-CFSDG 325
           +++ DVN     E        + ++       N   +     LGRG +  V++    ++ 
Sbjct: 8   RVYTDVNTHRPRE-------YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN 60

Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLLRLCGFCSTENERL--LVYPYMPN 382
             V VK LK         + + E++ +  L    N++ L         R   LV+ ++ N
Sbjct: 61  EKVVVKILKPVKKK----KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116

Query: 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442
                  +        L     +       + L Y H      I+HRDVK  N+++D + 
Sbjct: 117 TD----FKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEH 166

Query: 443 EAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELI 500
             + + D+GLA+       +       +     PE L   Q      D++  G +L  +I
Sbjct: 167 RKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224

Query: 501 TGQRALDFGRAANQRGVML----------DWVKKLHQEG--KLSQMVDKDLKGNFDRIEL 548
             +     G     + V +          D++ K + E   + + ++ +  +  ++R   
Sbjct: 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 284

Query: 549 EEMVQVA------LL--CTQFNPLHRPKMSEVLK 574
            E   +        L    +++   R    E ++
Sbjct: 285 SENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 5e-28
 Identities = 57/282 (20%), Positives = 100/282 (35%), Gaps = 23/282 (8%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
           +G G +G V        G  VAVK+L + +       +   E+  +    H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85

Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
            +                +     ++I     L     + +     RGL Y+H      I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---I 142

Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
           IHRD+K +N+ ++ED E  + DFGLA+  D     +T  V           L+    ++ 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQT 199

Query: 487 TDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE--------------GKLS 532
            D++  G ++ EL+TG+         +Q  ++L  V     E                L+
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259

Query: 533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLK 574
           QM   +    F        V +       +   R   ++ L 
Sbjct: 260 QMPKMNFANVFIGAN-PLAVDLLEKMLVLDSDKRITAAQALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-27
 Identities = 53/319 (16%), Positives = 109/319 (34%), Gaps = 56/319 (17%)

Query: 288 LKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQF 345
           LKRY   +             +G G  GIV           VA+K+L + +       + 
Sbjct: 16  LKRYQNLKP------------IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 63

Query: 346 QTEVETISLAVHRNLLRLCGFCSTE------NERLLVYPYMPNGSVASRLRDHIHGRPAL 399
             E+  +    H+N++ L    + +       +  LV   M         +         
Sbjct: 64  YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELD-- 117

Query: 400 DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
              R   +      G+ +LH      IIHRD+K +NI++  D    + DFGLA+      
Sbjct: 118 -HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGT 171

Query: 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML 519
           S + T    T  + APE +      E  D++  G ++ E++  +         +Q   ++
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231

Query: 520 DWV----KKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALL------------------ 557
           + +     +  ++ + +     + +  +  +   ++   +L                   
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291

Query: 558 --CTQFNPLHRPKMSEVLK 574
                 +P  R  + + L+
Sbjct: 292 SKMLVIDPAKRISVDDALQ 310

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (253), Expect = 4e-24
 Identities = 51/311 (16%), Positives = 95/311 (30%), Gaps = 49/311 (15%)

Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
           LG G F  V+      +   VA+K ++   +       + E++ +      +  +     
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 368 STENERLLVYPY--MPNGSV----------ASRLRDHIHGRPALDWARRKRIALGTARGL 415
           +    +LL +     PNG                    +    +     K+I+     GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 416 LYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVTTA-VRGTVGHI 473
            Y+H +C   IIH D+K  N+L++  D    +    +A L +             T  + 
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ------------------------------ 503
           +PE L         D++    L+ ELITG                               
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256

Query: 504 RALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNP 563
             L  G+           ++ + +            K  F + E +E+        Q +P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316

Query: 564 LHRPKMSEVLK 574
             R     ++ 
Sbjct: 317 RKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.1 bits (215), Expect = 2e-20
 Identities = 22/163 (13%), Positives = 47/163 (28%), Gaps = 20/163 (12%)

Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLK---------DYNIAGGEVQFQTEVETISLAVH 357
            ++G G    V+           VK  K               G++ F       +    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
           R L +L G    +      Y +  N  +   +      R  ++      +       +  
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD--EVLDMILEEVAK 118

Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460
            + +    I+H D+   N+L+  +    + DF  +  +     
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGW 157

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 76.7 bits (187), Expect = 6e-16
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 10/162 (6%)

Query: 34  EVVALVAVKNNLHDPYNVLENWDITSVDPC--SWRMITCSPDGY---VSALGLPSQSLSG 88
           +  AL+ +K +L +P   L +W   + D C  +W  + C  D     V+ L L   +L  
Sbjct: 7   DKQALLQIKKDLGNP-TTLSSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64

Query: 89  --TLSPWIGNLTKLQSVLLQNNA-ILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDL 145
              +   + NL  L  + +     ++GPIP ++ KL +L  L +++   +G IPD L  +
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124

Query: 146 GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
             L  L  + N+L+G+ P S+S + +L  +    N +SG++P
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 72.5 bits (176), Expect = 2e-14
 Identities = 27/117 (23%), Positives = 45/117 (38%), Gaps = 2/117 (1%)

Query: 46  HDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLL 105
               N+   +   S +               +     +++        +G    L  + L
Sbjct: 192 PTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDL 251

Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL-NNNSLTGS 161
           +NN I G +P  L +L+ L +L++S N   GEIP   G+L   +     NN  L GS
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGS 307

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 65.5 bits (158), Expect = 3e-12
 Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 1/60 (1%)

Query: 128 DLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           DL NN+  G +P  L  L  L+ L ++ N+L G  P+    ++   +   + N      P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.5 bits (145), Expect = 1e-10
 Identities = 20/63 (31%), Positives = 34/63 (53%), Gaps = 4/63 (6%)

Query: 147 NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI----SARTFKVTGNPLI 202
           NLN L L NN + G+ P+ L++++ L  +++S+NNL G +P+              N  +
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304

Query: 203 CGP 205
           CG 
Sbjct: 305 CGS 307

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.8 bits (143), Expect = 2e-10
 Identities = 18/77 (23%), Positives = 32/77 (41%), Gaps = 1/77 (1%)

Query: 63  CSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLE 122
            ++ +        ++ L L +  + GTL   +  L  L S+ +  N + G IP   G L+
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQ 291

Query: 123 KLQTLDLSNNKFTGEIP 139
           +      +NNK     P
Sbjct: 292 RFDVSAYANNKCLCGSP 308

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 74.3 bits (181), Expect = 8e-15
 Identities = 36/167 (21%), Positives = 65/167 (38%), Gaps = 7/167 (4%)

Query: 15  VLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDG 74
            L+L       +        +  L    N + +   +     +T +   + ++   SP  
Sbjct: 223 ELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLA 282

Query: 75  YVSALGLPSQSL-SGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK 133
            ++AL     +         I NL  L  + L  N I    P  +  L KLQ L  +NNK
Sbjct: 283 GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNK 340

Query: 134 FTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180
            +     SL +L N+N+L   +N ++   P  L+ +  +T + L+  
Sbjct: 341 VSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 67.7 bits (164), Expect = 1e-12
 Identities = 31/173 (17%), Positives = 59/173 (34%), Gaps = 29/173 (16%)

Query: 38  LVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVS---ALGLPSQSLSGTLSPWI 94
           L+A  N + D   +    ++  +     ++        ++    L L +  +S      +
Sbjct: 202 LIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISN--LAPL 259

Query: 95  GNLTKLQSVLLQNNAILGPIP--------------------ASLGKLEKLQTLDLSNNKF 134
             LTKL  + L  N I    P                    + +  L+ L  L L  N  
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319

Query: 135 TGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           +   P  +  L  L  L   NN ++     SL+ + ++  +   +N +S   P
Sbjct: 320 SDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 54.6 bits (130), Expect = 2e-08
 Identities = 33/136 (24%), Positives = 49/136 (36%), Gaps = 6/136 (4%)

Query: 93  WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
            +  LT L+S++  NN I    P  +     L  L L+ N+       +L  L NL  L 
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCT 212
           L NN ++   P  LS +  LT + L  N +S   P                    +    
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305

Query: 213 AVFPEPLSLPPNGLKD 228
                 L+L  N + D
Sbjct: 306 LKNLTYLTLYFNNISD 321

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.2 bits (116), Expect = 8e-07
 Identities = 12/67 (17%), Positives = 26/67 (38%), Gaps = 4/67 (5%)

Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180
           L +     L     T  +  +  DL  +  L+ +   +     + +  + +LT ++ S N
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNN 76

Query: 181 NLSGSLP 187
            L+   P
Sbjct: 77  QLTDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.8 bits (115), Expect = 1e-06
 Identities = 18/78 (23%), Positives = 33/78 (42%), Gaps = 5/78 (6%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L +    +L    +   +  S   L+++ TL          I D +  L NL  +  +N
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 75

Query: 156 NSLTGSCP-ESLSKIESL 172
           N LT   P ++L+K+  +
Sbjct: 76  NQLTDITPLKNLTKLVDI 93

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 5e-05
 Identities = 18/76 (23%), Positives = 34/76 (44%), Gaps = 6/76 (7%)

Query: 81  LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD 140
           L   +++ T+S    +L ++ ++      I       +  L  L  ++ SNN+ T   P 
Sbjct: 29  LGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP- 83

Query: 141 SLGDLGNLNYLRLNNN 156
            L +L  L  + +NNN
Sbjct: 84  -LKNLTKLVDILMNNN 98

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.7 bits (140), Expect = 5e-10
 Identities = 25/130 (19%), Positives = 42/130 (32%), Gaps = 28/130 (21%)

Query: 79  LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLE---------------- 122
           L L    +S         L  L  +LL  N +    P +   L                 
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217

Query: 123 --------KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTL 174
                    LQ L L++N +  +   +      L   R +++ +  S P+ L+      L
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDL 273

Query: 175 VDLSYNNLSG 184
             L+ N+L G
Sbjct: 274 KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.8 bits (117), Expect = 4e-07
 Identities = 30/156 (19%), Positives = 51/156 (32%), Gaps = 4/156 (2%)

Query: 52  LENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL 111
           L    +                  +  L L   +L         +L  L  + L  N I 
Sbjct: 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166

Query: 112 GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIES 171
                +   L  L  L L  N+     P +  DLG L  L L  N+L+    E+L+ + +
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226

Query: 172 LTLVDLSYNNLSGSLPKIS----ARTFKVTGNPLIC 203
           L  + L+ N               + F+ + + + C
Sbjct: 227 LQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.3 bits (113), Expect = 1e-06
 Identities = 33/170 (19%), Positives = 56/170 (32%), Gaps = 8/170 (4%)

Query: 28  PAGINYEVVALVAVKNNLH-------DPYNVLENWDITSVDPCSWRMITCSPDGYVSALG 80
           P GI      +    N +             L    + S           +    +  L 
Sbjct: 27  PVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD 86

Query: 81  LPSQSLSGTLSP-WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP 139
           L   +   ++ P     L +L ++ L    +    P     L  LQ L L +N       
Sbjct: 87  LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146

Query: 140 DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
           D+  DLGNL +L L+ N ++     +   + SL  + L  N ++   P  
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 58.9 bits (141), Expect = 5e-10
 Identities = 31/120 (25%), Positives = 46/120 (38%), Gaps = 14/120 (11%)

Query: 63  CSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLE 122
           C  R++ CS       LGL  + +   L P   +   L    LQNN I          L+
Sbjct: 10  CHLRVVQCS------DLGL--EKVPKDLPP---DTALLD---LQNNKITEIKDGDFKNLK 55

Query: 123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
            L TL L NNK +   P +   L  L  L L+ N L     +    ++ L + +     +
Sbjct: 56  NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 56.6 bits (135), Expect = 2e-09
 Identities = 24/74 (32%), Positives = 33/74 (44%), Gaps = 3/74 (4%)

Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
           +P  L        LDL NNK T        +L NL+ L L NN ++   P + + +  L 
Sbjct: 25  VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 174 LVDLSYNNLSGSLP 187
            + LS N L   LP
Sbjct: 83  RLYLSKNQLK-ELP 95

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 51.2 bits (121), Expect = 2e-07
 Identities = 33/161 (20%), Positives = 52/161 (32%), Gaps = 7/161 (4%)

Query: 65  WRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL 124
             +        V  LG      SG  +     + KL  + + +   +  IP  L     L
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN-ITTIPQGL--PPSL 173

Query: 125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
             L L  NK T     SL  L NL  L L+ NS++     SL+    L  + L+ N L  
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233

Query: 185 SLPKISA----RTFKVTGNPLICGPKATNNCTAVFPEPLSL 221
               ++     +   +  N +               +  S 
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 274

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 49.3 bits (116), Expect = 7e-07
 Identities = 34/181 (18%), Positives = 54/181 (29%), Gaps = 33/181 (18%)

Query: 46  HDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWI--GNLTKLQSV 103
              +N L    +  +     +        +     L    ++ T    I  G    L  +
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL 176

Query: 104 LLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI-----------------------PD 140
            L  N I     ASL  L  L  L LS N  +                          P 
Sbjct: 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 236

Query: 141 SLGDLGNLNYLRLNNNSLTG------SCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
            L D   +  + L+NN+++         P   +K  S + V L  N +     +I   TF
Sbjct: 237 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV--QYWEIQPSTF 294

Query: 195 K 195
           +
Sbjct: 295 R 295

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.0 bits (105), Expect = 1e-05
 Identities = 28/159 (17%), Positives = 57/159 (35%), Gaps = 31/159 (19%)

Query: 52  LENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNN--- 108
           L+N  IT +    ++ +       +  L L +  +S         L KL+ + L  N   
Sbjct: 38  LQNNKITEIKDGDFKNLK-----NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 109 ------------------AILGPIPASLGKLEKLQTLDLSN--NKFTGEIPDSLGDLGNL 148
                              I     +    L ++  ++L     K +G    +   +  L
Sbjct: 93  ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152

Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
           +Y+R+ + ++T + P+ L    SLT + L  N ++    
Sbjct: 153 SYIRIADTNIT-TIPQGLPP--SLTELHLDGNKITKVDA 188

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 15/80 (18%), Positives = 27/80 (33%), Gaps = 8/80 (10%)

Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTG------EIPDSLGDLGNLNYLRLNNNSLT 159
            NN  L  +P  L   + +Q + L NN  +         P       + + + L +N + 
Sbjct: 226 LNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

Query: 160 GSC--PESLSKIESLTLVDL 177
                P +   +     V L
Sbjct: 286 YWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 40.8 bits (94), Expect = 3e-04
 Identities = 14/65 (21%), Positives = 26/65 (40%), Gaps = 3/65 (4%)

Query: 124 LQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
           L+ +  S+     ++P  L    +   L L NN +T         +++L  + L  N +S
Sbjct: 12  LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68

Query: 184 GSLPK 188
              P 
Sbjct: 69  KISPG 73

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 59.1 bits (141), Expect = 6e-10
 Identities = 25/129 (19%), Positives = 43/129 (33%), Gaps = 9/129 (6%)

Query: 46  HDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLL 105
            D Y         S+          S    +        + S  +         L+ + +
Sbjct: 232 RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNV 291

Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPES 165
            NN ++  +PA   +LE+L     S N    E+P+      NL  L +  N L    P+ 
Sbjct: 292 SNNKLIE-LPALPPRLERL---IASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI 342

Query: 166 LSKIESLTL 174
              +E L +
Sbjct: 343 PESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 57.9 bits (138), Expect = 1e-09
 Identities = 23/85 (27%), Positives = 32/85 (37%), Gaps = 9/85 (10%)

Query: 105 LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPE 164
              NA    I +       L+ L++SNNK   E+P        L  L  + N L    PE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321

Query: 165 SLSKIESLTLVDLSYNNLSGSLPKI 189
               ++ L    + YN L    P I
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPDI 342

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.0 bits (94), Expect = 3e-04
 Identities = 17/68 (25%), Positives = 27/68 (39%), Gaps = 8/68 (11%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
              +L+   L N   L  +P     L   ++L  S N  T E+P+    L +L     N 
Sbjct: 39  QAHELE---LNNLG-LSSLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNL 90

Query: 156 NSLTGSCP 163
            +L+   P
Sbjct: 91  KALSDLPP 98

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.001
 Identities = 16/43 (37%), Positives = 23/43 (53%), Gaps = 5/43 (11%)

Query: 147 NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
             + L LNN  L+ S PE    +ESL     S N+L+  LP++
Sbjct: 39  QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPEL 76

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.2 bits (141), Expect = 7e-10
 Identities = 14/83 (16%), Positives = 31/83 (37%), Gaps = 5/83 (6%)

Query: 124 LQTLDLSNNKFTGE-IPDSLGDLGNLNYLRLNNNSLTGSC----PESLSKIESLTLVDLS 178
           +Q+LD+   + +     + L  L     +RL++  LT +       +L    +L  ++L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 179 YNNLSGSLPKISARTFKVTGNPL 201
            N L         +  +     +
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.9 bits (135), Expect = 4e-09
 Identities = 17/87 (19%), Positives = 30/87 (34%), Gaps = 9/87 (10%)

Query: 93  WIGNLTKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD---- 144
                + L+ + L +  +       + A+L     L+ LDLSNN         L +    
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423

Query: 145 -LGNLNYLRLNNNSLTGSCPESLSKIE 170
               L  L L +   +    + L  +E
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.1 bits (133), Expect = 6e-09
 Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 5/90 (5%)

Query: 100 LQSVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDLGNLNYLRLN 154
           +QS+ +Q   +        L  L++ Q + L +   T      I  +L     L  L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
           +N L       + +        +   +L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (120), Expect = 2e-07
 Identities = 14/76 (18%), Positives = 26/76 (34%), Gaps = 9/76 (11%)

Query: 123 KLQTLDLSNNKFTGE----IPDSLGDLGNLNYLRLNNNSLTGSCPESLSKI-----ESLT 173
            L+ L L++   +      +  +L    +L  L L+NN L  +    L +        L 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 174 LVDLSYNNLSGSLPKI 189
            + L     S  +   
Sbjct: 430 QLVLYDIYWSEEMEDR 445

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 3e-07
 Identities = 16/90 (17%), Positives = 31/90 (34%), Gaps = 5/90 (5%)

Query: 79  LGLPSQSLSGT-LSPWIGNLTKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNK 133
           L +  + LS    +  +  L + Q V L +  +       I ++L     L  L+L +N+
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 134 FTGEIPDSLGDLGNLNYLRLNNNSLTGSCP 163
                   +         ++   SL   C 
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 3e-06
 Identities = 20/123 (16%), Positives = 37/123 (30%), Gaps = 15/123 (12%)

Query: 46  HDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGT----LSPWIGNLTKLQ 101
                 + N  +              P   +  L L    +S +    L+  +     L+
Sbjct: 341 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 400

Query: 102 SVLLQNNAILGPIPASLGK-----LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156
            + L NN +       L +        L+ L L +  ++ E+ D L        L  +  
Sbjct: 401 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA------LEKDKP 454

Query: 157 SLT 159
           SL 
Sbjct: 455 SLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.002
 Identities = 14/59 (23%), Positives = 22/59 (37%), Gaps = 4/59 (6%)

Query: 147 NLNYLRLNNNSLTGSC----PESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201
            L  L L +  ++ S       +L    SL  +DLS N L  +       + +  G  L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.1 bits (126), Expect = 2e-08
 Identities = 19/64 (29%), Positives = 29/64 (45%), Gaps = 4/64 (6%)

Query: 92  PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
             + NL+KL ++   +N I    P  L  L  L  + L NN+ +   P  L +  NL  +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222

Query: 152 RLNN 155
            L N
Sbjct: 223 TLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 7e-06
 Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 4/61 (6%)

Query: 118 LGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDL 177
           L  L KL TL   +NK +   P  L  L NL  + L NN ++   P  L+   +L +V L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 178 S 178
           +
Sbjct: 225 T 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.2 bits (95), Expect = 2e-04
 Identities = 14/70 (20%), Positives = 24/70 (34%), Gaps = 4/70 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L     +    + +   +  +   L+ + TL       T  I   +  L NL  L L +
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 156 NSLTGSCPES 165
           N +T   P  
Sbjct: 73  NQITDLAPLK 82

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.7 bits (118), Expect = 5e-08
 Identities = 23/103 (22%), Positives = 36/103 (34%), Gaps = 26/103 (25%)

Query: 105 LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN--------------- 149
           L +  +   +   L +L  +  LDLS+N+     P +L  L  L                
Sbjct: 5   LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGV 61

Query: 150 -------YLRLNNNSLTG-SCPESLSKIESLTLVDLSYNNLSG 184
                   L L NN L   +  + L     L L++L  N+L  
Sbjct: 62  ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.2 bits (101), Expect = 8e-06
 Identities = 22/107 (20%), Positives = 30/107 (28%), Gaps = 24/107 (22%)

Query: 89  TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL----------------------QT 126
           T+   +  L  +  + L +N +    P +L  L  L                      Q 
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLPRLQE 69

Query: 127 LDLSNNKFTG-EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESL 172
           L L NN+         L     L  L L  NSL           E L
Sbjct: 70  LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.2 bits (96), Expect = 4e-05
 Identities = 20/121 (16%), Positives = 37/121 (30%), Gaps = 33/121 (27%)

Query: 125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP--------------------- 163
           + L L++   T  +   L  L  + +L L++N L    P                     
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58

Query: 164 ESLSKIESLTLVDLSYNNLS--------GSLPKISARTFKVTGNPLICGPKATNNCTAVF 215
           + ++ +  L  + L  N L          S P++      + GN L            + 
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL--VLLNLQGNSLCQEEGIQERLAEML 116

Query: 216 P 216
           P
Sbjct: 117 P 117

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.001
 Identities = 12/55 (21%), Positives = 20/55 (36%), Gaps = 4/55 (7%)

Query: 101 QSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGE---IPDSLGDLGNLNYL 151
           Q +LL NN +        L    +L  L+L  N    E          L +++ +
Sbjct: 68  QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (122), Expect = 9e-08
 Identities = 20/95 (21%), Positives = 36/95 (37%), Gaps = 4/95 (4%)

Query: 86  LSG-TLSP-WIGNLTKLQSVLLQ-NNAILGPIPASLGKLEKLQTLDLSNNKFTGE-IPDS 141
           L+G  L P   G L     +  +   + +    A      ++Q +DLSN+      +   
Sbjct: 7   LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGI 66

Query: 142 LGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVD 176
           L     L  L L    L+     +L+K  +L  ++
Sbjct: 67  LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 3e-05
 Identities = 16/74 (21%), Positives = 30/74 (40%), Gaps = 3/74 (4%)

Query: 125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
           QTLDL+      ++   L   G +   R   + +     E  S    +  +DLS + +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60

Query: 185 -SLPKISARTFKVT 197
            +L  I ++  K+ 
Sbjct: 61  STLHGILSQCSKLQ 74

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 8e-04
 Identities = 18/114 (15%), Positives = 35/114 (30%), Gaps = 4/114 (3%)

Query: 62  PCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQN-NAILGPIPASLGK 120
                 +       V      S  L          L  LQ + L     I+      LG+
Sbjct: 164 KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 223

Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTL 174
           +  L+TL +      G +      L +   L++N +  T     ++   ++  +
Sbjct: 224 IPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEI 274

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 1e-07
 Identities = 16/57 (28%), Positives = 20/57 (35%), Gaps = 1/57 (1%)

Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSC 162
            NN +       L  LE L TL L  N     IP        L +  L+ N    +C
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 3e-07
 Identities = 13/64 (20%), Positives = 18/64 (28%), Gaps = 3/64 (4%)

Query: 94  IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
           +  +     V       L  +P  L K      L LS N        +L     L  L L
Sbjct: 6   VSKVASHLEVNCDKRN-LTALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 154 NNNS 157
           +   
Sbjct: 63  DRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 6e-06
 Identities = 12/65 (18%), Positives = 22/65 (33%), Gaps = 3/65 (4%)

Query: 117 SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVD 176
            + K+     ++      T  +P  L    +   L L+ N L      +L     LT ++
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 177 LSYNN 181
           L    
Sbjct: 62  LDRAE 66

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 3e-06
 Identities = 13/84 (15%), Positives = 32/84 (38%), Gaps = 8/84 (9%)

Query: 105 LQNNAILGPIPAS----LGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTG 160
           L +  I  P P           +    +L     T  +  +  +L +++ +  NN+ +  
Sbjct: 3   LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60

Query: 161 SCPESLSKIESLTLVDLSYNNLSG 184
                +  + ++T + L+ N L+ 
Sbjct: 61  VQG--IQYLPNVTKLFLNGNKLTD 82

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 3e-06
 Identities = 12/70 (17%), Positives = 26/70 (37%), Gaps = 4/70 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
              +     L+  ++   +  +  +L  +  +  +N+         +  L N+  L LN 
Sbjct: 22  AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 156 NSLTGSCPES 165
           N LT   P +
Sbjct: 78  NKLTDIKPLA 87

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 2e-04
 Identities = 23/63 (36%), Positives = 33/63 (52%), Gaps = 4/63 (6%)

Query: 93  WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
            +  LTKL ++ L++N I   +P  L  L KLQ L LS N  +     +L  L NL+ L 
Sbjct: 151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLE 206

Query: 153 LNN 155
           L +
Sbjct: 207 LFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.003
 Identities = 13/40 (32%), Positives = 21/40 (52%), Gaps = 2/40 (5%)

Query: 92  PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN 131
             +  LTKLQ++ L  N I   +  +L  L+ L  L+L +
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.004
 Identities = 12/64 (18%), Positives = 25/64 (39%), Gaps = 4/64 (6%)

Query: 78  ALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE 137
              L  +S++  ++     L  +  ++  N+ I       +  L  +  L L+ NK T  
Sbjct: 28  KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDI 83

Query: 138 IPDS 141
            P +
Sbjct: 84  KPLA 87

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 47.2 bits (110), Expect = 3e-06
 Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 8/91 (8%)

Query: 100 LQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDLGNLNYL 151
           ++   L+ +AI       + A L + + ++ + LS N    E    + +++    +L   
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
             ++        E    +  L    L    L
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.5 bits (103), Expect = 2e-05
 Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 6/61 (9%)

Query: 117 SLGKLEKLQTLDLSNNKFTGEIPDSLGD-----LGNLNYLRLNNNSLTGSCPESLSKIES 171
           S  +   LQTL L  N+   +   +L       + +L +L LN N  +    + + +I  
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE-DDVVDEIRE 326

Query: 172 L 172
           +
Sbjct: 327 V 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.8 bits (96), Expect = 2e-04
 Identities = 23/114 (20%), Positives = 40/114 (35%), Gaps = 12/114 (10%)

Query: 54  NWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGN------LTKLQSVLLQN 107
             +  +    S   I       +  LGL    LS   +  + +         LQ++ LQ 
Sbjct: 223 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 282

Query: 108 NAILGPIPASL-----GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156
           N I      +L      K+  L  L+L+ N+F  E  D + ++  +   R    
Sbjct: 283 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 11/66 (16%)

Query: 129 LSNNKFTGEIPDSLGD------LGNLNYLRLNNNSLTGSCPESL-----SKIESLTLVDL 177
           L++   +     ++ D         L  LRL  N +      +L      K+  L  ++L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 178 SYNNLS 183
           + N  S
Sbjct: 310 NGNRFS 315

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 7e-06
 Identities = 16/112 (14%), Positives = 24/112 (21%)

Query: 46  HDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLL 105
           H    VL +           R            L L    +    +         +  L 
Sbjct: 125 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184

Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
            NN +                LD+S  +        L +L  L      N  
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 4e-04
 Identities = 10/66 (15%), Positives = 17/66 (25%), Gaps = 3/66 (4%)

Query: 124 LQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
            +     NN       D          L ++   +       L  ++ L        NL 
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236

Query: 184 GSLPKI 189
             LP +
Sbjct: 237 -KLPTL 241

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (84), Expect = 0.004
 Identities = 14/57 (24%), Positives = 21/57 (36%), Gaps = 3/57 (5%)

Query: 125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNN 181
           +      +K T EIP  L    N   LR     L      + S    L  +++S N+
Sbjct: 11  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (98), Expect = 4e-05
 Identities = 24/116 (20%), Positives = 40/116 (34%), Gaps = 3/116 (2%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
           N  + + + L+   I   I      L++   +D S+N+      D    L  L  L +NN
Sbjct: 16  NAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNN 72

Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNC 211
           N +          +  LT + L+ N+L          + K      I     TN  
Sbjct: 73  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (93), Expect = 2e-04
 Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 2/89 (2%)

Query: 86  LSGTLSPWIGNLTKLQSVLLQNNAILG--PIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
           ++ TL     N+ +L S+ L NN +     + + + K   L+ L+LS N+   E      
Sbjct: 53  MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKI 112

Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESL 172
               L  L L+ NSL+ +  +  + I ++
Sbjct: 113 KGLKLEELWLDGNSLSDTFRDQSTYISAI 141

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (91), Expect = 3e-04
 Identities = 19/98 (19%), Positives = 38/98 (38%), Gaps = 3/98 (3%)

Query: 92  PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG--EIPDSLGDLGNLN 149
           P +        +  +++ +   +      + +L +L+LSNN+     ++   +    NL 
Sbjct: 36  PDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94

Query: 150 YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
            L L+ N L         K   L  + L  N+LS +  
Sbjct: 95  ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 7e-04
 Identities = 14/67 (20%), Positives = 24/67 (35%), Gaps = 4/67 (5%)

Query: 96  NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
            L +    +L    +   +  S   L+++ TL            D +  L NL  +  +N
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71

Query: 156 NSLTGSC 162
           N LT   
Sbjct: 72  NQLTDIT 78

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 15/46 (32%), Positives = 21/46 (45%), Gaps = 4/46 (8%)

Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
            +N +    P  L  L  L+ LD+S+NK +      L  L NL  L
Sbjct: 158 SSNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	623
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.73
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.67
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.58
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.57
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.57
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.56
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.47
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.44
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.42
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.41
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.4
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.35
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.34
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.33
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.31
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.15
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.15
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.09
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.08
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.05
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.02
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.95
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.95
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.89
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.76
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.76
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.38
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.37
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.35
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.3
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.28
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.13
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.04
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.0
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.95
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.82
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.63
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.58
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.58
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.38
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.99
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.88
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.25
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.05
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	95.83

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-53  Score=417.67  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=201.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|++.+.||+|+||+||+|.+.+++.||||+++...  ....+|.+|++++++++||||++++|+|..++..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            5688889999999999999999889999999997543  34567999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.+++...   ...++|..+..++.|+|+||+|||++   +|+||||||+|||+++++.+||+|||+++.......
T Consensus        83 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          83 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             CCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999998753   45689999999999999999999999   999999999999999999999999999987765544


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                      .......||+.|+|||++.+..++.++|||||||++|||+|++.|+.....      ..+....+.....          
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~~~~----------  220 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGFR----------  220 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHHTCC----------
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHHhcCC----------
Confidence            444456799999999999999999999999999999999996555432211      1112222221111          


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ...+..++.++.+++.+||+.||++||||+||+++|++
T Consensus       221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            11122334678999999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=407.68  Aligned_cols=253  Identities=23%  Similarity=0.377  Sum_probs=214.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|++.+.||+|+||+||+|.++++..||||+++...  ....+|.+|++++++++||||++++|+|.+++..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            5788999999999999999999888999999998654  34568999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|..++...   ...+++..+.+++.|+++||+|||++   +|+||||||+||++++++.+||+|||+++.......
T Consensus        82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            999999997654   34689999999999999999999999   999999999999999999999999999987765544


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....       .+....+.. +.         
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------~~~~~~i~~-~~---------  218 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQ-GL---------  218 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHT-TC---------
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-------HHHHHHHHh-CC---------
Confidence            44455679999999999999999999999999999999998 7889864322       112222221 11         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....+...+.++.+++.+||+.||++|||+.+|+++|.+
T Consensus       219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            111222334689999999999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-52  Score=420.15  Aligned_cols=254  Identities=26%  Similarity=0.401  Sum_probs=199.0

Q ss_pred             CCCcCCceeccCCeEEEEEEeCC-C---cEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFSD-G---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      +|.+.++||+|+||+||+|.+.. +   ..||||.+.........++|.+|++++++++|||||+++|+|..++..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            45566899999999999998752 2   3699999876655555668999999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...   ...++|.++..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus       107 Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         107 EFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             ECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999988753   34699999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCCce----eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          458 RDSHV----TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       458 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      .....    .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.....       .+.+..+.....  
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-------~~~~~~i~~~~~--  251 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-------QDVINAIEQDYR--  251 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC--
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC--
Confidence            33221    123457899999999999999999999999999999998 8999863321       122222221111  


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          533 QMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                              ...+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus       252 --------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         252 --------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                    11223345779999999999999999999999999976

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-52  Score=414.28  Aligned_cols=254  Identities=28%  Similarity=0.422  Sum_probs=209.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|++.+.||+|+||+||+|.++++..||||+++...  ....+|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            5688889999999999999999888999999997543  345679999999999999999999998754 5679999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.+++....  ...++|..+.+++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+|+.......
T Consensus        90 ~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            9999999876532  23589999999999999999999999   999999999999999999999999999998765544


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                      .......||+.|+|||++.++.++.++|||||||++|||+||+.|+.....      ..+....+....          .
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~------~~~~~~~i~~~~----------~  228 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------NPEVIQNLERGY----------R  228 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTTC----------C
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhcC----------C
Confidence            444556799999999999999999999999999999999997666542221      111122221111          1


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ...+...+.++.+++.+||+.||++||||.||++.|++
T Consensus       229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            11122334678999999999999999999999999976

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-52  Score=418.92  Aligned_cols=257  Identities=27%  Similarity=0.397  Sum_probs=214.8

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||+++...  ...++|.+|++++++++|||||+++|+|.+++..++|||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            457888899999999999999976 58899999997543  345679999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        94 ~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          94 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             cccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            99999999999763  245799999999999999999999999   9999999999999999999999999999987665


Q ss_pred             CCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                      .........|++.|+|||++.+..++.++|||||||++|||++|+.|+......      ..... ....+         
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~-~i~~~---------  232 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYE-LLEKD---------  232 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHH-HHHTT---------
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHH-HHhcC---------
Confidence            554455556899999999999999999999999999999999987776432211      11111 11111         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      .....+...+.++.+++.+||+.||++|||+.||++.|+..
T Consensus       233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11122333457899999999999999999999999999774

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-52  Score=411.26  Aligned_cols=253  Identities=23%  Similarity=0.319  Sum_probs=203.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||+++..........+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            46889999999999999999975 69999999997655444556799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++..    ...+++..++.++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+|+......
T Consensus        85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999864    34799999999999999999999999   99999999999999999999999999998765433


Q ss_pred             C-ceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          460 S-HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       460 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      . ......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||........     .+ ...........    
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----~~-~~~~~~~~~~~----  227 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EY-SDWKEKKTYLN----  227 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-----HH-HHHHTTCTTST----
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-----HH-HHHhcCCCCCC----
Confidence            2 22345679999999999988776 6789999999999999999999964332111     11 11111111000    


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                           .....+.++.+++.+||+.||++|||+.|++++
T Consensus       228 -----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         228 -----PWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 011123678899999999999999999999764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-51  Score=406.05  Aligned_cols=258  Identities=29%  Similarity=0.421  Sum_probs=202.3

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||+||+|.++  ..||||+++.... ......|.+|++++++++|||||+++|++.. +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            367889999999999999999874  3599999975443 3344679999999999999999999998754 56899999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+++|+|.+++...   ...+++..+..++.|+++||+|||++   +||||||||+|||++.++.+||+|||+|+.....
T Consensus        84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            99999999999753   34699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC-ceeecccccccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          459 DS-HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       459 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      .. .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||......       ..+......+.....
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~~p~  230 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGYLSPD  230 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHTSCCCC
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCCCc
Confidence            22 23445679999999999864   35789999999999999999999999643221       111111122211110


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      . .    ..+...+.++.+++.+||+.||++|||+.||+++|+.
T Consensus       231 ~-~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~  269 (276)
T d1uwha_         231 L-S----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL  269 (276)
T ss_dssp             G-G----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             c-h----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            0 0    1122234679999999999999999999999999976

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=402.74  Aligned_cols=250  Identities=20%  Similarity=0.302  Sum_probs=208.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||+++... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            46999999999999999999864 69999999997544 23456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            9999999987652     589999999999999999999999   99999999999999999999999999998775433


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      . ......||+.|+|||++.+..++.++||||+||++|||+||+.||......       +.+......+...-      
T Consensus       171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~~~~~------  236 (293)
T d1yhwa1         171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPEL------  236 (293)
T ss_dssp             C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSCCC------
T ss_pred             c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCCCCC------
Confidence            2 334456999999999999999999999999999999999999999643221       11222222211110      


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ..+...+.++.+++.+||+.||++|||+.|++++
T Consensus       237 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             --SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             --CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              1112234678999999999999999999999764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-52  Score=411.10  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=197.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeec--CCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCST--ENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~--~~~~~lv  376 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||.++...... ....+.+|++++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57899999999999999999875 68999999997654332 34468999999999999999999999864  4568999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC--DPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      |||+++|+|.+++.........+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999999765444567999999999999999999999862  12499999999999999999999999999998


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      +..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......       +....+. .+.... 
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-------~~~~~i~-~~~~~~-  233 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIR-EGKFRR-  233 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHH-HTCCCC-
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-------HHHHHHH-cCCCCC-
Confidence            754332 334567999999999999999999999999999999999999999643221       1111211 122111 


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                              .+...+.++.+++.+||+.||++|||+.|++++
T Consensus       234 --------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         234 --------IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                    112234678999999999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-51  Score=408.84  Aligned_cols=254  Identities=24%  Similarity=0.372  Sum_probs=207.9

Q ss_pred             cCCCcCCc-eeccCCeEEEEEEeC---CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNI-LGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|.+.+. ||+|+||+||+|.+.   ++..||||+++........++|.+|++++++++|||||+++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            34555664 999999999999864   3568999999866545556689999999999999999999999865 568999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.+++...   +..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence            9999999999988653   35799999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCce--eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          457 HRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       457 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ......  .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......       +....+. .+.   
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~~~~~i~-~~~---  229 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIE-QGK---  229 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHH-TTC---
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHHH-cCC---
Confidence            543322  234468999999999999999999999999999999998 89999643211       1112221 111   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                            ....+...+.++.+++.+||+.||++||||.+|++.|+.
T Consensus       230 ------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         230 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                  111223345789999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-51  Score=408.30  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=203.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCC-----cEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDG-----ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      +.|+..++||+|+||+||+|.+++.     ..||||+++.........+|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577889999999999999987532     47999999766555556679999999999999999999999999999999


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ||||+.+|++.+++...   ...++|..+.+++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        87 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence            99999999999887754   35699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCc--eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ......  ......||+.|+|||++.++.++.++|||||||++|||++|+.|+......      .+.+..+.. +    
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~-~----  229 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAIND-G----  229 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHT-T----
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH------HHHHHHHhc-c----
Confidence            543222  223446899999999999999999999999999999999977766432211      112222211 1    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                           .....+...+.++.+++.+||+.||++||||.||++.|+.
T Consensus       230 -----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         230 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence                 1112233345779999999999999999999999999976

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=401.44  Aligned_cols=247  Identities=29%  Similarity=0.429  Sum_probs=207.6

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|++.+.||+|+||+||+|... +|+.||+|++++...  ......+.+|+++++.++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999999999975 689999999865432  233557899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            999999999999764    3699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .+....... ..       
T Consensus       159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~-~~-------  220 (263)
T d2j4za1         159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISR-VE-------  220 (263)
T ss_dssp             C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHT-TC-------
T ss_pred             C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHHHHc-CC-------
Confidence            2   23445799999999999999999999999999999999999999964322       111122111 11       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                         ..++...+.++.+++.+||+.||++|||+.|++++
T Consensus       221 ---~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         221 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ---CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence               01222234678999999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=413.95  Aligned_cols=258  Identities=27%  Similarity=0.384  Sum_probs=207.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC------CcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  373 (623)
                      ++|++.+.||+|+||+||+|.+..      ...||||.+...........+.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            578889999999999999998642      2369999997665555566799999999998 899999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 006968          374 LLVYPYMPNGSVASRLRDHIH-------------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAA  434 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~  434 (623)
                      ++||||+++|+|.++|+....                   ....+++..++.++.|+++||+|||++   +|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence            999999999999999976432                   123589999999999999999999999   9999999999


Q ss_pred             CeEECCCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCccccc
Q 006968          435 NILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAA  512 (623)
Q Consensus       435 NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~  512 (623)
                      |||++.++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999876544333 2334568999999999999999999999999999999998 89998642221


Q ss_pred             ccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhh
Q 006968          513 NQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLE  577 (623)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  577 (623)
                      .   .    +......+         .....+...+.++.+++.+||+.||++|||++||+++|.
T Consensus       274 ~---~----~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 A---N----FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             H---H----HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H---H----HHHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1   1    11111111         111223334578999999999999999999999999995

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=403.26  Aligned_cols=254  Identities=28%  Similarity=0.408  Sum_probs=203.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      ++|++.+.||+|+||.||+|.++++..||||+++...  ...+.|.+|+.++++++|||||+++|+|. ++..++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            5788999999999999999999888899999997543  34567999999999999999999999985 45689999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.+++....  ...++|..++.++.||+.||+|||++   +|+||||||+|||++.++++||+|||+++.......
T Consensus        94 ~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          94 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             TTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            9999999987642  24599999999999999999999999   999999999999999999999999999987765544


Q ss_pred             ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccccccC
Q 006968          461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLK  540 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  540 (623)
                      .......||+.|+|||++..+.++.++||||||+++|||+||+.|+.....      ..+.+..+.. +         ..
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~------~~~~~~~i~~-~---------~~  232 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQVER-G---------YR  232 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHT-T---------CC
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC------HHHHHHHHHh-c---------CC
Confidence            444456699999999999999999999999999999999998777653222      1112222211 1         11


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          541 GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       541 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ...+...+.++.+++.+||+.||++|||+.+|+++|++
T Consensus       233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  270 (285)
T d1fmka3         233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  270 (285)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence            11223345789999999999999999999999999987

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-50  Score=400.17  Aligned_cols=252  Identities=23%  Similarity=0.282  Sum_probs=205.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +.|++.+.||+|+||+||+|... +|..||||+++... ....+.|.+|++++++++|||||++++++.+++..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            45888899999999999999975 68999999997543 34456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++...   ...+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        91 ~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~  164 (288)
T d2jfla1          91 CAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  164 (288)
T ss_dssp             CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred             CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence            9999999998754   34699999999999999999999999   99999999999999999999999999997643211


Q ss_pred             Cceeeccccccccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                       .......||+.|+|||++.     ...++.++|||||||++|||+||+.||.......       .+....... ....
T Consensus       165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------~~~~i~~~~-~~~~  235 (288)
T d2jfla1         165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSE-PPTL  235 (288)
T ss_dssp             -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHHSC-CCCC
T ss_pred             -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCC-CCCC
Confidence             1223456999999999984     4567899999999999999999999996433211       111111111 1111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                             ..+...+.++.+++.+||+.||++|||+.|++++
T Consensus       236 -------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         236 -------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   1112234678999999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-50  Score=399.72  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=199.2

Q ss_pred             CceeccCCeEEEEEEeC---CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecccC
Q 006968          307 NILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN  382 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  382 (623)
                      +.||+|+||+||+|.+.   .++.||||+++..... ...++|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999864   3568999999754432 234579999999999999999999999965 567899999999


Q ss_pred             CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCCce
Q 006968          383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV  462 (623)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  462 (623)
                      |+|.++++..    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus        92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            9999998763    4699999999999999999999999   99999999999999999999999999998776544332


Q ss_pred             e--eccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccccccc
Q 006968          463 T--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKDL  539 (623)
Q Consensus       463 ~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  539 (623)
                      .  ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....       .+....+. .+.         
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i~-~~~---------  227 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLE-KGE---------  227 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHH-TTC---------
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHHHHHH-cCC---------
Confidence            2  33568999999999999999999999999999999998 8999864321       11111121 111         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          540 KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       540 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....+...+.++.+++.+||+.||++|||+.+|++.|++
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            111223345788999999999999999999999998875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=412.63  Aligned_cols=266  Identities=21%  Similarity=0.307  Sum_probs=206.7

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|++.+.||+|+||+||+|... +|+.||+|+++.........++.+|+.++++++|||||+++++|.++++.++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999975 6899999999765544555679999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      |+++|+|.+++.+.    ..+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999764    369999999999999999999997 5   899999999999999999999999999986543


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH--------------
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK--------------  523 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------------  523 (623)
                      .   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.................              
T Consensus       158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            2   22345799999999999999999999999999999999999999965332111000000000              


Q ss_pred             ----HHhhcC----cccccccc---ccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          524 ----KLHQEG----KLSQMVDK---DLKGNF-DRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       524 ----~~~~~~----~~~~~~~~---~~~~~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                          ......    ...+..+.   ...... ....+.++.+++.+||..||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                000000    00000000   000000 01123578999999999999999999999885

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-49  Score=390.01  Aligned_cols=246  Identities=26%  Similarity=0.402  Sum_probs=197.2

Q ss_pred             CcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeec----CCceEEEE
Q 006968          304 SAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST----ENERLLVY  377 (623)
Q Consensus       304 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~----~~~~~lv~  377 (623)
                      ...+.||+|+||+||+|... ++..||+|+++..... .....|.+|++++++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999975 6889999999765433 234568999999999999999999999864    34579999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEEC-CCCcEEEeecccccc
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLD-EDFEAVVGDFGLAKL  454 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~kl~Dfgla~~  454 (623)
                      ||+++|+|.+++...    ..+++..++.++.|+++||+|||++   +  |+||||||+|||++ +++.+||+|||+|+.
T Consensus        92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            999999999999764    4689999999999999999999998   6  99999999999997 578999999999986


Q ss_pred             cCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      ....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......      ....+.+.. +.....
T Consensus       165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~-~~~~~~  233 (270)
T d1t4ha_         165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTS-GVKPAS  233 (270)
T ss_dssp             CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTT-TCCCGG
T ss_pred             ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHc-CCCCcc
Confidence            4432   2345679999999999865 5999999999999999999999999632211      111122211 111111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .+        ...+.++.+++.+||+.||++|||+.|++++
T Consensus       234 ~~--------~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         234 FD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cC--------ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            11        1123568899999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-50  Score=400.10  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=205.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||+++....  ......+.+|++++++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56899999999999999999974 699999999975432  233457899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus        88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            999999999988764    4699999999999999999999999   999999999999999999999999999987754


Q ss_pred             CC-CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          458 RD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       458 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      .. ........||+.|+|||++.+..++.++||||+||++|||++|+.||......       ........ +..     
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~-~~~-----  227 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------LIFQKIIK-LEY-----  227 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHT-TCC-----
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-------HHHHHHHc-CCC-----
Confidence            33 22334567999999999999999999999999999999999999999743221       11111111 111     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                           .++...+.++.+++.+||+.||++|||+.|++++
T Consensus       228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                 1122234678999999999999999999997654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-49  Score=398.66  Aligned_cols=252  Identities=21%  Similarity=0.339  Sum_probs=191.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      +.|++.+.||+|+||+||+|... +|+.||||+++..........+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            56899999999999999999975 68999999998665555556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC---CCCcEEEeecccccccC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Dfgla~~~~  456 (623)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||++.   +++.+||+|||+++...
T Consensus        89 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          89 VSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             cCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999975    34699999999999999999999999   999999999999995   57899999999998765


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      ...  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......       +....... +..     
T Consensus       162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~-~~~-----  226 (307)
T d1a06a_         162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLFEQILK-AEY-----  226 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHT-TCC-----
T ss_pred             CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHhc-cCC-----
Confidence            332  234456999999999999999999999999999999999999999643211       11111111 111     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ..........+.++.+++.+||+.||++|||+.|++++
T Consensus       227 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         227 -EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence             01111112234678999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=396.38  Aligned_cols=254  Identities=22%  Similarity=0.370  Sum_probs=198.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCC----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|++.+.||+|+||.||+|.+..    +..||||.++..........|.+|++++++++||||++++|++. ++..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            578889999999999999998742    45799999876554555667999999999999999999999995 5678999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.+++...   ...+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 ~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          86 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999987654   34699999999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMV  535 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  535 (623)
                      ...........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.......    ..   ..+.. +...   
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----~~---~~i~~-~~~~---  228 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VI---GRIEN-GERL---  228 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HH---HHHHT-TCCC---
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----HH---HHHHc-CCCC---
Confidence            555545556678999999999999999999999999999999998 888886433211    11   11111 1111   


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                            ..+...+.++.+++.+||+.||++|||+.||+++|+.
T Consensus       229 ------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         229 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                  1222334779999999999999999999999999976

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-49  Score=401.96  Aligned_cols=264  Identities=25%  Similarity=0.381  Sum_probs=213.0

Q ss_pred             HHHHhcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec
Q 006968          296 LRAATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST  369 (623)
Q Consensus       296 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~  369 (623)
                      ++...++|++.+.||+|+||+||+|.+.      +++.||||+++.........+|.+|++++++++||||++++++|..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3334567999999999999999999863      4678999999866555556679999999999999999999999999


Q ss_pred             CCceEEEEecccCCChhhhhhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 006968          370 ENERLLVYPYMPNGSVASRLRDHIH--------------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHR  429 (623)
Q Consensus       370 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  429 (623)
                      .+..++||||+++|+|.++++....                    ....+++..+..++.|++.||+|||++   +||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence            9999999999999999999975321                    123589999999999999999999999   99999


Q ss_pred             CCCCCCeEECCCCcEEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCC-CCCC
Q 006968          430 DVKAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ-RALD  507 (623)
Q Consensus       430 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~-~p~~  507 (623)
                      ||||+|||+|.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            9999999999999999999999987654322 2334456899999999999999999999999999999999996 4565


Q ss_pred             cccccccccchHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          508 FGRAANQRGVMLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      ....       .+....+. .+...         ..+...+.++.+++.+||+.+|++||||.||+++|+..
T Consensus       245 ~~~~-------~e~~~~v~-~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         245 GMAH-------EEVIYYVR-DGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TSCH-------HHHHHHHH-TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCH-------HHHHHHHH-cCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            3221       11122221 22211         11223346789999999999999999999999999873

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-49  Score=399.87  Aligned_cols=247  Identities=28%  Similarity=0.339  Sum_probs=202.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      +.|+..+.||+|+||+||+|... +|+.||||+++......  ....+.+|++++++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35888999999999999999864 68999999997654332  2346899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|..++..    ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            99999998766654    34699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeecccccccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQM  534 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (623)
                      .     ....||+.|+|||++.+   ..++.++|||||||++|||++|+.||.....       .+.+....... ....
T Consensus       168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~~~~-~~~~  234 (309)
T d1u5ra_         168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNE-SPAL  234 (309)
T ss_dssp             B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSC-CCCC
T ss_pred             C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCC-CCCC
Confidence            2     33569999999999864   4589999999999999999999999963221       11112221111 1111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          535 VDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .        +...+.++.+++.+||+.||++|||+.|++++
T Consensus       235 ~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         235 Q--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             S--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             C--------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            1        11224678999999999999999999999874

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-49  Score=399.49  Aligned_cols=254  Identities=25%  Similarity=0.420  Sum_probs=202.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCc----EEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~l  375 (623)
                      ++|++.++||+|+||+||+|.+. +|+    .||||+++........++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46889999999999999999874 343    69999987665555677899999999999999999999999864 5678


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      ++||+.+|+|.+++...   ...+++..+++++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            89999999999988764   45799999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          456 DHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       456 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      ....... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......    ....   .+....    
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~~~~---~i~~~~----  230 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISS---ILEKGE----  230 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----GHHH---HHHHTC----
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----HHHH---HHHcCC----
Confidence            6544332 334568999999999999999999999999999999999 78887643221    1111   111111    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                            ....+...+.++.+++.+||+.||++|||+.||+++|+.
T Consensus       231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence                  111223345778999999999999999999999999876

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-48  Score=388.10  Aligned_cols=251  Identities=19%  Similarity=0.262  Sum_probs=206.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-----chHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||++++.....     ..+.|.+|++++++++|||||++++++.+++..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57899999999999999999974 69999999997543322     3457999999999999999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC----cEEEeecc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDFG  450 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfg  450 (623)
                      +||||+++|+|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++    .+|++|||
T Consensus        90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999764    3699999999999999999999999   999999999999999776    49999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC-
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG-  529 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  529 (623)
                      ++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......       +......... 
T Consensus       163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~  233 (293)
T d1jksa_         163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNY  233 (293)
T ss_dssp             TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTCC
T ss_pred             hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------HHHHHHHhcCC
Confidence            998765433  233456899999999999999999999999999999999999999743221       1111111110 


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ......    .    ...+.++.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~----~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         234 EFEDEY----F----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             CCCHHH----H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCchh----c----CCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            001000    0    1123678899999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.5e-48  Score=396.75  Aligned_cols=251  Identities=21%  Similarity=0.304  Sum_probs=207.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            57999999999999999999974 69999999997543 23455789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC--CCCcEEEeecccccccCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~Dfgla~~~~~  457 (623)
                      +++|+|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+++.+..
T Consensus       105 ~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            9999999998643   34699999999999999999999999   999999999999996  467899999999987754


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC-ccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG-KLSQMVD  536 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  536 (623)
                      ..  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....       .+.+....... ....   
T Consensus       179 ~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~---  246 (350)
T d1koaa2         179 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWNMDD---  246 (350)
T ss_dssp             TS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCSCC---
T ss_pred             cc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCc---
Confidence            33  33445699999999999999999999999999999999999999964321       11222221111 1111   


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ..    ....+.++.+++.+||..||++|||+.|++++
T Consensus       247 -~~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 -SA----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -GG----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -cc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00    11223678999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-49  Score=389.13  Aligned_cols=248  Identities=28%  Similarity=0.388  Sum_probs=196.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec-CCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST-ENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~  379 (623)
                      ++|++.+.||+|+||.||+|.+ .|..||||+++...   ..++|.+|++++++++||||++++|+|.+ .+..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            4577889999999999999998 57899999997532   34679999999999999999999999865 4668999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +++|+|.+++....  ...++|..+++++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||+++..... 
T Consensus        83 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          83 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             cCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            99999999997542  23589999999999999999999999   9999999999999999999999999999865432 


Q ss_pred             CceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCccccccccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDKD  538 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  538 (623)
                         .....+|..|+|||++.+..++.++||||||+++|||+| |+.|+......    ....+   +. .+         
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----~~~~~---i~-~~---------  216 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPR---VE-KG---------  216 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHH---HT-TT---------
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----HHHHH---HH-cC---------
Confidence               223457899999999999999999999999999999998 67776533221    11111   11 11         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          539 LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       539 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ....++...+.++.+++.+||+.||++||||.+|+++|+.
T Consensus       217 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            1112233344778999999999999999999999999976

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.8e-47  Score=394.14  Aligned_cols=252  Identities=19%  Similarity=0.277  Sum_probs=208.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|++.+.||+|+||.||+|... +|+.||||+++... ......+.+|++++++++|||||++++++.+++..++||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            57999999999999999999974 69999999997643 23345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC--CCCcEEEeecccccccCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~Dfgla~~~~~  457 (623)
                      +++|+|.+++...   ...+++..++.++.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+|+.+..
T Consensus       108 ~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         108 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence            9999998877643   34699999999999999999999999   999999999999998  678999999999998765


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      ..  ......||+.|+|||++.+..++.++||||+||++|||+||+.||......       +.+..... +..      
T Consensus       182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~-~~~------  245 (352)
T d1koba_         182 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKR-CDW------  245 (352)
T ss_dssp             TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHH-CCC------
T ss_pred             CC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh-CCC------
Confidence            33  334456999999999999999999999999999999999999999643221       11122111 111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..........+.++.+++.+||..||++|||+.|++++
T Consensus       246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            01111112234678999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=394.51  Aligned_cols=260  Identities=25%  Similarity=0.330  Sum_probs=198.6

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecC-C
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE-N  371 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~-~  371 (623)
                      .++|++.+.||+|+||.||+|.+.      +++.||||+++..........+.+|...+.++ +|+||+.+++++... +
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            467899999999999999999853      35689999998665555566788888888777 689999999988664 4


Q ss_pred             ceEEEEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD  439 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~  439 (623)
                      ..++||||+++|+|.++++....            ....+++..+..++.|+++||+|||++   +|+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence            68999999999999999975421            134589999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCc-eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCC-CCCCcccccccccc
Q 006968          440 EDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ-RALDFGRAANQRGV  517 (623)
Q Consensus       440 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~~~~~~  517 (623)
                      +++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||......     
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-----  243 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----  243 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-----
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-----
Confidence            9999999999999876543332 334457999999999999999999999999999999999975 466432211     


Q ss_pred             hHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                        ..+......+..         ...+...+.++.+++.+||+.||++|||+.||+++|++
T Consensus       244 --~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         244 --EEFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             --HHHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHHHHHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence              111111111211         11222234678999999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-48  Score=390.45  Aligned_cols=252  Identities=31%  Similarity=0.437  Sum_probs=203.4

Q ss_pred             CCceeccCCeEEEEEEeCC----CcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeec-CCceEEEEecc
Q 006968          306 KNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST-ENERLLVYPYM  380 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~  380 (623)
                      .++||+|+||+||+|.+.+    ...||||+++.........+|.+|++++++++||||++++|++.. ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999999753    236999999765545555689999999999999999999999875 56789999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      ++|+|.+++...   ...+++..+.+++.|+++||.|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999998753   44678999999999999999999999   999999999999999999999999999987654332


Q ss_pred             c---eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          461 H---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       461 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .   ......||+.|+|||.+.+..++.++||||||+++|||+||+.|+......      .++...+.. +..      
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~------~~~~~~i~~-g~~------  252 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQ-GRR------  252 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHT-TCC------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH------HHHHHHHHc-CCC------
Confidence            2   223356899999999999999999999999999999999988887532211      111122111 110      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                         ...+...+.++.+++.+||+.||++||||.||+++|+..
T Consensus       253 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               111222346799999999999999999999999999873

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=394.28  Aligned_cols=257  Identities=28%  Similarity=0.417  Sum_probs=204.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCc--EEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGA--LVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|++.+.||+|+||+||+|.+. +|.  .||||+++........+.|.+|+++++++ +|||||+++|+|..++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56888899999999999999875 343  58889887655555566899999999998 799999999999999999999


Q ss_pred             EecccCCChhhhhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcE
Q 006968          377 YPYMPNGSVASRLRDHI------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA  444 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  444 (623)
                      |||+++|+|.++++...            .....+++..+.+++.|+++||.|||+.   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            99999999999997531            2345799999999999999999999999   99999999999999999999


Q ss_pred             EEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCC-CCCcccccccccchHHHHH
Q 006968          445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR-ALDFGRAANQRGVMLDWVK  523 (623)
Q Consensus       445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~  523 (623)
                      ||+|||+++.......  .....||..|+|||.+.+..++.++|||||||++|||++|.. ||.....       .+...
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-------~~~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYE  237 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHH
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-------HHHHH
Confidence            9999999986543221  223458999999999999999999999999999999999765 5542211       11112


Q ss_pred             HHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          524 KLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      .+.. +         .....+...+.++.+++.+||+.||++||||.||+++|+..
T Consensus       238 ~i~~-~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         238 KLPQ-G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             HGGG-T---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHh-c---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2111 1         11112233447899999999999999999999999999773

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=387.29  Aligned_cols=255  Identities=30%  Similarity=0.420  Sum_probs=196.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC--C--CcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS--D--GALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|++.+.||+|+||.||+|.+.  +  ...||||+++......  ..++|.+|++++++++||||++++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888999999999999999863  2  2479999987654322  34579999999999999999999999965 4678


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +||||+++|++.+++...   ...+++..+..++.|+++||.|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            999999999999988764   34699999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCce--eeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          455 LDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       455 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      ........  .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||.....       .+.+..+...+. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------~~~~~~i~~~~~-  232 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEGE-  232 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSCC-
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-------HHHHHHHHhCCC-
Confidence            75543322  233458889999999999999999999999999999998 8999863221       111222222221 


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                              ....+...+.++.+++.+||+.||++||||.||++.|++
T Consensus       233 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         233 --------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                    111122234678999999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-48  Score=391.20  Aligned_cols=260  Identities=27%  Similarity=0.381  Sum_probs=211.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEe------CCCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCCce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~~~  373 (623)
                      ++|++.+.||+|+||.||+|.+      .+++.||||+++..........|.+|+.+++++ +|||||+++|+|.+++..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            5788899999999999999985      246789999998766555566799999999999 699999999999999999


Q ss_pred             EEEEecccCCChhhhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC
Q 006968          374 LLVYPYMPNGSVASRLRDHIH--------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD  439 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~  439 (623)
                      ++||||+++|+|.++++....              ....+++..+..++.||++||+|||++   +|+||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence            999999999999999976432              234689999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccch
Q 006968          440 EDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM  518 (623)
Q Consensus       440 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~  518 (623)
                      .++.+|++|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|++.|+......  ....
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~--~~~~  257 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DSKF  257 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--SHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence            999999999999997765433 3334567999999999999999999999999999999999955554322111  1111


Q ss_pred             HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          519 LDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ...    ...+         .....+...+.++.+|+.+||+.||++||||.||+++|+.
T Consensus       258 ~~~----i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         258 YKM----IKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             HHH----HHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHH----HhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            111    1111         1112222334779999999999999999999999999976

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=389.56  Aligned_cols=249  Identities=23%  Similarity=0.286  Sum_probs=208.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|++.+.||+|+||.||+|... +|+.||||++++...  ......+.+|+.++++++||||+++++++.+++..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            56899999999999999999974 799999999975432  233457899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        85 ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999998864    3689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......       ........ +..      
T Consensus       158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~~~~i~~-~~~------  222 (337)
T d1o6la_         158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILM-EEI------  222 (337)
T ss_dssp             TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH-CCC------
T ss_pred             CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-------HHHHHHhc-CCC------
Confidence            32 2334567999999999999999999999999999999999999999743321       11111111 111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRPK-----MSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  575 (623)
                          .++...+.++.+++.+||+.||++||+     +.|+++|
T Consensus       223 ----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                112223467889999999999999994     8888875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-47  Score=384.40  Aligned_cols=265  Identities=25%  Similarity=0.339  Sum_probs=201.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHH--HHHHHhhcCCCceeeeeeeeecCC----ceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQT--EVETISLAVHRNLLRLCGFCSTEN----ERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~--e~~~l~~l~H~niv~l~~~~~~~~----~~~  374 (623)
                      ++|.+.+.||+|+||.||+|++ +|+.||||+++...    ...+.+  |+..+..++||||++++++|...+    ..+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            4567788999999999999997 68999999996432    233444  455556789999999999997654    578


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCeEECCCCcEEEeec
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ-----CDPKIIHRDVKAANILLDEDFEAVVGDF  449 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl~Df  449 (623)
                      +||||+++|+|.+++++.     .++|..+.+++.|+|.||+|||+.     ..++|+||||||+|||++.++.+||+||
T Consensus        78 lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            999999999999999863     599999999999999999999973     1349999999999999999999999999


Q ss_pred             ccccccCCCCCc---eeeccccccccccccccccCC------CCCccchhhHHHHHHHHHhCCCCCCccccccc------
Q 006968          450 GLAKLLDHRDSH---VTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELITGQRALDFGRAANQ------  514 (623)
Q Consensus       450 gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~------  514 (623)
                      |+++........   ......||+.|+|||++.+..      ++.++|||||||++|||+||..|+........      
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            999877544322   223457999999999987643      57789999999999999999988753221111      


Q ss_pred             -ccchHHHHHHHhhcCccccccccccCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          515 -RGVMLDWVKKLHQEGKLSQMVDKDLKGNF-DRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       515 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                       ..............+..    ++.+.... .......+.+++.+||+.||++|||+.||+++|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence             01112233333222222    11111111 234557799999999999999999999999999763

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=387.98  Aligned_cols=258  Identities=28%  Similarity=0.386  Sum_probs=205.9

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC--------CCcEEEEEEecccccccchHHHHHHHHHHhhc-CCCceeeeeeeeecCC
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN  371 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~~~~~~~~  371 (623)
                      ++|.+.+.||+|+||.||+|...        ++..||||+++.........++.+|...+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            57888999999999999999853        23579999998766555566789999999888 8999999999999999


Q ss_pred             ceEEEEecccCCChhhhhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC
Q 006968          372 ERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD  439 (623)
Q Consensus       372 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~  439 (623)
                      ..++||||+++|+|.+++.....            ....+++.++++++.|++.||+|||+.   +|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence            99999999999999999975431            234689999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCC-ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCcccccccccc
Q 006968          440 EDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRGV  517 (623)
Q Consensus       440 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~  517 (623)
                      .++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||++ |+.||......     
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-----  244 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-----  244 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-----
Confidence            999999999999987654332 23345568999999999999999999999999999999998 67777532211     


Q ss_pred             hHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          518 MLDWVKKLHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                        . +......+.         ....+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus       245 --~-~~~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         245 --E-LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             --H-HHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --H-HHHHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence              1 111111111         111222234679999999999999999999999999976

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.5e-47  Score=385.24  Aligned_cols=246  Identities=26%  Similarity=0.340  Sum_probs=206.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||+++....  ......+.+|+.++++++||||+++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46889999999999999999974 699999999975432  233457899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+++|+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            999999999888763    4688999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .    ....+||+.|+|||++.+..++.++||||+||++|||+||+.||.....       .+....... +..      
T Consensus       157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~-~~~------  218 (316)
T d1fota_         157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILN-AEL------  218 (316)
T ss_dssp             C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHH-CCC------
T ss_pred             c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HHHHHHHHc-CCC------
Confidence            2    2346799999999999999999999999999999999999999974322       111222211 110      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  575 (623)
                          .++...+.++.+++.+||..||.+||     |+.++++|
T Consensus       219 ----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                11222336789999999999999996     89999886

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=388.17  Aligned_cols=260  Identities=24%  Similarity=0.383  Sum_probs=212.1

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC------CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCce
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER  373 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~  373 (623)
                      .++|.+.+.||+|+||+||+|.+.      ++..||||+++..........|.+|++++++++||||++++|+|..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            367888899999999999999863      35789999998665555556799999999999999999999999999999


Q ss_pred             EEEEecccCCChhhhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEe
Q 006968          374 LLVYPYMPNGSVASRLRDHI------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG  447 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  447 (623)
                      ++||||+++|+|.+++....      .....+++..+.+++.|+++||.|||++   +|+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence            99999999999999986532      2234579999999999999999999999   99999999999999999999999


Q ss_pred             ecccccccCCCCCce-eeccccccccccccccccCCCCCccchhhHHHHHHHHHhCC-CCCCcccccccccchHHHHHHH
Q 006968          448 DFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ-RALDFGRAANQRGVMLDWVKKL  525 (623)
Q Consensus       448 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~  525 (623)
                      |||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||+ .|+....       ..++...+
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-------~~~~~~~i  248 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFV  248 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHHHHHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-------HHHHHHHH
Confidence            999998765433322 23345899999999999999999999999999999999986 5554221       11222222


Q ss_pred             hhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhcC
Q 006968          526 HQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEGD  579 (623)
Q Consensus       526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  579 (623)
                      .. +...         ..+...+..+.+++.+||+.+|++|||+.+|+++|+..
T Consensus       249 ~~-~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         249 ME-GGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HT-TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             Hh-CCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            22 1111         11222346799999999999999999999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-46  Score=373.06  Aligned_cols=252  Identities=23%  Similarity=0.297  Sum_probs=205.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--------chHHHHHHHHHHhhcC-CCceeeeeeeeecC
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--------GEVQFQTEVETISLAV-HRNLLRLCGFCSTE  370 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~  370 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||+++......        ....+.+|+.+++++. ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57899999999999999999874 78999999997644221        1235889999999997 99999999999999


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      +..++||||+++|+|.++++..    ..+++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999763    4699999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCceeecccccccccccccccc------CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHH
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKK  524 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  524 (623)
                      +++......  ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||......       +....
T Consensus       156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~  226 (277)
T d1phka_         156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRM  226 (277)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH
T ss_pred             heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHH
Confidence            999876533  2344569999999999863      34688999999999999999999999743321       11111


Q ss_pred             HhhcCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          525 LHQEGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .. .+...      .........+.++.+++.+||+.||++|||+.||+++
T Consensus       227 i~-~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         227 IM-SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HH-HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HH-hCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            11 11111      0111111234679999999999999999999999775

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.2e-46  Score=374.97  Aligned_cols=257  Identities=22%  Similarity=0.270  Sum_probs=200.7

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc--chHHHHHHHHHHhhcCCCceeeeeeeeecCC----ce
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTEN----ER  373 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~  373 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||+++......  ....|.+|+++++.++||||+++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            57999999999999999999864 79999999997654332  2346899999999999999999999987644    37


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      ++||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++..+++|||.+.
T Consensus        87 ~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            8999999999999988764    4699999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCC--ceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcc
Q 006968          454 LLDHRDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKL  531 (623)
Q Consensus       454 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  531 (623)
                      .......  .......||+.|+|||++.+..++.++||||+||++|||+||+.||.....       .+...........
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~~~~  232 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVREDPI  232 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-------HHHHHHHHhcCCC
Confidence            6543322  233456799999999999999999999999999999999999999974322       1112222222211


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhhc
Q 006968          532 SQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRP-KMSEVLKMLEG  578 (623)
Q Consensus       532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~  578 (623)
                      ..   ....    ...+.++.+++.+||+.||++|| |++++++.|..
T Consensus       233 ~~---~~~~----~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         233 PP---SARH----EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CG---GGTS----SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CC---chhc----cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            10   0111    11236789999999999999999 89999887754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-46  Score=379.65  Aligned_cols=251  Identities=20%  Similarity=0.232  Sum_probs=206.0

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      .++|.+.+.||+|+||+||+|... +|+.||||.++...  .....+.+|+++|+.++||||+++++++.+++..++|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            367899999999999999999975 68899999997643  234568899999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC--CCcEEEeecccccccC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE--DFEAVVGDFGLAKLLD  456 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~Dfgla~~~~  456 (623)
                      |+++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.  ...+||+|||+++...
T Consensus        82 ~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            99999999999753   34699999999999999999999999   9999999999999985  4589999999998765


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC-cccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG-KLSQMV  535 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  535 (623)
                      ...  ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....       .+.+....... ......
T Consensus       156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~  226 (321)
T d1tkia_         156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEYTFDEEA  226 (321)
T ss_dssp             TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCCCCHHH
T ss_pred             cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCChhh
Confidence            432  23445689999999999999999999999999999999999999974322       11122221111 111000


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          536 DKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       536 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .    .    ..+.++.+++.+||..||++|||+.|++++
T Consensus       227 ~----~----~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         227 F----K----EISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             H----T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             c----c----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0    0    123668999999999999999999999984

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=379.09  Aligned_cols=258  Identities=26%  Similarity=0.286  Sum_probs=194.8

Q ss_pred             CCceeccCCeEEEEEEeC-CCcEEEEEEecccccccc----hHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEecc
Q 006968          306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG----EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM  380 (623)
Q Consensus       306 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  380 (623)
                      .++||+|+||+||+|... +|+.||||+++.......    ...+.+|+.++++++|||||++++++..++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999975 699999999975433221    246899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCCC
Q 006968          381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS  460 (623)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  460 (623)
                      .++++..+...    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            98876655432    45688999999999999999999999   999999999999999999999999999987654332


Q ss_pred             ceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC---cccccc-
Q 006968          461 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG---KLSQMV-  535 (623)
Q Consensus       461 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-  535 (623)
                       ......||+.|+|||++... .++.++||||+||++|||+||+.||......+.    ...+.......   ...... 
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~----l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ----LTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCTTTSSSTTS
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH----HHHHHHhcCCCChhhccchhc
Confidence             23345699999999998654 579999999999999999999999964332111    11111110000   000000 


Q ss_pred             --ccc-c--CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          536 --DKD-L--KGNFD-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       536 --~~~-~--~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ... .  ....+     .....++.+++.+||..||++|||+.|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence              000 0  00011     1123678999999999999999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-46  Score=386.81  Aligned_cols=246  Identities=22%  Similarity=0.287  Sum_probs=206.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY  377 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~  377 (623)
                      ++|++.+.||+|+||.||+|... +|+.||||+++....  ......+.+|+++++.++||||+++++++...+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47899999999999999999975 699999999965332  233456899999999999999999999999999999999


Q ss_pred             ecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCC
Q 006968          378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH  457 (623)
Q Consensus       378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  457 (623)
                      ||+.+|+|..++...    ..+++..++.++.|++.||.|||++   +||||||||+|||++.++.+||+|||+|+....
T Consensus       121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            999999999999764    3699999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccccccc
Q 006968          458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVDK  537 (623)
Q Consensus       458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  537 (623)
                      .    .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....       ......... +..      
T Consensus       194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~-~~~------  255 (350)
T d1rdqe_         194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVS-GKV------  255 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH-CCC------
T ss_pred             c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHHHHHhc-CCC------
Confidence            2    2345699999999999999999999999999999999999999964321       111222211 111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCCCCCCC-----CCHHHHHHH
Q 006968          538 DLKGNFDRIELEEMVQVALLCTQFNPLHR-----PKMSEVLKM  575 (623)
Q Consensus       538 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-----Ps~~evl~~  575 (623)
                          ..+...+.++.+++.+||..||++|     ||+.++++|
T Consensus       256 ----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                1112234678999999999999999     489999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1e-45  Score=383.05  Aligned_cols=250  Identities=25%  Similarity=0.321  Sum_probs=200.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc--cchHHHHHH---HHHHhhcCCCceeeeeeeeecCCceE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTE---VETISLAVHRNLLRLCGFCSTENERL  374 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e---~~~l~~l~H~niv~l~~~~~~~~~~~  374 (623)
                      ++|++.+.||+|+||.||+|... +|+.||||++......  .....+.+|   +++++.++|||||++++++.+++..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999975 6999999998643321  222334444   66777788999999999999999999


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      +||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence            999999999999999764    4688999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCcccc
Q 006968          455 LDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQ  533 (623)
Q Consensus       455 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  533 (623)
                      +....   .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.......    ... +.......    
T Consensus       157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~-~~~~~~~~----  224 (364)
T d1omwa3         157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHE-IDRMTLTM----  224 (364)
T ss_dssp             CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----HHH-HHHHSSSC----
T ss_pred             cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----HHH-HHHhcccC----
Confidence            65432   334569999999999865 568999999999999999999999997432211    111 11110000    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006968          534 MVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPK-----MSEVLKM  575 (623)
Q Consensus       534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  575 (623)
                        ..    .++...+.++.+++.+||+.||++|||     +.|+++|
T Consensus       225 --~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         225 --AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             --CC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             --CC----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence              00    111223467899999999999999999     7899875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-47  Score=384.12  Aligned_cols=248  Identities=25%  Similarity=0.352  Sum_probs=203.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccc--ccchHHHHHHHHHHh-hcCCCceeeeeeeeecCCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETIS-LAVHRNLLRLCGFCSTENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~-~l~H~niv~l~~~~~~~~~~~lv  376 (623)
                      ++|.+.+.||+|+||+||+|... +|+.||||++++...  ......+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999975 699999999975432  233445677777765 68999999999999999999999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccC
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD  456 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  456 (623)
                      |||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            9999999999999764    3589999999999999999999999   99999999999999999999999999998665


Q ss_pred             CCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccccccc
Q 006968          457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLSQMVD  536 (623)
Q Consensus       457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  536 (623)
                      .... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......       ........ +.      
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~-~~------  219 (320)
T d1xjda_         155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRM-DN------  219 (320)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH-CC------
T ss_pred             cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHc-CC------
Confidence            4332 334456999999999999999999999999999999999999999743221       11111111 11      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006968          537 KDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMS-EVLK  574 (623)
Q Consensus       537 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  574 (623)
                      +    .++...+.++.+++.+||..||++|||+. |+++
T Consensus       220 ~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         220 P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             C----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1    11222346789999999999999999995 6765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-46  Score=381.21  Aligned_cols=250  Identities=22%  Similarity=0.267  Sum_probs=198.1

Q ss_pred             cCCCcC-CceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhh-cCCCceeeeeeeeec----CCce
Q 006968          301 SNFSAK-NILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRNLLRLCGFCST----ENER  373 (623)
Q Consensus       301 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~H~niv~l~~~~~~----~~~~  373 (623)
                      ++|.+. +.||+|+||+||+|.. .+|+.||||+++.      ...+.+|++++.+ .+|||||++++++.+    ....
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            578776 4699999999999987 4689999999864      2357889998765 489999999999864    4568


Q ss_pred             EEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCcEEEeecc
Q 006968          374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFG  450 (623)
Q Consensus       374 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfg  450 (623)
                      ++||||+++|+|.+++...  ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence            9999999999999999753  234699999999999999999999999   9999999999999985   5679999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      +|+.......  .....||+.|+|||++.+..++.++|||||||++|||+||+.||.........    ..+.       
T Consensus       160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~----~~~~-------  226 (335)
T d2ozaa1         160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMK-------  226 (335)
T ss_dssp             TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred             eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH----HHHH-------
Confidence            9987654332  34456999999999999999999999999999999999999999643221110    0000       


Q ss_pred             cccccccc--cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          531 LSQMVDKD--LKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ..+....  +........+.++.+++.+||..||++|||+.|++++
T Consensus       227 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         227 -TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             0000011  1111112335789999999999999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-46  Score=376.01  Aligned_cols=265  Identities=22%  Similarity=0.319  Sum_probs=199.5

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++..... ....++.+|++++++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5789999999999999999997 46999999999754322 234578999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      |+.++ +..++...  ....+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCc-hhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99754 44444332  245699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCceeeccccccccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC--cccccc
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG--KLSQMV  535 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  535 (623)
                      .. ......||+.|+|||.+.... ++.++||||+||++|+|++|+.||........   .....+......  ......
T Consensus       156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGG
T ss_pred             cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhccccc
Confidence            32 233446999999999877655 58899999999999999999999974332111   111111100000  000000


Q ss_pred             -ccccCCCC------C-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          536 -DKDLKGNF------D-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       536 -~~~~~~~~------~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       .+.....+      .     .....++.+++.+||..||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             00000000      0     1123678899999999999999999999885

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.7e-45  Score=370.43  Aligned_cols=264  Identities=20%  Similarity=0.304  Sum_probs=201.1

Q ss_pred             cCCCcCCceeccCCeEEEEEEeCCCcEEEEEEeccccc-ccchHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEec
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY  379 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  379 (623)
                      ++|.+.+.||+|+||+||+|..++|+.||||+++.... .....++.+|+.++++++||||+++++++..++..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57889999999999999999998999999999976543 22345799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCCC
Q 006968          380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD  459 (623)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  459 (623)
                      +.++.+..+...    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||.+.......
T Consensus        82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            988766665543    35799999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc--Cc---ccc
Q 006968          460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE--GK---LSQ  533 (623)
Q Consensus       460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~  533 (623)
                      . ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+.   ...........  ..   ...
T Consensus       155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred             c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhccchhh
Confidence            2 23334589999999998754 569999999999999999999999964322111   11111110000  00   000


Q ss_pred             cc--ccccC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          534 MV--DKDLK-------GNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       534 ~~--~~~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..  .....       .........++.+++.+||+.||++|||+.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00  00000       00111223578899999999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-46  Score=370.89  Aligned_cols=241  Identities=23%  Similarity=0.372  Sum_probs=197.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-----chHHHHHHHHHHhhcC--CCceeeeeeeeecCCc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAV--HRNLLRLCGFCSTENE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~--H~niv~l~~~~~~~~~  372 (623)
                      ++|.+.+.||+|+||+||+|... +|+.||||+++......     ...++.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57899999999999999999974 68999999997543221     1234778999999986  8999999999999999


Q ss_pred             eEEEEecccC-CChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCcEEEeecc
Q 006968          373 RLLVYPYMPN-GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFG  450 (623)
Q Consensus       373 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfg  450 (623)
                      .++||||+.+ +++.+++...    ..+++..++.++.|+++||+|||++   +|+||||||+|||++. ++.+||+|||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            9999999976 5777777653    4699999999999999999999999   9999999999999985 4799999999


Q ss_pred             cccccCCCCCceeeccccccccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      +|+.....   ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....             ... +
T Consensus       157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~-~  219 (273)
T d1xwsa_         157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIR-G  219 (273)
T ss_dssp             TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHH-C
T ss_pred             cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhh-c
Confidence            99865432   2345679999999999987765 5778999999999999999999963211             000 1


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .      ..+...+    +.++.+++.+||+.||++|||+.|++++
T Consensus       220 ~------~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         220 Q------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             C------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             c------cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1      0111122    3678999999999999999999999885

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=372.16  Aligned_cols=265  Identities=23%  Similarity=0.321  Sum_probs=198.5

Q ss_pred             hcCCCcCCceeccCCeEEEEEEeC-C-CcEEEEEEeccccccc-chHHHHHHHHHHhhc---CCCceeeeeeeeec----
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCFS-D-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA---VHRNLLRLCGFCST----  369 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l---~H~niv~l~~~~~~----  369 (623)
                      .++|++.+.||+|+||+||+|... + ++.||||+++...... ....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999873 4 6789999997543322 234577888887765   79999999999853    


Q ss_pred             -CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEee
Q 006968          370 -ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD  448 (623)
Q Consensus       370 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  448 (623)
                       ....+++|||++++++......   ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             3467999999988776544432   245689999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhc
Q 006968          449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQE  528 (623)
Q Consensus       449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  528 (623)
                      ||+++.....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.   +..........
T Consensus       160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~  234 (305)
T d1blxa_         160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLP  234 (305)
T ss_dssp             CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred             hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCC
Confidence            9998864322  233456699999999999999999999999999999999999999974432111   11111110000


Q ss_pred             C--ccc-------ccccccc---CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          529 G--KLS-------QMVDKDL---KGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       529 ~--~~~-------~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .  ...       .......   ...+.......+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0  000       0000000   001112234678899999999999999999999886

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=363.13  Aligned_cols=263  Identities=18%  Similarity=0.281  Sum_probs=196.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecCC----ceEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN----ERLL  375 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~----~~~l  375 (623)
                      ++|.+.+.||+|+||+||+|.. .+|+.||||+++..........+.+|+++|++++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            5688999999999999999986 4799999999976554444567899999999999999999999986543    2345


Q ss_pred             EEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeeccccccc
Q 006968          376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL  455 (623)
Q Consensus       376 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  455 (623)
                      +++|+.+|+|.+++...     .+++..++.++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++..
T Consensus        88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55667799999999753     589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCc--eeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCccc
Q 006968          456 DHRDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGKLS  532 (623)
Q Consensus       456 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  532 (623)
                      ......  ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.....   .. ........
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~---~~-~~~~~~~~  235 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LG-ILGSPSQE  235 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HH-HHCSCCHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH---hh-hccCCChh
Confidence            443221  2344569999999999854 46789999999999999999999999643321111000   00 00000000


Q ss_pred             -----------c-ccccccCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          533 -----------Q-MVDKDLKGNFD-----RIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       533 -----------~-~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                                 . ..........+     .....++.+++.+||..||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       0 00000000000     0112468899999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=365.45  Aligned_cols=263  Identities=24%  Similarity=0.312  Sum_probs=195.1

Q ss_pred             CCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeeeeeeecC------CceE
Q 006968          302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------NERL  374 (623)
Q Consensus       302 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~------~~~~  374 (623)
                      +|...++||+|+||+||+|... +|+.||||+++....     .+.+|++++++++||||+++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            5777889999999999999975 699999999975432     235799999999999999999998542      3468


Q ss_pred             EEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-cEEEeeccccc
Q 006968          375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAK  453 (623)
Q Consensus       375 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~  453 (623)
                      +||||++++. ...+.........+++..++.++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+++
T Consensus        96 lv~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          96 LVLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence            9999998664 444433333456799999999999999999999999   999999999999999775 89999999998


Q ss_pred             ccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH--------HHHHH
Q 006968          454 LLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML--------DWVKK  524 (623)
Q Consensus       454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~  524 (623)
                      .......  .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+......        .+...
T Consensus       172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            7654332  234569999999998765 578999999999999999999999997543221111000        11111


Q ss_pred             Hhhc---CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          525 LHQE---GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       525 ~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ....   .....................++.+++.+||..||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1000   00011000001111112234678999999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=354.67  Aligned_cols=264  Identities=23%  Similarity=0.311  Sum_probs=195.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeec--------C
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST--------E  370 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~--------~  370 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||+++..... ....++.+|++++++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67899999999999999999974 7999999998654332 334578999999999999999999998855        3


Q ss_pred             CceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecc
Q 006968          371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG  450 (623)
Q Consensus       371 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  450 (623)
                      +..++||||++++.+..+...    ...++...++.++.|+++||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            467999999988776544432    44688999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC---ceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHh
Q 006968          451 LAKLLDHRDS---HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLH  526 (623)
Q Consensus       451 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  526 (623)
                      +++.......   .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........    ..-+....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~----~~~i~~~~  238 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ----LALISQLC  238 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHH
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH----HHHHHHhc
Confidence            9987653322   122335699999999998765 689999999999999999999999964322111    11111111


Q ss_pred             hcC--c-ccccccccc--------CCCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          527 QEG--K-LSQMVDKDL--------KGNFDR-------IELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       527 ~~~--~-~~~~~~~~~--------~~~~~~-------~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ...  . .........        ......       ....++.+++.+||+.||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            000  0 000000000        000000       112467889999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.8e-43  Score=352.80  Aligned_cols=258  Identities=19%  Similarity=0.194  Sum_probs=197.0

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCCCceeeee-eeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC-GFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~-~~~~~~~~~~lv~e  378 (623)
                      ++|++.+.||+|+||.||+|... +|+.||||+++...   ...++..|+++++.++|+|++..+ ++....+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            46899999999999999999874 68999999986543   234688999999999887766554 45567778899999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC---CCCcEEEeeccccccc
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLL  455 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Dfgla~~~  455 (623)
                      |+ ++++...+...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+|+.+
T Consensus        84 ~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          84 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             Ec-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99 56666665543   34699999999999999999999999   999999999999986   3557999999999987


Q ss_pred             CCCCCc------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC
Q 006968          456 DHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG  529 (623)
Q Consensus       456 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  529 (623)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..............+...... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~  235 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-T  235 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-S
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-C
Confidence            543322      233457999999999999999999999999999999999999999753332221111111111000 0


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          530 KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      ..     +.+...    .+.++.+++..||+.+|++||++.++.+.|++
T Consensus       236 ~~-----~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         236 PI-----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             CH-----HHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             Ch-----hHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            00     011111    23678999999999999999999999888876

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-42  Score=355.71  Aligned_cols=261  Identities=23%  Similarity=0.299  Sum_probs=192.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecCC------c
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------E  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~------~  372 (623)
                      ++|.+.+.||+|+||+||+|... +|+.||||+++..... .....+.+|+++|++++|||||+++++|...+      +
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            57899999999999999999974 6999999999754332 22446899999999999999999999997654      5


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++||||+ +.+|..+.+.     ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+|++|||+|
T Consensus        98 ~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence            69999999 5677776653     3699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeecccccccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH----HHhh
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK----KLHQ  527 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~  527 (623)
                      +.....    .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.................    ....
T Consensus       169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            876432    234569999999999876 4568999999999999999999999975432111000000000    0000


Q ss_pred             cC----------ccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          528 EG----------KLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       528 ~~----------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      ..          ...+.....+. ........++.+++.+||..||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00          00000000000 0111223567899999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-43  Score=351.76  Aligned_cols=264  Identities=20%  Similarity=0.241  Sum_probs=204.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...... ...++.+|+.+++.++||||+++++++...+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57899999999999999999974 78999999997654332 34578999999999999999999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccccccCCC
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR  458 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  458 (623)
                      ++.++++..++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.++.....
T Consensus        82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999988877764    34688999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCceeeccccccccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcC---ccc--
Q 006968          459 DSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEG---KLS--  532 (623)
Q Consensus       459 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~--  532 (623)
                      .. ......++..|+|||.+.... ++.++||||+||++|||++|+.||........   ...-+.......   ...  
T Consensus       155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (292)
T d1unla_         155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH---HHHHHHHHHCCCCTTTCTTG
T ss_pred             Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH---HHHHHHhhcCCCChhhhhhh
Confidence            32 233345788999999987665 68999999999999999999999753322111   011111111000   000  


Q ss_pred             -ccccc---------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          533 -QMVDK---------DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       533 -~~~~~---------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                       ...+.         .............+.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00000         00001112234578899999999999999999999875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.2e-42  Score=348.21  Aligned_cols=258  Identities=17%  Similarity=0.229  Sum_probs=204.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcCC-CceeeeeeeeecCCceEEEEe
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH-RNLLRLCGFCSTENERLLVYP  378 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e  378 (623)
                      ++|.+.+.||+|+||+||+|... +|+.||||+++...   ....+.+|++.++.+.| +|++.+++++......++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            57899999999999999999965 68999999986543   23457889999998875 899999999999999999999


Q ss_pred             cccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-----CCcEEEeeccccc
Q 006968          379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-----DFEAVVGDFGLAK  453 (623)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~Dfgla~  453 (623)
                      |+ +++|.+++...   ...+++.++..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+|+
T Consensus        82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence            98 78999988754   34689999999999999999999999   9999999999999974     5789999999998


Q ss_pred             ccCCCCCc------eeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhh
Q 006968          454 LLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQ  527 (623)
Q Consensus       454 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  527 (623)
                      ........      ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... ...+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~-~~~i~~~~~  233 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQ  233 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH-HHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH-HHHHHhccC
Confidence            76543221      23345799999999999999999999999999999999999999974332211111 111111111


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhhc
Q 006968          528 EGKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKMLEG  578 (623)
Q Consensus       528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  578 (623)
                      .....     .+...+    +.++.+++..|+..+|++||+++.+.+.|++
T Consensus       234 ~~~~~-----~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         234 STPLR-----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             HSCHH-----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             CCChH-----HhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            11111     111122    3678999999999999999999999888766

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-43  Score=358.41  Aligned_cols=254  Identities=24%  Similarity=0.307  Sum_probs=204.3

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC----CCcEEEEEEeccccc---ccchHHHHHHHHHHhhcCC-CceeeeeeeeecCCc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNI---AGGEVQFQTEVETISLAVH-RNLLRLCGFCSTENE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~H-~niv~l~~~~~~~~~  372 (623)
                      ++|++.+.||+|+||+||+|...    +|+.||||+++....   ......+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999852    488999999875432   1234568899999999977 899999999999999


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++||||+.+|+|.+++...    ..+....+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999999864    3577889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeeccccccccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHHHHhhcCc
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVKKLHQEGK  530 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  530 (623)
                      +.+............|++.|+|||.+.+.  .++.++||||+||++|||++|+.||........   .....+...... 
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~---~~~i~~~~~~~~-  252 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKSE-  252 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHCC-
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcccCC-
Confidence            87655444444556799999999999764  468899999999999999999999975432211   111111111110 


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006968          531 LSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRP-----KMSEVLKM  575 (623)
Q Consensus       531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  575 (623)
                                ..++...+.++.+++.+||++||++||     |++|+++|
T Consensus       253 ----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         253 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                      112223457899999999999999999     58898875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3e-42  Score=353.58  Aligned_cols=259  Identities=18%  Similarity=0.260  Sum_probs=197.4

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeec--CCceEEE
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCST--ENERLLV  376 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~--~~~~~lv  376 (623)
                      ++|++.+.||+|+||+||+|... +|+.||||+++..    ...++.+|+++|+.+. ||||+++++++..  ....++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            57999999999999999999974 6999999999753    2457899999999995 9999999999874  4568999


Q ss_pred             EecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-cEEEeeccccccc
Q 006968          377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLL  455 (623)
Q Consensus       377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~~~  455 (623)
                      |||+++++|..+.+       .+++..++.++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|+..
T Consensus       111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence            99999999876542       589999999999999999999999   999999999999998655 6899999999876


Q ss_pred             CCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCccccccccc-chH---------HHHHH
Q 006968          456 DHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRG-VML---------DWVKK  524 (623)
Q Consensus       456 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~-~~~---------~~~~~  524 (623)
                      .....  .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... ...         +|...
T Consensus       181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            54332  3445689999999998765 47999999999999999999999996543211100 000         11111


Q ss_pred             HhhcC--cccccccc--------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          525 LHQEG--KLSQMVDK--------DLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       525 ~~~~~--~~~~~~~~--------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .....  ........        ............++.+++.+||..||++|||++|+++|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000  00000000        00111112234678999999999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-42  Score=354.12  Aligned_cols=263  Identities=20%  Similarity=0.240  Sum_probs=190.8

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEeccccccc-chHHHHHHHHHHhhcCCCceeeeeeeeec------CCc
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCST------ENE  372 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~~~~~~------~~~  372 (623)
                      ++|.+.++||+|+||+||+|... +|+.||||+++...... ...++.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57889999999999999999975 69999999997654332 23468899999999999999999999864      367


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .++||||+.++.+. .+.      ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence            89999999765443 332      2489999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccchH-------------
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML-------------  519 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~-------------  519 (623)
                      +.....  .......||+.|+|||++.+..++.++||||+||+++||++|+.||.............             
T Consensus       167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            865432  23344568999999999999999999999999999999999999996432211100000             


Q ss_pred             --HHHHHHhhcC-cc-----ccccccccCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          520 --DWVKKLHQEG-KL-----SQMVDKDLKGN---FDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       520 --~~~~~~~~~~-~~-----~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                        ...+...... ..     ...........   .......++.+++.+||..||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              0001111110 00     01111111111   123346788999999999999999999999876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-41  Score=346.94  Aligned_cols=263  Identities=22%  Similarity=0.259  Sum_probs=194.0

Q ss_pred             hcCCCcCCceeccCCeEEEEEEe-CCCcEEEEEEecccccc-cchHHHHHHHHHHhhcCCCceeeeeeeeecC-----Cc
Q 006968          300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NE  372 (623)
Q Consensus       300 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~~~~~~~-----~~  372 (623)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++..... ....++.+|++++++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999986 47999999999754432 2334688999999999999999999998643     34


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEEeecccc
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA  452 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  452 (623)
                      .+++++|+.+|+|.+++..     ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            4677788889999998864     3599999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCceeeccccccccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCcccccccccchHHHHH----HHhh
Q 006968          453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVK----KLHQ  527 (623)
Q Consensus       453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~  527 (623)
                      .....    ......||+.|+|||...+. .++.++||||+||++|+|++|+.||.................    ....
T Consensus       169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            75432    23345689999999987665 468999999999999999999999964332111110000000    0000


Q ss_pred             c----------CccccccccccCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006968          528 E----------GKLSQMVDKDLKGNFDRIELEEMVQVALLCTQFNPLHRPKMSEVLKM  575 (623)
Q Consensus       528 ~----------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  575 (623)
                      .          ..........+.. .......++.+++.+||..||++|||+.|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            0          0000000000000 000123568899999999999999999999885

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.4e-37  Score=318.87  Aligned_cols=265  Identities=20%  Similarity=0.228  Sum_probs=190.2

Q ss_pred             cCCCcCCceeccCCeEEEEEEeC-CCcEEEEEEecccccccchHHHHHHHHHHhhcC-----------CCceeeeeeeee
Q 006968          301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-----------HRNLLRLCGFCS  368 (623)
Q Consensus       301 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~~~~~  368 (623)
                      .+|.+.++||+|+||+||+|+.. +|+.||||+++....  ....+.+|+.+++.+.           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            35889999999999999999974 799999999975432  2346788888887775           578999998875


Q ss_pred             c--CCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCc--
Q 006968          369 T--ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFE--  443 (623)
Q Consensus       369 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~--  443 (623)
                      .  ....+++++++..+........ ......+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.  
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred             eccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence            4  3455666766655543333222 2234578999999999999999999998 5   9999999999999986553  


Q ss_pred             ----EEEeecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCcccccccccc--
Q 006968          444 ----AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGV--  517 (623)
Q Consensus       444 ----~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~--  517 (623)
                          ++++|||.+......    .....||+.|+|||++....++.++||||+||+++||++|+.||...........  
T Consensus       167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                899999999865422    2345699999999999999999999999999999999999999864332111111  


Q ss_pred             -hHHHHHHH-------hhcC-ccccccc---------c----------ccCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 006968          518 -MLDWVKKL-------HQEG-KLSQMVD---------K----------DLKGNFDRIELEEMVQVALLCTQFNPLHRPKM  569 (623)
Q Consensus       518 -~~~~~~~~-------~~~~-~~~~~~~---------~----------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~  569 (623)
                       ....+...       .... ......+         .          ............++.+++.+||..||++|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence             11111100       0000 0000000         0          01123456677889999999999999999999


Q ss_pred             HHHHHH
Q 006968          570 SEVLKM  575 (623)
Q Consensus       570 ~evl~~  575 (623)
                      +|+++|
T Consensus       323 ~e~L~H  328 (362)
T d1q8ya_         323 GGLVNH  328 (362)
T ss_dssp             HHHHTC
T ss_pred             HHHhcC
Confidence            999875

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.93  E-value=6.4e-27  Score=237.21  Aligned_cols=161  Identities=29%  Similarity=0.536  Sum_probs=149.5

Q ss_pred             CCCchHHHHHHHHHHhCCCCCcccCCCCCCCCCCC--CcceeeeCCCC---cEEEEeCCCCCccc--ccCccccCCCCcc
Q 006968           29 AGINYEVVALVAVKNNLHDPYNVLENWDITSVDPC--SWRMITCSPDG---YVSALGLPSQSLSG--TLSPWIGNLTKLQ  101 (623)
Q Consensus        29 ~~~~~~~~~l~~~k~~~~~p~~~~~~w~~~~~~~c--~w~gv~c~~~~---~v~~L~L~~n~l~~--~~~~~~~~l~~L~  101 (623)
                      -|.+.|++||++||+++.||. .+++|. .+.|||  .|.||+|+..+   ||+.|+|++|+++|  .+|+.+++|++|+
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~-~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~   79 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPT-TLSSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCC-TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHHCCCCC-cCCCCC-CCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence            378899999999999999885 799997 567999  49999998643   79999999999998  5899999999999


Q ss_pred             eEEeec-CCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCC
Q 006968          102 SVLLQN-NAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN  180 (623)
Q Consensus       102 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  180 (623)
                      +|+|++ |+++|.+|..|++|++|++|+|++|+|.+..|..+..+.+|+.+++++|.+.+.+|..+.++++|+.+++++|
T Consensus        80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n  159 (313)
T d1ogqa_          80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence            999996 8999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCcCCCCcc
Q 006968          181 NLSGSLPKISA  191 (623)
Q Consensus       181 ~l~~~~p~~~~  191 (623)
                      .++|.+|+...
T Consensus       160 ~l~~~ip~~~~  170 (313)
T d1ogqa_         160 RISGAIPDSYG  170 (313)
T ss_dssp             CCEEECCGGGG
T ss_pred             ccccccccccc
Confidence            99999997654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=2.4e-23  Score=194.67  Aligned_cols=170  Identities=11%  Similarity=0.067  Sum_probs=120.5

Q ss_pred             CcCCceeccCCeEEEEEEeCCCcEEEEEEecccccc-----------------cchHHHHHHHHHHhhcCCCceeeeeee
Q 006968          304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-----------------GGEVQFQTEVETISLAVHRNLLRLCGF  366 (623)
Q Consensus       304 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~H~niv~l~~~  366 (623)
                      .+.+.||+|+||+||+|...+|+.||||+++.....                 ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            456899999999999999889999999987632110                 001234568888999999999888765


Q ss_pred             eecCCceEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCcEEE
Q 006968          367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV  446 (623)
Q Consensus       367 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  446 (623)
                      .    ..+++|||+++..+..           ++......++.|+++|++|||++   +|+||||||+|||++++ .++|
T Consensus        83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence            3    2479999998765332           33344567999999999999999   99999999999999965 5899


Q ss_pred             eecccccccCCCCCceeeccccccccccccccccCCCCCccchhhHHHHH
Q 006968          447 GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL  496 (623)
Q Consensus       447 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil  496 (623)
                      +|||.|....+.......  ..+...+ .+. ..+.|..++|+||..--+
T Consensus       144 iDFG~a~~~~~~~~~~~l--~rd~~~~-~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWREIL--ERDVRNI-ITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHHHHH--HHHHHHH-HHH-HHHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcHHHH--HHHHHHH-HHH-HcCCCCCcccHHHHHHHH
Confidence            999999865433221100  0000000 011 135678899999976444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.73  E-value=8.1e-18  Score=156.64  Aligned_cols=145  Identities=23%  Similarity=0.311  Sum_probs=119.7

Q ss_pred             CCCcceeeeCCC----------CcEEEEeCCCCCccccc-CccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEec
Q 006968           62 PCSWRMITCSPD----------GYVSALGLPSQSLSGTL-SPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLS  130 (623)
Q Consensus        62 ~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  130 (623)
                      -|+|..|.|+..          ..++.|+|++|.|++.+ +..|.++++|++|+|++|++.+..+..|..+++|++|+|+
T Consensus         7 ~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_           7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             EEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            367888888742          37899999999998755 5678999999999999999998899999999999999999


Q ss_pred             CCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCCCC
Q 006968          131 NNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPK  206 (623)
Q Consensus       131 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~  206 (623)
                      +|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.+....+-...    +...+.+|.+.|..+
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence            9999977777899999999999999999977788899999999999999999865432211    334556666666543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.67  E-value=4.8e-17  Score=151.34  Aligned_cols=134  Identities=20%  Similarity=0.350  Sum_probs=116.8

Q ss_pred             ceeeeCCCCcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCC-CCccCCCCCccEEEecCCCCCCCCCccccC
Q 006968           66 RMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLDLSNNKFTGEIPDSLGD  144 (623)
Q Consensus        66 ~gv~c~~~~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  144 (623)
                      .|-+|+.    +.++.++++|+ .+|..+.  +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..+..
T Consensus         4 ~~C~C~~----~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~   76 (192)
T d1w8aa_           4 AMCHCEG----TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG   76 (192)
T ss_dssp             TTSEEET----TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred             CCCEEcC----CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccc
Confidence            3556753    47899999999 7887763  68999999999998655 567789999999999999999888999999


Q ss_pred             CCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCCC
Q 006968          145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK  206 (623)
Q Consensus       145 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~  206 (623)
                      +++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|+.+.     +.+.+.+|++.|.+.
T Consensus        77 ~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~  143 (192)
T d1w8aa_          77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             ccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence            99999999999999977788899999999999999999988887664     678899999988754

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.58  E-value=4.8e-16  Score=156.17  Aligned_cols=135  Identities=26%  Similarity=0.456  Sum_probs=105.8

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCc-ceE-----------------------EeecCCCCCCCCCccCCCCCccEEEec
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKL-QSV-----------------------LLQNNAILGPIPASLGKLEKLQTLDLS  130 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L-~~L-----------------------~L~~N~l~~~~p~~~~~l~~L~~L~Ls  130 (623)
                      .++.+++++|.++|.+|..+.++..+ +.+                       ++++|.+.|.+|..+..+++|+.|+++
T Consensus       150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~  229 (313)
T d1ogqa_         150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA  229 (313)
T ss_dssp             TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECC
T ss_pred             ccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            45566666666666666655555443 444                       445555555566677788899999999


Q ss_pred             CCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCCCC
Q 006968          131 NNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPK  206 (623)
Q Consensus       131 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~  206 (623)
                      +|.+++.+| .++.+++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+|+|.+|....    +.+++.||+++||.+
T Consensus       230 ~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p  308 (313)
T d1ogqa_         230 KNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             SSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred             ccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence            999997655 688999999999999999999999999999999999999999999998643    567899999999976


Q ss_pred             CCCCC
Q 006968          207 ATNNC  211 (623)
Q Consensus       207 ~~~~~  211 (623)
                      . ..|
T Consensus       309 l-p~c  312 (313)
T d1ogqa_         309 L-PAC  312 (313)
T ss_dssp             S-SCC
T ss_pred             C-CCC
Confidence            4 355

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=4.8e-15  Score=145.08  Aligned_cols=129  Identities=27%  Similarity=0.282  Sum_probs=83.1

Q ss_pred             EEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccc
Q 006968           76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN  155 (623)
Q Consensus        76 v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  155 (623)
                      ++.|+|++|+|++ ++..+.++++|+.|+|++|.+.+..+..+..+.+|++|++++|.+++..+..+..+++|+.|++++
T Consensus        79 L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~  157 (266)
T d1p9ag_          79 LGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN  157 (266)
T ss_dssp             CCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             ccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccc
Confidence            4444444444442 233444444555555555554444444445555555555666666644455567788888888888


Q ss_pred             cccCCCCCcccCCCCcccEEECCCCcCcCcCCCC-cc----ccccccCCCCCCCCC
Q 006968          156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI-SA----RTFKVTGNPLICGPK  206 (623)
Q Consensus       156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~----~~~~~~~n~~~~~~~  206 (623)
                      |+|++..+..|..+++|+.|+|++|+|+ .+|.. +.    +.+.+.||||.|.|.
T Consensus       158 N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             ccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence            8888777777888889999999999988 55543 32    567888999888764

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.57  E-value=2.2e-15  Score=128.91  Aligned_cols=103  Identities=27%  Similarity=0.380  Sum_probs=90.9

Q ss_pred             EEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcccc
Q 006968           77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN  156 (623)
Q Consensus        77 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N  156 (623)
                      +.|+|++|+|+ .++ .+.++++|++|+|++|+|+ .+|..++.+++|+.|+|++|+|+ .+| .+..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            36899999998 555 4899999999999999998 67888999999999999999999 565 5899999999999999


Q ss_pred             ccCCCC-CcccCCCCcccEEECCCCcCcC
Q 006968          157 SLTGSC-PESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       157 ~l~~~~-p~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      +|++.. ...+..+++|+.|++++|+++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            998432 2568899999999999999984

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=2.1e-15  Score=149.17  Aligned_cols=132  Identities=23%  Similarity=0.295  Sum_probs=118.2

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|++.+..+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+++
T Consensus       106 ~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~  185 (284)
T d1ozna_         106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH  185 (284)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             cCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhh
Confidence            79999999999987777788889999999999999997777889999999999999999997778889999999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK  206 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~  206 (623)
                      +|++++..|..|..+++|+.|++++|++++..|..+.     +.+++++|++.|.|.
T Consensus       186 ~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             hccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence            9999988899999999999999999999987776553     668899999998754

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=9e-14  Score=135.84  Aligned_cols=129  Identities=24%  Similarity=0.211  Sum_probs=103.9

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      ..++.|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+++ .+|..+..+++|+.|++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l  107 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV  107 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred             cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence            36999999999999777788999999999999999998 455 3678999999999999999 66788888999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----ccccccCCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGP  205 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~  205 (623)
                      ++|.+.+..+..+..+.+|+.|++++|.+++..+..+.     +.+++++|.+...+
T Consensus       108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~  164 (266)
T d1p9ag_         108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP  164 (266)
T ss_dssp             CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred             cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence            99988876677777778888888888888765554433     44667777665443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=4.8e-14  Score=126.53  Aligned_cols=106  Identities=23%  Similarity=0.260  Sum_probs=90.5

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      ++..|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|+.|+|+
T Consensus        19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~   95 (162)
T d1a9na_          19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT   95 (162)
T ss_dssp             SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred             cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence            6899999999998 56777788999999999999999 454 58999999999999999994444456789999999999


Q ss_pred             ccccCCCCC--cccCCCCcccEEECCCCcCcC
Q 006968          155 NNSLTGSCP--ESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       155 ~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      +|+|+ .++  ..+..+++|+.|++++|+++.
T Consensus        96 ~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~  126 (162)
T d1a9na_          96 NNSLV-ELGDLDPLASLKSLTYLCILRNPVTN  126 (162)
T ss_dssp             SCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred             ccccc-ccccccccccccccchhhcCCCcccc
Confidence            99998 444  368889999999999999873

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.42  E-value=1.2e-13  Score=117.88  Aligned_cols=99  Identities=23%  Similarity=0.326  Sum_probs=84.0

Q ss_pred             ceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCC
Q 006968          101 QSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN  180 (623)
Q Consensus       101 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N  180 (623)
                      ++|+|++|+|+ .+| .+.++++|++|||++|+|+ .+|+.++.+++|+.|++++|.|+ .+| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            57999999999 566 4899999999999999999 78999999999999999999999 555 5999999999999999


Q ss_pred             cCcCcCC-CCcc-----ccccccCCCCCCC
Q 006968          181 NLSGSLP-KISA-----RTFKVTGNPLICG  204 (623)
Q Consensus       181 ~l~~~~p-~~~~-----~~~~~~~n~~~~~  204 (623)
                      +|+.... ..+.     +.+++++|++...
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            9995332 1121     5688999997543

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=1.1e-13  Score=136.72  Aligned_cols=131  Identities=22%  Similarity=0.275  Sum_probs=114.2

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      ..+..+++++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|++|++
T Consensus       129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l  208 (284)
T d1ozna_         129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL  208 (284)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence            36899999999999877788999999999999999999888899999999999999999999888999999999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCc----cccccccCCCCCCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS----ARTFKVTGNPLICG  204 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~~~~~~~n~~~~~  204 (623)
                      ++|++.+..|..|..+++|+.|+|++|++....+-..    .+.+....+.+.|.
T Consensus       209 ~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~  263 (284)
T d1ozna_         209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS  263 (284)
T ss_dssp             CSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred             cccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence            9999998888899999999999999999997654211    13444455556553

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=3.3e-13  Score=120.13  Aligned_cols=100  Identities=20%  Similarity=0.125  Sum_probs=84.1

Q ss_pred             CCCCcccccCccccCCCCcceEEeecC-CCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCC
Q 006968           82 PSQSLSGTLSPWIGNLTKLQSVLLQNN-AILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTG  160 (623)
Q Consensus        82 ~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  160 (623)
                      +++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+ 
T Consensus        16 ~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-   93 (156)
T d2ifga3          16 TRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-   93 (156)
T ss_dssp             CSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-
T ss_pred             cCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-
Confidence            455555 46777888999999999766 588666678999999999999999999666788999999999999999999 


Q ss_pred             CCCcccCCCCcccEEECCCCcCc
Q 006968          161 SCPESLSKIESLTLVDLSYNNLS  183 (623)
Q Consensus       161 ~~p~~~~~l~~L~~L~l~~N~l~  183 (623)
                      .+|.......+|+.|+|++|+|.
T Consensus        94 ~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          94 SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             ccChhhhccccccccccCCCccc
Confidence            66666555568999999999986

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.35  E-value=2.2e-12  Score=128.31  Aligned_cols=74  Identities=28%  Similarity=0.413  Sum_probs=65.4

Q ss_pred             CCCcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecC
Q 006968           62 PCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN  131 (623)
Q Consensus        62 ~c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  131 (623)
                      -|.|++|.|+..          ..++.|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|+|++
T Consensus         9 ~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_           9 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             EecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence            378999999742          4699999999999965556899999999999999999988888999999999999999


Q ss_pred             CCCC
Q 006968          132 NKFT  135 (623)
Q Consensus       132 N~l~  135 (623)
                      |+|+
T Consensus        89 n~l~   92 (305)
T d1xkua_          89 NQLK   92 (305)
T ss_dssp             SCCS
T ss_pred             CccC
Confidence            9886

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=1.2e-12  Score=116.40  Aligned_cols=109  Identities=22%  Similarity=0.267  Sum_probs=92.1

Q ss_pred             CCCcceEEeecCCCCCCCCCccCCCCCccEEEecCC-CCCCCCCccccCCCCccchhccccccCCCCCcccCCCCcccEE
Q 006968           97 LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNN-KFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLV  175 (623)
Q Consensus        97 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  175 (623)
                      ....+.++++++++. ..|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|++..|..|..+++|+.|
T Consensus         7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L   85 (156)
T d2ifga3           7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL   85 (156)
T ss_dssp             CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred             cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence            344567899999988 67888999999999999866 5884445679999999999999999997778889999999999


Q ss_pred             ECCCCcCcCcCCCCcc----ccccccCCCCCCCCC
Q 006968          176 DLSYNNLSGSLPKISA----RTFKVTGNPLICGPK  206 (623)
Q Consensus       176 ~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~  206 (623)
                      +|++|+|+...++.+.    ..+.+++|++.|.+.
T Consensus        86 ~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~  120 (156)
T d2ifga3          86 NLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA  120 (156)
T ss_dssp             ECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred             eccCCCCcccChhhhccccccccccCCCcccCCch
Confidence            9999999965555543    578999999999774

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.33  E-value=1.4e-12  Score=129.80  Aligned_cols=126  Identities=26%  Similarity=0.275  Sum_probs=108.3

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.+++++|+++ .+|..+  +++|+.|++++|.+++..+..|.+++.++.|++++|++++..+..+.++++|++|+|+
T Consensus       151 ~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~  227 (305)
T d1xkua_         151 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN  227 (305)
T ss_dssp             TCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred             ccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecc
Confidence            6889999999998 466543  6899999999999999999999999999999999999998778889999999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc-----------ccccccCCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----------RTFKVTGNPLICG  204 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----------~~~~~~~n~~~~~  204 (623)
                      +|+|+ .+|..|..+++|++|+|++|+|+......+.           +.+++++|++.+.
T Consensus       228 ~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~  287 (305)
T d1xkua_         228 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  287 (305)
T ss_dssp             SSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             ccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence            99999 7899999999999999999999953322221           4577899998654

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.31  E-value=6.1e-13  Score=119.20  Aligned_cols=107  Identities=21%  Similarity=0.216  Sum_probs=87.4

Q ss_pred             ccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCCCCc
Q 006968           92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIES  171 (623)
Q Consensus        92 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  171 (623)
                      +.+.+...|++|+|++|+|+ .+|..+..+++|+.|||++|+|+ .++ .+..+++|++|+|++|++++..+..+..+++
T Consensus        12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~   88 (162)
T d1a9na_          12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD   88 (162)
T ss_dssp             CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence            34678889999999999999 56777788999999999999999 674 5899999999999999999544445678999


Q ss_pred             ccEEECCCCcCcCcCCCC--c-----cccccccCCCCC
Q 006968          172 LTLVDLSYNNLSGSLPKI--S-----ARTFKVTGNPLI  202 (623)
Q Consensus       172 L~~L~l~~N~l~~~~p~~--~-----~~~~~~~~n~~~  202 (623)
                      |+.|+|++|+|+. +++.  +     -+.+.+++|++.
T Consensus        89 L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          89 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cccceeccccccc-cccccccccccccchhhcCCCccc
Confidence            9999999999984 2221  1     156778888763

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.15  E-value=5.1e-11  Score=110.40  Aligned_cols=102  Identities=34%  Similarity=0.527  Sum_probs=49.2

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+|++..+  ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+.. + ..+..+++|+.|+++
T Consensus        63 nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~  136 (199)
T d2omxa2          63 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELS  136 (199)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECC
T ss_pred             CcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccccccccc-c-cccchhhhhHHhhhh
Confidence            45555555555543221  445555555555555544 222 24455555555555555442 2 224445555555555


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      +|++. .++ .+..+++|+.|++++|++++
T Consensus       137 ~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~  164 (199)
T d2omxa2         137 SNTIS-DIS-ALSGLTSLQQLNFSSNQVTD  164 (199)
T ss_dssp             SSCCC-CCG-GGTTCTTCSEEECCSSCCCC
T ss_pred             hhhhc-ccc-cccccccccccccccccccC
Confidence            55554 222 34455555555555555553

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.15  E-value=5.4e-11  Score=110.27  Aligned_cols=120  Identities=26%  Similarity=0.402  Sum_probs=99.3

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|++++|+++. ++ .+..+++|++|+|++|++++..|  ++++++|++|++++|.+. .++ .+.++++|+.|+++
T Consensus        41 ~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~  114 (199)
T d2omxa2          41 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLF  114 (199)
T ss_dssp             TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECC
T ss_pred             CCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccc
Confidence            68999999999984 43 58899999999999999996433  999999999999999998 565 48899999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLIC  203 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~  203 (623)
                      +|.+...  ..+..+++|+.|++++|++.. +|.+..    +.+.+.+|.+..
T Consensus       115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~  164 (199)
T d2omxa2         115 NNQITDI--DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTD  164 (199)
T ss_dssp             SSCCCCC--GGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCC
T ss_pred             ccccccc--cccchhhhhHHhhhhhhhhcc-cccccccccccccccccccccC
Confidence            9999843  358899999999999999984 443322    567788887643

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.09  E-value=4.9e-13  Score=124.12  Aligned_cols=108  Identities=22%  Similarity=0.291  Sum_probs=80.5

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+|+ .++ .+.++++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+ +.+..+++|+.|+|+
T Consensus        49 ~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l-~~~~~l~~L~~L~L~  123 (198)
T d1m9la_          49 ACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMS  123 (198)
T ss_dssp             TCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CH-HHHHHHHHSSEEEES
T ss_pred             ccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-cc-ccccccccccccccc
Confidence            6788888888887 444 4778888888888888887 56655555677888888888888 44 347778888888888


Q ss_pred             ccccCCCCC--cccCCCCcccEEECCCCcCcCcCCC
Q 006968          155 NNSLTGSCP--ESLSKIESLTLVDLSYNNLSGSLPK  188 (623)
Q Consensus       155 ~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~  188 (623)
                      +|+|+ .++  ..+..+++|+.|+|++|+++...+.
T Consensus       124 ~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  158 (198)
T d1m9la_         124 NNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             EEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred             cchhc-cccccccccCCCccceeecCCCccccCccc
Confidence            88887 333  3577888888888888887754443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.08  E-value=1.3e-10  Score=108.50  Aligned_cols=119  Identities=28%  Similarity=0.394  Sum_probs=84.4

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++|+|++. + .++++++|++|+|++|+|++ +| .+.++++|+.|++++|.+. .+ ..+..+++|+.++++
T Consensus        69 ~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~  142 (210)
T d1h6ta2          69 NVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLG  142 (210)
T ss_dssp             TCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECC
T ss_pred             CCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-ccccccccccccccccccc-cc-ccccccccccccccc
Confidence            678888888888753 3 35778888888888888874 44 4777888888888888876 33 357777788888888


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLI  202 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~  202 (623)
                      +|.+++.  ..+..+++|+.+++++|++++. +.+..    +.+++++|.+.
T Consensus       143 ~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         143 NNKITDI--TVLSRLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             SSCCCCC--GGGGGCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC
T ss_pred             ccccccc--cccccccccccccccccccccc-ccccCCCCCCEEECCCCCCC
Confidence            8887742  3566778888888888888753 32221    55677777664

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.05  E-value=1.9e-10  Score=107.49  Aligned_cols=120  Identities=22%  Similarity=0.308  Sum_probs=99.1

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.|++++|++++ ++ .+..+++|++|+|++|+|++ ++ .++.+++|++|+|++|+|+ .+| .+..+++|+.|+++
T Consensus        47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~  120 (210)
T d1h6ta2          47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE  120 (210)
T ss_dssp             TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred             CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccc
Confidence            68999999999985 33 38889999999999999996 44 4789999999999999999 566 58999999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCc---cccccccCCCCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS---ARTFKVTGNPLI  202 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~---~~~~~~~~n~~~  202 (623)
                      +|.+. .+ ..+..+++|+.+++++|.+++..+...   -+.+.+++|.+.
T Consensus       121 ~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~  169 (210)
T d1h6ta2         121 HNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS  169 (210)
T ss_dssp             TSCCC-CC-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCC
T ss_pred             ccccc-cc-cccccccccccccccccccccccccccccccccccccccccc
Confidence            99997 44 468899999999999999985432211   156778888764

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.02  E-value=1.6e-10  Score=118.14  Aligned_cols=123  Identities=24%  Similarity=0.326  Sum_probs=82.6

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCC----------------
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI----------------  138 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~----------------  138 (623)
                      .++.|++++|.++. + +.+..+++|+.|++++|++++..|  +..+++|++|++++|++++..                
T Consensus       220 ~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n  295 (384)
T d2omza2         220 NLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN  295 (384)
T ss_dssp             TCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred             CCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccccc
Confidence            56777777777764 2 346667777777777777765332  666667777777766665321                


Q ss_pred             ----CccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCCC
Q 006968          139 ----PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG  204 (623)
Q Consensus       139 ----p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~  204 (623)
                          +..+..+++|+.|+|++|++++..  .+..+++|+.|++++|+|++ +|.+..    +.+++++|++...
T Consensus       296 ~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l  366 (384)
T d2omza2         296 QLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDL  366 (384)
T ss_dssp             CCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBC
T ss_pred             ccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCC
Confidence                134566778888888888888543  37788888888888888875 343322    5677888876543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.00  E-value=7.5e-13  Score=122.84  Aligned_cols=110  Identities=23%  Similarity=0.326  Sum_probs=90.5

Q ss_pred             ccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhccccccCCCCCcccCC
Q 006968           89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSK  168 (623)
Q Consensus        89 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  168 (623)
                      .++..+..|++|++|+|++|+|+ .++ .|.++++|++|+|++|+|+ .+|..+..+++|+.|++++|+++. ++ .+..
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~  113 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEK  113 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHH
T ss_pred             hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccc
Confidence            45678999999999999999999 555 5999999999999999999 788777777899999999999994 43 5888


Q ss_pred             CCcccEEECCCCcCcCcC--CC---Cc-cccccccCCCCCC
Q 006968          169 IESLTLVDLSYNNLSGSL--PK---IS-ARTFKVTGNPLIC  203 (623)
Q Consensus       169 l~~L~~L~l~~N~l~~~~--p~---~~-~~~~~~~~n~~~~  203 (623)
                      +++|+.|+|++|+|+...  ..   .. -+.+.+++|++.+
T Consensus       114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~  154 (198)
T d1m9la_         114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred             cccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence            999999999999998421  11   11 1567888988643

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.95  E-value=3.8e-10  Score=115.26  Aligned_cols=117  Identities=21%  Similarity=0.338  Sum_probs=94.9

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+++++++++..+  +.+++.++.+.++.|++++.  ..+..+++|+.|+|++|++++ ++ .+..+++|++|+|
T Consensus       263 ~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L  336 (384)
T d2omza2         263 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFF  336 (384)
T ss_dssp             TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEEC
T ss_pred             ccCCEeeccCcccCCCCc--cccccccccccccccccccc--cccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEEC
Confidence            378999999999986543  77889999999999999853  458889999999999999995 43 3888999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCC
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGN  199 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n  199 (623)
                      ++|+|+ .++ .+.++++|+.|++++|+|++.+| +..    +.+++++|
T Consensus       337 ~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         337 ANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             CCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            999998 454 68999999999999999997654 221    44566655

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.95  E-value=5.9e-10  Score=106.32  Aligned_cols=97  Identities=22%  Similarity=0.364  Sum_probs=46.4

Q ss_pred             CCcceeeeCCC----------CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCC-CCccCCCCCccEEEecC
Q 006968           63 CSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLDLSN  131 (623)
Q Consensus        63 c~w~gv~c~~~----------~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~  131 (623)
                      |.++.|.|...          ..+++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++..
T Consensus         8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1           8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            45666777531          13455555555554333334455555555555555544322 22344455555554432


Q ss_pred             -CCCCCCCCccccCCCCccchhccccccC
Q 006968          132 -NKFTGEIPDSLGDLGNLNYLRLNNNSLT  159 (623)
Q Consensus       132 -N~l~~~~p~~~~~l~~L~~L~l~~N~l~  159 (623)
                       |++....+..|.++++|++|++++|.+.
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~  116 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIK  116 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred             cccccccccccccccccccccccchhhhc
Confidence             3444344444455555555555555544

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.89  E-value=2.8e-09  Score=100.50  Aligned_cols=122  Identities=23%  Similarity=0.409  Sum_probs=86.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCC---------------
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP---------------  139 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---------------  139 (623)
                      +++.|+|++|.+++..|  +.++++|++|++++|.++ .++ .+.++++|+.|++++|.+.+..+               
T Consensus        64 ~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~  139 (227)
T d1h6ua2          64 NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN  139 (227)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             CCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhchhh
Confidence            68888888888876443  778888888888888887 343 57788888888888877663211               


Q ss_pred             -----ccccCCCCccchhccccccCCCCCcccCCCCcccEEECCCCcCcCcCCCCcc----ccccccCCCCCC
Q 006968          140 -----DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLIC  203 (623)
Q Consensus       140 -----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~  203 (623)
                           ..+.++++|+.|++++|.+++..  .+.++++|+.|+|++|++++ +|.+..    +.+++++|++..
T Consensus       140 ~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~  209 (227)
T d1h6ua2         140 QITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISD  209 (227)
T ss_dssp             CCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCB
T ss_pred             hhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCC
Confidence                 23556777888888888887432  37788888888888888875 343221    567777777643

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.83  E-value=2.1e-09  Score=101.47  Aligned_cols=103  Identities=25%  Similarity=0.389  Sum_probs=82.1

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      .++.++++++...+..  .+...+.++.+.++++.+....  .+.++++|+.|++++|.+++ . ..+.++++|++|+|+
T Consensus       108 ~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~-~-~~l~~l~~L~~L~Ls  181 (227)
T d1h6ua2         108 SIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSD-L-TPLANLSKLTTLKAD  181 (227)
T ss_dssp             TCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECC
T ss_pred             cccccccccccccccc--hhccccchhhhhchhhhhchhh--hhcccccccccccccccccc-c-hhhcccccceecccC
Confidence            6888899988877543  3667788899999998887543  47788899999999999884 3 237889999999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCc
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGS  185 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  185 (623)
                      +|++++ ++ .+.++++|+.|+|++|+|++.
T Consensus       182 ~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i  210 (227)
T d1h6ua2         182 DNKISD-IS-PLASLPNLIEVHLKNNQISDV  210 (227)
T ss_dssp             SSCCCC-CG-GGGGCTTCCEEECTTSCCCBC
T ss_pred             CCccCC-Ch-hhcCCCCCCEEECcCCcCCCC
Confidence            999984 44 488889999999999998853

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.76  E-value=1.4e-08  Score=101.80  Aligned_cols=99  Identities=27%  Similarity=0.383  Sum_probs=82.0

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhcc
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN  154 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  154 (623)
                      +++.|+|++++|+ .+|+.   +++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++ .++..   .+.|++|+|+
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence            5789999999998 67864   568999999999999 788764   57899999999998 66542   2469999999


Q ss_pred             ccccCCCCCcccCCCCcccEEECCCCcCcCcCC
Q 006968          155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP  187 (623)
Q Consensus       155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  187 (623)
                      +|.++ .+|. +..+++|+.|++++|.++...+
T Consensus       107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~  137 (353)
T d1jl5a_         107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD  137 (353)
T ss_dssp             SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred             ccccc-cccc-hhhhccceeecccccccccccc
Confidence            99998 6764 6889999999999999985444

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.76  E-value=5.2e-09  Score=99.55  Aligned_cols=107  Identities=13%  Similarity=0.187  Sum_probs=89.5

Q ss_pred             EEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCC-ccccCCCCccchhccc
Q 006968           77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRLNN  155 (623)
Q Consensus        77 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~  155 (623)
                      ..++.++++++ .+|+.+.  +++++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..|..++++++|.+..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            35667788888 7887663  589999999999996556679999999999999999986665 4688999999999864


Q ss_pred             -cccCCCCCcccCCCCcccEEECCCCcCcCcC
Q 006968          156 -NSLTGSCPESLSKIESLTLVDLSYNNLSGSL  186 (623)
Q Consensus       156 -N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  186 (623)
                       |++....+..|..+++|+.|++++|.++...
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~  119 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLP  119 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCC
T ss_pred             cccccccccccccccccccccccchhhhcccc
Confidence             7788777788999999999999999998543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.38  E-value=8.4e-07  Score=84.82  Aligned_cols=150  Identities=13%  Similarity=0.075  Sum_probs=99.1

Q ss_pred             HHHHHHhcCCCcCCceeccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcC-CCceeeeeeeeecCCc
Q 006968          294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENE  372 (623)
Q Consensus       294 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~~~~~~~~~  372 (623)
                      .++....+.|...+..+-++.+.||+... ++..+.+|+..... ......+.+|...+..+. +--+-+++.+...++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            45666667777665544444568999875 55667788875432 222335788888887664 3234567777778888


Q ss_pred             eEEEEecccCCChhhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------
Q 006968          373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ-------------------------------  421 (623)
Q Consensus       373 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------  421 (623)
                      .++||+++++.++.+.....      -.   ...++.++++.++.||+.                               
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             eEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            99999999998765443211      11   223445555666666632                               


Q ss_pred             -------------------------CCCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          422 -------------------------CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       422 -------------------------~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                                               ..+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                     012389999999999999876667999998763

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.37  E-value=8e-09  Score=107.41  Aligned_cols=110  Identities=24%  Similarity=0.298  Sum_probs=87.0

Q ss_pred             cEEEEeCCCCCcccc-cCccccCCCCcceEEeecCCCCC----CCCCccCCCCCccEEEecCCCCCCC----CCcccc-C
Q 006968           75 YVSALGLPSQSLSGT-LSPWIGNLTKLQSVLLQNNAILG----PIPASLGKLEKLQTLDLSNNKFTGE----IPDSLG-D  144 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~  144 (623)
                      +|+.||++.|++++. +...+..+++|+.|+|++|+|+.    .++..+..+++|++|||++|.|+..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            689999999999873 24446678999999999999882    3455678899999999999999631    222232 2


Q ss_pred             CCCccchhccccccCCC----CCcccCCCCcccEEECCCCcCcC
Q 006968          145 LGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       145 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      ..+|++|+|++|++++.    ++..+..+++|+.|+|++|.++.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            35799999999999753    45678889999999999999874

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.35  E-value=1.6e-06  Score=86.28  Aligned_cols=96  Identities=28%  Similarity=0.408  Sum_probs=72.7

Q ss_pred             CcEEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCCCCccccCCCCccchhc
Q 006968           74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL  153 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  153 (623)
                      .+++.|+|++|+|+ .+|..   +.+|+.|++++|+++ .++. +  .+.|++|+|++|.++ .+|. ++.+++|+.|++
T Consensus        58 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l  127 (353)
T d1jl5a_          58 PHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV  127 (353)
T ss_dssp             TTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeecc
Confidence            37999999999999 77865   457899999999998 4553 2  246999999999999 7775 688999999999


Q ss_pred             cccccCCCCCcccCCCCcccEEECCCCcCc
Q 006968          154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS  183 (623)
Q Consensus       154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  183 (623)
                      ++|.+.. .|..   ...+..+.+.++...
T Consensus       128 ~~~~~~~-~~~~---~~~l~~l~~~~~~~~  153 (353)
T d1jl5a_         128 DNNSLKK-LPDL---PPSLEFIAAGNNQLE  153 (353)
T ss_dssp             CSSCCSC-CCCC---CTTCCEEECCSSCCS
T ss_pred             ccccccc-cccc---cccccchhhcccccc
Confidence            9999884 3332   234445555544443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.30  E-value=1.8e-08  Score=89.36  Aligned_cols=87  Identities=25%  Similarity=0.262  Sum_probs=52.9

Q ss_pred             ccCccccCCCCcceEEeecCCCCCC--CCCccCCCCCccEEEecCCCCCCCCCc-cccCCCCccchhccccccCCCCCc-
Q 006968           89 TLSPWIGNLTKLQSVLLQNNAILGP--IPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNYLRLNNNSLTGSCPE-  164 (623)
Q Consensus        89 ~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~-  164 (623)
                      .++..+.++++|++|+|++|+|+..  ++..+..+++|+.|||++|+|+ .+++ ......+|+.|+|++|.+++.... 
T Consensus        56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~  134 (162)
T d1koha1          56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQ  134 (162)
T ss_dssp             HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSH
T ss_pred             hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccc
Confidence            3343445667777777777777743  2344556777777777777777 4443 233345677777777777654332 


Q ss_pred             ------ccCCCCcccEEE
Q 006968          165 ------SLSKIESLTLVD  176 (623)
Q Consensus       165 ------~~~~l~~L~~L~  176 (623)
                            .+..+++|+.||
T Consensus       135 ~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1         135 STYISAIRERFPKLLRLD  152 (162)
T ss_dssp             HHHHHHHHTTSTTCCEET
T ss_pred             hhHHHHHHHHCCCCCEEC
Confidence                  245567777664

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.28  E-value=8.9e-09  Score=91.43  Aligned_cols=107  Identities=21%  Similarity=0.153  Sum_probs=72.6

Q ss_pred             EEEEeCCCCCcccccCccccCCCCcceEEeecCCCCCCCCCccCCCCCccEEEecCCCCCCC--CCccccCCCCccchhc
Q 006968           76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE--IPDSLGDLGNLNYLRL  153 (623)
Q Consensus        76 v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l  153 (623)
                      ...|+++++...    +.+..+..+..+++.+|... .++..+.++++|++|+|++|+|+..  ++..+..+++|+.|+|
T Consensus        24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L   98 (162)
T d1koha1          24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL   98 (162)
T ss_dssp             SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred             hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence            445666655432    22444445555555555444 4444456789999999999999942  2355778999999999


Q ss_pred             cccccCCCCCc-ccCCCCcccEEECCCCcCcCcCCC
Q 006968          154 NNNSLTGSCPE-SLSKIESLTLVDLSYNNLSGSLPK  188 (623)
Q Consensus       154 ~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~  188 (623)
                      ++|.|+. +++ ......+|+.|++++|+++.....
T Consensus        99 s~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~  133 (162)
T d1koha1          99 SGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRD  133 (162)
T ss_dssp             TTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred             ccCcccc-chhhhhhhccccceeecCCCCcCcCccc
Confidence            9999994 443 333445799999999999865543

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.13  E-value=9.3e-08  Score=95.80  Aligned_cols=129  Identities=22%  Similarity=0.266  Sum_probs=87.7

Q ss_pred             CcEEEEeCCCCCccc----ccCccccCCCCcceEEeecCCCCCC-----CCCccCCCCCccEEEecCCCCCCC----CCc
Q 006968           74 GYVSALGLPSQSLSG----TLSPWIGNLTKLQSVLLQNNAILGP-----IPASLGKLEKLQTLDLSNNKFTGE----IPD  140 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~  140 (623)
                      ..++.|++++|.++.    .+...+...+.|+.|+|++|+|+..     +...+..+++|+.|+|++|.|+..    +..
T Consensus       158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~  237 (344)
T d2ca6a1         158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  237 (344)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence            367888888888763    2344566678889999998888632     344567788889999999888632    445


Q ss_pred             cccCCCCccchhccccccCCC----CCcccCC--CCcccEEECCCCcCcCc----CCCC------ccccccccCCCCC
Q 006968          141 SLGDLGNLNYLRLNNNSLTGS----CPESLSK--IESLTLVDLSYNNLSGS----LPKI------SARTFKVTGNPLI  202 (623)
Q Consensus       141 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~--l~~L~~L~l~~N~l~~~----~p~~------~~~~~~~~~n~~~  202 (623)
                      .+..+++|++|+|++|.|++.    +-..+..  ...|+.|++++|+|+..    +...      .-+.++++||.+.
T Consensus       238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            667788889999999988753    2222322  35688899999988631    1110      1245678888763

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.04  E-value=8.4e-06  Score=77.16  Aligned_cols=130  Identities=16%  Similarity=0.097  Sum_probs=84.6

Q ss_pred             eeccCC-eEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCc--eeeeeeeeecCCceEEEEecccCCCh
Q 006968          309 LGRGGF-GIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN--LLRLCGFCSTENERLLVYPYMPNGSV  385 (623)
Q Consensus       309 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL  385 (623)
                      +..|.. +.||+...+++..+.+|......    ...+..|...++.+....  +.+++++...++..++||+|++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            444553 58999988888889999865432    234677888887664333  45677777788889999999988664


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 006968          386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLH----------------------------------------------  419 (623)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH----------------------------------------------  419 (623)
                      .+..         ...   ...+.++++.|+-||                                              
T Consensus        94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            3211         000   111122222333333                                              


Q ss_pred             -----hCC----CCCeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          420 -----EQC----DPKIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       420 -----~~~----~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                           ...    .+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                 211    23489999999999999876677999998753

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.00  E-value=6.7e-07  Score=86.82  Aligned_cols=110  Identities=20%  Similarity=0.246  Sum_probs=69.9

Q ss_pred             cEEEEeCCCCCcccccCccccCCCCcceEEeecC-CCCCC-CCCccCCCCCccEEEecCC-CCCC---------------
Q 006968           75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNN-AILGP-IPASLGKLEKLQTLDLSNN-KFTG---------------  136 (623)
Q Consensus        75 ~v~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~---------------  136 (623)
                      +++.|+|+++.+++..+..++++++|++|+|+++ .++.. +..-+.++++|++|+|+++ .++.               
T Consensus        72 ~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~  151 (284)
T d2astb2          72 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT  151 (284)
T ss_dssp             CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCC
T ss_pred             CcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccc
Confidence            5777777777776666666667777777777763 44421 1111234566666666653 2321               


Q ss_pred             --------------CCCccccCCCCccchhcccc-ccCCCCCcccCCCCcccEEECCCC-cCcC
Q 006968          137 --------------EIPDSLGDLGNLNYLRLNNN-SLTGSCPESLSKIESLTLVDLSYN-NLSG  184 (623)
Q Consensus       137 --------------~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N-~l~~  184 (623)
                                    .+...+.++++|++|+|++| .+++.....+.++++|++|+|+++ .++.
T Consensus       152 ~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~  215 (284)
T d2astb2         152 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP  215 (284)
T ss_dssp             EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred             hhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCCh
Confidence                          01112245788999999885 477777778888999999999984 5664

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.95  E-value=4e-07  Score=91.05  Aligned_cols=128  Identities=20%  Similarity=0.227  Sum_probs=90.4

Q ss_pred             CcEEEEeCCCCCcc--c--cc---------CccccCCCCcceEEeecCCCCCC----CCCccCCCCCccEEEecCCCCCC
Q 006968           74 GYVSALGLPSQSLS--G--TL---------SPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTG  136 (623)
Q Consensus        74 ~~v~~L~L~~n~l~--~--~~---------~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~  136 (623)
                      ..++.|+|++|.++  +  .+         .......+.|+.|++++|+++..    +...+..++.|+.|+|++|+++.
T Consensus       121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  200 (344)
T d2ca6a1         121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP  200 (344)
T ss_dssp             TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred             ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence            37899999998863  1  11         11224567899999999988732    23345667889999999999873


Q ss_pred             C-----CCccccCCCCccchhccccccCCC----CCcccCCCCcccEEECCCCcCcCc-----------CCCCccccccc
Q 006968          137 E-----IPDSLGDLGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSGS-----------LPKISARTFKV  196 (623)
Q Consensus       137 ~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~-----------~p~~~~~~~~~  196 (623)
                      .     +...+..+++|+.|+|++|.++..    +...+..+++|+.|+|++|.|++.           .+....+.+++
T Consensus       201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~l  280 (344)
T d2ca6a1         201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL  280 (344)
T ss_dssp             HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred             cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEEC
Confidence            2     344577788999999999998632    445677889999999999998742           11112256777


Q ss_pred             cCCCC
Q 006968          197 TGNPL  201 (623)
Q Consensus       197 ~~n~~  201 (623)
                      ++|.+
T Consensus       281 s~N~i  285 (344)
T d2ca6a1         281 QYNEI  285 (344)
T ss_dssp             CSSCC
T ss_pred             CCCcC
Confidence            77764

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.82  E-value=5.4e-07  Score=93.14  Aligned_cols=111  Identities=23%  Similarity=0.244  Sum_probs=76.6

Q ss_pred             CcEEEEeCCCCCcccccCcc----c-cCCCCcceEEeecCCCCCCCC----CccCCCCCccEEEecCCCCCCC----CCc
Q 006968           74 GYVSALGLPSQSLSGTLSPW----I-GNLTKLQSVLLQNNAILGPIP----ASLGKLEKLQTLDLSNNKFTGE----IPD  140 (623)
Q Consensus        74 ~~v~~L~L~~n~l~~~~~~~----~-~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~----~p~  140 (623)
                      ..+..+++++|.+++.....    + ...+.|+.+++++|.++..-.    ..+....+|++|||++|+|++.    ++.
T Consensus       283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~  362 (460)
T d1z7xw1         283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ  362 (460)
T ss_dssp             TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence            46888889988887432221    1 234578889999888874422    2334556889999999988742    334


Q ss_pred             ccc-CCCCccchhccccccCC----CCCcccCCCCcccEEECCCCcCcC
Q 006968          141 SLG-DLGNLNYLRLNNNSLTG----SCPESLSKIESLTLVDLSYNNLSG  184 (623)
Q Consensus       141 ~~~-~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~  184 (623)
                      .+. ..+.|++|+|++|+|+.    .++..+..+++|++|+|++|+|+.
T Consensus       363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence            443 35678899999998874    244556677889999999998874

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.63  E-value=3.1e-06  Score=74.87  Aligned_cols=107  Identities=18%  Similarity=0.165  Sum_probs=66.7

Q ss_pred             cEEEEeCCCC-Cccc----ccCccccCCCCcceEEeecCCCCCC----CCCccCCCCCccEEEecCCCCCCC----CCcc
Q 006968           75 YVSALGLPSQ-SLSG----TLSPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTGE----IPDS  141 (623)
Q Consensus        75 ~v~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~  141 (623)
                      .++.|+|+++ .++.    .+-..+...+.|+.|+|++|.+...    +...+...+.|+.|+|++|.|+..    +-..
T Consensus        16 ~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~a   95 (167)
T d1pgva_          16 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS   95 (167)
T ss_dssp             SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred             CCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHH
Confidence            5788888763 4543    2334566667788888888877622    223344567788888888887732    2234


Q ss_pred             ccCCCCccchhccccccCCC-------CCcccCCCCcccEEECCCCc
Q 006968          142 LGDLGNLNYLRLNNNSLTGS-------CPESLSKIESLTLVDLSYNN  181 (623)
Q Consensus       142 ~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~  181 (623)
                      +...+.|++|+|++|.+...       +...+...++|+.|+++.+.
T Consensus        96 L~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          96 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            55566778888877765421       23344456777777776654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.58  E-value=0.00011  Score=74.08  Aligned_cols=76  Identities=12%  Similarity=0.067  Sum_probs=47.3

Q ss_pred             CceeccCCeEEEEEEeCC-CcEEEEEEecccc------cccchHHHHHHHHHHhhcC-C-C-ceeeeeeeeecCCceEEE
Q 006968          307 NILGRGGFGIVYKGCFSD-GALVAVKRLKDYN------IAGGEVQFQTEVETISLAV-H-R-NLLRLCGFCSTENERLLV  376 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~e~~~l~~l~-H-~-niv~l~~~~~~~~~~~lv  376 (623)
                      +.||.|....||+....+ ++.|+||.-....      ......+...|.+.|+.+. + | .+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998754 6789999754321      1112223456787776552 2 2 34455544  45567899


Q ss_pred             EecccCCC
Q 006968          377 YPYMPNGS  384 (623)
Q Consensus       377 ~e~~~~gs  384 (623)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.58  E-value=1.1e-05  Score=78.01  Aligned_cols=107  Identities=14%  Similarity=0.160  Sum_probs=81.6

Q ss_pred             CcEEEEeCCCC-Cccc-ccCccccC-CCCcceEEeecC--CCCCC-CCCccCCCCCccEEEecCC-CCCCCCCccccCCC
Q 006968           74 GYVSALGLPSQ-SLSG-TLSPWIGN-LTKLQSVLLQNN--AILGP-IPASLGKLEKLQTLDLSNN-KFTGEIPDSLGDLG  146 (623)
Q Consensus        74 ~~v~~L~L~~n-~l~~-~~~~~~~~-l~~L~~L~L~~N--~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~  146 (623)
                      .+++.|+|+++ .++. .+...+.. .++|+.|+|+++  .++.. +...+.++++|++|+|++| .+++.....+.+++
T Consensus       121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~  200 (284)
T d2astb2         121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN  200 (284)
T ss_dssp             TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred             HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence            37999999985 4543 22233333 478999999864  34422 3333456899999999986 58888888999999


Q ss_pred             Cccchhccc-cccCCCCCcccCCCCcccEEECCCC
Q 006968          147 NLNYLRLNN-NSLTGSCPESLSKIESLTLVDLSYN  180 (623)
Q Consensus       147 ~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N  180 (623)
                      +|++|+|++ +.+++.....++++++|+.|+++++
T Consensus       201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            999999999 5687766677889999999999987

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.38  E-value=1.3e-05  Score=70.75  Aligned_cols=89  Identities=16%  Similarity=0.156  Sum_probs=68.5

Q ss_pred             cCCCCcceEEeecC-CCCCC----CCCccCCCCCccEEEecCCCCCC----CCCccccCCCCccchhccccccCCC----
Q 006968           95 GNLTKLQSVLLQNN-AILGP----IPASLGKLEKLQTLDLSNNKFTG----EIPDSLGDLGNLNYLRLNNNSLTGS----  161 (623)
Q Consensus        95 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----  161 (623)
                      .+.++|++|+|+++ .++..    +-..+...+.|++|+|++|.+..    .+...+...+.|++|+|++|.|+..    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            45689999999974 56532    33456778899999999999973    2334556678999999999999852    


Q ss_pred             CCcccCCCCcccEEECCCCcCc
Q 006968          162 CPESLSKIESLTLVDLSYNNLS  183 (623)
Q Consensus       162 ~p~~~~~l~~L~~L~l~~N~l~  183 (623)
                      +-..+...++|+.|+|++|.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSC
T ss_pred             HHHHHHhCCcCCEEECCCCcCC
Confidence            3446778899999999999766

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.99  E-value=2.5e-05  Score=68.64  Aligned_cols=108  Identities=13%  Similarity=0.165  Sum_probs=77.1

Q ss_pred             cEEEEeCCC-CCccc----ccCccccCCCCcceEEeecCCCCCC----CCCccCCCCCccEEEecCCCCCCC----CCcc
Q 006968           75 YVSALGLPS-QSLSG----TLSPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTGE----IPDS  141 (623)
Q Consensus        75 ~v~~L~L~~-n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~  141 (623)
                      .++.|+|++ +.++.    .+-..+...++|++|+|++|.++..    +-..+...++|+.|++++|.++..    +-..
T Consensus        18 ~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~   97 (166)
T d1io0a_          18 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEA   97 (166)
T ss_dssp             TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHG
T ss_pred             CCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHH
Confidence            688899987 55653    2445566788999999999988743    233456678899999999998733    2355


Q ss_pred             ccCCCCccc--hhccccccCC----CCCcccCCCCcccEEECCCCcC
Q 006968          142 LGDLGNLNY--LRLNNNSLTG----SCPESLSKIESLTLVDLSYNNL  182 (623)
Q Consensus       142 ~~~l~~L~~--L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l  182 (623)
                      +...++|+.  |++++|.+..    .+...+...++|+.|+++.|..
T Consensus        98 l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          98 LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            667788876  4556777753    2445566788999999987754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.88  E-value=0.0019  Score=62.91  Aligned_cols=137  Identities=16%  Similarity=0.118  Sum_probs=78.0

Q ss_pred             CeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCce--eeee-----eeeecCCceEEEEecccCCChh
Q 006968          314 FGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL--LRLC-----GFCSTENERLLVYPYMPNGSVA  386 (623)
Q Consensus       314 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni--v~l~-----~~~~~~~~~~lv~e~~~~gsL~  386 (623)
                      --.||++..++|..|++|+.+....  ...++..|...+..+....+  +..+     ......+..+.++++++|..+.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            3589999999999999999865422  34567788888777643222  1111     1223355678899998764321


Q ss_pred             h--------------hhhhcc-----CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----CCCC
Q 006968          387 S--------------RLRDHI-----HGRPALDWAR-------------------RKRIALGTARGLLYLHE----QCDP  424 (623)
Q Consensus       387 ~--------------~l~~~~-----~~~~~l~~~~-------------------~~~i~~~ia~~L~~LH~----~~~~  424 (623)
                      .              .++...     ......++..                   +..+...+...++.+..    ....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            0              011110     0111222211                   11122222233333332    2244


Q ss_pred             CeEecCCCCCCeEECCCCcEEEeecccccc
Q 006968          425 KIIHRDVKAANILLDEDFEAVVGDFGLAKL  454 (623)
Q Consensus       425 ~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  454 (623)
                      ++||+|+.+.|||++++  ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            78999999999999754  46899998863

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.25  E-value=0.01  Score=59.15  Aligned_cols=72  Identities=18%  Similarity=0.230  Sum_probs=47.9

Q ss_pred             CceeccCCeEEEEEEeCC--------CcEEEEEEecccccccchHHHHHHHHHHhhcCCCcee-eeeeeeecCCceEEEE
Q 006968          307 NILGRGGFGIVYKGCFSD--------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL-RLCGFCSTENERLLVY  377 (623)
Q Consensus       307 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~~~~~~~~~~~lv~  377 (623)
                      +.|+.|-.-.+|+....+        ...|.+++.-.   ........+|..+++.+.-.+++ ++++++..    .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            467778888999998654        34566666542   12234567888888877533444 67777642    6899


Q ss_pred             ecccCCCh
Q 006968          378 PYMPNGSV  385 (623)
Q Consensus       378 e~~~~gsL  385 (623)
                      ||+++.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.05  E-value=0.026  Score=53.95  Aligned_cols=159  Identities=12%  Similarity=0.037  Sum_probs=83.5

Q ss_pred             cCHHHHHHHhcCCCcCCcee-----ccCCeEEEEEEeCCCcEEEEEEecccccccchHHHHHHHHHHhhcCCCce-----
Q 006968          291 YTFKELRAATSNFSAKNILG-----RGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-----  360 (623)
Q Consensus       291 ~~~~~l~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~H~ni-----  360 (623)
                      .+.+++.....+|.+.+...     .|---+.|+...++|+ +++|++....   ...+...|++++..+.+.++     
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~---~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC---CHHHHHHHHHHHHhhhhcccccccc
Confidence            45678888888888765543     4555678999886665 8899885432   22345556777766643322     


Q ss_pred             eeee-e--eeecCCceEEEEecccCCChhhh--------------hhhccC---CC--CCCC------------------
Q 006968          361 LRLC-G--FCSTENERLLVYPYMPNGSVASR--------------LRDHIH---GR--PALD------------------  400 (623)
Q Consensus       361 v~l~-~--~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~---~~--~~l~------------------  400 (623)
                      +... |  +....+....++.+..+......              ++....   ..  ....                  
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            1110 0  11223445666666655422110              010000   00  0000                  


Q ss_pred             HHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCcEEEeeccccc
Q 006968          401 WARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK  453 (623)
Q Consensus       401 ~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  453 (623)
                      .......+......+...+. ....++||+|+.+.||+++++...-|.||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            00111122222222222222 224489999999999999988777899999875

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=95.83  E-value=0.00023  Score=62.22  Aligned_cols=94  Identities=21%  Similarity=0.232  Sum_probs=66.6

Q ss_pred             cCccccCCCCcceEEeec-CCCCCC----CCCccCCCCCccEEEecCCCCCCC----CCccccCCCCccchhccccccCC
Q 006968           90 LSPWIGNLTKLQSVLLQN-NAILGP----IPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDLGNLNYLRLNNNSLTG  160 (623)
Q Consensus        90 ~~~~~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~  160 (623)
                      +.....+.++|++|+|++ |.++..    +-..+...+.|+.|+|++|.++..    +-..+...++|+.|++++|.++.
T Consensus         9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~   88 (166)
T d1io0a_           9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG   88 (166)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence            334445678999999997 557522    334456788999999999998743    22345667899999999999864


Q ss_pred             C----CCcccCCCCcccEEEC--CCCcCc
Q 006968          161 S----CPESLSKIESLTLVDL--SYNNLS  183 (623)
Q Consensus       161 ~----~p~~~~~l~~L~~L~l--~~N~l~  183 (623)
                      .    +-..+...++|+.++|  ++|.+.
T Consensus        89 ~g~~~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          89 SGILALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             HHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             hhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence            2    3356777888987655  456664